•-r*f
■■ ~li ■ ,	-t^i
	:*:
	
i>Hi-	
 
INE  NATIONAL LIBRARY OF MEDICINE  NATIONAL LIBRARY OF MEDICINE NATIONAL LIBRARY OF MEDICINE  NATIONAL LIBRAR
P%  r
1VN 3NI3I03W JO AlViail IVNOIIVN JNI3I03W JO ABVB9I1 1VNOUVN 1 N I 3 I 0 3 W JO A a V II S 11 IVNOIIVN 3NI3IQ3W JO A»V
;;'\
>€m^W!
I 1 V N INIJIUin JU AflVlDI I ITNUIMn 1NIJIUJH JU AST

1VN  1NDI03W JO UV1II1 IVNOIIVN  1NI3I03W JO ABVlBU IVNOIIVN INISIQiW JO ABVIBII IVNOIIVN  1 N I 3 I Q ] V¥ JO ABV

IINE NATIONAL LIBRARY OF MEDICINE NATIONAL LIBRARY OF MEDICINE NATIONAL LIBRARY OF MEDICINE NATIONAL LIBRAR
1VN  3NI3IQJW JO ABVaail IVNOIIVN  1NI3IQIW JO AlViail IVNOIIVN INI3IQ1W JO ABVBail IVNOIIVN 1N I 3 10 1 W JO ABV

INE  NATIONAL LIBRARY OF MEDICINE  NATIONAL LIBRARY OF MEDICINE NATIONAL LIBRARY OF MEDICINE  NATIONAL LIBRAR
S^V I
LIBRARY OF

PROPERTY OF THE
NATIONAL
LIBRARY OF
 MEDICINE
I1VN INI3I01W JO AIVBBM IVNOIIVN 1 N I 3 I C< 1 W JO ABV


s  ?
 
^N/
                                                 n/ «  \-2r  I  W-/  * Vff5>  ?  T"
   >            t            >            •     ^    S     &     i    -^     i     ^   i

LIBRARY OF MEDICINE  NATIONAL LIBRARY OF MEDICINE  NATIONAL LIBRARY OF MEDICINE   NATIONAL LIBRARY OF MEDICINE  NATIONAL LI

\  ? I.
jo A.vaeu ivnoiivn   inidicmw jo abvibii ivnoiivn  inoioiw jo aiviiii ivnoiivn   iNi3iaiw jo uviiii ivnoiivn  inijioiw jc
















LIBRARY OF MEDICINE   NATIONAL LIBRARY OF MEDICINE  NATIONAL LIBRARY OF MEDICINE   NATIONAL LIBRARY OF MEDICINE  NATIONAL LI
 
 
Psychopharmaca
    A BIBLIOGRAPHY OF PSYCHOPHARMACOLOGY
          1952-1957
U. S. DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
      PUBLIC HEALTH SERVICE 
 
Psychopharmaca
A BIBLIOGRAPHY OF PSYCHOPHARMACOLOGY
1 952-1 957
    Compiled for the Psychopharmacology Service Center
National Institute of Mental Health, National Institutes of Health
By Anne E. Caldwell, M. D.
U S. DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
                 %
         PUBLIC HEALTH SERVICE

     US. NATIONAL LIBRARY OF MEDICINE 
t
Z.WA

 no, /<?
 Id re?
t.a
PUBLIC HEALTH SERVICE  PUBLICATION NO. 581

   Public  Health Bibliography Series No. 19
       NATIONAL LIBRARY OF MEDiCl.iw
            WASHINGTON, D.  C.
       UNITED STATES


GOVERNMENT PRINTING OFFICE


     WASHINGTON  : 1958
For sale by the Superintendent of Documents, U.S. Government Printing Office
                  Washington 25, D.C. - Price $1.50 
TABLE OF CONTENTS
 Page
   1  INTRODUCTION

   5  DRUG INDEX

  17  SUBJECT LIST OF DRUGS
  19  Adrenochrome
  19  Adrenolutin
  20  Ataraxics
  25  Azacyclonol
' 29  BGE
  29  Benactyzine
  31  Bufotenine
  31  CB-1522
  31  Cannabis
  32  Chlorpromazine
  84  Covatin
  85  Ethylcrotonylurea
  86  Harmine
  86  Hibicon
  86  Hydroxyzine
  87  Ibogaine
  87  Iproniazid
  89  Lysergic acid amide
  89  Lysergic acid diethylamide
  99  Lysergic acid diethylamide, acetylated
  99  Lysergic acid diethylamide, brominated
 100  Lysergic acid ethylamide
 101  MER-22
 101  Medmain
 101  Mepazine
 103  Mephenesin
 105  Mephenesin carbamate
 105  Meprobamate
 110  Mescaline
 115  Methopromazine
 115  Methylphenidylacetate
 117  Methylpromazine
 118  N-Oblivon
 118  NP-207
 118  NP-207, brominated
Page
118  Ololiuqui
118  Opilon
119  PM-1090
119  Perphenazine
119  Phenaglycodol
119  Phenothiazines
120  Pipradrol
123  Prenderol
123  Proclorperazine
123  Promazine
125  Promethazine
127  Psychopharmaca
129  Psychotomimetics
131  Pyrathiazine
131  Quiactin
131  RP-4909
132  RP-6549
132  RP-7044
132  Rauwolfia alkaloids
132  Rauwolfia canescens alkaloids
133  Rauwolfia serpentina alkaloids
138  Rescinnamine
138  Reserpine
161  SKF-5
161  Serotonin
164  Stimulants
165  TMA
165  Thiazinamium
165  Triflupromazine
165  WIN-2299
165  WY-1107
165  Yohimbine

167  ANCILLARY SUBJECT LIST OF
       SPECIAL CONDITIONS
169  Aged
171  Alcoholism
176  Children
180  Pain

183  AUTHOR LIST
iii 
 
INTRODUCTION
 This bibliography was compiled by the National
 Library of Medicine of the Public Health Service
 at the request of the Psychopharmacology Service
 Center of the National Institute of Mental Health,
 Bethesda, Maryland.   It is another in a series of
 long bibliographies published  by the National
 Library of Medicine at intervals since 1950.

              Scope and  Coverage

 Psychopharmacology  is  defined  as psychiatric
 neuropharmacology, the study  of neuropharma-
 cologic  agents  from  a  psychiatric  viewpoint.
 Psychopharmaca are drugs that primarily affect
 the  mental  state;  the definition is,  of  course,
 necessarily arbitrary.
 This bibliography contains references to approxi-
 mately 2,500 articles published between January
 1952 1 and December 1956 and an  incomplete list-
 ing for 1957.  It covers all articles concerned with
 the  effect of psychopharmacologic agents on the
 psychologic, behavioral, and encephalographic re-
 actions of normal subjects, patients, and  labora-
 tory  animals.  Articles on the chemistry  and on
 the physiologic  effects of these agents are not in-
 cluded, unless they report encephalographic stud-
 ies or severe untoward effects, such as convulsions
 or death.

 Source Materials Used To Prepare the Bibliography
 Current List of Medical  Literature, 1952-May
     1957.
 Chemical Abstracts, 1952-January 1957.
 Excerpta Medica, Section 8 [Neurology and Psy-
    chiatry]  1952-1956.
 Psychological Abstracts, 1952-1956.
 Public card catalog of the National Library of
    Medicine.
 Published bibliographies  and the cited  articles
    themselves, which  frequently contain reviews
    of  the  literature  or  extensive  lists  of
    references.
 1 Except for two articles: Laborit (July 1951) ;  Laborit and
Huguenard  (October 1951).
Individual issues  (beyond those indexed in the
    May 1957 issue of the Current List of Medi-
    cal Literature) of:
  A. M. A. xVrchives of Neurology and Psychitry,
    March-December 1957.
  American Journal  of  Psychiatry, March-De-
    cember 1957.
  Annals of the New  York Academy of Sciences,
    March 1957.
  British Medical Journal, March-December 1957.
  Diseases  of the  Nervous System,  February-
    May 1957.
  Encephale, September 1956-December 1957.
  International Record of  Medicine, March-De-
    cember 1957.
  Journal of Clinical and Experimental Psycho-
    pathology and Quarterly Review of Psychi-
    atry and Neurology, September 1956-March
    1957.
  Journal of Mental Science, January-July 1957.
  Journal of Nervous and Mental Disease, June
    1956-December 1957.
  Psychiatric  Quarterly,  December 1956-April
    1957.
All material was examined, except for eight ar-
ticles which are marked "Not seen".   Abbrevia-
tions for journals are those of the Current List of
Medical Literature.

                 Organization
The bibliography consists of:

1. Drug Index.  Its purpose is to aid the  user in
locating entries in the bibliography and to facili-
tate use of the international literature on psycho-
pharmacology.  It lists the following types  of
terms with all necessary cross references:
(a) Chemical names of drugs, experimental code
      names, trade names, and generic names.
(b) Names of drug groups.
(c) Trade names of drug combinations with their
      composition. 
PSYCHOPHARMACA
 (d)  Terms  for special  therapeutic and research
      techniques used in psychopharmacology.
 In addition the Drug Index contains two types of
 lists:
 (1)  For individual drugs.  Under the generic
      name of a drug—or the experimental code
      name if that name is used  in the Subject
      List—are listed all chemical, code, and trade
      synonyms and trade names of drug combi-
      nations found in the literature.
 (2)  For drug groups.  Under the name of a drug
      group are listed its synonyms and then, in
      italics, the individual drugs of that group.
 2. Subject List of Drugs.  This section of the bibli-
 ography is arranged alphabetically by generic
 drug names.   If the generic name is not available,
 the experimental code name is used.  Also included
 in  alphabetical order  are  the names of  drug
 groups.  Under each drug name the references are
 grouped in various subdivisions.
  The meaning of most of the subdivisions is ob-
 vious ; only the following may require clarification:
  Additional data is the subdivision used to sepa-
 rate articles on a quantitative basis.  For example,
 therapeutic studies of  pipradrol  will be  found
 under PIPRADROL—Therapeutic studies, con-
 trolled or PIPRADROL—Therapeutic use but
 articles on pharmacotherapy in psychiatry that
 contain a little information on pipradrol will be
 found under PIPRADROL—Therapeutic use—
 Additional data.  This subdivision is used wher-
 ever quantitative  separation is expedient.
  Psychotherapeutic use  is the  subdivision for
 articles on psychotherapy  following administra-
 tion of a psychotomimetic drug.  It is also used in
 a wider sense for ataractic therapy within  a psy-
 chotherapeutic setting if the importance of con-
 comitant psychotherapy is particularly stressed.
 Comments, however, on the psychotherapy-facili-
 tating effect of ataraxics or on  the expediency of
 adjuvant psychotherapy are found in nearly all
 articles on ataractic therapy.
  Therapeutic studies, controlled and Thera-
 peutic use  are  the  subdivisions  for articles  on
 therapy of mental diseases generally found in in-
 stitutionalized patients.  They are further  subdi-
 vided as follows: Neuroses is the subdivision for
 articles  on outpatients and borderline psychotics.
Psychoses is used in the generally accepted mean-
ing and also occasionally for chronic severe neu-
roses. Psychosomatic diseases is the subdivision
for somatic diseases with an overlay of psychologic
or neurotic symptoms.
  Untoward effects is the subdivision used for ar-
ticles concerned solely or chiefly with injurious ef-
fects. This is further subdivided into Addiction
and Poisoning.  If an article is mainly concerned
with another topic (e. g., therapeutic use of the
drug) but  does contain a certain amount of in-
formation on untoward effects, it is marked with
a single asterisk.   A double asterisk after the ci-
tation means that  the article reports at least one
death.
  Various  special techniques is the subdivision
for articles on use of chlorpromazine in the various
lytic mixtures.  This is a departure from the usual,
more specific classification system in that articles
on  prolonged  sleep, hibernotherapy,  etc.,  are
grouped together.
  Various  [3 or  more]  is a subdivision  used
under names of drug groups for articles on  com-
binations or comparisons of three or more drugs of
the same group.    For similar articles on only two
drugs a subdivision that begins with the word
with is  used.
  With  at the beginning of a subdivision is used
for the following combinations, interactions or
comparisons and always  in  the following order:
(a) The drug used in combination with, or  com-
      pared with, another psychopharmacologic
      agent.
(b) The drug used in combination with, or  com-
      pared with,  "other drugs". "Other drugs"
      in this bibliography means "other than the
      new  psychopharmacologic agents".  These
      are mostly older sedatives or stimulants for
      which there are no main headings in the
      bibliography.
(c) The drug used in combination with, or com-
      pared with, physical methods, such as in-
      termittent photic stimulation, psychosurg-
      ery,  and the various shock therapies.

3. Ancillary Subject List of Special Conditions.  The
special conditions  in this list are AGED, ALCO-
HOLISM, CHILDREN, and PAIN. This section
of the bibliography contains all the articles re-
ferring to any of these conditions.  Although all
2 
INTRODUCTION
articles in this section are also cited under the drug
name in  the  Subject List of Drugs they  are re-
peated here in full bibliographic detail.

4. Author List.  This section of the bibliography
is arranged alphabetically by author's name, with
cross references from co-authors to main  author.
It repeats in full the reference as given in the
Subject List of Drugs, and is included  to enable
the reader to locate references by author.


              Acknowledgments
I am very grateful to those authors whose imagi-
nation opens new vistas, whose thoughts are stimu-
lating, and whose style is refreshing: they made
the task of reading 2500 papers bearable—I hope
they will find their articles adequately  indexed!
  I wish to thank Jonathan O. Cole, M. D., Lor-
raine Bouthilet, Ph. D., and C. Jelleff Carr, Ph. D.,
of the Psychopharmacology Service Center,  for
their many valuable, critical, and constructive sug-
gestions.
The National Library of Medicine welcomes com-
ments on this bibliography.  Letters should  be
addressed to the Director.
                     Anne E. Caldwell, M.  D.
December 1957.
3 
 
DRUG INDEX
 
 
Cross references in parentheses refer to terms in the Drug Index where more information is given.
 A-2601 see Chlorpromazine.
 A-4540-1-1 see Benactyzine.
 AY-5406-1 see Benactyzine.
 AY-55074 see Covatin.
 Acepromazine see CB-1522.
 6-Acetoxy-thymoxy-ethyl-dimethyl-amine see Opilon.
 8-Acetyl-10- [3-dimethylaminopropyl]  phenothiazine
   see CB-1522.
 Acetyl lysergic acid diethylamide
   see Lysergic acid diethylamide, acetylated.
 Acetylpromazine maleate see CB-1522.
 Adalat=Promethazine+Carbromal [1:40]
   see under Promethazine with other drugs.
 Adazine see Triflupromazine.
 Addictive effect
   see [Drug]—Untoward effects—Addiction
   see also headnote p. 19
 Adrenaline, pink see Adrenochrome.

 ADRENOCHROME.
   Adrenaline, pink.

 ADRENOLUTIN.

   3,5,6-Trihydroxy-N-methylindole.

 Alseroxylon see Rauwolfia serpentina  alkaloids.
 Aminazin see Chlorpromazine.
 Ampli (a) ctil see Chlorpromazine.
 Amril=Mephenesin+Reserpine+Acetylcarbr omal
   see Mephenesin with Reserpine and other drugs.

 Analeptics  see Stimulants.

 Anatensin=Mephenesin+Acetylcarbromal
   see under Mephenesin with other drugs.

 Anergan see Phenothiazines.

 Artificial hibernation (see Lytic cocktails)
 Ataractan see Azacyclonol.
Ataractic drugs see Ataraxics

Atarax  see Hydroxyzine.

ATARAXICS.

  Ataractic drugs.
  Neuroleptics.
  Neuroplegics.
  Orthothymics.
  Psycholeptics.
  Relaxants.
  Tranquilizers.
  Azacyclonol.
  Benactyzine.
  CB-1522.
  Chlorpromazine.
  Covatin.
  Ethylcrotonylurea.
  Hydroxyzine.
  Isothiazine  [under  Phenothiazines].
  Lysergic acid ethylamide.
  Mepazine.
   Mephenesin.
   Mephenesin carbamate.
   Meprobamate.
   Methopromazine.
   Methylpromazine.
   N-Oblivon.
   NP-207.
   NP-207, brominated.
   Opilon.
   Perphenazine.
   Phenaglycodol.
   Phenothiazines.
   Prenderol.
   Proclorperazine.
   Promazine.
   Promethazine.
   Pyrathiazine.
   Quiactin.
   RP-2955 [under Phenothiazines].
   RP-4909.
   RP-6U9.
   RP-70U-
   Rauwolfia alkaloids.
   Rauwolfia canescens alkaloids.
   Rauwolfia serpentina alkaloids.
   Rescinnamine.
   Reserpine.
   Serotonin.
   Thiazinamium.
   Triflupromazine.
   Wy-1107.

 Ataraxics see also Psychopharmaca.
 Ataraxics blocking psychotomimetics.
     see Psychotomimetics with Ataraxics—Interaction.
         [Psychotomimetic]   with  [Ataraxic]—Interac-
           tion.
    (see Model psychoses, blocked).
 Ataraxics, combined use.
   see Ataraxics—Various [3 or more]—Combined.
       [Ataraxic A] with [Ataraxic B]—Combined.
      e. g. Chlorpromazine with Reserpine—Combined.
 Ataraxics combined with stimulants.
   see [Ataraxic] with [Stimulant]—Combined.
      e. g. Reserpine with Pipradrol—Combined.
      Ataraxics with Stimulants.
 Ataraxics,  compared
   see Ataraxics—Various [3 or more]—Compared.
      [Ataraxic A] with [Ataraxic B]—Compared.
      e. g. Chlorpromazine with Reserpine—Compared.
 Ataraxoid=Hydroxyzine+Prednisolone.
   see Hydroxyzine with other  drugs.
 Atosil see  Promethazine.

 AZACYCLONOL

   <x,a-Diphenyl-4-piperidinemethanol.
   a- [4-Piperidyl ] benzhydrol  hydrochloride.
   Ataractan.
   Frenquel.
   MER-17.

 B6E
   (8-Hydroxy  "pseudo" tryptophan.
   "Blue-green to Ehrlich's reagent."

BOL-148 see  Lysergic acid diethylamide, brominated.
BYK-M1 see Mephenesin.
7 
Banisterine
PSYCHOPHARMACA
Banisterine see Harmine.

Beatilina see Benactyzine.

BENACTYZINE
  Benzilic  acid diethylaminoethylester hydrochloride.
  2-Diethylaminoethyl diphenylglycolate.
  A-4540-1-1.
  AY-5406-1.
  Beatilina.
  Cevanol.
  Lucidil.
  Nutinal.
  Parasan.
  Savitil.
  Suavitil  [Suavetil].

Benzilic  acid  di-ethyl-amino-ethyl-ester  hydrochloride
  see Benactyzine.
2\r-Benzyl-3-chloropropionamide see Hibicon.

Bogadin T. M. see Ibogaine.
Brom-LSD  see Lysergic acid diethylamide, brominated.

Brominated NP-207 see NP-207, brominated.

2-Brom-tf-lysergic acid diethylamide
  see Lysergic acid diethylamide, brominated.

Brom-piperidino-chlor-phenothiazine
  see NP-207, brominated.

BUFOTENINE
  Hydroxy-dimethylaminoethyl indole.
  IV,2^-Dimethyl-5-hydroxytryptamine.
  ^^-Dimethyl-serotonin.
  Cohoba.

p-Butylmercaptobenzohydryl-/3-dimethylaminoethyl sulfide
  see Covatin.

Butylthiophenylmethyldimethylaminoethyl  sulfide
  see Covatin.

CB-1522
  8-Acetyl-10- [3-dimethylaminopropyl ] phenothiazine.
  Acepromazine.
  Acetylpromazine maleate.
  Notensil.
  Plegicil.

CMP see N-Oblivon.

CP see Pipradrol.

Canescine see Rauwolfia  canescens  alkaloids.

CANNABIS
  Hashish.
  Marihuana.
  Dihydrocannabinol.
  Parahexyl.
    l-Hydroxy-3-^hexyl-6,6,9-trimethyl-7,8,9,10 - tetrahy -
      dro-6-dibenzopyran.
    Pyrahexyl.
    Synhexyl.
  Tetrahydrocannabinol.

Cannabism see under Cannabis—Intoxication

Central stimulants see Stimulants.

Cetiproman=Promethazine+Bromide.
  see under Promethazine with other drugs.

Cevanol see Benactyzine.

Chlor-benzhydryl-hydroxyethyl-diethylene-diamine
  see Hydroxyzine.
Chlorbromasin see Chlorpromazine.

2-Chloro-10- [3-diethylaminopropyl] phenothiazine
  see RP^909.

2-Chloro-10- [3-dimethylaminopropyl]  phenothiazine
  see Chlorpromazine.

2-Chloro-10-[3- [l-(2-hydroxyethyl)-4-piperazinyl] propyl ]-
  phenothiazine  see Perphenazine.

2-Chloro-10- [3-(l-methyl-4-piperazinyl)propyl] phenothia-
  zine see  Proclorperazine.

3-Chloro-10- [2 - (N-methyl-piperidyl-2) - ethyl]   phenothia-
  zine see NP-207.

1- [p-Chloro-a-phenylbenzyl] -4- [2-hydroxyethoxyethyl] pi-
    perazine  see Hydroxyzine.

2- [p-Chlorophenyl] -3-methyl-2,3-butanediol
  see Phenaglycodol.

Chlorpiprozine see Perphenazine.

CHLORPROMAZINE.

  2-Chloro-10-[3-dimethylaminopropyl]  phenothiazine.
  A-2601.
  Aminazin.
  Ampli(a)ctil.
  Chlorbromasin.
  HL-5746.
  Hibernal.
  Largactil.
  M+B-2378.
  Megaphen.
  Propaphenin.
  RP-4560.
  SKF-2601-A.
  Thorazine.

  DRUG COMBINATION.
    Thora-Dex.

Chrystoserpine see Reserpine.

Ciba-14 469 see MER-22.

Cocktails.
  (see Lytic  cocktail, classic).
  (see Lytic  cocktails).

Cohoba see Bufotenine.

Combinations of drugs.
  (see Drug  combinations).
  (see Drug  combinations, trademarks).

Combined use of drugs (see Drug combinations).

Comparisons  between  drugs  (see Drug  comparisons)

Compazine  see Proclorperazine.

COVATIN.

  p-Butylmercaptobenzohydryl-/3-dimethylaminoethyl sul-
    fide.
  Butylthiophenylmethyldimethylaminoethyl  sulfide.
  AY-55074.
  N-68.
  Suvren.

DEP see Prenderol.

DOL see Pipradrol.

Delysid see Lysergic  acid diethylamide.

Deserpidine see  Rauwolfia canescens alkaloids.

Desmethoxymethylreserpate trimethoxybenzoic acid ester
  see Rauwolfia canescens alkaloids. 
DRUG  INDEX
Hibernotherapy
 Desmethoxyreserpine see Rauwolfia canescens alkaloids.
 Diethylaminoethylcyclopentyl [2-thienyl] glycolate hydro-
   chloride see WIN-2299.

 2-Diethylaminoethyl  diphenylglycolate  see Benactyzine.
 Diethylamino-methylpropyl phenothiazine
   see RP-6549.

 10- [3-Diethylaminopropyl] -2-chlorophenothiazine
   see RP^909.

 10-(3-Diethylaminopropyl)phenothiazine see Wy-1107.
 2,2-Diethyl-l,3-propanediol see Prenderol.
 Dihydrocannabinol see Cannabis.

 10-[2-Dimethylaminoethyl] phenothiazine
   see Phenothiazines.

 10- [2-Dimethylamino-l-methylethyl] phenothiazine
   see Promethazine.

 10- (3-Dimethylamino-2-methylpropyl) phenothiazine
   see Methylpromazine.

 10-[3-Dimethylamino-2-methyl-propyl]-3-methoxy - pheno-
   thiazine see RP-7044.

 10- [3-Dimethylaminopropyl] -8-acetyl phenothiazine
   see CB-1522.

 10-[3-Dimethylaminopropyl]-2-chlorophenothiazine
   see Chlorpromazine.

 10-[3-Dimethylaminopropyl]-2-methoxy  phenothiazine
   see Methopromazine.

 10-[2-Dimethylamino propyl]  phenothiazine
   see Promethazine.
 10-[3-Dimethylaminopropyl] phenothiazine see Promazine.

 10- (3-Dimethylaminopropyl) -2-methyl phenothiazine
   see Methylpromazine.
 10-(3-Dimethylaminopropyl) -2- (trifluoromethyl)pheno-
   thiazine see Triflupromazine.

 #,#-Dimethyl-5-hydroxytryptamine see  Bufotenine.

 JV.iV-Dimethyl-serotonin see Bufotenine.

 2-Diphenylmethyl piperidine see MER-22.

 2-Diphenyloxymethyl piperidine see Pipradrol.

 a,a-Diphenyl-4-piperidinemethanol see Azacyclonol.

 l,2-Diphenyl-l-[4-piperidyl]-ethanol see  MER-22.

 Diprozine see Promethazine.

 Doroma  (see Adalat).

 Drug combinations.
   see [Drug] with [Drug]—Combined.
   see [Drug]  with [Drug]—Interaction.
   (see Ataraxics, combined use).
   (see Ataraxics combined with stimulants).
   (see Model  psychoses, blocked).
   (see Psychopharmaca combined with  non-psychophar-
    macologic agents).
   (see Psychotomimetics, blocked).

Drug Combinations, Trademarks.
  Adalat.
  Amril.
  Anatensw.
  Ataraxoid.
  Cetiproman.
  D or oma=Adalat.
  Mephate.
  Nembu-Serpin.
  Nor-Dis.
  Plimasin.
   Rauwidrin e.
   Riker 529-1
   Riker 529-2.
   Sedaltine.
   Serpatilin.
   Serpatonil.
   Thora-Dex.
   Triserpine.

 Drug comparisons.
   see [Drug] with [Drug]—Compared.
   (see Ataraxics, compared).
   (see Psychopharmaca compared with non-psychophar-
     macologic agents).
   (see Psychotomimetics, compared).
   (see Stimulants, compared).
 Drug evaluation see Psychopharmaca—Evaluation.
 Drug groups.
   (see Ataraxics)
   (see Phenothiazines)
   (see Psychopharmaca)
   (see Psychotomimetics)
   (see Stimulants)
 Drug interaction.
   see [Drug] with [Drug]—Interaction.
   (see Model  psychoses, blocked).
   (see Psychotomimetics, blocked).

 Drugs altering behavior (see Psychopharmaca)
 Ectylurea see Ethylcrotonylurea.
 Electroshock.
   see  [Drug]  with Shock therapies
       [Drug]  with Shock therapy [ECT]
 Equanil see Meprobamate.
 Eskaserp see Reserpine.

 2-Ethyl-cis-crotonylurea see Ethylcrotonylurea.

 ETHYLCROTONYLUREA.
   2-Ethyl-cis-crotonylurea.
   Ectylurea.
   MA-110.
   Nostyn.

 3-Ethyl-2-methyl-5-dimethylamino  indole  see  Medmain.
 2-Ethyl-3-propylglycidamide see Quiactin.
 Etizin see Phenothiazines.

 Evaluation  see Psychopharmaca—Evaluation.
 Fargan see  Promethazine.

 Fenethazine see Phenothiazines.
 Flower-her-Mother see Ololiuqui.
 Frenquel see Azacyclonol.

 Gendon see Rauwolfia serpentina alkaloids.
 Gerodyl see Pipradrol.

 HL-5746 see Chlorpromazine.

 Hallucinogens  see Psychotomimetics.

 HARMINE  [Harman].
  Banisterine.
  Telepathine.
  Yageine.

Harmonyl see  Rauwolfia canescens alkaloids.

Hashish see Cannabis.

Hibernal see Chlorpromazine.

Hibernotherapy (see Lytic cocktails) 
Hibicon
PSYCHOPHARMACA
 HIBICON.
   JV-Benzyl-S-chloropropionamide.
 Hydroxy-dimethylaminoethyl indole see Bufotenine.
 1-(2-Hydroxyethyl)-4-[3 - (2 - chloro -10 - phenothiazinyl) -
   propyl]-piperazine dihydrochloride see Perphenazine.
 l-(2-Hydroxyethyl)-4-[3 - (2 - chloro -10 - phenothiazyl)-
   propyl]-piperazine see Perphenazine.
 10 - (3-[l - (2-Hydroxyethyl) - 4-piperazinyl]-propyl) -2-chlo-
   rophenothiazine see Perphenazine.
 l-Hydroxy-3-n-hexyl-6,6,9-trimethyl-7,8,9,10 - tetrahydro-6-
   dibenzopyran see Cannabis.
 2-Hydroxy-3-o-tolyoxypropyl carbamate
   see Mephenesin carbamate.
 /3-Hydroxy "pseudo" tryptophan see BGE.
 5-Hydroxytryptamine see Serotonin.
 HYDROXYZINE.
   Chlor-benzhydryl-hydroxyethyl diethylene-diamine.
   l-(p-Chloro-a-phenylbenzyl)-4-(2 - hydroxyethoxyethyl)
     piperazine.
   Atarax.
   NP-212.
   DRUG COMBINATION.
     Ataraxoid.
 IIH see Iproniazid.
 IBOGAINE  [Ibogine].
   Bogadin T. M.
 Injurious effects.
   see [Drug]—Untoward effects.
   see also headnote p. 19.
 Interaction  (see  Drug interaction).
 Insulin shock.
   see [Drug] with Shock therapies.
      [Drug] with Shock therapy [ICT]
 Intermittent photic stimulation.
   see [Drug] with Intermittent photic stimulation.
 IPRONIAZID.
   IIH
   l-Isonicotinyl-2-isopropyl hydrazine.
   2-Isopropyl-l-isonicotinyl hydrazine.
   Marsilid.
   Ro 2-4572.
 l-Isonicotinyl-2-isopropyl hydrazine see Iproniazid.
 Isophenergan see Promethazine.
 [Isopromethazine] see under Promethazine.
  10- [2-Dimethylamino-l-methylethyl] phenothiazine.
  Atosil.
  Isophenergan.
  Lergigan.
  Lilly-01516.
2-Isopropyl-l-isonicotinyl hydrazine see Iproniazid.
 [Isothiazine] see under Phenothiazines.
  10-(2-Dimethyl  amino ethyl) phenothiazine.
  Anergan.
  Etizin.
  F£n£thazine.
  Lisergan.
  Lysergan.
  RP-3015.
 Koglucoid see Rauwolfia serpentina alkaloids.
 LA-111 see Lysergic acid amide.
 LAE-32 see Lysergic acid ethylamide.
 LSD-25 see Lysergic acid diethylamide.
 Lacumin  see Mepazine.
 Largactil see Chlorpromazine.
 Leptidrol see Pipradrol.
 Lergigan  see Promethazine.
 Levomepromazine see RP-7044.
 Lilly-01516  see Promethazine.
 Lilly-22641  see Rauwolfia canescens alkaloids.
 Liranol see Promazine.
 Lisergan  see Phenothiazines.
 Lucidil see  Benactyzine.
 Lysergan  see Phenothiazines.
 LYSERGIC ACID AMIDE.
  LA 111.
 LYSERGIC ACID DIETHYLAMIDE.
  LSD-25.
  Delysid.
 LYSERGIC ACID DIETHYLAMIDE, ACETYLATED.
  Acetyl lysergic  acid diethylamide.
 LYSERGIC ACID DIETHYLAMIDE,  BROMINATED.
  2-Brom-d-lysergic acid diethylamide.
  BOL-148.
  Brom-LSD.
 LYSERGIC ACID ETHYLAMIDE.
  LAE-32.
Lytic cocktail, classic
  =Chlorpromazine+Promethazine-f Meperidine
    [1:1: 2].
Lytic cocktails.
  see CB-1522— Cocktail.
      Chlorpromazine—Various special techniques.
      Mepazine—Cocktail.
MA-110 see Ethylcrotonylurea.
M+B-2378 see Chlorpromazine.
MC-2303 see Mephenesin carbamate.
MC-4703 see Triflupromazine.
MER-17 see Azacyclonol.
MER-22.
  l,2-Diphenyl-l-[4-piperidyl]-ethanol.
  2-Diphenylmethyl piperidine.
  Ciba-14469.
MRD-108  see Pipradrol.
MRE-108  see Pipradrol.
Marihuana see Cannabis.
Marsilid see Iproniazid.
MEDMAIN.
  2-Methyl-3-ethyl-5-dimethylaminoindole.
Megaphen see Chlorpromazine.
Mepantin  see Meprobamate. 
DRUG INDEX
Nor-Dis
 Mepavlon see Meprobamate.

 MEPAZINE.

   10- [A'-Methyl-S-piperidylmethyl] phenothiazine.
   Lacumin.
   P-391.
   Pacatal.
   Pecazine.
   W-1224.

 Mephate=Mephenesin-f-glutamic acid.
   see under Mephenesin—Therapeutic use.

 MEPHENESIN.

   3-o-Toloxy-l,2-propanediol.
   BYK-M1.
   Myanesin.
   Myocain.
   Tolserol.

   DRUG COMBINATIONS.
     Amril.
     Anatensin.
     Mephate.
     Sedaltine.

 MEPHENESIN CARBAMATE.

   2-Hydroxy-3-o-tolyoxypropyl carbamate.
   MC-2303.
   Tolseram.

 MEPROBAMATE.

   2-Methyl-2-n-propyl-l,3-propanediol dicarbamate.
   Equanil.
   Mepantin.
   Mepavlon.
   Meproban.
   Miltown.
   Oasil.
   Perequil.
   Quanil.
   Restenil.

 Meproban see Meprobamate.

 Meratran see  Pipradrol.

 MESCALINE.
   3,4,5-Trimethoxyphenethylamine.
   Peyote.

 METHOPROMAZINE.
   2-Methoxy-10-[3-dimethylaminopropyl]  phenothiazine.
   Mopazine.
   RP-4632.

 Methotrimeprazine  see RP-7044.
 3-Methoxy-10- [3-dimethylamino-2-methylpropyl] phenothi-
   azine see RP-7044.
 2-Methoxy-10- [3-dimethylaminopropyl] phenothiazine.
  see Methopromazine.
3,4-Methylene dihydroxyphenyl iso propylamine
  see SKF-5.
2-Methyl-3-ethyl-5-dimethylaminoindole see  Medmain.

Methyl  pentynol carbamate see N-Oblivon.

Methylphenidate see Methylphenidylacetate.

METHYLPHENIDYLACETATE.

  o-Phenyl-2-piperidine methylacetate.
  Methylphenidate.
  Phenidylate.
  Ritalin.
  DRUG COMBINATIONS.
    Plimasin.
    Serpatilin.
    Serpatonil.

10- [3-^-Methylpiperazinylpropyl] -2-chlorophenothiazine
  see Proclorperazine.
10-[2- (tf-Methyl-piperidy 1-2) ethyl] -3-chlorophenothiazine
  see NP-207.
10- [tf-Methyl-3-piperidylmethyl] phenothiazine.
  see Mepazine.

METHYLPROMAZINE.
  10- (3-Dimethylaminopropyl) -2-methyl phenothiazine.
  Temaril.
  Trimeprazine.

2-Methyl-2-n-propyl-l,3-propanediol dicarbamate
  see Meprobamate.
Methyl reserpate trimethoxybenzoic ester see Reserpine.
Methyl reserpate trimethoxycinnamic ester
  see Rescinnamine.
Miltown see Meprobamate.

Model psychoses.
  see Psychotomimetics—Studies, normal subjects.
      [Psychotomimetic drug]—Studies, normal subjects.
      e. g. Adrenochrome—Studies, normal subjects.
Model psychoses, blocked.
  see Psychotomimetics  with  Ataraxics—Interaction—
        Studies,  normal subjects.
      [Psychotomimetic drug]  with [Ataractic drug]—
        Interaction—Studies, normal subjects.
      e.  g.  Mescaline  with Azacyclonol—Interaction—
        Studies,  normal subjects.

Moderil see Rescinnamine.

Mopazine  see Methopromazine.
Multergan see Thiazinamium.

Multezin see Thiazinamium.

Music see Reserpine with Music.
Myanesin  see Mephenesin.

Myocain see Mephenesin.

N-68 see Covatin.

N-OBLIVON.

  Methyl pentynol carbamate.
  CMP.

NP-207.

  3-Chloro-10[2-(N-methyl-piperidyl-2)-ethyl]  phenothia-
    zine.
  Piperidinochlorphenothiazine.
  Piperido-chlorpromazine.

NP-207, BROMINATED.

  Brom-piperidino-chlor-phenothiazine.
  Brominated NP-207.

NP-212 see Hydroxyzine.

Na-so-le-na see Ololiuqui.

Nembu-Serpin=Reserpine-|-Nembutal.
  see under Reserpine with other  drugs.

Neuroleptics see Ataraxics.

Neuroplegics see Ataraxics.

Nor-Dis=Yohimbine-f Barbiturates-f-Bromides.
  see Yohimbine with other drugs. 
Nostyn
PSYCHOPHARMACA
Nostyn see Ethylcrotonylurea.

Notensil see CB-1522.

Nutinal see Benactyzine.

Oasil see  Meprobamate.

OLOLIUQUI.
  Flower-her-Mother.
  Na-so-le-na.
  Piule.

OPILON.
  6-Acetoxy-thymoxy-ethyl-dimethyl-amine.
  Thymoxyalkylamine.

Orthothymics see Ataraxics.
P-391 see Mepazine.

PM-1090.
  Tetramethyl succinimide.

Pacatal see Mepazine.

Padisal see Thiazinamium.

Pagalkadawa see Rauwolfia serpentina alkaloids.

Parahexyl  see Cannabis.

Parasan see  Benactyzine.

Pecazine see Mepazine.

Perequil see  Meprobamate.

PERPHENAZINE.
  2-Chloro-10- [3- [1- (2-hydroxy ethyl) -4-piperazinyl]  pro-
    pyl ] -phenothiazine.
  1- (2-Hydroxyethyl) -4- [3- (2-chloro-10-phenothiazinyl) -
    propyl] -piperazine dihydrochloride.
  1-[2-Hydroxyethyl] -4-[3- (2-chloro-10-phenothiazyl) -
    propyl ] -piperazine.
  Chlorpiprozine.
  Sch-3940.
  Trilafon.

Peyote see Mescaline.

PHENAGLYCODOL.

  2- [p-Chlorophenyl ] -3-methyl-2,3-butanediol.
  Ultran.

Phenergan see Promethazine.

Phenidylate see Methylphenidylacetate.

PHENOTHIAZINES.
  CB-1522.
  Chlorpromazine.
  [Isothiazine],
  Mepazine.
  Methopromazine.
  Methylpromazine.
  NP-207.
  NP-207, brommated.
  Perphenazine.
  Proclorperazine.
  Promazine.
  Promethazine.
  Pyrathiazine.
  [RP-2955].
  RP-4909.
  RP-6549.
  RP-70U-
  Thiazinamium.
  Triflupromazine.
  Wy-1107.
   a-Phenyl-2-piperidine methyl acetate
     see Methylphenidylacetate.

   Photic stimulation
     see [Drug] with Intermittent photic stimulation.

   Phrenopraxics see Psychopharmaca.

   Phrenotropics see Psychopharmaca.
   Piperidinochlorphenothiazine see NP-207.

   Piperido-chlorpromazine see NP-207.

   a-[2-Piperidyl]  benzhydrol  hydrochloride  see  Pipradrol.

   a-[4-Piperidyl] benzhydrol hydrochloride see Azacyclonol.

   PIPRADROL.
     2-Diphenyloxymethyl piperidine.
     a-[2-Piperidyl] benzhydrol hydrochloride.
     CP.
     DOL.
     Gerodyl.
     Leptidrol.
     MRD-108.
     MRE-108.
     Meratran.

   Piule see Ololiuqui.

   Placebo effect see Psychopharmaca—Evaluation.
   Plegicil see CB-1522.

   Plimasin=Methylphenidylacetate+Pyribenzamine.
     see under Methylphenidylacetate with other drugs.

   Poisoning see [Drug]—Untoward effects—Poisoning.
            see also headnote p. 19.

   PRENDEROL.

     2, 2-Diethyl-l, 3 propanediol.
     DEP.

   PROCLORPERAZINE  [Prochlorperazine].

     2-Chloro-10-[3-(l-methyl-4-piperazinyl)  propyl] pheno-
       thiazine.
     Compazine.
     RP-6140.
     Stemetil.

   PROMAZINE.

     10- [3-Dimethylaminopropyl] -phenothiazine.
     Liranol.
     Sparine.
     Tyzine.
     WY-1094.

   PROMETHAZINE.

     10-[2-Dimethylamino-l-methylethyl] phenothiazine.
     10-[2-Dimethylamino propyl] phenothiazine.
     Atosil.
     Diprozin.
     Fargan.
     Isophenergan.
     Isopromethazine.
     Lergigan.
     Lilly-01516.
     Phenergan.
     Prothazin.
     RP-3277.
     Thiergan.
     Vallergin.

     DRUG COMBINATIONS.
        Adalat.
        Cetiproman.
        Doroma=Adalat.

12 
DRUG INDEX
Rauwolfia canescens alkaloids
Propaphenin see Chlorpromazine.
Prothazin see  Promethazine.

Psychedelics see Psychotomimetics.

Psychic energizers see Stimulants.

Psycholeptics see Ataraxics.

PSYCHOPHARMACA.

  Drugs  altering behavior.
  Phrenopraxics.
  Phrenotropics.
  Psychopharmacologic agents.
  Psychotropics.

  Ataraxics.
  Psychotomimetics.
  Stimulants.

Psychopharmaca combined with non-psychopharmacologic
    agents.
  see [Psychopharmacon] with other drugs—Combined.
      e. g. Reserpine with other drugs—Combined.

Psychopharmaca compared with non-psychopharmacologic
    agents.
  see [Psychopharmacon] with other drugs—Compared.
      e. g. Reserpine with other drugs—Compared.

Psychopharmacologic  agents see Psychopharmaca.

Psychosocial considerations.
  see Ataraxics—Psychosocial considerations.

Psychosurgery.
  see [Drug]  with Psychosurgery.

Psychotogenics see Psychotomimetics.

PSYCHOTOMIMETICS [ Psychosomimetics ].

  Hallucinogens.
  Psychedelics.
  Psychotaraxics.
  Psychotogenics.
  Taraxics.
  Adrenochrome.
  Adrenolutin.
  BGE
  Bufotenine.
  Cannabis.
  Harmine.
  Ibogaine.
  Lysergic acid amide.
  Lysergic acid diethylamide.
  Lysergic acid diethylamide, acetylated.
  Lysergic acid diethylamide, brominated.
  Lysergic acid ethylamide.
  Medmain.
  Mescaline.
  Ololiuqui.
  TMA.
  WIN-2299.
  Yohimbine.

Psychotomimetics see also Psychopharmaca.
Psychotomimetics, blocked.
  see Psychotomimetics with Ataraxics—Interaction.
      [Psychotomimetic] with [Ataraxic]—Interaction.
      e.  g. Mescaline with Azacyclonol—Interaction.

Psychotomimetics,  compared.
  see Psychotomimetics—Various [3 or more]— Compared.
      [Psychotomimetic] with [Psychotomimetic]— Com-
        pared.                  .     .,,..,.,,
      e. g. Mescaline with Lysergic acid diethylamide—
        Compared.
Psychotonics  see  Stimulants.
Psychotropics see Psychopharmaca.

Pyrahexyl see Cannabis.

PYRATHIAZINE.
  10-[2-(l-Pyrrolidyl) ethyl] phenothiazine
  Pyrrolazo(a)te
  Pyrrolidine-ethyl phenothiazine.
  Rolazote.
  RP-4270.

Pyrrolazo(a)te see  Pyrathiazine.
Pyrrolidine-ethyl phenothiazine see  Pyrathiazine.

10-[2-(l-Pyrrolidyl)  ethyl] phenothiazine
  see Pyrathiazine.

Quanil see Meprobamate.

QUIACTIN.
  2-Ethyl-3-propylglycidamide.

Ro  2-4572 see Iproniazid.

RP-2955 see Phenothiazines.

RP-3015 see Phenothiazines.

RP-3277 see Promethazine.

RP-3554 see Thiazinamium.

RP-4270 see Pyrathiazine.

RP-4560 see Chlorpromazine.

RP-4632 see Methopromazine.

RP-4909.
  2-Chloro-10- (3-diethylaminopropyl) phenothiazine.

RP-6140 see Proclorperazine.

RP-6549.

  Diethylamino-methylpropyl phenothiazine

RP-7044.
  3-Methoxy-10- [3-dimethylamino-2-methylpropyl]  pheno-
    thiazine.
  Levomepromazine.
  Methotrimeprazine.

Raudixin see Rauwolfia serpentina  alkaloids.

Raunorine see Reserpine.

Raunormine see Rauwolfia canescens alkaloids.

Raupina see Rauwolfia serpentina  alkaloids.

Rau-Sed see Reserpine.

Rauwidrine=Rauwiloid -{-Amphetamine.
  see under Rauwolfia serpentina  alkaloids with other
      drugs [stimulants].

Rauwiloid see Rauwolfia serpentina alkaloids.

Rauwolflia see Rauwolfia serpentina alkaloids.

RAUWOLFIA ALKALOIDS.
  Rauwolfia canescens alkaloids.
  Rauwolfia serpentina alkaloids.

RAUWOLFIA CANESCENS  ALKALOIDS.
  Deserpidine.
    Desmethoxymethylreserpate trimethoxybenzoic ester.
    Desmethoxyreserpine.
    Canescine.
    Harmonyl.
    Lilly-22641.
    Raunormine.
    Recanescine. 
Rauwolfia canescens alkaloids
PSYCHOPHARMACA
  Rauwolscine.
  Reserpine.

  DRUG COMBINATIONS.
    Riker 529-1.
    Triserpine.

Rauwolfia canescens alkaloids see also  Reserpine.

RAUWOLFIA SERPENTINA ALKALOIDS.

  Pagalkadawa.
  Sarpagandha.
  Snakeroot.
  Single  alkaloids.
    Raupina.
    Rescinnamine.
    Reserpine.
    Sarpagin.
  Total alkaloids.
    Alseroxylon.
    Gendon.
    Rauwiloid.
    Ra-Valeas.
    Sarpagan.
    Serpalkon.
  Whole root preparations.
    Koglucoid.
    Raudixin.
    RauwolfBa.
    Serpina.
  DRUG COMBINATIONS.
    Rauwidrine.
    Sedaltine.

Rauwolfia serpentina alkaloids  see  also Rescinnamine.

Rauwolfia serpentina alkaloids see also Reserpine.

Rauwolscine see  Rauwolfia canescens alkaloids.

Ra-Valeas see Rauwolfia serpentina alkaloids.
Recanescine see Rauwolfia canescens alkaloids.

Relaxants see Ataraxics.

RESCINNAMINE.

  Methyl reserpate trimethoxycinnamic  ester.
  Trimethoxy cinnamoyl methyl reserpate.
  Moderil.

  DRUG COMBINATIONS.
    Riker 529-2.
    Triserpine.

Uesearch design  see Psychopharmaca—Evaluation.

RESERPINE.

  Methyl reserpate trimethoxybenzoic ester.
  Trimethoxybenzoyl methyl  reserpate.
  Chrystoserpine.
  Eskaserp.
  Raunorine.
  Rau-Sed.
  Reserpoid.
  Sandril.
  Sedaraupin.
  Serfin.
  Serolfia.
  Serpanray.
  Serpasil.
  Serpiloid.
  Serpine.

  ©BUG COMBINATIONS
    Amril.
    Nembu-Serpin.
    Riker 529-1.
    Riker 529-2.
    Serpatilin.
    Serpatonil.
    Triserpine.

Reserpoid see Reserpine.
Restenil see Meprobamate.
Riker 529-1=Reserpine [75%]+Deserpidine [25%].
  see Rauwolfia  canescens  alkaloids  with Reserpine—
    Combined [Riker 529-1].
Riker 529-2=Reserpine [75%]+Rescinnamine  [25%].
  see Rescinnamine with Reserpine—Combined  [Riker
    529-2].
Ritalin see Methylphenidylacetate.

Rolazote see Pyrathiazine.
Sch-3940 see Perphenazine.

SKF-5.
  3,4-Methylene dihydroxyphenyl isopropylamine.

SKF-2601-A see  Chlorpromazine.
Sandril see Reserpine.
Sarpagan see Rauwolfia serpentina  alkaloids.
Sarpagandha see Rauwolfia serpentina alkaloids.
Sarpagin see Rauwolfia serpentina alkaloids.
Savitil see Benactyzine.
Sedaltine=Mephenesin [100 mg].
          +Rauwolfia  serpentina alkaloids  (total  alka-
              loids) 55% [0.25 mg].
          +other drugs.
              aluminium hydroxide  [100 mg].
              bromvaletone [65 mg].
              carbromal [195mg].
  see Mephenesin.
    with Rauwolfia serpentina alkaloids and other drugs.
Sedaraupin  see Reserpine.
Sedation see Ataraxics.
Serfin see Reserpine.
Serolfia see Reserpine.

SEROTONIN.

  5-Hydroxytryptamine.

Serpanray see Reserpine.
Serpalkon see Rauwolfia serpentina  alkaloids.
Serpasil see Reserpine.

Serpatilin=Reserpine+Methylphenidylacetate [1:100].
  see under Reserpine with Methylphenidylacetate.

Serpatonil=Reserpine+Methylphenidylacetate  [1: 33].
  see under Reserpine with Methylphenidylacetate.
Serpiloid see Reserpine.

Serpina see Rauwolfia  serpentina alkaloids.
Serpine see Reserpine.

Shock therapy.
  see [Drug] with Shock therapies.
       [Drug] with  Shock therapy  [ECT]
       [Drug] with  Shock therapy [ICT]
 Sleep therapy.
   (see  Lytic cocktails).
   (see  Phenothiazines).

Snakeroot see Rauwolfia serpentina alkaloids. 
DRUG  INDEX
Yohimbine
 Social considerations.
   see Ataraxics—Psychosocial considerations.
 Sparine see Promazine.
 Stemetil see Proclorperazine.

 STIMULANTS.
   Analeptics.
   Psychic energizers.
   Psychotonics.
   Hibicon.
   Iproniazid.
   MER-22.
   Methylphenidylacetate.
   PM-1090.
   Pipradrol.
   SKF-5.

 Stimulants see also Psychopharmaca.
 Stimulants combined with ataraxics.
   see  [Ataraxic] with [Stimulant]—Combined.
       e. g., Reserpine with Pipradrol—Combined.
      Ataraxics with Stimulants.
 Stimulants, compared.
   see  [Stimulant A] with [Stimulant B]—Compared.
     e.  g. Methylphenidylacetate  with Pipradrol—Com-
       pared.

 Suavitil [Suavetil]  see Benactyzine.
 Suvren see Covatin.
 Synhexyl see  Cannabis.

 TMA.

   Trimethoxyamphetamine.
   3,4,5-Trimethoxyphenyl-/3-aminopropane.

 Taraxics see Psychotomimetics.

 Telepathine see Harmine.
 Temaril see Methylpromazine.
 Tetrahydrocannabinol see Cannabis.
 Tetramethyl succinimide see PM-1090.
 Thiazinamin see Thiazinamium.

 THIAZINAMIUM.
   Trimethylaminopropylphenothiazine sulfomethylate.
   Multergan.
   Multezin.
   Padisal.
   RP-3554.
   Thiazinamin.
   Thiazinamon.

 Thiazinamon see Thiazinamium.

 Thiergan see Promethazine.

 Thora-Dex=Chlorpromazine+Dexedrine.
  see under  Chlorpromazine  with other  drugs  [CNS
    stimulants]—Combined: Amphetamine.

Thorazine see  Chlorpromazine.

Thymoxyalkylamine see Opilon.
3-o-Toloxy-l,2-propanediol see Mephenesin.

Tolseram see Mephenesin  carbamate.

Tolserol see Mephenesin.
Trademarks of drug combinations.
   (see Drug combinations, trademarks).
Tranquilizers see Ataraxics.
2-Trifluoromethyl-10- (y-dimethylaminopropyl) phenothia-
  zine see Triflupromazine.

TRIFLUPROMAZINE.
  10- (3-Dimethylaminopropyl) -2- (trifluoromethyl)   phe-
    nothiazine.
  2-Trifluoromethyl-10- (y-dimethylaminopropyl)   pheno-
    thiazine.
  Adazine.
  MC-4703.
  Vesprin.

3,5,6-Trihydroxy-N-methylindole see Adrenolutin.
Trilafon see Perphenazine.
Trimeprazine see Methylpromazine.
Trimethoxyamphetamine see TMA.
Trimethoxybenzoyl methyl reserpate see Reserpine.
Trimethoxycinnamoyl  methyl reserpate.
  see Rescinnamine.
3,4,5-Trimethoxyphenethylamine see Mescaline.
3,4,5-Trimethoxyphenyl-)3-aminopropane see TMA.
Trimethylaminopropylphenothiazine sulfomethylate.
  see Thiazinamium.

Triserpine=Reserpine [60  %].
         +Rescinnamine  [20 %].
         -fDeserpidine [20 %].
  see Rauwolfia canescens alkaloids.
        with Rescinnamine and Reserpine—Combined.
Tyzine see  Promazine.
Ultran see  Phenaglycodol.

Untoward effects,  see [Drug]—Untoward effects.
                  see also headnote p. 19.
Vallergin see Promethazine.
Vesprin see Triflupromazine.
W-1224 see Mepazine.

WIN-2299.

  Diethylaminoethylcyclopentyl  [2-thienyl] glycolate hy-
    drochloride.

WY-1094 see Promazine.

WY-1107.

  10- (3-Diethylaminopropyl) phenothiazine.

Yageine see Harmine.

YOHIMBINE.
  DRUG COMBINATION.
    Nor-Dis.
15 
 
SUBJECT LIST
 OF DRUGS 
 
'A single asterisk after a citation indicates that the article includes data on untoward effects.
A double asterisk after a citation means that the article reports at least one death.
ADRENOCHROME.

  Delay, J.,  Thuillier,  J.  Psychiatrie experimental et
  psychopharmacologie.  [Experimental psychiatry  and
  psychopharmacology.] Sem.  hop.  Paris,  1956,  32-
  3187-3193.
  Evarts, E. V.  A review  of the neurophysiological ef-
  fects  of  lysergic acid diethylamide  (LSD) and other
  psychotomimetic agents.   Ann. N.  York Acad. Sc, 1957,
  66:479^95.
  Fabing, H. D.  The dimensions of neurology.  Neurol-
  ogy, 1955, 5:603-611.  Abstract: Excerpta med., Sect. 8,
  1956,9 :No. 1718.
  ---.   Experimental  psychoses which  mimic  schizo-
  phrenia.  Nebraska M. J., 1956, 41:455-459.
  ---.   The new  pharmacologic attack  in  psychiatry.
  Internat. Rec.  M.,  1956, 169:177-183.   Also: Drug &
  Cosmet. Indust., 1956, 78:32-33; 125-129.
  Fazekas, J. F., Toupin, H., Alman, R. W. Physiologic and
  pharmacologic basis for the chemotherapy of psychiatric
  states.  Am.  J. Med., 1956, 21:825-831.
  Hoffer, A.  Adrenolutin  as a  psychotomimetic  agent.
  In: Himwich, H. E., ed.  Tranquilizing  drugs.  Wash-
  ington, Am. Ass. Adv. Sc, 1957.  p.  73-100.
  ---.   Epinephrine  derivatives as  potential  schizophre-
  nic factors.  J. Clin.  Exp. Psychopath., 1957, 18 :27-60.
  ---,  Osmond, H., Smythies, J.  Schizophrenia; a new
  approach.  II. Result of a year's research. J. Ment. Sc,
  Lond., 1954, 100:29-45.
  Leake. C. D.  Drugs affecting mood  and behavior.   Texas
  Rep. Biol. M., 1955,13 -.793-818.
  Pearson, J., Dewhurst, K.  Mescaline: apotheosis of the
  devil's root.  Irish J. M. Sc, 1956: 139-143.
  Psychobiology and drugs. Internat. Rec. M., 1956, 169:
  231-232.
  Rinkel, M., Hyde, R. W., Solomon,  H. C.  Experimental
  psychiatry.  IV. Hallucinogens: tools in experimental
  psychiatry-  Dis. Nerv. Syst., 1955, 16:229-232.
  ---,  Solomon, H. C.  Chemical theories of psychosis.
  J. Clin. Exp.  Psychopath., 1957, 18:323-334.
  Turner, W. J., Merlis, S., Carl, A.  Concerning theories
  of  indoles  in schizophrenigenesis.  Am.  J. Psychiat.,
  1955,112:466-467.

Studies, animals
  Marrazzi, A. S.   The effects of certain drugs  on cerebral
  synapses.  Ann.  N.  York Acad. Sc, 1957, 66 :496-507.
  ---, Hart, E. R.  An electrophysiological analysis of
  drugs  useful in psychotic states.   In: Himwich, H. E.,
  ed. Tranquilizing drugs. Washington, Am. Ass. Adv. Sc.
  1957.  p. 9-21.
  ----,  ----.  An electrophysiological analysis  of  the
  actions of some drugs useful in the therapy of psychotic
  disorders.   J. Nerv. Ment. Dis., 1956, 124:388-392.
  Schwarz,  B. E„ Wakint, K. G., Bickford, R. G., Lichten-
  held,  F.  R.  Behavioral and electroencephalograph^
  effects of hallucinogenic drugs; changes in cats on intra-
  ventricular  injection.  A. M.  A. Arch. Neur. Psychiat.,
  1956,  75:83-90.  Abstract:  Excerpta med.,  Sect. 8,
  1957,10 :No. 328.
  Turner, W.  J.  The effect of lysergic acid diethylamide
  on Betta splendens: I. Dis. Nerv.  Syst.,  1956,  17:193-
  197.
  Witt, P.  N.  Der Netzbau der Spinne  als Test zur
 Priifung zentralnervos angreifender Substanzen.   [Con-
 struction of spider webs as a test  for drugs with CNS
 action.]  Arzneimitt. Forsch., 1956, 6:628-635.
Studies, normal subjects
  The chemical concept of psychoses.  What's new, 1955
   (189) : 3-7.
  Hoffer, A., Osmond, H., Smythies, J.  Schizophrenia; a
  new approach.  II.  Result of a  year's  research.  J.
  Ment. Sc, Lond., 1954,100:29-45.
  Jarvik,  M. E.  Mechanism of  action of lysergic acid
  diethylamide, serotonin, and related drugs.  In: Kline,
  N. S., ed. Psychopharmacology.  Washington, Am. Ass.
  Adv. Sc, 1956.  p. 145-154.
  Osmond, H.  Research  on schizophrenia.   In:  Abram-
  son, H. A., ed. Neuropharmacology.  Transactions of
  the second conference, May 1955, Princeton, N. J.   New
  York, Josiah Macy, Jr. Foundation, 1956.   p. 183-233.
  ----. A review of the clinical effects  of  psychotomi-
  metic agents. Ann. N. York Acad. Sc, 1957, 66: 418-434.
  Rinkel, M., Hyde, R. W., Solomon, H. C.  Experimental
  psychiatry.   III. A chemical concept of psychosis.  Dis.
  Nerv. Syst., 1954,15: 259-264.
  Stangl,  E.  Klinische  Erfahrungen  iiber die muskel-
  dynamische Wirkung des Adrenoxyls (Monosemikarba-
  zonderivat des Adrenochroms.)  [Clinical  experiences
  with the muscle dynamic effect of adrenoxyl (monosemi-
  carbazone  derivative of adrenochrome.)]   Ther.  Um-
  schau, Bern, 1953, 10: 64-66.
  Szatmari, A., Hoffer, A.,  Schneider, R.  The effect of
  adrenochrome and niacin on the electroencephalogram
  of epileptics.  Am. J. Psychiat., 1955, 111: 603-616.
Studies, patients
  Schwarz,  B.  E., Sem-Jacobsen, C.  W., Petersen,  M. C.
  Effects  of mescaline, LSD-25, and adrenochrome on
  depth electrograms in man.  A. M. A. Arch. Neur. Psy-
  chiat, 1956, 75: 579-587.
  Szatmari, A., Hoffer, A.,  Schneider, R.  The effect of
  adrenochrome and niacin on the electroencephalogram
  of epileptics.  Am. J. Psychiat., 1955, 111: 603-616.


with ADRENOLUTIN—COMPARED
  see ADRENOLUTIN

with IPRONIAZID—COMPARED
  see IPRONIAZID—Pharmacodynamics

with SEROTONIN—INTERACTION
  see ADRENOCHROME—Studies,  animals  [schwarz,
  wakim, & others]
ADRENOLUTIN

  Fabing, H.  D. Experimental psychoses which mimic
  schizophrenia.  Nebraska M. J., 1956,  41: 455-459.
  Rinkel, M., Solomon, H.  C.  Chemical  theories of psy-
  chosis.  J. Clin. Exp. Psychopath., 1957, 18: 323-334.
Studies,  animals
  Schwarz, B. E., Wakim, K. G., Bickford, R. G., Lichten-
  held,  F.  R.  Behavioral  and electroencephalographic
  effects of  hallucinogenic  drugs;  changes in cats on in-
  traventricular injection.   A. M.  A.  Arch.  Neur. Psy-
  chiat.,  1956, 75: 83-90.  Abstract: Excerpta med., Sect.
  8,1957,10: No. 328.

Studies,  normal subjects
  Hoffer, A.  Adrenolutin  as  a psychotomimetic agent.
  In: Himwich,  H. E., ed. Tranquilizing drugs.  Washing-
  ton, Am. Ass. Adv. Sc, 1957.  p. 73-100.
  ----.   Epinephrine  derivatives   as  potential schizo-
19 
Adrenolutin : Studies, normal subjects
PSYCHOPHARMACA
  phrenic  factors.  J. Clin.  Exp. Psychopath., 1957, 18:
  27-60.
  Osmond, H.  Research on schizophrenia.  In: Abram-
  son, H.  A., ed. Neuropharmacology.  Transactions of
  the second conference, May 1955, Princeton, N. J.  New
  York, Josiah Macy Jr. Foundation, 1956.  p. 183-233.
  ---.  A review of the clinical  effects of psychotomi-
  metic agents.   Ann. N. York Acad. Sc, 1957, 66 : 418-434.

with ADRENOCHROME—COMPARED
  see ADRENOLUTIN

with SEROTONIN—INTERACTION
  see ADRENOLUTIN—Studies, animals
ATARAXICS

  see also PSYCHOPHARMACA
          individual  ataraxics
          Cf. DRUG INDEX : ATARAXICS
  Ataractics.  [Roundtable discussion at meeting held in
  Atlantic City, N. J., November 1956.]   Pub. Health Rep.,
  1957, 72: 624-637.
  Azima, H.  Report on the international colloquium on
  chlorpromazine and neuroleptic medications in psychi-
  atric  treatment,  Paris, October 20-22, 1955.   Am. J.
  Psychiat.,  1956, 112: 749-750.
  Cole,  J. O., Ross, S., Bouthilet, L.   Recommendations
  for reporting studies of psychiatric drugs.    [Confer-
  ence held  in Washington,  D. C, January 1957.]  Pub.
  Health Rep., 1957, 72: 638-645.
  Le colloque international  de Paris  sur la chlorproma-
  zine et  les medicaments neuroleptiques en therapeu-
  tique   psychiatrique.   [International  colloquium  in
  Paris (October  1955)  on chlorpromazine  and neuro-
  leptic drugs  in  psychiatric  therapy.]   J.  m£d. Lyon,
  1956, 37: 103-105.
  Colloque international sur  la  chlorpromazine et les
  medicaments neuroleptiques en therapeutique psychi-
  atrique.  [International colloquium on chlorpromazine
  and neuroleptic drugs in psychiatric therapy.]   [Paris,
  October 1955]  EncCphale, 1956, 45:301-1266.  [Arti-
  cles within the scope  of  this  bibliography are listed
  individually]
  Conn, H.  F., ed.  Symposium  on the efficacy  of  new
  drugs. Med.  Clin. N. America,  1957, 41: 295-615.   [Ar-
  ticles within  the scope of this bibliography are listed
  individually]
  Deniker, P.   Hibernotherapies  et medicaments neuro-
  leptiques  en  therapeutique  psychiatrique.  [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapy.]
  Enctphale, 1957, 46 : 281-398.
  Fernandes, B.  Clorpromazina, reserpina e a chamada
  "farmacopsiquiatria".   [Chlorpromazine  and reserpine
  at the colloquium on  "pharmacopsychiatry".]   [Paris,
  October 1955]  J. me'd., Porto,  1956, 29: 237-243.
  Gerard, R. W.  Drugs for the soul; the rise of psycho-
  pharmacology.  Science, 1957, 125: 201-203.
  Happiness pills  in medical practice: a symposium.  J.
  Iowa M. Soc, 1957, 47 :57-65.
  Himwich,  H.  E., ed.   Tranquilizing  drugs.   197  p.
  [Symposium held in Atlanta, Georgia, December 1955]
  Washington, Am. Ass. Adv. Sc, 1957.   [Articles within
  the scope  of this bibliography are listed individually].
  Meprobamate  and other  agents used in  mental  dis-
  turbances.  [Conference held  in New York,   October
  1956]  Ann. N. York Acad. Sc,  1957, 67: 671-894.
  The pharmacology of psychotomimetic and psychother-
  apeutic drugs.   [Conference held in New York,  April
  1956.]  Ann. N. York Acad. Sc, 1957, 66: 415-840.  [Ar-
  ticles within  the scope of this bibliography are listed
  individually]
  Symposium on the evaluation of pharmacologic agents
  in psychiatry.   J. Clin. Exp. Psychopath., 1957, 18: 221-
  2S3.  [Articles within the scope of this bibliography are
  listed individually]                   .    .  .  ,    ,.
  Symposium on tranquilizing agents  in clinical medi-
  cine. Internat. Rec. M., 1956, 169: 177-232.   [All  arti-
  cles are listed  individually]
  Symposium on tranquillizers.  [Summary of proceed-
  ings.   British  Medical Association  annual  meeting,
  Newcastle upon Tyne, July 1957]  Brit.  M.  J.,  1957,
  2 •  219—221.
  Symposium:  Physiologic,  pharmacologic, neurologic,
  and psychologic actions of  drugs  recently introduced
  in  the  treatment of psychiatric disorders.  Psychiat.
  Res. Rep., Wash., 1955  (1) : 1-51.  [Articles within the
  scope of this  bibliography are listed  individually]
  Symposium: The neurophysiology  and neuropharma-
  cology  of the  new drugs.   Psychiat. Res.  Rep., Wash.,
  1956 (4) : 1-34.  [Articles within the scope of this bibli-
  ography are listed individually]
  Symposium: The relative values of drugs in the various
  psychiatric syndromes.  Psychiat.  Res. Rep., Wash.,
  1956 (4) :  35-78.  [All  articles are listed individually]
  Symposium: The significance  and  management of the
  complications  resulting from  new  drugs.   Psychiat.
  Res. Rep., Wash., 1956 (4) : 79-94.   [Both articles are
  listed individually]
  Tranquillizers in psychiatry.  [Report on Royal Medico-
  Psychological  Association meeting, London,  February
  1956]  Brit. M. J., 1956, 1: 512-513.
  Wikler, A. The relation of psychiatry to pharmacology.
  322 p.  Baltimore, Williams & Wilkins  [for the Amer-
  ican Society for Pharmacology and Experimental Ther-
  apeutics] 1957.

Combined
  see [Ataraxic  A] with [Ataraxic B]—Combined
      ATARAXICS—Various  [3 or  more]— Combined

Compared
  see [Ataraxic  A] with [Ataraxic B]—Compared
      ATARAXICS—Various  [3 or more]—Compared

Evaluation see PSYCHOPHARMACA—Evaluation

Pharmacodynamics
  Alexander, L.  Therapeutic process in electroshock and
  the newer drug therapies; psychopathological consider-
  ations.  J. Am. M. Ass., 1956,162 : 966-969.
  ---.  Objective approaches to treatment in psychiatry.
  Canad. Psychiat. Ass. J., 1957, 2: 77-94.
  Barsa,  J. A.  The dual action of  the tranquilizers.  Am.
  J. Psychiat., 1957,114: 74-75.
  Boor, W. de.   Considerations nosologiques sur la thera-
  peutique par les medicaments neuroleptiques.  [Noso-
  logic  considerations  on  treatment  with  neuroleptic
  drugs.] Enc6phale, 1956, 45 : 605-608.
  Delay,  J.  Allocution finale.   [Final address.] [Inter-
  national colloquium  on  chlorpromazine  and  neuro-
  leptic  drugs,  Paris,  October  1955]   Encephale,  1956,
  45:1181-1184.
  ----.  Introduction au colloque international. [Intro-
  duction to the international  colloquium.]  [On  chlor-
  promazine and neuroleptic drugs, Paris, October 1955]
  Ence'phale, 1956, 45 : 303-306.
  Deniker,  P.   Psychophysiologic aspects  of  the  new
  chemotherapeutic drugs in  psychiatry; some practical
  features of "neuroleptics" in order to screen new drugs.
  J. Nerv. Ment. Dis., 1956,124: 371-376.
  ----.  Recent advances in "pharmacopsychiatry "  J.
  Clin. Exp. Psychopath., 1956,17 : 381-384.
  Fazekas, J. F., Toupin, H., Alman, R.  W.  Physiologic
  and pharmacologic basis for the chemotherapy of psy-
  chiatric states. Am. J. Med., 1956, 21: 825-831.
  Himwich, H.  E.  Viewpoints  obtained  from  basic and
  clinical symposia on tranquilizing drugs.  In • Himwich,
  H. E.,  ed. Tranquilizing drugs.  Washington, Am Ass.
  Adv. Sc, 1957. p. 183-192.
20 
SUBJECT LIST
Ataraxics : Terminology
  Leake, C. D. Drugs affecting mood and behavior.  Texas
  Rep. Biol. M., 1955, 13 : 793-818.
  ----.  Introductory note [to symposium on tranquilizing
  drugs,  Atlanta,  Georgia,  December  1955]  In:  Him-
  wich, H. E., ed. Tranquilizing drugs.  Washington, Am.
  Ass. Adv. Sc, 1957.  p. 1-5.
  Marti-Ibanez, F.  The  historical  and  philosophic back-
  ground of  psychobiology.  J. Clin. Exp. Psychopath.,
  1956,17: 360-369.
  Orsi,  C.   I  farmaci atarassici.    [Ataraxics.]   Boll.
  chim. farm., 1956, 9: 432-436.
  Pennes, H. H.  The nature of drugs with mental actions
  and their relation to cerebral function.  Bull. N. York
  Acad. M., 11)57, 33 : 81-88.
  Perrault, M.   Sur les tranquilliseurs.   [Tranquilizers.]
  Progr. me'd., Par., 1957, 85 : 3-4; 7.
  Ravreby, M.  Pharmacology.   In: "Happiness pills" in
  medical practice: a symposium.   J. Iowa M. Soc, 1957,
  47:  57-59.
  Schmitt,  R. J.  The psychodynamics of the tranqui-
  lizing agents.  Psychiat. Q., 1957,  31: 17-30.
Placebo effect see PSYCHOPHARMACA—Evaluation
Psychosocial  considerations  [see headnote p. 19]

  see  also PSYCHOPHARMACA—Evaluation
Kramer, M.  Facts needed to assess public health and
social problems in the widespread use of the tranquiliz-
ing drugs. Pub.  Health Monogr., 1956  (41) :  1-31.
Laborit, H., Jaulmes, C.  De l'anesthesie potentialisee a
l'hibernation artificielle.  [From potentiated anesthesia
to  artificial  hibernation.]  Toulouse  me'd., 1952, 53:
821-829.  [p. 828]
Lasagna, L.,  McCann, W. P.  Effect of "tranquilizing"
drugs  on amphetamine toxicity in  aggregated  mice.
Science, 1957, 125 :1241-1242.
National Association of Science Writers.  Drug ther-
apy publicity.  Am. J. Psychiat.,  1956, 113: 77.
Overholser, W.  Psychobiologic advances and the man-
agement of hospitalized patients.  J. Clin. Exp. Psycho-
path., 1956, 17:378-380.
Pierson, C. A. La chlorpromazine et la maitrise de soi
dans  les angoisses  collectives.  [Chlorpromazine  and
self-control  in  mass hysteria.]  EncCphale, 1956, 45:
562-565.
"Rose is a rose is a rose is a rose".  Psychiat. Q., 1957,
31: 346-361.
Sainz, A., Bigelow, N., Barwise,  C.  On a methodology
for  the  clinical  evaluation  of phrenopraxic  drugs.
Psychiat. Q., 1957, 31:10-16.
Szasz, T. S.   Some observations on the use of tranquiliz-
ing drugs. A.  M. A. Arch. Neur. Psychiat.,  1957, 77:
86-92.
Tranquillizers and divorce.  Brit. M. J., 1957, 2:1122-
1123.
Tuteur, W.  Effect of chlorpromazine and reserpine on
budgets  of mental hospitals.   Am. J.  Psychiat., 1957,
113: 657-659.
tudies, animals
Berger, F. M., Campbell, G. L., Hendley, C. D., Ludwig,
B. J., Lynes, T. E.  The action of tranquilizers on brain
potentials and serotonin.  Ann. N. York Acad. Sc, 1957,
66: 686-694.
Brady, J. V.  A review of comparative behavioral phar-
macology. Ann.  N. York Acad. Sc, 1957, 66: 719-732.
Chauchard, P., Mazoue, H.  Recherches sur le mode d'
action centroplegique de quelques substances  psycho-
tropes.   [Research on the mode of centriplegic action of
some psychotropic substances.]   C. rend. Soc. biol., 1956,
150: 158-160.
Cook, L., Weidley, E.  Behavioral effects of some psycho-
pharmacological agents.   Ann. N. York Acad. Sc, 1957,
66: 740-752.
Hendley, C. D., Lynes, T. E., Berger, F. M.  Effect of
meprobamate on  electrical activity  of thalamus and
other subcortical areas.  In: Himwich, H. E., ed. Tran-
quilizing drugs.  Washington, Am. Ass. Adv.  Sc, 1957.
p. 35^6.
Kinnard, W. J.,  Carr, C. J.  A preliminary procedure
for the  evaluation of central nervous system  depres-
sants.   J. Pharm. Exp. Ther.,  1957, 121:354-361.
Lim, R. K., Pindell, M. H., Glass, H. G., Rink, K.  The
experimental evaluation of sedative agents in animals.
Ann. N.  York  Acad. Sc, 1956,  64:667-678.
Norton, S., De Beer, E. J.  Effects of drugs on the be-
havioral patterns of cats.  Ann. N. York Acad. Sc, 1956,
65: 249—257.
Pfeiffer,  C. C, Jenney, E. H.  The inhibition of the
conditioned response and the  counteraction  of schizo-
phrenia by muscarinic  stimulation of the brain.   Ann.
N.  York Acad. Sc, 1957, 66: 753-764.
Walaszek, E. J., Abood, L. G.  Effect  of tranquilizing
drugs  on fighting responses of  Siamese fighting fish.
Science, 1956, 124: 440-441.

erminology
Alexander, L.  Therapeutic process in electroshock and
the newer drug therapies; psychopathological consider-
ations.   J. Am. M. Ass., 1956, 162:966-969.
Cameron, A.  In: Fabing, H. D.  Designation of "tran-
quilizing agents" in neuropharmacology.  J.  Am. M.
 American  Psychiatric Association.  The contribution
 of  the tranquilizing drugs  and the dangers in their
 casual use for relief of everyday tensions.  J. Iowa M.
 Soc, 1957, 47 : 66.
 Ataractics.  [Roundtable discussion  at meeting  held
 in Atlantic Citv, N.  J., November  1956.]  Pub. Health
 Rep., 1957, 72 : 624-637.
 Ayd, F. J., Jr.  Tranquilizing drugs in private practice.
 N. York State  J. M., 1957, 57: 1742-1747.
 Azima, H.  The use of chlorpromazine and reserpine in
 psychological disorders in general  practice.  Canad. M.
 Ass. J., 1956, 74: 929-931.
 Brill,  H., Patton, R. E.  Analysis of 1955-56 population
 fall in New York  state mental  hospitals in  first  year
 of large-scale use of tranquilizing drugs. Am. J.  Psy-
 chiat., 1957, 114: 509-517.
 Carr, C. J., Kinnard, W. J., Jr.  The phrenotropic agents.
 Internat. Rec.  M., 1957, 170: 493-504.
 Cobb, S. Peace  of mind.  Am. J. Psychiat., 1957,  113:
 663-664.
 Cowden, R. C, Zax, M.,  Finney, R. C.   A preliminary
 note on the use of chlorpromazine with neuropsychiatric
 disorders.  A. M. A. Arch. Neur. Psychiat., 1955, 73 : 700-
 701.
 Dickel, H. A.,  Dixon, H. H.   Inherent  dangers  in use
 of tranquilizing  drugs in anxiety  states.  J. Am. M.
 Ass., 1957, 163 : 422-426.
 Drop in shock therapy.  Science, 1957, 125: 229.
 Expert committee  on addiction-producing drugs.  Sev-
 enth report. World Health Org. Techn. Rep.  Ser.,  1957
 (116)  : 1-15.
 Freyhan, F. A. The immediate  and long range effects
 of chlorpromazine  on the mental hospital.  In:  Chlor-
 promazine  and  mental health.   Philadelphia, Lea  &
 Febiger, 1955.  p. 71-84;  discussion p. 84-98.
 Friend,  D.  G., McLemore, G. A., Jr.   Some  abuses  of
 drugs  in ther.apy.  N. England  J. M., 1956,  254:1223-
 1231.                                          . .  *
 Hoch,  P. H.  New  drug therapy  in psychiatry: clinical
 uses and abuses in  mental  disorders.   Bull.  N. York
 Acad.  M., 1957, 33 : 474-486.
 Hollister, L. E. Complications from the use of tranqui-
 lizing  drugs. N. England J. M., 1957, 257 :170-177.  *  *
 Kahn, E.  Information values.   Am. J. Psychiat., 1957,
 114: 375-376.
 Kline, N. S.  Relation of psychiatry to the pharmaceuti-
cal  industry.   A. M.  A.  Arch.  Neur.  Psychiat., 1957,
 77:611-615. 
Ataraxics : Terminology
PSYCHOPHARMACA
  Ass., 1955, 158:1461.   Also:  Am.  J.  Psychiat.,  1955,
  112:392.
  Delay,  J.  Allocution finale.  [Final address.]  [Inter-
  national colloquium on chlorpromazine and neuroleptic
  drugs, Paris, October 1955.]  Ence'phale, 1956, 45:1181-
  1184.
  Deniker, P.  Hibernotherapies et medicaments neuro-
  leptiques  en  therapeutique psychiatrique.  [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapy.]
  Ence'phale, 1957, 46: 281-398.  [282-83]
  ---.   Psychophysiologic aspects of  the  new  chemo-
  therapeutic drugs in  psychiatry; some practical fea-
  tures of "neuroleptics"  in  order to screen new  drugs.
  J.  Nerv. Ment. Dis., 1956, 124:371-376.
  Fabing, H. D.  Designation of "tranquilizing agents"
  in  neuropharmacology.  J. Am. M. Ass., 1955, 158: 1461.
  Also: Am. J. Psychiat., 1955,112: 392.
  Gerard, R. W.  Drugs for the  soul; the rise of psycho-
  pharmacology.  Science,  1957, 125:201-203.
  "Rose is a rose is a rose is a rose"  Psychiat. 0., 1957,
  31: 346-361.
  Sainz, A., Bigelow, N., Barwise, C.  On a methodology
  for the clinical  evaluation  of  phrenopraxic  drugs.
  Psychiat. Q., 1957, 31:10-16.
  Sarro,  R.  Recents developpements de la therapeutique
  narcobiotique.   [Recent  developments  in narcobiotic
  therapy.]   Ence'phale, 1956, 45:501-510.
Therapeutic use
  Bender, L., Nichtern, S. Chemotherapy in child psy-
  chiatry.  N. York State J.  M., 1956, 56: 2791-2795.
  Bergy,  G. A.  Drugs of  sedation with tranquilizing ef-
  fects.   Am. Profes. Pharmacist, 1956, 22: 419; 534-538;
  619-621; 709-710; 797-799; 888-889; 917-919.
  Cohen, I.  M.  Drugs recently  introduced  in the treat-
  ment of psychiatric disorders.  Texas J. M.,  1956, 52:
  683-687.
  Dellaert, R. De modernste chemopharmaca in  de psy-
  chiatrie.   [New  chemical  psychopharmaca.]    Belg.
  tschr. geneesk., 1956, 12: 314-321.
  Deniker, P. Hibernotherapies et medicaments neuro-
  leptiques  en  therapeutique psychiatrique.  [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapy.]
  Encfphale, 1957, 46: 281-398.
  Fabing, H. D.  The ataractic drugs: their  uses and
  limitations in  psychiatry.  Am.  Profes. Pharmacist,
  1956, 22: 413-418.
  ---.  Trends  in  biological research  in schizophrenia.
  J.  Nerv. Ment. Dis., 1956, 124:1-7.
  Fishbein,  M.  The tranquilizing drugs.  Postgrad. M.,
  1956, 19: 509-511.
  Freedman, A. M., Effron, A. S., Bender, L. Pharmaco-
  therapy in children with psychiatric  illness.  J.  Nerv.
  Ment. Dis., 1955, 122: 479-486.  Abstract:  Year  book  of
  drug therapy, 1956-1957, p. 350-351.
  Fremming, K. H.  Medikamentel behandlung af synds-
  sygdomme.  [Medical treatment of mental disorders.]
  Mskr. prakt. laegegern., Kbh.,  1956,  34:331-342.
  Graffagnino, P. N., Furr, J. H.  New drugs in the treat-
  ment of emotional  disorders;  a  review.   Connecticut
  M. J. 1957, 21: 38-43.
  Graves, C. C.   Drug therapy  for the emotionally and
  mentally  disturbed;  the psychiatrist's point of  view.
  J.  Iowa M. Soc, 1957, 47: 15-16.
  Green,  A.  Actualites therapeutiques 1955 en psychia-
  tric   [Therapeutic progress  in  psychiatry  in  1955.]
  Ence'phale, 1956, 45 : 172-200.
  Hazards of tranquillity. Brit. M. J., 1957, 2:92-93.
  Hilliard, E. T.  The use of reserpine, chlorpromazine
  and allied drugs  in medicine and psychiatry.  Med.  J.
  Australia, 1956,43 (1) : 1035-1040.
  Kautz,  H. D.  Trends in drug therapy.  Hosp. Progr.,
  1957,38 (1) : 102-108; 126.
  Keyes,   B.  L.  Ataraxic drugs.  Pennsylvania  M. J.,
  1957, 60:177-181.
 Kinross-Wright, V.  A review of the newer d™g thera-
 pies in psychiatry.  Dis. Nerv. Syst., 1956,  17 : ±»f-±wu.
 ---. The uses and limitations of the newer drugs in the
 treatment of nervous conditions.  Wisconsin M.J., lyob,
 55 : 1073-1078.
 Kline, N. S.  Chemotherapy  in psychiatry j_recent ad-
 vances.   Seminar Internat.,  Hoddesdon, 195b,  5  (2) :

 Klingman, W. O.  Neurological and psychiatric disor-
 ders;  some recent advances in therapy.   Virginia M.
 Month., 1956,  83 : 240-246.
 Kugelmass, I. N. Psychochemotherapy of  mental defi-
 ciency in children.  Internat. Rec. M., 1956, 169:323-
 338
 Laboucarie, J.,  Barres, P., Rascol, A.  Aspects princi-
 paux des cures neuroplegiques en psychiatrie en 1956.
 [Principal features of neuroplegic therapy  in psychia-
 try in 1956.]  Toulouse me'd., 1956, 57: 851-867.
 Leake, C. D.  New mood-changing drugs.  Ohio M. J.,
 1956, 52: 369-373.
 Leiberman, D. M., Vaughan, G. F. The use of some new
 pharmacological agents in  psychiatry.  J.  Ment. Sc,
 Lond., 1957, 103:110-118.
 Margolis, L. H.  Pharmacotherapy in psychiatry; a re-
 view.  Ann. N.  York Acad. Sc, 1957, 66:698-718.
 Morgan,  D. R.   The  use  of  reserpine, chlorpromazine
 and allied drugs in medicine and psychiatry.  Med. J.
 Australia, 1956, 43 (1) : 1029-1035.
 Overholser, W.   La chlorpromazine, ouvre-t-elle une ere
 nouvelle  dans  les hopitaux  psychiatriques?   [Chlor-
 promazine—the beginning of a new era in  psychiatric
 hospitals?]  Ence'phale, 1956, 45:313-319.
 ----.  Psychobiologic  advances and the management of
 hospitalized patients.   J.  Clin. Exp. Psychopath., 1956,
 17: 378-380.
 Pennington, V. M.  Research findings  in phrenotropic
 drugs important to  every physician.  [benactyzine;
 chlorpromazine; mepazine;  meprobamate;  perphena-
 zine;  phenaglycodol;  Rauwolfia  serpentina   (whole
 root) ; reserpine; triflupromazine]  Mississippi Doctor,
 1957, 35:57-63.
 ----.  A two-year comparative study  of ataraxics in
 neuro-psychiatric patients.  J. Am.  Geriat.  Soc, 1957
 5:421-429.  [Not seen]
 Puca, A.  Nuove acquisizioni in terapia psichiatrica:
 ibernoterapia, sonno prolungato e neuroplegic^  [New
 acquisitions in  psychiatric therapy; artificial hiberna-
 tion, prolonged sleep  and neuroplegic  drugs.] [English
 summary]  Rass.  stud,  psichiat.,  1955,  44:849-856.
 Also: Ann. med. nav., Roma, 1956, 61: 42-49.
 Sargant,  W.  On chemical tranquillizers.  Brit. M. J.,
 1956, 1: 939-943.                                    *
 Smigel, J. O.   Mood therapy in the aged.  Med. Times,
 Great Neck, 1957, 85 :149-158.                       *

-Additional data
 Abrams,  R. E., Tice,  L. F.  Modern medicinals in  re-
 view. Am. J. Pharm., 1955,  127: 4-22.
 Allen, E. B.,  Prout,  C. T.   Alcoholism.  Progr. Neur.
 Psychiat., N.  Y., 1956,11: 338-351.
 Block, M. A.  Medical treatment of alcoholism.  J. Am.
 M. Ass., 1956,162 : 1610-1619.
 Funderburk, W. H., Wilcox, K. W., Wilcox, P. H.  Drug
 therapy; physiodynamic  therapy.  II. Progr. Neur.
 Psychiat., N.  Y., 1956, 11: 425-456.
 Hewitt,  D. W.   Alcoholism, a treatment guide for gen-
 eral  practitioners.  112 p.  Philadelphia,  Lea &  Febi-
 ger, 1957.                                           *
 Spencer,  R. S.  The use of ataraxic drugs in mental ill-
 ness.  Hawaii  M. J.,  1957, 16: 302.
 Stimulants and depressants.  Brit. M. J  1956  1 • 969-
 970.
 Tice, L. F.  Some important drug developments of 1956.
 Am. J. Pharm., 1956, 128: 398-409.
22 
SUBJECT LIST
Ataraxics : Various [3 or morel — Combined
   Tranquillizers.  Scot. M. J., 1957, 2: 46-47.
   Wortis, J.  Physiological treatment.  Am. J. Psychiat.,
   1956, 112: 526-529; 1957, 113 : 611-615.
 —Neuroses
   American Psychiatric Association.  The contribution
   of the tranquilizing  drugs and  the dangers in their
   casual use for relief of everyday tensions.   J. Iowa M.
   Soc, 1957, 47: 66.
   Ayd, F. J., Jr.  Tranquilizing drugs in private practice.
   N. York State J. M., 1957,  57:1742-1747.             *
   Batterman, R. C.  The evaluation of sedatives.  J. Am.
   Geriat. Soc, 1956,  4: 172-176.                        *
   Braun, M., Philipsborn, A.  Ataractics in private prac-
   tice.  Am. J. Psychiat., 1956, 113: 80-81.
   Cobb, S. Peace of mind.  Am. J. Psychiat., 1957, 113:
   663-664.
   Fazekas, J.  F., Shea, J.  G., Sullivan, P. D., Jr.  Atar-
   actics in medical practice.   GP, 1956, 14 (6) : 75-81.
   Feldman, D. J. Drug therapy  of  chronic  alcoholism.
   [chlorpromazine;  mephate; mephenesin;   mephenesin
   carbamate; meprobamate; promazine; reserpine.] Med.
   Clin. N. America, 1957, 41: 381-392.
   Fouks, Laine, Francois,  Pagot.  Note sur  les medica-
   tions recentes des  6tats nevrotiques anxieux et  depres-
   sifs.  [Note on recent medications  for anxious and de-
   pressive  neurotic  states.]   Ann. me'd. psychol., Par.,
   1956, 114 (1) : 608-615.
   French, E. G.  Epilepsy.  Am. J. Psychiat., 1957, 113:
   629-631.
   Gutenkauf,  C.  Internal  medicine.  In:   "Happiness
   pills" in medical practice:  a  symposium.  J. Iowa  M.
   Soc, 1957, 47: 59-64.
   Hazards of tranquillity.  Brit. M. J., 1957, 2: 92-93.   *
   Heilbrunn, G.  Selection of patients for modern psychi-
   atric  pharmacotherapy  in  general  practice.   North-
   west M., 1956, 55 :1198-1205.
   Held, R.  Sur  la  chlorpromazine et les  medicaments
   neuroleptiques;    incidences     psychotherapeutiques.
   [Chlorpromazine and neroleptic drugs ; psychotherapeu-
   tic incidences.]  Ence'phale, 1956, 45:1000-1004.
   Hubbard, O. E., Glasser,  J.  Newer  psychotropic drugs;
   their characteristics and use in general practice.  North-
   west M., 1956, 55:1191-1197.
   Leiberman, D. M., Vaughan, G. F. Tranquillizers. Prac-
   titioner, Lond., 1956,177 :  632-638.
   Moyer, J. H., Pevey, K., Kinross-Wright, V.   Tranquiliz-
   ing (ataractic)  agents: current  evaluation of their
   clinical use in patients who are not hospitalized,  [azac-
   yclonol ;  benactyzine; chlorpromazine;  ethylcrotonyl-
   urea ; hydroxyzine; meprobamate; phenaglycodol; pro-
   clorperazine; promazine] GP,  1957, 15 (6) : 97-118.   *
   Raymond, M. J., Lucas, C. J., Beesley, M. L., O'Connell,
   B. A., Roberts, J.  A.  F.  A trial of five tranquillizing
   drugs in psychoneurosis.  Brit. M.  J., 1957, 2:63-66.
   Sands, S. L.  Psychiatry.  In: "Happiness pills" in med-
   ical practice: a symposium. J. Iowa M. Soc, 1957, 47:
   64-65.                                              *
   Senseman, L. A. Tranquilizing drugs; uses  and abuses
   for the nervous patient.  Rhode Island M. J., 1956, 39:
   675-677; 680; 686.                                   *
   Skobba, J. S.   Drugs in  the management of emotional
   conditions, J. M. Ass. Georgia, 1956, 45:397-399.
   Sottong, P. C. The use and abuse of the tranquilizing
   drugs.  J. Tennessee M.  Ass.,  1956, 49:413-418.      *
   Weinberg, H. B.  Drug therapy for the emotionally and
   mentally disturbed; the  internists  point  of view.   J.
   Iowa M. Soc, 1957,47:17-19.

—Psychoses
  Bowes, H. A.  The ataractic drugs; the present posi-
  tion of chlorpromazine, frenquel, pacatal, and reserpine
  in  the  psychiatric  hospital. Am.  J.  Psychiat., 1956,
  113: 530-539.
  Feldman, P. E.  A comparative study of various atar-
  actic drugs.  Am. J. Psychiat., 1957, 113 : 589-594.    *
  Mielke, F. A.  Methods  employed and results obtained
  in psychiatric studies with new drugs acting on  the
  brain stem.  Am. J. Psychiat., 1957, 114: 134-139.
  Pennington, V. M.  A comparative study  of six  ata-
  raxics in 1130  neuro-psychiatric  cases.   Mississippi
  Doctor, 1956, 33: 336-339.
—Psychosomatic diseases
  Cahn, M. M.  The use of tranquilizing drugs  in derma-
  tology ; review and side reactions.  J.  Albert Einstein
  M. Center, 1956,  4:161-165.                         *
  Fabricant, N. D.  Tension  headache therapeutics.  Eye,
  Ear dc Month., 1956, 35: 658, 662.
  Friedman, A. P., Von  Storch, T. J.  A review of head-
  ache,  1950-1955.   N. York State J.  M., 1956,  56: 3883-
  3895.
  LeVan, P., Wright,  E. T.  Use of tranquilizers in dis-
  eases  of the skin; a preliminary report.  California  M.,
  1956, 85: 87-88.
  Mitis, Z. K.,  Ford, H.  Functional headaches.   Texas J.
  M., 1956, 52 : 678-683.
  Ogden, H. D.  Headache.  Ann. Allergy, 1956, 14: 385-
  428.
  Stewart, R. H. The use of tranquilizing drugs in gyne-
  cology.  West. J. Surg., 1956, 64: 650-657.
Untoward effects [see headnote p. 19].
  see ATARAXICS—Psychosocial considerations
     PHENOTHIAZINES—Untoward effects

Various [3 or more]—Combined
  Armour, P. S.  A regimen in acute alcoholism.   [Mephe-
  nesin+mephenesin carbamate+reserpine]  Arizona  M.,
  1956,13:169-172.
  Barsa, J. A., Kline,  N. S.  Use of meprobamate in  the
  treatment of psychotic patients. Am. J. Psychiat., 1956,
  112 :1023.  [ chlorpromazine+meprobamate+reserpine]
  Bouchard, M., Larue, G. H., Turmel, J.  Le frenquel en
  psychiatrie;  rapport preliminaire.   [Frenquel  in psy-
  chiatry ; preliminary report.]   [azacyclonol+chlorpro-
  mazine-|-reserpine]  Laval me'd., 1956, 21: 765-776.
  Fouks, Laine, Francois, Pagot. Note sur l'utilisation en
  psychiatrie d'un  nouveau neuroleptique.  [Note on  the
  use of a new neuroleptic drug in psychiatry.]  [chlor-
  promazine+hydroxyzine+reserpine]  Ann. me'd. psy-
  chol., Par., 1956,114 (1) : 605-608.
  ---,  ---, Pagaud.  Indications et modalites  d'admin-
  istration  des neuroleptiques  classiques.   [Indications
  and methods of administration of the classic neuroleptic
  drugs]   [chlorpromazine  cocktail4-reserpine]   Ann.
  me'd.  psychol, Par.,  1956, 114 (2) : 880-886.
  Fox,  V.   Treatment of withdrawal symptoms in  the
  management of  alcoholism,   [chlorpromazine+mepro-
  bamate-fpromethazine]  J. M. Ass. Georgia,  1956, 45:
  139-142.
  Lereboullet,  J., Pluvinage, R., Vidart, L.,  Benoit,  P.,
  Kapandji, I.  Le traitement du delirium tremens par la
  reserpine.  [Treatment  of delirium  tremens   with  re-
  serpine.]   [chlbr promazine'4- promethazine-)- reserpine]
  Bull.  Soc. me'd. hop. Paris, 1956, 72:604-605.
  Negri, V. U., Garavaglia, G.   Rilievi clinici sulla pecu-
  liare azione della reserpina in psichiatria.  [Reserpine
  in psychiatry; a  clinical study on its characteristic  ac-
  tion.]   [chlorpromazine cocktail+reserpine]   Minerva
  med., Tor., 1955,  46:1217-1229.
  Osinski, W. A.  Treatment of anxiety states  with me-
  probamate (miltown).   [chlorpromazine4-meprobamate
  4-resperpine],  Internat. Rec. M.,  1956, 169:589-595.
  Reda,  G. C, Germano,  V.  L'azione combinata della re-
  serpina e  cloropromazina nella  pratica  psichiatrica.
  [Combined effect  of reserpine and chlorpromazine in
  psychiatric practice.]   [English summary]    [chlorpro-
23 
Ataraxics: Various [3 or morel—Combined
PSYCHOPHARMACA
  mazine4-opilon+reserpine] Arch, psicol. neur., Milano,
  1956, 17 : 647-653.
  Silverberg, J. W., Gralnick, A.  Possible synergistic ac-
  tion of chlorpromazine, reserpine and frenquel.   A pre-
  liminary report.  Am. J. Psychiat., 1957, 114:173.

----with Shock therapies
  Bouchard, M., Larue, G. H., Turmel, J.  Le frenquel en
  psychiatrie; rapport preliminaire.  [Frenquel in psychi-
  atry; preliminary report]  [ azacyclonol 4-chlorproma-
  zine+reserpine+ECT]  Laval me'd., 1956,  21: 765-776.
  Fouks, L., Laine, Grimaud, Dariotis.  La fin des thera-
  peutiques de choc et l'avenement de nouvelles thSrapeu-
  tiques  psychiatriques actives; la reserpine (serpasil).
  [The end of shock therapies and advent  of the new
  psychiatric therapeutics; reserpine (serpasil).]  [chlor-
  promazine  cocktail4-reserpine4-CH 36  (=ICT)]  Ann.
  med. psychol., Par., 1954, 112 (2) : 764-768.        * *
  ---,---, Pagaud.  Indications et modalites d'adminis-
  tration  des neuroleptiques  classiques.   [Indications
  and  methods  of administration of  the classic  neuro-
  leptic  drugs.]   [chlorpromazine cocktail4-reserpine4-
  ICT] Ann. me'd. psychol, Par., 1956,114 (2) : 880-886.

 Various [3 or more]—Compared

  see also ATARAXICS—Studies, animals
  Armour, P. S.  A regimen in acute alcoholism.  [Mephe-
  nesin : mephenesin carbamate: reserpine.]   Arizona 31.,
  1956, 13:169-172.
  Barsa, J. A., Kline, N. S.  A comparative  study of re-
  serpine, chlorpromazine, and combined  therapy,   [chlor-
  promazine :  chlorpromazine+promethazine : chlorpro-
  mazine 4-reserpine : reserpine]   A. M.  A.  Arch. Neur.
  Psychiat., 1956, 76: 90-97.
  Bender, L., Nichtern, S.  Chemotherapy in child psy-
  chiatry,  [azacyclonol : chlorpromazine : mephenesin :
  meprobamate : promethazine: reserpine]  N. York State
  J. M., 1956, 56: 2791-2795.
  Chauchard, P., Mazoue, H.  Recherches sur le mode d'
  action centroplegique  de quelques substances  psycho-
  tropes.  [Research on the mode of  centriplegic action
  of some psychotropic substances.]  [chlorpromazine :
  covatin : meprobamate : reserpine]  C. rend. Soc biol,
  1956,150:158-160.
  De Busscher, J.  Impressions personnelles  sur les effets
  de l'atarax, de la chlorpromazine, de la reserpine et du
  AY 5406-1  (parasan) en therapeutique psychiatrique.
   [Personal   impressions  of  atarax,  chlorpromazine,
  reserpine  and  AY  5406-1  (parasan) in  psychiatric
  therapy]    [benactyzine: chlorpromazine: hydroxyzine :
  reserpine]   Ence'phale, 1956, 45 :1007-1023.
  Decourt, P. Mecanisme d'action de  la therapeutique
  narcobiotique en general, et de la chlorpromazine en par-
  ticulier, en psychiatrie.  [Mechanism  of action  of nar-
  cobiotic psychiatric  therapy in general, and of chlor-
  promazine in particular.]   [chlorpromazine : covatin :
  promethazine]  Ence'phale,  1956, 45 : 932-944.
  Elkes,  C.  Rauwolfia  alkaloids  and  reserpine  in the
  treatment  of the chronic psychotic patient,  [chlorpro-
  mazine+reserpine :  Rauwolfia  serpentina alkaloids :
   reserpine]  J. Ment. Sc, Lond., 1957, 103 : 464-474.
  Farah,  L.   Preliminary  study  on the use of hydroxy-
  zine  in psychosomatic  affections,   [chlorpromazine :
  hydroxyzine : resperine].  Internat. Rec. M., 1956, 169:
  379-389.  Abstract :  Excerpta med., Sect. 8, 1957, 10:
  No. 845.
  Fazekas, J. F., Shea,  J. C,  Sullivan,  P. D., Jr.  Atar-
  actics in medical practice,   [chlorpromazine : mepro-
  bamate : promazine : reserpine]  GP, 1956, 14 (6) : 75-
   81.
   Feldman, P. E.  A comparative study of various atar-
  actic drugs,  [azacyclonol :  chlorpromazine : chlorpro-
  mazine 4- reserpine : mepazine : reserpine]   Am.   J.
  Psychiat.,  1957, 113 : 589-594.
Ferguson, J. T., Linn,  F. V.  A new compound  for the
symptomatic treatment of tension and anxiety:  2-ethyl-
crotonylurea [nostyn.]  [ethylcrotonylurea :  meproba-
mate : reserpine : reserpine + methylphenidylacetate]
Antibiotic M., 1956, 3 :  329-333.
Forster, W., Henderson, A. L.  A clinical study  of fren-
quel (alpha[4-piperidyl]  benzhydrol hydrochloride) in
chronic schizophrenia,   [azacyclonol : chlorpromazine  :
reserpine]   Canad. M. Ass. J., 1957, 76: 97-101.
Fox,  V.  Treatment of withdrawal  symptoms in the
management of alcoholism,  [chlorpromazine : mepro-
bamate : promethazine]   J. M. Ass. Georgia,  1956, 45:
139-142.
Freedman, A. M., Effron,  A.  S., Bender,  L.  Pharma-
cotherapy in children  with  psychiatric illness,  [chlor-
promazine  :  mephenesin :  reserpine].  J.  Nerv. Ment.
Dis., 1955,  122: 479^486.  Abstract: Year book  of drug
therapy,  1956-1957, p.  350-351.
Friedman,  A. P.  Use  of tranquilizers in the treatment
of  headache,  [chlorpromazine : meprobamate  : reser-
pine] Am. Practitioner, 1957, 8: 94-97.
----, Von  Storch, T. J.  A review of headache, 1950-
1955.  [chlorpromazine : meprobamate : reserpine] N.
York State J. M., 1956, 56: 3883-3895.
Himwich, H. E., Rinaldi, F., Willis  D.  An examination
of phenothiazine derivatives with comparisons  of their
effects on the alerting reaction, chemical structure and
therapeutic efficacy,  [chlorpromazine  : mepazine : NP-
207 :  promazine : promethazine : pyrathiazine]   J.
Nerv. Ment.  Dis., 1956, 124: 53-57.
Kugelmass, I.  N.  Psychochemotherapy of mental de-
ficiency  in  children,  [chlorpromazine: mephenesin:
meprobamate: methylphenidylacetate: reserpine]   In-
ternat. Rec. M., 1956, 169 : 323-338.
Kurtzke, J. F.   Seizures with promazine.  Preliminary
report.   [: promazine+meprobamate;   : promazine4
reserpine;  : promazine4-methylphenidylacetate ; : meth-
ylphenidylacetate]  J.  Nerv. Ment. Dis., 1957.  125:119-
125.
Lasagna, L., McCann, W. P.  Effect  of "tranquilizing"
drugs on  amphetamine toxicity  in   aggregated  mice.
[chlorpromazine: promazine : reserpine]  Science, 1957,
125: 1241-1242.
Lehmann,  H. E., Csank, J.  Differential  screening of
phrenotropic  agents  in  man: psychophysiologic  test
data.    [chlropromazine  : proclorperazine : reserpine:
other drugs=depressants,  stimulants]  J. Clin. Exp.
Psychopath., 1957,  18 : 222-235.
Leiberman,  D.  M., Vaughan, G. F.  The  use  of some
new pharmacological  agents in psychiatry,   [chlorpro-
mazine : mepazine : reserpine]  J. Ment. Sc, Lond., 1957,
103:110-118.
Lemere, F.  Failure  of azacyclonol   (frenquel) to re-
lieve non-experimental mental confusion and  hallucina-
tions,  [azacyclonol : chlorpromazine : meprobamate :
reserpine]  Am. J. Psychiat., 1957, 113: 840-841.
---.  New  tranquilizing  drugs.   [chlorpromazine:
meprobamate: reserpine]  Northivest  M.,  1955,  54:
1098-1100.
---.  Promazine (sparine) in the treatment of psychi-
atric  disorders,  [chlorpromazine:  meprobamate: pro-
mazine : reserpine]  Northivest  M., 1956, 55 : 790-791.
 LeVan, P., Wright, E. T.   Use of tranquilizers in dis-
 eases of the skin; a preliminary report,  [chlorproma-
 zine : meprobamate: reserpine]  California M.,  1956, 85:
 S7-88.
 Malitz, S., Hoch, P. H., Lesse, S. A two-year  evaluation
 of chlorpromazine in clinical research  and  practice.
 [azacyclonol: chlorpromazine: reserpine]   Am. J. Psy-
 chiat., 1956, 113: 540-545.
 Margolis,  L. H.  Pharmacotherapy in psychiatry; a re-
 view,  [azacyclonol:  chlorpromazine: chlorpromazine+
 reserpine: meprobamate: reserpine]   Ann   N   York
 Acad. Sc, 1957. 66 : 698-718.
24 
SUBJECT LIST
Azacyclonol: Studies, animals
  Moyer, J. H., Pevey, K., Kinross-Wright, V.  Tranquil-
  izing  (ataractic) agents: current evaluation of their
  clinical use in patients who are not hospitalized,  [ben-
  actyzine  : chlorpromazine : meprobamate: phenaglyco-
  dol : promazine : reserpine]  GP, 1957, 15 (6) : 97-118.
  A  new drug  effective  on the central nervous system.
  [In English]  [benactyzine: chlorpromazine: reserpine]
  Danish M. Bull, 1955, 2:159-160.
  Noell, W. K., Chinn, H.  I.,  Haberer,  C. E.  Electroen-
  cephalographic evaluation of  the  sedative  effects  of
  antihistaminic  drugs,   [promethazine;  pyrathiazine;
  thiazinamium]  Air Force School of Aviation Medicine,
  Randolph Air Force Base, Texas, 1955 (55-35) : 1-20.
  Osinski,  W. A.  Treatment  of anxiety states with me-
  probamate  (miltown).   [chlorpromazine :  meproba-
  mate : reserpine] Internat. Rec M., 1956,169: 589-595.
  Ostenfeld, I.  Psykiske  urotilstande.  [Mental excite-
  ment.]   [English summary]  [benactyzine: chlorproma-
  zine : reserpine]   Nord. med., 1955, 54: 1517-1522.
  Pennington, V. M. A comparative study of six ataraxics
  in  1130  neuro-psychiatric cases,   [azacyclonol: chlor-
  promazine : meprobamate : pipradrol: Rauwolfia  serpen-
  tina  alkaloids,  whole  root: reserpine]  Mississippi
  Doctor, 1956, 33 : 336-339.
  ---.   A  two-year  comparative study of ataraxics  in
  neuro-psychiatric patients.  J. Am. Geriat. Soc, 1957,
  5:421-429.   [Not seen.]
  Pevey, J. K., Moyer, J. H.,  Handley,  C.  A., Heider,  C.
  A  comparison  of clinical  results with  phenobarbital,
  meprobamate and two  similar experimental compounds.
  [Abstract]  [benactyzine :  meprobamate : phenaglyco-
  dol]  J.  Pharm. Exp. Ther.,  1957, 119 :176.          *
  Raymond, M. J, Lucas, C. J., Beesley, M. L., O'Connell,
  B. A., Roberts, J. A. F.   A  trial of five tranquillizing
  drugs  in psychoneurosis.   [benactyzine :  chlorproma-
  zine :  meprobamate :  sedaltine  ( :amylobarbitone).]
  Brit. M. J., 1957, 2 : 63-66.
  Rinaldi, F., Rudy, L. H., Himwich, H. E.  Clinical evalu-
  ation of  azacyclonol, chlorpromazine, and reserpine  on
  a  group  of chronic psychotic  patients,   [azacyclonol:
  chlorpromazine: mepazine: reserpine] Am. J. Psychiat.,
  1956,  112 : 678-683.   Abstract: Excerpta med., Sect. 8,
  1956, 9 : No. 4986.
  Robinson, H. M., Jr.,  Robinson,  C. V., Strahan, J.  F.
  Hydroxyzine (atarax) hydrochloride in dermatological
  therapy,   [chlorpromazine  : hydroxyzine :   meproba-
  mate]  J. Am. M. Ass., 1956, 161: 604-606.
  Rudy, L.  H., Himwich, H. E., Tasher,  D. C.  Clinical
  evaluation of two phenothiazine compounds promazine
  and  mepazine.    [chlorpromazine:  mepazine : proma-
  zine]   Am. J. Psychiat., 1957, 113:979-983.
  ---, Rinaldi, F., Himwich,  H. E.   Comparative effects
  of azacyclonol, reserpine, and chlorpromazine  on mod-
  erately disturbed psychotic patients with long histories
  of hospitalization.   Psychiat.  Res. Rep., Wash., 1956
  (4) : 49-63.
  Shea, J.  G.,  Ehrmantraut, W. R., Ticktin, H.  E., Sul-
  livan, P. D., Jr., Fazekas, J. F.  Use of promazine in the
  management  of medical emergencies,  [chlorpromazine:
  promazine: promethazine]   Mil. M., 1956, 119 : 221-227.
  Smigel, J. O.  Mood therapy in the aged,   [chlorproma-
  zine : meprobamate  : promazine :  reserpine]  Med.
  Times, Great Neck,  1957, 85: 149-158.


with ATARAXICS
  see [Ataraxic A] with [Ataraxic B]

with ATARAXICS [2  or  more]
  see ATARAXICS— Various [3 or more]

with PSYCHOTOMIMETICS
  see [Psychotomimetic] with [Ataraxic]
      PSYCHOTOMIMETICS with  ATARAXICS
with STIMULANTS
  see also [Ataraxic]  with [Stimulant]
  Fabing, H. D.  The newer analeptic drugs.  Med. Clin.
  N. America, 1957, 41: 339-351.
AZACYCLONOL
  Symposium: Clinical value and limitations of reserpine,
  meratran, and a "new blocking agent."  Psychiat. Res.
  Rep., Wash., 1955 (1) : 105-152.  [All articles are listed
  individually]

Pharmacodynamics
  Bergy, G. A.  Drugs of  sedation with tranquilizing ef-
  fects.   Am. Profes. Pharmacist, 1956, 22: 419 ; 534-538 ;
  619-621; 709-710; 797-799; 888-889;  917-919.  [419;
  534-538.]
  Carr, C. J., Kinnard, W. J., Jr.  The phrenotropic agents.
  Internat. Rec. M., 1957, 170:493-504.
  Himwich, H. E.  Prospects  in psychopharmacology.  J.
  Nerv.  Ment. Dis., 1955, 122: 413-423.  Also:  Dis. Nerv.
  Syst.,  1956, 17:109-116.
  Leake, C. D. Drugs affecting mood and behavior. Texas
  Rep. Biol. M., 1955, 13:  793-818.
  ----.   New  mood-changing  drugs.  Ohio M. J., 1956,
  52: 369-373.
  Orsi,   C.   I  farmaci   atarassici.  [Ataraxics] Boll.
  chim.  farm., 1956, 95: 432-436.
  Pennes, H. H.  The nature of drugs with mental actions
  and their relation to cerebral function.   Bull.  N. York
  Acad. M., 1957, 33 : 81-88.
  Perrault, M.   Sur les tranquilliseurs.   [Tranquilizers.]
  Progr. me'd., Par., 1957,  85:3-4; 7.

Psychotherapeutic use

  see also AZACYCLONOL—Therapeutic  studies, con-
  trolled—Psychoses
     [ SARWER-F0NER4- KORAN YI ]
  Silverberg,  J.  W.,  Gralnick,  A.  Possible synergistic
  action  of chlorpromazine,  reserpine and frenquel. A
  preliminary report. Am. J. Psychiat., 1957, 114: 173.
  Toll, N.  Azacyclonol as an adjunct to psychotherapy.
  In: Himwich, H.  E.,  ed. Tranquilizing drugs.  Wash-
  ington, Am. Ass. Adv. Sc, 1957.  p. 103-113.
Studies,  animals
  Brown, B.  B.  Lysergic acid diethylamide antagonism
  of certain drugs.  Ann. N. York Acad. Sc, 1957, 66: 677-
  685.
  ---, Braun, D. L., Feldman, R. G.  The pharmacologic
  activity of alpha-(4-piperidyl)-benzhydrol hydrochloride
  (azacyclonol hydrochloride) ;  an  ataractive agent. J
  Pharm. Exp. Ther., 1956, 118: 153-161.
  ---, Feldman, R., Braun, D. L. Pharmacologic studies
  of an  LSD antagonist 4-piperidyl  diphenyl carbinol hy-
  drochloride.   [Abstract]  Fed. Proc,  Bait., 1955   14-
  322.
  Haley, T. J., McCormick,  W.  G.  Pharmacological ef-
  fects produced by intracerebral injection of drugs in the
  conscious mouse.  University  of  California, School of
  Medicine, Atomic Energy  Project,  Los  Angeles,  1956
  (UCLA-372) :  1-25.
  Himwich, H. E.  Discussion of papers on basic observa-
  tions of new psychopharmacological agents.  Psychiat.
  Res. Rep., Wash., 1956  (4) : 24-31.
  ----.   The effect of frenquel on EEG changes produced
  by  LSD-25  and mescaline.  In:  Cholden, L.,  ed.   Ly-
  sergic acid diethylamide and mescaline in experimental
  psychiatry.  New York,  Grime & Stratton, 1956.  p. 19-
  26.
  Lim, R. K., Pindell, M.  H.,  Glass, H. G.,  Rink, K.  The
  experimental evaluation of sedative agents in animals.
  Ann. N. York Acad. Sc, 1956, 64:667-678.
25 
Azacyclonol: Studies, animals
PSYCHOPHARMACA
  Marrazzi, A. S.,  Hart,  E.  R.  An  electrophysiological
  analysis of drugs useful in psychotic states.  In: Him-
  wich, H. E., ed. Tranquilizing drugs.  Washington, Am.
  Ass. Adv. Sc, 1957.  p. 9-21.
  ___,---.   An electrophysiological analysis of the ac-
  tions of some drugs useful in the therapy of psychotic
  disorders.  J. Nerv. Ment. Dis., 1956,  124:388-392.
  Monroe, R. R., Heath, R. G., Mickle, W. A., Miller, W.
  Cortical and subcortical recordings correlated with be-
  havior in patients and animals during the administra-
  tion of Rauwolfia, thorazine, and meratran.  Psychiat.
  Res. Rep., Wash., 1955  (1):  25-44. Abstract:  Chem.
  Abstr., 1956, 50: 2867gh.
  Norton, S., De Beer, E. J.  Effects  of drugs on the be-
  havioral patterns of cats.  Ann. N. York Acad. Sc, 1956,
  65'249—257.
  Peters, J. J., Vonderahe, A.  R.  Behavior of the sala-
  mander under the influence of LSD-25 and frenquel, and
  accompanying electrical activity of brain  and spinal
  cord. J. Nerv. Ment. Dis., 1956, 124: 69-73.
  Pfeiffer, C. C, Jenney, E. H.  The inhibition of the con-
  ditioned response and the counteraction of schizophrenia
  by muscarinic stimulation of the brain.  Ann. N. York
  Acad. Sc, 1957, 66: 753-764.
  Rinaldi, F.  The  experimental electroencephalographic
  approach to psychopharmacology.  Psychiat. Res. Rep.,
  Wash., 1956 (4) :  1-10.
  ---, Himwich, H. E.  Frenquel corrects certain cere-
  bral electrographic changes.  Science,  1955, 122:198-
  199.
  ---,----.   Drugs affecting psychotic behavior and the
  function  of the  mesodiencephalic  activating  system.
  Dis. Nerv. Syst., 1955, 16:133-141.   Abstract: Excerpta
  med., Sect. 8, 1956, 9 : No. 4566.
  ---, ----.  The  cerebral electrographic  changes in-
  duced by LSD and mescaline are corrected by frenquel.
  J. Nerv. Ment. Dis., 1955, 122: 424-432.  Abstract: Ex-
  cerpta med., Sect. 8, 1957, 10: No. 1601.
  Turner, W. J.  The effect of  lysergic acid diethylamide
  on  Betta  splendens.  II.  Frenquel. Dis. Nerv.  Syst.,
  1956,17:198.
Studies, normal subjects
  Brown, B. B., Braun, D. L., Feldman, R. J.  The phar-
  macologic activity of alpha-(4-piperidyl)-benzhydrol hy-
  drochloride  (azacyclonol hydrochloride) ; an ataractive
  agent.  J. Pharm. Exp. Ther., 1956, 118:153-161.
  Fabing, H. D.  Experimental compound MER-17  (fren-
  quel) : a new blocking  agent against the development
  of LSD-25 psychosis.  Tr. Am. Neur. Ass., 1955, 80th
  Meeting:  83-85.   Also: Psychiat. Res. Rep.,  Wash.,
  1955 (1): 140-144.  Abstract: Excerpt a med., Sect. 8,
  1957, 10: No. 1527.
  ---. Frenquel, a blocking agent against experimental
  LSD-25 and mescaline psychosis;  preliminary note on
  its clinical application.  Neurology, 1955, 5: 319-328.
  ----. New  blocking agent against  the development of
  LSD-25 psychosis.  Science,  1955, 121:208-210.
  Isbell, M., Logan, C. R.  Studies on the diethylamide of
  lysergic acid (LSD-25). II.  Effects of chlorpromazine,
  azacyclonol, and reserpine on the intensity of the LSD-
  reaction.  A. M.  A. Arch. Neur. Psychiat., 1957,  77:
  350-358.
Studies, patients
  Himwich, H. E.  The effect of frenquel on EEG changes
  produced by LSD-25 and mescaline.   In:  Cholden,  L.,
  ed.   Lysergic acid diethylamide and mescaline in ex-
  perimental psychiatry.  New York, Grune &  Stratton,
  1956. p. 19-26.
  Monroe, R. R., Heath, R. G., Mickle, W. A., Miller,  W.
  Cortical and subcortical recordings correlated with be-
  havior in patients and animals during  the  administra-
  tion of Rauwolfia, thorazine, and meratran. Psychiat.
  Res. Rep.,  Wash., 1955 (1): 25-44.  Abstract: Chem.
  Abstr., 1956, 50: 2867gh.
Therapeutic  studies, controlled
  Toll, N.  Azacyclonol as an adjunct to psychotherapy.
  In:  Himwich,  H. E., ed. Tranquilizing drugs.  Wash-
  ington, Am. Ass. Adv. Sc, 1957.   p. 103-113.

—Psychoses
  Bender, L., Nichtern,  S.  Chemotherapy in child psy-
  chiatry.  N. York State J. M„ 1956, 56: 2791-2795.
  Bouchard,  M., Larue, G. H., Turmel, J.  Le frenquel en
  psychiatrie;  rapport preliminaire.  [Frenquel in psy-
  chiatry;  preliminary report.]  Laval me'd., 1956, 21:
  765-776.
  Bowes, H. A.  The ataractic drugs; the present position
  of chlorpromazine, frenquel, pacatal,  and reserpine in
  the psychiatric  hospital.  Am. J. Psychiat., 1956, 113:
  530-539.
  Clark, L. D.  Further studies of the psychological effects
  of frenquel and a critical review of  previous reports.
  J. Nerv. Ment. Dis., 1956,  123: 557-560.
  Feldman, P. E.  A comparative study  of various atar-
  actic drugs.  Am. J. Psychiat., 1957,  113:589-594.
  Ferguson,  J. T.  Azacyclonol: use of a new pharma-
  cologic agent in chronic schizophrenia. Antibiotic M.,
  1956, 3:146-150.
  Forster,  W., Henderson, A. L.  A  clinical  study of
  frenquel  (alpha[4-piperidyl] benzhydrol hydrochloride)
  in chronic  schizophrenia.  Canad. M. Ass. J.,  1957, 76:
  97-101.
  Lemere, F.  Failure of azacyclonol (frenquel) to relieve
  non-experimental mental confusion and hallucinations.
  Am. J. Psychiat., 1957,  113 : 840-841.
  Lindan, O., Cahn, C. H., Lehmann, H. E. Clinical obser-
  vations with frenquel in chronic schizophrenia. Canad.
  Psychiat. Ass. J., 1956, 1: 89-91.
  Mason-Browne, N. L.  Selection  of patients for  treat-
  ment with alpha-4-piperidyl benzhydrol hydrochloride.
  J. Nerv. Ment. Dis., 1956,  123:130-140.
  Odland,  T. M.  Azacyclonol (frenquel)  hydrochloride
  in the  treatment  of chronic schizophrenia; a double-
  blind, controlled study.  J. Am. M. Ass., 1957,  165: 333-
  335.
  Peak, E. C, Canestrari, R.  E.,  Roebuck, B. E.  The ef-
  fects of  frenquel upon chronic disturbed patients.  J.
  Nerv. Ment. Dis., 1956, 124: 504-506.  Condensed: Am.
  J. Psychiat., 1957, 113 :  653.
  Pennington, V. M. A comparative study of six ataraxics
  in  1,130  neuro-psychiatric  cases.  Mississippi Doctor,
  1956, 33: 336-339.
  Rinaldi, F., Haynes, E.  E., Rudy, L. H., Himwich, H. E.
  Therapeutic effects of azacyclonol in psychotic patients.
  In:  Himwich,  H. E., ed. Tranquilizing drugs.  Wash-
  ington, Am. Ass. Adv. Sc, 1957.  p. 115-123.
  ---, Rudy, L. H., Himwich, H. E.  Clinical evaluation
  of  azacyclonol, chlorpromazine,  and  reserpine  on  a
  group of chronic psychotic  patients.   Am. J. Psychiat.,
  1956, 112:678-683.  Abstract: Excerpta med., Sect. 8,
  1956, 9: No. 4986.
  Rosner, B. S.,  Fierman, L.  B„ Kramer, J. F.  Clinical
  evaluation of meratran and frenquel on a chronic psy-
  chotic population. Am. J. Psychiat., 1957, 113 : 993-996.
  Rudy,  L. H., Rinaldi,  F., Himwich,  H.  E.   Compara-
  tive effects of  azacyclonol,  reserpine, and chlorproma-
  zine on  moderately disturbed psychotic patients with
  long histories of hospitalization.  Psychiat. Res. Rep.,
  Wash., 1956 (4) :  49-63.
  Sarwer-Foner,  G. J., Koranyi, E. K.  Clinical investi-
  gation of  azacyclonol  hydrochloride,  an  alleged anti-
  hallucinatory, anticonfusional  agent.  Canad. Psychiat.
  Ass. J.,  1956, 1:92-98.                              *

Therapeutic  use—Psychoses

  Allin, T. G., Jr., Pogge, R. C.  The use of  azacyclonol
  and pipradrol  in general practice.  Internat Rrr  V
  1956, 169:222-230.
26 
SUBJECT LIST
Azacyclonol: Therapeutic use — Psychoses — Additional data
 Ayd, F. J., Jr.  A clinical evaluation of frenquel.  J.
 Nerv. Ment. Dis., 1956, 124: 507-509.
 Barsa, J. A., Kline, N.  S.  Azacyclonol  (frenquel) in
 the treatment of chronic schizophrenics.  Am. J. Psy-
 chiat., 1956, 113:255-256.
 Bensoussan, P., Villiaumey, E. M., Rousseau, J.  Action
 symptomatique de l'azacyclonol sur un syndrome hallu-
 cinatoire  et  interpr6tatif  presentation  de  malade.
 [Symptomatic  (therapeutic)  effect of azacyclonol on a
 hallucinatory  and paranoid syndrome;  case presenta-
 tion.]  Ann. me'd. psychol, Par., 1956,  114 (1)  : 821-
 825.
 The chemical concept of psychoses.  What's new, 1955
 (189) : 3-7.
 Coats, E. A., Gray,  R. W.  Frenquel: clinical impres-
 sions  on the use of a new drug in the treatment of
 mental illness.   Nebraska M. J.,  1956, 41: 460-461.
 Cohen, S., Parlour, R. R. Preliminary observations on
 use of frenquel in hospital psychiatry.  J. Am. M. Ass.,
 1956, 162: 948-950.
 Collomb, H., Miletto,  G., Robert, H. Le frenquel en
 therapeutique psychiatrique.   [Frenquel in psychiatric
 therapy.]   Presse me'd.,  1956, 64:1602-1604.
 Fabing, H. D.  Adventures  in clinical neuropharma-
 cology.  Internat. Rec. M., 1956, 169:115-119.
 ---.  The dimensions of neurology.  Neurology, 1955,
 5: 603-611.  Abstract: Excerpta med., Sect. 8, 1956, 9 :
 No. 1718.
 ---.  Experimental compound MER-17  (frenquel) : a
 new blocking agent against the development of LSD-25
 psychosis. Tr. Am. Neur. Ass.,  1955, 80th Meeting: 83-
 85. Also:  Psychiat. Res. Rep., Wash., 1955 (1)  : 140-
 144.   Abstract: Excerpta med., Sect. 8, 1957, 10: No.
 1527.
 ---.  Frenquel, a blocking agent against experimental
 LSD-25 and mescaline psychosis; preliminary note on
 its clinical application.   Neurology, 1955, 5: 319-328.
 ---.  Trends in biological research in schizophrenia.
 J. Nerv. Ment. Dis., 1956, 124:1-7.
 ---, Hawkins, J. R. A year's experience with frenquel
 in clinical  and  experimental  schizophrenic psychoses.
 Dis. Nerv. Syst., 1955, 16: 329-338.  Abstract: Excerpta
 med.,  Sect. 8, 1956, 9: No. 4540.
 Fouks, Laine, Francois, Pagot.  La correction des effets
 secondaires des medications dites  neuroleptiques.  [Cor-
 rection of the secondary effects of so-called neuroleptic
 drugs.]  Ann. me'd. psychol, Par., 1956, 114 (1)  : 615-
 620.
 Moyer, J. H., Pevey, K., Kinross-Wright, V.  Tranquiliz-
 ing (ataractic)  agents:  current evaluation of their
 clinical use in patients who are not hospitalized.  GP,
 1957,15 (6) : 97-118.
 Niswander,  G. D.,  Holt,  E.  K.  Chemotherapy with
 azacyclonol in mental illness.  J. Nerv. Ment. Dis., 1956,
 123:473-476.
 Proctor, R. C, Odland, T.  Frenquel. Dis. Nerv. Syst.,
 1956, 17: 25-28.  Abstract: Excerpta med., Sect. 8, 1956,
 9: No. 4539.
 Puca,  A., Catapano,  V. D.  Un nuovo psicofarmaco: il
 frenquel.   [A new psychopharmacon: frenquel.]   Acta
 neur.,  Nap.,  1956,  11:526-529.   Abstract:  Excerpta
 med., Sect.  8, 1957, 10: No. 2082.
 Rinaldi,  F., Rudy, L. H., Himwich, H. E.  The use of
 frenquel in the  treatment of disturbed patients with
 psychoses  of long duration.  Am. J. Psychiat.,  1955,
 112:343-348.
 Sargant, W.  On  chemical tranquillizers.  Brit.  M. J.,
 1956, 1: 939-943.                                    *
 Silverberg,  J. W., Gralnick, A.  Possible  synergistic ac-
 tion of chlorpromazine, reserpine  and frenquel.  A pre-
 liminary report.   Am. J.  Psychiat., 1957, 114:173.
Turner, W. J., Merlis, S.  Chemotherapeutic trials in
psychosis.   I. Frenquel and pilocarpine.  Am. J. Psy-
chiat.,  1956, 113:248-249.
----Additional data
  Alexander, L.  Therapeutic process in electroshock and
  the newer drug therapies; psychopathological consider-
  ations.  J. Am. M. Ass., 1956, 162: 966-969.
  ---.   Objective approaches to treatment in psychiatry.
  Canad. Psychiat. Ass. J., 1957, 2:  77-94.
  Block, M. A.  Medical treatment of alcoholism.  J. Am.
  M. Ass., 1956, 162:1610-1619.
  Cohen, I. M.  Drugs  recently introduced in the treat-
  ment  of psychiatric disorders.  Texas  J. M., 1956, 52:
  683-687.
  Deniker, P.  Hibernotherapies et medicaments neuro-
  leptiques  en therapeutique  psychiatrique.  [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapy.]
  Encphale, 1957, 46:  281-398.  [363-64]
  Fabing, H. D.  The ataractic drugs: their uses and lim-
  itations in psychiatry.  Am.  Profes. Pharmacist, 1956,
  22: 413-418.
  ----.   The new pharmacologic attack in  psychiatry.
  Internat. Rec M., 1956, 169: 177-183.  Also:  Drug &
  Cosmet. Indust., 1956, 78: 32-33 ; 125-129.
  Fremming, K.  H.  Medikamentel behandlung af syn-
  dssygdomme.  [Medical treatment of mental disorders.]
  Mskr. prakt. laegegern., Kbh., 1956, 34: 331-342.
  Freyhan, F. A., Turner, P., Stenzler, R.   New drug ther-
  apies  in psychiatry.   Delaware M. J., 1956, 28: 180-186.
  Funderburk, W. H., Wilcox, K. W., Wilcox,  P. H.  Drug
  therapy;  physiodynamic  therapy.   II.  Progr.  Neur.
  Psychiat., N. Y., 1956, 11: 425^56.
  Graffagnino, P. N., Furr, J. H. New Drugs in the treat-
  ment  of  emotional  disorders;  a  review.  Connecticut
  M. J., 1957, 21: 38-43.
  Green, A.  Actualites  therapeutiques 1955 en psychi-
  atrie.   [Therapeutic progress in  psychiatry in 1955.]
  Ence'phale, 1956, 45 :172-200.
  Hagenauer, F., Rudy, L. H., Himwich,  H. E.  A com-
  parative evaluation of two central system stimulants in
  severe psychoses.  J.  Clin. Exp. Psychopath., 1957,  18:
  248-257.   Condensed as:  A comparative study  of two
  central nervous system  stimulants, MER-22 and  S.
  K. F.#5, on chronic, blocked and withdrawn psychotic
  patients.   Am. J. Psychiat.,  1957, 113: 840.
  Heilbrunn, G.  Selection of  patients for modern psy-
  chiatric pharmacotherapy in general practice.  North-
  west M., 1956, 55:1198-1205.
  Hilliard,  E. T.  The use of  reserpine,  chlorpromazine
  and allied  drugs in medicine and psychiatry.  Med. J.
  Australia, 1956, 43 (1) : 1035-1040.
  Hubbard, O. E., Glasser, J.  Newer  psychotropic drugs;
  their characteristics and use in general practice.  North-
  west M., 1956, 55 :1191-1197.
  Kautz, H. D.  Trends in drug therapy.  Hosp.  Progr.,
  1957, 38 (1) : 102-108; 126.
  Keyes, B.  L.  Ataraxic  drugs.  Pennsylvania  M. J.,
  1957, 60:177-181.
  Kinross-Wright, V.   A review of  the newer drug ther-
  apies in psychiatry.   Dis. Nerv. Syst., 1956, 17:187-190.
  Kline,  N.  S.  Chemotherapy  in psychiatry; recent ad-
  vances.  Seminary Internat., Hoddesdon, 1956.  5  (2)  •
  7-10.
  Klingman,  W.  O.  Neurological  and psychiatric dis-
  orders ; some recent advances in  therapy.  Virqinia M
  Month., 1956, 83 : 240-246.
  Laboucarie, J.,  Barres, P., Rascol,  A.   Aspects princi-
  paux des cures neuroplegiques en psychiatrie en 1956.
  [Principal  features  of neuroplegic therapy  in  psychi-
  atry in 1956.]  Toulouse me'd., 1956, 57:  851-867.
  Leiberman,  D. M.,  Vaughan, G. F.  Tranquillizers.
  Practitioner, Lond., 1956, 1^7 : 632-638.
  Margolis, L. H.  Pharmacotherapy  in psychiatry; a re-
  view.   Ann. N.  York Acad. Sc, 1957, 66:698-718.
  Martin, D. A.  The therapeutic and toxic effects of tran-
  quilizing  drugs: medical  aspects.  North  Carolina M
  J., 1956, 17 : 396-401. 
Azacyclonol : Therapeutic use — Psychoses — Additional data
PSYCHOPHARMACA
  Morgan,  D. R.  The use of reserpine, chlorpromazine
  and allied drugs in medicine and psychiatry.  Med. J.
  Australia, 1956, 43 (1) : 1029-1035.
  Senseman, L. A.  Tranquilizing drugs; uses and abuses
  for the nervous patient.  Rhode Island M. J., 1956, 39:
  675-677; 680; 686.
  Sottong, P. C.  The use and abuse of the tranquilizing
  drugs.  J. Tennessee M. Ass., 1956, 49: 413^18.
  Spencer, R. S.  The use of ataraxic drugs  in  mental
  illness.  Hawaii M. J., 1957, 16: 302.
  Stimulants and depressants.  Brit. M. J., 1956,  1: 969-
  970.
  Tranquillizers in psychiatry.  [Report on Royal Med-
  ico-Psychological Association Meeting, London,  Febru-
  ary 1956.]  Brit. M. J., 1956, 1: 512-513.
  Wortis, J.  Physiological treatment.  Am. J. Psychiat.,
  1956, 112: 526-529; 1957,113 : 611-615.


with ATARAXICS [2 or more]
  see ATARAXICS—Various  [3 or more]

with BGE—INTERACTION—Studies, normal  subjects
  see BGE [sherwood]

with CHLORPROMAZINE—COMBINED
Psychotherapeutic use
  see AZACYCLONOL—Psychotherapeutic use

Therapeutic use
  Ayd, F. J., Jr. Physiologic  and neurologic responses to
  chlorpromazine: their clinical significance  and their
  management.  Psychiat.  Res. Rep., Wash.,  1956  (4) :
  64-70.
  Barsa, J. A., Kline, N. S.  Azacyclonol (frenquel) in the
  treatment of  chronic schizophrenics.  Am. J. Psychiat.,
  1956,113: 255-256.
  Bouchard, M., Larue, G. H., Turmel, J.  Le frenquel en
  psychiatrie;  rapport preliminaire.  [Frenquel in psy-
  chiatry;  preliminary report]  Laval  me'd., 1956,  21:
  765-776.
  Cohen, S., Parlour, R. R. Preliminary observations on
  use of frenquel in hospital psychiatry.   J. Am. M. Ass.,
  1956, 162: 948-950.
  Fabing, H. D., Hawkins, J. R. A year's experience with
  frenquel in clinical and experimental schizophrenic psy-
  choses.  Dis.  Nerv. Syst., 1955,  16: 329-338.  Abstract:
  Excerpta med., Sect. 8,1956, 9 : No. 4540.
  Feldman, P.  K.  Two-year fate  study of  thorazine-
  treated patients.  Am.  J. Psychiat., 1957, 114: 237-240.
  Ferguson, J.  T.  Azacyclonol:  Use of a  new pharma-
  cologic agent in chronic schizophrenia.  Antibiotic M.,
  1956, 3: 146-150.
  Senseman, L. A.  Tranquilizing drugs; uses and abuses
  for the nervous patient.  Rhode Island M. J., 1956, 39:
  675-677; 680; 686.

with CHLORPROMAZINE—COMPARED

Studies, animals
  Haley, T. J., McCormick, W. G.  Pharmacological effects
  produced by intracerebral injection of drugs  in the con-
  scious mouse.  University of California, School of Med-
  icine,   Atomic  Energy Project,  Los  Angeles,  1956
  (UCLA-372)  : 1-25.

Studies, patients
  Malitz, S., Hoch, P. H., Lesse,  S.  A two-year evalua-
  tion of chlorpromazine  in clinical research  and prac-
  tice.  Am. J.  Psychiat., 1956, 113 : 540-545.

Therapeutic use
  Puca, A., Catapano, V. D.  Un  nuovo psicofarmaco:  il
  frenquel.   [A new  psychopharmacon : frenquel.]  Acta
  neur.,  Nap.,  1956,  11: 526-529.  Abstract:  Excerpta
  med., Sect. 8, 1957, 10: No. 2082.

with ETHYLCROTONYLUREA—COMBINED
  Ferguson, J. T.  Azacyclonol: use of a new pharmacol-
  ogic agent  in  chronic  schizophrenia.  Antibiotic M.,
  1956, 3:146-150.
with LYSERGIC ACID DIETHYLAMIDE
  see  LYSERGIC ACID DIETHYLAMIDE with AZACY-
        CLONOL—INTERACTION

with MER-22—COMPARED—Pharmacodynamics
  see  MER-22—Therapeutic studies, controlled

with MEPAZINE—COMBINED

Therapeutic studies, controlled
  Bouchard, M., Larue, G. H., Turmel, J.  Le frenquel en
  psychiatrie;  rapport preliminaire.  [Frenquel in psy-
  chiatry;  preliminary  report]   Laval me'd., 1956, 21:
  765-776.

with MEPROBAMATE—COMBINED
  see  AZACYCLONOL—Psychotherapeutic use

with MESCALINE
  see  MESCALINE with AZACYCLONOL

with METHYLPHENIDYLACETATE—COMBINED

Therapeutic studies, controlled
  Clark, L. D., Ellsworth, R. B., Barrett, W. W., Thurman,
  A. C, Holland, W.  Studies of the behavioral effects of
  ritalin.  Dis. Nerv. Syst., 1956, 17 : 317-321.

Therapeutic use
  Ferguson, J.  T.  Azacyclonol:  use  of a new pharma-
  cologic agent in chronic schizophrenia.  Antibiotic J/.,
  1956, 3: 146-150.

with PIPRADROL—COMBINED

  Himwich, H. E.   The effect of frenquel on EEG changes
  produced by LSD-25 and mescaline.  In:  Cholden,  L.,
  ed.   Lysergic acid diethylamide and mescaline in experi-
  mental psychiatry.  New  York, Grune &  Stratton, 1956.
  p. 19-26.
  Pennington, V. M.  A comparative  study  of six atar-
  axics  in  1,130  neuro-psychiatric  cases.   Mississippi
  Doctor, 1956, 33 : 336-339.
  Rinaldi,  F.,  Himwich,  H. E.  The cerebral  electro-
  graphic changes induced by  LSD  and  mescaline are
  corrected by frenquel.  J. Nerv. Ment. Dis., 1955, 122:
  424-432.
  ---, ---•  Frenquel corrects certain cerebral electro-
  graphic changes.  Science, 1955, 122: 198-199.
  Toll, N.  Azacyclonol as  an adjunct to  psychotherapy.
  In:   Himwich, H. E., ed. Tranquilizing  drugs.   Wash-
  ington, Am. Ass. Adv. Sc, 1957.  p. 103-113.

with PIPRADROL—COMPARED
  Carr, C. J., Kinnard, W. J., Jr.  The phrenotropic agents.
  Internat. Rec M., 1957, 170 : 493-504.
  Fabing, H. D.  Frenquel, a blocking agent against  ex-
  perimental LSD-25 and  mescaline  psychosis;  prelimi-
  nary note on its clinical application.  Neurology, 1955,
  5: 319-328.
  Forster, W., Henderson, A.  L.  A clinical study of fren-
  quel (alpha  [4-piperidyl] benzhydrol hydrochloride) in
  chronic schizophrenia.  Canad.  M.  Ass. J.  1957  76-
  97-101.
  Rosner, B. S., Fierman, L. B., Kramer,  J. F.  Clinical
  evaluation of maratran and frenquel on a chronic psy-
  chotic population.  Am. J. Psychiat., 1957,  113 : 993-996.

with PYRATHIAZINE—COMBINED
  see  following reference
28 
SUBJECT LIST
Benactyzine : Therapeutic studies, controlled —Neuroses
with RAUWOLFIA  CANESCENS  ALKALOIDS—COM-
    BINED
  Ferguson, J. T.  Azacyclonol:  use of a new pharma-
  cologic agent in chronic schizophrenia.  Antibiotic M.,
  1956, 3: 146-150.

with RAUWOLFIA SERPENTINA ALKALOIDS—COM-
    BINED
  Coats,  E. A., Gray, R.  W.  Frenquel: clinical impres-
  sions  of the use of a new drug  in  the treatment of
  mental illness.   Nebraska M. J., 1956, 41: 460-^61.

with RESERPINE—COMBINED
  see also AZACYCLONOL—Psychotherapeutic use
  Barsa, J. A., Kline, N. S.  Azacyclonol (frenquel) in
  the treatment of chronic schizophrenics.  Am. J. Psy-
  chiat, 1956, 113: 255-256.
  Cohen, S., Parlour, R. R. Preliminary observations on
  use of frenquel in hospital psychiatry.  J. Am. M. Ass.,
  1956, 162: 948-950.
  Fabing, H. D., Hawkins, J. R.  A year's experience with
  frenquel  in  clinical  and experimental schizophrenic
  psychoses.  Dis.  Nerv.   Syst.,  1955,  16:329-338.  Ab-
  stract : Excerpta med., Sect. 8, 1956, 9: No. 4540.
  Ferguson, J. T.  Azacyclonol: use of  a new  pharma-
  cologic agent in chronic schizophrenia.  Antibiotic M.,
  1956,  3: 146-150.

with OTHER DRUGS—COMBINED
  see also AZACYCLONOL—Psychotherapeutic use

  Coats, E. A., Gray, R.  W.  Frenquel:  clinical impres-
  sions on  the use  of  a  new drug in the treatment of
  mental illness.  Nebraska M. J., 1956, 41: 460-461.
  Rinaldi,  F., Himwich,  H. E.  The cerebral electro-
  graphic  changes induced by LSD and mescaline are
  corrected by frenquel.  J. Nerv.  Ment. Dis., 1955, 122:
  424-432.
  ___f  ___.  Frenquel corrects  certain cerebral electro-
  graphic changes.  Science, 1955, 122: 198-199.

with SHOCK THERAPIES—COMPARED
  Lemere, F.  Failure  of azacyclonol  (frenquel)  to re-
  lieve non-experimental mental confusion and hallucina-
  tions.  Am. J. Psychiat., 1957,  113: 840-841.

with SHOCK THERAPY  [ECT]-COMBINED
  Ayd F. J., Jr. A clinical evaluation of frenquel. J. Nerv.
  Ment.  Dis., 1956,124: 507-509.
  Bouchard, M., Larue, G. H., Turmel, J.  Le frenquel en
  psychiatrie; rapport preliminaire.   [Frenquel in psy-
  chiatry;  preliminary report.]   Laval  mid.,  1956, 21.

  CoaVs! E. A., Gray, R. W.  Frenquel: clinical impressions
  on the use of a new drug  in the treatment of mental
  illness.  Nebraska M. J., 1956, 41: 460-461.
  Collomb, H.,  Miletto, G., Robert, H.  Le  frenquel en
  therapeutique psychiatrique   [frenquel in psychiatric
  therapy.]  Presse me'd., 1956, 64:1602-1604.
  Fabing, H. D., Hawkins, J. R.  A year's experience with
  frenquel  in clinical and  experimental  schizophrenic
  rwvehoses  Dis. Nerv.  Syst.,  1955, 16:329-338.  Ab-
  ^STTxcewta med., Sect. 8, 1956, 9:^45*0    .  .
  Laboucarie,  J,  Barres,  P., Rascol, A.  Aspects  pnnci-
  paux des cures neuroplegiques en psychiatrie en 1966
  Principal features of neuroplegic therapy in psychiatry
  in 1956.]   Toulouse mM., 1956, 57. 851-867.
  Sargant,  W.  On  chemical  tranquillizers.   Brit.  M. J.,
  1956,  1:939-943.
BCE
  cii       a w  K   TC*nerience with "BGE", a naturally
  Sherwood, W. K.  HiXperiem-e w
  occurring indole compound.  J. Nerv. mem. ms., j.yo<,
  125:490-4191.
Additional data
  Fabing, H. D.  Experimental  psychoses which  mimic
  schizophrenia.  Nebraska M. J., 1956, 41: 455-459.
  ____.   Trends in  biological research in schizophrenia.
  J. Nerv. Ment. Dis., 1956, 124:1-7.
Studies,  normal subjects see BGE
with AZACYCLONOL—INTERACTION
      Studies, normal subjects
  see BGE [sherwood]
BENACTYZINE

Studies, animals
  Berger, F. M., Campbell, G. L., Hendley, C. D., Ludwig,
  B. J., Lynes, T. E.  The action of tranquilizers on brain
  potentials and serotonin.  Ann. N. York Acad. Sc, 1957,
  66: 686-694.
  Holten, C. H., Sonne, E.  Action of a series of benacty-
  zine-derivatives and other compounds on stress-induced
  behaviour in the rat.  Acta pharm. tox., Kbh.,  1955,
  11:148-155.                              ._
  Jacobsen, E. Suavitil; et nyt stof med specifik virking
  pa centralnervesystemet.  [Suavitil,  a new  drug with
  specific effect on the central nervous system.]   [English
  summary.]   Ugeskr. laeger, 1955, 117:1147-1151.
  ____,  Skaarup,  Y.  Experimental induction of conflict-
  behaviour in cats: the effect of some  anticholinergic
  compounds.   Acta pharm. tox., Kbh., 1955, 11: 125-134.
  Abstract: Chem. Abstr., 1956, 50: 2045ef.
  ___,  Sonne, E.  The effect of benzilic acid diethylami-
  noethylester HC1  (benactyzine)  on  stress-induced  be-
  haviour  in the  rat.  Acta pharm. tox., Kbh., 1955,  11:
  135-147.  Abstract:  Chem.  Abstr., 1956, 50: 2045fg.
  ____,----.   The effect of benactyzine on the conditioned
  responses in the rat.  Acta pharm. tox., Kbh., 1956,  12:
  310-320.  Abstract:  Chem.  Abstr.,  1956,  50:2045d;
  14967h.
Studies, normal subjects
  Coady, A., Jewesbury, E. C.  A clinical trial of benacty-
  zine hydrochloride (suavitil) as a  physical  relaxant.
  Brit. M.  J.,  1956, 1: 485^87.  Abstract: Excerpta Med.,
  Sect.  8, 1956, 9: 3890.
  Jacobsen, E. Suavitil; et nyt stof med specifik virking
  pa centralnervesystemet.   [Suavitil, a new drug with
  specific effect on the central nervous system.]  [English
  summary]   Ugeskr. laeger, 1955, 117:1147-1151.
  Munro, H. K.  On the effect of suavitil (benzilic acid
  diethylaminoethylester  hydrochloride)  on the  higher
  mental  functions  of normal subjects.  Acta psychiat.
  neur. scand., 1955, 30: 721-728.
  Raymond, M. J., Lucas,  C. J.  Benactyzine in psycho-
  neurosis, with a note on the E. E. G. changes in normal
  subjects.  Brit. M. J., 1956, 1: 952-954.

Therapeutic studies, controlled
  Coady, A., Jewesbury, E. C.  A clinical trial of benacty-
  zine hydrochloride (suavitil) as a  physical relaxant.
  Brit.  M.  J.,  1956, 1: 485-487.  Abstract: Excerpta Med.,
  Sect.  8,1956, 9: No. 3890.

—Neuroses
  Forbes,  H.  S., Earle,  B.  V.   Benactyzine  in psychoneu-
  rosis.  Brit. M. J., 1957, 1: 226.
  Hargreaves, G. R., Hamilton, M., Roberts, J. M.  Ben-
  actyzine as an aid in treatment of anxiety states;  pre-
  liminary report.  Brit. M. J., 1957, 1: 306-310.
  Jacobsen, E.  Suavitil; et nyt stof med specifik virking
  pa  centralnervesystemet.  [Suavitil, a new  drug with
  specific effect on the central nervous system.]  [English
  summary]   Ugeskr. laeger, 1955, 117:1147-1151.
  ----, Kehlet, H., Larsen, V., Munkvad, I., Skinhoj, K.
  The autonomic reaction of  psychoneurotics to a  new
456132—59---3
29 
Benactyzine :  Therapeutic studies, controlled —Neuroses
PSYCHOPHARMACA
  sedative: benactyzine NFN, suavitil (R)  (benzilic acid
  diethylaminoethylester  hydrochloride).  Acta psychiat.
  neur.  scand.,  1955,  30:627-642.  Abstract:  Excerpta
  med., Sect. 8, 1956, 9: No. 2668.
  Jensen,  O. 0.  Suavitil in  the treatment of  psycho-
  neuroses.  Danish M. Bull, 1955, 2 : 140-143.
  Kinross-Wright, V.,  Moyer, J. H.  Observations upon
  the therapeutic use  of benactyzine suavitil.   Am.  J.
  Psychiat., 1957, 114: 73-74.
  MacLean, R.  E.  Benactyzine  hydrochloride (suavitil)
  in out-patient psychiatric treatment: preliminary study.
  Med. J.  Australia, 1957, 44  (1) : 67-70.
  Moyer, J. H., Pevey,  K., Kinross-Wright, V. Tranquil-
  izing  (ataractic)  agents:  current evaluation  of their
  clinical  use in patients who are not hospitalized.  GP,
  1957,15 (6) : 97-118.
  Munkvad, I.  Treatment of  psychoses and psychoneu-
  roses  with a  new sedative (suavitil).  [In English]
  Acta  psychiat. neur.  scand.,  1955, 30:729-739.  Ab-
  stract : Excerpta med.,  Sect. 8, 1956, 9: No. 3086.
  Ostergaard Jensen,  O. Suavitil  in the treatment  of
  psychoneuroses.   [In English)  Danish M. Bull, 1955,
  2:140—143.
  Pevey, J. K., Moyer, J. H., Handley, C. A., Heider, C.  A
  comparison of clinical  results  with phenobarbital, me-
  probamate and two  similar experimental  compounds.
  [Abstract]    [benactyzine : meprobamate : phenagly-
  codol]   J. Pharm. Exp. Ther.,  1957,  119: 176.         *
  Plichet, A.  Un nouveau traitement des psychonevroses;
  le chlorhydrate  de  l'acide benzilique  diSthylamino-
  Sthylester.  [A new treatment of psychoneuroses; ben-
  zilic acid 2-diethylamino-ethyl  ester.]  Presse  me'd.,
  1955, 63:1748.
  Raymond, M. J., Lucas, C. J.  Benactyzine in psychoneu-
  roses, with a note on the E. E. G. changes in normal
  subjects.  Brit. M. J., 1956, 1: 952-954.              *
  ---, ---, Beesley,  M. L., O'Connell, B. A.,  Roberts,
  J. A. F.  A trial of five tranquillizing drugs in psycho-
  neurosis.  Brit. M. J., 1957,  2: 63-66.
  Seager,  C. P., Leitch,  A.  Benactyzine in psychoneurosis;
  a controlled  clinical trial in  hospital patients.  Brit.
  M. J., 1956, 2: 1407-1409.                           *
Therapeutic use
  Corni, L.  Esperienze cliniche con un nuovo farmaco  ad
  azione sul S.  N.  C,  la beatilina in soggeti affetti  da
  psicosi  e psiconevrosi.  [Clinical experiences with a
  new drug, beatiline, acting on the central nervous system
  in patients with psychoses and psychoneuroses.]  Gazz.
  med. ital, 1956, 115:  328-331.
  Davies,  E. B.  A new drug to relieve anxiety.  Brit. M. J.,
  1956, 1: 480H184.                                    *
  Deniker, P.   Hibernotherapies et medicaments neuro-
  leptiques  en   therapeutique psychiatrique.   [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapy.]
  Ence'phale, 1957, 46: 281-398.   [366; 390]
  Lemere, F.  Benactyzine (Suavetil).  Am. J. Psychiat.,
  1957, 114:371.
  Munkvad, I.   Treatment of psychoses and psychoneu-
  roses  with a  new sedative (suavitil).  [In  English]
  Acta  psychiat. neur.  scand.,  1955, 30:729-739.  Ab-
  stract : Excerpta med., Sect. 8,  1956,  9 : 3086.
  A new  drug  effective  on the  central nervous system.
  [In English]   Danish M. Bull, 1955, 2:159-160.
  Ostenfeld, I.  Psykiske urotilstande.  [Mental excite-
  ment.]   [English  summary]   Nord.  med.,  1955,  54:
  1517-1522.
  ----,  Suavitil; et nyt spasmolytikum med formentlig
  virkning pa anankasmer og dermed  beslaegtede lidelser.
  [Suavitil; a  new spasmolytic supposedly effective  in
  obessive-compulsive  and  related  disorders.]   [Eng-
  lish summary]  Nord. med., 1955, 54:1523-1525.
  Pennington, V. M.   Research  findings in phrenotropic
  drugs important to every physician.  Mississippi Doctor,
  1957, 35:57-63.
—Additional data
  Alexander, L.  Therapeutic process in electroshock and
  the newer drug therapies;  psychopathological consider-
  ations.  J. Am. M. Ass., 1956, 162 : 966-969.
  ----.   Objective approaches to treatment in psychiatry.
  Canad. Psychiat. Ass. J., 1957, 2: 77-94.
  Bergy,  G.  A.  Drugs of  sedation  with tranquilizing
  effects. Am. Profes. Pharmacist, 1956, 22: 419; 534-538;
  619-621; 709-710;  797-799;  888-889;  917-919.  [709-
  710.]
  Dellaert, R.  De  modernste chemopharmaca in  de  psy-
  chiatrie.   [New  chemical  psychopharmaca.]   Belg.
  tschr. geneesk., 1956, 12: 314-321.
  Fabing, H. D.  The ataractic  drugs; their uses  and
  limitations in psychiatry.  Am. Profes. Pharmacist, 1956,
  22: 413-418.
  Fremming, K.  H.  Medikamentel behandlung of synds-
  sygdomme.   [Medical  treatment of mental disorders.]
  Mskr. prakt. laegegern., Kbh., 1956, 34-331-342.
  Green, A.  Actualites  therapeutiques 1955  en psychia-
  trie.   [Therapeutic progress in psychiatry in 1955.]
  Ence'phale, 1956, 45:172-200.
  Keyes, B. L.  Ataraxic drugs.  Pennsylvania M. J., 1957,
  60:177-181.
  Kline,  N. S.  Chemotherapy in psychiatry;  recent ad-
  vances.  Seminar Internat., Hoddesdon, 1956, 5  (2) : 7-
  10.
  Laboucarie, J., Barres, P., Rascol, A.  Aspects princi-
  paux des cures neuroplegiques en psychiatrie en 1956.
  [Principal features of neuroplegic therapy in psychiatry
  in 1956.]  Toulouse me'd., 1956, 57: 851-867.
  Leiberman, D. M., Vaughan,  G.  F.   Tranquillizers.
  Practitioner, Lond., 1956, 177, 632-638.
  Perrault, M.  Sur les tranquilliseurs.   [Tranquilizers.]
  Progr. me'd., Par., 1957, 85: 3-4; 7.
  Senseman, L. A.  Tranquilizing drugs; uses and abuses
  for the nervous patient.  Rhode Island M. J., 1956, 39:
  675-677; 680; 686.
  Stimulants  and depressants.  Brit. M. J., 1956, 1: 969-
  970.
—Neuroses
  De Busscher, J.  Impressions personnelles sur les effets
  de l'atarax de  la chlorpromazine, de la reserpine et du
  AY-5406-1  (parasan)  en  therapeutique  psychiatrique.
  [Personal impressions of atarax, chlorpromazine, reser-
  pine and AY 5406-1 (parasan) in psychiatric therapy.]
  Ence'phale, 1956, 45:1007-1023.
  Fouks, Laine,  Francois, Pagot.  Note sur  les  medica-
  tions  recentes  des etat nevrotiques anxieux et depres-
  sifs.  [Note on recent medications  for anxious  and de-
  pressive neurotic states.]   Ann. me'd. psychol,  Par.,
  1956, 114 (1) :  608-615.
  Stokholm,  H.,  Zahle,  V.   Medicamentel  neurosebehan-
  dling; nogle  bemaerkninger.   [Medical treatment  of
  neuroses;  some remarks.]   Ugeskr.  laeger, 1955,  117:
  1511-1513.
with ATARAXICS  [2 or more]
  see ATARAXICS— Various [3 or more]—Compared

with OTHER DRUGS [barbiturates]—COMBINED
  De Busscher, J.  Impressions personnelles sur les effets
  de l'atarax, de la chlorpromazine,  de la reserpine  et
  du  AY-5406-1 (parasan) en therapeutique  psychia-
  trique.  [Personal impressions of atarax, chlorproma-
  zine, reserpine and AY-5406-1 (parasan)  in psychiatric
  therapy.]  Ence'phale, 1956, 45: 1007-1023.
  Ostenfeld, I.   Suavitil;  et  nyt  spasmolytikum  med
  formentlig virkning pa anankasmer og dermed beslaeg-
  tede lidelser.   [Suavitil;  a new spasmolytic supposedly
  effective in obsessive-compulsive and related disorders.]
  [English  summary]   Nord. med., 1955, 54- 1523-1525.
30 
SUBJECT  LIST
Cannabis : Intoxication
BUFOTENINE
Intoxication
  see BUFOTENINE—Pharmacodynamics
                      Studies, normal subjects
Pharmacodynamics
  Fabing,  H. D.  Experimental  psychoses  which  mimic
  schizophrenia.   Nebraska M. J., 1956, 41: 455-459.
  ---, Hawkins,  J. R.  Intravenous bufotenine injection
  in the human being.   Science,  1956, 123: 886-887.
  Fish, M. S., Horning, E. C.  Studies on hallucinogenic
  snuffs.  J. Nerv. Ment. Dis., 1956,  124: 33-37.
—Additional data
  Fabing, H. D.   The dimensions of neurology.  Neurol-
  ogy, 1955,  5: 603-611.  Abstract:  Excerpta med., Sect.
  8, 1956, 9: No. 1718.
  ---.  The  new pharmacologic attack in psychiatry.
  Internal Rec  M., 1956, 169:  177-183. Also: Drug &
  Cosmet. Indust., 1956, 78: 32-33 ; 125-129.
  ---.  Trends in  biological research in schizophrenia.
  J. Nerv. Ment. Dis., 1956,  124:1-7.
  Osmond, H.  Ololiuqui: the ancient Aztec narcotic; re-
  marks on the effects  of Rivea corymbosa  (ololiuqui).
  J. Ment. Sc, Lond., 1955, 101:  526-537.
  ---.  Research on schizophrenia.  In: Abramson, H.
  A., ed. Neuropharmacology. Transactions of the second
  conference, May  1955, Princeton,  N.  J.   New  York,
  Josiah Macy, Jr. Foundation, 1956.  p. 183-233.
  Page, I.  H., McCubbin, J.  W.  Serotonin  or tenure  for
  the pharmacologist.  Circulation,  N. Y., 1956, 14: 161-
  162.
  Sebrell,  W. H., Jr.  Chemistry in chronic disease  re-
  search.  Chem.  Eng. News, 1955,  33:1856-1860.
  Shaw, E. (N.), Woolley,  D. W.  Methylserotonins as
  potent antimetabolites of serotonin active both in vitro
  and in vivo.  J. Pharm. Exp. Ther., 1956, 116:164-176.
Studies, animals
  Evarts, E. [V.}  Brain effects of LSD in animals.  In:
  Cholden, L., ed.  Lysergic acid diethylamide and mes-
  caline in experimental psychiatry.  New York,  Grune
  & Stratton, 1956.  p. 55-56.
  ---.  Some  effects of bufotenine and lysergic acid di-
  ethylamide  on  the monkey.   A.   M. A.   Arch.  Neur.
  Psychiat., 1956,  75 : 49-53.
  ---,  Landau, W., Freygang, W.,  Jr., Marshall,  W. H.
  Some effects of lysergic  acid  diethylamide and bufo-
  tenine on electrical activity in the cat's visual system.
  Am. J. Physiol, 1955, 182 : 594-598.
  Jarvik, M. E.  Effect of LSD-25 on snails.   In : Abram-
  son, H. A., ed. Neuropharmacology.  Transactions of
  the third conference, May 1956, Princeton,  N. J.  New
  York, Josiah  Macy, Jr. Foundation, 1957.  p. 29-38.
  Marrazzi, A.  S. The  effects of certain drugs on cere-
  bral synapses.   Ann. N. York Acad. Sc, 1957, 66: 496-
  507.
  ---,  Hart, E.  R.   An electrophysiological  analysis of
  drugs useful  in  psychotic states.  In: Himwich,  H.  E.,
  ed.  Tranquilizing  drugs.   Washington, Am. Ass. Adv.
  Sc, 1957.  p.  9^21.
  ---,----. An  electrophysiological analysis of the  ac-
  tions of some drugs useful in the  therapy of psychotic
  disorders.  J. Nerv. Ment. Dis., 1956, 124:  388-392.
  Monroe, R. R.,  Heath, R.  C, Mickle, W. A., Miller,  W.
 Cortical and subcortical recordings correlated with  be-
 havior in patients and animals during  the  administra-
 tion of Rauwolfia, thorazine, and meratran. Psychiat.
 Res. Rep., Wash.,  1955 (1): 25-44.  Abstract:   Chem.
 Abstr., 1956, 50:2867gh.
 Turner, W. J.  The effect of lysergic acid  diethylamide
 on Betta splendens:  I.  Dis. Nerv. Syst., 1956, 17:193-
 197.
Studies, normal subjects
  Fabing,  H.  D. On going  berserk:  a neuro-chemical
  inquiry.   Am. J. Psychiat.,  1956, 113: 409-415.
  ----, Hawkins, J. R.  Intravenous bufotenine injection
  in the human being.  Science, 1956, 123: 886-887.
  ----,  Kropa,  E.  L.,  Hawkins,  J.  R.,  Leake, C.  D.
  Bufotenine effects in humans.   [Abstract]  Fed. Proc,
  Bait., 1956, 15 : 421.
  Fish, M. S., Horning,  E. C. Studies on hallucinogenic
  snuffs.  J. Nerv. Ment. Dis., 1956, 124: 33-37.
  Osmond, H. A review of the clinical effects of psycho-
  tomimetic agents.  Ann. N. York Acad. Sc, 1957, 66:
  418-434.
  Turner, W. J., Merlis, Carl, A.  Concerning theories of
  indoles in schizophrenigenesis.  Am. J. Psychiat.,  1955,
  112:466-467.
CB-1522
Cocktail see under CB-1522—Therapeutic use

Pharmacodynamics  and Studies, animals
  see also CB-1522—Therapeutic studies,  controlled
  Huguenard, P.  Etude  clinique d'un  nouveau neuro-
  plegique,  le  1522  CB   (maleate  d'acStlypromazine).
  [Clinical study of  a new  neuroplegic drug,  CB-1522
  (acetylpromazine maleate)].  Presse  me'd., 1957, 65:
  685-688.
Therapeutic studies, controlled
  Delay, J., Pichot, P., Ropert, R.  Un  noveau medica-
  ment  neuroleptique en psychiatrie.  Le maleate  acide
  de  l'e^hylone-3-dimeihylamino-3'-l-propyl-10-phenothia-
  zine  (1522 C. B.)   [A  new neuroleptic drug in psy-
  chiatry.  8-Acetyl-10- (3-dimethylaminopropyl) phenothi-
  azine (CB-1522) ]  Presse me'd., 1957, 65 : 491-493.
Therapeutic use
  Coirault, R.,  Girard,  V., Escafit, H., Benoit, P.   Utili-
  sation du 1522 CB en neuro-psychiatrie.  [Use of 1522
  CB in neuro-psychiatry.]   [CB-1522; CB-1522 cocktail]
  Bull.  Soc. me'd. mil fr., 1955,  49:247-249.  Abstract:
  Presse me'd., 1956, 64: 315.
  Laborit, H.,  Coirault, R.,  Damasio, R., Gaujard,  R.,
  Laborit, G.,  Charonnat, R.,  Lechat, P., Chareton,  J.
  Sur un type  nouveau d'anesthesie chirurgicale et sur
  l'emploi  en therapeutique  d'un depresseur  du cortex
  cerebral (S. C. T. Z.)  [A new type of surgical  anes-
  thesia and the therapeutic use of a cerebral cortex de-
  pressant (S. C. T. Z.)]   [thiamine hydrochloride+CB-
  1522]   Presse me'd., 1957, 65:1051-1054.
—Additional data
  Deniker, P.  Hibernotherapies  et medicaments neuro-
  leptiques  en  therapeutique  psychiatrique.   [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapy.]
  Ence'phale, 1957, 46:  281-398.  [p. 363]


with CHLORPROMAZINE—COMPARED see CB-1522

with  PROMETHAZINE  and OTHER  DRUGS—COM-
    BINED [=CB-1522 cocktail]
  see under CB-1522—Therapeutic  use
CANNABIS

Criminal use see CANNABIS—Intoxication  [johnson]

Intoxication

  see also CANNABIS—Studies, normal subjects
  Abdulla, A.  Cannabis indica als Volksseuche in Agyp-
  ten.   [Cannabis  indica  as  a national  epidemic  in
31 
Cannabis  : Intoxication
  Egypt.]   [English summary]   Schiceiz. med.  Wschr.,
  1953, 83 : 541-543.
  Durieux, G. P. Extension de l'intoxication par le canna-
  bis sativa Linnaeus.   [Distribution of the  intoxication
  with Cannabis sativa Linaeus.]   30  p.   Paris, 1953.
  [Thesis—Paris 1953, no. 754]
  Gonzalez Mas, R. Introduccion al estudio de  la toxi-
  comania por  canamo  indiano.   [Introduction  to  the
  study of toxicomania  for Indian cannabis.]  Medicina,
  Madr., 1953, 21: 130-136.
  Johnson, D. M. The hallucinogenic drugs, the insanity-
  producing drugs:  Indian hemp and datura ; a neglected
  aspect of forensic medicine, a loophole in the law. 45 p.
  London, Johnson, 1953.
  ---.  Indian hemp; a social menace.  112 p.  London,
  Johnson, 1952.
  Lindemann, E., Clarke, L. D.  Modifications in ego struc-
  ture and personality reactions under the influence of the
  effects of drugs.  Am. J. Psychiat., 1952, 108: 561-567.
  Osmond, H.   A review of the clinical effects of psycho-
  tomimetic agents. Ann. N. York  Acad. Sc, 1957,  66:
  418-434.
  Piedelievre, R., Derobert, L.  Une intoxication  profes-
  sionnelle devenue rare; un cas de cannabisme.  [Rare
  occupational poisoning; case of cannabism.] Ann. med.
  Ug., 1953, 33 : 23-25.
  Wikler,  A. Mechanisms of action  of drugs that  modify
  personality function.  Am.  J. Psychiat., 1952, 108: 590-
  599.
—Additional data
  Fabing,  H. D.  The dimensions of neurology.  Neurol-
  ogy,  1955, 5: 603-611.  Abstract:  Excerpta med., Sect.
  8, 1956,  9: No. 1718.
  ---.  The  new  pharmacologic attack  in psychiatry.
  Internat.  Rec M.,  1956,  169:177-183.   Also: Drug
  & Cosmet. Indust., 1956, 78: 32-33; 125-129.
  ---.  Experimental  psychoses which  mimic  schizo-
  phrenia.  Nebraska M. J.,  1956, 41: 455-459.
  Rothlin, E.  Die  zentralnervosen Wirkungen von Heil-
  mitteln.   [The central-nervous  effects of drugs.]  39 p.
  Stuttgart, Thieme, 1954.
  Turner, W. J., Merlis, S., Carl,  A.  Concerning theories
  of indoles in schizophrenigenesis.  Am. J. Psychiat.,
  1955,  112:466-467.
  Walther-Biiel, H.  tiber Pharmakopsychiatrie.   [Phar-
  maco-psychiatry.] Schweiz. med. Wschr., 1953, 83 : 483-
  487.  Abstract: Excerpta med., Sect. 8, 1954, 7: No. 1940.

—Therapy, controlled
  Carey, E. F.   A new approach to  the emergency treat-
  ment of sickness  caused by narcotic withdrawal, [res-
  erpine  : placebo]  Ann. N. York  Acad. Sc, 1955,  61:
  222-229.  Also : Illinois M. J., 1957, 111: 1-7.
Studies, animals
  Apter, J. T., Pfeiffer, C. C.   The effect of the hallucino-
  genic drugs LSD-25 and mescaline on the electroretino-
  gram.  Ann. N. York Acad. Sc, 1957, 66: 508-514.
  ----,----. Effect of hallucinogenic drugs on the electro-
  retinogram.   Am. J. Ophth., 1956,  42 (4, Part 2) : 206-
  211.
  Witt, P.  N.   Der Netzbau der  Spinne als Test  zur
  Priifung zentralnervos angreifender Substanzen.  [Con-
  struction of spider webs as a test for drugs with CNS
  action.]   Arzneimitt. Forsch., 1956, 6: 628-635.

Studies, normal subjects

  see  also CANNABIS—Intoxication
  Evarts,  E. V.  A review of the neurophysiological effects
  of lysergic acid diethylamide (LSD) and other  psycho-
  tomimetic agents. Ann. N. York Acad. Sc, 1957, 66:479-
  495.
PSYCHOPHARMACA
Therapeutic use
  Rolls,  E.  J.,  Stafford-Clark,  D.   Depersonalization
  treated  by Cannabis indica and psychotherapy.  Guy's
  Hosp. Rep., Lond., 1954,103 : 330-336.
  Thompson, L. J., Proctor, R. C.  The use of pyrahexyl
  in the treatment of alcoholic and drug withdrawal con-
  ditions.   North Carolina M. J., 1953,  14: 520-523.
CHLORPROMAZINE
  Atti del symposium sulla reserpina e cloropromazina in
  neuropsichiatria.  [Proceedings of the  symposium  on
  reserpine  and  chlorpromazine  in  neuropsychiatry.]
  Arch, psicol. neur., Milano, 1956,17: p. III-XI; 115-684.
  [Articles  within the  scope  of this  bibliography are
  listed individually.]
  Azima, H.  Report on the international colloquium  on
  chlorpromazine  and  neuroleptic  medications  in psy-
  chiatric treatment, Paris, October 20-22, 1955.  Am. J.
  Psychiat., 1956, 112: 749-750.
  Broggi, E. Risultati del convegno nazionale tenuto  a
  Vercelli il 24—25 settembre  su: ibernazione artificial,
  sonno  prolungato e  neuroplegic! in  neuropsichiatria.
  [Results of the national convention held at Vercelli on
  September  24-25  on artificial  hibernation, prolonged
  sleep  and neuroplegic drugs in  neuropsychiatry.]  En-
  ce'phale, 1956, 45:1035-1041.
  Chlorpromazine and mental health.  200 p.  [Proceed-
  ings of the symposium held under the auspices of Smith,
  Kline & French Laboratories in Philadelphia, Pa., June
  1955]  Philadelphia,  Lea & Febiger, 1955.  [Articles
  within the scope of this bibliography are listed indi-
  vidually.]
  Le colloque international de Paris sur la chlorproma-
  zine et  les medicaments  neuroleptiques en therapeu-
  tique   psychiatrique.  [International  colloquium  in
  Paris  (October  1955) on chlorpromazine  and  neuro-
  leptic drugs  in  psychiatric  therapy.]   J.  med.  Lyon,
  1956, 37:103-105.
  Colloque international sur la  chlorpromazine  et les
  medicaments neuroleptiques en therapeutique psychi-
  atrique.  [International  colloquium on chlorpromazine
  and neuroleptic drugs in psychiatric therapy.]   [Paris,
  October 1955]  Encephale,  1956,  45:301-1266.  [Arti-
  cles within the scope of this bibliography are listed in-
  dividually.]
  Conn,  H. F., ed.  Symposium on  the efficacy of new
  drugs.  Med.  Clin. N. America, 1957, 41: 295-615. [Ar-
  ticles within  the scope of this  bibliography are listed
  individually.]
  Deniker, P.  Hibernotherapies  et  medicaments  neuro-
  leptiques  en   tMrapeutique  psychiatrique.  [Hiberno-
  therapies and neuroleptic drugs  in psychiatric therapy.]
  Encephale, 1957, 46: 281-398.
  Fernandes, B.  Clorpromazina,  reserpina e a  chamada
  "farmacopsiquiatria".   [Chlorpromazine  and  reser-
  pine  at the  colloquium  on  "pharmacopsychiatry".]
  [Paris, October 1955]  J. me'd., Porto, 1956, 29: 237-243.
  Happiness pills  in medical practice: a symposium.  J.
  Iowa M. Soc,  1957, 47: 57-65.
  Himwich, H.  E.,  ed.  Tranquilizing  drugs.  197  p.
  [Symposium held in Atlanta, Georgia, December 1955]
  Washington, Am. Ass. Adv.  Sc, 1957.   [Articles within
  the scope of this bibliography are listed individually.]
  International  symposium on  chlorpromazine. J Clin.
  Exp.  Psychopath., 1956, 17:15-76; 129-188   [Articles
  within the scope  of  this bibliography are listed indi-
  vidually.]
  Laborit, H., Huguenard, P.  Pratique de l'hibernothera-
  pie en chirurgie et en medecine.   [The use of hiberno-
  therapy in surgery  and in medicine 1  256  r,   Paris
  Masson, 1954   [One chapter is within the scop*' of ttS
  bibliography.]  cf. ey, deschamps, beraeo. 
SUBJECT LIST
Chlorpromazine : History of psychiatric use
  Overholser, W., Waldrop, F. N, Riesenman, F. R., Fong,
  T. C. C, Farley, O. R., Hoffman, J. L.  Chlorpromazine
  and reserpine; symposium on experiences at Saint Eliz-
  abeths Hospital.  Med. Ann. District of Columbia, 1956,
  25 : 255-268 ; 2<>8.   [All articles are listed individually.]
  Revol, L.,  Achaintre, A., Balvet, P., Beaujard, M., Ber-
  thier, C, Brousolle, P., Lambert, P., Perrin, J., Requet,
  A.  La therapeutique par la chlorpromazine en pratique
  psychiatrique.   [Chlorpromazine therapy in psychiatric
  practice.]   151  p.  Paris, Masson,  1956.
  Symposium: Clinical  value and limitations of  chlor-
  promazine.  Psychiat. Res. Rep., Wash.,  1955 (1) : 53-
  104.   [All articles are listed individually]
  Symposium  on chlorpromazine in clinical  medicine.
  Internat. Rec M.,  1955, 168: 295-358.   [Articles within
  the  scope of this bibliography are listed  individually.]
  Symposium  on  tranquillizers.  [Summary of proceed-
  ings.  British   Medical Association  annual  meeting,
  Newcastle upon Tyne,  July 1957]  Brit. M. J., 1957, 2:
  219-221.
  Tranquillizers in psychiatry.  [Report on Royal Medico-
  Psychological Association  Meeting, London, February
  1956]  Brit. M. J., 1956, 1: 512-513.
  Zambianchi, A.  Echo  du symposium de Milan sur la
  reserpine  et la chlorpromazine en psychiatrie.   [Re-
  view of the symposium in Milan on reserpine and chlor-
  promazine in psychiatry.]   Encephale, 1956,  45 : 1071-
  1075.

Alone see CHLORPROMAZINE— . . .

Alone—Compared with chlorpromazine  as  potentiator
Alone—Compared with chlorpromazine cocktail
  see CHLORPROMAZINE—Various special techniques—
       Compared with Chlorpromazine alone
Artificial hibernation
  see  CHLORPROMAZINE—Various special techniques
As potentiator
  see CHLORPROMAZINE—Various special techniques
      CHLORPROMAZINE  with OTHER  DRUGS [CNS
       depressants]—COMBINED

Bibliographies and literature surveys
  Allen, E.  B., Prout, C. T.  Alcoholism.  Progr.  Neur.
  Psychiat.,  N. Y., 1955, 10: 510-521.
  Bryant, J. H., Bass, B. M.,  Hine, F. R.  Drug therapy;
  a survey of the literature.  State of Louisiana, Depart-
  ment  of  Institutions, Division  of Research,  Baton
  Rouge, 1956 (3) : 1-24.
  Demidova, L. P., Tarasov,  G. K.   Aminazin;  obzor in-
  ostrannoi literatury po primeneniiu v psikhiatrii odnogo
  iz proizvodnykh fenotiazina.   [Aminazine;  review of
  foreign literature on psychiatric use of a phenothiazine
  derivative.]  Zh. nevropat. psikhiat., Moskva, 1956, 56:
  192-199.
  Deniker, P.  Hibernotherapies  et  medicaments neuro-
  leptiques  en  therapeutique psychiatrique.   [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapy.]
  Encephale, 1957, 46: 281-398.
  Durand, V. J.,  Houillon,   G.  De quelques travaux
  Strangers sur la chlorpromazine.   [Foreign  works on
  chlorpromazine.]   Ann.  med. psychol, Par., 1955, 113
  (2) : 96-101.
  Funderburk, W. H., Wilcox, K. W.,  Wilcox, P. H.  Drug
  therapy;  physiodynamic  therapy.   II.  Progr.  Neur.
  Psychiat., N. Y., 1956, 11: 425-456.
  Gade, E. B., Heinrich,  K.  Die Bedeutung der Pheno-
  thiazinderivate,  insbesondere des  Megaphen,  fur Psy-
  chiatrie und Neurologic  [The importance  of  pheno-
  thiazine derivatives in  psychiatry  and neurology  with
  special  reference  to chlorpromazine.]  Fortsch.  Neur.
 Psychiat., 1955, 23 : 323-353.
 Le Guillant, L., Roelens, R.  Travaux sovietiques sur
 les neuroleptiques.  [Soviet studies of  neuroleptics.]
 Presse med., 1956, 64: 1225-1227.
  Munch-Petersen, S.  Effects of chlorpromazine  (largac-
  til) and reserpine  (serpasil) within the field of neurol-
  ogy ; a study of the pertinent literature.  Acta psychiat.
  neur. scand., 1956, Suppl. 108: 269-280.  Abstract: Ex-
  cerpta med., Sect. 8, 1957, 10: No. 727.
  Revol, L., Achaintre, A., Balvet, P., Beaujard, M., Ber-
  thier, C, Broussolle, P., Lambert, P., Perrin, J., Requet,
  A.  La therapeutique par la chlorpromazine en pratique
  psychiatrique.   [Chlorpromazine  therapy   in  psychi-
  atric practice.]  151 p.  Paris, Masson, 1956.
  Smith, Kline & French Laboratories.  Thorazine  refer-
  ence manual.  2d ed.  80 p.  Philadelphia, 1956.
  Societe parisienne d'expansion chimique.  Largactil,
  4560 R. P. Bibliographie.  182 p.  Paris, Spccia [Labora-
  toires Rhone-Poulenc] 1955.
  ---.   Largactil, 4560  R.   P.  Information  medicale.
  Paris,  Specia  [Laboratoires Rhone-Poulenc] 1954-1956.
  Tarasov,  G. K. Abzory,  kritika,  retsenzii aminazin;
  obzor literatury po primeneniiu v psikiatrii odnogo iz
  proizvodnykh  fenotiazina.   [Aminazin:  review of  the
  literature on  one  of the phenothiazine  derivatives  in
  psychiatric practice.]   Zh.  nevropat. psikhiat., Moskva,
  1955 55" 296—310.
  Wilcox, P. H,  Funderburk, W. H, Wilcox, K. W.  Drug
  therapy;  physiodynamic therapy.   II.  Progr.  Neur.
  Psychiat., N. Y., 1955, 10: 595-608.
  Wortis, J.  Physiological treatment.  Am. J. Psychiat.,
  1954, 110: 505-511; 1955, 111: 515-518; 1956, 112 : 526-
  529; 1957, 113  : 611-615.
Cocktail
  see CHLORPROMAZINE—Various special techniques

Diagnostic use
  Ellsworth, R. B., Clark, L. D.  Prediction of  the response
  of chronic schizophrenics to drug therapy ; a preliminary
  report on the  relationship  between palmar sweat and
  the behavioral effects of tranquilizing drugs.  J. Clin.
  Psychol, 1957, 13 : 59-61.
Hibernotherapy
  see CHLORPROMAZINE—Various special techniques

History of psychiatric use [in chronologic order]
  Laborit, H., Huguenard, P., Alluaume, R.  Un nouveau
  stabilisateur vegetatif; le 4560 RP.   [A new autonomic
  stabilizer; 4560  RP.]  [chlorpromazine alone; chlorpro-
  mazine+barbiturates]  Presse med., 1952,  60 : 206-208.
  [p. 207; 208]
  Hamon, Paraire, Velluz.   Remarques sur l'action  du
  4560 R. P. sur l'agitation maniaque.   [Effect of  R. P.
  4560 on manic agitation.]   Ann. med.  psychol, Par.,
  1952, 110 (1) :331-335.
  Guiraud, P.  [Intra-osteal  (coxal)  injection]  Discus-
  sion  to: Hamon, Paraire, Velluz.   Ann.  med. psychol,
  Par., 1952, 110 (1) : 335.
  Delay, J.,  Deniker, P., Harl, J. M. Utilisation en thera-
  peutique   psychiatrique d'une  phenothiazine  d'action
  centrale elective (4560 RP).  [Use of a phenothiazine
  with  elective  central  effect in psychiatric therapy.]
  Ann. me'd. psychol, Par., 1952, 110  (2) :  112-117.
  Follin, S.  Discussion to:  Delay, J., Deniker, P.,  Harl,
  J.  M. Ann. med. psychol, Par., 1952, 110 (2) :  126-127.
  Abely, P., Abdouchelli,  A.,  Fourment, J.,  Schmitz,  B.,
  Delteil, P.  Suite aux essais therapeutiques de reequili-
  bration instincto-affective; essai de traitement par la
  bromure tetra-ethyl d'ammonium en  comparaison avec le
  R. P. 45-60 et le C. 92-95.  [Further therapeutic studies
  on the restoration of instinctive-affective balance; thera-
  peutic trials with tetraethylammonium bromide in com-
  parison with R. P.  45-60 and with C. 92-95.]  Ann. med.
  psychol, Par.,  1952, 110 (2) : 262-207.
  Delay, J., Deniker, P., Harl, J. M. Traitement des etats
  d'excitation et d'agitation  par  une  methode  medica-
  menteuse  derivee  de l'hibernotherapie.   [Therapeutic
  method derived from hiberno-therapy in  excitation and
33 
Chlorpromazine: History of psychiatric use
PSYCHOPHARMACA
  agitation  states.]  Ann. med. psychol, Par., 1952, 110
  (2): 267-273.
  Deschamps, A.  Hibernation artificielle en psychiatrie.
  [Artificial hibernation in psychiatry.]   Presse me'd.,
  1952, 60:944-946.
  Gachkel, V., Brisset, C.  La cure de sommeil en psychi-
  atrie.   [Sleep therapy in psychiatry]   C. rend. Congr.
  alitn. neur.  France,  1952, 50:491-496.  Abstract  [in-
  complete!] : Ann. me'd. psychol, Par., 1952,110 (2) : 565.
  Delay, J., Deniker, P.  Le traitement des psychoses par
  une methode neurolytique derivee d'hibernotherapie; le
  4560 R. P. utilisee seul en cure prolonged et continue.
  [Treatment of psychoses by a neurolytic method derived
  from hibernotherapy;  prolonged  continuous  therapy
  with  4560 RP  alone.]  C. rend.  Congr.  ali6n. neur.
  France, 1952, 50: 497-502. Abstract: Ann. mCd. psychol,
  Par., 1952, 110  (2) : 564.
  ----, ----.  38 cas de psychoses traitees  par la cure
  prolonged et continue de 4560 R. P. [Thirty-eight psy-
  chotics  treated  by prolonged  and continuous adminis-
  tration  of 4560 RP.] C. rend. Congr. aliCn. neur.  France,
  1952, 50 : 503-513.  Abstract:  Ann.  med. psychol, Par.,
  1952, 110 (2) : 564.
  ----, ----, Harl, Grasset, A.  Traitements d'etats con-
  fusionnels par le chlorhydrate de dimethylaminopropyl-
  N-chlorophenothiazine  (4560  RP).  [Dimethylamino-
  propylchlorophenothiazine  (4560 RP)  therapy of con-
  fusional states.]  Ann. med.  psychol,  Par., 1952,  110
  (2) : 398-403.  Abstract: Excerpta med., Sect. 8,1954, 7:
  No. 1603.
  Hamon, J.,  Paraire, J.,  Velluz,  J.  Etats  anxieux et
  barbituriques potentialis£s.  [Anxiety states and poten-
  tiated barbiturates.]   Ann. me'd. psychol,  Par., 1952,
  110 (2) : 403-407.
  Ey, H.,  Berard, E. Les nouvelles techniques de cure de
  sommeil dans la pratique psychiatrique.   [New tech-
  niques of sleep therapy in psychiatric practice.]  Evolut.
  psychiat.,  1952: 661-682.
  Laborit H., Jaulmes, C.  De l'anesthSsie potentialisee a
  l'hibernation artificielle.  [From potentiated anesthesia
  to artificial hibernation.]  Toulouse med., 1952, 53: 821-
  829. [p. 828]
  ----.  Therapeutique neuroplegique et hibernation arti-
  ficielle :  essai d'eclaircissement d'une equivoque.  [Neu-
  roplegic therapy and artificial hibernation: attempt to
  clarify an equivocation]  Presse me'd., 1954, 62: 359-362.
  [p. 360]
  Deniker, P.  Hibernotherapies et medicaments neuro-
  leptiques  en  therapeutique psychiatrique.   [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapy.
  Ence'phale, 1957, 46:281-398.   [p. 291]
Intra-osteal injection
  see CHLORPROMAZINE—History of psychiatric  use
                              [guiraud]
                            Therapeutic use—Psychoses
                              [gtjikaud]
Lytic cocktail
  see CHLORPROMAZINE—Various special techniques

Pharmacodynamics

  see also CHLORPROMAZINE—Various special tech-
            niques—Pharmacodynamics
  Ayd, F.  J., Jr.   The  physiologic and neurologic action
  of chlorpromazine.  Psychiat. Res. Rep., Wash.,  1955
  (1) : 14-24.  Abstract: Chem.  Abstr., 1956, 50:2867def.
  Bakwin, H.  The uses  of chlorpromazine in pediatrics.
  J. Pediat., S. Louis, 1956, 48: 240-247.
  Bonello,  F. J.   Chlorpromazine  in general  practice.
  Internat. Rec. M., 1956, 169:197-212.
  Brisset,  C.  Chlorpromazine  et  sommeil.   [Chlorpro-
  mazine and sleep.]  Ence'phale, 1956, 45:1157-1161.
  Courvoisier, S.   Pharmacodynamic  basis for the use of
chlorpromazine  in psychiatry.  J. Clin. Exp.  Psycho-
path., 1956, 17: 25-37.
----.   Sur  les propriStes pharmacodynamics de  la
chlorpromazine  en  rapport  avec son  emploi  en  psy-
chiatrie.  [Pharmacodynamic basis for the use of chlor-
promazine in psychiatry.]  Ence'phale,  1956, 45:1248-
1257.
----, Fournel, J., Ducrot, R., Kolsky, M., Koetschet,  P.
Proprietes  pharmacodynamiques  du  chlorhydrate de
chloro-3- (dime4hylamino-3'-propyl) -10    phenothiazine
(4560 R. P.).  [Pharmacodynamic properties of chloro-
3-(dimethylamino-3'-propyl)-10 phenothiazine  (R. p,
4560).]   Arch,  internat. pharm. dyn.,  Gand,  1953,
92:305-361.
Decourt, P. Mecanisme  d'action de la therapeutique
narcobiotique en general, et de la  chlorpromazine en
particulier,  en psychiatrie.  [Mechanism  of action of
narcobiotic psychiatric therapy in  general, and of chlor-
promazine  in particular.]   Encephale,  1956, 45:932-
944.
Deniker,  P. Psychophysiologic  aspects  of the  new
chemotherapeutic  drugs in psychiatry;  some practical
features of  "neuroleptics" in order to screen new drugs.
J. Nerv. Ment. Dis., 1956,  124: 371-376.
De Risio, C, Manghi, E.  Premesse sperimentali e risul-
tati clinici  riguardanti l'impiego  della  cloropromazina
(largactil) in malatti neuropsichiatriche.   [The use of
chlorpromazine  (largactil)  in neuropsychiatric  dis-
eases :   experimental premises  and  clinical  results.]
[English summary]  Riv. sper. freniat., 1956, 80:345-
354. Abstract:  Excerpta  med., Sect. 8, 1957,  10:No.
1556.
Dundee, J. W.  A review of chlorpromazine hydrochlor-
ide.  Brit. J. Anaesth.,  1954, 26: 357-379.
Fazekas, J.  F., Toupin, H., Alman, R. W.  Physiologic
and pharmacologic basis  for the chemotherapy of  psy-
chiatric states.  Am. J. Med., 1956, 21: 825-831.
Gade, E. B., Heinrich,  K. Die Bedeutung der Pheno-
thiazinderivate,  insbesondere des Megaphen, fur  Psy-
chiatrie und Neurologie.   [The importance  of pheno-
thiazine derivatives in  psychiatry and neurology, with
special  reference to chlorpromazine.]   Fortsch. Neur.
Psychiat., 1955, 23 : 323-353.
Grana, E.   Recenti  acquisizioni su  un  nuovo  medica-
mento  neuroplegico: la cloropromazina.  [Recent ex-
periences  with a  new  neuroplegic drug: chlorproma-
zine.] _ Farmaco, ed. prat., Pavia, 1954, 9:419-422.
Himwich,  H. E.  Prospects  in  psychopharmacology.
J. Nerv. Ment.  Dis., 1955,  122:413-423.   Also:  Dis.
Nerv.^ Syst., 1956, 17:109-116.
Hopkin, D.  A. B.  The  action of  chlorpromazine.  Re-
view of French work.   Lancet, Lond., 1955,  1: 605-607.
Ibsen,  B., Pahle, H., Villumsen, A.  L.   Chlorpromazin
hydrochlorid  (largactil) ; en  oversigt.   [Chlorproma-
zine hydrochloride (largactil) ; review.]   [Brief English
summary]   Ugeskr.  laeger, 1954, 116:1769-1775.
Koetschet, P. Can it be  said that chlorpromazine has
specific properties?  Internal Rec M.,  1955, 168:295-
300.
Laborit, H.  Therapeutique  neuroplegique et hiberna-
tion artificielle: essai d'eclaircissement d'une equivoque.
[Neuroplegic therapy   and artificial hibernation: at-
tempt to clarify an  equivocation.]  Presse  me'd., 1954,
62: 359-362.
----.   Potentiated anesthesia. Internat. Rec M., 1954,
167: 315-320.
—-, Huguenard, P., Alluaume, R. Un  nouveau stabil-
isateur vegetatif; le 4560 RP.   [A new  autonomic sta-
bilizer ; 4560 RP]  Presse me'd., 1952, 60 • 206-208
Lehmann, H. E., Hanrahan, G. E.  Chlorpromazine, new
inhibiting agent for  psychomotor excitement and manic
states.   A. M. A. Arch. Neur. Psychiat., 1954, 71:227-

^f/eg*r'J' ¥*£?'  0LarSactil; a  new psychomotor
brake.   #. Afr. J. Clm.  Sc, 1954, 5: 22S-243.  Abstract:
34 
SUBJECT LIST
Chlorpromazine : Somnolence therapy
   Excerpta med., Sect. 8, 1956, 9: No. 1724.
   Malitz, S., Hoch, P. H., Lesse, S.  A two-year evaluation
   of chlorpromazine  in clinical  research  and  practice.
   Am. J. Psychiat., 1956, 113: 540-545.
   Marti-Ibafiez, F., Sackler, A. M., Sackler, M. D., Sackler,
   R. R.  The challenge  of bio- and chemotherapy in psy-
   chiatry.  J.  Clin. Exp.  Psychopath.,  1956, 17:15-18.
   Abstract: Excerpta med., Sect. 8, 1957, 10: No. 975.
   Mashkovskii, M. D.   [The pharmacologic  properties of
   aminazine and of other compounds of the phenothiazine
   order.]  Zh. nevropat. psikhiat., Moskva, 1956, 56: 81-93.
   Abstract: Chem. Abstr., 1956, 50:17174e.
   Meyers, F. H.  Pharmacology of chlorpromazine, reser-
   pine and related drugs.  In:  Kline, N. S., ed.  Psycho-
   pharmacology.   Washington,  Am.  Ass. Adv. Sc, 1956.
   p.  131-140.
   Moyer,  J.  H.  The  pharmacology of chlorpromazine.
   Internat. Rec. M., 1955, 168:301-311.
   Pennes, H.  H. The nature of drugs with mental actions
   and their relation to  cerebral function.  Bull. N. York
   Acad. M., 1957, 33: 81-88.
   Perrault, M.   Sur les tranquilliseurs.   [Tranquilizers.]
   Progr. med., Par., 1957, 85 : 3-4; 7.
   Sarro, R.  Recents developpements de la therapeutique
   narcobiotique.   [Recent developments  in narcobiotic
   therapy.]  Ence'phale, 1956, 45 : 501-510.
   Schipa,  S.   Basi farmacologiche  e farmacodinamiche
   delle  cure  neuroganglioplegiche.   [Pharmacologic and
   pharmacodynamic basis of neuroganglioplegic therapy.]
   Osp. psichiat., Nap., 1956, 24: 75-90.
   Vargas Romero, J.  Mecanismo de  accion de la clorpro-
   mazina  (45-60 R. P. Largactil).  [The mechanism of
   action of chlorpromazine (45-60 R. P. largactil).]  Rev.
   clin. espan., 1955, 58:  205-211. Abstract: Chem. Abstr.,
   1956, 59:1199gh.
   Wilson,  G. M., Wood, D. R.  Chlorpromazine.  Practi-
   tioner, Lond., 1955, 174 : 494-501.

 —Additional  data
   Cornman, H. D., III.  Epilogue.  Internat. Rec.  M., 1955,
   168:358.
   Kuschinsky, G.  Wichtige neue Arzneimittel.  [Impor-
   tant new drugs.]  Deut. med. Wschr., 1954, 79:1375-
   1376.
   Leake, C.  D.  Drugs affecting mood  and  behavior.
   Texas Rep. Biol. M., 1955, 13 : 793-818.
   ---.  New mood-changing  drugs. Ohio M.  J.,  1956,
   52: 369-372.
   New  and nonofficial remedies.  J. Am. M.  Ass., 1956,
   160: 287-289.
   Orsi, C.  I farmaci atarassici.  [Ataraxics.]  Boll. chim.
   farm., 1956, 95 : 432-436.
   Ravreby, M.   Pharmacology.  In: Happiness pills  in
   medical practice: a symposium.  J. Iowa M. Soc, 1957,
   47: 57-59.
   Rosner, K.  Therapeutische Anwendung der zentralner-
   vosen  Wirkung  einiger  Phenothiazmderivate in  der
   Allgemeinmedizin.  [Therapeutic use of effects of vari-
   ous phenothiazine derivatives on central nervous system
   in general practice.]   Med. Mschr., 1956, 10: 719-723.
   Schott, M.  B.  Bases  pharmaco-dynamiques et indica-
   tions   therapeutiques  generates   des  neuroplegiques.
   [Pharmacodynamic bases and general  therapeutic indi-
   cations of neuroplegics.]  J. me'd. Lyon, 1954,  35: 925-
   932.
   Viaud, P.   Les amines  derivees de la phenothiazine.
   [The amino-derivatives of phenothiazine.]  J.  Pharm.,
  Lond.,  1954, 6: 361-389.
Placebo effect see  PSYCHOPHARMACA—Evaluation

Prolonged sleep therapy
  see under CHLORPROMAZINE-SJeep therapy

Psychosocial considerations
  see  ATARAXICS—Psychosocial considerations
Psychotherapeutic use
  see also CHLORPROMAZINE—Various special tech-
            niques—Psychotherapeutic use
  Achaintre, A., Balvet, P., Beaujard, M., Broussolle, P.,
  Perrin, J., Leveque, F., Requet, A.  Evaluation of chlor-
  promazine  in psychotic  patients.   Internat.  Rec.  M.,
  1957,  170:175-182.
  Achaintre, A., Lauxerois, G.  Interet de la psychother-
  apie aupres des malades mentaux.  II. Psychotherapie
  explicative individuelle  dans  les psychoses de  longue
  evolution traitees par la chlorpromazine.  [The value of
  psychotherapy in mental diseases. II. Individual explan-
  atory psychotherapy in chronic psychoses treated with
  chlorpromazine.]  J. me'd. Lyon, 1956, 37 : 403-406.
  Bloch,  C.  Psychopathologie  et psychotherapie sous
  chlorpromazine a hautes doses.  [Psychopathology and
  psychotherapy with massive doses of chlorpromazine.]
  Ence'phale, 1956, 45 : 458-460.
  Bronner, A.  Chlorpromazine (thorazine) in office prac-
  tice.  Am. J. Psychother., 1956, 10: 460-466.
  Cowden, R. C,  Zax,  M., Hague, J.  R., Finney, R.  C.
  Chlorpromazine: alone and as an adjunct to group psy-
  chotherapy in  the  treatment of psychiatric  patients.
  Am. J. Psychiat., 1956, 112:898-902.  Abstract: Ex-
  cerpta med., Sect. 8, 1956, 9 : No. 4559.
  Garmany, G., May, A. R., Folkson, A.   The use and ac-
  tion of chlorpromazine in psychoneuroses.  Brit. M. J.,
  1954,  2: 439-441.
  Gibbs, J.  J., Wilkens, B., Lauterbach, C. G.  A  con-
  trolled clinical psychiatric study of [the drug] chlor-
  promazine.  J. Clin. Exp. Psychopath., 1957,18: 258-268.
  Condensed : Am. J.  Psychiat.,  1956,  113 : 254-255.
  Gomirato,  G., Gamna, G.  Ricerche comparative d'es-
  plorazione  psicofarmacologica; studio  dell'associazione
  di un barbiturico ad azione rapida (narcovene)  con un
  ganglioplegico (largactil).  [Comparative  psychophar-
  macologic investigations; study of a rapidly acting bar-
  biturate (narcovene)  combined with  a  ganglioplegic
  (largactil).]  Gior. psichiat., 1954, 82 : 347-359.
  Guiral, R. J.  Uso de la chlorpromazina en las distonias
  vegetativas de tipo psicosomato.  [Use of  chlorproma-
  zine in the psychosomatic type of autonomic dystonias.]
  Ence'phale, 1956, 45 : 541-546.
  Lariviere, P.  Quelques commentaires  sur  la chlorpro-
  mazine en pratique psychiatrique.   [Some remarks on
  chlorpromazine  in  psychiatric practice.]   [English
  summary] Canad. Psychiat. Ass. J., 1956,1:18-23.    *
  Lesse, S.  Psychotherapy and  ataraxics: some observa-
  tions  on combined psychotherapy and  chlorpromazine
  therapy. Am. J. Psychother., 1956, 10:  448-459.      *
  ----, Malitz, S., Hoch, P.  [H.]  Chlorpromazine therapy
  in private practice.  Its benefits and complications.  J.
  Nerv. Ment. Dis., 1957, 125: 25-35.
  Malitz, S., Hoch, P. H., Lesse, S.  A two-year evaluation
  of chlorpromazine in  clinical research and  practice.
  Am. J. Psychiat., 1956, 113: 540-545.
  Newbold H. L., Steed, W. D.  The use of  chlorproma-
  zine in psychotherapy.  J. Nerv. Ment. Dis., 1956, 123:
  270-274.
  Scherr, A.   Le  largactil en  psychiatrie extra-hos-
  pitaliere.  [Largactil in ambulatory psychiatry.]  Ence-
  phale, 1956, 45: 388-391.
  Silverberg, J. W., Gralnick, A.  Possible synergistic ac-
  tion of chlorpromazine, reserpine and frenquel.  A pre-
  liminary report.  Am. J. Psychiat., 1957, 114:173.
  Zellermayer, J.  [Largactil as a psychotherapeutic ad-
  juvant.]   [In  Hebrew]   Harefuah,  Tel-Aviv, 1955, 48:
  31.
Sleep therapy
  see CHLORPROMAZINE—. . .
      CHLORPROMAZINE—Various special techniques

Somnolence therapy see CHLORPROMAZINE—* . . 
Chlorpromazine : Studies, animals
PSYCHOPHARMACA
Studies, animals
  see also  CHLORPROMAZINE—Various  special tech-
              niques—Studies, animals
  Agafonov,  V. G.  Tormoziashchee vliianie  aminazina
  na tsentral'nyi effekt bolevogo razdrazheniia.   [The in-
  hibiting influence of aminazine on the central  effect of
  pain.]  Zh. nevropat.  psikhiat., Moskva, 1956, 56:J4-
  103.   Abstract: Chem.  Abstr., 1956, 50:17174f.
  Aksel, J. S. Etude clinique et experimentale de l'hiber-
  notherapie.  [Clinical  and experimental study of hiber-
  notherapy.]  Ence'phale, 1956,  45:566-571.
  Altschule,  M. D., Bower, W., Cook,  L.  Experiencias
  psiquiatricas com novo agente terapeutico: a cloropro-
  mazina.  [Psychiatric  experience with  a  new  thera-
  peutic agent, chlorpromazine.] Resenha clin. dent., S.
  Paulo, 1955, 24:111-113.
  Angeleri, F., Carreras, M., Urbani,  M.  Modificaziom
  indotte dal 4560 RP sui potenziali evocati registrati nella
  formazione reticolare  del tronco  dell'encefalo  e nella
  corteccia cerebrale.  [Changes induced by  RP 4560 in
  potentials  recorded  in the formatio reticularis  of the
  brain stem and  in  the cerebral  cortex.]  Riv., neur.
  Nap., 1954, 24:702-705.   Abstract:  Electroencephalo-
  graphy, Montreal, 1954, 6: 532.
  Archer, J.  D. Effects  of chlorpromazine on maze  per-
  formance of albino rats.   [Abstract]  Fed. Proc, Ball,
  1954, 13: 332.
  Arian,  E.,  Gomirato,  G. Recherches expenmentales
  sur  l'inhibition  des etats d'excitation d'origine sous-
  corticale par moyen  de  la  chlorpromazine et de la
  reserpine;  communication preliminaire.  [Experimental
  studies on  the inhibition  of sub-cortical excitation by
  chlorpromazine  and by  reserpine; preliminary com-
  munication.]  Encephale. 1946, 45 :1264-1266.
  Balestrieri, A., Fadiga, E. Intorno all'azione di alcuni
  derivati  della fenotiazina sul  sistema  nervoso  centrale.
  [Action of  some phenothiazine derivatives on the central
  nervous  system.]  Arch.  sc.  biol, Bologna, 1954, 38:
  620-633.  Abstract: Chem. Abstr., 1955, 49 :11887b.  Ex-
  cerpta med., Sect. 8, 1956,  9: No. 303.
  Bamdas, B. S., Glod, G. D., Lando, L. I., Levkovich, A. P.,
  Tarasov, Y. K., Khazen, I. M.   [The mechanism of action
  of aminazine.]  Zh.  nevropat. psikhiat., Moskva, 1956,
  56:  121-138.  Abstract: Chem. Abstr., 1956, 50:17175d.
  Baruk, H.  La catatonie experimentale par la chlorpro-
  mazine ;  la posologie et la methode d'administration la
  plus efficace en  therapeutique psychiatrique.   [Experi-
  mental  catatonia  produced with  chlorpromazine;  the
  dosage  and most effective method  of chlorpromazine
  therapy in  psychiatry.]  Ence'phale, 1956, 45: 474-476.
  ----, Launay, C, Lelord.  Etude sur Taction therapeu-
  tique du 4560 R. P. dans les etats d'excitation et d'agita-
  tion impulsive.  Donnees  cliniques et donnees experi-
  mental sur les modifications de la circulation cereb-
  rale.  [Study on the therapeutic action of 4560 RP in
  states of excitation and impulsive agitation.  Clinical
  and experimental information on the changes in cerebral
  circulation.] Ann.  me'd. psychol, Par., 1954, 112  (2) :
  66-71.
  ----, Launay, J., Berges, J. La catatonie experimentale
  par  la  chlorpromazine.   [Experimental catatonia in-
  duced by chlorpromazine.]  Ann. me'd. psychol, Par.,
  1955, 113 (1) : 439-441.
  ----, ----, ----.  La  catatonie experimentale  par la
  chlorpromazine a hautes doses chez le singe et dans la
  serie animale; action therapeutique du 45-60 R. P. dans
  le traitement des maladies mentales en clinique humaine
  (a doses  moderees et sans  association  medicamen-
  teuses).  [Experimental catatonia induced in  monkeys
  by massive doses of chlorpromazine; therapeutic effect
  of chlorpromazine in the treatment of mental disorders
  in humans with moderate doses and without  adjuvant
  medication.] Rev. neur.,  Par., 1955, 92:141-143.
____,----,----.  Physiologie psychiatrique experimen-
tale de la chlorpromazine chez les animaux et ses appli-
cations  therapeutiques chez  l'homme.  [Experimental
psychopharmacology of chlorpromazine in animals and
its  therapeutic applications in man.]  Encephale, 1956,
45 :1258-1263.
____, ----, ----.  La therapeutique par la chlorproma-
zine;  physiologie experimentale; physiologie  clinique;
resultats therapeutiques et progres de la therapeutique
psychiatrique.  [Chlorpromazine therapy ; experimental
physiology ; clinical physiology; therapeutic results and
progress in psychiatric treatment.]  Ann. me'd. psychol,
Par., 1955,113 (1) : 705-772.
----, Launay, S.,  Berges, J.  Action de la  reserpine sur
la psychomotricite et catatonie experimentale.   [Effect
of reserpine  on experimental psychomotricity and cata-
tonia.]  Rev. neur., Par., 1956, 95 : 62-63.
Begany, A. J., Seifter, J., Pless, H. H.,  Huber, R. D.,
Bruce, W.  F. Tranquilizing effect of  phenothiazines in
cats and rabbits.  Fed. Proc, Bait., 1956,  15: 399-400.
Benditt, E. P., Rowley, D. A.  Antagonism  of 5-hydroxy-
tryptamine by chlorpromazine.  Science, 1956, 123:24.
Berger, F. M., Campbell,  G. L., Hendley, C. D., Ludwig,
B. J., Lynes, T. E.  The action of tranquilizers on brain
potentials and serotonin.  Ann. N. York Acad.  Sc, 1957,
66: 686-694.
Blough, D. S. Some effects of drugs on visual discrimi-
nation in  the pigeon.  Ann. N. York Acad.  Sc, 1957,
66: 733-739.
Bower,  W. H., Altschule, M. D., Cook, L.  Psychiatric
experience  with  chlorpromazine.  Am.  Practitioner,
1955,  6:90-93. Abstract: Excerpta med., Sect. 8, 1956,
9: No. 4071.
Boyd, E. M., Miller, J. K.  Inhibition of locomotive activ-
ity by chlorpromazine hydrochloride.  [Abstract]  Fed.
Proc, Bait., 1954, 13 : 338.
Bradley, P. B., Hance, A. J.  The effect of chlorproma-
zine and methopromazine on the electrical  activity of
the brain in the cat.  Electroencephalography, Montreal,
1957,  9: 191-215.
----,----.  The effect of chlorpromazine on the electri-
cal activity  of  the  brain  of  the conscious  cat.  J.
Physiol, Lond., 1955,129 : 50P-51P.
Brodie, B. B., Shore,  P.  A., Silver, S. L.  Potentiating
action of chlorpromazine and reserpine. Nature, Lond.,
1955, 175: 1133-1134.   Abstract:  Chem.  Abstr., 1956,
50: 479g.
Burke, J. C, Hassert, G.  L.,  High, J. P.  The tranquiliz-
ing activity of 10-(3-dimethylaminopropyl)-2-(trifluoro-
methyl)-phenothiazine hydrochloride  (MC  4703)  and
related  phenothiazines   in  animals.   [Abstract]   J.
Pharm, Exp. Ther., 1957, 119 :136.
Carreras,  M., Angeleri, F.  Basi sperimentali alle indi-
cazioni  della cloropromazina e della reserpina nella
terapia  neuropsichiatrica.   [Experimental  basis  for
chlorpromazine and for reserpine therapy in  neuropsy-
chiatry.]  Riv. neurobiol, 1955, 1: 473-525.  [Not seen].
Abstract:  Excerpta med., Sect. 8, 1956, 9: No. 4991.
----, ----.  The location of action of chlorpromazine
in  the central nervous system.  Internat.  Rec. M., 1957,
170: 67-85.
----, ----.  Sull'azione  centrale  del potenzializzatore
4560 R. P.  [Central effect of the potentiator 45(50 R. P.]
Boll. Soc.  ital biol. sper., 1955, 31: 474-477.
Cazzullo, C. L., Guareschi, A.  Influenza di un derivato
della   fenotiazina,    largactil,  sull'attivita   elettrica
dell'encefalo del cane.   [Effect of a  phenothiazine de-
rivative largactil, on  the electric activity of  the brain,
in  dogs.]  [English summary]  Riv. neur., Xap., 1954,
24: 602-632.  Abstract:  Chem.  Abstr., 1956,  50: 8068b.
Excerpta med., Sect. 8, 1955, 8: No. 3097.
Cook, L., Weidley E.  Behavioral effects of some psycho-
pharmacological agents.   Ann. N. York Acad  Sc 1957
66: 740-752.
36 
SUBJECT LIST
Chlorpromazine : Studies, animals
 ----, Weidley, E. F., Morris, R. W., Mattis, P. A. Neuro-
 pharmacological and behavioral effects of chlorproma-
 zine (thorazine hydrochloride).  [Abstract]  J. Pharm.
 Exp. The,-., 1955) 113 : H-12.
 Courvoisier, S.  Pharmacodynamic basis for the use of
 chlorpromazine in psychiatry.   J. Clin. Exp. Psycho-
 path., 1956, 17: 25-37.
 ---.  Sur les  proprietes pharmacodynamiques de la
 chlorpromazine en rapport avec son emploi en psychia-
 trie.  [Pharmacodynamic basis for the use of chlorpro-
 mazine in  psychiatry.]  Ence'phale, 1956, 45 :1248-1257.
 ---, Fournel, J., Ducrot, R.,  Kolsky, M., Koetschet, P.
 Proprietes  pharmacodynamiques du  chlorhydrate  de
 chloro-3-(dimethylamino - 3' - propyl) -10 phenothiazine
 (4560 R. P.).  [Pharmacodynamic properties of chloro-
 3-(dimethylamino-3'-propyl)-10 phenothiazine  (R.  P.
 4560).]  Arch, internat. pharm. dyn,,  Gand, 1953,  92:
 305-361.
 Das, N. N., Dasgupta, S.  R., Werner, G.  Changes of
 behaviour  and electroencephalogram in rhesus monkeys
 caused  by chlor(o)promazine.  Arch, internat. pharm.
 dyn., Gand, 1954, 99: 451-457.  Condensed: Bull  Cal-
 cutta School Trop. Med., 1954, 1 (4) : 5-6.  Abstract:
 Chem. Abstr., 1955, 49: 6455e.
 ---, ----, ----.  The effect  of  chlorpromazine  on the
 electrical activity of the cerveau isole.   Arch. exp. Path.,
 Berl, 1955, 224 : 248-252.
 Dasgupta,  S. R.,  Mukherjee,  K. L., Werner,  G.  The
 activity of some central depressant drugs in acute decor-
 ticate and diencephalic preparations.   Arch,  internat.
 pharm, dyn., Gand, 1954, 97:149-156.   Abstract: Chem.
 Abstr., 1954, 48 : 11636g.
 Davis, G. D.  Effects of central excitant and depressant
 drugs on  locomotor activity in  the  monkey.  Am. J.
 Physiol., 1957, 188: 619-623.
 Delgado,  J. M.,  Milhailovic,  L.  Use  of intracerebral
 electrodes  to evaluate drugs  that act on the central
 nervous system.  Ann.  N.  York  Acad. Sc, 1956,  64:
 644-666.
 Dobkin, A. B., Gilbert, R. G. B., Lamoureux, L.  Physi-
 ological effects of chlorpromazine. Anaesthesia, Lond.,
 1954, 9:157-174.
 Eeckhoutte, R. van  Le chlorhydrate de chloro-3-dime-
 thylamino-3'-propyl-10-phenothiazine (4560 R.  P.) ;  son
 action sur le systeme nerveux et sur le systeme neuro-
 vegetatif.   [3-Chloro-10-(3-dimethylaminopropyl)  phe-
 nothiazine  (4560 R.P.) ; its action on  the nervous and
 autonomic  nervous  system.]   28  p.  Ambilli,  1953,
 [Thesis—Geneva 1953. no. 2168]
 Essig, C. F., Carter, W. W.  Convulsions and bizzare
 behavior in monkeys receiving chlorpromazine.  Proc
 Soc. Exp.  Biol, N. Y., 1957,  95: 726-729.
 Friebel,  H., Reichle, C.  Zur  analgetischen und anal-
 gesieverstarkenden   Wirkung   von   Chlorpromazin
 (Megaphen).  [Analgesic  and   analgesic-potentiating
 effect  of  chlorpromazine  (megaphen).]  Arch.  exp.
 Path., Berl, 1955, 226 : 551-557.  Abstract: Chem. Abstr.,
 1956, 50: 2063de.
 Garattini,  S., Valzelli, L.  Sbstanze interferenti sulla
 attivita potenziante gli ipnotici svolta dalla serotonina.
 [Substances that interfere with  the potentiating effect
 of serotonin on hypnotics.]  Boll Soc. ital  biol. sper.,
 1956 32 ■ 292—295.
 Gliedman,  L. H., Gantt, W. H.  The effect of reserpine
 and chlorpromazine on orienting  behavior and retention
 of conditioned reflexes.  South. M. J., 1956. 49: 880-889.
 Guha, G., Dasgupta, S. R., Werner, G.  Effects of some
 central depressant drugs on conditioned reflexes.  Bull.
 Calcutta School Trop. Med., 1954, 2: 46-47.  Abstract:
 Chem. Abstr., 1955, 49 :1270de.
Haley, T. J.,  McCormick,  W. G.  Pharmacological ef-
fects produced by intracrebral injection of drugs in the
conscious mouse.   University of  California, School of
Medicine, Atomic Energy Project,  Los  Angeles, 1956
 (UCLA-372) : 1-25.

    456132—59---4
Hamister, R. C.  Chlorpromazine in maze learning and
retention.  Psychol. Rep., 1956, 2 : 331.
Heim, F., Frodl, E.  Der Einfluss des Megaphen auf die
Spontan-und Hypermotilitat der  weissen Maus.  [Ef-
fect of megaphen on spontaneous and hypermotility of
white  mice.]   Arzneimitt.  Forsch., 1954,  4:514—515.
Abstract: Chem. Abstr., 1955, 49 : 518gh.
Hendley, C. D.,  Lynes, T. E., Berger, F. M. Effect of
meprobamate  on electrical  activity of thalamus and
other subcortical  areas.   In: Himwich,  H.  E.,  ed.
Tranquilizing  drugs.  Washington,  Am. Ass. Adv. Sc,
1957.  p. 35-46.
Hiebel, G.,  Bonvallet, M., Dell, P.   Action de la chlor-
promazine  (Largactil 45 60  RP) au niveau du systeme
nerveux  central.  [Effects of chlorpromazine on  cen-
tral nervous system.]   Sem. hop. Paris, 1954, 30:2346-
2353.  Abstract:  Excerpta med.,  Sect.  8, 1955,  8: No.
1219.
Himwich, H. E.  Discussion  of papers on basic observa-
tions of new psychopharmacological agents.  Psychiat.
Res. Rep., Wash., 1956 (4) : 24-31.
---, Rinaldi,  F.  Analysis of the action of benztropine
methanesulfonate  against Parkinsonism.     In:  Him-
wich, H. E., ed. Tranquilizing drugs. Washington, Am.
Ass. Adv. Sc,  1957. p. 47-57.
----,----,  Willis, D.  An examination of phenothiazine
derivatives  with comparisons of their effects on  the
alerting  reaction, chemical  structure and therapeutic
eflBcacy.  J. Nerv. Ment. Dis., 1956,  124: 53-57.
Hippius, H., Mellin, P., Rosenkotter, L. Megaphenwir-
kungen  im  EEG des Kaninchens.   [Megaphen  effects
on  the EEG of  rabbits.]  Zschr.  ges. exp. Med., 1955,
125 : 128-135.
Holten, C. H.,  Sonne, E.   Action of  a series  of benacty-
zine-derivatives  and other compounds on stress-induced
behaviour  in  the rat.  Acta pharm. tox., Kbh., 1955,
11:148-155.
Hunt, H. F.   Some effects of drugs on classical  (type
S)  conditioning. Ann.  N.  York  Acad. Sc, 1956,  65:
258-267.
Ingvar, D. H.,  Soderberg, U.  Effects of chlorpromazine
on  cerebral circulation  and electroencephalogram  in
cats.  A. M. A. Arch. Neur. Psychiat., 1957, 78: 254-258.
Irwin,  S., Govier, W. M.  Chlorpiprozine, a  new tran-
quilizer :  comparison  with chlorpromazine in   the
mouse,  rat,  cat,  dog,   and monkey.  [Abstract]  J.
Pharm. Exp. Ther., 1957, 119: 154-155.
Jacobsen, E.,  Skaarup,  Y.  Experimental  induction  of
conflict-behaviour  in  cats:  the effect  of some anti-
cholinergic compounds.   Acta pharm. tox., Kbh., 1955,
11:125-134.  Abstract:  Chem. Abstr., 1956, 50: 2045ef.
Kaminskii,  S.  D., Savchuk, V. I.  O deistvii aminazina
na  vysshuiu  nervuiu deiatel'nost'  sobak.  [Effect  of
aminazine  on  the higher nervous  functions in  dogs.]
Zh. nevropat. psikhiat., Moskva, 1956, 56 : 104-115.  Ab-
stract : Chem.  Abstr., 1956, 50: 17174hi.
Kinnard, W. J., Carr, C. J.  A preliminary procedure
for the evaluation of central nervous system depressants.
J. Pharm. Exp. Ther., 1957,121: 354-361.
Kopeloff, L. M., Chusid, J.  G., Kopeloff, N. Effect of
chlorpromazine  upon epileptic and normal monkeys.
Proc. Soc. Exp. Biol, N. Y., 1955, 90: 2S2-2S4.
Lasagna, L., McCann, W. P. Effect of "tranquilizing"
drugs on amphetamine  toxicity  in aggregated mice.
Science, 1957,  125 : 1241-1242.
Le  Guillant, L., Roelens, R.  Travaux  sovietiques sur
les  neuroleptiques.  [Soviet studies of neuroleptics.]
Presse med., 1956, 64 : 1225-1227.
---,---, Corre, Kestenberg, Plichet,  Bequart,  Bailly-
Salin.  Quelques remarques methodologiques sur Tac-
tion des  neuroleptiques.   [Certain  methodological con-
siderations  on the action of neuroleptic  drugs.]   En-
cephale, 1956, 45:1128-1135. 
Chlorpromazine : Studies, animals
PSYCHOPHARMACA
Lehmann, H. E. Neurophysiology activity of chlorpro-
mazine in clinical use.  J. Clin. Exp. Psychopath., 1956,
17:129-139.
Lim, R. K., Pindell, M. H., Glass, H. G, Rink, K.  The
experimental evaluation  of sedative agents in animals.
Ann. N. York Acad. Sc, 1956, 64: 667-678.
Longo, V. G., Von Berger, G. P., Bovet, D.  Action of
nicotine and of the "gangliopiegiques centraux" on the
electrical  activity of the  brain.  J.  Pharm. Exp. Ther.,
1954,  111: 349-359.  Abstract: Chem. Abstr., 1954, 48:
12301d.
Malmejac, J.,  Plane,  P.  Chlorpromazine et  activite
nerveuse  superieure.  [Chlorpromazine  and   higher
nervous activity.]   C.  rend. Soc. biol, 1955, 149: 677-
679.
Marrazzi, A. S.,  Hart, E. R.  An  electrophysiological
analysis of drugs useful  in psychotic states.  In: Him-
wich, H. E., ed. Tranquilizing drugs.  Washington, Am.
Ass. Adv. Sc, 1957.  p. 9-21.
---,  ---.   An  electrophysiological analysis  of  the
actions of some drugs useful in the therapy of psychotic
disorders.  J. Nerv. Ment. Dis., 1956,  124:388-392.
Martin, J. E., Beck, J. D.  Some effects of chlorproma-
zine hydrochloride  in  horses.  Am.  J. Vet. Res., 1956,
17: 678-686.
Masserman, J. H.,  Pechtel,  C.  Neurophysiology  and
pharmacologic  influences  on experimental  neuroses.
Am. J. Psychiat., 1956, 113 : 510-514.
Miller, R. E., Murphy, J. V., Mirsky, I. A.  Persistent
effect of chlorpromazine  on extinction of  avoidance re-
sponse.  A.  M.  A. Arch.  Neur. Psychiat., 1957, 78: 526-
530.
Monroe, R.  R.,  Heath, R. G, Mickle, W. A., Miller, W.
Cortical  and  subcortical  recordings  correlated  with
behavior in patients and animals during the adminis-
tration  of Rauwolfia,  thorazine, and  meratran.  Psy-
chiat. Res.  Rep. Wash., 1955  (1) : 25-44.  Abstract:
Chem. Abstr., 1956,  50: 2867gh.
Moran, N. C, Butler, W. M., Jr.  The pharmacological
properties of chlorpromazine sulfoxide, a major metabo-
lite of chlorpromazine; a comparison with chlorproma-
zine.  J. Pharm. Exp. Ther., 1956, 118: 328-337.
Murphree, O. D., Peters, J.  E.   The effect of electro-
convulsions, insulin comas and certain chemical agents
on fixations in the rat.   J. Nerv. Ment. Dis.,  1956, 124:
78-83.
Norton, S.,  De  Beer,  E. J.  Effects of drugs  on the
behavioral patterns of cats.  Ann.  N. York  Acad. Sc,
1956,  65: 249-257.
Pfeiffer,  C.  C, Jenney,  E. H.  The inhibition of the
conditioned  response  and the counteraction  of schizo-
phrenia by muscarinic stimulation  of the brain.  Ann.
X. York Acad. Sc, 1957,  66: 753-764.
Piala, J. J., High, J. P., Greenspan, K., Burke, J. C.  Fur-
ther laboratory observations on 10-(3-dimethylamino-
propyl) -2- (trifluoromethyl)-phenothiazine  hydrochlo-
ride (MC 4703).  [Abstract] J. Pharm. Exp. Ther., 1957,
119:176-177.
Preston, J. B.  Chlorpromazine:  a  possible mechanism
of  action.  [Abstract]   Fed. Proc, Bait.,  1956,  115:
468-469.
---.  Effects of chlorpromazine  on the  central  ner-
vous  system of the cat: a  possible neural basis for
action.  J. Pharm.  Exp.  Ther., 1956, 118:100-115.
Revol, L.  Chlorpromazine et  intoxication  alcoolique.
[Chlorpromazine  and  alcoholic  intoxication.]  Lyon
pharm., 1954, 5:349-350.
Rinaldi, F.  The  experimental  electroencephalographic
approach  to psychopharmacology.  Psychiat. Res.  Rep.,
Wash., 1956 (4) : 1-10.
----,  Himwich, H. E.   Drugs affecting  psychotic be-
havior and  the function of the mesodiencephalic acti-
vating system.   Dis.  Nerv.  Syst.,  1955, 16:133-141.
Abstract: Excerpta med.,  Sect.  8,  1956,  9: No. 4566.
----, ■----. The cerebral electrographic changes induced
by LSD  and mescaline are corrected by frenquel.  J.
Nerv. Ment. Dis., 1955, 122 : 424-432.
----,----.  The  site of action of antiparkinson drugs.
Confinia  neur., Basel, 1955,  15:  209-224.  Abstract:
Am. J. Physiol, 1954, 179:  665.  Excerpta med., Sect. 8,
1956, 9: 3616.
Sadove, M.  S., Balagot,  R. C, Reyes, R.  M.  The po-
tentiating  action  of chlorpromazine.  Current  Res.
Anesth.,  1956, 35  :165-181.
Schallek, W., Kuehn, A., Seppelin, D. K. Central depres
sant effects  of methyprylon.  J. Pharm. Exp. Ther.,
1956, 118:139-147.
Schneider, J. A.   Reserpine  antagonism of  morphine
analgesia in mice.   Proc  Soc. Exp. Biol, X.  Y., 1954,
87: 614-615.  Abstract: Chem. Abstr., 1955, 49: 4165 ef
Schwartzbaum, J. S.  Effects of reserpine and chlorpro-
mazine on nest building and thermal preference in rats.
Proc Soc. Exp. Biol, N. Y., 1955, 90: 275-277. Abstract:
Chem.  Abstr., 1956, 50: 2853ab.
Sheatz, G. C.  Studies on chlorpromazine in decerebrate
dogs  and  patients  with  irreversible brain  damage.
[Abstract]  J.  Pharm. Exp. Ther., 1955, 113 : 47-48.
Shumilina, A. I.  [The character  of conditioned reflex
activity of dogs following the administration of amina-
zine.]   Zh. nevropat. psikhiat., Moskva, 1956,  56:  116-
120. Abstract: Chem. Abstr.,  1956, 50: 17175bi.
Soulairac, A., Soulairac,  M. L. Etude experimentale de
Taction de la chlorpromazine sur le comportement ali-
mentaire et Tactivite spontanee du rat.  [Experimental
study  of  the effect  of chlorpromazine on  the feeding
behavior and spontaneous activity of rats.]  Encephale,
1956, 45: 927-931.
Steinmann, H.   Der Einfluss von Megaphen auf  das
Elektrokortikogramm der Katze.   [The effects of chlor-
promazine on the electrocorticogram of the cat.] [Eng-
lish summary] Zbl Neurochir., 1954,  14: 233-237.   Ab-
stract : Excerpta  med., Sect. 8, 1956, 9  : No. 534.
Taeschler, M.,  Rothlin, E.  Zur Charakterisierung der
zentralen Wirkung  von Phenothiazinderivaten.   [The
specific  central  effect  of phenothiazine  derivatives.]
Arch.  exp. Path., Berl,  1956, 228:184-186.   Abstract:
Chem. Abstr., 1956, 50 : 8902de.
Terzian, H.  Etude de Taction du largactil  (4560  RP)
et du pendiomide sur Tactivite electrique cerebrale du
lapin.  [Study  of the action of largactil and pendiomide
on  the electrical activity  of  the rabbit  brain.]   Rev.
neur., Par., 1954,  91: 445-453.
---, Ruberti,  R.  Studio sperimentale dell'azione del
largactil ed del pendiomid sull'attivita elettrica cereb-
rale del  coniglio.  [Experimental  study of the effect of
largactil and pendiomide on cerebral  electrical activity
in rabbits.]  Riv. neur., Nap., 1954,  24:686-702.   Ab-
stract  : Excerpta  med., Sect. 8, 1955, 8: No. 2717.
Turner,  W. J.  The effect  of lysergic acid diethylamide
on Betta splendens: I. Dis. Nerv. Syst., 1956,17 :193-197.
Votava,  Z., Vanecek, M.  The influence  of some  anti-
histaminics  and neuroplegics on the higher  nervous
activity  of rats  and dogs.   Physiol, bohem,, 1956, 5
 (Suppl.) : 58-62.
Walaszek, E. J.,  Abood, L. G.  Effect of tranquilizing
drugs  on fighting  responses  of  Siamese  fighting  fish.
Science, 1956, 124:440-441.
Werner,  G.   The  central actions of chlorpromazine.
Ence'phale, 1956,  45 : 920-926.
----.  The  effects   of  chlorpromazine.  [Abstract]
J. Am. M. Ass.,  1955, 157: 837.
Witt,  P. N.   Der Netzbau  der  Spinne als  Test zur
Prufung zentralnervos angreifender Substanzen.   [Con-
struction of spider webs as a test for drugs with CNS
action.]   Arzneimitt. Forsch., 1956, 6 : 628-635.
----.  Die Wirkung einer einmaligen Gabe von Largactil
auf den Netzbau der Spinne  Zilla-x-notata.  [Effect of
a single dose of chlorpromazine on the web construction
38 
SUBJECT LIST
Chlorpromazine : Studies, patients
  of  the  spider Zilla-x-notata.]    [English  summary]
  Mschr. Psychiat., Basel,  1955, 129: 123-128.
  ----,  Heimann, H.  Prufung der Wirkung einer ein-
  maligen Gabe von Largactil am Menschen mit  dem
  Durchstreichtest  von Meili und  an der  Spinne beim
  Netzbauverhalten.  [The effect of a single dose of lar-
  gactil tested  in man by Meili's  cross-out  test and  in
  spiders  by the  web-building test.]  Helvet.  physiol
  pharm. acta,  1954, 12: C  98-99.

Studies, normal subjects

  see  also CHLORPROMAZINE—Various special tech-
    niques—Studies, normal subjects
  Bente, D., Itil, T.  Zur Wirkung des Phenothiazinkorpers
  Megaphen  auf das menschliche  Hirnstrombild.  [The
  effect of the phenothiazine  megaphen  on the human
  EEG.]  Arzneimitt, Forsch., 1954,  4 : 418-423.  Abstract:
  Chem. Abstr., 1954, 48:13097b.
  Cahn, M.  M., Levy,  E.  J.  Ultraviolet  light factor  in
  chlorpromazine dermatitis. A. M. A. Arch. Derm., 1957,
  75 : 38-40.
  Carreras,  M., Angeleri,  F.  The  location of action  of
  chlorpromazine in the central nervous system. Internat.
  Rec. M., 1957, 170 : 67-85.
  Despinoy,  M., Saucet,  D.   Effects eiectro-encephalo-
  graphiques des stimulations auditives et lumineuses sur
  des sujets soumis a la chlorpromazine.   [Effect  of
  auditory an photic stimulations on the EEG of  subjects
  under the influence of  chlorpromazine.]   Encephale,
  1956, 45:877-883.
  Dobkin, A. B., Gilbert, R. G. B., Lamoureux, L.  Physio-
  logical effects of  chlorpromazine.  Anaesthesia, Lond.,
  1954, 9:157-174.
  Douglas, A. D. M., Bates, T. J. N.  Chlorpromazine  as
  a suicidal agent.   Brit.  M. J., 1957, 1:1514.
  ---, Lamoureux, L., Letienne,  R., Gilbert, R. G.  B.
  Some studies with largactil.   Canad. M. Ass. J., 1954,
  70: 626-628.
  Dubansky, B., Doubrava, O.,  Svoboda, E., Vyhnankova,
  M.  Hirnnervenstorungen nach einmaliger intravenoser
  Largactildosis bei zerebralintakten Personen.   [Brain
  nerve damage after single intravenous injection of lar-
  gactil in individuals  without brain  disease.]  Psychiat.
  Neur. med. Psychol, Lpz.,  1956, 8: 202-205.          *
  Ernst, K.  Psychopathologische Wirkungen des Pheno-
  thiazinderivates  "Largactil"  ("Megaphen")  in Selbst-
  versuch  und bei Kranken.  [Psychopathological effects
  of  the phenothiazine  derivative "largactil"   ("mega-
  phen") in self-experimentation and  in patients.] Arch.
  Psychiat.,  Berl,  1954,   192:573-590.   Abstract:  Ex-
  cerpta med.,  Sect. 8,  1955, 8:  No. 3520.
  Fazekas, J. F., Albert, S. N., Alman, R. W.  Influence of
  chlorpromazine and alcohol on cerebral hemodynamics
  and metabolism.   Am. J. M. Sc, 1955, 230:128-132.  Ab-
  stract : Excerpta med., Sect.  8, 1956, 9: No. 2934.
  Fraser, H. F., Isbell, H.  Chlorpromazine  and reser-
  pine.  A. Effects of each and of  combinations  of each
  with  morphine.  B. Failure  of  each  in treatment  of
  abstinence from morphine.  A. M. A. Arch. Neur. Psy-
  chiat., 1956, 76: 257-262.
  Galenko, V. E., Osberg, I. IU., Robiner, I. S., Frenkel,
  G.   M.   Kliniko-elektrofiziologicheskie   issledovaniia
  psikhicheski bol'nykh pri lechenii aminazinom.  [Amina-
  zine therapy  of mental  patients; clinical and  electro-
  encephalographic   study.]  Zh.   nevropat.   psikhiat.,
  Moskva, 1956, 56:300-306.  Abstract:  Chem. Abstr.,
  1956, 50:17176i.
  Glaser, E.  M., Newling, P.  S. B.  Side effects of chlor-
 promazine  hydrochloride.  Brit.  J. Pharm.,  1955, 10:
 429-^433.
 Heimann, H.,  Witt, P. N.  Die Wirkung einer einmali-
 gen Largactilgabe bei Gesunden; vergleichend  phycho-
 pathologisch—elektroencephalographische   Untersuch-
 ungen.   [Effect of single doses of chlorpromazine  in
  normal  individuals;  comparative  psychopathological-
  electroencephalographic studies.]  [English summary]
  Mschr. Psychiat., Basel, 1955,129 :104-123.
  Isbell, M., Logan,  C. R.  Studies on the diethylamide of
  lysergic acid  (LSD-25).  II. Effects of chlorpromazine,
  azacyclonol, and reserpine on the intensity of the LSD-
  reaction.  A.  M. A. Arch. Neur. Psychiat., 1957, 77 : 350-
  358.
  Knight, R. W., Kent, B., Morris, G., Rogers, S. Clinical
  studies  of an antiemetic agent, chlorpromazine.  [Ab-
  stract]   J. Laborat. Clin. M., 1953, 42: 828.
  Kornetsky, C, Humphries, O. Relationship between ef-
  fects  of a number of centrally  acting drugs and per-
  sonality.  A.  M. A. Arch. Neur. Psychiat., 1957, 77: 325-
  327.
  ---,----, Evarts, E. V.  Comparison of psychological
  effects of certain centrally acting drugs in man. A. M. A.
  Arch. Neur. Psychiat., 1957,  77 : 318-324.
  Laborit, H., Huguenard, P.,  Alluaume, R.  Un nouveau
  stabilisateur  vegetatif; le 4560 RP.  [A new autonomic
  stabilizer; 4560 RP.]  Presse med., 1952, 60:206-208.
  Lehmann, H. E.  Ein hemmendes Mittel zur Kontrolle
  und Behandlung psychomotorischer Erregungszustande;
  (Chlorpromazine,   Largactil, Thorazine,  Megaphen).
  [An inhibiting drug for control and treatment of psy-
  chomotor excitement: (chlorpromazine, largactil, thor-
  azine,   megaphen).]  Nervenarzt,   1954,  25:322-330.
  Abstract: Excerpta med., Sect. 8, 1955, 8: No. 1792.
  ---,  Csank,  J. Differential screening of phrenotropic
  agents in man: psychophysiologic test  data.  J. Clin.
  Exp. Psychopath., 1957,18 : 222-235.
  Moyer, J. H.,  Kent, B., Morris, G., Dizon, M., Rogers, S.,
  Spurr, C.  Clinical studies of an  anti-emetic agent, chlor-
  promazine.  Am. J. M. Sc, 1954, 228: 174-189.
  Pierson, C. A.  La chlorpromazine et la maitrise de soi
  dans  les  angoisses collectives.  [Chlorpromazine and
  self-control in mass  hysteria.]  Ence'phale,  1956, 45:
  562-565.
  Primac, D. W., Mirsky, A. F., Rosvold, H. E.   Effects of
  centrally acting drugs on two  tests of brain damage.
  A. M. A. Arch. Neur. Psychiat.,  1957, 77: 328-332.
  Sutter,  J. M., Pascalis, G.  Effets psychologiques  de la
  chlorpromazine.  [Psychologic  effects  of chlorproma-
  zine.]  Encephale, 1956, 45: 979-986.
  Tranquillizers and divorce.  Brit. M. J., 1957, 2:1122-
  1123.
  Witt,  P. N., Heimann, H.  Prufung der Wirkung einer
  einmaligen Gabe von  Largactil  am  Menschen mit dem
  Durchstreichtest  von  Meili  und an der  Spinne beim
  Netzbauverhalten.  [The effect  of a single dose of lar-
  gactil tested  in man  by Meili's cross-out test and  in
  spiders  by the web-building test.]  Helvet. physiol.
  pharm. acta, 1954,12 : C 98-99.

Studies, patients

  see also CHLORPROMAZINE—Various special  tech-
               niques—Studies, patients
  Ayd, F.  J., Jr.  Physiologic and  neurologic responses to
  chlorpromazine: their clinical   significance and  their
  management.   Psychiat. Res. Rep., Wash.,  1956 (4) :
  64-70.
  Bader, E. Extrapyramidal  symptoms following thora-
  zine medication.  Illinois M. J., 1956, 109: 28-29.
  Balestrieri, A. Azione della cloropromazina  e  della
  reserpina  sul  sistema nervoso  extrapiramidale.  [The
  effect of chlorpromazine and reserpine on the extrapyra-
  midal  nervous system.]  [English  summary]   Arch.
  psicol neur.,  Milano, 1956, 17: 483-512.
  Benassi, P., Cecacchi, G.  Rilievi elettroencefalografici
  nell'uso di un derivato  fenotiazinico   (45-60  R. P.).
  [Electroencephalographic findings in the use of a phe-
  nothiazine  derivative  (RP  4560).]  Riv. neur.,  Nap.,
  1953,  23: 535-542.  Abstract: Electroencephalography,
  Montreal, 1953, 5: 621. 
Chlorpromazine: Studies, patients
PSYCHOPHARMACA
Bente, D.  Elektroencephalographische Ergebnisse zur
Wirkungsweise  der  neuroleptischen  Behandlungsver-
fahren.   [Mechanism of action of neuroleptic  thera-
pies ;  EEG findings.]  Ence'phale,  1956, 45: 898-903.
Bolsi, D., Donegani, G, Grattarola, F. R.  I ganglio-
plegici ed il sistema neurovegetative negli schizofrenici.
[Ganglioplegics and  the autonomic nervous system  in
schizophrenia.]  Minerva med., Tor., 1953, 44:230-231.
[Not seen]
Bonafede, V. I.  Chlorpromazine (thorazine) treatment
of disturbed  epileptic  patients;  preliminary report.
A. M. A. Arch. Neur. Psychiat., 1955, 74: 158-162.
----.   Chlorpromazine  (thorazine)  treatment of dis-
turbed  epileptic  patients.   A.  M.   A.  Arch.   Neur.
Psychiat., 1957, 77: 243-246.
Bonnet, H.  Chlorpromazine et modifications de
Telectro-encephalogramme chez les malades mentaux;
correlations  cliniques.  [Chlorpromazine  and  EEG
changes  in  mental  disorders;   clinical  correlates.]
Ence'phale, 1956, 45 : 858-876.
Brooks, G. W.  Experiences  with  the use of chlorpro-
mazine and reserpine  in psychiatry  with  special ref-
erence to the significance and management of extra-
pyramidal  dysfunction.  N. England  J. M., 1956, 254:
1119-1123.  Abstract: Yearbook of drug therapy,  1956-
1957, p. 343-344.
Cahn,  M. M.,  Levy,  E. J.  Ultraviolet light factor  in
chlorpromazine dermatitis.  A. M. A. Arch. Derm., 1957,
75: 38-40.
Carreras, M.,  Angeleri,  F.  The location  of action  of
chlorpromazine in the central nervous system.  Internat.
Rec M., 1957,170: 67-85.
Chatagnon, P.,  Chanoit,  P.  Psychopiegie  transitoire,
resultat  clinique observe dans  des  etats  d'excitation
psycho-motrice a la  suite de Taction d'un derive  de  la
phenothiazine.   [Transient   psychoplegia,  a   clinical
result  observed  during the treatment of  psychomotor
excitation with a phenothiazine derivative.]  Ann. med.
psychol, Par., 1953, 111 (1) : 361-364.
Choppy, M., Le Beau, J., Petrie, A.  Modifications de la
personnalite apres les operations frontales  seiectives y
compris  la cingulectomie et apr£s traitement par  la
chlorpromazine.   [Personality changes  after  selective
frontal operations, including cingulectomy, and  after
chlorpromazine  therapy.]  Rev.  neur.,  Par.,  1955,
93: 843-849.
Ciocatto, E., Cattaneo, A. D., Solerio, L., Bianchetti,  L.
Studio farmacologico del largactil o potenzializzatore
RP 4560;  studio sperimentale sull'uomo.   [Pharma-
cological study of largactil or RP 4560 potentializer;
experimental study on humans.]  Gazz. med. ital, 1953,
112: 125-135.
Conrad,  K., Domanowsky,  K., Wieser, S.   Uber  extra-
pyramidale  Anfallszustande  bei  Behandlung  mit
Phenothiazinen.  [Extrapyramidal symptoms during
treatment  with phenothiazines.]  Fortsch.  Neur.
Psychiat, 1956, 24: 505-512.
Courvoisier, S.  Pharmacodynamic basis for the use of
chlorpromazine in psychiatry. J. Clin. Exp. Psychopath.,
1956,17: 25-37.
Cremieux, A., Alliez, J., Soulayrol, R.  Action de la chlor-
promazine  sur les etats hallucinatoires durables.   [Ef-
fect  of  chlorpromazine  on  chronic hallucinations ]
Ence'phale, 1956, 45: 643-646.
Delay, J., Deniker, P., Bourguignon, A., Lemperiere, T.
Complications d'allure  extrapyramidale au cours  des
traitements par la chlorpromazine et la reserpine; etude
clinique   et   eiectromyographique.   [Extrapyramidal
movement  disorders during chlorpromazine and  reser-
pine therapy; clinical  and electromyographic  studies.]
Ence'phale, 1956, 45 : 1093-1098.
Deniker,  P.  Psychophysiologic aspects  of  the new
chemotherapeutic drugs in psychiatry; some  practical
features of "neuroleptics" in  order to  screen new  drugs.
J. Nerv. Ment. Dis., 1956,124:  371-376.
----.  Recent advances  in  "pharmaco-psychiatry."  J.
Clin. Exp. Psychopath., 1956,17: 381-384.
Ey, H., Faure, H., Lairy, G. C.  Action du largactil sur
Telectro-encephalogramme  de malades  mentaux chro-
niques comparee a Taction des barbituriques.  [Compar-
ison between the effects of largactil and barbiturates on
the EEG of chronic mental patients.]  Encephale, 1956,
45: 843-852.
Fabisch,  W.  Chlorpromazine  and epilepsy.  Lancet,
Lond., 1955, 1:1277.                               *
Fernandes, B.  Effets psycho-somatiques de la  chlor-
promazine.   [Psychosomatic effects  of  chlorproma-
zine.] Encephale, 1956, 45: 328-333.
Fliigel, F., Bente, D. Das akinetisch-abulische Syndrom
und  seine  Bedeutung  fur  die  pharmakologisch-
psychiatrische  Forschung.   [Akinetic-abulic syndrome
and its  importance in psychopharmacologic research.]
Deut. med. Wschr., 1956, 81:2071-2074.
Freyhan, F. A.  Comments on the biological and psycho-
pathological  basis  of individual  variation in  chlor-
promazine therapy.   Encephale, 1956, 45 : 913-919.
----.  Psychomotility  and parkinsonism  in treatment
with neuroleptic drugs.  A. M. A. Arch. Neur. Psychiat.,
1957,  78: 465-472.
Fiinfgeld, E. W.  Zur  Frage der  Megaphenprovokation
bei der Elektrencephalographie.   [Problem of megaphen
activation in electroencephalography.]  Arch. Psychiat.,
Berl, 1956, 194: 571-583.
Funkenstein,  D. H.  Nor-epinephrine-like  and  epine-
phrine-like substances in relation  to human behavior.
J. Nerv. Ment. Dis., 1956,124: 58-68.
Galenko, V. E., Osberg, I.  IU., Robiner, I. S., Frenkel,
G.   M.  Kliniko-elektrofiziologicheskie   issledovaniia
psikhicheski bol'nykh pri lechenii aminazinom.   [Ami-
nazine therapy of mental patients; clinical and electro-
encephalographic   study.]   Zh.  nevropat.  psikhiat,
Moskva,  1956, 56:300-306.  Abstract:  Chem.  Abstr.,
1956, 50: 17176L
Glotfelty, J. S., Wilson, W. P.  Effects of tranquilizing
drugs on reticular system activity in man.  North Caro-
lina M. J., 1956,17 : 401-405.
Goldman, D.  The influence  of chlorpromazine on psy-
chotic thought content and mechanism.   Psychiat. Res.
Rep., Wash., 1955 (1) : 72-76.
Haase, H. J.  Psychiatrische Erfahrungen mit Megaphen
(Largactil) und dem Rauwolfiaalkaloid Serpasil unter
dem Gesichtspunkt des  psychomotorischen Parkinson-
syndroms.   [Psychiatric experiences with megaphen
(largactil) and Rauwolfia alkaloid  serpasil with special
reference to Parkinson's psychomotor syndrome.]  Ner-
venarzt, 1955, 26 : 507-510.
----.  Uber Begriff und Wirkungsweise des therapeu-
tisch erstrebten psychomotorischen  Serpasil-(Rauwolfia-
alkaloid-)  und  Largactil-(Megaphen-)  Parkinson-Syn-
droms.   [Definition and mode of action of the  psycho-
motor Parkinson syndrome therapeutically induced by
serpasil  and  largactil.]   [English summary]  Mschr.
Psychiat, Basel, 1956, 131: 201-214.
----. Uber Vorkommen und Deutung des psychomotor-
ischen Parkinsonsyndroms bei Megaphenbezw.  Largac-
til-Dauerbehandlung.  [Occurrence and interpretation
of  the psychomotor  Parkinson  syndrome  during  pro-
longed  therapy  with megaphen or largactil ]  Ner-
venarzt,  1954, 25 : 486-492.
Hall,  R. A., Jackson, R. B., Swain, J. M.  Neurotoxic re-
actions  resulting from chlorpromazine administration.
J. Am. M. Ass., 195(5. 161: 214-218.
Hartmann, K. Uber die Bildnereien Geisteskranker und
lhre  Bildkommentare;  Anmerkungen  zur  Megaphen-
therapie.  [Artistic creations  of mental patients  and
their own  comments on their paintings; notes on mega-
phen therapy.]   Zschr.  Psychother.,  1956,  6:7-15.
    , Hiob, J., Hippius,  H.   Comparative psychopathol-
ogy of shock  therapy  and  pharmacotheraov  Internal
Rec M., 1957, 170:119-124.
40 
SUBJECT LIST
Chlorpromazine : Studies, patients
----.----,----.   Zur vergleichenden Psychopathologie
der Schock-  und Phenothiazinwirkung.   [Comparative
psychodynamics of shock therapy and phenothiazines.]
Fortsch. Neur. Psychiat., 1955, 23 : 354-366.
Holmberg, G., Jonsson, B.,  Mellgren, A., Martens,  S.
EEG  changes in chlorpromazine and reserpine treat-
ment.   Acta psychiat.  neur. scand., 1956, Suppl. 106:
235-240.
Horst, L. van der  Donnees sur Temploi du largactil et
d'autres  derives de  la phenothiazine  en neurologie,
neuro-chirurgie et radiologie.  [The use of largactil and
other phenothiazines in  neurology, neurosurgery  and
radiology.]   Encephale, 1956, 45:717-721.
Janzarik, W.  Die Bedeutung der neuroplegischen Ther-
apie fur die Psychopathologie des schizophrenen Wahns.
 [Significance of  neuroplegic therapy for the  psycho-
pathology of schizophrenic hallucinations.] Ence'phale,
1956, 45: 635-642.
Kruse,  W. "Paradoxical" effect of chlorpromazine in a
case of periodic catatonia.  Am. J. Psychiat, 1957,  114:
463-464.
Kulcsar,  S.,  Erdelyi,  S.  Recherches  sur le  test  de
 Szondi  an cours du traitement par la chlorpromazine.
 [Studies of  the  Szondi test during  chlorpromazine
therapy.]  Ence'phale,  1957,  46 :140-145.
Lafon, R., Due, N., Labauge, R., Temple, J. P.  Incidents
et accidents  lies  a  Temploi de la chlorpromazine.  [In-
cidents and  accidents with the use of chlorpromazine.]
Ence'phale, 1956,  45 :1226-1228.
Lamarche, A., Roussel, A.,  Rosendorf.   Comparaisons
des resultats obtenus par la cure de sommeil, la cure de
somnolence,  et la cure a la  chlorpromazine seule  et &
dose  elevee; resultats de  quelques  eiectro-encephalo-
grammes de  controle.   [Comparison of results obtained
with sleep therapy, somnolence therapy and chlorproma-
zine therapy alone and  with elevated doses ; results con-
trolled  by EEG.]  Encephale, 1956, 45 : 884-890.
Lambert, P.  A., Diederichs, A., Toulet, M. Incidents et
complications des  traitements  par la chlorpromazine
employee insoiement chez Tadulte.  [Incidents and com-
plications of treatments with chlorpromazine used alone
in adults.]   Encephale, 1956, 45 :1229-1247.
Le Guillant.  Le syndrome neuroleptique: etude clinique
et psychotechnique.  [The neuroleptic syndrome: clini-
cal and psychometric study.] Ann. med. psychol, Par.,
1957, 115 (1) : 316-329.
Lehmann, H. E.  Neurophysiologic activity in chlorpro-
mazine in clinical use.  J. Clin.  Exp. Psychopath., 1956,
17:129-139.
Leroy,  C, Sigwald, J.  Les myoclonies et epilepsies ap-
paraissant chez certains malades au cours de Tadminis-
tration  de la chlorpromazine.  [Myoclonias and epilep-
tic convulsions occurring in some patients during chlor-
promazine therapy.]  Ence'phale, 1956, 45 : 904-909.
Letailleur, M., Morin, J., Monnerie, R.  Syndromes tran-
sitoires pseudo-parkinsoniens provoques  par la chloro-
promazine.   [Transient  pseudo-parkinson  syndromes
provoked by chlorpromazine.]   Encephale, 1956,  45:
1106-1109.
Liberson, W.  T.  Effects   of  chlorpromazine  hydro-
chloride (thorazine)  on EEG and on skin galvanic ac-
tivity.   [Abstract] Electroencephalography, Montreal,
1955, 7: 474.
Merlis,  S., Denber, H. C. B.  Studies on mescaline.  V.
Electroencephalographic evidence for the antagonism
between mescaline and chlorpromazine  hydrochloride.
J. Nerv. Ment. Dis., 1956, 123:542-545.
Meszaros, A. F.,  O'Reilly, P. O.   Relation of chlorpro-
mazine  to epilepsy.  Dis. Nerv. Syst, 1956, 17:159-162.
Abstract: Excerpta med., Sect. 8,1957,10: No. 723.
Mayr, F., Lechner, H.  Zur  Frage der Provokation bei
Temporallappen-Epilepsie im EEG.  [The question  of
provocation  in temporal lobe epilepsy  in the  EEG.]
Wien. klin. Wschr., 1954, 66:903-906.
Monroe, R. R., Heath, R. G., Mickle, W. A., Miller, W.
A comparison of cortical and subcortical brain waves in
normal,  barbiturate, reserpine,  and   chlorpromazine
sleep.  Ann. N.  Yorlt Acad. Sc,  1955, 61:56-71.  Ab-
stract : Excerpta med., Sect.  8, 1956, 9 : No. 3089.
----,----,----,----.  Cortical and subcortical record-
ings correlated with behavior in  patients and animals
during the administration of Rauwolfia, thorazine, and
meratran.  Psychiat. Res. Rep., Wash., 1955 (1) : 25-44.
Abstract: Chem. Abstr., 1956, 50: 2867gh.
Morgan,  D.  R.   The experimental  use of  reserpine in
the treatment of tremor-rigidity syndromes.  Med. J.
Australia, 1956, 43 (1) : 973-974.
Passouant, P., Pelissier, Minvielle, J., Dutartre.  Modi-
fications  eiectro-encephalographiques provoquees  par
la chlorpromazine  au cours  de Tepilepsie  et  de  la
schizophrenie.  [EEG changes induced by chlorproma-
zine in  epilepsy and  in schizophrenia.] Encephale,
1956, 45: 891-897.
Petrie, A., Le Beau, J.  The effects on personality of
chlorpromazine as compared with various brain opera-
tions.  Encephale, 1956,45 : 987-995.
---,----.   Psychologic changes in  man after chlorpro-
mazine and certain types of brain surgery.   J. Clin. Exp.
Psychopath., 1956,17 :170-179.
Pupo,  P. P., Zukerman,  E., Longo, R. H.  O  uso  do
amplictil (4560  RP, Rhodia) na  rotina do diagnostico
eletrencefalografico.  [Use  of chlorpromazine in EEG
diagnosis.]   [English summary] Arq.  neuropsiquiat.,
S. Paulo, 1955, 13:197-202.
Rockmore, L., Shatin, L., Funk, I. C.  Response of psy-
chiatric  patients to massive doses  of thorazine.  I.
Behavioral  and clinical  analysis.  Psychiat. Q., 1956,
30:189-203.
Sanguineti, I., Negri, V., Laricchia, R.  Le modificazioni
dell'EEG in malati  di mente sottoposti all'azione di  un
derivato  della  fenotiazina   (largactil-Farmitalia).
[Modifications in the EEG of mental patients subjected
to the effects of a phenothiazine derivative (largactil).]
[English summary]  Riv. neur., Nap., 1953, 23 : 513-534.
Sarrouy, C, Saint-Jean, Sendra, L. Sabatini R.  Etude
eiectro-encephalographique  de trente cas de toxicoses
traitees par le  4560 R. P.  [Electroencephalographic
study of 30  cases of toxicosis treated with 4560 R. P.]
Arch. fr. pediat., 1955,12: 37-42.
Scarpalezos S.  Le traitement ambulatoire par la chlor-
promazine des psychonevroses et de certaines manifes-
tations epileptiques (troubles  caracteriels et  myoclo-
nies).  [Ambulatory treatment with chlorpromazine in
psychoneuroses and in some manifestations of epilepsy
(character  disorders  and  myoclonias).]  Encephale,
1956, 45: 722-726.
Schmitt, R. J.  The psychodynamics of the tranquilizing
agents.  Psychiat. Q., 1957, 31:17-30.
Selbach,  C, Selbach,  H.  Phenothiazinwirkung  und
somato-psychische  Dynamik.  [Phenothiazine  action
and  psychosomatic   dynamics.]  Nervenarzt,   1956,
27:145-149.
Shagass, C.  Effect  of intravenous chlorpromazine on
the   electroencephalogram.   Electroencephalography,
Montreal, 1955, 7:306-308.  Abstract:  Chem.  Abstr.,
1956, 50:1184e.  Excerpta med., Sect. 8, 1956, 9 : No. 40.
Shatin, L., Rockmore, L., Funk, I. C.  Response  of psy-
chiatric  patients to massive  doses of thorazine.   II.
Psychological test performance  and comparative drug
evaluation.  Psychiat.  Q., 1956, 30: 402-416.
Steck,  H. Le syndrome extrapyramidal dans les cures
de  chlorpromazine  et  serpasil;  sa symptomatologie
clinique  et  son role therapeutique.  [Extrapyramidal
syndrome in chlorpromazine and serpasil therapy; its
clinical symptoms  and therapeutic role.]  Ence'phale,
1956, 45:1083-1089.
----.  Le syndrome extrapyramidal et diencephalique
au  cours des traitements au largactil  et au serpasil.
[Extrapyramidal and diencephalic syndrome  during
41 
Chlorpromazine: Studies, patients
PSYCHOPHARMACA
  largactil  and serpasil  therapy.]  Ann.  med. psychol,
  Par., 1954, 112 (2) : 737-744.
  Terzian,   H.  Etude  eiectroencephalographique   de
  Taction centrale de  la chlorpromazine  (4560 R. P.).
  [Electroencephalographic study of the central action of
  chlorpromazine  (4560 R.  P.).]  Sem.  hdp. Paris, 1954,
  30: 838-841.   Abstract: Excerpta med., Sect.  8, 1955,
  8: No. 47.
  ---.  Studio elettroencefalografico dell'azione centrale
  del  largactil  (4560  RP).  [Electroencephalographic
  study of  the central action of largactil (4560 RP).]
  Rass. neur. vegetal, 1952, 9: 211-215.
  Thiebaux,  M., Thiebaux,  R., Boyer,  R., Leborgne, F.,
  Kiffel, M.  Note sur Tapparition de troubles extrapyra-
  midaux au cours du traitement par le 4560 R. P.  [The
  occurrence of extrapyramidal  symptoms during treat-
  ment with 4560  RP.]  Ann. me'd. psychol, Par., 1954,
  112  (1) : 732.
  Turner, M., Berard, E.  Estudio del efecto de la cloro-
  promazina (4560 RP) sobre el electroencefalograma y el
  electrodermograma.   [Effect of chlorpromazine on the
  EEG  and   electrodermogram.]   [English   summary]
  Rev. Soc. argent biol, 1954, 30:163-169.
  ---, ---, Turner, N. Franco, N.  Etude des modifica-
  tions eiectro-encephalographiques,  eiectro-dermograph-
  iques et electro-myographiques provoquees par la clor-
  promazine.   [Electroencephalographic,   electrodermo-
  graphic  and electromyographic  changes  induced by
  chlorpromazine.]   [English  summary]   Anesthe'sie,
  Par., 1955, 12: 453-465.  Abstract: Chem. Abstr., 1956,
  50:3633f.  As:  Modificaciones  electroencefalograficas,
  electrodermatograficas,  y  electromiograficas provocadas
  en  el hombre por la cloropromazina.  [English sum-
  mary]  Rev.  Soc. argent,  biol,  1955, 31:54-63.  As:
  Modifications eiectroencephalographiques, eiectro-der-
  mographiques et eiectromyographiques provoquees par
  la chlorpromazine chez l'homme.   [English  summary]
  Electroencephalography, Montreal, 1956,  8: 25-34.
  Watterson,  D. J.  Chlorpromazine, depersonalization,
  and  visual hallucinosis.  Bull. Menninger Clin., 1956,
  20:20-24.  Abstract:  Excerpta  med., Sect.  8, 1956,
  9: No. 4558.

Terminology of therapies
  Delay, J.  Allocution finale.  [Final address.]   [Inter-
  national colloquium  on  chlorpromazine and neuroleptic
  drugs, Paris, October 1955] Ence'phale, 1956, 45:1181-
  1184. [p. 1182]
  ---, Deniker, P.  Le traitement des psychoses par une
  methode neurolytique derivee d'hibernotherapy; le 4560
  R. P. utilisee seul en cure prolongee et continue.  [Treat-
  ment of psychoses by a neurolytic  method derived from
  hibernotherapy; prolonged continuous therapy with 4560
  RP alone.]   C. rend. Congr. aliCn. neur. France, 1952,
  50: 497-502.  Abstract: Ann. me'd. psychol, Par., 1952,
  110  (2) :564.
  Laborit, H.  Therapeutique neuroplegique et hibernation
  artificielle:   essai d'eclaircissement  d'une  equivoque.
  [Neuroplegic  therapy and  artificial   hibernation:  at-
  tempt to clarify  an  equivocation.]  Presse me'd., 1954
  62:359-362.
  ---. L'homme  et son milieu.   [Man  and his environ-
  ment.]  Presse me'd., 1951, 59:1037-1038.
  ---, Huguenard,  P.  L'hibernation artificielle par
  moyens  pharmacodynamiques et physiques.   [Artificial
  hibernation by pharmacodynamic and physical means.]
  Presse me'd.,  1951, 59:1329.

Therapeutic studies, controlled

  see also  CHLORPROMAZINE—Various  special tech-
             niques—Therapeutic studies, controlled

  Ayd, F. J., Jr. Thorazine and serpasil treatment of pri-
  vate neuropsychiatry patients.   Am. J. Psychiat 1956
  113:16-21.                                    '     *'
Azima,  H., Durost, H. Effects of promazine in mental
syndromes.  Canad. M. Ass. J., 1957, 76: 442-446.
Bender, L.,  Nichtern, S.  Chemotherapy in child  psy-
chiatry.  N. York State J. M., 1956, 56: 2791-2795.
Bennett, A. E., Ford, F. R., Turk, R. E.  Clinical investi-
gation of chlorpromazine and reserpine in private  psy-
chiatric practice.  Am. J. Psychiat, 1956, 112: 782-787.
Condensed:  Am. Practitioner,  1956, 7:1576-1577.  Ab-
stract : Excerpta med., Sect. 8, 1956, 9: No. 4546.
Bonafede, V. I.  Chlorpromazine (thorazine) treatment
of  disturbed  epileptic patients;   preliminary  report.
A. M. A. Arch. Neur. Psychiat., 1955, 74:158-162.    *
---.   Chlorpromazine  (thorazine) treatment  of  dis-
turbed epileptic patients. A. M. A. Arch. Neur. Psychiat.,
1957,  77: 243-246.
Brooks, G. W.  Experiences with the use of chlorproma-
zine and reserpine in psychiatry, with special reference
to the significance and management of extrapyramidal
dysfunction.   N. England J. M., 1956, 254:1119-1123.
Abstract: Year book of drug therapy, 1956-1957, p. 343-
344.
Burdine, W. E.,  Shipley, T. E., Papas, T. A.   Studies on
the use of promazine in acute and chronic nervous  and
mental disturbances.  J. M.  Ass. Georgia, 1957, 46:171-
173.
Carillo-Broatch, A.  Le largactil dans le traitement de
Tepilepsie essentielle rebelle; resume d'une  communica-
tion preliminaire.   [Largactil  therapy of severe idio-
pathic epilepsy; summary  of  a  preliminary  report.
Encephale, 1956, 45: 1221-1223.
Charlin, A.  Action respective  de la chlorpromazine et
de la  r6serpine; hypotheses pathogeniques.  [The effect
of chlorpromazine  and of reserpine; pathogenic hypoth-
eses.]  Ence'phale, 1956, 45 :1099-1105.
Cummins, J. F., Friend, D. G.  Use of chlorpromazine in
chronic alcoholics.  Am. J.  M. Sc,  1954, 227: 561-564.
Abstract: Excerpta med.,  Sect. 8, 1955,  8: No. 3552.
Denhoff, E., Holden, R. H. The effectiveness of chlorpro-
mazine  (thorazine) with cerebral palsied children. J.
Pediat, S. Louis, 1955, 47 : 328-332.
Durling, D., Esen, F. M., Mautner, H. Central autonomic
regulation and mental retardation.  Ann. paediat., Basel,
1956, 187:467-470.
Ernst, K. Psychopathologische Wirkungen des Pheno-
thiazinderivates "Largactil"  ("Megaphen")  im Selbst-
versuch und bei Kranken.   [Psychopathological effects
of  the  phenothiazine derivative  "largactil"  ("mega-
phen")  in self-experimentation and in patients.  Arch.
Psychiat., Berl, 1954,192: 573-590.  Abstract: Excerpta
med.,  Sect. 8, 1955, 8: No. 3520.
Esen, F. M., Durling, D. Thorazine in the treatment of
mentally retarded  children.   Arch. Pediat, N. Y., 1956,
73:168-173.
Ey, H.,  Sakellaropoulos, P. L'etat primordial du deiire
et Taction therapeutique  de la chlorpromazine.  [The
primary delusional state and the therapeutic action of
chlorpromazine.]  Evolut. psychiat.,  1956:  489-497.
Fau, R., Chateau,  R.  La cure de sommeil  et la chlor-
promazine.  [Sleep therapy and chlorpromazine.]  En-
cephale, 1956,  45: 428-435.
Feldman,  P.  E. The personal  element in psychiatric
research.  Am. J. Psychiat, 1956, 113: 52-54.
Fox, V.  Treatment  of withdrawal  symptoms in the
management  of alcoholism.  J. M. Ass. Georgia, 1956,
45:139-142.
Fraser,  H. F.,  Isbell, H.  Chlorpromazine and reserpine.
A.  Effects of each and of  combinations of each with
morphine. B. Failure of each in  treatment of absti-
nence from morphine. A. M. A. Arch. Neur. Psychiat,
1956, 76: 257-262.
Freed, H., Peifer, C. A.  Treatment  of  hyperkinetic
emotionally disturbed children with prolonged adminis-
tration  of chlorpromazine.   Am.  J.  Psychiat.,  1956,
113:22-26.  Abstract:  Excerpta med.,  Sect.  8.  1957,
10: No.  1837.
42 
SUBJECT LIST
Chlorpromazine : Therapeutic studies, controlled — Neuroses
 Freedman, A. M., Effron, A. S., Bender, L.  Pharmaco-
 therapy in  children with psychiatric illness.  J. Nerv.
 Ment Dis.,  1955, 122: 479-486.  Abstract: Year book of
 drug therapy, 1956-1957, p. 350-351.
 Fromm, G.  H., Forsberg, I. A.  Controlled study on the
 value of chlorpromazine in allaying anxiety.  Dis. Nerv.
 Syst, 1956,17 :16-19.
 Gibbs, J. J., Wilkens, B., Lauterbach, C. G. A controlled
 clinical psychiatric study of [the drug] chlorpromazine.
 J.  Clin.  Exp. Psychopath.,  1957, 18: 258-268.  Con-
 densed: Am. J. Psychiat.,  1956, 113: 254-255.
 Horenstein, S.  Reserpine and chlorpromazine in hyper-
 active mental defectives.  Am. J.  Ment. Deflc, 1957,
 61:  525-529.                                        *
 Hormia,  A.  Yhdistetty serpasil-klooripromatsiinihoito
 psykiatriassa.   [Combined  serpasil-chlorpromazine
 treatment in psychiatry.]   [English summary]   Duo-
 decim, Hclsin., 1956, 72: 76-85.
 Hunt, B. R., Frank, T., Krush, T. P.   Chlorpromazine in
 the  treatment of severe emotional disorders of children.
 A. M. A. J. Dis. Child,, 1956, 91: 268-277.
 Knutsen, A. T.  Reserpin og klorpromazin i psykiatrien.
 [Reserpine and chlorpromazine in psychiatry.]   [Eng-
 lish   summary]  Tskr.   Norske   laegeforen.,    1956,
 76:368-371.
 Kugelmass, I.  N. Psychochemotherapy of mental defi-
 ciency in children.  Internat. Rec. M., 1956,169 : 323-338.
 Kurland, A. A. Chlorpromazine in the management of
 the   institutionalized  aged  psychiatric  patient  with
 chronic brain syndrome.  Dis. Nerv. Syst., 1955, 16: 366-
 369. Abstract: Excerpta med., Sect. 8, 1956, 9: No. 3996.
 Lafon, R., Due, N., Boyer, Abric, J., Pouget, R. Explor-
 ation psychologique des malades traites par le 4560 RP
 (chlorpromazine) et la reserpine.   [Psychologic exam-
 ination  of patients treated with RP 4560 (chlorproma-
 zine) and with  reserpine.]  Ence'phale, 1956, 45:996-
 999.
 Lamarche,  A.,  Roussel,  A.,  Rosendorf  Comparaisons
 des  resultats obtenus par la cure de sommeil, la cure de
 somnolence, et la cure a la chlorpromazine seule et a dose
 elevee; resultats de quelques electro-encephalogrammes
 de   controle.   [Comparison of  results  obtained  with
 sleep therapy, somnolence  therapy and chlorpromazine
 therapy  alone and  with  elevated doses;  results con-
 trolled by EEG.]  Ence'phale, 1956, 45: 884-890.
 Lancaster,  N. P., Jones, D.  H. Chlorpromazine  and
 insulin in psychiatry.  Brit. M. J., 1954, 2: 565-567.
 Lemere, F.  Combined chlorpromazine-reserpine therapy
 of psychiatric disorders.  A. M. A. Arch. Neur. Psychiat,
 1955,  74:1-2.  Abstract: Excerpta  med., Sect. 8, 1956,
 -9: No. 2235.
 Lesse, S. An evaluation of promazine hydrochloride in
 psychiatric practice.  Am.  J. Psychiat., 1957,  113: 984-
 987
 Meszaros, A. F., O'Reilly, P. O.  Relation of chlorproma-
 zine to  epilepsy.  Dis.  Nerv. Syst., 1956, 17:159-162.
 Abstract: Excerpta med., Sect. 8, 1957, 10: No.  723.  *
 Mitchell, E. H.  Chlorpromazine in  the treatment of
 acute alcoholism.  Am. J.  M. Sc, 1955, 229: 363-367.
 Abstract: Excerpta med., Sect. 8,1957,10: No. 884.  Q. J.
 Alcohol, 1955,  16: 589-590.                        * *
 ____.  Treatment of acute alcoholism with promazine
 (sparine).  J. Am. M. Ass.,  1956,  161: 44-45.  Con-
 densed:  Am.  Practitioner, 1956,  7: 1798-1799.  Ab-
 stract: Excerpta med., Sect. 8, 1957,  10: No.  359.    *
Monnerot, E., Monnerot, E., Benichou, L., Doco  Analyse
 des  roles respectifs du largactil et  du sommeil barbi-
 turique,  dans  les  cures  de  sommeil  potentialisees.
 [Analysis of the effect of  chlorpromazine and  of bar-
 biturates respectively  in potentiated sleep  therapy.]
 Ence'phale, 1956, 45:1190-1196.
Pennington, V. M.  A comparative study of six ataraxics
 in 1130  neuro-psychiatric  cases.  Mississippi Doctor,
1956, 33:336-339.
  Ranee, A. M., Jurquet, A., Roger, J.  Remarques sur la
  therapeutique des affections psychiatriques par la chlor-
  promazine et la reserpine; etude comparee des diverses
  modalites d'administration  de ces  drogues.   [Therapy
  of psychiatric disorders with chlorpromazine and reser-
  pine ; comparative study of the various methods of their
  administration.]  Ence'phale, 1956,  45:477-487.
  Reda,  G. C,  Germano, V.  L'azione combinata  della
  reserpina e cloropromazina nella pratica psichiatrica.
  [Combined  effect of reserpine  and chlorpromazine in
  psychiatric  practice.]   [English   summary]  Arch.
  psicol. neur., Milano, 1956, 17: 647-653.
  Rees, L., Lambert, C. A controlled study of the value of
  chlorpromazine in  the  treatment  of  anxiety-tension
  states.  Encephale, 1956, 45: 547-549.
  Rettig, J. H.  Chlorpromazine and mysoline in the con-
  trol of convulsive epilepsy in mentally deficient patients.
  J. Nerv.  Ment. Dis.,  1956,  124: 607-611.
  Rockmore, L.,  Shatin, L.,  Funk, I. C.  Response of psy-
  chiatric  patients to  massive doses of thorazine.  I. Be-
  havioral and  clinical analysis.  Psychiat.  Q., 1956, 30:
  189-203.
  Rosner,  H., Levine,  S., Hess, H., Kaye,  H. A compara-
  tive study of the effect on  anxiety of  chlorpromazine,
  reserpine, phenobarbital, and a placebo.  J. Nerv. Ment.
  Dis., 1955,122 : 505-512.   Abstract: Excerpta med., Sect.
  8, 1957, 10: No. 2093.
  Sainz, A. A.   Clinical applications of chlorpromazine
  in  psychiatry.  In:  Kline, N. S., ed. Psychopharmacol-
  ogy.  Washington,  Am. Ass. Adv.  Sc,  1956.  p. 39-58.
  ---.  The treatment of  drug and alcohol withdrawal
  effects with thorazine.  Psychiat. Q., 1957, 31: 275-284.
  Samuels, A. S. Phenergan  in treatment  of psychiatric
  patients. Dis. Nerv. Syst, 1957, 18:183-188.
  Schultz, J. D., Rea, E. L.,  Fazekas, J. F., Shea,  J. G.
  Chlorpromazine in  the management of acute  alcoholic
  states.  Q. J. Alcohol, 1955,  16:  245-250.  Abstract: Ex-
  cerpta med., Sect. 8, 1956, 9: No. 2598.
  Settel, E.  Chlorpromazine in  the treatment  of senile
  agitation.  GP, 1955, 12 (6) : 74-76.  Abstract: Excerpta
  med.,  Sect. 8, 1956, 9: No. 3612.
  Shatin, L.,  Rockmore, L., Funk, I.  C. Response of psy-
  chiatric patients to massive doses of thorazine.  II. Psy-
  chological test performance and comparative drug eval-
  uation.  Psychiat. Q., 1956, 30: 402-416.
  Smigel, J. O.  Mood therapy in the aged.  Med. Times,
  Great Neck, 1957, 85: 149-158.
  Sternberg,  U., Spitz, H., Goyne, J.  B.  Evaluation of
  chlorpromazine and reserpine  therapy with follow-up
  study.  J. Clin. Exp. Psychopath., 1957, 18: 258-268.
  Sutter, J. M.,  Pascalis, G.  Effets psychologiques de la
  chlorpromazine.   [Psychologic  effects  of chlorproma-
  zine.] Ence'phale, 1956, 45: 979-986.
  Wells, R. E. Use of reserpine (serpasil) in the manage-
  ment of chronic alcoholism.  J. Am. M. Ass., 1957  163 ■
  426-429.
  Winkelman, N. W., Jr. An appraisal of chlorpromazine;
  general principles for administration of chlorpromazine,
  based on experience with 1,090 patients.  Am. J. Psy-
  chiat, 1957, 113:961-971.
  Winter,  W. D., Frederickson,  W. K.  The short-term ef-
  fects of chlorpromazine on psychiatric patients. J. Con-
  sult Psychol, 1956, 20:431-434.
  Zeller, W.  W., Graffagnino, P.  N., Cullen, C. F., Reit-
  man, H. J.  Use of chlorpromazine and reserpine in the
  treatment of emotional disorders.   J. Am. M. Ass., 1956,
  160:  179-184.   Abstract: Year book of  drug therapy
  1956-1957, p. 343-342.

—Neuroses
  Chertok, L.  A propos de Temploi de medicaments neuro-
  leptiques  dans  le traitement  des  psychonevroses.
  [Neuroleptic drugs in the treatment of psychoneuroses.]
  Ence'phale, 1956, 45: 705-706. 
Chlorpromazine : Therapeutic studies, controlled — Neuroses
PSYCHOPHARMACA
  Dierkens, J., Reeth, P. C. van.  Essais cliniques d'un
  nouveau psychoplegique :  le meprobamate.  [Clinical
  trial of a new psychoplegic drug: meprobamate.]  [Eng-
  lish summary]  Bruxelles med., 1956, 36 : 2335-2340.
  Dubansky, B., Doubrava, O., Svoboda, E., Vyhnankova,
  M.  Hirnnervenstorungen nach einmaliger intravenoser
  Largactildosis bei zerebralintakten  Personen.   [Brain
  nerve  damage after single intravenous injection  of
  largactil  in  individuals   without   brain   disease.]
  Psychiat.  Neur. med. Psychol, Lpz.,  1956, 8: 202-205. *
  Gerhardt, U., Ziolko, H. U.  Zur Megaphenwirkung bei
  Neurotikern.  [Effects  of   megaphen  in   neurotics.]
  Aerztl Wschr., 1956, 11: 750-752.
  Marshall,  W.  Ambulatory  and comparative treatment
  of the anxiety neurosis  syndrome with chlorpromazine,
  phenobarbital, and dimethylane. S. Dakota J. M., 1956,
  9:384-388.
  Merry, J., Pargiter, R. A., Munro, H.  Chlorpromazine
  and chronic neurotic  tension.  Am.  J. Psychiat., 1957,
  113: 988-990.
  Moyer, J. H., Pevey, K., Kinross-Wright, V.  Tranquiliz-
  ing (ataractic) agents: current evaluation of their clini-
  cal use in patients who are not hospitalized.  GP, 1957,
  15  (6) : 97-118.                                     *
  Pellerito,  N.  L'Azione della cloropromazina  e della
  reserpina  sull'ansia  dei  psiconevrosici.   [Action  of
  chlorpromazine and reserpine on the anxiety of psycho-
  neurotics.]  Minerva med.,  Tor., 1956,  47:628-631.
  Raymond, M. J., Lucas,  C. J., Beesley, M. L., O'Connell,
  B. A., Roberts, J. A.  F. A trial of five tranquillizing
  drugs in psychoneurosis. Brit. M. J., 1957,  2: 63-66.
  Rees, W. L., Lambert, C. The value and limitations of
  chlorpromazine in the treatment of  anxiety states.  J.
  Ment. Sc, Lond., 1955,101: 834-840.
  Settel,  E.   Chlorpromazine in  the home treatment  of
  the agitated senile patient.  GP, 1956, 14 (5) : 97-100.
  Usdin, G. L.  Use of promazine in psychiatric practice;
  an early study.   J. Louisiana M. Soc, 1956, 108: 251-
  257.                                                *

—Psychoses

  see also CHLORPROMAZINE—Various special tech-
             niques—Therapeutic studies, controlled—
             Psychoses
  Andermann, K., Lindsay, J.  S.  Chlorpromazine.  Med.
  J. Australia, 1955, 42  (2) : 80-82.
  Azima, H.  Proponged sleep  treatment in mental dis-
  orders ;  some new psychopharmacological  considera-
  tions.  J. Ment. Sc, Lond., 1955,101: 593-603.
  Barsa, J. A., Kline, N. S. Combined reserpine-chlorpro-
  mazine in  treatment of disturbed psychotics.  A. M.  A.
  Arch. Neur. Psychiat., 1955, 74: 280-286.  Abstract: Am.
  J.  Psychiat., 1955, 111: 780.   Excerpta med., Sect.  8,
  1957, 10: No. 368.
  ---,---•  A comparative study  of reserpine, chlor-
  promazine, and combined therapy.   A. M. A. Arch. Neur.
  Psychiat.,  1956, 76: 90-97.
  ----, ----.  Promazine in  chronic  schizophrenic pa-
  tients.  Am. J. Psychiat., 1957,113 : 654.
  Boardman, R. H.,  Lomas, J., Markowe, M. Insulin and
  chlorpromazine in schizophrenia;  a comparative study
  in previously untreated cases.  Lancet, Lond., 1956,
  2: 487-491.
  Cahn, C. H., Lehmann, H. E.  Perphenazine;  observa-
  tions on the clinical effects of a new tranquillizing agent
  in psychotic  conditions.  Canad. Psychiat. Ass. J., 1957,
  2:104-112.
  Carrier, J., Guyotat, J., Grandmottet, J.   Electro-choc et
  largactil dans les acces maniaques.  [Electric shock
  therapy and  largactil in manic attacks.]  J. me'd. Lyon,
  1954, 35: 950-951.
  Charatan,  F.  B.  An  evaluation  of  chlorpromazine
  ("largactil")  in psychiatry.  J. Ment. Sc, Lond., 1954,
  100:882-893.  Abstract: Excerpta  med., Sect. 8, 1955,
  8: No. 3639.
 Cowden, R. C, Zax, M.,  Finney, R. C.  A preliminary
 note on the use of chlorpromazine with neuropsychiatry
 disorders.   A. M. A. Arch.  Neur.  Psychiat, 1955,  73:
 700-701.
 ---,---, Hague, J. R., Finney, R. C.  Chlorpromazine:
 alone and  as an adjunct to group psychotherapy in the
 treatment of psychiatric patients.  Am.  J. Psychiat.,
 1956,112:  898-902.
 Cutler, R.  P.,  Monroe, J. J., Anderson, T. E.  Effects of
 "tranquilizers"  upon pathological activity in psychotic
 patients.   I. Chlorpromazine.  II. Reserpine.  A. M. A
 Arch. Neur. Psychiat., 1957, 77 : 616-622; 1957, 78: 61-68!
 Delay, J.,  Pichot, P., Ropert, R.  Un nouveau  medica-
 ment neuroleptique en psychiatrie.  Le maleate acide
de Tethylone-3-dimethylamino-3' -propyl-10-phenothiazine
 (1522 C. B.)   [A new neuroleptic drug in  psychiatry.
 8-A c e t y 1-10- (3-dimethylaminopropyl)   phenothiazine
 (CB-1522).]  Presse med., 1957, 65 : 491-493.
 Feldman,  P.   E. A  comparative  study  of  various
 ataractic drugs.  Am. J. Psychiat.,  1957, 113: 589-594. *
----.  Two-year fate study of thorazine-treated patients.
 Am. J. Psychiat, 1957, 114: 237-240.                *
---, Lacy, B. S., Walker, A. E., Garrez, N. J.  A con-
 trolled, blind study of effects of thorazine on psychotic
 behavior.  Bull. Menninger Clin.,  1956, 20: 25-47.  Ab-
 stract : Excerpta med., Sect. 8,1956, 9: No. 4560.
Freeman,  H.,  Arnold, A.  L., Cline,  H. S.  Effects  of
 chlorpromazine and reserpine in chronic schizophrenic
patients.  Dis. Nerv. Syst., 1956,17 : 213-219.  Abstract:
Excerpta med., Sect. 8,1957,10: No. 144S.
----, Cline, H. S. Effects of chlorpromazine on chronic
lobotomized schizophrenic patients; a controlled study.
A. M. A. Arch. Neur. Psychiat.,  1956, 76: 500-507.
 Gaitz, C. M., Roy, H., Thompson, W., Kimbell, I.,  Mullen,
A. J., Pokorny, A. D.  Evaluation of chlorpromazine in
comparison with other methods of treatment of hospital-
ized psychiatric  patients,  using the  Lorr multidimen-
sional scale for rating psychiatric patients.  Psychiat.
Res. Rep., Wash., 1955 (1) : 84-95.
Gardner, M. J., Hawkins, H. M., Judah, L. N., Murphree,
O. D. Objective measurement of  psychiatric changes
produced  by chlorpromazine and  reserpine  in  chronic
schizophrenia.   Psychiat.  Res. Rep.,  Wash., 1955  (1):
77-83.
Goldman, D.  Comparison of clinical effects of chlor-
promazine  and reserpine in psychotic patients.  Am. J.
M. Sc, 1957, 233 : 137-144.                           *
  —. Chlorpromazine treatment  of hospitalized psy-
chotic patients.  J. Clin. Exp. Psychopath., 1956, 17: 45-
56.  Abstract: Excerpta med., Sect. 8, 1957,10: No. 372.*
Hall, R. A., Dunlap,  D. J.  A study of chlorpromazine:
methodology and results  with  chronic  semi-disturbed
schizophrenics.  J. Nerv. Ment. Dis.. 1955, 122: 301-314.
Abstract:  Excerpta med.,  Sect. 8,  1957,  10: No. 369.
Year book  of drug therapy, 1956-1957, p. 340-341.
Hiob, J.   Klinische  Erfahrungen  bei der Behandlung
von Psychosen mit Megaphen.   [Clinical experiences in
megaphen therapy of psychoses.]  Aerztl. Wschr., 1954,
9: 919-924.
Hollister, L. E., Jones, K. P., Brownfield, B., Johnson, F.
Chlorpromazine alone and with reserpine;  use in  the
treatment of mental diseases.  California M., 1955,  83:
218-221.  Abstract: Excerpta med., Sect. 8, 1956, 9: No.

----, Traub, L.,  Beckman, W.  G.  Psychiatric use  of
reserpine and chlorpromazine;  results of double-blind
studies.  In:  Kline,  N.  S.,  ed.  Psychopharmacology.
Washington, Am. Ass. Adv. Sc, 1956.  p. 65-74.
Hormia, A.  A comparison between combined reserpine-
chlorpromazine and chlorpromazine therapies in psychi-
atry. Acta psychiat. neur. scand.,  1956 31 • 437I446 *
Kinross-Wright,  V.  Chlorpromazine and  reserpine in
thetreatment of psychoses  Ann. N. York Acad. Sc,

$£:o^i'£!f  Abstract: Excerpta med->Sect-8-
44 
SUBJECT LIST
Chlorpromazine : Therapeutic use
Kovitz, B., Carter, J. T., Addison, W. P.  A comparison
of chlorpromazine and reserpine  in chronic psychosis.
A. M. A. Arch. Neur. Psychiat., 1955, 74:467-471.  Ab-
stract : Excerpta med., Sect. 8, 1957, 10: No. 2087.
Lafon, R., Due, N., Abric, J.,  Pouget, R., Comelade, P.
Etude  comparative du 4.560 R. P. (chlorpromazine) et
de la reserpine dans  les syndromes schizophreniques.
 [Comparative study of R. P. 4560 (chlorpromazine) and
reserpine in  schizophrenic  syndromes.]  Ence'phale,
1956, 45: 668-671.
Leiberman,  D. M., Vaughan, G. F. The use of some new
pharmacological agents  in psychiatry.   J. Ment Sc,
Lond., 1957,103 :110-118.
Lemere, F.  Failure of azacyclonol (frenquel)  to relieve
non-experimental  mental confusion and hallucinations.
Am. J. Psychiat, 1957, 113: 840-841.
Liberson, W.  T.  Effects of  chlorpromazine hydro-
chloride (thorazine)  on  EEG and on skin galvanic ac-
tivity.   [Abstract] Electroencephalography, Montreal,
1955, 7: 474.
Loch,  W.  Zur Behandlung  fortgeschrittener  Schizo-
phrenien mit Megaphen und Reserpin.  [Megaphen and
reserpine therapy of advanced  schizophrenia.]   Ner-
venarzt, 1956, 27 : 463-467.
 Lomas, J.   Treatment of schizophrenia;  "pacatal" and
chlorpromazine compared.  Brit. M. J., 1957, 2: 78-80.*
Mason-Browne, N. L.  Perphenazine—a drug modifying
consciousness.  Am. J. Psychiat., 1957, 114: 173-174.
Mitchell, P. H.  Chlorpromazine in  the treatment of
the  chronic disturbed schizophrenic patient.  J. Ment
Sc, Lond., 1956,102:151-154.
Michtom, J., Goldberg, N., Offenkrantz, W., Whittier, J.
Readmission rates for state  mental hospital patients
discharged  on maintenance ataractics.   Findings  with
a matched control group and  methodological considera-
tions.  J. Nerv. Ment Dis., 1957, 125: 478-480.
Osinski, W.  A.  Treatment  of  anxiety  states   with
meprobamate (miltown).  Internat. Rec. M., 1956, 169:
589-595.
Pate, W. H.  Chlorpromazine therapy  following trans-
orbital lobotomy.  J.  Nerv. Ment.  Dis., 1957, 125 : 44-50.
Pollack, B.  The effect of chlorpromazine on the return
rate of 250  patients released  from the  Rochester  State
Hospital.   Am. J. Psychiat.,  1956, 112:937-938.
Puech, J., Robin, C. Etude comparative des effets de la
cure de sommeil medicamenteux et de la chlorpromazine
injectable dans les psychoses.  [Comparative study of
sleep therapy and chlorpromazine injections in therapy
of psychoses.]   Sem. hop. Paris, 1956,  32: 3252-3264.
Rinaldi, F., Rudy, L. H., Himwich, H. E.   Clinical evalu-
ation of azacyclonol,  chlorpromazine, and reserpine on
a group of chronic psychotic patients.  Am. J. Psychiat.,
1956, 112: 678-683.  Abstract: Excerpta med.,  Sect. 8,
1956, 9: No. 4986.
Rudy,  L. H.,  Himwich,  H. E., Tasher, D.  C.  Clinical
evaluation of two phenothiazine compounds promazine
and  mepazine.  Am. J. Psychiat, 1957,  113: 979-983.
---, Rinaldi, F., Himwich, H. E.  Comparative effects
of azacyclonol, reserpine, and  chlorpromazine on moder-
ately disturbed psychotic patients with  long histories
of hospitalization.  Psychiat. Res. Rep., Wash.,  1956
(4) : 49-63.
Schneider, G.  Les indications de divers neuroleptiques
et les resultats obtenus  a la  clinique psychiatrique de
Lausanne.   [Indications  for various neuroleptic drugs
and  the results  obtained at  the psychiatric clinic of
Lausanne.]   Encephale,  1956, 45 :1024-1030.
Shepherd, M., Watt, D.  C.  A controlled clinical study
of chlorpromazine and reserpine in chronic schizophre-
nia.  J. Neur., Lond., 1956,19 : 232-235.
Simpson, R. W.   The  effects  of pacatal on  chronic
mental illness.  J. Ment.  Sc,  Lond., 1957, 103: 610-613.
Sommerness, M. D., Lucero,  R. J., Hamlon, J.  S., Ma-
  howald, A.  M.  Chlorpromazine:  a  controlled  study
  with highly disturbed patients.  Dis. Nerv. Syst, 1957,
  18:16-20.
  Szatmari, A.  Clinical and electroencephalogram investi-
  gation  on  largactil in  psychosis (preliminary study.)
  Am.  J.  Psychiat.,  1956,  112: 788-794.  Abstract: Ex-
  cerpta med., Sect. 8, 1956, 9:  No.  4557.                 *
  Tenenblatt,  S.  S.,  Spagno,  A.   A controlled  study  of
  chlorpromazine therapy in chronic psychotic  patients.
  J. Clin. Exp.  Psychopath., 1956,  17:81-92.
  Thorpe, J. G.,  Baker, A. A.  A  research  method  to
  assess a new tranquillizing  drug.  J.  Ment Sc, Lond.,
  1956,102: 790-795.
  Tripi, G.  Considerazioni generali sull'uso della  cloro-
  promazina e  della reserpina nel trattamento di circa
  trecento psicopatici.  [Observations on the use of  chlor-
  promazine and reserpine  in  the treatment of about 300
  mental  patients.]  Rass. neuropsichiat, 1955, 9:463-
  469.  Also: Arch,  psicol neur.,  Milano, 1956,  17: 635-
  639.
  Tuteur, W.   Combined reserpine-chlorpromazine ther-
  apy in highly disturbed psychotics.  Am. J. Psychiat,
  1955,112: 206.
  ---, Lepson, D.  Combined reserpine-chlorpromazine
  therapy in highly  disturbed  psychotics.   In: Himwich,
  H. E., ed.  Tranquilizing drugs.  Washington,  Am. Ass.
  Adv. Sc, 1957.  p.  163-172.
  ---, Stiller,  R., Whitehill, O.  Treatment of regressed
  schizophrenics with  chlorpromazine,  reserpine  and  a
  combination of  both  drugs.  Dis. Nerv. Syst, 1947, 18:
  100-105.
  Watt, D. C.  Reserpine and chlorpromazine in the treat-
  ment of chronic schizophrenics.   Ence'phale, 1956, 45:
  661-662.

—Psychosomatic  diseases
  Eiber, H. B.  Chlorpromazine-Rauwolfia serpentina com-
  bination in  the treatment  of essential  hypertension:
  preliminary report.  J. Am.  M. Ass., 1955, 158: 730-731.
  Friedman, A. P. Use of tranquilizers in the treatment
  of headache.  Am. Practitioner,  1957, 8: 94-97.
  Houde,  R. W.,  Wallenstein, S.  L. Analgetic power  of
  chlorpromazine alone and in combination with morphine.
  [Abstract] Fed. Proc, Bait, 1955,14 : 353.
  Kessler, L.  N., Barnard, R.  D.  A  new  tranquilizer
  meprobamate; its  use for pain associated with cancer.
  Preliminary report.  Med. Times, Great Neck,  1956, 84:
  431-435.
  Knight, R. W., Kent, B., Morris,  G., Rogers, S.  Clinical
  studies  of an antiemetic agent,  chlorpromazine.   [Ab-
  stract].  J. Laborat. Clin, M., 1953, 42:  828.
  LeVan,  P., Wright, E. T. Use of tranquilizers in diseases
  of the skin; a preliminary report.  California  M., 1956,
  85: 87-88.                                          *
  Moyer,  J. H., Kent,  B., Morris,  G., Dizon, M., Rogers,
  S., Spurr, C.  Clinical studies of an anti-emetic  agent,
  chlorpromazine. Am. J. M. Sc, 1954, 228: 174-189.
  Rees, L.  A  controlled trial of  chlorpromazine in the
  management  of patients suffering from asthma  asso-
  ciated with anxiety and tension  symptoms.  Encephale,
  1956, 45: 555-561.
  Robinson, H. M.,  Jr., Robinson, C.  V., Strahan, J. F.
  Hydroxzine (atarax) hydrochloride  in dermatological
  therapy. J.  Am.  M. Ass.,  1956, 161:604-606.
  Shubin, H., Heiken,  C. A., Glaskin, A., Pennes, E., Ar-
  senian,  J.  Chlorpromazine  as an  adjunct in managing
  tuberculous patients. Internat. Rec. M., 1957,  170: 369-
  373.

Therapeutic use

  see also CHLORPROMAZINE—Various  special tech-
            niques—Therapeutic  use
  Adasal, R., Ozsan, M., Karan, D., Yener, O.  Les resul-
  tats  obtenus  par la  chlorpromazine a la clinique psy-
45 
Chlorpromazine : Therapeutic use
PSYCHOPHARMACA
 chiatrique de la Faculte de Medecine d'Ankara.  [Re-
 sults obtained with chlorpromazine at the  psychiatric
 clinic  of the Faculte de Medecine d'Ankara.]  Ence'-
 phale, 1956, 45: 1204-1209.
 Albert, S. N., Rea, E.  L., Duverney, C. A.,  Shea, J.,
 Fazekas, J. F. The use  of chlorpromazine in the treat-
 ment of acute alcoholism.  Med. Ann. District of Colum-
 bia, 1954, 23: 245-247.
 Altschule, M. D.  Use of chlorpromazine and  reserpine
 in mental disorders.  N. England J. M., 1956,  254: 515-
 519.  Abstract:  Chem. Abstr., 1956, 50: 7318a.        *
 Anton-Stephens, D.  Preliminary  observations  on the
 psychiatric  uses  of  chlorpromazine  (largactil).  J.
 Ment. Sc, Lond., 1954,100: 543-557.
 Arnold, O. H., Hift, S., Solms, W.  Die Anwendung von
 Largactil in der Psychiatrie.  [Use of largactil in psy-
 chiatry.]   Wien. med. Wschr., 1953, 103:563-566.  Ab-
 stract : Excerpta med., Sect. 8,1954,  7: No. 1600.
 Atkinson,  R. P., Tucker,  W. I.   Clinical results  with
 chlorpromazine  (thorazine). Lahey  Clin. Bull, 1955,
 9:180-186.                                         *
 Ayd, F. J., Jr.  A critique of chlorpromazine and reser-
 pine therapy.  In: Himwich, H. E., ed.  Tranquilizing
 drugs.   Washington,  Am.  Ass.  Adv.  Sc.,  1957.   p.
 173-181.                                            *
 ----.  Large doses of chlorpromazine in the treatment
 of psychiatric patients.  Dis. Nerv.  Syst, 1955, 16:146-
 149.                                                *
 ----.  Treatment of psychiatric patients  with thora-
 zine.   South. M.  J.,   1955,  48:177-186.  Abstract:
 Excerpta med., Sect. 8,1956,  9: No. 4552.
 Azima, H., Ogle,  W.  Effects of  largactil in  mental
 syndromes.  Canad. M. Ass. J., 1954, 71:116-121.
 Bair, H. V., Herold, W.   Efficacy of chlorpromazine in
 hyperactive mentally retarded children.   A.M. A. Arch.
 Neur. Psychiat., 1955, 74: 363-364.   Abstract:  Excerpta
 med., Sect. 8,1956, 9: No. 1726.
 Bakwin, H.  The uses of chlorpromazine in pediatrics.
 J. Pediat, S. Louis, 1956, 48: 240-247.
 Balducci, M.  Possibilita, limiti,  indicaz'oni  e  contro-
 indicazioni del  4560 R.  P.  (largactil)  in psichiatria;
 controllo dei primi risultati con osservazione su 110 casi.
 [Possibilities, limitations, indications and contraindica-
 tions of 4560 RP (largactil) in  psychiatry; review of
 the early results with a study of 110 cases.]   Rass. stud.
 psichiat., 1955, 44: 709-729.  Abstract: Excerpta med.,
 Sect. 8, 1956, 9: No. 5010.
 Balduzzi, E., Escalar, G.   A proposito delle terapie cosid-
 dette  ganglioplegiche.   [The  so-called  ganglioplegic
 therapies.]   Rass.  stud, psichiat., 1953, 42: 1056-1064.
 ----,----.   Sulle terapie cosiddette ganglioplegiche.  II.
 II  4560 R.  P.  in psichiatria;  osservazioni su  100
 casi trattati.  [The so-called ganglioplegic  therapies.
 II.  RP 4560  in  psychiatry;  observations  on  100
 treated cases.]  [English summary  p. 148]   Rass. stud.
 psichiat, 1954, 43: 120-151.
 Barrett, J. E.  The value  of  chlorpromazine  hydro-
 chloride and reserpine in relation to other methods used
 in treating mental illness.  Virginia M. Month., 1955,
 82: 415-417.
 Baruk, H.  La catatonie experimentale par la chlorpro-
 mazine ; la posologie et  la methode d'administration la
 plus efficace en  therapeutique psychiatrique.  [Experi-
 mental catatonia produced  with chlorpromazine;  the
 dosage and  most effective method of  chlorpromazine
 therapy  in psychiatry.]   Ence'phale, 1956, 45 : 474-4:76.
 ----.   Les   therapeutiques   psychiatriques.  [Psychi-
 atric  therapies.]  128 p.  Paris,  Presses universitaires
 de France [Que sais-je?  Le point des connaissances
 actuelles  (691)] 1955.   Les  therapeutiques physiologi-
ques  sedatives;  cures  de  sommeil;  chlorpromazine.
 [Physiologic sedative therapies; sleep therapy; chlor-
 promazine.]  p. 109-116.
----,  Launay, J., Berges,  J.  La  therapeutique par la
chlorpromazine; physiologie  experimentale; physiologie
clinique;  resultats  therapeutiques  et  progrfes  de la
therapeutique  psychiatrique.   [Chlorpromazine  ther-
apy;  experimental  physiology;  clinical  physiology;
therapeutic results  and progress in psychiatric treat-
ment.]  Ann. me'd. psychol, Par., 1955, 113(1) : 705-772.
Belsasso,  M.  Terapia delle malattie mentali con reser-
pina  (serpasil) e cloropromazina  (largactil) ad alte
dosi.   [Treatment of mental disorders with high-dosage
reserpine  (serpasil) and  chlorpromazine  (largactil).]
Rass. giuliana med., Trieste, 1956,  12: 209-216.      *
Bender, L., Nichtern,  S.  Chemotherapy  in  child psy-
chiatry.   N. York State J. M., 1956, 56: 2791-2795.
Benedetti,  G.  Terapia  reserpinica  in  psichiatria.
[Reserpine  therapy  in psychiatry.]   [English  sum-
mary] Arch,  psicol. neur.,  Milano, 1956,  17:295-309.
Bergouignan,  M.  Action de la chlorpromazine en psy-
chiatrie : faits cliniques et significations possibles.  [The
psychiatric  effect of chlorpromazine: clinical facts and
their  possible  significance.]  Ence'phale, 1956, 45:1136-
1140.
----.   Le  largactil  en  therapeutique  psychiatrique.
[Largactil in  psychiatric therapy.]   Presse me'd.,  1953,
61:1133.
----.  Peut-on proposer une interpretation univoque des
effets therapeutiques de la chlorpromazine en psychia-
trie?   [Possibility of unequivocal interpretation of the
therapeutic effects of  chlorpromazine in  psychiatry.]
Ann.  me'd. psychol,  Par.,  1956, 114(1) : 409-413.
----,  D'Aulnay, J., Malineau, R. Retouches k notre ex-
perience du largactil  en psychiatrie.  [Additional ex-
periences  with largactil in psychiatry.]   J.  med. Bor-
deaux, 1955, 132: 254-261.  Abstract: Excerpta med.,
Sect.  8, 1955,  8 : No. 4917.
----,  Got, M., Malineau, R.  Notre  experience du lar-
gactil en psychiatrie.  [Our experience with largactil in
psychiatry.]  J. med.  Bordeaux, 1954,  131:135-145.
Berselli, G., Vicini, F. Osservazioni sull'impiego terapeu-
tico del largactil.  [Observations on the therapeutic use
of largactil.]  Riv. sper. freniat.,  1955, 79: 743-745.
Bertolini, O. L'azione del 4560 R. P. in diverse sindromi
psichiatriche.   [Effects of 4560 R. P. in various psychi-
atric syndromes.]  Riv. sper. freniat., 1954, 78: 205-224.
Bilikiewicz, T.   Leczenie largaktylem  w psychiatrii.
[Therapeutic  use  of largactil in  psychiatry.]   Wiado-
mos'ci  lek.,  1955,  8: 82-88.  Abstract: Excerpta  med.,
Sect. 8, 1956, 9: No. 3611.
Bleuler, M. Comparaison entre les effets de la chlor-
promazine et de la reserpine en psychiatrie.   [Compari-
son between the effects of chlorpromazine and reserpine.]
Ence'phale, 1956, 45 : 334-348.
----,  Stoll,  W. A.  Clinical use of reserpine  in psychi-
atry: comparison with chlorpromazine.  Ann. N.  York
Acad. Sc, 1955, 61:167-173.  Abstract: Excerpta  med.,
Sect. 8, 1956, 9: No. 4080.
Bonello,  F. J.  Chlorpromazine  in general practice.
Internat.  Rec. M., 1956, 169: 197-212.
Bonnet, H., Lauxerois, G. Le largactil  k Th6pital psy-
chiatrique ;  a propos d'une experience d'un an d'utilisa-
tion du medicament en  service ouvert et ferine.   [Lar-
gactil in a psychiatric hospital; one year's experience
with this  drug in ambulatory  and in  hospitalized pa-
tients.]  J. me'd.  Lyon,  1955,  36:165-172.  Abstract:
™« df" JlVOn'  1954' 35: 949-  Excerpta med., Sect. 8,
1955, 8: No. 4914.
Boon, A. A. Largactil en verwante middelen in de psy-
chiatrie en neurologie.   [Largactil  and related reme-

1955' 99P-S2735-27y41nd  neurology-]  Ned- tschr- ffetieesK

Bordeleau, J. M.  Clinical evaluation of chlorpromazine
and Rauwolfia serpentina in the psychiatric department
of a general hospital.  J. Florida M.  Ass., 1956, 42: 547-

Bower, W.  H.  Chlorpromazine in psychiatric illness
N. England J. M., 1954, 251: 689-692                 «
46 
SUBJECT LIST
Chlorpromazine : Therapeutic use
 Bram, G.  Chlorpromazine in psychiatry.  Brit. M.  J.,
 1954, 2: 754.
 Brehmer, G. von, Ruckdeschel, K. T.  Zur Technik der
 Winter schlaf behandlung.  [Technique  of  hibernation
 therapy.]  Deut.  med. Wschr., 1953,  78:1724-1725.   *
 Bringas Nunez,  E., Seggiaro, J.  A., Machado, M.  R.
 Primeros resultados obtenidos con el 4560 R.  P.  [First
 results obtained  with RP 4560.]   Prensa me'd. argent,
 1953, 40: 2613-2619.
 Broussolle, P.  Chlorpromazine in psychiatry.  J.  Clin.
 Exp. Psychopath.,  1955,  16 :113-119.  Also :  Internat.
 Rec M., 1955, 168 :  327-332.  Abstract:  Excerpta med.,
 Sect. 8, 1956, 9 : No.  2234.
 Buisson, J.  E. Therapeutiques de sommeil en psychi-
 atrie et en medecine psychosomatique.   [Sleep therapy
 in psychiatry  and  in psychosomatic  medicine.]   Sem.
 hop. Paris, 1954, 30:155-158.
 Carloni, G.  La reserpina e la chlorpromazina  nei malati
 mentali cronici.    [Reserpine and chlorpromazine  in
 chronic  mental disease.]  Arch,  psicol.  neur., Milano,
 1956, 17: 629-630.
 Carter, C. H.,  Maley, M. C.  Chlorpromazine therapy in
 children at  the Florida  farm colony.  Am.  J. M. Sc,
 1957, 233:131-136.
 Cervos Navarro, J., Unterharnscheidt, F.  Importancia
 de las fenotiacinas  en psiquiatria. [Importance of phe-
 nothiazines  in psychiatry.]   Res. espari. otoneuroft.,
 1956, 15: 75-92.
 Cloutier, F. La cure de  sommeil en therapeutique psy-
 chiatrique.   [Sleep  therapy in psychiatry.]  Laval me'd.,
 1953, IS : 332-342.
 Cohen, I. M.  Effects of chlorpromazine in psychiatric
 disorders; report of clinical observations  and impres-
 sions in 1000 cases. Am. J.  M. Sc, 1955, 229: 355-362.
 Abstract: Excertpa med., Sect. 8,  1956, 9: No. 4990.
 Cooper, H.  A. Hallucinogenic drugs.  Lancet, Lond.,
 1955, 1:1078-1079.
 Cossa, P., Bougeant, H., Postel, J. De quelques indica-
 tions et de  quelques incidents d'utilisation de la chlor-
 promazine.   [Some indications of and incidents  with
 ohlorpromazine  therapy.]   Encephale, 1956, 45:779-
 783.
 ---, ----,  Lombard, A.  L'emploi des neuropiegiques
 ■en psychiatrie. [The use of ganglion-blocking agents in
 psychiatry.]   Ann.  me'd. psychol, Par., 1953, 111(2) :
 628-633.  Abstract: Excerpta med., Sect. 8, 1954, 7: No.
 746.
 Cremieux, A.  Traitement de Tanxiete.   [Treatment of
 anxiety.]  Marseille me'd., 1956, 93:327-331.
 David, M., Benda, P., Klein, F. Traitement de Tetat de
 mal epileptique par la chlorpromazine.   [Treatment of
 epilepsv with  chlorpromazine.]   Bull. Soc. me'd.  hop.,
 Paris, i953, 69: 691-697.
 Davies,  T.  S.  Chlorpromazine  in mental  deficiency.
 Lamcet, Lond., 1954,  2: 819.
 ---.  Chlorpromazine  in  mental  deficiency. Ence-
 phale, 1956, 45: 830.
 De  Busscher, J.  Impressions  personneles sur  les
 effets de l'atarax, de la chlorpromazine, de la  reserpine
 et du AY 5406-1  (parasan)  en therapeutique psychia-
 trique.   [Personal impressions of atarax,  chlorproma-
 zine reserpine and AY 5406-1 (parasan) in psychiatric
 therapy. ]  Ence'phale, 1956, 45:1007-1023.
 Delay, J.  Introduction au colloque international.  [In-
 troduction  to  the  international  colloquium.]  [On
 chlorpromazine and neuroleptic drugs, Paris, October
 1955]  Encephale, 1956, 45 : 303-306.
___f Deniker, P.  L'action neuroleptique de la chlorpro-
 mazine en  therapeutique psychiatrique.  [The  neuro-
leptic action of chlorpromazine in psychiatric therapy.]
Sud me'd, chir., 1954, 87 : 3289-3296.  Abstract: Excerpta
med., Sect. 8,1955, 8: No. 754.
________Chlorpromazine and neuroleptic treatments
in  psychiatry.  J.   Clin.   Exp.   Psychopath.,  1956,
17:19-24.
----,   ----.  La  cure   neuroplegique.  [Neuroplegic
therapy.]  Acquis, me'd.  rec, Par.,  1954: 105-115.
---,  ----.  Neuroleptic effects of  chlorpromazine in
therapeutics of neuropsychiatry.  J. Clin. Exp. Psycho-
path., 1955, 16:104-112.  Also : Internat. Rec M., 1955,
168: 318-326.  Abstract: Excerpta  med., Sect. 8, 1956,
9: No. 4992.
---,  ----.  Les neuropiegiques en therapeutique psy-
chiatrique.  [Neuroplegic drugs in psychiatric therapy.]
Therapie, Par., 1953, 8 : 347-364.
---,----.  Peut on comparer la reserpine a la chlorpro-
mazine?  [Can one compare reserpine with chlorproma-
zine?]  Arch, psicol.  neur., Milano, 1956,  17: 631-633.
---,  ---, Pauwels,  R.   Cures de  sommeil et cures
neuroleptiques  en psychiatrie.  [Sleep therapies  and
neuroleptic therapies in  psychiatry.]  Ence'phale, 1956,
45:436-439.
---,---, Tardieu, Y.  Hibernotherapie et cure de som-
meil  en  therapeutique  psychiatrique   et  psycho-
somatique.  [Hibernotherapy and sleep therapy in psy-
chiatry  and psychosomatic  medicine.]  Presse me'd.,
1953, 61:1165-1166.
Delgado,  H. Acerca de nuestra  experiencia  con la
clorpromacina.   [Our experience with chlorpromazine.]
Ence'phale, 1956, 45 : 344-351.
Demartino, G.  One year of chlorpromazine therapy at
Montana State Hospital.   Northwest M., 1956, 55 :1206-
1209.
Denber, H.  C.  B.  Medical and other measures to be
taken to  keep  the  discharged  patient  from returning
to  the  institution.  In:  Chlorpromazine and  mental
health.  Philadelphia, Lea & Febiger, 1955. p. 141-153;
discussion p. 154-174.
Deniker,  P.  Hibernotherapies et medicaments neuro-
leptiques en therapeutique psychiatrique.   [Hiberno-
therapies and neuroleptic drugs in psychiatric therapy. ]
Ence'phale, 1957, 46: 281-398.                       *
Ditfurth, H. von Anwendungsmoglichkeiten des Mega-
phens in der psychiatrischen  Klinik  und  Forschung.
[Possibilities for the use  of megaphen in  psychiatric
practice and research.]   Nervenarzt,  1955,  26: 54-59.
Abstract: Excerpta med., Sect. 8, 1956, 9: No. 4074
Donnelly, J., Zeller, W.  Clinical research on chlorpro-
mazine and reserpine in state and private  psychiatric
hospitals; a comparative review of the clinical problems.
J. Clin. Exp. Psychopath.,  1956, 17:180-188.
Endara, J.  El  "Largactil" y nuestras  primeras aplica-
ciones neuro-psiquiatricas.  ["Largactil", and our first
use of it in neuro-psychiatry.]   Arch. crim. neuropsiq.,
Quito, 1954, 2: 297-312.   Abstract: Excerpta med., Sect.
8,1955,  8 : No. 3101.
Evrard, A., Vandierendonck, R.  Een terugblik op 100
met chloropromazine behandelde gevallen.  [100 Cases
treated with chlorpromazine.]  Belg.  tschr. geneesk.,
1957,13: 43-47.
Ey, H., Deschamps, A., Berard, E.  Les techniques de
cures de sommeil a Taide de neuropiegiques et Thiberna-
tion artificielle en psychiatrie.  [The technics of sleep
therapy with neuroplegics and artificial hibernation in
psychiatry.]  In: Laborit,  H., Huguenard, P.  Pratique
de Thibernotherapie en chirurgie et en  medecine.  [The
use of  hibernotherapy  in surgery  and in  medicine.]
Paris, Masson,  1954.  p. 181-203.
---, Faure, H.  Les diverses methodes d'emploi de la
chlorpromazine en therapeutique psychiatrique et leurs
indications.  [The various methods of chlorpromazine
therapies and their indications in psychiatric therapy.]
Encephale, 1956, 45: 361-371.
Falcon, M. Quelques observations cliniques sur Temploi
de  la  chlorpromazine.   [Clinical  observations on the
use of chlorpromazine.]   Ence'phale, 1956, 45: 587-591.
Falicki, Z., Galuszko, P., Jaworska, I., Kielak, L., Sule-
strowski, W.  Proba oceny wartosci leczniczej largaktylu
na  podstawie dotychczasowych spostrzezen w klinice
chorfib psychicznych A. M. w Gdansku.   [Evaluation of 
Chlorpromazine : Therapeutic use
PSYCHOPHARMACA
largactil therapy from observations  at the clinic for
mental diseases of the Academy of Medicine in Gdansk.]
[English summary p.  320]  Neur. &  polska, 1956, 6:
313-320.
Faure, J. L., Abric, J.  Remarques cliniques sut les indi-
cations valables de la chlorpromazine et de la reserpine
en neuro-psychiatrie  infantile.   [Clinical  remarks on
the indications for the use of chlorpromazine and reser-
pine  in  child   neuro-psychiatry.]  Pediatric,   1956,
11: 773-776.
Fazekas, J. F., Shea, J., Rea, E.  Use of chlorpromazine
in the management  of  acute  and postalcoholic states.
Internal Rec. M.,  1955, 168:333-339.  Abstract: Ex-
cerpta med., Sect. 8,1956, 9: No. 420.
----,  ----,  Sullivan, P. D., Jr.  Ataractics  in  medical
practice. GP, 1956,14 (6) : 75-81.
Feldman, P. E.  Clinical evaluation of chlorpromazine
therapy for  mental illnesses; analysis of one  year's
experience.  J. Clin. Exp.  Psychopath., 1957, 18:1-26.
Flaherty, J. A.  Effect of chlorpromazine medication on
children with severe emotional disturbances.  Delaware
M. J., 1955, 27:180-184.
Fliigel, F.  Neue klinische Beobachtungen zur Wirkung
des  Phenothiazinkorpers  Megaphen   auf  psychische
Krankheitsbilder.  [New  clinical observations  on the
effect of the phenothiazine derivative megaphen on the
symptoms of mental disorders.]  Med. Klin., Berl, 1953,
48:1027-1029.  Abstract: Excerpta med., Sect. 8, 1954,
7: No. 1609.
Ford, H. Jameson,  G.  K.  Chlorpromazine  in conjunc-
tion  with other psychiatric therapies: a clinical ap-
praisal.  Dis. Nerv. Syst,  1955, 16:179-185.
Freed, H.,  Peifer, C. A.   Some  considerations  on the
use of chlorpromazine in a child psychiatry clinic. J.
Clin.  Exp. Psychopath., 1956,  17:164-169.            *
Freeman, H.  A critique  of  the tranquilizing  drugs,
chlorpromazine and  reserpine, in neuropsychiatry.  N.
England J. M., 1956, 255: 877-883.
Freyhan, F. A.  The immediate and long range effects
of chlorpromazine on the mental hospital.  In:  Chlor-
promazine  and  mental  health.  Philadelphia,  Lea  &
Febiger, 1955.  p. 71-84; discussion p. 84-98.
----.   Psychomotility  and parkinsonism in treatment
with neuroleptic drugs.  A. M. A. Arch. Neur. Psychiat,
1957,  78: 465^72.
Friedgood, C. E., Ripstein, C. B.  Use of chlorpromazine
in the withdrawal of addicting drugs; preliminary re-
port.  N. England J. M., 1955, 252:230-233.
Friend, D. G., Wells, J. C, Jr.  The clinical use of chlor-
promazine.  Am. Practitioner, 1955,  6: 698-703.  Also
as:  Uso  clinico de  la  cloropromacina.   Rev.  me'd.
cubana, 1956, 67: 645-650.
Friese, K. H.  Vorlaufige Erfahrungen bei der Behand-
lung  psychiatrischer   Kranker  mit  Phenothiazinen.
[Experiences with phenothiazine therapy in psychiatry.]
Medizinische, 1956: 734-735.
Furtado, D.  Action de la chlorpromazine sur Tetat de
mal epileptique.  [(Therapeutic) effect of chlorproma-
zine on epileptic convulsions.]  Encephale, 1956, 45: 727-
729.
Gade, E. B., Heinrich,  K.   Die Bedeutung der Pheno-
thiazinderivate,  insbesondere des Megaphen, fur Psy-
chiatrie und Neurologie.  [The  importance of pheno-
thiazine derivatives  in  psychiatry and neurology,  with
special reference to chlorpromazine.]  Fortsch.  Neur.
Psychiat, 1955, 23 : 323-353.
----,  ----.   Klinische  Beobachtungen bei Megaphen-
behandlung in der Psychiatrie.   [Clinical observations
of megaphen treatment  in psychiatry.]   Nervenarzt,
1955,  26 : 49-54.  Abstract: Excerpta med., Sect. 8, 1956,
9: No. 4073.
Galenko, V. E.,  Osberg, I. IU., Azbukina,  V. D.  Pri-
menenie aminazina v psikhiatricheskoi klinike.   [Use of
aminazine  in  psychiatric clinics.]   Sovet.  med., 1956,
20:29-35.
----,----, Robiner, I. S., Frenkel, G. M.  Kliniko-elek-
trofiziologicheskie issledovaniia  psikhicheski  bol'nykh
pri lechenii aminazinom.  [Aminazine therapy of mental
patients; clinical and  electroencephalographic study.]
Zh. nevropat. psikhiat, Moskva, 1956, 56: 300-306. Ab-
stract :  Chem. Abstr., 1956, 50: 17176L
Galioni, E. F.  Reserpine and chlorpromazine,  their use
in alcoholic and geriatric patients. California M., 1956,
85: 97—99.                                          *
Gambs, A.  Essai d'application de la  chlorpromazine en
cures prolongees au traitement  de diverses affections
mentales, a  propos de 58 observations.  [The use of
chlorpromazine for prolonged sleep therapy of various
mental  diseases; 58 observations.] 136 p.  Lyon, 1954.
[Thesis—Lyon 1953/1954, no. 76]
Geyer,  H. W.  Response to thorazine  (chlorpromazine)
administration in  hyperkinetic mongolism.  Delaware
M. J., 1956, 28: 189-190.
Gherarducci, D.  A propos de Tutilisation de la  chlor-
promazine associee  a d'autres therapeutiques psychi-
atriques.  [Utilization  of chlorpromazine associated
with  other psychiatric therapeutics.]  Ence'phale, 1956,
45: 1187-1189.
Giacobini, E., Lassenius, B.  Clorpromazinebehandling;
biverkningar  och  komplikationer.   [Chlorpromazine
therapy; side  effects  and  complications.]   [English
summary]  Nord. med., 1954, 52 : 1693-1699.        *
Gliedman, L. H., Gantt, W. H.  The  effect of reserpine
and chlorpromazine on orienting behavior and retention
of conditioned reflexes.  South. M. J., 1956, 49: 880-889.
Gomirato, G.  Le applicazioni della  cloropromazina e
della reserpina  al  vaglio di due riunioni.  [Uses of
chloropromazine and reserpine  as  evaluated  by two
assemblies.]   Minerva med., Tor., 1955, 46: 1449-1452.
Haight, J.  Newer drug therapies.  Dis. Nerv. Syst., 1956,
17: 295-296.                                        *
Haq,  S. M., Smyth, V. O.  Preliminary observations on
the use  of largactil in psychiatry.  Med. J. Malaya, 1955,
9:205-211.  Abstract: Excerpta med., Sect. 8,  1956, 9:
No. 4070.
Heuyer, G., Dell, C, Pringuet, G.  Emploi de la chlor-
promazine en neuropsychiatrie infantile.  [Use of chlor-
promazine in child neurospychiatry.]  Encephale, 1956,
45:576-578.
----, Giraud, G.,  Galibert, J.  Traitement de Texcitation
psycho-motrice chez Tenfant par le 4560 R. P.  [R. P.
4560  therapy of psychomotor excitation  in children.]
Arch. fr. pediat, 1953, 10: 961-963.
Hilliard, E. T.  The use of reserpine, chlorpromazine and
^allied drugs in medicine and psychiatry.  Med. J. Aus-
tralia, 1956, 43 (1) :1035-1040.
Hoch, P. H.  Progress in psychiatric therapies.  Am. J.
Psychiat, 1955, 112: 241-247.
Hock, E. H. The use of chlorpromazine in mental dis-
orders.   J. Christ. M. Ass.,  India, 1956, 31: 285-291.
Hoff, H. Advantages and disadvantages  of treatment
with chlorpromazine and serpasil.   Ence'phale,  1956,
45:352-358.
----.  Vorteile  und Nachteile  der Behandlung  rait
Largactil  und  Serpasil.  [Advantages and disadvan-
tages of therapy  with  largactil and  with  serpasil.]
Wien. klin. Wschr., 1956, 68: 97-101.                *  *
Hoffman, J. L.  General summary to:  Chlorpromazine
and  reserpine;  symposium  on   experiences  at Saint
Elizabeths Hospital.  Med.  Ann.  District of Columbia.
1956, 25 : 267-268; 298.                              *
Hormia, A.  Klooripromatsiini psykiatriassa.   [Chlor-
promazine  in  psychiatry.]   [English summary] Duo-
decim, Helsin., 1955, 71: 1226-1242.
----.   Klooripromatsiinihotto psykiatriassa viiden vuo-
den kokemusten valossa.  [Chlorpromazine treatment
in psychiatry  in the light  of five years' experience.]
Suom. ladk. lehti, 1956, 11:1154-1158.
48 
SUBJECT LIST
Chlorpromazine : Therapeutic use
Howell, T. H., Harth, J. A. P., Dietrich, M.  The use of
chlorpromazine in geriatrics.  Practitioner, Lond., 1954,
173 : 172-173.
Kanner, L., Eisenberg, L.  Child psychiatry; mental de-
ficiency.  Am. J. Psychiat, 1957,113 : 617-622.
Kardos, G. Pertorini, R.  A largactil phychiatriai alkal-
mazasa.  [Psychiatric applications of chlorpromazine.]
Ideg. szemle, 1955, 8: 65-70.
Kielholz,  P.  Uber  die  Largactilwirkung bei  depres-
siven Zustanden und Manien sowie bei der Entziehung
von Morphin-  und   Barbitursuchtigen.  [Effects  of
largactil in  depressive states and manias and on with-
drawal in morphine and barbiturate addiction.]  [Eng-
lish summaries:  p. 304-305;  p.  308-309]   Schweiz.
Arch. Neur. Psychiat, 1954, 73 : 291-309.
--- , Labhardt,  F.  Treatment  of mental  disorders
with chlorpromazine.  J. Clin. Exp. Psychopath.,  1956,
17: 38-44.  Abstract: Excerpta med., Sect. 8, 1957, 10:
No. 371.
Kinross-Wright, V.  Chlorpromazine;  a major advance
in  psychiatric treatment.  Postgrad. M., 1954, 16: 297-
299.
---.  Chlorpromazine in psychiatric  disorders.  Med.
Clin. N. America, 1957, 41: 295-306.                *
---.  Chlorpromazine treatment of mental disorders.
Am. J. Psychiat, 1955, 111: 907-912.
---.  Clinical  application  of  chlorpromazine.  In:
Kline, N.  S., ed.  Psychopharmacology.  Washington,
Am. Ass. Adv. Sc, 1956.  p. 31-38.
---.  A review of the newer drug therapies in psy-
chiatry. Dis. Ne)-v. Syst., 1956, 17: 1S7-190.
---.  The  uses and limitations of the newer drugs in
the treatment of nervous conditions.   Wisconsin M. J.,
 1956, 55:1073-1078.
Kolle, K., Ruckdeschel, K. T.  Megaphenbehandlung in
der Psychiatrie.  [Megaphen therapy in psychiatry.]
 Munch, med.  Wschr.,  1954, 96: 533-536.
Labhardt,  F.  Behandlung von psychischen Storungen
mit Largactil.   [Largactil therapy of mental disorders.]
 Schiceiz. Arch. Neur. Psychiat, 1954, 73: 437-440.
---.  Einige allgemeine  und psychiatrische Gesichts-
 punkte zur Behandlung mit  neuroplegischen Medika-
 menten.  [General  and psychiatric news on  therapy
 with neuroplegic drugs.]   [Short  English  summary]
 Dermatologica, Basel, 1955, 111: 177-185.
 ___.   Technik,  Nebenerscheinungen  und  Komplika-
 tionen der Largactiltherapie.  [Technic, side effects and
 complications  of  largactil  therapy.]  [English  sum-
 mary:  p. 345]   Schweiz. Arch. Neur. Psychiat, 1954,
 73:338-345.  Abstract: Excerpta med., Sect.  8, 1955,
 8:  No. 1790.                                        *
Laborit, H., Huguenard, P., Alluaume, R. Un nouveau
 stabilisateur  vegetatif;  le 4560  RP.  [Anew  auto-
 nomic stabilizer ;  4560 RP.]   Presse med., 19.j2, 60 : 20b-
 208.
Laboucarie, J., Barres, P. Rascol, A.   Les cures neuro-
piegiques par la  chlorpromazine.   [Neuroplegic thera-
pies with  chlorpromazine.]  Toulouse med., 19-j.j,  56^
515— 5'->6
 Lafon, R. Temple, J. P., Abric, J.  Le 4560 Rp R dans
 le  traitement des etats  anxieux   [4o60 R. P. m the
 treatment of anxiety states.]   [Abstract]   Sem. hop.
 Paris 1953 29 : 3113.
 Largactil,  chlorpromazinii  chloridum  (INN).  Nord.
 med., 1955, 53 : 242-244.                        #
 Larue  L   Connaissances acquises sur les  resultats
 Therapeutiques du largactil.   [Th^apeutic results with
 largactil.]  Encephale, 1956, 45: 497-500.
Le  Guillant,  L.,  Roelens,  Corre, Kestenberg, Phchet,
 Beauart  Bailly-Salin.  Quelques remarques methodolo-
Soues sur Taction  des  neuroleptiques.  [Certain  me-
toodological considerations on the act o  of neuroleptlc
drugs.]  Encephale, 1956, 4o: 1128-1135.
Lehmann, H. E.  A dynamic concept of the  action of
chlorpromazine at physiological and psychological levels.
Encephale, 1956, 45 :1113-1118.
___.  Ein hemmendes  Mittel zur Kontrolle und Be-
handlung    psychomotorischer    Erregungszustande;
(Chlorpromazine,  Largactil,  Thorazine,  Megaphen).
[An inhibiting drug  for control  and treatment of psy-
chomotor excitement: (chlorpromazine, largactil, thora-
zine, megaphen).]  tfervenarsJ, 1954, 25 : 322-330.  Ab-
stract : Excerpta med., Sect. 8, 1955, 8: No. 1792.
---.  Selective inhibition of affective drive by pharma-
cological means.  Am. J. Psychiat, 1954, 110: 856-857.
----.  Therapeutic results with  chlorpromazine  (lar-
gactil) in psychiatric conditions.   Canad. M. Ass. J.,
1955 72: 91—99.
----\  Hanrahan, G.  E.   Chlorpromazine, new inhibit-
ing agent for psychomotor excitement and manic states.
A. M. A. Arch. Neur. Psychiat.,  1954, 71-227-237.
Lesse, S.,  Malitz, S., Hoch, P.  [H.]  Chlorpromazine
therapy in private practice.  Its benefits and complica-
tions.  J.  Nerv. Ment. Dis., 1957,  125: 25-35.       *
Lindqvist, R.   Nagra ord om chlorpromazinbehandling,
narmast i anledning av nagra neuropsykiatriska fall.
[Comments on chlorpromazine therapy, with special ref-
erence to  neuropsychiatric  cases.]  Sven. lak.  tidn.,
1955  52 ■ 2314—2317.
Lomas,  J.  Uses of  chlorpromazine in mental  hospital
patients.  Brit. M. J., 1955, 1: 879-882.  Abstract: Ex-
cerpta med., Sect. 8, 1956, 9: No. 1725.
Macchi, G., Manghi, E.,  Saginario, M.   Indicazioni  e
metodi di impiego del largactil (4560 R. P.)  in terapia
neuro-psichiatrica; studio  su 130  casi trattati.   [Indi-
cations and methods of use  of largactil in  neuropsy-
chiatric  therapy: study  of  130 treated cases.]  Riv.
sper. freniat,  1954, 78:183-204.
MacColl, K.   Chlorpromazine hydrochloride (largactil)
in  the  treatment of the  disturbed  mental defective.
Am. J. Ment. Defic, 1956, 61: 378-389.
MacGregor, J. MacW.  Largactil; a new psychomotor
brake.  S. Afr. J. Clin. Sc, 1954, 5: 228-243.  Abstract:
Excerpta med., Sect. 8,1956, 9: No. 1724.
Maisonneuve,  G.  Bilan d'un an  de traitement par la
Chlorpromazine.  [Chlorpromazine therapy; results of
one year.]  59 p. Lyon, 1954.   [Thesis—Lyon, 1953/
1954, no.  93]                                       *
Malitz, S., Hoch, P. H., Lesse, S.   A two-year  evaluation
of  chlorpromazine  in clinical research  and practice.
Am. J. Psychiat,  1956,  113:  540-545.                *
Margolis, L. H.  Pharmacotherapy in psychiatry; a re-
view.  Ann. N. York Acad. Sc, 1957, 66: 698-718.    *
Mariani,  G., Barsotti, U.  II largactil nella  cura delle
malattie mentali; risultati del trattamento in 100 casi.
 [Largactil therapy of mental illness ; therapeutic results
in  100 cases.]  Riv. pat. nerv., 1956, 77: 525-528.
Martin,  C. A. Epreuve du largactil en psychiatrie.
 [Experiences  with  largactil in  psychiatry.]  Laval
 med., 1954,  19:1079-1094.  Abstract:  Excerpta  med.,
 Sect's, 1956, 9 : No. 1723.
 Massari,  M.   Ansieta  e blocco  vegetativo.   [Anxiety
 and autonomic block.]  Minerva med.,  Tor., 1953, 44:
 231-232.   [Not seen]
 Massenti, C.   II trattamento neuroplegico negli stati di
 eccitamento e di agitazione.  [Treatment of excitement
 and  agitation  with neuroplegic  drugs.]  Lavoro neu-
 ropsichiat., 1954,14 : 493-505. Abstract: Excerpta med.,
 Sect. 8, li!55,  8: No.  1785.
 Mayr, F.  Erfahrungen mit der  Largactil-Behandlung
 in der Anstaltspsychiatrie.   [Experience with largactil
 treatment in  psychiatric hospitals.]   Ther. Umschau,
 Bern, 1955, 11: 184-191; 203-211.
 Mielke, F. A.  Methods employed and results obtained
 in psychiatric studies with new drugs acting  on the
 brain stem.   Am. J. Psychiat,  1957, 114:134-139.
 Miksztal, M. W. Chlorpromazine  (thorazine) and reser-
 pine in residential treatment of neuropsychiatric  dis-
49 
Chlorpromazine : Therapeutic use
PSYCHOPHARMACA
 orders  in children.  J. Nerv.  Ment. Dis.,  1956,  123:
 477-479.
 Milli, N., Marzi, F.  II serpasil nelle malattie mentali.
 [Serpasil in mental disease.]  Riv. pat. nerv., 1956, 77:
 502-505.
 Moore, J. N.  Largactil in psychotherapy.  Irish J. M.
 Sc, 1955: 409-412.  Abstract: Excerpta med.,  Sect. 8,
 1956, 9: No. 3613.
 Morgan, D. R.  The use of reserpine, chlorpromazine and
 allied drugs in medicine and  psychiatry.  Med. J. Aus-
 tralia, 1956, 43 (1) : 1029-1035.
 Moyer, J. H., Kinross-Wright, V.,  Finney, R. M.  Chlor-
 promazine as a therapeutic agent in clinical medicine.
 A. M. A. Arch. Int. M„ 1955, 95:202-218.  Abstract:
 Chem. Abstr., 1955, 49:  5687h.                       *
 Nayrac, P., Graux, P. Indications et contre-indications
 de la chlorpromazine en psychiatrie.  [Indications and
 contraindications of chlorpromazine therapy in psychia-
 try.] Ence'phale, 1956, 45 : 518-523.
 Neri, A.  Primi risultati ottenuti col largactil nelTospe-
 dale neuropsichiatrico prov. di Reggio Calabria.  [First
 results obtained with largactil in the neuropsychiatric
 hospital of the Reggio  Calabria  province.]  [English
 summary p. 800-801.]  Rass.  stud, psichiat, 1956,  45:
 783-804.
 ----.  Primi risultati ottenuti con Timpiego del largactil
 in malati mentali.   [First results with chlorpromazine
 therapy of mental patients.]   Ence'phale, 1956, 45 : 682-
 686.
 Obiols, J.  Notre experience sur la therapeutique par la
 chlorpromazine.  [Our experience with chlorpromazine
 therapy.]  Ence'phale, 1956, 45 : 698-699.
 Overholser, W. Chlorpromazine and  reserpine in psy-
 chiatric practice.  Postgrad. M., 1956, 19: 346-349.
 ----.  Has chlorpromazine inaugurated a new  era in
 mental hospitals?  J. Clin. Exp. Psychopath., 1956, 17:
 197-201.
 ----.  La chlorpromazine, ouvre-t-elle une ere nouvelle
 dans les hopitaux  psychiatriques?  [Chlorpromazine—
 the beginning of a new era  in  psychiatric hospitals?]
 Encephale, 1956, 45 : 313-319.
 Paerregaard, G.  Chlorpromazinbehandling pa  en psy-
 kiatrisk  modtageafdeling.  [Chlorpromazine treatment
 at a psychiatric   department.]    [English  summary]
 Nord. med., 1956, 56 :1238-1240.                    *  *
 Parsons,  E.  H.  New  chemical agents  in psychiatry.
 Postgrad. M., 1955,18 :193-198.
 Pennington,  V. M.  Research findings in  phrenotropic
 drugs important to every physician.  Mississippi Doctor,
 1957, 35: 57-63.
 Pollack, B.  Drug  therapy—clinical and  operational ef-
 fects : changes in mental hospital resulting from addi-
 tion of chlorpromazine to the total therapeutic program.
 Ment. Hosp., 1956, 7 (4) : 14-16.
 ----.  Mental illness.  Med.  Times,  Great Neck, 1955.
 83:439-450.
 ----.  Preliminary report on  500  patients treated with
 thorazine at Rochester  State Hospital.  Psychiat Q.,
 1955, 29: 439^56.
 Popov, E. A., Nevzorova, T. A.  Opyt primeneniia amina-
 zina v psikhiatricheskoi klinike.  [Result with amina-
 zine in psychiatric clinical  practice.]  Zh.  nevropat.
 psikhiat., Moskva, 1956, 56: 559-566.
 Puca, A.  Ibernoterapia, sonno prolungato e neuroplegia
 in  terapia psichiatrica.  [Hibernation, prolonged sleep
 and neuroplegic drugs in psychiatric treatment.]   Rass.
 internaz. clin. ter., 1955, 35: 805-809.
 ----. Nuove acquisizioni in  terapia psichiatrica; iber-
 noterapia,  sonno  prolungato  e neuroplegic!.   [New ac-
 quisitions in psychiatric therapy;  artificial hibernation,
 prolonged sleep and neuroplegic drugs.]  [English sum-
 mary]  Rass. stud, psichiat.,  1955, 44: 849-856.   Also:
 Ann. med. nav., Roma,  1956,  42-49.
Ramie, F., Lacaton, R., Sanchez, F., Boulanger, M.  Ef-
fets favorables du  largactil dans la pratique psychia-
trique algerienne.  [Good results with chlorpromazine
therapy  of mental  diseases  in  Algeria.]   Encephale,
1956, 45: 820-827.
Ramirez, F.  El largactil oral en el tratamiento de afec-
ciones mentales.  [Oral administration of largactil in
the  treatment  of  mental  disorders.]  Rev.  psiquiat
Uruguay, 1954, 19  (112)  : 37-44.
Rettig, J. H. Chlorpromazine for the control of psycho-
motor excitement in  the  mentally deficient; a prelimi-
nary study.  J. Nerv. Ment. Dis., 1955, 122: 190-194.  *
Rigal, J.,  Malet, P.  Considerations sur  Temploi du
largactil en psychiatrie.  [Largactil therapy in psychi-
atry.] J. me'd. Bordeaux, 1954, 131:1191-1196.       *
----, ----, Florentin, M.  Quelques considerations au
sujet de 300 cures de chlorpromazine dans les psychoses
et les nevroses.  [Some remarks  on chlorpromazine
therapy of 300 psychotics and neurotics.]   Encephale,
1956, 45: 592-598.
Rigotti, S.  Dal blocco del S'. N.  vegetativo all'iberna-
zione artificiale : primi risultati di un nuovo indirizzo di
terapia psichiatrica.   [From autonomic N. S.  blocking
to artificial hibernation;  first results with a  new psy-
chiatric therapy.]  Rass. neur. vegetat., 1952, 9:197-
210.   Abstract: Riv. neur., Nap., 1953, 23 :186-188.
----.  Ulteriori esperienze sull'impiego  in  psichiatria
della  dimetilamino-propil-N-clorofenotiazina  (Largac-
til).   [Further experiences with  the  use of dimethyl-
amino-propyl-chlorophenothiazine   (largactil)   in  psy-
chiatry.]   [English  summary]  Gior. psichiat.,  1953,
81: 211-222.
Rossi, M.  Moderne  terapie  psichiatriche  a   base  di
ganglioplegici e di alcaloidi della Rauwolfia  serpentina.
[Modern psychiatric  therapy  with ganglioplegics and
Rauwolfia  serpentina alkaloids.]   Arch, psicol  neur.,
Milano, 1956, 17: 642-644.                          *
Roxo, H.   Tratamento moderno  das doengas  mentais.
[Modern therapy of mental diseases.]  Arq. brasil. med.
nav.,  1956, 17: 4153-4162.
Sainz, A. A.  The management of side effects  of  chlor-
promazine and reserpine.  Psychiat. Q.,  1956, 30:647-
653.                                                *
Sal y Rosas, F., Jeri, R., Sanchez, J.  La chlorproma-
zine chez les malades  mentaux peruviens.  [Chlorproma-
zine  therapy of mental patients  in Peru.]   Ence'phale,
1956, 45: 599-604.
----,  ----, ----. Chlorpromazine  in  neuropsvchiatry.
J. Am. M. Ass., 1954,  156: 558.
Sargant, W.  On chemical tranquillizers.   Brit. M. J.,
1956, 1: 939-943.                                   *
Schiele, B. C, Anderson, R. W., Simon, W.  Current sta-
tus of chlorpromazine and reserpine in psychiatric prac-
tice.   J. Lancet, 1956, 76: 179-1S5.
Schmitt,  R. J.  The psychodynamics of the tranquiliz-
ing agents.  Psychiat. Q.,  1957, 31:17-30.
Schultz, J. D.  El uso de cloropromazina  (thorazine)
en los estados  aleoh61icos agudos.   [Use of  chlorpro-
mazine (thorazine)  in acute  alcoholic  states.]  Arch.
me'd.  Cuba, 1956, 7:18-20.
Seguin, A., Castro  de la  Mata, R.  Chlorpromazine in
neuropsychiatry. J. Am.  M. Ass., 1954, 156: 558.
Shea, J. G., Alman, R. W.,  Fazekas, J. F.   The use of
chlorpromazine in  the management of  patients with
head injury.  A. M. A. Arch. Int.  M., 1955, 96: 168-171.
Abstract:  Year  book of drug therapy, 1956-1957, p.

Sheatz, G. C.  Studies on  chlorpromazine in decerebrate
dogs and patients with irreversible brain damage.  [Ab-
stract] J. Pharm. Exp. Ther., 1955, 113: 47-iS.
Sigwald, J.   Les indications du traitement de diverses
affections neuropsychiatriques par la chloropromazine;
utilisation pratique  des  proprietes  neuropiegiques et
psychopiegiques de ce corps, posologie.  [Indications for
chlorpromazine therapy of neuropsychiatric disorders;
practical use of its neuroplegic and psychoplegic prop
erties ; dosage.]  Bull, me'd., Par., 1953, 67 : 319-322
50 
SUBJECT LIST
Chlorpromazine : Therapeutic use — Additional data
 ---, Bouttier,  D.  Le chlorhydrate de  choloro-3  (di-
 methylamino-3' -propyl) -10-phenothiazine   en  pratique
 neuropsychiatrique    courante.    [3-Chloro-10-(3'-di-
 methylaminopropyl)-phenothiazine   hydrochloride   in
 current  neuropsychiatry.]  Ann.  me'd., Par., 1953,  54:
 150-182.
 ---, ----.  L'utilisation des proprietes neuropiegiques
 du chlorhydrate de chloro-3-(dimethylamino-3'-propyl)-
 10-phenothiazine en therapeutique neuro-psychiatrique.
 [Utilization of the neuroplegic properties of chloro-3-(di-
 methylamino-3-propyl) -10-phenothiazine  hydrochloride
 in neuropsychiatric therapy.]  Presse me'd., 1953,  61:
 607-609.
 Sivadon, P., Schweich, M.,  Begoin, J.  Chlorpromazine
 et activites ergoth6rapiques.  [Chlorpromazine and oc-
 cupational therapy.]   Encephale, 1956, 45 : 449-455.
 Staehelin, J. E., Kielholz, P.  Largactil, ein neues vege-
 tatives Dampfungsmittel  bei psychischen  Storungen.
 [Largactil,  a new autonomic inhibitor in mental  dis-
 orders.]   Schweiz. med. Wschr., 1953, 83:581-586.   Ab-
 stract : Excerpta med., Sect. 8,1954, 7 : No. 1601.
 ---, Labhardt, F. Les resultats atteints par les neuro-
 piegiques dans le  traitement des psychoses et des n6v-
 roses.   [Results  in  the treatment  of  psychoses  and
 neuroses with neuroplegic drugs.]  Ence'phale, 1956, 45:
 511-517.
 Steigman, A. J., Vallbona, C.  Experience with chlor-
 promazine in pediatrics.  Internat. Rec.  M., 1955,  168:
 351-357.
 Tarasov,  G. K.  RezuTtaty klinicheskogo issledovaniia
 deistviia aminazina pri lechenii psikhicheski bol'nykh.
 [Results of clinical investigations on the effect of amina-
 zine  in   mental  patients.]   Zh.  nevropat.  psikhiat.,
 Moskva, 1956, 56:  146-154.
 Teani, E.  La cloropromazina nella pratica neuropsichi-
 atrica.  [Chlorpromazine in neuropsychiatric practice.]
 Minerva med., Tor., 1956, 47 :1677-1686.
 Temkov,  I., Ditsova, A.  Nashi  rezultati ot lechenieto
 na niakoi dushevni zaboliavaniia s largaktil.  [Results
 of the treatment  of  certain  mental  diseases with  lar-
 gactil.]  Suvrem.  med., Sofia, 1956, 7: 61-68.
 Tennenbaum, L.  Largactil.   [In Hebrew]   [English
 summary p. IV-V]  Dapim Refuiim, 1955, 14: 229-242.
 Terman,  L.  A.  Treatment  of  senile agitation  with
 chlorpromazine.   Geriatrics,  1955,  10:520-522.   Ab-
 stract : Excerpta med., Sect. 8, 1956, 9: No. 2582.
 Tolsma,  F. J.  Les neuroleptiques  et le probleme de
 Tadaptation  humaine.  [Neuroleptic  drugs  and  the
 problem  of human adaptation.]  Ence'phale, 1956,  45:
 1141-1149.
 ---, Jedeloo, G. C, Kemenade, J. J.  van  De betekenis
 van 4560 R. P.  (largactil)  in de psychiatrie.   [Use of
 4560  R.  P.  (largactil) in psychiatry.]   [English sum-
 mary]  Ned.  tsch.  geneesk., 1954,  98:997-1001.   Ab-
 stract : Excerpta med., Sect.  8, 1955,  8: No. 3103.
 Touraine, Y.  Action du 45-60 RP sur les deiires  avec
 agitation des traumatises craniens.  [Effect of  4560
 R. P. on  delirium  with  agitation  in head trauma.]
 Presse m4d., 1953, 61: 470.
 Vaughan, G. F., Leiberman, D.  M., Cook, L. C.  Chlor-
 promazine in psychiatry.  Lancet, Lond., 1955, 1:1083-
 1087.                                               *
 Vidart, L., Gasteau, E.  La cure de sommeil en pratique
 neuro-psychiatrique.   [Sleep  therapy  in neuropsychi-
 atric  practice.]  Rev. prat., Par., 1954, 4: 1583-1588.
Visintini, F.  Cloropromazina e reserpina in psichiatria.
 [Chlorpromazine and  reserpine in psychiatry.]  [Eng-
lish summary]  Arch,  psicol. neur.,  Milano, 1956,  17:
6H-621.                         .     ,„».,.
Wachsmuth, R. Phenothiazinderivate (Megaphen) in
der  Psychiatrie.  [Phenathiazine derivatives  (mega-
phen)  in psychiatry.]   Medizinische, 1955: 328-329.
____   Psychovegetative Umstimmungsbehandlung  mit
Phenothiazinderivaten, insbesondere in der Psychiatrie.
[Psycho-autonomic therapy with phenothiazine deriva-
  tives, with  special reference to psychiatry.]  Aerztl.
  Forsch., 1955, 9: 261-274.                            *
  Walther-Biiel, H.  L'action des medicaments neurolep-
  tiques dans la maladie de Huntington.  [Effect of neu-
  roleptic drugs  on  Huntington's  chorea.]   Ence'phale,
  1956, 45: 771-772.
  ----. Das neuroplegische Prinzip in pharmakopsychi-
  atrischer Betrachtung.   [The neuroplegic  principle in
  pharmacopsychiatric  considerations.]   [Brief English
  summary]  Mschr. Psychiat, Basel, 1955, 129: 286-296.
  Abstract: Excerpta med., Sect. 8, 1956, 9: No. 3891.
  Wardt-Kikkert, N. M. van de   Quelques aspects de Tap-
  plication de la  chlorpromazine dans un hopital psychi-
  atrique hollandais.   [Observations on the use of chlor-
  promazine in a Dutch psychiatric hospital.]   Ence'phale,
  1956, 45: 700-704.
  Webb,  R. R.  Largactil  in psychiatry.  Med. J.  Aus-
  tralia,  1955, 42  (1):   759-761.   Abstract: Excerpta
  med., Sect. 8,1956, 9 : No. 2233.
  Winkelman, N.  W., Jr.  Chlorpromazine in the treat-
  ment of  neuropsychiatric disorders.  J. Am.  M.  Ass.,
  1954, 155:18-21.  Abstract:  Chem. Abstr., 1954,  48:
  9562c.
  Wozowska, J., Pytel, A.   Largaktyl (chloropromazyna).
  [Largactil (chlorpromazine).]  Polski tygod. lek., 1955,
  10: 772-779.
  Zethraeus,   S.   Klorpromazinbehandling  vid  psykisk
  sjukdom.  [Chlorpromazine therapy of mental disease.]
  Sven. lak. tidn., 1955, 52: 1087-1103.                 *

—Additional data
  Abrams, R. E., Tice, L. F. Modern medicinals in review.
  Am. J. Pharm., 1955,127 : 4-22.
  Alexander, L.   Therapeutic process in electroshock and
  the newer  drug therapies; psychopathological consid-
  erations.  J. Am. M.  Ass., 1956, 162: 966-969.        *
  ---.  Objective approaches to treatment in psychiatry.
  Canad. Psychiat. Ass. J., 1957, 2: 77-94.              *
  Allen,  E. B., Prout,  C.  T.  Alcoholism. Progr. Neur.
  Psychiat., N. Y., 1956,11: 338-351.
  Balvet.   Les  conditions  d'environnement qu'  exige la
  therapeutique  par le largactil.  Environmental condi-
  tions required  by largactil  therapy.]  J.  me'd. Lyon,
  1954, 35: 947-948.
  Begany, A. J.,  Seifter, J., Pless,  H. H., Huber, R. D.,
  Bruce, W. F.  Tranquilizing effect of phenothiazines in
  cats and rabbits.  Fed. Proc, Bait., 1956,  15:399-400.
  Bell, J. P.  Magic  drugs in  psychiatry.  J. Kentucky
  M. Ass., 1954, 52: 788-789.
  Bergy,  G.  A.   Drugs of sedation with  tranquilizing
  effects.  Am. Profes.  Pharmacist, 1956, 22:419;  534-
  538; 619-621;   709-710;  797-799;  888-889;  917-919.
  [419;534-538.]
  Bleuler, M.  Fortschritte in der Behandlung von Erre-
  gungszustanden.  [Progress in the treatment of excita-
  tory states.]   [Abstract]  Praxis, Bern, 1954, 43 :  1030.
  Block, M. A.  Medical treatment of alcoholism.  J. Am.
  M. Ass., 1956, 162:1610-1619.
  Cant, G.  New  medicines for the mind; their meaning
  and promise.   26 p.  New York, Public Affairs Commit-
  tee, 1955.
  Carr, C. J., Kinnard, W. J., Jr.  The phrenotropic agents.
  Internat. Rec. M., 1957, 170: 493-504.
  Castillo, C. R.   Los fen6menos psiquicos y la terapeutica
  biol6gica.  [Psychic phenomena  and biological thera-
  peutics.]   Prensa me'd. argent., 1954, 41:3533-3538.
  Cohen, I. M.  Drugs  recently introduced in the  treat-
  ment of psychiatric disorders.  Texas J. M., 1956, 52:
  683-C>S7.
  Coulter, E. B.  Nursing  care problems  associated with
  the use of ataraxic drugs.  Hawaii M. J., 1957, 16: 303-
  304.                                               *
  Davis,  W.  A.,  Severinghaus, E.  L.  Drug therapy  in
  psychiatry  and neurology; medical and pharmacologic
  aspects.  J. M. Soc N. Jersey, 1956, 53:18-22. 
Chlorpromazine : Therapeutic use — Additional data
PSYCHOPHARMACA
 Dellaert, R.  De  modernste  chemopharmaca  in  de
 psychiatrie.   [New chemical psychopharmaca.]   Belg.
 tschr. geneesk., 1956, 12 : 314-321.
 Donini,  F. M.,  Belsasso,  M. Ravis, E.  Risultati tera-
 peutici ottenuti con il serpasil in 158 ammalati mentali.
 [Therapeutic results of serpasil in 158 mental patients.]
 Arch, psicol neur., Milano, 1956, 17: 394-398.
 Doyle, F. J.  New drugs in mental therapy and the im-
 plications  of  their use.  Hosp.  Progr., 1955,  36 (3) :
 50-51.
 Ebaugh, F. G.  The videclinic.  J. Am. M.  Ass., 1955,
 158: 732-733.
 Fabing, H. D.  The ataractic drugs : their uses and limi-
 tations in psychiatry.  Am. Profes. Pharmacist, 1956,
 22: 413-418.
 ---.  The  new pharmacologic  attack in psychiatry.
 Internat Rec. 31., 1956, 169:  177-183.  Also: Drug &
 Cosmet.  Indust., 1956, 78: 32-33; 125-129.          *
 ---.  Trends in biological  research in schizophrenia.
 J. Nerv.  Ment Dis., 1956, 124:1-7.
 Feldman, D.  J.  Drug  therapy of chronic alcoholism.
 Med.  Clin. N. America, 1957, 41: 381-392.
 ---.  The treatment of chronic alcoholism: a survey
 of  current methods.  Ann. Int. M., 1956, 44: 78-87.
 Freed, H.  Chlorpromazine and reserpine; new era in
 psychiatry?  Am. Practitioner, 1955, 6:706-708.
 Fremming, K. H.  Medikamentel behandling af synds-
 sygdomme.   [Medical treatment of mental disorders.]
 Mskr. prakt. laegegern., Kbh., 1956, 34: 331-342.
 French,  E. G.   Epilepsy.   Am. J. Psychiat., 1957, 113:
 629-631.
 Freyhan, F. A., Turner, P., Stenzler, R.  New drug thera-
 pies in psychiatry.  Delaware M. J., 1956, 28: 180-186.
 Graffagnino, P. N., Furr, J. H.  New drugs in the treat-
 ment  of emotional disorders; a  review.  Connecticut
 M. J., 1957, 21: 38-43.
 Green, A. Actualites therapeutiques 1955 en psychiatrie.
 [Therapeutic  progress  in  psychiatry in 1955.]  Ence-
 phale, 1956, 45: 172-200.
 Hewitt, D. W.  Alcoholism, a treatment guide for gen-
 eral practitioners.  112 p.   Philadelphia, Lea & Febiger,
 1957.
 Holtzer,  P. A.  Studiereis naar Parijs ter kennismaking
 met het praeparaat largactil  (4560 R. P.).   [Study trip
 to Paris  to obtain information on largactil  (4560 RP).]
 Geneesk. gids, 1953, 31: 465-469.
 Kautz, H. D.   Trends in  drug therapy. Hosp. Progr.,
 1957,  38  (1) : 102-108; 126.
 Keyes, B. L.  Ataraxic drugs.  Pennsylvania M. J., 1957,
 60:177-181.
 Kline, N. S.   Chemotherapy  in psychiatry;  recent ad-
 vances.  Seminar Internal,  Hoddesdon, 1956,  5  (2) :
 7-10.
 Klingman, W. O.   Neurological and psychiatric dis-
 orders ; some recent advances in therapy.  Virginia  M.
 Month., 1956, 83: 240-246.
 Kolle, K.  Siichte und ihre Bekampfung.  [Addictions
 and their control.]  [English summary]  Munch, med.
 Wschr., 1956, 98 : 7-10.
 Laboucarie, J., Barres,  P., Rascol, A.  Aspects princi-
 paux  des cures  neuropiegiques en psychiatrie  en 1956.
 [Principal features of neuroplegic therapy in psychiatry
 in 1956.]   Toulouse med., 1956, 57: 851-867.
 Liberson, W.  T.  The  new tranquilizing  drugs.  1.
 Neuropsychiatric aspects.   Am. J. Nurs., 1955, 55 : 1465-
 1467.
 Martin, D. A.  The therapeutic and  toxic effects of tran-
 quilizing drugs : medical aspects.  North Carolina M. J.,
 1956, 17: 396-401.
Mathis, M.  Toniques et sedatifs en neuro-psychiatrie
infantile.  [Tonics and sedatives in child neuro-psychi-
atry.]  Pediatrie, 1956, 11: 807-820.
Meyer, H. H.   Die moderne Behandlung psychiatrischer
Erkrankungen.  [Modern  treatment of  psychiatric dis-
 eases.]  Med.  Klin., Berl,  1956, 51: 1429-1432.
  Molina, A. La Rauwolfia serpentina, con especial refer-
  enda a la reserpina.   [Rauwolfia serpentina, with spe-
  cial reference to reserpine.]  Prensa me'd. argent., 1956,
  43: 423-425.  Also:  Rev. med.  cubana, 1956, 67: 623-
  627.
  New drugs  for patients with emotional disorders. J.
  Am. M. Ass., 1955, 157: 665.
  Overholser,  W.  Introductory  remarks [to:  Chlorpro-
  mazine and reserpine;  symposium on experiences at
  Saint Elizabeths  Hospital.]  Med. Ann. District of Co-
  lumbia, 1956, 25: 255.
  Paris Ruiz, L.  Aplicaciones terapeuticas de la cloro-
  promazina (largactil).   [Therapeutic uses of chlorpro-
  mazine (largactil).]   Rev. clin.  espan.,  1955, 59:47-50;
  110-117.  Abstract: Chem. Abstr., 1956,  50: 8053b.
  Roeder, F. D. Letter from Germany. Am. J. Psychiat,
  1956, 113: 506-509.
  Sebrell, W.  H., Jr.   Chemistry in chronic disease re-
  search. Chem. Eng. News, 1955, 33:1856-1860.
  Senseman, L. A.  Tranquilizing  drugs;  uses and abuses
  for the nervous patient.  Rhode Island M. J., 1956, 39:
  675-677; 680; 686.
  Smith, L. H.  Progress in psychiatry.   J. Am. M. Ass.,
  1955, 158: 46-47.
  Sottong, P. C.  The use and abuse of the tranquilizing
  drugs.  J. Tennessee M. Ass., 1956, 49 : 413-418.
  Spencer, R.  S.  The  use  of ataraxic drugs  in  mental
  illness.  Hawaii M. J., 1957, 16 : 302.
  Stimulants and depressants. Brit. M.  J., 1956,  1: 969-
  970.
  Tice, L. F. Some important drug developments of 1956.
  Am. J. Pharm., 1956,128: 398-409.
  Tranquilizing agents. N. England J.  M.. 39.15.  252:
  74-75.
  Tranquillizers. Scot. M. J., 1957, 2: 46-47.
  West, L. J., Swegan,  W. H.  An approach to alcoholism
  in the  military service.   Am. J. Psychiat., 1956,  112:
  1004-1009. Abstract: Excerpta med., Sect. 8, 1957, 10:
  No. 918.

—Literature surveys
  see CHLORPROMAZINE—Bibliographies and  litera-
       ture surveys

—Neuroses

    see also CHLORPROMAZINE—Various special tech-
              niques—Therapeutic use—Neuroses
  Ayd, F. J., Jr.  Tranquilizing drugs in private practice.
  N. York State J. M.,  1957, 57: 1742-1747.            *
  Azima, H. The use of chlorpromazine and reserpine in
  psychological disorders in general practice.   Canad. M.
  Ass. J., 1956, 74: 929-931.
  Baruk, H., Launay, J., Berges, J.  La chlorpromazine en
  therapeutique psychiatrique courante; schema de traite-
  ment a Tusage des medecins praticiens. [Chlorproma-
  zine in current psychiatric therapy; mode of treatment
  as used in general practice.] Rev. prat., Par., 1955, 5:
  3511-3517.                                        *
  Braun, M., Philipsborn, A.  Ataractics  in private prac-
  tice. Am. J. Psychiat., 1956,113 : 80-81.
  Brooks, W.,  Deutsch, L., Dickes, R.  The use of chlor-
  promazine hydrochloride in the treatment of barbiturate
  addiction  with acute withdrawal  syndrome,   im. J.
  Psychiat, 1955, 111: 696-698.  Abstract: Excerpta med.,
  Sect. 8,1956, 9 : No. 836.
  Cameron, D. E.  The recognition and treatment  of anx-
  iety states. Postgrad, il/., 1954,15 : 134-138.
  Cronqvist, S., Rayner, S., Wretmark, G.  Chlorproma-
  zmbehandling vid neuroser.  [Chlorpromazine therapy
  kq n^r0SeS-]   [EnSlisn  summary]  Nord.  med.,  1955,
  5o: 730—734.                                        *
  Doshay, L. J.  Problem situations in the treatment of
  paralysis  agitans. J. Am. M. Ass.,  1954, 156 • 680-684.
  Drugs  in  the treatment of depression. Lancet Lond
52 
SUBJECT LIST
Chlorpromazine : Therapeutic use — Psychoses
 Dunlop,  D.  M.  The barbiturates and other sedatives.
 Practitioner, Lond., 1957, 178 : 26-32.
 Eagles, J. B.  Chlorpromazine. Brit. M. J., 1955, 1: 46-
 47.                                                *
 Falcon, M.  Quelques observations cliniques sur Temploi
 de la chlorpromazine.  [Clinical observations on the use
 of chlorpromazine.]  Encephale, 1956, 45:587-591.
 Fliigel, F.  Erfahrungen mit Megaphen in der  psychia-
 trischen  und neurologischen Klinik.  [Experiences with
 chlorpromazine  in the  psychiatric  and  neurological
 clinic]  Arch. klin. Chir., 1954, 279: 767-772.
 Gatski, R. L.  Chlorpromazine in the treatment of emo-
 tionally  maladjusted children: preliminary report.  J.
 Am. M. Ass., 1955,157:  1298-1300.
 Gomirato, G.  L'azione della cloropromazina  e della
 reserpina su alcune  manifestazioni  sintomatologiche
 delle psiconevrosi. [Action of chlorpromazine and reser-
 pine on symptomatologic manifestations of psychoneu-
 roses.]   [English   summary.]  Arch,   psicol.  neur.,
 Milano, 1956, 17 : 531-543.
 Grimshaw, J. A. Chlorpromazine and reserpine ; limita-
 tions of their use in office practice.   J. Kansas M. Soc,
 1956, 57: 687-689.                                   *
 Heilbrunn,  G.  Selection of patients for  modern psy-
 chiatric  pharmacotherapy  in general practice.  North-
 west M.,  1956, 55 : 1198-1205.
 Held,  R.  Sur la  chlorpromazine et les  medicaments
 neuroleptiques;  incidences  psychotherapeutiques.
 [Chlorpromazine  and  neuroleptic drugs;  psychothera-
 peutic  incidences.]  Ence'phale, 1956, 45:1000-1004.
 Hoch, P.  H.   The effect of  chlorpromazine on moderate
 and mild mental  and  emotional  disturbances.  In:
 Chlorpromazine and mental health.  Philadelphia, Lea
 & Febiger, 1955.  p. 99-111; discussion p. 111-140.    *
 ---.  New  drug therapy  in  psychiatry:  clinical uses
 and abuses  in mental  disorders.  Bull. N. York Acad.
 M., 1957, 33: 474-486.                               *
 ---.  Practical and theoretical applications of the new
 drug therapies in psychiatry. A.  M. A.  Arch. Neur.
 Psychiat, 1956, 75: 325-328.                        *
 Hollister, L. E. Tranquilizing drugs and the generalist.
 Med. Times, Great Neck, 1956, 84:1021-1026.
 ---, Stannard, A. N.,  Drake, C. F.   Treatment of anx-
 ious patients with  drugs.  Dis. Nerv. Syst, 1956,  17:
 289-293.
 Hubbard, O. E., Glasser, J.  Newer psychotropic drugs;
 their   characteristics  and  use  in  general  practice.
 Northwest M., 1956, 55 : 1191-1197.
 Hutchinson, J. T.  The value of drugs in the treatment
 of neuroses.   Med. Illust., Lond.,  1956, 10: 541-544.
 Kohler, C, Bourjade, G.  De Tutilisation du 4.560 R. P.
 en  neuro-psychiatrie   infantile.  [Utilization  of 4560
 R. P. in  pediatric neuro-psychiatry.]  Pediatric, 1954,
 9:383-385.  Abstract:  J. med. Lyon, 1954, 35:948.
 Lafon,  R., Faure, J. L., Abric, J.  Etude semeiologique
 et therapeutique des troubles du sommeil chez  Tenfant.
 rSvmptomatologic  and therapeutic  study of  sleep dis-
 orders  in children.]  PMiatrie, 1956, 11: 743-753.
 Lepage,  M.   Le  traitement  de  Tanxiete chronique.
 [The treatment of chronic anxiety.]  Bull, me'd., Par.,
 1955, 69: 273-275.
 Montanari, M., Giua, A. M.  II comportamento di alcune
 funzioni neurovegetative nella terapia con neuroplegici
 (largactil)  delle  psiconevrosi.  [Behavior of  various
 autonomic functions in neuroplegic  (largactil)  therapy
 of  psychoneuroses.]  [English summary]  Rass. stud.
 psichiat,  1955, 44: 433-475.
 ----. L'influenza del  largactil sulle  funzioni neuro-
 vegetative nelle  psiconevrosi.  [The influence of lar-
 gactil on  the neuro-vegetative functions  in psychoneu-
 roses.]  Riv. pat.  nerv., 1956,  77:490-492.
 Montassut, M., Chertok, L., Bequart, P.  Hallucinations
auditives   anciennes  sans   systematisation  deiirante
actuelle,  traitees  par  la  chlorpromazine.  [Chlorpro-
mazine  therapy of  persistent auditory hallucinations
  without  currently  manifest  delusion.]  Ann,   med.
  psychol, Par., 1955,113 (1) : 800-804.
  Nichamin,  S. J.  Chlorpromazine in the treatment of
  mild behavior disturbances.  J. Michigan M.  Soc, 1956,
  55: 1469-1471.
  Ostenfeld,  I. Psykiske  urotilstande.   [Mental excite-
  ment.]   [English  summary]  Nord. med.,  1955,  54:
  1517-1522.
  Pierson, C. A.  La chlorpromazine et la maitrise  de soi
  dans  les angoisses  collectives.   [Chlorpromazine  and
  self-control  in mass hysteria.]   Encephale,  1956, 45:
  562-565.
  Pollack,  B.   The  addition  of chlorpromazine to the
  treatment  program  for emotional  and  behavior  dis-
  orders in the aging.  Geriatrics, 1956, 11: 253-259.
  Porot, M., Jouanneau, H.  Traitment par la chlorpro-
  mazine seule d'un  syndrome melancolique  chez  une
  femme enciente.  [Chlorpromazine therapy alone in a
  melancholia  syndrome in a pregnant woman.]  Algerie
  med., 1956, 60 : 395-397.
  Scarpalezos,  S.  Le traitment ambulatoire par la  chlor-
  promazine  des psychonevroses  et  de certaines  mani-
  festations epileptiques (troubles caracteriels  et  myo-
  clonies).  [Ambulatory treatment with chlorpromazine
  in  psychoneuroses  and  in   some  manifestations  of
  epilepsy (character disorders and myoclonias).]  Ence-
  phale, 1956, 45: 722-726.
  Scherr, A.  Le largactil en psychiatrie extra-hospital-
  iere.  [Largactil  in  ambulatory  psychiatry.]  Ence-
  phale, 1956,45: 388-391.
  Shorvon, H.  J.  Drug therapy in psychiatry.  Practi-
  tioner, Lond., 1955, 175: 161-169.
  Sigwald, J.   La cure ambulatoire par la chlorpromazine.
  [Ambulatory  therapy  with  chlorpromazine.]  Ence'-
  phale, 1956, 45 : 392-400.
  ---,  Bouttier,  D.,  Nicolas-Charles,  P.  Ambulatory
  treatment with chlorpromazine.   J.  Clin.  Exp. Psycho-
  path., 1956,17:57-69.
  Silverman,  M. The  clinical  response  of psychoneu-
  rotics to chlorpromazine. J. Ment. Sc, Lond., 1955,101:
  640-643.  Abstract:  Excerpta med., Sect. 8, 1956,  9:
  No. 4985.
  Skobba, J. S. Drugs in the management of  emotional
  conditions.   J. M. Ass. Georgia,  1956, 45: 397-399.
  Trethowan,  W. H.   Persistent sensory symptoms fol-
  lowing spontaneous hypoglycemia : response to chlorpro-
  mazine.  J. Nerv. Ment. Dis., 1955,  121: 274-278.  Ab-
  stract : Excerpta med., Sect. 8, 1950, 9: No. 1424.
  ----,  Scott, P. A.  Chlorpromazine in obsessive-compul-
  sive and allied disorders.  Lancet, Lond., 1955, 1: 781-
  785.  Abstract: Excerpta med,, Sect. 8, 1956, 9: No. 2231.
  Vernet, A., Genevard,  G. Applications  de la chlorpro-
  mazine en partique  medicale  courante  et en medecine
  psychosomatique.  [Uses of chlorpromazine in current
  medical  practice  and  in  psychosomatic  medicine.]
  [German summary]  Praxis, Bern, 1956, 45:385-389.
  Abstract: Excerpta med., Sect. 8, 1957, 10: No. 1400.
  Weinberg, H. B. Drug therapy for the emotionally and
  mentally disturbed;  the internist's  point of view.  J.
  Iowa M. Soc, 1957, 47 :17-19.

—Psychoses
    see also CHLORPROMAZINE—Various special tech-
               niques—Therapeutic use—Psychoses
  Abely, P., Abdouchelli, A., Fourment, J., Schmitz, B.,
  Delteil, P.  Suite aux essais therapeutiques de reequili-
  bration instinctivo-affective; essai de traitement par la
  bromure  tetra-ethyl  d'ammonium en comparaison avec
  le R.  P. 45-60 et le C. 92-95.   [Further therapeutic
  studies on the restoration of instinctive-affective bal-
  ance; therapeutic  trials with tetraethylamonium bro-
  mide in comparison with R. P. 45-60 and with C. 92-95.]
  Ann. me'd. psychol, Par., 1952, 110 (2) : 262-267.
  Achaintre, A., Balvet, P., Beaujard, M.,  Broussolle, P.,
  Perrin, J., Leveque, F., Requet, A.  Evaluation of chlor-
53 
Chlorpromazine : Therapeutic  use — Psychoses
PSYCHOPHARMACA
 promazine in psychotic patients.  Internat. Rec. M., 1957,
 170:175-182.
 Achaintre, A., Dubor, P., Lauxerois, G. Trois modes par-
 ticuliers d'administration de la chlorpromazine dans les
 affections psychiatriques a longue evolution.   [Three
 special methods of chlorpromazine therapy in chronic
 psychiatric diseases.]  Encephale, 1956, 45 : 444-448.
 Altschule, M. D., Bower, W., Cook, L.  Experiencias psi-
 quiatricas com  novo agente terapeutico: a cloroproma-
 zina.  [Psychiatric experience  with a new therapeutic
 agent: chlorpromazine.]  Resenha clin.  cient., S. Paulo,
 1955,  24: 111-113.
 Arnold, O. H., Hift, S., Solms, W. Uber die Anwendung
 eines  zentral vegetativen Hemmungsstoffes in der psy-
 chiatrischen Therapie.  [Application of a new central
 autonomic  inhibitor in  psychiatric therapy.]   Wien.
 med. Wschr., 1952, 102: 964-965.
 Bader, E.  Extrapyramidal symptoms following thora-
 zine medication.  Illinois M. J., 1956, 109: 28-29.
 Baker, A. A. Observations on the effect of largactil in
 psychiatric illness.  J. Ment. Sc, Lond., 1955, 101:175-
 182.  Abstract:  Excerpta med., Sect. 8,1955, 8: No. 4918.
 Baruk, H.,  Launay,  C, Lelord.  Etude sur  Taction
 therapeutique du 4560 R. P. dans les etats d'excitation
 et d'agitation impulsive.  Donnees cliniques  et donnees
 experimentales  sur les modifications de la  circulation
 cerebrale.  [ Study on the therapeutic action  of 4560 RP
 in states of excitation and impulsive agitation. Clinical
 and experimental information  on the changes in cere-
 bral circulation.]  Ann.  me'd.  psychol,  Par., 1954,  112
 (2) : 66-71.
 ----,  Launay,  J.,  Berges, J.   La  catatonie experi-
 mentale par la  chlorpromazine 9. hautes doses chez le
 singe et dans la serie animale;  action therapeutique du
 45-60  R. P. dans le traitement des maladies mentales en
 clinique humaine (a doses moderees et sans associations
 medicamenteuses).   [Experimental catatonia induced
 in monkeys by massive doses of chlorpromazine; thera-
 peutic effect of chlorpromazine  in  the treatment of
"mental disorders in humans with moderate doses and
 without  adjuvant medication.]   Rev. neur.,  Par., 1955,
 92:141-143.
 ----,----,----.  Sur ene serie de resultats therapeuti-
 ques  spectaculaires  par  la chlorpromazine  dans  des
 psychoses graves suivant une posologie particuliere sans
 association  medicamenteuse.    [Series  of  spectacular
 therapeutic results with  chlorpromazine in severe psy-
 choses ; use of chlorpromazine  in particular dosage and
 without  associated  medication.]   Ann. me'd.  psychol,
 Par., 1955, 113 (1) : 442-449.
 ----,----,----.  La therapeutique par la chlorproma-
 zine ;  physiologie experimentale; physiologie  clinique;
 resultats therapeutiques et  progres de la therapeutique
 psychiatrique.   [Chlorpromazine therapy ; experimental
 physiology; clinical physiology; therapeutic results and
 progress in psychiatric treatment.]  Ann. me'd. psychol,
 Par., 1955, 113 (1) : 705-772.
 Beaujard,  Hamoneau.  Remarque sur Temploi du  lar-
 gactil  dans les schizophrenies chroniques.  [An observa-
 tion on the use of largactil in  chronic  schizophrenia.]
 J. med. Lyon, 1955,  36: 325-327.  Abstract: Excerpta
 med., Sect. 8, 1956, 9: No. 1212.
 Bensoussan, P. A., Klein, F. Sur quelques incidents de
 la cure de sommeil au chlorhydrate de chloro 3 (dimethy-
 lamino-3'-propyl)-10-phenothiazine.  [Some incidents in
 sleep therapy with chloro 3 (dimethylamino-3'-propyl)-
 10-phenothiazine hydrochloride.]   Ann. me'd.  psychol,
 Par., 1953, 111  (1) : 529-532.                         *
 Berthier, C, Bonneru-Couchoud, M., Barnaud, J. Con-
 siderations sur le traitement par la chlorpromazine as-
 sociee  & la therapeutique specifique dans la  P.  G.;  a
 propos de deux  cas  recents. [Chlorpromazine therapy
 combined  with  specific therapy in general  paralysis;
 report  of two recent cases.]  J. me'd. Lyon, 1956, 37: 293-
 295.
----,  ----, ----.  A  propos du traitement des  deiires
alcooliques subaigus et chroniques.  [Treatment  of sub-
acute and chronic alcoholic delirium.]  Rev. neur., Par.,
1956,  94: 673-674.
Bertolini, O. F.  Cloropromazina e reserpina nel trat-
tamento delle psicopatie.   [Chlorpromazine and reser-
pine in the treatment of mental diseases.]  Arch, psicol.
neur.,  Milano, 1956, 17 : 623-627.                    *
Bird,  E. G., Goss, J. D., Jr., Denber, H. C. B.  Chlorpro-
mazine in the treatment of mental illness: a study of
750 patients.  Am. J.  Psychiat., 1955, 111: 930.      *
Bobon, J. Chloropromazine et cure de sommeil.  [Chlor-
promazine and  sleep  therapy.]   Ence'phale,  1956,  45:
421-427.                                          * *
Borel, J., Camar, R. Bailly, R.  La cure de largactil, ses
doses, sa dur6e.   [Largactil  therapy;  dosage; dura-
tion.]   Ann.  med.  psychol, Par.,  1956, 114(1) : 86-91.
Bower, W. H., Altschule,  M. D., Cook, L.  Psychiatric
experience  with   chlorpromazine.  Am. Practitioner,
1955,  6: 90-93.   Abstract: Excerpta med., Sect. 8, 1956,
9: No. 4071.
Bowes, H. A.  The  ataractic drugs; the present position
of chlorpromazine, frenquel, pacatal, and reserpine in
the psychiatric hospital.   Am. J. Psychiat., 1956, 113:
530-539.
Braun, M., Philipsborn, A. Ataractics in private prac-
tice.  Am. J. Psychiat., 1956,113 : 80-81.
Broussolle, P., Hamoneau, G.   Traitement prolonge a la
chlorpromazine  (45.60 R. P.)  ; treize  observations de
psychoses  graves.  [Prolonged treatment  with  chlor-
promazine ; thirteen  patients  with severe  psychoses.]
Lyon  me'd., 1953, 85(2) : 389-401.
----,  Scherr,  A.  Une amelioration spectaculaire par
chlorpromazine  intraveineuse  apres cure  de  Sakel.
[Spectacular improvement with  intravenous chlorpro-
mazine after  Sakel cure.]  Ann.  me'd. psychol, Par.,
1954, 112 (2) : 748-751.
Bukowczyk, A.   Szkic postepowania podczas leczenia
largaktylem w klinice psychiatrycznej A. M. w  Lodzi.
[Procedure in largactil therapy at the psychiatric clinic
of the Academy of Medicine of L6dz]   [Brief English
summary]. Neur. dc polska, 1955, 5 : 432-434.
Cares, R. M., Asrican, E., Fenichel, M., Sack,  P.,  Sever-
ing, J.  Therapeutic and toxic effects of chlorpromazine
among 3,014 hospitalized cases. Am. J. Psychiat, 1957,
114: 318-327.                                      * *
Carillo-Broatch, A.  Largactil  en el tratamiento de las
psicosis  traumaticas;  resumen.  [Largactil in   the
treatment of traumatic  psychoses; a summary.]  En-
ce'phale, 1956, 45:1224-1225.
----.  Tratamiento de la  esquizofrenia cronica.  [Treat-
ment  of chronic schizophrenia.]   [English summary]
Rev. neur. psiquiat., Lima, 1955, 18:441-445.  Abstract:
Excerpta med., Sect. 8,1957,10: No. 1981.
Chatagnon,  P.,  Chanoit, P. Psychopiegie  transitoire,
resultat clinique observe  dans des etats  d'excitation
psycho-motrice a la suite  de Taction d'un derive de la
phenothiazine.   [Transient psychoplegia, a clinical re-
sult observed during  the treatment of psychomotor ex-
citation with a  phenothiazine  derivative.]   Ann. mid.
psychol,Par., 1953, 111 (1) : 361-364.
Cocheme, R.  Le delirium tremens mortel; statistiques;
recherche des causes  de Tinefflcacite des traitements.
[Fatal  delirium  tremens;  statistics; research  on  the
causes for the ineffectiveness of the treatment.]  Rev.
neur.. Par., 1956, 94: 657-660.
Contini, M. L'uso  del ganglioplegico 4560 R. P  in  psi-
chiatria.  [Use  of  the ganglioplegic 4560  RP in psy-
chiatry.]  Rass.  stud, psichiat.,  1954, 43:1133-1138.
De Caro, D., Mulas, L.  L'impiego della terapia  gangli-
oplegica mediante il '4560 R. P."  nelle malattie mentali.
Esperienze e risultati su  52 casi trattati.   [Ganglio-
plegic  therapy of mental disease with "4560 RP"   Ex-
periences and results in  52 treated cases.]  Acta neur.,
Nap.,  1954, 9 : 611-627.
54 
SUBJECT LIST
Chlorpromazine : Therapeutic use — Psychoses
  Decherney,  G., Beaudry,  A.  Thorazine therapy; diffi-
  culty in predicting the outcome.  Delaware M. J., 1955,
  27:186-187.  Abstract: Excerpta med., Sect. 8, 1956,
  9: No. 1216.
  Delay, J., Deniker, P.  38 cas de psychoses traitees par
  la cure  prolongee et continue de 4560 R.  P.  [Thirty-
  eight psychotics  treated by  prolonged and continuous
  administration of 4560  RR]  C. rend. Congr.  alie'n.
  neur.  France, 1952, 50: 503-513. Abstract: Ann. me'd.
  psychol, Par., 1952,110 (2) : 564.
  ---,  ----.  Le  traitement  des  psychoses  par  une
  m6thode neurolytique  derivee  d'hibernotherapie; le
  4560 R.  P. utilisee seul en cure prolongee  et  continue.
  [Treatment  of psychoses by a  neurolytic method de-
  rived from hibernotherapy; prolonged continuous ther-
  apy with 4560  RP alone.]  C. rend. Congr. alie'n. neur.
  France,   1952,  50:497-502.    Abstract:  Ann.  me'd.
  psychol, Par., 1952, 110 (2) : 564.
  ---, ----•  Harl,  J. M.  Traitement des  etats d'excita-
  tion et  d'agitation  par une  methode medicamenteuse
  derivee de Thibernotherapie.  [Therapeutic method de-
  rived from  hiberno-therapy in excitation and  agitation
  states.]  Ann.  me'd. psychol,  Par., 1952, 110  (2) : 267-
  273.
  ---, ----, ----•  Utilisation en therapeutique psychi-
  atrique d'une phenothiazine  d'action centrale elective
  (4560 RP).  [Use of a phenothiazine with elective cen-
  tral effect in psychiatric therapy.]  Ann. me'd. psychol,
  Par. 1952,110 (2)  : 112-117.
  ---, ---, ---, Grasset,  A.  Traitements  d'etats con-
  fusionnels par le chlorhydrate de dimethylaminopropyl-
  N-chlorophenothiazine  (4560 RP).   [Dimethylamino-
  propylchlorophenothiazine  (4560 RP) therapy of con-
  fusional states.]  Ann. me'd.  psychol, Par.,  1952,  110
  (2)  : 398-403.  Abstract:  Excerpta med., Sect. 8, 1954,
  7: No. 1603.
  ---,----, Ropert, R.  Etude de 300 dossiers de malades
  psychotiques traites par  la chlorpromazine en service
  ferme  depuis 1952.  [Hospitalized  psychotic  patients
  treated with chlorpromazine since 1952;  analysis of  300
  case histories.]  Ence'phale, 1956, 45 : 528-535.
  ---, ----,  ----.   Quatre  annees d'experience  de la
  chlorpromazine  dans  le   traitement  des   psychoses.
  [Four  years of  experience  with chlorpromazine in
  therapy of psychoses.]  Presse me'd., 1956, 64: 493^96.
 ---, ----, ----, Wiart, C. Les indications des  cures
  neuroleptiques  prolongees  dans  le traitement  des psy-
  choses   chroniques.   [Indications for the  prolonged
 neuroleptic therapy in the treatment of chronic psy-
 choses.]   Arch, psicol. neur., Milano,  1956, 17:401-407.
 Denber, H. C. B.  Some aspects of chlorpromazine treat-
 ment with reference to the problem of depression.  Dis.
 Nerv. Syst.,  1957, 18: 35-36.                         *
 ---, Bird,  E. G.   Chlorpromazine in the treatment of
 mental illness.  II.  Side effects and relapse  rates.  Am.
 J. Psychiat, 1955,  112: 465.                         *
 ---,----.  Chlorpromazine in the treatment of mental
 illness.    III.  The  problem  of depression.   Am.  J.
 Psychiat., 1956,  112:1021.  Discussion : ibid., 1956, 113 :
 368-369.
 ---t----.  Chlorpromazine in the treatment of mental
 illness   IV.  Final  results with analysis of  data  on
 1,523  patients. Am. J. Psychiat,  1957, 113: 972-978.  *
 Deschamps, A. Quelques resultats des cures  de  sommeil
 en  hopital  psychiatrique   (a  base  de chlorpromazine
 associee  a d'autres drogues).   [Some results  of sleep
 therapy in a psychiatric hospital (based  on  chlorprom-
 azine associated with other drugs).]  Ence-phale, 1956,
 45: 412-415.
Deutsch, L., Waxenberg, S. E., Dickes, R. Brief chlor-
promazine treatment of disturbed patients in a psychi-
atric  reception hospital.  J. Nerv. Ment. Dis., 1957, 125 :
273-278.
 Dewhurst, K.  Chlorpromazine  in the management of
 chronic psychotics. Irish J. M. Sc, 1955, 6: 83-87.  Ab-
 stract : Excerpta med., Sect. 8, 1955, 8: No. 3896.
 Dukay,  A.  P.   Chlorpromazine  in  the  treatment of
 chronic psychotic patients.  J. Michigan M. Soc, 1956,
 55: 664-670.
 Dupont,  A., Madoux-Joubert.  Resultats obtenus chez
 22 schizophrenes hommes et 37 schizophrenes femmes
 traites par  le 4560 R. P.  [Results of chlorpromazine
 treatment of 22 male and  37  female schizophrenics.]
 Ann. me'd. psychol, Par., 1955, 113  (1) : 634-639.
 Elkes, J., Elkes, C.   Effect of chlorpromazine  on  the
 behavior of chronically  overactive psychotic  patients.
 Brit. M. J., 1954, 2 : 560-565.  Abstract: Excerpta med.,
 Sect. 8,1955, 8 : No. 1794.
 Engelmeier, M.  P.  Die  Methodik der psychiatrischen
 Behandlung mit lytischen  Substanzen.   [Methods of
 psychiatric therapy with lytic substances.]  Nervenarzt,
 1956, 27 : 64-69.  Abstract: Excerpta med., Sec. 8, 1957.
 10: No. 1551.
 Escourolle, R.  Traitement des etats  deiirants de Tal-
 coholisme chronique.  [Treatment of delirious states in
 chronic alcoholism.]   France me'd., 1954, 17 (6) : 15-19.
 Evrard, A., Vandierendonck, R.  Over het chloroproma-
 zine bij  de  manisch-depressieve  en  schizophrene  psy-
 chosen.    [Chlorpromazine  in   mauic-depressive  and
 schizophrenic psychoses.]   Belg.  tschr. geneesk., 1955,
 11: 401H109.
 Fau, R.,  Chateau, R., Dusserre.  Traitement  des  psy-
 choses aigues  et  subaigues par les neuropiegiques.
 [Treatment  of acute and subacute psychoses with neu-
 roplegic drugs.]   [Abstract]  J.  med. Lyon, 1954,  35:
 948.
 Fong, T. C.  Chlorpromazine and reserpine in  geriatric
 patients.   Med.  Ann. District of Columbia, 1956,  25:
 260-263.
 Forrer, G. R.  Thorazine  in the  treatment of acutely
 disturbed psychotic patients. J. Michigan M. Soc, 1956,
 55: 825-827.
 Fries, P. E., Gunne, L. M., Lundgren,  S., Viding,  G.,
 Ohrberg, K.  Orienterande undersokning av chloroprom-
 azinets kliniska och farmakologiska  effekt a psykia-
 triskt klientel.  [Investigation of the clinical and phar-
 macological  effects  of chlorpromazine on psychiatric
 patients.]  Nord. psykiat. medl, Kbh., 1955, 9:192-201.
 Abstract: Excerpta med., Sect. 8,1956, 9: No. 4072.
 Galenko, V. E., Osberg, I. IU., Azbukina, V. D.  Amina-
 zin v psikhiatricheskoi klinike.   [Aminazine in psychi-
 atric practice.]   Zh. nevropat psikhiat., Moskva, 1956,
 56:162-165.
 Gayral, L., Herve, Y., Fourny, L., Carrie, J.  Chlorprom-
 azine et  reserpine dans  la  post-cure  insulinique des
 schizophrenes.    [Chlorpromazine and  reserpine after
 insulin shock therapy  in  schizophrenia.]   Encephale,
 1956, 45: 663-667.
 Gerest, F.  Traitement de Tacces maniaque par  la chlor-
 promazine.   [Chlorpromazine therapy of manic states.]
 Ence'phale, 1956,  45 : 536-540.                        *
 ---, Maisonneuve.  Le traitement de Tacces maniaque.
 [Chlorpromazine therapy of manic states]  Lyon me'd.,
 1954, 86 (1)  :3-15.  Abstract: Excerpta med., Sect. 8,
 1955, 8: No. 3104.
 Gerle, B.  Striking effects of chlorpromazine treatment
 in paranoid  schizophrenia.   Ence'phale, 1956,  45: 687-
 690.
Goldman,  D.  The  effect  of  chlorpromazine on severe
 mental and emotional disturbances.  In:  Chlorproma-
zine and mental health.  Philadelphia, Lea &  Febiger,
 1955. p. 20-40; discussion p. 40-69.
----.  The  influence of chlorpromazine  on psychotic
thought content and mechanism.  Psychiat. Res. Rep.,
 Wash., 1955 (1) :  72-76.
----.  Treatment of psychotic states with chlorproma-
zine.  J. Am. M. Ass., 1955, 157:1274-1278.
55 
Chlorpromazine : Therapeutic use — Psychoses
PSYCHOPHARMACA
Gottlieb, J.  S., Tourney, G.,  Beckett, P. G, Lowinger,
P.  Drug therapy  of  the psychoses.  31 ed.  Clin.  N.
America, 1956, 40:1385-1399.
Gouttebroze, V.  Une annee d'experience de traitement
du delirium tremens; 61 cas recueillis  dans le service
de neuro-psychiatrie de THopital Bellevue, St. Etienne.
[Treatment of delirium tremens; one year's experience
in 61 cases from  the neuro-psychiatric service of the
Hopital  Bellevue,  St.  Etienne.]  85  p.   Lyon,  1955.
[Thesis—Lyon, 1954/1955, no. 94]
Gragg, L.  Chlorpromazine in a state hospital.  J. Ken-
tucky 31. Ass., 1956, 54 : 587-589.
Graves, C. C.  Drug therapy for the emotionally and
mentally disturbed; the psychiatrist's  point  of  view.
J. Ioiva 31. Soc, 1957, 47 :15-16.
Grosz,  H. J.  Dilantin  intoxication, with  a report  of
one case. Am. Practitioner,  1956, 7:1633-1636.
Guiraud, P.   [Intra-osteal (coxal)  injection]  Discus-
sion to: Hamon, Paraire,  Velluz.  Remarques sur Tac-
tion du  4560 R. P. sur Tagitation maniaque.  [Effect of
R. P. 4560 on manic agitation.]  Ann. med.  psychol,
Par., 1952, 110 (1)  : 335.
Hagnell, O.,  Korsfeldt, B., Peterson, B., Widmark,  M.
Chlorpromazinbehandling  vid psykoser.  [Chlorproma-
zine  therapy  of  psychoses.]   [English  summary]
Nord. med., 1955, 53 : 726-730.                       *
Henne,  M., Durand,  V. J.,  Bures, I. de  Important syn-
drome deiirant d'allure paranoide evoluant depuis trois
ans, disparu apres trois semaines de chlorpromazine per
os; analyse critique ecrite de la malade.  [Severe de-
lirium with paranoid traits of three years duration ;  re-
covery after  3 weeks of oral chlorpromazine  therapy;
critical  analysis  written by  the patient.]   Encephale,
1956,  45: 672-676.
Hoch, P. H.  New drug therapy in psychiatry: clinical
uses and abuses in mental  disorders.  Bull.  N. York
Acad. 31., 1957, 33 : 474-486.
---.   Practical  and theoretical  applications of  the
new drug therapies in psychiatry.  A. 31 A. Arch. Neur.
Psychiat. 1956, 75 : 325-328.
Hyvert,  M.  La  chlorpromazine,  traitement  des psy-
choses   chroniques.  [Chlorpromazine  treatment  in
chronic psychoses.]  Ence'phale, 1956, 45:617-627.
---, Fagard, H., Huchon, J.   Premiers resultats  du
traitement par la chlorpromazine d'un nombre impor-
tant  de malades  chroniques.  [Initial  results  with
chlorpromazine treatment of a significant number of
chronic patients.]   Ann. mCd. psychol, Par., 1955, 113
(1) : 645-653.
Janzarik, W.  Zur  Psychopathologie der  Megaphen-
wirkung.  JPsychopathology  of  the effects of  mega-
phen.]  Nervenarzt, 1954,  25:330-335.  Abstract: Ex-
cerpta med., Sect. 8,1955, 8 : No. 1795.
Kasak,  M.,  Schaefer, D.  L., Winter, W.  The  use of
chlorpromazine and  reserpine in a psychiatric hospital:
one year's experience.  Marquette M. Rev., 1955, 21:
17-24.
Kehoe,  M. J., Pollard, J. C.  Some observations on the
minimal effective  dosage  of  chlorpromazine.  J. Nerv.
3Ient. Dis., 1956,123 : 275-280.
Keil, C.  Psychoses et neuropiegiques.   [Psychoses and
neuroplegic drugs.]  Rev.  med. Liege, 1955, 10 :100-102.
Kelley,  J. W.  Thorazine-chlorpromazine.  Nebraska 31.
J., 1954, 39:305-307.  Abstract: Excerpta med., Sect.
8,1955,  8: No. 1797.                                 *
Kielholz, P.  Behandlung von depressiven  und halluzi-
natorischen  Zustanden mit  Largactil, Histamin und
Insulin. [Largactil, histamine  and  insulin therapy of
depressive  and hallucinatory states.]  Schweiz. Arch.
Neur. Psychiat, 1954, 73 : 431-436.  Abstract: Excerpta
med., Sect. 8,1955, 8 : No. 1788.
Kinross-Wright,  V.  Intensive  chlorpromazine  treat-
ment  of schizophrenia.   Psychiat.  Res.  Rep.,  Wash.,
1955 (1) : 53-02.                                    *
     Kokkoris, P., Kordas, P., Nikolopoulos, Yannins, M.
     The results of chlorpromazine treatment with chronic
     psychoses in Dromokaition.  J. Nerv. Ment. Dis., 1957,
     125 : 102-111.
     Kranz, H.  Krankheitsdauer und Recidivhaufigkeit bei
     Chlorpromazinebehandlung endogener Psychosen,  [Du-
     ration of disease and relapse rate of endogenous psy-
     choses treated with chlorpromazine.]  Encephale, 1950,
     45: 628-634.
     Kris, E. B., Carmichael, D. M.  Follow-up study  on pa-
     tients treated with thorazine ; preliminary report.  Am.
     J. Psychiat., 1956, 112 :1022.
     Kurland,  A.  A. Chlorpromazine  in  the treatment of
     schizophrenia ; a study of 75 cases.  J. Nerv. 3Ient. Dis.,
     1955, 121: 321-329.
     Labhardt, F.  Die Largactiltherapie bei Schizophrenien
     und  anderen  psychotischen  Zustanden.   [Largactil
     therapy  in  schizophrenia and other psychotic  condi-
     tions.]  [English  summary, p.   337-338.]  Schweiz.
     Arch.  Neur. Psychiat,  1954,  73:309-338.  Abstract:
     Excerpta med., Sect. 8,1955, 8 : No. 1789.
     Laboucarie, J. Barres, P.,  Rascol, A.  L'action  de la
     chlorpromazine dans  le traitement des psychoses deli-
     rantes systematisees et des schizophrenies.  [Effect of
     chlorpromazine therapy in chronic delirium and schizo-
     phrenia.]  Ence'phale, 1956, 45 : 691-697.
     ----. Rascol, A., Benichou, L. L'action de la chlorpro-
     mazine dans  les schizophrenies.   [Mechanism of  action
     of chlorpromazine in schizophrenia.]  Ann. med.  psy-
     chol, Par., 1954,112 (2) : 751-757.
     Lafon, R., Due, N.,  Labauge, R., Temple, J. P. Le
     traitement du delirium tremens par le 4560  R. P.   [The
     treatment of delirium tremens with 4560 R. P.]  En-
     ce'phale, 1956, 45 :1219-1220.                       *  *
     ---, ----, Ribstein, M., Pages,  H.  Le  traitement des
     syndromes schizophreniques par la 4560 R. P. (chlorpro-
     mazine).  [Treatment of schizophrenic syndromes with
     chlorpromazine.]  Montpellier med., 1954, 46 : 284-291.
     Abstract: Excerpta med., Sect. 8, 1955, 8: No. 3642.
     Lambert, P. A., Toulet, M., Diederichs, A.  L'emploi de
     la chlorpromazine dans le traitement des psychoses de
     Tadulte; en dehors de la cure de sommeil.  [The  use of
     chlorpromazine in the treatment of psychoses in  adults
     (apart from  sleep therapy).] Vie med., Par. 1955, 30:
     799-804.                                            *
     Lecomte, G., Certhaux, A., Garrabe, J.  Chlorpromazine
     en  perfusions  continues  dans quelques  etats psycho-
     patiques.   [Chlorpromazine in continuous perfusion in
     some psychopathic  states.]   Encephale,  1956,  45: 382-
     387.
     Leconte, M.. Barbier, A.  Guerison par Tassociation
     chlorpromazine-reserpine  d'un grave  syndrome  hebe-
     phreno-catatonique datant de 10 ans.  [Combined chlor-
     promazine-reserpine  therapy of a  severe hebephrenic-
     catatonic syndrome of ten years' duration.]  Ann. med.
     psychol, Par., 1956,  114  (2) : 637-645.
     Leon, C. A.  The use of thorazine as an adjunct in the
     treatment of schizophrenia.   Bull  Tulane 31. Fac, 1954,
     14:17-28.
     Lewis, L. F.  The use of chlorpromazine  and of serpasil
     in the treatment of psychotic patients.  Carib.  31. J.,
     Trinidad, 1956, 18 : 51-66.                            *
     Litteral, E. B., Wilkinson, W. E.  The advantages, dis-
     advantages and limitations of the use of chlorpromazine
     as a substitute for  certain somatic treatment methods
     in psychiatry.  Psychiat. Res. Rep.,  Wash,, 1955  (1):
     63-71.                                              *
     Lukomskii, 1.1., Pavlenkova, E. F.  O primenenii  amina-
     zina v psikhiatricheskoi  klinike.   [Aminazine therapy
     in a psychiatric clinic]  Zh. nevropat. psikhiat., Moskva,
     1956, 56: 575-576.
     Margolis, L. H. Pharmacotherapy in psychiatry • a re-
     view.  Ann, N. York Acad. Sc, 1957, 66 • 698-718 '
     ---, Fischer,  A., Butler, R. N.,  Simon,  A.  Clinical
     observations with chlorpromazine.  In : Kline, N. S., ed.

56 
SUBJECT LIST
 Psychopharmacology.  Washington, Am. Ass. Adv. Sc,
 1956.  p. 1-30.
 Maroncelli, P. Trattamento di alcune psicosi con tecnica
 derivata  dall'ibernazione  artificiale.   [Treatment  of
 various psychoses with a technic derived from artificial
 hibernation.]  [English summary.] Gior. psichiat, 1953,
 81: 223-244.  Abstract: Riv. neur., Nap., 1953, 23 : 828-
 829.
 Martin, P., Vidal,  G., Portal, H.  Cures de sommeil et
 4560 R. P. chez les psychopathes dans les  conditions
 habituelles de Thopital psychiatrique.  [Sleep therapy
 and 4560 RP for mental disorders under ordinary psy-
 chiatric hospital conditions.]   Vie m6d., Par., 1954, 35:
 807-810.
 Matarazzo, A.   Sul sonno prolungato e  su Tuso dei
 ganglioplegici in terapia psichiatrica; risultati ottenuti
 in alcuni  malati di mente trattati con  la "cloroproma-
 zina" (largactil o 4560 R. P.).   [Prolonged sleep and the
 use  of ganglioplegic drugs in psychiatric  therapy; re-
 sults obtained with "chlorpromazine" (largactil or 4560
 RP)  in the treatment of mental patients.]  Pisani, 1954,
 68: 599-622.  Abstract: Excerpta med.,  Sect.  8, 1955, 8:
 No.  3100.
 Mendes, F., Galvao, P.  Experiencia clinica com a cloro-
 promazina (4560 R. P.) em psicoses.  [Clinical  expe-
 rience with chlorpromazine (4560 R. P.) in psychoses.]
 [English summary]  J. med.,  Porto, 1955,  26: 149-156.
 Meyer, H. H.  Die Behandlung exogener Psychosen mit
 Phenothiazinderivaten.   [The  treatment of  exogenous
 psychoses with phenothiazine derivatives.]  Ence'phale,
 1956, 45 : 524-527.
 ----.  Die Therapie der  endogenen Psychosen.  [Ther-
 apy of endogenous psychoses.]   Deut. med. Wschr., 1957,
 82: 76-80.
 ----.  Die Winterschlafbehandlung  in  der Psychiatrie
 und  Neurologie.   [Hibernotherapy in  psychiatry and
 neurology.]  Deut. med. Wschr., 1953, 78: 1097-1100.
 ----,  Schmitt, W.,  Kieser, J.  Das  Delirium tremens.
 [Delirium tremens.]   Deut. med.  Wschr.,  1955, 80:
 1389-1391.
 Miles, J.  Largactil and  occupational therapy.  Canad.
 ■J. Occup. Ther., 1956, 23 :11-13.
 Miles, J. E.  Psychosis with phantom limb pain treated
 :by cMorpromazine.  Am. J. Psychiat.,  1956, 112:1027-
 1028.
 Morgan, D.  R.  Chlorpromazine  and reserpine in the
 treatment of  chronic mental illness.  Med.  J. Australia,
 1956, 43 (2) : 57-62.
 ----.  The combined use of chlorpromazine  and reser-
 pine in the treatment of chronic  mental illness:  a pre-
 liminary report.  31 ed.  J. Australia, 1955, 42 (2) : 77-80.
 Abstract:  Excerpta med., Sect.  8,  1956, 9: No. 1728.
 Munch-Petersen, S.  Chlorpromazine (largactil)  in the
 management of psychotic patients. Acta psychiat. neur.
 scand., 1955, 30:643-658.   Abstract:  Excerpta  med.,
 Sect. 8,1956, 9 : No. 5009.
 Nuzum, J. W.  The successful  treatment of a  post-
 gastrectomy  schizophrenic  psychosis  with   chlorpro-
 mazine; report of a case.  Am.  Practitioner, 1955, 6:
 1849-1851.
 Pachter, M.  A clinical  evaluation  of  chlorpromazine
 therapy in chronic schizophrenics.  Am. J.  Psychiat.,
 1957,113 : 931.
 Patton, G. O., Garneau, J.  The ataraxic drugs in dis-
 turbed secluded psychiatric patients.   Canad. Serv. M.
 J., 1957,13 :127-133.
 Perret, A., Becker, J., Lacoste, G.  Traitments psychi-
 atriques par le 4560 R. P.   [Psychiatric treatments with
 4560 RR]  Vie med.,  Par., 1953, 34:463-464.
Perrin, J., Diedrichs.   Essai d'evaluation de la valeur
 therapeutique de la chlorpromazine chez 1,400 malades
 mentaux   internes.  [Evaluation  of   chlorpromazine
therapy  in 1400  hospitalized mental  patients.]   Ence-
phale, 1956, 45: 609-613.

                                                      57
Chlorpromazine : Therapeutic use — Psychoses
---, Toulet, M.  Utilisation de la chlorpromazine dans
le traitement des psychoses chroniques.  [Use of chlor-
promazine in  the  treatment of chronic  psychoses.]
Encephale, 1956, 45:1210-1218.
Persson, I. Klorpromazin  ved arteriosclerotisk sinds-
sygdom  og  dementia  senilis.   [Chlorpromazine  in
therapy of arteriosclerotic psychosis and senile  demen-
tia.]   [English  summary]  Nord. med., 1955, 53: 235-
237. Abstract: Excerpta med., Sect. 8,1955, 8: No. 3897.
Petelski, M.  Wyniki leczenia largaktylem 109 chorych
na schizofrenie  (67 kobiet i 42 mezczyzn).   [Results of
largactil therapy of schizophrenia in 109 patients (67
women and  42  men).]  [English  summary]  Polski
tygod.  lek., 1956, 11: 1366-1370.
Phillip, E. Erfahrungen  mit Megaphen in  der  Behan-
dlung  psychisch Erkrankter.  [Experience with mega-
phen in the treatment of the mentally ill.]  Nervenarzt,
1955,   26:59-65.   Abstract: Excerpta  med., Sect. 8,
1956, 9 : No. 4075.
Piekarska, A.  W  sprawie stosowanta largaktylu w
leczeniu  chor6b psychicznych;   doniesienie pierwsze.
[Largactil therapy in psychic disorders;  preliminary
report.]   [English summary]   Neur. &c. polska, 1955,
5: 623-635.
Racamier, P. C, Baudrand, C.  Les cures prolongees et
continues de chlorpromanzine a Thopital psychiatrique.
[Prolonged and continued therapy with chlorpromazine
in  the psychiatric hospital.]  [Abstract]  Ann. me'd.
psychol, Par., 1954 112 (2) : 449-450.
---, Blanchard, M.,  Baudrand,  C. Les   cures  pro-
longees de chlorpromazine  dans  les  etats schizophren-
iques.   [Prolonged chlorpromazine  therapy in schiz-
ophrenic reactions.]   Ence'phale,  1956, 45 : 647-655.
Rees,  E.  L.,   Metabolism  of the schizophrenic child;
etiologic hypothesis.  Report of  six  cases treated with
chlorpromazine hydrochloride.  J. Am. M. Women Ass.,
1956, 11:11-16.
Revol,  L.  Chlorpromazine  et intoxication  alcoolique.
[Chlorpromazine and  alcoholic   intoxication.]   Lyon
pharm., 1954, 5 : 349-350.
Riesenman, F.  R.  Chlorpromazine.  Med.  Ann,  Dis-
trict of Columbia, 1956, 25 : 258-260.
Rivas,  M.  La terapia  cloropromazinica  prolungata
ad alte dosi in psichiatria.  [Prolonged chlorpromazine
therapy with massive doses in psychiatry.]   Ence'phale,
1956, 45: 469-470.
Rondepierre, J., Hivert,, P. H., Honore, B.,  Vaugelade,
S.  Resultats favorables obtenus  par les neuroleptiques
dans les psychoses de facheux pronostic.   [Favorable
results obtained with neuroleptics in psychoses  of poor
prognosis.]  Ann. med. psychol,  Par.,  1955, 113  (2) •
853-859.
Rouvroy, M.  Remarques concernant le traitement des
psychoses  chroniques.  [Remarks on  the  therapy of
chronic psychoses.]  Encephale,  1956, 45:707-708.
Sabshin, M.,  Ramot,  J.   Pharmacotherapeutic  evalua-
tion and the psychiatric setting.   A. M. A. Arch. Neur
Psychiat, 195(5, 75 : 362-370.
Saglia, N.   Osservazioni di  carattere tecnico  sulla
terapia degli schizofrenici cronici con  cloropromazina.
[Technical observations on chlorpromazine therapy in
chronic schizophrenia.]   Arch,   psicol neur.,   Milano
1956, 17 : 634-635.
Sanguineti, I.,  Laricchia, R. La  chlorpromazine dans
les maladies mentales;  indications  de son emploi et
limites de son efficacite therapeutique. [Chlorpromazine
in mental disorders;  indications  for its use and limits
of its therapeutic effiicacy.]  Encephale, 1956, 45 • 1197-
1203.
---»---> Negri, V.  SulTimpiego di un derivato della
fenotiazina nella  cura delle  malattie  mentali.  [The
use of a phenothiazine derivative in the treatment of
mental diseases.]   Acta  neur.,  Nap.,  1953,  8:801-823.
Abstract: Excerpta med., Sect. 8, 1954,  7: No. 3806. 
Chlorpromazine : Therapeutic use — Psychoses
PSYCHOPHARMACA
Santangelo, G.  Modificazioni indotte dal trattamento
reserpinico  protrato  sulla  sintomatologia  psichica  e
comportamentale nelle schizofrenie  croniche.  [Modi-
fications induced by prolonged reserpine treatment on
psychic symptomatology and behavior in chronic schiz-
ophrenia.]   [English  summary]  Arch, psicol  neur.,
Milano, 1956,17: 388-393.
Sarro, R.  Recent developpements de la therapeutique
narcobiotique.  [Recent developments  in  narcobiotic
therapy.]  Ence'phale, 1956, 45:501-510.
Schneider, G.  Les cures prolongees a la chlorpromazine.
[Prolonged chlorpromazine therapy.]   Ence'phale, 1956,
45:372-376.
Seager, C. P.   Chlorpromazine in treatment of elderly
psychotic women.  Brit. M. J., 1955, 1: 882-885.  Ab-
stract : Excerpta  med., Sect. 8, 1956, 9: No. 1727.
Segerath, F.  Uber Erfahrungen mit der Megaphenbe-
handlung in der  Psychiatrie.  [Experience with  mega-
phen treatment in  psychiatry.]   3Iiinch. med. Wschr.,
1954, 96:260-261.
Sereiskii, M.  IA., Tolmaskaia, E. S., Golodets, R. G.,
Samter, N. F.  Lechenie bol'nykh shizofreniei aminazi-
nom.  [Treatment  of schizophrenia  with aminazine.]
Zh. nevropat.  psikhiat, Moskva,  1956, 56:155-161.
Sigwald, J.,  Henne,  M.  L'utilisation  des  proprietes
neuropiegiques de la chlorpromazine dans le traitement
de  divers cas de psychoses deiirantes  chroniques et
subaigues.  [Utilization of the neuroplegic properties of
chlorpromazine in  the  treatment of  various cases of
chronic and subacute delusional psychosis.]  Sem. hop.
Paris, 1954, 30: 2978-2984.   Abstract: Excerpta med.,
Sect. 8,1955, 8: No. 3641.
Sikes, Z. S.  Korsakoff and Wernicke syndromes:  his-
tory  and treatment.   J. Nerv.  3Ient. Dis., 1956, 123:
448-451.
Silver, A.  A.  Management of children with schizo-
phrenia.  Am. J. Psychother., 1955, 9:196-215.
Silverberg, J.  W., Gralnick,  A.  Possible  synergistic ac-
tion of chlorpromazine, reserpine and frenquel.  A pre'
liminary report.  Am. J. Psychiat, 1957, 114:173.
Simonetti, L.  I  neuroplegic!  nel  trattamento  delle
psicosi confusionali acute.   [Neuroplegic drugs in the
treatment of  acute confusional  psychoses.]   [English
summary]   Neuropsichiatria, 1954,  10:265-275.   Ab-
stract : Excerpta  med.,  Sect. 8, 1955, 8: No. 3640.
Sinsi, C, Vizioli, R.   Chlorpromazina e reserpina in
terapia psichiatrica.  [Chlorpromazine and reserpine in
psychiatric   therapy.]    [English   summary]    Osp.
psichiat., Nap., 1955, 23: 83-96.
Sizaret,  P.   La  chlorpromazine dans  les  psychoses
aigues alcooliques.  [Chlorpromazine  in acute alcoholic
psychoses. ]  Ence'phale, 1956, 45 : 736-738.
----, Salomon, F. Action d'un neuroplegique sympathi-
colytique dans les etats confusionnels alcooliques.  [Ef-
fects of  a neuroplegic sympatholytic on alcoholic con-
fusions.] Ann. mCd. psychol, Par., 1953, 111 (1) : 88-92.
Skliarenko, E. A.  O  primenenii aminazina  v psikhia-
tricheskoi praktike; pradvaritel'noe soobshchenie.  [Use
of aminazine in psychiatric practice; preliminary com-
munication.]   Zh. nevropat.  psikhiat., 3Ioskva, 1956, 56:
166-171.
Souder, C. L.  Thorazine in surgical-psychiatric  emer-
gencies.  Delaware M. J., 1955, 27 :191-193.
Spinka, I. E.  Thorazine in the treatment of mental ill-
ness  in  a state  hospital.   Illinois  M.  J.,  1956, 109:
126-128.  Condensed : Am.  Practitioner, 1956, 7:1433.
Staehelin, J. E.  Einige allgemeine Bemerkungen fiber
die Largactiltherapie in der psychiatrischen  Universi-
tatsklinik Basel.  [General comments on largactil ther-
apy at the Basel University psychiatric clinic] Schweiz.
Arch. Neur. Psychiat, 1954,  73 : 288-291.  Abstract: Ex-
cerpta med., Sect. 8,1955, 8 : No. 1787.
Thai, N.  Clinical evaluation of chlorpromazine therapy
for psychiatric disorders.  Northwest M., 1956, 55: 653-
656.
  Thiebaux, M., Boyer, R.  Le 4560 RP  (largactil)  en
  therapeutique psychiatrique.  A propos de quelques ob-
  servations.  [Experiences with 4560 RP  (largactil) in
  psychiatric therapy.]  [Abstract]   Ann. me'd. psychol,
  Par., 1953, 111 (2) : 84.
  Tuteur, W., Stiller, R., Whitehill, O., Lepson, D. Results
  with chlorpromazine and reserpine on chronically nude,
  untidy, destructive  and combative  patients: their sus-
  tained improvement after  discharge  with continued
  medication.  Am. J. Psychiat., 1956, 112: 741.
  Ugelstad, E.   Chlorpromazine treatment in senile psy-
  choses.  Acta psychiat. neur. scand., 1956,  Suppl. 106:
  60-62.
  Ushakov,  G.  K., Kislenkov,  V. A., Grigorova, E. V,
  Verbliunskaia, A. A.  O kupirovanii aminazinom psik-
  homotornogo vozbuzhdeniia.   [Treatment  of psycho-
  motor excitation  with  aminazine.]   Zh.   nevropat.
  psikhiat, Moskva, 1956, 56 : 571-574.  Abstract: Chem,
  Abstr., 1956, 50:17178e.
  Vogt, W.  Beitrag zum klinischen  Vergleich  der Wir-
  kung von Largactil und Serpasil.  [Clinical comparison
  of the effects  of largactil and serpasil.]   Schweiz. Arch.
  Neur. Psychiat., 1956, 77: 330-336.
  Walther-Biiel, H.  Zur klinischen Therapie der endo-
  genen  Psychosen.   [On clinical therapy of endogenic
  psychoses.]  Nervenarzt, 1954, 25:191-194.
  Wardt-Kikkert,  N.  M. van  de,  Rentmeester, J.  Het
  largactil en zijn  toepassing in de psychiatrie.  [The use
  of largactil  in psychiatry.]  Geneesk.  gids, 1953, 31:
  499-507.
  Winnik, H. Z., Tennenbaum, L.  Largactil in psychiatric
  treatment.   [English summary]  Harefuah,  Tel-Aviv,
  1954, 47:95-100.
  Yohe, C.  Preliminary report on eighteen months' ex-
  perience  with chlorpromazine  at  the  Yankton  State
  Hospital, Yankton,  South Dakota.  S. Dakota J.  M.,
  1956, 9 : 59-62 ; 74.
  Zurabashvili, A. D.  Ob osnovnykh voprosakh  terapii
  shizofrenii.   [Basic  problems   in  the  treatment  of
  schizophrenia.]  Zh. nevropat. psikhiat., Moskva, 1956,
  56:605-611.

—Psychosomatic diseases

    see also CHLORPROMAZINE— Various special tech-
     niques—Therapeutic use—Psychosomatic diseases
  Antonelli, F.   Applicazione della cloropromazina nella
  pratica reumatologica, con particolare riferimento alia
  nevrosi reumatica.   [Application of chlorpromazine in
  rheumatology,  with  special reference to  rheumatic
  neurosis.]  Arch, psicol. neur.,  Milano, 1956, 17:558-
  561.
  Archibald, H. C. Chlorpromazine  for  headache.  Am.
  J. Psychiat., 1955,112: 390.
  Argelander, H.  Ein Behandlungversuch mit Megaphen
  bei  vegetativen  Neurosen.  [Therapeutic  trial  with
  megaphen  in autonomic neuroses.]  Aerztl.  Wschr.,
  1954, 9: 634-639.  Abstract: Excerpta  med..  Sect.  8,
  1955, 8: No. 2817.
  Asher, L. M.  Use  of chlorpromazine in treatment of
  certain gastrointestinal disturbances;  preliminary  re-
  port.  J. Am. 31. Ass., 1956, 160:1281-1285.           *
  Cahn, M. M.  The use of tranquilizing  drugs in derma-
  tology; review and  side reactions.  J.  Albert Einstein
  M. Center, 1956, 4 :161-165.
  Chlorpromazine. Cancer Bull  Texas,  1956 8 • 47
  Delay, J. Deniker, P., Tardieu, Y.  Resultats de Thiber-
  notherapie dans trois affections psychosomatiques.  [Re-
  sults  of  hibernotherapy  in  three psychosomatic  dis-
  eases.]  Ann, m6d. psychol, Par., 1953, 111 (2) • 224-227.
  Dobkm A. B., Lamoureux, L., Letienne, R., Gilbert, R.
  G. B. Some  studies with largactil.   Canad  M A^
  J., 1954, 70: 626-628.                   vanaa. M. Ass.

  Fabricant, N. D.  Tension headache therapeutics  Eue
  Ear dc Month., 1956,35 : 658;  662.     eidI»e«ucs.  &ye,
58 
SUBJECT  LIST
Chlorpromazine : Untoward effects
Friedman, A. P., Von Storch, T. J. A review of head-
ache,  1950-1955.  N. York State J. M., 1956, 56: 3883-
3895.
Friend, D. G.,  Cummins, J. F.  New antiemetic drug.
J. Am. M. Ass., 1954,153 : 480-481.
Graham, J. R.  Headache.  D3I, January: 1-45.
Guilly, P. Formes cliniques et traitement de Tinsomnie.
[Clinical  forms  and  treatment  of  insomnia.]  Rev.
prat., Par., 1954, 4: 1571-1581.
Guiral, R. J.  Uso de la chlorpromazina en las distonias
vegetativas de  tipo psicosomato.   [Use of  chlorproma-
zine in the psychosomatic type of autonomic dystonias.]
Ence'phale, 1956, 45: 541-546.
Gutenkauf,  C.  Internal  medicine.  In:  "Happiness
pills"  in medical practice: a symposium.  J. Iowa M.
Soc, 1957, 47: 59-64.
Howell, T. H., Harth, J. A. P., Dietrich, M.  The use of
chlorpromazine  in  geriatrics.    Practitioner,  Lond.,
1954,  173:172-173.
Korting, G. W., Borelli, S., Kimmig, J.  Welche Bedeu-
tung besitzen die Phenothiazine fur die Behandlung von
Hautkrankheiten?  [Of  what  significance  are pheno-
thiazines in  the  treatment of  skin diseases?]  Derm.
Wschr., 1956, 134 :1245-1252.
Linke, H.  Erfahrungen  in der Behandlung akuter und
chronischer Schmerzzustande  mit den Phenothiazin-
korpern  Megaphen und  Atosil.   [Experiences in  the
treatment of acute and  chronic pain states with  the
phenothiazine derivatives megaphen and atosil.]  [Eng-
lish summary.]  Munch, med. Wschr., 1955, 97:1689-
1692.
Loewenthal, L. J. A.  Chlorpromazine in dermatological
practice.  Med. Proc, Johannesb., 1955, 1:  122-125.
McCullagh, W. H., Ingram, W., Jr. Headaches and hot
tempers.  Dis. Nerv. Syst., 1956,17 : 279-281.
MacKenzie-Van der Noordaa, M.  C.  Depressie na ge-
bruik van reserpine wegens essentiele hypertensie.  [De-
pression after reserpine therapy of essential hyperten-
sion.]  [English summary]  Ned.  tschr. geneesk., 1956,
100:1003-1004.
Mitis, Z. K., Ford, H.  Functional  headaches. Texas J.
M., 1956, 52 : 678-683.
Monaco, R. N.,  Leeper, R. D., Robbins, J. J., Calvy, G. L.
Intermittent  acute porphyria treated with chlorproma-
zine.   N. England J. 31., 1957, 256:309-311.
Ogden H. D.  Headache.  Ann. Allergy, 1956,  14:385-
428.
Pellerat, J.   Un  nouveau medicament  sedatif et  anti-
prurigineux.   [A new sedative and antipruritic drug.]
Lyon me'd., 1953, 85 (1) : 270.
___,  Teichner, Y.  La chlorpromazine  (4.560 R. P.) en
dermatologie.   [Chlorpromazine  (4560 RP) in derma-
tology.]  J. med. Lyon, 1953, 34: 611-618.            *
Pinakapani, S., Haranath, P. S. R. K.  Chlorpromazine
in the treatment of hiccough and emesis. Ind. J. M. Sc,
1955,   9: 764-766.   Abstract:  Excerpta med.,  Sect.  8,
1956^  9 : No. 3421.
Racz,  S., Gallai, Z.  Angaben zur Rolle des Largactils
bei der Behandlunng einiger  Hautkrankheiten.  [Role
of largactil in  the treatment of several skin diseases.]
Derm. Wschr., 1956, 134: 770-773.
Reiss, F. Psoriasis and  stress.  Dermatologica, Basel,
1956,113:71-78.
Rossini,  R., Dazzi, P.  Sindromi psichiche nel morbo di
Basedow  e  tiroidectomia;  efficacia  terapeutica  della
cura del sonno.  [Psychic syndromes in Basedow's dis-
ease and thyroidectomy; effectiveness of sleep therapy.]
Gior.  din. med., 1953, 34:1018-1028.  Abstract: Riv.
neur., Nap., 1954, 24: 305.
Sapir, M., Stroun, J., Hepner, L., Reverchon, J., Selzer, S.
A propos de Taction psycho-somatique de la chlorproma-
zine et de la reserpine.  [Psychosomatic action of chlor-
promazine and  reserpine.]   Ence'phale, 1956,  45:488-

493.
  Schnyder U. W., Schauwecker, R.  Largactil und Serpa-
  sil in der Dermatologie.   [Largactil and  serpasil in
  dermatology.]   [English  summary]   Dermatologica,
  Basel, 1955, 111: 185-197.
  Sercl, M., Bartousek,  V.,  Jachova, D.   Experiences
  cliniques sur la neuroplegique et Thibernation dans les
  affections du systeme nerveux.  [Clinical experiences
  with neuroplegia and hibernation in diseases of the ner-
  vous system.]  Gaz. me'd. France, 1956, 63 :1981-1982 ;
  1984; 1987-1988.
  Stewart, R. H. The use of tranquilizing drugs in gyne-
  cology.  West. J. Surg., 1956, 64: 650-657.
  Teichner, Y.  Etudes d'un nouveau derive de la pheno-
  thiazine (chloropromazine—4560 R. P.) en dermatologie.
  [A new  phenothiazine derivative (chlorpromazine 4560
  R. P.) in dermatology.]   74 p.  [Mimeographed] Lyon,
  1953.  (Thesis—Lyon, 1952/1953 no.  117)
  Tilley, R. F., Barry, H., Jr.   Chlorpromazine treatment
  for  relief  of itching in severe and  refractory neuro-
  dermatitis.  N. England J. M., 1955, 252 : 229-230.
  Vernet,  A., Genevard, G. Applications de la chlorpro-
  mazine  en pratique medicale courante  et en medecine
  psychosomatique.   [Uses of chlorpromazine in current
  medical practice and in psychosomatic medicine.]  [Ger-
  man summary]  Praxis,  Bern, 1956, 45:  385-389.  Ab-
  stract : Excerpta med., Sect. 8, 1957, 10: No. 1400.

—Terminology
  see CHLORPROMAZINE—Terminology of therapies

Untoward effects [see headnote p. 19]
  see also CHLORPROMAZINE—Various  special  tech-
             niques—Untoward effects
           PHENOTHIAZINES—Untoward effects
  Andersen,  H.  Leucopeni under  Largactilbehandling.
  [Leukopenia  with chlorpromazine  therapy.]   Ugeskr.
  laeger, 1954, 116 :1733-1734.
  Ayd, F. J., Jr. A clinical  evaluation of frenquel.  J.
  Nerv. Ment. Dis., 1956,124 : 507-509.
  ----. The dermatologie and systemic manifestations
  of chlorpromazine hypersensitivity; their clinical sig-
  nificance and management.   J. Nerv. 31ent. Dis., 1956,
  124:84-87.                                      * *
  ----. Physiologic and  neurologic responses  to chlor-
  promazine : their clinical significance and  their manage-
  ment.  Psychiat. Res. Rep., Wash.,  1956 (4) : 64-70.
  ----. Fatal hyperpyrexia during chlorpromazine ther-
  apy.  J. Clin. Exp. Psychopath., 1956,17:189-192.  *  *
  Blood dyscrasias  associated with chlorpromazine ther-
  apy. J. Am. 31. Ass., 1956, 160: 287.               *  *
  Boardman, R. H.  Fatal case of  toxic hepatitis impli-
  cating chlorpromazine.  Brit. 31. J., 1954, 2 : 579.   *  *
  Boleman,  A. P.  Agranulocytosis associated with ad-
  ministration of thorazine.  J. Am.  M.  Ass., 1955,  157:
  364.                                            *  *
  Borel, J., Lacombe, J., Camar, R.  Les poussees de rhum-
  atisme  chronique  pendant la cure de largactil.  [At-
  tacks of chronic rheumatism during largactil therapy.]
  Ence'phale, 1956, 45: 813-817.
  Briggs, G. W., Petersen, J. R.  Agranulocytosis occur-
  ring  during chlorpromazine therapy: a case  report.
  Am. Practitioner, 1956, 7:1431-1432.
  Carey,  J. B., Magraw,  R.  M.  Agranulocytosis  with
  chlorpromazine.  Am. J. Psychiat., 1956, 112:565.
  Cohen,  I. M.  Complications of chlorpromazine therapy.
  Am. J. Psychiat., 1956,113 :115-121.
  ----.  Undesirable effects and clinical toxicity of chlor-
  promazine.  J. Clin.  Exp.  Psychopath.,  1956, 17:153-
  163.
  Craddock, W. L.   Toxic effects of chlorpromazine; he-
  patitis and agranulocytosis.  U. S. Armed Forces M. J.,
  1956, 7:1726-1740.                               * *
  Dean, S. R.  Ataractics.  Am. J. Psychiat., 1956, 112:
  850.
59 
Chlorpromazine : Untoward effects
PSYCH0PHAR3IACA
 Denber, H. C. B.  Appraisal of drug reactions.  J. Am.
 31. Ass., 1955,158: 586-587.
 Donnadieu, A., Florentin, M., Florentin.  Les incidents
 au cours  du traitement des troubles  mentaux par le
 largactil.  [Incidents during  chlorpromazine therapy
 of  mental disorders.] Ann. me'd. psychol, Par.,  1955,
 113 (2): 205-216.  Abstract:  Excerpta med., Sect. 8,
 1956, 9 : No.  4555.
 Drugs and driving.   J. Am. 31. Ass., 1954, 156: 628-629.
 Elliott, R. N., Schrut, A. H., Marra, J. J.  Fatal  acute
 aseptic necrosis of the liver associated with  chlorproma-
 zine.  Am. J. Psychiat, 1956,  112: 940.             * *
 Essig, C. F., Carter, W. W.  Convulsions and bizzare be-
 havior in  monkeys  receiving chlorpromazine.   Proc.
 Soc. Exp. Biol, N. Y.,  1957, 95: 726-729.
 Ey, H. Faure, H. Rappard, P.  Les reactions d'intol-
 6rance vis-H-viz de  la chlorpromazine.  [Chlorproma-
 zine intolerance.]  Ence'phale, 1956, 45 : 790-796.
 Farber,  I. J. Drug fatalities.  Am. J. Psychiat., 1957,
 114:371-372.                                    * *
 Farley, O. R.  Complications and concomitants.  Med.
 Ann. District of Columbia,  1956, 25: 263-267.       * *
 Fazekas, J. F., Shea,  J. G., Ehrmantraut, W. R., Alman,
 R.  W.  Convulsant action of phenothiazine  derivatives.
 J. Am. M. Ass., 1957, 165: 1241-1245.
 Fernandes, B., Leitao, G.  Incidents  and accidents in
 chlorpromazine therapy.  J.  Clin.  Exp. Psychopath.,
 1956, 17: 70-76.
 Friedgood,  C.  E.,   Ripstein,  C.  B.  Chlorpromazine
 (thorazine)  in the  treatment of  intractable hiccups.
 [inducing depression]  J. Am. M. Ass., 1955, 157: 309-
 310.
 Friend, D. G, McLemore,  G.  A., Jr.   Some abuses  of
 drugs  in therapy.  N. England J. 31., 1956, 254:1223-
 1231.                                            * *
 Fullerton, A. G. Psychiatric uses of  meratran.  J. 3Ient.
 Sc, Lond., 1956, 102 : 801-804.
 Goldman,  D.  Agranulocytosis associated with admin-
 istration of chlorpromazine.  Report of three cases with
 description of treatment and recovery.  A.  M.  A.  Arch,
 Int. 31., 1955, 96:496-499.   [Fourth patient * *]
 ---.  The major complications of treatment of psy-
 chotic states with chlorpromazine  and reserpine and
 their management.   Psychiat. Res. Rep., Wash., 1956
 (4) :79-88.
 Hodges, H.  H., LaZerte, G. D.  Jaundice and agranu-
 locytosis  with fatality following chlorpromazine  ther-
 apy.  J. Am. M. Ass., 1955, 158:114-116.         * *
 Hollister, L.  E.  Complications from the use of tranquil-
 izing drugs.  N. England J. 31., 1957, 257 :170-177.   * *
 ----.  Unexpected  asphyxial  death and tranquilizing
 drugs.  Am. J. Psychiat, 1957, 114: 366-367.       * *
 Holmes, C. R.,  Stone, H. M.  Agranulocytosis due  to
 chlorpromazine; report of a case with recovery.  J. S.
 Carolina 31. Ass., 1956, 52 : 42^5.
 Horbaczewski,  J.   Agranulocytosis  associated  with
 chlorpromazine therapy.  Canad. 31. Ass. J., 1956, 75:
 412^15.                                         * *
 Hussar,  A. E.  Complications of chlorpromazine and
 reserpine therapy.  GP, 1957, 15 (5) : 85-93.
 Jacobson,  A.  Ritalin—a new agent for mild depres-
 sions ;  a  preliminary report.  31ed. Ann.  District  of
 Columbia, 1956, 25 : 491^94; 527-528.
 Kinross-Wright, V.   Complications  of chlorpromazine
 therapy.  Dis. Nerv. Syst., 1955, 16:114-119. Abstract:
 Excerpta med., Sect. 8,1956,  9: No. 2232.
 Kramer, M.  Facts needed to assess public health and
 social problems in the widespread use of the tranquiliz-
 ing drugs.  Pub. Health 31onogr., 1956 (41) : 1-31.
 Krasilowsky, D.  Complications observed in 50 mental
 patients treated with  largactil.  [In  Hebrew]  [English
 summary p.  III-IV]   Dapim  Refuiim, 1955,  14: 225-
 228. Abstract: Excerpta med., Sect. 8,1956,  9 : No. 4553.
Kruse, W.  "Paradoxical" effect of chlorpromazine in a
case of periodic catatonia. Am, J. Psychiat, 1957, 114:
463-464.
Lafon, R., Due, N., Labauge, R., Temple, J. P.  Incidents
et accidents lies a Temploi de la chlorpromazine.  [In-
cidents and accidents with the use of chlorpromazine.]
Ence'phale, 1956 : 45 : 1226-1228.
Lambert, P.,  Barnaud,  J.  Apparition  de  deux syn-
dromes meiancoliques au  cours de  traitements  par le
45.60 RP.  [Occurrence  of two melancholy  syndromes
during treatment with 4560  RP.]   [Abstract]  J. m4d.
Lyon, 1954, 35 : 951.
Lambert, P. A., Diederichs, A., Toulet, M.  Incidents et
complications des traitements par  la chlorpromazine
employee insolement  chez  Tadulte.   [Incidents  and
complications of treatments  with chlorpromazine used
alone in  adults.]  Encephale, 1956, 45: 1229-1247.
Lemere,  F.   New  tranquilizing drugs.  Northwest 31.,
1955, 54:1098-1100.
Loftus, L. R., Huizenga, K.  A., Stauffer, M. H.,  Rome,
H. P., Cain, J. C.  Jaundice  caused by chlorpromazine
(thorazine).   J. Am.  31. Ass., 1955,  157: 1286-1288.
Lomas, J. Agranulocytosis during chlorpromazine ther-
apy. Brit. M. J., 1954, 2 : 358-359.
---, Boardman, R. H., Markowe, M.  Complications of
chlorpromazine therapy in 800 mental-hospital patients.
Lancet, Lond.,  1955, 1:1144-1147.  Abstract: Excerpta
med,, Sect. 8, 1956, 9 : No. 4076.
Mitchell, P. H., Sykes, P., King, A. Effects  of pacatal
on symptoms in chronic psychotic  female in-patients.
Brit. M. J., 1957, 1: 204-207.
Montassut, M., Chertok, L.,  Leroy,  C.  Crise comitiale
et alterations electroencephalographiques au cours d'un
traitement  par chlorpromazine.  [Epileptic crises and
electroencephalographic changes during chlorpromazine
therapy.]  Ann. med. psychol, Par.,  1955, 113  (1) : 804-
807.
Moyer, J. H.  The  pharmacology  of chlorpromazine.
Internal Rec. M., 1955,168 : 301-311.
Munch-Petersen,  S.  Et  tilfaelde  af  agranulocytose
under largactilbehandling. [An incident of agranulocy-
tosis during  largactil  therapy.]  Ugeskr.  laeger, 1954,
116:1787.
Pauly, R.  Nouvelle note sur les dangers de la  thera-
peutique par le largactil.  (A propos d'un infarctus du
myocarde survenu  au cours d'une  cure  ambulatoire.)
[Additional note on the danger of chlorpromazine ther-
apy.   (Myocardial infarct in the course of ambulatory
treatment.)]   J. med. Bordeaux,  1954, 131: 5S7-588.
Perrot, R. M., Moreau-Gaudry, G., Le Borgne, Y.  Man-
ifestations cardiaques d'hypokaliemie dans la cure a la
chlorpromazine.  [Cardiac manifestations of hypokale-
mia  in  chlorpromazine  therapy.]   Presse me'd., 1956,
64: 2076.
Pollack,  B.   Recurrent  thorazine-induced agranulocy-
tosis. Am. J. Psychiat.,  1956, 113: 557-558.
Prokopowycz,  V.   Agranulocytosis  following  use of
chlorpromazine therapy.   J. Am. 31. Ass.,  1955, 157:
1042. Also as: Agranulocytosis following chlorproma-
zine  therapy.  J. 3Iichigan 31. Soc, 1955, 54:1468.  *  *
Raskin, N.   Agranulocytosis in patients  treated with
thorazine;  report  of  a fatal case.   Am.  J. Psychiat.,
1957, 113: 991-992.                                *  *
Rea, E. L., Shea, J., Fazekas, J. F.   Hypotensive action
of chlorpromazine.  J. Am.  31. Ass., 1954,  156:1249-
1250.                                            *  *
Roberts,  S. E.   A chlorpromazine  (thorazine)-induced
cephalalgia and its management.  A. 31. A. Arch. Otolar.,
1956, 63: 208-209.
Robie, T. R.  Pseudo-tabes syndrome as complication of
tranquilizer drug therapy. Am. J. Psychiat, 1956, 113:
463-464.
Roebuck, B. E.  Agranulocytosis associated with chlor-
promazine therapy.  J. Nerv. 3lent. Dis., 1956, 124: 248-
250.                                              *  *
60 
SUBJECT LIST
Chlorpromazine: Various special techniques —
          Compared with chlorpromazine alone
  Ross, W.  D.  Mistakes in the use of chlorpromazine.
  Ohio 31. J., 1957, 53 :182-183.                      * *
  Rotstein, J., Frick, P. S., Schiele, B. C. Agranulocytosis
  associated with chlorpromazine therapy.  A. M. A. Arch.
  Int. 31., 1955, 96: 781-786.
  Samad, I.  A.  Complications of chlorpromazine therapy.
  Lancet, Lond., 1955,1:1327.
  Sarwer-Foner, G. J., Ogle, W.  Psychosis and enhanced
  anxiety produced by  reserpine and chlorpromazine.
  Canad. M. Ass. J., 1956, 74: 526-532.
  Schadelijke  bijwerkingen van  largactil.  [Untoward
  side effects of largactil.]   Ned. tschr. geneesk., 1955, 99:
  2537-2538.
  Schick, G., Virks, J.  Agranulocytosis associated with
  chlorpromazine therapy;  report  of a case  and review
  of the literature.   N. England J. M., 1956, 255: 798-802.
  Schlichther, W., Bristow, M. E., Schultz, S., Henderson,
  A. L.   Seizures occurring during intensive chlorproma-
  zine therapy.  Canad. M. Ass. J., 1956, 74 : 364-366.
  Stenback, A.  Psykiatrisk klorpromazinbehandling med
  letalt  forlopp.  [Psychiatric  chlorpromazine therapy
  with fatal outcome.]  [English summary)   Nord. med.,
  1956, 56: 1622-1623.                               * *
  Tasker, J. R. Fatal agranulocytosis during treatment
  with chlorpromazine.  Brit. M. J., 1955, 1: 950-951. * *
  Tatum, A. L.  Complications of chlorpromazine therapy
  in 800  mental hospital patients.  Wisconsin M. J., 1955,
  54: 521.
  Theriault, J. C.  A fatality associated with chlorproma-
  zine (largactil)  therapy.  Canad. M. Ass. J., 1956, 74:
  148-149.                                         * *
  Tillim, S.  J.  Agranulocytosis associated with chlorpro-
  mazine therapy.   Am. J. Psychiat., 1956, 112:1028.
  Tintera, J.  W.  Office rehabilitation of  the alcoholic.
  N. York State J. M., 1956, 56: 3896-3902.
  Tuteur, W.  A case of fatal agranulocytosis due to chlor-
  promazine.  Am. J. Psychiat., 1956, 113 : 76.        * *
  ----,  Lepson, D. Combined  reserpine-chlorpromazine
  therapy in highly disturbed psychotics.   In: Himwich,
  H. E.,  ed. Tranquilizing drugs.   Washington, Am. Ass.
  Adv. Sc,  1957.  p. 163-172.                       * *
  Vallat, J. N., Lepetit, Texier, M.  Quelques reflexions
  sur les incidents et accidents  du traitement par  la
  chlorpromazine en pratique  psychiatrique.  [Some re-
  marks  to  the incidents and accidents of chlorpromazine
  therapy in psychiatry.]   Ence'phale,  1956, 45: 784-789.
  Wardell,  D.  W.  Untoward reactions to tranquilizing
  drugs.   Am, J. Psychiat, 1957,113 : 745.
  Weiss,  D. M.  Changes in blood pressure with electro-
  shock therapy in a patient receiving chlorpromazine hy-
  drochloride (thorazine).  Am. J. Psychiat, 1955, 111:
  617-619.
  Zatuchni,  J. Miller, G.  Jaundice during chlorpromazine
  therapy.  N. England J. M., 1954, 251:1003-1006.

—Poisoning
  D'Avossa,  B.  Tentato  suicidio  con cloropromazina.
  [Attempted suicide  with chlorpromazine.]   Riv. sper.
  freniat., 1956, 80: 674-675.
  Beal, J. A.  Chlorpromazine  poisoning.  Brit. M.  J.,
  1955, 2:1620.
  Douglas, A. D. M., Bates, T. J. N. Chlorpromazine as
  a  suicidal agent.   Brit.  M. J., 1957, 1: 1514.
  Henne, M., Henne, S.  Intoxication aigue au cours d'une
  tentative de suicide par chlorpromazine.  [Suicide  at-
  tempted   with  chlorpromazine;  acute   intoxication.]
  Ann. me'd.  psychol, Par., 1956,114 (2) : 309-314.
  Mauceri, J., Strauss, H.   Effects of chlorpromazine on
  the electroencephalogram with report of a case of chlor-
  promazine intoxication.  Electroencephalography, Mont-
  real, 1956,  8:671-675.
  Samuels, A. S.  Acute chlorpromazine poisoning.  Am.
  J. Psychiat, 1957,113 : 746-748.
  Sinha, G. B., Mitra ,S. K.  A case of acute chlorproma-
  zine hydrochloride poisoning.  J. Ind. 31. Ass., 1955, 24:
  557-558.
  Spratt, R. J., Dean, E. F.  Unsuccessful suicide  with
  chlorpromazine.  Rocky Mountain M. J., 1957, 54:153-
  154.
  Vallat, J. N., Lepetit.  Intoxication par la chlorproma-
  zine  (largactil)  au cours d'une tentative  de suicide.
  [Attempted suicide with  chlorpromazine (largactil).]
  Presse me'd., 1954, 62 : 752.
  ----,----, Texier, M.  Quelques reflexions sur les inci-
  dents  et accidents du traitement par la chlorpromazine
  en pratique psychiatrique.  [Some remarks to the in-
  cidents and  accidents of chlorpromazine  therapy  in
  psychiatry.]  Ence'phale, 1956, 45: 784-789.
  Wardt-Kikkert, N. M. van de  Quelques aspects de Tap-
  plication  de la chlorpromazine dans un hopital psychia-
  trique hollandais.  [Observations  on  the use of chlor-
  promazine in a Dutch psychiatric hospital.]  Ence'phale,
  1956, 45: 700-704.

Various special techniques

Hibernotherapies and Sleep  therapies
[artificial hibernation, prolonged sleep, etc.]

Chlorpromazine in lytic cocktails or combined  with either
meperidine or barbiturates  or promethazine.

The potentiating action  of chlorpromazine.

  see also  CHLORPROMAZINE with  OTHER DRUGS
             [CNS depressants]—COMBINED
  Laborit,  H.  Potentiated  anesthesia.  Artificial hiber-
  nation.   General  technic  of artificial  hibernation.
  Internat. Rec. M., 1954,167 : 315-320. 321-323. 324-327.
  ----.   Therapeutique neuroplegique et hibernation arti-
  ficielle : essai d'eclaircissement d'une equivoque.   [Neu-
  roplegic  therapy and artificial hibernation; attempt to
  clarify an equivocation.]   Presse mid.,  1954, 62: 359-
  362.
  ----,  Huguenard,  P.  L'hibernation  artificielle   par
  moyens pharmacodynamiques et physiques.   [Artificial
  hibernation by pharmacodynamic and physical means.]
  Presse me'd., 1951, 59 :1329.
  ----,  ----.  Technique actuelle de l'hibernation  artifi-
  cielle.  [Present  technique of artificial  hibernation.]
  Presse med., 1952. 60:1455-1456.
  ---->  ---->  Alluaume, R.  Un  nouveau stabilisateur
  veg£tatif; le 4560 RP.  [A new  autonomic stabilizer;
  4560 RP.]  Presse me'd.,  1952, 60 : 206-208.
  ----, Jaulmes, C.  De Tanesthesie potentialisee a l'hiber-
  nation artificielle.  [From  potentiated  anesthesia  to
  artificial  hibernation.]  Toulouse  med.,  1952, 53:821-
  829.

—Compared with Chlorpromazine alone
  Baruk, H.   La catatonie experimentale  par  la  chlor-
  promazine ; la posologie et la methode d'administration
  la plus eflScace  en  therapeutique  psychiatrique.   [Ex-
  perimental catatonia produced  with  chlorpromazine;
  the dosage and most effective method of chlorpromazine
  therapy in psychiatry.]   Ence'phale, 1956, 45: 474-476.
  ----.  Les therapeutiques psychiatriques. [Psychiatric
  therapies.]   128  p.  Paris,  Presses  universitaires  de
  France   [Que  sais-je?  Le  point  des  connaissances
  actuelles  (691)] 1955.    Les  therapeutiques  physiolo-
  giques sedatives; cures  de  sommeil; chlorpromazine.
  [Physiologic  sedative therapies;  sleep therapy;  chlor-
  promazine.] p. 109-116.
  ----, Launay, J., Berges, J., Mijolla, A. de. Etude clinique
  de Taction therapeutique  de la reserpine.  Comparaison
  avec Taction des extraits totaux.  [Clinical study of the
  therapeutic  effect of reserpine;  comparison with  total
  extracts.]  Ann.  med. psychol,  Par.,  1957.  115  m •
  704-708.                                         v ; '
456132—59---5
61 
Chlorpromazine : Various  special techniques —
Compared with  chlorpromazine alone
PSYCHOPHARMACA
 Bergouignan, M.  La largactil en therapeutique psychia-
 trique.   [Largactil  in  psychiatric therapy.]   Presse
 me'd., 1953, 61:1133.
 Bobon, J.  Chlorpromazine et cure de sommeil.  [Chlor-
 promazine and sleep therapy.]   Encephale,  1956, 45:
 421-427.
 Charatan, F. B. An evaluation of chlorpromazine ("lar-
 gactil") in psychiatry.  J. Ment Sc,  Lond., 1954, 100:
 882-893.  Abstract: Excerpta med., Sect. 8, 1955, 8: No.
 3639.
 Delay, J.  Introduction au colloque  international.  [In-
 troduction to the international colloquim.]  [On chlor-
 promazine and neuroleptic drugs, Paris, October 1955]
 Ence'phale, 1956, 45 :303-306.
 ----, Deniker, P.  Peut on comparer la reserpine a  la
 chlorpromazine?   [Can  one compare  reserpine with
 chlorpromazine?]  Arch, psicol. neur., Milano, 1956,17:
 631-633.
 ----,----. Le traitement des psychoses par une meth-
 ode neurolytique derivee d'hibernotherapy; le 4560 R. P.
 utilisee seul en cure prolongee et continue.  [Treatment
 of psychoses by a neurolytic method derived from hiber-
 notherapy ; prolonged continuous therapy with 4560 RP
 alone.]  C. rend.  Congr.  alie'n. neur. France, 1952, 50:
 497-502.   Abstract:  Ann.  med.  psychol,  Par.,  1952,
 110(2) :564.
 Deniker, P.  Hibernotherapies  et medicaments  neuro-
 leptiques  en  therapeutique psychiatrique.   [Hiberno-
 therapies and neuroleptic drugs in psychiatric therapy.]
 Encephale, 1957, 46:281-398.  [295-305.]
 Ey,  H., Faure, H., Lairy,  G. C.  Action du largactil sur
 Teiectroc-encephalogramme de malades mentaux chron-
 iques comparee Sl Taction des barbituriques.  [Compari-
 son between the effects of largactil and barbiturates on
 the  EEG of chronic mental patients.]  Ence'phale, 1956,
 45:  843-852.
 ----,----, Rappard, P. Les reactions d'intoierance vis-
 a-vis de la chlorpromazine.   [Chlorpromazine intoler-
 ance.]  Encephale, 1956,  45 : 790-796.                *
 Fau, R., Chateau, R.  La cure de sommeil et la chlor-
 promazine.  [Sleep therapy and chlorpromazine.]  En-
 cCphale, 1956, 45:428-435.                          *
 Gaitz, C. M., Roy, H., Thompson, W., Kimbell, I., Mullen,
 A. J., Pokorny, A. D.  Evaluation of chlorpromazine  in
 comparison with other methods of treatment of hospital-
 ized psychiatric patients, using the Lorr multidimen-
 sional scale for rating psychiatric patients.  Psychiat.
 Res. Rep., Wash., 1955 (1) : 84-95.
 Hiob, J.  Klinische Erfahrungen bei  der Behandlung
 von  Psychosen mit Megaphen.   [Clinical experiences  in
 megaphen therapy of psychoses.]  Aerztl. Wschr., 1954,
 9: 919-924.
 Laborit, H.  Therapeutique  neuroplegique  et hiberna-
 tion artificielle:  essai  d'eclaircissement d'une  equi-
 voque.  [Neuroplegic therapy and artificial hibernation :
 attempt to clarify an equivocation.]  Presse me'd., 1954,
 62:359-362.
 ----.  Potentiated anesthesia.  Internal Rec. M., 1954,
 167: 315-320.
 Lamarche, A., Roussel, A.,  Rosendorf  Comparaisons
 des  resultats obtenus par  la cure de  sommeil, la cure de
 somnolence, et la cure a la  chlorpromazine seule et a
 dose eievee;  resultats de quelques eiectro-encephalo-
 grammes de controle.  [Comparison of results obtained
 with sleep therapy, somnolence therapy and chlorproma-
 zine  therapy  alone and  with elevated  doses;  results
 controlled  by EEG.]  Ence'phale, 1956, 45: 884-890.
 Medina,  F.  Sono  prolongado na terapeutica psiquia-
 trica.  [Prolonged  sleep in psychiatric therapy.]   Med.
 contemp., Lisb., 1954, 72 : 323-331.
Monnerot,  E., Monnerot,  E.,  Benichou,  L., Doco  An-
 alyse des roles respectifs du largactil et du sommeil
barbiturique, dans les cures  de sommeil potentialisees.
 [Analysis of the effect of chlorpromazine and of bar-
62
 biturates  respectively in  potentiated sleep  therapy.]
 Encephale, 1956, 45 : 1190-1196.
 Perret, A.,  Becker,  J., Lacoste, G.  Traitements psy-
 chiatriques  par le 4560 R. P.  [Psychiatric treatments
 with 4560 RP. ]   Vie med., Par., 1953, 34: 463-464.
 Puech, J., Robin, C.  Etude comparative des effets de
 la cure de sommeil medicamenteux et de la chlorproma-
 zine injectable dans les psychoses.  [Comparative study
 of sleep therapy and chlorpromazine injections in ther-
 apy  of psychoses.]  Sem. hop.  Paris, 1956,  32:3252-
 3264.
 Rigal,  J., Malet, P., Florentin, M. Quelques  considera-
 tions au sujet de 300 cures de chlorpromazine dans les
 psychoses et les, nevroses.  [Some  remarks  on chlor-
 promazine  therapy of 300 psychotics and neurotics.]
 Ence'phale, 1956, 45 : 592-598.

-History of psychiatric use
 see CHLORPROMAZINE—History  of psychiatric use

-Literature surveys
   see CHLORPROMAZINE—Bibliographies  and liter-
         ature surveys

-Pharmacodynamics
 Courvoisier, S.  Pharmacodynamic basis for  the use of
 chlorpromazine in psychiatry.   J. Clin. Exp. Psycho-
 path., 1956,  17: 25-37.
 ----.  Sur  les  proprietes  pharmacodynamiques  de  la
 chlorpromazine en  rapport avec  son emploi en psy-
 chiatrie.   [Pharmacodynamic basis  for the use  of
 chlorpromazine   in   psychiatry.]  Ence'phale,   1956,
 45: 1248-1257.
-Psychosocial considerations
 see CHLORPROMAZINE—Psychosocial considerations
-Psychotherapeutic use
 Azima, H.   Prolonged sleep treatment in mental dis-
 orders  ; some  new  psychopharmacological  considera-
 tions.  J. Ment Sc, Lond., 1955,101: 593-603.
 ----.   La valeur de la situation anaclitique facilitee
 par la chlorpromazine.  [(Therapeutic)  value  of the
 anaclitic  situation,  facilitated  by  chlorpromazine.]
 Ence'phale, 1956, 45 : 972-978.
 Bronner,  A.  Chlorpromazine   (thorazine)   in  office
 practice.  Am. J. Psychother., 1956, 10:460-466.
 Durand, C, Horneffer, C, Rallo,  J.  Preparation a  la
 psychotherapie dans les nevroses par les cures de chlor-
 promazine.  [Treatment  of neuroses with chlorproma-
 zine  as a preparation for psychotherapy.]   Schweiz.
 Arch. Neur. Psychiat., 1956, 77 : 485-487.
 Engelmeier,  M. P.  Methoden  kombinierter  lytischer
 Therapie.   [Methods  of  combined  lytic therapies.]
 Ence'phale, 1956, 45 : 461-468.
 Ey, H., Faure, H.  Sleep  therapy and  the use of chlor-
 promazine.   Internat, Rec M., 1957, 170: 1-10.
 Gomirato, G. Gamna,  G.  Ricerche comparative d'es-
 plorazione psicofarmacologica; studio dell'associazione
 di un barbiturico ad azione rapida (narcovene)  con un
 ganglioplegico  (largactil).  [Comparative psvchophar-
 macologic investigations; study of a rapidly acting bar-
 biturate  (narcovene)  combined  with a  ganglioplegic
 (largactil).]   Gior. psichiat., 1954,  82:347-359.
 Scherr, A.  Le  largactil  en  psychiatrie  extra-hospi-
  * \er(T  [Largactil  in  ambulatory psychiatry.] En-
 cephale, 1956, 45: 388-391.
-Studies, animals
 Baruk, H. Launay, J., Berges, J.  Physiologie psychia-
 trique experimentale de la chlorpromazine chez  les ani-
 maux et ses applications therapeutiques chez Thomme.
 LLxpenmental  psychopharmacology of chlorpromaziae
 in animals  and its therapeutic applications  in man.]
 Ence'phale, 1956, 45:1258-1263.
 Belot, P., Decourt, P.  Effet du N68 sur des  perturba-
 tions psychiques d'ongine instinctive  chez des  chiens. 
SUBJECT  LIST
Chlorpromazine : Various special  techniques — Therapeutic use
 [The effect of N-68 on psycho-sexual disorders of dogs.]
 Ann. med. psychol, Par., 1956, 114 (2) : 112-116.
 Brodie, B. B.,  Shore, P. A., Silver,  S. L.  Potentiating
 action of chlorpromazine and reserpine.  Nature, Lond.,
 1955, 175 : 1133-1134.  Abstract: Chem. Abstr., 1956, 50 :
 479g.
 Courvoisier, S. Pharmacodynamic basis for the use of
 chlorpromazine in psychiatry.  J-  Clin, Exp. Psycho-
 path., 1956, 17: 25-37.
 ----.  Sur les proprietes pharmacodynamiques de la
 chlorpromazine en rapport  avec son emploi en psychia-
 trie.   [Pharmacodynamic basis for  the use of chlorpro-
 mazine in  psychiatry.]  Encephale,  1956, 45 :1248-1257.
 Eeckhoutte, R. van.  Le chlorhydrate  de chloro-3-di-
 methylamino-3'-propyl-10-phenothiazine  (4560 R.  P.) ;
 son action sur le systeme nerveux et sur le systeme neu-
 rovegetatif.       [ 3-Chlor o-lO- (3-dimethylaminopropyl)
 phenothiazine (4560 R. P.) ;  its action  on the nervous
 and autonomic nervous system.]  28 p.  Ambilly, 1953.
 [Thesis—Geneva  1953, no. 2168]
 Friebel, H., Reichle, C.  Zur analgetischen und anal-
 gesieverstarkenden Wirkung von Chlorpromazin  (Mega-
 phen).  [Analgesic  and analgesic-potentiating effect of
 chlorpromazine (megaphen).]  Arch. exp. Path., Berl,
 1955, 226: 551-557.  Abstract: Chem. Abstr., 1956, 50 :
 2063 de.
 Revol, L.  Amplification par la chlorpromazine de Teffet
 hypothermisant des barbituriques chez  le lapin.  [Am-
 plification of the hypothermic effect of  barbiturates by
 chlorpromazine in rabbits.]  Ann. pharm. fr., 1954, 12:
 500.
 Sadove, M. S., Balagot, R.  C, Reyes, R. M.  The poten-
 tiating action of chlorpromazine.  Current Res. Anesth.,
 1956, 35:165-181.
 Votava, Z.,  Vanecek, M.   The influence of some anti-
 histaminics and neuroplegics on the higher nervous ac-
 tivity  of  rats and dogs.   Physiol bohem.,  1956,  5
 (Suppl.) : 58-62.

—Studies, normal subjects
 Hemmer,  R.  Beobachtungen fiber  psychische Verande-
 rungen unter  potenzierter  Narkose.  [Observations  on
 psychic changes  in potentiated  anesthesia.]   [English
 summary.]  Zbl.  Neurochir., 1953, 13 : 360-364.
 Reda, G. C, Ballardini, G.,  Riccio, L.  Esami psicologici
 in soggetti  trattati con largactil.   [Psychological ex-
 amination  of patients  treated   with  largactil.]  Riv.
 sper. freniat., 1955, 79 : 509-514.

—Studies, patients
 Bolsi, D., Donegani,  G., Grattarola, F. R. I  ganglio-
 plegici ed  il sistema neurovegetative negli schizofrenici.
 [Ganglioplegics and the autonomic nervous  systeiri in
 schizophrenia.]   Minerva med.,  Tor., 1953, 44: 230-231.
 [Not seen]                               ..
 Conrad, K., Domanowsky,  K., Wieser,  S.  Uber extra-
 pyramidal Anfallszustande bei Behandlung mit Pheno-
 thiazinen    [Extrapyramidal symptoms  during treat-
 ment with phenothiazines.]  Fortsch. Neur. Psychiat,
 1956, 24:505-512.
 Dogan, S., Vukadinovic, D.,  Longhino, A.  Djelovanje
 lariactila i phenergana na  elektroencefalogram kod
 enilepticara.   [Effect of largactil and phenergan  on
 effioencephalograpby  in epilepsy.]   [English  sum-
 mary r. 951  Neuropsihijatnja, 1954,  2:88-100.  Ab-
 stract ?Excerpta  med., Sect. 8, 1955, 8: No. 2385.
 Ev H  Faure, H., Lairy, G. C.  Action  du largactil sur
 Telectro-encephalogramme  de malades mentaux  chroni-
 ques  comparee a  Taction des barbituriques.  [Compari-
 son between the effects  of largactil and  barbiturates
 on the EEG of chronic  mental patients.]  Ence'phale,
 1956,45:843-852.
 Hemmer R.  Beobachtungen fiber psychische Verander-
 ungen unter potenzierter  Narkose.  [Observations  on
 psychic changes  in potentiated anesthesia.]  [English
 summary]  Zbl. Neurochir., 1953, 13 : 360-364.
 Laborit, H., Coirault, R., Hainaut, J., Weber, B.  Action
 des neuropiegiques sur Texcitabilite neuromusculaire;
 les mouvements ioniques transmembranaires; 1 equilibre
 thermocationique; consequences physiologiques et ther-
 apeutiques;  une  application clinique: le delirium tre-
 mens.  [Effect of neuroplegic drugs on  neuromuscular
 excitability; transmembrane ionic movements, thermo-
 cationic equilibrium;  physiologic  and therapeutic  con-
 sequences ; clinical application: delirium tremens.]  En-
 ce'phale, 1956, 45:1166-1177.               .        .  .
 Reda, G. C, Ballardini, G., Riccio, L. Esami psicologici
 in soggetti trattati con largactil.  [Psychological exam-
 ination of patients treated with largactil.]  Riv. sper.
 freniat, 1955,  79 : 509-514.

-Terminology
 see CHLORPROMAZINE—Terminology of therapies

-Therapeutic studies, controlled
 Azima, H.   Prolonged sleep treatment  in  mental dis-
 orders;  some new psychopharmacological considera-
 tions. J. Ment. Sc, Lond., 1955,101: 593-603.
 Ey, H., Faure, H.  Sleep therapy and the use of chlor-
 promazine.  Internat. Rec M., 1957, 170:1-10.
 Fau, R., Chateau, R.  La cure de sommeil et la chlorpro-
 mazine.   [Sleep therapy  and chlorpromazine.]  En-
 ce'phale, 1956,  45:428^135.                       *  *
 Lamarche,  A., Roussel, A., Rosendorf   Comparaisons
 des resultats obtenus par la cure de sommeil, la cure de
 somnolence, et la cure a  la chlorpromazine seule et  a.
 dose  eievee;  resultats  de quelques eiectro-encephalo-
 grammes de contrfile.  [Comparison of results obtained
 with sleep therapy, somnolence therapy and chlorproma-
 zine therapy  alone and with  elevated  doses;  results
 controlled by EEG.]   Ence'phale, 1956, 45: 884-890.
 Monnerot, E., Monnerot, E., Benichou, L. Doco Analyse
 des roles respectifs du largactil et du sommeil barbitu-
 rique, dans les cures de sommeil potentialisees.  [Analy-
 sis of the effect of chlorpromazine and of barbiturates
 respectively in potentiated sleep therapy.]  Ence'phale,
 1956, 45:1190-1196.
—Therapeutic studies, controlled—Psychoses
 Barsa, J. A., Kline, N. S.   A comparative study of reser-
 pine, chlorpromazine, and combined therapy.  A. 31. A.
 Arch. Neur. Psychiat, 1956, 76 : 90-97.
 Charatan,  F. B.   An  evaluation of  chlorpromazine
 ("largactil") in psychiatry.  J. Ment.  Sc, Lond.,  1954,
 100: 882-893.  Abstract: Excerpta med., Sect.  8,  1955,
 8: No. 3639.
 Gaitz, C. M., Roy, H., Thompson, W., Kimbell, I., Mullen,
 A.  J., Pokorny, A. D.  Evaluation  of  chlorpromazine
 in  comparison  with  other methods of treatment of
 hospitalized psychiatric patients, using the Lorr multi-
 dimensional  scale  for   rating  psychiatric  patients.
 Psychiat. Res. Rep., Wash., 1955 (1) : 84-95.         *
 Lafon, R.,  Due,  N., Abric, J.,  Pouget, R., Comelade, P.
 Etude comparative du 4.560 R. P. (chlorpromazine)  et
 de la reserpine dans les syndromes schizophreniques.
  [Comparative study of R. P. 4560 (chlorpromazine) and
 reserpine  in  schizophrenic  syndromes.]   Ence'phale,
 1956, 45: 668-671.
 Puech, J., Robin, C.  fitude comparative des effets de  la
 cure  de  sommeil medicamenteux et de la chlorproma-
 zine injectable dans les psychoses.  [Comparative study
 of  sleep therapy  and  chlorpromazine  injections  in
 therapy  of psychoses.]   Sem.  hop. Paris, 1956, 32:
 3252-3264.

—Therapeutic use
 Adasal, R.,  Ozsan, M., Karan, D., Yener, O.  Les resul-
 tats obtenus par la chlorpromazine & la clinique psychi-
 atrique de la  Faculte de Medecine d'Ankara.  [Results
 obtained with chlorpromazine at the psychiatric  clinic
63 
Chlorpromazine :  Various special techniques —Therapeutic use
PSYCHOPHARMACA
 of the Faculte de Medecine d'Ankara.]  Ence'phale, 1956,
 45 : 1204-1209.
 Aivazian, G. H.  Chlorpromazine in the withdrawal of
 habit-forming drugs in addicts.  Dis. Nerv. Syst, 1955,
 16 : 57-60.  Abstract: Excerpta  med.,  Sect. 8,  1956, 9:
 No. 413.
 Angel, J.  Cures de sommeil et largactil.  [Sleep thera-
 pies and largactil.]  Ence'phale, 1956, 45 : 416-420.
 Balducci,  M.  Possibility, limiti, indicazioni e contro-
 indicazioni del 4560 R. P.  (largactil) in psichiatria;
 controllo dei primi risultati con osservazione su 110 casi.
 [Possibilities, limitations,  indications and contraindica-
 tions of 4560 RP (largactil) in psychiatry; review of the
 early results with a study of 110 cases.]  [English sum-
 mary]  Rass. stud, psichiat., 1955,  44: 709-729.  Ab-
 stract : Excerpta med., Sect. 8, 1956, 9 : No. 5010.
 Balduzzi, E., Escalar, G.  A proposito delle terapie cosid-
 dette  ganglioplegiche.   [The  so-called  ganglioplegic
 therapies.]  Rass. stud, psichiat., 1953,  42: 1056-1064.
 ----,  ----.  Sulle terapie  cosiddette  ganglioplegiche.
 II.  II 4560 R. P. in psichiatria;  osservazioni su 100
 casi trattati.  [The so-called ganglioplegic therapies.
 II. RP 4560 in psychiatry; observations on 100 treated
 cases.]  [English summary p.148]   Rass. stud, psichiat.,
 1954, 43: 120-151.
 Berard,  E.  Cures de  somnopiegie  en clinique neuro-
 psychiatrique.  [Somnoplegic  therapy in neuropsychia-
 tric practice.]  Encephale, 1956, 45 :  401-411.
 Bergouignan, M., D'Aulnay,  J., Malineau, R. Retouches
 a notre  experience du largactil en  psychiatrie.  [Addi-
 tional experiences with  largactil  in  psychiatry.]  J.
 med. Bordeaux, 1955, 132 :  254-261.  Abstract: Excerpta
 med., Sect. 8,1955, 8: No. 4917.
 Berselli, G., Vicini, F.  Osservazioni sull'impiego tera-
 peutico del largactil.  [Observations on the therapeutic
 use of largactil.]  Riv. sper. freniat, 1955, 79: 743-745.
 Bertolini, O.  L'azione del  4560 R. P. in diverse sindromi
 psichiatriche.  [Effects of 4560 R. P. in various psychi-
 atric syndromes.]  Riv. sper. freniat, 1954, 78 :  205-224.
 Bobon, J.  Chlorpromazine et cure de sommeil.  [Chlor-
 promazine  and sleep  therapy.]   Ence'phale, 1956, 45:
 421-427.
 Boszormenyi, Z., Gimes, M., Orthmayr, A.  A largactil
 pharmakodynamias hatasa es therapias eredmenyei  a
 psychiatriaban.   [Pharmacodynamic  effects  and the
 therapeutic results of largactil in  psychiatry.]   Orv.
 hetil,  1955, 96 :1039-1045.  Abstract:  Excerpta med.,
 Sect.  8,  1956, 9: No.  2238.   [A  very  short  English
 abstract]
 Boon,  A. A.   Largactil en  vermante middelen  in de
 psychiatrie en neurologie.   [Largactil and  related rem-
 edies in psychiatry and neurology.]  Ned. tschr. geneesk.,
 1955, 99: 2735-2741.
 Brehmer, G. von, Ruckdeschel, K. T.  Zur Technik der
 Winterschlafbehandlung.   [Technique  of hibernation
 therapy.]  Deut. med. Wschr., 1953, 78:1724-1725.   *
 Buisson, J. E. Therapeutiques de sommeil en  psychia-
 trie et en medecine psychosomatique.  [Sleep therapy in
 psychiatry and in psychosomatic medicine.]  Sem. hop.
 Paris, 1954, 30: 155-158.
 Cervos Navarro, J., Unterharnscheidt, F.  Importancia
 de las fenotiacinas  en psiquiatria.   [Importance of
 phenothiazines in psychiatry.]  Rev. espan. otoneuroft,
 1956,15: 75-92.
 Cloutier, F.  La cure de sommeil en therapeutique psy-
 chiatrique.  [Sleep therapy in psychiatry.]  Laval me'd.,
 1953,18: 332-342.
 Delay, J. Introduction au colloque  international.   [In-
 troduction to the international colloquium.]  [On chlor-
 promazine and neuroleptic drugs, Paris, October 1955]
 Ence'phale, 1956, 45 : 303-306.
----, Deniker, P.  Les neuropiegiques en therapeutique
 psychiatrique.  [Neuroplegic drugs  in psychiatric  ther-
 apy.]   Thtrapie, Par., 1953, 8 : 347-364.
----,  ----,  Pauwels, R.  Cures  de sommeil  et  cures
neuroleptiques en  psychiatrie.   [Sleep  therapies  and
neuroleptic therapies in psychiatry.]   Ence'phale, 1956,
45 : 436-439.
----,----, Tardieu, Y.  Hibernoth6rapie et cure de som-
meil  en therapeutique  psychiatrique  et psycho-soma-
tique.   [Hibernotherapy and sleep therapy in psychiatry
and psychosomatic medicine.]  Presse mid.,  1953,  61:
1165-1166.
Demay, G., Montremy, J. de, Mises, R.   Les  curarisants
par voie rectale en psychiatrie. [Rectal administration
of curare-like drugs in psychiatry.]  Ann. me'd. psychol,
Par., 1953,  111 (1) : 660-665.
Deniker, P.  Hibernotherapies et medicaments neuro-
leptiques  en  therapeutique psychiatrique.    [Hiberno-
therapies and neuroleptic drugs in psychiatric  therapy.]
Ence'phale, 1957, 46:281-398.   [295-300.]
Ditfurth, H. von.  Anwendungsmoglichkeiten des Mega-
phens  in der  psychiatrischen  Klinik  und  Forschung.
[Possibilities  for  the use of megaphen in  psychiatric I
practice and  research.]   Nervenarzt,  1955, 26:54-59.
Abstract: Excerpta med., Sect. 8, 1956, 9: No.  4074.
Engelmeier, M. P.  Lytische Therapie in der Nerven-
klinik.  [Lytic threapy  in neuropsychiatric hospitals.]
[English summary p.  148.]   Mschr.  Psychiat., Basel, i
1956, 131: 89-150.
Escalar, G., Balduzzi, E.  Sull'impiego della  cloropro-
mazina come  terapia di antishock.  [Use of  chlorpro-
mazine as  antishock therapy.]   Arch,  psicol.  neur.,
3Iilano, 1956, 17 : 655-657.
Ey, H., Berard, E.  Les nouvelles  techniques de cure de
sommeil dans  la pratique psychiatrique.  [New technics
of  sleep  therapy  in psychiatric  practice.]   Evolut.
psychiat, 1952: 661-682.
----, ----.  Sobre una  tecnica de tratamiento por el \
sueilo  prolongado  interrumpido.  [Method of  intermit- ;
tent and prolonged sleep therapy.] Dia me'd., B. Air., ,
1954, 26:1385-1389.
----,  Deschamps, A., Berard,  E.  Les  techniques de
cures de sommeil a Taide de neuropiegiques et l'hiber-
nation  artificielle  en psychiatrie.   [The technics of ,
sleep therapy  with neuroplegics and artificial hiberna- ,
tion in psychiatry.]  In: Laborit,  H., Huguenard, P. !
Pratique de Thibernotherapie en  chirurgie et  en  mede-
cine.   [The use of hibernotherapy in surgery and in
medicine.]   Paris, 31asson, 1954.   p. 181-203.          ,
----, Faure, H. Les diverses  methodes d'emploi de la .
chlorpromazine en therapeutique  psychiatrique et leurs
indications.  [The  various methods of chlorpromazine
therapies and  their indications in psychiatric  therapy.]
Ence'phale, 1956, 45 : 361-371.                          \
----,  ----.   Sleep therapy  and  the  use of  chlorpro- ;
mazine.  Internat. Rec. M., 1957,  170:1-10.
Gachkel, V., Brisset, C.  La cure  de sommeil en psychi-
atrie.  [Sleep therapy in psychiatry.]   C. rend. Congr.
alien, neur. France, 1952, 50: 491-496.  Abstract:  [in-
complete !]  Ann.  me'd. psychol, Par., 1952,  110 (2):
565.
Gade,  E. B., Heinrich,  K.  Die Bedeutung  der Pheno- \
thiazinderivate, insbesondere des Megaphen,  ffir Psychi- !
atrie und Neurologic  [The  importance of phenothia-
zine derivatives in  psychiatry  and neurology,  with spe- '
cial  reference  to  chlorpromazine.]  Fortsch.  Neur. i
Psychiat., 1955, 23 : 323-353.
Galenko, V. E., Osberg, I. IU., Azbukina,  V. D. Pri- i
menenie aminazina v psikhiatricheskoi  klinike. [Use of |'
aminazine  in  psychiatric  clinics.]  Sovet.  med., 1956, '
20:29-35.
Gallian, U., Gamna,  G.   Primi tentativi  di terapia di
sindromi amenziali con preparati derivati dalle tecniche 11
della "ipotensione controllata" e della "ibernazione arti-1
ficiale"; nota preliminare.  [First attempts  to treat the i
syndrome of amentia with drugs derived from the tech- j
nics of "controlled hypotension"  and  "artificial  hiber-
nation"; preliminary note.]   Minerva  med., Tor 1953,
44:357-360.
64 
SUBJECT  LIST
Chlorpromazine :  Various special techniques — Therapeutic use
  Gambs, A.  Essai d'application de la chlorpromazine en
  cures prolongees au traitement  de diverses  affections
  mentales,  a propos de 58 observations.   [The use of
  chlorpromazine for prolonged sleep therapy of various
  mental diseases.  58 observations.]  136 p.  Lyon, 1954.
  [Thesis—Lyon 1953/1954, no. 76]
  Ganry,  C. H.  J.  La  cure de sommeil en  psychiatrie.
  [Sleep therapy in psychiatry.]  102 p.  [Mimeographed]
  Paris, 1953.  [Thesis—Paris 1953, no. 395]
  Gascard, E. La place  de la cure de sommeil en thera-
  peutique.  [The place of sleep therapy in therapeutics.]
  Marseille med., 1953, 90 : 516-519.
  Gherarducci, D.  A propos de Tutilisation de la chlorpro-
  mazine  associee  a  d'autres  therapeutiques psychia-
  triques. [Utilization of chlorpromazine associated with
  other psychiatric therapeutics.]  Encephale,  1956, 45:
  1187-1189.
  Giacobini, E.,  Lassenius, B.  Clorpromazinbehandling;
  biverkningar  och  komplikationer.   [Chlorpromazine
  therapy ; side effects and complications.]  [English sum-
  mary]   Nord.  med., 154, 52: 1693-1699.             *
  Hamon, J., Paraire, J.,  Velluz, J.  Etats anxieux et bar-
  bituriques potentialises.   [Anxiety states  and potenti-
  ated barbiturates.]  Ann. med. psychol, Par., 1952, 110
  (2) : 403-407.
  Hoff, H. Advantages  and disadvantages of treatment
  with chlorpromazine  and  serpasil.  Ence'phale,  1956,
  45:352-358.
  ----.  Vorteile und Nachteile der Behandlung mit Lar-
  gactil und  Serpasil.   [Advantages and disadvantages
  of therapy with  largactil  and with  serpasil.]   Wien.
  klin. Wschr., 1956, 68:  97-101.                     * *
  Kolle, K., Mikorey, M.  Kunstlicher Winterschlaf in der
  Psychiatrie; vorlaufige  Mitteilung.  [Preliminary re-
  port on artificial hibernation in psychiatry.]  Deut. med.
  Wschr.,  1953, 78 : 1723-1724.
  ----, Ruckdeschel, K. T.  Megaphenbehandlung in der
  Psychiatrie.    [Megaphen   therapy   in   psychiatry.]
  Munch, med. Wschr., 1954,  96: 533-536.
  Korganova, A. N.  Lechenie  aminazinom podrostkov v
  psikhiatricheskoi klinike; predvaritel'noe soobshchenie.
  [Aminazine  therapy of  adolescents  at a  psychiatric
  clinic;  preliminary  communication.]   Zh. nevropat.
  psikhiat., Moskva, 1956, 56:  567-570.
  Laboucarie, J., Combes, P.  Valeur et limites des cures
  de sommeil en psychiatrie.  [Value and limitations of
  sleep therapy in psychiatry.]  Toulouse me'd.,  1954, 55:
  221-232.
  Laburthe-Tolra, J. Essai sur Temploi therapeutique de
  l'hibernation artificielle dans les intoxications barbitu-
  riques graves.   [Clinical  study on artificial hiberna-
  tion in the treatment of severe barbiturate  poisoning.]
  57 p.  Paris, 1954.  [Thesis—Paris, 1954, no. 930]  [Not
  seen]
  Lange, E.  Die Behandlung psychischer Erkrankungen
  mit  Propaphenin   (HL  5746,  Winterschlafmittel).
  [Treatment of psychic disorders with propaphenin (HL
 5746, a hibernation drug).]  Deut.  Gesundhwes., 1955,
 10: 524-527.   Abstract:  Excerpta med.,  Sect. 8,  1956,
 9:  No. 3085.
 Librando, L., Paretti, E.  Considerazioni su  un biennio
 di  esperienza in terapia ganglioplegica, in psichiatria.
 [Two years of ganglioplegic therapy in psychiatry.] Riv.
 sper. freniat, 1955, 79: 696-699.
 Lomas, J. Uses of chlorpromazine in  mental hospital
 patients.  Brit.  M. J., 1955, 1: 879-882.  Abstract: Ex-
 cerpta med.,  Sect. 8, 1956, 9 : No. 1725.
 Macchi,  G., Manghi, E., Saginario, M.   Indicazioni e
 metodi di impiego del largactil (4560 R. P.)  in terapia
 neuro-psichiatrica; studio su 130 casi trattati.   [Indi-
 cations and methods of use of largactil in neuropsy-
 chiatric therapy: study of 130 treated cases.]  Riv. sper.
freniat., 1954, 78:183-204.
Malitz, S„ Hoch, P. H., Lesse, S.  A two-year evaluation
 of chlorpromazine in clinical research and practice.  Am.
 J. Psychiat, 1956, 113 : 540-545.
 Mancini,  G. Terapia con largactil e gardenal in dis-
 timici e psiconevrotici.   [Largactil and gardenal in the
 therapy of manic-depressive psychosis and psychoneuro-
 ses.]   [Brief English  summary]   Acta  neur.,  Nap.,
 1954, 9:585-590.
 Manghi, E., Saginario, M.  In tema di narcoterapia:
 risultati  ottenuti  con  Tassociazione di  farmaci del
 gruppo della fenotiazina.  [On sleep therapy: results
 with phenothiazine combinations.]  [English summary]
 Riv.  sper. freniat., 1955,  79: 757-770.   Abstract: Ex-
 cerpta med., Sect. 8,  1957, 10: No.  966.
 Marck, H.  La  cure de  sommeil; etude  de 103 cas.
 [Sleep therapy; a study  of  103 cases.]   79 p.  Paris,
 1953.  [Thesis—Paris, 1953, no. 579]               * *
 Mariani, G., Barsotti, U.  II largactil nella cura  delle
 malattie mentali;  risultati del  trattamento in 100 casi.
 [Largactil therapy of mental illness ; therapeutic results
 in 100 pases.]  Riv. pat nerv.,  1956, 77: 525-528.
 Martini,  F.  La terapia del sonno nella pratica psichia-
 trica ; risulati  ottenuti  in un  gruppo  di 111  malati.
 [ Sleep therapy in psychiatric practice; results obtained
 with  a group of 111 patients.]  Riv. pat. nerv.,  1956,
 77: 549-550.
 Massari,  M. Ansieta e  blocco  vegetativo.  [Anxiety
 and autonomic block.]  Minerva med.,  Tor., 1953, 44:
 231-232.   [Not seen]
 Massenti, C. II trattamento neuroplegico negli stati di
 eccitamento e di agitazione.  [Treatment of excitement
 and agitation with neuroplegic drugs.]   Lavoro neuro-
 psichiat.,  1954,  14: 493-505.  Abstract: Excerpta med.,
 Sect. 8,1955, 8: No. 1785.
 Mayr, F.  Erfahrungen mit der  Largactil-Behandlung in
 der  Anstaltspsychiatrie.   [Experience  with  largactil
 treatment in psychiatric hospitals.]  Ther. Umschau,
 Bern, 1955, 11:184-191; 203-211.
 Medina,  F.   Sono prolongado  na  terapeutica  psiqui-
 atrica.  [Prolonged   sleep  in   psychiatric  therapy.]
 Med. contemp., Lish., 1954, 72: 323-331.
 Mignault, G. Two years' experience using the pheno-
 thiazine amine derivatives in anaesthesia and artificial
 hibernation  with special mention of the new derivative
 pacatal.   Canad. Anaesth. Soc.  J., 1957, 4: 37-42.
 Nayrac, P., Graux, P.  Indications et contre-indications
 de la  chlorpromazine  en psychiatrie.  [Indications and
 contraindications  of  chlorpromazine therapy  in  psy-
 chiatry.]   Ence'phale, 1956, 45 : 518-523.
 Neveu,  P.  L'hibernation, traitement  d'urgence  des
 syndromes de choc decompense en psychiatrie.  [Hiber-
 nation, an emergency treatment of decompensated shock
 syndromes in psychiatry.]  Ence'phale,  1956, 45: 377-
 381.
 Oules, J.,  Salles, P., Soubrie, R.  Tentative de suicide
 au phenergan.   [Attempted suicide with  phenergan.]
 Ann. me'd. psychol, Par., 1956,114 (1) : 271-273.
 Panse, F.   Der  medikamentose Winterschlaf (ohne
 Unterkuhlung)  in  der  Psychiatrie.  [Pharmaceutical
 hibernation without hypothermia in psychiatry.]  3Ied.
 Klin., Berl, 1953, 48:1344-1345.
 Pauly,  R.  Remarques a  propos d'une statistique per-
 sonnels sur les avantages, les  limites et les accidents
 de  Thibernotherapie a la chlorpromazine.  [Comments
 on  personal  experiences with chlorpromazine hiberno-
 therapy,  its  advantages,  limitations and  accidents.]
J.  med. Bordeaux, 1954, 131: 235-244.               * *
 Piazzesi, W.   Considerazioni e dati sulla  ipnoterapia in
 campo psichiatrico.   [Considerations and data on sleep
 therapy in psychiatry.]  Riv. pat. nerv.,  1954, 75:  541-
 579.  Abstract: Excerpta med., Sect. 8,1955, 8 : No. 3102.
 Picard, P., Le Bras, R., Navarranne, P.  Un cas de coma
insulinique prolonge  au  cours  d'une cure  de Sakel
traite  et gueri par hibernation.   Constatations  eiectro-
encephalographiques.  [Successful  hibernotherapy of
prolonged insulin coma during  Sakel  therapy;  electro-
65 
Chlorpromazine :  Various special techniques —Therapeutic use
PSYCHOPHARMACA
encephalographic tracings.]  Ann. me'd. psychol, Par.,
1953,  111(2) : 253-259.
Picard, P., Navarranne, P.  Quelques reflexions sur les
applications  de  l'hibernation  artificielle  en  neuro-
psychiatrie. [Artificial hibernation in neuropsychiatry.]
Enctphale, 1956,  45: 456-457.
Piedelievre, Deniker, Marmier.  Les toxicomanies et les
cures de desintoxication.   [Drug  addiction and detoxi-
cation.]   Concours med., 1955, 77 :1723-1726.
Pires, N., Pinho, R. de, Fernando, L., Pint, M.,  Caval-
canti,  U., Aguiar, H.  Sur  110  cas traites par le som-
meil   hibernal.  [Hibernotherapy of   110  patients.]
Ence'phale, 1956, 45: 677-681.                     *  *
Popov, E. A., Nevzorova,  T. A.  Opyt primeneniia ami-
nazina v  psikhiatricheskoi  klinike.  [Result with ami-
nazine in psychiatric  clinical practice.]  Zh. nevropat.
psikhiat., 31oskva, 1956, 56: 559-566.
Poslavsky,  A.  Psychological  considerations on  con-
tinuous sleep-treatment.  Fol. psychiat. &c neerl, 1955,
58:482-485.
Puca, A.  Ibernoterapia, sonno prolungato e neuroplegic!
in terapia psichiatrica.  [Hibernation, prolonged sleep
and neuroplegic drugs in psychiatric treatment.]   Rass.
internaz.  clin.  ter., 1955, 35: 805-809.
----,  Nuove acquisizioni in terapia psichiatrica; iber-
noterapia, sonno prolungato e neuroplegic^  [New ac-
quisitions in psychiatric therapy; artificial hibernation,
prolonged sleep and neuroplegic drugs.]  [English sum-
mary]  Rass.  stud, psichiat,  1955, 44: 849-856. Also
Ann. med. nav., Roma, 1956,  61: 42-49.
Ramee, F., Lacaton,  R., Sanchez, F.,  Boulanger, M.
Effets favorables du  largactil dans la pratique psychi-
atrique algerienne.  [Good  results with chlorpromazine
therapy of mental diseases in  Algeria.]  Ence'phale,
1956, 45: 820-827.
Rigal,  J.,  Malet, P.   Considerations sur Temploi du
largactil  en  psychiatrie.    [Largactil therapy  in psy-
chiatry.] . J. mCd. Bordeaux, 1954,131:1191-1196.
----,  ----, Florentin, M.   Quelques  considerations au
sujet de 300 cures de chlorpromazine dans les psychoses
et  les  nevroses.   [Some remarks on  chlorpromazine
therapy of 300 psychotics and  neurotics.]  Encephale,
1956, 45: 592-598.
Rigotti, S.  Dal  blocco del  S. N.  vegetativo  all'iberna-
zione artificiale : primi risultati di un nuovo indirizzo di
terapia psichiatrica.   [From autonomic N. S. blocking
to artificial hibernation;  first results with a new psy-
chriatric  therapy.]  Rass. neur. vegetal, 1952, 9:197-
210.  Abstract: Riv. neur., Nap., 1953, 23:186-188.
----,   Ulteriori esperienze   sull'impiego  in psichiatria
della  dimetilamino-propil-clorofenotiazina  (Largactil).
 [Further experiences with  the use of  dimethylamino-
propyl-n-chlorophenothiazine (largactil) in psychiatry.]
 [English  summary]   Gior.  psichiat, 1953, 81: 211-222.
Rizzo, E. M.,  Russo,  S.  SulTuso dei ganglioplegici in
terapia psichiatrica.  [The use  of ganglioplegics  in
psychiatric therapy.]  [English  summary]  Gior. psi-
chiat, 1954,  82 :127-151.   Abstract:  Excerpta med.,
Sect. 8, 1955, 8: No. 2815.
Sagripanti, P.  Ipnoterapia  con largactil in psichiatria.
 [Sleep therapy  with  largactil  in  psychiatry.]  Riv.
sper. freniat.,  1954, 78:155-182.
----.  Primi risultati clinici del'ipnoterapia esequita con
nuovi preparati.   [First clinical results  of sleep therapy
with  new preparations.]   31inerra med.,  Tor., 1953,
44 : 232-233.   [Not seen]
Sal y Rosas, F., Jeri, R., Sanchez,  J.  La chlorpromazine
chez les malades mentaux peruviens.   [Chlorpromazine
therapy of mental patients in Peru.]   Ence'phale, 1956,
45: 599-604.
----,  ----, ----.  Chlorpromazine in  neuropsychiatry.
J. Am. 31. Ass., 1954, 156:  558.
Sauri,  J.  J.  El  pendiomid (C. 9295)   y  el  ampliactyl
 (R. P. 4560)  en la cura del suefio.  [Pendiomide (C.
  9295) and chlorpromazine (4560 RP) in sleep therapy.]
  Prensa mCd. argent, 1955, 42: 447-452.
  Seabra-Dinis,  J.  A terapeutica pelo sono  prolongado.
  [Prolonged  sleep  therapy.]   •/.  mCd.,  Porto,  1954,
  23: 233-251.
  Seitz, D.  Die Schlafbehandlung mit Phenothiazinen in
  der  Neurologic  [Sleep therapy  with phenothiazines
  in neurology.]  Nervenarzt, 1956, 27:19-23.
  Seyffert, H. M., Strubel, H.  Klinische Erfahrungen mit
  dem Schlafmittel und Tagessedativum Doroma.   [Clini-
  cal experience with  doroma, a hypnotic and  diurnal
  sedative.]  Medizinische, 1956, 2 : 997-999.
  Sigwald, J.  Les indications du traitement de diverses
  affections  neuropsychiatriques par la chloropromazine;
  utilisation pratique des proprieties neuropiegiques et
  psychopiegiques de ce corps, posologie.   [Indications for
  chlorpromazine therapy of neuropsychiatric disorders;
  practical use of its neuroplegic and psychoplegic prop-
  erties; dosage.]  Bull, med., Par., 1953, 67:319-322.
  Silva, L. M. da, Zusman, W., Portella Nunes, E.  Tech-
  nicas de sono prolongado  em psiquiatria.   [Prolonged
  sleep technics  in psychiatry.]  [English summary] Hos-
  pital, Rio, 1954, 46: 355-367.
  Sivadon, P., Forzy, C.  Etude critique de 150  cas de
  cure  de sommeil.   [Critical study of sleep therapy; 150
  observations.]    Ann. med.  psychol,  Par.,  1955, 113
  (1) : 433-438.
  Sogliani, G.  Ipnoterapia  con  cloropromazina  e Rau-
  wolfia;   posologia,   associazioni,   confronti.   [Sleep
  therapy with chlorpromazine and Rauwolfia; posology,
  combinations  and  comparisons.  Minerva  med., Tor.,
  1955,  46:1253-1259.
  Staehelin, J. E.,  Labhardt,  F.  Les resultats  atteints
  par les neuropiegiques dans la traitement des psychoses
  et des nevroses.   [Results in the treatment of psychoses
  and neuroses with neuroplegic drugs.]  Encephale, 1956,
  45: 511-517.
  Steigman, A. J.,  Vallbona,  C.  Experience with  chlor-
  promazine  in  pediatrics.  Internat.  Rec.  M.,  1955,
  168: 351-357.
  Trelles, J. O., Saavedra, A.  Cura de sueno con largactil
  en el  tratamiento de  algunos desordenes mentales;
  (Primeros resultatos en el Peru).   [Sleep therapy with
  largactil in  the treatment of  some mental  disorders.
  (First results in Peru).]  Rev. neur.  psiquiat,  Lima,
  1954.  17: 125-161.
  Tripi, G.  L'associazione ganglioplegici e barbiturici in
  psichiatria.  I.   [Association  of  ganglioplegics  and
  barbiturates  in psychiatry. I.]  [Brief  English sum-
  mary] Rass. stud, psichiat., 1954, 43:907-918.
  Vidart, L., Gasteau, E.  La cure de sommeil en pratique
  neuro-psychiatrique.  [Sleep  therapy  in  neuropsychi-
  atric  practice.]   Rev. prat., Par., 1954, 4:1583-1588.
  Wozowska, J., Pytel, A.  Largaktyl (chloropromazyna),
  [Largactil (chlorpromazine).]  Polski tygod. lek,, 1955,
  10: 772-779.

—Therapeutic use—Neuroses
  Delgado, H. The treatment of compulsive neurosis with
  chlorpromazine.  In: Overholser, W.,  ed. Washington,
  D. C. St.  Elizabeths Hospital Centennial papers, 1855-
  1(,»55.  Washington.  Centennial Commission, St. Eliza-
  beths Hospital, 11)56. p. 233-244.
  Drugs in  the  treatment of depression.  Lancet, Lond.,
  1955, 1: 1065.
  Durand, C, Horneffer, C, Rallo, J.  Preparation a la
  psychotherapie  dans les  nevroses  par les cures  de
  chlorpromazine.   [Treatment  of neuroses  with chlor-
  promazine  as   a  preparation  for  psychotherapy.]
  Schweiz. Arch. Neur. Psychiat., 1956, 77: 485^87.
  Miroux, M.   Action  combinee  du  chlorpromazine,  du
  promethazine et d'un serum tissulaire specifique.  [Com-
  bined action of chlorpromazine, promethazine  and of a
  specific tissue serum.]  Gaz. med. France, 1955  62:592.
  Pamboukis, G., Paleologue, A., Montoussis,  Nl, Hakas,
66 
SUBJECT LIST
Chlorpromazine : Various special techniques —
                  Therapeutic use — Psychoses
  P.  Resultats par  Tapplication d'une cure de  sommeil
  dans les psycho-nevroses.   [Results of sleep therapy in
  psychoneuroses.]   Encephale,  1956, 45:550-554.
  Pauly,  R.   Remarques a propos d'une  statistique per-
  sonnelle sur les avantages, les  limites et les accidents de
  Thibernotherapie a la chlorpromazine.   [Comments on
  personal experiences with chlorpromazine hibernother-
  apy, its advantages, limitations and accidents.]  J. med.
  Bordeaux, 1954, 131:235-244.                      * *
  Scherr, A.  Le  largactil en psychiatrie extra-hospitali-
  ere.  [Largactil in ambulatory psychiatry.]  Encephale,
  1956. 45 : 388-391.
  Shorvon,  H. J.   Drug therapy in psychiatrv.  Practi-
  tioner.  Lond., 1955, 175 : 161-169.
  Sigwald, J. La  cure ambulatoire par la chlorpromazine.
  [Ambulatory therapy with   chlorpromazine.]   Ence'-
  phale, 1956, 45:392-400.

—Therapeutic use—Psychoses
  Abely,  P., Abdouchelli, A., Fourment, J.,  Schmitz,  B.,
  Delteil, P.  Suite aux essais therapeutiques de  reequili-
  bration instinctivo-affective; essai de traitement  par la
  bromure tetra-ethyl d'ammonium en comparaison avec
  le  R. P.  45-60  et le C.  92-95.  [Further therapeutic
  studies on the  restoration of instinctive-affective bal-
  ance; therapeutic trials with tetraethylammonium bro-
  mide in comparison with R. P.  45-60 and with C. 92-95.]
  Ann. med. psychol, Par., 1952, 110 (2) : 262-2G7.
  Achaintre, A., Balvet, P., Beaujard, M.,  Broussolle,  P.,
  Perrin, J., Leveque, F., Requet, A.  Evaluation of  chlor-
  promazine  in psychotic patients.  Internat.  Rec. M.,
  1957,170: 175-1S2.
  ---Dubor, P.,  Lauxerois, G.  Trois modes particuliers
  d'administration de la chlorpromazine dans les  affec-
  tions psychiatriques a longue evolution.   [Three special
  methods of chlorpromazine therapy  in  chronic psychi-
  atric diseases.]  Encephale, 1956. 45 : 444-44S.
  Aksel, J. S.  Etude clinique et  experimentale de Thiber-
  notherapie.  [Clinical and experimental study of  hiber-
  notherapy.]   Encephale, 1956, 45:566-571.
  Barsa, J. A., Kline, N. S. Depression treated with  chlor-
  promazine and  promethazine.   Am. J. Psychiat., 1957,
  113 : 744-745.
  Bensoussan, P. A., Klein, F. Sur quelques incidents de
  la cure  de sommeil au chlorhydrate de chloro 3 (dime-
  thylamino-3'-propyl)-10-phenothiazine.    [Some   inci-
  dents in sleep therapy with chloro 3 (dimethylamino-3'-
  propvl)-10-phenothiazine  hydrochloride.]  Ann.  med.
  psychol. Par., 1953, 111 (1) : 529-532.                *
  Broussolle, P., Hamoneau, G.   Traitement prolonge a
  la chlorpromazine  (45.60 R. P.) ; treize observations de
  psychoses  graves.   [Prolonged treatment with  chlor-
  promazine; thirteen patients  with severe psychoses.]
  Lyon med., 1953, 85 (2) : 389-401.
  Bird,  E. G., Goss,  J. D. Jr., Denber,  H. C. B.  Chlor-
  promazine in the treatment of mental illness : a study of
  750 patients. Am. J. Psychiat.,  1955, 111: 930.
  Bizzi, B.   Sorprendente miglioramento  di una psicosi
  cronica  irriducible in  seguito  a trattamento  con dosi
  elevate  di cloropromazina.   [Surprising improvement of
  an  irreducible chronic psychosis following treatment
  with massive doses of chlorpromazine.]   Arch, psicol.
 neur., Milano, 1956,17 : 640-642.
 Bonetti, U., Pedrinoni, L.  II largactil nella cura della
 schizofrenia.  [Largactil in the  treatment of schizo-
 phrenia.]   Riv. pat. nerv., 1955, 76: 815-828.
 Bustamante, 31.  Invernacion  curativa  en neurologia
 y psiquiatria ; resultados con el 4,560 (largactil).  [Arti-
 ficial hibernation in neurology and psychiatry; results
 with 4560 RP  (largactil).  Bol. cult. Cons. gen. col. me'd.
 Espaua, 1954, 17 (81) : 29-42.
 Carillo-Broatch, A.  Largactil  en  el tratamiento de las
 psicosis  traumaticas ; resumen.   [Largactil in the  treat-
 ment of  traumatic psychoses ; a summary.] Ence'phale,
 1950,45:1224-1225.
 ----.  Tratamiento de la esquizofrenia cronica.  [Treat-
 ment  of chronic schizophrenia.]   [English summary]
 Rev. neur. psiquiat, Lima, 1955, 18 : 441-445.  Abstract:
 Excerpta med., Sect. 8,1957, 10: No. 1981.
 Carpitella A.,  Cirincione,  E.   L'associazione ganglio-
 plegici e barbiturici  in  psichiatria.   [Association  of
 ganglioplegics and barbiturates in psychiatry.]   [Eng-
 lish summary]  Rass. stud, psichiat, 1954, 43 : 919-936.
 Coirault, R.,  Laborit,  H.,  Missenard, R., Jolivet, B.,
 Hainaut, J., Weber, B. Le delirium tremens. [Delirium
 tremens.]  Encephale, 1956, 45 : 762-770.
 Contini M.  L'uso del ganglioplegico 4560 R. P. in psichi-
 atria.  [Use of the ganglioplegic 4560 RP in psychiatry..]
 Rass.  stud,  psichiat, 1954, 43:1133-1138.
 Delgado, H. Acerca de nuestra experiencia con la clor-
 promacina.   [Our  experience  with  chlorpromazine.]
 Encephale,  1956, 45:344-351.                        *
 Denber,  H. C. B., Bird, E. G.  Chlorpromazine  in the
 treatment  of  mental illness.   II. Side effects and re-
 lapse rates.  Am. J. Psychiat, 1955, 112 : 465.
 Deschamps, A.  Hibernation artificielle en psychiatrie.
 [Artificial hibernation in  psychiatry.]  Presse  me'd.,
 1952, 60: 944-946.
 ----. Quelques resultats des cures de sommeil en hopital
 psychiatrique (a base de  chlorpromazine  associee  &
 d'autres  drogues).   [Some results of sleep therapy in  a
 psychiatric  hospital  (based on chlorpromazine  associ-
 ated with other drugs).]  Ence'phale, 1956, 45 : 412-415.
 ----, Cadoret, M. Cures  de sommeil prolonge en prat-
 ique medico-psychiatrique par  la methode dite d'hiber-
 nation.  [Prolonged sleep  therapies  by  the so-called
 hibernation method in medicine and psychiatry.]   Presse
 med., 1953, 61: 878-880.
 Engelmeier, M.  P.   Methoden kombinierter lytischer
 Therapie.  [Methods of combined lytic therapies.]  En-
 cephale, 1956, 45: 451^68.
 ----.  Die  Methodik  der psychiatrischen Behandlung
 mit  lytischen  Substanzen.   [Methods of psychiatric
 therapy with lytic  substances.]  Nervenarzt, 1956, 27:
 64-69. Abstract: Excerpta med.,  Sect. 8, 1957,  10: No.
 1551.
 Fau, R.,  Chateau, R., Dusserre.  Traitement des psy-
 choses aigues  et subaigues  par  les  neuropiegiques.
 [Treatment of acute and subacute psychoses with neuro-
 plegic  drugs.]   [Abstract]  J. med. Lyon, 1954, 35:948.
 Fiore, C.  Risultati  terapeutici dell'associazione  neuro-
 ganglioplegici-barbiturici  ed  elettrochock  in   alcune
 malatti mentali.   [Therapeutic results  of  combined
 neuroganglioplegics, barbiturates  and electroshock in
 some mental diseases.]  Rass. neuropsichiat,  1955, 9:
 85-98.
 Fliigel, F.   Erfahrungen  mit Megaphen in der  psychi-
 atrischen und neurologischen  Klinik.   [Experiences
 with chlorpromazine in the psychiatric and neurological
 clinic] Arch. klin. Chir., 1954, 279: 767-772.
 Follin, S.  Discussion to: Delay, J., Deniker, P., Harl,
 J. M. Ann. med. psychol, Par., 1952,110 (2) : 126-127.
 ----, Soubrier, P. Recidives de Tonirisme sous Taction
 de  la chlorpromazine.   [Recurrent  oneirism  during
 treatment with chlorpromazine.]   Ann. me'd. psychol,
 Par., 1954, 112 (2) : 218-222.                         *
 ----, ----.   Sur Tutilisation  d'une substance  neuro-
 plegique  dans un service  de psychiatrie.   [The  use of
 a neuroplegic drug  in a  psychiatric hospital service.]
 [Abstract] Ann. me'd. psychol,  Par., 1953. Ill (2) : 403.
 Galenko, V. E., Osberg, I. IU., Azbukina, V. D. Aminazin
 v psikhiatricheskoi klinike.   [Aminazine in psychiatric
practice.]   Zh. nevropat. psikhiat., Moskva, 1956, 56 •
 162-165.
 Gouttebroze, V.   Une annee  d'experience de  traite-
 ment du delirium tremens; 61 cas recueilllis dans le
service de neuro-psychiatrie d THopital Bellevue, St.
Etienne.   [Treatment of  delirium tremens; one year's
 experience in 61 cases from the neuropsychiatric service 
Chlorpromazine : Various special techniques —
Therapeutic use — Psychoses
of the H6pital Bellevue, St. Etienne.]  85 p. Lyon, 1955.
[Thesis—Lyon, 1954/1955, no. 94]
Hamon, Paraire, Velluz.   Remarques sur Taction du
4560 R. P. sur Tagitation maniaque.   [Effect of R. P.
4560 on manic agitation.]  Ann.  me'd. psychol, Par.,
1952, 110 (1) :331-335.
Hiob, J. Klinische Erfahrungen bei der Behandlung von
Psychosen mit Megaphen.   [Clinical experiences in meg-
aphen  therapy of psychoses.]   Aerztl Wschr.,  1954, 9:
919-924.
Knittel, W.,  Lange, E.  Moderne medikamentose  Be-
handlung  der  Schlafstorungen.  [Modern medicamen-
tous treatment of sleep disorders.]  Psychiat. Neur. med.
Psychol, Lpz., 1955, 7:112-117.
Laborit, H.   Climatisation au lit du malade par refrig-
erateur a air.  [Climatization by an  air conditioner
at the patient's bedside.]  Presse me'd., 1957, 65:1240.
---, Coirault,  R., Damasio, R., Gaujard, R., Laborit, G.,
Charonnat,  R., Lechat, P., Chareton, J.  Sur  un type
nouveau d'anesthesie  chirurgicale et sur Temploi en
therapeutique d'un depresseur du cortex cerebral (S. C.
T.  Z.)   [A  new type of surgical anesthesia  and the
therapeutic  use of a cerebral cortex  depressant  (S. C.
T.  Z.)]  [thiamine  hydrochloride]  Presse me'd., 1957,
65:1051-1054.
Lacroix-Herpin, M. P. de  Cure  de  sommeil dans les
hallucinations. [Sleep therapy in hallucinations.] 60 p.
Paris,  1954.   [Thesis—Paris, 1954, no.  248]
Lafon, R., Due, N.,  Ribstein,  M., Pages, H.  Le traite-
ment des  syndromes schizophreniques par la 4560 R. P.
 (chlorpromazine).   [Treatment of  schizophrenic  syn-
dromes with chlorpromazine.]  Montpellier me'd., 1954,
46: 284-291.   Abstract: Excerpta med., Sect.  8, 1955,
8: No. 3642.
Laroche, C, Bonnet de la Tour.  Traitement du  delirium
tremens par  les perfusions intraveineuses d'ACTH asso-
ciees a de faibles doses  de  clorpromazine et de  pro-
methazine.   [Treatment of delirium  tremens by intra-
venous perfusions of ACTH associated with small doses
of chlorpromazine and promethazine.]   [English sum-
mary]  ThCrapie, Par., 1956, 11: 711-714.
Letailleur, M., Morin, J., Demay,  J.,  Monnerie, R.  La
chlorpromazine dans le traitement des deiires aigus  et
subaigus  alcooliques.   [Chlorpromazine  in  the treat-
ment  of  acute and subacute delirium tremens.]  En-
ce'phale, 1956,  45: 739-743.
---,---, Monnerie, R., Demay, J.   Traitement d'atta-
que du delirium tremens par la synergie of chlorproma-
zine (4560 R. P.) mebubarbital. [Treatment of delirium
tremens by chlorpromazine (4560 RP) and mebubarbital
synergism.]   Ann.  me'd.  psychol, Par., 1954,  112(2) :
 76-80.
 Lieser, H.   Uber die synergistische Megaphen-Krampf-
 behandlung. [Synergistic combination of megaphen with
 shock therapy.]  Nervenarzt, 1956, 27:69-72.
 Lundquist,   G., Leche, H. G.  Nagra  erfarenheter  av
 lergiganbehandling vid psykoser.   [Experiences  with
 lergigan therapy of psychoses.]   Sven. lak.  tidn.,  1954,
 51:1402-1412.  Abstract: Excerpta  med., Sect. 8,  1955,
 8: No. 1793.
 Maroncelli,  P.  Trattamento  di alcune psicosi con tec-
 nica derivata dall'ibernazione artificiale.  [Treatment of
 various psychoses  with  a technic  derived from  arti-
 ficial hibernation.]   [English summary]  Gior. psi-
 chiat., 1953, 81:223-244.  Abstract: Riv. neur.,  Nap.,
 1953,  23: 828-829.
 Martin, P.,  Vidal, G., Portal, H.  Cures  de sommeil et
 4560  R. P.  chez  les psychopathes dans  les conditions
 habituelles  de ThSpital psychiatrique.  [Sleep therapy
 and 4560 RP for mental disorders under  ordinary psy-
 chiatric  hospital  conditions.]  Vie me'd.,  Par.,  1954,
 35: 807-810.
 Massenti, C.  Considerazioni pratiche sulla  condotta
 della  terapia neuroplegica.   [Treatment  with neuro-
PSYCHOPHARMACA
plegic  drugs;  practical  considerations.]  Riv-  sper.
freniat., 1955, 79 : 699-705.
Matarazzo,  A.  Sul sonno  prolungato e su  luso dei
ganglioplegici in  terapia  psichiatrica;  risultati  ot-
tenuti in alcuni malati di mente trattati con la  cloro-
promazina"  (largactil o 4560 R. P.)   [Prolonged sleep
and  the  use of  ganglioplegic drugs in  psychiatric
therapy;  results  obtained  with   "chlorpromazine"
(largactil or 4560 RP) in the treatment of mental pa-
tients ]   Pisani, 1954, 68 : 599-622.  Abstract: Excerpta
med., Sect. 8, 1955, 8: No. 3100.
Mendes, F., Galvao, P.  Experiencia clinica com a cloro-
promazina (4560  R. P.) em  psicoses.   [Clinical ex-
perience with chlorpromazine  (4560 R. P.)  in psy-
choses.]   [English summary]   J. m4d., Porto,  1955,
26:149-156.
Meyer, H. H.  Die Behandlung exogener Psychosen mit
Phenothiazinderivaten.   [The treatment  of exogenous
psychoses with phenothiazine derivatives.]  Encephale,
1956, 45: 524-527.
---.  Die moderne Behandlung  psychiatrischer Erk-
rankungen.   [Modern  treatment  of  psychiatric  dis-
eases.]  31ed. Klin., Berl, 1956, 51:1429-1432.
---, Die Therapie der  endogenen Psychosen.   [Ther-
apy  of endogenous psychoses.]  Deut.  med.  Wschr.,
1957, 82: 76-80.
---, Die Winterschlafbehandlung in der  Psychiatrie
und  Neurologic   [Hibernotherapy in psychiatry and
neurology.]   Deut. med.  Wschr., 1953, 78: 1097-1100.
Osterman,  E.,  Lassenius,  B. Lytsk  cocktail  inom
pasykiatrien; behandling av  delirium acutum  (deiire
aigu)  och  forlangt  insulincoma. [Lytic  cocktail  in
psychiatry;  treatment  of  delirium acutum  (acute
delirium) and prolonged insulin coma.]   [French sum-
mary]  Nord. med., 1955, 53:722-726.  Abstract: Ex-
cerpta med., Sect. 8, 1956, 9: No. 3079.
Perret, A.,  Becker, J., Lacoste,  G.   Traitements psy-
chiatriques  par le 4560 R. P.   [Psychiatric treatments
with 4560 RP.]  Vie me'd., Par., 1953, 34: 463-464.
Perrin, J., Toulet, M.  Utilisation de la chlorpromazine
dans le traitement des psychoses chroniques.   [Use of
chlorpromazine in the treatment of chronic psychoses.]
Ence'phale,  1956, 45:1210-1218.
Pomme, B., Planche, R., Gibert, J.  La chlorpromazine
dans le traitement des deiires aigus alcooliques.  [Chlor-
promazine in the treatment of acute alcoholic delirium.]
Ence'phale,  1956, 45 : 744-753.
Racamier, P. C, Baudrand, C.  Les cures prolongees et
 continues de chlorpromazine a Thopital psychiatrique.
 Prolonged and continued therapy with  chlorpromazine
 in the psychiatric hospital.]   [Abstract]  Ann.  me'd.
 psychol, Par. 1954, 112(2) : 449-450.
 Ravina, A.,  Pestel,  M., Albouy, R.   Alcoolisme aigu et
 delirium tremens en milieu hospitalier  parisien.  Con-
 siderations cliniques et therapeutiques  a propos de 40
 cas recents.  [Acute alcoholism  and delirium tremens
 in a Paris hospital setting.   Clinical and therapeutic
 considerations  regarding 40  recent  cases.]  Bull  Soc.
 med. hop. Paris, 1955, 71: 698-703.
 Riser, M., Laboucarie, J, Barres, P.  Hibernation dans
 les  psychoses hyperthermiques.   [Hibernation in hyper-
 thermic  psychoses.]   Ann. me'd. psychol, Par., 1953,
 111(2) : 207-212.
 ---, Geraud, J., Laboucarie, J., Rascol, A., Clausse, S.,
 Garrigues, M. P.  Considerations etiologiques et thera-
 peutiques  sur  les  delirium tremens; a  propos de  75
 cas.  [Etiologic and  therapeutic considerations of de-
 lirium  tremens;  75  cases.]   Rev.   neur., Par., 1956,
 94: 662-667.
 Rives, Menager, V. Neuroplegic et delirium tremens.
 [Neuroplegic therapy and delirium tremens.]   Anes-
 thCsie, Par., 1953, 10: 450-453.
 Rizzo, E. M.  SulTazione del largactil associato ai bar-
 biturici  in  malati di mente.   [The effect of largactil
68 
SUBJECT LIST
Chlorpromazine: Various special techniques —
    Therapeutic use — Psychosomatic diseases
  combined with barbiturates on mental patients.]   Riv.
  neur., Nap., 1953, 23 : 824-828.
  Royer, P., Beis, M., Burner, M.  Essai de traitement d'un
  deiire chronique par  cure de sommeil.   [Sleep therapy
  of a patient in chronic delirium.]  Rev.  me'd. Nancy,
  1954,  79: 600-607.  Abstract:  Excerpta med., Sect.  8,
  1955, 8: No. 4920.
  Ruyer, M.  Hibernation dans les confusion alcooliques
  aigues.   [Hibernation in acute  alcoholic  confusions.]
  82 p.   [Mimeographed]   Strasbourg, 1954.   [Thesis—
  Strasbourg, 1954, no. 74]
  Sagripanti, P.  Leucotomia  e ipnoterapia in un caso  di
  psicosi ossessiva.  [Leukotomy and sleep therapy  in an
  obsessive psychotic patient.]  Minerva med., Tor.,  1953,
  44: 259-260.  [Not seen]
  Sarro, R.  Recents developpements de la therapeutique
  narcobiotique.   [Recent developments  in narcobiotic
  therapy.]  Ence'phale, 1956, 45:501-510.
  Scherrer, P.,  Leclerc, J., Bize, N.  Un cas d'encephalite
  psychosique azotemique gueri par hibernation chez une
  cesarisee.  [A  case of  uremic psychotic  encephalitis
  after  cesarean  section cured by artificial hibernation.]
  Ann. med. psychol, Par., 1953,111(1) : 519-523.
  Segerath, F.  Uber Erfahrungen mit der  Megaphenbe-
  handlung in  der Psychiatrie.  [Experience with mega-
  phen  treatment in psychiatry.]  3Iiinch. med. Wschr.,
  1954,  96: 260-261.
  Simonetti,  L.  I neuroplegic! nel trattamento delle psi-
  cosi confusionali acute.  [Neuroplegic drugs in the treat-
  ment  of  acute  confusional psychoses.]   [English  sum-
  mary]  Neuropsichiatria, 1954, 10: 265-275.  Abstract:
  Excerpta med.,  Sect. 8,1955, 8 : No. 3640.
  Sivadon, P., Koechlin, P., Markich,  H.   Trois observa-
  tions de cure de sommeil & Taide du 4560 R. P.  [Three
  cases  of sleep  therapy with  4560 RP.]   Ann.  med.
  psychol, Par., 1953, 111(1) : 204-207.
  Tonini, G.,  Bizzi, B.  La terapia del sonno come ausilio
  nella  comprensione  della  fisiopatologia  delT attivita
  nervosa superiore  nelTuomo.  I. La terapia del sonno:
  basi teoriche; tecnica; risultati.  [Sleep therapy as an
  aid in comprehension of the physiopathology of activity
  of the higher nervous system in humans.  I. Sleep  ther-
  apy:  theoretical  bases;  technic;  results.]   [English
  summary]  Rass.  stud, psichiat., 1954, 43: 780-803.
  Vurdelja, N.,  Jelesic, G.  Psychosenbehandlung mit Hi-
  bernation nach  Laborit.   [Psychoses treated by La-
  borit's hibernation method.]   Wien.  Arch.  Psychol,
  1955,  5:193-197.  Abstract: Excerpta  med.,  Sect.  8,
  1957,10:  No. 1982.
  Walther-Buel, H.  Zur klinischen Therapie der endoge-
  nen Psychosen.   [On clinical therapy of  endogenic psy-
  choses.]  Nervenarzt, 1954, 25 :191-194.

—Therapeutic use—Psychosomatic diseases
  Antonelli, F.  Applicazione  della cloropromazina  nella
  pratica reumatologica, con particolare riferimento alia
  nevrosi reumatica. [Application of chlorpromazine in
  rheumatology, with special reference to rheumatic neu-
  rosis.]  Arch, psicol. neur., Milano,  1956, 17: 558-561.
  Bartsch,  W., Sperling,  E.   Schmerzbehandlung  mit
  Phenothiazinderivaten (Megaphen und Atosil).  [Phe-
  nothiazine derivatives (megaphen and atosil)  in  ther-
  apy of pain.]  Nervenarzt, 1956, 27 : 458-463.
  Broglie, M., Jbrgensen, G.,  Voss,  G.  Uber die neuro-
  ganglioplegische Behandlung innerer Krankheiten mit
  Phenothiazinderivaten unter besonderer Beriicksichti-
" gung  des  Asthma bronchiale.   [Neuro-ganglioplegic
  therapy with  phenothiazine derivatives in internal di-
  seases, particularly bronchial asthma.]  Aerztl. Wschr.,
  1953, 8: 1148-1152.
  Buisson, J.  E.  Therapeutiques de sommeil en psychia-
  trie et en medecine psychosomatique.   [Sleep therapy
  in psychiatry and  in psychosomatic medicine.]   Sem.
  hop. Paris, 1954, 30:155-158.

     456132—59----<3
Cremieux, A.  Traitement de Tanxiete.  [Treatment of
anxiety.]  3Iarseille med., 1956, 93 : 327-331.
Delay, J., Deniker, P., Tardieu, Y.  Hibernotherapie et
cure  de  sommeil  en therapeutique psychiatrique et
psycho-somatique.  [Hibernotherapy and sleep therapy
in psychiatry and psychosomatic  medicine.]   Presse
me'd., 1953, 61:1165-1166.
----,  ----,   ----.  Resultats  de  Thibernotherapie
dans  trois affections  psychosomatiques.   [Results of
hibernotherapy in three psychosomatic diseases.]  Ann.
med.  psychol., Par., 1953, 111(2) : 224-227.
Fabris, F. A  propos du traitement de la douleur des
cancereux.  [Contribution to the treatment of pain in
cancer patients.]   Presse med.,  1955, 63 : 727.
Fliigel, F. Erfahrungen mit Megaphen in der psychia-
trischen und neurologischen Klinik.  [Experiences with
chlorpromazine  in the  psychiatric  and neurological
clinic] Arch. klin. Chir., 1954,  279: 767-772.
Furtado,  D.  Chlorpromazine dans les depressions des
hypertendus.   [Chlorpromazine therapy of depressions
in hypertensive patients.]  Ence'phale, 1956, 45 : 572-575.
Guilly, P.  Formes cliniques et traitement de Tinsomnie.
[Clinical forms and treatment of insomnia.]  Rev. prat,
Par., 1954, 4: 1571-1581.
Heimendinger, E., Klotz, G., Champy, M. Essais de cure
de sommeil dans quelques affections oto-rhino-laryngo-
logiques.  [Trial sleep therapy in various otorhinolaryn-
gological  diseases.]  Rev. otoneur.,  Par., 1956, 28:138-
143.
Kleinsorge, H., Rosner, K.  Schlaftherapie mit  Pheno-
thiazinderivaten.   [Sleep therapy  with  phenothiazine
derivatives.]   Ther. Gegenwart, 1956, 95:441-446.  *
Klose, G., Siemon, G.  Hinweis auf die  Moglichkeit
einer Dauerschlafbehandlung der Tuberkulose mit Me-
gaphen und Atosil.   [Suggestion of the possibility to
use prolonged sleep therapy  with megaphen and atosil
in tuberculosis.]   Beit. Klin. Tuberk., 1955, 113:424-
431.                                                *
Korting, G. W., Borelli, S., Kimmig, J.  Welche Bedeu-
tung besitzen die Phenothiazine fur  die Behandlung von
Hautkrankheiten?  [Of what significance are phenothi-
azines  in  the  treatment  of skin  diseases?]   Derm.
Wschr., 1956, 134: 1245-1252.
Linke, H.   Erfahrungen in der  Behandlung akuter und
chronischer Schmerzzustande  mit  den  Phenothiazin-
korpern Megaphen und Atosil.  [Experiences  in the
treatment  of acute and chronic pain states with the
phenothiazine derivatives megaphen and atosil.]   [Eng-
lish  summary]  Munch, med.  Wschr., 1955, 97:1689-
1692.
----.   Uber die  Wirkung des Phenothiazin-Heilschlafs
schlafs bei schweren  vegetativ thalamischen Schmerz-
zustanden.  [Effects  of phenothiazine  induced thera-
peutic sleep in severe pain of autonomic and thalamic
origin.] Aerztl  Wschr., 1956,11: 815-819.
Rossini, R., Dazzi, P.   Sindromi psichiche nel morbo di
Basedow  e tiroidectomia;  efficacia terapeutica  della
cura del sonno.   [Psychic syndromes in Basedow's di-
sease and thyroidectomy; effectiveness of  sleep  ther-
apy.]   Gior. clin. med., 1953, 34:1018-1028.  Abstract:
Riv. neur., Nap., 1954, 24: 305.
Salomone, F. P., Peria,  G., Rodolico,  G., Cacoiola, R.
Le medicazioni neuroplegiche nelle terapia del  dolore.
[Neuroplegics in therapy of pain.]   31inerva chir., Tor.,
1955,10: 296.
Sercl, M.,  Bartousek, V., Jachova, D. Experiences  clini-
ques sur la neuroplegique et l'hibernation  dans les af-
fections du systeme nerveux.  [Clinical experiences with
neuroplegia and hibernation  in diseases of the  nervous
system.]  Gaz. med. France,  1956, 63:1981-1982; 1984;
19S7-1988.
Sollgruber, A.   Erfahrungen  fiber die Phenothiazin-
Schlaftherapie in  der  internen Medizin.   [Experiences
with phenothiazine sleep therapy in internal medicine.]
Wien. med. Wschr., 1955,105 : 807-808. 
Chlorpromazine: Various special  techniques-
Therapeutic use — Psychosomatic diseases
PSYCH0PHAR3IACA
   Walhs, R.  Potentiation  of  hypnotics and analgesics;
   clinical experience with chlorpromazine.  N. York State
   J. M., 1955, 55 : 243-245.

 —Untoward effects [see headnote p. 19]

     see also  CHLORPROMAZINE—Untoward effects
   Baruk, H.  La catatonie experimentale par la  chlor-
   promazine ; la posologie et la methode d'administration
   la  plus efficace en therapeutique psychiatrique.   [Ex-
   perimental catatonia produced  with chlorpromazine;
   the dosage and most effective method of chlorpromazine
   therapy in psychiatry.]  Ence'phale,  1956, 45:474-476.
   ----.   Quelques precisions sur la therapeutique par le
   sommeil en psychiatrie; sommeil et narcose; danger des
   facteurs toxiques.  [Notes on sleep therapy in psychia-
   try ; sleep and narcosis ; danger of toxic factors.]   Ann.
   me'd. psychol, Par.,  1953, 111 (2) : 523-525.
   ----.   Les therapeutiques psychiatriques.   [Psychia-
   tric therapies.] 128 p.  Paris, Presses universitaires de
   France [Que sais-je?  Le  point des  connaissances
   actuelles   (691)]  1955.   Les therapeutiques  physiolo-
   giques  sedatives;  cures  de  sommeil; chlorpromazine.
   [Physiologic sedative therapies; sleep therapy  chlor-
   promazine.]   p. 109-116.
   ----, Launay, J., Berges,  J.  Physiologie psychiatrique
   experimentale de la  chlorpromazine  chez  les animaux
   et  ses applications therapeutiques chez l'homme.   [Ex-
   perimental  psychopharmacology  of chlorpromazine in
   animals and its therapeutic applications in man.]   En-
   cephale, 1956, 45 : 1258-1263.                       *  *
   Belot, P., Decourt, P.  Effet du N68  sur des perturba-
   tions psychiques d'origine instinctive chez des chiens.
   [The effect of N-68 on psycho-sexual disorders of dogs.]
   Ann. med. psychol, Pur.,  1956, 114 (2) : 112-116.
   Charatan,  F.  B.   An  evaluation of chlorpromazine
   ("largactil")  in psychiatry.  J. Ment. Sc,  Lond., 1954,
   100: 882-893.   Abstract: Excerpta med., Sect. 8, 1955
   8: No. 3639.                                      *  *'
   Gutenkauf,  C.  Internal  medicine.   In:  "Happiness
   pills" in medical practice: a symposium.  J. Iowa M.
   Soc, 1957, 47: 59-64.
   Neuwirtova, R., Zwetschke, O., Zahradka,  L.  Pokus  o
   sebevrazdu  largactilem  a  barbiturany.  [Attempted
   suicide with  largactil and  barbiturates.]   [English
   summary]   Cas. lek. cesk., 1956, 95 : 1361-1364.
   Ratschow,  M.  Der Heilschlaf mit Phenothiazin-Deri-
   vaten   (Atosil und  Megaphen).   [Therapeutic  sleep
   with phenothiazine derivatives (atosil and  megaphen)]
   Medizinische, 1953: 1351-1354.

—with Intermittent Photic  Stimulation
   see under CHLORPROMAZINE  with   INTERMIT-
            TENT  PHOTIC STIMULATION
              Studies, patients

—with Psychosurgery—Combined
   see CHLORPROMAZINE  with PSYCHOSURGERY
        [SAGRIPANTl]

—with Shock therapy [ECT1—Combined

for shock therapies with chlorpromazine alone
see CHLORPROMAZINE with  SHOCK THERAPIES
                       with SHOCK THERAPY [ECT]
                        with SHOCK THERAPY [ICT]
  Abely, P.,  Abdouchelli, A., Fourment, J., Schmitz,  B.,
  Delteil, P.   Suite aux  essais therapeutiques  de reequili-
  bration instinctive-affective; essai de traitement par la
  bromure tetra-ethyl d'ammonium  en comparaison avec
  le R.  P. 45-60 et  le  C. 92-95.  [Further  therapeutic
  studies on the  restoration of instinctive-affective  bal-
  ance ; therapeutic trials with  tetraethylammonium bro-
  mide in  comparison with R. P. 45-60  and with C. 92-
  95.]   Ann. m4d. psychol, Par., 1952, 110(2) : 262-267.
  Bobon, J. Chlorpromazine et cure de sommeil.  [Chlor-
   promazine  and sleep therapy.]   Ence'phale,  1956,  45:
   421-427.
   Carpitella,  A., Cirincione,  E.   L'associazione ganglio-
   plegici e barbiturici  in  psichiatria.   [Association  of
   ganglioplegics and barbiturates in psychiatry.]   [Eng-
   lish summary]  Rass. stud, psichiat, 1954, 43 : 919-936.
   Fiore, C. Risultati terapeutici dell'associazione neuro-
   ganglioplegici-barbiturici   ed  elettrochock  in   alcune
   malattie  mentali.   [Therapeutic  results  of  combined
   neuroganglioplegics,  barbiturates  and  electroshock  in
   some mental  diseases.]   Rass. neuropsichiat, 1955,  9:
   85-98.
   Furtado,  D.  Chlorpromazine dans les  depressions des
   hypertendus.   [Chlorpromazine therapy of depressions
   in hypertensive patients]   [ECT]  Encephale, 1956, 45:
   572-575.
   Gherarducci,  D.  A propos de  Tutilisation  de la chlor-
   promazine  associee a d'autres therapeutiques  psychi-
   atriques.   [Utilization of  chlorpromazine  associated
   with other  psychiatric therapeutics.]  Encephale, 1956,
   45 : 1187-1189.
   Kalinowsky,  L. B.  The  danger  of various types  of
   medication  during  electric  convulsive  therapy. Am.
   J. Psychiat.,  195(1,  112:745.                      * *
   Lafon, R., Due, N., Abric, J., Pouget, R., Comelade,  P.
   Etude comparative du 4.560 R. P. (chlorpromazine)  et
   de la  reserpine dans  les syndromes schizophreniques.
   [Comparative study of R.  P. 4560 (chlorpromazine) and
   reserpine in  schizophrenic syndromes.]   Ence'phale,
   195(5. 45:668-671.   [also  metrazol  shock]
   Librando, L.,  Paretti,  E.  Considerazioni su un biennio
   di esperienza in  terapia  ganglioplegica,  in psichiatria.
   [Two  years of ganglioplegic  therapy in  psychiatry.]
   [ECT]  Riv. sper. freniat., 1955, 79  : 696-699.
   Lieser,  H.  Lasst sich die auftretende Angst  vor einer
   Schockbehandlung beeinflussen?  [Can one control fear
   of shock therapy?]   Deut med. Wschr., 1956,  81: 1503-
   1504.
   ----.   Uber  die  synergistische  Megaphen-Krampfbe-
   handlung.   [Synergistic combination of megaphen with
   shock therapy.]  Nervenarzt, 1956, 27 : 69-72.
   Marck, H. La cure de sommeil; etude de 103 cas.   [Sleep
   therapy:  a  study of  103 cases.]   79 p.  Paris   1953
   [Thesis—Paris, 1953, no.  579]
   Pauly, R.  Remarques a  propos d'une statistique per-
   sonnels sur les avantages, les limites et les  accidents
   de Thibernotherapie a la  chlorpromazine.   [Comments
   on  personal  experiences  with chlorpromazine  hiber-
   notherapy, its advantages, limitations and accidents]
   [ECT]  J. me'd. Bordeaux, 1954, 131: 235-244       * *
   Sal y Rosas,  F., Jeri,  R.,  Sanchez, J.  La" chlorproma-
   zine chez  les  malades mentaux peruviens.  [Chlorpro-
   ™in^th.e™ Py of mental  Patients in Peru.]  Encephale.
   1956, 45: 599-604.
  —-.——.----• Chlorpromazine  in neurospychiatrv.
  J. Am. 31. Ass., 1954,156 : 558.
  Wachsmuth, R. Phenothiazinderivate (Megaphen)  in
   der  Psychiatrie.   [Phenothiazine derivatives (mega-
  phen) in psychiatry.]  Medizinische, 1955 : 32K-329.
—with Shock therapy [7C77]—Combined

  fej G°lse' ,J>  Coma insulinique et coma par hi-

  S2, J$^£Z!$nanA coma by hibernati--i

—with Shock  therapy  [ICT]—Compared
  see also preceding reference
  Azima,  H.   Prolonged sleep treatment  in  mental dis-
  SferS;rn£me  nGW  Psychopharmacological considera-
  tions.  [Chlorpromazine 4- barbiturates]  J  i/>„/ ar
  Lond., 1955,  101:593-603.                   '         "'

with ATARAXICS [2 or more]
  see ATARAXICS— Various [3 or more1
70 
SUBJECT  LIST
Chlorpromazine : with Mepazine Compared :
             Therapeutic studies, controlled
 with AZACYCLONOL
  see AZACYCLONOL—Psychotherapeutic use
      AZACYCLONOL with CHLORPROMAZINE

 with CB-1522—COMPARED see CB-1522

 with Chlorpromazine as potentiator—Compared
 with  Chlorpromazine cocktail—Compared
  see CHLORPROMAZINE—Various special techniques
      —Compared with Chlorpromazine alone

 with CETIPROMAN—COMPARED
  see under CHLORPROMAZINE with  PROMETHA-
       ZINE— COMPARED—Studies, animals

 with COVATIN—COMBINED
 Pharmacodynamics
  Decourt, P.  Mecanisme d'action de  la therapeutique
  narcobiotique en general, et de la chlorpromazine en par-
  ticulier, en psychiatrie.  [Mechanism of action of nar-
  cobiotic psychiatric therapy in general, and of  chlor-
  promazine in particular.]  Encephale, 1956, 45 : 932-944.
 Therapeutic use
 —Neuroses
  Arnold, O. H.  Erfahrungsbericht fiber das Tagesseda-
  tivum Covatin.   [Experiences with the day-time seda-
  tive covatin.]   Wien. med.  Wschr., 1956, 106: 510-512.

 —Psychoses
  Fouks, Laine, Francois, Pagot.  La correction des effets
  secondaires des medications dites neuroleptiques.  [Cor-
  rection of the secondary effects of so-called neuroleptic
  drugs.]  Ann.  med. psychol, Par., 1956, 114(1): 615-
  620.
  Mielke,  F. A.   Methods  employed and results obtained
  in psychiatric  studies with  new  drugs  acting on the
  brain stem. Am. J. Psychiat., 1957, 114:134-139.
  Sarro, R.  Recents developpements de la therapeutique
  narcobiotique.    [Recent developments in  narcobiotic
  therapy.]  Ence'phale, 1956, 45 : 501-510.
  Werenberg, H.  Covatinbehandling af  psykoser og neu-
  roser.   [Covatin therapy of psychoses and  neuroses.]
  Ugeskr.  laeger, 1956, 118 :1099-1100.

 with COVATIN—COMPARED
  Belot, P., Decourt, P.  Effet du N68  sur des perturba-
  tions psychiques d'origine  instinctive  chez  des chiens.
  [The effect of N-68 on psycho-sexual disorders of dogs.]
  Ann, med. psychol, Par., 1956,114(2) : 112-116.
  Decourt, P. Mecanisme d'action de  la therapeutique
  narcobiotique  en general,  et  de la chlorpromazine  en
  particulier, en psychiatrie.  [Mechanism' of action of
  narcobiotic psychiatric therapy in  general, and of  chlor-
  promazine in  particular.].  Encephale, 1956, 45:932-
  944.
  Leyritz,  Le Bezu, Azoulay. Etat  depressif  avec  obses-
  sion resistant  au largactil; guerison rapide par la cova-
  tine (N68) ; resultats moins heureux dans quinze cas dif-
  ferents.  [Depressive state with obsession resistant to
  chlorpromazine therapy; rapid recovery with covatin;
  less beneficial results in fifteen other  patients.]   Ann.
  med. psychol, Par., 1956,  114(2) : 856-861.

with HYDROXYZINE—COMBINED
  Fouks, Laine, Francois, Pagot.  La correction des effets
  secondaires  des  medications  dites  neuroleptiques.
  [Correction of the secondary effects of so-called neuro-
  leptic drugs.]   Ann. med. psychol, Par., 1956, 114(1) :
  615-620.
  Laboucarie, J., Barres, P., Rascol, A. Aspects principaux
  des cures neuropiegiques en psychiatrie en 1956.  [Prin-
  cipal features  of neuroplegic therapy  in psychiatry in
  1956.]   Toulouse med., 1956, 57 : 851-S67.
with HYDROXYZINE—COMPARED
  Farah, L.  Preliminary study on the use of hydroxyzine
  in psychosomatic affections.  Internat. Rec. 31., 1956,
  169: 379-389.  Abstract: Excerpta med.,  Sect.  8, 1957,
  10: No. 845.
  Robinson, H. M., Jr., Robinson, C. V., Strahan, J. F.
  Hydroxyzine (atarax) hydrochloride  in dermatological
  therapy.  J. Am. 31. Ass., 1956,161: 604-606.

with LYSERGIC ACID DIETHYLAMIDE
  see LYSERGIC ACID DIETHYLAMIDE with CHLOR-
       PROMAZINE

with  LYSERGIC ACID   DIETHYLAMIDE, BROMI-
         NATED
  see LYSERGIC  ACID  DIETHYLAMIDE, BROMI-
         NATED  with CHLORPROMAZINE

with LYSERGIC ACID ETHYLAMIDE—COMPARED—
       Themd6it tic us€
  see LYSERGIC ACID  ETHYLAMIDE—Therapeutic
        use

with MEPAZINE—COMBINED
  Bouchard, M., Larue, G. H., Turmel, J.   Le frenquel
  en psychiatrie;  rapport preliminaire.  [Frenquel  in
  psychiatry; preliminary report.]   Laval me'd., 1956, 21:
  765-776.
  Bowes, H. A.  The ataractic drugs;  the  present posi-
  tion of chlorpromazine, frenquel, pacatal, and reserpine
  in the psychiatric hospital.  Am. J. Psychiat., 1956, 113 :
  530-539.
  Braun, M.  Pacatal.  Am. J. Psychiat, 1957, 113: 838-
  839.
  ---.  Treatment of  psychoses with  a combination of
  pacatal and thorazine.  Am. J.  Psychiat, 1957,  114:
  460.
  Bruckman,  N.,  Kitchener, M., Saunders, J.  C, Kline,
  N. S.  Mepazine  (pacatal)—further  report.  Am. J.
  Psychiat, 1957, 114 : 262-263.
  Feldman, P.  E.  Two-year  fate  study  of thorazine-
  treated patients.  Am. J. Psychiat, 1957, 114: 237-240.
  Friese, K. H.  Vorlaufige Erfahrungen bei der Behand-
  lung   psychiatrischer Kranker  mit  Phenothiazinen.
  [Experiences with phenothiazine therapy in psychiatry.]
  31edizinische, 1956: 734-735.
  Hiob,  J., Hippius,  H. Uber die Behandlung von Psy-
  chosen mit  dem Phenothiazinderivat Pacatal.  [The
  treatment of psychoses with the phenothiazine deriva-
  tive pacatal.]   3Ied.  Klin., Berl, 1955,  50:1746-1748.
  Abstract: Excerpta med., Sect. 8,1957, 10 : No. 1544.
  Patton, G. O.,  Garneau, J.  The ataraxic drugs in  dis-
  turbed secluded psychiatric patients.   Canad. Serv. M.
  J., 1957, 13 : 127-133.
  Simpson, R.  W.  The  effects of  pacatal on  chronic
  mental illness.  J. Ment. Sc, Lond., 1957, 103: 610-613.

with MEPAZINE—COMPARED

Studies, animals
  Nieschulz, O., Popendiker, K.,  Hoffmann, I.  Weitere
  pharmakologische  Untersuchungen  Uber  N-Methyl-
  piperidyl-(3)-methyl-phenothiazin.   [Further pharma-
  cological  studies  of  N-methyl-piperidyl-(3)-methyl-
  phenothiazine]     [English  summary]    Arzneimitt.
  Forsch., 1955, 5 : 680-695.

Therapeutic studies,  controlled—Psychoses
  Leiberman, D. M., Vaughan, G. F.  The  use of some
  new pharmacological agents in psychiatry. J.  Ment.
  8c, Lond., 1957, 103:110-118.
  Lomas, J. Treatment of schizophrenia;  "pacatal"  and
  chlorpromazine compared.  Brit. 31. J., 1957, 2: 78-80.
  Rudy, L. H., Himwich, H.  E., Tasher, D. C.  Clinical
  evaluation of two phenothiazine compounds promazine
  and mepazine.   Am. J. Psychiat,  1957, 113: 979-983. 
Chlorpromazine : with Mepazine Compared :
Therapeutic studies, controlled
PSYCHOPHARMACA
  Simpson, R. W.  The effects of pacatal on chronic men-
  tal illness.  J. Ment. Sc, Lond., 1957,103: 610-613.
  Thorpe, J. G., Baker, A. A.  A research method to assess
  a new tranquilizing drug.  J. Ment. Sc, Lond., 1956,
  102: 790-795.

Therapeutic use
  MacGregor, J. MacW.  Pacatal-a clinical trial of a new
  ataractic drug.  S. Afr. 31.  J., 1956, 30:1108-1111.
  Mitchell, P. H., Sykes, P., King, A.  Effects of pacatal on
  symptoms in chronic psychotic in-patients.   Brit M. J.,
  1957, 1:204-207.                                  *
  Seitz, D.  Die Schlafbehandlung mit Phenothiazinen in
  der Neurologic  [Sleep therapy with phenothiazines in
  neurology.]  Nervenarzt, 1956, 27:19-23.

with MEPHENESIN—COMBINED
Psychotherapeutic use
  Berger, H.  Management of neuroses by the  internist
  and general practitioner.   N. York State J. 31., 1956,
  56: 1783-1788.

with MEPHENESIN—COMPARED
  Mitchell, E. H.  Chlorpromazine in  the treatment of
  acute alcoholism.  Am.  J.  31.  Sc, 1955, 229:363-367.
  Abstract: Excerpta  med.,  Sect. 8,  1957, 10: No.  884.
  Q. J. Alcohol, 1955,16 : 589-590.
  Sainz, A. A.  The treatment of  drug and alcohol with-
  drawal effects with thorazine.   Psychiat. Q., 1957,  31:
  275-284.

with MEPROBAMATE—COMBINED
  Barsa, J. A., Kline, N. S.   Use  of meprobamate in  the
  treatment of psychotic patients.  Am. J. Psychiat., 1956,
  112:1023.
  Borrus, J.  C.  Meprobamate in psychiatric disorders.
  Med. Clin. N. America, 1957, 41: 327-337.
  Fox, V.  Treatment  of  withdrawal symptoms in  the
  management of alcoholism.  J.  M.  Ass.  Georgia, 1956,
  45:  139-142.
  Hormia,  A. Meprobamaatista  neuropsykiatriassa  sa-
  atuja  hoitokokemuksla.   [Meprobamate therapy   in
  neuropsychiatry.]  [English summary] Duodecim, Hel-
  sin., 1956, 72: 1019-1024.
  Osinski, W. A. Treatment of anxiety states with me-
  probamate  (miltown).  Internat.  Rec.  31.,  1956, 169:
  589-595.

with MEPROBAMATE—COMPARED

Therapeutic studies, controlled
  Dierkens, J., Reeth,  P. C.  van.  E'ssais cliniques d'un
  nouveau  psychopiegique:  le meprobamate.   [Clinical
  trial of  a  new  phychoplegic  drug: meprobamate.]
  [English summary]  Bruxelles  med., 1956,  36:2335-
  2340.
  Kessler,  L.  N., Barnard,  R.  D.  A  new tranquilizer
  meprobamate,  its  use for pain associated with cancer.
  Preliminary report.  3Ied. Times, Great Neck, 1956,  84:
  431-435.
  LeVan, P.,  Wright, E. T.  Use of tranquilizers in dis-
  eases of the skin ; a preliminary report.   California M.,
  1956, 85: 87-88.
  Osinski, W. A. Treatment of anxiety states with me-
  probamate  (miltown).  Internat.  Rec  31.,  1956, 169:
  589-595.
  Robinson, H. M., Jr., Robinson, C. V., Strahan, J. F.
  Hydroxyzine (atarax) hydrochloride in dermatological
  therapy.  J. Am. M. Ass., 1956,161: 604-606.

Therapeutic use
  Follin,  S., Sigg, B., Pivet, S., Girard, C.  Essais d'une
  nouvelle  drogue tranquillisante. [Clinical study of a
  new tranquilizer.]   [Meprobamate]  Ann.  me'd.  psy-
  chol, Par., 1956, 114 (1) : 825-830.
  Lemere,  F.  New tranquilizing drugs.  Northwest M.,
  1955, 54:1098-1100.

with  MESCALINE                 lfl„TV_
  see MESCALINE with CHLORPROMAZINE

with METHOPROMAZINE—COMPARED
  see METHOPROMAZINE

with  METHYLPHENIDYLACETATE—COMBINED

Therapeutic studies, controlled
  Ayd, F. J., Jr.  A clinical evaluation of methyl-pheni-
  dylacetate  hydrochloride  (ritalin).   J.  Clin.  Exp.
  Psychopath., 1957, 18: 342-346.
  Clark, L. D., Ellsworth, R. B„ Barrett, W. W., Thurman,
  A. C, Holland, W.  Studies of the behavioral effects of
  ritalin.  Dis. Nerv. Syst., 1956,17 : 317-321.
  Madi,  M. L.,  Kovitz, B.  Experiences with  methyl-
  phenidylacetate  hydrochloride  (ritalin)  in psychotic
  patients.  Antibiotic 31., 1956, 3 : 309-311.

Therapeutic use
  Ayd, F. J., Jr.  Physiologic and neurologic responses to
  chlorpromazine:  their clinical  significance  and their
  management.  Psychiat. Res. Rep., Wash., 1956 (4) : 64-
  70.

with METHYLPHENIDYLACETATE and RESERPINE
  see  CHLORPROMAZINE  with   RESERPINE  and
         METHYLPHENIDYLACETATE

with N-OBLIVON—COMPARED
  see N-OBLIVON—Studies, animals

with NP-207—COMBINED
  see NP-207  with CHLORPROMAZINE—COMBINED
with NP-207—COMPARED
  see NP-207

with PERPHENAZINE—COMPARED
  see PERPHENAZINE—Studies, animals
                        Therapeutic studies, controlled

with PIPRADROL—COMBINED

Studies, animals
  Rinaldi,  F., Himwich, H.  E.  The  cerebral  electro-
  graphic changes  induced by  LSD and mescaline  are
  corrected by frenquel.  J. Nerv. 3Ient.  Dis.,  1955, 122:
  424-432.

Therapeutic use
  Antos,  R. J.  A  preliminary report of  clinical studies
  on a new stimulant.  Arizona M.,  1954, 11: 397-399.
  Ayd, F. J., Jr.  Physiologic and neurologic responses to
  chlorpromazine:  their clinical  significance  and their
  management.  Psychiat. Res. Rep., Wash., 1956 (4) : 64-
  70.
  Begg, W. G. A., Reid,  A. A. "Meratran", a  new stimu-
  lant drug. Brit. M. J., 1956, 1: 946-949.
  Le Guillant. Le  syndrome neuroleptique: prevention et
  traitement.  [The  neuroleptic  syndrome:   prevention
  and treatment]  Ann, me'd. psychol, Par. 1957. 115(1):
  329-338.
  Pennington, V. M. A comparative study of six ataraxics
  in 1130 neuro-psychiatric cases.   31ississippi Doctor,
  1956, 33: 336-339.

with PROCLORPERAZINE—COMPARED
  see PROCLORPERAZINE with CHLORPROMAZINE

with PROMAZINE—COMPARED
Therapeutic studies, controlled
  Azima, H., Durost, H. Effects of promazine in mental
  syndromes.  Canad. 31. Ass. J., 1957, 76: 442-446
  Barsa,  J. A., Kline, N. S.  Promazine in chronic schizo-
  phrenic patients.  Am. J. Psychiat, 1957 113 • 654
72 
SUBJECT  LIST
Chlorpromazine : with Rauwolfia serpentina alkaloids
  Burdine, W. E., Shipley, T. E., Papas, T. A.  Studies on
  the use of promazine in acute and chronic nervous and
  mental disturbances.  J. M. Ass. Georgia, 1957, 46:171-
  173.
  Lesse, S.  An evaluation of promazine  hydrochloride
  in psychiatric practice.  Am. J. Psychiat.,  1957, 113:
  984-987.
  Mitchell,  E. H.   Treatment  of  acute  alcoholism with
  promazine (sparine).  J. Am. M. Ass., 1956,  161:44-45.
  Condensed: Am.  Practitioner, 1956,  7:1798-1799.  Ab-
  stract: Excerpta  med., Sect. 8, 1957, 10: No.  359.
  Usdin, G. L.  Use of promazine in psychiatric practice;
  an early study.   J. Louisiana M. Soc, 1956, 108:251-
  257.

Therapeutic use
  Blackley,  R. J.   Disappearance of  chlorpromazine-in-
  duced photosensitivity on substitution of promazine;
  report on eight cases.  Am. Practitioner, 1957, 8: 46-47.
  Craddock, W. L.   Toxic effects of chlorpromazine; hepa-
  titis and agranulocytosis.  U. S. Armed Forces M. J.,
  1956, 7:1726-1740.
  Fazekas, J. F., Schultz, J. D., Sullivan, P. D., Shea, J. G.
  Management of acutely disturbed patients with proma-
  zine (sparine).   J. Am. M. Ass., 1956, 161: 46-49.  Con-
  densed : Am. Practitioner, 1956, 7:1807.
  Lemere, F.  Promazine (sparine) in the treatment of
  psychiatric disorders.  Northwest M., 1956, 55 : 790-791.
  Martin,  D.  A.  The  therapeutic and toxic effects  of
  tranquilizing drugs: medical aspects.  North Carolina
  M. J., 1956, 17: 396-401.
  Rudy, L H.,  Himwich, H. E.,  Tasher,  D.  C. Clinical
  evaluation of  two phenothiazine compounds promazine
  and mepazine.  Am.  J. Psychiat., 1957, 113: 979-983.
  Shea, J. G, Ehrmantraut, W. R., Ticktin, H. E., Sullivan,
  P. D., Jr., Fazekas, J. F.  Use of promazine in the man-
  agement of medical emergencies.  3IU. M., 1956,  119:
  221-227.                                           *
  Voegele, G. E., May, R. H.  Epileptiform seizures under
  promazine therapy; occurrence in two cases without his-
  tory of former seizures.  Am. J. Psychiat., 1957, 113:
  655-656.

with PROMETHAZINE—COMBINED
  see CHLORPROMAZINE—Various  special techniques

with PROMETHAZINE—COMPARED

Pharmacodynamics
  Baruk, H., Launay, J., Berges,  J.  Physiologie psychi-
  atrique experimentale de  la chlorpromazine  chez les
  animaux et ses applications therapeutiques  chez Thom-
  me.   [Experimental  psychopharmacology of  chlorpro-
  mazine in animals  and its therapeutic applications in
  man.] Ence-phale, 1956, 45:1258-1263.

Studies, animals
  see also preceding reference.
  Cazzullo, C. L., Guareschi, A. Influenza  di un  derivato
  della fenotiazina, largactil,  sull'attivita elettrica delT
  encefalo del cane.  [Effect of  a phenothiazine deriva-
  tive largactil,  on the electric activity of the  brain, in
  dogs.]  [English  summary]  Riv. neur., Nap., 1954, 24:
  602-632.  Abstract:  Chem. Abstr., 1956, 50:  8068b.  Ex-
  cerpta med., Sect. 8,1955, 8 : No. 3097.
  Courvoisier, S. Pharmacodynamic basis for the use of
  chlorpromazine in psychiatry.  J.  Clin. Exp. Psycho-
  path., 1956,17: 25-37.
  ___.  Sur les proprietes  pharmacodynamiques  de la
  chlorpromazine en rapport avec son  emploi  en psychia-
  trie.   [Pharmacodynamic  basis for the use  of  chlor-
  promazine in  psychiatry.]   Ence'phale, 1956, 45 :1248-
  1257
  Guareschi, A., Cazzullo, C. L.   SulTazione centrale del
  fargan-  analisi  sintomatologica ed elettroencefalo-
  grafica  [The central action of fargan: symptomatic
  and electroencephalographic analysis.]   [English sum-
  mary] Acta neur., Nap., 1954, 9: 274-293.
  Nieschulz, O., Popendiker, K.,  Hoffmann, I.  Weitere
  pharmakologische  Untersuchungen  fiber   N-Methyl-
  piperidyl-(3)-methyl-phenothiazin.   [Further pharma-
  cological   studies  of   N-methyl-piperidyl-(3)-methyl-
  phenothiazine]   [English   summary]  Arzneimitt
  Forsch., 1955, 5 : 680-695.
  Schmiterlbw, C. G., Hedqvist, H.  Cetiproman, ett nytt
  preparat  for psykiatriskt  bruk.   [Cetiproman, a new
  preparation for psychiatric use.]   Sven. lak, tidn., 1955,
  52 ; 2318-2326.

Therapeutic studies, controlled
  Samuels,  A.  S.  Phenergan  in treatment of psychiatric
  patients.  Dis. Nerv. Syst, 1957,18:183-188.

Therapeutic use
  Erwin, H. J.  Clinical observations on the use of pro-
  methazine hydrochloride in psychiatric disorders.  Am.
  J. Psychiat., 1957,113 : 783-787.
  Rigal.  Traitement de la manie et des  etats d'hyper-
  thymie par  le 3277  R.  P.  (phenergan).  [Phenergan
  therapy  of  mania  and of hyperthymic conditions.]
  J. me'd. Bordeaux, 1952,129 : 899-901.
  Shea, J. G.,  Ehrmantraut, W. R., Ticktin, H. E„ Sulli-
  van,  P. D., Jr., Fazekas,  J. F. Use of promazine in the
  management of medical emergencies. Mil. M., 1956,119 :
  221-227.
with  PROMETHAZINE  and OTHER  DRUGS—COM-
    BINED [=lytic cocktail]
  see  CHLORPROMAZINE—Various special techniques

with RP-4909—COMPARED see RP-4909

with RP-6549—COMPARED see RP-6549

with RP-7044—COMPARED
  see RP-7044—Studies, animals  and Therapeutic  use

with   RAUWOLFIA   SERPENTINA   ALKALOIDS-
    COMBINED

Therapeutic studies, controlled
  Eiber,  H.  B.   Chlorpromazine-Rauwolfia   serpentina
  combination in the treatment of essential hypertension:
  preliminary report.  J. Am. M. Ass., 1955, 158: 730-731.
  ---. Chlorpromazine (thorazine)-Rauwolfia combina-
  tion  in neuropsychiatry; preliminary report.  A. M. A.
  Arch. Neur. Psychiat, 1955, 74: 36-39.  Abstract:  Ex-
  cerpta med., Sect. 8,1956, 9: No. 1218.

Therapeutic use
  Sprowls,  J.  B.  Drugs for  a changing world.  Am.  J.
  Pharm., 1955,127: 42-52.
  Telatin, L.  La Rauwolfia  in neuropsichiatria.  [Rau-
  wolfia in  neuropsychiatry.]   Arch, psicol. neur.,  Milano,
  1956,17:  411-413.
with   RAUWOLFIA   SERPENTINA   ALKALOIDS-
    COMPARED
  Baruk, H., Launay, J., Berges, J., Mijolla, A. de.  Etude
  clinique de Taction therapeutique de la reserpine. Com-
  paraison  avec Taction  des  extraits totaux.   [Clinical
  study of  the therapeutic effect of reserpine; comparison
  with total  extracts.]  Ann. me'd.  psychol, Par.,  1957,
  115(1) : 704-708.
  Eiber, H.   B.   Chlorpromazine-Rauwolfia  serpentina
  combination in the treatment of  essential hypertension:
  preliminary report.   J. Am. M. Ass., 1955, 158: 730-731.
  Sogliani,  G.   Ipnoterapia  con  cloropromazina e Rau-
  wolfia; posologia, associazioni, confronti.  [Sleep ther-
  apy  with  chlorpromazine  and  Rauwolfia; posology,
  combinations  and comparisons.  Minerva med., Tor.,
  1955, 46:1253-1259. 
Chlorpromazine: with Rauwolfia serpentina alkaloids and Other drugs
PSYCHOPHARMACA
with  RAUWOLFIA  SERPENTINA  ALKALOIDS  and
    OTHER DRUGS—COMBINED
  Germano, V., Bellavitis, U. Prime osservazioni cliniche
  sull'uso par enter ale degli alcaloidi della rauwolfia  in
  psichiatria.   [First clinical observations on the  paren-
  teral use of Rauwolfia alkaloids in psychiatry.]   [bar-
  biturates]  Riv. sper. freniat., 1955, 79 : 713-722.
  Rosina, P.  L. Reserpina  nelle psicosi acute.  [Reser-
  pine in acute psychoses.]  [barbiturates]  Arch,  psicol.
  neur., Milano, 1956, 17 : 417.

with RESERPINE—COMBINED

Studies, animals
  Courvoisier,  S.  Pharmacodynamic  basis for the use of
  chlorpromazine  in psychiatry.  J.  Clin. Exp. Psycho-
  path.,  1956, 17: 25-37.
  ----.  Sur les proprietes pharmacodynamiques de  la
  chlorpromazine en rapport avec son emploi  en psychia-
  trie.   [Pharmacodynamic basis for the use  of chlor-
  promazine in psychiatry.]  Ence'phale, 1956,  45:1248-
  1257.
  Everett, G. M., Toman, J. E. P., Smith, A. H., Jr.  Re-
  duction of electroshock seizure latency and other cen-
  tral actions of reserpine.  [Abstract]  Fed. Proc, Bait,
  1955, 14: 337.
  Ferro Milone,  F.,  Gomirato,  G. Observations  experi-
  mentales  sur le comportement de Tactivite corticale
  spontanee  et evoquee sous Taction des neuroleptiques.
   [Changes in spontaneous and evoked cortical activity
  under the influence of neuroleptic drugs; experimental
  results.]  Ence'phale, 1956, 45 : 853-857.
  Schwartzbaum, J. S.  Effects of reserpine and chlorpro-
  mazine on nest building and thermal preference in rats.
  Proc.  Soc. Exp.  Biol,  N. Y., 1955, 90:275-277.  Ab-
  stract : Chem. Abstr., 1956, 50: 2853ab.
  Terzian, H.  Etude experimentale de Taction de la reser-
  pine  (serpasil)  sur les structures nerveuses  centrales.
   [Experimental study of the effects of reserpine  (ser-
  pasil)  on the  central nervous system.]  Ence'phale,
  1956, 45: 835-842.

Studies, patients
  Bente, D.  Elektroencephalographische Ergebnisse zur
  Wirkungsweise  der  neuroleptischen  Behandlungsver-
  fahren.  [Mechanism of action of neuroleptic therapies ;
  EEG findings.]  Ence'phale, 1956, 45 : 898-903.
  ----, Itil, T.  Das Verhalten des Hirnstrombilders  bei
  hochdosierter Behandlung mit Reserpin  (Serpasil) und
  bei  medikamentos erzeugten  parkinsonahnlichen  Zu-
  standsbildern.   [The encephalogram  during  reserpine
   (serpasil)  therapy with  massive doses  and in drug-
  induced  parkinsonism.]   Med.  Klin.,  Berl,  1955, 50:
  1296-1301.
  Brooks, G. W.  Experiences with the use of chlorpro-
  mazine and reserpine in psychiatry, with special refer-
  ence to the significance and management of extrapyram-
  idal dysfunction.   N. England J. M., 1956, 254:1119-
  1123.  Abstract:  Year book of drug therapy, 1956-1957,
  p. 343-344.
  Fliigel, F.  Uber medikamentos erzeugte parkinsonism-
  liche  Zustandsbilder.  [Drug-induced   parkinsonism.]
  3led. Kin., Berl, 1955, 50: 634-635.
  ----, Bente,  D.  Das akinetisch-abulische Syndrom und
  seine Bedeutung ftir die pharmakologisch-psychiatrische
  Forschung.  [Akinetic-abulic  syndrome  and its   im-
  portance   in psychopharmacologic  research.]   Deut,
  med. Wschr., 1956, 81: 2071-2074.
  Shuman, J.  Paralysis agitans developing during reser-
  pine therapy. J. Am. M. Ass., 1955,158: 73.

Therapeutic studies, controlled
  Bordeleau, J. M.  Clinical evaluation of chlorpromazine
  and Rauwolfia serpentina in the psychiatric department
 of  a general hospital.  J.  Florida  M. Ass.,  1956, 42:
 547_554
 Brooks,' G. W.  Experiences with the use of chlorproma-
 zine and reserpine in psychiatry, with special reference
 to  the significance and management of extrapyramidal
 dysfunction.  N. England J. 31., 1956, 254:1119-1123.
 Abstract: Year book of drug therapy, 1956-1957, p. 343-
 344
 Eiber,  H.  B.  Chlorpromazine  (thorazine)-Rauwolfia
 combination in neuropsychiatry;  preliminary report.
 A.  M. A. Arch. Neur.  Psychiat, 1955, 74:36-39.  Ab-
 stract :  Excerpta med., Sect. 8, 1956, 9: No. 1218.
 Hollister, L. E., Jones, K. P., Brownfield, B., Johnson,
 F.   Chlorpromazine alone and  with reserpine; use in
 the treatment  of mental diseases.   California 31., 1955,
 83:218-221.  Abstract: Excerpta med.,  Sect. 8,  1956,
 9:  No. 1219.                                        *
 ____, Traub,  L., Beckman, W.  G.  Psychiatric use of
 reserpine and  chlorpromazine;  results of double-blind
 studies.  In:  Kline,  N.  S., ed.  Psychopharmacology.
 Washington, Am.  Ass. Adv. Sc, 1956.   p. 65-74.
 Hormia, A.  Yhdistetty serpasil-klooripromatsiinihoito
 psykiatriassa.   [Combined  serpasil-chlorpromazine
 treatment in psychiatry.]   [English  summary]  Duo-
 decim, Helsin,, 1956, 72: 76-85.
 Knutsen, A. T.  Reserpin og klorpromazin i psykiatrien.
 [Reserpine and chlorpromazine  in psychiatry.]   [Eng-
 lish  summary]  Tskr.  Norske  laegeforen.,  1956, 76:
 368-371.
 Lemere,  F.  Combined  chlorpromazine-reserpine  ther-
 apy  of psychiatric  disorders.  A.  M. A. Arch.  Neur.
 Psychiat,  1955,  74:1-2.  Abstract:  Excerpta  med.,
 Sect. 8, 1956, 9: No. 2235.
 Ranee,  A. M., Jurquet, A., Roger, J. Remarques sur la
 therapeutique  des  affections  psychiatriques  par la
 chlorpromazine et la  reserpine; etude  comparee des
 diverses  modalites  d'administration de  ces  drogues.
 [Therapy of psychiatric disorders with chlorpromazine
 and reserpine; comparative study of the various  meth-
 ods of their administration.]  Ence'phale, 1956, 45 : 477-
 487.
 Reda,  G.  C,  Germano,  V. L'azione  combinata  della
 reserpina e cloropromazina nella pratica psichiatrica.
 [Combined effect of reserpine and chlorpromazine in
 psychiatric practice.]  [English summary] Arch, psicol
 neur., Milano, 1956, 17: 647-653.
 Wells,  R. E.   Use of reserpine  (serpasil)  in the man-
 agement  of chronic alcoholism.   J. Am. 31. Ass., 1957,
 163: 426-429.

-Psychoses
 Barsa, J. A.,  Kline, N. S. Combined reserpine-chlor-
 promazine  in treatment of disturbed psychotics.  A. M.
 A. Arch. Neur. Psychiat, 1955, 74:280-286.  Abstract:
 Am. J. Psychiat, 1955, 111: 780. Excerpta med., Sect.
 8,1957,10 : No. 368.
 ----. ----•  A comparative study  of reserpine,  chlor-
 promazine, and combined therapy.  A. 31. A. Arch, Neur.
 Pschiat., 1956, 76:90-97.
 ----»----•  Use of reserpine in disturbed psychotic pa-
 tients.   Am. J. Psychiat., 1956,112 : 684-691.  Abstract:
 Excerpta med., Sect. 8,1956, 9 : No. 4543.
 Elkes,  C.  Rauwolfia alkaloids and  reserpine in the
 treatment  of  the chronic  psychotic patient.  J.  3Ient.
 Sc, Lond.,  1957, 103 : 464-474.
 Feldman, P. E.  A  comparative study of various atar-
 actic drugs.  Am. J.  Psychiat, 1957, 113 : 589-594.   *
 Hormia,  A.  A comparison between combined reserpine-
 chlorpromazine  and chlorpromazine therapies in  psy-
 chiatry.  Acta psychiat. neur. scand., 1956, 31; 437-446.*
 Kinross-Wright,  V.   Chlorpromazine  and reserpine  in
 the treatment of psychoses.  Ann. N. York Acad Sc
 1955, 61:174-182.  Abstract:  Excerpta med  SpM-  8
  1956, 9: No. 2236.                           ''
  Loch,  W.   Zur  Behandlung  fortgeschrittener  Schizo-
74 
SUBJECT LIST
Chlorpromazine : with Reserpine Combined :
                Therapeutic use — Psychoses
phrenien mit Megaphen und Reserpin.  [Megaphen and
reserpine therapy  of  advanced  schizophrenia.]  Ner-
venarzt,  1956, 27: 463-467.
Michtom, J., Goldberg, N., Offenkrantz, W., Whittier, J.
Readmission rates for state  mental hospital patients
discharged on maintenance ataractics.  Findings with
a matched control group and methodological considera-
tions.  J. Nerv. 3Ient. Dis., 1957,  125: 478-480.
Morgan,  D. R.  Chlorpromazine  and  reserpine in  the
treatment of chronic mental illness. 3Ied. J. Australia,
1956, 43  (2) : 57-62.
Schmidt, K. E.  Combined treatment with chlorproma-
zine and reserpine. J. Ment. Sc, Lond., 1957, 103: 200-
208.
Tuteur, W.   Combined reserpine-chlorpromazine  ther-
apy in highly disturbed psychotics.  Am. J. Psychiat.,
1955. 112 : 206.  Abstract: Excerpta med., Sect.  8,  1956,
9: No. 2243.
----,  W.,  Lepson,  D.  Combined  reserpine-chlorpro-
mazine  therapy in highly  disturbed  pyschotics.    In:
Himwich, H. E., ed. Tranquilizing drugs.  Washington,
Am. Ass.  Adv. Sc, 1957.  p. 163-172.
---,  Stiller, R.,  Whitehill,  O.  Treatment  of  re-
gressed schizophrenics with chlorpromazine, reserpine
and a combination of both drugs.  Dis. Nerv. Syst., 1957,
18:100-105.                                        *
   [Therapeutic  progress in  psychiatry  in 1955.]  En-
   cephale, 1956, 45:172-200.
   Hilliard, E. T.  The use of reserpine, chlorpromazine
   and allied drugs in medicine and psychiatry.   3Ied. J.
   Australia,  1956, 43 (1) : 1035-1040.
   Hoff, H.  Advantages and disadvantages of treatment
   with chlorpromazine  and  serpasil.  Ence'phale, 1956,
   45:352-358.
   Kinross-Wright, V.  Clinical application of chlorpro-
   mazine.  In:  Kline,  N. S.,  ed.  Psychopharmacology.
   Washington, Am. Ass. Adv. Sc, 1956.   p. 31-38.
   ----.  A review of the newer  drug therapies in psy-
   chiatry. Dis. Nerv. Syst., 1956, 17 :187-190.
   Kline, N. S., Saunders, J.  C.  Reserpine in psychiatric
   and neurologic disorders.  Med. Clin. N. America, 1957,
   41: 307-326.
   Maccagnani, G.  Trattamento di alcune  sindromi psi-
   chiche dell'eta senile  con  reserpina, con reserpina as-
   sociata a cloropromazina.  [Treatment of senile psychic
   syndromes with reserpine and with reserpine associated
   with chlorpromazine.]  Arch,  psicol. neur.,   31ilano,
   1956, 17 : 452-454.
   Malitz, S., Hoch, P. H., Lesse,  S.  A  two-year evalua-
   tion of chlorpromazine in clinical research and prac
   tice.  Am. J. Psychiat., 1956,113 : 540-545.
   Margolis, L. H. Pharmacotherapy in psychiatry; a re-
   view.  Ann. N. York Acad. Sc, 1957, 66: 698-718.
   Mathis,  M. Toniques et sedatifs en neuro-psychiatrie
   infantile.  [Tonics and sedatives  in  child  neuropsy-
   chiatry.]   Pediatric,  1956, 11: 807-820.
   Paerregaard,  G. Chlorpromazinbehandling pa en psy-
   kiatrisk modtageafdeling.   [Chlorpromazine treatment
   at  a  psychiatric  department.]  [English  summary]
   Nord. med., 1956, 56: 1238-1240.
   Puca,  A.  Ibernoterapia,  sonno prolungato  e  neuro-
   plegic! in terapia psichiatrica.  [Hibernation, prolonged
   sleep and neuroplegic drugs in psychiatric treatment.]
   Rass. internaz. din. ter., 1955, 35 : 805-809.
   ----.  Nuove  acquisizioni in terapia psichiatrica; iber-
   noterapia,  sonno prolungato e neuroplegici.   [New ac-
   quisitions  in  psychiatric  therapy; artificial  hiberna-
   tion, prolonged sleep and neuroplegic drugs.]   [English
   summary]   Rass.  stud,  psichiat,  1955,  44:849-856.
  Also: Ann. med. nav., Roma, 1956, 61: 42-49.
   Ramee, F., Lacaton,  R., Sanchez,  F., Boulanger, M.
   Effets favorables du largactil dans  la pratique psychia-
   trique algerienne.  [Good  results with chlorpromazine
   therapy of mental diseases  in Algeria.]  Ence'phale,
   1956, 45: 820-827.
   Visintini, F.  Cloropromazina e reserpina in psichiatria.
   [Chlorpromazine and  reserpine in  psychiatry.]  [Eng-
  lish  summary]  Arch, psicol. neur., Milano,  1956, 17:
  611-621.

—Neuroses
  Azima,  H., Kent, I., Cleghorn, R. A.   Rauwolfia alka-
  loids in mental syndromes.   Canad. M.  Ass.  J., 1955,
   73: 866-871.
  Coirault, R., Girard, V.,  Benoit, P.  Utilisation du ser-
  pasil en neuropsychiatrie.  [Use of serpasil  in neuro-
  psychiatry.]  Bull. Soc me'd. mil. fr., 1955, 49: 249-250.
  Abstract: Presse me'd., 1955, 64: 315.
  Macchi, G., Manghi, E., Saginario,  M.  L'impiego della
   reserpina  in  narcoterapia;  primi  risultati.   [Use  of
  reserpine in sleep  therapy; first results.]  Gior. psi-
  chiat,  1954, 82:1130-1134.
  Rauwolfia et etats  depressifs.  [Rauwolfia and depres-
  sive states.] Rev. prat, Par., 1956, 6: 3342.

—Psychoses
   Ellsworth, R.  B.,  Clark,  L. D.  Prediction  of the re-
  sponse of  chronic  schizophrenics to drug therapy; a
  preliminary report  on the relationship  between palmar
  sweat  and the behavioral  effects  of  tranquilizing
   drugs.  J. Clin. Psychol, 1957,13: 59-61.
Therapeutic use
  Belsasso, M.  Terapia delle malattie mentali con reser-
  pina  (serpasil)  e  cloropromazina  (largactil)  ad  alte
  dosi.   [Treatment of mental disorders with high-dosage
  reserpine  (serpasil)  and chlorpromazine  (largactil).
  Rass. giuliana med.,  Trieste,  1956,  12:209-216.     *
  Bender, L., Nichtern, S.  Chemotherapy in child  psy-
  chiatry.  N. York State J. 31.,  1956, 56: 2791-2795.
  Borenstein, P., Dabbah,  M., Bare,  D.  Contribution a
  Tetude  de la reserpine en psychiatrie ; resultats cliniques
  et electro-encephalographiques. [Research on reserpine
  in psychiatry; clinical and electroencephalographic re-
  sults.]  Ann, me'd. psychol, Par., 1956, 114(1) : 545-580.
  Abstract: Excerpta med., Sect. 8, 1957, 10 : No. 1532.
  Broggi, E.  La Rauwolfia serpentina Benth  nella cura
  di alcune psicopatie.  [Rauwolfia serpentina Benth in
  the treatment of some mental diseases.]  Arch, psicol.
  neur., 3Iilano, 1956, 17: 399-401.
  Bosinelli, M.  Reserpina  e reserpina associata  a cloro-
  promazina in neuropsichiatria infantile.   [Reserpine
  and  reserpine combined  with  chlorpromazine in child
  neuropsychiatry.]  Arch,  psicol.  neur.,  Milano, 1956,
  17: 478-479.
 Cervos  Navarro,  J., Unterharnscheidt, F. Importancia
 de las fenotiacinas  en psiquiatria.  [Importance of phe-
  nothiazines in  psychiatry.]   Rev.  espan, otoneuroft,
 1956, 15: 75-92.
 Coirault,  R.,  Girard,  V.,  Benoit, P.  Utilisation du  ser-
 pasil en neuro-psychiatrie.   [Use of serpasil in neuro-
 psychiatry.]   Bull.  Soc. me'd. mil.  fr., 1955, 49:249-250.
 Abstract: Presse me'd,, 1956, 64 : 315.
 Fliigel,  F.  Therapeutique par  medication neuroleptique
 obtenue en realisant systematiquement des etats parkin-
 soniformes.  [Therapeutic results obtained with neuro-
 leptic drugs by the systematic provocation  of parkin-
 sonism.]  Ence'phale, 1956, 45 : 1090-1092.
 Freeman, H.  A critique of the tranquilizing drugs, chlor-
 promazine and reserpine, in neuropsychiatry. N. Eng-
 land J. 31., 1956, 255 : 877-883.
 Geyer, H. W.  Thorazine (chlorpromazine) and serpasil
 therap'y in hyperactive patient  of low mentality.  Dela-
 ware 31. J., 1955, 27: 187-189.
 Gherarducci, D. A propos de Tutilisation  de la chlorpro-
 mazine  associee a  d'autres  therapeutiques  psychi-
 atriques    [Utilization of  chlorpromazine  associated
 with other psychiatric therapeutics.]  Ence'phale, 1956,
 45: 1187-1189.
 Green, A.  Actualites therapeutiques  1955 en psychiatrie. 
Chlorpromazine : with Reserpine Combined :
Therapeutic use — Psychoses
PSYCHOPHARMACA
  Feldman, P.  E.  Two-year  fate  study  of  thorazine-
  treated patients.  Am. J. Psychiat, 1957, 114: 237-240.
  Gayral, L., Herve, Y., Carrie, J., Fourny, L.  Les cures
  insuliniques prolongees et la post-cure  dans le traite-
  ment  de  la   demence  precoce.   [Prolonged  insulin
  treatment and after  treatment in therapy of dementia
  praecox.]  Toulouse med., 1955, 56: 501-513.
  ---,  ---, Fourny,  L., Carrie,  J.   Chlorpromazine et
  reserpine dans la  post-cure insulinique des  schizo-
  phrenes.  [Chlorpromazine and reserpine after insulin
  shock therapy in schizophrenia.]  Ence'phale, 1956, 45:
  663-667.
  Huchtemann,  K., Pflugfelder, G.  Serpasilkuren in der
  Psychiatrie;  Bericht iiber  100 Kuren.   [Serpasil  ther-
  apy in psychiatry; report on 100 cases.]  Schweiz. med.
  Wschr.,  1955,  85: 627-630.   Abstract:  Excerpta med.,
  Sect. 8,1956, 9: No. 2242.
  Kasak,  M., Schaefer, D.  L., Winter, W.  The use of
  chlorpromazine and reserpine in a psychiatric hospital:
  one year's experience.  Marquette 31.  Rev., 1955, 21:
  17-24.
  Leconte, M.,  Barbier, A.  Guerison par Tassociation
  chlorpromazine-reserpine  d'un  grave  syndrome hebe-
  phreno—catatonique  datant de 10  ans.   [Combined
  chlorpromazine-reserpine  therapy  of  a severe hebe-
  phrenic-catatonic  syndrome,  of ten years'  duration.]
  Ann.  me'd. psychol,  Par., 1956,  114(2) : 637-645.
  Lewis, L. F.  The use of chlorpromazine  and of serpasil
  in the treatment of  psychotic  patients.  Carib. M. J.,
  Trinidad, 1956,  18: 51-66.                         * *
  Morgan, D. R.  The combined use of chlorpromazine and
  reserpine in the treatment of chronic mental illness: a
  preliminary report.   Med.  J. Australia, 1955,  42  (2)  :
  77-80.  Abstract:  Excerpta med.,  Sect.  8, 1956, 9: No.
  1728.
  Patton, G. O., Garneau, J.   The ataraxic drugs in dis-
  turbed  secluded psychiatric patients.    Canad. Serv.
  M. J., 1957,13 : 127-133.
  Racamier, P. C, Blanchard, M., Baudrand, C.  Les cures
  prolongees de chlorpromazine dans les etats  schizo-
  phreniques.    [Prolonged  chlorpromazine therapy  in
  schizophrenic  reactions.] Ence'phale, 1956, 45 : 647-655.
  Rhijn, C. H. van.  De invloed van reserpine  (serpasil)
  op acute en chronische geestesziekten.   [The effects of
  reserpine on acute and chronic mental diseases.]  [Eng-
  lish summary]  Ned. tschr.  geneesk.,  1956,  100:1775-
  1790.
  Sarro, R. Recents developpements de la therapeutique
  narcobiotique.   [Recent developments   in narcobiotic
  therapy.] Ence'phale, 1956, 45: 501-510.
  Silverberg, J.  W., Gralnick, A.  Possible synergistic ac-
  tion of chlorpromazine, reserpine and frenquel.  A pre-
  liminary report.  Am. J. Psychiat., 1957, 114:173.

Untoward  effects [see  headnote p. 19]
  Barsa, J. A., Kline, N. S. Agranulocytosis while receiv-
  ing combined  reserpine-chlorpromazine therapy.   Re-
  port of two cases.  Dis. Nerv. Syst, 1956,  17: 88-90.
  Abstract: Excerpta med.,  Sect. 8, 1957,  10: No. 2092.
  Kline, N. S., Barsa, J., Gosline, E.  Management of the
  side effects of reserpine and combined  reserpine-chlor-
  promazine treatment.  Dis.  Nerv.  Syst., 1956, 17:352-
  358.
  ---,  ----, ----.  Management of  side effects of reser-
  pine and combined reserpine-chlorpromazine treatment.
  In: Himwich,  H. E.,  ed.  Tranquilizing drugs.  Wash-
  ington, Am. Ass. Adv. Sc, 1957.  p. 149-161.

with RESERPINE—COMPARED

  Deniker,  P.  Hibernotherapies  et  medicaments neuro-
  leptiques en therapeutique psychiatrique.  [Hibernother-
  apies  and neuroleptic drugs in psychiatric therapy.]
  Encephale, 1957, 46: 281-398.
   Studies, animals
     Baruk, H., Launay, S., Berges, J.  Action de la reserpine
     sur la psychomotricite et catatonie experimentale.  [Ef-
     fect of reserpine on experimental psychomotricity and
     catatonia.]  Rev.  neur., Par., 1956, 95: 62-63.
     Delay, J., Deniker, P., Tardieu,  Y.,  Lemperiere,  T.
     Medicaments et cures neuroleptiques en therapeutique
     psychiatrique:  premiers essais de la reserpine; compa-
     raison avec les  effets de la chlorpromazine.  [Drugs and
     neuroleptic  therapies  in the  treatment of psychiatric
     diseases; first  trials with  reserpine; comparison with
     the effects of chlorpromazine.]  Presse me'd., 1955, 63:
     633-665.
     Courvoisier, S.  Pharmacodynamic basis for the use  of
     chlorpromazine in psychiatry.  J.  Clin. Exp. Psycho-
     path., 1956., 17: 25-37.
     ---.  Sur les proprietes  pharmacodynamiques de  la
     chlorpromazine en rapport avec son emploi en psychia-
     trie.  [Pharmacodynamic basis for the use of chlor-
     promazine in psychiatry.]   Ence'phale,  1956, 45:1248-
     1257.
     Gliedman, L. H., Gantt, W. H.  The effects of reserpine
     and chlorpromazine on orienting behavior and retention
     of conditioned reflexes.  South. 31. J., 1956, 49: 880-889.
     Schneider, J.  A.  Reserpine  antagonism of  morphine
     analgesia in mice. Proc. Soc. Exp. Biol, N. Y., 1954,
     87: 614-615.  Abstract: Chem. Abstr., 1955, 49 : 4165ef.

   Studies, patients
     Balestrieri,  A.  Azione della  cloropromazina e della
     reserpina sul sistema  nervoso extrapiramidale.   [The
     effect of  chlorpromazine and reserpine  on the extrapy-
     ramidal  nervous  system.]   [English summary]  Arch.
     psicol. neur., Milano, 1956,  17: 483-512.
     Freyhan, F. A.  Psychomotility  and parkinsonism  in
     treatment with neuroleptic drugs.  A. M. A. Arch. Neur.
     Psychiat., 1957, 78 : 465^72.
     Le Guillant.  Le syndrome neuroleptique : etude clinique
     et psychotechnique.  [The  neuroleptic  syndrome: clini-
     cal and psychometric study.]  Ann. me'd. psychol, Par.,
     1957, 115 (1) : 316-329.
     Monroe,  R. R.,  Heath, R. G, Mickle, W. A., Miller, W.
     A comparison of cortical and subcortical brain waves  in
     normal,  barbiturate,  reserpine,   and  chlorpromazine
     sleep.  Ann. N. York  Acad. Sc, 1955,  61: 56-71.  Ab-
     stract : Excerpta med., Sect. 8, 1956, 9 : No. 3089.
   Therapeutic studies, controlled
     Ayd, F.  J., Jr.  Thorazine  and serpasil treatment  of
     private neuropsychiatric patients.  Am. J. Psychiat.,
     1956, 113: 16-21.                                    *
     Bennett, A. E.,  Ford, F. R., Turk, R. E.  Clinical investi-
     gation of chlorpromazine and reserpine in private psychi-
     atric practice.   Am.  J. Psychiat.,  1956, 112: 782-7S7.
     Condensed : Am.  Practitioner, 1956, 7 : 1576-1577.  Ab-
     stract:  Excerpta  med,, Sect.  8,  1956, 9: No.  4546.
     Brooks,  G. W.   Experiences with the  use  of chlorpro-
     mazine and reserpine in psychiatry, with special refer-
     ence to the significance and management of extrapyram-
     idal dysfunction.  N.  England J. M.,  1956, 254: 1119-
     1123. Abstract: Year  book  of drug therapy, 1956-1957,
     p. 343-344.
     Charlin,  A.  Action respective de  la chlorpromazine  et
     de la reserpine; hypotheses pathogeniques.   [The effect
     of  chlorpromazine and of reserpine;   pathogenic hy-
     potheses.] Ence'phale, 1956, 45 :1099-1105.
     Horenstein, S.  Reserpine and chlorpromazine in hyper-
     active mental  defectives.   Am. J.  Ment. Defic  1957,
     61: 52.5-529.                                         *
     Kline, N. S.  Clinical  applications of  reserpine.  In:
     Kline, N. S., ed.   Psychopharmacology.  Washington,
     Am. Ass. Adv.  Sc, 1956. p. 81-108.
     Lafon, R., Due, N., Boyer, Abric, J., Pouget, R.  Explor-
     ation psychologique des malades traites par le 4560 RP
     (chlorpromazine)  et la reserpine.   (Psychologic exam-

76 
SUBJECT  LIST
Chlorpromazine : with Reserpine Compared :  Therapeutic use
  ination of patients treated with  RP  4560 (chlorpro-
  mazine) and with reserpine.]  Encephale, 1956, 45: 996-
  999.
  Lemere, F.  Combined chlorpromazine-reserpine ther-
  apy of psychiatric  disorders.   A. M.  A. Arch. Neur.
  Psychiat, 1955, 74 :1-2.  Abstract: Excerpta med., Sect.
  8, 1956, 9: No. 2235.
  Ranee, A. M., Jurquet, A., Roger, J.  Remarques sur la
  therapeutique  des  affections   psychiatriques  par  la
  chlorpromazine  et la reserpine; etude comparee des
  diverses modalites  d'administration  de ces  drogues.
  [Therapy of psychiatric disorders with chlorpromazine
  and reserpine; comparative study of the various meth-
  ods of their administration.] Ence'phale, 1956, 45 : 477-
  4S7.
  Rosner, H., Levine, S., Hess, H., Kaye, H.  A compara-
  tive study of the effect on  anxiety of chlorpromazine,
  reserpine, phenobarbital, and a placebo.  J.  Nerv. 3Ient.
  Dis.. 1955,  122 : 505-512.  Abstract: Excerpta med., Sect.
  S. 1957, 10 : No. 2093.
  Sternberg, U.,  Spitz, H., Goyne, J. B.  Evaluation  of
  chlorpromazine  and reserpine  therapy  with  follow-up
  study.  J.  Clin,  Exp. Psychopath..  1957, 18: 258-268.
  Zeller, W. W., Graffagnino, P. N, Cullen, C. F., Reitman,
  H. J. Use  of chlorpromazine and reserpine in  the treat-
  ment of emotional  disorders.   J. Am. 31. Ass., 1956,
  160:  179-184.  Abstract: Year book of drug  therapy,
  1956-1957: 341-342.

—Neuroses
  Pellerito, N.  L'Azione  della  cloropromazina  e della
  reserpina sull'ansia dei psiconevrosici.   [Action of chlor-
  promazine and reserpine on the anxiety of psychoneu-
  rotics.]  Minerva med., Tor., 1956, 47:628-631.

—Psychoses
  Barsa, J. A., Kline, N. S.  Combined reserpine-chlorpro-
  mazine in treatment of disturbed psychotics.   .4. 31.  A.
  Arch. Neur. Psychiat, 1955, 74 : 280-286. Abstract: Am.
  J. Psychiat., 1955, 111: 780.,
  ---,----.  A comparative study of reserpine, chlorpro-
  mazine, and  combined therapy.  A. 31.  A. Arch. Neur.
  Psychiat., 1956, 76: 90-97.
  Cutler, R. P., Monroe, J. J., Anderson, T. E. Effects of
  "tranquilizers"  upon pathological activity in  psychotic
  patients.  I. Chlorpromazine.  II. Reserpine.  A. M.  A.
  Arch. Neur. Psychiat, 1957, 77 : 616-622; 1957, 78 : 61-68.
  Freeman, H., Arnold, A. L., Cline, H. S.  Effects of chlor-
  promazine  and reserpine  in chronic schizophrenic  pa-
  tients.  Dis. Nerv. Syst., 1956,  17:213-219.  Abstract:
  Excerpta med., Sect.  8, 1957, 10: No. 1448.
  Gardner, M. J., Hawkins, H. M., Judah, L. N., Murphree,
  0. D.  Objective measurement  of  psychiatric changes
  produced by  chlorpromazine and reserpine in  chronic
  schizophrenia.  Psychiat.  Res.  Rep.,  Wash., 1955 (1) :
  77-83.
  Goldman,  D.  Comparison of clinical effects  of chlor-
  promazine and reserpine in psychotic patients.  Am. J.
  M. Sc, 1957,  233 : 137-144.                           *
  Hollister, L. E., Traub, L., Beckman, W. G.  Psychiatric
  use of reserpine  and chlorpromazine; results of double-
 blind  studies.  In: Kline, N.  S., ed.  Psychopharma-
 cology.  Washington, Am. Ass. Adv. Sc, 1956.  p. 65-74.
 Kinross-Wright, V.  Chlorpromazine and reserpine  in
 the treatment of psychoses.  Ann. N. York Acad.  Sc,
 1955, 61:174-182.  Abstract: Excerpta med., Sect.  8,
 1956! 9: No. 2236.
 Kovitz, B.,  Carter, J. T., Addison, W. P. A comparison
 of  chlorpromazine and reserpine in chronic psychosis.
 A  M A Arch. Neur. Psychiat,  1955, 74: 467-471.  Ab-
 stract: Excerpta med., Sect. 8, 1957, 10: No. 2087.
 Lafon, R., Due, N., Abric, J., Pouget, R., Comelade, P.
 Etude comparative du  4.560  R. P.  (chlorpromazine)
 et de la reserpine dans les syndromes schizophreniques.
 [Comparative study of R.  P.  4560  (chlorpromazine)
  and reserpine in schizophrenic syndromes.]  Ence'phale,
  1956, 45: 668-671.
  Loch,  W.  Zur  Behandlung fortgeschrittener  Schizo-
  phrenien mit Megaphen und Reserpin.   [Megaphen and
  reserpine  therapy  of  advanced  schizophrenia.]  Ner-
  venarzt, 1956, 27: 463-467.
  Schneider, G. Les  indications de divers neuroleptiques
  et les resultats  obtenus & la clinique psychiatrique de
  Lausanne.  [Indications for various neuroleptic drugs
  and  the  results obtained at the psychiatric clinic of
  Lausanne.]   Ence'phale, 1956, 45:1024-1030.
  Shepherd, M., Watt, D. C.   A controlled clinical study
  of chlorpromazine  and  reserpine  in  chronic  schizo-
  phrenia.  J. Neur., Lond., 1956,19 : 232-235.
  Tripi, G.  Considerazioni generali sull'uso della cloro-
  promazina e della  reserpina nel trattamento di circa
  trecento   psicopatici.  [Observations  on  the   use  of
  chlorpromazine and reserpine in the treatment of about
  300 mental patients.]   Rass. neuropsichiat, 1955,  9:
  463—469.   Also:  Arch,  psicol. neur., Milano, 1956,  17:
  635-639.
  Watt, D. C.   Reserpine and chlorpromazine in the treat-
  ment  of chronic schizophrenics.  Ence'phale, 1956,  45:
  661-662.

Therapeutic use
  Baruk, H., Launay,  J., Berges, J., Mijolla,  A. de  Etude
  clinique  de  Taction therapeutique de la  reserpine.
  Comparaison avec Taction des extraits  totaux.   [Clini-
  cal study  of the therapeutic effect of reserpine; com-
  parison with total extracts.]  Ann.  me'd. psychol, Par.,
  1957, 115  (1) : 704-708.
  Beley, A., Foncin,  J.  F., Leyrie, J.  Quelques incon-
  venients  des doses  eievees de reserpine chez le jeune
  arriere turbulent;  indications posologiques.   [Compli-
  cations with massive reserpine  doses in  disturbed re-
  tarded children; dosage indications.]  Encephale, 1956,
  45: 802-807.
  Benedetti,  G.   Terapia  reserpinica   in  psichiatria.
  [ Reserpine therapy  in psychiatry. ]   [ English summary ]
  Arch, psicol neur., Milano, 1956,17: 295-309.
  Bleuler, M.   Comparaison entre les effets de la chlor-
  promazine et de la reserpine en psychiatrie.  [Com-
  parison between  the effects of chlorpromazine and reser-
  pine  in psychiatry.] Ence'phale, 1956,  45 : 334-348.   *
  ---, Stoll, W. A.  Clinical use of reserpine in psychia-
  try :  comparison with  chlorpromazine.  Ann. N. York
  Acad. Sc, 1955, 61:167-173.  Abstract: Excerpta med.,
  Sect. 8,1956, 9: No.  4080.
  Delay,  J.  Introduction  au colloque  international.
  [Introduction to the international colloquium.]  [On
  chlorpromazine  and neuroleptic drugs,  Paris,  October
  1955]   Ence'phale, 1956, 45 : 303-306.
  ---,   Deniker,  P.  Chlorpromazine  and neuroleptic
  treatments in psychiatry.  J. Clin. Exp.  Psychopath.,
  1956, 17: 19-24.
  ---, ----.  Peut on comparer la reserpine 3. la chlor-
  promazine?   [Can  one  compare reserpine with chlor-
  promazine?]  Arch, psicol. neur., Milano, 1956, 17: 631-
  633.
  ----,----, Tardieu, Y., Lemperiere, T.   Medicaments et
  cures neuroleptiques en therapeutique psychiatrique:
  premiers  essais  de  la reserpine; comparaison avec les
  effets de  la  chlorpromazine.  [Drugs  and neuroleptic
  therapies in the  treatment of psychiatric diseases; first
  trials  with  reserpine;  comparison  with the effects of
  chlorpromazine.] Presse me'd., 1955,  63 : 663-665.
  Deniker,  P.  Hibernotherapies et medicaments neuro-
  leptiques  en therapeutique  psychiatrique.   [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapy.]
  Encephale, 1957,  46 : 281-398.                        *
  Erdmann, C. E.  Neues fiber die Rauwolfia-Behandlung
  unter besonderer Berucksichtigung der Literatur in den
  USA.   [Review  of Rauwolfia therapy with special ref- 
Chlorpromazine : with Reserpine Compared : Therapeutic use
PSYCHOPHARMACA
  erence to literature in the United States of America.]
  Nervenarzt, 1956, 27 : 75-79.
  Faure, J. L., Abric, J.  Remarques cliniques sur les indi-
  cations valables de la chlorpromazine et  de la  reser-
  pine en neuro-psychiatrie infantile.  [Clinical remarks
  on the indications for the use of chlorpromazine and
  reserpine in child neuro-psychiatry.]  Pe'diatrie, 1956,
  11: 773-776.
  Gherarducci, D.  A propos de Tutilisation de la  chlor-
  promazine  associee a d'autres therapeutiques psychia-
  triques.  [Utilization  of  chlorpromazine   associated
  with other  psychiatric therapeutics.]  Ence'phale, 1956,
  45: 1187-1189.
  Hoch,  P. H.  Practical and theoretical applications of
  the new drug therapies in psychiatry.  A. M. A. Arch.
  Neur. Psychiat., 1956, 75 : 325-328.
  Hoff,  H. Advantages and disadvantages of treatment
  with chlorpromazine and serpasil.  Ence'phale, 1956, 45:
  352-358.
  Kinross-Wright, V.  A review of the newer drug  thera-
  pies in psychiatry.  Dis. Nerv. Syst., 1956, 17: 187-190.
  Landgrebe, B.  tlber Erfahrungen mit Reserpin (Seda-
  raupin)  in der psychiatrischen Klinik.  [Experience
  with reserpine (sedaraupin)  in a psychiatric hospital.]
  Medizinische, 1955:610-613.
  Malitz, S.,  Hoch, P. H.,  Lesse, S.  A two-year evalua-
  tion of chlorpromazine in clinical research and practice.
  Am. J. Psychiat., 1956,113 : 540-545.
  Margolis, L. H.  Pharmacotherapy in psychiatry; a re-
  view.   Ann. N. York Acad. Sc,  1957, 66: 698-718.
  Pollack, B.  Mental illness.  Med.  Times,  Great Neck,
  1955,  83:439-450.
  Sarwer-Foner, G. J., Ogle, W.  Psychodynamic aspects
  of reserpine:  its uses and effects in open psychiatric
  settings. Canad. Psychiat. Ass.  J.,  1956, 1:11-17.
  Schiele, B.  C, Anderson, R. W., Simon, W.  Current
  status of chlorpromazine and reserpine  in psychiatric
  practice. J. Lancet, 1956, 76 :179-185.
  Visintini,  F.  Chlorpromazina  e  reserpina in  psichi-
  atria.  [Chlorpromazine  and reserpine  in  psychiatry.]
  [English summary]  Arch, psicol neur., Milano, 1956,
  17: 611-621.
—Neuroses
  Gomirato,  G.  L'azione  della cloropromazina e della
  reserpina  su  alcune  manifestazioni sintomatologiche
  delle psiconevrosi.  [Action of chlorpromazine and reser-
  pine on symptomatologic manifestations of psychoneu-
  roses.]  [English summary]  Arch, psicol. neur., Milano,
  1956,  17: 531-543.
  Ostenfeld,  I.  Psykiske  urotilstande.  [Mental excite-
  ment.]  [English summary]  Nord. med.,  1955, 54:1517-
  1522.
  Senseman,  L. A.  Tranquilizing drugs; uses and abuses
  for the nervous patient.  Rhode  Island 31.  J., 1956, 39:
  675-677; 680; 686.

—Psychoses
  Bertolini, O. F.  Cloropromazina e reserpina nel trat-
  tamento delle psicopatie.   [Chlorpromazine and reser-
  pine in the treatment of mental diseases.]  Arch,  psicol.
  neur., Milano, 1956,  17:623-627.                    *
  Ellsworth,  R. B.,  Clark, L.  D.  Prediction  of the  re-
  sponse of chronic schizophrenics  to drug therapy; a pre-
  liminary report on  the relationship between palmar
  sweat and the behaviorial effects of tranquilizing drugs.
  J. Clin. Psychol, 1957, 13:59-61.
  Leiberman, D. M., Vaughan, G. F.  The use of some new
  pharmacological agents  in  psychiatry.  J.  Ment.  Sc,
  Lond., 1957, 103:110-118.
  Mielke, F.  A.  Methods employed and results obtained
  in psychiatric  studies with  new drugs  acting  on the
  brain stem. Am. J. Psychiat, 1957, 114:134-139.
  Montagnari, F., Germano, V.  Stato preeclamptico con
  episodio confuso onirico troncato con reserpina endo-
  vena.   [Intravenous reserpine immediately effective in
  treatment of a pre-eclamptic state with eP1*0*®0* °°ei"
  ric confusion.]  Riv. sper. freniat.,  1956, 80: 977-y79.
  Racamier, P. C, Blanchard, M., Baudrand, C. Les cures
  prolongees de  chlorpromazine dans  les  etats  schizo-
  phreniques.   [Prolonged  chlorpromazine   therapy  in
  schizophrenic reactions.]  Encephale, 1956, 45 : 647-655.
  Santangelo,  G.  Modificazioni indotte dal trattamento
  reserpinico protrato  sulla  sintomatologia psichica  e
  comportamentale  nelle  schizofrenie croniche.   [Modi-
  fications  induced  by prolonged reserpine  treatment  on
  psychic symptomatology and behavior in chronic schizo-
  phrenia ]  [English summary]   Arch,  psicol.  neur.,
  Milano, 1956, 17 : 388-393.          r
  Siguier, F., Giabicani, A.,  Betourne, C, Goglin, W.  Le
  serpasil dans les deiires alcooliques.  [Serpasil  in  al-
  coholic delirium.]  Bull.  Soc. med.  hop.  Paris, 1956,
  72 : 605-607.  Abstract: Excerpta med., Sect. 8,1957,10:
  No. 1976.
  Vogt, W.   Beitrag zum klinischen Vergleich der Wirkung
  von Largactil und Serpasil.  [Clinical comparison of the
  effects of largactil and serpasil.]  Schweiz. Arch. Neur.
  Psychiat, 1956, 77 : 330-336.
  Weber, E. Ein Rauwolfiaalkaloid  in der  Psychiatrie:
  seine   Wirkungsahnlichkeit  mit   Chlorpromazin.   [A
  Rauwolfia alkaloid in psychiatry: similarity of its  ef-
  fects to those of chlorpromazine.]  Schweiz. med. Wschr.,
  1954, 84: 968-970.

Untoward  effects
  Altschule, M. D.  Use of chlorpromazine and reserpine
  in mental disorders. N. England J. 31., 1956, 254: 515-
  519.  Abstract: Chem. Abstr., 1956, 50: 7318a.
  Goldman, D.  The major complications of  treatment of
  psychotic  states with chlorpromazine and reserpine and
  their  management.  Psychiat. Res. Rep.,  Wash., 1956
  (4) : 79-88.
  Sapir, M., Stroun, J., Hepner,  L.,  Reverchon, J., Selzer,
  S.  A propos de  Taction psycho-somatique de la chlor-
  promazine et de  la reserpine.  [Psychosomatic  action
  of chlorpromazine and reserpine.]  Encephale, 1956, 45:
  488-493.

with RESERPINE and METHYLPHENIDYLACE-
    TATE—COMBINED
  Madi, M. L., Kovitz, B.  Experiences with methyl-pheni-
  dylacetate hydrochloride  (ritalin)  in  psychotic pa-
  tients. Antibiotic 31., 1956, 3 : 309-311.
  Wells, R. E.  Use of reserpine  (serpasil) in the manage-
  ment  of chronic alcoholism.  J. Am. M. Ass., 1957, 163:
  426-429.

with RESERPINE  and OTHER  DRUGS—COMBINED
  Gherarducci, D.  A propos de Tutilisation de la chlor-
  promazine associee a d'autres therapeutiques psychia-
  triques.  [Utilization of chlorpromazine associated with
  other psychiatric therapeutics.]   [sedatives; hypnotics]
  Ence'phale, 1956, 45 : 1187-1189.
  Hewat, J. K., Leach, P. W., Simpson, R. W. Chlorprom-
  azine,  reserpine, and isoniazid treatment in mental dis-
  order ; a preliminary communication,  [isoniazid] Brit.
  M. J., 1955, 2:1119-1120.  Abstract: Excerpta  med.,
  Sect. 8,1956, 9 : No. 2657.
  Reda,  G. C, Germano, V.   L'azione combinata della
  reserpina e cloropromazina nella  pratica  psichiatrica,
  [Combined effect of reserpine and  chlorpromazine in
  psychiatric  practice.]   [barbiturates]  [English sum-
  mary] Arch, psicol. neur., 3Iilano, 1956,17 : 647-653.

with  RESERPINE  and  SHOCK  THERAPY  [ECT]-
    COMBINED
  Bente, D. Elektroencephalographische Ergebnisse  zur
  Wirkungsweise der  neuroleptischen Behandlungsver-
  fahren.  [Mechanism of action of neuroleptic therapies;
  EEG findings. ] Ence'phale, 1956, 45 : 898-903
78 
SUBJECT  LIST
Chlorpromazine: with Other drugs [CNS depressants] Combined:
                      Analgesics [narcotics] — Therapeutic use
  Bordeleau, J. M.  Clinical evaluation of chlorpromazine
  and Rauwolfia serpentina in the psychiatric department
  of a general hospital.  J. Florida M. Ass., 1956, 42: 547-
  554.
  Foster, M. W., Jr., Gayle, R. F., III.  Chlorpromazine and
  reserpine as adjuncts in electroshock treatment.  South.
  M. J., 1956, 49 : 731-735.
  Gherarducci, D.  A propos de Tutilisation de la chlor-
  promazine associee & d'autres therapeutiques psychia-
  triques.   [Utilization  of  chlorpromazine  associated
  with  other psychiatric therapeutics.]   Encephale, 1956,
  45:1187-1189.
  Paerregaard,  G.  Chlorpromazinbehandling pa en psy-
  kiatrisk  modtageafdeling.  [Chlorpromazine treatment
  at  a  psychiatric department.]   [English  summary]
  Nord. med., 1956, 56 :1238-1240.

with RESERPINE and  SHOCK  THERAPY  [ICT]—
    COMBINED
  Hormia,   A.   Havaintoja  klooripromatsiini-reserpiini-
  insuliinisokkihoitoyhdistelmasta.   [Observations   on
  combined chlorpromazine, reserpine and insulin coma
  therapy.]  [English   summary]  Duodecim,  Hclsin.,
  1956,  72:948-955.                                * *

with SEROTONIN
  see SEROTONIN with  CHLORPROMAZINE

with TRIFLUPROMAZINE—COMPARED
Studies, animals
Therapeutic use
  see TRIFLUPROMAZINE—Studies,  animals

with OTHER DRUGS  [CNS depressants]—COMBINED:

  see also  CHLORPROMAZINE—Various  special tech-
   niques

Alcohol

—Studies,  animals
  Revol, L.  Chlorpromazine et intoxication  alcoolique.
  [Chlorpromazine  and  alcoholic  intoxication.]  Lyon
  pharm., 1954,5 : 349-350.

—Studies, normal subjects
  Fazekas, J. F., Albert, S. N., Alman, R. W.  Influence of
  chlorpromazine and  alcohol on  cerebral hemodynamics
  and metabolism.  Am. J. M. Sc,  1955, 230:128-132.  Ab-
  stract : Excerpta  med., Sect. 8, 1956, 9: No. 2934.
  Schultz,  J. D., Rea, E. L., Fazekas, J. F., Shea, J. C.
  Chlorpromazine in the management of acute alcoholic
  states.  Q.  J.  Alcohol,  1955,  16:245-250.   Abstract:
  Excerpta med., Sect.  8, 1956, 9: No. 2598.

—Untoward effects
  Drugs and driving. J. Am. M. Ass., 1954,156 : 628-629.
  Friend, D. G., Wells, J. C, Jr.  The clinical use of chlor-
  promazine.  Am. Practitioner, 1955, 6 : 698-703.  Also as:
  Uso clinico de la cloropromacina. Rev.  me'd. cubana,
  1956, 67: 645-650.
  Gutenkauf, C.   Internal  medicine.   In: "Happiness
  pills" in  medical practice: a  symposium.  J. Iowa  31.
  Soc, 1957, 47 : 59-64.
  Staehelin, J. E., Kielholz, P.  Largactil, ein neues vege-
  tatives Dampfungsmittel bei  psychischen Storungen.
  [Largactil, a  new autonomic inhibitor in mental  dis-
  orders.]  Schweiz. med. Wschr., 1953, 83: 581-586.  Ab-
  stract : Excerpta med., Sect. 8, 1954, 7 : No.  1601.
  Tillim, S. J.  Agranulocytosis  associated with chlorpro-
  mazine therapy.   Am. J. Psychiat., 1956, 112:1028.
  Tintera  J W  Office rehabilitation of the  alcoholic.
  N. York State J. M.,  1956, 56 : 3896-3902.
 Wallis, R.  Potentiation of hypnotics and analgesics;
 clinical experience with chlorpromazine.  N. York State
 J. 31., 1955, 55: 243-245.
Analgesics [narcotics]

—Studies, animals
  Arian, E.,  Gomirato,  G.   Recherches  experimentales
  sur Tinhibition  des  etats  d'excitation  d'origine sous-
  corticale par moyen de la chlorpromazine et de la reser-
  pine ;  communication  preliminaire.   [Experimental
  studies on  the inhibition of sub-cortical excitation by
  chlorpromazine and by reserpine; preliminary communi-
  cation.]  Encephale, 1956, 45:1264-1266.
  Eeckhoutte, R.  van.   Le chlorhydrate  de chloro-3-di-
  methylamino-3'-propyl-10-phenothiazine  (4560 R. P.) ;
  son action sur le systeme nerveux  et  sur le systeme
  neurovegetatif.   [3-Chloro-10- (3-dimethylaminopropyl)
  phenothiazine  (4560  R. P.) ; its action  on the nervous
  and autonomic nervous system.]  28 p.  Ambilly, 1953.
  [Thesis—Geneva, 1953, no. 2168.]
  Friebel,  H., Reichle,  C.  Zur  analgetischen und anal-
  gesieverstarkenden Wirkung von Chlorpromazin (Meg-
  aphen).  [Analgesic and analgesic-potentiating effect of
  chlorpromazine  (megaphen).]   Arch. exp. Path., Berl,
  1955,  226:551-557.  Abstract: Chem. Abstr., 1956, 50:
  2063 de.
  Martin, J. E.,  Beck, J. D.   Some effects of chlorproma-
  zine hydrochloride in  horses.   Am. J. Vet. Res., 1956,
  17: 678-686.
  Sadove, M. S., Balagot, R. C, Reyes, R. M.  The potenti-
  ating action of chlorpromazine.  Current Res. Anesth.,
  1956,  35:165-181.
  Schneider,  J.  A.  Reserpine antagonism  of  morphine
  analgesia in mice.  Proc.  Soc Exp.  Biol, N.  Y., 1954,
  87 : 614-615.  Abstract: Chem.  Abstr., 1955, 49: 4165ef.
  Wirth, W.  Versuche  zur  kombinierten Wirkung von
  Megaphen mit stark wirksamen Analgeticis.   [Experi-
  ments on megaphen  combined with  powerful analge-
  sics.]  Arch.  exp. Path., Berl., 1954, 222: 75-76.

—Studies, normal subjects
  Fraser H. F., Isbell, H. Chlorpromazine and reserpine.
  A.  Effects  of each and of combinations of each with
  morphine.  B.  Failure of  each in treatment of absti-
  nence from morphine.  A. 31. A. Arch. Neur.  Psychiat,
  1956, 76: 257-262.

—Therapeutic studies, controlled
  Houde, R, W., Wallenstein, S.  L.  Analgetic power of
  chlorpromazine alone and in combination with morphine.
  [Abstract.]  Fed. Proc, Bait, 1955,14: 353.
  Jackson, G. L.,  Smith, D.  A.   Analgesic properties of
  mixtures of chlorpromazine with morphine and meperi-
  dine.  Ann, Int. 31., 1956, 45 : 640-652.
  Sadove, M. S., Balagot, R. C.  The  value of chlorproma-
  zine  in the management  of pain.  Internat.  Rec.  M.,
  1955,  168: 346-350.
—Therapeutic use
  Bakwin,  H.  The uses of chlorpromazine in pediatrics.
  J. Pediat, S. Louis, 1956, 48 : 240-247.
  Dobkin, A. B., Gilbert, R. G. B., Lamoureux, L.  Physio
  logical effects of chlorpromazine.  Anaesthesia, Land.,
  1954, 9:157-174.
  Faucett, R. L.  Drug addiction and other considerations
  in the management of pain with narcotic drugs.  Proc.
  3Iayo Clin., 1957, 32 : 45-54.
  Gordon, R. A., Campbell, M. The use of chlorpromazine
  in intractable  pain associated with terminal carcinoma.
  Canad. 31. Ass. J., 1956. 75 : 420-421.
  Lieser, H.  Lasst sich die  auftretende Angst vor einer
  Schockbehandlung beeinflussen? [Can one control fear
  of shock therapy?]   Deut.  med. Wschr., 1956. 81- 1503-
  1504.
  Litteral, E.  B., Wilkinson,  W.  E.   The advantages,  dis-
  advantages  and limitations of the use of chlorproma-
  zine as a substitute for certain somatic treatment meth-
  ods in psychiatry.   Psychiat,  Res.  Rep., Wash.,  1955
  (1) : 63-71. 
Chlorpromazine: with Other drugs [CNS depressants] Combined:
Analgesics [narcotics] — Therapeutic use                                                PSYCHO pH ARM AC A
   Lucas, J., Albert, S. N., Bateman,  J. C,  Klopp,  C. T.
   Thorazine as an aid in management of cancer patients.
   [Abstract.]  Proc.  Am.  Ass. Cancer Res., 1954, 1(2) :
   30.
   Sadove, M. S., Levin, M. J., Rose, R. F., Schwartz, L,
   Witt, F. W.  Chlorpromazine and narcotics in the man-
   agement of pain of malignant lesions.  J.  Am. M. Ass.,
   1954, 155: 626-628.
   Vialard, C.  Note  sur  Tutilisation  du largactil  (4560
   R. P.)  comme potentilisateur  de  medicaments  anal-
   gesiques chez les cancereux douloureux resistants aux
   opiaces.  [Largactil  (4560  RP)  potentiating analgesic
   drugs in the treatment of  cancer patients who are in
   pain  and resistant to opiates.]  Anesthe'sie, Par.,  1953,
   10: 216-224.
   Wallis, R.  Potentiation of hypnotics and analgesics;
   clinical experience with  chlorpromazine. N. York  State
   J. 31., 1955, 55 : 243-245.
 —Untoward effects
   Fernandes, B., Leitao,  G.  Incidents and  accidents in
   chlorpromazine therapy,  [apomorphine.]   J. Clin. Exp.
   Psychopath., 1956, 17 : 70-76.

 Anticonvulsants
 —Studies, patients
   Bente, D., Itil, T. Zur Wirkung des Phenothiazinkorpers
   Megaphen auf das menschliche  Hirnstrombild.   [The
   effect  of the phenothiazine megaphen on the  human
   EEG.]  Arzneimitt Forsch., 1954, 4: 418-423.  Abstract:
   Chem. Abstr., 1954,48:13097b.
   Bonafede, V. I.  Chlorpromazine  (thorazine)  treatment
   of  disturbed epileptic  patients; preliminary  report.
   A. M. A. Arch. Neur. Psychiat., 1955, 74:158-162.
   ---.   Chlorpromazine  (thorazine)  treatment  of dis-
   turbed epileptic patients.  A. M. A. Arch. Neur. Psychiat.,
   1957,  77:243-246.
   Denber, H. C. B., Merlis, S. Studies on mescaline IV:
   Antagonism between mescaline and chlorpromazine. In:
   Kline, N.  S., ed.  Psychopharmacology.   Washington,
   Am. Ass. Adv. Sc,  1956.  p. 141-144.                *
   Meszaros, A. F., O'Reilly, P. O.  Relation of chlorprom-
   azine to epilepsy.  Dis.  Nerv. Syst, 1956,  17:159-162.
   Abstract: Excerpta med., Sect. 8, 1957, 10: No. 723.

—Therapeutic studies, controlled
   Bonafede, V. I.  Chlorpromazine  (thorazine)  treatment
   of disturbed  epileptic   patients; preliminary  report.
  A. M. A. Arch. Neur. Psychiat., 1955, 74: 158-162.     *
   ---.   Chlorpromazine   (thorazine)  treatment  of dis-
   turbed epileptic patients.  A. M. A. Arch. Neur. Psychiat.,
   1957, 77:243-246.
   Carillo-Broatch, A. Le largactil  dans le traitement de
   Tepilepsie  essentielle  rebelle;  resume d'une  communi-
   cation preliminaire.  [Largactil  therapy of severe idio-
  pathic epilepsy;  summary  of  a  preliminary report.]
  Encephale, 1956, 45:1221-1223.
  Meszaros, A. F., O'Reilly, P. O.  Relation of chlorprom-
  azine to epilepsy. Dis.  Nerv. Syst, 1956,  17:159-162.
  Abstract: Excepta med., Sect. 8,  1957, 10: No. 723.   *
  Rettig, J. H. Chlorpromazine and mysoline in the con-
   trol of convulsive epilepsy in mentally deficient patients.
  J. Nerv. Ment. Dis., 1956,124: 607-611.

—Therapeutic use
  Le Guillant.  Le syndrome neuroleptique: prevention et
  traitement.  [The neuroleptic syndrome: prevention and
  treatment]   Ann. me'd.  psychol,  Par., 1957,  115  (1)  •
  329-338.
  McCullagh, W. H., Ingram, W., Jr.  Headaches and hot
  tempers.  [Diphenylhydantoin]  Dis. Nerv. Syst.,  1956,
  17: 279-281.
  MacGregor, J.  MacW.   Largactil; a new psychomotor
  brake.  S. Afr. J. Clin. Sc, 1954, 5 : 228-243.  Abstract:
  Excerpta med., Sect. 8,1956, 9: No. 1724.
—Untoward effects  [see headnote p. 19]
  Cares, R. M„ Asrican, E., Fenichel, M., Sack, P., Severing,
  J.  Therapeutic  and  toxic  effects of chlorpromazine
  among 3,014 hospitalized cases.  Am. J. Psychiat., 1957,
  114: 318-327.   [case report p. 326-27]             * *
  Hollister, L. E. Unexpected asphyxial death and tran-
  quilizing drugs. Am. J. Psychiat, 1957, 114: 366-367. * *

Hypnotics
—Therapeutic use
  Kemper, H.  Erfahrungen mit einem neuen Schlafmittel
  aus der Piperidinreihe in der Psychiatrie.  [Experiences
  with a new piperidine hypnotic in psychiatry.]  [methy-
  prylon.]  Deut. med. Wschr., 1955, 80:1034-1035.  Ab-
  stract : Excerpta med., Sect. 8, 1956, 9: No. 3082.
  Laborit, H., Coirault, R.,  Damasio,  R., Gaujard,  R.,
  Laborit, G.,  Charonnat, R., Lechat, P., Chareton, J.  Sur
  un type nouveau d'anesthesie chirurgicale et sur Tem-
  ploi en therapeutique d'un depresseur du cortex cerebral
  (S. C. T.  Z.).   [A new type of surgical anesthesia and
  the therapeutic use of a cerebral cortex depressant (S. C.
  T. Z.)]  [thiamine hydrochloride]  Presse me'd., 1957,
  65:1051-1054.
  Schmitt, W.  Klinische Prufung einer neuen Piperidin-
  Verbindung als Schlafmittel.  [Clinical trial of a new
  piperidine  compound  as  soporific]   [methyprylon]
  Med.  Klin,,  Berl,  1955, 50:1223-1224.  Abstract:  Ex-
  cerpta med., Sect.  8, 1956, 9 : No. 3610.

with OTHER  DRUGS [CNS depressants]—COMPARED

  Abely, P., Abdouchelli, A.,  Fourment,  J., Schmitz,  B.,
  Delteil, P.  Suite aux essais therapeutiques de reequil-
  ibration instincto-affective; essai  de  traitement par la
  bromure tetra-ethyl  d'ammonium  en  comparaison avec
  le R. P. 45-60 et le  C. 92-95.    [Further  therapeutic
  studies on the restoration of instinctive-affective bal-
  ance; therapeutic  trials with tetraethylammonium bro-
  mide in comparison with R. P. 45-60 and with C. 92-95.]
  Ann. med. psychol, Par., 1952,110 (2) : 262-267.
  Ey, H., Faure, H.,  Lairy, G. C.  Action du largactil sur
  Telectro-encephalogramme de malades mentaux chroni-
  ques comparee  a Taction des barbituriques.   [Compari-
  son between the  effects of largactil and barbiturates
  on the  EEG of chronic mental patients.]  Ence'phale,
  1956, 45: 843-852.
  Glaser, E. M., Newling, P. S. B.  Side effects of chlorpro-
  mazine hydrochloride,  [hyoscine;  normal  subjects]
  Brit J. Pharm., 1955, 10: 429-433.
  Lehmann, H. E.,  Csank,  J.  Differential screening of
  phrenotropic agents in man: psychophysiologic test data.
  [normal subjects]   J. Clin. Exp. Psychopath.,  1957,
  18: 222-235.
  Monnerot, E., Monnerot, E., Benichou, L., Doco Analyse
  des roles respectifs du largactil et du sommeil barbitu-
  rique, dans les cures de sommeil potentialisees.  [Analy-
  sis of the effect of chlorpromazine and of barbiturates
  respectively in  potentiated sleep  therapy.]  Ence'phale,
  1956, 45:1190-1196.
  Shatin, L., Rockmore, L., Funk, I. C.  Response of psy-
  chiatric patients to  massive doses of thorazine.   II.
  Psychological test performance and  comparative drug
  evaluation,  [barbiturates]  Psychiat.  Q.,   1956,  30:
  402^16.


with OTHER  DRUGS  [CNS stimulants]—COMBINED:

Amphetamine

—Psychotherapeutic use
  Bronner, A.  Chlorpromazine (thorazine)  in office prac-
  tice.  Am. J. Psychother., 1956, 10: 460-466.
80 
SUBJECT  LIST
Chlorpromazine : with Psychosurgery Compared
 —Therapeutic use
  Feldman, P. E.  Two-year fate study of thorazine-treated
  patients,  [dextroamphetamine;  ephedrine  sulphate]
  Am. J. Psychiat., 1957, 114: 237-240.
  Hart, T. M.  Use of a chlorpromazine-dextroampheta-
  mine combination  in anxiety neuroses.   Am.  Practi-
  tioner, 1956, 7:1988-1990.
  Hoch,  P. H.   Practical and theoretical  applications
  of the new drug therapies in psychiatry.  A. M. A. Arch.
  Neur. Psychiat, 1956, 75 : 325-328.
  Kinross-Wright, V.  Chlorpromazine; a major advance
  in psychiatric treatment.  Postgrad. 31., 1954, 16:297-
  299.
  Le Guillant.  Le syndrome neuroleptique: prevention et
  traitement.  [The neuroleptic syndrome : prevention and
  treatment]   Ann. me'd.  psychol, Par.,  1957, 115  (1)  :
  329-338.
  Malitz,  S., Hoch, P. H., Lesse, S.  A two-year evalua-
  tion of  chlorpromazine in  clinical  research  and prac-
  tice. Am. J.  Psychiat., 1956, 113: 540-545.
  Sigwald, J. La cure ambulatoire par la chlorpromazine.
  [Ambulatory therapy with chlorpromazine.]  Ence'phale,
  1956, 45:392-400.
  ---, Bouttier, D., Nicolas-Charles, P.   Ambulatory
  treatment with chlorpromazine.  J. Clin. Exp.  Psy-
  chopath., 1956,  17:57-69.

 Strychnine

 —Therapeutic use
  Gouttebroze,  V. Une annee d'experience de traitement
  du delirium tremens; 61 cas recueillis  dans le  service
  de neuro-psychiatrie de THopital Bellevue, St. Etienne.
  [Treatment of  delirium tremens; one year's experience
  in 61 cases from the neuro-psychiatric  service of the
  Hopital  Bellevue,  St.  Etienne.]  85  p.   Lyon, 1955.
  [Thesis—Lyon, 1954/1955, no. 94]
  Kammerer, T.,  Ebtinger,  R.  Premiers  resultats du
  traitement du delirium tremens par le  chlorpromazine
  (Largactil).  [First results of chlorpromazine  therapy
  in delirium tremens.]   Strasbourg  me'd.,  1954, 5: 287-
  291. Abstract: Ann. med. psychol, Par., 1954, 112 (1)  :
  102.
  ---, Mengus, M., Ebtinger, R.  Traitement du delirium
  tremens par la  chlorpromazine. [Chlorpromazine in the
  treatment of delirium tremens.]  [Abstract]  Ann. me'd.
  psychol, Par., 1954,  112 (2) : 439.
  Postel, J., Cossa, P.   Etat actuel de  la therapeutique du
  delirium tremens; sur 165 cas.   [Present  state of the
  therapv of delirium tremens; 165 cases.]  Rev.  neur.,
  Par., 1956, 94 : 660-662.
  Ravina,  A., Pestel,  M., Albouy, R.  Alcoolisme aigu et
  delirium tremens en milieu hospitalier  parisien.   Con-
  siderations cliniques et therapeutiques &  propos de 40
  cas recents.   [Acute alcoholism and  delirium tremens
  in a Paris hospital setting.  Clinical and therapeutic
  considerations regarding 40 recent cases.]  Bull. Soc
  me'd. hop. Paris, 1955, 71: 698-703.


with OTHER DRUGS [disulfiram]—COMBINED

Therapeutic studies, controlled
  Cummins, J. F., Friend, D. G.  Use of chlorpromazine
  in chronic alcoholics.  Am. J. 31. Sc, 1954, 227: 561-564.
  Abstract: Excerpta med., Sect. 8,1955, 8: No. 3552.

Therapeutic use
  Friend, D. G.,  Wells, J. C, Jr. The clinical use of chlor-
  promazine.  Am. Practitioner,  1955, 6: 698-703.   Also
  as : Uso clinico de la cloropromacina.  Rev. me'd. cubana,
  1956, 67: 645-650.
  MacGregor, J. MacW.  Largactil; a new psychomotor
  brake  S Afr. J. Clin. Sc,  1954, 5 : 228-243. Abstract:
  Excerpta med.,  Sect. 8, 1956, 9: No.  1724.
  Tintera, J.  W.  Office rehabilitation of the alcoholic.
  N. York State J. 31., 1956, 56: 3896-3902.
  Williams, E. L.  The management of the chronic alco-
  holic.  Postgrad. M. J., Lond., 1954,  30:626-630.

with OTHER DRUGS [insulin]—COMBINED

Therapeutic studies, controlled
  Lancaster,  N. P.,  Jones,  D. H.  Chlorpromazine and
  insulin  in psychiatry.  Brit. 31. J., 1954,  2: 565-567.

with INTERMITTENT PHOTIC STIMULATION

Studies, normal subjects
  Despinoy, M.,  Saucet, D.   Effets  eiectro-encephalo-
  graphiques des stimulations auditives et lumineuses sur
  des sujets soumis a la chlorpromazine.  [Effects of audi-
  tory  and  photic stimultions on the EEG of subjects
  under  the influence of chlorpromazine.]  Encephale,
  1956, 45: 877-883.                                  *

Studies,  patients
  Azima,  H.  Proponged sleep  treatment  in mental dis-
  orders ; some new  psychopharmacological  considera-
  tions. [chlorpromazine+barbiturates+IPS]   J.  Ment
  Sc,Lond., 1955, 101:593-603.                      *
  Fabisch, W.  Chlorpromazine and  epilepsy.  Lancet,
  Lond.,   1955, 1: 1277.                              *
  Leroy, C, Sigwald,  J.  Les myoclonies et epilepsies ap-
  paraissant chez certains malades au cours de Tadminis-
  tration  de  la chlorpromazine.   [Myoclonias and epi-
  leptic convulsions  occurring in  some  patients during
  chlorpromazine therapy.]   Ence-phale,  1956,  45 : 904-
  909.                                               *

with PSYCHOSURGERY—COMBINED
  Delay,  J.,  Deniker,  P.,  Ropert,  R.  Quatre  annees
  d'experience  de la chlorpromazine  dans  le  traite-
  ment  des psychoses.  [Four years of experience with
  chlorpromazine in therapy of psychoses.]   Presse vied.,
  1956,  64:493-496.
  Pate, W. H.   Chlorpromazine therapy following  trans-
  orbital lobotomy.  J. Nerv. Ment. Dis., 1957, 125: 44-50.
  Sagripanti, P. Leucotomia e ipnoterapia in un caso di
  psicosi ossessiva.  [Leukotomy and sleep therapy in an
  obsessive psychotic patient.]  3Iinerva med., Tor., 1953,
  44:259-260.   [Not seen]
with PSYCHOSURGERY—COMPARED
  Ayd,  F.  J., Jr. A critique of chlorpromazine and reser-
  pine  therapy.  In:  Himwich, H. E., ed.  Tranquilizing
  drugs.   Washington, Am. Ass. Adv. Sc, 1957.  p. 173-
  181.
  Choppy, M., Le Beau, J., Petrie, A. Modifications de la
  personnalite apres les operations frontales seiectives y
  compris la cingulectomie  et apres traitement par la
  chlorpromazine.  [Personality changes  after selective
  frontal  operations,  including cingulectomy, and  after
  chlorpromazine therapy.]  Rev. neur., Par.,  1955, 93:
  843-849.
  Deniker, P.   Hibernotherapies et medicaments neuro-
  leptiques en therapeutique psychiatrique.  [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapv.]
  Encephale, 1957, 46 : 281-398.  [p. 370]
  Kokkoris,  P., Kordas,  P., Nikolopoulos, Yanniris, M.
  The results of chlorpromazine treatment  with chronic
  psychoses in Dromokaition.  J. Nerv. 3Ient Dis., 1957,
  125:102-111.
  Malitz, S., Hoch, P. H., Lesse, S.  A two-year evaluation
  of chlorpromazine   in  clinical research  and practice.
  Am. J. Psychiat, 1956, 113:540-545.
  Margolis, L.  H. Pharmacotherapy  in psychiatry; a re-
  view.  Ann. N. York Acad. Sc, 1957, 66: 698-718.
  Pate, W. H.   Chlorpromazine therapy following trans-
  orbital lobotomy.  J. Nerv. Ment. Dis., 1957, 125 : 44-50.
  Petrie, A., Le Beau, J.  The effects  on personality of
81 
Chlorpromazine : with Psychosurgery Compared
PSYCHOPHARMACA
  chlorpromazine as compared with various brain oper-
  ations.  Encephale, 1956, 45 : 987-995.
  Petrie, A., Le Beau, J. Psychologic changes in man after
  chlorpromazine and certain types of brain surgery.  J.
  Clin. Exp. Psychopath., 1956, 17 :170-179.
  Pollack, B.  Preliminary  report on 500 patients treated
  with thorazine at Rochester State Hospital.  Psuehiat.
  Q., 1955, 29 : 439-456.

with SHOCK THERAPIES—COMBINED

  see also CHLORPROMAZINE
        Various special  techniques with Shock therapy

  Achaintre, A., Balvet,  P., Beaujard, M.,  Brousolle, P.,
  Perrin, J., Leveque, F., Requet, A.  Evaluation of chlor-
  promazine in psychotic  patients.  Internat.  Rec.  31.,
  1957, 170:175-182.
  ---, Dubor,  P.  Les therapeutiques alternantes  et leur
  emploi  en  psychiatrie.   [Alternating therapies   and
  their use in psychiatry.]   [Abstract]  J. med. Lyon,
  1954, 35 : 952.
  ---, ----,   Lauxerois,  G.  Trois  modes particuliers
  d'administration  de la chlorpromazine dans les affec-
  tions psychiatriques a longue evolution.  [Three  special
  methods of  chlorpromazine therapy in chronic psychi-
  atric diseases.]  Ence'phale, 1956, 45 : 444-448.
  Boszormenyi, Z., Gimes,  M., Orthmayr, A.  A largactil
  pharmakodynamias hat&sa es therapias  eredmenyei  a
  psychiatriaban.   [Pharmacodynamic   effects  and  the
  therapeutic  results  of largactil  in psychiatry]   Orv.
  hetil,  1955,  96 : 1039-1045.  Abstract: Excerpta med.,
  Sect.  8,  1956, 9: No. 2238.  [A  very  short  English
  abstract]
  Cervos Navarro, J., Unterharnscheidt, F.  Importancia
  de  las fenotiacinas en  psiquiatria.   [Importance of
  phenothiazines in psychiatry.]  Rev. espan. otoneuroft,
  1956, 15:  75-92.
  Deniker,  P.   Hibernotherapies  et  medicaments neuro-
  leptiques  en  therapeutique  psychiatrique.  [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapy.]
  Encephale, 1957, 46:281-398.   [367-69; 380; 382; 392;
  395.]
  Falcon, M.  Quelques observations cliniques sur Temploi
  de la chlorpromazine.  [Clinical observations on  the use
  of chlorpromazine.]  Ence'phale, 1956, 45:587-591.
  Follin, S., Soubrier, P.  Sur Tutilisation d'une substance
  neuroplegique  dans un  service de psychiatrie.   [The
  use of a neuroplegic drug in a psychiatric hospital serv-
  ice.]   [Abstract]  Ann.  med. psychol, Par.,  1953, 111
   (2) :403.
  Ford,  H., Jameson, G. K.  Chlorpromazine in conjunc-
  tion with other  psychiatric therapies:  a clinical ap-
  praisal.  Dis. Nerv. Syst,  1955, 16 : 179-185.
  Kelley, J. W. Thorazine-chlorpromazine.   Nebraska 3f.
  J.,  1954,  39:305-307.  Abstract: Excerpta med.,  Sect.
  8, 1955, 8: No. 1797.
  Lafon, R.  Due, N., Ribstein, M., Pages,  H.  Le traite-
  ment des syndromes schizophreniques  par la 4560 R. P.
   (chlorpromazine).   [Treatment  of schizophrenic  syn-
  dromes with chlorpromazine.]   MontpcUier med., 1954,
  46: 2S4-291.   Abstract: Excerpta med,, Sect. 8, 1955, 8:
  No. 3642.
  Lewis, L. F.  The use of  chlorpromazine  and of serpasil
  in the treatment of psychotic patients.   Carib. 31. J.,
  Trinidad, 1956, 18: 51-66.
  Mendes, F., Galvao, P. Experiencia clinica com  a cloro-
  promazina (4560 R. P.)  em psicoses.  [Clinical experi-
  ence with chlorpromazine (4560 R. P.)   in psychoses.]
   [English  summary] J. me'd., Porto, 1955, 26: 149-156.
  Roeder, F. D.  Letter from Germany.  Am. J. Psychiat.,
  1956. 113: 506-509.
  Rondepierre, J., Hivert, P. H., Honore, B., Vaugelade, S.
  Resultats  favorables  obtenus par les   neuroleptiques
  dans les  psychoses  de facheux pronostic.  [Favorable
  results obtained with neuroleptics in psychoses  of  poor
  prognosis.]  Ann.  mCd. psychol, Par., 1955,  113 (2) :
  853-859.
with SHOCK THERAPIES—COMPARED

  Avd  F. J., Jr.  A critique of chlorpromazine and reser-
  pine therapy.  In: Himwich,  H. E.,  ed.  Tranquilizing
  drugs.  Washington, Am. Ass.  Adv. Sc, 1957.  p. 173-
  181.
  Deniker,  P.  Hibernotherapies et medicaments  neuro-
  leptiques  en  therapeutique psychiatrique.   [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapy.]
  Encephale, 1957,  46:281-398.  [367-69]
  Fries, P.  E.,  Gunne,  L.  M., Lundgren, S., Vidmg,  G.,
  Ohrberg, K.  Orienterande  undersokning av chloropro-
  mazinets  kliniska och farmakologiska effekt a psyki-
  atriskt  klientel.   [Investigation  of  the  clinical  and
  pharmacological effects  of  chlorpromazine on psychi-
  atric patients.]   Nord. psykiat. medl, Kbh., 1955, 9 :192-
  201. Abstract: Excerpta med.,  Sect. 8, 1956, 9 : No. 4072.
  Goldman, D.  Chlorpromazine treatment of hospitalized
  psychotic patients. J. Clin. Exp. Psychopath., 1956, 17:
  45-56.  Abstract:  Excerpta  med., Sect. 8, 1957, 10: No.
  372.
  Hartmann, K., Hiob,  J., Hippius, H.  Comparative psy-
  chopathology of shock therapy and  pharmacotherapy.
  Internat. Rec. M., 1957, 170:119-124.
  ___t ----,----.  Zur vergleichenden Psychopathologie
  der  Schock-  und  Phenothiazinwirkungen.  [Compara-
  tive psychodynamics  of  shock therapy and phenothia-
  zines.]  Fortsch. Neur.  Psychiat.,  1955,  23: 354-366.
  Kokkoris,  P., Kordas, P.,  Nikolopoulos,  Yanniris, M.
  The results of chlorpromazine treatment with chronic
  psychoses in Dromokaition. J. Nerv. Ment. Dis., 1957,
  125: 102-111.
  Margolis, L. H.  Pharmacotherapy in psychiatry; a re-
  view.  Ann. N. York  Acad.  Sc, 1957, 66: 698-718.

with  SHOCK THERAPY  [ECT]—COMBINED

  see also  CHLORPROMAZINE—Various special tech-
             niques with Shock  therapy  [ECT]
Studies,  animals
  Eeckhoutte,  R.  van.  Le  chlorhydrate  de  chloro-3-
  dimethylamino-3'-propyl-10-phenothiazine  (4560 R. P.) ;
  son action sur  le  systeme  nerveux  et sur  le systeme
  neurovegetatif.   [3-Chloro-10- (3-dimethylaminopropyl)
  phenothiazine (4560  R.  P.) ; its action on the nervous
  and autonomic nervous system.]  28 p.  Ambilly, 1953,
  [Thesis—Geneva, 1953, no.  2168]

Studies, patients
  Bente, D. Elektroencephalographische Ergebnisse zur
  Wirkungsweise  der  neuroleptischen  Behandlungsver-
  fahren.  [Mechanism of action of neuroleptic therapies;
  EEG findings.]  Encephale,  1956, 45 : 898-903.
  Passouant, P., Pelissier, Minvielle, Jr., Dutartre. Mod-
  ifications eiectro-encephalographiques provoquees par la
  chlorpromazine au cours de Tepilepsie et de la schizo-
  phrenic.   [EEG changes induced by chlorpromazine in
  epilepsy and  in schizophrenia.]  Encephale, 1956, 45:
   891-897.
  Weiss, D. M.  Changes  in  blood pressure with electro-
   shock therapy  in a patient  receiving chlorpromazine
   hydrochloride (thorazine). Am. J. Psychiat., 1955, 111:
   617-619.

 Therapeutic use
  Ayd, F.  J.,  Jr.   Chlorpromazine  therapy  for  anxiety
   associated with electroshock  therapy.   Conflnia neur.,
   Basel, 1956, 16:168-173.
   Bennett, A. E.,  Ford, F. R., Turk, R. E.  Clinical investi-
   gation of chlorpromazine and reserpine  in private psy-
   chiatric practice.  Am. J. Psychiat, 1956, 112: 7S2-7S7.
   Condensed:  Am.  Practitioner, 1956, 7:157(5-1577.   Ab-
   stract : Excerpta med., Sect. 8, 1956, 9 : No. 4.~>46.
82 
SUBJECT  LIST
Chlorpromazine: with Shock therapy [ECT] Combined:
                            Therapeutic use—Psychoses
 Bertolini, O.  L'azione del 4560 R. P. in diverse sindromi
 psichiatriche.  [Effects  of 4560 R. P. in various psychi-
 atric syndromes.]  Riv. sper. freniat, 1954, 78: 205-224.
 Bordeleau, J. M.  Clinical evaluation of chlorpromazine
 and Rauwolfia serpentina in the psychiatric department
 of a general hospital.  J. Florida 31. Ass., 1956,  42 : 547-
 554.
 Bronner, A. Chlorpromazine  (thorazine) in office prac-
 tice.  Am. J. Psychother., 1956, 10 : 460-466.
 Ditfurth, H. von  Anwengdngsmoglichkeiten des Mega-
 phens  in  der  psychiatrischen Klinik und Forschung.
 [Possibilities for the use of  megaphen in psychiatric
 practice  and research.]  Nervenarzt, 1955, 26: 54-59.
 Abstract: Excerpta med,, Sect. 8, 1956, 9: N'o. 4074.
 Gade,  E. B., Heinrich,  K.  Die Bedeutung der Pheno-
 thiazinderivate,  insbesondere  des Megaphen, fur Psy-
 chiatrie und  Neurologie.   [The  importance of pheno-
 thiazine derivatives in  psychiatry and neurology with
 special reference to chlorpromazine.]  Fortsch. Neur.
 Psychiat., 1955, 23 : 323-353.
 Haq, S. M., Smyth,  V. O. Preliminary observations on
 the use of largactil  in psychiatry.  Med. J.  Malaya,
 1955, 9 : 205-211.  Abstract: Excerpta med., Sect. 8,1956,
 9: No. 4070.
 Kardos, G., Pertorini, R. A largactil psychiatriai alkal-
 mazasa.  [Psychiatric applications of chlorpromazine.]
 Ideg. szemle, 1955, 8 :  65-70.
 Kinross-Wright,  V.   Clinical application  of  chlorpro-
 mazine.  In: Kline,  N. S., ed.  Psychopharmacology.
 Washington, Am. Ass. Adv. Sc, 1956.  p. 31-38.
 Laboucarie, J., Barres P., Rascol, A.  Aspects principaux
 des cures neuropiegiques en psychiatrie en 1956.  [Prin-
 cipal features  of neuroplegic  therapy in psychiatry in
 1956.]  Toulouse  med., 1956, 57: 851-867.
 Lesse,  S., Malitz, S., Hoch,  P. [H.]  Chlorpromazine
 therapy in  private practice.  Its benefits and complica-
 tions.   J. Nerv. Ment. Dis., 1957,  125: 25-35.
 Lieser, H.  Lasst sich die auftretende Angst vor einer
 Schockbehandlung beeinflussen?  [Can one control fear
 of shock therapy?]  Deut. med. Wschr., 1956, 81:1503-
 1504.
 MacColl, K. Chlorpromazine hydrochloride (largactil)
 in the treatment of the disturbed mental defective. Am.
 J.  Ment. Defic, 1956, 61: 378-389.
 Malitz, S.,  Hoch, P. H., Lesse, S.   A two-year evalu-
 ation of chlorpromazine in clinical  research and prac-
 tice.  Am. J. Psychiat., 1956, 113: 540-545.
 Margolis, L. H.  Pharmacotherapy in psychiatry; a  re-
 view.   Ann. N.  York  Acad. Sc, 1957, 66:698-718.    *
 Martin, C.  A.  Epreuve  de  largactil  en  psychiatrie.
 [Experiences  with  largactil  in  psychiatry.]    Laval
 me'd.,  1954, 19:1079-1094. Abstract: Excerpta med.,
 Sect. 8, 1956, 9 : No. 1723.
 Mayr,  F.  Erfahrungen mit der  Largactil-Behandlung
 in  der Anstaltspsychiatrie.  [Experience with largactil
 treatment in psychiatric hospitals.]   Ther.  Umschau,
 Bern, 1955, 11: 184-191; 203-211.
 Paerregaard, G.   Chlorpromazinbehandling pa. en psy-
 kiatrisk modtageafdeling.  [Chlorpromazine  treatment
 at  a  psychiatric department]    [English summary]
 Nord. med., 1956, 56 : 1238-1240.
 Puca, A. Ibernoterapia,  sonno prolungato e neuroplegici
 in terapia psichiatrica.   [Hibernation, prolonged sleep
 and neuroplegic drugs in psychiatric treatment.]  Rass.
 internaz. clin. ter., 1955, 35: 805-809.
 Resch, J. A., Schut, J. W., Bernstein, I. C.  Premedica-
 tion in  electric  convulsive therapy.  Am. J. Psychiat.,
 1956, 113: 78.
 Shulman, L., Ginsberg, M. A preliminary review of the
 uses of chlorpromazine in psychiatric diseases.  S. Afr.
 31. J., 1956, 30: 815-818.
 Wachsmuth, R.   Phenothiazinderivate (Megaphen)  in
 der Psychiatrie.  [Phenothiazine derivatives  (mega-
phen) in psychiatry.]  31edizinsche, 1955: 328-329.
  Wilcox, P. H., Wilcox, K. W.  Shock therapy;  physio-
  dynamic therapy.  1.  Progr. Neur. Psychiat., N. Y., 1956,
  11: 401-424.

—Psychoses
  Abely, P., Abdouchelli,  A., Fourment, J.,  Schmitz,  B.,
  Delteil, P.   Suite  aux  essais  therapeutiques  de  re-
  equilibration instincto-affective; essai de traitement par
  la bromure  tetra-ethyl  d'ammonium  en  comparaison
  avec le R. P. 45-60 et  le C. 92-95.  [Further therapeutic
  studies  on the restoration of instinctive-affective bal-
  ance ;  therapeutic  trials  with  tetraethylammonium
  bromide in  comparison  with R. P. 45-60  and with C.
  92-95.]  Ann. me'd. psychol,  Par., 1952,  110  (2) : 262-
  267._
  Carillo-Broatch, A.   Tratamiento de la esquizofrenia
  cronica.  [Treatment  of chronic schizophrenia.]   [Eng-
  lish  summary]   Rev. neur. psiquiat, Lima, 1955, 18:
  441-445.   Abstract: Excerpta med., Sect.  8, 1957, 10:
  No. 1981.
  Carrier, J.,  Guyotat,  J.,  Grandmottet, J.  Electro-choc
  et largactil dans les acces maniaques.   [Electric shock
  therapy and largactil  in manic attacks.]  J. me'd. Lyon,
  1954, 35: 950-951.
  Delay, J., Deniker, P.,  Ropert, R.  Etude  de 300 dossiers
  de malades  psychotiques traites par la  chlorpromazine
  en service ferme depuis  1952.  [Hospitalized psychotic
  patients treated with  chlorpromazine since 1952: analy-
  sis of 300 case histories.]  Ence'phale, 1956, 45 : 528-535.
  Denber, H.  C. B., Bird, E. G. Chlorpromazine  in the
  treatment of mental  illness.   III. The  problem of de-
  pression.  Am.  J.  Psychiat., 1956, 112:1012.  Discus-
  sion : ibid., 1956, 113 : 368-369.
  Foster,  M. W., Jr., Gayle,  R. F., III.  Chlorpromazine
  and  reserpine as adjuncts in  electroshock treatment.
  South. M.  J., 1956, 49: 731-735.
  Goldman, D. Chlorpromazine treatment  of hospitalized
  psychotic  patients.   J.  Clin.  Exp. Psychopath.,  1956,
  17 : 45-56.   Abstract:  Excerpta med., Sect. 8, 1957, 10 :
  No. 372.
  Kinross-Wright, V.  Chiorpromazine treatment of  men-
  tal disorders.  Am. J. Psychiat., 1955, 111: 907-912.
  Kranz, H.  Krankheitsdauer  und Recidivhaufigkeit bei
  Chlorpromazinbehandlung endogener Psychosen.   [Dur-
  ation of disease and  relapse rate of endogenous psy-
  choses treated with chlorpromazine.]  Encephale,  1956,
  45 : 628-634.
  Laboucarie,  J.,  Barres,  P., Rascol, A.   L'action de la
  chlorpromazine dans le traitement des psychoses deiir-
  antes systematisees et des schizophrenies.   [Effect  of
  chlorpromazine  therapy  in  chronic   delirium  and
  schizophrenia.]   Encephale, 1956,  45 : 691-697.
  ----, Rascol, A., Benichou,  L.  L'action  de la chlorpro-
  mazine dans les schizophrenies.   [Mechanism of action
  of chlorpromazine in  schizophrenia.]  Ann.  med. psy-
  chol, Par., 1954, 112 (2)  : 751-757.
  Lamarche, A., Roussel,  A., Rosendorf.   Comparaisons
  des resultats obtenus par la cure de sommeil, la cure de
  somnolence,  et la cure a la chlorpromazine seule et h
  dose eievee; resultats de  quelques electro-encephalo-
  grammes de controle.  [Comparison of results obtained
  with sleep therapy, somnolence therapy and chlorpro-
  mazine therapy alone and with elevated doses;  results
  controlled  by EEG.]   Ence'phale, 1956, 45: 884-890.
  Litteral, E. B., Wilkinson, W. E.  The advantages, dis-
  advantages and limitations of the use of chlorpromazine
  as a substitute for certain  somatic treatment methods
  in  psychiatry. Psychiat Res. Rep., Wash., 1955  (1)  :
  63-71.
  Perrin, J.,  Toulet, M.  Utilisation de la chlorpromazine
  dans le traitement des psychoses chroniques.  [Use of
  chlorpromazine in the treatment of chronic psychoses ]
  Ence'phale, 1956, 45 :1210-1218.
  Phillip, E.  Erfahrungen  mit Megaphen in der Behand-
  lung psychisch  Erkrankter.  [Experience with mega-
83 
Chlorpromazine: with Shock therapy [ECT] Combined:
Therapeutic use—Psychoses
PSYCH0PHAR3IACA
  phen in the treatment of the mentally ill.]  Nervenarzt,
  1955, 26 : 49-65.  Abstract: Excerpta med., Sect. 8, 1956,
  9: No. 4075.
  Rogg, S. G. Thorazine and electroshock.  Delaware M.
  J., 1955,  27: 83-84.

Untoward  effects [see headnote p. 19]
  Bini, L.  see Kalinowsky, L. B. Am. J. Psychiat., 1956,
  113: 79.                                          *  *
  Deniker, P.  Hibernotherapies et  medicaments neuro-
  leptiques en therapeutique psychiatrique.   [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapy.]
  Encephale, 1957,  46: 281-398.   [p.  368]             *  *
  Epstein,  J. Drugs and electroconvulsive therapy.  J.
  Am. M. Ass., 1956, 160: 503.
  Kalinowsky,  L.  B.  The  danger of  various  types of
  medication during electric convulsive therapy.  Am. J.
  Psychiat, 1956, 112: 745.                          *  *
  ---.   Additional remarks on  the  danger of  premedi-
  cation in electric convulsive therapy.  Am. J. Psychiat.,
  1956, 113:  79-80.

with SHOCK THERAPY [ECT]—COMPARED
  Ayd, F.  J., Jr.   Chlorpromazine therapy for  anxiety
  associated  with  electroshock therapy.  Confinia neur.,
  Basel, 1956, 16:168-173.
  Carrier,  J., Guyotat,  J., Grandmottet, J.  Electro-choc
  et largactil dans  les acces maniaques.  [Electric shock
  therapy and largactil in manic  attacks.]  J. me'd. Lyon,
  1954, 35: 950-951.
  Kranz, H.  Krankheitsdauer  und Recidivhaufigkeit bei
  Chlorpromazinbehandlung endogener Psychosen. [Dura-
  tion of disease and relapse rate  of endogenous psychoses
  treated with  chlorpromazine.]  Ence'phale, 1956,  45:
  628-634.
  Kurland, A. A. Chlorpromazine in  the management of
  the institutionalized aged  psychiatric  patient  with
  chronic brain syndrome.  Dis. Nerv. Syst., 1955,16 : 366-
  369.
  Lehmann, H. E., Hanrahan, G. E.  Chlorpromazine, new
  inhibiting agent for psychomotor excitement and manic
  states.  A. M. A. Arch. Neur. Psychiat.,  1954, 71: 227-
  237.
  Lesse,  S.,  Malitz, S., Hoch,  P. [H.]   Chlorpromazine
  therapy in private practice.   Its benefits and complica-
  tions.  J. Nerv. Ment. Dis., 1957, 125: 25-35.
  MacColl, K.  Chlorpromazine hydrochloride (largactil)
  in the treatment of the disturbed mental defective.  Am.
  J. 3Ient.  Defic, 1956, 61: 378-389.
  Maisonneuve,  G.   Bilan  d'un an  de traitement par la
  chlorpromazine.   [Chlorpromazine  therapy; results of
  one year.]   59 p. Lyon,  1954.  [Thesis—Lyon, 1953/
  1954, no. 93]
  Malitz, S.,  Hoch, P.  H., Lesse, S.   A two-year evalua-
  tion of chlorpromazine in clinical research and practice.
  Am. J. Psychiat,  1956, 113 : 540-545.
  Passouant, P., Pelissier, Minvielle, J., Dutartre. Modi-
  fications  eiectro-encephalographiques provoquees par la
  chlorpromazine au cours de Tepilepsie et de la schizo-
  phrenic  [EEG  changes induced by chlorpromazine in
  epilepsy  and in  schizophrenia.]  Ence'phale, 1956,  45:
  891-897.
  Phillip, E.  Erfahrungen mit Megaphen in der Behand-
  lung psychisch Erkrankter.   [Experience with mega-
  phen in the treatment of the mentally ill.]  Nervenarzt,
  1955, 26 : 59-65.  Abstract: Excerpta med., Sect. 8, 1956,
  9: No. 4075.
  Pollack, B. Mental  illness.   Med.  Times, Great Neck,
  1955, 83: 439-450.
  ---.  Preliminary report on 500 patients treated  with
  thorazine at Rochester State Hospital.   Psychiat. Q.,
  1955, 29:439-456.

with  SHOCK THERAPY [ICT]—COMBINED
  Adam,  H.,  Golse, J.   Coma  insulinique  et coma  par
  hibernation.  [Insulin coma and coma by hibernation.]
  [chlorpromazine cocktail] Encephale, 1956, 4o:4<l-473.
  Galenko, V. E., Osberg, I. IU., Azbukina, V. D.  Amina-
  zin v psikhiatricheskoi klinike.  [Aminazine in psychi-
  atric practice.]  Zh. nevropat. psikhiat., Moskva, 1956,
  56:162-165.
  Hes, J. P.,  Bracha,  S.  The influence of reserpine on a
  disturbed male ward and a method for assessing this.
  J. Ment. Sc, Lond., 1956, 102 : 546-549.
  Hormia, A.  Havaintoja klooripromatsiini—reserpiini—
  insuliinisokkihoitoyhdistelmasta.    [Observations   on
  combined chlorpromazine,  reserpine and  insulin coma
  therapy.]   [English  summary]   Duodecim,  Helsin.,
  1956, 72: 948-955.                                 * *
  Lancaster,  N. P., Jones, D. H.  Chlorpromazine and in-
  sulin  in  psychiatry,   [with insulin and  ICT]   Brit.
  M. J., 1954, 2 : 565-567.
  Maderna, A.,  Micheletto, T.  Primi risultati sull'asso-
  ciazione  largactil-insulina nella  terapia  di  Sakel.
  [First results with  a largactil-insulin combination in
  SakeTs therapy.]  Pisani, 1954, 68: 587-598.
  Obiols, J. Notre experience sur la therapeutique par la
  chlorpromazine.  [Our experience with chlorpromazine
  therapy.] Encephale, 1956, 45 : 698-699.
  Ramee, F.,  Lacaton, R., Sanchez,  F., Boulanger,  M.
  Effets favorables du largactil dans la pratique psychi-
  atrique algerienne.   [Good results with chlorpromazine
  therapy  of  mental  diseases in Algeria.]   Encephale, '
  1956, 45: 820-827.
  Requet, Leveque.  Cure de Sakel et  chlorpromazine as-
  socies.  [Combined Sakel and chlorpromazine therapy.] •
  J. med. Lyon, 1956, 37: 407-409.  Abstract:  Excerpta
  med., Sect. 8,  1957, 10 : No. 954.
  Tarasov, G. K.  Rezul'taty klinicheskogo issledovaniia
  deistviia aminazina  pri lechenii psikhicheski bol'nykh.
  [Results of clinical investigations on the effect of amina- \
  zine in  mental  patients.]   Zh.  nevropat.  psikhiat,
  Moskva, 1956,  56: 146-154.

with  SHOCK THERAPY  [ICT]—COMPARED
  Adam, H., Golse, J.  Coma insulinique et coma par hiber-
  nation.   [Insulin  coma  and coma by  hibernation.]
  [chlorpromazine cocktail] Encephale, 1956, 45:471-473. ,
  D'Aulnay, J.,  Malineau,  R.  Depuis  Tavenement de la ,
  chlorpromazine la cure  de Sakel est-elle condamnee? ,
  [Is SakeTs therapy obsolete since the advent of chlor-
  promazine  therapy?]   Encephale, 1956, 45:656-660.   i
  Azima, H.   Proponged  sleep treatment in mental dis- ,
  orders;  some new  psychopharmacological  considera-
  tions,  [chlorpromazine 4- barbiturates]  J.  Ment. Sc, ;
  Lond., 1955, 101: 593-603.
  Boardman, R. H., Lomas, J., Markowe, M.  Insulin and
  chlorpromazine in schizophrenia; a  comparative study ':
  in previously  untreated cases.  Lancet, Lond., 1956, 2:
  487-491.                                             i
   COVATIN

   Pharmacodynamics
     Decourt, P.  Mecanisme  d'action de  la  therapeutique
     narcobiotique en general,  et  de la  chlorpromazine en
     particulier,  en psychiatrie.  [Mechanism of action of  ;
     narcobiotic psychiatric therapy in general, and of chlor-  ;
     promazine in particular.]   Ence'phale, 1956, 45 : 932-944.

   —Additional data
     Perrault, M.  Sur les tranquilliseurs.   [Tranquilizers.]  '
     Progr. med., Par., 1957, 85: 3-4 ;  7.                   ,

   Studies, animals
     Belot, P., Decourt, P. Etats psycho-nevrotiques chez des
     chevaux de course;  leur traitement par  un  narcobioti-
     que, le N68.  [Neuroses of race horses; their treatment
     with  the narcobiotic drug N-68.]  Ann.  me'd  mvchol,  \
     Par.,  1956, 114(2) : 103-112.                   v y

84 
SUBJECT  LIST
Ethylcrotonylurea : with Ataraxics
  ---» ----•  Effet du N68 sur les perturbations psychi-
  ques d'origine instinctive chez des chiens.  [The effect
  of N-68 on psycho-sexual disorders of dogs.]  Ann. me'd.
  psychol, Par., I9r>0, 114  (2) : 112-116.
  Chauchard, P., Mazoue, H.  Recherches sur  le mode
  d'action centropiegique de quelques substances psycho-
  tropes.  [Research on the mode of centriplegic action
  of some psychotropic substances.]   C. rend. Soc  biol,
  1956, 150:158-160.
  Weidmann, H., Petersen, P. V.   Farmakologisk under-
  s0gelse af Covatin, et nyt stoff  med sedativ virkning.
  [Pharmacological investigation of covatin,  a new sub-
  stance with  sedative  action.]   [English  summary]
  Ugeskr. laeger, 1955,117 :378-381.
  ---,----.  A new group of potent sedatives. J. Pharm.
  Exp. Ther., 1953, 108: 201-216.
 Studies, normal subjects
  Arnold, O. H.  Erfahrungsbericht fiber das Tagesseda-
  tivum Covatin.  [Experiences with the  day-time seda-
  tive covatin.]   Wien. med. Wschr., 1956, 106:510-512.
 Therapeutic  studies, controlled
  Arnold, O. H.  Erfahrungsbericht fiber das Tagesseda-
  tivum Covatin.  [Experiences with the  day-time seda-
  tive covatin.]   Wien. med. Wschr., 1956, 106:510-512.
  Sarwer-Foner, G. J., Koranyi, E. K., Dancey, T. E.  Clin-
  ical investigation of suvren—a new sedative  prepara-
  tion.  Canad.  M. Ass. J., 1957, 76:933-937.
 —Neuroses
  Werenberg, H. Covatin et nyt sedativum.  [Covatin, a
  new sedative.]  Ugeskr. laeger, 1955, 117:381-383.
 Therapeutic  use
  Leyritz, Le Bezu, Azoulay.  Etat depressif avec obses-
  sion resistant au largactil; guerison rapide  par la cova-
  tine  (N68) ; resultats moins heureux dans quinze cas
  differents.   [Depressive state with obsession  resistant
  to chlorpromazine therapy;  rapid recovery with cova-
  tin; less beneficial results in fifteen other patients.]
  Ann. me'd. psychol, Par., 1956, 114 (2) : 856-861.
  Werenberg, H.  Covatinbehandling af psykoser og neu-
  roser.  [Covatin therapy of psychoses  and neuroses.]
  Ugeskr. laeger, 1956,118:1099-1100.

 —Additional data
  Fremming, K. H.  Medikamental behandling af synds-
  sygdomme.  [Medical treatment of mental disorders.]
  Mskr. prakt. laegegern., Kbh., 1956, 34:331-342.
  Laboucarie, J., Barres, P.,  Rascol, A.  Aspects  prin-
  cipaux des cures neuropiegiques en psychiatrie en 1956.
  [Principal features of neuroplegic therapy in psychiatry
  in 1956.]  Toulouse me'd., 1956, 57 : 851-867.
  Leiberman, D. M., Vaughan,  G.  F.   Tranquillizers.
  Practitioner, Lond., 1956, 177: 632-638.

 —Neuroses
  Ellermann, M. Virkningen af covatin (et nyt  dagseda-
  tivum) pa et ambulant patientmateriale.  [The effect of
  covatin  (a new  daytime sedative)  in  out-patients.]
  [English summary]  Nord.  med.,  1955, 54:1531.  Ab-
  stract : Excerpta med., Sect. 8, 1956, 9: No. 4568.
  Fouks, Laine,  Francois, Pagot.  Note sur  les medica-
  tions recentes des etats  nevrotiques anxieux et depres-
  sifs.   [Note on recent medications for anxious and de-
  pressive neurotic  states.]  Ann. mCd.  psychol,  Par.,
  1956, 114(1) :  608-615.

—Psychoses
  Fouks, Laine, Francois, Pagot.   La correction  des
  effets secondaires des medications dites neuroleptiques.
  [Correction of the secondary effects of so-called neuro-
  leptic  drugs.]   Ann. med. psychol,  Par., 1956, 114(1) :
  615-620.                       ,   ,,     1A   V1 .
  Mielke, F.  A.   Methods employed and results  obtained
  in psychiatric studies  with new drugs acting on the
  brain stem.  Am. J. Psychiat, 1957, 114:134-139.
  Sarro, R.  Recents d6veloppements de la therapeutique
  narcobiotique.   [Recent  developments  in narcobiotic
  therapy.]  Ence'phale, 1956, 45: 501-510.

Untoward effects in psychoses
  Leyritz, Le Bezu, Azoulay.  Etat depressif avec obses-
  sion resistant au largactil; guerison rapide par la cova-
  tine (N68) ; resultats moins  heureux dans quinze cas
  differents.  [Depressive state with  obsession resistant
  to chlorpromazine  therapy;  rapid recovery with cova-
  tin ; less beneficial results in  fifteen other patients.]
  Ann. me'd. psychol, Par., 1956, 114(2) : 856-861.


with ATARAXICS [2 or  more]
  see  ATARAXICS—Various   [3  or  more]—Compared

with  CHLORPROMAZINE
  see CHLORPROMAZINE with  COVATIN

with PIPRADROL—COMPARED
  see COVATIN—Pharmacodynamics

with PROMETHAZINE—COMPARED
  see COVATIN—Pharmacodynamics
               Studies,  animals [weidmann-[-Petersen]
ETHYLCROTONYLUREA

Studies, animals
  Asung, C. L., Charcowa, A. I., Villa, A. P.  Effects of a
  new  tranquilizing drug  (nostyn)  on the behavior pat-
  terns of children recovered from tuberculous menin-
  gitis. Sea View Hosp. Bull, N.  Y., 1956, 16:80-85.
  Ferguson, J. T., Linn, F. V. A new compound for the
  symptomatic treatment of tension and anxiety: 2-ethyl-
  crotonylurea (nostyn).  Antibiotic M., 1956, 3: 329-333.
  Kinnard, W. J., Carr, C.  J. A preliminary procedure
  for the  evaluation  of central  nervous system depres-
  sants.  J. Pharm. Exp. Ther., 1957,121: 354-361.
  Lim, R.  K., Pindell, M. H., Glass, H. G., Rink, K. The
  experimental evaluation of sedative agents in animals.
  Ann. N.  York Acad. Sc, 1956, 64: 667-678.
  Pindell,  M. H., Fancher, O. E., Lim, R. K. S.  Sedative-
  hypnotic properties of 2-ethyl-crotonylurea.  Fed. Proc,
  Bait, 1953, 12: 357.

Studies, patients
  Ferguson, J. T., Linn, F. V. A new compound for the
  symptomatic treatment of tension and anxiety: 2-ethyl-
  crotonylurea  (nostyn).  Antibiotic  M., 1956,  3:329-
  333.

Therapeutic studies, controlled
  Asung, C. L., Charcowa, A. I., Villa, A. P.  Effects of a
  new  tranquilizing drug  (nostyn)  on the behavior pat-
  terns of children recovered from tuberculous menin-
  gitis. Sea View Hosp. Bull, N.  Y., 1956, 16: 80-85.
  Ferguson, J. T., Linn, F. V. A new compound for the
  symptomatic treatment of tension and anxiety: 2-ethyl-
  crotonylurea (nostyn).  Antibiotic M., 1956, 3: 329-333.

Therapeutic use
  Ferguson, J. T.  Successful therapeutic  regimen for
  the management of behavior problems  in  the elderly.
  J. Am. Geriat. Soc, 1956, 4:1080-1084.
  Moyer, J. H., Pevey, K., Kinross-Wright, V.  Tranquil-
  izing (ataractic)  agents:  current evaluation of their
  clinical  use in patients who are not hospitalized.  GP,
  1957, 15  (6) : 97-118.


with ATARAXICS [2 or more]
  see ATARAXICS—Various  [3  or  more]—Compared 
Ethylcrotonylurea: with Azacyclonol
PSYCHOPHARMACA
with AZACYCLONOL
  see AZACYCLONOL with ETHYLCROTONYLUREA

with MEPROBAMATE—COMPARED
Studies, animals see following reference
Therapeutic studies, controlled
  Ferguson, J. T., Linn,  F. V. A new  compound for the
  symptomatic treatment of tension and anxiety: 2-ethyl-
  crotonylurea (nostyn).  Antibiotic M., 1956, 3 : 329-333.

with RESERPINE—COMPARED
Therapeutic studies, controlled see preceding reference
with  RESERPINE + METHYLPHENIDYLACETATE 4-
  anticonvulsants—COMPARED
Therapeutic studies, controlled see preceding reference
HARMINE
  Fabing, H. D.  The dimensions of neurology.  Neurol-
  ogy,  1955, 5 : 603-611.  Abstract:  Excerpta med., Sect.
  8, 1956, 9 : No. 1718.
  ---.   Experimental psychoses  which  mimic  schizo-
  phrenia.  Nebraska 31. J., 1956, 41: 455-459.
  ---.   The new pharmacologic attack in psychiatry.
  Internat. Rec.  M., 1956, 169:177-183.  Also: Drug &
  Cosmet. Indust, 1956, 78: 32-33 ; 125-129.
  Jarvik,  M. E.  Mechanism of  action of lysergic acid
  diethylamide, serotonin, and related drugs.  In: Kline,
  N. S., ed.  Psychopharmacology.  Washington, Am. Ass.
  Adv. Sc, 1956.  p.  145-154.
  Osmond, H.  Ololiuqui:  the ancient Aztec narcotic; re-
  marks on the effects of Rivea corymbosa  (ololiuqui).
  J. 3lcnt. Sc, Lond.,  1955,  101: 526-537.
  ---.  Research on schizophrenia.   In: Abramson, H. A.,
  ed.  Neuropharmacology.  Transactions  of the second
  conference, May 1955, Princeton, N. J. New York, Josiah
  3Iacy, Jr. Foundation, 1956.  p. 183-233.
  Rinkel, M., Solomon, H. C.  Chemical theories of psy-
  chosis.  J.  Clin. Exp. Psychopath., 1957,  18: 323-334.
  Shaw,  E., Woolley, D. W.  Yohimbine and ergot alka-
  loids  as naturally  occurring antimetabolites  of sero-
  tonin.  J. Biol. Chem., 1953, 203 : 979-989.
  Turner, W. J., Merlis, S., Carl,  A.  Concerning theories
  of indoles  in schizophrenigenesis.   Am.  J. Psychiat,
  1955, 112: 466-467.
  Woolley, D. W., Shaw, E.  Some neurophysiological as-
  pects of serotonin.  Brit. 31. J., 1954, 2: 122-126.

Studies, animals
  Corriol, J., Mercier, J. Etude eiectroencephalographique
  de Tharmine.   [Electroencephalographic  study of har-
  mine.]  C. rend. Soc biol.,  1952.  146:1356-1359.   Ab-
  stract : Chem. Abstr., 1953, 47: 7095h.

Studies, patients
  Pennes, H. H.,  Hoch, P. H.  Psychotomimetics, clinical
  and theoretical considerations: harmine, WIN-2299 and
  nalline.  Am. J. Psychiat, 1957, 113: 887-892.
HIBICON

Studies, animals
  Harned, B. K., Cunningham, R. W., Clark, M. C, Hine,
  C. H., Kane, M. M., Smith, F. H., Jr., Vessey, R. E., Yuda,
  N. N., Zabransky, F. W.  The pharmacology of N-benzyl-
  /3-chloropropionamide (hibicon), a new anticonvulsant.
  J. Pharm. Exp. Ther.,  1953, 107: 403-423.

Therapeutic studies, controlled
  Hawkes,  C.  D.   N-Benzyl-/3-chlorpropionamide  (hibi-
  con) ;  a  new  approach  to  anticonvulsant  therapy.
  A. 31. A. Arch. Neur. Psychiat, 1952, 67: 815-820.
Therapeutic use—Psychoses
  Merlis,  S., Martin, D.  W.   Hibicon in treatment of
  epileptics with mental disorder.  Psychiat. Q., 195b, 30:
  387-401.
HYDROXYZINE

Studies, animals
  Ende, M.  Clinical evaluation of atarax; a non-barbitu-
  rate calming agent.  Virginia M. Month., 1956, 83 : 503-

  Farah, L.  Preliminary study on the use of hydroxyzine
  in psychosomatic affections.   Internat. Rec M., 1956,
  169:379-389.  Abstract:  Excerpta  med., Sect.  8, 1957,
  10: No.  845.               m         _  _  _
  Heuyer,  G., Lang, J. L„  Chevreau,  J.  P., Juredieu.
  Premiers resultats obtenus par un  derive du chlorben-
  zhydryl en psychiatrie infantile.  [First results with a
  chlorbenzhydryl  derivative   in   child   psychiatry.]
  Encephale, 1956, 45 : 579-586.
  Segal,  L.  J., Tansley, A. E.  A clinical  trial  with hy-
  droxyzine  (atarax) on a group of  maladjusted educa-
  tionally subnormal children.  J. 3Ient. Sc, Lond., 1957,
  103: 677-681.
  Shalowitz, M.  Hydroxyzine: a new therapeutic agent
  for senile anxiety states; a preliminary report.   Geriat-
  rics, 1956, 11: 312-315.  Abstract: Excerpta med., Sect.
  8, 1957, 10 : No. 1417.
  Walaszek, E. J., Abood,  L. G.   Effect of tranquilizing
  drugs on  fighting responses  of Siamese fighting fish.
  Science, 1956, 124 : 440-441.

Studies, normal subjects
  Farah, L.  Preliminary study on the use of hydroxyzine
  in psychosomatic  affections.   Internal  Rec. 31., 1956,
  169: 379-389.   Abstract: Excerpta  med., Sect. 8, 1957,
  10: No. 845.
Therapeutic studies, controlled

—Neuroses
  Segal,  L.  J., Tansley, A. E.  A clinical trial with hy-
  droxyzine  (atarax)  on a group of maladjusted educa-
  tionally subnormal children.  J. Ment. Sc, Lond., 1957,
  103: 677-681.
  Shalowitz, M.  Hydroxyzine: a new  therapeutic agent
  for senile anxiety states; a preliminary report.  Geriat-
  rics, 1956, 11: 312-315.  Abstract: Excerpta med., Sect.
  8, 1957, 10: No. 1417.

—Psychosomatic diseases
  Farah, L.  Preliminary study on the use of hydroxyzine
  in  psychosomatic  affections.  Internat. Rec.  M.,  1956,
  109:379-389.   Abstract: Excerpta med., Sect. 8,  1957,
  10: No. 845.
  Robinson, H. M.,  Jr., Robinson, C. V., Strahan, J. F.
  Hydroxyzine (atarax) hydrochloride in dermatological
  therapy.  J. Am. 31.  Ass., 1956, 161: 604-606.

Therapeutic use
  De Busscher, J.  Impressions personnelles dur les effets
  de l'atarax, de la  chlorpromazine, de la reserpine et du
  AY 5406-1 (parasan) en  therapeutique psychiatrique.
   [Personal  impressions   of   atarax,  chlorpromazine,
  reserpine  and  AY  5406-1  (parasan)  in psychiatric
  therapy.]  Encephale, 1956, 45 : 1007-1023.
  Fouks,  Laine,  Francois,  Pagot.  La  correction  des
  effets secondaires des medications  dites neuroleptiques.
   [Correction of the secondary effects  of  so-called neuro-
  leptic  drugs.]  Ann.  me'd.  psychol, Par., 1956, 114(1):
  615-620.
  ----,----,----,----•  Note sur Tutilisation en psychi-
   atrie d'un nouveau neuroleptique.  [Note on the use of
   a  new neuroleptic  drug  in psychiatry.]    inn  me'd.
   psychol, Par., 1956,  114(1) :  605-608.
86 
SUBJECT  LIST
Iproniazid : Studies, animals
 —Additional data
   Bergy, G. A.   Drugs  of sedation  with  tranquilizing
   effects.  Am. Profes.  Pharmacist, 1956,  22:419; 534-
   538;  619-621;  709-710;  797-799;  888-889;  917-919.
   [709-710.]
   Block, M. A.  Medical treatment of alcoholism.  J. Am.
   31. Ass., 1956, 162: 1610-1619.
   Cohen, I. M. Drugs recently  introduced  in the treat-
   ment of psychiatric disorders.  Texas J. 31., 1956, 52:
   683-687.
   Dellaert,  R.  De modernste chemopharmaca in de psy-
   chiatrie.  [New chemical psychopharmaca.]  Belg. tschr.
   geneesk., 1956,12: 314-321.
   Deniker,  P.  Hibernotherapies et medicaments neuro-
   leptiques  en therapeutique  psychiatrique.  [Hiberno-
   therapies and neuroleptic drugs in psychiatric therapy.]
   Encephale, 1957, 46: 281-398.   [364-65]
   Fabing, H.  D.  The ataractic drugs:  their uses and
   limitations  in psychiatry.  Am. Profes. Pharmacist,
   1956. 22: 413-418.
   Kautz, H. D. Trends in drug therapv.  Hosp. Progr.,
   1957, 38(1) : 102-108; 126.
   Kline, N. S.   Chemotherapy in psychiatry;  recent ad-
   vances.  Seminar Internat.,  Hoddesdon, 1956,  5(2) : 7-
   10.
   Laboucarie,  J. Barres, P., Rascol, A.  Aspects princi-
   paux des cures  neuropiegiques en psychiatrie  en 1956.
   [Principal features of neuroplegic therapy in psychiatry
   in 1956.]  Toulouse med., 1956, 57 : 851-867.
   Senseman, L. A.  Tranquilizing drugs; uses and abuses
   for  the nervous patient.  Rhode Island 31. J.,  1956,
   39: 675-677 ;  6S0 ; 686.
   Spencer,  R.  S.  The use of  ataraxic drugs in mental
   illness. Hawaii M. J., 1957, 16: 302.
   Tice, L. F. Some important drug developments of 1956,
   Am. J.  Pharm., 1956, 128: 398-409.
   Wortis, J. Physiological treatment.  Am. J. Psychiat.,
   1957, 113: 611-615.

 —Neuroses
   Ayd, F. J., Jr.  Tranquilizing drugs in private practice.
   Y. York State J. 31., 1957. 57: 1742-1747.
   Ende, M.  Clinical evaluation of atarax; a non-barbitu-
   rate calming agent.  Virginia 31. 3Ionth.,  1956,  83: 503-
   505.
   Fouks, Laine, Francois, Pagot.  Note sur les medications
   recentes des etats  nevrotiques anxieux  et  depressifs,
   [Note on recent medications for anxious and depressive
   neurotic states.]   Ann.  me'd. psychol,  Par., 1956, 114
   (1) : 608-615.
   Heilbrunn, G. Selection of patients for modern psychi-
   atric pharmacotherapy in general practice.  Northwest
   31., 1956, 55 :  1198-1205.
   Heuyer, G.,  Lang,  J. L., Chevreau, J.  P., Juredieu.
   Premiers  resultats obtenus par un derive du chlorben-
   zhydryl en psychiatrie infantile.  [First results with a
   chlorbenzhydryl   derivative    in   child   psychiatry.]
   Encephale, 1956, 45 : 579-586.
   Moyer, J. H.,  Pevey, K., Kinross-Wright, V.  Tranquiliz-
   ing  (ataractic)  agents:  current evaluation of  their
   clinical use, in patients who  are not hospitalized. GP,
   1957. 15(6) : 97-118.
   Seneca, H.   Hydroxyzine (atarax)  as a therapeutic
   agent.   Antibiotic 31., 1957, 4 : 25-30.


with ATARAXICS [2 or more]
  see ATARAXICS—Various [3 or more]

with CHLORPROMAZINE
  see CHLORPROMAZINE with HYDROXYZINE

with MEPROBAMATE—COMPARED
  Robinson, H. M., Jr., Robinson, C. V., Strahan, J.  F.
  Hvdroxvzine  (atarax)  hydrochloride  in dermatological
  therapy.  J. Am. M. Ass., 1956,  161: 604-606.
with RESERPINE—COMBINED
  Fouks, Laine, Francois, Pagot.  La correction des effets
  secondaires des medications dites neuroleptiques.  [Cor-
  rection of the secondary effects of so-called neuroleptic
  drugs.]  Ann. mCd. psychol, Par., 1956, 114(1) : 615-620.
  Laboucarie,  J.,  Barres, P., Rascol, A.   Aspects  princi-
  paux  des cures neuropiegiques  en psychiatrie en 1956.
  [Principal features of neuroplegic therapy in psychiatry
  in 1956.]   Toulouse med., 1956, 57: 851-867.

with RESERPINE—COMPARED
  Farah, L.  Preliminary study on the use of hydroxyzine
  in psychosomatic affections.  Internat. Rec. M., 1956,
  169 : 379-389.  Abstract:  Excerpta med., Sect. 8, 1957,
  10: No. 845.


with OTHER DRUGS—COMBINED
  Warter, P. J. Prednisolone-hydroxyzine combination in
  rheumatoid arthritis.  J. 31.  Soc N. Jersey, 1957, 54 :7-
  10.
IBOGAINE

  Fabing, H. D.   Experimental psychoses which mimic
  schizophrenia.  Nebraska 31. J., 1956, 41: 455-459.
  ---.   The new  pharmacologic attack in psychiatry.
  Internal Rec.  M.,  1956, 169:177-183.  Also:  Drug &
  Cosmet. Indust, 1956, 78: 32-33 ; 125-129.
  ---.   Trends in biological research  in schizophrenia.
  J. Nerv. Ment. Dis., 1956, 124 : 1-7.
  Schneider,  J. A.,  Sigg, E. B.  Neuropharmacological
  studies on  ibogaine, an indole alkaloid with  central-
  stimulant properties.  Ann  N.  York Acad. Sc, 1957, 66:
  765-776.
  Turner, W. J., Merlis, S., Carl, A.  Concerning theories
  of indoles  in schizophrenigenesis.  Am. J. Psychiat.,
  1955,112: 466-467.
Intoxication
  Osmond, H.  Ololiuqui: the ancient Aztec narcotic; re-
  marks on the effects  of Rivea corymbosa  (ololiuqui).
  J. 3Ient. Sc, Lond., 1955,101: 526-537.
  ---.  Research on schizophrenia. In : Abramson H. A.,
  ed.  Neuropharmacology.  Transactions of the second
  conference, May 1955,  Princeton,  N. J.   New York,
  Josiah 3Iacy, Jr. Foundation, 1956. p. 183-233.
  Schweitzer, A.   Old black  magic reborn.  In: Garrett,
  E. J.,  ed. Beyond the five senses.  Philadelphia, Lippin-
  cott, 1957.  p. 203-208.

Studies, animals
  Schneider,  J. A.,  Sigg, E. B.  Neuropharmacological
  studies  on  ibogaine, an indole alkaloid with  central-
  stimulant properties.   Ann. N.  York Acad. Sc,  1957
  66: 765-776.
IPRONIAZID
Pharmacodynamics
  Crane, G. E.  Further studies on iproniazid phosphate;
  isonicotinil-isopropylhydrazine phosphate, marsilid.  J.
  Nerv. Ment. Dis., 1956, 124: 322-331.

Studies, animals
  Besendorf, H.,  Pletscher,  A. Beeinflussung  zentraler
  Wirkungen  von  Reserpin   und  5-Hydroxytryptamin
  durch  Isonicotinsaurehydrazide.   [The  influence  of
  isonicotinic  acid  hydrazides on the central  effects of
  reserpine and of 5-hydroxytryptamine.]  [English sum-
  mary]  Helvet. physiol. pharm. acta, 1956, 14: 383-390.
  Brown,  B. B.  Lysergic acid diethylamide antagonism
  of certain drugs.  Ann. N. York Acad. Sc, 1957, 66 ■ 677-
  685.
87 
Iproniazid : Studies, animals
PSYCHOPHARMACA
  Brodie, B. B., Pletscher, A., Shore, P. A.  Possible role
  of serotonin in brain  function and reserpine  action.
  [Abstract]  J. Pharm. Exp. Ther., 1956, 116: 9.
  Jenkins,  D. E.,  Chofnas, I., Boren,  H.,  Guthrie,  R.
  Clinical  and laboratory observations on  iproniazid.
  Tr. 12. Conf. Chemother. Tuberc, 1953: 141-145.     *
  Marrazzi, A. S.  The effects of certain drugs on cerebral
  synapses.  Ann. N. York Acad. Sc, 1957, 66: 496-507.
  ---, Hart, E. R.  An electrophysiological analysis of the
  actions of some drugs useful in the therapy of psychotic
  disorders.  J. Nerv. Ment. Dis., 1956, 124 : 388-392.
  Schallek, W., Walz, D.  Effects of isoniazid  and ipronia-
  zid on the central nervous system of the dog.  Am. Rev.
  Tuberc, 1954, 69 : 261-266.
  Verdeaux, G., Marty, R.   Action sur Teiectroecephalo-
  gramme  de  substances pharmacodynamiques  d'interet
  clinique.   [Effect of clinically important drugs  on the
  encephralogram.]   Rev. neur., Par., 1954,  91: 405-427.
  [p. 423]
Studies, normal subjects
  Bennett, I. F., Cohen, D., Starer, E. Isoniazid in treat-
  ment of  the chronic schizophrenic patient.  A. 31.  A.
  Arch. Neur. Psychiat, 1954,  71: 54-65.  [p. 55]       *
  Bloch, R. G., Dooneief, A. S., Buchberg, A. S., Spellman,
  S. The clinical effect of isoniazid and  iproniazid in the
  treatment of pulmonary tuberculosis. Ann. Int. M.,
  1954, 40: 881-900.                                  *
  Bosworth, D. M.  The treatment of tuberculous  lesions
  of bones and joints with iproniazid (marsilid). N. York
  State J. M., 1956, 56:1281-1284.                     *
  ---, Fielding, J.  W., Acosta, M. G. Use  of iproniazid
  in nontuberculous bone and joint infections. J. Am.  M.
  Ass., 1955, 157 : 132-136.
  Cheifetz, I., Paulin, C, Tuatay, H., Rubin,  E. H. Ipro-
  niazid in pulmonary tuberculosis.  Dis. Chest,  1954, 25:
  390-396.                                           *
  Crane, G. E.  Further studies on iproniazid phosphate;
  isonicotinil-isopropylhydrazine phosphate, marsilid.  J.
  Nerv. 3lent. Dis., 1956, 124 : 322-331.                *
  ---.  The psychiatric side-effects of iproniazid.  Am. J.
  Psychiat, 1956, 112:494-501.                        *
  Jenkins,  D. E.,  Chofnas, I., Boren,  H.,  Guthrie,  R.
  Clinical and laboratory observations on iproniazid.  Tr.
  12. Conf. Chemother. Tuberc, 1953:141-145.          *
  Lukinovich, N., Vichi, A. Modifications psychologiques
  au cours du traitement de tuberculeux par le "marsilid".
  [Psychologic modifications in tuberculous subjects dur-
  ing "marsilid" therapy.]   [English summary]   3Ischr.
  Psychiat., Basel, 1956, 132: 364-380.
  O'Connor, J. B., Howlett, K. S. Side effects accompany-
  ing use of iproniazid.   Tr. 12. Conf. Chemother. Tuberc,
  1953:139-140.                                      *
  ---, ---, Wagner, R. R.  Side effects accompanying
  use of iproniazid.  Am. Rev. Tuberc, 1953, 68: 270-272.*
  Pleasure, H.  Psychiatric and neurological side-effects
  of isoniazid and iproniazid.  A.  M.  A.   Arch. Neur.
  Psychiat, 1954, 72: 313-320.                         *
  Selikoff, I.  J., Robitzek, E. H., Ornstein, G. G.  Treat-
  ment of pulmonary tuberculosis with hydrazide  deriva-
  tives of isonicotinic acid. J. Am. M. Ass., 1952, 150-
  973-980.                                           *
  ---, ---, ----•  Withdrawal symptoms upon  discon-
  tinuance of iproniazid and isoniazid therapy.  Am. Rev.
  Tuberc, 1953, 67:212-216.                          *
  Verdeaux, G., Marty, R.  Action  sur Teiectroencephalo-
  gramme  de  substances pharmacodynamiques d'interet
  clinique.   [Effect  of clinically important drugs  on the
  encephalogram.]   Rev. neur.,  Par., 1954,  91: 405-427
  [p. 423]
  Wiedorn, W. S., Ervin, F. Schizophrenic-like psychotic
  reactions with administration of isoniazid.   A. M. A.
  Arch. Neur. Psychiat,  1954, 72: 321-324.             *
Therapeutic studies, controlled
  Ayd, F. J., Jr.  A preliminary report on marsilid.  Am. J.
  Psychiat, 1957, 114:459.                           *
  Kamman, G. R., Freeman, J. G, Lucero, R.. J. 'The effect
  of 1-Isonicotinyl 2-isopropyl  hydrazide  (IIH) on  the
  behavior of long-term mental patients.  J. Nerv. Ment.
  Dis., 1953, 118 : 391-407.

Therapeutic use
  Pennington, V. M.  Research findings in phrenotropic
  drugs important to every physician.  Mississippi Doctor,
  1957, 35 : 57-63.
  Smith, J. A.  The use of the isopropyl derivative of
  isonicotinylhydrazine  (marsilid)  in the treatment of
  mental disease ; a preliminary report. Am. Practitioner,
  1953, 4: 519-520.

with ADRENOCHROME—COMPARED
with LYSERGIC ACID  DIETHYLAMIDE—COMPARED
  see IPRONIAZID—Pharmacodynamics

with  LYSERGIC ACID DIETHYLAMIDE—INTERAC-
    TION
  see LYSERGIC ACID DIETHYLAMIDE with IPRONI-
    AZID—INTERACTION
      Studies, animals

with  RAUWOLFIA  CANESCENS ALKALOIDS
  see RAUWOLFIA CANESCENS ALKALOIDS with
    IPRONIAZID—COMBINED
      Therapeutic studies, controlled

with RESERPINE—COMBINED
  see RESERPINE  with  IPRONIAZID—COMBINED
        Studies, animals
with RESERPINE—COMPARED
  see IPRONIAZID—Pharmacodynamics

with SEROTONIN see SEROTONIN with IPRONIAZID


with OTHER DRUGS—COMBINED

Therapeutic use
  Ayd,  F. J., Jr.    A preliminary  report on  marsilid.
  [amphetamine] Am. J. Psychiat, 1957, 114: 459.
  O'Connor, J. B., Howlett, K. S.  Side effects accompany-
  ing use  of iproniazid.   [barbiturates]  Tr. 12. Conf.
  Chermother. Tuberc, 1953:139-140.

Untoward effects [sec headnote p. 19]
  Bloch, R. G., Dooneief, A. S., Buchberg, A. S., Spellman,
  S.  The clinical effect of isoniazid and iproniazid in the
  treatment  of pulmonary  tuberculosis,  [anesthetics]
  Ann. Int. M., 1954, 40: 881-900.
  Cheifetz, I., Paulin, C, Tuatay, H., Rubin, E.  H. Ipro-
  niazid in pulmonary  tuberculosis,  [anesthetics]  Dis.
  Chest, 1954, 25: 390-396.
  Selikoff, I. J., Robitzek, E. H., Ornstein, G. G.  Treat-
  ment  of pulmonary tuberculosis with hydrazide deriva-
  tives of isonicotinic acid,  [anesthetics]  J. Am. M. Ass.,
  1952,150: 973-980.

with  OTHER DRUGS—COMPARED

  Bennett, I. F., Cohen, D., Starer, E.  Isoniazid in treat-
  ment  of the chronic schizophrenic patient,  [isoniazid]
  A. 31. A. Arch. Neur. Psychiat., 1954, 71: 54-65.
  Crane, G. E. Further studies on iproniazid phosphate;
  isonicotinil-isopropylhydrazine   phosphate,   marsilid.
  [amphetamine]  J. Nerv. Ment. Dis., 1956, 124 : 322-331.
  Schallek, W., Walz, D. Effects of isoniazid and ipronia-
  zid on the central nervous system of the dog.   [isonia-
  zid]  Am. Rev. Tuberc, 1954, 69: 261-266.
  Selkoff, I. J., Robitzek, E. H., Ornstein, G. G. Treatment
  of pulmonary tuberculosis with hydrazide derivatives of
88 
SUBJECT LIST
Lysergic acid diethylamide : Pharmacodynamics —
                                 Additional data
isonicotinic  acid,   [isoniazid]   J. Am. M.  Ass., 1952,
150: 973-980.
Verdeaux, G., Marty, R.  Action sur l'electroence-phalo-
gramme de  substances pharmacodynamiques d'interet
clinique.   [Effect of clinically important drugs  on  the
encephalogram.]   [isoniazid]   Rev.  neur.,  Par., 1954,
91: 405-127.  [p. 423]
LYSERGIC ACID  AMIDE
Studies, normal subjects
  Solms, H.  Chemische Struktur und Psychose bei Lyser-
  gsaure-Derivaten.  [Chemical structure of and psychosis
  produced by lysergic acid derivatives.]   Praxis, Bern,
  1956, 45: 746-749.
  ---.  Relationships between  chemical structure  and
  psychoses with the use of psychotoxic substances. "Com-
  parative pharmacopsychiatric  analysis:"  A  new  re-
  search  method.  J. Clin. Exp. Psychopath., 1956, 17:
  429-433.

with LYSERGIC ACID DIETHYLAMIDE—COMPARED
with  LYSERGIC  ACID  ETHYLAMIDE—COMPARED
  see LYSERGIC ACID AMIDE
LYSERGIC ACID DIETHYLAMIDE
  Abramson, H.  A., ed.  Neuropharmacology.  Transac-
  tions of the second conference,  May 1955,  Princeton,
  N. J. 328 p.  Transactions of the third conference, May
  1956, Princeton, N. J.  381 p. New York, Josiah Macy,
  Jr. Foundation, 1956; 1957.  [Articles within the scope
  of this bibliography are listed individually]
  Cholden, L., ed. Lysergic acid diethylamide and mesca-
  line in experimental  psychiatry.  85 p.   [Round table
  at  American  Psychiatric Association annual meeting
  held  in Atlantic City,  N. J., May 1955.]  New York,
  Grune & Stratton, 1956.  [Articles within the scope of
  this bibliography are listed  individually.]
  Denber, H. C.  B., Rinkel, M., ed.  Psychodynamic  and
  therapeutic aspects of  mescaline and lysergic acid di-
  ethylamide.   [Round  table  at American  Psychiatric
  Association annual meeting  held in Chicago, 111., May
  1956]  J. Nerv. Ment. Dis., 1957, 125 : 423-451.  [Preface
  p. 423-424; Summary of discussion  p. 450-451]   [All
  articles are listed individually]

Bibliographies
  Cerletti, A.  Literature  on  LSD-25.  In:  Abramson,
  H.  A., ed.  Neuropharmacology.  Transactions of the
  second  conference, May  1955, Princeton, N. J.  New
  York, Josiah Macy, Jr.  Foundation, 1956.  Appendix p.
  301-308.                              ,         i#  .
  Sandoz Chemical Works, inc., Sandoz Pharmaceuticals.
  Annotated bibliography; LSD 25—Delysid  (d-lysergic
  acid diethylamide).  56 p.  Hanover, N. J., 1956.
  N. S., ed. Psychopharmacology.  Washington, Am, Ass.
  Adv. Sc, 1956.  p.  145-154.
  Rinkel, M.  Pharmacodynamics of LSD and mescaline.
  J. Nerv. Ment. Dis., 1957, 125 : 424-427.
  Rothlin, E.   Lysergic acid diethylamide  and related
  substances.   Ann. N.  York Acad.  Sc, 1957, 66: 668-676.
  ---, Cerletti, A. Pharmacology of LSD-25.  In: Chol-
  den, L.,  ed.   Lysergic acid diethylamide and mescaline
  in  experimental  psychiatry.   New York,  Grune  &
  Stratton, 1956. p. 1-7.
  Smith, R.  The CNS  action of d-lysergic acid diethyla-
  mide  (LSD-25).  3Iod.  Hosp., 1953, 80  (1) : 106-110.
  Solms,  H.  Relationships  between chemical structure
  and psychoses with the  use of psychotoxic substances.
  •Comparative pharmacopsychiatric analysis:"   A new
  research method.  J. Clin. Exp. Psychopath., 1956, 17:
  429^33.
  Thuillier, J.  La serotonine.   [Serotonin.]   Concours
  me'd., 1956, 78 : 3177-3181.
  Walther-Biiel, H.  Uber Pharmakopsychiatrie.  [Phar-
  maco-psychiatry.]   Schweiz.  med.  Wschr.,  1953,  83:
  483-487.  Abstract: Excerpta med., Sect. 8, 1954, 7 : No.
  1940.
  Wikler,  A.  The  uses of drugs in psychiatric research.
  Am. J. Psychiat, 1956,112: 961-969.
—Additional data
  Carr, C. J., Kinnard, W. J., Jr.  The phrenotropic agents.
  Internat. Rec. M., 1957,170: 493-504.
  The chemical concept of psychoses.  What's new, 1955
  (189)  :3-7.
  Fabing, H.  D.  Experimental  psychoses which mimic
  schizophrenia.  Nebraska 31. J., 1956, 41: 455-459.
  ---.   The  new pharmacologic  attack in psychiatry.
  Internat. Rec M.,  1956,  169 :177-183.  Also : Drug &
  Cosmet. Indust., 1956, 78: 32-33; 125-129.
  Fazekas, J.  F., Toupin,  H., Alman,  R.  W. Physiologic
  and pharmacologic basis for the chemotherapy of psy-
  chiatric states.   Am. J. Med., 1956, 21: 825-831.
  Fremming,  K. H.  Medikamentel behandling  af synds-
  sygdomme.   [Medical treatment of mental disorders.]
  3tskr. prakt. laegegern., Kbh., 1956, 34: 331-342.
  Funderburk, W.  H., Wilcox, K. W., Wilcox, P. H. Drug
  therapy; physiodynamic  therapy.  II.  Progr. Neur.
  Psychiat, N. Y., 1956, 11:425-456.
  Graffagnino, P. N., Furr, J. H. New drugs in the treat-
  ment  of emotional disorders; a review.  Connecticut
  M. J., 1957, 21: 38-43.
  Green, A.  Actualites therapeutiques  1955 en psychia-
  trie.   [Therapeutic  progress in  psychiatry  in  1955.]
  Ence'phale, 1956, 45 :172-200.
  Kautz, H. D.  Trends in  drug therapy.  Hosp. Progr.,
  1957, 38 (1) : 102-108;  126.
  Klingman, W. O.  Neurological  and psychiatric disor-
  ders ;  some  recent  advances  in  therapy.  Virginia M.
  Month., 1956, 83 : 240-246.
  Leake, C. D.  Drugs affecting mood and behavior.  Texas
  Rep. Biol. M., 1955, 13: 793-818.
  Pennes, H. H. The nature of drugs with mental actions
  and their relation to cerebral function.  Bull. N. York
  Acad. 31., 1957,33 : 81-88.
  Rinkel, M.,  Solomon, H. C. Chemical theories of psy-
  chosis.  J.  Clin. Exp. Psychopath., 1957, 18:323-334.
  Rothlin, E.  Die zentralnervosen Wirkungen von Heil-
  mitteln. [The  central-nervous effects of drugs.]  39 p.
  Stuttgart, Thieme, 1954.
  Sebrell, W.  H.,  Jr.  Chemistry  in  chronic  disease re-
  search.  Chem. Eng. News, 1955, 33:1856-1860.
  Turner, W.  J., Merlis, S.,  Carl, A.  Concerning theories
  of indoles   in schizophrenigenesis.   Am.  J.  Psychiat.,
  1955,112: 466-467.
  Wilcox, P. H., Funderburk, W. H., Wilcox, K. W.  Drug
  therapy; physiodynamic  therapy.   II.   Progr.  Neur.
  Psychiat, N. Y., 1955, 10: 595-608.
Pharmacodynamics
  Berthiaume, M.  La diethylamide de Tacide lysergique
  en psychiatrie.  [Lysergic acid diethylamide in psychia-
  try ]   Union me'd. Canada, 1956, 85 : 555-560. Abstract:
  Excerpta med., Sect. 8,1957,10: No. 1385.
  Delay J.,  Thuillier,  J.   Psychiatrie experimentale  et
  psychophlrmacologie.   [Experimental  psychiatry and
  psychopharmacology.]  Sem. hop. Paris, 1956, 32:  3187-
  3193
  Evarts E V.  A review of the neurophysiological effects
  of lvse'reic acid diethylamide (LSD)  and other psycho-
  tomimetic  agents.  Ann.  N. York Acad. Sc,  1957, 66:
  479_495
  Jarvik M  E.  Mechanism of action of  lysergic acid di-
  ethylamide, serotonin, and related drugs.  In: Kline,
89 
Lysergic acid  diethylamide : Pharmacodynamics —
Additional data
  Woolley, D. W., Shaw, E.  Some neurophysiological as-
  pects of serotonin.  Brit. M. J., 1954, 2:122-126.
  Wortis, J.  Physiological treatment.  Am. J. Psychiat.,
  1955, 111:515-518; 1957, 113:611-615.
Placebo effect see PSYCHOPHARMACA—Evaluation
Psychotherapeutic use
  Abramson, H. A.  Lysergic acid diethylamide (LSD-25) :
  NIX.   As an adjunct to brief psychotherapy, with spe-
  cial  reference to  ego  enhancement.    J.  Psychol,
  Provincet, 1956, 41:199-229.
  ---.   Lysergic acid diethylamide (LSD-25).   III. As
  an adjunct to psychotherapy with elimination  of  fear
  of homosexuality.  J.  Psychol, Provincet, 1955, 39:
  127-155.
  ----.   Some observations  on normal  volunteers  and
  patients.  In: Cholden, L., ed.  Lysergic acid diethyla-
  mide and mescaline in experimental psychiatry.  New
  York, Grune & Stratton, 1956.  p. 51-54.
  ---.  Verbatim recording and transference studies with
  lysergic acid diethylamide  (LSD-25).   J. Nerv. Ment
  Dis., 1957,125 : 444-450.
  Cooper, H. A.  Hallucinogenic drugs.   Lancet,  Lond.,
  1955, 1:1078-1079.                                 *
  Day, J.  The role and reaction  of the  psychiatrist in
  LSD therapy. J. Nerv. Ment. Dis., 1957,  125:437-438.
  Elkes,  C, Elkes,  J., Mayer-Gross, W.   Hallucinogenic
  drugs.  Lancet, Lond., 1955, 1: 719.                  *
  Frederking, W. Intoxicant drugs (mescaline and lyser-
  gic acid  diethylamide)  in psychotherapy.  J. Nerv.
  Ment Dis., 1955,121: 262-266.  Abstract: Excerpta med.,
  Sect. 8,. 1956, 9: No. 4084.
  ---.  Uber die Verwendung von Rauschdrogen (Meska-
  lin und Lysergsaurediaethylamid)  in der Psychothera-
  pie.  [The use of  intoxicating drugs  (mescaline  and
  lysergic acid diethylamide)  in psychotherapy.]   [Eng-
  lish summary]  Psyche, Stuttg., 1953, 7 : 342-364.
  Hoch, P. H. Remarks on LSD and mescaline. J. Nerv.
  Ment. Dis., 1957,125 : 442-444.
  Katzenelbogen, S., Fang, A. D.  Narcosynthesis effects
  of sodium amytal, methedrine and LSD-25.  Dis. Nerv.
  Syst, 1953, 14: 85-88.  Abstract: Excerpta med., Sect.
  8,1954, 7: No. 3819.
  MacDonald, J. M., Galvin, J. A.  Experimental psychotic
  states.  Am. J. Psychiat., 1956, 112 : 970-976.
  Osmond, H. A review of the clinical effects of psychoto-
  mimetic agents. Ann. N. York Acad. Sc, 1957, 66: 418-
  434.
  Sandison, R. A.  The clinical uses of lysergic acid di-
  ethylamide. In: Cholden, L., ed.  Lysergic acid diethyl-
  amide  and mescaline in experimental psychiatry. New
  York, Grune & Stratton, 1956.  p. 27-34.
  ---.   Psychological aspects  of the LSD  treatment of
  the neuroses.  J.  Ment. Sc, Lond.,  1954,  100:508-515.
  Abstract: Excerpta med., Sect. 8, 1955, 8: No. 3895.
  ---, Spencer, A. M., Whitelaw, J. D. A.  The therapeutic
  value of lysergic  acid  diethylamide in  mental  illness.
  J. Ment. Sc, Lond., 1954, 100: 491-507.  Abstract: Ex-
  cerpta med., Sect. 8,1955, 8 : No. 930.
  ----, Whitelaw, J. D. A.  Further studies in the thera-
  peutic  value  of lysergic acid diethylamide in  mental
  illness.   J. Ment.  Sc, Lond., 1957, 103:332-343.
  Savage, C.  The LSD psychosis as a transaction between
  the psychiatrist and patient.  In: Cholden, L., ed.  Ly-
  sergic acid diethylamide and mescaline in experimental
  psychiatry.  New  York, Grune & Stratton, 1956.  p. 35-
  43.
  ----.  The resolution and subsequent remobilization of
  resistance by LSD  in psychotherapy.  J. Nerv. Ment.
  Dis., 1957,125 : 434-437.
  Shorvon, H.  J.   Drug therapy  in  psychiatry.  Prac-
  titioner, Lond., 1955, 175:161-169.
  Wortis, J.  Physiological treatment.  Am. J. Psychiat.,
  1955, 111: 515-518.
PSYCHOPHARMACA
Studies, animals
  Abramson, H. A.  Blocking of the LSD-25 reaction in
  Siamese fighting fish.  In: Abramson, H. A., ed.  Neuro-
  pharmacology.   Transactions of  the third conference,
  May 1956, Princeton, N. J.  New York, Josiah Macy, Jr.
  Foundation, 1957.  p. 9-27.
  ___, Evans, L. T.  Lysergic acid diethylamide (LSD-
  25). II. Psychobiological effects on the Siamese fighting
  fish. Science, 1954,120: 990-991.
  ---, Jarvik, M.  E.  Lysergic acid diethylamide (LSD-
  25) : IX. Effect on snails.  J. Psychol, Provincet, 1955,
  40: 337-340.
  ---, Sklarofsky, B., Baron, M. O., Gettner, H. H. Block-
  ing of brain extract on lysergic acid diethylamide reac-
  tion in Siamese  fighting fish.  Science,  1957, 125: 397-
  398.
  ---,  ----,  ----,  ----.  Lysergic  acid  diethylamide
  (LSD-25)  antagonists.  I.  Blocking  effect  of brain
  extract in the  Siamese fighting fish; preliminary report.
  A. M. A. Arch. Neur.  Psychiat, 1957, 77: 439^145.
  Apter, J. T., Pfeiffer,  C. C.  The effect of the hallucino-
  genic drugs LSD-25 and mescaline on the  electroretino-
  gram.  Ann. N. York Acad. Sc, 1957, 66 : 508-514.
  ---,----.  Effect of hallucinogenic drugs on the elec-
  troretinogram. Am. J. Ophth., 1956, 42 (4,  Part 2) : 206-
  211.
  Blickenstorfer, E.  Zum atiologischen Problem der Psy-
  chosen vom akuten exogenen Reaktionstypus; Lyser-
  gsaurediathylamid, ein  psychisch wirksamer toxischer
  Spurenstoff.  [Etiology of psychoses of the acute, exoge-
  nous reaction  type; lysergic acid diethylamide, a psy-
  chotoxic drug effective in minute doses.]  Arch.  Psy-
  chiat,  Berl,  1952,  188:226-236.    Abstract:  Chem.
  Abstr., 1952, 45:11418b.  Excerpta med.,  Sect. 8, 1953,
  6: No. 807.
  Blough, D. S.  Some effects of drugs on visual discrim-
  ination in the pigeon. Ann. N. York Acad. Sc, 1957, 66:
  733-739.
  Bradley, P. B. The effect of some drugs  on the electrical
  activity of the brain in the cat.   [Abstract]   Electro-
  encephalography, Montreal, 1953, 5:471.  Also: Elec-
  troencephalography,  31ontreal, 1953, Suppl. 3 : 21.
  ---, Elkes, J.  The effect of amphetamine and d-lysergic
  acid diethylamide (LSD-25) on  the  electrical activity
  of the brain of  the  conscious cat.   J.  Physiol, Lond.,
  1953, 120:13P-14P.
  ---, Hance,  A.  J.  The effects  of  intraventricular in-
  jections of d-lysergic acid diethylamide (LSD-25)  and
  5-hydroxytryptamine  (serotonin) on the  electrical ac-
  tivity of the brain of  the conscious cat.   J. Physiol,
  Lond., 1956, 132: 50P-51P.
  Brown, B. B.  Lysergic acid diethylamide antagonism of
  certain drugs.  Ann.  N. York Acad. Sc, 1957,  66:677-
  685.
  ---, Braun, D. L., Feldman, R.  G.   The pharmacologic
  activity of alpha-(4-piperidyl)-benzhydrol  hydrochloride
  (azacyclonol hydrochloride) ; an ataractive agent.   J.
  Pharm. Exp. Ther., 1956,118 : 153-161.
  Buscaino, G. A.,  Frongia, N.  Modificazioni biochimiche,
  elettroencefalografiche,  istochimiche ed istopatologiche,
  in  cani, durante Tintossicazione sperimentale acuta  e
  cronica da dietilamide  delTacido lisergico.  [Biochem-
  ical, electroencephalographic, histochemical and histo-
  pathologic changes in dogs during experimental acute
  and chronic lysergic acid  diethylamide  intoxication.]
  [English summary]   Acta neur.,  Nap., 1953, 8: 641-695.
  Cerletti,  A.   Lysergic  acid diethylamide  (LSD)  and
  related compounds.   In:  Abramson,  H. A., ed. Neuro-
  pharmacology.  Transactions of  the second conference,
  May 1955, Princeton,  N. J.  New  York, Josiah 3Iacy, Jr.
  Foundation, 1956.  p.  9-84.
  ---, Rothlin, E. Role of 5-hydroxytryptamine in mental
  diseases and its  antagonism to lysergic  acid derivatives.
  Nature, Lond.,  1955, 176:785-786.  Abstract • Chem.
90 
SUBJECT  LIST
Lysergic acid diethylamide : Studies, animals
 Abstr., 1956, 50: 4389fgh.  Excerpta med., Sect. 8, 1957,
 10: No. 973.
 Cook, L., Weidley, E. Behavioral effects of some psycho-
 pharmacological agents.  Ann. N. York Acad. Sc, 1957,
 66: 740-752.
 Delay, J., Lhermitte, F., Verdeaux,  G., Verdeaux, J.
 Modifications de Teiectrocorticogramme du lapin par la
 diethylamide de Tacide d-lysergique (LSD-25).  [Elec-
 trocorticographic changes produced in the rabbit with
 lysergic acid diethylamide.]  Rev. neur., Par., 1952,  86:
 81-88.
 Delgado, J.  M., Mihailovic, L.  Use of intracerebral
 electrodes to evaluate drugs that act on the central
 nervous system.  Ann.  N. York  Acad. Sc,  1956,  64:
 644-666.
 Elkes, J.  Effects of psychosomimetic drugs in animals
 and man.  In:  Abramson, H. A., ed.  Neuropharmacol-
 ogy.   Transactions  of the third conference, May 1956,
 Princeton, N. J. New York, Josiah Macy,  Jr. Founda-
 tion, 1957. p.205-295.
 ---, Elkes, C, Bradley, P. B. The effect of some drugs
 on the electrical activity of the brain, and on behaviour.
 /. 3Ient. Sc, Lond.,  1954, 100: 125-128.
 Evarts, E. [V.]  Brain effects of LSD in animals.   In:
 Cholden, L., ed. Lysergic acid diethylamide and mes-
 caline in experimental psychiatry.  New York, Grune &
 Stratton, 1956.  p. 55-56.
 ---.  Some effects  of bufotenine and lysergic acid di-
 ethylamide  on  the monkey.   A.  M. A.  Arch. Neur.
 Psychiat, 1956, 75 : 49-53.
 ---,  Landau, W., Freygang, W., Jr., Marshall, W. H.
 Some  effects of lysergic acid diethylamide and bufote-
 nine  on electrical activity in  the  cat's visual  system.
 Am, J. Physiol, 1955,182 : 594-598.
 ---, Marshall,  W. H.  The  effects of lysergic acid di-
 ethylamide on the excitability cycle of the lateral genic-
 ulate.   Tr. Am. Neur. Ass., 1955, 80th Meeting: 58-60.
 Garello, L.,  Dolce,  G.  Intorno alia abione risolvente
 della dietilamide dell'acido lisergico e della metilanfe-
 tamina sulla catalessia sperimentale da  5-idrossitrip-
 tamina (5 HT) ; ricerche sperimentali sul cane.  [An-
 tagonistic effect of diethylamide of lysergic acid and of
 methylamphetamine on experimental  catalepsy caused
 by 5-hydroxytryptamine;  experimental  research   on
 dogs.]    [English summary]   Sistema nerv.,  3lilano,
 1956,  8:61-80.   Abstract:  Chem. Abstr., 1956,   50:
 17196a.
 Haley, T. J., McCormick, W. G.  Pharmacological effects
 produced by intracerebral injection of drugs in the con-
 scious mouse. University of California, School of Medi-
 cine, Atomic Energy  Project, Los Angeles, 1956 (UCLA-
 372) : 1-25.
 Himwich, H. E.  The effect of frenquel on EEG changes
 produced by LSD-25 and mescaline.  In: Cholden, L.,
 ed.  Lysergic acid diethylamide and  mescaline  in  ex-
 perimental psychiatry.  New York, Grune  & Stratton,
 1956.  p. 19-26.
 Jarvik, M. E.  Effect of LSD-25 on snails.  In: Abram-
 son,  H. A., ed.  Neuropharmacology.  Transactions of
 the third conference, May 1956, Princeton,  N. J.  New
 York, Josiah Macy, Jr. Foundation, 1957.  p. 29-38.
 Keller, D. L., Umbreit, W. W.  Chemically  altered per-
 manent behavior patterns  in  fish and their  cure  by
 reserpine.  Science, 1956,124 : 407.
 ___f____. permanent alteration of behavior in mice by
 chemical and psychological means.  Science, 1956, 124:
 723-724.
 Marrazzi, A. S.  The effects of certain drugs on cerebral
 synapses.  Ann.  N. York Acad.  Sc, 1957, 66: 496-507.
___  jjart  E R.  An electrophysiological  analysis of
drugs useful in psychotic states.  In: Himwich, H. E.,  ed.
Tranquilizing  drugs.  Washington, Am.  Ass. Adv.  Sc,
1957.  p. 9-21.
___  ____   An electrophysiological analysis of the  ac-
 tions of some drugs useful in the therapy of psychotic
 disorders.  J. Nerv. Ment. Dis., 1956, 124: 388-392.
 ----,----.  The possible role of inhibition at adrenergic
 synapses in  the  mechanism  of  hallucinogenic and  re-
 lated drug actions. J. Nerv.  Ment. Dis., 1955, 122: 453-
 457.
 Masserman,  J. H., Pechtel, C.  An experimental inves-
 tigation of factors influencing drug action.  Psychiat.
 Res. Rep.,  Wash., 1956 (4) : 95-113.
 ----, ----.  Neurophysiology and  pharmacologic  in-
 fluences on experimental neuroses.  Am. J. Psychiat,
 1956,113: 510-514.
 Monroe, R. R., Heath, R. G, Mickle, W. A., Miller,  W.
 Cortical and subcortical recordings correlated with  be-
 havior in patients and animals  during the  administra-
 tion of Rauwolfia, thorazine, and meratran.  Psychiat.
 Res.  Rep.,  Wash., 1955  (1):  25-44.  Abstract:  Chem,
 Abstr., 1956, 50 : 2867gh.
 Murphree, O. D., Peters, J.  E.   The effect of electro-
 convulsions,  insulin comas and certain chemical agents
 on fixations in the rat.  J. Nerv. Ment. Dis., 1956, 124:
 78-83.
 Nathan, P., Aprison,  M. H., Himwich, H. E.  Effect of
 some centrally  acting drugs on compulsive circling.
 Proc. Soc Exp. Biol, N. Y., 1955, 90: 364-367. Abstract:
 Chem. Abstr., 1956, 50:3632cd.
 Peters, J.  J., Vonderahe, A.  R.   Behavior of the sala-
 mander  under the influence  of  LSD-25 and frenquel,
 and accompanying electrical activity of brain and spinal
 cord.  J. Nerv. Ment. Dis., 1956,124: 69-73.
 Pfeiffer, C. C, Jenney, E. H.  The inhibition of the con-
 ditioned response and the counteraction of schizophre-
 nia by  muscarinic  stimulation of the brain. Ann.  N.
 York Acad. Sc, 1957, 66 : 753-764.
 Purpura, D. P. Electrophysiological analysis of psycho-
 togenic drug action.   (1) Effect of LSD on specific affe-
 rent systems in the cat.  (2)  General nature of lysergic
 acid  diethylamide  (LSD)  action on  central synapses.
 A. M. A. Arch. Neur.  Psychiat, 1956, 75:122-131; 132-
 143.  Abstract:  Excerpta med.,  Sect. 8, 1956,  9: No.
 4451; No. 4452.
 ----.   Electrophysiological analysis  of psychotogenic
 drug  action on the evoked potentials of the cat's brain.
 Tr. Am. Neur. Ass., 1955, 80th Meeting: 60-67.
 ----.  Experimental analysis of the inhibitory action of
 lysergic acid diethylamide on cortical dendritic activity.
 Ann. N. York Acad. Sc, 1957, 66 : 515-536.
Rinaldi,  F.   The  experimental electroencephalographic
 approach to  psychopharmacology. Psychiat. Res. Rep.,
 Wash.,  1956  (4)  : 1-10.
---,  Himwich,   H.  E.  The cerebral  electrographic
 changes  induced  by LSD and mescaline are corrected
 by frenquel.   J.  Nerv.  Ment. Dis., 1955, 122: 424-432.
 Abstract: Excerpta med., Sect. 8, 1957, 10: No. 1601.
----,----.  Frenquel corrects certain cerebral electro-
graphic changes.   Science, 1955, 122:198-199.
Rinkel, M., Hyde., R. W., Solomon, H. C.  Experimental
psychiatry.  IV.  Hallucinogens: tools in experimental
psychiatry. Dis. Nerv. Syst., 1955,16 : 229-232.
Rothlin,  E., Cerletti, A.  Uber einige pharmakologische
Untersuchungen an Mausen mit congenitaler Drehsucht.
 [Some pharmacological studies on mice with congenital
waltzing syndrome.]    Helvet  physiol  pharm. acta,
1952,  10:319-327.  Abstract: Chem.  Abstr., 1953,  47-
766hi.
Roubicek, J., Srnec, J.  Experimentdini psychosa vyvo-
land LSD.    [Experimental psychosis caused by  LSD.]
 [English summary]   Cas. lek. cesk., 1955, 94:189-195.
Abstract: Chem. Abstr., 1955, 49 :11875e. Excerpta med
Sect.  8, 1955, 8: No. 4844.
Rovetta, P.  Effects of mescaline and LSD on  evoked
responses  especially  of  the  optic system  of the cat.
Electroencephalography, 31ontreal, 1956, 8:15-24.  Ab-
stract : Excerpta  med., Sect. 8, 1957, 10: No. 501.
91 
Lysergic acid diethylamide : Studies, animals
PSYCHOPHARMACA  '.
  Sacchi, U., Bonamini, F., Dolce, G., Garello, L. Dietila-
  mide dell'acido lisergico e catalessia da 5-idrossitripta-
  mina  nel  cane.   [Lysergic  acid  diethylamide and  5-
  hydroxytryptamine catalepsy in dogs.]  Boll Soc ital
  biol. sper., 1955, 31: 665-667.
  ---, Brusa, A., Gianniotti, G.  Lesions del sistema ner-
  voso centrale del Carassius auratus da 5 HT ed azione
  protettrice  delTLSD.   [Lesions of the central nervous
  system in Carassius auratus caused by  serotonin and
  the protective  action  of  lysergic acid diethylamide.]
  Boll. Soc ital. biol. sper., 1956,32: 438-441.
  Schwarz, B. E., Wakim, K. G., Bickford, R. G, Lichten-
  held, F. R.  Behavioral and electroencephalographic ef-
  fects of hallucinogenic drugs; changes in cats on intra-
  ventricular injection.   A.  M. A. Arch.  Neur. Psychiat.,
  1956, 75: 83-90. Abstract: Excerpta med., Sect. 8, 1957,
  10: No. 328.
  Sherwood,  S. L.  Effects of drugs  on  the behavior  of
  animals and on psychoses of man.  In : Abramson, H. A.,
  ed. Neuropharmacology.   Transactions of the second
  conference, May  1955, Princeton,  N.  J.  New York,
  Josiah Macy, Jr. Foundation, 1956.  p. 85-182.
  Shore, P. A., Silver, S. L., Brodie, B. B.  Interaction of
  reserpine, serotonin, and lysergic acid diethylamide in
  brain.  Science, 1955,122 : 284-285.
  ---,---■,----.  Interaction of serotonin and lysergic
  acid diethylamide (LSD) in  the central nervous system.
  Experientia, Basel,  1955, 11: 272-273.
  Smith, K., Moody, A. C.  Schizophrenia and the Siamese
  fighting fish. Dis. Nerv. Syst, 1956,17: 327-328.
  Turner, W. J.  The effect  of lysergic acid diethylamide
  on Betta splendens: I.  II.  Frenquel.  Dis. Nerv. Syst,
  1956,17:193-197; 198.
  Verdeaux, G., Marty, R.  Action sur Teiectroencephalo-
  gramme de substances pharmacodynamiques d'interet
  clinique.   [Effect of clinically important drugs on the
  encephalogram.]  Rev. neur., Par., 1954, 91: 405-427.
  Winter, C. A., Flataker,  L.  Effects of lysergic  acid
  diethylamide  upon performance of trained rats.  Proc.
  Soc Exp. Biol, N.  Y., 1956, 92:285-289.   Abstract:
  Chem.  Abstr.,  1956, 50:14891i.
  Witt, P. N. Ein einfaches Prinzip zur Deutung einiger
  Proportionen  im Spinnennetz.   [A simple principle for
  the interpretation of several proportions in spider webs.]
  [English summary]   Behaviour,  Leiden, 1951-52,  4:
  172-189.
  ---.   Der Netzbau der  Spinne als Test zur Prufung
  zentralnervos angreifender Substanzen.  [Construction
  of spider webs as a test for drugs with CNS action.]
  Arzneimitt. Forsch., 1956, 6 : 628-635.
  Woolley, D. W.  Production of abnormal (psychotic?)
  behavior in mice  with lysergic acid diethylamide, and
  its partial prevention with cholinergic drugs  and seroto-
  nin. Proc Nat. Acad. Sc U. S., 1955, 41: 338-344.  Ab-
  stract : Chem. Abstr., 1956, 50:12286def.
  ---, Shaw, E. N.  Evidence for  the  participation  of
  serotonin in mental processes.  Ann. N. York Acad. Sc,
  1957, 66: 649-667.

Studies, normal subjects
  Abramson, H. A.  Lysergic acid diethylamide  (LSD-
  25) : XIX. As an adjunct to brief psychotherapy, with
  special  reference  to   ego  enhancement. J.  Psychol,
  Provincet, 1956, 41:199-229.
  ----.   Some  observations  on  normal  volunteers and
  patients.  In: Cholden, L.,  ed.  Lysergic acid diethyl-
  amide and mescaline in experimental psychiatry.  New
  York, Grune & Stratton, 1956.  p. 51-54.
  ----.   Tolerance to LSD-25 and a theory of psychoses.
  In: Abramson, H. A., ed. Neuropharmacology.  Trans-
  actions of the second conference, May 1955, Princeton,
  N. J.   New York, Josiah Macy, Jr. Foundation,  1956.
  p. 259-300.
  ---, Jarvik, M. E., Gorin, M.  H., Hirsch, M. W.  Ly-
  sergic  acid diethylamide  (LSD-25) : XVII. Tolerance
development  and its relationship to a  theory of psy-
chosis.  J. Psychol, Provincet, 1956, 41: 81-105.
___, ----, Hirsch, M. W.   Lysergic acid diethylamide
(LSD-25) : VII.  Effect  upon two measures of motor
performance.  J. Psychol, Provincet., 1955, 39: 455-464.
____}  ____, ----.   Lysergic  acid  diethylamide (LSD-
25) :' X. Effect on reaction time to auditory  and visual,
stimuli.  J. Psychol, Provincet,  1955, 40:39-52.  Ab-
stract : Excerpta med., Sect. 8,1956, 9: No. 3942.
___,___,---, Ewald, A. T.   Lysergic acid diethylamide
(LSD-25) : V.  Effect on spatial relations abilities. J.
Psychol, Provincet, 1955, 39: 435-442.
---, ---, Kaufman, M. R., Kornetsky, C,  Levine, A.,
Wagner, M.  Lysergic acid  diethylamide (LSD-25) : I.
Physiological and  perceptual  responses.  J. Psychol,
Provincet, 1955,  39:3-60.   Abstract:  Excerpta  med.,
Sect. 8„ 1955, 8 : No. 3172.
---, ---, Levine,  A., Kaufman, M. R., Hirsch, M. W.
Lysergic acid diethylamide  (LSD-25) : XV.  The effects
produced  by substitution of a  tap water placebo. J.
Psychol, Provincet, 1955, 40: 367-383.
---,  Kornetsky,  C, Jarvik,  M.  E.,  Kaufman, M. R.,
Ferguson,  M. W.   Lysergic acid  diethylamide (LSD-
25) :  XI.  Content  analysis  of clinical reactions.  J.
Psychol, Provincet., 1955, 40: 53-60.
---, Waxenberg,  S. E., Levine,  A., Kaufman, M. R.,
Kornetsky, C.  Lysergic acid diethylamide  (LSD-25):
XIII. Effect  on Bender-Gestalt test  performance. J.
Psychol, Provincet, 1955,  40: 341-349.  Abstract: Ex- '•
cerpta med.,  Sect. 8, 1956, 9: No.  3008.
Agnew, N., Hoffer, A. Nicotinic acid  modified lysergic
acid diethylamide psychosis.  J. 3Ient. Sc, Lond., 1955,
101:12-27.   Abstract: Excerpta  med.,  Sect.  8,  1956,
9: No. 850.
Alema,  G.  Allucinazioni da acido lisergico  in  cieco
senza bulbi  oculari.  [Lysergic acid hallucinations in :
blindness after bilateral enucleation.]  Riv. neur.,  Nap., :
1952,  22: 720-733.
Anderson, E. W., Rawnsley, K.  Clinical studies  of ly- !
sergic  acid  diethylamide.   Mschr.  Psychiat., Basel,
1954,  128:38-55.   Abstract:  Excerpta  med., Sect. 8, :
1955, 8 : No. 1800.
Arnold, O. H., Hoff, H.  Korperschemastorungen bei
LSD-25.  [Disturbances in perception of body structure
caused  by  LSD-25.]   Wien.  Zschr. Nervenh.,  1953,
6: 259-274.                                           i
----,  ----.  Untersuchungen fiber die  Wirkungsweise
von Lysergsaure-Diathylamid.  I.  [Studies   on  the
mechanism of action of lysergic acid diethylamide.  I.] j
Wien. Zschr. Nervenh., 1953, 6:129-150.
Belleville, R. E.   MMPI score  changes induced by ly-
sergic acid diethylamide (LSD-25).   J. Clin. Psychol,
1956, 12: 279-282.
Bercel, N. A., Travis, L. E., Olinger, L. B., Dreikurs, E.
Model psychoses induced by LSD-25 in normals. I. Psy-
chophysiological  investigations, with  special  reference
to  the  mechanism  of  the  paranoid  reaction. II.
Rorschach test findings.  A. M. A. Arch. Neur. Psychiat.,
1956, 75 :  588-611;  612-618.  Abstract:  Excerpta med.,
Sect. 8, 1957,10: No. 1984; 1985.
Berlin, L., Guthrie, T., Weider, A., Goodell, H.,  Wolff
H. G.   Studies in human cerebral function: the effects
of mescaline and  lysergic acid  on cerebral  processes
pertinent  to creative activity.  J. Nerv. 3Ient. Dis., 1955,
122: 487-491.  Text without drawings:  Tr. Am. Neur,
Ass.,  1955, 80th Meeting: 188-190.
Blickenstorfer, E.  Zum atiologischen Problem der Psy-
chosen  vom akuten  exogenen  Reaktionstypus;  Ly-
sergsaurediathylamid,  ein   psychisch  wirksamer  tox-
ischer Spurenstoff.  [Etiology of psychoses of the acute,
exogenous reaction type; lysergic acid diethylamide,  a
psychotoxic drug effective in minute doses.]  Arch. Psy-
chiat.,  Berl,  1952, 188:226-236.   Abstract:  Chem.
Abstr.,  1952, 46:11418b.  Excerpta med.. Sect 8 1953,
6: No. 807.                                   '   '
92 
SUBJECT  LIST
Lysergic acid diethylamide : Studies, normal subjects
 Boardman, W. K., Goldstone, S., Lhamon, W. T.  Effects
 of lysergic acid diethylamide (LSD)  on the time sense
 of  normals.  A  preliminary  report.   A. M.  A. Arch.
 Neur. Psychiat., 1957, 78: 321-324.
 Bradley, P. B., Elkes, C, Elkes, J. On some  effects of
 lysergic acid diethylamide (LSD-25) in normal volun-
 teers.  J.  Physiol, Lond., 1953, 121: 50P-51P.
 Brown, B. B., Braun, D. L., Feldman, R. G.  The pharma-
 cologic activity of alpha-(4-piperidyl)-benzhydrol hydro-
 chloride   (azacyclonol  hydrochloride) ;  an attractive
 agent.  J. Pharm. Exp. Ther., 1956, 118:153-161.
 Callaway, E., III.  On  the  production  of hallucinated
 and psychosis-like states.  Ann. Int.  M., 1955, 42: 721-
 728.
 Cerletti, A., Rothlin, E.  Role of 5-hydroxytryptamine in
 mental  diseases  and its antagonism to lysergic acid
 derivatives.  Nature, Lond.,  1955, 176: 785-786.   Ab-
 stract :  Chem.   Abstr.,  1956,  50:4389fgh.   Excerpta
 med., Sect. 8, 1957, 10: No. 973.
 Clark,  L.  D.,   Bliss,  E.  L.  Psychopharmacological
 studies of lysergic acid diethylamide (LSD-25) intoxi-
 cation.    Effects  of  premedication  with   BOL-148
 (2-bromo-d-lysergic acid diethylamide), mescaline, atro-
 pine, amobarbital, and chlorpromazine.   A. M. A. Arch.
 Neur. Psychiat, 1957, 78: 653-655.
 ---, Clark, L. S. The effects of cortisone on LSD-25
 intoxication in schizophrenic patients.  J. Nerv. Ment.
 Dis., 1956, 123 : 561-562.
 Delay, J., Pichot, P., Laine, B., Perse, J.  Les modifica-
 tions de la personnalite produits par la diethylamide de
 Tacide  lysergique  (LSD 25) ; etude  par le  test de
 Rorschach.   [Personality changes produced by lysergic
 acid diethylamide; a study  with the Rorschach test.]
 Ann. mCd. psychol, Par., 1954, 112(2)  : 1-13.  Abstract:
 Excerpta  med., Sect. 8, 1955, 8: No. 839.
 DeShon,  H. J.,  Rinkel,  M.,  Solomon,  H. C.  Mental
 changes   experimentally  produced by  d-lysergic  acid
 diethylamide tartrate.  Psychiat. Q., 1952, 26: 33-53.
 Di Mascio, A.,  Greenblatt, M., Hyde,  R. W. A study of
 the effects of  LSD:  Physiologic  and  psychological
 changes   and  their  interrelations.  Am. J.  Psychiat,
 1957, 114: 309-317.
 ---, Suter, E., Hyde,  R. W.,  Greenblatt, M.   Physio-
 logical effects of L. S. D.; report of a detailed  investi-
 gation in  one subject.  Psychiat. Q., 1957, 31: 57-71.
 Ebaugh, F. G.  The videclinic.  J. Am. M. Ass.,  1955,
 158: 732-733.
 Elkes, J.  Effects of psychosomimetic drugs in animals
 and man.  In: Abramson, H.  A., ed. Neuropharmacol-
 ogy.  Transactions of the third cconference, May 1956,
 Princeton, N. J.  New York, Josiah Macy, Jr. Founda-
 tion, 1957. p. 205-295.
 ---, Elkes, C, Bradley, P. B.  The effect of some drugs
 on the electrical activity of the brain,  and on behaviour.
 J. Ment.  Sc, Lond.,  1954, 100:125-128.
 Fabing, H. D.  Experimental compound MER-17 (fren-
 quel) : a  new blocking  agent against the development
 of LSD-25 psychosis.   Tr. Am. Neur. Ass., 1955, 80th
 Meeting:  83-85.  Also : Psychiat. Res. Rep., Wash., 1955
 (1) : 140-144.  Abstract: Excerpta med., Sect. 8,  1957,
 10: No. 127.
 ---. Frenquel,  a blocking agent against experimental
 LSD-25 and mescaline  psychosis; preliminary note on
 its  clinical  application.  Neurology,  1955, 5:319-328.
----  New  blocking agent against the development of
 LSD-25 psychosis.  Science, 1955, 121:208-210.
 Fragoso Mendes, J.  Nota previa sobre o emprego do
L.  S. D.  25 na  produ^ao  de  psicoses  experimentais.
 [Preliminary note on the use  of LSD-25 in the pro-
 duction  of  experimental psychoses.]  Med.  contemp.,
Lisb., 1956, 74: 565-570.
 Frederking, W.  Intoxicant  drugs (mescaline and ly-
sergic acid diethylamide)  in psychotherapy.  J. Nerv.
3Ient Dis  1955,  121:262-266.  Abstract:   Excerpta
med.," Sect/8, 1956, 9: No. 4084.

    456132—59---7
     ----.   Uber die Verwendung von Rauschdrogen  (Mes-
     kalin und Lysergsaurediaethylamid) in der Psychother-
     apie.   [The use of intoxicating drugs (mescaline and
     lysergic acid diethylamide)  in  psychotherapy.]   [Eng-
     lish summary]  Psyche,  Stuttg., 1953, 7 : 342-364.
     Gamna, G., Bonfante, B., Villata,  E. Autoesperienze
     con LSD.   [Personal  experience with  LSD.]   [Brief
     English summary]  Rass. stud, psichiat, 1954, 43: 979-
     988.  Abstract: Excerpta med., Sect. 8, 1955, 8: No. 3109.
     Gastaut, H., Ferrer, S., Castells, C, Lesevre, N., Lusch-
     nat, K.  Action de la diethylamide de Tacide  d-lyser-
     gique (LSD 25) sur les fonctions psychiques et Telectro-
     encephalogramme.  [Effect of d-lysergic  acid diethyla-
     mide  on psychic functions and the electroencephalo-
     gram.]   [English summary]   Confinia  neur.,  Basel,
     1953,  13:102-120.  Abstract:  Excerpta med., Sect.  8,
     1954, 7: No. 1623.
     Ginzel, K. H., Mayer-Gross, W. Prevention of psycho-
     logical effects of d-lysergic acid diethylamide (LSD-25)
     by its 2-brom derivative  (BOL 148). Nature,  Lond.,
     1956,   178:210. Abstract:  Chem.   Abstr.,  1956, 50:
      17147hi.
     Haase,  H. J.   Modellpsychosen und  deren  Bedeutung
     ftir die Vertiefung unserer Kenntnisse Uber endogene
     und  exogene Psychosen.  [Model psychoses  and their
     significance for an improved understanding of  endo-
     genous and exogenous psychoses.]   Med. Klin.,  Berl,
     1956,51:1881-1883.   [Not seen].
     Hirsch, M.  W., Jarvik, M. E., Abramson, H.  A. Ly-
     sergic  acid diethylamide  (LSD-25) : XVIII. Effects of
     LSD-25 and six related  drugs upon handwriting.  J.
     Psychol,  Provincet.,  1956, 41:11-22.  Abstract: Ex-
     cerpta med., Sect. 8,1956, 9: No. 3944.
     Hoch, P. H.   Studies in routes of  administration and
     counteracting  drugs.   In: Cholden,  L.,  ed.  Lysergic
     acid diethylamide and mescaline in experimental psy-
     chiatry.  New  York, Grune & Stratton, 1956.  p. 8-12.
     ---, Cattell, J. P., Pennes, H. H. Effect of drugs; the-
     oretical considerations from a psychological viewpoint.
     Am. J. Psychiat, 1952,108: 585-589.
     ----,----,----.  Effects of mescaline and lysergic acid
      (d-LSD-25).   Am. J. Psychiat, 1952, 108 : 579-584.
     ----,----,----.  Psychoses produced by administration
     of drugs.   Res. Pub.  Ass. Res. Nerv. Ment. Dis., 1953,
     32:287-296.
     Hurst, L. A., Reuning, H., Wyk, A. J. van, Crouse, H. S.,
     Booysen, P. J., Nelson, G. Experiences with d-lysergic
     acid diethylamide  (LSD) ; a  symposium.  S.  Afr.  J.
     Laborat. Clin. M., 1956, 2 : 289-310.
     Hyde, R. W., Von Mering, O., Morimoto, K.  Hostility in
     the lysergic psychosis.  J. Nerv. Ment Dis., 1953, 118:
     266-267.
     Isbell, H., Belleville,  R. E., Fraser, H. F., Wikler, A.,
     Logan,  C. R.  Studies  on lysergic acid  diethylamide
      (LSD-25).  I. Effects in former morphine addicts and
     development of tolerance during chronic intoxication.
     A. M. A. Arch. Neur. Psychiat., 1956, 76:468-478.
     ---, Fraser, H. F., Wikler, A., Belleville, R. E.   Toler-
     ance to diethylamide  of lysergic acid (LSD-25).  [Ab-
     stract]  Fed. Proc, Bait., 1955,14 : 354.
     ---,  Logan, C. R.   Studies  on the diethylamide  of
     lysergic acid (LSD-25).   II. Effects of chlorpromazine,
     azacyclonol, and reserpine on the intensity of the LSD-
     reaction.   A.  M. A. Arch.  Neur.  Psychiat., 1957, 77:
     350-358.
     Jarvik, M. E., Abramson, H. A., Hirsch, M. W.  Lysergic
     acid diethylamide (LSD-25) :  IV.  Effect on attention
     and  concentration.  J.  Psychol, Provincet., 1955, 39:
     373-383.
     ----,  ----, ----.  Lysergic acid diethylamide  (LSD-
     25) : VI. Effect upon  recall and recognition of various
     stimuli.  J. Psychol,  Provincet, 1955, 39: 443-454.
     ----,  ----, ----.  Comparative subjective  effects  of
     seven drugs including lysergic acid diethylamide (LSD-
     25).   J. Abnorm. Psychol, 1955, 51:657-662.

93 
Lysergic acid diethylamide : Studies, normal subjects
PSYCHOPHARMACA
Johnson, D. M.  The hallucinogenic drugs, the insanity-
producing drugs: Indian hemp and datura ; a neglected
aspect of forensic medicine,  a loophole in  the  law.
45 p.  Addendum.  LSD and schizophrenia,  (p. 40).
London, Johnson, 1953.
Kornetsky, C. Relation of physiological and psychologi-
cal effects of lysergic acid diethylamide.  A. M. A. Arch.
Neur. Psychiat, 1957, 77 : 657-658.
---,  Humphries,  O.  Relationship between  effects  of
a  number  of  centrally acting  drugs  and  personality.
A. 31. A. Arch. Neur. Psychiat, 1957, 77:325-327.
---, ---,  Evarts, E. V.  Comparison of psychological
effects of certain centrally acting drugs in man.   A. M.
A. Arch. Neur. Psychiat, 1957, 77 : 318-324.
Lennard, H., Jarvik, M. E., Abramson, H. A.  Lysergic
acid diethylamide  (LSD-25) : XII. A preliminary state-
ment of its effects upon interpersonal communication.
J. Psychol,  Provincet,  1956, 41:185-198.   Abstract:
Excerpta med., Sect. 8, 1956, 9: No. 3943.
Levine, A., Abramson, H. A., Kaufman, M. R., Markham,
S.  Lysergic acid  diethylamide  (LSD-25) : XVI. The
effect  on intellectual functioning  as  measured  by the
Wechsler-Bellevue  intelligence   scale.  J.   Psychol,
Provincet., 1955, 40: 385-395.
---, ---,  ---, ---, Kornetsky, C.  Lysergic acid di-
ethylamide  (LSD-25) : XIV. Effect on  personality  as
observed in psychological tests.  J. Psychol, Provincet,
1955, 40: 351-366.
Liebert,  R.  S., Wapner, S., Werner, H.  Studies in the
effects of lysergic  acid diethylamide (LSD-25) ; visual
perception  of verticality in schizophrenic  and normal
adults. A. M. A. Arch. Neur. Psychiat., 1957, 77:193-
201.
MacDonald, J. M., Galvin, J. A.  Experimental psychotic
states.  Am. J. Psychiat., 1956, 112: 970-976.
Matefi,  L. Mezcalin-  und   Lysergsaurediiithylamid-
Rausch; Selbstversuche mit besonderer Berficksichti-
gung eines Zeichentests.  [Mescaline  and lysergic acid
diethylamide intoxication ; autoexperiments with special
consideration  of a drawing test.]   [English summary]
Confinia neur., Basel, 1952, 12 :146-177.  Abstract: Ex-
cerpta med., Sect.  8, 1953, 6: No. 1204.
Mayer-Gross, W., McAdam, W., Walker,  J. W.  Lyserg-
saure-Diathylamid und Kohlenhydratstoffwechsel.  [Ly-
sergic acid diethylamide and carbohydrate metabolism.]
Nervenarzt, 1952, 23 : 30-31.
Montanari, C,  Tonini, G.  Azioni della 5-idrossitrip-
tamina sul sistema nervoso  centrale; suo  impiego  in
psichiatria  sperimentale.  [Effects  of  5-hydroxytryp-
tamine on the CNS ; its use in experimental psychiatry.]
Riv.  sper.  freniat, 1955, 79: 465-483.  Abstract: Ex-
cerpta med., Sect. 8,1956, 9: No. 3076.
Osmond, H.  Research on schizophrenia.  In: Abram-
son, H.  A., ed.  Neuropharmacology.   Transactions  of
the second conference, May 1955, Princeton, N. J.  New
York,  Josiah  Macy, Jr. Foundation, 1956.   p. 183-233.
----.  A review of the  clinical effects  of psychotomi-
metic  agents.  Ann. N. York Acad. Sc,  1957, 66: 418-
434.
Primac,  D. W.,  Mirsky,  A. F., Rosvold,  H. E.  Effects
of centrally acting drugs on two tests  of brain damage.
A. 31.  A. Arch. Neur. Psychiat,  1957, 77: 328-332.
Rinkel, M.  Experimentally induced psychoses in man.
In: Abramson, H. A., ed. Neuropharmacology.  Trans-
actions of  the second conference,  May 1955, Princeton,
N. J.  New York, Josiah 3Iacy, Jr. Foundation,  1956.
p. 235-258.
---,  DeShon, H. J., Hyde, R. W., Solomon, H. C.  Ex-
perimental  schizophrenia-like symptoms. Am.  J. Psy-
chiat., 1952, 108: 572-578.
---, Hyde, R. W., Solomon, H. C.  Experimental psy-
chiatry.  III.  A chemical concept of psychosis.  Dis.
Nerv. Syst, 1954, 15 : 259-264.
___t____,----.  Experimental psychiatry.  IV. Hallu-
cinogens : tools in experimental psychiatry.  Dis. Nerv.
Syst., 1955,  16 : 229-232.
___,---,---, Hoagland, H.  Experimental psychiatry.
II. Clinical and physio-chemical observations in experi-
mental psychosis.  Am. J. Psychiat., 1955, 111: 881-895.
Roubicek, J., Srnec, J.  Experimentaini psychosa vyvo-
land LSD.   [Experimental  psychosis caused by LSD.]
[English summary]   Cas. lek. cesk., 1955, 94: 189-195.
Abstract: Chem.  Abstr., 1955,  49:11875e.  Excerpta
med., Sect. 8, 1955, 8: No. 4844.
Ruiz-Ogara,   C,   Marti-Tusquets,  J.  L.,  Gonzalez-
Moncliis, E.  Psicosis lisergica.  [Lysergic psychosis.]
Rev.  psiquiat.  psicol,  Barcel,  1956,  2: 566-590.  Ab-
stract : Excerpta  med., Sect. 8, 1957, 10: No. 1986.
Salvatore, S., Hyde, R. W.  Progression of effects of ly-
sergic acid diethylamide (LSD).   A. 31. A. Arch. Neur.
Psychiat, 1956, 76 : 50-59.
Savage, C.  The  LSD  psychosis as  a  transaction be-
tween the psychiatrist and patient.  In:  Cholden, L.,
ed.   Lysergic  acid diethylamide  and mescaline in ex-
perimental psychiatry.   New  York, Grune & Stratton,
1956.  p. 35-43.
----.  Lysergic acid  diethylamide;  a  clinical-psycho-
logical study.   Am. J. Psychiat, 1952,108 : 896-900.  Ab-
stract : Excerpta  med., Sect. 8, 1953, 6: No. 419.
---.  Variations in  ego feeling  induced by d-lysergic
acid diethylamide (LSD-25).  Psychoanal Rev., 1955,
42:1-16.  Abstract: Excerpta med., Sect. 8, 1956, 9: No.
3007.
---,  Cholden, L.  Schizophrenia and  the model psy-
choses.  J. Clin. Exp. Psychopath., 1956, 17: 405-413.
Schwarz, B. E. Electroencephalographic studies of ani-
mals and human  beings under hypnosis.  40 p.  [Type-
written] Rochester,  1955.  (Thesis—Minnesota.)
---,  Bickford, R. G., Mulder,  D. W.,  Rome,  H. P.
Mescaline and LSD-25 in activation of temporal lobe
epilepsy.  Neurology, 1956,  6 : 275-280.
---,  ---, Rome, H.  P.  Reversibility  of  induced psy-
chosis with chlorpromazine.  Proc. Mayo Clin., 1955,
30: 407-417.
Slater, P. E., Morimoto, K., Hyde, R. W.   The effect of
group administration upon symptom formation under
LSD.  J. Nerv. Ment. Dis.,  1957,  125: 312-315.
Sloane,  B.,  Lovett Doust,  J. W.  Psychophysiological
investigations  in experimental  psychoses;  results of
the exhibition of d-lysergic acid diethylamide to  psy-
chiatric patients. J. 3Ient. Sc,  Lond., 1954, 100:129-
144.  Abstract: Excerpta med., Sect. 8,  1955, 8: No. 843.
Solms,  H.  Chemische   Struktur  und  Psychose bei
Lysergsaure-Derivaten.   [Chemical  structure  of  and
psychosis  produced  by lysergic  acid   derivatives.]
Praxis, Bern, 1956, 45: 746-749.
----.  Lysergsaure-athylamid (LAE),  ein neues, stark
sedativ wirkendes  Psychoticum  aus dem  Mutterkorn.
 [Lysergic acid ethylamide (LAE), a new strongly seda-
tive  psychotomimetic  drug  from  Mother  of Rye.]
Schweiz. med. Wseh r., 1953, 83 : 356-360.
Stoll, W. A.  Rorschach-Versuche  unter LSD-Wirkung.
 [Rorschach tests under the influence of LSD.]   [Eng-
lish  summary, p.  269.] Rorschachiana,  Bern, 1952,
1:249-270.   Abstract:  Excerpta med., Sect. 8, 1954,
7: No. 3119.
Tonini, G., Montanari,  C.  Effects  of experimentally
induced psychoses on artistic expression.  [In English]
 Confinia  neur.,  Basel,  1955, 15:225-239.  Abstract:
Excerpta med., Sect. 8, 1957, 10: No. 1439.
Verdeaux, G., Marty, R.  Action sur Teleetroencephalo-
gramme de  substances pharmacodynamiques d'interet
clinique.  [Effect of  clinically important drugs on the
encephalogram.]   Rev.  neur., Par.,  1954,  91:405-427.
von Felsinger, J. M., Lasagna, L., Beecher, H. K.  The
response of normal men to lysergic acid derivatives (di-
 and  mono-ethyl  amides).  J. Clin.  Exp.  Psychovath.,
1956, 17: 414-428.
94 
SUBJECT  LIST
Lysergic acid diethylamide : Studies, patients
  Ward,  R. H.  A  drug-taker's notes.  222 p.  London,
  Gollancz, 1957.
  Wikler, A.  Mechanisms of action of drugs that modify
  personality function.  Am. J. Psychiat, 1952, 108: 590-
  599.

Studies, patients
  Alema, G., Donini, G.  Sugli effetti della intossicazione
  sperimentale con dietilamide dell'acido lisergico in due
  casi  di  anosognosia visiva.  [Effects  of  experimental
  lysergic acid diethylamide poisoning in 2 cases of visual
  anosognosia.]  Riv. sper. freniat, 1956, 80: 943-952.
  Anderson, E. W.,  Rawnsley, K.  Clinical  studies of ly-
  sergic acid diethylamide.  Mschr. Psychiat, Basel, 1954,
  128:38-55.   Abstract: Excerpta med., Sect.  8, 1955,
  8: No. 1800.
  Arnold, O. H., Hoff, H.  Untersuchungen fiber die Wirk-
  ungsweise von  Lysergsaure-Diathylamid.  I.   [Studies
  on the mechanism of action of  lysergic acid diethyla-
  mide. I.]  Wien. Zschr. Nervenh., 1953, 6: 12!)-150.
  Belsanti,   R.  Modificazioni   neuro-psico-biochimiche
  indotte   dalla  dietilamide   dell'acido   lisergico  in
  schizofrenici e  frenastenici.  [Neurological,  psycholog-
  ical and biochemical effects of lysergic acid diethylamide
  in schizophrenic and phrenasthenic subjects.]   [English
  summary]   Acta  neur.,  Nap.,  1952,  7:340-349.   Ab-
  stract : Excerpta med., Sect. 8, 1953, 6: No. 801.
  Berthiaume, M. La diethylamide de Tacide lysergique
  en psychiatrie.  [Lysergic  acid  diethylamide in  psy-
  chiatry.]  Union med, Canada, 1956, 85 : 555-560.   Ab-
  stract : Excerpta med., Sect. 8,1957,10 : No. 1385.
  Callaway, E., III.  On the production of hallucinated and
  psychosis-like  states.  Ann. Int. M., 1955, 42: 721-728.
  Callieri,  B.,  Ravetta,  M. Effetti  della  dietilamide
  dell'acido lisergico  sulla  sintomatologia  psichica di
  schizofrenici;  studio psicopatologico.   [Effects of ly-
  sergic acid diethylamide  on the psychic  symptoms of
  schizophrenia; psychopathological study.]  [Brief Eng-
  lish  and French  summaries.]  Rass.  stud,  psichiat,
  1955, 44: 39-88.  Abstract: Excerpta med., Sect. 8, 1956,
  9: No. 3091.
  Cholden, L. S., Kurland, A., Savage, C.  Clinical reac-
  tions and tolerance  to LSD in  chronic schizophrenia.
  J.  Nerv. 31ent.  Dis.,  1955,  122:211-221.  Abstract:
  Excerpta med.,  Sect. 8, 1956, 9 : No. 4015.
  Clark, L. D.,  Clark, L. S.  The  effects of  cortisone on
  LSD-25 intoxication in schizophrenic patients.  J. Nerv.
  Ment. Dis., 1956, 123 : 561-562.
  Cline, H. S., Freeman, H.  Resistance to lysergic acid in
  schizophrenic patients.  Psychiat. 0., 1956, 30: 676-683.
  Elkes, J.  Effects  of psychosomimetic drugs in  animals
  and man. In:  Abramson, H. A., ed. Neuropharmacol-
  ogy.  Transactions  of the  third conference,  May 1956,
  Princeton, N. J. New York, Josiah  Macy, Jr.  Founda-
  tion,  1957.  p. 205-295.
  ---,  Elkes, C, Bradley, P. B.  The effect of some drugs
  on the electrical activity of the brain, and on behaviour.
  J. Ment. Sc, Lond., 1954, 100:125-128.
  Fliigel, F., Bente, D.  Das akinetisch-abulische Syndrom
  und seine Bedeutung ffir die pharmakologisch-psychi-
  atrische  Forschung.  [Akinetic-abulic  syndrome   and
  its  importance  in   psychopharmacologic   research.]
  Deut. med. Wschr., 1956, 81: 2071-2074.
  Gastaut, H., Terzian,  H., Gastaut, Y.  Etude d'une ac-
  tivite eiectroencephalographique meconnue: "le rythme
  rolandique en arceau".   [Investigation of a misunder-
  stood electroencephalographic activity:  "the  rolandic
 rhythm in arc".]   31arseille med., 1952, 89:296-310.
 Giberti, F., Gregoretti, L.  Prime esperienze di antago-
 nismo psicofarmacologico; psicosi sperimentale da LSD
 e trattamento con  cloropromazina e reserpina.  [First
 trials of  psychopharmacological antagonism; experi-
 mental psychoses induced with d-lysergic  acid  diethyl-
 amide and treated with chlorpromazine and reserpine.]
 [English  summary]  Sistema  nerv.,   Milano,  1955,
7:301-310.  Abstract:  Excerpta  med., Sect. 8, 1956,
9: No. 4547.
Hoch, P. H.  Experimental psvchiatry.   Am.  J.  Psy-
chiat, 1955, 111: 787-790.
---,  Cattell, J. P.,  Pennes, H.  H.  Effect  of  drugs;
theoretical considerations from  a psychological view-
point.  Am. J. Psychiat, 1952, 108 : 5S5-589.
---,----,----.  Effects of mescaline and lysergic acid
 (d-LSD-25).  Am. J. Psychiat, 1952, 108: 579-584.
----,----,----.  Psychoses produced by administration
of drugs.  Res.  Pub. Ass.  Res. Nerv. Ment Dis., 1953,
32: 287-296.
Landis, C, Clausen, J.  Certain effects of mescaline and
lysergic acid on psychological functions.   J. Psychol,
Provincet, 1954, 38: 211-221.  Abstract: Excerpta med.,
Sect.  8, 1955, 8 : No. 1336.
Liddell,  D.  W., Weil-Malherbe,  H.  The  effects  of
methedrine and  of lysergic acid diethylamide on mental
processes and on the blood adrenaline level.  J. Neur.,
Lond.,  1953, 16:7-13.  Abstract:  Chem.  Abstr., 1953,
47:11560L
Liebert, R. S., Wapner, S., Werner, H.  Studies in the
effects of lysergic acid diethylamide (LSD-25)  ; visual
perception of verticality  in  schizophrenic  and  normal
adults.  A. 31. A. Arch. Neur. Psychiat., 1957, 77:193-
201.
MacDonald, J. M., Galvin, J. A.  Experimental psychotic
states.   Am. J. Psychiat, 1956, 112: 970-976.
Martens, S.  Intracerebral elektrografi;  ett  viktigt
hjalpmedel  i psykiatrisk forskning.   [Electroencepha-
lography, an important aid in psychiatric research.]
Sven. lak. tidn., 1956, 53: 2855-2863.
Mayer-Gross, W., McAdam, W., Walker, J.  W.  Further
observations on the effects of lysergic acid diethylamide.
/. 31 ent. Sc, Lond.,  1953, 99: 804-808.
Montanari,  C,  Tonini, G.  Azioni  della  5-idrossitrip-
tamina sul  sistema nervoso centrale; suo impiego  in
psichiatria   sperimentale.  [Effects   of    5-hydroxy-
tryptamine  on   the  CNS;  its  use  in   experimental
psychiatry.]  Riv. sper. freniat., 1955, 79 : 465^83.  Ab-
stract : Excerpta med., Sect. 8, 1956, 9 : No.  3076.
Pennes,  H. H.   Clinical  reactions of schizophrenics  to
sodium amytal,  pervitin hydrochloride, mescaline sul-
fate,  and d-lysergic  acid  diethylamide (LSD-25).  J.
New. 31 ent. Dis., 1954, 119 : 95-112.
---,   Hoch, P.  H.  Psychotomimetics,   clinical  and
theoretical  considerations:  harmine,  WIN-2299  and
nalline.   Am. J. Psychiat, 1957, 113: 887-892.
Portella Nunes, E.   Investigates com a dietilamida  do
acido  lisergico.   [Clinical studies  with  lysergic  acid
diethylamide.]   [English summary]   J. brasil psiquiat.,
1955,  4: 407-418.
Rinkel,  M.  Experimentally  induced  psychoses   in
man.   In: Abramson, H. A., ed.  Neuropharmacology.
[2 conf. 1955]  New  York, Josiah Macy,  Jr. Founda-
tion,  1956.  p. 235-258.
----,   Hyde,  R.  W., Solomon, H.  C.  Experimental
psychiatry. III.  A  chemical  concept of psychosis. Dis.
Nerv. Syst, 1954, 15 : 259-264.
Roubicek,  J.,  Srnec,  J.    Experimentaini  psychosa
vyvoland LSD.   [Experimental  psychosis caused  by
LSD.]   [English  summary]  Cas.  Ick.  ccsk.,  1955,
94:189-195.  Abstract: Chem.  Abstr., 1955, 49: 11875e!
Excerpta med., Sec. 8,1955, 8 : No. 4844.
Ruiz-Ogara, C,  Marti-Tusquets, J. L., Gonzalez-Mon-
clus,   E.  Psicosis   lisergica.   [Lysergic   psychosis.]
Rev.  psiquiat.  psicol, Barcel, 1956, 2:566-590.  Ab-
stract:  Excerpta  med.,  Sect.  8,  1957, 10: No. 1986
Sandison, R. A.,  Spencer, A. M., Whitelaw,  J. D. A.  The
therapeutic value of lysergic acid  diethylamide  in men-
tal illness.  J. Ment Sc, Lond., 1954,100: 491-507.  Ab-
stract : Excerpta med., Sect. 8, 1955, 8: No. 930.
Sanguineti,  I., Negri, V. U., Laricchia, R.  Ritmi elet-
trici  cerebrali  dopo  somministrazione di  mescalina e
di acido  lisergico (LSD 25) in malati di mente.  [Elec-
95 
Lysergic acid diethylamide : Studies, patients
PSYCHOPHARMACA
  trical rhythms of the brain following administration of
  mescaline and lysergic acid  (LSD 25) to mental  pa-
  tients.]   Riv.  sper.  freniat, 1955, 79:  771-797.  Ab-
  stract : Excerpta med., Sect. 8, 1957,10: No. 1060.
  Sanguineti,  I., Zapparoli,  G. C, Laricchia, R.   Studio
  clinicobiologico delle reazioni  indotte dal  solfato  di
  mescalina e dall'acido  lisergico (LSD-25) in malati di
  mente.  [Clinical and physiological study of mescaline
  sulfate- and lysergic acid (LSD)-induced reactions  in
  mental patients.]   Riv. sper. freniat, 1956, 80: 887-918.
  Savage,  C.  Lysergic  acid  diethylamide; a  clinical-
  psychological study.  Am. J. Psychiat., 1952, 108: 896-
  900.  Abstract: Excerpta med.,  Sect. 8, 1953, 6 : No. 419.
  ----.  Variations in ego feeling induced by d-lysergic
  acid diethylamide (LSD-25).  Psychoanal. Rev., 1955,
  42:1-16.  Abstract: Excerpta  med., Sect. 8,  1956, 9:
  No. 3007.
  ---, Cholden, L.  Schizophrenia  and the model  psy-
  choses.  J. Clin. Exp. Psychopath.,  1956,17 : 405^13.
  Schwarz, B. E., Bickford, R. G, Mulder, D. W.,  Rome,
  H. P.  Mescaline and LSD-25 in activation of temporal
  lobe epilepsy.  Neurology, 1956,  6 : 275-280.
  ---, Sem-Jacobsen, C. W., Peterson, M.  C.  Effects of
  mescaline, LSD-25, and adrenochrome on depth electro-
  grams in man.  A. M. A. Arch. Neur. Psychiat., 1956,
  75: 579-587.
  Sherwood,  S. L.  Effects of  drugs on  the behavior  of
  animals and on psychoses of man.   In: Abramson, H. A.,
  ed. Neuropharmacology. Transactions of the second
  conference,  May  1955,  Princeton, N.  J. New  York,
  Josiah Macy, Jr. Foundation, 1956.  p. 85-182.
  Sloane,  B.,  Lovett  Doust,  J. W.  Psychophysiological
  investigations in experimental psychoses; results of the
  exhibition of d-lysergic acid diethylamide to psychiatric
  patients.  J. Ment.  Sc, Lond., 1954, 100:129-144.  Ab-
  stract : Excerpta med., Sect. 8, 1955, 8:  No. 843.
  Solms, H.   Lysergsaure-athylamid  (LAE),  ein  neues,
  stark sedativ wirkendes Psychoticum aus dem Mutter-
  korn.  [Lysergic acid ethylamide (LAE), a new strongly
  sedative  psychotomimetic  drug from  Mother of Rye.]
  Schweiz. med. Wschr.,  1953, 83:356-360.
  Verdeaux, G., Marty, R.  Action sur Teiectroencephalo-
  gramme de  substances  pharmacodynamiques d'interet
  clinique.   [Effect  of clinically important drugs on the
  encephalogram.]   Rev. neur., Par., 1954, 91: 405-427.


with AZACYCLONOL—INTERACTION

Pharmacodynamics
  Jatzkewitz,  H.   Pharmakologische  Aspekte  in  der
  Schizophrenieforschung.  [Pharmacological  aspects  in
  schizophrenia research.]  Nervenarzt, 1956, 27 :150-152.

Psychotherapeutic use
  Sandison, R. A., Whitelaw, J. D. A. Further studies in
  the therapeutic value of lysergic acid diethylamide in
  mental illness.  J. Ment. Sc, Lond., 1957, 103: 332-343.

Studies, animals
  Abramson, H. A.  Blocking of the LSD-25 reaction in
  Siamese fighting fish.  In: Abramson, H. A., ed. Neuro-
  pharmacology.  Transactions of the third conference,
  May 1956, Princeton, N. J.  New York, Josiah Macy, Jr.
  Foundation, 1957.  p. 9-27.
  Brown, B. B.  Lysergic acid diethylamide antagonism
  of certain drugs.  Ann. N.  York Acad.  Sc,  1957, 66:
  677-685.
  ----, Braun, D. L., Feldman,  R. G.  The pharmacologic
  activity  of  alpha-(4-piperidyl)-benzhydrol  hydrochlo-
  ride (azacyclonol  hydrochloride) :  an ataractive agent.
  J. Pharm. Exp. Ther., 1956, 118:153-161.
  ---, Feldman, R., Braun, D. L.   Pharmacologic studies
  of an LSD antagonist 4-piperidyl  diphenyl  carbinol
  hydrochloride.  [Abstract]   Fed. Proc, Bait., 1955, 14,
  322.
  Himwich, H. E.  The effect of frenquel on EEG changes
  produced by LSD-25 and mescaline.   In: Cholden, L.,
  ed.   Lysergic acid diethylamide  and mescaline in ex-
  perimental psychiatry.  New York, Grune d  Stratton,
  1956. p. 19-26.
  Monroe,  R. R., Heath, R. G., Mickle,  W. A., Miller, W.
  Cortical  and  subcortical  recordings  correlated  with
  behavior in patients and animals during the adminis-
  tration   of   Rauwolfia,  thorazine,   and   meratran.
  Psychiat. Res. Rep., Wash., 1955 (1) : 25-44.  Abstract:
  Chem. Abstr., 1956, 50: 2867gh.
  Peters, J. J., Vonderahe,  A. R.  Behavior of  the  sala-
  mander  under the influence  of  LSD-25 and  frenquel,
  and accompanying electrical activity of brain and spinal
  cord. J. Nerv. Ment. Dis., 1956,124 : 69-73.
  Rinaldi,  F.,  Himwich,  H. E.  Frenquel  corrects cer-
  tain  cerebral  electrographic changes.  Science, 1955,
  122:  198-199.
  ---, ----.  The cerebral electrographic  changes in-
  duced by LSD and mescaline are corrected by frenquel.
  J.  Nerv.  Ment.   Dis.,  1955, 122:424-432.  Abstract:
  Excerpta med., Sect.  8, 1957, 10: No. 1601.
  Smith, K., Moody, A. C.  Schizophrenia and the Siamese
  fighting fish.  Dis. Nerv. Syst, 1956, 17 : 327-328.
  Turner,  W. J.  The effect of lysergic acid diethylamide
  on Betta  splendens.  II.  Frenquel.  Dis. Nerv. Syst.,
  1956,17:198.
  Winter,  C. A.,  Flataker, L.  Effects of  lysergic  acid
  diethylamide upon performance of trained rats.  Proc.
  Soc.  Exp. Biol,  N.  Y.,  1956,  92:285-289.  Abstract:
  Chem. Abstr., 1956, 50:14891L

Studies, normal subjects
  Brown,  B. B.,  Braun, D.  L.,  Feldman,  R. G.  The
  pharmacologic activity of alpha-(4-piperidyl)-benzhy-
  drol  hydrochloride  (azacyclonol  hydrochloride) ; an
  ataractive agent. J. Pharm. Exp. Ther., 1956,  118:153-
  161.
  Clark, L. D.  Further studies of the psychological ef-
  fects of frenquel and a critical review of previous re-
  ports.  J. Nerv. Ment. Dis., 1956, 123 : 557-560.
  Fabing,  H. D.  Adventures in clinical neuropharmacol-
  ogy.  Internat. Rec  M., 1956, 169: 115-119.
  ---. Experimental compound MER-17 (frenquel) : a
  new  blocking agent against the development of LSD-25
  psychosis.  Tr.  Am.  Neur. Ass., 1955, 80th  Meeting:
  83-85.  Also: Psychiat.  Res. Rep., Wash., 1955  (1):
  140-144.  Abstract: Excerpta med., Sect. 8,1957,10: No.
  1527.
  ----. Frenquel, a blocking agent against experimental
  LSD-25 and mescaline psychosis; preliminary note on
  its clinical application.  Neurology, 1955, 5 : 319-328.
  ---. New blocking agent against the development of
  LSD-25 psychosis.  Science,  1955, 121: 208-210.
  Isbell, H., Logan, C.  R.  Studies on the diethylamide of
  lysergic acid (LSD-25).   II.  Effects of chlorpromazine,
  azacyclonol, and reserpine on the intensity of the LSD-
  reaction.  A. M.  A. Arch. Neur.  Psychiat., 1957, 77 : 350-
  358.

Studies, patients
  Clark, L. D.  Further studies of the psychological effects
  of frenquel and a critical review of previous reports,
  J. Nerv. Ment. Dis., 1956, 123: 557-560.
  Malitz, S., Hoch, P.  H., Lesse, S.  A two-year  evalua-
  tion  of chlorpromazine in clinical research and practice.
  Am.  J. Psychiat, 1956, 113: 540-545.
  Monroe,  R. R., Heath, R. G., Mickle, W. A.,  Miller, W.
  Cortical and subcortical recordings correlated with be-
  havior in patients and animals during the administra-
  tion  of Rauwolfia, thorazine, and meratran.   Psychiat.
  Res.  Rep.,  Wash., 1955  (1) : 25-44.   Abstract: Chem.
  Abstr., 1956, 50 : 2867gh.
96 
SUBJECT  LIST
Lysergic acid diethylamide: with Pipradrol Interaction
with CHLORPROMAZINE—INTERACTION

Pharmacodynamics
  Hoch, P. H.  Progress in psychiatric therapies.  Am. J.
  Psychiat., 1955,112: 241-247.
  ---.  Studies in routes of administration and counter-
  acting drugs.  In: Cholden,  L., ed. Lysergic acid di-
  ethylamide and mescaline in experimental psychiatry.
  New York, Grune & Stratton, 1956.  p. 8-12.
  Jatzkewitz, H.  Pharmakologische Aspekte in der Schi-
  zophrenieforschung.   [Pharmacological aspects in schi-
  zophrenia research.]  Nervenarzt, 1956, 27:150-152.

Psychotherapeutic use
  Giberti, F., Gregoretti, L. Prime esperienze di antago-
  nismo psicofarmacologico; psicosi sperimentale da LSD
  e trattamento con cloropromazina e reserpina.  [First
  trials of psychopharmacological antagonism; experi-
  mental  psychoses   induced   with   d-lysergic  acid
  diethylamide and  treated  with  chlorpromazine  and
  reserpine.]   [English summary]  Sistema nerv.,  Mi-
  lano, 1955, 7: 301-310.  Abstract:  Excerpta med., Sect.
  8, 1956, 9: No. 4547.
  Sandison, R. A., Whitelaw, J. D. A.  Further  studies in
  the therapeutic value of  lysergic acid diethylamide in
  mental illness.  J. Ment. Sc, Lond., 1957, 103: 332-343.

Studies, animals
  Bradley, P. B., Hance, A. J.  The effect of chlorproma-
  zine and methopromazine on the  electrical activity of
  the brain  in the cat.  Electroencephalography, Mont-
  real, 1957, 9:191-215.
  Cook, L., Weidley, E. Behavioral effects of  some psy-
  chopharmacological  agents.  Ann.  N.  York Acad. Sc,
  1957, 66: 740-752.
  Courvoisier, S. Pharmacodynamic basis for  the use of
  chlorpromazine in psychiatry.  J. Clin. Exp. Psycho-
  path., 1956, 17:25-37.
  Rinaldi, F.,  Himwich,  H.  E.  The  cerebral electro-
  graphic changes induced by LSD and mescaline are cor-
  rected by frenquel.  J. Nerv. Ment Dis., 1955, 122: 424-
  432.
  Smith, K., Moody, A.  C.  Schizophrenia and the Siamese
  fighting fish.  Dis. Nerv. Syst., 1956, 17 : 327-328.
  Taeschler, M., Rothlin, E.  Zur Charakterisierung der
  zentralen Wirkung  von  Phenothiazinderivaten.  [The
  specific  central  effect  of phenothiazine derivatives.]
  Arch. exp. Path., Berl, 1956, 228:184-186.   Abstract:
  Chem. Abstr., 1956, 50 : 8902de.
  Turner, W. J.  The effect of lysergic acid diethylamide
  on Betta splendens : I. Dis. Nerv. Syst, 1956,17 :193-197.

Studies, normal subjects
  Abramson, H. A.  Some observations on normal volun-
  teers and patients.  In: Cholden, L., ed.   Lysergic acid
  diethylamide and mescaline in experimental psychiatry.
  New York, Grune & Stratton, 1956.  p. 51-54.
  Cerletti, A.   Lysergic  acid  diethylamide  (LSD)  and
  related  compounds.   In: Abramson, H. A.,  ed.  Neuro-
  pharmacology.  Transactions of the second conference,
  May 1955, Princeton, N. J. New York, Josiah Macy, Jr.
  Foundation,  1856. p. 9-84.
  Clark, L. D., Bliss, E. L.  Psychopharmacological stud-
  ies  of lysergic  acid  diethylamide  (LSD-25) intoxica-
  tion   Effects  of  premedication   with  BOL-148  (2-
  bromo-d-lysergic acid diethylamide),  mescaline, atro-
  pine amobarbital, and chlorpromazine. A. M. A. Arch.
  Neur. Psychiat, 1957, 78 : 653-655.
  Isbell H Logan, C. R.   Studies on the diethylamide of
  lysergic acid (LSD-25).  II. Effects of chlorpromazine,
  azacvclonol  and reserpine on the intensity of the LSD-
  Son  A  M.  A.  Arch. Neur.  Psychiat,  1957, 77:

  Schwarz B.  E., Bickford, R. G., Rome, H. P. Reversi-
  bilitv  o'f  induced   psychosis  with  chlorpromazine.
  Pro!. Mayo Clin., 1955, 30 : 407-417.
Studies, patients
  Hoch, P. H.  Experimental psychiatry.  Am. J.  Psy-
  chiat, 1955, 111: 787-790.
  Malitz, S., Hoch, P. H., Lesse, S.  A two-year evalua-
  tion  of chlorpromazine in clinical research and prac-
  tice.   Am. J. Psychiat., 1956,113 : 540-545.
  Obiols, J. Notre experience sur la  therapeutique par
  la chlorpromazine.   [Our experience with chlorproma-
  zine  therapy.]  Ence'phale, 1956, 45 : 698-699.
  Schwarz, B. E., Sem-Jacobsen, C. W., Petersen, M. C.
  Effects of mescaline,  LSD-25, and  adrenochrome on
  depth electrograms in man. A. M. A. Arch. Neur. Psy-
  chiat, 1956, 75: 579-587.
Therapeutic studies, controlled—Psychoses
  Sandison, R. A., Whitelaw, J. D. A.   Further studies in
  the therapeutic value of lysergic acid diethylamide in
  mental illness.  J. Ment. Sc, Lond., 1957, 103: 332-343.

with IPRONIAZID—COMPARED
  see IPRONIAZID—Pharmacodynamics
with IPRONIAZID—INTERACTION

Studies, animals
  Brown,  B. B.  Lysergic acid diethylamide antagonism
  of certain drugs.  Ann. N. York Acad. Sc,  1957,  66:
  677-685.

with LYSERGIC ACID AMIDE—COMPARED
  see LYSERGIC ACID AMIDE

with   LYSERGIC  ACID  DIETHYLAMIDE,  ACETY-
    LATED—COMPARED
  Rothlin,  E.  Lvsergic  acid diethylamide  and  related
  substances.  Ann. N. York Acad. Sc, 1957, 66: 668-676.

with   LYSERGIC  ACID  DIETHYLAMIDE,  BROMI-
     NATED—COMBINED

Studies, normal subjects
  Clark,  L.  D.,  Bliss,  E. L. Psychopharmacological
  studies  of lysergic  acid diethylamide intoxication. A.
  31. A. Arch. Neur.  Psychiat, 1957, 78:653-655.
  Ginzel, K. H., Mayer-Gross, W. Prevention of psycho-
  logical effects of LSD-25 by its brom derivative (BOL-
  148). Nature, Lond., 1956, 178 : 210.
with  LYSERGIC  ACID  DIETHYLAMIDE, BROMI-
     NATED—COMPARED
  see  LYSERGIC  ACID  DIETHYLAMIDE,   BROMI-
        NATED

with  LYSERGIC  ACID  ETHYLAMIDE—COMPARED
  see LYSERGIC ACID ETHYLAMIDE

with MEPROBAMATE—INTERACTION

Studies, animals
  Cook, L., Weidley, E.   Behavioral effects  of  some psy-
  chopharmacological agents. Ann. N. York Acad.  Sc,
  1957, 66: 740-752.

with MESCALINE
  see  MESCALINE  with LYSERGIC ACID DIETHYL-
        AMIDE

with METHOPROMAZINE—INTERACTION
  see  METHOPROMAZINE—Studies, animals

with NP-207—INTERACTION
  see NP-207—Studies, animals [taeschler+rothlin]

with PIPRADROL—INTERACTION

Studies, animals
  Neue Mittel  zur  Pharmakotherapie der Psychosen?
   [New drugs for the pharmacotherapy of psychoses?]
  Deut. med. Wschr., 1955, 80:1777.
97 
Lysergic acid diethylamide : with Pipradrol Interaction
PSYCHOPHARMACA
  Winter, C. A.,  Flataker, L.  Effects  of  lysergic acid
  diethylamide  upon performance of trained rats.  Proc.
  Soc  Exp. Biol, N.  Y., 1956, 92:285-289.  Abstract:
  Chem. Abstr., 1956, 50:14891L

with   RAUWOLFIA   SERPENTINA   ALKALOIDS-
  INTERACTION
  Hoch,  P.  H.  Experimental psychiatry.  Am. J. Psy-
  chiat., 1955, 111: 787-790.
  ----, Studies in routes of administration and counter-
  acting  drugs.  In: Cholden,  L., ed.  Lysergic acid di-
  ethylamide and mescaline in experimental psychiatry.
  New York, Grune & Stratton, 1956.  p. 8-12.

with RESERPINE—INTERACTION

Pharmacodynamics
  Jatzkewitz,   H.   Pharmakologische   Aspekte in  der
  Schizophrenieforschung.  [Pharmacological  aspects in
  schizophrenia research.]  Nervenarzt, 1956, 27 :150-152.

Studies,  animals
  Brown, B. B.  Lysergic acid diethylamide antagonism
  of certain drugs.  Ann. N. York Acad. Sc, 1957, 66 : 677-
  685.
  Burton,  R. M.   The  analeptic  action  of lysergic acid
  diethylamide on reserpine-sedated mice.  Ann. N. York
  Acad. Sc, 1957, 66: 695-697.
  Cook,  L., Weidley, E. Behavioral effects of some psy-
  chopharmacological  agents.  Ann. N.  York Acad. Sc,
  1957, 66: 740-752.
  Keller, D. L., Umbreit, W. W.  Chemically altered per-
  manent  behavior  patterns in  fish and  their cure by
  reserpine.  Science,  1956, 124: 407.
  ----, ----.   Permanent alteration of behavior in mice
  by  chemical  and psychological means.  Science, 1956,
  124: 723-724.
   Purpura, D. P.  Electrophysiological  analysis  of psy-
  chotogenic drug action.  (1) Effect of LSD on specific
  afferent  systems in the cat. A. M. A. Arch. Neur. Psy-
  chiat, 1956, 75: 122-131.
  Rothlin,  E.  Lysergic acid  diethylamide  and  related
  compounds.  Ann. N. York Acad. Sc, 1957, 66: 668-676.
   Shore, P. A., Silver, S. L., Brodie, B. B.  Interaction of
  reserpine, serotonin,  and lysergic acid diethylamide in
  brain.  Science, 1955, 122 : 284-285.
   Smith, K., Moody, A. C.   Schizophrenia and the Siamese
  fighting  fish.  Dis. Nerv. Syst, 1956, 17: 327-328.
  Turner,  W. J.  The effect of  lysergic acid diethylamide
  on Betta splendens:  I.  Dis. Nerv. Syst, 1956, 17:193-
  197.
  Winter,  C. A.,  Flataker, L.  Effects  of  lysergic acid
   diethylamide upon performance of trained rats.  Proc.
  Soc. Exp. Biol, N.  Y., 1956,  92:285-289.  Abstract:
   Chem. Abstr., 1956, 50:14891i.

 Studies, normal subjects
   Isbell, H., Logan, C. R.   Studies on the diethylamide of
   lysergic  acid (LSD-25).  II. Effects of chlorpromazine,
   azacyclonol,  and reserpine on the intensity of the LSD-
   reaction. A. 31. A. Arch. Neur. Psychiat., 1957, 77 : 350-
   358.
 Studies, patients
   Giberti,  F., Gregoretti,  L.  Prime esperienze di antago-
  nismo psicofarmacologico ; psicosi sperimentale da LSD
  e trattamento con cloropromazina e reserpina.   [First
  trials  of psychopharmacological antagonism;  experi-
  mental psychoses  induced with d-lysergic acid diethyl-
  amide and treated with chlorpromazine and reserpine.]
   [English  summary]  Sistema  nerv.,  3Iilano,  1955,
  7:301-310.   Abstract:  Excerpta  med.,  Sect. 8, 1956,
  9: No. 4547.

 with SEROTONIN
  see  SEROTONIN with LYSERGIC ACID  DIETHYL-
    AMIDE—INTERACTION
with YOHIMBINE—COMPARED
  see YOHIMBINE with  LYSERGIC ACID  DIETHYL-
    AMIDE—COMPARED

with  OTHER DRUGS-INTERACTION

Pharmacodynamics
  Hoch, P. H.  Studies in routes of administration and
  counteracting  drugs.  In:  Cholden,  L.,  ed. Lysergic
  acid diethylamide and mescaline in experimental psy-
  chiatry.  New York, Grune & Stratton, 1956.  p. 8-12.

Studies, animals
  Cook, L., Weidley, E.  Behavioral effects of some psy-
  chopharmacological agents,  [morphine]  Ann. N. York
  Acad. Sc, 1957,  66 : 740-752.

Studies, normal subjects
  Agnew,  N., Hoffer, A.  Nicotinic acid  modified lysergic
  acid diethylamide psychosis.  J. Ment. Sc,  Lond., 1955,
  101: 12-27.  Abstract: Excerpta  med., Sect.  8,  1956,
  9: No. 850.
  Clark,   L.  D.,  Bliss,  E.  L.  Psychopharmacological
  studies  of lysergic acid  diethylamide  (LSD-25) intoxi-
  cation.   Effects  of  premedication   with  BOL-148
  (2-bromo-d-lysergic acid diethylamide), mescaline, atro-
  pine, amobarbital, and chlorpromazine.  A. M. A. Arch.
  Neur. Psychiat.,  1957, 78 : 653-655.
  Hoffer,  A.  Studies with niacin and LSD.   In: Cholden,
  L., ed.  Lysergic acid diethylamide and mescaline in
  experimental psychiatry.  New York, Grune & Stratton,
  1956.  p. 44-45.
  Osmond, H.  A  review of the clinical  effects of psycho-
  tomimetic agents.   Ann. N. York Acad.  Sc, 1957, 66:
  418-434.
  Tonini, G., Montanari, C.  Effects of experimentally in-
  duced  psychoses on artistic  expression.   [In  English]
  Confinia neur., Basel, 1955, 15: 225-239.  Abstract: Ex-
  cerpta med., Sect. 8,1957, 10: No. 1439.

 Studies, patients
  Elkes,  J.  Effects of psychosomimetic drugs in animals
  and man.  In: Abramson, H. A., ed.  Neuropharmacol-
  ogy.  Transactions of the third conference, May 1956,
  Princeton, N. J.   New York,  Josiah 31acy,  Jr., Founda-
  tion, 1957.  p. 205-295.
  Hoch,   P. H.  Experimental  psychiatry.  Am. J. Psy-
  chiat., 1955, 111: 787-790.
  Liddell, D.  W., Weil-Malherbe, H.  The effects  of
  methedrine and  of lysergic acid diethylamide on mental
  processes and on the blood adrenaline level.  J.  Neur.,
  Lond.,  1953, 16: 7-13.  Abstract: Chem. Abstr., 1953,
  47:11560L
  Katzenelbogen,  S., Fang, A.  D.   Narcosynthesis  effects
   of sodium amytal, methedrine and LSD-25.  Dis. Nerv.
   Syst,  1953, 14 :  85-88.  Abstract: Excerpta med., Sect.
  8, 1954, 7: No. 3819.
  Pennes, H. H.  Clinical reactions of  schizophrenics to
   sodium amytal, pervitin hydrochloride,  mescaline, sul-
   fate, and  d-lysergic  acid diethylamide  (LSD-25).  J.
   Nerv. 31 ent Dis., 1954,  119: 95-112.
   Sandison, R. A., Spencer, A. M., Whitelaw, J. D. A. The
   therapeutic value of lysergic acid diethylamide in men-
   tal illness.  J.  3Ient.  Sc,  Lond., 1954,  100:491-507.
   Abstract: Excerpta med., Sect. 8, 1955, 8 : No. 930.


 with INTERMITTENT  PHOTIC STIMULATION
 Studies, normal subjects
   Bradley,  P. B.,  Elkes, C, Elkes, J.  On  some effects  of
   lysergic acid diethylamide  (LSD-25) in normal volun-
   teers.   J. Physiol, Lond., 1953, 121: 50P-51P.
   Elkes,  J.   Effects of psychosomimetic drugs in animals
   and man.  In:  Abramson, H. A., ed. Neuropharmacol-
   ogy.  Transactions of  the third conference, May 1956.
98 
SUBJECT LIST
Lysergic acid diethylamide, brominated: with NP-207 Interaction
  Princeton, N. J.  New York, Josiah Macy, Jr. Founda-
  tion, 1957.  p. 205-295.  [p. 266-67]
  Osmond, H.  A review of the  clinical effects of psy-
  chotomimetic agents.   Ann.  N. York  Acad. Sc, 1957,
  66:418-4134.

with  PSYCHOSURGERY
  Rinkel, M.  Experimentally induced psychoses in man.
  [1 chr. schiz. 6 weeks post-lob.] In : Abramson, H. A.,
  ed. Neuropharmacology.   [2.  conf. 1055]   New  York,
  Josiah Macy, Jr. Foundation, 1956. p. 235-258.  [241-
  43]

with  SHOCK THERAPY [ECT]—INTERACTION
  Hoch, P. H.  Studies  in routes of administration and
  counteracting drugs.   In : Cholden, L.,  ed. Lysergic acid
  diethylamide and mescaline in experimental psychiatry.
  New York, Grune & Stratton, 1956.  p. 8-12.
LYSERGIC ACID DIETHYLAMIDE,  ACETYLATED
  Rothlin,  E.  Lysergic  acid  diethylamide  and related
  substances.  Ann. N. York Acad. Sc, 1057, 66: 668-676.

with LYSERGIC ACID DIETHYLAMIDE—COMPARED
    LYSERGIC  ACID   DIETHYLAMIDE,  BROMI-
      NATED—COMPARED
    LYSERGIC ACID ETHYLAMIDE—COMPARED
  see preceding reference [rothlin]
 LYSERGIC  ACID DIETHYLAMIDE, BROMINATED
  Jarvik, M. E.  Mechanism of action  of  lysergic acid
  diethylamide, serotonin, and related drugs.  In: Kline,
  N. S., ed.   Psychopharmacology.  Washington, Am. Ass.
  Adv. Sc, 1956.  p. 145-154.
  Rinkel, M., Solomon, H. C.  Chemical theories of psy-
  chosis. J. Clin. Exp. Psychopath., 1957, 18: 323-334.
  Rothlin, E.  Lysergic  acid  diethylamide and related
  substances.  Ann. N. York Acad. Sc, 1957, 66: 668-676.
 Studies, animals
  Abramson, H. A.  Blocking of the LSD-25  reaction in
  Siamese fighting fish.  In: Abramson, H. A., ed. Neuro-
  pharmacology.  Transactions of the third  conference,
  May 1956, Princeton, N.  J.  New York, Josiah 3Iacy,
  Jr. Foundation, 1957.  p. 9-27.
  ---, Jarvik,  M.  E.  Lysergic acid diethylamide (LSD-
  25) : IX. Effect  on snails.  J. Psychol, Provincet, 1955,
  40:337-340.
  Bradley, P. B., Hance, A. J.  The effects of intraventric-
  ular  injections of d-lysergic acid diethylamide (LSD-
  25)  and 5-hydroxytryptamine (serotonin) on the elec-
  trical activity of  the brain of  the  conscious cat.   J.
  Physiol, Lond., 1956,132: 50P-51P.
  Cerletti, A., Rothlin, E.  Role of 5-hydroxytryptamine
  in mental diseases and  its antagonism to  lysergic acid
  derivatives.  Nature, Lond., 1955,  176:785-786.  Ab-
  stract : Chem. Abstr., 1956, 50: 4389fgh.  Excerpta med.,
  Sect. 8,1957,10:  No. 973.
  Rothlin,  E.  Lysergic  acid diethylamide  and  related
  compounds.  Ann. N. York Acad.  Sc, 1957, 66: 668-676.
  Salmoiraghi,  G. C, Sollero, L., Page, I.  H.  Blockade by
  brom-lysergic-acid-diethylamide  (BOL) of  the poten-
  tiating action of  serotonin and reserpine on hexobarbital
  hypnosis.   J.  Pharm. Exp. Ther.,  1956, 117:166-168.
  Abstract: Chem.  Abstr., 1956, 50: 14105gh.

Studies, normal subjects
 Abramson,  H. A., Jarvik,  M. E., Gorin, M. H., Hirsch,
 M. W.  Lysergic acid diethylamide  (LSD-25) :  XVII.
  Tolerance development and its relationship to a theory
  of psychosis.  J. Psychol, Provincet, 1956, 41: 81-105.
  Cerletti, A., Rothlin, E.  Role of 5-hydroxytryptamine
  in mental diseases and its antagonism to lysergic acid
  derivatives.  Nature,  Lond.,  1955,  176:785-786.  Ab-
  stract: Chem Abstr., 1956, 50: 4389fgh.  Excerpta med.,
  Sect. 8,1957,10: No. 973.
  Clark, L. D., Bliss, E. L.  Psychopharmacological studies
  of lysergic acid diethylamide  (LSD-25)  intoxication.
  Effects  of  premedication  with  BOL-148  (2-bromo-
  tf-lysergic  acid  diethylamide),   mescaline,   atropine,
  amobarbital, and chlorpromazine.  A. M. A. Arch. Neur.
  Psychiat, 1957, 78: 653-655.
  Ginzel, K. H., Mayer-Gross, W.  Prevention of psycho-
  logical effects of d-lysergic acid diethylamide (LSD-25)
  by its  2-brom derivative (BOL  148).   Nature,  Lond.,
  1956,  178:210.  Abstract:  Chem.  Abstr., 1956, 50:
  17147M.
  Hirsch, M. W., Jarvik, M. E., Abramson, H. A.  Lysergic
  acid diethylamide (LSD-25) : XVIII. Effects of LSD-25
  and six related drugs upon handwriting.   J.  Psychol,
  Provincet.,  1956, 41:11-22.   Abstract: Excerpta med.,
  Sect. 8, 1956, 9 : No. 3044.
Studies, patients
  Cholden, L. S., Kurland, A.,  Savage, C.  Clinical reac-
  tions and tolerance to LSD in chronic schizophrenia.
  J. Nerv. Ment. Dis., 1955, 122 : 211-221.  Abstract: Ex-
  cerpta  med., Sect. 8, 1956, 9: No. 4015.


with CHLORPROMAZINE—INTERACTION
Studies, animals
  Taeschler, M., Rothlin, E.  Zur Charakterisierung der
  zentralen Wirkung von Phenothiazinderivaten.   [The
  specific central effect  of phenothiazine  derivatives.]
  Arch. exp.  Path., Berl, 1956, 228:184-186.  Abstract:
  Chem. Abstr., 1956,  50: 8902de.

with LYSERGIC ACID DIETHYLAMIDE—COMBINED
Studies, normal subjects
  see  LYSERGIC  ACID  DIETHYLAMIDE,   BROMI-
        NATED—Studies, normal subjects
         [clark4-bliss] [ginzkl+mayer-gross]

with LYSERGIC ACID DIETHYLAMIDE—COMPARED
  see  LYSERGIC ACID  DIETHYLAMIDE,   BROMI-
        NATED

with  LYSERGIC  ACID  DIETHYLAMIDE,   ACETY-
       LATED—COMPARED
  Rothlin,  E.  Lysergic  acid  diethylamide and related
  substances.  Ann.  N.  York Acad.  Sc,  1957,  66:668-
  676.

with  LYSERGIC ACID  ETHYLAMIDE—COMPARED
  see preceding reference [rothlin]


with NP-207—INTERACTION
Studies, animals
  Taeschler, M., Rothlin, E. Zur Charakterisierung der
  zentralen Wirkung von Phenothiazinderivaten.   [The
  specific  central effect  of phenothiazine  derivatives.]
  Arch.  exp. Path., Berl,  1956, 228:184-186.  Abstract:
  Chem. Abstr., 1956, 50:8902de.
Therapeutic use
  Malitz, S., Hoch, P. H.  Preliminary evaluation of a new
  phenothiazine derivative, NP-207.   Psychiat.  Q., 1956,
  30:633-646.
99 
Lysergic acid diethylamide, brominated: with Reserpine Interaction
PSYCHOPHARMACA
with RESERPINE—INTERACTION
Studies, animals
  Burton, R. M.  The  analeptic action of lysergic acid
  diethylamide on reserpine-sedated mice.  Ann. N. York
  Acad. Sc, 1957, 66 : 695-697.
  Rothlin, E. Lysergic acid diethylamide and related com-
  pounds. Ann. N. York Acad. Sc, 1957, 66: 668-676.
  Salmoiraghi, G. C. Sollero, L., Page, I. H.  Blockade by
  brom-lysergic-acid-diethylamide (BOL) of the potentiat-
  ing  action of serotonin and reserpine on hexobarbital
  hypnosis.  J. Pharm. Exp. Ther., 1956, 117:166-168. Ab-
  stract : Chem. abstr., 1956, 50:14105gh.

with SEROTONIN—INTERACTION
Studies, animals
  see   LYSERGIC  ACID  DIETHYLAMIDE, BROMI-
    NATED—Studies, animals
LYSERGIC ACID ETHYLAMIDE
  Jarvik, M. E. Mechanism of action of lysergic acid di-
  ethylamide,  serotonin, and  related drugs.   In:  Kline,
  N. S., ed.  Psychopharmacology. Washington, Am. Ass.
  Adv. Sc, 1956.  p. 145-154.
  Rothlin,  E.   Lysergic acid  diethylamide and  related
  substances.  Ann. N. York Acad. Sc, 1957, 66: 668-676.
  Rothlin, E., Cerletti, A. Pharmacology of LSD-25. In:
  Cholden, L.,  ed.  Lysergic acid diethylamide and mesca-
  line in experimental psychiatry.   New York, Grune &
  Stratton, 1956.  p. 1-7.
Studies, animals
  Abramson, H. A.  Blocking of  the LSD-25 reaction in
  Siamese fighting fish.  In: Abramson, H. A., ed. Neuro-
  pharmacology.  Transactions of the  third conference,
  May 1956, Princeton, N. J.  New York, Josiah Macy, Jr.
  Foundation,  1957.  p. 9-27.
  ----, Jarvik, M. E.  Lysergic acid  diethylamide (LSD-
  25 : IX. Effect on snails.  J. Psychol, Provincet., 1955,
  40: 337-340.
  Cerletti,  A.   Lysergic acid  diethylamide (LSD) and
  related compounds.  In: Abramson,  H.  A.,  ed. Neuro-
  pharmacology.  Transactions of the second conference,
  May 1955, Princeton, N. J.  New York, Josiah Macy, Jr.
  Foundation,  1956.  p. 9-84.
  Jarvik, M. E. Effect of LSD-25 on snails.  In: Abram-
  son, H. A.,  ed. Neuropharmacology.   Transactions of
  the third conference, May 1956, Princeton, N. J.  New
  York,  Josiah Macy, Jr. Foundation, 1957. p. 29-38.
  Rothlin, E., Cerletti, A.  Uber einige pharmakologische
  Untersuchungen an Mausen mit congenitaler Drehsucht.
  [Some pharmacological studies  on  mice with congenital
  waltzing syndrome.]  Helvet. physiol. pharm. acta, 1952,
  10: 319-327.   Abstract: Chem. Abstr.,  1953, 47: 766hi.
  Turner, W. J.  The effect of lysergic acid diethylamide
  on Betta splendens:  I.  Dis.  Nerv. Syst., 1956, 17:193-
  197.

Studies, normal subjects
  Hirsch, M. W., Jarvik, M. E., Abramson, H. A. Lysergic
  acid diethylamide  (LSD-25) : XVIII. Effects of LSD-25
  and six related drugs upon handwriting. J. Psychol,
  Provincet., 1956, 41:11-22.   Abstract: Excerpta  med.,
  Sect. 8, 1956, 9: No. 3944.
  Jarvik, M. E., Abramson, H. A.,  Hirsch, M. W. Compar-
  ative subjective effects of seven  drugs including lysergic
  acid  diethylamide (LSD-25).   J. Abnorm. Psychol,
  1955, 51:657-662.
  Solms, H. Chemische Struktur und  Psychose bei Ly-
  sergsaure-Derivaten.  [Chemical structure of and psy-
  chosis produced by lysergic acid derivatives.]  Praxis,
  Bern, 1956, 45: 746-749.
  ----.  Lysergsaure-athylamid (LAE), ein neues,  stark
  sedativ  wirkendes Psychoticum aus  dem  Mutterkorn.
  [Lysergic acid ethylamide (LAE), a  new strongly sed-
  ative  psychotomimetic drug  from  Mother of  Rye.]
  Schweiz. med. Wschr., 1953, 83: 356-360.
  ---.  Lysergsaure-monoathylamid (LAE), ein neuar-
  tiges Psychotikum mit sedativer Wirkung aus dem Mut-
  terkorn.  [Lysergic acid monoethylamide (LAE), a new
  psychotomimetic drug with sedative effect from Mother
  of Rye.]  Schweiz. Arch. Neur. Psychiat., 1954, 73: 440-
  444.
  ----.  Relationships between chemical  structure and
  psychoses with  the  use  of  psychotoxic  substances.
  "Comparative pharmacopsychiatric analysis:" A new re-
  search method.  J.  Clin. Exp. Psychopath., 1956, 17:
  429^433.
  Tonini, G., Montanari, C.  Effects of experimentally in-
  duced psychoses on artistic expression.  [In  English]
  Confinia neur., Basel, 1955, 15: 225-239.  Abstract: Ex-
  cerpta med., Sect. 8, 1957, 10:  No. 1439.
  ---,  ----.   Effetti psichici della monoetilamide dell'
  acido  lisergico  (LAE  32).  ,[Psychological effects of
  lysergic  acid   monoethylamide  (LAE 32).]   Gior.
  psichiat, 1955, 83 : 355-357.
  vol Felsinger, J. M., Lasagna, L., Beecher, H. K.  The
  response of  normal men to lysergic acid  derivatives
  (di- and mono-ethyl amides).  J. Clin.  Exp. Psychopath.,
  1956,17: 414-428.
Studies, patients
  Callieri, B., Ravetta, M.  Contributo  alio studio psico-
  patologico degli  effetti della  monoetilamide dell'acido
  lisergico.   [Contribution  to   the  psych opathological
  study of the effects of lysergic acid monoethylamide.]
  Arch,  psicol neur., Milano, 1956, 17:43-83.
  Cholden, L. S., Kurland, A., Savage,  C.  Clinical reac-
  tions  and tolerance to LSD in chronic schizophrenia.
  J.  Nerv. Ment. Dis., 1955, 122: 211-221.  Abstract: Ex-
  cerpta med., Sect. 8,1956, 9: No. 4015.
  Solms, H.  Lysergsaure-athylamid  (LAE), ein neues,
  stark  sedativ wirkendes Psychoticum aus dem Mutter-
  korn.  [Lysergic acid ethylamide (LAE), a new strongly
  sedative psychotomimetic drug from  Mother  of  Rye.]
  Schweiz. med. Wschr., 1953, 83 : 356-360.
  ---.  Lysergsaure-monoathylamid (LAE), ein neuarti-
  ges Psychotikum mit sedativer Wirkung aus dem Mut-
  terkorn.  [Lysergic acid monoethylamide (LAE), a new
  psychotomimetic drug with sedative effect from Mother
  of Rye.]  Schweiz. Arch. Neur. Psychiat., 1954, 73: 440-
  444.
  Tonini, G., Montanari, C.  Effetti psichici della mono-
  etilamide dell'acido lisergico (LAE 32).  [Psychological
  effects of lysergic acid monoethylamide  (LAE  32).]
  Gior.  psichiat., 1955, 83: 355-357.
Therapeutic use
  Solms,  H.   Lysergsaure-monoathylamid  (LAE),  ein
  neuartiges Psychotikum mit sedativer Wirkung aus dem
  Mutterkorn.   [Lysergic acid  monoethylamide  (LAE),
  a new psychotomimetic drug with sedative effect from
  Mother of Rye.]  Schweiz. Arch. Neur. Psychiat., 1954,
  73: 440-444.


with CHLORPROMAZINE—COMPARED
  see preceding reference [solms]

with LYSERGIC ACID  AMIDE—COMPARED
  see LYSERGIC ACID AMIDE

with LYSERGIC ACID  DIETHYLAMIDE—COMPARED
  see LYSERGIC ACID ETHYLAMIDE

with LYSERGIC   ACID  DIETHYLAMIDE,  ACETY-
     LATED—COMPARED
  Rothlin, E.  Lysergic  acid diethylamide  and related
  substances.  Ann. N. York Acad. Sc,  1957, 66: 668-676.
100 
SUBJECT  LIST
Mepazine : Therapeutic studies, controlled—Psychoses
with LYSERGIC   ACID  DIETHYLAMIDE,   BROMI-
    NATED—COMPARED
  see preceding reference [rothlin]

with MESCALINE—COMPARED
  see MESCALINE with LYSERGIC  ACID ETHYLA-
     MIDE—COMPARED

with OTHER DRUGS [barbiturates]—COMBINED
  see  LYSERGIC  ACID ETHYLAMIDE—Therapeutic
MER-22

Studies, animals
 Tripod, J., Sury, K,  Hoffmann, K.   Zentralerregende
 Wirkung eines neuen Piperidinderivatives.  [Centrally
 stimulating effect of a new piperdine derivative.]  [with
 methylphenidylacetate, pipradrol compared]  Experien-
 tia, Basel, 1955, 10: 261-262.  Abstract:  Chem. Abstr.,
 1955, 48:10920g.
Studies, normal subjects
 Drassdo, A., Schmidt, M. Kreislauf, geistige Leistungs-
 fahigkeit  und Stoffwechsel  unter dem  Einfluss  von
 2-Diphenylmethylpiperidinhydrochlorid.   [Effect of  2-
 diphenylmethylpiperidinehydrochloride on blood circu-
 lation,  mental  efficacy  and  metabolism.]    [English
 summary] Med. Mschr., 1956,10: 738-743.

Therapeutic studies, controlled
 Hagenauer, F., Rudy, L. H., Himwich, H. E. A compara-
 tive evaluation of two new central  nervous system stim-
 ulants in  severe psychoses.  J. Clin. Exp. Psychopath.,
 1957, 18: 248-257.   Condensed as:  A comparative study
 of two central nervous system stimulants, MER-22 and
 S. K. F. #5,  on chronic, blocked  and withdrawn  psy-
 chotic patients.  Am.  J. Psychiat.,  1957, 113 : 840.


with  AZACYCLONOL—COMPARED
   Pharmacodynamics see preceding  reference.

with METHYLPHENIDYLACETATE—COMPARED
 see MER-22—Studies, animals

with PIPRADROL—COMPARED
 see MER-22—Studies, animals
               Therapeutic studies, controlled


with  OTHER DRUGS  [barbiturates]—COMBINED
 see MER-22—Studies, normal subjects
MEDMAIN
 Jarvik,  M. E.  Mechanism  of  action  of  lysergic  acid
 diethylamide,  serotonin, and related drugs.  In: Kline,
 N. S., ed.  Psychopharmacology. Washington, Am. Ass.
 Adv. Sc, 1956.  p. 145-154.
 Rinkel,  M., Solomon, H.  C.   Chemical theories of psy-
 chosis.  J. Clin. Exp. Psychopath., 1957, 18:323-334.
 Shaw, E., Woolley, D. W.  Pharmacological properties of
 some antimetabolites of serotonin having unusually high
 activity on isolated tissues.  J. Pharm. Exp. Ther., 1954,
 111: 43-53.
 Woolley, D. W., Shaw, E.  A biochemical and pharma-
 cological  suggestion  about certain  mental  disorders.
 Proc Nat. Acad. Sc. U. S., 1954, 40: 228-231.  Abstract:
 Science, 1954, 119: 587-588.
 ___  ____  Some  neurophysiological aspects of sero-
 tonin.  Brit M. J., 1954, 2: 122-126.

     456132—59---8
with SEROTONIN—INTERACTION see MEDMAIN
MEPAZINE

Cocktail
  Mignault, G.  Two years' experience using the pheno-
  thiazine amine derivatives in anaesthesia and artificial
  hibernation with special mention of the new derivative
  pacatal. [mepazine+promethazine+meperidine] Canad.
  Anaesth. Soc. J., 1957, 4: 37-42.

Pharmacodynamics
  Kopf, R.  Phenthiazinderivaternes  farmakologi,  med
  speielt  henblik pa N-methylpiperidyl-3-methylphenthia-
  zin (lacumin [R]).   [Pharmacology of phenothiazine
  derivatives,  particularly  N-methylpiperidyl-3-methyl-
  phenothiazine  (lacumin  [R]) ]   [Brief English sum-
  mary]  Nord. med., 1955, 54:1779-1782.
  Rosner, K.  Therapeutische Anwendung der zentralner-
  vosen Wirkung  einiger  Phenothiazinderivate in  der
  Allgemeinmedizin.  [Therapeutic use of effects of var-
  ious phenothiazine derivatives on central nervous sys-
  tem in general practice.]  Med. Mschr., 1956, 10:719-
  723.
Studies, animals
  Apter, J., Rinsley, D.  B. Counteraction of the effects of
  mezapine on the eye by means of parasympathomimetic
  drugs.   J. Clin. Exp. Psychopath., 1957, 18:335-341.
  Himwich, H. E., Rinaldi, F., Willis, D.  An examination
  of phenothiazine derivatives with comparisons of their
  effects on the alerting reaction,  chemical structure and
  therapeutic efficacy.  J. Nerv. Ment. Dis., 1956, 124: 53-
  57.
  Nieschulz, O., Hoffmann, I., Popendiker, K.  Pharma-
  kologische  Untersuchungen  fiber  N-Alkyl-piperidyl-
  phenothiazin-Derivate.  [Pharmacological studies of N-
  alkyl-piperidyl-phenothiazine  derivatives.]   [English
  summary]  Arzneimitt. Forsch., 1956, 6: 651-660.
  ---, Popendiker, K.,  Hoffmann, I. Weitere pharmakol-
  ogische Untersuchungen fiber  N-Methyl-piperidyl-(3)-
  methyl-phenothiazin.  [Further pharmacological studies
  of N-methyl-piperidyl-(3)-methyl-phenothiazine]  [Eng-
  lish summary]  Arzneimitt. Forsch., 1955, 5 : 680-695.
  ---,---, Sack, K. H.  Pharmakologische Untersuchun-
  gen  fiber  N - Alkyl - piperidyl -  phenothiazin - Derivate.
  [Pharmacological  studies  of  N-alkyl-piperidyl-pheno-
  thiazine derivatives.]  Arzneimitt Forsch., 1954, 4: 232-
  242.
Studies, patients
  Hartmann, K., Hiob, J., Hippius, H. Zur vergleichenden
  Psychopathologie der Schock- und Phenothiazinwirkun-
  gen.  [Comparative psychodynamics of shock therapy
  and phenothiazines.]   Fortsch.  Neur.  Psychiat.,  1955,
  23:354-366.
  Horst, L. van der.  Donnees sur Temploi du largactil et
  d'autres derives de  la phenothiazine  en neurologie,
  neuro-chirurgie et radiologie.  [The use of largactil and
  other phenothiazines in neurology, neurosurgery  and
  radiology. ]  Ence'phale, 1956,45: 717-721.

Therapeutic studies, controlled
  Gillie,  A. K.  The use of pacatal in low-grade mental
  defectives.   J. Ment. Sc, Lond., 1957,103: 402^05.
  MacGregor, J. MacW.  Pacatal—a clinical trial of a new
  ataractic drug. S. Afr. M. J., 1956, 30 :1108-1111.

—Psychoses
  Baker, A. A., Thorpe, J. G.  Placebo response.  A. M. A.
  Arch. Neur. Psychiat., 1957, 78: 57-60.
  Bruckman, N., Kitchener,  M.,  Saunders, J. C, Kline,
  N. S.   Mepazine  (pacatal)—further report.   Am. J.
  Psychiat, 1957, 114: 262-263.
101 
Mepazine : Therapeutic studies, controlled—Psychoses
PSYCHOPHARMACA
  Feldman, P. E.  Clinical evaluation of pacatal.  Am. J.
  Psychiat, 1957, 114: 143-146.                        *
  ----.  A comparative study of various ataractic drugs.
  Am. J. Psychiat, 1957, 113 : 589-594.                 *
  Leiberman, D. M., Vaughan, G. F.  The use of some new
  pharmacological  agents in  psychiatry.  J. Ment.  Sc,
  Lond., 1957, 103:  110-118.
  Lomas,  J.   Treatment of  schizophrenia ;  "pacatal"
  and  chlorpromazine  compared.  Brit.  31.  J.,  1957,
  2: 78-80.                                          *
  Mitchell, P. H., Sykes, P., King, A.  Effects of pacatal on
  symptoms in chronic psychotic female in-patients. Brit.
  M. J., 1957, 1: 204-207.                           * *
  Rinaldi, F., Rudy, L. H., Himwich, H. E.  Clinical evalu-
  ation  of azacyclonol, chlorpromazine, and  reserpine on
  a group of chronic psychotic patients.  Am. J. Psychiat.,
  1956,  112 : 678-683.  Abstract: Excerpta med., Sect. 8,
  1956, 9 : No. 4986.
  Rudy, L. H., Himwich,  H. E., Tasher, D. C.  Clinical
  evaluation of two phenothiazine compounds promazine
  and mepazine.   Am. J.  Psychiat., 1957,113: 979-983.  *
  Simpson, R. W.  The effects of pacatal on chronic men-
  tal illness.  J. 31ent Sc, Lond., 1957, 103: 610-613.
  Thorpe, J. G., Baker, A. A. A research method to assess
  a new tranquillizing drug.   J. Ment  Sc, Lond., 1956,
  102: 790-795.

Therapeutic use
  Ayd, F. J., Jr.  Tranquilizing drugs in private practice.
  N. York State J. M., 1957, 57: 1742-1747.             *
  Friese, K. H.  Vorlaufige Erfahrungen bei der Behand-
  lung  psychiatrischer  Kranker mit   Phenothiazinen.
  [Early results in phenothiazine therapy in psychiatry.]
  31edizinische, 1956: 734-735.                        *
  Laurendeau, E.  Essai clinique sur un nouveau derive
  du phenothiazine: le pacatal.  [Clinical trial of a new
  phenothiazine  derivative: pacatal.]  Union  me'd.  Can-
  ada, 1956, 85:1424-1425.
  Lienau, C.  Heilschlafbehandlung mit Pacatal bei Alko-
  holismus und Morphinismus.   [Therapeutic sleep treat-
  ment  with pacatal  in alcoholism  and  morphinism.]
  Munch, med. Wschr., 1957, 99: 80-81.
  Pennington,  V. M.  Research findings in  phrenotropic
  drugs important  to every physician.  Mississippi Doc-
  tor, 1957, 35: 57-63.
  Sangowicz, J., Gauthier, J.  Resume d'une etude clinique
  sur pacatal et medomine, portant respectivement sur 40
  cas.   [Results of a clinical  study on  pacatal and  me-
  domin, concerning 40 cases respectively.]   Union med,
  Canada, 1956, 85 : 1170-1171.

—Additional data
  Bergy, G. A.  Drugs of sedation with tranquilizing ef-
  fects.   Am.  Profes.  Pharmacist,  1956, 22:419;  534-
  538;  619-621;  709-710; 797-799;  888-889; 917-919.
  [709-710.]
  Boon, A. A.  Largactil  en verwante middelen in de psy-
  chiatrie en neurologic   [Largactil and related remedies
  in  psychiatry  and  neurology.]  Ned.  tschr. geneesk.,
  1955, 99: 2735-2741.
  Dellaert, R.  De  modernste chemopharmaca in  de psy-
  chiatrie.  [New chemical psychopharmaca.]  Belg. tschr.
  geneesk., 1956, 12: 314-321.
  Deniker, P.  Hibernotherapies et medicaments neuro-
  leptiques en  therapeutique  psychiatrique.  [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapy.]
  Ence'phale, 1957, 46 : 281-398.   [p. 362]
  Hilliard, E. T.   The use of reserpine, chlorpromazine
  and allied drugs  in medicine and psychiatry.  31ed. J.
  Australia, 1956, 43 (1) : 1035-1040.
  Kline, N. S.  Chemotherapy in psychiatry;  recent ad-
  vances.  Seminar Internat., Hoddesdon, 1956,  5  (2) :
  7-10.
  Leiberman,  D.  M.,  Vaughan, G.  F.  Tranquillizers.
  Practitioner, Lond., 1956, 177: 632-638.
  Morgan,  D. R.  The use of reserpine, chlorpromazine
  and allied drugs in medicine and psychiatry.   Med. J.
  Australia, 1956, 43  (1) -.1029-1035.
  Wortis, J.  Physiological treatment.   Am. J. Psychiat,
  1957, 113: 611-615.

—Psychoses
  Bowes, H. A. The ataractic drugs ; the present position
  of chlorpromazine, frenquel, pacatal, and reserpine  in
  the psychiatric hospital. Am. J. Psychiat., 1956, 113:
  530-539.
  Braun, M.   Pacatal.  Am. J. Psychiat, 1957, 113: 838-
  839.
  Hiob, J.,  Hippius,  H.  Uber die Behandlung von Psy-
  chosen mit dem Phenothiazinderivat Pacatal.  [The
  treatment of psychoses  with the phenothiazine deriva-
  tive  pacatal.]  Med. Klin., Berl,  1955, 50:1746-1748.
  Abstract: Excerpta med.. Sect. 8, 1957, 10: No. 1544.  *
  Kline,  N.  S.  Pacatal.  Am.  J. Psychiat,  1956, 113:
  565.                                               *
  ---,  Jacob,  G.  M.  Use  of  pacatal  (N-methylpi-
  peridyl-[3]-methylphenothiazine)   in  psychiatric  pa-
  tients.  Am.  J.  Psychiat.,  1955,  112:63. Abstract:
  Excerpta med., Sect. 8, 1956, 9 : No. 3080.             *
  Patton, G.  O., Garneau, J.  The ataraxic  drugs in dis-
  turbed secluded psychiatric patients.  Canad. Serv. M.
  J., 1957, 13 :127-133.
  Werenberg, H.  Lacuminterapi  ved  svaere  sindsyg-
  domme.  [Lacumin therapy in severe mental disorders.]
  [English summary]   Nord.  med., 1955, 54: 1787-1789.
  Abstract: Excerpta med., Sect. 8,1956, 9: No. 4567.  * *

Untoward effects [see headnote p. 19]

  see also PHENOTHIAZINES— Untoward effects
  Apter,  J., Rinsley, D. B.  Counteraction of the effects
  of mepazine on the eye by means of parasympathomi-
  metic drugs. J. Clin. Exp. Psychopath., 1957, 18:335-
  341.
  Ayd, F. J.,  Jr.  A clinical  evaluation of frenquel.   J.
  Nerv. Ment. Dis., 1956,124 : 507-509.
  ---.   A clinical  evaluation  of pacatal.   Dis. Nerv.
  Syst, 1957, 18 :142-144.
  Feldman, P. E., Bertone, J., Panthel, H.  Fatal  agranu-
  locytosis  during treatment  with pacatal.   Am. J. Psy-
  chiat, 1957, 113 : 842-843.                         * *


with ATARAXICS [2 or more]
  see ATARAXICS—Various [3 or more]—Compared

with AZACYCLONOL
  see AZACYCLONOL with  MEPAZINE—COMBINED

with CHLORPROMAZINE
  see CHLORPROMAZINE with MEPAZINE

with METHYLPHENIDYLACETATE—COMBINED
  Ayd, F. J., Jr.  A  clinical evaluation of pacatal.  Dis.
  Nerv. Syst, 1957,18:142-144.

with PIPRADROL—COMBINED see preceding reference

with PROMAZINE—COMPARED
  Rudy,  L. H., Himwich, H. E.,  Tasher, D.  C.  Clinical
  evaluation of two phenothiazine compounds promazine
  and mepazine.  Am. J.  Psychiat, 1957, 113: 979-983.

with PROMETHAZINE—COMPARED
Studies,  animals
  Nieschulz, O.,  Popendiker,  K.,  Hoffmann, I.  Weitere
  pharmakologische Untersuchungen  fiber  N-Methyl-pi-
  peridyl-(3)-methyl-phenothiazin.   [Further pharmaco-
  logical studies of N-methyl-piperidyl-(3)-methyl-pheno-
  thiazine]   [English  summary]  Arzneimitt.   Forsch.,
  1955, 5: 680-695.
102 
SUBJECT  LIST
Mephenesin : Therapeutic studies, controlled
with PROMETHAZINE and OTHER DRUGS—COM-
    BINED
  see MEPAZINE—Cocktail

with RESERPINE—COMBINED
Therapeutic studies, controlled
  Bruckman,  N., Kitchener, M., Saunders, J. C,  Kline,
  N. S.  Mepazine  (pacatal)—further report.  Am. J.
  Psychiat, 1957, 114: 262-263.                      * *


with OTHER DRUGS  [sedatives]—COMBINED

  see also MEPAZINE—Cocktail
  Gillie, A. K.  The use of pacatal in low-grade mental
  defectives.  J. Ment. Sc,  Lond., 1957, 103: 402-405.
  Kleinsorge,  H. Erfahrungen  mit  der  Schlaftherapie
  innerer Erkrankungen.   [Experiences with  sleep ther-
  apy  of internal diseases.]  [Abstract]  Med.  Mschr.,
  1953, 7: 760.
  ___,  Rosner,  K.  Klinikai megfigyeiesek phenothiazin
  keszitmenyekkel.  [Clinical observations on phenothia-
  zine  preparations.]   Magy. belorv.  arch., 1956, 9:106-
  109.
  ___, ----.   Schlaftherapie mit Phenothiazinderivaten.
  [Sleep therapy with phenothiazine derivatives.]   Ther.
  Gegenwart, 1956, 95 : 441-446.
  Kleinzorge, Rezner.   Primenenie proizvodnykh fenotia-
  zina dlia terapii snom.   [Use of phenothiazine  deriva-
  tives in sleep therapy.] Zh. nevropat. psikhiat, Moskva,
  1956, 56: 296-299.
  Laurendeau, E.  Essai clinique sur un  nouveau derive
  du phenothiazine: le  pacatal.   [Clinical trial  of a new
  phenothiazine derivative: pacatal.]  Union med.  Can-
  ada, 1956, 85:1424-1425.
  Lienau, C.   Heilschlafbehandlung  mit Pacatal  bei Al-
  koholismus  und  Morphinismus.   [Therapeutic sleep
  treatment with pacatal in alcoholism and morphinism.]
  Munch, med. Wschr., 1957. 99 : 80-81.
  MacGregor, J. MacW.  Pacatal—a  clinical trial  of  a
  new ataractic drug.   S. Afr.  31. J., 1956, 30:1108-1111.
  Seitz, D.  Die Schlafbehandlung mit Phenothiazmen in
  der  Neurologie.  [Sleep therapy  with  phenothiazines
  in neurology.]  Nervenarzt, 1956, 27:19-23.

 and with Shock therapy [ECT]
  see following reference


 with  SHOCK THERAPY  [ECT]-COMBINED

  MacGregor, J. MacW.  Pacatal—a clinical trial  of  a
  new ataractic drug.   S. Afr. M. J., 1956, 30:1108-1111.
MEPHENESIN
Placebo effect see PSYCHOPHARMACA—Evaluation

Psychotherapeutic use
  Berger, H.  Management of neuroses by the internist
  and general practitioner.  N. York State J. M., 1956, 56:
  1783-1788.  '                                  _   .
  Paul, L.  Mephenesin in anxiety-tension states.   Psycho-
  somat 31., 1952,14: 378-382.
 diethyl-l,3-propanediol (prenderol) on the central nerv-
 ous system. J. Pharm. Exp. Ther., 1953, 107 : 344-355.
 Hendley, C. D., Lynes, T. E., Berger, F. M.  Effect of
 meprobamate  on electrical activity of thalamus and
 other subcortical areas.  In: Himwich, H. E., ed. Tran-
 quilizing drugs.  Washington, Am. Ass. Adv. Sc, 1957.
 p. 35-46.
 Masserman, J. H., Pechtel, C.  An experimental investi-
 gation of  factors influencing  drug  action.  Psychiat.
 Res. Rep.,  Wash., 1956 (4) : 95-113.
 ----, ----.  Neurophysiology and  pharmacologic  in-
 fluences  on experimental neuroses.  Am. J.  Psychiat,
 1956,113: 510-514.
 Rinaldi, F., Himwich, H. E. The site of action of anti-
 parkinson  drugs.  Confinia neur., Basel, 1955, 15:  209-
 224.  Abstract: Am. J.  Physiol,  1054,  179:  665.   Ex-
 cerpta med., Sect. 8, 1956, 9 : No. 3616.
 Yoshii, N, Tsukiyama, K., Hiraiwa, K.  Effect of myane-
  sin on the flexion and on the electrical activities of the
  cerebral cortex and the brain stem. Fol psychiat. neur.
  jap., 1954, 7 : 285-292.

Studies, normal subjects
 Felisati, D., Fregni, R.   Effets de la mianesina sur dif-
  ferents  types  de nystagmus;  enregistrement  par la
  methode  eiectrographique.  [Effects of  myanesin  on
  different types of nystagmus; electroencephalographic
  study.]  Ann. otolar., Par., 1953, 70: 508-516.
  Mendenhall, J. H.,  Ewing, J. A.  Further psychometric
  evaluation of the effect of mephenesin on anxiety.  J.
  31ent. Sc, Lond., 1954,100: 262-266.  Abstract: Excerpta
  med., Sect. 8,1955, 8: No. 927.

Therapeutic studies, controlled
  Armour, P. S.  A  regimen in acute alcoholism.  [Me-
  phenesin;  mephenesin carbamate; reserpine; also com-
  bined and compared] Arizona M., 1956, 13:169-172.
  Bender, L., Nichtern, S.  Chemotherapy in child psychi-
  atry.  N.  York State J. 31., 1956, 56: 2791-2795.
  Dickes, R., Flamm, G. H., Coltrera, J., Tobin,  M.   The
  effect of mephenesin on muscle tension.  An experimen-
  tal study.  A. M. A.  Arch. Neur. Psychiat., 1955, 74: 590-
  597. Abstract: Excerpta med., Sect. 8, 1956, 9: No. 4998.
  Freedman, A. M., Effron, A. S., Bender, L.  Pharmaco-
  therapy in children with psychiatric illness.  J. Nerv.
  Ment. Dis., 1955, 122 : 479-486.  Abstract:  Year book of
  drug therapy, 1956-1957, p. 350-351.
  Hampson, J. L., Rosenthal, D., Frank, J. D. A compara-
  tive study of  the effect of mephenesin and  placebo on
  the symptomatology of a mixed group of psychiatric
  outpatients.  Bull. Johns Hopkins Hosp., 1954,  95:170-
  177. Abstract: Excerpta med., Sect. 8,1956, 9 : No. 2662.
  Hare, E.  H.   The  effects of mephenesin in   neurotic
  anxiety.   J. Ment  Sc, Lond., 1955, 101: 172-174.   Ab-
  stract : Excerpta med., Sect. 8,1956, 9 : No. 1717.
  Herman, M.,  Effron, A. S.  Tolserol in  the treatment of
  the post-alcoholic  state.  In: Podolsky,  E., ed.  Man-
  agement of addictions.  New  York, Philosophical Li-
  brary, 1955.  p.209-217.
  Kugelmass,  I. N.   Psychochemotherapy  of  mental de-
  ficiency in children. Internat. Rec. M., 1956, 169:323-
  338.
  Mailer,  A. B.  Effects of mephenesin and prenderol on
  intellectual  functions  of mental  patients.   J.   Clin.
  Psychol, 1954,10 : 283-285.
  Mendenhall,  J. H.,  Ewing, J. A.  Further psychometric
  evaluation of the  effect of mephenesin on anxiety.  J.
  Ment. Sc, Lond.,  1954, 100: 262-266.  Abstract: Ex-
  cerpta med., Sect. 8,1955, 8: No. 927.
  Sainz, A.  A.   The treatment of drug and alcohol with-
  drawal effects with thorazine.  Psychiat. Q.,  1957, 31:
  275-284.
  Scott, P. A.  A controlled study of the effect of mephene-
  sin  on  psychiatric out-patients.  J.  31 ent. Sc,  Lond.,
  1955, 101:163-171.  Abstract: Excerpta  med., Sect. 8,
  1956,9: No. 1716.
Studies, animals
  Batterman, R. C, Leifer, P., Grossman, A. J. The advan-
  tages of a new combination sedative mixture. Am. Prac-
  titioner, 1956, 7:1795-1798.
  Felisati D  Fregni, R.  Effets de la mianesina sur dif-
  ferents 'types de  nystagmus;  enregistrement par  la
  methode  eiectrographique.    [Effects  of myanesin  on
  different  types of  nystagmus;  electroencephalographic
  studv 1  Ann. otolar., Par., 1953, 70: 508-516.
    Funderburk, W.  H., Unna, K. R.  Site of action of 2,2-

                                                      103 
Mephenesin : Therapeutic studies, controlled
PSYCHOPHARMACA
  Rosenthal,  D., Frank,  J. D.   Psychotherapy and  the
  placebo effect.  Psychol. Bull, 1956, 53 : 294.
  ---, Imber, S. D. The effects of mephenesin and practice
  on the Bender-Gestalt performance  of psychiatric out-
  patients. J. Clin. Psychol, 1955,11: 90-92.
  Swyer, G. I. M.  Treatment of the  premenstrual syn-
  drome ; value of ethisterone, mephenesin, and a placebo
  compared.  Brit. M. J., 1955, 1:1410-1412.
  Tavener, R. H. A new drug in  post-alcoholic tension
  states.  Canad. M. Ass. J., 1954, 71: 387-388.  Abstract:
  Excerpta med., Sect. 8,1955, 8 : No. 3553.
  Wolf,  S., Pinsky, R.  Effects of placebo administration
  and occurrence of toxic reactions. J. Am. M. Ass., 1954,
  155: 339-341.

Therapeutic use
  Berger, H. Management of neuroses by the internist
  and general practitioner.  N. York State J. M., 1956, 56:
  1783-1788.
  Block, S. L. Effect of mephenesin  upon anxiety. A. M. A.
  Arch.   Neur.  Psychiat.,  1953,  69: 727-731.   Abstract:
  Excerpta med., Sect. 8, 1954, 7: No. 1605.             *
  Chatterjee, P. K., Datta, J. K. Mephenesin in morphine
  addiction.  J. Ind.  31. Ass.,  1956,  26 : 23-24.  Abstract:
  Excerpta med., Sect. 8,1956,  9: No. 3522.
  Elkes, J.  Effects of psychosomimetic drugs in animals
  and man.  In: Abramson, H. A., ed. Neuropharmacol-
  ogy.   Transactions of the third conference, May 1956,
  Princeton, N.  J.  New York, Josiah  Macy, Jr. Founda-
  tion,1957. p. 205-295.  [p. 278]
  ----,  Elkes.,  C, Bradley,  P.  B. The  effect of some
  drugs  on the  electrical  activity  of  the brain, and on
  behaviour.  J. Ment Sc, Lond.,  1954, 100:125-128.
  Ende,  M., Youngblood, W.  The use of  myanesin  (tol-
  serol)  in black widow spider bite. Virginia M. Month.,
  1953, 80: 24-25.
  Ewing, J. A., Mendenhall, J. H.  Clinical evaluation of
  the effect of mephenesin on anxiety.  J. Ment. Sc, Lond.,
  1953, 99:464-472.
  Feldman, D. J. Drug therapy of chronic  alcoholism.
  [also  mephate]  Med. Clin.  N. America, 1957, 41:381-
  392.
  Frankl, V. E.  Zur Behandlung der Angst.   [Therapy of
  anxiety.]  Wien. med. Wschr.,  1952,  102:535-537.  Ab-
  stract  : Excerpta med., Sect. 8, 1953,  6: No. 408.
  Freedman, A.  M., Kremer, M. W., Robertiello, R., Ef-
  fron, A. S. The treatment of behavior disorders in chil-
  dren with tolserol.   J. Pediat, S. Louis, 1955, 47: 369-
  372.                                              *
  Goldman, H. I.  Clinical evaluation  of  tolserol  in the
  post-alcoholic  syndrome.  Rocky Mountain M. J., 1954,
  51: 698-699.
  Greenhouse, H. R.   Treatment of the postintoxication
  state in alcoholics  with mephenesin and other  drugs.
  Q. J. Alcohol, 1954, 15 : 43-46. Abstract:  Excerpta med.,
  Sect. 8,1954, 7: No. 4228.
  Holt, W. E.  Effect of mephenesin  on  psychotic patients.
  J. Nerv. Ment. Dis., 1952,115: 343-350.
  Hutchinson, J. T. The value of drugs in the treatment
  of neuroses. Med. Illust., Lond., 1956, 10: 541-544.
  Jassin, A.  El estado de  ansiedad  en  la tensi6n premen-
  strual  y en el  climaterio,  tratado con tolseron.  [State
  of anxiety in premenstrual tension in climacteric; ther-
  apy with tolseron.]  Prensa  mCd.  argent,  1952, 39:
  2653-2655.
  Laurence, D. R.  Effect of mephenesin in spastic paraly-
  sis.  Lancet, Lond., 1952,  1: 178-180.               *
  Leupold-Lowenthal,  H.,  Ringel,  E.  Erfahrungen bei
  Behandlung der Angst mit Myocain.   [Experiences with
  myocaine therapy  of anxiety.]  Wien.  med. Wschr.
  1952, 102: 969-970.
 Mecham, M. J., Stromsta, C, Soderberg, G.  Effects of
 tolserol on the speech  errors  off mentally defective
 children.  Am. J. Phys. M., 1955, 34: 535-536.
  Monro, A. B., Steadman, H. H.  Myanesin in psychiatry.
  J.  Ment. Sc, Lond, 1953,  99:  285-287.  Abstract: Ex-
  cerpta med., Sect. 8,1954, 7, No. 751.
  O'Sullivan, C. J.  Myanesin in tension states.  J. Irish
  M. Ass., 1955, 36:167-169.
  Paul,  L.  Mephenesin in anxiety-tension states.  Psy-
  chosomat. M., 1952,14: 378-382.
  Spreng, R.  W.  E.  Tolserol  in  acute alcoholism.  J.
  Nerv.  Ment.  Dis.,  1953, 118: 545-551.   Abstract:  Ex-
  cerpta med., Sect. 8,1955, 8: No. 4384.
  Stiess,  A.  Klinische Erfahrungen mit Dihydroxy-2-
  methylphenoxy-propan   (Byk-M  1).  [Clinical  experi-
  ence   with   dihydroxy-2-methlyphenoxy-propanediol
  (Byk-M 1)]  Ther. Gegenwart, 1953, 92:289-292.
  Weber, H. J., Lehner, F. H. Erfahrungen mit Dihydro-
  methylphenoxy-propan (BYK-M 1).  [Experiences with
  3-o-toloxy-l, 2-propanediol  (BYK-M 1).   Schweiz. Arch.
  Neur.  Psychiat, 1954, 73: 370-378.

—Additional data
  Allen, E.  B., Prout,  C.  T. Alcoholism.  Progr. Neur.
  Psychiat., N. Y., 1955, 10: 510-521; 1956, 11: 338-351.
  Block, M. A.  Medical treatment  of alcoholism.  J. Am.
  M. Ass., 1956, 162 :1610-1619.
  Fabing,  H. D. The new pharmacologic attack  in psy-
  chiatry.  Internat. Rec. M., 1956, 169:177-183.  Also
  Drug  &  Cosmet.  Indust., 1956,  78: 32-33; 125-129.
  Feldman,  D. J., Zucker,  H. D.   Present-day  medical
  management of alcoholism. J. Am. M. Ass., 1953, 153:
  895-901.
  Green, A.  Actualites therapeutiques 1955 en psychia-
  trie.  [Therapeutic progress  in  psychiatry in 1955.]
  Ence'phale, 1956, 45 :172-200.
  Happiness pills in  medical practice:  a  symposium.  J.
  Iowa M. Soc, 1957, 47 : 57-65.
  Latham,  F.  A.  Symposium on  alcoholism.  Manage-
  ment  of the acute phases. Memphis M. J., 1953, 28:
  128-131.
  Ravreby, M. Pharmacology.   In: Happiness  pills in
  medical  practice: a symposium.  J. Iowa M. Soc, 1957,
  47: 57-59.
  Rees, L.  The role of drugs in the treatment of anxiety-
  tension states.  Med. Press, Lond., 1952, 227: 295-298.
  Sargant, W.  On chemical tranquillizers.  Brit. M. J.,
  1956, 1:  939-943.                                   *
  Tintera, J. W.   Office rehabilitation of the alcoholic.
  N.  York  State J. M., 1956, 56: 3896-3902.
with ATARAXICS [2 or more]
  see ATARAXICS— Various [3 or more]

with CHLORPROMAZINE
  see CHLORPROMAZINE with  MEPHENESIN

with MEPHENESIN CARBAMATE
  see MEPHENESIN CARBAMATE—Therapeutic stud-
    ies, controlled

with MEPROBAMATE—COMPARED
Studies, animals
  Berger,  F. M.  The pharmacological properties of 2-
  methyl-2-n-propyl-l,3-propanediol  dicarbamate  (mil-
  town), a  new interneural blocking agent.  J. Pharm.
  Exp. Ther., 1954, 112: 413^23. Abstract: Chem. Abstr.,
  1955, 49: 2610L

with PRENDEROL^COMPARED
  see PRENDEROL— Studies, animals
                     Therapeutic studies, controlled

with RAUWOLFIA  SERPENTINA  ALKALOIDS  and
  OTHER DRUGS—COMBINED  [sedaltine]
  Raymond, M. J., Lucas, C. J., Beesley, M. L., O'Connell,
  B. A., Roberts, J. A. F.  A  trial of five tranquillizing
  drugs in psychoneurosis.  Brit. M. J., I957t 2 • 63-66 
SUBJECT  LIST
Meprobamate : Placebo effect
with RESERPINE—COMBINED
  see under MEPHENESIN CARBAMATE—Therapeutic
    studies, controlled

with RESERPINE—COMPARED
Studies, animals
  Tripod, J., Bein, H. J., Meier, R.  Characterization of
  central effects of serpasil (reserpin, a new alkaloid of
  Rauwolfia serpentina B.) and of their antagonistic re-
  actions.  Arch, internat. pharm. dyn., Gand, 1954,  96:
  406-425.
Therapeutic studies, controlled
    see  under  MEPHENESIN  CARBAMATE—Thera-
     peutic studies, controlled
with RESERPINE and OTHER DRUGS—COMBINED
Studies, animals and Therapeutic use
  Batterman,  R. C, Leifer, P., Grossman, A. J.  The ad-
  vantages of a new combination sedative mixture.  Am.
  Practitioner, 1956, 7:1795-1798.
 with OTHER DRUGS—COMBINED
 Studies, animals
  Reinhard, J. F., Chessin, M., Tornaben, J., Lewis, M. N.
  Pharmacologic  evaluation of a new sedative-hypnotic
  drug combination.   [Abstract]  Fed. Proc, Bait., 1954,
  13:396.
 Therapeutic studies, controlled
  McLaughlin, J. J.,  Schlan, L. S.  3-o-Toloxy  1,2 pro-
  panediol as an adjunct in the treatment of drug addic-
  tion. Illinois M. J., 1953,103 : 247-249.
  Mitchell, E. H.  Chlorpromazine in the treatment of
  acute alcoholism.  Am. J. M. Sc,  1955, 229:363-367.
  Abstract: Excerpta  med.,  Sect. 8,  1957,  10: No. 884.
  Q. J. Alcohol, 1955, 16: 589-590.
  Tavener, R.  H.  A new drug in post-alcoholic  tension
  states.   Canad. M. Ass., J., 1954, 71: 387-388. Abstract:
  Excerpta med., Sect. 8,1955, 8: No. 3553.
 Therapeutic use
  Allen, E. B., Prout, C. T. Alcoholism.  Progr. Neur.
  Psychiat., N. Y., 1956, 11: 338-351.
  Friedlander, H. S.  Anxiety,  tension and emotional
  stress; a report on the joint use of mephenesin and a
  barbiturate in their treatment in general practice.  Med.
  Times, Great Neck, 1953, 81: 411^15.
  Greenhouse, H. R.  Treatment  of the postintoxication
  state in alcoholics with mephenesin and other drugs.
  Q. J. Alcohol, 1954,15 : 43-46.  Abstract: Excerpta med.,
  Sect. 8,1954, 7: No. 4228.
  Spreng,  R.  W. E.   Tolserol  in acute alcoholism.  J.
  Nerv. Ment. Dis.,  1953,  118:545-551.   Abstract: Ex-
  cerpta med., Sect. 8,1955, 8: No. 4384.

with OTHER DRUGS [benzazoles]—COMPARED
Studies, animals
  Funderburk,  W. H. King, E. E., Domino, E. F., Unna,
  K. R.  Pharmacological properties of benzazoles.  II.
  Sites of action in the central nervous system.  J. Pharm.
  Exp. Ther., 1953,107 : 356-367.
  ___t___f Unna, K. R.  Pharmacological properties of
  benzazoles. III.  Effect of 2-aminobenzothiazoles on the
  electroencephalogram. J. Pharm. Exp.  Ther., 1953, 108:
  94-103.
 King, E.  E.  Differential action of anesthetics and inter-
  neuron depressants upon EEG arousal  and recruitment
  responses  J. Pharm. Exp. Ther., 1956, 116: 404-417.
MEPHENESIN CARBAMATE
  Mephenesin carbamate.  J. Am. M. Ass., 1956,160: 289.
Studies, animals
  Dressel, P. E., Slater, I. H.  Observations on the phar-
  macology  of mephenesin carbamate.  Proc.  Soc. Exp.
  Biol, N. Y., 1952, 79: 286-287.
Therapeutic studies, controlled
  Armour, P. S. A regimen in acute alcoholism  [Mephen-
  esin ; mephenesin carbamate; reserpine;  also combined
  and compared.]  Arizona M., 1956,13 :169-172.
Therapeutic use
  Block, M. A.  Medical treatment of alcoholism.   J. Am.
  31. Ass., 1956, 162:1610-1619.
  Feldman,  D. J.  Drug  therapy of  chronic alcoholism.
  Med. Clin. N. America, 1957, 41: 381-392.

with MEPHENESIN
with RESERPINE
  see MEPHENESIN CARBAMATE—Therapeutic stud-
    ies, controlled
MEPROBAMATE

  Gerard, R. W.  Drugs for the soul; the rise of psycho-
  pharmacology.   [Includes report on conference held in
  New York, October 1956]  Science, 1957, 125: 201-203.
  Meprobamate and other agents used in mental disturb-
  ances.  [Conference held in New York, October 1956]
  Ann. N. York Acad. Sc, 1957, 67 : 671-894.
  Wallace Laboratories.  Miltown—the tranquilizer with
  muscle  relaxant action.  33 p.  [Literature  survey]
  New Brunswick, N. J., 1957.

Pharmacodynamics
  Berger, F. M.  Meprobamate; its pharmacologic prop-
  erties and clinical uses.  Internat. Rec M., 1956, 169:
  184-196.
  Borrus, J. C.  Meprobamate in  psychiatric disorders.
  Med. Clin. N. America, 1957, 41: 327-337.
  Fasanaro, F., Ventra, D.  Un nuovo farmaco tranquil-
  lizzante: il meprobamato; esperienze cliniche.  [A new
  tranquilizing drug: meprobamate;  clinical experience.]
  Minerva med., Tor., 1956, 47: 2169-2175.
  Fazekas, J.  F.,  Toupin, H., Alman, R.  W.  Physiologic
  and pharmacologic basis for  the chemotherapy of psy-
  chiatric states.   Am. J. Med., 1956, 21: 825-831.
  Floris,  V.,  Rambelli,  L.  L'impiego   del  2-metil-2-n-
  propil-l,3-propandiolo   dicarbamato   in   psichiatria.
  [Use of 2-methyl-2-n-propyl-l, 3-propanediol dicarbamate
  in psychiatry.]  Minerva med.,  Tor.,  1956, 47:1455-
  1457.
  Leake,  C.  D.  Drugs  affecting  mood and behavior.
  Texas Rep. Biol M., 1955,13 : 793-818.  Abstract: Chem.
  A bstr., 1956,50:9615b.
  ----.  New  mood-changing  drugs.  Ohio  M. J., 1956,
  52:369-372.
  Meprobamate.  J. Am. 31. Ass., 1956, 160:  1405.
  Pennes, H. H. The nature of drugs with mental actions
  and their relation to cerebral function.  Bull N. York
  Acad. M., 1957, 33 : 81-88.
  Perrault, M.  Sur les tranquilliseurs.   [Tranquilizers.]
  Progr. me'd., Par., 1957, 85 : 3-4; 7.
  Ravreby, M. Pharmacology. In: Happiness pills in
  medical  practice: a symposium.   J. Iowa  M. Soc, 1957,
  47:57-59.
  Rotteglia,  E. Miltown; nuovo  sedativo  nelTansieta e
  nelle psicosi.  [Miltown:  a new sedative in anxiety and
  psychoses.]  Boll. chim. farm., 1956, 95 :10-11.

Placebo effect see PSYCHOPHARMACA—Evaluation 
Meprobamate : Psychotherapeutic use
PSYCHOPHARMACA
Psychotherapeutic use

  McLaughlin, B. E.  Miltown in the treatment of chron-
  ically ill psychiatric out-patients.  Pennsylvania 31. J.,
  1957, 60: 989-992.
  Ruchwarger, A.   Meprobamate in  anxiety reactions in-
  volving depression.  31ed.  Ann. District of Columbia,
  1956, 25: 555-556 ; 586.

Studies, animals
  Berger, F. M.  The pharmacological properties  of 2-
  methyl-2-n-propyl-l,3-propanediol  dicarbamate   (mil-
  town), a new interneural blocking agent.  J. Pharm.
  Exp. Ther., 1954, 112 : 413-423.  Abstract: Chem. Abstr.,
  1955, 49 :2610i.
  ---, Campbell, G.  L., Hendley, C.  D., Ludwig, B. J.,
  Lynes, T. E.  The action of tranquilizers on brain po-
  tentials and serotonin.  Ann.  N. York Acad. Sc, 1957,
  66: 686-694.
  Chauchard,  P., Mazoue, H.   Recherches  sur  le  mode
  d'action  centropiegique de quelques substances psycho-
  tropes.  [Research on the mode of  centriplegic  action of
  some  psychotropic  substances.]   C. rend. Soc.  biol,
  1956,150:158-160.
  Cook, L., Weidley, E.  Behavioral effects  of some psy-
  chopharmacological agents.  Ann.  N. York Acad.  Sc,
  1957, 66: 740-752.
  Davis, G. D.  Effects of central excitant and depressant
  drugs  on locomotor activity  in the monkey.   Am. J.
  Physiol, 1957,188 : 619-623.
  Essig,  C. F., Ainslie, J. D.  Addiction to meprobamate
  (equanil, miltown).  J. Am. M. Ass., 1957, 164:1382.
  Ferguson, J. T., Linn,  F. V.  A new compound for the
  symptomatic treatment of tension  and anxiety: 2-ethyl-
  crotonylurea  (nostyn).  Antibiotic M., 1956, 3 : 329-333.
  Hendley, C. D., Lynes, T. E.,  Berger, F. M.  Effect of
  meprobamate  on  electrical activity of thalamus  and
  other subcortical areas. In: Himwich, H. E., ed. Tran-
  quilizing drugs.   Washington, Am. Ass. Adv. Sc, 1957.
  p. 35-46.
  ---,  ----,  ----.  Effect  of 2-methyl-2-n-propyl-l,3-
  propanediol dicarbamate (miltown)  on  central nervous
  system.  Proc. Soc.  Exp. Biol, N. Y., 1954,  87: 608-610.
  Abstract: Chem. Abstr., 1955, 49 : 4872fg.
  ---, ----, ----.  Effect of 2-methyl-2-n-propyl-l,3-pro-
  panediol dicarbamate  (miltown) on electrical activity
  of the  brain.  [Abstract]   Fed. Proc, Bait., 1955,  14:
  351.
  Kinnard, W.  J.,  Carr,  C.  J.  A preliminary procedure
  for the evaluation  of central nervous  system depres-
  sants.  J. Pharm. Exp. Ther., 1957, 121:354-361.
  Lim, R. K., Pindell, M. H., Glass,  H. G, Rink, K.   The
  experimental evaluation of sedative agents in animals.
  Ann. N. York Acad. Sc, 1956, 64 : 667-678.
  Masserman, J. H.,  Pechtel, C. Neurophysiologic  and
  pharmacologic  influences  on  experimental  neuroses.
  Am. J. Psychiat., 1956,113 : 510-514.
  Pfeiffer,  C.  C, Jenney, E. H.  The inhibition of  the
  conditioned response  and the counteraction of schizo-
  phrenia by muscarinic stimulation of the brain.  Ann.
  N. York Acad. Sc, 1957, 66 : 753-764.
  Norton, S., De Beer, E. J.  Effects of drugs on the be-
  havioral patterns of cats.  Ann. N. York Acad.  Sc, 1956,
  65:249-257.
  Schallek, W., Kuehn, A., Seppelin, D. K.  Central depres-
  sant effects of methyprylon.  J. Pharm. Exp. Ther., 1956,
  118:139-147.
  Swinyard, E. A., Chin, L., Fingl, E. Withdrawal hyper-
  excitability following chronic  administration of mepro-
  bamate to mice. Science, 1957,125 : 739-741.
  Walaszek, E. J., Abood, L. G.  Effect of tranquilizing
  drugs  on fighting  response of Siamese  fighting  fish.
  Science, 1956,124 : 440-441.
Studies, normal subjects
  Reitan, R. M. The comparative effects of placebo, ultran,
  and  meprobamate on  psychologic  test  performances.
  Antiobiotic M., 1957,4 -.158-165.
  Smith, J. A., Rutherford, A., Fanning, R.  A comparison
  of phenaglycodol (ultran), meprobamate  and placebo
  in abstinent alcoholics.  Am. J. Psychiat., 1957, 114:
  364-365.

Studies, patients
  Essig, C. F., Ainslie, J. D.  Addiction  to meprobamate
  (equanil, miltown).  J. Am. M. Ass., 1957, 164:1382.
  Glotfelty, J. S., Wilson, W. P.  Effects of tranquilizing
  drugs on reticular system activity in man.  North Car-
  olina M. J., 1956,17: 401-405.
  Lanzoni, E., Cavazzuti, G. B. Azione del meprobamato
  sui bambini della prima infanzia; rilievi clinici ed elet-
  troencefalografici.  [Effect of meprobamate on infants;
  clinical and electroencephalographic studies.]  31inerva
  med., Tor.,  1956, 47 :  2191-2192.

Therapeutic studies, controlled
  Dierkens, J., Reeth, P. C. van. Essais cliniques d'un
  nouveau  psychopiegique:  le meprobamate.   [Clinical
  trial  of  a  new psychoplegic  drug:  meprobamate.]
  [English summary]   Bruxelles m4d., 1956,  36:2335-
  2340.                                             *
  Selling,  L.   S.   Clinical study  of a new  tranquilizing
  drug;  use  of  miltown   (2-methyl-2-n-propyl-l,3-pro-
  panediol dicarbamate).  J. Am. 31. Ass., 1055,157 :1594-
  1506. Abstract:  Excerpta med., Sect. 8,  1956, 9: No.
  1719.
  ---, A  clinical study  of miltown,  a new tranquilizing
  agent.  J. Clin. Exp. Psychopath., 1956, 17: 7-14.  Ab-
  stract : Excerpta  med., Sect. 8,  1957, 10: No. 391.
  Smigel, J. O.  Mood  therapy in the aged.   Med. Times,
  Great Neck, 1957, 85 :149-158.

—Neuroses
  Bender, L.,  Nichtern,  S.  Chemotherapy  in child psy-
  chiatry.   N. York State J. M.,  1956, 56: 2791-2795.
  Dickel, H. A., Dixon, H. H., Wood, J., Shanklin, J. G.
  Electromyographic  studies  on  patients treated  with
  meprobamate.   West. J. Surg.,  1956, 64:197-201.
  Ferguson, J. T., Linn,  F. V.  A new compound for the
  symptomatic treatment of  tension  and  anxiety: 2-
  ethylcrotonylurea (nostyn).  Antibiotic  31.,  1956, 3:
  329-333.
  Fox, V.  Treatment of withdrawal symptoms in the
  management of alcoholism.  J. M. Ass. Georgia,  1956,
  45 : 139-142.
  Gardner, A. Meprobamate—a clinical study.  Am. J.
  Psychiat, 1957, 114 : 524-526.
  Heller, G. C, Walton, D., Black, D.  A.  Meprobamate in
  the treatment  of tension states.  J. Ment. Sc, Lond.,
  1957, 103: 581-588.
  Hollister, L. E., Stannard, A. N., Drake, C. F. Treat
  ment of anxious patients with drugs.  Dis. Nerv. Syst.,
  1956, 17: 289-293.
  Kugelmass, I.  N. Psychochemotherapy of mental de-
  ficiency  in  children.   Internat. Rec. M., 1956,  169:323-
  338.
  Millen,  F.  J.  Miltown—clinical experiences  in neuro-
  psychiatric  office use.   Wisconsin M. J., 1957, 56:198-
  201.
  Moyer, J. H., Pevey, K., Kinross-Wright, V.  Tranquiliz-
  ing  (ataractic)  agents:  current  evaluation  of  their
  clinical  use in  patients who are not hospitalized.  GP,
  1957, 15  (6) : 97-118.                               *
  Osinski, W. A.  Treatment of anxiety states with mepro-
  bamate  (miltown).  Internat  Rec. M., 1956  169"589-
  595.
  Pennington, V. M.  Meprobamate (Miltown) in premen-
  strual tension.   J. Am. 31. Ass., 1957, 164; 638-640.
106 
SUBJECT  LIST
Meprobamate : Therapeutic use — Additional data
  Pevey, J. K., Moyer, J. H., Handley, C. A., Heider, C.
  A comparison  of clinical results  with phenobarbital,
  meprobamate  and two  similar experimental  agents.
  [Abstract]  [benactyzine:  meprobamate:  phenagly-
  codol]  J. Pharm. Exp. Ther., 1957, 119: 176.
  Raymond, M. J., Lucas, C. J., Beesley, M. L., O'Connell,
  B. A., Roberts,  J. A. F.   A trial of five tranquillizing
  drugs in psychoneurosis.   Brit. M. J., 1957, 2: 63-66.
  Smith, J. A., Rutherford, A.,  Fanning, R.  A compari-
  son   of  phenaglycodol  (ultran),   meprobamate  and
  placebo in abstinent alcoholics.  Am. J. Psychiat., 1957,
  114: 364-365.
  West, E. D., Fernandes da Fonseca, A.   Controlled trial
  of meprobamate.  Brit. M. J., 1956, 2:1206-1209.

 —Psychoses
  Barsa, J. A., Kline, N. S.  Use of meprobamate  in the
  treatment  of  psychotic  patients.   Am.  J.  Psychiat.,
  1056,112 : 1023.
  Lemere, F.  Failure off azacyclonol (frenquel)  to re-
  lieve non-experimental mental confusion and hallucina-
  tions.  Am. J. Psychiat., 1957,113 : 840-841.
  Pennington, V. M.  A comparative study of six ataraxics
  in  1130  neuro-psychiatric cases.   Mississippi Doctor,
  1956, 33: 336-339.
  ---, Meprobamate, a tranquilizing drug  with muscle
  relaxant properties in psychotic cases.  In: Himwich,
  H. E., ed.  Tranquilizing drugs.  Washington, Am. Ass.
  Adv. Sc, 1957.   p. 125-131.
  ---.  Use of miltown (meprobamate) with psychotic
  patients.  Am. J. Psychiat, 1957, 114: 257-260.
  Thai, N.   Premedication for  electroshock treatment.
  Effect of meprobamate in 120 psychotic patients.  Dis.
  Nerv. Syst, 1956, 17: 52-57.
  Tucker, K.,  Wilensky,  H.  A clinical evaluation of me-
  probamate therapy in a  chronic schizophrenic popula-
  tion.  Am. J. Psychiat, 1957,  113: 698-703.          *

 —Psychosomatic diseases
  Friedman, A. P.  Use of tranquilizers  in the treatment
  of headache.  Am. Practitioner, 1957,  8: 94-97.
  Kessler,  L. N.,  Barnard, R.  D.  A new  tranquilizer
  meprobamate; its use  for pain associated  with cancer.
  Preliminary report.  Med. Times, Great Neck, 1956, 84:
  431-435.
  Lasagna, L. A study of hypnotic drugs in patients with
  chronic  diseases;  comparative  efficacy   of  placebo;
  methyprylon   (noludar)   meprobamate    (miltown,
  equanil)  pentobarbital;   phenobarbital;   secobarbital.
  J. Chronic Dis., 1956, 3 : 122-133.
  LeVan, P., Wright, E.  T.  Use off tranquilizers in dis-
  eases of the skin; a preliminary report.  California M.,
  1956, 85: 87-88.
  Robinson, H. M., Robinson, C. V.,  Strahan, J. F.  Hy-
  droxyzine  (atarax) hydrochloride in dermatological
  therapy.  J. Am.  M. Ass., 1956, 161: 604-606.
  So!ioloff, O.  J.  Meprobamate  (miltown) as adjunct in
  treatment of anogenital pruritus.  A. M. A. Arch. Derm.,
  1956, 74:393-396.

Therapeutic use
  Berger,  F. M.  Meprobamate;  its pharmacologic prop-
  erties and clinical uses.   Internat. Rec. M., 1956, 169:
  184-196.
  Borrus,  J. C.  Meprobamate in psychiatric  disorders.
  Med. Clin. N. America, 1957, 41: 327-337.             *
  ----.  Study of effect of  miltown (2-methyl-2-n-propyl-
  13-propanediol  dicarbamate)   on  psychiatric  states.
  J  Am M.  Ass.,  1955, 157:1596-1598.  Abstract:  Ex-
  cerpta med., Sect. 8,1956, 9: No. 1720.
  Collomb,  H., Miletto, G., Chaupm, M. Le meprobamate
  dans  le  traitment  des   psychoses et des  nevroses.
  rMpnrobamate in the treatment of  psychoses and neu-
  roses ]   Rev. prat, Par.,  1956, 6: 1200-1204.
  Fasanaro, F., Ventra, D.   Un  nuovo farmaco tranquil-
  izzante: il meprobamato;  esperienze cliniche.   [A new
 tranquilizing drug: meprobamate; clinical experience.]
 3Iinerva med., Tor., 1956, 47 : 1455-1457.
 Fazekas, J. F., Shea, J. G., Sullivan, P. D., Jr.  Ataractics
 in medical practice.  GP, 1956, 14  (6) : 75-81.
 Feldman,  D. J.  Drug therapy of chronic alcoholism.
 Med. Clin. N. America, 1957, 41: 381-392.
 Ferrari, D.  II meprobamato in psichiatria ; osservazioni
 cliniche.   [Meprobamate in psychiatry;  clinical obser-
 vations.] —Minerva med,, Tor., 1956, 47: 1458-1462.
 Floris, V., Rambelli, L.  L'impiego del 2-metil-2-n-propil-
 1,3-propandiolo dicarbamato  in  psichiatria.   [Use  of
 2-methyl-2-n-propyl-l,3-propanediol dicarbamate in psy-
 chiatry.]   Minerva med., Tor., 1956, 47: 1455-1457.
 Follin, S., Sigg, B., Pivet, S., Girard,  C.  Essais d'une
 nouvelle  drogue tranquillisante.   [Clinical study of a
 new tranquilizer.]   [Meprobamate]  Ann. me'd. psychol,
 Par., 1956, 114 (1) : 825-830.
 Gillette, H. E. Relaxant effects of meprobamate in dis-
 abilities  resulting  from musculoskeletal and central
 nervous  system disorders.   Clinical  observations   in
 fifty-five  cases.  Internat. Rec. M., 1956, 169:453-468.
 Abstract: Excerpta med., Sect. 8, 1957, 10: No. 1841.
 Hollister, L. E.  Tranquilizing  drugs and the generalist.
 Med. Times, Great Neck, 1956, 84: 1021-1026.         *
 Hormia, A.  Meprobamaatista  neuropsykiatriassa saat-
 uja hoitokokemuksla.  [Meprobamate therapy in neuro-
 psychiatry.]  [English summary]  Duodecim, Helsin.,
 1956, 72:1019-1024.
 Imberciadori, S., Manganaro, D.   Effetti  della sommin-
 istrazione di 2-metil-2-n-propil-l, 3-propandiolo dicarba-
 mato  (meprobamato) nei malati di mente.   [Effects  of
 administration  of  2-methyl-2-n-propyl-l,3-propanediol
 dicarbamate  (meprobamate)  in  mental  disorders.]
 31inerva med., Tor., 1956, 47: 2181-2184.
 Lasagna,  L.  The newer hypnotics.  Med,  Clin. N. Amer-
 ica, 1957, 41: 359-368.                              *
 Lepage, M.  Le traitement de Tanxiete chronique.  [The
 treatment of chronic anxiety.]  Bull me'd., Par., 1955,
 69: 2737275.
 Margolis,  L. H.  Pharmacotherapy in  psychiatry; a  re-
 view.  Ann. N. York Acad.  Sc, 1957, 66: 698-718.
 Osterman, E.,  Lassenius,  B., Bohn,  L., Elkjaer,   P.
 Meprobamat  i  psykiatrisk praxis.  [Meprobamate  in
 psychiatric practice.]  Sven. lak.  tidn., 1956, 53: 2689-
 2698.
 Peak,  W. P.  Meprobamate  (miltown)  in  rheumatic
 diseases.   J. Am. M. Ass., 1957, 163 : 535-538.
 Pennington, V. M.  Research  findings in phrenotropic
 drugs important to every physician.  Mississippi Doc-
 tor, 1957, 35: 57-63.
 Phillips, R. E. Use of meprobamate (miltown) for the
 treatment of emotional  disorders. Am. Practitioner,
 1956, 7:1573-1576.
 Ravina, A.  Une nouvelle medication de Tanxiete et des
 psychoses.   [A new medication  for anxiety and psy-
 choses.]   [Meprobamate] Presse  me'd., 1955,  63:1233.
 Abstract:  Praxis, Bern, 1956, 45: 749.
-Additional data
 Alexander, L.  Therapeutic process in electroshock and
 the newer drug therapies; psychopathological considera-
 tions.   J. Am. M. Ass., 1956, 162 : 966-969.
 ----.  Objective approaches to treatment in psychiatry.
 Canad. Psychiat. Ass. J., 1957, 2 : 77-94.
 Allen, E.  B., Prout, C. T. Alcoholism.  Progr. Neur.
 Psychiat., N. Y., 1956,11: 338-351.
 Ayd, F. J., Jr.  Tranquilizing drugs in private practice.
 N. York State J. M., 1957, 57: 1742-1747.             *
 Bergy, G. A. Drugs of  sedation with tranquilizing ef-
 fects.  Am. Profes.  Pharmacist, 1956, 22 : 419; 534-538;
 619-621;  709-710;  797-799; 888-889; 917-919.   [619-^
 621.]
 Block, M. A.  Medical treatment of alcoholism. J. Am
 31. Ass., 1956, 162:1610-1619.
107 
Meprobamate : Therapeutic use — Additional data
PSYCHOPHARMACA
 Cohen, I. M.  Drugs recently introduced in the treat-
 ment  of  psychiatric  disorders.   Texas J. M., 1956, 52:
 683-687.
 Dean, S. R.  Ataractics.  Am. J. Psychiat., 1956, 112:
 850.
 Deniker,  P.  Hibernotherapies  et  medicaments  neuro-
 leptiques  en therapeutique psychiatrique.   [Hiberno-
 therapies and neuroleptic drugs in psychiatric therapy.]
 Ence'phale, 1957, 46:281-298.   [p. 365.]
 Fabing, H. D. The ataractic drugs: their uses and lim-
 itations in psychiatry.  Am. Profes. Pharmacist, 1956,
 22: 413-418.
 ---.  The  new pharmacologic attack in psychiatry.
 Internat.  Rec.  M., 1956,  169:177-183.  Also: Drug &
 Cosmet. Indust., 1956, 78: 32-33 ; 125-129.
 Fishbein, M.  The tranquilizing drugs.  Postgrad. M.,
 1956, 19: 509-511.
 Fouks, Laine, Francois, Pagot.  Note sur les medications
 recentes  des etats nevrotiques anxieux  et depressifs.
 [Note on recent medications for anxious  and  depres-
 sive neurotic states,]  Ann. me'd. psychol, Par., 1956,
 114(1) : 608-615.
 Fremming, K. H.   Medikamentel behandling af syn-
 dssygdomme.  [Medical treatment of mental disorders.]
 Mskr. rakt. laegegern., Kbh., 1956,  34:331-342.
 French, E. G. Epilepsy.  Am. J. Psychiat., 1957, 113:
 629-631.
 Graffagnino, P. N., Furr, J. H.   New drugs in the treat-
 ment  of  emotional disorders;  a review.   Connecticut
 M. J.,  1957, 21: 38-43.
 Gutenkauf,  C.  Internal  medicine.   In:  "Happiness
 pills"  in  medical practice: a symposium.  J. Iowa M.
 Soc, 1957, 47: 59-64.
 Happiness pills in medical practice: a symposium.  J.
 Iowa M. Soc, 1957, 47: 57-65.
 Heilbrunn, G.  Selection of patients for modern psy-
 chiatric pharmacotherapy in general practice.  North-
 west M., 1956, 55 :1198-1205.
 Hubbard, O. E., Glasser, J.   Newer psychotropic drugs;
 their  characteristics and  use  in  general practice.
 Northwest M., 1956, 55:1191-1197.
 Kautz, H. D.  Trends in drug therapy.  Hosp. Progr.,
 1957, 38 (1) : 102-108; 126.
 Keyes, B.  L.  Ataraxic  drugs.  Pennsylvania  M.  J.,
 1957, 60:177-181.
 Kinross-Wright V. A review off the newer drug thera-
 pies in psychiatry.  Dis. Nerv. Syst, 1956, 17:187-190.
 ----.  The uses and  limitations of the newer drugs in
 the treatment of nervous conditions.   Wisconsin M. J.,
 1956, 55:1073-1078.
 Kline,  N. S.  Chemotherapy in  psychiatry; recent  ad-
 vances.  Seminar Internat., Hoddesdon,  1956, 5 (2) :
 7-10.
 Klingman, W. O.  Neurological and  psychiatric dis-
 orders ; some recent advances in therapy.   Virginia M.
 Month., 1956, 83: 240-246.
 Laboucarie, J., Barres, P., Rascol, A.  Aspects princi-
 paux des  cures neuropiegiques en psychiatrie en 1956.
 [Principal features of neuroplegic therapy in psychiatry
 in 1956.]  Toulouse me'd., 1956, 57: 851-867.
 Overholser, W.  La chlorpromazine, ouvre-t-elle une ere
 nouvelle dans les hopitaux psychiatriques ?   [Chlorpro-
 mazine—the beginning off a new era in psychiatric hos-
 pitals?]   Ence'phale, 1956, 45 : 313-319.
 Skobba, J. S.  Drugs  in the  management of emotional
 conditions.  J. M. Ass. Georgia,  1956, 45: 397-399.
 Spencer, R. S.  The use of ataraxic drugs in mental ill-
 ness.  Hawaii M. J., 1957,16:  302.
 Stewart, R. H. The use of tranquilizing drugs in gyne-
 cology.  West. J. Surg., 1956, 64: 650-657.
Stimulants and depressants. Brit. M. J., 1956. 1 • 969-
 970.
Weinberg, H. B. Drug therapy for the emotionally and
mentally disturbed; the internist's point of view.   J
 Iowa M. Soc, 1957, 47 :17-19.
  Wortis, J. Physiological treatment.  Am. J. Psychiat,
  1956, 112: 526-529 ; 1957, 113 : 611-615.

—Neuroses
  Berglund, M., Blumenthal, B., Flordh, P.  Restenil (me-
  probamat) pa ett psykiatriskt poliklinikmaterial.  [Re-
  stenil   (meprobamate)  in  psychiatric   outpatients.]
  Sven. lak. tidn., 1956, 53 : 3362-3364.
  Borroni, G., Casadio, V.  Sull'impiego terapeutico di un
  farmaco  antiansia  muscolorilassante.    [Therapeutic
  use  of  a muscle relaxant anti-anxiety drug.]  Gazz.
  med. ital, 1956,115 : 365-367.
  Bross, R. B.  Near  fatality with  combined ECT and
  reserpine.  Am. J. Psychiat., 1957,113 : 933.
  Catalano-Nobili, C, Cerquetelli, G.  Esperienza  tera-
  peutica con i meprobamati in psichiatria.   [Clinical ex-
  perience with meprobamate in psychiatry.]   Minerva
  med., Tor., 1956, 47: 2185-2191.
  Colombati, S. L'azione  tranquillante di un nuovo far-
  maco neurolettico.   [Tranquilizing action of a  new
  neuroleptic drug.]   Minerva med., Tor., 1956, 47: 2175-
  2178.
  Lemere, F.  New  tranquilizing drugs.  Northwest M.,
  1955, 54:1098-1100.
  Rigotti, S.  Sull'impiego clinico  di un  nuovo  farmaco
  ad azione sedativa; il 2  metil-2-n-propil-l,3-propandiolo
  dicarbamato.  [Clinical use of a new drug with  sedative
  action;   2  methyl-2-n-propyl-l,3-propanediol   dicarba-
  mate.]  Minerva med., Tor., 1956, 47: 2178-2181.
  Sottong, P. C.  The use  and abuse  of the tranquilizing
  drugs.   J. Tennessee M. Ass., 1956,  49 : 413-418.
  Turvey,  S. E. Meprobamate  (equanil)  for  relief  of
  anxiety  and  nervous tension  from  various  causes.
  Canad.  M. Ass. J., 1956,  74: 863-865.  Abstract: Ex-
  cerpta med., Sect. 8,1957,10 : No. 362.
  Thimann, J., Gauthier, J. W.  Miltown as a tranquilizer
  in the treatment of alcohol addicts.  Q. J. Alcohol, 1956,
  17:19-23.
  Walker,  A.   Las  nuevas drogas  atar&xicas.  [New
  ataraxic drugs.]  Prensa me'd. argent, 1956, 43:2667-
  2669.

—Psychosomatic diseases
  Cahn, M. M.   The use of tranquilizing drugs in derma-
  tology;  review and side  reactions.  J. Albert  Einstein
  M. Center, 1956, 4: 161-165.                         *
  Castrovilli, G., Ginoulhiac, R., Merli,  G. M.  II mepro-
  bamato: alcune  indicazioni del suo uso in medica in-
  terna;  studio clinico  e  sperimentale.   [Meprobamate:
  some indications for its use in internal medicine;  clin-
  ical  and  experimental  study.]  3Iinerva med., Tor.,
  1956, 47: 1465-1474.
  Cicala, P.  Osservazioni sull'impiego del meprobamato,
  con particolare riguardo agle stati ansiosi di  soggetti
  enteropatici.   [Use of meprobamate, especially in states
  of anxiety in cases  of  intestinal diseases.]   Minerva
  med.. Tor., 1956, 47: 1463-1464.
  Ermiglia, G.  Sull'impiego del meprobamato in ginecolo-
  gia;  primi risultati.  [Use of meprobamate  in gyne-
  cology;  initial  results.]   Minerva med., Tor., 1956,
  47: 1477-1478.
  Fabricant, N. D. Tension headache therapeutics.  Eye,
  Ear dc Month., 1956, 35 : 658; 662.
  Friedman, A. P., Von Storch, T. J.  A review  of head-
  ache, 1950-1955.  N. York State  J. M., 1956, 56:3883-
  3895.
  Kaminsky, A., Sevinsky, B., Kaplan, A.  Il metil-propil-
  propanediol-dicarbamato (meprobamato) in dermatolo-
  gia.  [Meprobamate in  dermatology.]  Minerva med.,
  Tor., 1956, 47:1478-1480.  Also: Dia  me'd.,  B.  Air.,
  1956, 28: 2284-2286.
  Mitis, Z. K., Ford, H.  Functional headaches. Texas
  J. M., 1956, 52 : 678-683.
  Ogden, H. D.  Headache.  Ann. Allergy, 1Q5Q,  14 : 385-
108 
SUBJECT LIST
Meprobamate : with Reserpine
 Williamson, P.  Office  treatment of atopic  dermatitis.
 Med. Times, Great Neck, 1956, 84: 1086-1087.

Untoward effects [see headnote p. 19]
 Carmel, W. J., Jr.,  Dannenberg, T.  Nonthrombocyto-
 penic purpura due to miltown (2-methyl-2-n-propyl-l,3
 propanediol dicarbamate).  N. England  J. M.,  1956,
 255: 770-771.
 Carmichael, L. P.  Serum sickness  type of  reaction to
 meprobamate.  J. Florida M. Ass., 1957, 43: 779.
 Friedman, H. T., Marmelzat, W. L.  Adverse reactions
 to meprobamate.  J. Am. M. Ass., 1956, 162:  628-630.
 Gottlieb, F. I.  Tranquilizers and purpura hemorrhagica.
 J. Am. M. Ass., 1956,161: 96.
 Hollister,  L. E.  Complications from the use of tran-
 quilizing drugs.  N. England J. M., 1957,  257:170-177.
 Kositchek, R. J.  Reactions to meprobamate.  J. Am. M.
 Ass., 1956,161:644.
 Levan, N. E., Mundy, C. F.  Untoward reaction to mepro-
 bamate (Equanil).  California M.,  1956, 85:190.
 Potential  hazards of meprobamate.  J. Am.  M. Ass.,
 1957,164:1332-1333.
 Steffen, C. G, Chervin, M., Van Vranken, B. Reaction
 following  the  use of meprobamate (miltown).  Cali-
 fornia M., 1956, 85 :189-190.
 Toxic effects of meprobamate.  Brit 31. J., 1957, 2: 300.
 Witherspoon, F. G.  Toxic purpura from meprobamate.
 Am. Practitioner, 1957, 8: 270-271.

—Addiction
 Essig, C. F., Ainslie, J. D. Addiction to  meprobamate
  (equanil, miltown).  J. Am. M. Ass., 1957, 164: 1382.
 Expert committee on addiction-producing drugs.  Sev-
 enth report.  World Health Org. Techn. Rep. Ser., 1957
  (116) : 1-15.   [p. 12-15].
 Hollister,  L. E. Tranquilizing drugs and the generalist.
 Med.  Times, Great Neck,  1956, 84:  1021-1026.
 Lemere, F. Drug habituation.  J. Am. M. Ass., 1956,160:
 1431.
 ---.    Habit-forming  properties   of  meprobamate.
 A. M. A. Arch. Neur. Psychiat., 1956, 76:205-206.
 ---.  Promazine (sparine) in the treatment of psychi-
 atric  disorders.  Northwest M., 1956, 55 :  790-791.
 Margolis,  L. H.  Pharmacotherapy  in psychiatry; a re-
 view.  Ann. N. York Acad. Sc, 1957, 66: 698-718.
 Swinyard, E. A., Chin, L., Fingl, E.  Withdrawal hyper-
 excitability following chronic administration of mepro-
 bamate to mice.  Science, 1957,125 : 739-741.
 Tucker, K., Wilensky, H.  A. clinical  evaluation of
 meprobamate therapy in a chronic  schizophrenic popu-
 lation.  Am. J. Psychiat, 1957, 113: 698-703.

—Poisoning
 Allen, A. G., Black, A. V. Near-fatal case of intoxication
 with meprobamate treated with electro-stimulation and
 levarterenol.   Ohio M.  J.,  1956, 52:1303.
 Charet, R., Brill, B., Elloso, C.  Coma after miltown
 overdose.  Ann. Int. M., 1956, 45 :1211-1213.
 Collins-Dineen, M.  Meprobamate toxicity;  report of a
 case.  Ohio M. J., 1956, 52:1304-1305.
 Deisher, J. B.   Ingestion of  12 grams of  meprobamate
 with recovery.  Northwest M., 1956, 55:1083-1085.
 Fryers, G. R.  Drugs for tension and anxiety.  [Com-
 pared with barbiturates.]  Brit. M. J., 1957, 1: 1074.
 Heberden, P., Cooper, W.  Attempted suicide with me-
 probamate treated with leptazol.  Brit M.  J., 1957, 1:
 1513.
 Hiestand, E. C. Overdosage with meprobamate; presen-
 tation of case.   Ohio M. J., 1956, 52:1306-1307.
 Lockhart,  W. E.  Suicidal miltown, hazard of overhy-
 dration in treatment. Southwest. 31., 1956, 37: 428. * *
 Senseman, L. A.  Tranquilizing drugs; uses  and abuses
 for the nervous patient.  Rhode Island M. J., 1956, 39:
 675-677; 680; 686.
  Shane, A. M., Hirsch, S. Three cases of meprobamate
  poisoning.   Canad. M. Ass. J., 1956, 74: 908-909.

with ATARAXICS  [2 or more]
  see ATARAXICS— Various [3 or more]

with AZACYCLONOL—COMBINED
       see AZACYCLONOL—Psychotherapeutic use

with CHLORPROMAZINE
  see CHLORPROMAZINE with  MEPROBAMATE

with ETHYLCROTONYLUREA
  see ETHYLCROTONYLUREA  with MEPROBAMATE

with HYDROXYZINE
  see HYDROXYZINE with MEPROBAMATE

with LYSERGIC ACID DIETHYLAMIDE
       see  LYSERGIC  ACID DIETHYLAMIDE with
         MEPROBAMATE

with MEPHENESIN
  see MEPHENESIN with MEPROBAMATE

with METHYLPHENIDYLACETATE and RESERPINE
       see  MEPROBAMATE  with  RESERPINE  and
         METHYLPHENIDYLACETATE—COMBINED

with N-OBLIVON—COMPARED
  see N-OBLIVON—Studies, animals

with PHENAGLYCODOL—COMPARED
  see MEPROBAMATE—Studies  normal subjects

with PIPRADROL—COMBINED
  Pennington, V. M.  A comparative study of six atarax-
  ics in 1130 neuro-psychiatric cases.  Mississippi Doctor,
  1956, 33: 336-339.

with PROMAZINE—COMBINED
  Fox,  V. The  management of acute alcoholism; experi-
  ences with an additional series of 61 cases.  Am. Practi-
  tioner, 1956, 7:1461-1464.
  Kurtzke, J. F. Seizures with promazine.  Preliminary
  report. J. Nerv. Ment. Dis., 1957,125 :119-125.
with PROMAZINE—COMPARED
  Lemere, F. Promazine (sparine)  in the treatment of
  psychiatric disorders.  Northwest  M.,  1956, 55:790-
  791.

with RESERPINE—COMBINED
  Barsa, J. A., Kline, N. S.  Use of meprobamate in the
  treatment of psychotic patients.  Am. J. Psychiat., 1956,
  112:1023.
  Hormia,  A.  Meprobamaatista  neuropsykiatriassa
  saatuja hoitokokemuksla.   [Meprobamate  therapy  in
  neuropsychiatry.]  [English   summary]   Duodecim,
  Helsin., 1956, 72: 1019-1024.
  Osinski,  W.  A.   Treatment of  anxiety  states with
  meprobamate (miltown).  Internat. Rec. M., 1956, 169:
  589-595.
with RESERPINE—COMPARED
  Lemere, F.  New tranquilizing drugs.   Northwest M.,
  1955, 54:1098-1100.
  ----.   Promazine (sparine) in  the treatment of psychi-
  atric disorders.  Northwest M., 1956, 55: 790-791.
  LeVan, P., Wright, E. T. Use of tranquilizers in diseases
  of the skin; a preliminary report.  California M., 1956,
  85: 87-88.
  Osinski, W. A.  Treatment  of anxiety  states with  me-
  probamate  (miltown).  Internat.  Rec.  M.,  1956, 169-
  589-595. 
Meprobamate : with Reserpine and Methylphenidylacetate
PSYCHOPHARMACA
with RESERPINE and METHYLPHENIDYLACETATE—
    COMBINED
  Sottong, P. C.  The use and abuse of the tranquilizing
  drugs.  J. Tennessee 31. Ass., 1956, 49: 413^18.

with OTHER DRUGS—COMBINED

  Ayd, F. J., Jr. Tranquilizing drugs in private practice.
  [stimulants]  N. York  State J. 31, 1957, 57:1742-1747.
  Borrus, J.  C.  Meprobomate in psychiatric disorders.
  [amphetamine]  Med.  Clin.  N.  America, 1957, 41: 327-
  337.
  Osinski, W. A. Treatment of anxiety  states with mepro-
  bamate (miltown).  [amphetamine,  amobarbital; also
  compared]   Internat. Rec. 31., 1956,  169:589-595.
  Peak, W. P.  Meprobamate (miltown) in rheumatic dis-
  eases,  [prednisolone]  J. Am.  M. Ass., 1957, 163: 535-
  538.

with SHOCK  THERAPY [ECT]—COMBINED

  Laboucarie,  J.,  Barres, P., Rascol, A.  Aspects princi-
  paux des cures neuropiegiques  en psychiatrie en 1956.
  [Principal features of neuroplegic therapy in psychiatry
  in 1956.]  Toulouse me'd., 1956, 57 : 851-867.
  Osinski, W.  A.  Treatment of anxiety states with me-
  probamate  (miltown).  Internat. Rec. 31.,  1956, 169:
  589-595.
  Thai, N.  Premedication  for  electroshock  treatment.
  Effect  of meprobamate in  120  psychotic patients. Dis.
  Nerv. Syst, 1956,17 : 52-57.
MESCALINE

  Cholden, L., ed.  Lysergic acid diethylamide and mesca-
  line in experimental psychiatry.  85 p.  [Round table at
  American Psychiatric Association annual meeting held
  in Atlantic City, N. J., May 1955]  New York, Grune &
  Stratton, 1956.   [Articles  within the scope of this bib-
  liography are listed individually.]
  Denber, H. C. B., Rinkel,  M.,  ed.  Psychodynamic  and
  therapeutic  aspects of mescaline and lysergic  acid di-
  ethylamide.   [Round  table at  American  Psychiatric
  Association  annual  meeting held in Chicago, 111., May
  1956.]  J. Nerv. Ment. Dis., 1957,125: 423^51.  [Preface
  p.  423-424;  Summary  of discussion  p.  450-451]   [All
  articles are listed individually]

Diagnostic use see under MESCALINE—Studies, patients

Intoxication
  see MESCALINE—Pharmacodynamics
                    Studies, normal subjects

Pharmacodynamics
  Delay, J., Thuillier, J. Psychiatrie experimentale et
  psychopharmacologie.   [Experimental  psychiatry  and
  psychopharmacology.]  Sem. hop. Paris, 1956, 32 : 3187-
  3193.
  Evarts, E. V. A review of the neurophysiological effects
  of lysergic acid diethylamide (LSD) and other psychot-
  omimetic agents.  Ann. N. York Acad. Sc, 1957, 66: 479-
  495.
  MacDonald, J. M., Galvin, J. A.  Experimental psychotic
  states. Am. J. Psychiat, 1956,112 : 970-976.
  Pearson, J., Dewhurst,  K.  Mescaline: apotheosis of the
  devil's root.  Irish J.  31. Sc, 1956:139-143.
  Rinkel, M.  Pharmacodynamics of LSD and mescaline.
  J. Nerv. Ment. Dis., 1957,125 : 424-427.
  Walther-Biiel, H. Uber Pharmakopsychiatrie.   [Phar-
  maco-psychiatry.]  Schweiz. med. Wschr., 1953, 83: 483-
  487.  Abstract: Excerpta med., Sect. 8, 1954, 7 : No. 1940.
—Additional data
  The chemical concepts of psychoses.  What's new, 1955
  (189) : 3-7.                               v,. v   •  .
  Fabing, H. D.  Experimental psychoses which mimic
  schizophrenia.  Nebraska  M. J., 1956, 41: 455-459.
  ----   The new pharmacologic attack in psychiatry.
  Internal Rec. 31., 1956, 169: 177-183.  Also:  Drug &
  Cosmet. Indust, 1956, 78: 32-33 ; 125-129.
  Fazekas, J. F., Toupin, H., Alman,  R. W.  Physiologic
  and pharmacologic basis for the chemotherapy of psy-
  chiatrie states.  Am. J. Med., 1956, 21: 825-831.
  Fremming, K. H. Medikamentel behandling af syndssyg-
  domme.  [Medical  treatment  of   mental  disorders.]
  Mskr. prakt. laegegern., Kbh., 1956, 34: 331-342.
  Funderburk, W. H., Wilcox, K. W., Wilcox, P. H.  Drug
  therapy;  physiodynamic  therapy.   II.  Progr. Neur.
  Psychiat, N. Y., 1956, 11: 425-456.
  Graffagnino, P. N., Furr, J. H.  New drugs in the treat-
  ment  of emotional disorders;  a review.   Connecticut
  M. J., 1957, 21: 38-43.
  Kautz, H. D.  Trends in drug  therapy.  Hosp. Progr.,
  1957, 38 (1):102-108; 126.
  Klingman,  W. O.  Neurological and  psychiatric  dis-
  orders ; some recent advances in therapy.   Virginia M.
  Month., 1956, 83 : 240-246.
  Leake,  C.  D. Drugs  affecting mood and  behavior.
  Texas  Rep.  Biol.  M.,  1955,  13:793-818.   Abstract:
  Chem. Abstr., 1956, 50: 9615b.
  Pennes, H. H.  The nature of drugs with mental actions
  and their relation  to cerebral function. Bull. N. York
  Acad. 31., 1957, 33 : 81-88.
  Peretz, D. I., Smythies, J. R., Gibson, W. C.  A new hal-
  lucinogen : 3,4,5-trimethoxyphenyl-/3-aminopropane with
  notes  on the stroboscopic phenomenon.  J. Ment. Sc,
  Lond.,  1955, 101: 317-329.
  Rothlin, E.  Die zentralnervosen Wirkungen  von Heil-
  mitteln.  [The central-nervous effects of drugs.]  39 p.
  Stuttgart, Thieme,  1954.
  Turner, W. J., Merlis, S., Carl, A.  Concerning  theories
  of indoles  in schizophrenigenesis.   Am. J.  Psychiat,
  1955, 112: 466-467.
  Wilcox, P. H., Funderburk, W. H., Wilcox, K.  W.  Drug
  therapy;  physiodynamic   therapy.   II. Progr. Neur.
  Psychiat., N. Y., 1955, 10: 595-608.
  Wortis, J.  Physiological treatment.   Am. J.  Psychiat,
  1957, 113: 611-615.

Psychotherapeutic use
  Denber, H. C. B., Merlis, S.  A note on some therapeutic
  implications of the mescaline-induced state.  Psychiat.
  Q., 1954, 28:634-640. Abstract: Excerpta med., Sect.
  8,1956, 9 : No. 2659.
  ---,  ——.  Studies  on mescaline.  VI.  Therapeutic
  aspects  of  the  mescaline-chlorpromazine  combination.
  J.  Nerv. 31 ent  Dis., 1955,  122:  463-169.  Abstract:
  Excerpta med., Sect. 8, 1957, 10: No. 889.
  Frederking, W.  Intoxicant drugs  (mescaline and ly-
  sergic acid diethylamide)  in psychotherapy.  J.  Nerv.
  Ment.  Dis.,  1955,  121:262-266. Abstract:  Excerpta
  med., Sect. 8,1956,  9: No. 4084.
  ---.   Tiber  die   Verwendung   von   Rauschdrogen
  (Meskalin  und Lysergsaurediaethylamid)  in der Psy-
  chotherapie.  [The use of intoxicating drugs (mescaline
  and  lysergic acid  diethylamide)   in psychotherapy.]
  [English summary]  Psyche, Stuttg., 1953, 7: 342-364.
  Hoch, P. H.  Remarks on LSD and mescaline.  J. Nerv.
  31 ent Dis., 1957, 125 : 442-444.
  MacDonald, J. M., Galvin, J. A.  Experimental psychotic
  states.  An. J. Psychiat., 1956, 112:970-976.
  Merlis,  S.  The effects of mescaline sulfate  in chronic
  schizophrenia.  J.  Nerv. 31ent.  Dis., 1957, 125: 432-434.
  Osmond, H.  A review of the clinical effects of psychoto-
  mimetic agents.  Ann. N. York Acad. Sc, 1957  66: 418-
  434.
110 
SUBJECT  LIST
Mescaline :  Studies, normal subjects
  Peretz, D. I., Smythies, J. R., Gibson, W. C.  A new hal-
  lucinogen : 3,4,5-trimethoxyphenyl-/3-aminopropane with
  notes on  the  stroboscopic phenomenon.  J.  Ment Sc,
  Lond., 1955, 101: 317-329.
  Teirich, H.  Uber eine Meskalinschadigung.   [Injurious
  effect  of  mescaline.]   Psyche,  Stuttg.,  1954,  7: 637-
  640.                                               *

Studies, animals
  Apter, J.  T., Pfeiffer, C. C.  Effect of hallucinogenic
  drugs  on  the  electroretinogram.   Am. J. Ophth., 1956,
  42 (4, Part 2) : 206-211.
  ---,----.  The effect of the hallucinogenic drugs LSD-
  25 and mescaline on  the electroretinogram.  Ann. N.
  York Acad. Sc, 1957. 66:  508-514.
  Bridger, W. H., Gantt, W. H. The effect of mescaline on
  differentiated conditional reflexes.   Am. J. Psychiat.,
  1956,113 : 352-360.
  Cook, L., Weidley, E.  Behavioral effects of some psycho-
  pharmacological agents.  Ann. N. York Acad. Sc, 1957,
  66: 740-752.
  Courvoisier, S.  Pharmacodynamic basis for the use of
  chlorpromazine in psychiatry.  J. Clin. Exp. Psychopath.,
  1956,17 : 25-37.
  ---.  Sur les proprietes pharmacodynamiques de la
  chlorpromazine en rapport  avec son emploi en psychia-
  trie.   [Pharmacodynamic basis  for  the  use of chlor-
  promazine in  psychiatry.]  Encephale, 1956, 45 :1248-
  1257.
  Haley, T. J., McCormick, W. G. Pharmacological effects
  produced  by intracerebral injection of drugs in the con-
  scious mouse.   University of California, School of 3Iedi-
  cine, Atomic Energy Project, Los Angeles, 1956 (UCLA-
  372) :  1-25.
  Himwich, H. E.  The effect of frenquel on EEG changes
  produced  by  LSD-25 and mescaline.  In: Cholden, L.,
  ed.  Lysergic acid  diethylamide and mescaline in ex-
  perimental psychiatry. New  York, Grune  & Stratton,
  1956. p. 19-26.
  Marrazzi, A. S. The effects of certain drugs on cerebral
  synapses.  Ann. N.  York Acad. Sc, 1957, 66: 496-507.
  ---,  Hart, E. R.   An electrophysiological  analysis of
  drugs useful in psychotic states.  In: Himwich, H. E.,
  ed.  Tranquilizing drugs.   Washington, Am. Ass. Adv.
  Sc, 1957.   p. 9-21.
  ---,----.  An electrophysiological analysis of the ac-
  tions of some drugs useful  in the therapy of psychotic
  disorders.  J. Nerv. Ment. Dis., 1956, 124: 388-392.
  ---,----. The possible role of inhibition at adrenergic
  synapses in the mechanism of hallucinogenic and related
  drug actions.  J. Nerv. Ment. Dis., 1955, 122: 453-457.
  Rinaldi, F.  The experimental electroencephalographic
  approach  to psychopharmacology.  Psychiat. Res. Rep.,
  Wash., 1956 (4) : 1-10.
  ---,  Himwich, H.  E.  The  cerebral  electrographic
  changes induced by LSD and mescaline are corrected by
  frenquel.  J. Nerv. Ment.  Dis., 1955, 122: 424-432.  Ab-
  stract : Excerpta med.,  Sect. 8, 1957,  10: No. 1601.
  ---, ----.  Frenquel corrects certain cerebral  electro-
  graphic changes.  Science, 1955, 122 : 198-199.
  Rinkel, M., Hyde, R. W., Solomon, H. C.  Experimental
  psychiatry.  IV. Hallucinogens:  tools in experimental
  psychiatry.  Dis. Nerv. Syst.,  1955, 16: 229-232.
 Rovetta, P.  Effects of mescaline and LSD  on evoked
 responses  especially of the optic system of  the  cat.
 Electroencephalography, Montreal, 1956, 8:15-24.  Ab-
 stract : Excerpta med., Sect. 8, 1957, 10: No. 501.
 Schwarz, B. E., Wakim, K. G., Bickford, R. G., Lichten-
 held, F.  R.  Behavioral  and  electroencephalographic
 effects  of hallucinogenic drugs; changes in  cats on in-
 traventricular injection.  A. M. A. Arch. Neur. Psychiat,
 1956, 75 : 83-90. Abstract: Excerpta med., Sect.  8, 1957,

 Sturtevant, F. M., Drill, V.  A.  Effects of mescaline in
 laboratory animals and influence of ataraxics on mesca-
  line-response.  Proc. Soc. Exp. Biol, N. Y., 1956, 92 : 383-
  387.  Abstract: Chem. Abstr., 1956, 50:15956b.
  Turner, W. J. The effect of lysergic acid diethylamide on
  Betta splendens: I. Dis. Nerv. Syst, 1956, 17:193-197.
  Verdeaux, G., Marty, R. Action sur Teiectroencephalo-
  gramme de  substances pharmacodynamiques d'interet
  clinique.   [Effect of clinically important drugs on  the
  encephalogram.]  Rev.  neur., Par., 1954, 91: 405-427.
  Witt, P. N.  Der  Netzbau  der Spinne  als Test  zur
  Prtifung zentralnervos angreifender Substanzen.  [Con-
  struction of spider webs as  a test for drugs with CNS
  action.]  Arzneimitt Forsch.,  1956, 6:628-635.

Studies, normal subjects
  Ardis,  J.  A., McKellar, P.  Hypnagogic imagery  and
  mescaline.  J. 31ent. Sc, Lond., 1956, 102: 22-29.
  Beltran del  Rio, C. A.  Estudio del peyote en el Indio
  tarahumara,  habituado a su  masticacion.  [Study of
  habitual  peyote-chewing  in  the Tarahumara.]  61 p.
  Mexico, 1953.   (Thesis—Mexico)
  Berlin, L., Guthrie, T., Weider, A.,  Goodell, H., Wolff,
  H. G.  Studies in human cerebral function : the effects of
  mescaline and lysergic  acid on cerebral processes perti-
  nent to creative activity.  J.  Nerv. Ment Dis., 1955, 122 :
  487-491.   Text without drawings: Tr. Am. Neur. Ass.,
  1955, 80th Meeting: 188-190.
  Callaway, E.,  III.   On the production of hallucinated
  and  psychosis-like  states.  Ann. Int. M.,  1955, 42:721-
  728.
  Delay,  J.,  Denber, Deniker,  P., Raclot, M.,  Ropert, M.
  Deux  auto-observations   d'intoxication   mescalinique
  experimentale.  [Mescaline  intoxication;  two auto-ex-
  periments.]   Ann.  me'd, psychol,  Par., 1956, 114 (2)  :
  306-309.  Abstract: Excerpta med., Sect. 8,1957,10:  No.
  1963.
  Ebaugh, F. G.  The videclinic. J. Am. M.  Ass., 1955,
  158: 732-733.
  Endo, K.  Experimental study of  mescalin intoxication
  on relation between clinical picture and EEG in man.
  Fol  psychiat. neur. jap., 1952, 6 :104-113.
  Fabing, H. D.  Frenquel, a  blocking agent against  ex-
  perimental LSD-25 and mescaline psychosis; prelimi-
  nary note on its clinical application.  Neurology, 1955,
  5:319-328.
  Frederking,  W.  Intoxicant  drugs  (mescaline  and  ly-
  sergic acid diethylamide)  in psychotherapy.  J. Nerv.
  Ment  Dis.,   1955,  121:262-266.  Abstract: Excerpta
  med., Sect. 8, 1956, 9: 4084.
  ---. tiber  die Verwendung von Rauschdrogen (Mes-
  kalin and  Lysergsaurediaethylamid)  in der Psycho-
  ther apie.  [The use of intoxicating drugs  (mescaline
  and  lysergic  acid  diethylamide)  in  psychotherapy.]
  [English summary]  Psyche, Stuttg., 1953, 7: 342-364.
  Hoch, P. H.  Studies in routes of administration and
  counteracting  drugs.  In:  Cholden, L.,  ed.  Lysergic
  acid  diethylamide  and mescaline  in  experimental psy-
  chiatry.  New York, Grune  &  Stratton, 1956.  p. 8-12.
  ---, Cattell,  J. P.,  Pennes, H.  H.   Effect of drugs;
  theoretical considerations from a psychological view-
  point.  Am. J. Psychiat., 1952, 108 : 585-589.
  ---,---■,----.  Effects of mescaline and lysergic acid
  (d-LSD-25).  Am. J.  Psychiat,  1952, 108:579-584.
  ---•, Pennes, H. H.,  Cattell, J. P. Psychoses produced
  by administration of drugs.  Res. Pub. Ass. Res. Nerv.
  Ment. Dis., 1953, 32 : 287-296.
  Huxley, A.  The doors of perception.   79 p.  New York,
  Harper, 1954.
  ----.  Heaven  and  hell.  88 p.  London,  Chatto &
  Wind us, 1956.
  ----.  Mescaline and the "other world."   In: Cholden,
  L., ed.   Lysergic acid diethylamide and mescaline in
  experimental psychiatry.   New York, Grune  d Stratton,
  1956.  p. 46-50. 
Mescaline : Studies, normal subjects
PSYCHOPHARMACA
   Kelly, J.   The  influence of  mescaline  on  Rorschach
   responses.   [In  English]  Psychol  Forsch., 1954, 24:
   542-556.
   Lindemann,  E.,  Clarke,  L.  D.  Modifications  in ego
   structure and personality reactions under the influence
   of the effects of drugs.  Am. J. Psychiat., 1952,108: 561-
   567.
   Marriott, A.  The opened door.  New Yorker, 1954, 30
   (32, Sept. 25) : 90-101.
   Matefi,  L.  Mezcalin-  und   Lysergsaurediathylamid-
   Rausch; Selbstversuche mit  besonderer Berficksichti-
   gung eines Zeichentests.   [Mescaline and lysergic acid
   diethylamide  intoxication; autoexperiments with  spe-
   cial consideration of a drawing test.]   [English  sum-
   mary] Confinia  neur., Basel, 1952,  12: 146-177.   Ab-
   stract : Excerpta med., Sect. 8, 1953, 6: No. 1204.
   Mayer-Gross, W., McAdam, W., Walker, J. W. Further
   observations on the effects of lysergic acid diethylamide.
   /. Ment. Sc, Lond., 1953, 99:  804-808.
   Osmond, H.  Research on schizophrenia.  In: Abram-
   son, H.  A.,  ed.  Neuropharmacology.  Transactions of
   the second conference, May 1955, Princeton, N. J.  New
   York, Josiah Macy, Jr. Foundation, 1956.  p. 183-233.
   ----. A review of the clinical effects of psychotomimetic
   agents.  Ann. N. York Acad. Sc, 1957, 66: 418-434.
   ---, Smythies, J.  Schizophrenia: a new approach.  J.
   Ment. Sc, Lond., 1952, 98: 309-315.
   Pearson, J.,  Dewhurst,  K.   Mescaline:  apotheosis of
   the devil's root.   Irish J. M. Sc, 1956:139-143.
   The peyote cult.  Science, 1952, 115: 503-504.
   Rinkel, M., Hyde, R. W.,  Solomon, H. C.  Experimental
   psychiatry.  IV.  Hallucinogens: tools  in experimental
   psychiatry.  Dis. Nerv. Syst,  1955, 16 : 229-232.
   Schwarz, B. E., Bickford, R.  G., Mulder, D. W., Rome,
   H. P. Mescaline and LSD-25 in activation of temporal
   lobe epilepsy.  Neurology, 1956, 6: 275-280.
   ---, ---, Rome, H. P.  Reversibility of induced psy-
   chosis with chlorpromazine.   Proc.  Mayo  Clin., 1955,
   30:407-417.
   Stevenson, I.  Comments on the psychological effects of
   mescaline and allied drugs.   J. Nerv. Ment. Dis., 1957,
   125: 438-442.
   ---, Sanchez, A. J.  The antidotal action of sodium suc-
   cinate in the  mescaline  psychosis.  Am. J.  Psychiat.,
   1957, 114: 328-332.
   Tonini, G., Montanari, C.  Effects of  experimentally in-
   duced psychoses on artistic expression.  [In English]
   Confinia neur., Basel, 1955, 15: 225-239.  Abstract: Ex-
   cerpta med., Sect. 8,1957,10: No. 1439.
   Verdeaux, G, Marty, R.  Action sur l'eiectroencephalo-
   gramme  de  substances pharmacodynamiques d'interet
   clinique.  [Effect of clinically important drugs on the
   encephalogram.]   Rev. neur.,  Par., 1954, 91: 405-427.
   Wikler, A.   Clinical and electroencephalographic studies
   on the effects of  mescaline,  N-allylnorniorphine  and
   morphine in man; a pharmacologic analysis of the func-
   tions of  the spontaneous electrical activity of the cere-
   bral cortex.   J. Nerv. Ment. Dis., 1954, 120:157-175.
   ---.  Mechanisms of action of drugs that modify per-
   sonality  function.   Am. J. Psychiat, 1952, 108: 590-599.
   Wilhelm, M. T. J. Interet de Tepreuve mescalinique
   dans les maladies mentales.   [The  mescaline  test  in
   mental diseases.]  153 p.  [Typewritten] Strasbourg,
   1955.  [Thesis—Strasbourg 1955, no. 48]
  Wolf, R., Das Raum-und Zeiterleben unter abnormen
  Bedingungen, besonders  im  Meskalinrausch.  [Space
  and time perception under anomalous conditions, espe-
  cially  during  mescaline  intoxication.]   Deut.  med.
  Wschr., 1952,  77:168-170.

Studies, patients
  Callaway, E., III.   On the production of hallucinated and
  psychosis-like states.  Ann. Int. M., 1955, 42: 721-728.
  Cattell, J. P.  The influence of mescaline on psychody-
  namic material. J. Nerv. Ment. Dis., 1954,119 : 233-244.
 Delay, J.,  Deniker,  P., Raclot,  M.,  Ropert,  M.  La
 mescaline chez  les malades mentaux;  (constatations
 cliniques).   [The effect of mescaline on mental patients;
 (clinical observations).]   Ann.  me'd.  psychol,  Par.,
 1956, 114 (2) : 300-305.  Abstract: Excerpta med., Sect.
 8, 1957, 10: No. 1962.
 Denber,  H.  C.  B.  Chlorpromazine   et  mescaline.
 [Chlorpromazine and mescaline.]  Ence'phale, 1956, 45:
 440-443.
 ----.   Studies on mescaline.  III. Action  in epileptics.
 Psychiat.  Q.,  1955,  29:433-437.  Abstract:  Excerpta
 med., Sect. 8, 1956, 9 : No. 3660.
 ----.   Studies on mescaline.  VII. The role of anxiety
 in the  mescaline-induced state and its influence on the
 therapeutic result.  J. Nerv. Ment. Dis., 1956,124: 74-77.
 ---, Merlis, S.  Studies  on  mescaline.   I. Action in
 schizophrenic patients; clinical observations and brain
 wave patterns, showing effects before and after electric
 convulsive treatments. Psychiat. Q., 1955, 29 : 421-429.
 ---, ----.   Studies  on mescaline IV: Antagonism be-
 tween mescaline and chlorpromazine.  In: Kline, N. S.,
 ed.  Psychopharmacology.  Washington, Am. Ass. Adv.
 Sc,  1956.  p. 141-144.
 Deniker, P.   Biological changes  in man  following in-
 travenous administration of mescaline.  J. Nerv. Ment.
 Dis., 1957,125 : 427-431.
 ---.   Recent advances in  "pharmaco-psychiatry."  J.
 Clin. Exp. Psychopath., 1956,17: 381-384.
 Endo, K.  Experimental study of mescalin intoxication
 on relation between clinical picture and EEG in man.
 Fol. psychiat. neur. jap., 1952, 6 :104-113.
 Hoch, P. H.   Experimental psychiatry. Am. J. Psychiat,
 1955, 111: 787-790.
 ---, Cattell, J. P.,  Pennes, H. H.  Effect of drugs; the-
 oretical considerations from a psychological viewpoint.
 Am. J. Psychiat, 1952,108 : 585-589.
 ---,----,----. Effects of mescaline and lysergic acid
 (d-LSD-25).  Am. J. Psychiat., 1952, 108:579-584.
 ---, Pennes, H. H., Cattell, J. P.  Psychoses produced
 by administration of drugs.  Res. Pub. Ass. Res. Nerv.
 Ment Dis., 1953, 32 : 287-296.
 Kelly, J.  The influence of mescaline on  Rorschach re-
 sponses.  [In English]  Psychol. Forsch., 1954, 24: 542-
 556.
 Landis, C, Clausen, J.  Certain effects of mescaline and
 lysergic acid on psychological functions.  J. Psychol,
 Provincet., 1954, 38: 211-221.  Abstract: Excerpta med.,
 Sect. 8,1955, 8: No. 1336.
 Martens,  S.   Intracerebral  elektrografi;   ett  viktigt
 hjalpmedel  i psykiatrisk forskning.  [Electroencepha-
 lography, an important aid in  psychiatric research.]
 Sven. lak. tidn., 1956, 53: 2855-2863.
 Merlis,  S.  The effects of mescaline sulfate in chronic
 schizophrenia.  J. Nerv. Ment. Dis., 1957, 125: 432-434.
 ---, Denber, H. C. B.  Studies on mescaline.  V. Elec-
 troencephalographic evidence  for the  antagonism be-
 tween mescaline and  chlorpromazine hydrochloride.  J.
 Nerv. Ment. Dis., 1956,123 : 542-545.
---, Hunter, W.  Studies  on mescaline.  II. Electro-
 encephalogram  in  schizophrenics; effects  of  adminis-
 tration  after electric convulsive  treatment of  schizo-
 phrenic patients.  Psychiat.  Q., 1955, 29 : 430-432. Ab-
 stract :  Excerpta med., Sect.  8, 1956, 9: No.  3659.
Pearson, J.,  Dewhurst, K. Mescaline : apotheosis of the
 devil's root.  Irish J. 31. Sc, 1956: 139-143.
Pennes, H. H.  Clinical reactions of schizophrenics to
 sodium  amytal, pervitin hydrochloride, mescaline sul-
 fate, and d-lysergic acid diethylamide  (LSD-25).  J.
 Nerv. Ment. Dis., 1954,119 : 95-112.
---, Hoch,  P. H.  Psychotomimetics, clinical and the-
 oretical considerations: harmine, WIN-2299  and nal-
 line. Am. J. Psychiat., 1957,113 : 887-892
Sanguineti, I., Negri, V. U., Laricchia, R.  Ritmi elettrici
 cerebrali dopo somministrazione di mescalina e di acido
 lisergico (LSD 25) in malati di mente.   [Electrical 
SUBJECT  LIST
Mescaline :  with Chlorpromazine Interaction : Studies, normal subjects
  rhythms of the brain following administration of mes-
  caline and lysergic acid (LSD 25) to mental patients.]
  Riv.  sper. freniat,  1955,  79: 771-797.   Abstract:  Ex-
  cerpta med., Sect. 8,1957,10: No. 1060.
  ---,  Zapparoli, G.  C,  Laricchia, R.   Studio clinico-
  biologico delle reazioni indotte dal solfato di mescalina
  e dall'acido lisergico (LSD-25)  in  malati di mente.
  [Clinical and physiological study of  mescaline sulfate-
  and lysergic acid (LSD)-induced  reactions in mental
  patients.]  Riv. sper.  freniat,  1956,  80:887-918.
  Schwarz, B. E., Bickford, R. G.,  Mulder, D. W., Rome,
  H. P.  Mescaline and LSD-25 in  activation of temporal
  lobe epilepsy.  Neurology, 1956, 6 : 275-280.
  ---,  Sem-Jacobsen,  C. W.,  Petersen, M. C.  Effects of
  mescaline, LSD-25, and adrenochrome on depth electro-
  grams in  man.  A. M. A.  Arch.  Neur.  Psychiat., 1956,
  75: 579-587.
  Verdeaux, G., Marty, R.  Action sur Teiectroencephalo-
  gramme de  substances pharmacodynamiques d'interet
  clinique.  [Effect of clinically  important drugs on the
  encephalogram.]  Rev. neur. Par.,  1954, 91: 405-427.
  Wilhelm, M. T. J.   Interet de Tepreuve  mescalinique
  dans  les maladies mentales.   [The  mescaline test in
  mental  diseases.]  153 p.   [Typewritten]   Strasbourg,
  1955.  [Thesis—Strasbourg 1955, no. 48]

Therapeutic studies, controlled
  Delay, J., Deniker, P., Raclot, M.,  Ropert, M.  La mesca-
  line chez les  malades  mentaux; (constatations  cli-
  niques).  [The effect of mescaline  on mental patients;
  (clinical  observations).]  Ann.  me'd.  psychol, Par.,
  1956,  114 (2) : 300-305. Abstract: Excerpta med., Sect.
  8,1957,10: No. 1962.
  Merlis,  S.  The effects of mescaline sulfate in chronic
  schizophrenia.  J. Nerv. 31ent. Dis., 1957, 125:  432-434.
 with AZACYCLONOL—INTERACTION
 Studies, animals
   Hart, E. R., Langfitt, T. W., Marrazzi, A. S.  Some cere-
   bral synaptic  aspects  of the pharmacology  of  toxic
   psychoses, tranquilizers  and antidotes.  [Abstract]   J.
   Pharm. Exp. Ther., 1956, 116:27-28.
   Himwich, H. E. The effect of frenquel on EEG changes
   produced by LSD-25 and mescaline.  In: Cholden, L.,
   ed.  Lysergic acid diethylamide and mescaline  in  ex-
   perimental psychiatry.   New York, Grune & Stratton,
   1956.  p. 19-26.
   Marrazzi, A. S.  The effects of certain drugs on cerebral
   synapses.  Ann. N. York Acad Sc, 1957, 66:496-507.
   ---, Hart, E. R.  An electrophysiological analysis of
   drugs useful in psychotic states.  In: Himwich, H. E.,
   ed.  Tranquilizing drugs.  Washington, Am. Ass. Adv.
   Sc, 1957.  p. 9-21.
   ---, ----.  An electrophysiological analysis of the  ac-
   tions of some drugs useful in the therapy of psychotic
   disorders.  J. Nerv. Ment. Dis., 1956, 124: 388-392.
   Rinaldi, F., Himwich, H. E.  The cerebral electrographic
   changes induced by LSD and mescaline are corrected by
   frenquel.  J.  Nerv.  Ment.  Dis.,  1955, 122: 424-432.  Ab-
   stract : Excerpta med., Sect. 8,  1957, 10: No. 1601.
  -—,----.  Frenquel corrects certain cerebral electro-
  graphic changes.  Science, 1955,122:198-199.
  Sturtevant, F. M., Drill,  V.  A.  Effects  of mescaline in
  laboratory animals and influence of ataraxics  on mes-
  caline-response.  Proc Soc.  Exp. Biol, N. Y., 1956, 92:
  383-387.  Abstract: Chem. Abstr., 1956, 50:15956b.

Studies, normal subjects
  Clark, L. D., Further studies of the psychological effects
  of frenquel and a critical review of previous  reports.
 J. Nerv. Ment. Dis., 1956, 123: 557-560.
 Fabing  H. D.   Adventures in clinical neuropharmacol-
 ogy.  Internal Rec. 31., 1956, 169:115-119.
   ---.  Frenquel, a blocking agent against experimental
   LSD-25 and mescaline psychosis;  preliminary note on
   its clinical application.  Neurology, 1955, 5: 319-328.
   ----.  New blocking agent against the development of
   LSD-25 psychosis. Science, 1955,121: 208-210.

 Studies, patients
   Malitz, S., Hoch, P. H., Lesse, S.  A two-year evaluation
   of chlorpromazine in clinical research and practice.  Am.
   J. Psychiat., 1956, 113: 540-545.

 with CHLORPROMAZINE—INTERACTION

 Pharmacodynamics
   Hoch, P. H.  Progress in psychiatric therapies.  Am. J.
   Psychiat, 1955,  112 : 241-247.

 Psychotherapeutic use
   Denber, H. C. B. Chlorpromazine et mescaline. [Chlor-
   promazine and mescaline.  Ence'phale, 1956, 45: 440-443.
   ---.  Studies on mescaline.  VII.  The role of anxiety
   in the mescaline-induced state and its influence on the
   therapeutic result. J. Nerv. Ment. Dis.,  1956, 124: 74-
   77.
   ---, Merlis, S.  A note on some therapeutic implications
   of the mescaline induced state.  Psychiat. Q., 1954, 28:
   634-640. Abstract: Excerpta med., Sect. 8, 1956, 9: No.
   2659.
   ---, ----.  Studies on  mescaline.   VI. Therapeutic
   aspects  of the  mescaline-chlorpromazine  combination.
   J. Nerv. Ment. Dis., 1955, 122: 463-469.  Abstract: Ex-
   cerpta med., Sect. 8,1957,10: No. 889.

 Studies, animals
   Cook, L., Weidley, E.  Behavioral effects of some psycho-
   pharmacological agents.  Ann. N. York Acad.  Sc,  1957,
   66: 740-752.
   Courvoisier, S.  Pharmacodynamic  basis for the use of
   chlorpromazine in psychiatry.  J. Clin. Exp. Psychopath.,
   1956, 17: 25-37.
   ---.  Sur les  proprietes  pharmacodynamiques  de la
   chlorpromazine  en rapport avec son emploi en psychi-
   atrie.  [Pharmacodynamic basis  for  the  use  of chlor-
   promazine  in  psychiatry.]   Ence'phale, 1956,  45 :1248-
   1257.
   Deniker, P.  Psychophysiologic  aspects  of  the  new
   chemotherapeutic drugs in psychiatry; some  practical
   features of "neuroleptics" in order to screen new drugs.
   J. Nerv. Ment. Dis., 1956,124 : 371-376.
   Hart, E. R., Langfitt, T. W., Marrazzi, A.  S.  Some cer-
   ebral synaptic aspects of the pharmacology of toxic psy-
   choses,  tranquilizers  and  antidotes.  [Abstract]  J.
   Pharm. Exp. Ther., 1956,116: 27-28.
   Marrazzi, A. S.  The effects of certain drugs on cerebral
   synapses.  Ann.  N. York Acad. Sc,  1957, 66: 496-507.
  ----, Hart, E. R. An electrophysiological analysis of
   drugs useful in  psychotic  states.  In:  Himwich, H. E.,
   ed.  Tranquilizing drugs.   Washington, Am. Ass.  Adv.
   Sc, 1957.  p. 9-21.
  ----,  ----.   An electrophysiological  analysis of the
  actions of some drugs useful in the therapy of psychotic
  disorders.  J. Nerv. Ment. Dis., 1956, 124: 388-392.
  Rinaldi, F., Himwich, H. E. The cerebral electrographic
  changes induced  by LSD and mescaline are corrected by
  frenquel.  J. Nerv. Ment. Dis., 1955, 122: 424-432.
  Sturtevant, F. M., Drill, V. A.  Effects of mescaline in
  laboratory animals and influence of  ataraxics on mesca-
  line-response.  Proc Soc  Exp. Biol,  N.  Y., 1956, 92:
  383-387.  Abstract: Chem. Abstr., 1956, 50:15956b.

Studies, normal subjects
  Delay,  J., Denber, Deniker, P., Raclot, N., Ropert, M.
  Deux auto-observations d'intoxication  mescalinique ex-
  perimentale.   [Mescaline  intoxication;   two  auto-ex-
  periments.] Ann. med.  psychol,  Par., 1956, 114  (2) :
  306-309.  Abstract: Excerpta med., Sect. 8, 1957. 10:
  No. 1963.
113 
Mescaline :  with Chlorpromazine Interaction : Studies, normal subjects
PSYCHOPHARMACA
  Schwarz, B. E., Bickford, R. G, Rome, H. P.  Reversi-
  bility of induced psychosis with chlorpromazine.  Proc
  3Iayo Clin., 1955, 30: 407-417.

Studies, patients
  Denber, H. C. B.  Studies on mescaline.  VII. The role
  of anxiety in the mescaline-induced  state and  its in-
  fluence on the therapeutic result.  J.  Nerv. Ment. Dis.,
  1956, 124: 74-77.
  ---, Merlis,  S.  Studies on mescaline IV: Antagonism
  between  mescaline   and chlorpromazine.  In:  Kline,
  N. S., ed. Psychopharmacology.  Washington, Am. Ass.
  Adv. Sc, 1956.  p. 141-144.
  Deniker, P.  Biological changes in man following intra-
  venous administration of mescaline.  J. Nerv. Ment Dis.,
  1957,125: 427-431.
  ---.   Recent advances in "pharmaco-psychiatry".  J.
  Clin. Exp. Psychopath., 1956, 17:381-384.
  Hoch,  P. H.  Experimental psychiatry.  Am. J. Psy-
  chiat, 1955, 111 : 787-790.
  Malitz, S., Hoch, P.  H., Lesse, S.  A two-year evaluation
  of chlorpromazine  in  clinical  research and practice.
  Am. J. Psychiat., 1956,113 : 540-545.
  Merlis, S., Denber,  H. C. B.  Studies  on mescaline.   V.
  Electroencephalographic evidence  for the antagonism
  between  mescaline  and chlorpromazine hydrochloride.
  J. Nerv. Ment. Dis., 1956,123 : 542-545.
  Obiols, J.  Notre experience sur la therapeutique par la
  chlorpromazine.  [Our experience with chlorpromazine
  therapy.]  Ence'phale, 1956, 45 : 698-699.
  Schwarz, B.  E., Sem-Jacobsen, C. W., Peterson, M. C.
  Effects of mescaline, LSD-25,  and  adrenochrome  on
  depth electrograms in man.  A. M. A. Arch. Neur. Psy-
  chiat., 1956, 75: 579-587.

Therapeutic studies, controlled
  Delay, J., Deniker, P., Raclot, M., Ropert, M.   La mesca-
  line chez les malades  mentaux;  (constatations  clin-
  iques).  [The effect of  mescaline on  mental patients;
  (clinical  observations).]   Ann.  med.  psychol, Par.,
  1956, 114 (2) : 300-305.  Abstract: Excerpta med., Sect.
  8,1957,10 : No. 1962.
  Denber,   H.  C.  B. Chlorpromazine  et   mescaline.
  [Chlorpromazine  and  mescaline.]   Ence'phale,  1956,
  45:440-443.
  ---.   Studies on mescaline.  VII. The role  of anxiety
  in the mescaline-induced state and  its influence on the
  therapeutic result.   J. Nerv. Ment. Dis., 1956, 124: 74-
  77.

with LYSERGIC ACID DIETHYLAMIDE—COMBINED

Studies, normal subjects
  Clark, L. D., Bliss,  E. L.  Psychopharmacological stud-
  ies of lysergic acid diethylamide (LSD-25) intoxication.
  Effects of  premedication with BOL-148  (2-bromo-
  (Z-lysergic acid diethylamide), mescaline, atropine, amo-
  barbital, and chlorpromazine.  A.  M. A. Arch. Neur.
  Psychiat, 1957, 78 : 653-655.

with LYSERGIC ACID DIETHYLAMIDE—COMPARED

  Courvoisier,  S.  Pharmacodynamic  basis for the use of
  chlorpromazine  in  psychiatry.   J.  Clin.  Exp. Psycho-
  path., 1956, 17: 25-37.
  Jarvik, M. E.  Mechanism of  action of lysergic acid
  diethylamide, serotonin, and related drugs.   In: Kline,
  N. S., ed.  Psychopharmacology.  Washington, Am. Ass.
  Adv. Sc, 1956.  p. 145-154.
  Jatzkewitz,  H.  Pharmakologische   Aspekte  in  der
  Schizophrenieforschung.  [Pharmacological  aspects in
  schizophrenia research.]   Nervenarzt, 1956, 27 :150-152.
  Pearson, J., Dewhurst, K. Mescaline  : apotheosis of the
  devil's root.  Irish J. M. Sc, 1956:139-143.
  Rinkel, M., Solomon, H. C.  Chemical theories  of  psy-
  chosis.  J. Clin.  Exp. Psychopath.,  1957, 18:323-334,
  Savage, C, Cholden, L.  Schizophrenia and  the model
  psychoses.  J. Clin. Exp. Psychopath., 1956, 17 : 405-413.
  Wikler, A.  The uses of drugs  in psychiatric research.
  Am. J. Psychiat,, 1956, 112 : 961-969.

Studies, animals
  Cook, L., Weidley, E.   Behavioral effects of some psycho-
  pharmacological agents.  Ann. N. York Acad. Sc, 1957,
  66: 740-752.
  Keller, D. L., Umbreit, W. W.  Chemically altered per-
  manent behavior patterns in fish  and  their cure by
  reserpine.  Science, 1956, 124: 407.
  ___> ----.  Permanent alteration of behavior in mice
  by chemical  and psychological  means.  Science, 1956,
  124: 723-724.
Studies, normal subjects
  Hoch,  P. H., Cattell, J. P., Pennes, H.  H.  Effects of
  mescaline  and  lysergic  acid   (d-LSD-25). Am. J.
  Psychiat, 1952, 108 :  579-584.
  Matefi,  L.  Mezcalin-  und  Lysergsaurediathylamid-
  Rausch; Selbstversuche mit  Berticksichtigung  eines
  Zeichentests.  [Mescaline and lysergic acid diethylamide
  intoxication; autoexperiments  with special  considera-
  tion of a drawing test.]  [English summary]  Confinia
  neur.,  Basel,  1952,  12:146-177.  Abstract: Excerpta
  med., Sect. 8, 1953, 6: No. 1204.
  Mayer-Gross, W., McAdam, W., Walker, J. W. Further
  observations on the effects of lysergic acid diethylamide.
  J. Ment Sc,  Lond., 1953, 99: 804-808.
  Rinkel, M.  Experimentally induced psychoses in man.
  In: Abramson, H.  A., ed.  Neuropharmacology.  Trans-
  actions of the second conference, May 1955,  Princeton,
  N. J.   New York, Josiah 3Iacy, Jr. Foundation, 1956.  p.
  235-258.
  Tonini, G.,  Montanari, C.  Effects  of experimentally
  induced psychoses on artistic expression.   [In English]
  Confinia neur., Basel, 1955, 15 : 225-239.  Abstract:  Ex-
  cerpta med., Sect. 8, 1957, 10: No. 1439.

Studies, patients
  Cholden, L. S., Kurland, A.,  Savage, C. Clinical reac-
  tions and tolerance  to LSD in chronic schizophrenia.
  J. Nerv. 3Ient Dis.,  1955, 122 : 211-221.  Abstract:  Ex-
  cerpta med., Sect. 8,  1956, 9: No. 4015.
  Hoch, P.  H., Cattell, J. P., Pennes,  H. H.  Effects of
  mescaline  and lysergic  acid  (d-LSD-25).  Am. J.
  Psychiat, 1952, 108: 579-584.
  Landis, C, Clausen, J.  Certain effects of mescaline and
  lysergic acid  on psychological  functions.  J. Psychol.,
  Provincet, 1954, 38:  211-221.  Abstract: Excerpta med.,
  Sect. 8,1955, 8 : No. 1336.
  Sandison, R. A., Spencer, A. M., Whitelaw, J. D. A.  The
  therapeutic value  of lysergic acid diethylamide in men-
  tal illness.  J. Ment Sc, Lond.,  1954, 100: 491-507.  Ab-
  stract : Excerpta med., Sect. 8, 1955, 8: No. 930.

with  LYSERGIC  ACID  ETHYLAMIDE—COMPARED

Studies, normal subjects
  Tonini, G., Montanari, C.  Effetti psichici della monoe-
  tilamide dell'acido lisergico  (LAE 32).  [Psychological
  effects of  lysergic  acid  monoethylamide  (LAE  32).]
  Gior. psichiat, 1955, 83 : 355-357.

with METHOPROMAZINE—INTERACTION
 Therapeutic use
  Delay, J., Deniker, P., Raclot,  M., Ropert, M.  La  mes-
  caline chez les malades mentaux;  (constatations  clin-
  iques).  [The effect of mescaline  on mental patients;
   (clinical observations).]  Ann. me'd. psychol, Par.,  1956,
   114 (2): 300-305.   Abstract:  Excerpta med.,  Sect. 8,
   1957, 10: No. 1962.
114 
SUBJECT  LIST
Methylphenidylacetate : Studies, animals
 with PROMETHAZINE—INTERACTION
 Therapeutic studies, controlled
  Denber, H. C. B.   Studies on mescaline.  VII. The role
  of anxiety in the mescaline-induced state and its  in-
  fluence on the therapeutic result.  J. Nerv. Ment Dis.,
  1956, 124: 74-77.

 with RESERPINE—INTERACTION
 Studies, animals
  Burton, R. M.  The analeptic  action of lysergic acid
  diethylamide on reserpine-sedated mice.  Ann. N.  York
  Acad. Sc, 1957, 66 : 695-697.
  Cook, L., Weidley, E. Behavioral effects of some psycho-
  pharmacological agents.  Ann. N. York Acad. Sc,  1957,
  66: 740-752.
  Marrazzi, A. S. The effects of certain drugs on cerebral
  synapses.  Ann. N. York Acad. Sc, 1957, 66: 496-507.
  ---, Hart, E. R.  An electrophysiological analysis of
  drugs useful in psychotic states.  In: Himwich, H.  E.,
  ed. Tranquilizing drugs.  Washington, Am. Ass.  Adv.
  Sc, 1957.  p. 9-21.
  ---,----.  An electrophysiological analysis of the  ac-
  tions of some drugs useful in the therapy of psychotic
  disorders. J. Nerv. Ment. Dis., 1956, 124: 388-392.
  Sturtevant, F. M., Drill, V. A.  Effects of mescaline in
  laboratory animals and influence of ataraxics on mes-
  caline-response.  Proc Soc. Exp. Biol, N. Y., 1956, 92:
  383-387.  Abstract: Chem. Abstr., 1956, 50:15956b.
 Studies, patients
  Hoch, P. H. Experimental psychiatry.  Am. J. Psychiat,
  1955, 111: 787-790.

 with SEROTONIN—INTERACTION
  see SEROTONIN with MESCALINE

 with TMA—COMPARED see TMA

 with OTHER  DRUGS—INTERACTION
 Studies, animals
  Cook, L., Weidley, E. Behavioral effects of some psycho-
  pharmacological agents.  Ann. N. York Acad. Sc,  1957,
  66: 740-752.
  Rovetta, P.  Effects of mescaline and LSD on evoked
  responses  especially of the  optic system  of  the cat.
  Electroencephalography, Montreal, 1956, 8:15-24.  Ab-
  stract : Excerpta med., Sect. 8, 1957,10: No. 501.

 Studies, normal subjects
  Tonini,  G., Montanari,  C.   Effects of experimentally
  induced psychoses on artistic  expression.   [In  Eng-
  lish]  Confinia  neur.,  Basel, 1955,  15:225-239.  Ab-
  stract : Excerpta med., Sect. 8, 1957, 10: No. 1439.

 Studies, patients
  Deniker, P. Recent advances in  "pharmaco-psychiatry."
  J. Clin. Exp. Psychopath., 1956, 17: 381-384.
  Hoch, P. H. Experimental psychiatry.  Am. J. Psychiat,
  1955, 111: 787-790.
  Pennes, H. H.  Clinical reactions of schizophrenics to
  sodium amytal, pervitin  hydrochloride, mescaline sul-
  fate, and d-lysergic acid diethylamide (LSD-25).  J.
  Nerv. Ment. Dis., 1954, 119 : 95-112.

with  INTERMITTENT PHOTIC STIMULATION
Studies, normal subjects
  Elkes, J.  Effects  of psychosomimetic drugs in animals
  and man.  In: Abramson, H.  A., ed.  Neuropharmacol-
  ogy. Transactions of the third conference, May  1956,
  Princeton  N J.  New York, Josiah Macy, Jr. Founda-
  tion, 1957!  p. 205-295. [p. 266-67]
  Osmond H  A review of the  clinical effects of psycho-
  tomimetic  agents.   Ann. N. York Acad. Sc, 1957, 66:
  418-434.
with SHOCK THERAPY [EST]
Studies, patients
  Hoch, P. H. Experimental psychiatry. Am. J. Psychiat.,
  1955, 111: 787-790.
METHOPROMAZINE
  Deniker,  P.   Hibernotherapies et medicaments neuro-
  leptiques  en  therapeutique psychiatrique.   [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapy.]
  Ence'phale, 1957, 46:281-398.  [p. 362; 383-84.]
  Perrault, M.  Sur les tranquilliseurs.  [Tranquilizers.]
  Progr. med., Par., 1957, 85: 3-4; 7.
  Viaud,  P. Les amines  derivees de la phenothiazine.
  [The amino-derivatives of phenothiazine.]  J.  Pharm.,
  Lond., 6: 361-389.
Studies, animals
  Bradley, P. B., Hance, A. J.  The effect of chlorpromazine
  and methopromazine on the electrical activity of  the
  brain  in  the  cat.  Electroencephalography,  Montreal,
  191-215.
Therapeutic use
  see METHOPROMAZINE [deniker]
with CHLORPROMAZINE—COMPARED
  see METHOPROMAZINE

with  LYSERGIC  ACID  DIETHYLAMIDE—INTER-
        ACTION
      see METHOPROMAZINE—Studies, animals

with MESCALINE
  see MESCALINE with METHOPROMAZINE—INTER-
    ACTION— Therapeutic use
METHYLPHENIDYLACETATE

  Fabing, H. D.  The newer analeptic drugs.  Med. Clin.
  N. America, 1957, 41: 339-351.
  Symposium: The relative values of drugs in the various
  psychiatric syndromes.   Psychiat Res. Rep., Wash.,
  1956 (4) : 35-78.  [All articles are listed individually]
Diagnostic use
  Stier,  C.  Die Anwendung des zentralen  Stimulans
  Ritalin bei depressiven Zustanden und zur Untersttit-
  zung der Elektroschoektherapie.  [The use of  ritalin, a
  stimulant of the central nervous system, in depressive
  states  and  as  adjuvant  in  electroshock  therapy.]
  Ther. Gegenwart, 1955, 94 : 92-95.

Studies,  animals
  Cole, J., Glees, P.  Ritalin as an antagonist to  reserpine
  in monkeys.  Lancet, Lond., 1956, 1: 338.
  ---,----.  Some effects of methyl-phenidate  (ritalin)
  and amphetamine on normal and leucotomized  monkeys.
  ,/. Ment. Sc, Lond., 1957, 103: 406-417.
  Davis,  G. D.  Effects of central excitant and depressant
  drugs on locomotor activity  in  the monkey. Am. J.
  Physiol, 1957,  188: 619-623.
  Meier,  R., Gross, F., Tripod, J.  Ritalin, eine neuartige
  synthetische Verbindung mit spezifischer  zentralerre-
  gender Wirkungskomponente.  [Ritalin, a new  synthetic
  compound  with  specific   analeptic  action.]   Klin.
  Wschr., 1954,  32:445^50.  Abstract:  Chem.  Abstr.,
  1954, 48: 8945e.
  Plummer, A. J., Maxwell, R., Earl, A. E. Influence of
  methyl-alpha-phenyl-2-piperidine  acetate hydrochloride
  on the pharmacological actions of reserpine.  [Abstract]
  Fed. Proc, Bait, 1956,15: 468.
115 
Methylphenidylacetate : Studies, normal subjects
PSYCHOPHARMACA
Studies, normal subjects
  Drassdo, A.,  Schmidt,  M.  Ritalin, ein zentrales Stim-
  ulans  mit  neuartiger  chemischer  Konstitution.  1.
  Kreislauf untersuchungen. 2. Verbesserung der geistigen
  Leistungsfahigkeit  und  psychische  Wirkung   durch
  Ritalin.  [Ritalin, a central stimulant of novel  chem-
  ical  constitution.  1.  Studies  on blood  circulation.
  2.  Improvement of  mental efficacy and the psychologic
  effects of ritalin.]  [English  summaries, p.  310; 395]
  Med. 3Ischr.,  1954, 8: 306-310; 393-395.
  Gruber,  K.,  Illig,  H.,  Pflanz,  M. Zur Prufung  der
  sogenannten  zentralen  Stimulantien  am  Menschen.
  [Evaluation  of  so-called  central stimulants in  man.]
  Deut. med. Wschr.,  1956, 81:1130-1133.
  Heiss, R., Becker, H., Hiltmann, H., Honsberg, I.  Uber
  psychische Wirkungen eines neuartigen Psychotonikums.
  [Psychological  effects  of  a  new central stimulant.]
  Medizinische, 1956:260-262.
  Morpurgo, V.   Osservazioni  cliniche su  una   nuova
  sostanza ad  azione eccitante centrale.   [Clinical ob-
  servations on a new substance with central stimulating
  effect]   [English  summary]    Minerva  anest., Tor.,
  1956,  22:110-114.  Abstract:   J.  Am.  M. Ass., 1956,
  161:1514.

Therapeutic studies,  controlled
  Arbesman, C. E. Report of the Committee on drugs of
  the research  council of the American Academy  of Al-
  lergy, 1954-1955.  Plimasin.   J. Allergy, 1955, 26 : 379-
  381.  Abstract as:  Clinical studies in allergy with  sev-
  eral new drugs.   Drug I. J. Allergy, 1955, 26: 87.
  Ayd, F. J., Jr. A clinical evaluation of methyl-phenidy-
  lacetate hydrochloride (ritalin). J. Clin. Exp. Psycho-
  path., 1957, 18:342-346.
  Carey, B., Weber, M.,  Smith, J. A. Methyl-phenidylace-
  tate  hydrochloride  (ritalin)   in  the  treatment  of
  chronic schizophrenic patients.  Am. J. Psychiat., 1956,
  113: 546-547.
  Clark, L. D., Ellsworth, R. B., Barrett, W. W., Thurman,
  A. C, Holland, W.  Studies of the behavioral effects of
  ritalin.  Dis. Nerv. Syst, 1956,  17: 317-321.
  Daly, D. D.,  Yoss, R. E.  The treatment of narcolepsy
  with methyl  phenylpiperidylacetate: a preliminary re-
  port.   Proc. Mayo Clin., 1956,  31: 620-625.
  Davidoff, E.,  Best, J. L., McPheeters, H. L.   The effect
  of  ritalin  (methyl-phenidylacetate hydrochloride) on
  mildly depressed ambulatory  patients.   N. York State
  J. M., 1957, 57 : 1753-1757.
  Ferguson, J.  T.  Improved behavior patterns  in the hos-
  pitalized mentally ill  with reserpine and methyl-pheni-
  dylacetate. Psychiat. Res. Rep., Wash., 1956 (4) : 35-43.
  ---.  What's new and usable  in the chemical treatment
  of abnormal  behavior.  J. Michigan M.  Soc., 1956, 55:
  1095-1101.
  ---,  Funderburk,  W.  H.  Improving senile behavior
  with reserpine  and ritalin; new approach with  use of
  methyl phenylpiperidylacetate.  J. Am.  M. Ass., 1956,
  160:259-263.  Abstract: Excerpta med., Sect. 8, 1956,
  9: No. 3520.  Year book of drug therapy, 1956-1957, p.
  344-346.
  ---,  Linn,  F.  V.,  Sheets,  J.  A., Jr., Nickels, M. M.
  Methylphenidate  (ritalin)  hydrochloride   parenteral
  solution ; preliminary report.  J. Am. M. Ass., 1956, 162:
  1303-1304.
  Friedlaender, S.  Report of the Committee on new drugs
  of the  research council of the American  Academy of
  Allergy, 1955-1956.  Plimasin.   J. Allergy,  1956,  27:
  288-290.
  Jacobson, A. Ritalin—a new agent for mild  depres-
  sions ; a preliminary report.   Med. Ann. District of Co-
  lumbia, 1956, 25 : 491-494; 527-528.
  Kugelmass, I. N.  Psychochemotherapy of mental de-
  ficiency in children.  Internal Rec M.,  1956, 169: 323-
  338.
  McPheeters, H., Fox, W. W.  Evaluation  of reserpine
  and  methyl phenidylacetate  used separately and in
  combination in  chronic psychotic patients.  J.  Ken-
  tucky M. Ass., 1956, 54: 785-791.
  Madi,  M.  L.,  Kovitz,  B.  Experiences with methyl-
  phenidylacetate hydrochloride (ritalin) in psychotic pa-
  tients.  Antibiotic M., 1956, 3 : 309-311.
  Rashkis, H. A., Smarr,  E. R.  Drug and milieu effects
  with chronic schizophrenics.  A. M. A. Arch. Neur. Psy-
  chiat, 1957, 78: 89-94.
  Wells, R. E. Use of reserpine (serpasil) in the manage-
  ment  of chronic alcoholism.   J. Am. M. Ass., 1957, 163:
  426-429.

Therapeutic use
  Alema, G., Sergio,  C.  Prime  esperienze  cliniche con
  una nuova sostanza psicomimetica.  [First clinical ex-
  periences with a new psychomimetic drug.]  Riv. sper.
  freniat, 1956,  80 : 989-994.
  Brooks, G. W. Experiences with the use of chlorpro-
  mazine and reserpine in psychiatry, with special refer-
  ence to the significance and management of extrapyra-
  midal dysfunction.  N.  England J. M., 1956, 254:1119-
  1123.  Abstract: Year book of dru\g therapy, 1956-1957,
  p. 343-344.
  Coulter, E. B. Nursing care problems associated with
  the use of ataraxic drugs. Hawaii M.  J., 1957, 16: 303-
  304.
  Fabing, H. D.  The newer analeptic drugs.  Med. Clin.
  N. America, 1957, 41: 339-351.
  Ferguson, J. T.   Further evaluation of the new drug:
  methyl-phenidylacetate.  [Abstract]  J. Pharm.  Exp.
  Ther., 1956, 116: 20.
  ---.   Successful therapeutic regimen for the manage-
  ment  of  behavior  problems  in the  elderly.  J.  Am.
  Geriat Soc, 1956, 4 :1080-1084.
  ---.   Treatment of reserpine-induced depression with
  a new analeptic:  phenidylate.  Ann. N. York Acad. Sc,
  1955,  61:101-107.  Abstract: Excerpta med., Sect. 8,
  1956,  9: No. 1721.
  Geller, W. Behandlung depressiver  Verstimmungs-
  zustande mit einem neuen zentralen Stimulans.  [Treat-
  ment of depressive states with a new central stimu-
  lant.]   Medizinische, 1955:606-608.
  Kurtzke, J. F. Seizures with promazine.   Preliminary
  report. J. Nerv. Ment Dis., 1957, 125 :119-125.      *
  Natenshon, A. L. Clinical  evaluation of ritalin.   Dis.
  Nerv. Syst, 1956,17: 392-396.
  Pennington, V. M.  Research findings in  phrenotropic
  drugs important  to every physician.   Mississippi Doc-
  tor, 1957, 35: 57-63.
  Sainz, A.  A.  The management of side effects of chlor-
  promazine and reserpine.  Psychiat.  Q., 1956, 30: 647-
  653.
  Stier, C.  Die Anwendung des zentralen Stimulans
  Ritalin bei  depressiven Zustanden  und  zur  Unter-
  stiitzung der Elektroschoektherapie.   [The use of rita-
  lin, a stimulant  of the central nervous system, in de-
  pressive states and as adjuvant in electroshock therapy.]
  Ther. Gegenwart, 1955,  94 : 92-95.

—Additional data
  Block, M. A.  Medical treatment of alcoholism.  J. Am.
  M. Ass., 1956, 162:1610-1619.
  Cohen, I. M. Drugs recently introduced in the treatment
  of psychiatric disorders.  Texas J. M., 1956, 52: 683-687.
  Fabing, H. D. The ataractic drugs: their  uses and lim-
  itations in  psychiatry.   Am.  Profes. Pharmacist,  1956,
  22:413-418.
  Funderburk, W. H., Wilcox, K.  W„ Wilcox, P. H.   Drug
  therapy;  physiodynamic therapy.  II.   Progr.  Neur.
  Psychiat., N. Y., 1956, 11: 425-456.
116 
SUBJECT LIST
Me thylpromazine
   Graffagnino, P. N., Furr, J. H. New drugs in the treat-
   ment of emotional disorders;  a review.  Connecticut M.
   J., 1957, 21: 38-43.
   Heilbrunn, G. Selection of patients for modern psychi-
   atric pharmacotherapy in general practice.  Northwest
   M., 1956, 55 :1198-1205.
   Billiard, E. T.  The use of reserpine,  chlorpromazine
   and allied  drugs  in medicine and psychiatry. Med. J.
   Australia, 1956, 43 (1) : 1035-1040.
   Kautz, H. D.  Trends in drug therapy.  Hosp. Progr.,
   1957,38 (1) : 102-108; 126.
   Kinross-Wright, V.  A review of the new drug therapies
   in psychiatry. Dis. Nerv. Syst.,  1956, 17:187-190.
   ---.  The  uses  and limitations of  the  newer drugs
   in the treatment of nervous conditions.  Wisconsin M. J.,
   1956, 55:1073-1078.
   Klingman,  W. O.  Neurological and psychiatric  dis-
   orders ; some recent advances in therapy.   Virginia M.
   Month., 1956, 83 : 240-246.
   Leake, C. D.  Drugs affecting mood and behavior.  Texas
   Rep. Biol. M., 1955,13: 793-818. Abstract:  Chem. Abstr.,
   1956, 50: 9615b.
   ---. New mood-changing drugs.  Ohio M. J., 1956, 52:
   369-373.
   Morgan, D. R. The use of reserpine, chlorpromazine and
   allied drugs in medicine and psychiatry.  Med. J. Aus-
   tralia, 1956, 43 (1) : 1029-1035.
   Sottong, P. C. The use and abuse  of the  tranquilizing
   drugs. J. Tennessee M. Ass., 1956, 49 : 413-418.
   Weinberg, H. B.   Drug therapy for  the emotionally and
   mentally disturbed;  the internist's point of view.   J.
   Iowa M. Soc, 1957, 47:17-19.
   Wortis, J.  Physiological  treatment.  Am. J. Psychiat.,
   1957,  113: 611-615.

 with AZACYCLONOL
   see AZACYCLONOL with  METHYLPHENIDYLACE-
         TATE—COMBINED

 with CHLORPROMAZINE
   see CHLORPROMAZINE with METHYLPHENIDYL-
        ACETATE

 with CHLORPROMAZINE  and RESERPINE
   see CHLORPROMAZINE   with   RESERPINE   and
        METHYLPHENIDYLACETATE

 with MER-22—COMPARED
   see MER-22—Studies, animals

 with MEPROBAMATE and RESERPINE
   see MEPROBAMATE with RESERPINE  and METH-
        YLPHENIDYLACETATE

 with PROMAZINE—COMBINED
   see PROMAZINE with METHYLPHENIDYLACETATE

 with PIPRADROL—COMPARED

  see also under MER-22—Studies, animals
  Daly,  D. D., Yoss, R. E.  The treatment of  narcolepsy
  with methyl phenylpiperidylacetate: a preliminary  re-
  port.  Proc. Mayo Clin., 1956, 31: 620-625.
  Fabing, H. D.  The newer analeptic drugs.  Med. Clin.
  N. America, 1957, 41: 339-351.

with RESERPINE
  see RESERPINE with METHYLPHENIDYLACETATE
with RESERPINE  and CHLORPROMAZINE
  see CHLORPROMAZINE   with   RESERPINE   and
       METHYLPHENIDYLACETATE—COMBINED

with RESERPINE and MEPROBAMATE
  see MEPROBAMATE with  RESERPINE  and METH-
       YLPHENIDYLACETATE—COMBINED
with OTHER DRUGS—COMBINED

  see  also  METHYLPHENLD YLACETATE — Studies,
              normal subjects
            RESERPINE  with  METHYLPHENIDYL-
            ACETATE and OTHER DRUGS

Therapeutic studies, controlled
  Arbesman, C. E. Report of the Committee on drugs of
  the research council of the American Academy of Al-
  lergy, 1954-1955.  Plimasin. J. Allergy, 1955, 26 : 379-
  381.   Abstract  as:  Clinical  studies  in  allergy  with
  several new drugs. Drug I. J. Allergy, 1955, 26: 87.
  Carter,  C.  H.  The effects of  reserpine and methyl-
  phenidylacetate (ritalin) in mental defectives, spastics,
  and epileptics.  Psychiat. Res. Rep.,  Wash., 1956  (4) :
  44-48.
  Friedlaender, S.  Report  of the  Committee on new
  drugs of the research council of the American Academy
  of Allergy, 1955-1956.  Plimasin.   J.  Allergy, 1956, 27:
  288-290.
  Fuchs, M.,  Brown, H.  Plimasin in  the  treatment of
  hay fever.  Med. Ann. District of Columbia, 1956, 25:
  553-554.
  Kuhn,  B.  H.  Plimasin;  a  preliminary evaluation.
  A. M. A. Arch. Derm., 1955, 72: 59-62.
  Morpurgo,  V.  Osservazioni  cliniche  su una  nuova
  sostanza ad azione eccitante centrale.  [Clinical obser-
  vations on  a  new substance  with central stimulating
  effect]   [English  summary]   [anesthetics]   Minerva
  anest, Tor., 1956, 22:110-114.   Abstract: J. Am. M.
  Ass., 1956, 161:1514.
  Polak,  F.  tiber  eine  antiallergische  Wirkung  des
  Rauwolfiaalkaloids Reserpin.  [An antiallergic effect of
  the Rauwolfia alkaloid reserpine.]  [plimasin]   Schweiz.
  med. Wschr., 1955, 85 : 751-752.
  Rashkis, H. A.,  Smarr, E. R.  Drug and  milieu effects
  with  chronic schizophrenics,  [amobarbital;  trihexy-
  phenidyl]  A. M. A. Arch. Neur. Psychiat, 1957, 78 : 89-
  94.
  Wortmann, F. Erfahrungen mit einem neuartigen an-
  tiallergisch wirksamen Kombinationspraparat.   [Expe-
  riences with a new antiallergic combination  prepara-
  tion.]   [Plimasin]  Schweiz.  med. Wschr., 1954,  84:
  715-716.

with OTHER DRUGS—COMPARED

  see also METHYLPHENIDYLACETATE—Studies, nor-
           mal subjects
Therapeutic studies, controlled
  Daly, D. D., Yoss, R. E.   The treatment  of narcolepsy
  with methyl phenylpiperidylacetate:  a preliminary re-
  port.  Proc. Mayo  Clin., 1956, 31: 620-625.
Therapeutic use
  Fabing, H. D. The newer analeptic drugs. Med. Clin.
  N. America, 1957, 41: 339-351.


with SHOCK THERAPY [ECT]
  Stier,  C.  Die Anwendung des zentralen  Stimulans
  Ritalin bei depressiven Zustanden und zur Untersttit-
  zung der Elektroschoektherapie.  [The use of ritalin, a
  stimulant of the central  nervous system,  in depressive
  states  and  as  adjuvant  in  electroshock  therapy.]
  Ther. Gegenwart, 1955, 94: 92-95.
METHYLPROMAZINE

  Callaway, J. L., Olansky, S.  Trimeprazine: an adjuvant
  in the management of itching dermatoses.  North Caro-
  lina M. J., 1957, 18: 320-321.  [Not seen]
117 
Methylpromazine
PSYCHOPHARMACA
Feldman, P.  E., Statman, J.  Agranulocytosis during
treatment with  methylpromazine.   Am.  J.  Psychiat.,
1957, 114: 464-465.
N-OBLIVON

Studies, animals
  Chauchard, P., Mazoue,  H.  Effets du  carbamate de
  methyl-3-pentyne-l ol-3  (N-oblivon)  sur  les  centres
  nerveux.   [Effects of 3-methyl-l-pentyne-3-ol carbamate
  (N-oblivon) on nerve centers.]  C. rend. Soc biol, 1956,
  150: 679-680.
  Halpern,  B. N.  Proprietes sedatives  et anticonvulsi-
  vantes du carbamate de methyl-3 pentyne-1 ol-3.   [Seda-
  tive and anticonvulsant properties of 3-methyl-l-pentyne-
  3-ol carbamate.]  C. rend.  Soc. biol, 1956, 150:1152-
  1157.
  ---,  Lehmann,  A.  Bases  experimentales de Taction
  therapeutique  d'une nouvelle  medication  sedative et
  antianxieuse: le carbamate de methyl-3 pentyne-1 ol-3.
  [Experimental bases of the therapeutic action of a new
  sedative and tranquilizing drug: 3-methyl-l-pentyne-3-ol
  carbamate.]   Presse med., 1957, 65 : 622-625.
Therapeutic use
  Laboucarie, J., Barres, P., Rascol, A.  Aspects princi-
  paux des cures neuropiegiques en psychiatrie en 1956.
  [Principal features of neuroplegic therapy in psychiatry
  in 1956.]   Toulouse me'd., 1956, 57 : 851-867.
  Mathis, M. Toniques  et  sedatifs  en neuro-psychiatrie
  infantile.  [Tonics and  sedatives in child neuropsy-
  chiatry.]   Pediatric 1956, 11: 807-820.
  PerraHlt, M.  Sur les tranquilliseurs.   [Tranquilizers.]
  Progr. me'd., Par., 1957, 85 : 3-4; 7.
with CHLORPROMAZINE—COMPARED
with MEPROBAMATE—COMPARED
with PROMETHAZINE—COMPARED
with RESERPINE—COMPARED
  see N-OBLIVON—Studies, animals
NP-207
Studies, animals
  Himwich, H. E., Rinaldi, F., Willis, D.  An examination
  of phenothiazine derivatives with comparisons of their
  effects on the alerting reaction, chemical structure and
  therapeutic efficacy,  [chlorpromazine: mepazine: NP-
  207 :  promazine : promethazine : pyrathiazine : Wy-1107]
  J.  Nerv. Ment. Dis., 1956, 124: 53-57.
  Taeschler, M., Rothlin, E.  Zur Charakterisierung der
  zentralen Wirkung von Phenothiazinderivaten.  [The
  specific  central  effect  of phenothiazine  derivatives.]
  Arch. exp. Path., Berl,  1956, 228: 184-186.  Abstract:
  Chem. Abstr., 1956, 50: 8902de.
Therapeutic use  [see headnote p. 19]
  Hollister, L. E.  Complications from the use of tranquil-
  izing drugs.  N. England J. M., 1957, 257: 170-177  [p.
  177]                                              *
  Kinross-Wright,  V.  Clinical trial of a new phenothia-
  zine  compound:  NP-207.  Psychiat  Res.  Rep., Wash.,
  1956  (4) : 89-94.                                   *
  Labhardt, F. Erfahrungen mit einem neuen Neuroplegi-
  cum.   [Experiences with  a  new neuroplegic drug.]
  [NP-207]   Schweiz. Arch.  Neur. Psychiat., 1956, 77:
  481^85.                                          *
  Malitz, S., Hoch, P.  H.  Preliminary evaluation of a
  new  phenothiazine derivative, NP-207.  Psychiat.  Q.,
  1956,  30:  633-^46.
  ---, ---,  Lesse, S.  A two-year evaluation of chlor-
  promazine  in  clinical research and  practice.   Am. J.
  Psychiat, 1956, 113 : 540-545.                       *
  Remy, M.  A propos d'un nouveau neuroplegique : le NP
  de Sandoz.  [A new neuroplegic drug: NP by Sandoz.]
  [Abstract]   Schweiz.  Arch.  Neur. Psychiat, 1956, 77:
  480.                                              *
Untoward effects see NP-207—Therapeutic use


with CHLORPROMAZINE—COMBINED

Therapeutic use
  Labhardt,  F.  Erfahrungen  mit einem  neuen  Neuro-
  plegicum.  [Experiences with a new neuroplegic drug.]
  [NP-207]  Schweiz. Arch. Neur.  Psychiat., 1956,  77:
  481-485.
with CHLORPROMAZINE—COMPARED see NP-207

with  LYSERGIC ACID DIETHYLAMIDE—INTERAC-
  TION
  see NP-207—Studies, animals [taeschler+kothlin]

with  LYSERGIC   ACID  DIETHYLAMIDE,  BROMI-
    NATED—INTERACTION

Studies, animals
  see NP-207—Studies, animals [taeschler+rothlin]

Therapeutic use
  see NP-207—Therapeutic use [malitz+hoch]

with PROMETHAZINE—COMBINED
  see NP-207 with CHLORPROMAZINE—COMBINED
with OTHER DRUGS—COMBINED  and  COMPARED
  see NP-207—Studies, animals
NP-207, BROMINATED
Therapeutic use
  Malitz, S., Hoch, P. H.,  Lesse, S.  A two-year evalua-
  tion of chlorpromazine in clinical research  and prac-
  tice.   Am. J. Psychiat., 1956,113 : 540-545.
OLOLIUQUI
Studies, normal subjects
  Osmond, H. Ololiuqui: the ancient Aztec narcotic; re-
  marks  on the  effects of Rivea  corymbosa (ololiuqui).
  J. Ment. Sc, Lond., 1955, 101: 526-537.
  ---.   Research  on schizophrenia.  In:  Abramson, H.
  A., ed.   Neuropharmacology.  Transactions of the sec-
  ond conference, May 1955, Princeton, N.  J.  New York,
  Josiah Macy, Jr. Foundation, 1956. p. 183-233.
  ---.   A review of the clinical effects of psychotomi-
  metic agents.  Ann. N. York Acad. Sc,  1957, 66:418-
  434
OPILON
Studies, animals
  Greff,  K., Schumann,  H. J.  Zur Pharmakologie des
  Sympathicolyticums  6-Acetoxythymoxy-aethyldimethy-
  lamin.   [Pharmacology of the sympatholytic 6-acetoxy-
  thymoxy-ethyldimethylamine.]  Arzneimitt    Forsch.,
  1953, 3:341-345.
Studies, patients
  Serra,  C, Severgini, B.  Ricerche elettroencefalogra-
  fiche sopra un nuovo simpaticolitico  di sintesi.  [Elec-
118 
SUBJECT  LIST
Phenothiazines
  troencephalographic studies of a new synthetic sympa-
  tholytic]   Riv. neur., Nap., 1953, 23 : 494-504.
Therapeutic use
  Germano,  V., Bellavitis, U.  Osservazioni cliniche  e
  terapeutiche sull'use del cloridrato 6  acetossi-timossi-
  etildimetil-amina  (opilon)  negli stati d'ansia e nelle
  terapie da shock.  [Clinical and therapeutic observa-
  tions on the use  of 6-acetoxythymoxy-ethyl-dimethyla-
  mine hydrochloride  (opilon)  in  anxiety states and
  shock therapy.]   [English summary]  Riv. neur., Nap.,
  1955, 25: 928-940.
  Walch,  R., Hoheisel, H.  P.  Uber die Behandlung von
  vegetativen Zustanden  nach Kopftrauma mit Opilon.
  [Opilon therapy of autonomic nervous conditions after
  head injuries.]  Deut. med. Wschr., 1952, 77: 767-768.


with CHLORPROMAZINE and RESERPINE

Therapeutic use
  Reda, G. C, Germano, V. L'azione combinata della re-
  serpina e  cloropromazina  nella pratica psichiatrica.
  [Combined effect  of reserpine and chlorpromazine  in
  psychiatric  practice.]   [English  summary]    Arch.
  psicol. neur., Milano, 1956, 17: 647-653.


with OTHER DRUGS—COMBINED

Psychotherapeutic and Therapeutic use
  Engelmeier, M. P. Lytische Therapie in der Nerven-
  klinik.  [Lytic therapy in neuropsychiatric hospitals.]
  [English summary]  Mschr. Psychiat., Basel,  1956, 131:
  89-150.


with SHOCK THERAPY  [ECT]
  see OPILON—Therapeutic use [germano4-bellavitis]
PM—1090
Therapeutic use—Psychoses
 Edwalds, R. M.  Experimental studies with  PM  1090;
 preliminary report.  Internat. Rec. M., 1956, 169: 469-
 472.   Abstract:  Excerpta med., Sect. 8,  1957, 10: No.
 1546.                                               *
 PERPHENAZINE

 Studies animals
  Cahn, C.  H., Lehmann, H.  E.  Perphenazine; observa-
  tions on the clinical effects of a new tranquillizing agent
  in psychotic conditions.  Canad. Psychiat. Ass. J., 1957,
  2:104-112.
  Irwin, S, Govier, W.  M.  Chlorpiprozine,  a new tran-
  quilizer : comparison with chlorpromazine in the mouse,
  rat, cat, dog, and monkey.   [Abstract]  J. Pharm. Exp.
  Ther., 1957, 119: 154-155.
Therapeutic studies, controlled
  Ayd,  F. J., Jr.  A clinical  appraisal of trilafon.   Am.
  J. Psychiat, 1957, 114 : 554-555.
  Cahn, C.  H., Lehmann, H.  E.  Perphenazine; observa-
  tions  on the clinical effects of a new tranquillizing agent
  in psychotic conditions.   [perphenazine+reserpine**]
  Canad. Psychiat. Ass.  J., 1957,  2:104-112.            *
  Mason-Browne, N. L.  Perphenazine—a drug modifying
  consciousness.  Am. J. Psychiat, 1957, 114:173-174.

Therapeutic use
  Ayd  F  J  Jr.  Tranquilizing drugs in private practice.
  N York State J. M., 1957, 57 :1742-1747.
  ---.  The treatment of anxiety,  agitation and excite-
  ment in the aged; a preliminary report on trilafon.  J.
  Am. Geriat. Soc, 1957, 5: 92-96.
  Pennington, V. M.  Research findings in  phrenotropic
  drugs important to every physician.  3Iississippi Doctor,
  1957, 35: 57-63.
  Shanon, J., Kaplan, S. M., Pierce, C. M., Ross, W. D. An
  interesting reaction  to  a  tranquilizer:  tonic  seizures
  with perphenazine (trilafon).   Am. J. Psychiat.,  1957,
  114: 556.


with CHLORPROMAZINE—COMPARED
  see PERPHENAZINE—Studies, animals
                        Therapeutic studies, controlled

with RESERPINE—COMBINED
  Cahn, C. H., Lehmann, H. E.  Perphenazine;  observa-
  tions on the clinical effects of a new tranquillizing agent
  in psychotic conditions.  Canad. Psychiat. Ass.  J.,  1957,
  2:104-112.                                      *  *
PHENAGLYCODOL
Studies, animals
  Slater, I. H., Jones, G. T„ Young, W. K. Mode of action
  of phenaglycodol, a new neurosedative agent.  Proc. Soc.
  Exp. Biol, N. Y., 1956, 93: 528-531.

Studies, normal subjects
  Reitan, R. M.  The comparative effects of placebo, ultran,
  and  meprobamate on psychologic  test performances.
  Antibiotic M., 1957, 4:158-165.
  Smith, J. A., Rutherford, A., Fanning, R. A comparison
  of phenaglycodol (ultran), meprobamate and placebo in
  abstinent  alcoholics.   Am. J. Psychiat, 1957, 114: 364-
  365.
Therapeutic studies, controlled
  Moyer, J. H., Pevey, K., Kinross-Wright, V. Tranquiliz-
  ing  (ataractic) agents: current evaluation of their clin-
  ical use in patients who are not hospitalized.   GP,  1957,
  15 (6) : 97-118.                                    *
  Pevey, J.  K., Moyer, J.  H., Handley, C. A.,  Heider, C.
  A comparison of clinical results  with phenobarbital,
  meprobamate and two similar experimental compounds.
  [Abstract] [benactyzine: meprobamate: phenaglycodol]
  J. Pharm. Exp. Ther., 1957, 119: 176.                *

Therapeutic use
  Pennington, V. M.  Research  findings in phrenotropic
  drugs important to every physician.  Mississippi Doctor,
  1957, 35: 57-63.
  Senseman, L. A.  Tranquilizing drugs; uses and abuses
  for the nervous patient.  Rhode Island M. J., 1956, 39:
  675-677; 680; 686.


with ATARAXICS [2 or more]
  see  ATARAXICS—Various [3  or more]—Compared

with MEPROBAMATE—COMPARED
  see  PHENAGLYCODOL—Studies, normal subjects
PHENOTHIAZINES
  see also individual phenothiazines
          Cf. DRUG INDEX : PHENOTHIAZINES
  Deniker,  P.   Hibernotherapies  et medicaments neuro-
  leptiques en  therapeutique  psychiatrique.  [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapy.]
  Encephale, 1957, 46: 281-398.
  Gade, E. B., Heinrich, K.  Die Bedeutung der Pheno-
  thiazinderivate, insbesondere des Megaphen, fur Psychi-
119 
Phenothiazines
PSYCHOPHARMACA
  atrie  und  Neurologic   [The  importance  of pheno-
  thiazine derivatives in psychiatry and neurology with
  special reference to  chlorpromazine.]  Fortsch. Neur.
  Psychiat, 1955, 23 : 323-353.
  Koetschet, P.  Can it be said that chlorpromazine has
  specific properties?  Internat. Rec. M., 1955, 168:295-
  300.
  Mashkovskii, M. D.  [The pharmacologic properties  of
  aminazine and of other compounds of the phenothiazine
  order.]  Zh. nevropat. psikhiat, Moskva, 1956, 56: 81-83.
  Abstract: Chem. Abstr., 1956, 50:17174e.
  Rosner, K. Therapeutische Anwendung der zentralner-
  vosen Wirkung einiger Phenothiazinderivate in der All-
  gemeinmedizin.  [Therapeutic use of effects of various
  phenothiazine derivatives on central nervous system  in
  general practice.]  Med. Mschr., 1956, 10: 719-723.
  Viaud, P.  Les  amines derivees de la phenothiazine.
  [The  amino-derivatives of phenothiazine.]   J. Pharm.,
  Lond., 1954, 6: 361-389.
  Westerink, D.  De farmacologie en toepassing der feno-
  thiazinederivaten. [The pharmacology and use of phe-
  nothiazine derivatives.]  Pharm. wbl, Amst, 1956, 91:
  113-125.

Studies, animals
  Begany, A. J.,  Seifter, J., Pless, H. H., Huber,  R. D.,
  Bruce, W. F. Tranquilizing effect of phenothiazines  in
  cats and rabbits.  Fed. Proc, Ball, 1956, 15: 399-400.
  Burke J. C, Hassert, G. L., High, J. P. The tranquiliz-
  ing activity of 10-(3-dimethylaminopropyl)-2-(trifluoro-
  methyl)-phenothiazine hydrochloride (MC 4703) and re-
  lated phenothiazines in animals.   [Abstract]  J. Pharm.
  Exp. Ther., 1957, 119: 136.
  Himwich, H. E., Rinaldi, F., Willis, D.  An examination
  of phenothiazine derivatives with comparisons of their
  effects on the alerting reaction, chemical structure and
  therapeutic efficacy,   [chlorpromazine: mepazine : NP-
  207 : promazine: promethazine: pyrathiazine : Wy-1107]
  J. Nerv. 3Ient. Dis., 1956, 124 : 53-57.
  Hosko, M. J., Gore, E. M., Tislow, R., Seifter,, J. Taming
  effect of  promazine in  the rhesus monkey.   [Abstract]
  J. Pharm. Exp. Ther., 1957, 119:153-154.
  Nieschulz, O., Hoffmann, I.,  Popendiker, K.  Pharma-
  kologische  Untersuchungen  fiber  N-Alkyl-piperidyl-
  phenothiazin-Derivate.   [Pharmacological studies of  N-
  alkyl-piperidyl-phenothiazine  derivatives.]    [English
  summary]  Arzneimitt. Forsch., 1956, 6: 651-660.
  ---, Popendiker, K., Hoffmann, I. Weitere pharmakolo-
  gische Untersuchungen  iiber  N-Methyl-piperidyl-(3)-
  methyl-phenothiazin.   [Further pharmacological stud-
  ies  of   N-methyl-piperidyl-(3)-methyl-phenothiazine]
  [English summary] Arzneimitt.   Forsch., 1955, 5: 680-
  695.
  ---,---, Sack, K. H.  Pharmakologische Untersuchun-
  gen   fiber   N-Alkyl-piperidyl-phenothiazin-Derivate.
  [Pharmacological  studies  of N-alkyl-piperidyl-pheno-
  thiazine derivatives.]  Arzneimitt. Forsch., 1954, 4: 232-
  242.

Studies, normal subjects
  Noell, W. K„ Chinn, H.  I., Haberer, C. E.  Electroen-
  cephalographic evaluation of the sedative effects of anti-
  histaminic drugs,  [promethazine;  pyrathiazine; thia-
  zinamium]  Air  Force School  of  Aviation  Medicine,
  Randolph Air Force Base,  Texas, 1955  (55-35)  : 1-20.

Studies, patients
  Avenarius, R.  Zur  Wirkungsweise von  Rauwolfiaal-
  kaloiden  und Phenothiazinderivaten bei Schizophrenen.
  [Mechanism  of  action  of  Rauwolfia  alkaloids and
  phenothiazine derivatives in  schizophrenics.]  Nerven-
  arzt, 1956, 27:454-458.
  Hartmann, K., Hiob, J., Hippius, H.  Zur vergleichenden
  Psychopathologie der Schock- und Phenothiazinwirkung.
  [Comparative psychodynamics  of shock therapy and
  phenothiazines.]  Fortsch.  Neur. Psychiat,  1955,  23:
  354-366.
  Selbach,  C,  Selbach,  H.  Phenothiazinwirkung und
  somato-psychische  Dynamik.  [Phenothiazine  action
  and psychosomatic  dynamics.]   Nervenarzt, 1956, 27:
  145-149.
Therapeutic use
  Begany, A. J., Seifter, J., Pless, H. H., Huber, R. D„
  Bruce, W. F.  Tranquilizing effect of phenothiazines in
  cats and rabbits.  Fed. Proc, Bait., 1956, 15:399-400.
  Himwich, H. E., Rinaldi, F., Willis, D.  An examination
  of phenothiazine derivatives with comparisons of their
  effects on the alerting reaction, chemical structure and
  therapeutic efficacy.  J. Nerv. Ment Dis., 1956, 124: 53-
  57.
Untoward effects  [see headnote p.  19]
  Fazekas, J. F., Shea, J. G., Ehrmantraut, W. R., Alman,
  R. W.  Convulsant action of phenothiazine derivatives.
  J. Am. 31. Ass., 1957, 165:1241-1245.
  Feldman,  P.  E.  An unusual  death  associated with
  tranquilizer therapy,  ["with a phenothiazine drug"]
  Am. J. Psychiat, 1957, 113: 1032-1033.            * *
  ---,  Statman,  J.  Agranulocytosis  during  treatment
  with  methylpromazine.   Am. J. Psychiat, 1957, 114:
  464-465.
  Hollister,  L.  E.  Complications  from the  use of tran-
  quilizing drugs.  N.  England  J.  M., 1957, 257:170-
  177.                                             * *
  ---.   Unexpected  asphyxial death  and  tranquilizing
  drugs. Am. J. Psychiat., 1957, 114: 366-367.       * *
PIPRADROL
  Fabing, H. D. The newer analeptic drugs.  Med. Clin.
  N. America, 1957, 41: 339-351.
  Symposium:  Clinical  value and  limitations of reser-
  pine, meratran, and a "new blocking agent".  Psychiat.
  Res. Rep., Wash., 1955 (1) : 105-152.   [All articles are
  listed individually]
  Symposium:  Physiologic,  pharmacologic, neurologic,
  and psychologic actions of drugs recently introduced in
  the treatment of psychiatric disorders.  Psychiat. Res.
  Rep., Wash., 1955 (1)  : 1-51.  [Articles within the scope
  of this bibliography are listed individually]
Pharmacodynamics
  Carr, C. J., Kinnard, W. J., Jr.  The phrenotropic agents.
  Internal Rec M., 1957, 170: 493-504.
  Fabing, H. D.  Frenquel, a  blocking agent against ex-
  perimental LSD-25 and  mescaline psychosis;  prelimi-
  nary note on its clinical application.  Neurology, 1955,
  5:319-328.
  Leake, C. D.  Drugs affecting mood and behavior. Texas
  Rep. Biol. 31., 1955, 13: 793-818.
  Neue  Mittel  zur Pharmakotherapie  der Psychosen?
  [New drugs  for  the  pharmacotherapy of psychoses?]
  Deut. med. Wschr., 1955, 80: 1777.
  Pipradrol hydrochloride.  J. Am. 31. Ass.,  1956, 160:
  390.
  Proctor, R. C, Odland, T.  Frenquel.  Dis. Nerv. Syst,
  1956, 17 : 25-28.   Abstract: Excerpta med., Sect. 8,1956,
  9: No. 4539.

Placebo effect see PSYCHOPHARMACA—Evaluation
Studies,  animals
  Antos, R. J.  A preliminary report of clinical studies on
  a new stimulant.  Arizona M., 1954, 11; 397-399.
  Brown, B. B., Werner, H. W. Pharmacologic studies on
  a  new  central  stimulant,  a-(2-piperidyl)  benzhydrol
  hydrochloride (MRD-108).  J. Pharm. Exp. Ther., 1954,
  110:180-187.  Abstract: Fed. Proc, Bait., 1953, 12: 304.
120 
SUBJECT  LIST
Pipradrol : Therapeutic  use
 ---, Braun, D. L., Feldman, R. G. The pharmacologic
 activity of alpha-(4-piperidyl)-benzhydrol hydrochloride
 (azacyclonol hydrochloride) ; an  ataractive agent.  J.
 Pharm. Exp. Ther., 1956, 118:153-161.
 Himwich, H. E.  The effect of frenquel on EEG changes
 produced by LSD-25 and mescaline.   In: Cholden, L.,
 ed.   Lysergic  acid  diethylamide and mescaline in  ex-
 perimental psychiatry.  New York, Grune  & Stratton,
 1956.  p. 19-26.
 Monroe, R. R., Heath, R. G., Mickle, W. A. Miller, W.
 Cortical and subcortical recordings correlated with be-
 havior in patients and animals during the  administra-
 tion of Rauwolfia, thorazine, and  meratran.  Psychiat.
 Res. Rep.,  Wash., 1955  (1) : 25-44.  Abstract: Chem.
 Abstr., 1956, 50: 2867gh
 Rinaldi, F., Himwich, H. E.  The cerebral electrographic
 changes induced by LSD and mescaline are corrected by
 frenquel.  J. Nerv. Ment. Dis., 1955, 122: 424-432.
 ---,----.  Drugs affecting psychotic behavior and  the
 function of the mesodiencephalic activating system.  Dis.
 Nerv. Syst, 1955,16:133-141. Abstract: Excerpta med.,
 Sect. 8, 1956, 9: No. 4566.
 ---,----.  Frenquel corrects  certain cerebral electro-
 graphic changes. Science, 1955, 122:198-199.
Studies, normal  subjects
 Antos, R. J. A preliminary report of clinical studies on
 a new stimulant.  Arizona  M., 1954, 11: 397-399.
 Begg, W. G. A., Reid, A. A.  "Meratran", a new stimu-
 lant drug.  Brit. M. J., 1956,1: 946-949.
 Cohen,  S.  Clinical experiences with pipradrol and a
 pipradrol-reserpine  combination.   Internal Rec.  31.,
 1956, 169: 751-756.
 Fabing, H. D.  The  newer analeptic drugs.  Med. Clin.
 N. America, 1957, 41: 339-351 [p.  344]
 Gottschalk, L. A., Kapp, F. T., Ross, W. D., Kaplan, S.
 M., Silver, H., MacLeod J. A., Kahn, J. B.,  Jr.,  Van
 Maanen, E. F., Acheson, G. H.   Explorations in testing
 drugs  affecting  physical and mental  activity; studies
 with a new drug of potential value in psychiatric illness.
 J. Am. 31. Ass., 1956, 161:1054-1058.
 Kleemeier, R. W., Rich, T. A., Justiss, W. A.  The ef-
 fects of alpha-(2-piperidyl) benzhydrol hydrochloride
  (meratran) on psychomotor performance in a group of
 aged males.  J.  Geront., 1956, 11:165-170.
 Monroe, R. R., Heath, R. G., Mickle, W. A., Miller, W.
 Cortical and subcortical recordings correlated with be-
 havior in patients and  animals during the administra-
 tion of Rauwolfia, thorazine. and meratran.  Psychiat.
 Res. Rep., Wash.,  1955 (1):25^4.   Abstract: Chem.
 Abstr., 1956, 50: 2867gh.
 Payne,  R. B.,  Moore, E. W. Effects of some analeptic
 and depressant drugs on tracking behavior.  J. Pharm.
 Exp. Ther., 1955,115 : 480-484.   Abstract: Chem. Abstr.,
 1956, 50:3632ab.
Therapeutic studies, controlled
 Antos, R. J. A preliminary report of clinical studies on
 a new stimulant.  Arizona  M., 1954, 11: 397-399.
 Begg, W. G. A., Reid, A. A.  "Meratran", a new stimu-
 lant drug.  Brit. M. J., 1956,1: 946-949.                *
 Cohen, S.    Clinical experiences with pipradrol  and
 a pipradrol-reserpine combination.  Internat. Rec M.,
 1956, 169: 751-756.                                   *
 Daly, D. D., Yoss,  R. E.  The treatment of narcolepsy
 with methyl phenolypiperidylacetate:  a preliminary re-
 port.   Proc 3Iayo Clin., 1956, 31: 620-625.
 Fabing, H.  D.  Alpha-(2-piperidyl) benzhydrol hydro-
 chloride, a new central stimulant, in the treatment of
 blepharospasm,  spasmodic  torticollis  and  narcolepsy;
 preliminary report.  Tr.  Am.   Neur.  Ass.,  1954,  79th
 Meeting: 159-163.
 ___   Clinical  experience  with meratran:  a  new
 central nervous system stimulant.  Dis. Nerv. Syst.,
 1955, 16: 10-15.
  ---.  Experiencia  clinica  con  meratran;  un nuevo
  estimulante nervioso central.   [Clinical experience with
  meratran; a new central nervous  system stimulant.]
  Rev. m6d. cubana, 1955, 66: 923-931.
  Gelvin, E. P., McGavack, T.  H., Kenigsberg, S. Alpha-
  (2-piperidyl) benzhydrol hydrochloride  (pipradrol)  as
  an adjunct in the dietary management of obesity.   N.
  York State J. M., 1955, 55 : 2336-2338.
  ---,---, Pogge, R. C.  Alpha-(piperidyl) benzhydrol
  hydrochloride (meratran) as an anorexigenic agent in
  the management of obesity.   Clin. Res. Proc, 1955, 3:
  40-41.
  Martin, K. E., Overley, H. G., Krone, R. E.  Pipradrol:
  combined therapy for geriatric and agitated  patients.
  Internat. Rec. M., 1957,  170: 33-36.                   *
  Monroe, R. R., Heath, R. G., Mickle, W. A., Miller, W.
  Cortical and subcortical recordings  correlated with be-
  havior in patients and animals during the administra-
  tion of Rauwolfia, thorazine, and meratran.  Psychiat.
  Res. Rep.,  Wash., 1955  (1): 25-44.  Abstract: Chem.
  Abstr.  1956, 50:2867gh.                             *

—Psychoses
  Fullerton, A. G.  Psychiatric uses  of  meratran.  J.
  Ment. Sc, Lond.,  1956, 1052; 801-804.
  Houston, F.   Group behaviour in chronic schizophrenics
  treated with meratran.  Brit. M. J., 1956,  1: 949-952.
  Abstract: Excerpta med., Sect. 8, 1957, 10: No. 2084.  *
  Le Guillant   Le syndrome neuroleptique:  prevention et
  traitement.   [The  neuroleptic syndrome:  prevention
  and treatment.]  Ann.  me'd. psychiol,  Par., 1957,  115
   (1) : 329-338.
  Pennington, V. M. A comparative study of .six ataraxics
  in  1130  neuro-psychiatric cases.   Mississippi Doctor,
  1956, 33:336-339.
  Rosner, B. S., Fierman, L.  B., Kramer, J. F.   Clinical
  evaluation of meratran and frenquel  on a chronic psy-
  chotic population.  Am. J.  Psychiat,  1957,  113:993-
  996.
  Schut, J. W., Himwich, H. E.  The effect of  meratran
  on twenty-five institutionalized mental patients.  Am. J.
  Psychiat, 1955, 111: 837-840.
Therapeutic use
  Allin, T. G., Jr.,  Pogge, R.  C.  The use of azacyclonol
  and pipradrol in general practice.   Internat. Rec. 31.,
   1956,  169: 222-230.
  Andren, H.  E. Meratran: a new drug proposed as an
  alternative to shock therapy in depressions.  Clin. Res.
  Proc, 1955,  3: 41.
  ----.   Treatment of depression with meratran and elec-
  troshock.  Dis. Nerv. Syst, 1955,16: 275-276.  Abstract:
  Excerpta med., Sect. 8, 1956, 9: No.  4541.
  Antos, R. J.  Meratran.  Use of a new antidepressant
  in internal medicine.  Southwest. M., 1955, 36:166-167.
   ---.   Use  of an antidepressant in general  practice.
   3Ied.  Times, Great Neck, 1955, 83: 612-614.
   Bensoussan, P., Villiaumey, E. M. Note sur les premiers
  resultats de Tutilisation d'un nouveau  medicament de-
  pressolytique: le chlorhydrate de pipradrol.  [Note  on
  the first results with the use of a new antidepressive
  drug:  pipradrol  chlorhydrate.]  Ann. me'd.  psychol,
   Par., 1956, 114 (1) : 438-443.
   Fabing, H. D.  The newer analeptic drugs.  Med. Clin.
   N. America, 1957, 41: 339-351.                       *
  ---,  Hawkins, J. R.,  Moulton, J.  A.  Clinical studies
   on a-(2-piperidyl) benzhydrol hydrochloride, a new anti-
   depressant drug.  Am.  J. Psychiat., 1955, 111: 832-836.
   Forster, W., Henderson, L.,  Schultz, S.  The clinical
   effects of alpha-(2-piperidyl)-benzhydrol  hydrochloride
   (meratran) in states of inactivity in elderly psychiatric
   patients.  Canad. M.  Ass.  J., 1955,  72: 678-681.   Ab-
   stract : Digest Neurol.  Psychiat.,  1955,  23:278.   Ex-
   cerpta med., Sect. 8, 1956, 9: No. 2227. 
Pipradrol : Therapeutic use
PSYCH0PHAR31ACA
  Kistner, R. W., Duncan, C. J.  Use of pipradrol in ob-
  stetrics and gynecology. N. England J. M., 1956, 254:
  507-510.
  Levy, S.  Mild depression states.  Northwest M., 1954,
  53: 1233-1236.
  Lonnberg, B.  Leptidrol  (pipradrol), ett nytt psyko-
  analepticum.  [Leptidrol (pipradrol), a new psycho-
  analeptic]  Sven. lak. tidn.,  1956, 53: 3346-3357.
  Oettinger, L., Jr. Meratran; preliminary report of a
  new drug for the treatment of behavior  disorders in
  children.   Dis. Nerv. Syst, 1955, 16: 229-302.       *
  Perlstein, I. B. The use of pipradrol in the problems of
  obesity.  Internat. Rec. M., 1957, 170: 55-58.
  Pomeranze, J. A new  antidepressant (M. R. D.-108)
  in geriatrics.  [Abstract]  J.  Geront, 1954, 9:486.
  Proctor, R. C. A new therapeutic approach to certain
  cases of alcoholism.  South. M. J., 1956, 49: 73-75.
  ---, Griffin, R.  A.  Clinical studies on alpha-(2-piper-
  idyl) benzhydrol hydrochloride (meratran)  in prophy-
  lactic treatment  of alcoholism.  Clin. Res. Proc, 1955,
  3:149.
  Talley, J. E.  Meratran, a new cerebral stimulant: re-
  port on the results of clinical investigation.   Psychiat.
  Res. Rep., Wash., 1955 (1) : 133-139.

—Additional data
  Bergy,  G. A.  Drugs of sedation with tranquilizing ef-
  fects.  Am. Profes. Pharmacist, 1956, 22 : 419 ; 534-538;
  619-621;  709-710;  797-799;  888-889; 917-919.   [419;
  534-538.]
  Block, M. A.  Medical treatment of alcoholism.  J. Am.
  M. Ass., 1956,  162: 1610-1619.
  Cohen, I. M.  Drugs recently introduced in the treat-
  ment of psychiatric disorders.  Texas J. M., 1956, 52:
  683-687.
  Fabing, H. D.  Adventures in clinical neuropharmacol-
  ogy.  Internat. Rec. M., 1956, 169:115-119.
  ---.  The ataractic drugs: their uses and  limitations
  in psychiatry.  Am. Profes. Pharmacist, 1956, 22: 413-
  418.
  Fouks, Laine,  Francois, Pagot.  Note sur les medications
  recentes  des etats nevrotiques anxieux et  depressifs.
  [Note on recent medications for anxious and depressive
  neurotic  states.]   Ann. med. psychol, Par., 1956, 114
  (1)  : 608-615.
  Fremming, K. H. Medikamentel behandling af synds-
  sygdomme.  [Medical  treatment of  mental  disorders.]
  Mskr. prakt. laegegem., Kbh., 1956, 34 : 331-342.
  Freyhan, F. A.,  Turner, P., Stenzler,  R.  New drug
  therapies in psychiatry.  Delaware M. J., 1956, 28:180-
  186.                                              *
  Funderburk, W. H., Wilcox, K. W., Wilcox, P. H.  Drug
  therapy;   physiodynamic  therapy.   II. Progr.  Neur.
  Psychiat., N. Y.,  1956,  11: 425-456.
  Graffagnino, P. N., Furr, J. H.  New drugs in the treat-
  ment of  emotional  disorders;  a review.  Connecticut
  M. J., 1957, 21: 38-43.
  Hagenauer, F., Rudy,  L. H., Himwich,  H. E.  A com-
  parative evaluation of two central system stimulants in
  severe psychoses. J. Clin. Exp. Psychopath., 1957, 18:
  248-257.  Condensed as: A comparative study of two
  central nervous system stimulants, MER-22 and S. K. F.
  #5, on chronic,  blocked and withdrawn psychotic pa-
  tients.  Am. J. Psychiat, 1957, 113 : 840.
  Heilbrunn, G. Selection of  patients for  modern psy-
  chiatric pharmacotherapy in general practice.  North-
  west 31., 1956, 55 :1198-1205.
  Hilliard,  E. T.   The use of  reserpine, chlorpromazine
  and allied drugs in medicine and psychiatry.  Med.  J.
  Australia, 1956, 43 (1) : 1035-1040.
  Hubbard, O. E., Glasser, J.  Newer psychotropic drugs;
  their characteristics and use in general practice.  North-
  west M., 1956, 55  :1191-1197.
  Kautz, H. D.  Trends in drug therapy.  Hosp. Progr.,
  1957, 38 (1) :  102-108; 126.
  Kinross-Wright, V.  A  review  of  the  newer drug
  therapies in psychiatry.  Dis. Nerv. Syst., 1956,17:187-
  190.
  ----.  The uses and limitations of the newer drugs in
  the treatment of nervous conditions.  Wisconsin M. J.,
  1956, 55:1073-1078.
  Klingman, W.  O.  Neurological  and psychiatric dis-
  orders ; some recent advances in therapy.  Virginia M.
  31onth., 1956, 83 : 240-246.
  Laboucarie, J., Barres, P., Rascol, A. Aspects  princi-
  paux des cures  neuropiegiques en psychiatrie en 1956.
  [Principal features of neuroplegic therapy in psychiatry
  in 1956.]  Toulouse me'd., 1956, 57: 851-867.
  Leake,  C. D.   Drugs affecting  mood  and  behavior.
  Texas Rep. Biol. M., 1955,13 : 793-818.  Abstract: Chem.
  Abstr., 1956, 50: 9615b.
  ---.  New mood-changing drugs. Ohio M. J., 1956,
  52: 369-373.
  Margolis, L. H.  Pharmacotherapy in psychiatry; a re-
  view.   Ann. N. York Acad. Sc, 1957, 66: 698-718.
  Morgan, D. R.  The  use of reserpine, chlorpromazine
  and allied drugs in medicine and  psychiatry.  Med. J.
  Australia, 1956, 43 (1) : 1029-1035.
  New drugs for  patients with emotional disorders. J.
  Am. 31. Ass., 1955, 157 : 665.
  Stimulants and  depressants.  Brit. M. J., 1956, 1: 969-
  970.
  Weinberg, H. B.  Drug therapy for the emotionally and
  mentally  disturbed; the internist's point of view.  J.
  Iowa M. Soc, 1957, 47 :17-19.
  Wortis, J. Physiological treatment.  Am. J. Psychiat,
  1956,112: 526-529.

with AZACYCLONOL
  see AZACYCLONOL with PIPRADROL

with CHLORPROMAZINE
  see CHLORPROMAZINE with PIPRADROL

with COVATIN—COMPARED
  see COVATIN—Pharmacodynamics

with LYSERGIC  ACID DIETHYLAMIDE
  see LYSERGIC ACID DIETHYLAMIDE with PIPRA-
         DROL—INTERACTION
       Studies, animals

with MER-22—COMPARED
  see MER-22—Studies, animals
               Therapeutic studies, controlled

with MEPAZINE—COMBINED
  see MEPAZINE with PIPRADROL

with MEPROBAMATE—COMBINED
  see MEPROBAMATE with PIPRADROL

with METHYLPHENIDYLACETATE—COMPARED
  see MER-22—Studies, animals
      METHYLPHENIDYLACETATE   with  PIPRA-
       DROL—COMPARED

with RAUWOLFIA SERPENTINA  ALKALOIDS
  see RAUWOLFIA SERPENTINA ALKALOIDS  with
        PIPRADROL—COMBINED

with RESERPINE
  see RAUWOLFIA SERPENTINA ALKALOIDS  with
        PIPRADROL—COMBINED
      RESERPINE with  PIPRADROL—COMBINED
with OTHER DRUGS—COMBINED

  Begg, W. G. A., Reid, A. A.  "Meratran", a new stimu-
  lant drug.   Brit. 31. J., 1956,1: 946-949.
122 
SUBJECT  LIST
Promazine : Studies, animals
  Martin, K. E., Overley, H. G., Krone, R. E.  Pipradrol:
  combined therapy for geriatric and  agitated patients.
  Internat. Rec M., 1957,170 : 33-36.

with OTHER DRUGS—COMPARED
  Fabing, H. D.  The newer analeptic drugs.  Med.  Clin.
  N. America, 1957, 41: 339-351.
  Le Guillant  Le syndrome neuroleptique:  prevention et
  traitement.  [The  neuroleptic  syndrome:  prevention
  and  treatment.]   Ann. me'd.  psychol, Par., 1957, 115
  (1) : 329-338.


with SHOCK THERAPY [ECT]

  Andren,  H. E.  Meratran: a new drug proposed as an
  alternative to shock therapy in depressions.  Clin. Res.
  Proc, 1955, 3 : 41.
  ---.  Treatment  of  depression  with meratran   and
  electroshock.  Dis. Nerv. Syst,  1955, 16 :  275-276.   Ab-
  stract: Excerpta med., Sect. 8, 1956, 9: No. 4541.
  Laboucarie, J., Barres, P.,  Rascol, A.  Aspects princi-
  paux des cures neuropiegiques en psychiatrie en  1956.
  [Principal features of neuroplegic therapy in psychiatry
  in 1956.]   Toulouse me'd., 1956, 57 : 851-867.
PRENDEROL

Studies, animals
  Funderburk, W. H., Unna, K. R.  Site of action of 2,2-
  diethyl-l,3-propanediol  (prenderol) on the central nerv-
  ous system.  J. Pharm. Exp. Ther., 1953, 107: 344-355.

Therapeutic studies, controlled
  Mailer, A. B.  Effects of mephenesin and prenderol on
  intellectual functions of mental patients. J. Clin. Psy-
  chol, 1954, 10: 283-285.
  Selling, L. S. Findings in patients suffering from anx-
  iety states treated with  a muscle  relaxant.  South.
  M. J., 1953, 46 :1204-1210.

Therapeutic use
  Lacchin,  R.  Osservazioni cliniche  sull'impiego di  un
  nuovo farmaco: il prenderol.  [Clinical observations
  on use of a new drug:  prenderol.]  Riv. sper. freniat,
  1952, 76: 649-655.
  Perlstein,  M. A.  Prenderol: a new drug used with  re-
  tarders in petit mal epilepsy.   Neurology, 1953, 3: 744-
  751.


with MEPHENESIN—COMPARED
  see PRENDEROL—Studies, animals
                    Therapeutic studies, controlled
PROCLORPERAZINE

Pharmacodynamics
Studies, animals
  see PROCLORPERAZINE—Therapeutic use
                               [duchesnay]

Studies, normal subjects
  Lehmann, H. E., Csank, J.  Differential  screening  of
  phrenotropic  agents  in  man: psychophysiologic  test
  data.  J. Clin. Exp. Psychopath., 1957, 18: 222-235.

Therapeutic use
  Broussolle, P., Dubor (Dubon [sic]) P. Premier bilan
  des effets cliniques d'un nouveau neuroleptique.  [First
  results of  a  new neuroleptic's clinical effects] [Ab-
  stract] Ann. me'd. psychol, Par., 1956, 114  (2) : 512.
  Duchesnay, G.  Interet du stemetil  (6. 140 R.  P.) en
  therapeutique.  [Stemetil   (6140  RP) ;  its  place  in
  therapeutics.]   Bull,  me'd., Par.,  1957,  71: 13-15.
  Fazekas, J. F., Shea, J. G., Ehrmantraut, W. R., Alman,
  R. W.  Convulsant action of phenothiazine  derivatives.
  J. Am. M. Ass., 1957, 165: 1241-1245.                 *
  Lesse, S.   An evaluation of prochlorperazine  in the
  ambulatory treatment  of psychiatric  patients.  Inter-
  nat. Rec M., 1957, 170: 599-602.
  Moyer, J. H., Pevey, K., Kinross-Wright,  V. Tranquil-
  izing  (ataractic)  agents:  current  evaluation of  their
  clinical  use in patients who are not hospitalized.  GP,
  1957, 15 (6) : 97-118.
  Vischer, T. J.  Clinical study of proclorperazine, a new
  tranquilizer for the treatment of nonhospitalized psy-
  choneurotic patients.  N. England J. M., 1957, 256: 26-
  27.

—Additional data
  Ayd, F.  J., Jr. Tranquilizing drugs in private practice.
  N. York State J. M., 1957, 57:1742-1747.
  Deniker, P.  Hibernotherapies  et medicaments  neuro-
  leptiques en  therapeutique  psychiatrique.   [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapy.]
  Ence'phale, 1957, 46: 281-398.  [362; 381]            *
  Keyes, B. L. Ataraxic drugs.  Pennsylvania M. J.,  1957,
  60:177-181.
  Kline, N. S.  Chemotherapy in psychiatry; recent ad-
  vances.  Seminar Internal, Hoddesdon,  1956, 5  (2)  :
  7-10.
  Senseman, L. A.  Tranquilizing  drugs; uses and abuses
  for the nervous patient. Rhode Island M. J., 1956, 39:
  675-677; 680; 686.
  Tice, L. F.  Some important drug developments of  1956.
  Am. J. Pharm., 1956, 128: 398-409.
Untoward effects [see headnote p. 19]
  Hollister, L. E.  Complications from the use  of tranquil-
  izing drugs.  N. England J. M.,  1957, 257 :170-177.  [p.
  172]
  ---.   Unexpected asphyxial death and  tranquilizing
  drugs. Am. J. Psychiat, 1957,114: 366-367.        * *


with CHLORPROMAZINE—COMPARED
  Duchesnay, G.  Intergt du stemetil (6. 140 R.  P.)  en
  therapeutique.  [Stemetil (6140  RP) ; its place in thera-
  peutics.]  Bull, med.,  Par., 1957, 71:13-15.
  Lehmann,  H. E.,  Csank, J. Differential screening  of
  phrenotropic  agents in man:  psychophysiologic test
  data.   [: chlorpromazine:  reserpine : other  drugs=de-
  pressants; stimulants]  J.  Clin.  Exp. Psychopath.,  1957,
  18:222-235.

with RESERPINE—COMPARED
    see preceding reference
with OTHER DRUGS—COMPARED
    see preceding reference
PROMAZINE
Pharmacodynamics

  see also PROMAZINE with PROMETHAZINE—COM-
              PARED—Pharmacodynamics
  Fazekas, J. F., Toupin, H., Alman, R. W. Physiologic
  and pharmacologic basis for the chemotherapy of psy-
  chiatric states.  Am. J. Med., 1956, 21: 825-831.
Studies, animals
  Himwich, H. E., Rinaldi, F., Willis, D. An examination
  of phenothiazine derivatives with comparisons of their
  effects on the alerting reaction, chemical structure and
  therapeutic efficacy.  J. Nerv. Ment Dis., 1956, 124 • 53-
  57.
123 
Promazine : Studies, animals
PSYCHOPHARMACA
   Hosko, M. J., Gore, E. M., Tislow, R., Seifter, J. Taming
   effect of promazine  in the rhesus monkey.  [Abstract]
   J. Pharm. Exp. Ther., 1957, 119:153-154.
   Lasagna, L., McCann, W. P.  Effect of "tranquilizing"
   drugs on amphetamine  toxicity  in aggregated mice.
   Science, 1957,  125 :1241-1242.

 Studies, patients
   Fazekas, J. F., Shea, J. G., Ehrmantraut, W.  R., Alman,
   R. W.  Convulsant action of phenothiazine derivatives.
   J. Am. M. Ass., 1957, 165:1241-1245.
   Glotfelty, J. S., Wilson,  W. P.   Effects of tranquilizing
   drugs on reticular system activity in man.  North Caro-
   lina M. J., 1956, 17: 401-405.
   Kurtzke, J. F.  Seizures with promazine.  Preliminary
   report.  J. Nerv. Ment. Dis., 1957, 125: 119-125.

 Therapeutic studies, controlled
   Azima, H., Durost, H.  Effects of promazine in mental
   syndromes.  Canad.  31.  Ass. J., 1957, 76: M2-A46.    *
   Burdine, W. E., Shipley, T. E„ Papas, T. A.   Studies on
   the use of promazine in  acute and chronic  nervous  and
   mental disturbances.  J. M. Ass. Georgia, 1957, 46:171-
   173.
   Figurelli,  F. A.  The promazine treatment of alcohol-
   ism ;  a preliminary report.   Indust. M. & S., 1956,  25:
   376-380.
   Lesse, Sr.  An evaluation of promazine hydrochloride
   in psychiatric  practice.   Am. J. Psychiat, 1957, 113:
   984-987.                                           *
   Mitchell, E. H.  Treatment of  acute alcoholism with
   promazine (sparine).  J. Am. M. Ass., 1956, 161: 44-45.
   Condensed: Am. Practitioner, 1956, 7:1798-1799.   Ab-
   stract : Excerpta med., Sect. 8,1957,10: No. 359.
   Moyer, J. H., Pevey, K.,  Kinross-Wright, V.  Tranquil-
   izing  (ataractic) agents:  current evaluation of their
   clinical use in  patients who are not hospitalized.   GP,
   1957,15 (6) : 97-118.                              *  *
   Smigel, J. O.  Mood therapy in the aged.  Med. Times,
   Great Neck, 1957, 85 :149-158.
—Neuroses
   Usdin, G. L.  Use of promazine in psychiatric practice;
   an early  study.  J. Louisiana M.  Soc, 1956, 108:251-
   257.

—Psychoses
   Barsa, J. A., Kline, N. S.  Promazine in chronic schizo-
   phrenic patients.  Am. J. Psychiat., 1957, 113 : 654.    *
   Frain, M. K.  Promazine treatment of chronic psychoses
   in 100 hospitalized patients.  J. Nerv. Ment. Dis., 1957,
   125: 529-533.                                       *
  Mangun, C. W., Webb, W. W. Promazine hydrochloride
  in the treatment of  chronic catatonic schizophrenics.
  J. Nerv. 3Ient. Dis., 1956,123 : 553-556.                *
  Rudy, L.  H., Himwich, H. E., Tasher, D.  C. Clinical
  evaluation of two phenothiazine compounds promazine
  and mepazine.  Am. J. Psychiat, 1957, 113: 979-983.  *
  Sibilio, J. P., Andrew, G., Dart, D., Moore, K. B., Steh-
  man, V. A.  Treatment of chronic schizophrenia with
  promazine hydrochloride.  A. 31. A. Arch. Neur. Psy-
  chiat, 1957, 78: 419-424.

Therapeutic use
  Blackley,  R.  J.  Disappearance  of chlorpromazine-
  induced photosensitivity on substitution of  promazine;
  report on eight cases.  Am. Practitioner, 1957, 8: 46-47.
  Deniker,  P.  Hibernotherapies et  medicaments neuro-
  leptiques  en  therapeutique  psychiatrique.    [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapy.]
  Ence'phale, 1957, 46 : 281-398.  [361-62; 395]         *
  Fazekas, J. F., Schultz, J. D., Sullivan, P. D., Shea, J. G.
  Management of acutely disturbed patients with proma-
  zine (sparine).  J. Am. 31. Ass., 1956, 161: 46-49.  Con-
  densed : Am. Practitioner, 1956, 7 :1807.
   ---, Shea, J. G., Sullivan, P. D., Jr.   Ataractics in med-
   ical practice. GP, 1956, 14 (6) : 75-81.
   ---, Sullivan, P. D., Schultz, J.  D. Use of dimethyl-
   amino-n-propylphenothiazine in the  management of pa-
   tients with acute mental  disturbances.   Med. Ann. Dis*
   trict of Columbia, 1956, 25: 67-69.
   Fox, V. The management of acute  alcoholism; experi-
   ences with an additional series of 61 cases.  Am. Practi-
   tioner, 1956, 7:1461-1464.
   Lemere, F.  Promazine (sparine) in the treatment of
   psychiatric disorders.  Northwest  M.,  1956,  55:790-
   791.                                               *
   Plazak, D. J. A case of  corticotropic hormone-induced
   psychosis treated with promazine hydrochloride.  Mil.
   31  1957 120 * 99—101
   Shea, J.G., Ehrmantraut, W.  R.,  Ticktin, H. E., Sulli-
   van, P. D., Jr., Fazekas, J. F.   Use of promazine in the
   management of  medical  emergencies.   Mil.  31.,  1956
   119:221-227.                                       *'

—Additional data
   Ayd, F. J., Jr.  Tranquilizing drugs  in private practice
   N. York State J. 31., 1957, 57: 1742-1747.
   Block, M. A. Medical treatment of alcoholism.  J. Am
   M. Ass., 1956, 162:1610-1619.
   Cohen, I. M.  Drugs recently introduced in the treat-
   ment of psychiatric  disorders.  Texas J. M.,  1956, 52-
   683-687.
   Fabing, H. D. The ataractic drugs:  their uses and lim-
   itations in psychiatry.  Am. Profes. Pharmacist,  1956.
   22: 413-418.
   Feldman, D. J.   Drug  therapy of chronic alcoholism.
   Med.  Clin. N. America,  1957, 41:381-392.
   Graffagnino, P. N., Furr, J. H.  New drugs in the treat-
   ment of emotional disorders;  a review.  Connecticut
   M. J., 1957, 21: 38-43.
   Gutenkauf,  C.    Internal medicine.  In: "Happiness
   pills" in medical practice: a symposium.  J. Iowa  M.
   Soc,  1957, 47:59-64.
   Happiness pills  in medical practice: a symposium.  J
   Iowa M. Soc, 1957, 47: 57-65.
   Heilbrunn, G.  Selection  of patients for modern psy-
   chiatric pharmacotherapy in general practice.  North-
   west M., 1956, 55:1198-1205.
   Hewitt, D. W.  Alcoholism, a treatment  guide for gen-
   eral practitioners. 112 p.  Philadelphia, Lea d Febiger,

   Kautz, H. D.  Trends in  drug therapy.   Hosp. Progr.,
   1957,38 (1): 102-108; 126.
  Keyes,  B.  L. Ataraxic  drugs.  Pennsylvania  M.  J.,
  1957, 60: 177-181.
  Kline, N. S.  Chemotherapy in psychiatry; recent ad-
   vances.  Seminar Internat., Hoddesdon,  1956 5  (°) •
  7-10.                                        '
  Ravreby, M.  Pharmacology.   In:  "Happiness pills" in
  medical practice: a symposium. J. Iowa M. Soc, 1957,
  tc i *. dt—&y.
  Skobba, J. S.  Drugs in the management of emotional
  conditions.  J. M. Ass. Georgia, 1956, 45: 397-399
  Spencer, R. S.   The use  of ataraxic drugs  in mental
  illness.  Hawaii M. J., 1957,16: 302.
  To£«'  \' FV £°me  imP°rtant drug developments  of
  1956.  Am. J. Pharm., 1956, 128: 398-409
  IS?1?\o'*£h£!lological treatment.   Am. J. Psychiat,
  iwo i,  ±16: oil—615.

Untoward effects  [see headnote p. 19]

  see also PROMAZINE with PROMETHAZINE—COM-
          n„^A^E^—Pnar-rnacodynamics
          PHENOTHIAZINES-tf/irourcrd effects
  Fazekas J. F., Shea,  J. G„ Ehrmantraut, W. R„ Alman,
  k. w.  Convulsant action  of phenothiazine derivatives.
  J. Am. M. Ass., 1957,165:1241-1245.
  Hollister, L. E.  Complications from the use of tranquil-
  izing drugs.  N.  England J. M., 1957, 257:170-177.
124 
SUBJECT  LIST
Promethazine : Studies, animals
  Kurtzke, J. F.  Seizures with promazine.  Preliminary
  report.  J. Nerv. Ment. Dis., 1957, 125:119-125.
  Reinhart, M. J., Silverstein, B. S., Cross, T. N. A case of
  agranulocytosis  following "sparine"  administration.
  Am. J. Psychiat., 1957, 114: 462-463.
  Voegele, G. E., May, R. H.  Epileptiform seizures under
  promazine therapy ; occurrence in two cases without his-
  tory of  former  seizures.   Am. J. Psychiat., 1957,  113:
  655-656.

 with ATARAXICS [2 or more]
  see ATARAXICS—Various [3 or more]—Compared

 with CHLORPROMAZINE—COMPARED
  see CHLORPROMAZINE with PROMAZINE

 with MEPAZINE
  see MEPAZINE with PROMAZINE—COMPARED

 with MEPROBAMATE
  see MEPROBAMATE with PROMAZINE

 with METHYLPHENIDYLACETATE—COMBINED
  Kurtzke, J. F.  Seizures with promazine.  Preliminary
  report.  J. Nerv. Ment. Dis., 1957,125 :119-125.        *

 with PROMETHAZINE—COMPARED
 Pharmacodynamics
  Shea, J. G., Ehrmantraut, W. R., Ticktin, H. E., Sullivan,
  P. D.,  Jr., Fazekas, J. F.  Use of promazine in the man-
  agement of medical emergencies.  Mil.  M., 1956,  119:
  221-227.

 with RESERPINE—COMBINED
  Kurtzke, J. F.  Seizures with promazine.  Preliminary
  report.  J. Nerv. Ment Dis., 1957, 125:119-125.
 with RESERPINE—COMPARED
 Therapeutic studies, controlled
  Frain, M. K.  Promazine treatment of chronic psychoses
  in 100 hospitalized patients. J. Nerv. Ment. Dis., 1957,
  125:529-533.
 Therapeutic use
  Lemere, F.  Promazine  (sparine) in the treatment  of
  psychiatric disorders.  Northwest M., 1956, 55 : 790-791.

 with OTHER DRUGS—COMBINED
 Studies,  patients
  Fazekas, J. F., Shea, J. G., Ehrmantraut, W. R., Alman,
  R. W.   Convulsive action of phenothiazine derivatives.
  [metrazol]  J. Am. M. Ass., 1957, 165:1241-1245.

 with SHOCK THERAPY [ECT]—COMBINED
  Usdin, G. L.  Use of promazine in psychiatric practice;
  an early study.  J. Louisiana  M. Soc, 1956   108: 251-
  257.

with SHOCK THERAPY  [ECT]—COMPARED
  Frain, M. K.  Promazine treatment of chronic psychoses
  in 100  hospitalized patients.  J.  Nerv. Ment. Dis., 1957,
  125:529-533.
PROMETHAZINE

Lytic cocktail
 see CB-1522r-Cochtail
     CHLORPROMAZINE—Various  special techniques
     M E PAZ INE—Cocktail
Pharmacodynamics
  Decourt, P.  Mecanisme  d'action de la therapeutique
  narcobiotique en general, et de  la chlorpromazine  en
  particulier, en psychiatrie.  [Mechanism of action  of
  narcobiotic psychiatric therapy in general, and of chlor-
  promazine in particular.]   Ence'phale, 1956, 45 : 932-944.
  Gade, E. B., Heinrich, K.  Die Bedeutung  der  Pheno-
  thiazinderivate, insbesondere des  Megaphen, ffir Psychi-
  atrie und Neurologie.  [The importance of phenothia-
  zine  derivatives in  psychiatry  and neurology, with
  special  reference  to  chlorpromazine.]  Fortsch. Neur.
  Psychiat., 1955, 23 : 323-353.
  Kuschinsky, G. Wichtige neue Arzneimittel.  [Impor-
  tant  new  drugs.]   Deut.  med.  Wschr.,  1954, 79:1375-
  1376.
  Marti-Ibanez, F., Sackler, A. M., Sackler, M. D., Sackler,
  R. R.  The challenge of bio- and chemotherapy  in psy-
  chiatry.  J. Clin.  Exp. Psychopath.,  1956,  17: 15-18.
  Abstract: Excerpta med.,  Sect. 8, 1957, 10: No. 975.
  Mashkovskii,  M. D.  [The pharmacologic properties  of
  aminazine and of other compounds of the phenothiazine
  order.]  Zh. nevropat. psikhiat, Moskva, 1956, 56: 81-93.
  Abstract: Chem. Abstr., 1956, 50:17174e.
  Promethazine hydrochloride.  J.  Am.  M.  Ass., 1956,
  161:  457-458.
  Rosner, K.  Therapeutische Anwendung der  zentral-
  nervosen Wirkung einiger Phenothiazinderivate in der
  Allgemeinmedizin.    [Therapeutic  use   of  effects   of
  various phenothiazine  derivatives  on central nervous
  system  in  general practice.]   Med. Mschr., 1956, 10:
  719-723.
  Tice, L. F.  Some important drug developments  of 1956.
  Am. J. Pharm., 1956,  128: 398-409.
  Viaud, P.  Les amines derivees de la phenothiazine.
  [The amino-derivatives of phenothiazine.]  J. Pharm.,
  Lond., 1954, 6: 361-389.

Studies, animals
  Baruk, H.,  Launay, J., Berges,  J.  Physiologie psychia-
  trique experimentale  de la chlorpromazine chez les ani-
  maux et ses applications  therapeutiques chez l'homme.
  [Experimental psychopharmacology of  chlorpromazine
  in animals and its therapeutic applications in man.]
  Ence'phale, 1956, 45:1258-1263.
  Courvoisier, S.  Pharmacodynamic basis for the use  of
  chlorpromazine in  psychiatry.   J.  Clin. Exp. Psycho-
  path., 1956, 17: 25-37.
  ----.  Sur  les proprietes  pharmacodynamiques de  la
  chlorpromazine en  rapport avec son emploi en psychi-
  atrie.  [Pharmacodynamic basis  for the use of chlor-
  promazine in psychiatry.]  Ence'phale,  1956, 45:1248-
  1257.
  Guareschi, A., Cazzullo, C.  L.  Sull'azione centrale del
  fargan:  analisi  sintomatologica  ed   elettroencefalo-
  grafica.   [The central action of  fargan: symptomatic
  and electroencephalographic analysis.]   [English sum-
  mary.]  Acta neur., Nap.,  1954, 9 : 274-293.
  Himwich, H. E., Rinaldi, F., Willis, D. An examination
  of phenothiazine derivatives with comparisons of their
  effects on the alerting reaction, chemical structure and
  therapeutic efficacy.  J. Nerv. Ment. Dis., 1956, 124: 53-
  57.
  Nathan, P., Aprison,  M. H., Himwich, H. E. Effect  of
  some  centrally acting drugs on compulsive circling.
  Proc Soc. Exp. Biol, N. Y., 1955, 90: 364-367.  Abstract:
  Chem. Abstr., 1956, 50: 3632cd.
  Rinaldi, F., Himwich, H. E. The site of action  of anti-
  parkinson drugs.  Confinia neur., Basel, 1955, 15: 209-
  224.  Abstract: Am.  J. Physiol, 1954, 179: 665.  Ex-
  cerpta med., Sect. 8,1956, 9: No. 3616.
  Votava, Z., VanSCek, M. The influence of some antihista-
  minics and neuroplegics on  the higher nervous  activity
  of rats and dogs.  Physiol, bohem., 1956, 5 (Suppl.) ■ 58-
  62.
456132—59---9
125 
PSYC
  Walaszek, E. J., Abood, L. G.  Effect of tranquilizing
  drugs on  fighting  response of Siamese  fighting fish.
  Science, 1956, 124: 440-441.
  Weidmann, H., Petersen, P. V. Farmakologisk under-
  s0gelse af Covatin, et nyt  stoff med sedativ virkning.
  [Pharmacological investigation of covatin, a new sub-
  stance  with  sedative  action.]   [English  summary]
  Ugeskr. laeger, 1955, 117: 378-381.
  ----,----.  A new group of potent sedatives.  J. Pharm.
  Exp. Ther., 1953,108: 201-216.
Studies, normal subjects
  Noell, W. K., Chinn, H. I., Haberer, C. E.  Electroen-
  cephalographic evaluation of the sedative effects of anti-
  histaminic drugs. Air Force School of Aviation Medi-
  cine, Randolph  Air Force Base, Texas, 1955  (55-35) :
  1-20.
  Payne, R. B., Moore, E. W. Effects of some analeptic
  and depressant drugs on tracking behavior.  J. Pharm.
  Exp. Ther.. 1955,115 : 480-484.  Abstract:  Chem. Abstr.,
  1956 50: 3632ab.
Studies, patients
  see PHENOTHIAZINES—Studies, patients
Therapeutic studies, controlled
  Bender, L., Nichtern, S.   Chemotherapy  in child psy-
  chiatry.  N. York State J. M., 1956, 56: 2791-2795.
  Fox, V.  Treatment  of withdrawal symptoms  in  the
  management of alcoholism.  J. M. Ass. Georgia, 1956,
  45:139-142.
  Samuels, A. S.  Phenergan in treatment of psychiatric
  patients.  Dis. Nerv. Syst,  1957, 18:183-188.
  Tolan,  E. J., Olariu, J.  Treatment of parkinsonism.
  Preliminary report on use of promethazine in 12 cases.
  Am. J. Psychiat, 1957, 114: 518-523.
Therapeutic use
  Boittelle, G., Boittelle-Lentulo, C. Quelques remarques
  sur Taction du  3277 R. P.  chez les malades mentaux.
  [Effect of 3277  R. P. on mental patients.]  Ann. me'd.
  psychol, Par., 1952, 110 (2) : 295-296.
  Deniker,  P.  Hibernotherapies et medicaments neuro-
  leptiques en  therapeutique psychiatrique.   [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapy.]
  Encephale, 1957, 46: 281-398.   [361; 379 ; 385]
  Hedqvist, H.  Nagra erfarenheter av promethazinklorid
  som  sedativum  och  hypnoticum.   [Experience with
  promethazine chloride as sedative and hypnotic]  Sven.
  lak. tidn., 1954, 51:1286-1297.
  Kautz, H. D. Trends in drug therapy.  Hosp.  Progr.,
  1957, 38 (1) : 102-108; 126.
  Klingman,  W. O.  Neurological and  psychiatric  dis-
  orders ; some recent advances in therapy.  Virginia M.
  Month., 1956, 83 : 240-246.
  Leiberman, D. M., Vaughan, G. F. Tranquillizers. Prac-
  titioner, Lond., 1956,177: 632-638.
  Morgan,  D. R.   The use of reserpine, chlorpromazine
  and allied drugs in medicine  and psychiatry.  Med. J.
  Australia, 1956, 43 (1) : 1029-1035.
  Roeder, F. D. Letter from Germany. Am. J. Psychiat.,
  1956, 113: 506-509.
—Neuroses
  Erwin, H.  J.  Clinical observations   on the use of
  promethazine hydrochloride in  psychiatric  disorders.
  Am. J. Psychiat., 1957,113 : 783-787.
  Jacobowsky, B.  Experiences  from clinical psychiatry,
  with special  reference to general  and methodological
  viewpoints.  Acta psychiat. neur. scand., 1952,  Suppl.
  80 : 86-101. _                                      *
  Martin, G.  liber die sedativen Eigenschaften des Anti-
  histaminicums Atosil.  [The  sedative qualities of the
  antihistaminic atosil.]  Ther. Gegenwart,  1953, 92 : 338-
  340.
  Shorvon, H. J.  Drug therapy in  psychiatry.  Practi-
  tioner, Lond., 1955, 175 :161-169.
—Psychoses
  Guiraud, P.  Discussion  to: Hamon, Paraire, Velluz.
  Remarques sur l'action du  4560 R.  P.  sur l'agitation
  maniaque.  [Effect of R. P. 4560 on manic agitation.]
  Ann. me'd. psychol, Par.,  1952, 110 (1) : 335.
  Lundquist, G.,  Leche, H. G.  Nagra erfarenheter av
  lergiganbehandling vid psykoser.   [Experiences with
  lergigan therapy of psychoses.]  Sven. lak. tidn., 1954,
  51:1402-1412.  Abstract: Excerpta med., Sect. 8, 1955,
  8: No. 1793.
  Rigal.  Traitement de la manie et des etats d'hyperthy-
  mie par le 3277 R. P. (phenergan).  [Phenergan therapy
  of mania  and hyperthymic  conditions.]   J.  me'd.
  Bordeaux, 1952, 129: 899-901.
—Psychosomatic  diseases
  Bente, D.  Zur Wirkung des  Phenothiazinkorpers Atosil
  auf das Schmerzgeschehen.  [Effect of the phenothiazine
  derivative atosil on pain.]  Arch. exp. Path., Berl, 1954,
  222: 71-73.
  Guilly, P.  Formes cliniques et traitement de l'insomnie.
  [Clinical forms and treatment of insomnia.]  Rev. prat,
  Par., 1954, 4 :1571-1581.
  Haggenmiiller, F. Atosil-Sirup in der Kinderheilkunde.
  [Atosil elixir in pediatrics.]  3Ied. Klin., Berl, 1952, 47:
  320-321.
  Kleinsorge, H., Rosner, K.   Schlaftherapie mit Pheno-
  thiazinderivaten.   [Sleep therapy  with phenothiazine
  derivatives.]  Ther. Gegenwart, 1956, 95 : 441-446.
  Korting,  G. W., Borelli,  S., Kimmig, J.   Welche Be-
  deutung besitzen die Phenothiazine fur die  Behandlung
  von Hautkrankheiten?  [Of what significance are pheno-
  thiazines in the treatment  of skin diseases?]   Derm.
  Wschr., 1956, 134:1245-1252.
  Scholten,  C.  tiber  besondere therapeutische Eigen-
  schaf ten des Antihistaminicums Atosil.  [Special thera-
  peutic  qualities of  the antihistaminic atosil.]   Med.
  31schr., 1953, 7: 552-554.
Untoward effects [see headnote p. 19]
  Lbfgren, B.  Sedativa och  hypnotica.   [Sedatives and
  hypnotics.]   [Brief  English  summary]  Nord.  med.,
  1955, 53: 220-222.
  Niedermeyer, E.  liber einen  Fall von  akuter halluzi-  ]
  natorischer Psychose durch Phenerganvergiftung.  [A
  case of acute hallucinatory psychosis caused by phener-
  gan poisoning.]  Klin. 3Ied., Wien,  1956,  11: 280-284.  '■
  Abstract: Excerpta med., Sect. 8, 1957, 10: No. 872.
  Oules, J., Salles, P.,  Soubrie,  R.  Tentative de suicide  ■
  au phenergan.   [Attempted suicide with  phenergan.]
  Ann. me'd. psychol, Par., 1956, 114(1) : 271-273.         \

with ATARAXICS [2 or more]
        see  ATARAXICS—Various  [3  or more]

with CB-1522 and OTHER DRUGS—COMBINED
       see CB-1522—Cocktail

with CHLORPROMAZINE—COMBINED
  see CHLORPROMAZINE—Various  special techniques
with CHLORPROMAZINE—COMPARED
       see  CHLORPROMAZINE   with  PROMETHA-
           ZINE—COMPARED
with CHLORPROMAZINE and OTHER DRUGS—COM-
         BINED
  see CHLORPROMAZINE—Various  special techniques

with COVATIN—COMPARED
  see PROMETHAZINE—Pharmacodynamics [decourt]
               Studies, animals [weidmann+petersen]
126 
SUBJECT LIST
Psychopharmaca
with MEPAZINE and OTHER DRUGS—COMBINED
  see MEPAZINE—Cocktail

with MESCALINE—INTERACTION
  see MESCALINE with PROMETHAZINE

with N-OBLIVON—COMPARED
  see N-OBLIVON—Studies, animals

with NP-207—COMBINED
  see NP-207 with  CHLORPROMAZINE—COMBINED

with PROMAZINE—COMPARED
  see PROMAZINE with PROMETHAZINE

with RP-6549—COMPARED see RP-6549

with RAUWOLFIA    SERPENTINA    ALKALOIDS -
        COMPARED
  Erwin, H. J.  Clinical observations on the use of pro-
  methazine hydrochloride in psychiatric disorders.  Am.
  J. Psychiat., 1957, 113: 783-787.


with OTHER DRUGS—COMBINED

Studies, animals
  Guareschi, A., Cazzullo, C. L.  Sull'azione centrale del
  fargan:  analisi sintomatologica ed elettroencefalogra-
  fica.   [The central action of fargan:  symptomatic and
  electroencephalographic analysis.]  [English summary]
  [meperidine]  Acta neur., Nap.,  1954, 9 : 274-293.
  Schmiterlow, C. G., Hedqvist, H.  Cetiproman, ett nytt
  preparat for psykiatriskt bruk.   [Cetiproman, a new
  preparation for psychiatric use.]  Sven. lak. tidn., 1955,
  52:2318-2326.
Therapeutic studies, controlled
  Kellner, H.  Klinische  Erfahrungen  mit einem  neuen
  phenothiazinhaltigen  Schlafmittel.   [Clinical experi-
  ences with  a new phenothiazine-containing  soporific]
  [Adalat]  Med. Kim., Berl,  1956, 51: 728-729.
  Nitsch, W., Thein, K.  Klinische Erfahrungen mit dem
  neuen Schlafmittel Doroma.   [Clinical experiences with
  the new  sedative Doroma.]  [Adalat]   Ther. Gegen-
  wart, 1956,  95:264.

Therapeutic use
  Demay, G., Montremy, J. de,  Mises, R. Les curarisants
  par voie rectale en psychiatrie.  [Rectal administration
  of curare-like drugs in psychiatry.]  Ann. me'd. psychol,
  Par., 1953, 111 (1) : 660-665.
  Schmiterlow, C. G., Hedqvist, H.  Cetiproman, ett nytt
  preparat for  psykiatriskt  bruk.  [Cetiproman, a new
  preparation for psychiatric use.]  Sven. lak. tidn., 1955,
  52:2318-2326.
  Seabra-Dinis, J.   A terapeutica  pelo sono prolongado.
  [Prolonged  sleep  therapy.]   J.  me'd.,  Porto, 1954, 23:
  233—251.
  Seyffert, H. M., Strubel, H.  Klinische Erfahrungen mit
  dem Schlafmittel und Tagessedativum Doroma.  [Clin-
  ical experience with doroma, a  hypnotic and diurnal
  sedative.]   [Adalat]  Medizinische, 1956, 2: 997-999.
  Williams, E. L.  The management of  the chronic al-
  coholic,   [with disulflram]   Postgrad.  M.  J., Lond.,
  1954, 30:626-630.

—Psychoses
  Ey, H., Berard, E.  Les nouvelles techniques de cure de
  sommeil dans la pratique psychiatrique.  [New technics
  of sleep therapy in psychiatric practice.] Evolut. psy-
  chiat, 1952:661-682.                #
  Gallian,  U., Gamna, G.  Primi  tentativi di terapia di
  sindromi amenziali con preparati derivati dalle tecniche
  della  "ipotensione controllata" e della "ibernazione ar-
  tificiale"' nota preliminare.   [First attempts  to treat
  the svndrome of  amentia with drugs derived from the
  technics  of "controlled hypotension" and "artificial hi-
  bernation" ; preliminary note.]   Minerva  med.,  Tor.,
  1953, 44:357-360.
  Golse, J.  Le traitement du deiire aigu par l'hibernation.
  [Hibernotherapy  of  acute  delirium.]    Ann.  me'd.
  psychol, Par., 1952,110 (2) : 731-734.
  Laborit, H., Coirault, R., Damasio, R., Gaujard, R., La-
  borit, G., Charonnat, R., Lechat, P., Chareton, J.  Sur un
  type nouveau d'anesthesie chirurgicale et sur l'emploi
  en therapeutique  d'un depresseur  du cortex cerebral
  (S.  C. T. Z.)   [A new type of surgical anesthesia and
  the  therapeutic use of a cerebral  cortex  depressant
  (S.  C. T. Z.]   [thiamine hydrochloride]   Presse  me'd.,
  1957, 65:1051-1054.
  Lacroix-Herpin, M. P. de   Cure de sommeil dans les
  hallucinations.  [Sleep therapy in hallucinations.]  60
  p.  Paris, 1954. [Thesis—Paris, 1954, no. 248]
  Rives, Menager, V.  Neuropiegie et delirium tremens.
  [Neuroplegic  therapy and  delirium  tremens.]   Anes-
  the'sie, Par., 1953, 10: 450-453.
—Psychosomatic diseases
  Lundy, J. S.  Modern technics for the  relief of  pain.
  [+ethchlorvynol]  J. Lancet, 1957, 77:32-37.
  Zettel, G. Zur Therapie der Schlafstorungen.  [Ther-
  apy of sleep  disorders.]   [Adalat]  Ther.  Gegenwart,
  1956, 95:455-456.


with INTERMITTENT PHOTIC STIMULATION
Studies, patients
  Leroy, C,  Sigwald, J.  Les  myoclonies et epilepsies
  apparaissant chez certains malades au cours de l'admin-
  istration  de  la   chlorpromazine.  [Myoclonias  and
  epileptic  convulsions occurring in some patients during
  chlorpromazine therapy.]  Ence'phale, 1956, 45: 904-909.



PSYCHOPHARMACA
  see also ATARAXICS
          PSYCHOTOMIMETICS
           STIMULANTS
  Cole, J. O., Ross, S., Bouthilet, L.  Recommendations for
  reporting studies  of psychiatric drugs.  [Conference
  held in Washington, D. C, January 1957]  Pub. Health
  Rep., 1957, 72: 638-645.
  An evaluation of the newer pharmacologic agents and
  their role in  current psychiatric  practice. Psychiat.
  Res. Rep., Wash., 1956 (4) : 1-129.   [Symposium; arti-
  cles within  the scope of  this bibliography are  listed
  individually]
  Gerard, R. W.  Drugs for the soul; the rise of psycho-
  pharmacology.  [Includes report on conference on the
  "Evaluation  of pharmacotherapy  in mental  illness"
  held in Washington, D. C,  September  1956]  Science,
  1957, 125:201-203.
  Himwich, H. E., ed.  Tranquilizing drugs. 197 p.  [Sym-
  posium held in Atlanta, Georgia, December 1955] Wash-
  ington, Am. Ass.  Adv. Sc, 1957.  [Articles within the
  scope of this bibliography are listed individually]
  Kline, N. S., ed.  Psychopharmacology.  165 p.   [Sym-
  posium held in Berkeley, Calif., December 1954]  Wash-
  ington,  Am.  Ass.  Adv. Sc, 1956.  [Articles within
  the scope of this bibliography are  listed individually.]
  Mcllwain, H.  Chemotherapy and  the central nervous
  system.  328  p.  Boston,  Little, Brown d Company,
  1957.
  Pharmacologic products  recently introduced in  the
  treatment  of  psychiatric disorders.  Psychiat. Res.
  Rep., Wash.,  1955  (1): 1-152.   [Symposium; articles
  within the scope of this bibliography are listed individ-
  ually]
  The pharmacology of psychotomimetic and psychothera-
  peutic drugs.  [Conference held in New  York, April 
Psychopharmaca
PSYCHOPHARMACA
  1956]  Ann. N. York Acad. Sc, 1957, 66: 415-840.  [Ar-
  ticles within the scope of  this bibliography are listed
  individually]
  Symposium on tranquilizing agents in clinical medicine.
  Internat. Rec. M., 1956, 169:177-232.   [All articles are
  listed individually]
  Symposium: The role of drug therapies in current and
  future  psychiatric   practice. Psychiat.   Res.  Rep.,
  Wash., 1956 (4) : 95-129.
Bibliographies and literature surveys
  Green, A.  Actualites therapeutiques 1955 en psychia-
  trie.    [Therapeutic  progress  in  psychiatry  in 1955.]
  Ence'phale, 1956, 45 :172-200.
  Wikler, A.  The relation of psychiatry to pharmacology.
  322 p.  Baltimore, Williams d Wilkvns [for the Ameri-
  can Society for Pharmacology and Experimental Thera-
  peutics] 1957.
  Wortis, J.  Physiological treatment.  Am. J. Psychiat,
  1957, 113: 611-615.

Evaluation

  see also ATARAXICS—Psychosocial considerations
  Abramson, H. A., Jarvik,  M. E.,  Levine, A., Kaufman,
  M. R., Hirsch, M. W.  Lysergic acid diethylamide (LSD-
  25) :  XV. The effects produced by substitution  of a tap
  water  placebo.   J. Psychol, Provincet, 1955, 40:367-
  383.
  Alexander, L.  Objective  approaches to treatment in
  psychiatry.  Canad.  Psychiat Ass. J., 1957, 2: 77-94.
  Allen, A., Mackinnon, H. L.  Response to wonder drugs.
  Dis. Nerv. Syst., 1956,17 : 262-263.
  Altschule, M. D.  Use of chlorpromazine and reserpine
  in mental disorders.  N. England  J. M., 1956, 254: 515-
  519.
  Baker, A. A., Thorpe, J. C.  Deteriorated psychotic pa-
  tients—their  treatment and its assessment.  J. Ment.
  Sc, Lond., 1956, 102:  780-789.
  ---, ----.  Placebo  response.  A. M. A. Arch. Neur.
  Psychiat., 1957, 78: 57-60.
  Batterman, R. C.  The evaluation of sedatives.  J. Am.
  Geriat. Soc, 1956, 4 :172-176.
  Bazzi,  T.   Reserpina  e psicoterapia.   [Reserpine  and
  psychotherapy.]  [English   summary]  Arch,   psicol.
  neur., Milano, 1956, 17 : 675-681.
  Chertok, L. A  propos de Temploi de medicaments neu-
  roleptiques dans le   traitement  des  psychonevroses.
  [Neuroleptic drugs in the treatment of psychoneuroses.]
  Ence'phale,  1956, 45 : 705-706.
  Clark, L. D.  Evaluation of the therapeutic effects of
  drugs in  psychiatric  patients.  Dis. Nerv. Syst, 1956,
  17: 282-286.
  Cole, J. O., Ross, S.,  Bouthilet, L.  Recommendations
  for reporting studies of psychiatric drugs.  [Conference
  held in Washington, D. C, January 1957]   Pub. Health
  Rep., 1957, 72: 638-645.
  Di  Mascio, A., Suter, E., Hyde, R. W., Greenblatt, M.
  Physiological effects of L. S. D.; report of a detailed in-
  vestigation in one subject.  Psychiat. Q., 1957, 31: 57-71.
  Feldman, P. E.  The personal element in psychiatric re-
  search.  Am. J. Psychiat., 1956,113 : 52-54.
  Fischer, H. K.,  Dlin, B. M. The  dynamics of  placebo
  therapy; a clinical study.   Am. J. M. Sc, 1956, 232 : 504-
  512.
  Gerard, R. W.   Drugs for  the soul; the rise of  psycho-
  pharmacology.  [Includes  report on conference on the
  "Evaluation of pharmacotherapy in mental illness" held
  in Washington,  D. C, September  1956]  Science, 1957,
  125:201-203.
  Gliedman, L. H., Gantt, W. H., Teitelbaum, H. A. Some
  implications of conditional reflex studies for placebo re-
  search. Am. J. Psychiat.,  1957, 113:1103-1107.
  Gore,  C.  P., Egan, G. P.,  Walton, D.  The place of
  reserpine  in the treatment of the  chronic psychotic pa-
  tient.   Am. J. Psychiat, 1957, 114: 333-337.
 Gottschalk, L. A., Kapp, F. T., Ross, W. D., Kaplan, S.
 M., Silver,  H., MacLeod, J. A.,  Kahn,  J. B., Jr., Van
 Maanen, E. F., Acheson, G. H.  Explorations in testing
 drugs  affecting physical and mental activity; studies
 with a new drug of potential value in psychiatric ill-
 ness.  J. Am. M. Ass., 1956, 161:1054-1058.
 Hampson,  J.  L.,  Rosenthal, D.,  Frank, J. D. A com-
 parative study of the effect of mephenesin and placebo
 on the symptomatology of a mixed group of psychiatric
 outpatients.  Bull. Johns Hopkins Hosp., 1954, 95 :170-
 177.  Abstract: Excerpta med., Sect. 8,1956, 9: No. 2662.
 Held,  R.  Sur la chlorpromazine et  les medicaments
 neuroleptiques;   incidences    psychotherapeutiques.
 [Chlorpromazine and neuroleptic  drugs; psychothera-
 peutic incidences.]  Ence'phale, 1956, 45 :1000-1004.
 Heller, G. C, Walton, D., Black, D. A.  Meprobamate in
 the treatment  of tension states.   J. Ment. Sc, Lond.,
 1957, 103: 581-588.
 Hes, J. P.,  Bracha, S. The influence of reserpine on a
 disturbed male ward and a method for assessing this.
 J. Ment. Sc, Lond., 1956,102: 546-549.
 Hoffer, A.   Experimental pharmacodynamics  and psy-
 chobiology.  J. Clin. Exp. Psychopath., 1956,17 : 376-377.
 Houde, R. W., Wallenstein, S. L.  Clinical aspects of the
 evaluation of  analgesics.   J. Am.  Geriat.  Soc,  1956,
 4: 167-171.
 Kline, N. S.  Relation of psychiatry to the pharmaceuti-
 cal industry.   A. M. A. Arch.  Neur. Psychiat.,  1957,
 77: 611-615.
 Lomas,  J.  Tranquillizing drugs in  psychoneurosis.
 Brit. M. J., 1957,  2: 238.
 Meath, J. A., Feldberg, T. M., Rosenthal, D., Frank, J. D.
 Comparison of reserpine and placebo in treatment of
 psychiatric outpatients.  A. M. A. Arch. Neur.  Psychiat,
 1956, 76: 207-214.
 Mielke, F. A. Methods employed and results obtained in
 psychiatric studies with new drugs acting on  the brain
 stem.  Am. J. Psychiat., 1957, 114:134-139.
 New drugs for patients with emotional disorders.  J.
 Am. M. Ass., 1955, 157 : 665.
 Osmond, H.  Research  on  schizophrenia.  In: Abram-
son,  H. A.,  ed.  Neuropharmacology.  Transactions of
the second  conference, May 1955,  Princeton,  N. J.  New
York, Josiah Macy, Jr. Foundation, 1956.   p. 183-233.
Rashkis, H. A., Smarr, E. R.  Drug and milieu effects
with  chronic  schizophrenics.   A.  M. A. Arch.  Neur.
Psychiat., 1957, 78 : 89-94.
----,  ----.  Psychopharmacotherapeutic research;  a
triadistic approach.   A. M. A. Arch. Neur.  Psychiat,
 1957, 77: 202-209.
 "Rose is a  rose is a rose is a rose"  Psychiat. Q., 1957,
31:346-361.
Rosenthal,  D., Frank, J. D.  Psychotherapy and the
placebo effect.  Psychol Bull. 1956, 53 : 294.
Roth, M. In : Symposium on tranquillizers.  Brit. M. J.,
1957, 2: 221.
 Sabshin, M., Ramot,  J.  Pharmacotherapeutic evalua-
 tion and the psychiatric setting.   A. 31. A. Arch. Neur.
Psychiat, 1956, 75: 362-370.
 Sainz,  A., Bigelow, N., Barwise,  C. On a methodology
for the clinical  evalaution  of  phrenopraxic  drugs.
Psychiat. Q., 1957, 31:10-16.
 Schrut, A. H.   Controlled study on clinical use of reser-
pine in  psychotic patients  with  special comments on
source of error.   J. Nerv. Ment. Dis., 1955,122 : 513-517.
 Symposium on the evaluation of pharmacologic agents
in psychiatry.  J. Clin. Exp. Psychopath., 1957, 18: 221-
283.  [Articles within the scope of this bibliography are
listed individually]
 Thorpe, J. G., Baker, A. A.  A research method to assess
a new tranquillizing drug.  J. Ment. Sc,  Lond.,  1956,
 102: 790-795.
 Tranquilizers.  Nebraska M. J., 1956, 41: 417.
 West, L. J.  Problems in measuring the effects of drugs
 on emotions.  Psychiat. Res. Rep., Wash., 1955 (1): 45.
128 
SUBJECT  LIST
Psychotomimetics : Intoxication — History
  Whitman, R. M., Lipton,  M. A., Kavan,  E.  Rauwiloid
  and preoperative anxiety; a double blind placebo study.
  Q. Bull Northwest Univ.  31. School, 1956, 30:170-174.
  Wikler, A.  The relation  of psychiatry  to pharmacol-
  ogy.  322 p.  Baltimore,  Williams d Wilkins [for the
  American Society  for Pharmacology and Experimental
  Therapeutics] 1957.
  Wolf, S.  The  evaluation of therapeutic agents,  with
  special  reference  to the tranquilizing  drugs.  23 p.
  Washington.  Am.  Psychiat.  Ass. Mental Hospital Serv-
  ice [Monograph series (2)] 1957.
  ---, Pinsky, R. Effects of placebo administration and
  occurrence of toxic  reactions.   J. Am.  M. Ass.,  1954
  155:339-341.

 Pharmacodynamics
  Bazzi, T. Reserpina e psicoterapia.  [Reserpine and
  psychotherapy.]   [English  summary]   Arch,  psicol,
  neur., 3Iilano, 1950, 17 : 675-681.
  Boor, W. de.   Pharmakopsychologie und Psychopath-
  ologie.  [Psychopharmacology  and  psychopathology.]
  291 p.  Berlin, Springer, 1956.
  Carr,  C. J., Kinnard, W. J., Jr.  The phrenotropic agents.
  Internat Rec. M.,  1957,  170:493-504.
  Fabing, H. D.  The new pharmacologic  attack in psy-
  chiatry.  Internat. Rec. M., 1956,  169:177-183.  Also:
  Drug  d  Cosmet Indust., 1956, 78: 32-33;  125-129.
  Himwich, H.  E.  Prospects in  psychopharmacology.
  J. Nerv. Ment.  Dis., 1955,  122:413-423.  Also:  Dis.
  Nerv.  Syst., 1956, 17 : 109-116.
  ---.  Viewpoints  obtained  from basic and  clinical
  symposia on tranquilizing drugs.   In:  Himwich, H. E.,
  ed.  Tranquilizing  drugs.  Washington, Am. Ass.  Adv.
  Sc, 1957.  p. 183-192.
  Leake, C.  D.  Drugs  affecting mood  and  behavior.
  Texas  Rep.  Biol  M.,  1955,  13:793-818.  Abstract:
  Chem. Abstr., 1956, 50: 9615b.
  ---.  Introductory note [to symposium  on tranquiliz-
  ing drugs, Atlanta, Georgia, December 1955]  In: Him-
  wich,  H. E.,  ed.  Tranquilizing drugs.   Washington,
  Am. Ass. Adv. Sc,  1957.  p. 1-5.
  Mayer-Gross, W.  A survey of the pharmacological
  possibilities in  psychiatry.  Ence'phale,  1956,  45:  307-
  312.
  Rinkel, M.  Summary of papers on drugs affecting be-
  havior.  J. Nerv. Ment.  Dis., 1955, 122:496-497.
  Tedeschi, G. F.   Psicoterapia e  farmacoterapia.  [Psy-
  chotherapy and  pharmacotherapy.] Arch, psicol neur.,
  Milano, 1956, 17 : 682-684.

Placebo effect see PSYCHOPHARMACA—Evaluation

Psychosocial considerations
  see ATARAXICS—Psychosocial considerations

Terminology
  Gerard, R. W.  Drugs for the soul; the rise of psycho-
  pharmacology.   Science,  1957, 125 : 201-203.
  Himwich,  H.  E.   Prospects in psychopharmacology.
  J.  Nerv. Ment. Dis.,  1955, 122: 413-423. Also : Dis. Nerv.
  Syst, 1956,17:109-116.
  Kety, S. S. The conference and  its aim.  Ann. N. York
  Acad. Sc, 1957,  66 : 417.
  Puca, A.  Ibernoterapia, sonno prolungato  e neuroplegia
  in  terapia psichiatrica.   [Hibernation,  prolonged sleep
  and neuroplegic  drugs in psychiatric treatment.]  Rass.
 internaz. din. ter., 1955, 35: 805-809.  ["psicofarmaci" p.
 809]
 Rinkel, M.  Experimentally induced psychoses in man.
 In: Abramson, H. A., ed. Neuropharmacology.  Trans-
 actions of the second  conference, May 1955, Princeton,
 N.  J.   New York, Josiah Macy, Jr. Foundation, 1956.
 p. 235-258.  [p. 240-41]
 "Rose is a rose is a rose is a rose'  Pyschiat.  Q., 1957,
 31:346-361.
   Sainz, A., Bigelow, N.,  Barwise, C.  On a methodology
   for the clinical evaluation of phrenopraxic drugs.  Psy-
   chiat Q., 1957, 31:10-16.



 PSYCHOTOMIMETICS

   see also PSYCHOPHARMACA
           individual psychotomimetics
           Cf. DRUG INDEX  : PSYCHOTOMIMETICS
   Abramson,  H. A., ed.    Neuropharmacology.   Trans-
   actions of the second conference, May 1955, Princeton,
   N. J.  328 p.  Transactions of the third conference, May
   1956, Princeton, N. J. 381 p.  New York, Josiah Macy,
   Jr. Foundation, 1956; 1957.  [Articles within the scope
   of this bibliography are listed individually]
   Cholden, L., ed.  Lysergic acid diethylamide and mesca-
   line in experimental psychiatry.  85 p. [Round table at
   American Psychiatric Association annual  meeting held
   in Atlantic City, N. J., May 1955]  New York, Grune d
   Stratton, 1956.  [Articles within the scope of this bibli-
   ography are listed individually]
   Cole, J. O., Ross, S., Bouthilet, L.   Recommendations
   for reporting studies of psychiatric drugs.   [Confer-
   ence  held in Washington, D. C, January 1957]   Pub.
   Health Rep., 1957, 72: 638-645.
   Denber,  H.  C. B., Rinkel, M., ed., Psychodynamic and
   therapeutic  aspects of mescaline and lysergic  acid di-
   ethylamide.   [Round table  at  American Psychiatric
   Association  annual meeting held in Chicago, 111.,  May
   1956]  J. Nerv. Ment Dis., 1957,125 : 423-451.  [Preface
   p. 423^24;  Summary of discussion p.  450-451]  [All
   articles are listed individually]
   Gerard,  R. W.  Drugs for the soul;  the rise of psycho-
   pharmacology.  Science, 1957, 125 : 201-203.
   Kline, N. S., ed.  Psychopharmacology.  165 p.  [Sym-
   posium  held  in  Berkeley,  Calif.,  December 1954]
   Washington, Am. Ass. Adv. Sc, 1956.  [Articles within
   the scope of  this bibliography are listed individually.]
   The pharmacology of psychotomimetic and psychothera-
   peutic drugs.  [Conference held in  New York, April
   1956]  Ann. N. York Acad. Sc, 1957, 66: 415-840.  [Ar-
   ticles within the scope  of this bibliography are listed
   individually]
   Symposium:  Physiologic,  pharmacologic,  neurologic,
   and psychologic actions of  drugs recently introduced
   in the treatment  of  psychiatric disorders.  Psychiat.
   Res. Rep., Wash., 1955 (1) : 1-51.  [Articles within the
   scope of this bibliography are listed individually]
   Symposium: The neurophysiology and neuropharmacol-
   ogy of the new drugs. Psychiat. Res. Rep., Wash., 1956
   (4) : 1-34.  [Articles within the scope of this bibliogra-
   phy are listed individually]
   Wikler, A.  The relation of psychiatry to pharmacology.
   322 p. Baltimore, Williams d Wilkins [for  the Amer-
   ican Society for Pharmacology and Experimental Thera-
   peutics] 1957.

Compared
  see [Psychotomimetic] with [Psychotomimetic]
        Compared
      PSYCHOTOMIMETICS— Various [3 or more]
        Compared

Intoxication—History

  see also PSYCHOTOMIMETICS—Studies, normal
            subjects
  Fabing, H. D.  Experimental psychoses which mimic
  schizophrenia. Nebraska M. J., 1956, 41: 455^59.
  ----.  On going  berserk: a neuro-chemical  inquiry.
  Am. J. Psychiat., 1956, 113 : 409-415.
  Marti-Ibaiiez, F.  The historical and philosophic back-
  ground of psychobiology.  J. Clin.  Exp.  Psychopath.,
  1956, 17:360-369.
129 
Psychotomimetics : Pharmacodynamics
PSYCH0PHAR3IACA
Pharmacodynamics
  Callaway, S., III.  On the production of hallucinated and
  psychosis-like states.  Ann.  Int. M., 1955,  42: 721-728.
  Carr, C. J.,  Kinnard,  W.  J., Jr.  The  phrenotropic
  agents.  Internat. Rec. M., 1957, 170: 493-504.
  The  chemical concept of psychoses.  What's new, 1955
  (189) : 3-7.
  Delay, J., Thuillier, J.  Psychiatrie  experimentale  et
  psychopharmacologie.  [Experimental psychiatry  and
  psychopharmacology.]   Sem. hop. Paris, 1956, 32: 3187-
  3193.
  Deniker, P.  Recent advances in "pharmaco-psychiatry."
  J. Clin. Exp. Psychopath., 1956, 17: 381-384.
  Evarts, E. V.  A review of the neurophysiological effects
  of lysergic acid diethylamide (LSD) and other  psy-
  chotomimetic agents.  Ann.  N.  York Acad.  Sc, 1957,
  66:479-495.
  Fabing, H. D.  The dimensions  of neurology.  Neurol-
  ogy,  1955, 5 : 603-611. Abstract: Excerpta med., Sect. 8,
  1956, 9: No. 1718.
  ----.  Experimental psychoses  which  mimic  schizo-
  phrenia. Nebraska M. J., 1956, 41: 455-459.
  Himwich, H. E.  Discussion of papers on basic observa-
  tions of  new psychopharmacological agents.  Psychiat.
  Res. Rep., Wash., 1956 (4) : 24-31.
  ----.  Prospects  in  psychopharmacology.  J.  Nerv.
  Ment. Dis., 1955, 122:413-423. Also: Dis. Nerv. Syst.,
  1956, 17:109-116.
  Hoch,  P. H., Pennes, H.  H., Cattell, J.  P.  Psychoses
  produced by  administration of drugs.  Res.  Pub.  Ass.
  Res. Nerv. Ment. Dis., 1953,  32:287-296.
  Hoffer, A.  Experimental pharmacodynamics and psy-
  chobiology.  J.  Clin. Exp. Psychopath.,  1956, 17:376-
  377.
  Jarvik, M. E.  Mechanism  of action of  lysergic  acid
  diethylamide, serotonin, and related drugs.  In: Kline,
  N. S., ed.  Psychopharmacology.  Washington, Am. Ass.
  Adv. Sc, 1956.  p. 145-154.
  Leake, C. D. Drugs affecting mood and behavior.  Texas
  Rep. Biol M., 1955,  13: 793-818.
  Page, I. H.  Chemistry of the brain. Past  imperfect,
  present indicative, and—future perfect?  Science, 1957,
  125 : 721-727.
  Pearson, J.,  Dewhurst,  K.   Mescaline:  apotheosis  of
  the devil's root.  Irish J. 31. Sc, 1956: 139-143.
  Rinkel, M., Hyde, R. W., Solomon, H. C.  Experimental
  psychiatry.  IV. Hallucinogens: tools in experimental
  psychiatry.  Dis. Nerv. Syst., 1955, 16: 229-232.
  ---,  Solomon, H. C.   Chemical   theories of  psy-
  chosis.  J. Clin. Exp. Psychopath., 1957, 18 : 323-334.
  Sherwood, W. K.  Experience with "BGE", a naturally
  occurring indole compound.  J.  Nerv. Ment. Dis., 1957,
  125: 490-491.
  Turner, W. J., Merlis,  S.,  Carl, A.  Concerning theories
  of indoles in schizophrenigenesis.  Am.  J.  Psychiat.,
  1955,112: 466-467.
  Woolley, D. W., Shaw, E.  Some neurophysiological as-
  pects of serotonin.  Brit. M. J., 1954, 2:122-126.

Placebo effect see PSYCHOPHARMACA—Evaluation

Studies, animals
  Jarvik, M. E.  Effect of LSD-25 on snails.  In: Abram-
  son, H. A., ed.  Neuropharmacology.  Transactions of
  the  third conference, May 1956, Princeton, N. J.  New
  York, Josiah 31acy,  Jr. Foundation, 1957.  p. 29-38.
  Marrazzi, A. S.  The effects of certain drugs on cerebral
  synapses. Ann. N.  York Acad. Sc, 1957, 66 : 496-507.
  ----, Hart,  E.  R.   An  electrophysiological analysis of
  drugs useful in  psychotic states.  In: Himwich, H.  E.,
  ed.  Tranquilizing  drugs.  Washington,  Am. Ass.  Adv.
  Sc,  1957. p. 9-21.
  ----,----.  An electrophysiological analysis of the  ac-
  tions of some drugs useful  in the therapy of psychotic
  disorders.  J. Nerv. Ment. Dis., 1956, 124: 388-392.
  Schwarz, B. E., Wakim, K. G., Bickford, R. G., Lichten-
  held, F. R.   Behavioral and electroencephalographic ef-
  fects of hallucinogenic drugs;  changes in cats on intra-
  ventricular injection.   A.  M.  A. Arch. Neur. Psychiat,
  1956, 75 : 83-90.  Abstract: Excerpta med., Sect. 8,1957,
  10: No. 328.
  Turner, W. J.  The effect  of lysergic acid diethylamide
  on Betta splendens: I. Dis. Nerv. Syst, 1956,17 :193-197.

Studies, normal subjects
  Fabing, H. D.  On going berserk:  a neuro-chemical in-
  quiry.   Am. J. Psychiat, 1956, 113 : 409-415.
  ----.  Trends in biological  research in schizophrenia.
  J. Nerv. Ment. Dis., 1956, 124:1-7.
  Huxley, A.  Heaven and  hell. 88  p.  London,  Chatto
  d Windus, 1956.
  Lindemann,  E., Clarke,  L. D. Modifications in ego
  structure and personality  reactions under the influence
  of the effects of drugs.   Am. J. Psychiat., 1952,108: 561-
  567.
  Osmond, H.  Ololiuqui: the ancient Aztec narcotic; re-
  marks on the effects  of Rivea corymbosa  (ololiuqui).
  J. Ment. Sc, Lond., 1955,101: 526-537.
  ----.  Research  on   schizophrenia. In:  Abramson,
  H. A., ed.   Neuropharmacology.   Transactions  of the
  second  conference, May  1955, Princeton,  N. J.  New
  York, Josiah 3Iacy, Jr. Foundation, 1956.  p. 183-233.
  ---.  A review of the clinical effects of psychotomime-
  tic agents.   Ann. N. York Acad. Sc, 1957, 66: 418-434.
  Solms,  H.   Relationships between chemical structure
  and psychoses  with the use of psychotoxic substances
  "Comparative pharmacopsychiatric  analysis": A new
  research method.  J.  Clin. Exp. Psychopath., 1956, 17:
  429^33.
  Stevenson, I.  Comments on the psychological effects of
  mescaline and  allied  drugs.   J. Nerv. Ment Dis., 1957,
  125: 438-442.
  Turner, W.  J., Merlis, S.,  Carl, A.   Concerning theories
  of indoles  in  schizophrenigenesis.  Am.  J. Psychiat.,
  1955,112: 466-467.
Studies, patients
  Cholden, L.  S., Kurland, A., Savage, C. Clinical reactions
  and tolerance to LSD  in chronic schizophrenia. J. Nerv.
  3Ient Dis., 1955,  122:211-221.  Abstract:  Excerpta
  med., Sect. 8, 1956, 9 : No. 4015.
  Pennes, H.  H., Hoch, P. H.  Psychotomimetics, clinical
  and   theoretical considerations:  harmine,  WIN-2299
  and nalline. Am. J. Psychiat, 1957, 113: 887-892.
  Sandison, R. A.  The clinical uses of  lysergic acid
  diethylamide.  In:  Cholden,   L.,  ed.   Lysergic acid
  diethylamide and mescaline in experimental psychiatry.
  New York, Grune d Stratton, 1956.   p. 27-34.
Terminology
  Gerard, R. W.  In: Abramson, H. A., ed.  Neuropharma-
  cology.   Transactions of the second conference, May
  1955,  Princeton, N.  J.  New York,  Josiah 3Iacy,  Jr.
  Foundation, 1956.  p.  241.   ["psychosomimetic"]
  ----.  Drugs for  the soul; the rise of psychopharma-
  cology.   Science,  1957, 125 : 201-203.  ["psychosomim-
  etic"]
  Osmond,  H.  A  review of the clinical effects  of psy-
  chotomimetic agents.  Ann.  N. York Acad.  Sc, 1957,
  66: 418-4:4.

 Various [3 or more]—Compared

  see also PSYCHOTOMIMETICS—Studies, animals
  Cholden, L. S., Kurland, A.,  Savage, C.  Clinical reac-
  tions and tolerance to LSD in chronic schizophrenia.  J.
  Nerv. 3Ient.  Dis., 1955,  122: 211-221.  Abstract:  Ex-
  cerpta med., Sect. 8, 1956, 9: No. 4015.
  Hoffer, A.  Epinephrine derivatives as potential schizo-
  phrenic factors.  J. Clin. Exp. Psychopath., 1957,18: 27-
130 
SUBJECT  LIST
RP^909
   Pennes, H. H., Hoch, P. H.  Psychotomimetics, clinical
   and theoretical considerations : harmine, WIN-2299 and
   nalline. Am. J. Psychiat., 1957, 113 : 887-892.
   Rolls,  E.   J., Stafford-Clark,  D.   Depersonalization
   treated by  Cannabis indica.  Guy's Hosp. Rep., Lond.,
   1954, 103:  330-336.
   Solms, H.  Relationships between chemical structure
   and psychoses with the use of psychotoxic substances.
   "Comparative pharmacopsychiatric analysis:"  A new
   research method.  J. Clin. Exp. Psychopath., 1956, 17:
   429-433.


 with ATARAXICS—INTERACTION

   see also  [Psychotomimetic]  with  [Ataraxic]-Inter-
                action
   Deniker,  P.  Psychophysiologic  aspects of  the  new
   chemotherapeutic  drugs in psychiatry;  some practical
   features of  "neuroleptics"  in  order  to  screen  new
   drugs.  J. Nerv. Ment. Dis., 1956, 124: 371-376.
   ---.  Hibernotherapies et medicaments neuroleptiques
   en therapeutique psychiatrique.  [Hibernotherapies and
   neuroleptic drugs  in psychiatric therapy.]  Ence'phale,
   1957, 46 : 281-398.   [355-56]
   Evarts, E. V.  A review of the neurophysiological effects
   of lysergic acid  diethylamide (LSD)  and  other  psy-
   chotomimetic agents.  Ann. N. York Acad. Sc, 1957, 66:
   479-495.
   Fabing, H. D. Adventures in clinical neuropharmacol-
   ogy.  Internat Rec M., 1956, 169:115-119.
   ---.  The  dimensions  of neurology.  Neurology, 1955,
   5: 603-611.  Abstract: Excerpta med., Sect.  8, 1956, 9:
   No. 1718.
   Fazekas, J. F., Toupin,  H., Alman, R. W.  Physiologic
   and pharmacologic basis for the chemotherapy of psy-
   chiatric states.  Am. J. 3Ied., 1956, 21: 825-831.
   Fazio, C.  Risultati e considerazioni sull'impiego della
   reserpina nel trattamento delle psicosi.  [Results and
   considerations on the use of reserpine in the treatment
   of psychoses.] Arch,  psicol. neur., Milano., 1956, 17:
   313-315.
   Forster, W., Henderson, A. L.  A clinical study of fren-
   quel (alpha [4-piperidyl] benzhydrol hydrochloride) in
   chronic schizophrenia.   Canad. 31. Ass. J., 1957, 76: 97-
   101.
   Graffagnino, P. N., Furr, J. H.  New drugs in the treat-
   ment  of emotional disorders; a review.  Connecticut
   31. J., 1957, 21: 38-43.
   Himwich, H. E.  Discussion of papers on basic observa-
   tions of new psychopharmacological agents.  Psychiat.
   Res. Rep., Wash., 1956 (4) : 24-31.
   Hoch,  P. H.  Experimental  psychiatry.  Am.  J. Psy-
   chiat, 1955, 111: 787-790.
  Jatzkewitz, H. Pharmakologische Aspekte in der Schizo-
  phrenieforschung.   [Pharmacological aspects in schizo-
  phrenia research.]   Nervenarzt, 1956, 27 :150-152.
  Osmond, H.  A review  of the clinical effects of psy-
  chotomimetic agents.  Ann. N. York Acad. Sc, 1957, 66 :
  418-434.
  Sebrell, W.  H., Jr.  Chemistry in  chronic disease re-
  search.  Chem. Eng. News, 1955, 33:1856-1860.
  Wikler, A.  The uses of  drugs in psychiatric research.
  Am. J. Psychiat, 1956, 112: 961-969.

Studies, animals
  Cook, L., Weidley, E.  Behavioral effects of some psycho-
  pharmacological agents.  Ann. N. York Acad. Sc, 1957,
  66: 740-752.
  Marrazzi, A. S. The effects of certain drugs on cerebral
  synapses.  Ann. N.  York Acad. Sc, 1957, 66:496-507.
 ___, Hart,  E.  R.   An electrophysiological analysis of
 drugs useful in psychotic states.  In: Himwich, H. E.
 ed.   Tranquilizing  drugs.  Washington,  Am.  Ass. Adv.
 Sc, Idol.  p. 9-21.
  ——,----.  An electrophysiological analysis of the ac-
  tions of some drugs useful in the therapy of psychotic
  disorders.  J. Nerv. Ment. Dis., 1956, 124: 388-392.
  Rinaldi, F.  The  experimental electroencephalographic
  approach to psychopharmacology.  Psychiat. Res. Rep.,
  Wash., 1956 (4) : 1-10.


with INTERMITTENT  PHOTIC STIMULATION
Combined
  Bradley, P. B., Elkes, C, Elkes, J.  On some effects of
  lysergic acid diethylamide  (LSD-25) in normal  volun-
  teers.  J. Physiol, Lond., 1953, 121: 50P-51P.
  Elkes, J.   Effects of psychosomimetic drugs in animals
  and man.  In: Abramson, H. A., ed.   Neuropharma-
  cology.  Transactions of the third conference, May 1956,
  Princeton, N. J.   New York, Josiah Macy, Jr. Founda-
  tion, 1957.  p. 205-295.  [p. 266-67]
  Osmond,  H.  A review  of  the clinical  effects of psy-
  chotomimetic agents.  Ann. N. York Acad. Sc, 1957, 66:
  418-434.
  Peretz, D. I., Smythies, J. R., Gibson, W. C.  A new hal-
  lucinogen : 3,4,5-trimethoxyphenyl-/3-aminopropane with
  notes  on  the stroboscopic phenomenon.  J. 3Ient. Sc,
  Lond., 1955,  101:317-329.
Compared
  Huxley, A.  Heaven and hell.  88 p.  London, Chatto d
  Windus, 1956.
PYRATHIAZINE

  Viaud, P.  Les amines  derivees  de la phenothiazine.
  [The  amino-derivatives  of phenothiazine.]  J. Pharm.,
  Lond., 1954, 6: 361-389.

Studies, animals
  Himwich, H. E., Rinaldi, F., Willis, D.  An examination
  of phenothiazine derivatives with comparisons of their
  effects on the alerting reaction, chemical structure and
  therapeutic efficacy,  [chlorpromazine: mepazine: NP-
  207 ; promazine: promethazine: pyrathiazine: Wy-1107]
  J. Nerv. 31 ent. Dis., 1956,124: 53-57.

Studies, normal subjects
  see PHENOTHIAZINES—Studies, normal subjects


with AZACYCLONOL—COMBINED

  Ferguson, J. T.  Azacyclonol: use of  a  new pharma-
  cologic agent in chronic schizophrenia.  Antibiotic M.,
  1956, 3:146-150.
QUIACTIN

Studies, animals and Therapeutic studies, controlled
  Feuss, C. D., Gragg, L., Jr.  Quiactin: an adjunct in the
  treatment of chronic psychoses.  Dis. Nerv. Syst., 1957
  18: 29-33.

Therapeutic use—Psychoses
  Coats, E. A., Gray, R. W.  Quiactin in treatment of emo-
  tional and mental disorders.  Dis. Nerv. Syst, 1957 18 •
  191-193.
RP-4909
Therapeutic use
  Broussolle, P., Hamoneau, G. Traitement prolonge a la
  chlorpromazine (45.60 R. P.) ; treize  observations  de 
RP^I909
PSYCHOPHARMACA
  psychoses graves.   [Prolonged treatment with chlorpro-
  mazine ;  thirteen  patients  with  severe  psychoses.]
  Lyon  me'd., 1953,  85 (2) : 389-401.

with CHLORPROMAZINE—COMPARED  see RP-4909
RP-6549

Therapeutic use—Psychoses
  Deniker,  P.   Hibernotherapies et medicaments neuro-
  leptiques en  therapeutique psychiatrique.  [Hiberno-
  therapies and neuroleptic drugs in psychiatric therapy.]
  Ence'phale, 1957, 46: 281-398.  [p. 362-63]


with CHLORPROMAZINE—COMPARED
with PROMETHAZINE—COMPARED
  see RP-6549
RP-7044
Pharmacodynamics
  Deniker, P. Hibernotherapies et medicaments neuro-
  leptiques en  therapeutique  psychiatrique.   [Hiberno-
  therapies and neuroleptic drugs in  psychiatric  ther-
  apy.]   Encephale, 1957, 46:  281-398.  [p. 363]
  Perrault, M.  Sur les tranquilliseurs.  [Tranquilizers.]
  Progr. me'd., Par., 1957, 85 : 3-4; 7.

Studies, animals and Therapeutic use
  Sigwald, J., Henne, M., Bouttier, D., Raymondeaud, C,
  Quetin, A.  Activite  d'une  nouvelle  phenothiazine en
  psychiatrie  et en neurologie; proprietes therapeutiques
  du maleate acide de levo methoxy-3  (dimethylamino-3'
  methyl-2' propyl) 10 phenothiazine  (7044 RP).   [Ac-
  tivity of a new phenothiazine in psychiatry and neurol-
  ogy; therapeutic properties  of 10-(3-dimethylamino-2-
  methyl-propyl)-3-methoxyphenothiazine.]  Presse  me'd.,
  1956, 64:2011-2014.


with CHLORPROMAZINE—COMPARED
  see RP-7044—Studies, animals and Therapeutic use
RAUWOLFIA ALKALOIDS
  see also RAUWOLFIA CANESCENS ALKALOIDS
          RAUWOLFIA SERPENTINA ALKALOIDS
          RESCINNAMINE
          RESERPINE

  Pharmaceuticals & Drugs Committee, Council of Scien-
  tific & Industrial Research.  Symposium on Rauwolfia,
  Calcutta, 1955.  [Abstracts]   38 p.  Lucknow, Pioneer
  Press, 1955.  [Abstracts within the scope of this bibliog-
  raphy are listed individually.]
  Schneider, J. A.  The pharmacology of Rauwolfia.  In
  following reference p. 109-143.
  Woodson, R.  E.,  Youngken, H.  W., Schlittler,  E.,
  Schneider, J . A.  Rauwolfia: botany,  pharmacognosy,
  chemistry & pharmacology.  149  p.  Boston,  Little,
  Brown d Company, 1957.
  Yonkman, F. F., ed.   Reserpine (serpasil) and  other
  alkaloids of Rauwolfia  serpentina:  chemistry, pharma-
  cology, and clinical applications.  Reserpine in the treat-
  ment  of neuropsychiatric,  neurological  and  related
  clinical  problems.  [Conferences held  in New  York,
  February 1954 and February 1955.]  Ann. N. York Acad.
  Sc, 1954, 59: 1-140;  1955, 61: 1-280.   [Articles within
  the scope of this bibliography are listed individually.]
Bibliographies and literature surveys
  Bein,  H. J.  The pharmacology of Rauwolfia.  Pharm.
  Rev., 1956, 8: 435-483.
  Kline,  N.  S.  Use  of Rauwolfia serpentina Benth.  in
  neuropsychiatric conditions.  Ann. N. York Acad. Sc,
  1954, 59: 107-132.
  Penick, S. B. and Company  Rauwolfia and  alkaloids, a
  bibliography ; chemistry, pharmacology, pharmacognosy,
  therapeutic uses.  50 p.   New York, 1956.
  ---.   Suppl. 1. 18 p.  New York, 1957.
  Ray, P. K.  The use of Rauwolfia serpentina in psychi-
  atry.  Ind. J. Neur. Psychiat., 1952, 3:380-398.
RAUWOLFIA CANESCENS ALKALOIDS

  Bein, H. J.  The pharmacology of Rauwolfia.  Pharm.
  Rev., 1956, 8: 435-483.
  Schneider, J. A.  The pharmacology of Rauwolfia.  In:
  Woodson,  R.  E.,  Youngken,  H. W., Schlittler,  E.,
  Schneider, J. A.  Rauwolfia:  botany, pharmacognosy,
  chemistry  & pharmacology.  Boston, Little, Brown d
  Company, 1957.  p. 109-143.

Studies, animals
  Cronheim, G., Orcutt, J. A., Toekes, I. M.  Pharmacolog-
  ical properties of canescine (recanescine), a new alka-
  loid isolated from Rauwolfia  canescens Linn. Proc.
  Soc. Exp. Biol, N. Y., 1955,  89: 21-23.
  ---, Toekes, I. M.  Comparison of "sedative" properties
  of single alkaloids of  Rauwolfia and their mixtures.
  /. Pharm. Exp. Ther., 1957, 119: 357-360.
  Kohli, J. D., De, N. N.  Pharmacological action of rau-
  wolscine.  Nature, Lond.,  1956, 117: 1182.  Abstract:
  Chem. Abstr., 1956, 50:14097bc.
  Pfeiffer, C. C, Jenney, E. H.  The inhibition of the con-
  ditioned response and the counteraction of schizophrenia
  by muscarinic stimulation of the brain.  Ann.  N. York
  Acad. Sc, 1957, 66: 753-764.
  Schneider, J. A., Plummer, A.  J., Earl, A. E.,  Barrett,
  W. E., Rinehart, R., Dibble,  R.  C.   Pharmacological
  studies with deserpidine,  a new alkaloid  from Rau-
  wolfia canescens.  J.  Pharm. Exp. Ther., 1955,  114:10-
  13.
  Shore, P. A., Carlsson, A., Brodie, B. B.  Mechanism of
  serotonin-release by reserpine.   [Abstract]  Fed. Proc,
  Ball, 1956, 15: 483.
  Slater, I. H., Rathbun, R. C, Henderson, F. G., Neuss, N.
  Pharmacological properties of  recanescine, a new seda-
  tive alkaloid from  Rauwolfia  canescens Linn.  Proc.
  Soc. Exp. Biol, N. Y., 1955, 88: 293-295.

Therapeutic studies, controlled
  Pennington, V. M.  A  two-year comparative study of
  ataraxics in neuropsychiatric patients.  J. Am. Geriat.
  Soc, 1957, 5: 421-A29.   [Not seen]
  Zeller, W. W., Graffagnino, P. N., Cullen, C. F., Reitman,
  H. J.  Use of chlorpromazine and reserpine in the treat-
  ment  of  emotional disorders.  J. Am. M. Ass.,  1956,
  160:179-184.  Abstract:  Year book  of  drug  therapy,
  1956-1957, p. 341-342.

—Psychoses
  Ferguson, J. T.  Comparison of reserpine and harmonyl
  in psychiatric patients; a preliminary report.   J. Lan-
  cet, 1956, 76:389-390.
  Gallagher, W. J., Berry, J. M.,  Durden, W. D.,  Lazenby,
  W. D.  Comparative  study of reserpine, 11-desmethoxy-
  reserpine,  and  Rauwolfia  alkaloids  in  treatment of
  schizophrenia.  In:  Himwich, H. E., ed. Tranquilizing
  drugs.   Washington, Am.  Ass. Adv. Sc, 1957.  p. 133-
  147.                                               *
  Malamud, W., Barton, W. E., Fleming, A. M., Middleton,
  P. McK., Friedman, T. T., Schleifer, M. J.  The evalua-
132 
SUBJECT  LIST
Rauwolfia serpentina alkaloids : Pharmacodynamics
  tion of the effects of  derivatives  of Rauwolfia  in the
  treatment of schizophrenia.  Am. J. Psychiat., 1957,114:
  193-200.
Therapeutic  use
  Kline, N. S., Saunders, J. C.  Reserpine in psychiatric
  and neurologic disorders.  Med. Clin. N. America, 1957,
  41:307-326.
  Morgan, D. R.  The use  of reserpine, chlorpromazine
  and allied  drugs in medicine and  psychiatry.  Med. J.
  Australia, 1956, 43 (1) : 1029-1035.

with  AZACYCLONOL—COMBINED
  Ferguson,  J. T.  Azacyclonol:  use of  a new  pharma-
  cologic agent  in chronic schizophrenia.  Antibiotic M.,
  1956, 3: 146-150.

with IPRONIAZID—COMBINED
Therapeutic  studies, controlled
  Gallagher, W. J., Berry, J. M., Durden, W. D., Lazenby,
  W D.  Comparative study of reserpine, 11-desmethoxy-
  reserpine,  and  Rauwolfia alkaloids in  treatment of
  schizophrenia. In:  Himwich, H.  E., ed. Tranquilizing
  drugs.  Washington, Am.  Ass. Adv. Sc, 1957.   p. 133-
  147.
 Studies, animals
   Cronheim, G., Toekes, I. M.  Comparison of "sedative"
   properties of  single alkaloids of Rauwolfia and their
   mixtures,  [reserpine:   rescinnamine:   deserpidine:
   Riker 529-1: Riker 529-2 :  triserpine]  J. Pharm. Exp.
   Ther., 1957, 119: 357-360.
 Therapeutic studies, controlled
   Malamud, W.,  Barton, W. E., Fleming, A. M., Middleton,
   P. McK., Friedman, T. T., Schleifer, M. J.   The evalua-
   tion of the effects of derivatives of Rauwolfia  in the
   treatment  of  schizophrenia.   Am.  J.  Psychiat,  1957,
   114:193-200.

 with RESERPINE—COMBINED [Riker  529-1]

 Studies, animals
   Cronheim, G.,  Toekes, I. M.  Comparison of "sedative"
   properties of  single alkaloids of Rauwolfia and their
   mixtures.  J. Pharm. Exp.  Ther., 1957,  119: 357-360.

 Therapeutic studies, controlled
   Gallagher, W.  J., Berry, J. M., Durden,  W. D., Lazenby,
  W. D.  Comparative study  of reserpine, 11-desmethoxy-
   reserpine and Rauwolfia  alkaloids in  treatment of
  schizophrenia.   In:  Himwich, H. E., ed. Tranquilizing
  drugs.  Washington, Am. Ass. Adv. Sc, 1957.  p. 133-
  147.

with RESERPINE—COMPARED
  York  Acad.  Sc, 1955,  61:17-26.  Abstract: Excerpta
  med.,  Sect. 8,1956, 9: No. 2480.

Studies, animals
  Cronheim, G., Toekes, I. M.  Comparison of "sedative"
  properties of single alkaloids of Rauwolfia and their
  mixtures,  [reserpine: rescinnamine: deserpidine: Rik-
  er 529-1: Riker  529-2: triserpine]  J. Pharm. Exp.
  Ther., 1957, 119 : 357-360.
  Slater, I. H., Rathbun, R. C, Henderson, F. G., Neuss, N.
  Pharmacological properties of recanescine, a new seda-
  tive alkaloid from Rauwolfia  canescens Linn.  Proc,
  Soc Exp. Biol, N. Y., 1955, 88: 293-295.

Therapeutic studies, controlled
Therapeutic use

  see RAUWOLFIA CANESCENS ALKALOIDS
        Therapeutic studies, controlled
        Therapeutic use



RAUWOLFIA SERPENTINA ALKALOIDS

  see also  RAUWOLFIA ALKALOIDS
          RESCINNAMINE
          RESERPINE
  Raudixin in  the treatment of the affective disorders.
  Original reports by clinical and laboratory investigators.
  Monogr. Ther. Squibb Inst M. Res., 1956, 1 (2) : 1-44
  [Articles within  the scope of  this bibliography  are
  listed  individually]

 diagnostic use
  Benda, C. E. The differentiation  between mental de-
  ficiency and emotional disorders, and some therapeutic
  experiments with  Rauwolfia  serpentina  (koglucoid).
  [In English]  Arch, pediat. Uruguay,  1955, 26: 32^6
 harmacodynamics
  Abrams, R. E., Tice, L. F. Modern medicinals in review.
  Am. J. Pharm., 1955,127 : 4-22.
  Alseroxylon.  Rauwolfia.  Reserpine.  J\ Am. 31. Ass.,
  1955, 159: 1206-1207.
  Bein,  H. J.   The pharmacology of Rauwolfia.  Pharm.
  Rev., 1956, 8: 435^83.
  Bergy, G. A.  Drugs of sedation with tranquilizing ef-
  fects.  Am. Profes. Pharmacist, 1956, 22: 419; 534-538;
  619-621;  709-710; 797-799; 888-889;  917-919.  [797-
  799; 888-889 ; 917-919.]
  Ciba   Pharmaceutical Products, inc.  The  Rauwolfia
  story,  from primitive medicine  to alkaloidal  therapy.
  63 p.   Summit, N. J., 1954.
  ----.  The story of serpasil.  55 p.  Summit, N. J., 1955.
  Deniker,  P.  Hibernotherapies et medicaments  neuro-
  leptiques en  therapeutique psychiatrique.  [Hiberno-
  therapies and neuroleptic  drugs in psychiatric ther-
  apy.]  Ence'phale, 1957, 46: 281-398.
  Goldstein, S. W. New drugs; old drugs.  Am. J. Pharm.,
  1954,126: 404-408.
  Kiessling,  J.  Rauwolfia serpentina;  Uberblick fiber
  Chemie,  Pharmakologie und moderne Therapie.  [Rau-
  wolfia serpentina; review  on its  chemistry, pharma-
  cology and  modern therapy.]   Zschr.  drztl Fortbild.,
  1956, 50: 637-650.
  Kress, R.   Chemisches und  Medizinisches fiber Rau-
  wolfia serpentina Benth.  [Chemical and medical data
  on Rauwolfia serpentina Benth.] Pharmazie,  1953, 8:
  726-728.
  Kuschinsky, G.  Wichtige neue Arzneimittel.  [Impor-
  tant new drugs.]  Deut. med. Wschr.,  1953, 78:646.
  Leake, C. D.  Drugs affecting mood and behavior.  Texas
  Rep.   Biol.  M.,  1955,  13:793-818.   Abstract:  Chem.
  Abstr., 1956, 50: 9615b.
  ----.   New mood-changing  drugs.   OTiio M. J., 1956,
  52:369-373.
Pharmacodynamics
  Schneider, J. A., Plummer, A. J., Earl, A. E., Gaunt, R.
  Neuropharmacological  aspects of  reserpine.  Ann.  N.

      456132—59---10
with RAUWOLFIA SERPENTINA ALKALOIDS—COM-
    PARED
  Achor,  R. W.,  Hanson, N.  O.  Hypertension  treated
  with Rauwolfia canescens; a comparison with Rauwolfia
  serpentina.   N.  England J. M., 1956, 255: 646-650.  *
  Gallagher, W. J., Berry, J. M., Durden, W. D., Lazenby,
  W. D.  Comparative study of reserpine, 11-desmethoxy-
  reserpine,  and  Rauwolfia alkaloids  in treatment of
  schizophrenia.   In:  Himwich,  H. E.,  ed. Tranquilizing
  drugs.  Washington, Am. Ass.  Adv. Sc, 1957.  p. 133-
  147.

with RESCINNAMINE and  RESERPINE—COMBINED
    [triserpine] 
Rauwolfia serpentina alkaloids : Pharmacodynamics
PSYCH0PHAR31ACA
  Peters, L.  Pharmacology of the useful antihypertensive
  drugs.  A. M. A. Arch. Int. M., 1956, 98: 409-415.
  Piccinelli,  O.  Farmacologia e clinica della  Rauwolfia
  serpentina.   [Pharmacology  and  clinical  aspects  of
  Rauwolfia serpentina.]  Farmaco, ed. prat, Pavia, 1954,
  9: 574-582.
  Plummer,  A. J., Earl A., Schneider,  J. A., Trapold, J.,
  Barrett, W.   Pharmacology of Rauwolfia alkaloids,  in-
  cluding  reserpine.  Ann.  N.  York Acad. Sc, 1954, 59:
  8-21.
  Rauwolfia  serpentina.  Bull.  Calcutta School  Trop.
  3Ied., 1954, 1 (3) : 22-23.
  Schneider, J. A. The pharmacology of Rauwolfia.  In:
  Woodson,  R. E., Youngken, H. W., Schlittler,  E., Schnei-
  der,  J. A.  Rauwolfia: botany, pharmacognosy,  chem-
  istry &  pharmacology.   Boston, Little, Brown d Com-
  pany, 1957.  p. 109-143.
  Thompson, J.  From  snake pit to snake root.  Bull. M.
  Libr. Ass., 1956, 44: 465-472.
  Vivien, P. Les effets neuro-psychiques du Rauwolfia et
  de ses alcaloides.  [Neurological and phychological  ef-
  fects  of  Rauwolfia  and  its  alkaloids.]   Ann.  me'd.
  psychol, Par., 1955, 113 (1) : 217-226.
Placebo effect see PSYCHOPHARMACA—Evaluation

Psychotherapeutic use
  see RESERPINE—Psychotherapeutic use

Studies, animals
  Baruk, H., Launay, S., Berges, J. Action de la reserpine
  sur la psychomotricite et catatonie experimentale.  [Ef-
  fect  of reserpine on  experimental psychomotricity and
  catatonia.] Rev. neur., Par., 1956, 95: 62-63.
  Cronheim, G., Brown, W., Cawthorne, J., Toekes, I.  M.,
  Ungari, J.  Pharmacological  studies with rescinnamine,
  a new  alkaloid isolated from Rauwolfia  serpentina.
  Proc. Soc. Exp. Biol, N.  Y.,  1954, 86: 120-124.
  ---, Stipp,  C,  Brown,  W.  Hypotensive agents from
  Rauwolfia serpentina: reserpine and other  alkaloids.
  [Abstract]  J. Pharm. Exp. Ther., 1954, 110:13.
  ---, Toekes, I. M.  Sedative effect of Rauwolfia serpen-
  tina.  [Abstract] Fed. Proc, Ball, 1954, 13: 345.
  Kahan, I.  H. Accidental Rauwolfia poisoning in  a dog.
  J. Am. Vet. M. Ass., 1955, 216 : 472.
  Kohli, J. D., Mukerji, B.  Comparative activity of reser-
  pine and total  alkaloids of Rauwolfia.  [Abstract]  In:
  Pharmaceuticals & Drugs Committee, Council of Scien-
  tific  & Industrial Research.  Symposium on  Rauwolfia,
  Calcutta,  1955.  Lucknow,  Pioneer Press, 1955.   p.
  33-34.
  Norton, S., De Beer, E. J.  Effects of drugs on the be-
  havioral patterns  of cats.  Ann.  N. York  Acad.  Sc,
  1956, 65: 249-257.
  Pfeiffer, C. C, Jenney, E. H.  The inhibition  of the con-
  ditioned response and the counteraction of schizophrenia
  by muscarinic stimulation of the brain.  Ann. N. York
  Acad. Sc, 1957, 66: 753-764.
  Rubin, B., Malone, M. H., Waugh, M. H., Burke, J. C.
  Comparative activity of Rauwolfia serpentina  whole
  root  and  reserpine  in  laboratory  animals.  Monogr.
  Ther. Squibb Inst. M. Res.,  1956, 1  (2) : 40-44.

Studies, normal subjects
  Kline, N.  S.  Use of Rauwolfia serpentina  Benth.  in
  neuropsychiatric conditions.  Ann. N. York Acad.  Sc,
  1954, 59:107-132.  Abstract:  Chem. Abstr., 1954,  48:
  10220c.
  Whitman, R. M., Lipton, M. A., Kavan, E.  Rauwiloid
  and preoperative anxiety; a  double blind placebo study.
  Q.  Bull. Northwest Univ. M. School, 1956, 30: 170-174.

Studies, patients
  Avenarius,  R.  Zur  Wirkungsweise  von   Rauwolfia-
  alkaloiden  und  Phenothiazinderivaten  bei  Schizo-
  phrenen.  [Mechanism of action of Rauwolfia alkaloids
  and  phenothiazine  derivatives  in   schizophrenics.]
  Nervenarzt, 1956, 27 : 454-458.
  Baruk, H., Launay, J.,  Berges, J., Lanten-Laura, G.
  Etude de l'action de la reserpine sur l'initiative psycho-
  motrice et les grandes constantes physiologiques et bio-
  logiques.   Comparison sur Taction des extraits totaux.
  [Study of the effects of reserpine on psychomotor initia-
  tive and the significant physiologic and biologic values;
  comparison with  the effects of  total extracts.]  Ann.
  me'd. psychol, Par., 1957, 115 (1) : 708-712.

Therapeutic studies, controlled
  Blumberg, A. G.,  Cohen, L., Miller, J. S. A.  The effect
  of Rauwolfia serpentina on anxiety states. J. Hillside
  Hosp., 1954, 3 :140-146.  Abstract: Excerpta med., Sect.
  8,1955, 8: No. 3900.
  Kline,  N. S.  Use of Rauwolfia  serpentina Benth. in
  neuropsychiatric conditions.  Ann. N.  York Acad. Sc,
  1954,   59:107-132.  Abstract:   Chem.  Abstr.,  1954,
  48:10220c.
  Marini, M., Caprini, G., Benciolini, P. La  Rauwolfia in
  malate croniche, normotese ed ipertese; contributo clin-
  ico.  [Rauwolfia  in chronic, normotensive and hyper-
  tensive patients; clinical  contribution.]   Arch, psicol.
  neur., Milano, 1956,17 : 419-432.
  Smigel, J. O. Mood therapy in the aged.  Med. Times,
  Great Neck, 1957, 85:149-158.

—Neuroses
  Folkson, A., May, A. R.  Use of reserpine and Rauwolfia
  in psychoneuroses.   Brit.  M.  J., 1955,  2:1121-1122.
  Abstract: Excerpta  med., Sect. 8, 1956, 9:  No. 2658.
  Hollister, L. E., Stannard,  A. N, Drake,  C. F.  Treat-
  ment of anxious patients with drugs.  Dis. Nerv. Syst.,
  1956,17: 289-293.
  Meller, R. L.   Reserpine  and  alseroxylon therapy in
  emotionally disturbed patients.  J. Lancet, 1955, 75: 339-
  342.  Abstract:  Excerpta med., Sect. 8,1956, 9: No. 5000.
  Thimann, J.,  Bucknam,  F.  G., Gauthier, J. W.,  O'Con-
  nell, T. A.  Rauwiloid therapy in alcoholism.   Am. J.
  Psychiat., 1957,113 : 694-697.
  Weir, H. F., Anderson, R. L.  The effects of reserpine
  and  Rauwolfia in minor  disorders  of adjustment in
  children.  Monogr.  Ther. Squibb Inst. M.  Res.,  1956,  1
  (2): 33-39.                                         *

—Psychoses
  Azima, H., Cramer-Azima, F.  J.,  De  Verteuil, R.  A
  comparative  behavioral and psychodynamic study of
  reserpine and equally potent doses of raudixin in schiz-
  ophrenics.  Monogr. Ther.  Squibb Inst. M. Res., 1956,
  1(2): 15-25.                                       *
  Baruk, H., Launay, J., Berges, J., Mijolla,  A. de. Etude
  clinique de Taction therapeutique de la reserpine. Com-
  paraison avec  Taction des extraits  totaux.   [Clinical
  study of the therapeutic effect of reserpine ; comparison
  with total extracts.]   Ann. me'd. psychol, Par., 1957,
  115 (1) : 704-708.
  Elkes, C.  Rauwolfia alkaloids and reserpine in  the
  treatment of the chronic psychotic  patient.   J. Ment.
  Sc, Lond., 1957,  103: 464-474.
  Gallagher, W. J., Berry, J.  M., Durden, W. D., Lazenby,
  W. D.  Comparative study  of reserpine, 11-desmethoxy-
  reserpine, and Rauwolfia  alkaloids in  treatment of
  schizophrenia.  In: Himwich, H. E., ed.  Tranquilizing
  drugs. Washington, Am. Ass. Adv. Sc, 1957. p. 133-147. *
  Holt, E. K., Ward-Dunn, G., Nedilsky, B. T., Niswander,
  G. D.  Clinical comparison of raudixin and rau-sed in
  chronic mental illness.  Dis. Nerv. Syst,  1955,  16: 222-
  223. Abstract: Excerpta med., Sect. 8, 1956, 9 : No.4564.
  Malamud, W., Barton, W. E., Fleming, A. M., Middleton,
  P. McK., Friedman, T. T., Schleifer,  M. J. The evalua-
  tion of the  effects  of derivatives of Rauwolfia in the
  treatment of  schizophrenia.  Am. J. Psychiat  1957
  114:193-200.
134 
SUBJECT  LIST
Rauwolfia serpentina alkaloids :  Therapeutic use —Psychosomatic diseases
  Pennington, V. M.  A comparative study of six ataraxics
  in 1130  neuro-psychiatric cases.  Mississippi  Doctor,
  1956,33:336-339.
  Ruskin, I. W., Avol, M.  Rauwolfia tranquilization  for
  the disturbed aged.  J. Am.  Geriat. Soc,  1956, 4:998-
  1003.
  Torsegno,  M., Zucchi,  M.  Trattamento  di  ammalati
  mentali con un preparato iniettabile di alcoloidi totali
  di Rauwolfia  serpentina  Benth.  [Therapy of mental
  patients  with an injectable preparation of total alka-
  loids from  Rauwolfia  serpentina Benth.]   Minerva
  med., Tor., 1955, 46: 604-607.  Abstract: Excerpta med.,
  Sect. 8, 1956,  9: No. 3087.                           *
  Tripi, G.   Considerazioni generali sull'uso della cloro-
  promazina e  della reserpina  nel trattamento di circa
  trecento   psicopatici.  [Observations  on  the  use  of
  chlorpromazine and reserpine in the treatment of about
  300   mental  patients.]   Rass.  neuropsichiat., 1955,
  9:463-469.  Also:  Arch, psicol.  neur., Milano, 1956,
  17:635-639.
—Psychosomatic diseases
  Doyle, J. C.  Raudixin (Squibb Rauwolfia  serpentina) :
  a clinical investigation of thirty patients suffering from
  premenstrual  tension.  Monogr.  Ther.  Squibb Inst. M.
  Res., 1956, 1 (2) : 9-14.
  Eiber, H.  B.   Chlorpromazine-Rauwolfia  serpentina
  combination in the treatment of essential hypertension :
  preliminary report. J. Am. M. Ass., 1955,158: 730-731.
  Ferrara, R. J., Pinkus, H. Alseroxylon in the treatment
  of pruritic and psychogenic dermatoses.  A. M. A. Arch.
  Derm., 1955, 72: 23-28.
  Leslie, G.  Rauwolfia serpentina in the  treatment of
  psoriasis.  Monogr. Ther. Squibb Inst. M.  Res., 1956, 1
  (2) : 29-32.
  Policzer, M.,  Szekely, A., Foldes, J.  A Rauwolfia ser-
  pentina alkalmazasa  a  vegetativ mtikodesek  regulatio-
  zavaraiban.  [Use of Rauwolfia serpentina  in autonomic
  disorders.]  Orv. hetil,  1955,  96:548-549.
  cial reference to reserpine.]  Prensa me'd. argent., 1956,
  43:423-425.  Also: Rev.  mCd. cubana,  1956, 67:623-
  627.
  Pennington, V. M. Research findings in phrenotropic
  drugs important to every physician,  [whole root]  Mis-
  sissippi Doctor, 1957, 35: 57-63.
  Rauwolfia  serpentina: raudixin.  Univ.  Michigan M.
  Bull, 1953,19 : 278-279.
  Telatin, L.  La Rauwolfia in  neuropsichiatria.  [Rau-
  wolfia in neuropsychiatry.]  Arch, psicol. neur., Milano,
  1956,17: 411-113.
  Thuillier, J.  Rauwolfia  serpentina.  Concours  me'd.,
  1954, 76: 3353-3354.
  Vergani, O., Aldeghi, E.  L'impiego degli alcaloidi totali
  di Rauwolfia serpentina  in neuropsichiatria infantile.
  [Use of total alkaloids of Rauwolfia  serpentina in child
  neuropsychiatry.]    [English   summary]    Minerva
  pediat., Tor., 1956, 8:1161-1165.

—Additional data
  Carr, C. J., Kinnard, W. J., Jr.  The phrenotropic agents.
  Internat. Rec. M., 1957,170: 493-504.
  Cremieux, A.  Traitement de Tanxiete.   [Treatment of
  anxiety.]  Marseille med., 1956, 93 : 327-331.
  Feldman, D. J.  The treatment of chronic alcoholism :  a
  survey of current methods. Ann. Int. M., 1956, 44 : 78-87.
  Hoch, P. H.  Progress in  psychiatric therapies. Am. J.
  Psychiat, 1955,112: 241-247.
  Klingman,  W. O.  Neurological and psychiatric disor-
  ders ; some recent advances in therapy.  Virginia M.
  Month., 1956, 83 : 240-246.
  New drugs  for  patients with emotional   disorders.
  J. Am. M. Ass., 1955,157 : 665.
  Skobba, J. S.  Drugs  in the management of  emotional
  conditions.  J. M. Ass. Georgia, 1956, 45 : 397-399.
  Sprowls, J. B.   Drugs for a  changing world.  Am. J.
  Pharm., 1955,127 : 42-52.
  Tranquilizing agents. N. England  J.  M.,  1955,  252:
  74-75.
  Weinberg, H. B.  Drug therapy for the emotionally and
  mentally disturbed; the  internist's  point of view.  J.
  Iowa M. Soc, 1957,47 :17-19.
—Neuroses
  Frank, D.  E.  Practical  significance and treatment of
  anxiety.  Med. Times, Great Neck, 1956, 84: 924-928.

—Psychoses
  Garavaglia, G.  Risultati clinici in campo neuropsichia-
  trico  con  alcaloidi  totali  di  Rauwolfia  serpentina
  (iniettabile ed orale).  [Clinical results of total  Rau-
  wolfia  serpentina alkaloids  (injectable and oral)  in
  neuropsychiatry.]  Minerva med., Tor., 1955, 46:1259-
  1263.
  Palazzuoli,  M.   Osservazioni  preliminari  sull'azione
  degli estratti di Rauwolfia  serpentina (Ra-Valeas) in
  malati di mente eccitati  ed ansiosi.  [Preliminary ob-
  servations on the action of Rauwolfia  serpentina extracts
  (Ra-Valeas)  in excited and anxious mental  patients.]
  Riv. pat. nerv., 1956, 77: 251-254.
  Ray, P. K.  The use of Rauwolfia serpentina in psychia-
  try.  Ind. J. Neur. Psychiat., 1952, 3 : 380-398.
  Rosina, P. L. Gli alcaloidi totali di Rauwolfia in psichi-
  atria ;  premesse  fisiologiche  ed  esperienze cliniche.
  [Total Rauwolfia alkaloids in  psychiatry ; physiological
  basis  and  clinical experience.]  Minerva med.,  Tor.,
  1955, 46:1249-1262.
  ----.   Reserpina  nelle psicosi  acute.   [Reserpine in
  acute psychoses.]  Arch, psicol. neur.,  Milano,  1956,
  17:417.

—Psychosomatic diseases
  Cahn, M. M. The use of tranquilizing drugs in derma-
  tology; review and side  reactions.   J. Albert Einstein
  M. Center, 1956,  4:161-165.                        *
Therapeutic use
  Benda, C.  E.  The  differentiation  between  mental
  deficiency and emotional disorders, and some thera-
  peutic experiments with  Rauwolfia serpentina (koglu-
  coid).  [In  English]   Arch, pediat.  Uruguay,  1955,
  26: 32-46.
  Broggi, E.  La Rauwolfia serpentina Benth nella cura
  di alcune psicopatie.  [Rauwolfia serpentina Benth  in
  the treatment of some mental diseases.]  Arch, psicol
  neur., Milano, 1956, 17: 399-401.
  Carloni, G.  La reserpina e la cloropromazina nei malati
  mentali  cronici.   [Reserpine  and  chlorpromazine  in
  chronic mental disease.]   Arch, psicol. neur.,  Milano,
  1956,17: 629-630.
  Floris, V.  L'impiego  della  Rauwolfia serpentina  in
  neuropsichiatria.   [Use  of  Rauwolfia  serpentina   in
  neuropsychiatry.]   Minerva  med.,  Tor., 1956, 47: 944-
  945.
  Germano, V., Bellavitis, U.  Prime osservazioni cliniche
  sull'uso parenterale degli alcaloidi della  rauwolfia  in
 psichiatria.   [First clinical observations on the paren-
 teral  use  of Rauwolfia alkaloids in psychiatry.]  Riv.
 sper. freniat, 1955, 79: 713-722.                     *
 Lagrue, G.  Rauwolfia serpentina  (ou sarpagandah)  et
 ses alcaloi'des. [Rauwolfia serpentina (or sarpagandah)
 and its alkaloids.]  Vie me'd., Par., 1956, 37 (Special-
 May)  : 111-112.
 Maccagnani, G.  Trattamento di alcune sindromi psich-
 iche dell'eta senile con reserpina, con reserpina associata
 a cloropromazina.  [Treatment of senile  psychic syn-
 dromes with reserpine and  with  reserpine associated
 with  chlorpromazine.]  Arch,  psicol.  neur., Milano,
 1956,17:452-454.
 Molina A.  La Rauwolfia serpentina, con especial refer-
 enda  a' la reserpina.   [Rauwolfia serpentina, with spe- 
Rauwolfia serpentina alkaloids : Therapeutic use — Psychosomatic diseases
PSYCHOPHARMACA
  Fabricant, N. D.  Tension headache therapeutics.  Eye,
  Ear dc Month., 1956,35 : 658; 662.
  Finch, J. W.  Experience with Rauwolfia.  31od. Med.,
  1954, 22 (9) : 22-23.
  Genest, J., Adamkiewicz, L., Robillard, R., Tremblay, G.
  Clinical uses of Rauwolfia. II.  In psoriasis and in con-
  stitutional leanness.  Canad. M. Ass.  J., 1955,  72: 490-
  491.  Also as: Nouvelles applications therapeutiques de
  la  reserpine et  des extraits de la Rauwolfia.  [New
  therapeutic use  of reserpine and Rauwolfia extracts.]
  Union me'd. Canada,  1954,  83:915-916.  Preliminary
  communication: new  therapeutic applications of reser-
  pine and  of purified extracts of Rauwolfia.  Canad. M.
  Ass. J., 1954, 71 (August-News and Notes) : 73.
  Grupper, C. Le traitement du prurit en dermatologie
  par la Rauwolfia serpentina, note preliminaire.  [Rau-
  wolfia serpentina therapy of pruritus in dermatology;
  preliminary  note.]   Bull. Soc  fr.  derm, syph., 1955,
  62: 159-162.
  Pomeranze, J.  Preliminary observations on the use of
  Rauwolfia in labile  diabetes.   Monogr.  Ther. Squibb
  Inst. M. Res., 1956,1(2): 26-28.
  Wilkins, R. W.  Clinical usage of Rauwolfia alkaloids,
  including reserpine (serpasil).  Ann. N. York Acad. Sc,
  1954, 59 : 36-44.  Also : N. England J. M., 1954, 59 :1-7.
  ----.   Current therapeutics:  Rauwolfia  serpentina.
  Practitioner, Lond., 1954, 173: 84-89.
  ---.  New  drug therapies  in arterial  hypertension.
  A.M. A. Arch. Int. M., 1952, 37:1144-1155.
  ---, Judson, W. E. The use of Rauwolfia serpentina in
  hypertensive patients.  N. England J. M.,  1953, 248:
  48-53.  Abstract: Proc. N. England Cardiovas.  Soc,
  1951-1952: 34.
  Wright, W. T., Jr., Pokorny,  C, Foster, T. L. Alseroxy-
  lon; a study of the psychological  effects  of the drug.
  J. Kansas M. Soc, 1956, 57 : 410-411.

Untoward effects [see headnote p. 19]
  Achor, R. W., Hanson, N. O.  Hypertension treated with
  Rauwolfia canescens; a comparison with Rauwolfia ser-
  pentina.  N. England  J. M.,  1956, 255 : 646-650.
  ---,---, Gilford, R. W., Jr. Hypertension treated with
  Rauwolfia serpentina (whole  root)  and with reser-
  pine : Controlled study disclosing occasional severe de-
  pression.   J. Am. 31. Ass., 1955, 159: 841-845.
  Duboucher, G.  Etats depressifs d'allure meiancolique
  au cours du  traitement de Thypertension arterielle par
  la  reserpine ou les alcaloides de Rauwolfia serpentina.
  [Depressive  states  with  melancholia  during treatment
  of  arterial hypertension with  reserpine or Rauwolfia
  serpentina alkaloids.]  Alge'rie me'd., 1956, 60:417-420.
  Faucett, R. L., Litin,  E. M., Achor, R.  W. P.  Neuro-
  pharmacology action of Rauwolfia compounds and its
  psychodynamic  implications.  A.  M. A.  Arch. Neur.
  Psychiat, 1957, 77: 513-518.
  Feinblatt, T. M., Feinblatt, H. M.,  Ferguson, E. A., Jr.
  Rauwolfia-ephedrine as a hypotensive-tranquilizer.  J.
  Am. M. Ass., 1956,161: 424-426. Abstract: Chem. Abstr.,
  1956, 50:14098L
  Friend, D. G., McLemore, G. A., Jr.  Some abuses of
  drugs  in  therapy.   N. England J.  M., 1956, 254:1223-
  1231.
  Harris, T. H. Depression induced  by Rauwolfia com-
  pounds.  Am. J. Psychiat, 1957, 113: 950.
  Hollister, L. E.  Hematemesis and  melena complicating
  treatment with Rauwolfia alkaloids. A. M. A. Arch. Int.
  M., 1957, 99: 218-221.
  Jones, H. H., Jr.  Reversible depression and parkinso-
  nian occurring during treatment of hypertension with
  Rauwolfia. [whole root] J. Oklahoma 31. Ass., 1955, 48:
  380-381.
  Kass, I., Brown, E. C.  Treatment  of hypertensive pa-
  tients  with Rauwolfia  compounds  and  reserpine;  de-
  pressive and psychotic changes. J. Am. M. Ass., 1955,
  159:1513-1516.
  Lasater, J. H., Collins, J. D.  Are we causing depression?
  Northwest M., 1956, 55 : 863-864.
  Lemieux, G., Davignon, A., Genest, J.  Depressive states
  during Rauwolfia therapy for arterial hypertension; a
  report of 30 cases.  Canad. M. Ass. J., 1956, 74: 522-526.
  Levy, S.  Mild depression states.  Northwest M., 1954,
  53; 1233-1236.
  Litin, E. M., Faucett, R. L., Achor, R. W. P.  Depression
  in hypertensive patients treated with  Rauwolfia serpen-
  tina.  Proc. Mayo Clin., 1956, 31: 233-237.
  Locket, S. Oral preparations of Rauwolfia serpentina in
  treatment of essential hypertension.  Brit. M. J., 1955,
  1: 809-813.
  Muller, J. C, Pryor, W. W., Gibbons, J. E„ Orgain, E. S.
  Depression and  anxiety  occurring during  Rauwolfia
  therapy.  J. Am.  M. Ass.,  1955, 159: 836-839.  Abstract:
  Excerpta med., Sect. 8,1957, 10: No. 1536.  Year book of
  drug therapy, 1956-1957, p. 323-324.
  Nick, J.  Depressions  meiancoliques  secondaires  a
  Tusage therapeutique de Rauwolfia serpentina chez des
  hypertendus.   [Melancholia  in hypertensive patients
  caused by therapeutic  use of Rauwolfia serpentina.]
  Bull. Soc me'd. hop. Paris, 1955, 71: 884-893.  Abstract:
  Excerpta med., Sect. 8,1956,9: No. 4544.
  Paine,  R.  Hypertension;  precaution in  treatment.
  Missouri M., 1956, 53 : 947-949.
  Rauwolfia et etats depressifs.  [Rauwolfia and depres-
  sive  states.]   Rev. prat.,  Par., 1956, 6:3342.
  Wilkins, R. W.   Hypertension:  recent trends in treat-
  ment. Med. Clin. N. America, 1953, 37 :1303-1312.
  ---, Judson, W.  E., Stone, R. W., Hollander, W., Huck-
  abee, W. E., Friedman, I. H.  Reserpine in the treatment
  of hypertension:  A note on  the  relative  dosage and
  effects.  N. England J. M., 1954, 250 : 477-478.


with ATARAXICS [2 or more]
  see  ATARAXICS—Various  [3 or more]—Compared

with AZACYCLONOL
  see  AZACYCLONOL with  RAUWOLFIA   SERPEN-
    TINA ALKALOIDS

with CHLORPROMAZINE
  see CHLORPROMAZINE  with RAUWOLFIA SERPEN-
    TINA ALKALOIDS

with LYSERGIC ACID DIETHYLAMIDE
  see  LYSERGIC  ACID  DIETHYLAMIDE  with RAU-
    WOLFIA SERPENTINA ALKALOIDS

with MEPHENESIN and  OTHER DRUGS—COMBINED
  [sedaltine]

  Raymond, M. J., Lucas,  C. J., Beesley, M. L„ O'Connell,
  B. A., Roberts, J. A. F.  A  trial of five tranquillizing
  drugs in psychoneurosis.  Brit. 31. J., 1957, 2: 63-66.

with PIPRADROL—COMBINED

  Antos, R. J.  Meratran.  Use  of a new antidepressant in
  internal medicine.   Southwest. M., 1955, 36:166-167.
  ---. A preliminary report of clinical studies on a new
  stimulant. Arizona M., 1954,11: 397-399.
  Pennington, V. M.  A comparative study of six ataraxics
  in 1130  neuro-psychiatric cases.   Mississippi Doctor,
  1956, 33: 336-339.

with PROMETHAZINE
  see  PROMETHAZINE  with  RAUWOLFIA  SERPEN-
    TINA ALKALOIDS—COMPARED

with RAUWOLFIA CANESCENS ALKALOIDS
  see   RAUWOLFIA  CANESCENS  ALKALOIDS  with
    RAUWOLFIA  SERPENTINA ALKALOIDS
136 
SUBJECT  LIST
Rauwolfia serpentina alkaloids : with Other drugs  Combined : Stimulants
with RESCINNAMINE—COMPARED
Studies, animals
  Cronheim, G., Brown, W., Cawthorne, J., Toekes, I. M.,
  Ungari, J. Pharmacological studies with rescinnamine,
  a new alkaloid isolated from Rauwolfia  serpentina.
  Proc Soc. Exp. Biol, N. Y., 1954, 86:120-124.
  Kohli, J.   D.,  Mukerji, B.  Comparative activity  of
  reserpine and total alkaloids of Rauwolfia.  [Abstract]
  In:  Pharmaceuticals & Drugs Committee.  Council of
  Scientific   &   Industrial  Research.  Symposium  on
  Rauwolfia,  Calcutta,  1955.  Lucknow, Pioneer Press,
  1955. p. 33-34.

with RESERPINE—COMBINED
  Grupper,  C.  Le traitement du prurit en dermatologie
  par  la Rauwolfia serpentina, note preliminaire.  [Rau-
  wolfia serpentina therapy of pruritus in  dermatology;
  preliminary note.]  Bull. Soc. fr. derm, syph., 1955, 62:
  159-162.

with RESERPINE—COMPARED
Studies, animals
  Cronheim, G., Brown, W., Cawthorne, J., Toekes, I. M.,
  Ungari, J. Pharmacological studies with rescinnamine,
  a new alkaloid isolated from Rauwolfia  serpentina.
  Proc. Soc. Exp. Biol, N. Y., 1954, 86:120-124.
  Kohli, J. D., Mukerji, B.  Comparative activity of reser-
  pine and total alkaloids of Rauwolfia.  [Abstract]  In :
  Pharmaceuticals &  Drugs Committee, Council of Scien-
  tific & Industrial Research.  Symposium on Rauwolfia,
  Calcutta,  1955.  Lucknow, Pioneer Press, 1955. p. 33-34.
  Rubin, B., Malone,  M. H., Waugh,  M. H., Burke,  J. C.
  Comparative activity of  Rauwolfia  serpentina whole
  root  and  reserpine  in laboratory animals.   Monogr.
  Ther. Squibb Inst. M. Res., 1956, 1  (2) : 40-44.

Studies, patients
  Baruk,  H., Launay,  J., Berges,  J., Lanteri-Laura,  G.
  Etude de Taction de la reserpine sur Tinitiative psycho-
  motrice et les grandes constantes physiologiques et bio-
  logiques.  Comparaison sur Taction des extraits totaux.
  [Study of the effects of reserpine on psychomotor initia-
  tive and the significant physiologic and biologic values;
  comparison with the  effects of total  extracts.]   Ann.
  me'd. psychol, Par., 1957, 115 (1) : 708-712.

Therapeutic studies, controlled
  Azima,  H., Cramer-Azima,  F. J., De Verteuil, R.  A
  comparative  behavioral  and  psychodynamic  study  of
  reserpine and equally potent doses of raudixin in schizo-
  phrenics.  Monogr.  Ther. Squibb  Inst. M. Res., 1956, 1
  (2) : 15-25.
  Baruk, H., Launay, J., Berges, J.,  Mijolla, A. de. Etude
  clinique de Taction therapeutique  de la reserpine. Com-
  paraison avec Taction des  extraits totaux.   [Clinical
  study of the therapeutic effect of reserpine; comparison
  with total extracts.]  Ann. me'd. psychol,  Par., 1957,
  115 (1) : 704-708.
  Elkes, C.   Rauwolfia alkaloids and  reserpine in the
  treatment of the chronic  psychotic patient.   J. 3Ient
  Sc, Lond., 1957,  103 : 464-474.
  Folkson, A., May, A. R.  Use of reserpine and Rauwolfia
  in psychoneuroses.  Brit. M. J., 1955, 2 :1121-1122. Ab-
  stract : Excerpta med., Sect. 8,1956, 9 : No. 2658.
 Gallagher, W. J., Berry, J. M., Durden, W. D., Lazenby,
 W. D.  Comparative study of reserpine, 11-desmethoxy-
 reserpine  and   Rauwolfia  alkaloids  in treatment  of
 schizophrenia.  In:  Himwich, H. E.,  ed. Tranquilizing
 drugs Washington,  Am. Ass. Adv. Sc, 1957. p. 133-147.
 Holt E  K. Ward-Dunn, G, Nedilsky, B. T„ Niswander,
 G  D*  Clinical comparison of raudixin and rau-sed in
 chronic mental illness.  Dis. Nerv. Syst, 1955, 16: 222-
 223  Abstract: Excerpta med., Sect. 8,1956, 9: No. 4564.
 Kline N  S.   Use of  Rauwolfia  serpentina  Benth.  in
  neuropsychiatric conditions.  Ann. N. York Acad. Sc,
  1954,   59:107-132.   Abstract:   Chem.  Abstr.,   1954,
  48:10220c.
  Marini, M., Caprini, G., Benciolini, P.  La Rauwolfia in
  malate croniche,  normotese  ed  ipertese;  contributo
  clinico.   [Rauwolfia in chronic, normotensive and hyper-
  tensive patients;  clinical  contribution.]  Arch, psicol.
  neur., Milano, 1956, 17: 419-432.
  Meller, R. L.   Reserpine and alseroxylon  therapy in
  emotionally   disturbed   patients.  J.   Lancet,   1955,
  75: 339-342.  Abstract: Excerpta med., Sect. 8, 1956, 9:
  No. 5000.
  Pennington, V. M.  A comparative study of six ataraxics
  in  1130  neuro-psychiatric  cases.  31ississippi Doctor,
  1956, 33: 336-339.
  Ruskin, I. W., Avol,  M.  Rauwolfia tranquilization for
  the disturbed aged.  J. Am. Geriat. Soc, 1956, 4:998-
  1003.
  Torsegno, M., Zucchi, M.  Trattamento di  ammalati
  mentali con un preparato  iniettabile di  alcaloidi totali
  di Rauwolfia serpentina Benth.  [Therapy of mental
  patients  with  an  injectable preparation of  total  alka-
  loids  from  Rauwolfia  serpentina Benth.] Minerva
  med., Tor., 1956, 46: 604-607.  Abstract: Excerpta med.,
  Sect. 8,1956, 9: No. 3087.
  Tripi, G.  Considerazioni generali sull'uso  della  cloro-
  promazina e della reserpina  nel  trattamento di  circa
  trecento  psicopatici.  [Observations  on  the use  of
  chlorpromazine and reserpine in the treatment of about
  300  mental   patients.]  Rass.  neuropsichiat.,   1955,
  9:  463-469.   Also:  Arch,  psicol neur., Milano,  1956,
  17: 635-639.
  Weir, H. F., Anderson, R. L.   The effects of reserpine
  and Rauwolfia in minor  disorders of  adjustment in
  children.  Mongr. Ther. Squibb Inst.  M. Res., 1956, 1
   (2) : 33-39.
Therapeutic use
  Kline, N. S., Saunders, J.  C.  Reserpine in psychiatric
  and neurologic disorders.  Med. Clin. N. America,  1957,
  41: 307-326.
  Telatin, L.   La Rauwolfia in neuropsichiatria.   [Rau-
  wolfia in neuropsychiatry.] Arch, psicol. neur., Milano,
  1956, 17: 411-413.
Untoward effects
  Achor, R. W. P., Hanson, N. O., Gifford,  R. W., Jr.
  Hypertension treated with Rauwolfia serpentina  (whole
  root)  and with reserpine:  Controlled study disclosing
  occasional severe depression.   J.  Am.  31.  Ass.,  1955,
  159: 841-845.
  Tweedy,  P.  S.  Treatment of  hypertension.  Lancet,
  Lond., 1955, 2 : 249.


with OTHER DRUGS—COMBINED
Barbiturates

  see also CHLORPROMAZINE
    with RAUWOLFIA SERPENTINA ALKALOIDS and
           OTHER DRUGS—COMBINED
  Sogliani, G.  Ipnoterapia  con cloropromazina e  Rau-
  wolfia ;   posologia,   associazioni,   confronti.  [Sleep
  therapy with chlorpromazine  and Rauwolfia; posology,
  combinations and comparisons.]  3Iinerva med.,  Tor.,
  1955, 46:1253-1259.

Stimulants
  Feinblatt, T. M., Feinblatt, H. M., Ferguson, E. A., Jr.
  Rauwolfia-ephedrine  as  a  hypotensive-tranquilizer.  J.
  Am. 31.  Ass.,  1956,  161:424-426.  Abstract:  Chem.
  Abstr., 1956,  50 :14098L
  Prouet, P. E.  Rauwolfia and amphetamine therapy in
  the treatment of  psychosomatic complaints. J.  Loui-
  siana 31. Soc, 1955,107 :114-116.
137 
Rauwolfia serpentina alkaloids : with Other drugs Combined : Stimulants
PSYCHOPHARMACA
Thimann, J., Bucknam, F. G., Gauthier, J. W., O'Con-
nell, T. A.  Rauwiloid  therapy  in alcoholism,  [rau-
widrine] Am.  J. Psychiat, 1957,  113: 694-697.
Trinity, G. J.   Management of the depressed  patient.
Med. Times, Great Neck, 1954, 82: 753-757.
RESCINNAMINE
  see also RAUWOLFIA ALKALOIDS
         RAUWOLFIA SERPENTINA ALKALOIDS

Pharmacodynamics
  Klohs,  M. W., Draper, M. D., Keller, F.  Alkaloids of
  Rauwolfia serpentina Benth.  III. Rescinnamine, a new
  hypotensive and sedative principle.  J. Am. Chem. Soc,
  1954, 76: 2843.
Studies, animals
  Cronheim, G., Brown, W., Cawthorne, J., Toekes, I. M.,
  Ungari, J. Pharmacological studies with rescinnamine,
  a  new  alkaloid  isolated  from  Rauwolfia serpentina.
  Proc. Soc. Exp. Biol, N. Y., 1954, 86:120-124.
  ---, Toekes, I. M.  Comparison of "sedative" properties
  of single alkaloids of Rauwolfia and their  mixtures.
  J. Pharm. Exp. Ther., 1957,119: 357-360.
  ----,  ----.   Comparison of  some  pharmacological
  properties of rescinnamine and reserpine, two alkaloids
  isolated from Rauwolfia serpentina.  J. Pharm. Exp.
  Ther., 1955,113:13.
  Kohli, J. D., Mukerji, B. Comparative activity of reser-
  pine and total alkaloids of Rauwolfia.  [Abstract]  In:
  Pharmaceuticals & Drugs Committee, Council of Scien-
  tific & Industrial Research.   Symposium on Rauwolfia,
  Calcutta, 1955.  Lucknow, Pioneer Press, 1955. p. 33-34.
  Kroneberg, G.  Rescinnamin, das zweite sedative Alka-
  loid der Rauwolfia serpentina.  [Rescinnamine, the sec-
  ond  sedative  alkaloid  of  Rauwolfia  serpentina.]
  Arzneimitt. Forsch., 1956, 6: 579-583.
  Orcutt, J. A., Cronheim, G. E.  Quantitative comparison
  of the hypotensive and sedative effects of rescinnamine
  in dogs.  Fed. Proc, Bait, 1955, 14: 375-376.
  Shore, P. A., Carlsson, A., Brodie, B. B.   Mechanism of
  serotonin-release by reserpine.  [Abstract]  Fed. Proc,
  Bait., 1956, 15: 483.
Therapeutic studies, controlled
  Malamud, W., Barton, W. E., Fleming, A. M., Middleton,
  P. McK., Friedman, T. T.,  Schleifer, M. J. The  evalua-
  tion of the effects of derivatives of Rauwolfia  in the
  treatment of schizophrenia.   Am. J. Psychiat.,  1957,
  114:193-200.
Therapeutic use
  Hollister, L. E., Stannard, A. N., Drake, C. F.   Treat-
  ment of anxious patients with drugs.  Dis. Nerv. Syst.,
  1956,17:289-293.
  Kline, N. S., Saunders, J. C.  Reserpine  in psychiatric
  and neurologic disorders.  Med. Clin. N. America, 1957,
  41:307-326.
  Reserpine and the mind.  Lancet, Lond., 1955,  2:330-
  331.                                              *
  Smirk,  F. H., McQueen, E. G.  Comparison of rescinna-
  mine and reserpine as hypotensive  agents.   Lancet,
  Lond., 1955, 2:115-116.                            *
  Winton, S. S. Therapeutic value and limitations of an
  ataractic  drug  (rescinnamine).  Internal  Rec. M.,
  1957,170:665-671.
Untoward effects [see headnote p. 19]
  see under RESCINNAMINE—Therapeutic use


with  RAUWOLFIA  CANESCENS  ALKALOIDS  and
     RESERPINE—COMBINED [triserpine]
  see RESCINNAMINE—Studies, animals [cronheim4-
  toekes, 1957]
with RAUWOLFIA SERPENTINA ALKALOIDS—COM-
    PARED—Studies, animals
  see RESCINNAMINE—Studies,  animals [ceonheim+
    BBOWN+others] [kohli4-mukerji]

with RESERPINE—COMBINED [RIKER 529-2]

Studies, animals
  Cronheim, G., Toekes, I. M.  Comparison of "sedative"
  properties of single alkaloids  of Rauwolfia  and their
  mixtures.    [reserpine:  rescinnamine:  deserpidine:
  Riker 529-1: Riker 529-2: triserpine]  J. Pharm. Exp.
  Ther., 1957,119: 357-360.
Therapeutic studies, controlled
  Gallagher, W. J., Berry, J. M., Durden, W. D., Lazenby,
  W. D.  Comparative study of reserpine, 11-desmethoxy-
  reserpine, and  Rauwolfia alkaloids  in treatment of
  schizophrenia.  In: Himwich, H. E., ed. Tranquilizing
  drugs.  Washington, Am. Ass. Adv. Sc., 1957.  p. 133-147.

with RESERPINE—COMPARED
  see RESCINNAMINE
  except  for:
    Pharmacodynamics
    Studies, animals  [orcutt4-ceonheim]
    Therapeutic use [winton]
RESERPINE
  see also RAUWOLFIA SERPENTINA ALKALOIDS
  Atti del symposium sulla reserpina e cloropromazina
  neuropsichiatria.  [Proceedings of the symposium on
  reserpine  and  chlorpromazine  in  neuropsychiatry.]
  Arch,  psicol. neur., Milano, 1956, 17: p. III-XI; 115-
  684.  [Articles within the scope of this bibliography are
  listed individually.]
  Azima, H.  Report on the international colloquium on
  chlorpromazine  and neuroleptic medications in psychi-
  atric treatment, Paris,  October  20-22, 1955.   Am. J.
  Psychiat, 1956,112: 749-750.
  Broggi, E.  Risultati del convegno nazionale tenuto a
  Vercelli il 24-25 settembre su: ibernazione artificiale,
  sonno  prolungato e neuroplegici in neuropsichiatria.
  [Results  of the  national convention held at Vercelli on
  September  24-25  on  artificial hibernation, prolonged
  sleep and neuroplegic  drugs in neuropsychiatry.]  En-
  cephale, 1956, 45:1035-1041.
  Le colloque international de  Paris  sur la chlorprom-
  azine et les medicaments neuroleptiques en therapeu-
  tique  psychiatrique.   [International  colloquium  in
  Paris (October 1955) on chlorpromazine and neuroleptic
  drugs  in  psychiatric therapy.]  J. me'd. Lyon, 1956, 37:
  103-105.
  Colloque international sur la chlorpromazine et  les
  medicaments neuroleptiques en therapeutique psychia-
  trique.   [International colloquium on chlorpromazine
  and neuroleptic drugs in psychiatric therapy.]   [Paris,
  October 1955]  Ence'phale, 1956, 45 : 301-1266.   [Articles
  within the scope  of this bibliography are listed indi-
  vidually.]
  Fernandes, B.  Clorpromazina, reserpina e a chamada
  "farmacopsiquiatria".   [Chlorpromazine and reserpine
  at the colloquium on  "pharmacopsychiatry".]   [Paris,
  October 1955] J. me'd., Porto, 1956, 29:237-243.
  Happiness pills in medical practice: a symposium.  J.
  Iowa 31. Soc, 1957,47: 57-65.
  Overholser, W., Waldrop, F. N., Riesenman, F. R., Fong,
  T. C. C,  Farley, O. R., Hoffman, J. L.  Chlorpromazine
  and reserpine; symposium on experiences at Saint Eliz-
  abeths Hospital.  Med. Ann.  Disrict of Columbia, 1956,
  25 : 255-268: 298.  [All articles are listed individually.]
  Pharmaceuticals & Drugs Committee, Council of Scien-
  tific & Industrial Research.  Symposium on Rauwolfia,
138 
SUBJECT LIST
Reserpine : Psychotherapeutic  use
 Calcutta, 1955.  [Abstracts]  38 p.  Lucknow, Pioneer
 Press, 1955.  [Abstracts within the scope of this bibliog-
 raphy are listed individually.]
 Raudixin in  the treatment of the affective disorders.
 Original reports by clinical and laboratory investigators.
 Monogr. Ther. Squibb Inst. M. Res., 1956, 1 (2) : 1-44.
  [Articles within the scope of this bibliography are listed
 individually.]
 Stoll, W. A.  Conference on reserpine in the treatment
 of neuropsychiatric, neurological, and  related clinical
 problems.  New York,  February 1955.   Schweiz. med.
  Wschr.,   1955,  85:439-440.  [English  title-German
  text]
 Symposium:  Clinical value and limitations of reserpine,
 meratran, and a "new blocking  agent".  Psychiat. Res.
 Rep., Wash.,  1955  (1) : 105-152.   [All articles are listed
 individually.]
  Symposium on tranquillizers.  [Summary  of proceed-
  ings.  British  Medical  Association,  annual meeting,
 Newcastle upon Tyne, July 1957] Brit. M.  J., 1957, 2:
 219-221.
 Tranquillizers in  psychiatry.  [Report on Royal Med-
  ico-Psychological Association Meeting,  London, Febru-
  ary  1956]  Brit. M. J. 1956, 1: 512-513.
  Yonkman, F. F.,  ed.  Reserpine  (serpasil)  and other
  alkaloids of  Rauwolfia serpentina: chemistry, pharma-
  cology,  and   clinical  applications.  Reserpine  in  the
  treatment of neuropsychiatric, neurological and related
  clinical  problems.   [Conferences held in  New  York,
  February 1954 and  February  1955.]  Ann. N. York
  Acad. Sc, 1954, 59:1-140;  1955, 61:1-280.  [Articles
  within  the scope  of  this bibliography  are  listed  indi-
  vidually.]
  Zambianchi,  A. Echo du symposium de Milan sur la
  reserpine et la chlorpromazine en psychiatrie.  [Review
  of the symposium  in Milan on reserpine and chlorprom-
  azine in psychiatry.]  Ence'phale, 1956, 45:1071-1075.

Bibliographies and literature surveys
  Bein, H. J.   The pharmacology of Rauwolfia.  Pharm.
  Rev., 1956, 8: 435^83.
  Bryant, J. H., Bass, B. M., Hine, F. R.  Drug therapy; a
  survey of the literature.  State of Louisiana, Depart-
 ment  of Institutions,  Dimsion  of  Research, Baton
  Rouge, 1956  (3) :  1-24.
  Deniker, P.   Hibernotherapies  et  medicaments neuro-
  leptiques en therapeutique  psychiatrique.   [Hiberno-
  therapies and neuroleptic drugs in psychiatric  ther-
  apy.]   Encephale, 1957, 46: 281-398.
  Erdmann, C.  E.  Neues fiber  die  Rauwolfia-Behand-
  lung unter besonderer Berucksichtigung der Literatur
  in den  USA.   [Review of Rauwolfia therapy with spe-
 cial  reference to  literature in  the U.  S. A.]  Nerven-
  arzt, 1956, 27: 75-79.
  Funderburk, W. H., Wilcox, K. W., Wilcox, P. H. Drug
  therapy; physiodynamic  therapy.   II.  Progr.  Neur.
  Psychiat, N. Y., 1956, 11: 425-456.
 Galenko, V.  E.  Serpazil; obzor inostrannoi literatury.
  [Serpasil; review of  foreign literature.]  Zh. nevropat.
 psikhiat, 3Ioskva, 1956, 56: 344-352.  Abstract:  Chem.
 Abstr.,  1956,  50:17177g.                 .           .
 Kline, N. S.  Use of Rauwolfia  serpentina Benth.  in
 neuropsychiatric conditions.  Ann. N.  York Acad. Sc,
 1954,59:107-132.
 Mikes,   A.   Serpasil;  pregled   literature.  [Serpasil,
  literature review.]  Med. arch., Sarajevo, 1955, 9:161-

 Munch-Petersen,  S.   Effects of chlorpromazine  (lar-
 gactil)   and  reserpine  (serpasil)  within the field  of
 neurology a study of  the  pertinent literature.  Acta
 psycliat. neur. scand., 1956, Suppl. 108: 269-280
 Penick  S  B and Company  Rauwolfia  and alkaloids,
 a bibliography; chemistry,  pharmacology,  pharmacog-
 nosy! S^utic uses,  50 p.   NewYork, 1956.
 —I.  SupplTl.  18 p.   New York, 1957.
  Reserpine.  Antibiotic  31.,  1957,  4:108-113.  Also:
  Internat Rec. M., 1957, 170:214-219.
  Wilcox, P. H., Funderburk, W. H., Wilcox, K. W. Drug
  therapy;  physiodynamic  therapy.  II.  Progr.  Neur.
  Psychiat, N. Y., 1955,10: 595-608.
  Wortis, J.  Physiological  treatment.  Am. J. Psychiat.,
  1955, 111: 515-518;  1956, 112: 526-529; 1957,  113 : 611-
  615.
Diagnostic use
  Ellsworth,  R.  B., Clark,  L. D.  Prediction of  the  re-
  sponse of chronic  schizophrenics to drug  therapy; a
  preliminary report on the relationship between palmar
  sweat and the behaviorial effects of tranquilizing drugs.
  J. Clin. Psychol, 1957, 13: 59-61.
  Shankel,  L. W., Whittier,  J. R.  Effects of  reserpine
  therapy on Funkenstein test reactions in maladapting
  patients.  Dis. Nerv. Syst, 1956, 17: 258-261.
Pharmacodynamics
  Bein, H.  J.  The pharmacology of Rauwolfia.   Pharm.
  Rev., 1956, 8: 435-483.
  Ciba Pharmaceutical Products, inc.  The story of ser-
  pasil.   55 p.  Summit, N. J., 1955.
  Deniker,  P.  Psychophysiologic  aspects of  the new
  chemotherapeutic drugs in psychiatry; some practical
  features of "neuroleptics" in order to screen new drugs.
  J. Nerv. Ment Dis., 1956, 124:371-376.
  Fazekas, J. F., Toupin, H., Alman, R.  W.  Physiologic
  and pharmacologic  basis for the chemotherapy of psy-
  chiatric states.  Am. J. Med., 1956, 21: 825-831.
  Himwich,  H.  E.  Prospects in  psychopharmacology.
  J.  Nerv.  Ment. Dis.,  1955, 122:413-423.  Also: Dis.
  Nerv. Syst, 1956, 17:109-116.
  Leake,  C.  D.  Drugs  affecting  mood and  behavior.
  Texas Rep. Biol M., 1955,13: 793-818.
  ----. New mood changing drugs.  Ohio M. J., 1956, 52:
  369-373.
  Meyers, F. H.  Pharmacology of chlorpromazine, reser-
  pine and related drugs.  In: Kline, N. S., ed.   Psycho-
  pharmacology.   Washington, Am. Ass. Adv.  Sc, 1956.
  p.131-140.
  Moore, R.  B., Pierce, W. J., Dennison, A. D., Jr.  The
  story  of  reserpine.  J. Indiana M. Ass.,  1954, 47:853-
  861.
  Orsi,   O.  I  farmaci  atarassici.  [Ataraxics.]  Boll.
  chim. farm., 1956, 95: 432-436.
  Pennes, H. H.  The nature of drugs with mental actions
  and their relation  to cerebral  function.  Bull N. York
  Acad. M., 1957, 33: 81-88.
  Perrault, M.   Sur  les tranquilliseurs.   [Tranquilizers.]
  Progr. med., Par., 1957, 85: 3-4; 7.
  Ravreby,  M.  Pharmacology.  In: Happiness  pills  in
  medical practice: a symposium.   J. Iowa M. Soc, 1957,
  47:57-59.
  Reserpine.  J. Am. M. Ass., 1955, 159:1206-1207.
  Schipa, S.  Basi farmacologiche e farmacodinamiche
  delle  cure neuroganglioplegiche. [Pharmacologic and
  pharmacodynamic  basis of neuroganglioplegic therapy.]
  Osp. psichiat., Nap., 1956, 24: 75-90.
  Schneider, J. A. The pharmacology of Rauwolfia.  In:
  Woodson, R. E., Youngken, H. W., Schlittler, E., Schnei-
  der, J. A.  Rauwolfia: botany, pharmacognosy, chemis-
  try & pharmacology.  Boston, Little, Brown d Company,
  1957.  p. 109-143.

 Placebo  effect see PSYCHOPHARMACA—Evaluation
 Psychosocial considerations
  see ATARAXICS—Psychosocial considerations
 Psychotherapeutic use
  Achaintre, A., Lauxerois, G. Interet  de la psychother-
  apie auprfes des malades mentaux.  II. Psychotherapie
  explicative individuelle  dans les psychoses  de longue
  evolution traitees par la chlorpromazine.   [The value
139 
Reserpine :  Psychotherapeutic use
PSYCHOPHARMACA
  of psychotherapy in mental diseases.  II. Individual ex-
  planatory psychotherapy in chronic psychoses treated
  with chlorpromazine.]  J. me'd. Lyon, 1956, 37: 403-406.
  Bazzi,  T.  Reserpina e psicoterapia.   [Reserpine and
  psychotherapy.]    [English  summary]   Arch,  psicol.
  neur., Milano, 1956, 17: 675-681.
  Berger, H.  Management of neuroses by  the  internist
  and general practitioner. N.  York State J. M., 1956,
  56:1783-1788.
  Cowden, R.  C, Zax, M.,  Sproles, J. A.  Group psycho-
  therapy in conjunction with a physical treatment.  J.
  Clin. Psychol, 1956, 12: 53-54.
  ---,---,----.  Reserpine alone and as an adjunct to
  psychotherapy in the treatment  of schizophrenia.  A.
  M. A. Arch.  Neur. Psychiat., 1955, 74: 518-522.
  Mielke, F. A.   Uber  die medikamentose  und  psycho-
  therapeutische  Ffihrung  der  Serpasil-Kur.    [Medical
  and psychotherapeutic management of serpasil therapy.]
  Schweiz. med.  Wschr.,  1956, 86:162-165.  Abstract:
  Excerpta med., Sect. 8, 1957,10: No. 1531.
  Sarwer-Foner, G. J., Ogle, W. Psychodynamic aspects
  of reserpine: its  uses and effects in open psychiatric
  settings. Canad.  Psychiat Ass. J., 1956, 1:11-17.
  ---, ----.  Psychosis and enhanced anxiety produced
  by resperine and chlorpromazine.  Canad. 31.  Ass. J.,
  1956, 74: 526-532.
  ---,----.   The use of reserpine in an open psychiatric
  setting.  Canad. M. Ass.  J., 1955, 73:187-191.
  Silverberg, J. W., Gralnick, A.  Possible synergistic ac-
  tion of chlorpromazine, reserpine and frenquel.  A pre-
  liminary report.  Am. J. Psychiat., 1957,  114:173.
  Tedeschi, G. F. Psicoterapia e farmacoterapia.  [Psy-
  chotherapy and pharmacotherapy.]  Arch, psicol. neur.,
  Milano, 1956, 17:  682-684.
  Tyhurst, J. S., Richman, A. An evaluation of the clini-
  cal significance of reserpine.  J. Nerv. Ment. Dis., 1955,
  122: 492-495.
  Westcott, G. F.  Serpasil as an adjunct to brief inten-
  sive  psychotherapy  with two psychotic  patients.   J.
  Nerv. Ment.  Dis.,  1956, 123 : 53-56.
  Wodraska, T.  W.  The effect  of reserpine on chronic
  schizophrenia.  Med. Times, Great Neck, 1955, 83 :1029-
  1033.
Studies,  animals
  Arian, E., Gomirato, G. Recherches experimentales sur
  Tinhibition des etats d'excitation d'origin sous-corticale
  par moyen  de  la chlorpromazine et de la  reserpine;
  communication preliminaire.  [Experimental studies on
  the inhibition of sub-cortical excitation by chlorproma-
  zine  and  by reserpine;  preliminary communication.]
  Ence'phale, 1956, 45 : 1264-1266.
  Baruk, H., Launay, S., Berges, J.   Action de la reserpine
  sur  la psychomotricile  et  catatonie  experimentale.
  [Effect of reserpine on  experimental phychomotricity
  and catatonia.]   Rev. neur., Par., 1956, 95:62-63.
  Batterman,  R. C, Leifer, P., Grossman, A. J.   The ad-
  vantages of  a new combination sedative mixture.  Am.
  Practitioner, 1956, 7: 1795-1798.
  Bein,  H. J.   Zur Pharmakologie des Reserpin, eines
  neuen  Alkaloids   aus Rauwolfia  serpentina  Benth.
  [Pharmacology of reserpine, a new alkaloid from Rau-
  wolfia  serpentina Benth.]   [English summary]   Ex-
  perientia, Basel, 1953, 9:107-110.
  ----,   Gross, F.,  Tripod, J., Meier, R.   Experimentelle
  Untersuchungen fiber "Serpasil"  (Reserpin), ein neues,
  sehr wirksames Rauwolfiaakaloid mit neuartiger zen-
  traler  Wirkung.   [Experimental studies  on  serpasil
  (reserpine)  a new and very effective Rauwolfia alkaloid
  with a new and different  central  effect.]  Schweiz. med.
  Wschr., 1953, 83 : 1007-1012.
  Berger, F. M.,  Campbell,  G. L„ Hendley, C. D., Ludwig,
  B. J., Lynes, T. E. The action  of tranquilizers on brain
  potentials and serotonin.  Ann. N. York Acad. Sc, 1957,
  66: 686-694.
Besendorf, H., Pletscher,  A.   Beeinflussung zentraler
Wirkungen  von   Reserpin und  5-Hydroxytryptamin
durch  Isonicotinsaurehydrazide.   [The influence  of
isonicotinic  acid  hydrazides on  the  central effects of
reserpine and of 5-hydroxytryptamine.]  [English sum-
mary]  Helvet. physiol. pharm. acta, 1956, 14: 383-390.
Bianchi, C.   Reserpine and serotonin in experimental
convulsions.  Nature, Lond., 1957, 179:202-203.
Brady, J. V.   Assessment of drug effects on emotional
behavior.  Science, 1956, 123:1033-1034.   Abstract:
Chem. Abstr., 1956, 50:15959b.
----. A comparative approach to the evaluation of drug
effects upon affective behavior.  Ann. N. York Acad. Sc,
1956, 64: 632-643.
----.  A review  of comparative behavioral  pharma-
cology.   Ann.  N. York Acad. Sc, 1957, 66: 719-732.
Brodie, B. B., Olin, J. S., Kuntzman, R. G., Shore, P. A.
Possible interrelationship between release of brain nore-
pinephrine and serotonin by reserpine.  Science, 1957,
125:1293-1294.
----, Pletscher, A., Shore, P.  A.  Evidence that sero-
tonin has a  role in brain function.  Science, 1955, 122:
968.
---, ----, ----.   Possible role of serotonin in brain
function and reserpine action.  [Abstract]   J.  Pharm.
Exp. Ther.,  1956, 116 : 9.
---, Shore, P. A.,  Silver, S. L. Potentiating action of
chlorpromazine and  reserpine.  Nature, Lond., 1955,
175 :1133-1134.  Abstract: Chem. Abstr., 1956, 50:479g.
Brown,  B. B.  Lysergic  acid diethylamide antagonism
of certain drugs.   Ann.  N. York Acad.  Sc, 1957,  66:
677-685.
Carreras, M., Angeleri, F.  Basi sperimentali alle indi-
cazoni della cloropromazina  e della reserpina nella
terapia  neuropsichiatrica.  [Experimental  basis  for
chlorpromazine and for  reserpine therapy in  neuro-
psychiatry.]   Riv.  neurobiol,  1955,  1: 473-525.  [Not
seen]  Abstract: Excerpta med., Sect. 8, 1956, 9:  No.
4991.
Chauchard,  P., Mazoue, H.  Recherches sur  le mode
d'action  centropiegique de quelques substances  psycho-
tropes.   [Research  on the mode of centriplegic action of
some psychotropic substances.]  C. rend. Soc. biol, 1956,
150: 158-160.
Chen, G., Ensor, C. R., Bohner, B. A  facilitation action
of reserpine on the central nervous system.  Proc. Soc
Exp. Biol, N.  Y., 1954, 86: 507-510.
Chusid, J. G., Kopeloff, L. M., Kopeloff, N.  Reserpine
(serpasil) effects on epileptic monkeys.  Proc. Soc Exp.
Biol, N. Y., 1955, 88: 276-277.
Cole, J.,  Glees, P.  Ritalin as an antagonist to reserpine
in monkeys,  Lancet, Lond., 1956, 1: 338.
Courvoisier, S.  Pharmacodynamic basis for the use of
chlorpromazine in psychiatry.  J. Clin. Exp.  Psycho-
path., 1956,17:25-37.
---.  Sur les proprietes  pharmacodynamiques de la
chlorpromazine   en  rapport  avec   son   emploi  en
psychiatrie.   [Pharmacodynamic basis for  the use of
chlorpromazine in psychiatry.]  Ence'phale, 1956, 45:
1248-1257.
Cronheim, G., Brown, W.,  Cawthorne, J., Toekes, I. M.,
Ungari, J. Pharmacological studies with rescinnamine,
a  new alkaloid  isolated  from  Rauwolfia   serpentina.
Proc Soc. Exp. Biol, N. Y.,  1954, 86:120-124.
---, Stipp, C, Brown,  W.  Hypotensive  agents from
Rauwolfia serpentina:  reserpine and other alkaloids.
[Abstract]  J. Pharm. Exp. Ther., 1954,110:13.
——, Toekes, I. M.  Comparison of "sedative" properties
of  single alkaloids of Rauwolfia and their mixtures.
[Reserpine:  rescinnamine: deserpidine: Riker 529-1:
Riker  529-2:  triserpine.]  J.  Pharm. Exp.  Ther., 1957,
.Lxy * qot—ouO.
—7»---• Comparison  of some pharmacological prop-
erties  of rescinnamine  and  reserpine,  two alkaloids
140 
SUBJECT  LIST
Reserpine : Studies, animals
isolated from Rauwolfia  serpentina.  J. Pharm.  Exp.
Ther., 1955, 113 : 13.
Davis, G. D.  Effects of central excitant and depressant
drugs on  locomotor  activity in  the  monkey.  Am. J.
Physiol, 1957,188: 619-623.
Delay,  J.,  Deniker,  P.,  Tardieu, Y., Lemperiere,  T.
Medicaments et  cures  neuroleptiques en therapeutique
psychiatrique: premiers essais de la reserpine;  com-
paraison avec les effets de la chlorpromazine.  [Drugs
and neuroleptic therapies in the  treatment of psychia-
tric diseases; first trials with reserpine; comparison
with the effects of chlorpromazine.]  Presse me'd.,  1955,
63: 663-665.
Delgado, J. M., Mihailovic, L.  Use of intracerebral elec-
trodes to evaluate drugs that act on the central nervous
system.   Ann. N. York Acad. Sc, 1956, 64:644-666.
Earl, A. E. A report on the tranquilizing effect of reser-
pine (serpasil).  Internat. J. Anesth., 1954, 1:214-219.
---.  Reserpine (serpasil)  in veterinary  practice.  J.
Am. Vet. M. Ass., 1956, 129 : 227-233.   Abstract: Chem.
Abstr., 1956, 50:15890h.
Ederle,  W.  Zur zentralnervosen Wirkung des Serpasil.
[Effects  of serpasil on  the central  nervous system.]
Nervenarzt, 1956, 27 : 33.
Everett, G. M., Toman, J. E. P., Smith, A. H., Jr.  Reduc-
tion of  electroshock seizure latency and other central
actions  of resperine.  [Abstract]  Fed. Proc, Bait, 1955,
14:337.
Ferro Milone, F., Gomirato, G.  Observations  experi-
mentales  sur le  comportement  de  Tactivite corticale
spontanee  et evoquee  sous  Taction des neuroleptiques.
[Changes in  spontaneous and  evoked cortical activity
under the influence of neuroleptic drugs; experimental
results.] Ence'phale, 1956, 45 : 853-857.
Gangloff,  H., Monnier, M.   Topische  Bestimmung des
zerebralen Angriffs von Reserpine (Serpasil).  [Local
determination of  cerebral  effects of  reserpine.]   Ex-
perientia, Basel, 1955, 11:404-407.   Abstract:  Chem.
Abstr., 1956, 50: 4384b.
Garattini,  S., Valzelli, L.  Sostanze  interferenti  sulla
attivita potenziante gli ipnotici svolta dalla serotonina.
[Substances that interfere with  the potentiating  effect
of serotonin  on hypnotics.   Boll. Soc. ital.  biol.  sper.,
1956,32: 292-295.
Gliedman, L. H., Gantt, W.  H.  The effects of reserpine
and chlorpromazine on orienting behavior and retention
of conditioned reflexes. South. 31. J., 1956, 49: 880-889.
Guha, G., Dasgupta, S. R., Werner, G.  Effects of some
central  depressant drugs  on conditioned reflexes.  Bull.
Calcutta School Trop. 31 ed., 1954, 2:46-47.   Abstract:
Chem. Abstr., 1955, 49 : 12709de.
Hall, J. F., Warren, J. M., Harlow, H.  F.  The effects
of reserpine  (serpasil) on the delayed response in mon-
keys.  J. Psychol, Provincet, 1955,  40:  159-161.  Ab-
stract :  Excerpta med., Sec.  8, 1956, 9: No. 2245.
Hendley, C. D.,  Lynes, T. E.,  Berger, F. M.  Effect of
meprobamate on electrical  activity  of thalamus and
other subcortical areas.  In: Himwich, H. E., ed.  Tran-
quilizing drugs.  Washington, Am. Ass. Adv. Sc, 1957. p.
35-46.
Hess, S. M., Shore, P. A.,  Brodie,  B. B.  Persistence
of reserpine action  after  the disappearance of drug
from brain: effect of serotonin.  J. Pharm. Exp. Ther.,
1956, 118: 84-89.
Himwich, H. E.  Discussion of papers on basic obser-
vations  of  new  psychopharmacological agents.  Psy-
chiat. Res. Rep., Wash., 1956 (4) : 24-31.
___ Rinaldi F.  Analysis of the action of benztropine
methanesulfona'te  against  Parkinsonism.   In:  Him-
wich, H. E., ed. Tranquilizing drugs.   Washington, Am.
Ass. Adv. Sc, 1957. p. 47-57.
Holten  C. H., Sonne,  E.  Action of  a series of benac-
tyzine-derivatives  and other  compounds  on stress-in-
duced behaviour  in  the rat.  Acta  pharm.  tox.,  Kbh.,
1955, 11:148-155.
Keller, D. L., Umbreit, W. W.  Chemically altered per-
manent behavior patterns in fish and  their cure  by
reserpine.  Science, 1956, 124: 407.
---,  ----.  Permanent alteration of behavior in mice
by chemical  and psychological  means.  Science, 1956,
124: 723-724.
Krehmer, E.  Untersuchungen fiber den Antagonismus
des Sedaraupin (Reserpin) gegenuber zentralerregen-
den Substanzen (Pervitin,  Coffein,  Cocain).  [Antag-
onism of sedaraupin  (reserpin)  to  central stimulants
(pervitin,  caffeine,  cocaine).]  53  p. Giessen, 1956.
[ Thesis—Giessen]
Kroneberg,  G.  Rescinnamin,  das zweite sedative Al-
kaloid der Rauwolfia serpentina.   [Rescinnamine,  the
second  sedative alkaloid of Rauwolfia  serpentina.]
Arzneimitt. Forsch., 1956, 6: 579-583.
Lasagna, L.,  McCann, W. P.  Effect of "tranquilizing"
drugs on amphetamine  toxicity  in  aggregated mice.
Science, 1957, 125:1241-1242.
Lim,  R. K., Pindell, M. H„ Glass,  H. G., Rink, K. The
experimental evaluation  of sedative agents in animals.
Ann.  N. York Acad. Sc, 1956, 64: 667-678.
Longo,  V.  G.,  Napolitano, L.   Effetti della reserpina
sulle  reazioni elettroencefalografiche e  motorie pro-
vocate dalla  stimolazione dell'ipotalamo.   [Effects of
reserpine on  the  electroencephalographic  and  motor
reactions induced by stimulation of the hypothalamus.]
Farmaco,  ed.  sc, Pavia, 1955, 10: 297-305.  Abstract:
Chem. Abstr., 1955, 49:13517gh.
Marrazzi, A.  S., Hart,  E. R.  An electrophysiological
analysis of drugs useful in psychotic states.   In: Him-
wich, H. E., ed. Tranquilizing drugs.  Washington, Am.
Ass. Adv. Sc, 1957.  p. 9-21.
---,  ----.  An electrophysiological analysis of the  ac-
tions  of some drugs useful in the therapy of psychotic
disorders.  J. Nerv. Ment. Dis.,  1956,  124: 388-392.
Mason, J.  W., Brady, J. V.  Plasma 17-hydroxycorti-
costeroid changes related to reserpine effects on emo-
tional behavior.  Science, 1956,  124: 982-984.
Masserman, J. H., Pechtel, C.   An experimental inves-
tigation of factors influencing  drug action.   Psychiat
Res. Rep., Wash., 1956 (4) : 95-113.
---, ----.  Neurophysiology   and pharmacologic  in-
fluences  on experimental neuroses. Am. J. Psychiat,
1956, 113: 510-514.
Meier, R., Bein, H. J., Gross, F., Tripod, J., Tuchmann-
Duplessis,  H.  Effets de la reserpine, un nouvel alca-
loide  de la Rauwolfia Serpentina Benth., sur le systeme
nerveux central de Tanimal.    [Effect of reserpine, a
new alkaloid from  Rauwolfia serpentina Benth., on  the
central nervous system in animals.]  C. rend. Acad.
sc, 1954, 238: 961-963.
Miller, N. E.  Effects of drugs on motivation; the value
of using a  variety of measures.   Am. N.  York Acad.
Sc, 1956, 65 : 318-333.
Monroe, R. R., Heath, R. G., Mickle,  W. A., Miller, W.
Cortical and subcortical recordings correlated with be-
havior in patients  and  animals during the administra-
tion of Rauwolfia,  thorazine, and meratran.  Psychiat.
Res.  Rep.,  Wash.,  1955  (1):  25-44.  Abstract: Chem.
Abstr., 1956, 50:2867gh.
Miiller, J.  M.,  Schlittler, E., Bein, H.  J.  Reserpin,  der
 sedative Wirkstoff aus  Rauwolfia serpentina  Benth.
 [Reserpine, the sedative principle from Rauwolfia  ser-
pentina Benth.] [English summary] Experientia, Basel,
1952, 8:338.
Murphree, O.  D., Peters, J. E. The effect of electro-
convulsions,  insulin comas and  certain chemical agents
on fixations  in the  rat.   J. Nerv.  Ment.  Dis., 1956
124: 78-83.
Nathan, P., Aprison, M. H., Himwich, H.  E. Effect
of some centrally acting drugs on compulsive  circling.
Proc.  Soc Exp. Biol,  N.  Y.,  1955,  90:364-367.   Ab-
 stract: Chem. Abstr., 1956, 50: 3632cd.
141 
Reserpine : Studies, animals
PSYCHOPHARMACA
Passouant,  P.,  Passouant-Fontaine,  T., Cadilhac,  J.
Les  effets de la  reserpine sur le comportement et les
rythmes corticaux et  rhinencephaliques du chat chro-
nique.  [Effect  of reserpine on  cortical and  rhinen-
cephalic rhythms in chronic cat.]   C. rend. Soc. biol,
19f>6, 150: 779-782.
Pletscher, A., Shore, P. A., Brodie, B. B.  Serotonin as
a mediator of reserpine action in brain.  J. Pharm. Exp.
Ther., 1956,116: 84-89.
Plummer, A. J.,  Barrett, W.  E., Wagle, G., Yonkman,
F. F.  Sedative and hypnotic action of reserpine in un-
anesthetized animals.  Fed. Proc, Bait., 1953, 12: 357-
358.
---, Earl, A., Schneider, J.  A., Trapold, J.,  Barrett,
W.  Pharmacology of Rauwolfia alkaloids,  including
reserpine.  Ann.  N. York Acad. Sc, 1954, 59: 8-21.
Reserpine  and  the nervous  system.  Lancet,  Lond.,
1955, 2:1326.
Rinaldi, F.  The experimental electroencephalographic
approach to psychopharmacology. Psychiat. Res. Rep.,
Wash.,  1956 (4) : 1-10.
---, Himwich,   H. E.   A comparison of  effects of
reserpine  and some barbiturates on the electrical  ac-
tivity of cortical  and subcortical structures of the brain
of rabbits.  Ann. N. York Acad. Sc, 1955, 61: 27-35.
---,----.  Drugs affecting psychotic behavior and the
function of  the mesodiencephalic  activating  system.
Dis. Nerv. Syst, 1955, 16:133-141.  Abstract: Excerpta
med., Sect. 8, 1956, 9: No. 4566.
Rubin,  B.,  Malone, M. H., Waugh, M. H., Burke, J. C.
Comparative activity  of Rauwolfia serpentina  whole
root  and reserpine in  laboratory,  animals.   Monogr.
Ther. Squibb Inst.  M. Res., 1956, 1 (2) : 40-44.
Salmoiraghi, G. C, Sollero, L., Page, I. H. Blockade by
brom-lysergic-acid-diethylamide  (BOL)  of  the  poten-
tiating  action of  serotonin, and reserpine on hexobarbi-
tal hypnosis.  J.  Pharm. Exp. Ther., 1956, 117:166-168.
Abstract: Chem.  Abstr., 1956, 50:14105gh.
Schneider, J. A.  Further characterization of central
effects of reserpine (serpasil).   Am. J. Physiol, 1955,
181:  64-68.   Abstract: Chem. Abstr.,  1955, 49: 11187e.
---.  Reserpine antagonism  of morphine analgesia in
mice.  Proc. Soc. Exp. Biol, N. Y., 1954, 87: 614-615.
Abstract: Chem.  Abstr., 1955, 49: 4165ef.
---, Earl, A. E.  Behavior and electroencephalographic
studies with serpasil  (reserpine) : a new alkaloid from
Rauwolfia  serpentina.   [Abstract]  Fed. Proc, Ball,
1954, 13:130.
---, ----.  Effects of serpasil on behavior and auto-
nomic regulating mechanisms.  Neurology, 1954, 4: 657-
667.
---, Plummer, A. J., Earl, A. E., Barrett, W. E., Rine-
hart, R., Dibble, R. C.  Pharmacological studies with
deserpidine, a new alkaloid from Rauwolfia canescens.
J. Pharm. Exp. Ther., 1955, 114: 10-13.
---, ---,  ---,  Gaunt,  R.  Neuropharmacological  as-
pects of reserpine.  Ann. N. York Acad. Sc,  1955, 61:
17-26.  Abstract: Excerpta med., Sect. 8, 1956, 9:  No.
2480.
Schwartzbaum, J.  S.  Effects  of reserpine and chlor-
promazine on nest building and  thermal preference in
rats.  Proc. Soc Exp. Biol,  N. Y.,  1955, 90:275-277.
Abstract: Chem.  Abstr., 1956, 50: 2853ab.
Shore, P. A., Carlsson, A., Brodie, B. B.  Mechanism of
serotonin-release  by reserpine.   [Abstract]  Fed. Proc,
Bait., 1956,  15 : 483.
----, Silver,  S. L.,  Brodie, B. B.  Interaction of reser-
pine, serotonin, and lysergic acid diethylamide in brain.
Science, 1955, 122: 284-285.
Sidman, M.   Drug-behavior interaction.  Ann. N. York
Acad. Sc, 1956, 65 : 282-302.
Slater, I. H., Rathbun, R. C, Henderson, F. G., Neuss, N.
Pharmacological  properties of recanescine, a new seda-
tive  alkaloid from Rauwolfia canescens Linn.  Proc.
Soc  Exp. Biol, N. Y., 1955, 88: 293-295.
  Smith, R. P., Wagman, A. I., Riopelle, A. J.  Effects of
  reserpine on conditioned avoidance behavior m normal
  and  brain-operated monkeys.  J.  Pharm. Exp.  Ther.,
  1956,  117:136-141.   Abstract:  Chem.   Abstr.,  1956,
  50:13278d.
  Stein, L.  Reserpine and the learning of fear.  Science,
  1956, 124:1082-1083.
  Terzian,  H.  Etude  experimentale de  Taction  de la
  reserpine (serpasil)  sur les structures  nerveuses cen-
  trales.  [Experimental study of the effects of reserpine
  (serpasil) on the central nervous  system.]  Ence'phale,
  1956. 45: 835-842.
  Tripod, J., Bein, H. J.,  Meier, R.   Characterization of ■
  central effects of serpasil (reserpin, a new alkaloid of
  Rauwolfia serpentina  B.)  and of their antagonistic re- ;
  actions.   Arch, internat. pharm. dyn., Gand,  1954, 96: ;
  406^25.
  Turner, W. J.  The effect of lysergic acid diethylamide ;
  on Betta splendens: I. Dis. Nerv. Syst., 1956,  17:193-
  197.
  Weiskrantz, L., Wilson, W. A., Jr.  Effect of reserpine on ;
  learning and performance.   Science, 1956, 123:1116-
  1118.  Abstract: Excerpta med., Sect 8, 1956, 9: No. >
  1705. Chem. Abstr., 1956, 50:13281L
  ---, ----.  The effects of reserpine on  emotional be- •
  havior of normal  and brain-operated monkeys.   Ann.
  N. York Acad. Sc, 1955, 61: 36-55.
  Winter,  C. A., Flataker,  L.  Effects of lysergic acid (
  diethylamide upon performance of trained rats.   Proc.
  Soc.  Exp. Biol, N.  Y., 1956,  92:285-289.  Abstract: i
  Chem. Abstr., 1956, 50:14891i.
  Walaszek, E. J., Abood, L.  G.   Effect of tranquilizing
  drugs  on fighting response  of  Siamese fighting fish.
  Science, 1956,124: 440-441.
Studies, normal subjects
  Arellano. Effects  of  reserpine in psychiatric patients.
  J. Am. M. Ass., 1955,157 : 530.
  Budnick, I. S.,  Leikin, S., Hoeck,  L. E.   Effect in the
  newborn infant of reserpine administered ante partum.
  A. M. A. J. Dis. Child., 1955, 90: 286-289.          *  *
  Colombati, S., Benassi, P.  Osservazioni elettroencefalo-
  grafiche su un  alcaloide  della  Rauwolfia  (serpasil) ;
  [Encephalographic  observations  with an alkaloid of ;
  Rauwolfia (serpasil).]   Gazz.  med. ital,  1955,  114:
  69-72.
  Dale, P. W. The actions of reserpine.  Connecticut  31. J.,
  1955, 19:652-655.   Abstract: Chem. Abstr., 1956, 50:
  4380h.
  Dennison, A. D., Jr., White, P. T.,  Moore, R. B., Pierce,
  W. J.   Effect of  reserpine  upon  the human electro-
  encephalogram.  Neurology, 1955, 5: 56-58.  Abstract:
  Excerpta med., Sect. 8,1955, 8: No. 2712.
  Fraser, H. F., Isbell, H.   Chlorpromazine and reserpine.
  A. Effects of each and of combinations of each with
  morphine.  B. Failure of each in treatment of abstinence
  from morphine.  A. M.  A.  Arch. Neur. Psychiat,  1956,
  76: 257-262.
  Hollister, L. E., Traub, L., Beckman, W. G.  Psychiatric
  use of  reserpine and chlorpromazine: results of double-
  blind  studies.   In:  Kline,  N.  S.,  ed.  Psychophar-
  macology.  Washington, Am. Ass. Adv.  Sc,  1956.  p.
  65-74.                                              *
  Isbell, M., Logan, C. R.  Studies on the diethylamide of
  lysergic acid (LSD-25). II. Effects of chlorpromazine,
  azacyclonol, and reserpine on the intensity of the LSD-
  reaction.  A. M. A. Arch. Neur. Psychiat., 1957, 77:350-
  358.
  Jeri, R.  Observaciones  con la reserpina (serpasol) en
  sujetos sanos y en pacientes psiquiatricos.   [Observa-
  tions with reserpine (serpasol)  in normal subjects and
  in psychiatric  patients.]    [English summary]   Rev.
  neur. psiquiat., Lima, 1955, 18:108-124.  Abstract as:
  Effects of reserpine in psychiatric patients.  J. Am. M.
142 
SUBJECT  LIST
Reserpine :  Studies, patients
 Ass., 1955, 157: 530.  Abstract: Excerpta med., Sect. 8,
 1956,9 : No. 1225.
 Kline,  N.  S.  Use of Rauwolfia serpentina Benth. in
 neuropsychiatric conditions. Ann. N. York Acad. Sc,
 1954,  59 :107-132.  Abstract: Chem. Abstr., 1954, 48:
 10220c.
 Lehmann, H. E., Csank, J. Differential screening of
 phrenotropic agents in man : psychophysiologic test data.
 /. Clin. Exp. Psychopath., 1957,18: 222-235.
 Phillips, T.  Overdose of reserpine.  Brit. M. J., 1955,
 2:969.
 Plummer, A. J., Earl, A., Schneider, J. A., Trapold, J.,
 Barrett, W.  Pharmacology of Rauwolfia alkaloids, in-
 cluding reserpine.  Ann.  N. York Acad.  Sc, 1954, 59:
 8-21.   [17-18]
 Reserpine and the nervous system.  Lancet, Lond., 1955,
 2:1326.
 Sellers, A. M., Hafkenschiel, J. H.  Sedative and anti-
 hypertensive  effect  of intravenous reserpine in man.
  [Abstract] Fed. Proc, Bait., 1954, 13: 404.
 ---,  ----.  Studies  of intravenous reserpine in man.
  [Abstract] Am.  J. 31. Sc, 1954, 228: 114.
 Talbot, M. W., Jr. The use of reserpine in irritable and
 hypertonic infants.  Ann. N. York Acad. Sc, 1955, 61:
 188-197.  Abstract:  Excerpta med., Sect.  8, 1956, 9:
 No. 2635.

Studies, patients
 Arellano.  Effects of reserpine in psychiatric patients.
 J. Am. 31. Ass., 1955,157 : 530.
 Balestrieri, A.   Azione della  cloropromazina e della
 reserpina  sui sistema nervoso extrapiramidale.   [The
 effect  of  chlorpromazine and  reserpine  on the  extra-
 pyramidal nervous system.]  [English summary]   Arch.
 psicol. neur., 31ilano, 1956, 17 : 483-512.
 Baruk, H., Launay,  J.,  Berges, J., Lanteri-Laura, G.
 Etude  de  Taction   de  la  reserpine  sur  Tinitiative
 psychomotrice et les grandes constautes physiologiques
 et biologiques.   Comparison sur  Taction des extraits
 totaux.   [Study of  the  effects  of reserpine  on psy-
 chomotor initiative  and the significant physiologic and
 biologic  values;  comparison with the effects  of total
 extracts.]  Ann. mCd. psychol, Par.,  1957, 115  (1) :
 708-712.
 Bente, D.  Elektroencephalographische  Ergebnisse zur
 Wirkungsweise  der  neuroleptischen  Behandlungsver-
 fahren.  [Mechanism of action of neuroleptic therapies;
 EEG findings.]  Ence'phale, 1956,45: 898-903.
 ___,  Itil, T.  Das Verhalten des  Hirnstrombildes bei
 hochdosierter Behandlung mit Reserpin  (Serpasil) und
 bei medikamentos  erzeugten  parkinsonahnlichen Zu-
 standsbildern.  [The encephalogram  during reserpine
  (serpasil)  therapy  with  massive  doses and in drug-
 induced parkinsonism.]  Med.  Klin., Berl, 1955, 50:
 1296-1301.
 Brooks, G. W.  Experiences with  the use of chlorpro-
 mazine and reserpine in psychiatry, with special refer-
 ence to the significance of extra-pyramidal dysfunction.
 N. England J. 31., 1956, 254:1119-1123.  Abstract: Year-
 book of drug therapy, 1956-1957, p. 343-344.
 Colombati, S.  Modificazioni del tracciato  E. E. G. da
 reserpina.  [Modifications of  electroencephalographic
 tracings  during  reserpine  therapy.]   [English sum-
 mary]  Arch, psicol. neur., Milano, 1956, 17: 569-580.
 ___  Benassi, P.  Osservazioni elettroencefalografiche
 su un  alcaloide  della Rauwolfia (serpasil).  [Encepha-
 lographic  observations with an alkaloid of Rauwolfia
 (serpasil).]   Gazz.  med. ital, 1955, 114:69-72.
 De Caro, D.  Manifestazioni extrapiramidali e convul-
 sive osservate durante la terapia con la  reserpina; con-
 tribute  clinico   ed  E.   E.  grafico.  [Extrapyramidal
 symptoms and convulsions  during reserpine therapy;
 clinical  and  electroencephalographic tracings.]  Acta
 neur   Nap.,  1956,   11:426-453.   Abstract:  Excerpta
 med.'!'Sect. 8,1957,10: No. 1538.
----.  Modificazioni E. E. G. provocate dalla reserpina
nell'uomo.  [Electroencephalographic changes in man
induced  by reserpine.]  Arch,  psicol.  neur., Milano,
1956, 17: 581-591.
Delay, J., Deniker, P., Bourguignon, A., Lemperiere, T.
Complications d'allure extrapyramidale  au cours  des
traitements par  la  chlorpromazine  et  la  reserpine;
etude clinique et eiectromyographique.  [Extrapyram-
idal movement disorders during  chlorpromazine and
reserpine  therapy;   clinical  and  electromyographic
studies.]  Encephale, 1956, 45 :1093-1098.
Deniker, P.  Psychophysiologic aspects  of the new
chemotherapeutic drugs in psychiatry;  some practical
features of "neuroleptics" in order to screen  new drugs.
J. Nerv. Ment Dis., 1956,124 : 371-376.
---.  Recent advances in "pharmaco-psychiatry."  J.
Clin. Exp. Psychopath., 1956,17 : 381-384.
Ferguson, R. S.  Influences of reserpine on E.  C.  T.:
preliminary observations.  J. 3Ient  Sc, Lond., 1956,
102: 826-829.
Fliigel,  F., Bente,  D.  Das  akinetisch-abulische Syn-
drom  und  seine  Bedeutung  ftir die  pharmakologisch-
psychiatrische Forschung.   [Akinetic-abulic syndrome
and its  importance in psychopharmacologic research.]
Deut. med. Wschr., 1956, 81: 2071-2074.
Fogel, E. J. Physiological studies  after continuous ser-
pasil therapy over 18 months.   Dis. Nerv. Syst., 1956,
17: 322-323.
Freyhan, F.  A.   Psychomotility and parkinsonism in
treatment  with  neuroleptic drugs.  A. M. A.  Arch.
Neur. Psychiat., 1957, 78: 465-472.
Funkenstein,  D.  H.  Nor-epinephrine-like and  epine-
phrine-like substances in relation to human behavior.
J. Nerv. Ment. Dis., 1956, 124: 58-68.
Gerstenbrand,  F.,  Weingarten, K.  Serpasil-Behand-
lung  bei extrapyramidalen  Hyperkinesen.  [Serpasil
treatment  of  extrapyramidal  hyperkinesia.]   Wien.
klin. Wschr., 1956, 68: 656-659.
Haase,  H.  J.  Psychiatrische Erfahrungen  mit Mega-
phen  (Largactil) und dem Rauwolfiaalkaloid Serpasil
unter dem  Gesichtspunkt des psychomotorischen Park-
insonsyndroms.   [Psychiatric experiences with mega-
phen  (largactil)  and  the  Rauwolfia alkaloid serpasil
with special reference to Parkinson's psychomotor syn-
drome.]  Nervenarzt, 1955, 26: 507-510.
---.   Uber Begriff und Wirkungsweise des therapeu-
tisch  erstrebten  psychomotorischen Serpasil-(Rauwol-
fiaalkaloid-)   und  Largactil-(Megaphen-)  Parkinson-
Syndroms.  [Definition and mode of action  of the psy-
chomotor Parkinson syndrome therapeutically induced
by  serpasil  and   largactil.]  [English  summary]
Mschr. Psychiat, Basel, 1956, 131:  201-214.
----.   Uber  Vorkommen  und Deutung  des psychomo-
torischen  Parkinsonsyndroms  bei  Megaphen-  bezw.
Largactil-Dauerbehandlung.  [Occurrence  and  inter-
pretation of the psychomotor Parkinson syndrome dur-
ing prolonged  therapy with megaphen  or  largactil.]
Nervenarzt, 1954, 25: 486^92.
Hafkenschiel, J. H., Sellers, A. M., King, G. A., Thorner,
M. W.  Preliminary observations on the effects of paren-
teral reserpine on cerebral blood flow, oxygen and  glu-
cose metabolism, and electroencephalograms of patients
with essential hypertension.  Ann.  N. York Acad.  Sc.
1955, 61:  78-84.  Abstract: Chem.  Abstr., 1955,  49:
12711L
Hess,  R.  Vorlauflge elektroencephalographische  Be-
funde   bei Serpasil-Therapie.  [Preliminary   electro-
encephalographic  findings   in   serpasil   therapy.]
Schweiz. med. Wschr., 1955, 85 : 442-443.
Holmberg, G., Jonsson, B.,  Mellgren, A., Martens,  S.
EEG  changes in chlorpromazine and reserpine treat-
ment.   Acta   psychiat.  neur.  scand.,   1956,   Suppl.
106:235-240.
Janzarik,  W.   Die  Bedeutung  der  neuroplegischen
  Therapie  fiir die Psychopathologie des schizophrenen
143 
Reserpine : Studies, patients
PSYCHOPHARMACA
   Wahns.   [Significance of neuroplegic therapy for the
   psychopathology  of  schizophrenic  hallucinations.]
   Ence'phale, 1956, 45 : 635-642.
   Kernohan, G.  A.  Stupor  during  reserpine therapy.
   Brit. 31. J., 1957, 1:1475-1476.
   Kirkpatrick,  W. L., Sanders, F.  Clinical evaluation of
   reserpine in  a  state hospital.  Ann. N. York Acad. Sc,
   1955,  61:123-143.
   Lafon,  R., Boyer,  Due, N., Minvielle,  J., Pouget, R.
   Effets  comparatifs de  Tinjection  intraveineuse  de
   serotonine  et   de  reserpine;   etude psychometrique
   neurovegetative et eiectroencephalographique.   [The
   comparative  effects of intravenous serotonin and reser-
   pine;  a  psychometric,  neuro-autonomic  and electro-
   encephalographic study.]   Ann.  med. psychol,  Par.,
   1956,  114  (2) : 463-466.
   Le  Guillant  Le   syndrome   neuroleptique:   etude
   clinique  et  psychotechnique.  [The  neuroleptic syn-
   drome : clinical and psychometric study.]  Ann. med.
   psychol, Par., 1957,115 (1) : 316-329.
   Martelli,  G.  Azione della reserpina a dosi terapeutiche
   sull'elettroencefalogramma  di  malati mentali.   [The
   effects of reserpine therapy on the EEG of mental pa-
   tients.]   [English  summary]  Gior.  psichiat,   1956,
   84:323-335.
   ---.   Variazioni E. E. G. da reserpina in neuropsichia-
   tria.   [Electroencephalographic variations with  reser-
   pine in neuropsychiatry.] Arch,  psicol  neur., Milano,
   1956 17: 595—596.
   Monroe, R. R., Heath, R. G., Mickle, W. A., Miller, W.
   A comparison of cortical and  subcortical  brain  waves
   in normal, barbiturate,  reserpine,  and chlorpromazine
   sleep.  Ann.  N. York Acad.  Sc, 1955, 61:56-71.  Ab-
   stract : Excerpta med., Sect. 8,  1956, 9: No. 3089.
   ---,---,----,----.  Cortical and subcortical record-
   ings correlated with behavior in patients  and animals
   during the administration of Rauwolfia,  thorazine, and
   meratran.  Psychiat.  Res. Rep.,  Wash.,  1955  (1) : 25-
   44. Abstract:  Chem. Abstr., 1956, 50: 2867gh.
   Morgan, D.  R.  The experimental  use of  reserpine in
   the treatment  of tremor-rigidity syndromes.  Med. J.
   Australia, 1956, 43  (1) : 973-974.
   Richman,  A., Tyhurst, J. S. An extrapyramidal syn-
   drome with resperine.  Canad. 31. Ass. J., 1955, 72: 457-
   458.
   Schmitt, R. J.  The psychodynamics of the tranquilizing
   agents. Psychiat. Q., 1957, 31:17-30.
   Shankel,  L. W.,  Whittier, J. R.  Effects  of  reserpine
   therapy on Funkenstein  test reactions in  maladapting
   patients.  Dis.  Nerv. Syst., 1956,  17: 258-261.
   Shuman, J.  Paralysis agitans  developing during reser-
   pine therapy.  J. Am. 31. Ass., 1955, 158:  73.
   Steck, H.  Le syndrome  extrapyramidal  dans les cures
   de  chlorpromazine et  serpasil;  sa  symptomatologie
  clinique et son role  therapeutique.   [Extrapyramidal
   syndrome in  chlorpromazine and serpasil  therapy; its
   clinical symptoms  and therapeutic role.]  Ence'phale,
   1956, 45:1083-1089.
  ---.   Le syndrome extrapyramidal  et  diencephalique
   au  cours  des traitements au largactil et  au serpasil.
   [Extrapyramidal and diencephalic  syndrome  during
  largactil and  serpasil  therapy.]   Ann.  me'd.  psychol,
  Par., 1954, 112 (2) :  737-744.
  Tonini, G.,  Montanari,  C.   Modificazioni  elettroence-
  falografiche  nel  corso  della  terapia  con reserpina.
   [Electroencephalographic changes  during   reserpine
  therapy.]  Arch,  psicol.  neur.,  31ilano,  1956, 17:592-
  593.
Therapeutic studies, controlled
  Abse,  D. W., Curtis, T. E., Dahlstrom, W. G.,  Hawkins,
  D. R.,  Toops, T. C.  The use of reserpine in the manage-
  ment of acute mental disturbance on an in-patient serv-
  ice: preliminary report. J. Nerv. Ment.  Dis.,  1956,
  124: 239-247.
Armour, P. S.  A regimen  in  acute alcoholism.  [Me-
phenesin ; mephenesin carbamate; reserpine; also com-
bined and compared]  Arizona M., 1956, 13:169-172.
Ayd, F. J., Jr.  Thorazine and serpasil treatment of pri-
vate neuropsychiatric patients.  Am. J. Psychiat., 1956,
113:16-21.                                         *
Barrett, J. E.  The value  of chlorpromazine  hydro-
chloride and reserpine in relation to other methods used
in treating mental illness.   Virginia  M.  Month., 1955,
82: 415-417.
Bender, L., Nichtern, S.  Chemotherapy in child psy-
chiatry.  N. York State J. M., 1956, 56:2791-2795.
Bennett, A. E., Ford, F. R.,  Turk, R. E.  Clinical inves-
tigation  of chlorpromazine and  reserpine in  private
psychiatric practice.  Am. J. Psychiat., 1956, 112: 782-
787.   Condensed :  Am. Practitioner, 1956, 7:1576-1577
Abstract: Excerpta med., Sect. 8, 1956, 9: No. 4546.
Brooks, G. W.  Experiences with the use of chlorproma-
zine and reserpine in psychiatry, with special reference
to the significance and management of extrapyramidal
dysfunction.   N. England J. M., 1956, 254:1119-1123.
Abstract: Year book of drug therapy, 1956-1957, p. 343-
344.
Carey, E. F.  A new approach to the emergency treat-
ment of sickness caused by narcotic withdrawal. Illi-
nois 31. J., 1957, 111: 1-7.   Also: Ann. N. York Acad.
Sc, 1955, 61: 222-229.
Carter, C. H.  The effects  of reserpine  and methyl-
phenidylacetate (ritalin) in mental  defectives, spastics,
and  epileptics.  Psychiat. Res. Rep., Wash., 1956 (4) :
44-48.
Charlin, A.  Action respective  de  la chlorpromazine et
de la reserpine; hypotheses  pathogeniques.  [The effect
of chlorpromazine and of reserpine; pathogenic hypoth-
eses.]  Ence'phale, 1956, 45 :1099-1105.
Dale,  P. W.  The actions  of reserpine.   Connecticut
M. J., 1955, 19 : 652-655.  Abstract:  Chem. Abstr., 1956,
50:4380h.
Davies, D. L.  Clinical trials with especial reference to
reserpine.  Ence'phale, 1956, 45 :1031-1034.
Ferguson, J. T.  Comparison of reserpine and harmonyl
in psychiatric patients; a preliminary report. J. Lancet,
1956, 76: 389-390.
---, Funderburk, W.  H.   Improving senile behavior
with reserpine and ritalin; new approach with  use of
methyl phenylpiperidylacetate.  J. Am. 31. Ass., 1956,
160:259-263.  Abstract: Excerpta med,,  Sect. 8, 1956,
9; No. 3520.   Year book of  drug therapy, 1956-1957, p.
344-346.
Fischer, E.  Reserpine (serpasil) in mental deficiency
practice.  J. 31ent Sc, Lond.,  1956, 102:542-545.
Fox, V.  Treatment  of withdrawal symptoms in the
management of alcoholism.  J. M.  Ass. Georgia, 1956,
45:139-142.
Fraser, H. F., Isbell, H.  Chlorpromazine and reserpine
A. Effects  of  each and of  combinations  of each with
morphine.  B. Failure  of each in treatment of absti-
nence from morphine.  A. 31. A. Arch. Neur. Psychiat.,
1956, 76: 257-262.
Freedman, A. M.,  Effron,  A. S., Bender, L. Pharmaco-
therapy in children with psychiatric  illness.   J. Nerv.
Ment,  Dis., 1955,  122:479-486.  Abstract: Year book
of drug therapy, 1956-1957,  p. 350-351.
Fremming, K. H., Perregaard, I.   Serpasil som seda-
tivum i psykiatrien.   [Serpasil as a sedative in psychia-
tric  practice.]  [English summary]   Ugeskr.  laeger,
1955, 117:599-603.  Abstract: Excerpta  med.,  Sect. 8,
1956, 9 : No. 3608.
Gerard, D. L., Weisselberger,  D., Kritz, D.  Reserpine
in the postwithdrawal  rehabilitation  of  adolescent
opiate addicts.  A. M.  A. Arch. Neur. Psychiat., 1956,
76:106-108.                                        *
Harris, R. D.,  Rowley, E.  H.  Reserpine in cerebral
palsy.  J. Pediat., S. Louis,  1956, 49: 398-400.
144 
SUBJECT  LIST
Reserpine : Therapeutic studies, controlled — Neuroses
 Horenstein, S. Reserpine and chlorpromazine in hyper-
 active mental defectives.   Am.  J. Ment. Defic, 1957,
 61: 525-529.                                        *
 Hunt, B. R,, Frank, T., Krush, T. P.  Chlorpromazine in
 the treatment of severe emotional disorders of children.
 A. M. A. J. Dis. Child., 1956, 91: 268-277.
 Jeri, R.  Observaciones con la reserpina (serpasol) en
 sujetos  sanos y en pacientes psiquiatricos.  [Observa-
 tions with reserpine (serpasol) in normal subjects and
 in  psychiatric patients.]   [English  summary]  Rev.
 neur. psiquiat., Lima,  1955, 18: 108-124.  Abstract  as:
 Effects of reserpine in psychiatric patients.  J. Am. M.
 Ass.,  1955, 157: 530.  Abstract:   Excerpta med., Sect.
 8,1956,9: No. 1225.
 Kline, N. S.  Clinical applications  of reserpine.  In:
 Kline, N. S., ed.  Psychopharmacology.   Washington,
 Am. Ass. Adv. Sc, 1956.  p. 81-108.
 ---.  Use of Rauwolfia serpentina Benth. in  neuro-
 psychiatric   conditions.    Ann.  N.  York Acad.  Sc,
 1954, 59 :107-132.   Abstract: Chem. Abstr., 1954, 48:
 10220 c.
 Knutsen,  A.  T.  Reserpin  og klogpromazin i  psykia-
 trien.  [Reserpine and chlorpromazine in psychiatry.]
 [English summary]   Tskr.  Norske  laegeforen., 1956,
 76:368-371.
 Kugelmass, I. N.   Psychochemotherapy  of mental defi-
 ciency in children.  Internat. Rec. 31., 1956, 169 : 323-338.
 Lafon, R., Due, N., Boyer,  Abric, J., Pouget,  R.  Ex-
 ploration  psychologique des  malades  traites  par  le
 4560 RP (chlorpromazine)  et la reserpine.  [Psycho-
 logic  examination  of patients treated  with  RP 4560
 (chlorpromazine)  and  with reserpine.]   Encephale,
 1956, 45: 996-999.
 Lemere,  F.   Combined  chlorpromazine-reserpine ther-
 apy  of  psychiatric disorders. A. 31. A.  Arch. Neur.
 Psychiat., 1955, 74:1-2.  Abstract:  Excerpta med.,
 Sect. 8, 1956, 9: No. 2235.
 Marini, M., Caprini, G., Benciolini, P.  La  Rauwolfia in
 malate croniche, normotese ed ipertese; contributo clin-
 ico.  [Rauwolfia in chronic, normotensive and  hyper-
 tensive patients; clinical contribution.]    Arch,  psicol.
 neur., 3Iilano, 1956, 17: 419-432.
 McGrath, S.  D., Ryan, J.  P., Fennelly, J.  J.  The use of
 reserpine  (serpasil)  in psychiatry.   J.  Irish M. Ass.,
 1956, 39:1-A.  Abstract: Excerpta med., Sect.  8, 1957,
 10: No. 2089.
 Morton, H. G., Warson, S. R.  Control study on reserpine
 in small  group of  children  with  neurologic disorders.
 J. Florida 31. Ass.,  1957, 43 : 786.
 Nicolaou, G. T., Kline, N. S.  Reserpine in the treatment
 of disturbed adolescents.  Psychiat. Res. Rep.,  Wash..
 1955 (1) : 122-132.
 Niswander, G. D.,  Haslerud, G. M., Brody, N., Casey,
 T. M.  Reserpine and  methylphenidylacetate effects on
 socialization  and activity.   J. Nerv.  31 ent. Dis., 1957,
 125 : 51-56.
 Pelzman, O.,  Conigliaro, V.   Osservazioni preliminari
 sull'uso clinico di un derivato di Rauwolfia serpentina
 in malati di mente. [Preliminary study of the clinical
 use  of a Rauwolfia  serpentina  derivative in  mental
 patients.]  [English summary]  Gior. phichiat., 1955,
 83:131-147.  Abstract:  Excerpta med.,  Sect. 8, 1956,
 9: No. 1221.
 Ranee, A. M., Jurquet, A., Roger,  J.  Remarques sur la
 therapeutique des affections psychiatriques par la chlor-
 promazine et la reserpine; etude comparee des diverses
 modalites d'administration  de ces drogues.  [Therapy
 of psychiatric disorders with chlorpromazine and reser-
 pine; comparative  study  of  the  various methods  of
 their administration.]   Ence-phale, 1956,  45:477-487.
 Reda,  G. C,  Germano,  V.  L'azione  combinata della
 reserpina e cloropromazina  nella pratica  psichiatrica.
 [Combined effect of reserpine and chlorpromazine  in
psychiatric  practice.]    [English  summary]    Arch.
psicol. neur., Milano, 1956,17: 647-653.
  Ricci,  G. C,  Ricordati, M.   Un  alcaloide della Rau-
  wolfia serpentina  nella terapia della ipertensione  e  di
  alcune   psicopatie;   rassegna  critica   ed  esperienze
  cliniche.  [Rauwolfia serpentina alkaloid  in the treat-
  ment of hypertension  and of  certain  psychopathies;
  critical considerations and clinical experiences.]  [Eng-
  lish summary p. 128] Rass. flsiopat., 1954, 26:91-131.
  Rosner, H., Levine, S., Hess, H., Kaye, H.  A comparative
  study of the effect on anxiety of chlorpromazine, reser-
  pine, phenobarbital, and a placebo.  J. Nerv. 3Ient Dis.,
  1955, 122: 505-512.  Abstract: Excerpta med., Sect.  8,
  1957,10 : No. 2093.
  Smigel, J. O.  Mood therapy in the aged.  Med. Times,
  Great Neck, 1957, 85 :149-158.
  Sternberg, U., Spitz, H.,  Goyne, J. B.   Evaluation of
  chlorpromazine  and reserpine therapy  with follow-up
  study.  J. Clin, Exp. Psychopath., 1957,18 : 258-268.
  Ware, L. M., Prout,  C. T.  A controlled study of reser-
  pine in the treatment of mental illness.  Bull  N. York
  Acad. 31., 1956, 32: 643-650.
  Zeller, W. W.,  Graffagnino, P. N., Cullen, C. F., Reitman,
  H. J.  Use of chlorpromazine and reserpine in the treat-
  ment of emotional disorders.  J. Am. M.  Ass., 1956, 160:
  179-184.  Abstract:  Year book of drug  therapy, 1956-
  1957, p.341-342.

—Cannabis intoxication
  Carey, E. F.   A new approach to the emergency treat-
  ment of  sickness caused by narcotic withdrawal.  Illi-
  nois M. J., 1957, 111: 1-7.  Also:  Ann. N. York Acad.
  Sc, 1955, 61: 222-229.

—Neuroses
  Bazzi,  T. Reserpina e psicoterapia.  [Reserpine  and
  psychotherapy.]   [English  summary]   Arch,   psicol.
  neur., 31ilano,  1956, 17: 675-681.
  Calloway, N. O.  Tranquilization  and sedation by the
  use of  a combination of small doses of  reserpine  and
  pentobarbital  sodium.   Illinois M.  J., 1956, 110: 232-
  234.
  Cohen, S.  Clinical experiences with pipradrol and  a
  pipradrol-reserpine combination.  Internal  Rec.  31.,
  1956,169: 751-756.
  Davidoff, E., Best, J. L., McPheeters, H.  L. The effect
  of ritalin (methyl-phenidylacetate hydrochloride)  on
  mildly  depressed ambulatory  patients.  N. York State
  J. M., 1957, 57: 1753-1757.
  Davies, D. L., Shepherd, M.  Reserpine in the treatment
  of anxious and depressed patients.  Lancet, Lond., 1955,
  2:117-120.  Abstract: Excerpta med., Sect. 8,  1956, 9 :
  No. 1224.
  Ferguson, J. T. What's new and usable in the chemical
  treatment of abnormal behavior. J. Michigan M. Soc,
  1956, 55:1095-1101.
  Ferguson, R. S. A clinical trial of reserpine in the treat-
  ment of anxiety.  J. 31ent Sc, Lond., 1956, 102: 30-42.
  Abstract: Excerpta med., Sect. 8, 1957, 10: No. 1534.
  Folkson, A., May, A. R.  Use of reserpine and Rauwolfia
  in  psychoneuroses.  Brit.  31.  J.,   1955, 2:1121-1122.
  Abstract: Excerpta med.,  Sect. 8, 1956, 9:  No. 2658.
  Hare, E. H., Seager, C. P.,  Leitch, A.  Reserpine in
  anxiety  states.  Lancet, Lond.,  1956, 1: 545-547.  Ab-
  stract: Year book  of  drug therapy,  1956-1957, p. 336-
  337.
  Hollister, L. E. Stannard,  A.  N., Drake, C. F.  Treat-
  ment of anxious patients with drugs. Dis. Nerv. Syst.,
  1956,17: 289-293.
  Kinard, S., Mills, L. C, Terrell, J., Moyer, J. H.   Use of
  d-amphetamine to curb the  increased appetite and over-
  eating induced by reserpine therapy.  J.  Am.  Geriat
  Soc, 1956, 4:1073-1077.
  Kline, N. S.   Clinical applications of reserpine.  In:
  Kline, N. S., ed.  Psychopharmacology.   Washington,
  Am. Ass. Adv. Sc, 1956. p. 81-108. 
Reserpine : Therapeutic studies, controlled — Neuroses
PSYCH0PHAR3IACA
  Meath, J. A., Feldberg, T. M., Rosenthal, D., Frank, J. D.
  Comparison of reserpine and placebo in treatment of
  psychiatric outpatients.  A. 31. A. Arch. Neur. Psychiat.,
  1956, 76: 207-214.
  Meller,  R.  L.  Reserpine and  alseroxylon  therapy in
  emotionally  disturbed   patients.  J.  Lancet,  1955,
  75:339-342.  Abstract:  Excerpta  med., Sect.  8, 1956,
  9: No. 5000.
  Moyer, J. H., Pevey, K., Kinross-Wright, V.  Tranquiliz-
  ing (ataractic) agents : current evaluation of their clini-
  cal use in patients who are not hospitalized.  GP, 1957,
  15  (6) :97-118.
  Pellerito, N.  L'Azione della cloropromazina e della re-
  serpina sull'ansia dei psiconevrosici.  [Action of chlor-
  promazine  and  reserpine on the anxiety  of  psycho-
  neurotics.]   3Iinerva med., Tor., 1956, 47: 628-631.
  Randolph,  A. G,  Thompson,  L.  J.  The  use of  di-
  methylane-reserpine combination in mental disorders;
  a preliminary report. North Carolina M. J., 1957,  18:
  17-20.
  Ritter, N. S.  Experience with reserpine in the treat-
  ment of alcoholism.  Q.  J.  Alcohol, 1956,  17:195-197.
  Abstract: Excerptamed,, Sect. 8,1957,10: No. 883.
  Rosenthal,  D., Frank, J. D.   Psychotherapy and  the
  placebo effect. Psychol. Bull, 1956, 53 : 294.
  Sarwer-Foner, G. J., Ogle, W. The use of reserpine in an
  open psychiatric setting.   Canad. 31. Ass. J., 1955,  73:
  187-191.                                            *
  ---, ----.  Psychodynamic  aspects  of  reserpine:  its
  uses and effects in open psychiatric  settings.   Canad.
  Psychiat. Ass. J., 1956,1:11-17.
  Talbot, M. W., Jr.  The use of reserpine in irritable and
  hypertonic  infants.  Ann. N. York Acad. Sc, 1955,  61:
  188-197.  Abstract:  Excerpta  med.,  Sect. 8,  1956,  9:
  No. 2635.
  Weir, H. F., Anderson, R. L. The effects of reserpine and
  Rauwolfia in minor disorders of adjustment in children.
  3Ionogr. Ther. Squibb Inst 31. Res., 1956, 1(2): 33-39.
  Wells, R. E.  Use  of reserpine (serpasil) in the man-
  agement of chronic alcoholism. J. Am. 31. Ass., 1957,
  163: 426-429.

—Psychoses
  Altshuler, I. M. Music potentiating drugs.   A prelim-
  inary report.  Music therapy, 1955, 5: 120-126.
  Arnold, A.  L., Freeman,  H.  Reserpine in hospitalized
  psychotics; a controlled study on chronically disturbed
  women. A. M. A.  Arch. Neur. Psychiat., 1956, 76: 281-
  285.
  Azima, H., Cramer-Azima,  F.  J., De Verteuil, R.  A
  comparative  behavioral and psychodynamic study of
  reserpine and  equally  potent doses  of raudixin  in
  schizophrenics.  Monogr. Ther. Squibb Inst. M. Res.,
  1956, 1 (2) : 15-25.                                 *
  Barsa,  J. A., Kline, N. S.  Combined reserpine-chlor-
  promazine  in   treatment   of   disturbed  psychotics.
  A. M. A. Arch.  Neur. Psychiat., 1955, 74: 280-286.   Ab-
  stract :  Am.  J. Psychiat.,  1955,  111: 780.  Excerpta
  med., Sect. 8,1957,10 : No. 368.
  ■---■,----.  A comparative study of reserpine, chlorpro-
  mazine, and combined therapy. A. 31. A. Arch. Neur.
  Psychiat, 1956. 76  : 90-97.
  ----, ----.   Reserpine in the treatment of psychotics
  with  convulsive  disorders.  A.  M.  A.  Arch. Neur.
  Psychiat.,  1955, 74 : 31-35.   Abstract: Excerpta med.,
  Sect. 8, 1956, 9: No. 1730.                            *
  ----, ----.   Treatment of two  hundred disturbed psy-
  chotics with reserpine. J. Am. M. Ass., 1955, 158:110-
  113.  Abstract:  Excerpta med., Sect. 8, 1956,  9:  No.
  2246.                                             * *
  ----,----.  Use of reserpine in disturbed psychotic pa-
  tients.  Am.  J. Psychiat,   1956,  112:684-691.   Ab-
  stract : Excerpta med., Sect.  8, 1956, 9: No. 4543.   *  *
  Baruk, H., Launay, J., Berges, J., Mijolla, A. de Etude
  clinique de Taction therapeutique de la reserpine.  Com-
paraison avec  Taction des extraits  totaux.   [Clinical
study of the therapeutic effect of reserpine; comparison
with total  extracts.]  Ann.  med. psychol, Par., 1957,
115 (1) : 704-708.
Boudwin, J.,  Kline, N.  S.  Use  of reserpine in chronic
non-disturbed psychotics.  Psychiat.  Res. Rep., Wash.,
1956 (4) : 71-78.
Cowden, R. C, Zax, M., Sproles, J. A.  Group psycho-
therapy in conjunction with a  physical treatment.  J.
Clin. Psychol, 1956,12: 53-54.
----, ——,----.  Reserpine alone and as an adjunct to
psychotherapy  in  the  treatment   of  schizophrenia.
A. M. A. Arch.  Neur. Psychiat,  1955, 74: 518-522.
Cutler, R. P., Monroe, J. J., Anderson, T. E.  Effects of
"tranquilizers" upon pathological activity in psychotic
patients.  I.  Chlorpromazine.  II. Reserpine.   A. M. A.
Arch.   Neur.  Psychiat,   1957,   77:616-622;   1957,
78:61-68.
Dice, N., Bagchi,  B. K., Waggoner,  R. W.  Investiga-
tion of effects of intravenous  reserpine in disturbed
psychotic   and  brain-damaged  patients;  electroen-
cephalographic correlation.  J.  Nerv. Ment.  Dis., 1955,
122:472-478.
Elkes, C.  Rauwolfia  alkaloids  and reserpine in  the
treatment of the chronic  psychotic  patient.   J. Ment.
Sc, Lond.,  1957, 103 : 464-474.
Feldman, P.  E.  A comparative study of various ata-
ractic  drugs.  Am. J.  Psychiat., 1957, 113:589-594.  *
Ferguson,  J. T.  Improved  behavior patterns in  the
hospitalized  mentally  ill with  reserpine  and methyl-
phenidylacetate.  Psychiat. Res. Rep., Wash., 1956 (4) :
35-43.
---,  Linn, F.  V.   A  new compound for the sympto-
matic  treatment  of tension and  anxiety:   2-ethylcro-
tonylurea (nostyn).  Antibiotic M., 1956, 3:329-333.
Finn, M. H.,  Nadolski, F., Guy W., Gross, M.  Clinical,
psychological and  myoneural changes in psychotic  pa-
tients  under  oral serpasil  medication.  J. Nerv. Ment.
Dis.,  1955,  122:458-462.  Abstract:   Excerpta  med.,
Sect. 8,1957,10: No. 370.
Frain,  M. K.  Promazine treatment of chronic psychoses
in 100 hospitalized patients.   J. Nerv. 3Ient. Dis., 1957,
125: 529-533.
Freeman,  H., Arnold, A.  L., Cline,  H. S.  Effects  of
chlorpromazine and reserpine in chronic schizophrenic
patients.   Dis.  Nerv.  Syst, 1956,  17:213-219.  Ab-
stract: Excerpta med., Sect. 8, 1957, 10:  No. 1448.
Gardner, M.  J., Hawkins, H. M., Judah, L. N.,  Mur-
phree, O.  D.  Objective  measurement  of psychiatric
changes produced  by chlorpromazine and reserpine in
chronic schizophrenia.  Psychiat.  Res.  Rep., Wash.,
1955 (1) :77-83.
Goldman,  D.  Comparison of clinical effects  of chlor-
promazine  and reserpine in psychotic patients. Am. J.
31. Sc, 1957,  233:137-144.                           *
Gore, C. P., Egan,  G.  P., Walton, D.  The place of re-
serpine in  the  treatment of the chronic psychotic pa-
itent.  Am. J. Psychiat., 1957, 114 : 333-337.
Hes, J. P., Bracha, S. The influence  of  reserpine on
a disturbed male ward and a method for assessing this.
J. 31 ent. Sc, Lond., 1956,102 : 546-549.
Hickerson, G. X., Jr., Swain, J. M., Tempey, F. W.  Re-
serpine in acute  psychotic  states;  report  of a con-
trolled study.  J. Nerv. 31ent. Dis., 1956, 124: 614-617.
Hollister, L. E.,  Traub, L.,  Beckman, W. G.  Psychi-
atric use of  reserpine and chlorpromazine: results of
double-blind  studies.   In: Kline, N.  S., ed.  Psycho-
pharmacology.  Washington,  Am. Ass. Adv. Sc, 1956.
p. 65-74.
Holt, E. K., Ward-Dunn, G., Nedilsky, B. T., Niswander,
G. D.  Clinical comparison of raudixin and rau-sed in
chronic mental illness.  Dis. Nerv. Syst., 1955, 16: 222-
223.  Abstract:  Excerpta  med.,  Sect. 8, 1956  9 • No.
4564.
146 
SUBJECT  LIST
Reserpine : Therapeutic studies, controlled — Psychoses
 Kinross-Wright, V.  Chlorpromazine and  reserpine in
 the treatment of psychoses.  Ann. N. York  Acad. Sc,
 1955,  61:174-182.   Abstract: Excerpta  med., Sect. 8,
 1956, 9: No. 2236.
 Kline,  N. S.  Clinical applications of reserpine.  In:
 Kline,  N. S.,  ed.  Psychopharmacology.   Washington,
 Am, Ass. Adv. Sc, 1956.  p. 81-108.                  *
 Koltonow, L.  Reserpine in  the treatment of patients
 with chronic  mental disease;  a controlled  study.  J.
 Nerv. 31 ent. Dis., 1956, 123 : 392-394.
 Kovitz, B., Carter, J. T., Addison, W. P.  A comparison
 of chlorpromazine  and reserpine in chronic  psychosis.
 A. M. A.  Arch. Neur. Psychiat, 1955, 74: 467-471.  Ab-
 stract : Excerpta med., Sect. 8, 1957, 10: No. 2087.
 Lafon, R., Due, N., Abric, J., Pouget, R., Comelade, P.
 Etude  comparative du 4. 560 R. P.  (chlorpromazine)
 et de la reserpine dans les syndromes schizophreniques.
 [Comparative study  of  R.  P. 4560  (chlorpromazine)
 and  reserpine in  schizophrenic   syndromes.]  Ence'-
 phale, 1956, 45: 668-671.
 Lehman,  E., Haber, J., Lesser, S. R.  The use of reser-
 pine in autistic children.  J. Nerv. Ment. Dis., 1957, 125:
 351-356.
 Leiberman, D. M., Vaughan,  G. F.  The use of some new
 pharmacological agents in  psychiatry.  J.  Ment.  Sc,
 Lond.,  1957, 103 :110-118.
 Lemere, F.  Failure of azacyclonol (frenquel) to relieve
 non-experimental mental confusion and hallucinations.
 Am. J. Psijchiat., 1957,113 : 840-841.
 Loch,  W.   Zur Behandlung fortgeschrittener  Schizo-
 phrenien  mit Megaphen und Reserpin.   [Megaphen and
 resperine therapy of  advanced schizophrenia.]  Nerven-
 arzt, 1956, 27: 463-467.
 Luiz, H. A.  Experiences with the use of reserpine on the
 chronically disturbed mental patient.  S. Afr. M.  J.,
 1956, 30:1049-1051.                                 *
 Lyager, T., Rontorp, P.  S.   Behandling of  psykotiske
 patienter  med  reserpin   (serpasil).   [Reserpine  in
 therapy of  psychoses.]   [English  summary]  Ugeskr.
 laeger, 1955,  117 : 603-610.  Abstract: Excerpta med.,
 Sect. 8, 1956, 9 : No. 3609.                          * *
 McDonald, R. E., Ellsworth,  R. B., Eniss, J. Behavioral
 changes of chronic schizophrenics in response to reser-
 pine.  A. M. A. Arch.  Neur. Psychiat., 1956, 75: 575-578.
 Abstract: Excerpta med., Sect. 8,1957,10: No.  888.
 McPheeters, H., Fox, W. W.  Evaluation  of reserpine
 and methyl phenidylacetate used separately and in com-
 bination in chronic psychotic patients.  J. Kentucky 31.
 Ass., 1956, 54: 785-791.
 Malamud, W.,  Barton, W. E„ Fleming, A.  M., Middle-
 ton, P. McK.,  Friedman, T.  T.,  Schleifer, M. J.  The
 evaluation of the effects of derivatives of Rauwolfia in
 the treatment of schizophrenia. Am. J. Psychiat, 1957,
 114:193-200.
 Michtom, J., Goldberg, N., Offenkrantz, W„ Whittier, J.
 Readmission rates  for state mental hospital  patients
 discharged on maintenance ataractics.  Findings with a
 matched control  group and methodological  considera-
 tions.  J. Nerv. Ment. Dis., 1957,125 : 478-480.
 Naidoo, D.  The effect of reserpine (serpasil)  on the
 chronic disturbed schizophrenic: a comparative study of
 Rauwolfia alkaloids and electroconvulsive  therapy.  J.
 Nerv. 31 ent. Dis., 1956,  123 :1-13.                    *
 Negri,  F.   Effetto della reserpina  e della  reserpina
 associata a psicotonici in  alcune psicopatie  senili.  [Ef-
 fect of reserpine  and  of  reserpine  combined  with
 psychotonics in senile psychoses.]  [English summary]
 Arch, psicol neur., Milano, 1956,  17: 441-451.
 Pearl, D., Vander Kamp, H., Olsen, A. L., Greenberg,
 P.  D,  Armitage, S.  G.  The effects of reserpine  on
 schizophrenic patients.  A. M. A. Arch. Neur.  Psychiat,
 1956, 76 :198-204.  Condensed : Am. J. Psychiat, 1956,
 112 ■ 936
Penman,' A.  S., Dredge, T. E. Effect of reserpine and
 open-ward privileges on chronic schizophrenics. A.M. A.
 Arch. Neur. Psychiat, 1956, 76 : 42-49.
 Pennington, V. M.  A comparative  study of six ata-
 raxics in 1130 neuro-psychiatric cases. Mississippi Doc-
 tor, 1956, 33: 336-339.
 Rashkis, H. A., Smarr, E. R.  Drug  and milieu  effects
 with  chronic schizophrenics.   A.  31. A.  Arch.  Neur.
 Psychiat, 1957, 78 : 89-94.
 Rinaldi, F., Rudy, L. H., Himwich, H. E.  Clinical evalua-
 tion of azacyclonol, chlorpromazine, and reserpine on a
 group  of chronic psychotic patients.  Am. J.  Psychiat.,
 1956, 112: 678-683.   Abstract: Excerpta med., Sect. 8,
 1956,9 : No. 4986.
 Rudy,  L. H., Rinaldi, F., Himwich, H. E.  Comparative
 effects of azacyclonol, reserpine, and  chlorpromazine on
 moderately  disturbed psychotic patients with long his-
 tories  of hospitalization.  Psychiat.  Res.  Rep., Wash.,
 1956 (4) : 49-63.
 Ruskin, I. W.,  Avol, M. Rauwolfia tranquilization  for
 the disturbed aged.  J. Am.  Geriat. Soc,  1956, 4:998-
 1003.
 Schneider, G.  Les indications de divers neuroleptiques
 et les  resultats obtenus a la  clinique psychiatrique de
 Lausanne.   [Indications for  various neuroleptic drugs
 and the results  obtained  at  the psychiatric clinic of
 Lausanne.]  Encephale, 1956,45 :1024-1030.
 Schrut, A. H. Controlled study on clinical use of reser-
 pine in psychotic patients with special  comments on
 sources of error.  J. Nerv. 3Ient. Dis., 1955,122 : 513-517.
 Abstract: Excerpta med., Sect. 8, 1957,  10: No. 1533.
 Shepherd, M., Watt, D. C. A  controlled clinical study of
 chlorpromazine and reserpine in chronic schizophrenia.
 J. Neur., Lond., 1956, 19:232-235.                   *
 Sommerness, M. D., Lucero, R. J., Hamlon, J.  S., Erick-
 son, J. L., Matthews, R.  A controlled study of reserpine
 on chronically disturbed patients.  A. 31. A. Arch. Neur.
 Psychiat., 1955, 74: 316-319.   Abstract: Excerpta med.,
 Sect. 8,1956, 9 : No. 3607.
 Swenson, W. M., Gislason,  S., Anderson, D. E.  Be-
 havioral evaluation of chronic mental hospital patients
 treated with reserpine.  A. 31. A. Arch. Neur. Psychiat.,
 1956, 76:60-64.
 Torsegno, M., Zucchi, M. Trattamento di ammalati men-
 tali con un preparato iniettabile di  alcaloidi totali di
 Rauwolfia serpentina Benth.   [Therapy of mental  pa-
 tients with  an  injectable preparation of total alkaloids
 from Rauwolfia serpentina Benth.]  31inerva med., Tor.,
 1955,  46: 604-607.  Abstract: Excerpta med., Sect. 8,
 1956, 9: No. 3087.
 Tripi,  G.  Considerazioni generali  sull'uso della cloro-
 promazina e della reserpina  nel trattamento di circa
 trecento psicopatici.   [Observations on the use of chlor-
 promazine and reserpine in the  treatment of  about 300
 mental patients.]   Rass. neuropsichiat., 1955, 9: 463-
469.  Also:  Arch, psicol. neur. Milano, 1956, 17:635-
 639.
Tuteur, W.  Combined reserpine-chlorpromazine therapy
 in highly disturbed psychotics.  Am.  J. Psychiat, 1955,
 112: 206.  Abstract: Excerpta med., Sect. 8,1956, 9: No.
 2243.
----,  Lepson, D.  Combined reserpine-chlorpromazine
 therapy  in   highly  disturbed psychotics.  In:  Him-
 wich,  H. E., ed. Tranquilizing  drugs.   Washington,
 Am. Ass. Adv. Sc, 1957.  p. 163-172.
----, Stiller, R., Whitehill, O. Treatment of regressed
schizophrenics  with chlorpromazine,  reserpine  and a
 combination of both  drugs.  Dis.  Nerv. Syst,  1957,
18:100-105.
Watt, D. C.   Reserpine  and chlorpromazine in the treat-
ment   of  chronic   schizophrenics.  Encephale,  1956,
45: 661-662.
Wing,  L.  The use of  reserpine in  chronic  psychotic
patients: a  controlled trial.   J. Ment. Sc, Lond., 1956
102: 530-541.                                       * 
Reserpine : Therapeutic studies, controlled —
Psychosomatic diseases
PSYCHOPHARMACA
—Psychosomatic diseases
  Friedman, A. P.  The treatment of headache with  re-
  serpine.  Ann. N. York Acad.  Sc, 1955,  61:276-280.
  Also:  Neurology,  1955,  5: 805-808.   Abstract:   Ex-
  cerpta med., Sect. 8, 1956, 9: No. 1555; 3226.
  Kupperman, H. S., Blatt, M. H., Vosburgh, L. F., Canis,
  J., Wetchler, B.  Effect  of  reserpine,  with or without
  hormonal therapy, upon the  female climacteric.  J. Am.
  Geriat. Soc, 1956, 4: 160-166.                       *
  LeVan, P.,  Wright, E. T. Use of tranquilizers in dis-
  eases of the skin ; a preliminary report.  California 31.,
  1956.  85:87-88.                                     *
  Polak, F.  Uber eine antiallergische Wirkung des  Rau-
  wolfiaalkaloids Reserpin.  [An antiallergic effect of the
  Rauwolfia alkaloid reserpine.]  Schweiz. med. Wschr.,
  1955, 85: 751-752.
  Policzer, M., Szekely, A., Fbldes,  J.  A Rauwolfia ser-
  pentina alkalmazasa a vegetatlv mukodesek regulatio-
  zavaraiban.  [Use of Rauwolfia  serpentina in autono-
  mic disorders.]   Orv. hetil, 1955, 96:548-549.
  Seemann, D.  Erfahrungen fiber Reserpinbehandlung in
  der Geriatrie.  [Reserpine in geriatrics.]  Wien.  med.
  Wschr., 1956, 106 : 930.
  Sellers, A.  M., Hafkenschiel, J.  H.  Sedative and  anti-
  hypertensive effect of intravenous  reserpine  in  man.
  [Abstract]  Fed.  Proc, Bait.,  1954, 13: 404.
  ----,----.  Studies of intravenous reserpine  in  man.
  [Abstract] Am. J. 31. Sc, 1954, 228:114.

Therapeutic use
  Altschule, M. D.  Use of chlorpromazine and reserpine
  in mental disorders.  N. England J. M., 1956, 254: 515-
  519.   Abstract: Chem. Abstr., 1956, 50: 7318a.        *
  Andreev, A.  L.   Olechenii  psikhicheskikh  zabolevanii
  serpazilom.   [Treatment of  mental diseases with ser-
  pasil.]  Zh. nevropat. psikhiat,  3Ioskva, 1956, 56: 294-
  295.   Abstract: Chem. Abstr., 1956, 50:17176gh.
  D'Avossa,  B.  Considerazioni sui trattamento di 102
  pazienti  neuropsichiatrici  con  reserpina.   [Observa-
  tions  regarding reserpine therapy in 102  neuropsychiat-
  ric patients.]   Arch, psicol  neur., 3Iilano, 1956, 17:
  546-558.
  Ayd, F. J., Jr. A critique of chlorpromazine and reser-
  pine therapy.  In: Himwich, H.  E., ed.  Tranquilizing
  drugs. Washington, Am.  Ass. Adv. Sc. 1957. p. 173-181. *
  Ayerbe,  A., Acuna,  M.  Resultados  obtenidos con la
  reserpina en  clinica psiquiatrica.  [Results obtained
  with resperine in psychiatric practice.]  Sem.  me'd., B.
  Air., 1956, 108 : 232-234.
  Beley, A.,  Foncin, J. F., Leyrie,  J.  Quelques incon-
  venients des doses eievees  de reserpine chez  le  jeune
  arriere turbulent;  indications posologiques.   [Compli-
  cations with massive reserpine doses in disturbed re-
  tarded children; dosage indications.]  Ence'phale,  1956,
  45: 802-807.                                        *
  Belsasso, M. Terapia delle malattie mentali con reser-
  pina  (serpasil)  e cloropromazina (largactil) ad alte
  dosi.   [Treatment of mental disorders with high-dosage
  reserpine (serpasil)  and chlorpromazine  (largactil).]
  Rass. giuliana med., Trieste, 1956, 12 : 209-216.       *
  Benassi,  P.,  Fava, D.  Trattamento con  reserpina di
  alcune tossicomanie.   [Reserpine  treatment  of  drug
  addiction.]   [English  summary]   Arch,  psicol.  neur.,
  3Iilano, 1956, 17 : 601-607.                           *
  Benedetti, G.  Terapia reserpinica in psichiatria.   [Re-
  serpine therapy  in  psychiatry.]   [English  summary]
  Arch, psicol. neur., 31ilano,  1956, 17: 295-309.
  Bennett, A. E.  Clinical trial of reserpine in psychotic
  and  psychoneurotic illnesses.  In: Kline,  N.  S.,  ed.
  Psychopharmacology.   Washington, Am. Ass. Adv. Sc,
  1956.   p. 109-117.
  Berthiaume,  M.  Actualites therapeutiques  en neuro-
  psychiatrie; la reserpine (serpasil).   [Therapeutic ad-
vances in neuropsychiatry; reserpine  (serpasil).]   Un-
ion mCd. Canada, 1956, 85:1039-1042.
Bleuler, M.   Comparaison entre les effects de la chlor-
promazine et de la reserpine en  psychiatrie.  [Com-  ;
parison between  the effects of chlorpromazine and re-
serpine in psychiatry.]   Ence'phale, 1956,  45:334-348.
----,  Stoll, W. A. Clinical use of reserpine in psychia-
try: comparison  with chlorpromazine.  Ann. N. York
Acad. Sc, 1955, 61:167-173.   Abstract:  Excerpta med.,
Sect.  8. 1956, 9: No. 4080.
Boon, A. A.  Largactil en verwante middelen in de
psychiatrie en neurologie.  [Largactil  and related reme-  ,
dies in psychiatry and neurology.]  Ned. tschr. geneesk.,
1955,  99: 2735-2741.
Bordeleau, J. M.  Clinical evaluation of  chlorpromazine  ,
and Rauwolfia serpentina in the psychiatric department  :
of a general hospital. J. Florida 31. Ass., 1956, 42: 547-
554.
Borenstein, P., Dabbah, M., Bare,  D.  Contribution a
Tetude de la reserpine  en psychiatrie;  resultats clini-
ques  et  eiectro-encephalographiques.  [Research  on  '
reserpine in  psychiatry;  clinical and  electroencephalo-  :
graphic results.]   Ann.  med. psychol,  Par.,  1956,  114
(1) : 545-580.  Abstract: Excerpta  med., Sect.  8, 1957,
10: No. 1532.                                          ;
Bosinelli, M.  Reserpina  e reserpina associata  a cloro-  ■
promazina in  neuropsichiatria infantile.   [Reserpine
and reserpine combined with chlorpromazine in child  :
neuropsychiatry.]  Arch,  psicol.  neur., 3Iilano,  1956,  :
17: 478-479.
Bukowczyk, A.   O zastosowaniu  leczniczym  rezerpiny
(serpasilu)   w psychiatrii;  streszczenie  przegladowe.
[Therapeutic application of reserpine  (serpasil) in psy-  ,
chiatry.]  Neur. dc polska, 1956, 6 : 73-80.
Clough, P. W.  Reserpine in the  treatment  of neuro-
psychiatric disorders. Ann. Int. 31., 1955, 43 : 632-637.
Coirault, R., Girard, V., Benoit, P.  Utilisation du  ser-
pasil  en neuro-psychiatrie.  [Use of serpasil in neuro-
psychiatry.]  Bull. Soc. med. mil fr.,  1955, 49: 249-250.  ,
Abstract: Presse med., 1956. 64: 315.
Colombati, S., Benassi, P.  Impiego de un alcaloide della  .
Rauwolfia  in neuropsichiatria.   [Use of  a  Rauwolfia  !
alkaloid in neuropsychiatry.]   Gazz. med. ital, 1954,
113: 301-303.
De Busscher, J.  Impressions  personnelles  sur  les
effets de l'atarax, de la chlorpromazine, de la reserpine  1
et du AY 5406-1 (parasan) en therapeutique psychia-  '
trique.   [Personal impressions  of atarax,  chlorproma-
zine,  reserpine and AY 5406-1 (parasan) in psychiatric
therapy.]  Encephale, 1956, 45:1007-1023.
De Falco, A., Grassi, B.  La reserpina nel trattamento
delle  malattie mentali.   [Reserpine in the treatment of
mental diseases.]  Arch,  psicol.  neur., 3Iilano, 1956,
17: 432-438.
Delay, J., Deniker, P. Chlorpromazine  and neuroleptic
treatments in  psychiatry.  J. Clin. Exp.  Psychopath.,
1956,  17: 19-24.
----,  ——.   Peut on comparer la reserpine a la chlor-
promazine?  [Can one compare reserpine with chlor-
promazine?]   Arch, psicol. neur., 3Iilano, 1956, 17 : 631-
633.
----,  ----,  Tardieu,  Y.,  Lemperiere, T.  Medicaments
et cures neuroleptiques en theapeutique psychiatrique:
premiers  essais de la reserpine;  comparaison  avec les
effets de la  chlorpromazine.   [Drugs and neuroleptic
therapies in the treatment of psychiatric diseases;  first
trials with reserpine;  comparison with the effects of
chlorpromazine.]  Presse med., 1955, 63:663-665.
----.  ----, ----, ----.   Premiers  essais  en therapeu-
tique psychiatrique de la reserpine alcaloide  nouveau
de "Rauwolfia serpentina." [First investigations on the
use of reserpine, a new alkaloid of "Rauwolfia serpen-
tina" in psychiatric therapy.]  [Abstract]   Ann. me'd.
psychol, Par., 1954, 112 (2) : 448.
148 
SUBJECT LIST
Reserpine : Therapeutic use
 ---. ----, Wiart, C.  Complements a notre experience
 de la  reserpine.   [Additional  experiences with reser-
 pine.]  Encephale, 1956, 45:1042-1048.
 Delgado Roig, J., Franco Hernandez, M.  El uso de la
 reserpina en la clinica psiquiatrica; nota previa.  [Use
 of reserpine  in psychiatric  practice; preliminary re-
 port.]   [English  summary]  Hispalis med., 1955, 12:
 507-512.
 Deniker,  P.  Hibernotherapies  et medicaments neuro-
 leptiques en  therapeutique  psychiatrique.   [Hiberno-
 therapies and neuroleptic drugs in psychiatric therapy.]
 Encephale,  1957, 46 : 281-398.
 Donnelly,  J., Zeller,  W.   Clinical research on chlor-
 promazine and reserpine in state and private psychiatric
 hospitals; a comparative review of  the clinical prob-
 lems.  J. Clin. Exp. Psychopath., 1956, 17 :180-188.
 Donini, F. M., Belsasso, M.,  Ravis,  E.  Risultati tera-
 peutici ottenuti con il serpasil in 15S ammalati  mentali.
 [Therapeutic results of serpasil in 158 mental patients.]
 Arch,  psicol. neur., 3Iilano, 1956, 17:394-398.
 Dubansky,  B.  Neue  Wege  in  der Behandlung  der
 Chorea minor.  Vorlaufige Mitteilung.  [New  methods
 of  treating  chorea  minor.    Preliminary   report.]
 Schweiz. med. Wschr., 1956, 86: 122-123.
 Ederle, W.  Zur zentralnervosen  Wirkung des Serpasil.
 [Effects of serpasil on the  central nervous  system.]
 Nervenarzt, 1956, 27: 33.
 Erdmann, C. E.  Neues fiber  die Rauwolfia-Behandlung
 unter  besonderer Berficksichtigung der Literatur in den
 USA.  [Review of Rauwolfia  therapy with special refer-
 ence to  literature in the United States  of  America.]
 Nervenarzt, 1956,  27 : 75-79.
 Faure, J. L., Abric, J. Remarques cliniques sur les indi-
 cations valables de la chlorpromazine et de la reserpine
 en neuro-psychiatrie  infantile.   [Clinical remarks on
 the indications for the use of chlorpromazine and reser-
 pine in child neuro-psychiatry.]   Pe'diatrie, 1956, 11:
 773-776.
 Fazekas, J. F.. Shea, J. G, Sullivan, P. D., Jr.  Atarac-
 tics in medical practice.  GP, 1956,  14  (6) : 75-81.
 Finke, H.   Beitrag zur Reserpine-Therapie in  der Psy-
 chiatrie.   [Contribution to reserpine therapy in psy-
 chiatry.]   [English  summary]   3Iunch. med. Wschr.,
 1956, 98: 872-.S74.
 Freed, H.   Chlorpromazine and  reserpine;  new era in
 psychiatry?  Am.  Practitioner,  1955, 6:706-708.
 Freeman, H.   A  critique of the tranquilizing drugs,
 chlorpromazine  and   reserpine,   in neuropsychiatry.
 N. England J. 31., 1956, 255 : 877-883.
 Freyhan,  F. A.  Psychomotility  and parkinsonism in
 treatment   with neuroleptic  drags.  A. M. A.  Arch.
 Neur. Psychiat., 1957, 78: 465-472.
 Galioni, E. F.  Reserpine and chlorpromazine,  their use
 in alcoholic and geriatric patients.  California 31., 1956,
 85:97-99.
 Garavaglia, G., Negri, V. U.   L'uso della  reserpina
 negli state di eccitamento psichico.   [Use of reserpine
 in psychic  excitation  states.]   [English  summary]
 Arch, psicol. neur., Milano, 1956,17 : 376-387.
 Garcia, J. A., Ferreira, L. R.   Investigagoes terapguticas
 com  um   dos  alcaloides  da  Rauwolfia  serpentina.
 [Therapeutic  tests of one of the Rauwolfia serpentina
 alkaloids.]  [English  summary]  Rev.  brasil.  med.,
 1955, 12: 291-294.
 Gherarducci, D.  A propos de Tutilisation de la chlor-
 promazine associee a d'autres  therapeutiques  psychia-
 triques.  [Utilization   of  chlorpromazine  associated
 with other psychiatric therapeutics.]  Ence'phale, 1956,
 45:1187-1189.
 Giberti F.,  Garello, L.  Risultati del trattamento con
 reserpina in psichiatria.  [Results of reserpine therapy
 in  psychiatry.]   [English  summary]   Sistema  nerv.,
Milano, 1955, 7 : 29-42.  Abstract: Excerpta med., Sect.
8,1956,9 : No. 4079.
Gliedman, L. H., Gantt, W. H.  The effects of reserpine
and chlorpromazine on orienting behavior and retention
of conditioned reflexes.  South. 31. J., 1956, 49: 880-889.
Gomes d'Araujo, H., Jr.   Utilizagao da reserpina (ser-
pasil)   em  neuro-psiquiatria.   [Reserpine   in  neuro-
psychiatry.]  3Iedico, Nova Goa, 1955, 6: 656-669.  Ab-
stract : Excerpta med., Sect. 8,1956,9 : No. 1223.
Gomirato, G.   Le applicazioni della cloropromazina e
della  reserpina al vaglio di due  riunioni.  [Uses of
chlorpromazine and reserpine as evaluated by two  as-
semblies.]  3Iinerva med., Tor.,  1955, 46:1449-1452.
Gosline, E., Kline, N. S.  Use of reserpine on an admis-
sion service.  Psychiat.  Res. Rep., Wash.,  1955 (1) :
112-121.                                           *
Grandon, R. C, Heffley, W., Hensel, T., Bashore, S.   A
new medical adjunct to the treatment of alcoholism ; the
use of reserpine (serpasil).   Am. Practitioner, 1956, 7:
231-234.
Greenfield, A. R.  A new type of sedation for the acute
alcoholic.  Am. Practitioner,  1956,   7:241-244.  Ab-
stract:  Year book of drug therapy, 1956-1957, p. 337-
338.
Grenier, J., Larue, G. H., Parent, R., Turmel, J.   La
reserpine en psychiatrie.   [Reserpine in psychiatry.]
Laval me'd., 1956, 21:181-189.
Haight,  J.  Newer drug  therapies.  Dis. Nerv.  Syst,
1956,17: 295-296.
Hes, J.  P., Bracha, S.  [Reserpine in psychiatric treat-
ment.]   [English  abstract]  Harefuah, Tel-Aviv, 1956,
51: 101-106.
Hilliard, E. T.  The use  of reserpine, chlorpromazine
and allied drugs in  medicine and psychiatry.  Med. J.
Australia, 1956,43  (1) : 1035-1040.
Hoch, P. H. Progress in psychiatric therapies.  Am. J.
Psychiat., 1955,112 : 241-247.
Hoff,  H.  Advantages and disadvantages of treatment
with chlorpromazine and serpasil. Ence'phale, 1956, 45:
352-358.
---.  Vorteile  und  Nachteile  der   Behandlung  mit
Largactil und Serpasil.  [Advantages and disadvantages
of therapy with largactil and with  serpasil.]   Wien.
klin. Wschr., 1956, 68: 97-101.
Hoffman, J. L.  General summary  to: Chlorpromazine
and  reserpine; symposium  on  experiences  at  Saint
Elizabeths Hospital.  31ed. Ann. District of Columbia,
1956, 25 : 267-268;  298.                              *
Howard, J. C, Jr., Vinci, F. J.  Use of the tranquilizing
properties of reserpine;  a review.   Internat.  Rec M.,
1956,169: 213-221.
Jensen,  E. S.  Serpasilbehandling pa andssvagehospital.
[Serpasil therapy  in a hospital for the mentally defi-
cient.]  Ugeskr. laeger, 1955,117 :1463-1465.
Kinross-Wright, V.  A review  of the  newer drug ther-
apies  in psychiatry. Dis. Nerv. Syst,  1956, 17:187-
190.
----.  The uses and limitations of the newer drugs in
the treatment of nervous  conditions.   Wisconsin M. J.,
1956, 55: 1073-1078.
Kirk,  D. L., Bauer, A. M.  Effects of reserpine (serpa-
sil) on  emotionaly maladjusted high  grade mental re-
tardates.  Am. J.  3Ient. Defic, 1956, 60: 779-784.  Ab-
stract :  Excerpta med., Sect. 8, 1957, 10:  No. 152S.   *
Kirkpatrick,  W. L., Sanders,  F.  Clinical  evaluation
of reserpine in a  state hospital.  Ann. N.  York Acad.
Sc, 1955, 61:123-143.
Kline, N. S., Saunders, J. C.  Reserpine in psychiatric
and neurologic disorders.  Med. Clin. N. America, 1957,
41: 307-326.                                        *
---,  Stanley, A. M. Use of reserpine in a  neuropsy-
chiatric  hospital.    Ann.  N.   York  Acad.  Sc,  1955,
61: 85-91.  Abstract: Excerpta med., Sect.  8, 1956, 9:
No. 1230.                                          * 
Reserpine : Therapeutic use
PSYCHOPHARMACA
Labhardt,  F.  Einige allgemeine  und  psychiatrische
Gesichtspunkte  zur  Behandlung  mit neuroplegischen
MediUamenten.   [General  and psychiatric  views  on
therapy with neuroplegic drugs.]   [Short English sum-
mary] Dermatologica, Basel, 1955, 111:177-185.
Lambros, V. S.  The use of reserpine in certain neuro-
logical disorders; organic convulsive states, enuresis,
and head  injuries.  Ann.  N. York  Acad.  Sc,  1955,
61:211-214.  Abstract:  Excerpta  med., Sect. 8,  1956,
9:  No. 2481.
Landgrebe,  B.  Uber Erfahrungen mit Reserpin (Seda-
raupin)  in der  psychiatrischen Klinik.  [Experience
with reserpine (sedaraupin) in a psychiatric hospital.]
Medizinische, 1955: 610-613.
Le  Guillant, L.,  Roelens,  Corre,  Kestenberg, Plichet,
Bequart,  Bailly-Salin.   Quelques   remarques  method-
ologiques sur  Taction  des neuroleptiques.  [Certain
methodological considerations  on  the action of neuro-
leptic drugs.]  Ence'phale, 1956, 45:1128-1135.
Luttrell, R. R., Morrison, A. V.  A preliminary report
on  the tranquilizing effect of reserpine.  Ann. N. York
Acad. Sc, 1955, 61:183-187.  Abstract: Excerpta  med.,
Sect. 8,1956, 9: No. 4078.
Ma, J., Crandell, A.  The use of reserpine in the treat-
ment of mental  patients  who are  tuberculous.  Am.
Rev. Tuberc, 1956,  74:457-461.
Macias Castro, I. Notas terapeuticas: uso y abuso de
la Rauwolfia serpentina.  [Therapeutic notes: use and
abuse  of Rauwolfia serpentina.]   Arch.  Hosp. univ.,
Habana, 1955, 7:  61-65.                             *
Margolis, L. H.   Pharmacotherapy in psychiatry; a re-
view.  Ann. N. York Acad. Sc, 1957, 66: 698-718.
Martelli, G.  Azione della reserpina a dosi terapeutiche
sulTelettroencefalogramma  di malati mentali.   [The
effects of reserpine therapy on the EEG of mental pa-
tients.]  [English  summary]   Gior. psichiat.,  1956,
84: 323-335.
Mathis, M.   Toniques et sedatifs en neuro-psychiatrie
infantile.  [Tonics  and  sedatives  in  child  neuro-
psychiatry.]  Pe'diatrie, 1956, 11: 807-820.
Maurel, H., Wilhelm, Spielmann, J. P. Les indications
psychiatriques de  la reserpine.    [Psychiatric indica-
tions for reserpine.]  Encephale,  1956, 45 :1049-1055.
Menger,  P.   Serpasil et sclerose en plaques.  [Serpasil
and multiple sclerosis.]  Ann.  me'd. psychol, Par., 1956,
114 (2) : 886-890.
Miksztal, M. W.  Chlorpromazine  (thorazine) and re-
serpine in  residential  treatment  of neuropsychiatric
disorders  in children.  J.  Nerv.  31ent.  Dis.,  1956,
123: 477^79.
Milli, N., Marzi,  F.   II serpasil nelle malattie mentali.
[Serpasil in mental disease.]  Riv.  pat. nerv.,  1956,
77: 502-505.
Morgan,  D. R.  The use of reserpine, chlorpromazine
and allied drugs in medicine and psychiatry.  Med. J.
Australia, 1956, 43  (1) :  1029-1035.                  *
Noce, R. H., Williams, D. B., Rapaport, W.  Reserpine
(serpasil)  in the management of the mentally ill.   J.
Am. M. Ass., 1955, 158:11-15.
---,  ----, ----.   Reserpine (serpasil) in the manage-
ment of  the mentally ill and  mentally  retarded; pre-
liminary report.   J.  Am. M. Ass.,  1954,  156: 821-824.
Abstract: Excerpta med., Sect. 8,  1956, 9: No. 1222.
Overholser, W.   Chlorpromazine and reserpine in psy-
chiatric practice.  Postgrad. M., 1956, 19 : 346-349.
----.   La chlorpromazine, ouvre-t-elle une 6re nouvelle
dans les hopitaux psychiatriques?  [Chlorpromazine—
the beginning of a new era in psychiatric hospitals?]
Encephale, 1956,  45 : 313-319.
----.   Has  chlorpromazine inaugurated a new era  in
mental  hospitals?   J.  Clin.  Exp.  Psychopath.,  1956,
17:197-201.
Parsons, E.  H.  New chemical agents  in psychiatry.
Postgrad. M., 1955,18:193-198.
Pennington, V.  M.  Research findings in phrenotropic
drugs important to  every  physician.  Mississippi Doc-
tor, 1957, 35: 57-63.
----.   The use of reserpine (serpasil) in three hundred
and fifty neuropsychiatric cases.  Psychiat. Res. Rep.,
Wash., 1955 (1) : 105-111.                           *
Pisani,  D.,  Micalizzi,  F.,  Motta,  E.  Rilievi  clinici
sull'impiego della reserpina in  psichiatria.   [Clinical
results  with reserpine in  psychiatry.]  Pisani, 1955,
69 (2) : 85-102.   Abstract: Excerpta med., Sect. 8, 1956,
9: No. 4548.
---,  ----, ----.  Risultati benefici sui  deterioramento
mentale patologico (DMP), in seguito a trattamento con
reserpina  (serpasil).  [Good  results with  reserpine
(serpasil) in  mental deterioration.]  Pisani, 1955, 69
(2) :  103-114.  Abstract: Excerpta med., Sect. 8, 1956,
9: No. 4081.
Pollack, B.  Mental illness.  3Ied. Times, Great Neck,
1955, 83:439-450.
Rea, E. L., Fazekas, J. F.  Effects  of parenterally ad-
ministered reserpine.  A.  M. A.  Arch. Int.  M., 1955,
95: 538-539.
Reserpine and the mind.  Lancet, Lond., 1955, 2:330-
331.
Richman, A., Tyhurst,  J.  S.  An extrapyramidal syn-
drome with reserpine. Canad. 31. Ass. J., 1955, 72: 457-
458.
Rossi, M.  Moderne terapie  psichiatriche a base di
ganglioplegici e di alcaloidi della Rauwolfia serpentina.
[Modern psychiatric therapy with ganglioplegics  and
Rauwolfia  serpentina alkaloids.]  Arch, psicol. neur.,
3Iilano, 1956, 17 : 642-644.                           *
Roxo, H.  Tratamento  moderno das  doengas mentais.
[Modern therapy of mental diseases.]  Arq. brasil. med.
nav., 1956, 17 : 4153-4162.
Sacerdoti, G., Vegro, G.  La reserpina  in psichiatria
infantile.   [Reserpine in child psychiatry.]   [English
summary]   Arch, psicol.  neur., 3Iilano,  1956, 17:459-
477.
Safe dosage levels in reserpine.   Am. J. Psychiat., 1956,
113: 376-377.                                       *
Sainz, A. A.  Considerations on  the cerebral action of
reserpine.  In:  Kline, N. S., ed.  Psychopharmacology.
Washington, Am. Ass. Adv. Sc, 1956.  p. 59-63.
---.  The management of side effects of chlorproma-
zine and reserpine.  Psychiat.  Q., 1956,  30: 647-653.  *
Santangelo, F.  Effetti terapeutici del serpasil su un
gruppo di malati mentali.   [Therapeutic effects of ser-
pasil in a group of mental patients.] Arch, psicol. neur.,
3Iilano, 1956, 17 : 408-411.
Sargant, W.   On chemical tranquillizers.  Brit. 31. J.,
1956,  1:939-943.                                   *
Schiele,  B.  C, Anderson, R. W„ Simon, W.  Current
status of chlorpromazine and  reserpine in psychiatric
practice.  J. Lancet, 1956, 76 :179-185.              *
Schmitt, R. J.  The psychodynamics of the tranquilizing
agents. Psychiat. Q., 1957,31:17-30.
Shapiro, J.  Serpasil—its use as a sedative  in  certain
disturbed mental patients.  J.  Oklahoma 31. Ass., 1955,
48:171-173.   Abstract: Excerpta med., Sect.  8, 1956,
9: No. 1731.
Steelman, H. F.  The use of serpasil for restlessness in
acute closed head injuries: a preliminary report.  Ari-
zona M., 1955,12: 22.
Struck, G. Zur Rauwolfia-Therapie in der Psychiatrie;
vorlaufige  Mitteilung fiber  65  behandelte  Patienten.
[Rauwolfia  therapy in psychiatry; preliminary report
on 65 treated  patients.]   Nervenarzt, 1956,  27: 79-82.
Tolsma,  F. J.   Les  neuroleptiques et le problemes  de
Tadaptation  humaine.  [Neuroleptic  drugs  and  the
problem of  human  adaptation.]  Ence'phale,  1956, 45:
1141-1149.
150 
SUBJECT LIST
Reserpine : Therapeutic use — Additional data
  Tourney, G., Isberg, E. M., Gottlieb, J. S.  The use of
  reserpine in  an acute psychiatric treatment  setting.
  A. 31. A. Arch. Neur. Psychiat., 1955, 74: 325-328.  Ab-
  stract: Excerpta med, Sect. 8, 1956, 9: No. 3088.     *
  Tyhurst, J. S., Richman, A.  Clinical  experience with
  psychiatric  patients on reserpine-preliminary  impres-
  sions.  Canad. M. Ass. J., 1955, 72: 458-459.
  ---,----.  An evaluation of the clinical significance of
  reserpine.  J. Nerv. Ment. Dis., 1955,  122: 492-495.  *
  Villien, L. M. The use of reserpine in the treatment of
  disturbed geriatric  patients.  J. Louisiana 31. Soc, 1956,
  108:126-129.
  Visintini, F.  Cloropromazine  e reserpina in psichiatria.
  [Chlorpromazine and  reserpine in psychiatry.]  [Eng-
  lish summary]   Arch, psicol.  neur.,  31ilano, 1956,  17:
  611-621.
  Voelkel,  A.  Beitrag  sur  Sedaraupin-Therapie   bei
  psychisch Kranken.   [Sedaraupin therapy of mental
  patients.]  3Iedizinische,  1955 : 227-228.
  ---.   Zur Reserpin-Therapie bei psychisch Kranken.
  II. [Reserpine therapy of mental disorders. II.] Deut.
  med. J., 1956, 7 : 72-74.
  Wallis,  I.  Ueber   Sedaraupin-Therapie  bei  cerebral
  geschadigten Kindern. [Sedaraupin therapy of brain-
  damaged children.]  Med. Klin.,  Berl, 1956, 51: 2221-
  2223.  [Not seen]
  Walther-Biiel, H. L'action des medicaments neurolepti-
  ques dans la maladie de Huntington.   [Effect of neuro-
  leptic drugs on Huntington's chorea.]   Encephale, 1956,
  45: 771-772.
  ---.  Das  neuroplegische  Prinzip  in  pharmakopsy-
  chiatrischer  Betrachtung.  [The neuroplegic principle
  in pharmacopsychiatric considerations.]   [Brief Eng-
  lish summary]  Mschr. Psychiat., Basel, 1955, 129: 286-
  296. Abstract: Excerpta med., Sect. 8,1956, 9 : No. 3891.
  ---.  Zur  Serpasil-Behandlung neuropsychiatrischer
  Zustande.  [Serpasil therapy for neuropsychiatric con-
  ditions.]  Praxis, Bern, 1956, 45: 733-736.         * *
  Watkins, C.  The  use of reserpine  in cerebral palsy.
  South. M. J., 1956, 49 : 1488-1494.
  Zimmerman, F. T., Burgemeister, B.  B.   Preliminary
  report upon the effect of reserpine on  epilepsy and be-
  havior problems  in children.   Ann. N. York Acad.  Sc,
  1955, 61: 215-221.                                  *

—Additional data
Fabing, H. D.  The ataractic drugs: their uses and lim-
itations in psychiatry.  Am. Profes. Pharmacist, 1956,
22:413-418.
----.   The new pharmacologic attack in psychiatry.
Internat.  Rec M.,  1956,  169:177-183.   Also:  Drugs
d Cosmet. Indust, 1956, 78: 32-33; 125-129.          *
----.   Trends in biological research  in  schizophrenia.
J. Nerv. Ment. Dis., 1956,124:1-7.
Feldman,  D. J. Drug  therapy of chronic alcoholism.
Med. Clin. N. America, 1957, 41: 381-392.
Fremming, K. H.  Medikamentel behandling af synds-
sygdomme.   [Medical treatment of mental disorders.]
31skr. prakt.  laegegern., Kbh., 1956, 34: 331-342.
French, E. G.  Epilepsy.  Am. J. Psychiat., 1957, 113:
629-631.
Freyhan,  F.  A., Turner,  P.,  Stenzler, R.  New drug
therapies  in psychiatry.   Delaware  M.  J.,  1956,  28:
180-186.
Graffagnino,  P. N., Furr, J. H.  New drugs in the treat-
ment  of emotional  disorders; a review.  Connecticut
31. J., 1957, 21: 38-43.
Graves, C. C.  Drug therapy for  the emotionally and
mentally disturbed;  the  psychiatrist's point of view.
J. Iowa 31. Soc, 1957, 47 :15-16.
Green, A.  Actualites therapeutiques 1955 en psychia-
trie.  [Therapeutic  progress  in psychiatry  in 1955.]
Ence'phale, 1956, 45:172-200.
Kautz, H. D.  Trends in  drug therapy.   Hosp.  Progr.,
1957, 38 (1) : 102-108; 126.
Keyes,  B. L.  Ataraxic  drugs.  Pennsylvania  M.  J.,
1957, 60:177-181.
Kline,  N.  S.   Chemotherapy in psychiatry; recent ad-
vances. Seminar  Internat.,  Hoddesdon,  1956, 5  (2)  :
7-10.                                               *
Laboucarie, J, Barres, P.,  Rascol, A.  Aspects princi-
paux des  cures neuropiegiques en psychiatrie en 1956.
[Principal features of neuroplegic therapy in psychiatry
in 1956.]  Toulouse med., 1956, 57: 851-867.
Liberson, W. T. The new tranquilizing drugs.  1. Neu-
ropsychiatric aspects.  Am. J. Nurs., 1955, 55:1465-
1467.
Martin, D. A.  The therapeutic and toxic effects of tran-
quilizing drugs: medical aspects.  North Carolina 31. J.,
1956, 17: 396-401.
Overholser, W. Introductory remarks [to: Chlorproma-
zine and reserpine;  symposium on experiences at Saint
Elizabeths Hospital.]  Med. Ann. District of Columbia,
1956, 25: 255.
Puca, A. Ibernoterapia, sonno prolungato e neuroplegici
in terapia psichiatrica.   [Hibernation, prolonged sleep
and neuroplegic drugs in psychiatric treatment.]  Rass.
internaz. clin. ter., 1955, 35 : 805-809.
----.   Nuove acquisizioni in terapia psichiatrica; iber-
noterapia,  sonno prolungato e neuroplegici.  [New  ac-
quisitions in  psychiatric therapy; artificial hibernation,
prolonged  sleep  and  neuroplegic drugs.]   [English
summary]   Rass.  stud,  psichiat,  1955,  44:849-856.
Also: Ann. med. nav.,  Roma, 1956, 61:42-49.
Sebrell, W. H., Jr.   Chemistry in chronic disease  re-
search. Chem. Eng. News, 1955, 33:1856-1860.
Smith, L. H.  Progress  in psychiatry. J. Am.  M. Ass.,
158: 46-47.
Spencer, R. S.  The use  of ataraxic drugs  in mental
illness.  Hawaii M. J., 1957, 16 : 302.
Tice, L. F. Some important drug developments of 1956.
Am. J.  Pharm., 1956, 128: 398-409.                   *
Stimulants and depressants.  Brit. M. J., 1956, 1: 969-
970.
Tranquillizers.  Scot. 31.  J., 1957, 2: 46-47.
Treatment of  alcoholics with  reserpine.  Alcoholism
Treatment Digest, New  Haven, 1956 (30) : 2-4.
West, L. J., Swegan, W. H. An approach to alcoholism
in the military service.  Am.  J. Psychiat.,  1956, 112:
1004-1009.   Abstract:  Excerpta  med.,  Sect.  8,  1957,
10: No. 918.
 Alexander, L.  Therapeutic process in electroshock and
 the newer drug therapies ; psychopathological considera-
 tions.  J. Am. 31. Ass., 1956, 162: 966-969.            *
 ---.  Objective  approaches to treatment in psychiatry.
 Canad. Psychiat. Ass. J., 1957, 2: 77-94.              *
 Allen, E. B., Prout,  C. T.   Alcoholism.   Progr.  Neur.
 Psychiat., N. Y., 1956, 11: 338-351.
 Bell, J. P.  Magic drugs in psychiatry.  J. Kentucky 31.
 Ass., 1954, 52 : 788-789.
 Bleuler,  M.  Fortschritte in der Behandlung von Erre-
 gungszustanden.   [Progress in the treatment of excita-
 tory states.]   [Abstract]  Praxis, Bern, 1954, 43 :1030.
 Block, M. A. Medical treatment of alcoholism. J. Am.
 31. Ass., 1956,162 : 1610-1619.
 Cant, G.  New medicines for the mind; their meaning
 and  promise.  26p.  New  York,  Public  Affairs  Com-
 mittee, 1955.
 Cohen, I. M.  Drugs recently introduced  in the  treat-
 ment of  psychiatric disorders.  Texas J. M., 1956, 52:
 683-687.    '                  „  r
 Davis, W. A.,  Severinghaus, E.  L. Drug  therapy  in
 psychiatry and neurology;  medical and pharmacologic
 aspects.  J. M. Soc. N. Jersey, 1956, 53:18-22.
 Dellaert, R.  De modernste chemopharmaca in de psy-
 chiatrie'  [New   chemical   psychopharmaca.]  Belg.
 tschr. geneesk., 1956, 12 : 314-321.
 Doyle  F J.  New drugs in mental therapy and the im-
plications of their use.  Hosp.  Progr., 1955, 36 (3) :
50-51. 
Reserpine : Therapeutic use — Literature surveys
PSYCHOPHARMACA
—Literature surveys
  see RESERPINE—Bibliographies and literature sur-
      veys

—Neuroses
  Arnot, R.  The place of sedatives in the treatment of
  psychoneurotics.   Am.  J.  Psychiat,  1956,  113:10-15.
  Abstract: Excerpta med., Sect. 8, 1957, 10:  No. 392.
  Ayd, F. J., Jr.  Tranquilizing drugs in private practice.
  N. York State J. 31., 1957, 57: 1742-1747.             *
  Azima,  H.  The  use  of chlorpromazine and reserpine
  in psychological disorders in general practice.  Canad.
  M. Ass. J., 1956, 74: 929-931.
  ---,  Kent, I., Cleghorn,  R.  A.  Rauwolfia alkaloids
  in mental syndromes.  Canad. 31. Ass. J., 1955,  73: 866-
  871.                                                *
  Berger, H.  Management of neuroses by the internist
  and general practitioner.  N. York State J. 31., 1956, 56:
  1783-1788.
  Braun, M., Philipsborne, A. Ataractics in private prac-
  tice.  Am. J. Psychiat., 1956, 113: 80-81.
  Bross, R. B.  Near fatality with combined ECT  and
  reserpine.  Am.  J. Psychiat, 1957, 113: 933.
  Chertok,  L.   A  propos de  Temploi  de  medicaments
  neuroleptiques dans le  traitement des  psychonevroses.
  [Neuroleptic drugs in the treatment of psychoneuroses.]
  Encephale, 1956, 45 : 705-706.
  Coirault, R, Girard, V., Benoit, P.  Utilisation du  ser-
  pasil  en neuropsychiatrie.  [Use of serpasil in neuro-
  psychiatry.]  Bull. Soc. me'd. mil. fr., 1955, 49:249-250.
  Abstract: Presse me'd., 1955, 64: 315.
  Drake, F. R.,  Ebaugh, F. G.  The use of reserpine in
  office  psychiatry: preliminary report.  Ann. N. York
  Acad. Sc, 1955, 61:198-205.  Abstract: Excerpta med.,
  Sect. 8, 1956, 9: No. 1226.
  Dunlop, D. M. The barbiturates and other sedatives.
  Practitioner, Lond., 1957, 178: 26-32.                 *
  Durlach, J. Traitement de la maigreur  par la  reser-
  pine.   [Treatment  of  underweight  with  reserpine.]
  Concours me'd., 1956, 78: 725-728.  Condensed : Bull. Soc.
  me'd. h op. Paris, 1956, 72: 165-168.
  Gilardi, A.  Neuartige  sedative Therapie bei  Verhal-
  tensstorungen im Kindesalter.   [New sedative  therapy
  of behavior disorders in children.]  Praxis,  Bern, 1956,
  45:993-995.
  Gomirato,  G.  L'azione  della  cloropromazina  e della
  reserpina  su  alcune manifestazioni  sintomatologiche
  delle psiconevrosi.  [Action of chlorpromazine and re-
  serpine on symptomatologic manifestations  of psycho-
  neuroses.]   [English  summary.]  Arch,  psicol  neur.,
  Milano, 1956, 17: 531-543.
  Grimshaw, J.  A.  Chlorpromazine and reserpine; lim-
  itations of their  use  in office practice.  J.  Kansas M.
  Soc, 1956, 57: 687-689.                              *
  Heilbrunn, G.  Selection  of patients for modern psy-
  chiatric pharmacotherapy in general practice.   North-
  west M., 1956, 55 :1198-1205.
  Held,  R.  Sur la chlorpromazine et les medicaments neu-
  roleptiques; incidences  psychotherapeutiques.  [Chlor-
  promazine and  neuroleptic  drugs;   psychotherapeutic
  incidences.]  Ence'phale,  1956, 45:1000-1004.
  Hoch, P. H.  New drug therapy in psychiatry: clinical
  uses and  abuses  in mental disorders.  Bull. N.  York.
  Acad. 31., 1957, 33: 474-486.                         *
  ----.   Practical and theoretical applications of the new
  drug  therapies in psychiatry.   A.  M.  A. Arch.  Neur.
  Psych iat„ 1956, 75 : 325-328.                         *
  Hollister, L. E.  Tranquilizing drugs and the generalist.
  Med. Times, Great Neck, 1956,  84: 1021-1026.        *
  Hubbard,  O. E. Glasser, J.  Newer psychotropic drugs;
  their  characteristics  and  use  in   general  practice.
  Northwest M., 1956, 55 :1191-1197.
  Hutchinson, J. T.  The value of drugs in the treatment
  of neuroses.  3Ied. lllust, Lond., 1956, 10:541-544.
  Lemere, F.   New tranquilizing drugs.  Northwest  M.,
  1955, 54:1098-1100.                         .     J  *
  Macchi, G.,  Manghi, E., Saginario,  M. L'impiego della
  reserpina in  narcoterapia;  primi  risultati.  [Use  of
  reserpine in sleep therapy ; first results.] Gior. psichiat,
  1954, 82: 1130-1134.
  Ostenfeld,  I.  Psykiske  urotilstande.   [Mental excite-
  ment.]  [English summary]   Nord. med., 1955, 54:1517-
  1522.
  Sacerdoti, G., Mantelli, A.  La reserpina nel tratta-
  mento  ambulatoriale nei disturbi del comportamento
  nell'infanzia.  [Reserpine in the ambulatory treatment
  of behavior  disorders  in childhood.]   [English  sum-
  mary]   Gazz. med. ital, 1955, 114:189-191.
  Shankel, L. W.,  Whittier, J. R.  Effects  of reserpine
  therapy on Funkenstein test reactions in  maladapting
  patients.  Dis. Nerv. Syst, 1956, 17: 258-261.
  Simko, A., Erzsebet, B. S.  Das Reserpin (Sedaraupin)
  in der psychiatrischen Praxis; geschichtliche Ubersicht
  und Erfahrungen aus der ambulanten Praxis.   [Reser-
  pine (sedaraupin) in psychiatry; historical review and
  experiences  in ambulatory patients.]   Psychiat. Neur.
  med. Psychol, Lpz., 1956, 8 :134-143.
  ---,  Stiaszny,   E.   Psychiatriai   betegek  reserpin
  kezelese.  [Reserpine therapy of psychiatric patients.]
  Ideg. szemle, 1956, 9: 53-59.
  Smith, S. K.   The use of reserpine  in private  psychia-
  tric practice.  Ann. N. York Acad. Sc, 1955, 61: 206-210.
  Abstract: Excerpta med., Sect. 8, 1956, 9 : No. 1227.    *
  Sottong, P. C.  The use and  abuse of the  tranquilizing
  drugs.   J. Tennessee M. Ass., 1956, 49: 413-418.      *
  Stead,  J. S.,  Wing, J. K.  Parkinsonism during treat-
  ment with  reserpine.  Lancet, Lond.,  1955, 1: 823-824.

—Psychoses
  Adler, H. Use of serpasil on  a disturbed ward.  Dis.
  Nerv.  Syst.,  1955,  16:122-124.  Abstract:  Excerpta
  med., Sect. 8,1956, 9: No. 4082.
  Avol, M., Vogel, P. J.   Treatment of delirium tremens
  with reserpine  (serpasil) ;  a  preliminary  report.   J.
  Am. 31.  Ass., 1955, 159:1516-1520.  Abstract: Excerpta
  med., Sect. 8, 1956, 9: No.  4001.  Year book of drug
  therapy, 1956-1957, p. 338.
  Barison, F., Massignan, L.   La reserpina  nelle schizo-
  frenie   catatoniche.   [Reserpine  in  catatonic schizo-
  phrenia.]  [English summary]   Arch, psicol.  neur.,
  3Tilano, 1956, 17: 347-358.
  Baumberger,  W.  Erfahrungen  mit  dem Rauwolfla-
  alkaloid Reserpin (Serpasil) bei ehronischen Geistes-
  kranken.  [Experiences  with  the Rauwolfia  alkaloid
  reserpine (serpasil)   in chronic  mental disorders.]
  Praxis,  Bern, 1955, 44: 721-724. Abstract:  Excerpta
  med., Sect. 8, 1956, 9:  No. 4542.
  Bertolini, O. F.   Cloropromazina e resperpina  nel trat-
  tamento delle psicopatie.  [Chlorpromazine  and reser-
  pine in the  treatment  of  mental diseases. 1  Arch.
  psicol. neur., 3tilano, 1956, 17:623-627.              *
  Bleuler, M.  Das Wesen der  Serpasil-Behandlung an
  Schizophrenen.  [The mechanism of serpasil treatment
  in   schizophrenia.]  Schweiz.   med.  Wschr.,   1955,
  85:443-444.
  Bower,  H. M.  A clinical evaluation  of  reserpine in
  the  treatment  of  chronic  mental  patients.  3Ied. J.
  Australia,  1955, 42  (2) : 82-86.  Abstract:  Excerpta
  med., Sect. 8, 1956, 9:  No. 1732.
  Bowes,  H.  A.  The ataractic drugs; the  present posi-
  tion  of  chlorpromazine, frenquel, pacatal,  and reser-
  pine in the psychiatric hospital.  Am.  J. Psychiat,
  1956, 113: 530-539.
  Braun,  M., Philipsborn, A.  Ataractics in  private prac-
  tice.  Am. J. Psychiat., 1956, 113: 80-81.
  Brooks,  C.   The  clinical use of reserpine in mental
  cases.   J. Alabama  31. Ass., 1956,  26: 9-11.
  Cachin,  M.,  Pergola, F.,  Potet, F.,  Debesse,  B.   Le
  traitement  du  delirium  tremens  par   la  reserpine.
152 
SUBJECT LIST
Reserpine : Therapeutic use — Psychoses
 [Treatment  of  delirium  tremens  with  reserpine.].
 Bull. Soc. me'd. hdp. Paris, 1956, 72 : 597-603.  Abstract:
 Excerpta med.,  Sect. 8, 1957, 10:  No. 1430.
 Campden-Main,  B.  C,  Wegielski,  Z.  The control of
 deviant  behavior in  chronically  disturbed psychotic
 patients by the  oral administration of reserpine.  Ann.
 N. York Acad. Sc, 1955, 61: 117-122.
 Cargnello,  D.  La  terapia reserpinica  nelle schizo-
 frenie croniche.  [Reserpine therapy of chronic schizo-
 phrenia.]  [English  summary]   Arch,  psicol  neur.,
 Milano, 1956, 17 : 359-375.
 ---.  La  therapie  par la  reserpine dans les schizo-
 phrenies  chroniques.   [Reserpine therapy  of chronic
 schizophrenia.]   Ence'phale, 1956,  45:1056-1070.
 Carillo-Broatch, A.  Tratamiento de la esquizofrenia
 cronica.  [Treatment of chronic schizophrenia.]  [Eng-
 lish  summary]  Rev.   neur.  psiquiat,  Lima,  1955,
 18:441-445.   Abstract: Excerpta med.,  Sect.  8, 1957,
 10:  No. 1981.
 Delay, J., Deniker, P., Ropert, R., Wiart, C.  Les indi-
 cations des  cures  neuroleptiques prolongees  dans le
 traitement des psychoses chroniques.  [Indications for
 the  prolonged neuroleptic therapy in the treatment of
 chronic psychoses.]   Arch, psicol. neur., 3Iilano, 1956,
 17: 401-407.                                         *
 Deschamps,  A.   Quelques resultats  des  cures  de som-
 meil en hopital  psychiatrique (a  base de chlorproma-
 zine  associee it  d'autres drogues).   [Some  results of
 sleep therapy in a psychiatric hospital (based on  chlor-
 promazine associated with other drugs).]  Ence'phale,
 1956, 45: 412-415.
 De Smedt, R.  La  reserpine en clinique psychiatrique.
 [Reserpine  in   psychiatric  practice.]    Acta  neur.
 psychiat belg., 1955, 55 : 399-408.
 Dillon, D., Swain, J. M.  Gastro-intestinal hemorrhage
 as a complication of reserpine administration: report
 of two cases.  Am. J. Psychiat, 1956, 113 : 462-463.    *
 Ellsworth, R. B., Clark, L. D.   Prediction of the re-
 sponse  of  chronic  schizophrenics to drug therapy;  a
 preliminary report on the relationship between palmar
 sweat  and  the behaviorial  effects of  tranquilizing
 drugs.  J.  Clin. Psychol, 1957, 13: 59-61.
 Fazio, C.  Risultati e considerazioni sull'impiego della
 reserpina nel trattamento  delle psicosi.   [Results  and
 considerations on the use of reserpine in the treatment
 of psychoses.]  Arch, psicol. neur., 3Iilano, 1950,  17:
 313-315.
 Flach, F. F.  Clinical effectiveness of reserpine.  Ann.
 N. York Acad.  Sc, 1955,  61:161-166.   Abstract:  Ex-
 cerpta med., Sect. 8, 1956,  9: No. 3084.
 Fliigel,  F.  Neuro-psychiatrische  Erfahrungen   fiber
 die Wirkung  des Rauwolfia-Alkaloides  Reserpin (Ser-
 pasil).   [Neuropsychiatric  experience with the effects
 of the Rauwolfia alkaloid reserpine (serpasil).]  Med.
 Klin., Berl, 1955, 50 : 509-510.
 Fogel,  E.  J. Physiological studies  after  continuous
 serpasil therapy over   18  months.  Dis. Nerv.  Syst,
 1956, 17 : 322-323.                               .  *  .*
 Fong, T. C.  Chlorpromazine and reserpine in geriatric
 patients.  Med.   Ann.   District  of  Columbia,  1956,
 25 ■ 260—263
 Foote, E. S.  Reserpine in treatment of chronic psy-
 chotics ; preliminary observations. Brit  31. J  1955, 1:
 1192-1193.   Abstract: Excerpta med., Sect. 8,  195b, \):
 No 4993
 Forster,' W.,  Schlichther, W., Henderson, A. L.  Reser-
 pine in chronic psychoses.  Canad. M. Ass  ^j, 1955, 73:
 951-955. Abstract:  Excerpta med., Sect.  8, 1956, 9 : No.
 4551
Freund R  B   Observations during the treatment of
175  Dsvchotic patients  with reserpine.  Psychiat. Q.,
1955, 29:381-389.  Abstract:  Excerpta  med.,  Sect. 8,
1956' 9 : No. 4994.          ., _  _       _
Gavral  L., Herve, Y., Carrie, J., Fourny, L.  Les cures
msuliniques prolongees  et  la post-cure dans le traite-
ment de la demence precoce.  [Prolonged insulin treat-
ment and after treatment in therapy of  dementia
praecox.]  Toulouse med., 1955, 56: 501-513.
---, ---, Fourny, L., Carrie,  J.  Chlorpromazine et
reserpine  dans  la  post-cure insulinique des  schizo-
phrenes.   [Chlorpromazine and  reserpine after insulin
shock therapy in schizophrenia.]  Ence'phale, 1956, 45:
663-667.
Gilberti, F.  Risultati e considerazioni sull'impiego della
reserpina  nel trattamento  delle psicosi:  osservazioni
generali.  [Results  of and considerations on the use of
reserpine  in the treatment of psychoses: general ob-
servations.]  [English summary]   Arch, psicol. neur.,
Milano, 1956, 17 : 316-346.
Glynn, J.  D.  Rauwolfia serpentina (serpasil)  in psy-
chiatry.  J. Neur., Lond., 1955, 18: 225-227.
Gottlieb, J. S., Tourney, G., Beckett, P. G., Lowinger, P.
Drug therapy of the psychoses.  Med. Clin. N. America,
1956, 40:1385-1399.
Hildebrand,  H.  J.  Erfahrungen  bei  der Behandlung
psychisch Kranker  mit Serpasil.  [Experiences in the
therapy of  mental patients with serpasil.]  [English
summary] 3Iiinch. med. Wschr., 1956, 98:1093-1098.   *
Hiob, J., Hippius, H.   Klinische Erfahrungen mit dem
Rauwolfia-Alkaloid   Reserpin  in  der  Psychiatrie.
[Clinical experiences with the Rauwolfia alkaloid reser-
pine in psychiatry.]  Deut. med. Wschr.,  1955, 80 :1497-
1500.
Hoch, P. H.  New drug therapy in psychiatry:  clinical
uses and  abuses in mental disorders.   Bull. N.  York
Acad. 31., 1957, 33 : 474-486.
---.  Practical and theoretical applications of the new
drug therapies in  psychiatry.  A. 31. A.  Arch. Neur.
Psychiat, 1956, 75 : 325-328.
Hoffman, J. L., Konchegul, L. Clinical and psychological
observations on psychiatric patients treated with reser-
pine : a preliminary report.   Ann. N. York  Acad. Sc,
1955, 61:144-149.  Abstract: Excerpta  med., Sect. 8,
1956, 9 : No. 3083.
Hollister, L. E.,  Krieger, G.  E., Kringel, A., Roberts,
R. H. Treatment of chronic schizophrenic reactions with
reserpine.  Ann. N. York Acad. Sc,  1955, 61:92-100.
Abstract: Excerpta med., Sect. 8, 1956, No. 1231.     *
Huchtemann, K., Pflugfelder, G.  Serpasilkuren in der
Psychiatrie; Bericht fiber 100 Kuren.  [Serpasil therapy
in psychiatry; report on  100 cases.]   Schweiz.  med.
Wschr., 1955, 85: 627-630.  Abstract: Excerpta med.,
Sect. 8,1956, 9 : No. 2242.
Jorstad,  J.  Reserpin  ved  psykoser.   [Reserpine  in
psychoses.]   [English summary]   Nord.  med., 1956, 55:
794-798.                                          * *
Kasak, M.,  Schaefer,  D. L.,  Winter,  W.  The use of
chlorpromazine and reserpine in a psychiatric hospital:
one  year's experience.  Marquette 31. Rev.,  1955, 21:
17-24.
Kernohan,  G.  A.  Stupor  during reserpine  therapy.
Brit M. J., 1957, 1: 1475-1476.                      *
Kozlowski, V. L. Mentally  disturbed patients;  a study
of low dosage serpasil.  Med. Times, Great Neck, 195(5,
84: 1219-1224.                                      *
Lauterbbck,  J. J., Nagy, K.  Anstaltserfahrungen mit
dem Rauwolfia-Alkaloid Reserpin.   [Hospital experi-
ences with  the  Rauwolfia alkaloid reserpine.]  Wien.
kUn. Wschr., 1955, 67 : 839-843.
Lereboullet, J., Pluvinage, R.,  Vidart,  L., Benoit, P.,
Kapandji, I.  Le traitment du delirium  tremens par la
reserpine.  [Treatment of delirium tremens with reser-
pine.]  Bull Soc me'd. hdp. Paris, 1956, 72: 604-605.
Lewis, L. F.  The use of chlorpromazine  and of serpasil
in the treatment of  psychotic patients.  Carib. 31. J.,
Trinidad, 1956, 18: 51-66.
Lidvall, H. F. Klinisk provning av Serpasil vid psykoser.
[Clinical trial with serpasil in  psychoses.]  Sven. lak.
tidn., 1956, 53:1729-1732.
153 
Reserpine : Therapeutic use — Psychoses
PSYCHOPHARMACA
Ljungberg,  E.  Om  reserpinbehandling  av  kroniska
schizofrenier  och   akuta  orostillstand.   [Reserpine
management of  chronic schizophrenia  and acute anx-
iety.]  Sven. lak. tidn., 1956, 53 : 2128-2140.
McNeill, J. F., Johnston, W. C, Pietuchow,  W.  Serpasil
in a hospital  for the mentally ill with criminal tend-
encies.  N. York State J. M., 1956, 56:1911-1914.  Ab-
stract : Year book of drug therapy, 1956-1957, p. 335-336.
Maffezzoni, G.,  Giamattei, L.  La reserpina nel trat-
tamento di ammalati mentali.  [Reserpine in the treat-
ment of mental disorders.]   Osp. psichiat., Nap., 1956,
24:157-164.
Masini, A., Pescetto, G., Tosca, L.  Effetti somatici ed
impiego  psichiatrico della reserpina.  [Somatic effects
and psychiatric use of  reserpine.]   Arch, psicol neur.,
Milano, 1956,  17 : 249-256.
Maurel,  H., Wilhelm,  Spielmann, J.  P.   Essai  thera-
peutique de la reserpine en psychiatrie hospitaliere; a
propos de 80 observations.  [Reserpine therapy in a
mental  hospital;  80 observations.]   Concours  me'd.,
1955, 77: 3351-3355.  Abstract: Excerpta med., Sect. 8,
1956, 9: No. 4545.
Mazza, A. Pedrelli, M.  La cura con reserpina nella
schizofrenia.  [Reserpine  therapy  in  schizophrenia.].
Riv. sper. freniat.,  1956, 80: 877-886.
Mellgren, A.  Nagot om serpasil och dess anvandning
inom psykiatrin.  [Psychiatric use of serpasil.]  Sven.
lak. tidn.,  1956,  53 :1564-1575.
Meyer, H. H.  Die Therapie der endogenen Psychosen.
 [Therapy   of  endogenous  psychoses.]   Deut.   med.
Wschr., 1957,  82: 76-80.
Mielke, F. A. Methods employed and  results  obtained
in  psychiatric studies  with  new drugs acting on  the
brain  stem.  Am. J. Psychiat, 1957, 114:134-139.
----.  Uber das Rauwolfia-Alkaloid Reserpin (Serpa-
sil)  in der Psychiatrie.  [The Rauwolfia alkaloid re-
serpine  (serpasil)  in   psychiatry.]  Arch. Psychiat.,
Berl,  1956, 194: 263-288.
----.  Uber die medikamentose und  psychotherapeu-
tische Ffihrung der Serpasil-Kur.  [Medical and  psy-
chotherapeutic  management  of   serpasil  therapy.]
 Schweiz. med. Wschr., 1956, 86:162-165. Abstract: Ex-
cerpta med., Sect. 8, 1957, 10: No. 1531.
----.  tibersicht der klinischen  Erfahrungen  mit  Ser-
persil am Burgholzli.  [Review  of  the clinical experi-
 ence with serpasil at the Burgholzli hospital.]  Schweiz.
med. Wschr., 1955, 85: 440-442.
 Montagnari, F., Germano, V.  Stato preeclamptico  con
 episodio  confuso  onirico troncato  con  reserpina  en-
 dovena.  [Intravenous reserpine immediately effective
in  treatment  of a  pre-eclamptic state with episode of
oneiric confusion.]   Riv. sper. freniat., 1956, 80:977-
979.
 Moore, J. N.,  Martin, E. A.  Trial of reserpine in treat-
ment  of schizophrenia.  Brit.  M. J., 1957, 1: 8-14.    *
Morgan, D. R.   Chlorpromazine and reserpine  in  the
 treatment of chronic mental illness.  Med. J. Australia,
 1956,43 (2) : 57-62.
----.  The combined use of chlorpromazine and reser-
 pine in the treatment of chronic mental illness: a pre-
 liminary report. Med. J. Australia, 1955, 42 (2) : 77-80.
 Abstract:  Excerpta med., Sect.  8, 1956, 9: No. 1728.
 Muratti, J. B.   Reserpina:  su  uso terapeutico en la
 esquizofrenia;  nota previa.   [Reserpine: therapeutic
use in schizophrenia; preliminary note.]  Dia me'd., B.
 Air., 1956, 28: 880-883.
 Negri, V.  U., Garavaglia, G.   Rilievi clinici sulla pecu-
liare azione della reserpina in psichiatria.  [Reserpine
in psychiatry;  a clinical study on its characteristic ac-
tion.]  Minerva med., Tor., 1955, 46:1217-1229.
 Neuer, H.  Serpasil in the treatment of acute alcoholic
 psychoses.  Ohio 31. J., 1955, 51:  749-751.  Abstract:
 Excerpta med.,  Sect. 8,1956,9: No. 4004.
Patton, G. O., Garneau, J.  The ataraxic drugs in dis-
turbed  secluded  psychiatric  patients.  Canad.  Serv.
M. J., 1957,13:127-133.
Payn, S. B., Rockwell, F. V.  Short-term treatment of
psychiatric patients with reserpine.  N. York State J.
M., 1956, 56:1769-1773.
Pivnicki, D.  Serpasil u psihijatriskoj praksi.   [Serp-
asil in psychiatric treatment.]   [German  summary]
Med. arch., Sarajevo, 1956,10:109-117.
Racamier, P. C,  Blanchard,  M.,  Baudrand, C.  Les
cures prolongees de chlorpromazine dans les etats schi-
zophreniques.  [Prolonged chlorpromazine  therapy in
schizophrenic reactions.]  Ence'phale,  1956,  45:647-
655.                                               *
Rhijn, C.  H. van.  De invloed van reserpine (serpasil)
op acute en chronische geestesziekten.   [The effects of
reserpine on acute and chronic mental diseases.]  [Eng-
lish summary]  Ned.  tschr. geneesk., 1956, 100:1775-
1790.                                             * *
Sabshin, M., Ramot, J.   Pharmacotherapeutic  evalua-
tion and the psychiatric setting.  A. M. A.  Arch. Neur.
Psychiat, 1956, 75: 362-370.
Sacerdoti, G.  Prime esperienze in  neuropsichiatria
con un nuovo alcaloide della  Rauwolfia serpentina: il
serpasil;  nota preventiva.  [First experience in neu-
ropsychiatry with a new alkaloid of Rauwolfia serpen-
tina:  serpasil;  preliminary note.]   Gazz.  med. ital,
1955,  114:63-65.   Abstract:  Excerpta  med., Sect. 8,
1956,9: No. 1220.
Sainz, A.  A.   The use of reserpine in ambulatory and
hospitalized geriatric psychotics.  Ann. N.  York. Acad.
Sc, 1955, §1:12-11.  Abstract: Excerpta med., Sect. 8,
1956, 9: No. 1229.
Santangelo, G.  Modificazioni indotte dal  trattamento
reserpinico protrato sulla  sintomatologia  psichica e
comportamentale nelle schizofrenie croniche.  [Modifi-
cations induced by prolonged reserpine treatment on
psychic symptomatology and behavior in chronic schizo-
phrenia.]   [English  summary]  Arch,  psicol  neur.,
Milano, 1956, 17: 388-393.
Schneider, H.  Erfahrungsbericht fiber Rauwolfia-Alka-
loid-Behandlung.   [Experiences  with Rauwolfia alka-
loid therapy.]  Nervenarzt, 1956, 27 : 72-75.  Abstract:
Excerpta med., Sect. 8,1957, 10: No. 2088.             *
Sheth, S., Khairnar, D. B.  Study of reserpine in mental
diseases.   Ind. Practitioner, Bombay, 1956, 9: 259-269.
Abstract: Excerpta med., Sect.  8, 1957, 10: No. 1530.
----,----•  Use of reserpine in  mental diseases.  Ind.
Practitioner, Bombay, 1955, 8: 893-903.  Abstract: Ex-
cerpta med., Sect. 8, 1956, 9: No. 2244.
Siguier, F., Giabicani, A., Betourne,  C, Goglin,  G.  Le
serpasil dans les deiires alcooliques.   [Serpasil in alco-
holic delirium.]  Bull. Soc. me'd. hop. Paris, 1956, 72:
605-607.  Abstract: Excerpta med.,  Sect.  8, 1957,  10:
No. 1976.
Silver, A. A. Management  of  children with  schizo-
phrenia.  Am. J.  Psychother., 1955,  9:196-215.
Silverberg, J. W., Gralnick,  A.  Possible synergistic
action of chlorpromazine,  reserpine  and  frenquel.   A
preliminary report.  Am. J.  Psychiat, 1957, 114:173.
Sinsi, C, Vizioli,  R.  Chlorpromazina e  reserpina in
terapia  psichiatrica.   [Chlorpromazine  and reserpine
in psychiatric  therapy.]  [English  summary]   Osp.
pschiat., Nap., 1955, 23 : 83-96.
Tasher, D. C, Chermak, M.  W.  The use of reserpine
 in shock-reversible  patients  and  shock-resistant pa-
tients. Ann. N. York Acad. Sc, 1955, 61:108-116.  Ab-
stract : Excerpta med., Sect. 8, 1956, 9: No. 1733.
Teani, E.  La reserpina in  neuropsichiatria.  [Reser-
 pine  in  neuropsychiatry.]   Riv.  sper.  freniat.,  1956,
 80: 615-637.  Abstract:  Excerpta med.,  Sect. 8, 1957,
 10: No. 2086.
Tuteur, W., Stiller, R., Whitehill, O., Lepson,  D.  Re-
 sults  with chlorpromazine and reserpine on chronically
 nude,  untidy,  destructive  and combative patients:
154 
SUBJECT  LIST
Reserpine : Therapeutic use — Psychosomatic diseases
 their sustained improvement after discharge with con-
 tinued medication.  Am. J. Psychiat, 1956, 112: 741.
 Vogt, W.  Beitrag zum klinischen Vergleich der Wirk-
 ung von Largactil und  Serpasil.   [Clinical  comparison
 of the effects of largactil and serpasil.]  Schweiz. Arch.
 Neur. Psychiat,  1956, 77: 330-336.
 Waldrop, F. N.  Reserpine.   Med. Ann. District of Co-
 lumbia, 1956, 25 : 256-258.                           *
 Weber, E.  Ein  Rauwolfiaalkaloid in der Psychiatrie:
 seine  Wirkungsahnlichkeit   mit  Chloropromazin.   [A
 Rauwolfia  alkaloid  in  psychiatry:  similarity of  its
 effects to  those of  chlorpromazine.]  Schweiz.  med.
 Wschr., 1954, 84: 968-970.
 Weishaus, J.  Use of reserpine (serpasil) in psychotic
 patients; a preliminary report.   Dis. Nerv.  Syst.,  1955,
 16: 347-350.  Abstract:  Excerpta  med., Sect.  8,  1956,
 9: No. 4996.                                        *
 Wodraska,  T. W.  The effect of reserpine  on chronic
 schizophrenia.  3Ied.  Times, Great Neck, 1955, 83:1029-
 1033.
 Zonta, G.,  Masciangelo, P.  M.,  Gentili,  E.  Risultati
 dell'impiego di serpasil nella cura  di soggetti psicotici.
  [Results of the  use of  serpasil in therapy of psychotic
 patients.]  Riv.  sper. freniat., 1955, 79:521-526.

—Psychosomatic diseases
 Barrett, B. M., Hansel, F. K. Reserpine a new adjunct
 in the management of  resistant headache  patterns; a
 preliminary  report.  Ann.  N. York Acad. Sc,  1955,
 61:250-266.  Abstract:  Excerpta  med., Sect.  8,  1956,
 9: No. 1554.
 Bartfield, H.  Use of reserpine in psychogenic  rheuma-
 tism, osteoarthritis,  and rheumatoid arthritis; a pre-
 liminary report.  J. Am. M. Ass., 1955, 159:1510-1513.
 Berger, H.  Management of neuroses by the internist
 and  general  practitioner.  N.  York State J. M.,  1956,
 56:1783-1788.
  Bernstein, S., Detre,  T.  Effects of reserpine (serpasil)
 on homeostasis  in patients presenting psychosomatic
 symptoms.  [Abstract]  A. M. A. Arch.  Neur. Psychiat.,
 1955, 74: 337.
  Brunsting,   L.  A.   Neurodermatitis.  Minnesota  M.,
 1955, 38: 291-292.
  Cahn, M. M.  The use of tranquilizing  drugs in derma-
 tology ; review and side reactions. J. Albert Einstein
 M. Center,  1956,  4:161-165.
 Caccialanza, P.  Osservazioni sull'azione  antiprurigi-
 nosa di un alcaloide  della Rauwolfia serpentina Benth.
  [Antipruriginous action of  an  alkaloid  of Rauwolfia
  serpentina  Benth.]  [English  summary!   Gior.  ital.
  derm, sif., 1955, 96: 82-87.
 Fabricant, N. D. Tension headache therapeutics.  Eye
 Ear  dc Month.,  1956, 35: 658; 662.
 Friedman,  A. P.  Use of tranquilizers in the treatment
 of headache.  Am. Practitioner, 1957,  8: 94-97.
 ___  Von  Storch, T. J.  A  review of  headache,  1950-
 1955   N.  York  State J. M., 1956, 56:3883-3895.
 Genest, J.,  Adamkiewicz, L., Robillard, R., Tremblay,
 G.  Clinical  uses of Rauwolfia.  II. In  psoriasis  and
 in constitutional leanness.  Canad.  M. Ass. J.,  1955,
 72-490-491.  Also  as:  Nouvelles applications  thera-
 peutiques de  la  reserpine et des extraits  de la Rau-
 wolfia  [New therapeutic use of reserpine and Rau-
 wolfia extracts.]  Union me'd.  Canada, 1954,  83:915-
 916   Preliminary  communication:  new  therapeutic
 applications  of  reserpine  and of purified  extracts of
 Rauwolfia.  Canad. M. Ass.  J., 1954, 71 (August-News
 and Notes) : 73.                  .          ... .   nA„
 Greenblatt  R. B.  Use of reserpine (serpasil) in  cer-
 Sn  gynecologic disorders.   Ann. N.  York Acad.  Sc,
 1954  59' 133-135.
 Grnnner' C.   Le traitement du  prurit  en dermatologie
 oar la Rauwolfia serpentina, note preliminaire.   [Rau-
 w^ifi* Sroentina therapy of pruritus  in dermatology;
preliminary note.]  Bull Soc. fr.  derm, syph., 1955,
62:159-162.
Gutenkauf,  C.  Internal medicine.  In:  "Happiness
pills" in medical practice: a  symposium.  J. Iowa M.
Soc, 1957, 47 : 59-64.                               *
Hamke, H.  Das Rauwolfia-Alkaloid Reserpin  in der
Behandlung  der vegetativen  Storungen.  [Rauwolfia
alkaloid reserpine treatment of autonomic disorders.]
Ther. Gegenwart, 1955, 94: 218-219.
Harris, R.   Clinical use of reserpine (serpasil) in geri-
atrics.  Ann. N. York Acad. Sc, 1954, 59: 95-106.
Abstract: Chem. Abstr., 1954, 48 :10220b.
----.   Results  of reserpine therapy in hypertension.
J. Geront, 1954, 9 : 484-485.
Hauser, A., Wenner,  R.  Serpasil  in  der Behandlung
klimakterischer  Ausfallserscheinungen.   [Serpasil  in
the management of climacteric dysfunction.]   Gynae-
cologia, Basel, 1956, 142 : 300-303.
Korting, G. W., Borelli, S., Kimmig, J.  Welche Bedeu-
tung  besitzen die Phenothiazine ffir  die Behandlung
von Hautkrankheiten?   [Of what significance are phe-
nothiazines in the treatment of skin diseases?]  Derm.
Wschr., 1956,134:1245-1252.
Kurz,   C.  A  propos  de  la   reserpine.   [Reserpine]
Gaz. me'd. France, 1956,  63: 877-881.                *
Lereboullet, J.,  Vidart,  L.,  Amstutz,  C.   Membre
fantome douloureux avec syndrome depressif. Gueri-
son spectaculaire par la reserpine.   [Painful phantom
limb with a depressive syndrome; spectacular cure with
reserpine.]  Rev. neur., Par., 1955, 92: 386-387.
Leutschaft,  R.  Behandlung   vegetativer  Dysregula-
tionen  mit  Reserpin.   [Treatment  of autonomic dys-
function with reserpine.]  3Ied. Klin., Berl, 1955, 50:
1906-1909.
Mohun, M.  Globus.  Laryngoscope, 1955, 65: 73-79.
Mitis, Z. K., Ford, H.   Functional  headaches.  Texas
J. M., 1956, 52 : 678-683.
Montagnari, F., Germano, V.   Stato preeclamptico con
episodio  confuso  onirico   troncato   con  reserpina
endovena.   [Intravenous reserpine  immediately effec-
tive in treatment of a pre-eclamptic state with episode
of  oneiric  confusion.]   Riv.  sper.  freniat,  1956, 80:
977-979.
Moore, R. B., Pierce, W. J., Dennison, A. D., Jr. The
story of reserpine.  J. Indiana M.  Ass., 1954, 47: 853-
861.
Ogden, H. D.  Headache.  Ann. Allergy, 1956, 14: 385-
428.
Panaccio, V.  L'action de la  reserpine dans certaines
affections  dermatologiques.   [Action  of  reserpine in
various dermatological diseases.]  Union  me'd. Canada,
1955, 84: 672-674.
Rein, C. R., Goodman, J. J. Efficacy of reserpine (ser-
pasil)  in  dermatological therapy.  A.  M.  A. Arch.
Derm.  Syph., 1954, 70: 713-717.                     *
----, ----.  The tranquilizing efficacy of reserpine in
dermatological  therapy.  Ann.  N.  York  Acad.  Sc,
1955, 61: 230-235.                                  *
Rizzente, S.  Osservazioni cliniche  su di  un nuovo ipo-
tensivo e sedativo in geriatria.  [Clinical observations
on a new hypotensive and sedative drug in geriatrics.]
Arch, psicol neur., Milano, 1956,17: 454-456.
 Sapir, M., Stroun, J., Hepner, L., Reverchon, J., Selzer, S.
A  propos de  Taction  psycho-somatique de  la chlor-
promazine  et de la reserpine.  [Psychosomatic action
 of chlorpromazine and reserpine.]   Ence'phale, 1956, 45 :
488-493.                                           *
 Schnyder, U. W., Schauwecker, R.  Largactil und Ser-
pasil in der Dermatologie.   [Largactil and  serpasil in
dermatology.]   [English summary] Dermatologica, Ba-
sel, 1955, 111: 185-197.
 Segal,  M., Attinger, E.  O.  The use of reserpine as an
 adjunct in the management  of patients with chronic
 bronchial asthma and chronic pulmonary emphysema:
155 
Reserpine : Therapeutic use — Psychosomatic diseases
PSYCH0PHAR31ACA
  preliminary studies.  Ann. N. York Acad. Sc, 1955, 61:
  267-275.
  Stewart, R. H.  The use of tranquilizing drugs in gyne-
  cology.  West. J. Surg., 1956, 64: 650-657.
  Wilkins,  R. W.  Clinical usage of Rauwolfia alkaloids,
  including reserpine  (serpasil).   Ann. N.  York  Acad.
  So., 1954, 59: 36-44.  Also: N. England J. 31., 1954, 59 :
  1-7.

Untoward effects [see headnote p. 19]
  Achor, R.  W. P.,  Hanson, N.  O., Gifford,  R.  W., Jr.
  Hypertension treated with Rauwolfia serpentina (whole
  root)  and  with reserpine:  Controlled study disclosing
  occasional severe depression.  J. Am. M. Ass., 1955, 159:
  841-845.
  Budnick, I. S., Leikin, S., Hoeck,  L.  E.  Effect  in the
  newborn infant of reserpine administered ante partum.
  A. M. A. J. Dis. Child., 1955, 90: 286-289.            * *
  Burrell, R. H.  Depression associated with reserpine
  therapy.  N. Zealand M. J.,  1956, 55 : 228-231.
  ---.  Reserpine  depression treated  with sodium suc-
  cinate; a preliminary report.  N. Zealand M. J., 1955,
  54:565-567.
  Cahn, C. H.  Complication during reserpine therapy.
  Am.  J.  Psychiat, 1955,  112: 64.   Abstract: Excerpta
  med.,  Sect.  8, 1956, 9: No. 1729.
  Dean, S. R.  Ataractics.  Am. J. Psychiat, 1956,  112:
  850.
  De Caro, D.  Manifestazioni extrapiramidali  e  con-
  vulsive osservate  durante la terapia con la reserpina;
  contributo  clinico  ed E.  E. grafico.   [Extrapyramidal
  symptoms and convulsions during reserpine therapy;
  clinical  and electroencephalographic  tracings.]   Acta
  neur., Nap., 1956,11:  426-453. Abstract: Excerpta med.,
  Sect. 8, 1957, 10 : No.  1538.
  Della  Pietra, V., Fina, G.  Un caso di edema cerebrale
  acuto  in corso di terapia reserpinica.  [A case of acute
  cerebral edema during reserpine  therapy.]   Osp. psi-
  chiat, Nap., 1956, 24: 91-95.
  Doyle, A. E., Smirk, F.  H.  Drug therapy in hyper-
  tension; a  critical review.   Practitioner,  Lond.,  1955,
  174: 135-143.
  Essellier, A. F., Goerre, J.,  Wegmann, A.   Zur medika-
  mentosen Behandlung der  Hypertonie.  Klinische  Er-
  fahrungen mit Serpasil, Serpasil-Ritalin und Serpasil-
  Nepresol.   [Drug  therapy  of hypertension.  Clinical
  experiences with serpasil, serpasil-ritalin and serpasil-
  nepresol]  Schweiz. med. Wschr.,  1955, 85: 808-811. * *
  Farley, O. R.  Complications and  concomitants.   31ed.
  Ann. District of Columbia,  1956, 25 :  2(53-2(57.      * *
  Faucett, R.  L., Litin, E. M., Achor, R. W. P.   Neurophar-
  macologic action  of Rauwolfia compounds and its psy-
  chodynamic implications.  A. 31.  A.  Arch.  Neur. Psy-
  chiat., 1957. 77 : 513-518.                          * *
  Ferguson, J. T. Treatment of reserpine-induced depres-
  sion with a new analeptic:  phenidylate.  Ann. N. York
  Acad.  Sc, 1955, 61:101-107. Abstract: Excerpta  med.,
  Sect. 8, 1956, 9 : No. 1721.
  Freis, E. D.  Mental depression in hypertensive patients
  treated for  long periods with large doses of reserpine.
  N.  England J. 31.,  1954, 251: 1006-1008.
  Fullerton, A. G.   Psychiatric uses  of  meratran.  J.
  31ent.  Sc, Lond.. 1956, 102 : 801-N04.
  Goldman, D.  The major complications of treatment of
  psychotic states with  chlorpromazine and reserpine and
  their management.   Psychiat.  Res. Rep.,  Wash., 1956
  (4) : 79-88.
 Harris, T. H.  Depression induced by Rauwolfia com-
  pounds.  Am. J. Psychiat., 1957, 113 : 950.
  Helander, S., Hood, B. Depressionsrisken vid rauwolfia-
  behandling.    [Hazards  of   depression  in  Rauwolfia
  therapy.]  Sven. lak.  tidn., 1956, 53:1021-1023.      * *
  Hodgkinson, R. The effects of reserpine on hyperten-
  sive patients over a period  of two years.  Brit.  Heart
 J., 1956, 18: 523-528.
 Hollister, L. E.  Complications from the use of tran-
 quilizing drugs.  N. England J. 31., 1957, 257:170-177.
 Hussar, A. E.  Complications of  chlorpromazine and
 reserpine therapy.  GP, 1957, 15 (5) : 85-93.
 Jacobson, A.   Ritalin—a  new agent for mild depres-
 sions ;  a  preliminary report.  Med.  Ann. District  of
 Columbia, 1956, 25 : 491-494; 527-528.
 Kass, I., Brown, E.  C.  Treatment of hypertensive
 patients with  Rauwolfia  compounds and  reserpine;
 depressive and psychotic changes.   J. Am. 31. Ass., 1955,
 159:1513-1516.
 Kernohan,  G.  A.  Stupor during  reserpine  therapy.
 Brit. 31. J., 1957,1:1475-1476.
 Kline, N. S., Barsa, J., Gosline, E.  Management of side
 effects  of reserpine and combined reserpine-chlorpro-
 mazine treatment.  In:  Himwich,  H. E., ed. Tranquil-
 izing drugs.  Washington, Am. Ass. Adv. Sc, 1957.  p.
 149-161.
 ---,----,----.  Management of  the side  effects  of
 reserpine and combined reserpine-chlorpromazine treat-
 ment. Dis. Nerv. Syst., 1956, 17: 352-358.
 Kramer, M.  Facts needed to assess public health and
 social problems in the widespread  use of the tranquil-
 izing drugs.  Pub. Health 31onogr., 1956 (41) : 1-31.
 Lemere, F.  New  tranquilizing drugs.  Northwest M.,
 1955, 54:1098-1100.
 Litin, E. M., Faucett,  R. L., Achor, R. W. P.  Depres-
 sion in hypertensive patients treated with  Rauwolfia
 serpentina.  Proc. 3Iayo Clin., 1956, 31: 233-237.
 Ljungberg,  E.  Depressionsrisken  vid rauwolfiabehan-
 dling.   [Risks  of depression with  Rauwolfia therapy.]
 Sven. lak. tidn., 1956, 53 : 2875-2880.
 McArthur, J. G, Isaacs, B.  Mental effects of reserpine.
 Lancet, Lond., 1955, 2 : 347.
 MacKenzie-Van der  Noordaa, M.  C.   Depressie  na
 gebruik van reserpine wegens  essentiele hypertensie.
 [Depression after  reserpine therapy of essential hyper-
 tension.]  [English  summary]  Ned. tschr.  geneesk.,
 1956,  100:1003-1004.
 Margolis, L. H. Pharmacotherapy  in psychiatry; a re-
 view.  Ann. N. York Acad. Sc, 1957, 66: 698-718.
 Nordman, L. O.  Reserpinutlosta depressiva psykoser.
 [Depressive psychosis precipitated by reserpine  ther-
 apy.]  Sven. lak. tidn., 1956, 53 :1641-1647.
 Payn, S. B.  Hypothermia  following reserpine.  Am. J.
 Psychiat.,  1956,  112:657.  Abstract: Excerpta med.,
 Sect.  8,1956, 9: No. 4995.
 Piatt, R., Sears, H. T. N.  Reserpine in severe hyperten-
 sion.  Lancet, Lond., 1956,  1: 401-403.             * *
 Possible danger from reserpine.  Brit.  31. J., 1957, 2:
 49.                                              * *
 Reisner, H.  Zwischenfalle bei Gaben hoher  Dosen von
 Reserpin (Serpasil).   [Incidents with massive doses of
 reserpine.]  Wien. klin. Wschr., 1956, 68: 872-874.   **
 Reserpine and the mind.  Lancet,  Lond., 1955, 2:330-
 331.
 Reserpine and the nervous system.  Lancet, Lond., 1955,
 2:1326.
 Robie, T. R. Pseudo-tabes syndrome as complication of
 tranquilizer drug therapy.   Am. J.  Psychiat, 1956,113:
 463^64.
 Sarwer-Foner, G. J., Ogle, W.  Psychosis and enhanced
 anxiety  produced  by reserpine and chlorpromazine.
 Canad. 31. Ass.  J., 1956, 74 : 526-532.
 Schroeder, H. A., Perry, H.  M., Jr.  Psychosis apparently
 produced by reserpine.  J. Am. M.  Ass.,  1955, 159: 839-
 840.   Abstract: Excerpta  med., Sect. 8, 1957, 10: No.
 1536.   Year book of drug therapy, 1956-1957, p. 324-325.
 Smirk, F. H., McQueen, E. G. Comparison of rescinna-
 mine  and  reserpine  as hypotensive agents.  Lancet,
 Lond., 1955, 2 :115-116.
Tweedy, P.  S.  Treatment  of hypertension.   Lancet,
 Lond., 1955, 2:  249.
156 
SUBJECT LIST
Reserpine : with Methylphenidylacetate : Therapeutic studies, controlled
 Usdin, G. L.  Use of promazine in psychiatric practice;
 an early study.  J. Louisiana 31. Soc, 1956, 108: 251-
 257.
 Wallace, D. C.  Treatment of hypertension; hypotensive
 drugs and  mental changes.  Lancet, Lond.,  1955, 2:
 116-117.
 Wardell, D. W.  Untoward reactions to tranquilizing
 drugs.  Am. J. Psychiat, 1957, 113 : 745.           * *
 Winsor, T.  Human pharmacology of reserpine.  Ann.
 N. York Acad. Sc, 1954, 59 : 61-81.

—Poisoning
 Hubbard, B. A.  Reserpine.  J.  Am. 31. Ass., 1955,  157:
 468.
 Phillips, T.  Overdose of reserpine.  Brit. 31. J., 1955,
 2: 969.
 Plummer, A. J., Earl, A., Schneider, J. A., Trapold, J.,
 Barrett, W.  Pharmacology of Rauwolfia serpentina
 alkaloids, including reserpine.   Ann. N. York Acad. Sc,
 1954,59:8-21. [17-18]


with ATARAXICS [2 or more]
 see ATARAXICS—Various [3 or more]

with AZACYCLONOL
 see AZACYCLONOL—Psychotherapeutic use
    AZACYCLONOL with RESERPINE

with CHLORPROMAZINE
 see CHLORPROMAZINE with  RESERPINE

with  CHLORPROMAZINE  and  METHYLPHENIDYL-
   ACETATE
 see  CHLORPROMAZINE  with   RESERPINE  and
   METHYLPHENIDYLACETATE

with ETHYLCROTONYLUREA—COMPARED

Therapeutic studies, controlled—Psychoses
  Ferguson, J. T.,  Linn, F. V.  A new compound for the
  symptomatic treatment of tension and anxiety: 2-ethyl-
  crotonylurea  (nostyn).  Antibiotic M., 1956, 3 : 329-333.

with HYDROXYZINE
 see HYDROXYZINE with RESERPINE

with IPRONIAZID—COMBINED

Studies, animals
 Besendorf, H., Pletscher,  A.   Beeinflussung zentraler
 Wirkungen  von  Reserpin und  5-Hydroxytryptamin
 durch   Isonicotinsaurehydrazide.   [The  influence  of
 isonicotinic acid hydrazides on the  central  effects of
 reserpine and of 5-hydroxytryptamine.]   [English sum-
 mary]  Helvet. physiol. pharm. acta, 1956, 14: 383-390.
 Brodie,  B. B., Pletscher, A., Shore,  P. A.  Possible role
 of serotonin  in  brain  function and reserpine action.
 [Abstract]  J. Pharm.  Exp. Ther., 1956, 116:9.
 Burton, R. M.  The  analeptic action of  lysergic acid
 diethylamide  on reserpine-sedated mice.  Ann. N.  York
 Acad. Sc, 1957, 66 : 695-697.
 Chessin, M., Dubnick, B.,  Kramer, E. R., Scott, C. C.
 Modifications of  pharmacology of reserpine and serot-
 onin by  iproniazid.  [Abstract]  Fed, Proc, Bait., 1956,
 15:409.
with IPRONIAZID—COMPARED
 see IPRONIAZID—Pharmacodynamics

with LYSERGIC ACID DIETHYLAMIDE
 see LYSERGIC ACID DIETHYLAMIDE with RESER-
 PINE
with  LYSERGIC   ACID DIETHYLAMIDE,   BROMI-

 see   LYSERGIC  ACID  DIETHYLAMIDE,   BROMI-
       NATED with RESERPINE

    456132—59---11
with MEPAZINE
  see MEPAZINE with RESERPINE—COMBINED

with MEPHENESIN—COMBINED—Therapeutic stud-
        ies, controlled
  see under MEPHENESIN CARBAMATE—Therapeutic
             studies, controlled

with MEPHENESIN—COMPARED
Studies, animals
  see MEPHENESIN with RESERPINE—COMPARED

Therapeutic studies, controlled
  see under MEPHENESIN CARBAMATE—Therapeutic
             studies, controlled

with MEPHENESIN and OTHER DRUGS
  see MEPHENESIN with RESERPINE and  OTHER
        DRUGS

with MEPHENESIN CARBAMATE
  see MEPHENESIN CARBAMATE—Therapeutic stud-
        ies, controlled

with MEPROBAMATE
  see MEPROBAMATE with RESERPINE
with   MEPROBAMATE  and   METHYLPHENIDYL-
         ACETATE
  see MEPROBAMATE with RESERPINE and METHYL-
        PHENIDYLACETATE

with MESCALINE—INTERACTION
  see MESCALINE with RESERPINE

with METHYLPHENIDYLACETATE—COMBINED

Studies, animals
  Burton, R. M.  The  analeptic action of  lysergic  acid
  diethylamide  on reserpine-sedated mice. Ann. N. York
  Acad. Sc, 1957, 66 : 695-697.
  Cole, J., Glees, P.  Ritalin as an antagonist to reserpine
  in monkeys.  Lancet, Lond., 1956,1: 338.
  Davis, G. D.  Effects of central excitant and depressant
  drugs on  locomotor  activity  in the monkey.  Am.  J.
  Physiol, 1957, 188 : 619-623.
  Meier, R., Gross, F., Tripod, J.  Ritalin, eine neuartige
  synthetische  Verbindung  mit  spezifischer zentralerre-
  gender Wirkungskomponente.    [Ritalin,  a new  syn-
  thetic compound with specific  analeptic action.]  Klin.
  Wschr., 1954, 32:  445-450.  Abstract: Chem. Abstr.,
  1954, 48: 8945e.
  Plummer,  A.  J., Maxwell, R., Earl, A. E.   Influence of
  methyl-alpha-phenyl-2-piperidine acetate hydrochloride
  on the pharmacological  actions  of  reserpine.   [Ab-
  stract]  Fed.  Proc, Bait, 1956,15 : 468.

Studies, normal subjects
  Miescher,   P.  Therapeutische Versuche  zur  sympto-
  matischen  Behandlung psychoneurotischer Storungen.
  [Therapeutic experiments on  the symptomatic treat-
  ment of psychoneurotic disorders.]  Praxis, Bern, 1956,
  45:1041-1043.

Therapeutic studies,  controlled
  Ayd, F. J., Jr.  A clinical evaluation of methyl-phenidyl-
  acetate hydrochloride (ritalin).  J. Clin. Exp. Psycho-
  path., 1957, 18: 342-346.
  Carter, C. H.  The  effects of  reserpine  and methyl-
  phenidylacetate (ritalin) in mental defectives, spastics,
  and  epileptics.  Psychiat. Res. Rep., Wash., 1956  (4) :
  44-48.
  Christe, R.  Action therapeutique comparee de deux as-
  sociations  de serpasil  et de  ritaline.  [Comparative
  therapeutic effect of two serpasil-ritalin combinations.]
  Schweiz. med. Wschr.,  1956, 86:1318-1321.
  Clark, L.  D., Ellsworth, R. B., Barrett, W. W., Thur-
  mam A. C, Holland, W.  Studies of the behavioral  ef-
  fects of ritalin.  Dis. Nerv. Syst., 1956, 17: 317-321.
157 
Reserpine : with Methylphenidylacetate : Therapeutic studies, controlled
PSYCHOPHARMACA
  Davidoff, E., Best, J. L., McPheeters, H. L.  The effect
  of ritalin  (methyl-phenidylacetate hydrochloride)  on
  mildly depressed  ambulatory patients.  N. York State
  J. 31., 1957, 57 : 1753-1757.
  Ferguson, J. T. Improved behavior patterns in the hos-
  pitalized  mentally  ill  with  reserpine and  methyl-
  phenidylacetate.   Psychiat. Res. Rep., Wash., 1956 (4) :
  35-43.
  ----.  A new  therapeutic approach  to abnormal be-
  havior in geriatrics.  Geriatrics, 1956, 11: 217-219.
  ----.  What's  new and usable  in the chemical treat-
  ment of abnormal behavior.  J. Michigan M. Soc, 1956,
  55:1095-1101.
  ---,  Funderburk, W.  H. Improving senile behavior
  with reserpine and ritalin;  new approach with use of
  methyl phenylpiperidylacetate.  J.  Am. M.  Ass., 1956,
  160 : 259-263.  Abstract: Excerpta med,, Sect. 8, 1956,
  9: No. 3520.  Year book of drug therapy, 1956-1957, p.
  344-346.
  McPheeters, H. Fox, W. W.  Evaluation of reserpine
  and  methyl phenidylacetate used  separately and  in
  combination, in  chronic  psychotic patients. J. Ken-
  tucky 31. Ass., 1956, 54: 785-791.
  Madi, M. L., Kovitz, B.  Experiences with methyl-pheni-
  dylacetate hydrochloride (ritalin) in psychotic patients.
  Antibiotic M., 1956, 3 : 309-311.
  Miescher,  P.  Therapeutische  Versuche zur  sympto-
  matischen Behandlung psychoneurotischer  Storungen.
  [Therapeutic experiments on the symptomatic  treat-
  ment  of  psychoneurotic  disorders.]  Praxis,  Bern,
  1956, 45:1041-1043.
  Negri, F.  Effetto della reserpina e della reserpina as-
  sociata a psicotonici  in alcune psicopatie senili.  [Ef-
  fect  of  reserpine  and  of  reserpine combined  with
  psychotonics in senile psychoses.]  [English  summary]
  Arch, psicol. neur., Milano, 1956, 17: 441-451.
  Niswander, G. D., Haslerud, G. M., Brody,  N., Casey,
  T. M. Reserpine and methylphenidylacetate effects  on
  socialization and  activity.  J. Nerv.  Ment  Dis., 1957,
  125: 51-56.
  Rashkis, H. A., Smarr,  E. R.  Drug and milieu effects
  with chronic  schizophrenics.  A.  M.  A.  Arch.  Neur.
  Psychiat., 1957, 78: 89-94.

Therapeutic use
  Benassi, P., Fava, D.  Trattamento con reserpina di  al-
  cune tossicomanie.  [Reserpine  treatment of drug ad-
  diction.]   [English summary]   Arch, psicol. neur., Mi-
  lano, 1956, 17: 601-607.
  Ferguson, J. T. Successful therapeutic regimen for the
  management of behavior problems in the elderly.  J.
  Am. Geriat. Soc, 1956, 4:1080-1084.
  ---.  Treatment of reserpine-induced depression with
  a new analeptic: phenidylate.  Ann. N. York Acad. Sc,
  1955, 61:101-107.  Abstract:  Excerpta med.,  Sect. 8,
  1956, 9: No. 1721.
  Hauser, A.,  Wenner, R.  Serpasil in der Behandlung
  klimakterischer  Ausfallserscheinungen.  [Serpasil  in
  the  management of climacteric dysfunction.]   Gynae-
  cologia, Basel, 1956,142: 300-303.
  Huchtemann, K., Pflugfelder, G.  Serpasilkuren in der
  Psychiatrie; Bericht Uber 100 Kuren.  [Serpasil ther-
  apy in psychiatry ; report on 100 cases.]  Schweiz. med.
  Wschr.,  1955,  85: 627-630. Abstract:  Excerpta med.,
  Sect. 8,1956, 9: No. 2242.
  Kline, N. S., Saunders, J. C.  Reserpine in psychiatric
  and neurologic disorders.  Med.  Clin.  N. America, 1957,
  41:307-326.
  Kron, R.   Zur  medikamentosen  Behandlung von Herz-
  neurosen.  [Medical management of cardiac  neuroses.]
  Praxis, Bern, 1956, 45 : 872-873.
  Lapinsohn, L. I.  Ritalin and serpasil in the treatment
  of Parkinson's  disease.  Dis. Nerv. Syst., 1956, 17: 363-
  364.
  Mielke,  F.  A.  Uber die medikamentose und  psycho-
  therapeutische  Fuhrung  der Serpasil-Kur.  [Medical
  and psychotherapeutic management of serpasil therapy.]
  Schweiz. med.  Wschr.,  1956, 86:162-165.  Abstract:
  Excerpta med., Sect. 8, 1957, 10: No. 1531.
  Niswander, G. D., Holt, E. K.  Combination reserpine-
  methylphenidylacetate  in epileptics  with psychosis.
  Dis. Nerv. Syst, 1957,18 : 11-15.
  Sottong, P. C.  The use and abuse of the tranquilizing
  drugs.   J. Tennessee M. Ass., 1956, 49: 413-418.
  Tice, L.  F.  Some important drug developments of 1956.
  Am. J. Pharm., 1956,128: 398-409.

with METHYLPHENIDYLACETATE  and CHLORPRO-
    MAZINE
  see  CHLORPROMAZINE  with  RESERPINE  and
    METHYLPHENIDYLACETATE

with METHYLPHENIDYLACETATE and MEPROBA-
    MATE
  see MEPROBAMATE with RESERPINE and  METH-
    YLPHENIDYLACETATE

with   METHYLPHENIDYLACETATE  and   OTHER
    DRUGS [anticonvulsants]—COMBINED
  Ferguson, J. T., Linn, F. V.  A new compound for the
  symptomatic treatment of tension and anxiety:  2-ethyl-
  crotonylurea [nostyn].  Antibiotic 31., 1956, 3: 329-333.
  Niswander, G. D., Holt, E. K.  Combination reserpine-
  methylphenidylacetate  in  epileptics with  psychosis
  Dis. Nerv. Syst., 1957,18 :11-15.

with N-OBLIVON—COMPARED
  see N-OBLIVON—Studies, animals

with PERPHENAZINE—COMBINED
  see PERPHENAZINE with RESERPINE

with PIPRADROL—COMBINED
Therapeutic studies, controlled
  Cohen,  S.  Clinical  experiences with pipradrol and  a
  pipradrol-reserpine  combination.  Internat. Rec.  M.,
  1956, 169: 751-756.
  Le Guillant.  Le syndrome neuroleptique: prevention et
  traitement.   [The neuroleptic  syndrome:  prevention
  and treatment.]  Ann. med. psychol, Par., 1957, 115
  (1) : 329-338.
  Martin,  K. E., Overley, H. G, Krone, R. E.  Pipradrol:
  combined therapy for geriatric  and agitated patients.
  Internal Rec. M., 1957,170: 33-36.
  Pennington,  V.  M. A  comparative  study   of  six
  ataraxics in 1130 neuro-psychiatric cases.  Mississippi
  Doctor, 1956, 33 : 336-339.
Therapeutic use
  Antos, R. J.  Meratran.  Use of a new antidepressant
  in internal medicine.  Southwest 31., 1955, 36:166-167.
  ----.  Use  of an antidepressant  in  general practice.
  31 ed Times, Great Neck, 1955, 83: 612-614.

with PROMAZINE
  see PROMAZINE with RESERPINE

with RAUWOLFIA CANESCENS ALKALOIDS
  see RAUWOLFIA  CANESCENS ALKALOIDS with
    RESERPINE

with RAUWOLFIA SERPENTINA ALKALOIDS
  see RAUWOLFIA  SERPENTINA ALKALOIDS with
    RESERPINE

with RESCINNAMINE
  see RESCINNAMINE with RESERPINE

with SEROTONIN
  see SEROTONIN with  RESERPINE
158 
SUBJECT  LIST
Reserpine :  with Other drugs Compared : Studies, normal subjects
 with YOHIMBINE—COMPARED

 Pharmacodynamics
  Meyers, F. H.  Pharmacology of chlorpromazine, reser-
  pine and related drugs.  In: Kline, N. S., ed.  Psycho-
  pharmacology.  Washington, Am.  Ass.  Adv. Sc, 1956.
  p. 131-140.
  Rinkel, M., Solomon,  H. C.   Chemical theories of psy-
  chosis.  J. Clin. Exp.  Psychopath., 1957, 18 : 323-334.


 with OTHER DRUGS—COMBINED
 Studies, animals
  Arian, E., Gomirato, G.  Recherches experimentales sur
  l'inhibition des  etats d'excitation d'origin sous-corticale
  par moyen de  la  chlorpromazine et de la reserpine;
  communication  preliminaire.   [Experimental studies on
  the inhibition of sub-cortical excitation by chlorproma-
  zine and  by reserpine; preliminary communication.]
  [morphine]   Encephale, 1956, 45:1264-1266.
  Brodie, B. B., Shore,  P. A., Silver S.  L.  Potentiating
  action of chlorpromazine and reserpine. Nature, Lond.,
  1955,  175:1133-1134.   Abstract:  Chem.  Abstr., 1956,
  50: 479g.
  Salmoiraghi,  G. C, Sollero, L., Page,  I. H. Blockade
  by  brom-lysergic-acid-diethylamide   (BOL)   of  the
  potentiating  action   of  serotonin and reserpine  on
  hexobarbital  hypnosis.  J.  Pharm.  Exp. Ther., 1956,
  117:166-168.  Abstract: Chem. Abstr., 1956, 50: 14105-
  £h.
  Schneider, J. A.   Reserpine antagonism of morphine
  analgesia  in  mice.  Proc. Soc. Exp.  Biol,  N. Y., 1954,
  87: 614-615.  Abstract: Chem. Abstr.,  1955, 49 : 4165ef.

 Studies, normal subjects
  Fraser,   H.  F.,   Isbell,   H.   Chlorpromazine  and
  reserpine.   A. Effects of each  and of  combinations of
  each with morphine.  B. Failure of each in treatment
  of abstinence from morphine. A. M. A. Arch.  Neur.
  Psychiat., 1956, 76 : 257-262.
  Kleinsorge, H.,  Gossmann, K.  Die Flimmerverschmel-
  zungsfrequenz als Testmethode ftir den Nachweis einer
  potenzierenden  Wirkung von Reserpin auf Barbiturate.
  [Flicker fusion frequency as a test  method for deter-
  mination of the potentiating effect of reserpine on bar-
  biturates.]  Arzneimitt. Forsch., 1956, 6: 495-496.

Studies, patients
  De Caro,  D.  Modificazioni  E. E. G.  provocate dalla
  reserpina nell'uomo.   [Electroencephalographic changes
  in  man  induced   by   reserpine.]   [metrazol]   Arch.
  psicol. neur., Milano, 1956,17 : 581-591.

Therapeutic  studies, controlled
  Boudwin, J., Kline, N. S.  Use of  reserpine in chronic
  non-disturbed psychotics.  [analeptics]  Psychiat. Res.
  Rep., Wash., 1956 (4) : 71-78.
  Calloway,  N.  O. Tranquilization and  sedation by the
  use of a combination  of small doses of reserpine and
  pentobarbital  sodium.   Illinois M. J.,  1956, 110: 232-
  234
  Kinard, S., Mills, L. C, Terrell, J., Moyer, J. H. Use  of
  d-amphetamine to curb the increased  appetite and over-
  eating induced  by  reserpine therapy.  J. Am. Geriat.
  Soc, 1956,  4:1073-1077.
  Kleinsorge, H.,  Gossmann, K.   Die Flimmerverschmel-
  zungsfrequenz als Testmethode ftir den Nachweis einer
  potenzierenden Wirkung von Reserpin auf Barbiturate.
  [Flicker  fusion  frequency as a test method for deter-
 mination of the  potentiating effect of reserpine on bar-
 biturates.]   Arzneimitt.  Forsch., 1956,  6 : 495-496.
 Le Guillant  Le syndrome neuroleptique: prevention  et
 traitement.  [The   neuroleptic  syndrome:   prevention
 nnri  treatment.]    [amphetamine;  trihexyphenidyl]
 Ann  me'd. psychol, Par., 1957, 115  (1) : 329-338.
 Pelzman, O.,  Conigliaro, V.   Osservazioni  preliminari
   sulT uso clinico di un derivato di Rauwolfia serpentina
   in malati di mente.   [Preliminary study on the clinical
   use  of a Rauwolfia serpentina derivative in mental
   patients.]  [ethchlorvynol]   [English summary]  Gior.
   psichiat, 1955, 83:  131-147.  Abstract: Excerpta med.,
   Sect. 8, 1956, 9 : No. 1221.
   Randolph, A. G, Thompson, L. J.  The use of dimethy-
   lane-reserpine combination in mental disorders; a pre-
   liminary report.  North Carolina M. J., 1957, 18: 17-20.
   Rashkis, H. A.,  Smarr,  E. R.   Drug and milieu effects
   with chronic schizophrenics,   [amobarbital;  trihexy-
   phenidyl]  A. M. A. Arch. Neur. Psychiat, 1957, 78: 89-
   94.
   Ricci, G. C, Ricordati, M.  Un alcaloide della Rauwolfia
   serpentina nella terapia della  ipertensione e di alcune
   psicopatie;  rassegna  critica  ed  esperienze  cliniche.
   [Rauwolfia serpentina alkaloid in the treatment of hy-
   pertension and  of certain psychopathies; critical con-
   siderations   and  clinical  experiences.]   [sedatives]
   [English summary p. 128] Rass. fisiopat., 1954, 26:91-
   131.

Therapeutic use
   Avol, M., Vogel, P. J.  Treatment of delirium  tremens
   with reserpine (serpasil)  : a  preliminary report,  [par-
   aldehyde] J. Am. 31. Ass.,  1955,  159:1516-1520.   Ab-
   stract : Excerpta med., Sect. 8,1956, 9: No. 4001.  Year-
   book of drug therapy, 1956-1957, p. 338.
   Delay, J., Deniker, P.  Peut on comparer la reserpine a
   la chlorpromazine?   [Can one compare reserpine with
   chlorpromazine?]   [barbiturates]   Arch, psicol neur.,
   Milano, 1956,17: 631-633.
   Garcia, J. A., Ferreira, L. R.   Investigates terapeuticas
   com um dos alcaloides da Rauwolfia serpentina.   [Ther-
   apeutic tests of one of  the Rauwolfia serpentina alka-
   loids.]   [ganglioplegics]  [English summary]  Rev.
   brasil. med., 1955, 12 : 291-294.
   Huchtemann, K., Pflugfelder,  G. Serpasilkuren in der
   Psychiatrie;  Bericht fiber 100 Kuren.  [Serpasil ther-
   apy in psychiatry; report on 100 cases.]  [barbiturates]
   Schweiz.  med.  Wschr.,  1955,  85:627-630.  Abstract:
   Excerpta med., Sect. 8,1956, 9: No. 2242.
   Jeri, R.  Observaciones  con la reserpina (serpasol)  en
   sujetos sanos y en  pacientes  psiquiatricos.   [Observa-
   tions with reserpine (serpasol) in normal subjects and
   in psychiatric patients.]    [anticonvulsants]  Rev. neur.
   psiquiat, Lima,  1955, 18:108-124.  Abstract as : Effects
   of reserpine  in  psychiatric patients.   J. Am. M. Ass.,
   1955, 157: 530.  Abstract: Excerpta med., Sect. 8, 1956
   9: No. 1225.                                         *
   Kline,  N. S.  Clinical applications of  reserpine.   In:
   Kline,  N. S.,  ed.  Psychopharmacology.  Washington
   Am. Ass. Adv. Sc, 1956.  p. 81-108.
  ----, Barsa, J., Gosline, E. Management of (the) side
   effects of reserpine and  combined reserpine-chlor-
   promazine treatment.  Dis. Nerv.  Syst., 1956, 17: 352-
  358.  Also: Himwich, H.  E.,  ed.  Tranquilizing drugs.
   Washington, Am. Ass. Adv.  Sc, 1957.  p. 149-161.
  ----, Saunders, J.  C.  Reserpine  in psychiatric and
   neurologic disorders.  Med. Clin. N. America, 1957  41 •
   307-326.
  Mielke, F. A.  Uber die  medikamentose und  psycho-
   therapeutische  FUhrung  der   Serpasil-Kur.   [Medical
   and psychotherapeutic management of serpasil therapy.]
   [sedatives]  Schiveiz. med.  Wschr., 1956,  86:162-165
  Abstract: Excerpta  med., Sect. 8, 1957, 10: No.  1531
  Noce, R.  H., Williams, D. B., Rapaport, W.  Reserpine
   (serpasil)  in the  management  of the mentally  ill
   [barbiturates]   J.  Am. 31.  Ass.,  1955,  158:  11-15.

with OTHER DRUGS—COMPARED
Studies, normal subjects
  Lehmann, H.  E., Csank,  J.  Differential screening of
  phrenotropic agents in man : psychophysiologic test data.
159 
Reserpine : with Other drugs Compared : Studies, normal subjects
PSYCHOPHARMACA
   [depressants; stimulants]  J.  Clin. Exp. Psychopath.,
   1957, 18:222-235.

Therapeutic studies, controlled
   Abse, D. W., Curtis, T. E., Dahlstrom, W. G., Hawkins,
   D. R., Toops, T. C.  The use of reserpine in the manage-
   ment of acute mental disturbance on an in-patient serv-
   ice; preliminary report,  [powdered  opium]  J. Nerv.
   Ment. Dis., 1956,124 : 239-247.
   Calloway, N. O.  Tranquilization  and sedation  by the
   use of a combination of small doses of reserpine and
   pentobarbital sodium.   Illinois 31. J., 1956, 110:  232-
   234.
   Pelzman,  O., Conigliaro,  V. Osservazioni preliminari
   sulT uso clinico  di un derivato  di Rauwolfia serpentina
   in malati di mente.  [Preliminary study on the clinical
   use  of  a Rauwolfia  serpentina derivative in  mental
   patients.]   [ethchlorvynol]   [English summary] Gior.
   psichiat, 1955, 83 : 131-147.  Abstract: Excerpta med.,
   Sect. 8,1956, 9: No. 1221.


with MUSIC
Therapeutic studies, controlled—Psychoses
   Altshuler, I. M.  Music potentiating drugs. A prelim-
   inary report.  Music therapy, 1955, 5: 120-126.

with PSYCHOSURGERY—COMPARED
   see under RESERPINE with SHOCK  THERAPIES-
    COMPARED

with SHOCK  THERAPIES—COMBINED
  Jeri  R.  Observaciones  con  la reserpina (serpasol) en
   sujetos sanos y  en pacientes psiquiatricos.  [Observa-
   tions with reserpine (serpasol) in normal subjects and
   in  psychiatric  patients.]   [English  summary]  Rev.
   neur. psiquiat, Lima, 1955, 18:108-124.  Abstract as :
   Effects of reserpine in psychiatric  patients.   J.  Am.
  M. Ass., 1955, 157 : 530.  Abstract:  Excerpta med., Sect.
  8,1956, 9: No. 1225.
  Macchi, G.   Trattamento combinato  di reserpina con
   altre terapie psichiatriche.  [Reserpine combined with
   other  psychiatric   therapies.]   [English  summary]
  Arch, psicol. neur., Milano, 1956,  17:661-670.

with  SHOCK THERAPIES—COMPARED
  Ayd, F. J., Jr. A critique of chlorpromazine and reser-
  pine therapy.  In: Himwich, H. E., ed.  Tranquilizing
  drugs.  Washington, Am.  Ass. Adv. Sc, 1957.   p. 173-
  181.
  Margolis, L. H.  Pharmacotherapy in psychiatry; a re-
  view. Ann.  N. York Acad.  Sc, 1957,  66: 698-718.

with SHOCK THERAPY  [ECT]—COMBINED
  Bennett,  A.  E.  Clinical trial of reserpine in psychotic
  and  psychoneurotic illnesses.  In: Kline,  N.   S.,  ed.
  Psychopharmacology.   Washington, Am. Ass. Adv. Sc,
  1956.  p. 109-117.
  ---, Ford, F. R., Turk, R. E.  Clinical investigation of
  chlorpromazine  and reserpine  in private psychiatric
  practice.  Am. J. Psychiat.. 1956,  112: 782-787.  Con-
  densed : Am. Practitioner, 1956, 7: 1576-1577.
  Abstract: Excerpta med., Sect. 8, 1956, 9: No. 4546.
  Bente, D.  Elektronencephalographische Ergebnisse zur
  Wirkungsweise  der  neuroleptischen  Behandlungsver-
  fahren.  [Mechanism of action of neuroleptic therapies ;
  EEG findings.]   Encephale,  1956, 45 : 898-903.
  Bordeleau, J. M.   Clinical evaluation of chlorpromazine
  and Rauwolfia serpentina in the psychiatric department
  of  a general hospital.  J.  Florida M. Ass., 1956, 42:
  547-554.
  Carillo-Broatch,  A.  Tratamiento  de la esquizofrenia
  cronica.   [Treatment of chronic schizophrenia.]   [Eng-
  lish summary]   Rev.  neur.  psiquiat, Lima, 1955, 18:
  441-445.  Abstract: Excerpta med.,  Sect. 8, 1957, 10:
  No. 1981.
  Ferguson, R.  S.  Influences  of reserpine on E. C. T.:
  preliminary observations.  J. Ment.  Sc, Lond.,  1956,
  102: 826-829.
  Foster, M. W., Jr., Gayle, R. F., III. Chlorpromazine
  and reserpine as  adjuncts in electroshock treatment.
  South. 31. J., 1956, 49: 731-735.                    * *
  ---, Gayle, R. F., Jr.  Dangers in combining reserpine
  (serpasil) with electroconvulsive therapy.  J. Am. M.
  Ass.,  1955, 159:1520-1522.  Abstract: Excerpta med.,
  Sect. 8, 1956, 9: No. 4067.  Year book of drug  therapy
  1956-1957, p. 325-326.                             * *
  Gosline, E., Kline, N. S.  Use of reserpine on an admis-
  sion service.  Psychiat. Res. Rep., Wash., 1955 (1) : 112-
  121.
  Huchtemann,  K., Pflugfelder, G.  Serpasilkuren in der
  Psychiatrie; Bericht fiber 100 Kuren.   [Serpasil  ther-
  apy in psychiatry; report on 100 cases.]  Schweiz. med
  Wschr., 1955, 85:627-630.  Abstract: Excerpta med
  Sect. 8,1956, 9: No. 2242.
  Kirkpatrick, W. L., Sanders, F.  Clinical evaluation of
  reserpine in a state  hospital.  Ann. N. York Acad. Sc
  1955, 61: 123-143.
  Lauterbbck, J. J., Nagy, K.   Anstaltserfahrungen mit
  dem Rauwolfia-Alkaloid Reserpin.   [Hospital experi-
  ences with the Rauwolfia alkaloid reserpine.]  Wien
  klin. Wschr., 1955, 67 : 839-843.
  Lewis, L. F.   The use of chlorpromazine  and of serpasil
  in the treatment of psychotic patients.  Carib. 31. J.,
  Trinidad, 1956,18: 51-66.
  Margolis, L. H.  Pharmacotherapy in psychiatry;  a re-
  view.   Arm. N. York Acad. Sc, 1957,  66: 698-718.     *
  Negri, V. U.,  Garavaglia,  G.  Rilievi clinici sulla pe-
  culiare azione della  reserpina in psichiatria.   [Reser-
  pine in psychiatry; a clinical study on its characteristic
  action.]  3Iinerva med.,  Tor., 1955, 46:  1217-1229.
  Noce, R. H., Williams, D. B.,  Rapaport,  W.  Reserpine
  (serpasil) in the management of the mentally ill.  J
  Am, M. Ass., 1955,158 :11-15.
  Resch, J. A., Schut, J. W., Bernstein,  I. C.  Premedica-
  tion in electric convulsive therapy.   Am. J. Psychiat,
  1956, 113: 78.                                       *
  Rhijn, C. H. van   De invloed  van reserpine (serpasil)
  op acute en chronische geestesziekten.  [The effects of
  reserpine on acute and chronic mental  diseases.]  [Eng-
  lish summary] Ned.  tschr. geneesk., 1956,  100:1775-
  1790.
  Schneider, H.   Erfahrungsbericht fiber Rauwolfia-Alka-
  loid-Behandlung.   [Experiences with Rauwolfia  alka-
  loid therapy.]   Nervenarzt, 1956, 27:  72-75.  Abstract:
  Excerpta med., Sect. 8,1957,10 : No. 2088.
  Smith, S. K.  The use of reserpine in private psychiatric
  practice. Ann. N. York Acad.  Sc,  1955, 61:206-210.
  Abstract: Excerpta med., Sect. 8, 1956, 9. No. 1227.
  Struck, G.  Zur Rauwolfia-Therapie in der Psychiatrie;
  vorlaufige Mitteilung  fiber 65  behandelte  Patienten.
  [Rauwolfia therapy in psychiatry; preliminary report
  on 65 treated patients.]  Nervenarzt, 1956, 27 : 79-82.
  Tasher, D. C,  Chermak, M. W. The use  of reserpine in
  shock-reversible patients and shock-resistant  patients.
  Ann. N. York  Acad. Sc, 1955, 61:108-116.  Abstract:
  Excerpta med., Sect. 8,1956, 9 : No. 1733.

Untoward effects [see headnote p. 19]
  Baudoin, de  Accident mortel par association de l'eiec-
  trochoc a une  cure de reserpine.  [Fatal accident  with
  combination of  electroshock  and reserpine therapy.]
  [Abstract.]   Presse me'd., 1956, 64: 1174.          * *
  Bracha, S., Hes,  J.  P.  Death occurring during  com-
  bined  reserpine-electroshock  treatment.   Am   J  Psy-
  chiat., 1956,  112:745.                             * *
  Bross, R. B.   Near fatality with combined ECT and re-
  serpine.  Am. J. Psychiat., 1957, 113 : 933.
  Dean, S. R.  Ataractics.  Am. J. Psychiat., 1956,  112:
160 
SUBJECT  LIST
Serotonin : Studies, animals
  Epstein,  J.  Drugs   and  electroconvulsive  therapy.
  J. Am. M. Ass., 1956,160: 503.
  Hiob, J., Hippius, H.  Klinische Erfahrungen  mit dem
  Rauwolfia-Alkaloid Reserpin in der Psychiatrie.  [Clin-
  ical experiences with  the Rauwolfia alkaloid reserpine
  in psychiatry.]  Deut. med. Wschr., 1955, 80:1497-1500.
  Kalinowsky, L. B.  The danger of various types of med-
  ication during electric convulsive therapy.   Am. J. Psy-
  chiat, 1956,112: 745.                              * *
  Kurz, C.  A propos de la reserpine.  [Reserpine]  Gaz.
  med. France, 1956, 63 : 877-881.                    * *
  Luiz, H. A.  Experiences with the use of  reserpine on
  the chronically disturbed mental patient.   &. Afr. M. J.,
  1956, 30:1049-1051.

with  SHOCK THERAPY [ECT]—COMPARED

  Barsa, J. A., Kline,  N.  S.  Use  of reserpine in disturbed
  psychotic patients.  Am. J. Psychiat., 1956,112: 684-691.
  Abstract: Excerpta med., Sect.  8,1956, 9 : No. 4543.
  Davies, D. L.,  Shepherd,  M.  Reserpine in the treatment
  of anxious and depressed patients.  Lancet, Lond., 1955,
  2:117-120.  Abstract: Excerpta med., Sect.  8, 1956, 9:
  No. 1224.
  Hickerson, G. X., Jr., Swain, J. M., Tempey,  F. W.  Re-
  serpine  in acute psychotic states ; report of a controlled
  study.  J.  Nerv.  Ment. Dis., 1956, 124: 614-617.
  Naidoo, D.  The effect of reserpine  (serpasil) on the
  chronic  disturbed schizophrenic: a comparative study
  of Rauwolfia  alkaloids and electroconvulsive  therapy.
  J. Nerv. Ment. Dis., 1956, 123 :1-13.
  Tasher, D. C,  Chermak, M. W.   The use of reserpine in
  shock-reversible patients and  shock-resistant patients.
  Ann. N. York Acad. Sc, 1955, 61:108-116.  Abstract:
  Excerpta med., Sect. 8,1956, 9:  No. 1733.
SKF-5
 Hagenauer, F., Rudy, L. H., Himwich, H. E.  A compara-
 tive evaluation  of the two  new  central nervous  sys-
 tem stimulants in severe psychoses.  J. Clin. Exp. Psy-
 chopath., 1957, 18 : 248-257.   Condensed as: A compara-
 tive study of two central nervous system stimulants,
 MER-22 and S. K. F. # 5, on chronic, blocked and with-
 drawn psychotic patients.  Am. J. Psychiat., 1957, 113:
 840.
SEROTONIN
 Callaway, E.,  III.  On the production of hallucinated
 and psychosis-like states.  Ann. Int. M.,  1955, 42: 721-
 728.
 Carr, C. J., Kinnard, W. J., Jr.  The phrenotropic agents.
 Internat. Rec. M., 1957, 170: 493-504.
 Cerletti, A., Rothlin,  E.  Role of 5-hydroxytryptamine
 in mental diseases and its antagonism to lysergic acid
 derivatives.   Nature,  Lond.,  1955,  176:785-786.  Ab-
 stract : Chem. Abstr., 1956, 50: 4389 fgh. Excerpta med.,
 Sect. 8,1957,10: No. 973.
 The chemical concept  of psychoses.  What's new, 1955
 (189)  : 3-7.
 Cossio, M.  Rapporti tra reserpina (serpasil)  e 5-idros-
 sitriptamina: nota preventiva.  [Relation between  res-
 erpine  (serpasil)  and 5-hydroxytryptamine; prelim-
 inary note.]   Riv. sper. freniat., 1955, 79: 865-867.
 Delay,  J., Thuillier, J.  Psychiatrie experimentale et
 psychopharmacologie.   [Experimental  psychiatry  and
 psychopharmacology.]   Sem. hdp. Paris, 1956, 32: 3187-
 3193
 Fabing, H. D.   Trends in biological  research in schizo-
 phrenia.  J. Nerv. Ment. Dis., 1956, 124:1-7.
 Jarvik. M  E.   Mechanism  of action of  lysergic acid
 diethylamide, serotonin, and related drugs.  In: Kline,
   N.   S.,  ed.  Psychopharmacology.  Washington,   Am.
   Ass. Adv. Sc, 1956.  p. 145-154.
   Jatzkewitz, H.  Pharmakologische Aspekte in der  Schi-
   zophrenieforschung.    [Pharmacological  aspects  in
   schizophrenia research.]   Nervenarzt,  1956, 27:  150-
   152.
   Klingman, W.  O.  Neurological and psychiatric dis-
   orders;  some  recent  advances  in  therapy.   Virginia
   M. Month., 1956, 83: 240-246.
   Leake,  C. D.   Drugs  affecting  mood  and  behavior.
   Texas  Rep.  Biol.  31.,  1955,  13:793-818.  Abstract:
   Chem. Abstr., 1956  50: 9615b.
   Page, I. H.  Chemistry of the brain.  Past imperfect,
   present indicative,  and—future perfect?  Science,  1957,
   125: 721-727.
   ---.  Serotonin   (5-hydroxytryptamine).     Physiol.
   Rev., 1954, 34: 563-588.
   ----, McCubbin, J. W.  Serotonin  or  tenure for the
   pharmacologist.  Circulation, N. Y.,  1956, 14:161-162.
   Pennes,  H. H.  The nature of drugs with  mental ac-
   tions and  their  relation to cerebral function.   Bull.
   N. York Acad. M., 1957, 33: 81-88.
   Psychobiology  and drugs. Internal Rec.  31.,  1956,
   169:231-232.
   Rinkel, M., Solomon, H. C. Chemical theories of psy-
   chosis.  J. Clin. Exp. Psychopath., 1957, 18: 323-334.
   Rothlin, E.,  Cerletti, A.  Pharmacology  of  LSD-25.
   In:  Cholden, L., ed.  Lysergic acid  diethylamide and
   mescaline  in  experimental  psychiatry.   New  York,
   Grune d Stratton, 1956.   p. 1-7.
   Serotonin. J. Am. M. Ass., 1956, 161: 460-461.
   Shaw, E. (N.), Woolley, D. W.  Methylserotonins as
   potent antimetabolites of serotonin active both in  vitro
   and in vivo.  J. Pharm. Exp. Ther., 1956, 116:164-176.
   Thuillier, J.  La  serotonine.   [Serotonin.]    Concours
   med., 1956, 78 : 3177-3181.
   Wikler,  A.  The relation  of psychiatry  to pharma-
   cology.   322  p.   Baltimore, Williams d Wilkins  [for
   the American  Society for Pharmacology and Experi-
   mental Therapeutics] 1957.
   ---.   The use of drugs in psychiatric research.  Am.
   J. Psychiat, 1956, 112: 961-969.
   Woolley, D. W., Shaw, E.  A biochemical and pharma-
   cological suggestion  about certain mental  disorders.
   Proc. Nat. Acad. Sc. U. S., 1954, 40: 228-231.  Abstract:
   Science, 1954,119: 587-588.
   ----,----. Evidence for the participation of serotonin
   in mental processes. Ann.  N. York Acad. Sc, 1957, 66:
   649-667.
   ----,  ----.  Some  neurophysiological aspects  of  sero-
   tonin.  Brit. M. J., 1954, 2:122-126.
   Wortis, J.  Physiological treatment.  Am. J. Psychiat.,
  1957, 113: 611-615.

Studies, animals
   Besendorf, H., Pletscher,  A.  Beeinflussung zentraler
   Wirkungen  von Reserpin und  5-Hydroxytryptamin
   durch Isonicotinsaurehydrazide.  [The influence of iso-
  nicotinic acid  hydrazides  on  the  central  effects  of
   reserpine and of 5-hydroxytryptamine.]   [English  sum-
  mary]  Helvet. physiol pharm. acta, 1956, 14: 383-390.
  Bianchi,  C.  Reserpine and serotonin in experimental
  convulsions.  Nature, Lond., 1957,  179: 202-203.
  Bonamini, F.,  Garello, L.  Catatonia sperimentale nei
  cani da  5-idrossitriptamina, introdotta  nella  cisterna
  magna.   [Experimental catatonia in dogs induced  by
  5-hydroxytryptamine,   introduced  into  the   cisterna
  magna.]   Sistema  nerv.,  Milano,   1956,  8:157-166.
   [Not, seen]
  Brown, B. B.  Lysergic acid diethylamide antagonism of
  certain drugs.  Ann. N. York  Acad. Sc, 1957, 66:677-
  685.
  Cook, L., Weidley,  E.  Behavioral effects of some psy-
  chopharmacological agents. Ann. N. York Acad. Sc,
  1957, 66: 740-752. 
Serotonin : Studies, animals
PSYCHOPHARMACA
 Dolce, G., Garello, L.  La catalessia de serotonina nella
 Rana  esculenta:  tecnica  sperimentale.   [Catalepsy
 caused by serotonin  in  Rana  esculenta; experimental
 technic]  Boll Soc.  ital biol sper., 1956, 32: 441-443.
 Feldberg, W., Sherwood, S. L.  Injections of drugs into
 the  lateral ventricle  of  the cat.   J.  Physiol,  Lond.,
 1954, 123:148-167.
 ----, ----.  Intraventricular injections  of  acetylcho-
 line  and of 5-hydroxytryptamine (serotonin)  into  the
 conscious cat.   J. Physiol,  Lond., 1953, 120:12P.
 Garello,  L., Dolce, G.  Intorno  alia azione risolvente
 della dietilamide  dell'acido  lisergico  e della  metilan-
 fetamina  sulla catalessia sperimentale da  5-idrossi-
 triptamina  (5 HT) ;  ricerche sperimentali sui  cane.
 [Antagonistic effect of diethylamide  of lysergic acid
 and  of methylamphetamine  on experimental catalepsy
 caused by 5-hydroxytryptamine;  experimental  research
 on dogs.]   [English summary]  Sistema nerv., 31ilano,
 1956,  8:61-80.  Abstract:   Chem,  Abstr.,  1956,  50:
 17196a.
 ----, ----.  Modificazione degli  effetti  della stricnina
 sulla funzione  motoria della Rana  esculenta  determi-
 nata dalla somministrazione  di serotonina.   [Modifica-
 tion  of the effects of strychnine on motor function in
 Rana esculenta through administration of  serotonin.]
 Boll Soc.  ital. biol. sper., 1956, 32 : 443-445.
 Haley, T. J., McCormick, W. G.  Pharmacological effects
 produced by intracerebral injection of drugs in the con-
 scious mouse.  University of  California, School of 3Iedi-
 cine, Atomic Energy Project,  Los  Angeles, 1956 (UCLA-
 372)  : 1-25.
 Marrazzi,  A. S.  The effects of certain drugs on cerebral
 synapses.   Ann. N. York Acad. Sc, 1957, 66: 496-507.
 ----, Hart, E. R.  An electrophysiological analysis of
 drugs unseful in psychotic states.  In: Himwich,  H. E.,
 ed.  Tranquilizing drugs.   Washington, Am. Ass. Adv.
 Sc.,1951.  p. 9-21.
 ----,----.  An electrophysiological analysis of the  ac-
 tions of some drugs useful in the therapy of psychotic
 disorders.   J. Nerv. Ment. Dis., 1956, 124: 388-392.
 ----,----•  The possible role  of inhibition at adrenergic
 synapses in the mechanism of hallucinogenic and related
 drug actions.  J. Nerv. Ment. Dis., 1955, 122:453-457.
 Pfeiffer, C. C, Jenney, E. H.  The inhibition of the con-
 ditioned response and the counteraction of schizophrenia
 by muscarinic stimulation of the brain.  Ann.  N.  York
 Acad. Sc, 1957, 66: 753-764.
 Sacchi, U., Bonamini, F., Dolce, G., Garello,  L.  Dietil-
 amide dell'acido lisergico e catalessia da 5-idrossitrip-
 tamina nel cane.  [Lysergic  acid diethylamide and 5-
 hydroxytryptamine catalepsy in dogs.]   Boll. Soc ital.
 biol. sper., 1955, 31: 665-667.
 ----,  ----,  Garello, L., Dolce, G.   Studio  delT azione
 catalettizzante della 5-HT per introduzione nel sistema
 ventricolare o negli spazi subaracnoidei del cane.  [Cat-
 aleptic  action of 5-HT introduced into  the ventricular
 system or subarachnoid space in dogs.]   Boll Soc. ital.
 biol sper., 1956, 32 :179-182.   Abstract: Chem. Abstr.,
 1956, 50: 6680gh.
 ----, Brusa,  A.,  Gianniotti,  G.  Lesioni del  sistema
 nervoso  centrale  del  Carassius auratus da  5 HT  ed
 azione protettrice dell'LSD.   [Lesions of the central
 nervous  system in Carassius auratus  caused by  sero-
 tonin and the protective action of lysergic acid diethyl-
 amide.]  Boll Soc. ital. biol  sper., 1956, 32:438-411.
----, Garello, L., Dolce, G., Bonamini, F. L'azione cat-
alettizzante della 5-idrossitriptamina introdotta  nella
cisterna  magna  del  cane.   [Cataleptic action  of  5-
hydroxytryptamine introduced into the cisterna magna
of dogs.]  Boll. Soc. ital. biol  sper., 1955, 31: 663-665.
Salmoiraghi, G. C, Sollero, L., Page, I. H. Blockade by
brom-lysergic-acid-diethylamide (BOL)  of the poten-
tiating action of serotonin and reserpine on hexobarbital
   hypnosis.   J.  Pharm.  Exp. Ther., 1956, 117:166-168.
   Abstract:  Chem.  Abstr., 1956,  50: 14105gh.
   Schwarz, B. E., Wakim, K. G., Bickford, R. G., Lichten-
   held,  F.  R.  Behavioral  and  electroencephalographic
   effects of hallucinogenic drugs ; changes in cats on intra-
   ventricular injection.  A.  M. A. Arch. Neur. Psychiat.,
   1956, 75: 83-90.
   Shaw, E., Woolley, D. W. Pharmacological properties of
   some  antimetabolites  of  serotonin having unusually
   high activity on isolated tissues.  J. Pharm. Exp. Ther.,
   1954, 111: 43-53.
   ----,----.  Yohimbine and ergot alkaloids as naturally
   occurring antimetabolites  of serotonin.  J. Biol. Chem.,
   1953,203: 979-989.
   Sherwood, S. L.  Effects  of drugs  on the behavior of
   animals and on  psychoses of  man.  In: Abramson,
   H. A., ed.  Neuropharmacology. Transactions of the
   second conference,  May 1955,  Princeton,  N. J.  New
   York,  Josiah 3Iacy,  Jr. Foundation, 1956.  p. 85-182.
   Shore, P. A., Silver, S. L.,  Brodie, B. B.  Interaction of
   reserpine, serotonin, and lysergic acid diethylamide in
   brain. Science, 1955,122: 284-285.
   ----,----,----.  Interaction of serotonin and lysergic
   acid diethylamide (LSD) in the central nervous system.
   Experientia, Basel, 1955,11: 272-273.

Studies, normal subjects
   Montanari,  C, Tonini,  G.  La  5-idrossitriptamina in
   psichiatria.   [5-Hydroxytryptamine   in  psychiatry.]
   Riv. sper. freniat., 1955, 79: 745-750.  Abstract:  Chem.
   Abstr., 1956, 50: 8065 i.
   Poloni, A.   Serotonina  e sehizofrenia.  1. Osservazioni
   sulle interferenze fra l'azione della  serotonina  (S.) e
   della dietilamide dell'acido lisergico (LSD. 25), mesca-
   lina (M.) e bulbocapnina (B.) nell'uomo e nell'animale.
   2. Azione della  serotonina (S.)  sola e associata  ai bar-
   biturici (Ba.), alia dietilamide dell'acido lisergico (LSD.
   25), alia mescalina  (M.) e alia  bulbocapnina (B.) sui
   tracciato  EEG. di schizofrenici, epilettici e altri  am-
   malati di mente.  [Serotonin and schizophrenia.  1. Ob-
   servations on the antagonism between serotonin, lysergic
   acid diethylamide, mescaline and bulbocapnine in man
   and animal.  2. Action of serotonin alone or associated
   with barbiturates, lysergic acid diethylamide, mescaline
   and bulbocapnine on the electro-encephalogram of pa-
   tients  with  schizophrenia,  epilepsy,  and other  mental
   diseases.]  [English summaries p. 292; 381.]   Cervello,
   1955, 31:271-294; 355-382.  Abstract:  Chem.  Abstr.,
   1956, 50: 8911ab.

Studies, patients

   see also  preceding reference tPOLONi]
           SEROTONIN—Studies, animals [Shekwood]
  Lafon, R., Boyer, Due, N., Minvielle, J., Pouget, R.  Ef-
  fets comparatifs de Tinjection intraveineuse de  seroto-
  nine et de reserpine; etude psychometrique neurovege-
  tative  et eiectroencephalographique.  [The comparative
  effects of intravenous serotonin and reserpine; a psycho-
  metric, neuro-autonomic and  electroencephalographic
  study.]  Ann. med. psychol, Par., 1956,  114 (2): 463-
  466.
  Sherwood, S. L.  The response of psychotic patients to
  intraventricular injections.  Proc. R.  Soc.  31.,  Lond.,
  1955, 48: 855-863.

Therapeutic studies, controlled

  see also  SEROTONIN—Studies, animals csherwood]
  Montanari,  C,   Tonini,  G.  La  5-idrossitriptamina in
  psichiatria.    [5-Hydroxytryptamine  in   psychiatry.]
  Riv. sper. freniat, 1955, 79: 745-750.  Abstract: Chem.
  Abstr., 1956, 50: 8065i.
  Poloni, A.  Esperienze cliniche con  la  serotonina  nelle
  malattie mentali.  [Clinical experiences with serotonin 
SUBJECT  LIST
Serotonin : with Medmain Interaction
    in mental illness.] Cervello, 1956, 32 : 243-246.  Abstract:
    Excerpta med., Sect. 8,1957,10: No. 1539.
    Sherwood, S. L.  The response of psychotic patients to
    intraventricular injections.   Proc. R.  Soc. M.,  Lond.,
(    1955, 48: 855-863.

  with ADRENOCHROME—INTERACTION
    Schwarz, B.  E., Wakim, K. G, Bickford, R. G., Lichten-
    held, F. R.   Behavioral and electroencephalographic ef-
    fects of hallucinogenic drugs; changes in cats on intra-
    ventricular injection.  A. M.  A. Arch. Neur. Psychiat,
    1956, 75: 83-90.

!  with ADRENOLUTIN—INTERACTION
    see preceding reference

  with CHLORPROMAZINE—INTERACTION
  Studies, animals
    Benditt, E.  P., Rowley,  D. A.  Antagonism of  5-hy-
    droxytryptamine  by chlorpromazine.  Science,   1956,
    123: 24.
    Garattini,  S., Valzelli,  L.  Sostanze  interferenti  sulla
    attivita potenziante gli  ipnotici svolta dalla serotonina.
    [Substances  that interfere with the potentiating effect
    of serotonine on hypnotics.]   Boll. Soc ital. biol. sper.,
    1956,  32:292-295.

  with IPRONIAZID—INTERACTION
  Studies, animals
    Besendorf, H., Pletscher, A.  Beeinflussung  zentraler
    Wirkungen   von   Reserpin  und  5-Hydroxytryptamin
    durch  Isonicotinsaurehydrazide.   The  influence  of
    isonicotinic acid  hydrazides  on the central effects of
    reserpine and of 5-hydroxytryptamine.]   [English sum-
    mary.]  Helvet. physiol pharm. acta, 1956, 14: 383-390.
    Brodie,  B. B., Pletscher, A., Shore, P. A.  Possible role
    of serotonin  in brain function and  reserpine action.
    [Abstract.]   J. Pharm.  Exp. Ther., 1956,  116:9.
    Chessin, M.,  Dubnick, B., Kramer, E. R., Scott,  C. C.
    Modifications of pharmacology of reserpine and.  sero-
    tonin  by iproniazid.   [Abstract.]  Fed.  Proc,  Bait,
    1956, 15: 409.
    Marrazzi, A. S.   The effects of certain drugs on cerebral
    synapses.  Ann. N. York Acad. Sc, 1957, 66: 496-507.

  with LYSERGIC ACID DIETHYLAMIDE—INTERAC-
     TION
   Cerletti, A., Rothlin, E.  Role of 5-hydroxytryptamine
   in mental diseases and its antagonism to  lysergic acid
   derivatives.   Nature,  Lond.,  1955,  176: 785-786.   Ab-
   stract : Chem. Abstr., 1956, 50:  4389fgh.  Excerpta med.,
   Sect. 8,1957,10: No. 973.
   Rothlin, E., Cerletti, A.  Pharmacology of LSD-25. In:
   Cholden, L., ed.  Lysergic  acid diethylamide and mes-
   caline  in experimental psychiatry.  New York,  Grune d
   Stratton, 1956.  p. 1-7.

 Studies, animals
  see also  under SEROTONIN—Studies, animals
           SEROTONIN—Studies, normal subjects
                           [P0L0NI:i
  Abramson, H. A.  Blocking of the LSD-25 reaction  in
  Siamese fighting fish.   In : Abramson, H.  A., ed.  Neuro-
  pharmacology. Transactions  of the third conference,
  1956,  Princeton,  N. J.  New York, Josiah  Macy,  Jr.
  Foundation, 1957.   p. 9-27.
  ___  Jarvik, M. E.  Lysergic acid diethylamide (LSD-
  25) ; IX. Effect on snails.  J. Psychol, Provincet.,  1955,
  40' 337—340.
  __1  Sklarofsky,  B.,  Baron, M.  O.,  Gettner, H.  H.
  Blocking  of brain extract on lysergic acid diethylamide
   reaction in  Siamese fighting fish.  Science, 1957,  125:
   397-398.
   ---■> ----,  ----,  ----.   Lysergic acid  diethylamide
   (LSD-25) antagonists.  I. Blocking effect of brain ex-
   tract in the Siamese  fighting fish;  preliminary report.
   A. M. A. Arch. Neur. Psychiat., 1957, 77: 439-445.
   Bradley, P. B., Hance,  A. J.  The  effects  of intra-
   ventricular injections of  d-lysergic acid  diethylamide
   (LSD-25) and 5-hydroxytryptamine (serotonin) on the
   electrical activity of the brain of the conscious cat.  J.
   Physiol, Lond., 1956,132: 50P-51P.
   Cerletti, A.  Lysergic acid diethylamide (LSD) and re-
   lated compounds.  In: Abramson,  H.  A., ed.  Neuro-
   pharmacology.  Transactions of  the second conference,
   May 1955, Princeton, N. J.  New York, Josiah Macy, Jr.
   Foundation, 1956.  p.  9-84.
   Keller, D. L., Umbreit, W. W.  Chemically altered per-
   manent behavior patterns in fish  and their cure by
   reserpine.  Science, 1956, 124: 407.
   ---, ----.  Permanent alteration of behavior in mice
   by chemical and psychological means.  Science,  1956,
   124: 723-724.
   Rothlin,  E.  Lysergic acid  diethylamide  and  related
   substances.  Ann. N. York Acad. Sc, 1957, 66: 668-676.
   Schwarz, B. E., Wakim, K. G, Bickford, R. G., Lichten-
   held, F. R.  Behavioral and electroencephalographic ef-
   fects of hallucinogenic drugs; changes in cats on intra-
   ventricular injection.  A.  M. A. Arch. Neur. Psychiat.,
   1956, 75: 83-90.  Abstract: Excerpta med.,  Sect. 8, 1957,
   10: No. 328.
   Turner, W. J.  The effect of lysergic acid diethylamide
   on Betta splendens: I. Dis. Nerv. Syst, 1956, 17:193-
   197.
   Winter, C. A.,  Flataker,  L.  Effects  of lysergic  acid
   diethylamide upon performance of trained rats.  Proc.
   Soc  Exp. Biol,  N. Y.,  1956,  92:285-289.  Abstract:
   Chem. Abstr., 1956, 50: 14891L
   Woolley, D. W.  Production of abnormal  (psychotic?)
   behavior in mice with lysergic acid diethylamide, and its
   partial prevention with cholinergic drugs and serotonin.
   Proc. Nat. Acad. Sc U. S., 1955, 41: 338-344.  Abstract:
   Chem. Abstr., 1956, 50:12286def.
   ---, Shaw, E. N.   Evidence for the  participation of
   serotonin in mental processes.  Ann. N. York Acad. Sc,
   1957,  66: 649-667.

 Studies, normal subjects and patients

   see also SEROTONIN—Studies, normal subjects
                           [POLONI]
   Montanari, C, Tonini, G.  Azioni della 5-idrossitripta-
   mina sui sistema  nervoso centrale;  suo impiego  in
   psichiatria sperimentale.   [Effects of 5-hydroxytrypta-
   mine  on the CNS; its use  in experimental  psychiatry.]
   Riv. sper.  freniat,  1955,  79: 465-483.  Abstract:  Ex-
   cerpta med., Sect. 8,1956, 9: No. 3076.

 with   LYSERGIC   ACID   DIETHYLAMIDE,  BRO-
    MINATED—INTERACTION
   Cerletti, A., Rothlin, E.  Role of 5-hydroxytryptamine
   in mental diseases and its antagonism to lysergic acid
   derivatives.  Nature, Lond., 1955, 176: 785-786.   Ab-
   stract : Chem. Abstr., 1956,  50: 4389fgh.  Excerpta med.,
   Sect. 8,1957,10: No. 973.
   Rothlin, E., Cerletti, A. Pharmacology of LSD-25.  In:
   Cholden, L., ed.  Lysergic  acid diethylamide and mes-
   caline in experimental psychiatry.  New York, Grune d
   Stratton, 1956.  p. 1-7.
 Studies, animals
   see LYSERGIC  ACID  DIETHYLAMIDE,  BROMI-
           NATED—Studies, animals

with MEDMAIN—INTERACTION  see MEDMAIN 
Serotonin : with Mescaline Interaction
PSYCH0PHAR31ACA
with MESCALINE—INTERACTION
Studies, animals
  see also  SEROTONIN—Studies, normal subjects
                           [POLONI]
  Cook, L., Weidley, E.  Behavioral effects of some psy-
  chopharmacological agents.  Ann.  N. York  Acad.  Sc,
  1957, 66: 740-752.
  Schwarz, B. E., Wakim, K. G., Bickford, R. G., Lichten-
  held, F. R.   Behavioral and electroencephalographic ef-
  fects of hallucinogenic drugs; changes in cats on intra-
  ventricular injection. A. M. A. Arch. Neur. Psychiat.,
  1956, 75 : 83-90.  Abstract: Excerpta med., Sect. 8,1957,
  10: No. 328.

Studies, normal subjects
Studies, patients
  see SEROTONIN—Studies, normal subjects [Polony

with RESERPINE—COMPARED
  Cossio, M.   Rapporti tra reserpina (serpasil) e 5-idros-
  sitriptamina ; nota preventiva.  [Relation between  re-
  serpine (serpasil) and  5-hydroxytryptamine; prelimi-
  nary note.]  Riv. sper, freniat, 1955, 79: 865-867.

Studies, patients
  see SEROTONIN—Studies, patients
        [LAFON, BOYER 4-otherS]

with RESERPINE—INTERACTION
  Rinkel, M., Solomon, H. C.  Chemical theories of psy-
  chosis.  J.  Clin, Exp. Psychopath., 1957, 18: 323-334.

Studies,  animals
  Bianchi,  C.  Reserpine and serotonin in experimental
  convulsions.  Nature, Lond., 1957,  179: 202-203.
  Brodie, B. B., Olin, J. S., Kuntzman, R. G., Shore, P. A.
  Possible  interrelationship  between  release  of brain
  norepinephrine  and  serotonin by  reserpine.  Science,
  1957, 125: 1293-1294.
  ---, Pletscher,  A., Shore, P. A. Evidence that serotonin
  has a role in brain function.  Science, 1955, 122: 968.
  ---, ----, ----. Possible role of serotonin in brain
  function and reserpine action.  [Abstract]   J.  Pharm.
  Exp. Ther., 1956, 116: 9.
  Garattini, S., Valzelli, L.  Sostanze interferenti sulla
  attivitil potenziante gli ipnotici svolta dalla serotonina.
  [Substances that interfere with the potentiating effect
  of serotonin on hypnotics.]  Boll.  Soc. ital.  biol. sper.,
  1956, 32: 292-295.
  Hess, S. M., Shore, P. A, Brodie, B. B.  Persistence of
  reserpine action after the disappearance of  drug from
  brain: effect of serotonin.  J. Pharm. Exp. Ther., 1956,
  118: 84-89.
  Pletscher, A., Shore, P.  A., Brodie, B. B. Serotonin as
  a mediator of reserpine action in brain.   J. Pharm. Exp.
  Ther., 1956, 116: 84-89.
  Shore, P. A. Carlsson, A., Brodie,  B. B.  Mechanism of
  serotonin-release by reserpine.  [Abstract]  Fed. Proc,
  Bait., 1956, 15: 483.
  ----, Silver, S. L., Brodie, B. B.  Interaction of reser-
  pine, serotonin, and lysergic acid diethylamide in brain.
  Science, 1955, 122: 284-285.

with YOHIMBINE—INTERACTION
  see YOHIMBINE—Pharmacodynamics


with OTHER DRUGS—COMBINED
Studies, animals
  see under SEROTONIN—Studies, animals
      SEROTONIN—Studies, normal subjects [Poloni:
Studies, normal subjects and patients
  see also SEROTONIN—Studies, normal subjects
                           [POLONI]
  Montanari,  C, Tonini,  G.  Azioni  della  5-idrossitrip-
  tamina sui  sistema nervoso centrale; suo impiego in
  psichiatria  sperimentale.   [Effects of  5-hydroxytryp-
  tamine on CNS;  its use in experimental psychiatry.]
  Riv. sper.  freniat., 1955, 79 : 465-483.
Therapeutic studies, controlled
  see SEROTONIN—Therapeutic  studies, controlled
                    [MONTANARI 4-TONINI]
                    [POLONI]

with OTHER DRUGS—COMPARED
Therapeutic studies, controlled
  Sherwood, S. L.  The response of psychotic patients to
  intraventricular injections. Proc R. Soo. M.,  Lond.,
  1955, 48: 855-863.


with PSYCHOSURGERY
  [18 mos.  post-op.] see preceding reference [Sherwood:



STIMULANTS
  see also PSYCHOPHARMACA
          individual stimulants
          Cf.  DRUG  INDEX : STIMULANTS
  Fabing, H. D.  The  newer analeptic  drugs,   [methyl-
  phenidylacetate;  pipradrol]  Med.  Clin.  N.  America,
  1957, 41:339-351.
  Hagenauer,  F., Rudy, L. H., Himwich, H. E.  A com-
  parative evaluation of two central system stimulants in
  severe  psychoses. J.  Clin. Exp.  Psychopath.,  1957,
  18: 248-257. Condensed as : A comparative study of two
  central nervous system stimulants, MER-22 and S. K. F.
  #5, on chronic, blocked and withdrawn psychotic pa-
  tients.  Am. J. Psychiat., 1957, 113: 840.
  Tripod, J., Sury,  E.,  Hoffmann, K.   Zentralerregende
  Wirkung eines neuen Piperidinderivatives.  [Centrally
  stimulating effect  of a new piperidine  derivative.]  Ex-
  perientia, Basel, 1955, 10: 261-262.   [MER-22 : methyl-
  phenidylacetate:  pipradrol]  Abstract:  Chem. Abstr.,
  1955, 48: 10920g.
  Wikler, A.  The  relation  of  psychiatry to  pharma-
  cology.  322 p. Baltimore,  Williams  d  Wilkins  [for
  the American Society  for  Pharmacology and Experi-
  mental Therapeutics]   1957.
Compared
  see STIMULANTS
      [Stimulant] with [Stimulant]—Compared

Evaluation see PSYCHOPHARMACA—Evaluation
Terminology
  Delay, J.  Allocution finale.  [Final address.]   [Inter-
  national colloquium on chlorpromazine and neuroleptic
  drugs.  Paris, October 1955] Ence'phale, 1956, 45:1181-
  1184.   ["Les psyehotoniques .  . ." p. 1184]
  Negri, F.  Effetto della reserpina e della reserpina as-
  sociata a  psicotonici in alcune psicopatie senili.  [Ef-
  fect of reserpine  and of reserpine combined with psy-
  chotonics  in senile  psychoses.]  Arch,  psicol.  neur.,
  Milano, 1956,17 : 441-451.   *


with ATARAXICS—COMBINED
  see STIMULANTS cfabinG]
      [Ataraxic] with [Stimulant]—Combined
164 
SUBJECT  LIST
Yohimbine
TMA

  Peretz, D. I., Smythies, J. R„  Gibson, W. C.  A new
  hallucinogen:   3,4,5-trimethoxyphenyl-)3-aminopropane
  with notes on the  stroboscopic  phenomenon.  J. Ment
  Sc, Lond., 1955,101: 317-329.
THIAZINAMIUM
  Glide,  E.  B., Heinrich,  K.  Die Bedeutung der Pheno-
  thiazinderivate, insbesondere des Megaphen, ftir Psy-
  chiatrie  und Neurologie.  [The importance  of  pheno-
  thiazine  derivatives in  psychiatry and neurology, with
  special reference  to chlorpromazine.]  Fortsch.  Neur.
  Psychiat, 1955, 23: 323-353.
  Marti-Ibanez, F., Sackler, A. M., Sackler, M. D.,  Sack-
  ler, R. R.  The challenge of  bio- and chemotherapy in
  psychiatry.  J. Clin. Exp. Psychopath., 1956,  17:15-18.
  Abstract: Excerpta med., Sect. 8, 1957, 10: No. 975.
  Mashkovskii, M. D.  [The pharmacologic properties of
  aminazine and of other  compounds of the phenothiazine
  order.]  Zh. nevropat. psikhiat, 3Ioskva, 1956, 56:81-
  93.  Abstract: Chem. Abstr., 1956, 50: 1717e.
  Viaud, P.   Les  amines  derivees de  la phenothiazine.
  [The amino-derivatives of phenothiazine.]  J. Pharm.,
  Lond., 1954, 6 : 361-389.
Studies,  normal subjects
  see PHENOTHIAZINES—Studies, normal subjects

Therapeutic use
  Broglie,  M., Jorgensen,  G, Voss,  G. Uber die  neuro-
  ganglioplegische Behandlung innerer Krankheiten mit
  Phenothiazinderivaten  unter besonderer  Berticksichti-
  gung  des  Asthma  bronchiale.  [Neuro-ganglioplegic
  therapy with phenothiazine derivatives  in internal dis-
  eases,  particularly bronchial  asthma.]  Aerztl Wschr.,
  1953, 8:1148-1152.
TRIFLUPROMAZINE
Studies, animals
  Burke, J. C, Hassert, G. L., High, J. P.  The tranquiliz-
  ing activity of 10-(3-dimethylaminopropyl)-2-(trifluoro-
  methyl)-phenothiazine  hydrochloride  (MC 4703)  and
  related  phenothiazines  in  animals.  [Abstract]  J.
  Pharm. Exp. Ther., 1957, 119 :136.
  Piala, J.  J.,  High, J.  P., Greenspan,  K., Burke,  J. C.
  Further  laboratory observations on 10-(3-dimethylam-
  inopropyl ) -2- (trifluoromethyl) -phenothiazine    hydro-
  chloride   (MC  4703).   [Abstract]  J.  Pharm.  Exp.
  Ther., 1957, 119:176-177.

Therapeutic use
  Pennington,  V. M. Research findings  in phrenotropic
  drugs important to every physician.  3Iississippi Doc-
  tor, 1957, 35: 57-63.

with CHLORPROMAZINE—COMPARED
  see TRIFLUPROMAZINE—Studies, animals
WIN-2299

Studies, patients
  Hoch  P  H., Pennes, H. H.,  Cattell, J. P.,  Psychoses
  produced by administration of drugs.   Res. Pub.  Ass.
  Res. Nerv. 31ent Dis., 1953, 32: 287-296.
  Pennes  H. H., Hoch, P.  H.   Psychotomimetics, clini-
  cal and' theoretical considerations : harmine, WIN-2299
  and nalline. Am. J. Psychiat., 1957, 113: 887-892.

      456132—59---12
WY-1107

  Himwich, H. E., Rinaldi, F., Willis, D.  An examination
  of phenothiazine derivatives with comparisons of their
  effects on the alerting reaction, chemical structure and
  therapeutic efficacy.  J. Nerv.  3Ient  Dis., 1956,  124:
  53-57.

Therapeutic use
  Fazekas, J. F., Shea, J.  G., Ehrmantraut, W. R., Alman,
  R. W.  Convulsant action of phenothiazine derivatives.
  J. Am. 31. Ass.,  1957, 165: 1241-1245.                *
YOHIMBINE

Pharmacodynamics
  Shaw, E., Woolley, D. W.  Yohimbine and ergot  alka-
  loids  as naturally occurring  antimetabolites  of  sero-
  tonin.  J. Biol. Chem., 1953, 203: 979-989.

—Additional data
  The chemical concept of psychoses.  What's new, 1955
  (189) : 3-7.
  Fabing,  H. D.  The  dimensions  of  neurology.  Neu-
  rology,  1955,  5:603-611.  Abstract:   Excerpta  med.,
  Sect.  8, 1956, 9: No. 1718.
  ----.   The  new pharmacologic attack in psychiatry.
  Internat.  Rec. M., 1956,  169:177-183.   Also:  Drug
  d  Cosmet. Indust, 1956, 78: 32-33; 125-129.
  Jarvik,  M. E.  Mechanism of action of lysergic acid
  diethylamide, serotonin, and related drugs.  In: Kline,
  N.  S.,  ed.  Psychopharmacology.  Washington,  Am.
  Ass. Adv. Sc, 1956.  p. 145-154.
  Meyers, F.  H.  Pharmacology of  chlorpromazine,  re-
  serpine and related drugs.  In: Kline, N. S., ed.  Psy-
  chopharmacology.   Washington, Am.  Ass.  Adv.  Sc,
  1956.   p. 131-140.
  Pearson, J.,  Dewhurst,  K. Mescaline:  apotheosis of
  the devil's root.  Irish J. 31.  Sc, 1956: 139-143.
  Rinkel,  M., Solomon,  H. C.  Chemical theories of psy-
  chosis.  J.  Clin. Exp. Psychopath., 1957. 18 : 323-334.
  Woolley, D.  W.,  Shaw, E.  Some  neurophysiological
  aspects of serotonin.  Brit. 31. J., 1954, 2: 122-125.

Studies, normal subjects
  Dennemark, H.  G. Sympathicolytica  (insbes.  Yohim-
  bin) und ihre pharmakologische Wirkung.  [The phar-
  macological effect of sympatholytics with special refer-
  ence  to yohimbine.]  Ther. Gegenwart, 1953,  92: 262-
  265.


with LYSERGIC ACID  DIETHYLAMIDE—COMPARED
Studies, animals
  Keller, D. L., Umbreit, W. W.   Chemically altered per-
  manent behavior patterns  in  fish and their  cure  by
  reserpine.  Science, 1956, 124 : 407.
  ----,  ----.  Permanent alteration of  behavior in mice
  bv  chemical and psychological means.  Science,  1956,
  124:723-724.

with RESERPINE—COMPARED
  see RESERPINE  with YOHIMBINE—COMPARED

with SEROTONIN—INTERACTION
  see YOHIMBINE—Pharmacodynamics


with OTHER DRUGS [Sedatives]—COMBINED

Therapeutic use
  Reggiani, R.  Contributo clinico alio studio  di  un far-
  maco   equilibratore  del  sistema  nervoso-vegetativo.
  [A  new pharmaceutic  stabilizer  for the  autonomic
  nervous  system.]   [Nor-Dis]   Policlinico, sez.  prat,
  1954, 61:1111-1115.
165 
 
ANCILLARY SUBJECT LIST OF
   SPECIAL CONDITIONS 
 
  * A single asterisk after a citation indicates that the article includes data on untoward effects.
* *A double asterisk after a citation means that the article reports at least one death.
AGED

Ataraxics
  Pennington,  V. M.  A two-year comparative  study of
  ataraxics in  neuro-psychiatric patients.  J. Am. Geriat.
  Soc, 1957, 5 : 421-429.  [Not seen]
  Smigel, J. O. Mood therapy in the aged.  Med. Times,
  Great Neck, 1957, 85 : 149-158.                       *

Azacyclonol
  Ayd,  F.  J., Jr.  A clinical evaluation of frenquel.  J.
  Nerv. Ment. Dis., 1956,124: 507-509.

Chlorpromazine
  Achaintre, A., Balvet, P., Beaujard, M., Broussolle, P.,
  Perrin, J., Leveque, F., Requet, A.  Evaluation of  chlor-
  promazine in psychotic  patients.   Internat.  Rec M.,
  1957, 170:175-182.
  Fong, T.  C.  Chlorpromazine and reserpine in geriatric
  patients.  Med. Ann. District of  Columbia, 1956, 25:
  260-263.
  Galioni,  E. F.  Reserpine and chlorpromazine, their use
  in alcoholic and geriatric patients.  California M., 1956,
  85:97-99.                                        * *
  Hoff, H.  Advantages and  disadvantages of treatment
  with chlorpromazine and  serpasil.  Ence'phale,  1956,
  45:352-358.
  ---.  Vorteile und Nachteile der Behandlung mit Lar-
  gactil und  Serpasil.  [Advantages and disadvantages
  of therapy with largactil  and with  serpasil.]   Wien.
  klin. Wschr., 1956, 68 : 97-101.                     * *
  Howell, T. H., Harth, J. A. P., Dietrich, M.  The  use of
  chlorpromazine in geriatrics. Practitioner, Lond., 1954,
  173:172-173.
  Kurland, A.  A. Chlorpromazine in the management of
  the   institutionalized aged  psychiatric  patient  with
  chronic  brain syndrome.   Dis.  Nerv. Syst, 1955, 16:
  366-369.  Abstract:  Excerpta  med.,  Sect.  8, 1956, 9:
  No. 3996.
  Lesse, S., Malitz,  S., Hoch, P. [H.]   Chlorpromazine
  therapy  in private practice.  Its benefits and complica-
  tions. J. Nerv. Ment. Dis., 1957,125: 25-35.
  Persson,  I.  Klorpromazin ved arteriosclerotisk  sinds-
  sygdom og dementia senilis.  [Chlorpromazine in ther-
  apy of arteriosclerotic psychosis and senile dementia.]
  [English summary]  Nord. med., 1955, 53 : 235-237. Ab-
  stract : Excerpta med., Sect.  8, 1955, 8: No. 3897.
  Pollack,  B.  The addition of chlorpromazine to the treat-
  ment program for  emotional and behavior disorders in
  the aging. Geriatrics, 1956,11: 253-259.
  Seager, C. P.  Chlorpromazine in treatment of elderly
  psychotic women.  Brit. M. J., 1955, 1: 882-885.  Ab-
  stract : Excerpta med., Sect. 8, 1956, 9: No. 1727.
  Settel, E. Chlorpromazine in the home treatment of
  the agitated senile patient.  GP,  1956, 14 (5) : 97-100.
  ___.  Chlorpromazine in the treatment of senile agi-
  tation.  GP, 1955, 12 (6): 74-76.   Abstract: Excerpta
  med., Sect. 8,1956, 9 : No. 3612.
  Smigel, J. O.  Mood  therapy in the aged.  Med.  Times,
  Great Neck,  1957, 85 :149-158.
  Terman, L. A. Treatment of senile agitation with chlor-
  promazine'   Geriatrics,  1955,  10:520-522.  Abstract:
  Excerpta med., Sect. 8,1956, 9: No. 2582.
  Ugelstad E.  Chlorpromazine treatment in  senile psy-
  choses.  Acta psychiat. neur. scand., 1956,  Suppl.  106:

  60-62.
—Untoward effects [see headnote]
  Gerest, F.  Traitement de l'acces maniaque par la chlor-
  promazine.  [Chlorpromazine therapy of manic states.]
  Ence'phale, 1956,45 : 536-540.
  Paerregaard, G.  Chlorpromazinbehandling  pa en psy-
  kiatrisk modtageafdeling.  [Chlorpromazine treatment
  at  a psychiatric  department.]   [English  summary]
  Nord. med., 1956, 56:1238-1240.                    * *
  Pollack, B.  Recurrent  thorazine-induced agranulocy-
  tosis. Am. J. Psychiat., 1956,113 : 557-558.
  Prokopowycz, V.   Agranulocytosis following use  of
  chlorpromazine therapy.  J. Am. M. Ass., 1955,157:1042.
  Also  as:   Agranulocytosis  following  chlorpromazine
  therapy.   J. 3tichigan M. Soc, 1955, 54 :1468.       * *
  Schick, G., Virks,  J.   Agranulocytosis associated with
  chlorpromazine therapy; report of a case and  review of
  the literature.  N. England J. M., 1956, 255: 798-802.

—with Reserpine
  Hoff, H.   Advantages and disadvantages of treatment
  with  chlorpromazine  and serpasil.  Ence'phale, 1956,
  45:352-358.
  Maccagnani G.  Trattamento di alcune sindromi psichi-
  che dell'eta senile con reserpina, con reserpina, associata
  cloropromazina.  [Treatment  of  senile  psychic syn-
  dromes with reserpine and with reserpine associated
  with chlorpromazine.] Arch, psicol. neur., 31ilano, 1956,
  17: 452-454.

—with other drugs
  Hoch,  P. H.  Practical and theoretical applications of
  the new drug therapies in psychiatry,  [amphetamine]
  A. M. A. Arch. Neur.  Psychiat., 1956, 75: 325-328.

Ethylcrotonylurea
  Ferguson,  J. T.  Successful therapeutic regimen for  the
  management of behavior problems in the elderly.   J. Am.
  Geriat. Soc, 1956, 4:1080-1084.

Hydroxyzine
  Fouks, Laine, Francois, Pagot.  Note sur Tutilisation en
  psychiatrie d'un nouveau neuroleptique.  [Note  on  the
  use of a new neuroleptic drug in psychiatry.]   Ann. me'd.
  psychol, Par., 1956,114 (1) : 605-608.
  Shalowitz, M.  Hydroxyzine: a new therapeutic agent
  for senile anxiety states; a preliminary report.  Geriat-
  rics, 1956,  11: 312-315. Abstract: Excerpta med., Sect.
  8,1957,10: No. 1417.

Iproniazid
  Ayd, F. J.,  Jr. A preliminary report on marsilid.  Am. J.
  Psychiat,  1957,114: 459.

Mepazine
  Laurendeau, E.  Essai clinique sur un nouveau derive
  du phenothiazine: le pacatal.  [Clinical trial of a new
  phenothiazine  derivative: pacatal.]   Union me'd. Can-
  ada, 1956, 85:1424-1425.

Meprobamate
  Lasagna, L.  A study of hypnotic drugs in patients with
  chronic diseases; comparative efficacy of placebo; methy-
  prylon (noludar)  meprobamate  (miltown,  equanil)
  pentobarbital; phenobarbital; secobarbital.   J. Chronic
  Dis., 1956, 3:122-133.
  Smigel, J. O.  Mood  therapy in the aged.   Med. Times,
   Great Neck, 1957, 85:149-158. 
Aged : Methylphenidylacetate
PSYCHOPHARMACA
 Methylphenidylacetate
   Ayd, F. J., Jr.   A clinical evaluation of methyl-phenidyl-
   acetate hydrochloride  (ritalin).  J. Clin. Exp. Psycho-
   path., 1957, 18: 342-346.
   Davidoff, E., Best, J. L., McPheeters, H. L.  The effect
   of ritalin  (methyl-phenidylacetate  hydrochloride)  on
   mildly depressed, ambulatory patients.  N. York State
   J. M., 1957, 57:1753-1757.
   Ferguson, J. T.  Successful therapeutic regimen for the
   management of behavior problems in the elderly.  J. Am.
   Geriat. Soc, 1956, 4:1080-1084.
   ---Funderburk, W. H.   Improving senile behavior with
   reserpine and  ritalin; new approach with use of methyl
   phenylpiperidylacetate.   J. Am. M. Ass., 1956, 160: 259-
   263.   Abstract:  Excerpta med.,  Sect. 8, 1956,  9:  No.
   3520.   Year book of drug therapy, 1956-1957, p. 344-346.

 —with Reserpine
   see AGED—Reserpine with Methylphenidylacetate

 Methylpromazine—Untoward effects [see headnote p. 169]
   Feldman, P. E., Statman, J.  Agranulocytosis  during
   treatment with methylpromazine.   Am.  J.  Psychiat,
   1957, 114: 464-465.

 Perphenazine
   Ayd, F. J., Jr.  The treatment of anxiety, agitation and
   excitement in the aged ; a preliminary report on trilafon.
   J. Am. Geriat. Soc, 1957, 5: 92-96.

 Pipradrol
   Allin, T. G., Jr., Pogge, R. C.  The use of azacyclonol
   and pipradrol  in general practice.   Internal Rec 31.,
   1956,169: 222-230.
   Fabing, H. D.   The newer analeptic drugs.  31 ed. Clin.
   N. America, 1957, 41: 339-351.
   Forster, W., Henderson,  L„  Schultz, S.  The  clinical
   effects effects of alpha- (2-piperidyl) -benzhydrol hydro-
   chloride (meratran) in states of inactivity  in elderly
   psychiatric patients. Canad. M. Ass. J., 1955, 72: 678-
   681.  Abstract: Digest Neurol. Psychiat, 1955, 23 : 278.
   Excerpta med., Sect. 8, 1956, 9: No. 2227.
   Fullerton, A. G.  Psychiatric uses of meratran. J. Ment.
   Sc, Lond., 1956,102: 801-804.
   Kleemeier, R.  W., Rich, T. A., Justiss,  W. A. The ef-
   fects of alpha-(2-piperidyl) benzhydrol hydrochloride
   (meratran) on psychomotor performance in a group of
   aged males.  J. Geront., 1956,11:165-170.
   Lbnnberg, B.  Leptidrol  (pipradrol),  ett  nytt  psyko-
   analepticum.   [Leptidrol  (pipradrol), a  new psycho-
   analeptic]  Sven. lak. tidn., 1956, 53: 3346-3357.
   Martin, K. E.,  Overley, H. G., Krone, R. E. Pipradrol:
   combined therapy for geriatric  and agitated patients
   [with  metabolic  supplement].  Internat. Rec. M., 1957,
   170:33-36.
   Pomeranze, J.   A new  antidepressant  (M. R. D.-108)
   in geriatrics.   [Abstract.]  J. Geront., 1954, 9: 486.

Proclorperazine
   Lesse, S. An evaluation  of proclorperazine in the am-
   bulatory treatment  of psychiatric patients.  Internat
   Rec M., 1957, 170: 599-602.
   Vischer, T. J.   Clinical study of proclorperazine, a  new
  tranquilizer for the treatment of nonhospitalized  psy-
   choneurotic patients.  N.  England  J.  M., 1957, 256:
   26-27.

Promazine
   Burdine, W.  E.,  Shipley,  T.  E., Papas,  T. A.  Studies
  on the use of promazine in acute and chronic nervous
  and mental disturbances.   J. M. Ass. Georgia, 1957, 46:
  171-173.
  Smigel, J. O.  Mood therapy in the aged.  Med. Times,
  Great Neck, 1957, 85:149-158.
  Usdin, G. L.  Use of promazine in psychiatric practice;
   and early study.  J. Louisiana 31.  Soc, 1956, 108:251-
   257.

Rauwolfia serpentina alkaloids
   Maccagnani,  G.  Trattamento  di  alcune  sindromi
   psichiche dell'eta. senile  con reserpina,  con  reserpina
   associata a  cloropromazina.   [Treatment of senile psy-
  chic syndromes with reserpine  and with reserpine as-
   sociated with chlorpromazine.]  Arch, psicol. neur., 3Ii-
   lano, 1956,17: 452-454.
   Pennington, V.  M.  Research findings in phrenotropic
   drugs important to every physician [whole  root].  Mis-
   sissippi Doctor,  1957, 35 : 57-63.
   Ruskin, I. W., Avol, M.  Rauwolfia tranquilization for
  the disturbed aged.  J. Am. Geriat. Soc, 1956, 4:998-
  1003.
   Smigel, J. O.  Mood therapy in  the aged.  Med. Times,
   Great Neck, 1957,  85 :149-158.

Rescinnamine
  Winton, S. S.  Therapeutic value and limitations of an
  ataractic  drug   (rescinnamine).   Internat. Rec.  M.,
  1957, 170: 665-671.

Reserpine
  see also AGED—Rauwolfia serpentina alkaloids
  Ayd, F. J., Jr.  Tranquilizing drugs in private practice.
  N. York State J. M., 1957, 57: 1742-1747.            *
  Ferguson, J. T., Funderburk, W. H.  Improving senile
  behavior with reserpine and ritalin  ; new approach with
  use of  methyl phenylpiperidylacetate.   J. Am.  M. Ass.,
  1956, 160:259-263. Abstract: Excerpta  med., Sect. 8,
  1956, 9: No. 3520.  Year book of drug therapy, 1956-
  1957, p. 344-346.
  Fong, T. C.   Chlorpromazine and reserpine  in geriatric
  patients. 3Ied.  Ann.  District of Columbia, 1956,  25:
  260-263.
  Galioni, E. F.  Reserpine and chlorpromazine, their use
  in alcoholic and  geriatric patients.  California M., 1956,
  85: 97-99.                                          *
  Harris, R. Clinical use of reserpine  (serpasil) in geriat-
  rics. Ann. N. York Acad. Sc,  1954,  59:95-106.  Ab-
  stract : Chem. Abstr., 1954, 48:10220b.
  ----.   Results  of reserpine  therapy  in  hypertension.
  J. Geront., 1954, 9 : 484-485.
  Hauser, A.,  Wenner,  R.  Serpasil  in  der Behandlung
  klimakterischer  Ausfallserscheinungen.  [Serpasil in
  the management of climacteric dysfunction.]   Gynae-
  cologia, Basel, 1956, 142 : 300-303.
  Hoff, H.  Advantages and disadvantages of treatment
  with chlorpromazine  and serpasil.  Ence'phale, 1956,
  45:352-358.
  ----.   Vorteile  und  Nachteile  der  Behandlung  mit
  Largactil und Serpasil.   [Advantages and disadvan-
  tages of therapy  with  largactil and  with serpasil.]
  Wien. klin. Wschr., 1956, 68 : 97-101.
  Kinard, S.,  Mills, L. C, Terrell, J., Moyer,  J. H.  Use
  of d-amphetamine to  curb the increased appetite  and
  over-eating  induced by reserpine   therapy.   J. Am.
  Geriat. Soc, 1956, 4:1073-1077.
  V"^1^"' HAS" Blatt' M- H> Vosburgh, L. F., Canis,
  J., Wetchler, B.  Effect of reserpine,  with  or  without
  hormonal therapy, upon  the female  climacteric.  J. Am.
  Geriat.  Soc,  1956, 4: 160-166.                         *
  Lyager,  T.,  Rontorp, P. S.   Behandling af psykotiske
  patienter med reserpin (serpasil).  [Reserpine in ther-
  apy of psychoses.]  [English summary]  Ugeskr. laeger,
  ™«J' 117;603-61<>-  Abstract: Excerpta med.,  Sect. 8,
  1956, 9: No.  3609.                                 * *
  Negri,  F.  Effetto della  reserpina e  della reserpina
  associata a psicotonici in alcune psicopatie senili   [Ef-
  fect of  reserpine and of reserpine  combined with  psy-
  chotonics in senile psychoses.]   [English  summary]
  Arch, psicol. neur., 31ilano, 1956,17 :  441-451.
170 
ANCILLARY SUBJECT LIST
Alcoholism : Chlorpromazine
 Rizzente, S.  Osservazioni cliniche su di un nuovo ipo-
 tensivo e sedativo in geriatria.  [Clinical observations
 on a new hypotensive and sedative drug in geriatrics.]
 Arch, psicol. neur., Milano, 1956,  17:454-456.
 Ruskin, I. W., Avol, M.  Rauwolfia tranquilization for
 the disturbed aged.  J. Am. Geriat. Soc, 1956, 4: 998-
 1003.
 Sainz, A. A.  The use of reserpine in ambulatory and
 hospitalized geriatric psychotics.  Ann. N. York Acad.
 Sc, 1955, 61: 72-77.  Abstract: Excerpta med., Sect. 8,
 1956, 9: No. 1229.
 Seemann, D.  Erfahrungen fiber Reserpmbehandlung in
 der Geriatrie.  [Reserpine in  geriatrics.]  Wien. med.
 Wschr., 1956, 106 : 930.
 Villien, L. M.  The use of reserpine in the treatment of
 disturbed geriatric patients. J. Louisiana M. Soc, 1956,
 108:126-129.
 Voelkel, A.  Beitrag sur Sedaraupin-Therapie bei psy-
 chisch Kranken.   [Sedaraupin  therapy of  mental pa-
 tients.]  3Iedizinische, 1955: 227-228.
 ---.  Zur Reserpin-Therapie bei psychisch  Kranken.
 II.  [Reserpine therapy of mental disorders.  II.]  Deut.
 med. J., 1956, 7 : 72-74.

-with Chlorpromazine
 see AGED—Chlorpromazine with Reserpine

-with Methylphenidylacetate
 Davidoff, E., Best, J. L., McPheeters, H. L.  The effect
 of  ritalin  (methyl-phenidylacetate hydrochloride)  on
 mildly depressed ambulatory  patients.   N.  York State
 J. 31., 1957, 57 : 1753-1757.
 Ferguson, J. T.  A new therapeutic approach to abnor-
 mal behavior  in  geriatrics.  Geriatrics, 1956, 11: 217-
 219.
 ---. Successful therapeutic  regimen for the manage-
 ment of behavior  problems  in the  elderly.   J. Am.
 Geriat. Soc, 1956,4:1080-1084.
 ---,  Funderburk,  W.  H.   Improving  senile behavior
 with reserpine and ritalin; new approach with use of
 methyl phenylpiperidylacetate.  J. Am. M. Ass., 1956,
 160: 259-263.  Abstract: Excerpta med., Sect. 8, 1956,
 9: No. 3520.  Year  book of  drug therapy,  1956-1957,
 p. 344-346.
 Hauser, A., Wenner, R.  Serpasil in der Behandlung
 klimakterischer Ausfallserscheinungen.  [Serpasil in
 the management of climacteric dysfunction.]  Gynae-
 cologia, Basel, 1956,142 : 300-303.
 Negri, F.  Effetto della reserpina e della reserpina asso-
 ciata a psicotonici in alcune  psicopatie senili.  [Effect
 of  reserpine and  of reserpine  combined with  psycho-
 tonics in senile psychoses.]  [English summary] Arch.
 psicol. neur., 3Iilano, 1956, 17 :  441-451.
ALCOHOLISM

Azacyclonol
  [acute]
  Allin, T.  G., Jr., Pogge, R. C.  The use of azacyclonol
  and pipradrol in general practice.  Internal Rec 31.,
  1956,169:222-230.               *,».,.      i  a m
  Block M. A.  Medical treatment of alcoholism.  J. Am.
  M.Asa., 1956, 162: 1610-1619.                   .
  Clark L  D  Further studies  of  the psychological ef-
  fects of frenauel and a critical review of previous re-
  ports   J Nerv.  Ment. Dis., 1956, 123:557-560.
  Collomb  H., Miletto,  G., Robert,  H.   Le frenquel en
  therapeutique PsycMatrique.  frenquel in psychiatric
  therapy]  Presse me'd., 19. >6, 64.1602-1604.
  Proctor, R. C, Odland, T.  Frenquel. Dis. Nerv. Syst,

  Tnrne1/ W5_J-,  Merlis,  S.  Chemotherapeutic trials in
  nsvehosis * I. Frenquel and pilocarpine.  Am.  J. Psy-
  £^1956, 113: 248-249.
CB-1522 cocktail
  [delirium tremens]
  Coirault, R., Girard, V., Escafit, H.,  Benoit, P.  Utili-
  sation du 1522 CB en neuro-psychiatrie.  [Use of 1522
  CB in neuro-psychiatry.]  Bull. Soc med. mil. fr., 1955,
  49 : 247-249.  Abstract:  Presse med., 1956, 64: 315.

Cannabis
  Thompson, L. J., Proctor, R. C.   The use of pyrahexyl
  in the treatment of alcoholic and drug withdrawal con-
  ditions.  North Carolina M. J., 1953, 14: 520-523.


Chlorpromazine-\-Alcohol
—Studies,  animals
  Revol, L.   Chlorpromazine et intoxication  alcoolique.
  [Chlorpromazine  and  alcoholic  intoxication.]  Lyon
  pharm., 1954, 5: 349-350.

—Studies,  normal subjects [not intoxicated]
  Fazekas, J. F., Albert,  S. N., Alman, R. W.  Influence
  of  chlorpromazine and alcohol  on  cerebral hemody-
  namics and metabolism.  Am. J.  M. Sc, 1955, 230: 128-
  132.  Abstract: Excerpta med.,  Sect. 8, 1956, 9:  No.
  2934.
  Schultz,  J.  D., Rea, E.  L., Fazekas,  J. F.,  Shea, J. G.
  Chlorpromazine in the  management of acute alcoholic
  states.   Q.  J.  Alcohol,  1955,  16:245-250.  Abstract:
  Excerpta med., Sect. 8, 1956, 9: No. 2598.

—Untoward  effects in non-intoxicated subjects
  Drugs and driving.  J.  Am. M. Ass., 1954, 156: 628-629.
  Friend, D. G., Wells, J. C, Jr.  The clinical use of chlor-
  promazine.   Am. Practitioner, 1955,  6:698-703.  Also
  as: Uso clinico de la cloropromacina.  Rev. me'd. cubana,
  1956, 67:645-650.
  Gutenkauf,  C.  Internal  medicine.   In:  "Happiness
  pills" in medical practice: a symposium.   J. Iowa M.
  Soc, 1957, 47 :59-64.
  Staehelin, J. E., Kielholz, P. Largactil, ein neues vege-
  tatives  Dampfungsmittel bei  psychischen  Storungen.
   [Largactil,  a new  autonomic inhibitor in  mental dis-
  orders.]   Schweiz. med. Wschr.,  1953, 83 :581-586.  Ab-
  stract : Excerpta med.,  Sect. 8, 1954,  7: No. 1601.
  Tillim,   S.  J.  Agranulocytosis  associated  with chlor-
  promazine therapy.  Am. J. Psychiat, 1956, 112:1028.
   Tintera, J. W.  Office rehabilitation of the alcoholic.
  N. York  State J. M., 1956, 56 : 3896-3902.
   Wallis,  R.   Potentiation of hypnotics and  analgesics;
  clinical experience with chlorpromazine.  N. York State
  J. 31., 1955, 55 :243-245.


 Chlorpromazine therapy  of alcoholism
  Allen, E. B., Prout, C. T.  Alcoholism.  Progr. Neur.
  Psychiat., N. Y., 1955, 10:510-521; 1956, 11:338-351.
  Berthier, C, Bonneru-Couchoud,  M.,  Barnaud, J.   A
  propos du traitement des deiires  alcooliques subaigus et
  chroniques.  [Treatment of subacute and chronic alco-
  holic delirium.]  Rev.  neur., Par., 1956, 94:673-674.
  Block, M. A.  Medical treatment of alcoholism.   J. Am.
  M. Ass.,  1956, 162:1610-1619.
  Cummins,  J. F., Friend, D. G.   Use  of chlorpromazine
  in  chronic  alcoholics.  Am. J.  31. Sc,  1954, 227: 561-
  564.  Abstract:  Excerpta  med., Sect.  8, 1955, 8:  No.

  Escourolle,  R.  Traitement des etats  delirants de  1'
  alcoolisme chronique.   [Treatment of delirious states in
  chronic  alcoholism.]  France med., 1954, 17 (6)  : 15-19.
   Feldman,  D. J. Drug  therapy  of chronic alcoholism.
  3Ied. Clin.  N.  America, 1957, 41:381-392.
  West, L. J., Swegan, W. H.  An  approach to alcoholism
  in  the military service.  Am. J. Psychiat., 1956,  112:
  1004-1009.  Abstract:   Excerpta med.,  Sect. 8, 1957,
  10: No. 918.
171 
Alcoholism : Chlorpromazine
PSYCHOPHARMACA
[acute]
Albert, S.  N.,  Rea,  E. L., Duverney, C. A.,  Shea, J.,
Fazekas, J. F.  The use of chlorpromazine in the treat-
ment  of acute  alcoholism.  Med. Ann.  District of Co-
lumbia, 1954, 23: 245-247.
Bonello, F. J. Chlorpromazine in general practice.  In-
ternat. Rec. M., 1956,169:197-212.
Cares, R. M., Asrican, E., Fenichel, M., Sack, P., Sever-
ing, J. Therapeutic and toxic  effects  of chlorproma-
zine among 3,014 hospitalized cases.  Am. J. Psychiat.,
1957,  114: 318-327.
Cocheme,  R.  Le  delirium  tremens  mortel;  statis-
tiques; recherche des causes de l'inefficacite des traite-
ments.  [Fatal delirium tremens;  statistics; research
on the causes for the ineffectiveness of the  treatment.]
Rev. neur., Par., 1956, 94: 657-660.
Cossa, P.,  Bougeant, H., Postel, J. De quelques indi-
cations et de quelques incidents d'utilisation de la chlor-
promazine.  [Some  indications  of  and  incidents with
chlorpromazine therapy.]  Ence'phale,   1956,  45:779-
783.
Fau, R., Chateau, R., Duserre.  Traitement  des psycho-
ses aigues  et subaigues par les neuropiegiques.  [Treat-
ment of acute  and subacute psychoses with neuroplegic
drugs.]  [Abstract] J. me'd. Lyon, 1954, 35: 948.
Fazekas, J.  F., Schultz, J.  D.,  Sullivan, P.  D.,  Shea,
J. G.  Management  of acutely disturbed patients with
promazine (sparine).   J. Am. 31. Ass., 1956, 161: 46-49.
Condensed: Am. Practitioner, 1956,  7:1807.
----,  Shea, J., Rea, E.  Use of  chlorpromazine  in  the
management of acute and postalcoholic states.  Inter-
nat. Rec  M.,  1955,  168: 333-339.  Abstract:  Excerpta
med.,  Sect. 8,1956, 9 : No. 420.
Feldman, D. J. The treatment of chronic  alcoholism:
a survey of current methods.  Ann. Int. M., 1956,  44:
78-87.
Fox,   V.  Treatment of  withdrawal symptons in  the
management of alcoholism.   J. M. Ass. Georgia, 1956,
45:139-142.
Galioni, E. F.  Reserpine and chlorpromazine, their use
in alcoholic and geriatric patients.  California M., 1956,
85:97-99.
Hewitt, D. W.  Alcoholism,  a treatment guide for gen-
eral   practitioners.   112  p.  Philadelphia,   Lea   d
Febiger, 1957.
Hoff,  H.  Advantages and disadvantages of  treatment
with  chlorpromazine  and serpasil.  Ence'phale, 1956,
45 ■ 352—358.                                      * *
——.   Vorteile und  Nachteile  der Behandlung  mit
 Largactil  and  Serpasil.  [Advantages  and  disadvan-
 tages of  therapy  with  largactil  and  with  serpasil.]
 Wien. klin. Wschr., 1956, 68: 97-101.                * *
 Meyer,  H. H., Schmitt, W.,  Kieser, J.  Das Delirium
 tremens.  [Delirium  tremens.] Deut.  med.  Wschr.,
 1955,  80:1389-1391.
 Mitchell,  E. H.  Chlorpromazine  in the treatment of
acute alcoholism.  Am. J. M.  Sc, 1955, 229:363-367.
Abstract:  Excerpta med., Sect. 8, 1957, 10: No.  884.
 Q. J.  Alcohol,  1955, 16: 589-590.                   * *
----.   Treatment of  acute alcoholism with  promazine
  (sparine).  J. Am. M. Ass.,  1956, 161:44-45.   Con-
 densed : Am. Practitioner, 1956, 7 :1798-1799.  Abstract:
 Excerpta med., Sect. 8,1957,10: No. 359.
 Moore, J.  N.  Largactil in psychotherapy.  Irish J. M.
 Sc, 1955: 409-412.  Abstract:  Excerpta med., Sect. 8,
 1956,  9: No. 3613.
 Revol, L.   Chlorpromazine  et  intoxication  alcoolique.
 [Chlorpromazine  and  alcoholic  intoxication.]  Lyon
 pharm., 1954, 5 : 349-350.
 Sainz, A.  A. The treatment of drug and alcohol with-
 drawal effects with thorazine.   Psychiat. Q., 1957, 31:
 275-284.
 Schultz, J. D.  El  uso de cloropromazina  (thorazine)
 en los estados alcoh61icos agudos.  [Use of chlorproma-
 zine (thorazine)  in acute alcoholic states.]   Arch. mtd.
 Cuba,  1956, 7:18-20.                  x  „   _. ,
 ____, Rea, E. L„  Fazekas, J. F., Shea,  J. G.  Chlorpro-
 mazine in the management of acute  alcoholic states.
 Q.  J.  Alcohol, 1955,  16:245-250.   Abstract: Excerpta
 med., Sect. 8, 1956, 9: No. 2598.     r
 Siguier, F., Giabicani, A., Betourne, C, Goglin, Or.  Le
 serpasil dans les deiires alcooliques.   [Serpasil in al-
 coholic delirium.]  Bull Soc mCd. hdp. Paris, 1956, 72:
 605-607.  Abstract: Excerpta med.,  Sect. 8, 1957,  10:
 No. 1976.
 Sizaret,  P.  La  chlorpromazine   dans  les  psychoses
 aigues alcooliques.   [Chlorpromazine in acute alcoholic
 psychoses.]  Encephale, 1956, 45:736-738.
 ____f  Salomon,  F.  Action d'un neuroplegique sympa-
 thicolytique dans les etats confusionnels alcooliques.
  [Action of a  neuroplegic sympatholytic in alcoholic
 confusions.]  Ann. me'd.  psychol, Par., 1953, 111 (1) :
 88-92.

 [chronic]
 MacGregor, J  MacW. Largactil; a new psychomotor
 brake. S. Afr. J. Clm. Sc, 1954, 5 : 228-243.  Abstract:
 Excerpta med., Sect. 8, 1956, 9 : No. 1724.
 Newbold, H. L.,  Steed, W. D.  The use of chlorproma-
 zine in psychotherapy.  J. Nerv. Ment. Dis., 1956, 123:
 270-274.
  Sikes, Z. S. Korsakoff and Wernicke syndromes:  his-
 tory and treatment.  J. Nerv. Ment. Dis., 1956, 123: 448-
 451.
 Wells, R. E. Use of reserpine (serpasil) in the  manage-
  ment of chronic alcoholism.  J. Am. M. Ass., 1957, 163:
  426-429.
—Lytic  cocktail
  see Chlorpromazine  therapy of alcoholism
        —Various  special techniques
—Untoward effects [see headnote p. 169]
  Fernandes, B., Letiao, G. Incidents and  accidents In
  chlorpromazine  therapy.    [chlorpromazine+apomor-
  phine]  J. Clin.  Exp. Psychopath., 1956, 17: 70-76.
  Friend, D. G., Wells, C. J., Jr.  The clinical use of
  chlorpromazine.  Am. Practitioner,  1955,  6:698-703.
  Also as: Uso clinico  de  la cloropromacina.  Rev. me'd.
  cubana, 1956, 67 : 645-650.
  Lafon, R., Due, N., Labauge, R., Temple, J. P. Le traite-
  ment  du delirium  tremens  par  le  4560 R. P.   [The
  treatment  of delirium tremens in 4560 R.  P.]  Ence'-
  phale, 1956, 45 :1219-1220.                        * *
  Rea, E. L., Shea, J., Fazekas, J. F.  Hypotensive  action of
  chlorpromazine.  J.  Am.  31. Ass., 1954, 156:1249-1250.
  Tintera, J. W.  Office rehabilitation  of  the alcoholic.
  N. York State J. M., 1956, 56: 3896-3902.

—Various  special  techniques
  [acute]
  Coirault, R., Laborit, H., Missenard, R., Jolivet, B., Hai-
  naut, J., Weber, B.  Le  delirium tremens.  [Delirium
  tremens.]  Ence'phale, 1956, 45 : 762-770.
  Fau,  R., Chateau, R. Dusserre.   Traitement  des psy-
  choses  aigues   et  subaigues par les  neuropiegiques.
   [Treatment of acute and subacute psychoses with neu-
  roplegic  drugs.]  [Abstract]  J.  me'd.  Lyon,  1954,
  35: 948.
  Follin,  S., Soubrier, P.  Recidives  de  l'onirisme sous
  Taction  de la  chlorpromazine.   [Recurrent  oneirism
  during  treatment  with  chlorpromazine.]   Ann.  me'd.
  psychol, Par., 1954, 112 (2) : 218-222.
  Gouttebroze, V.  Une annee d'experience de traitement
  du delirium tremens; 61 cas recueillis dans le service
  de neuro-psychiatrie de l'Hopital Bellevue, St. Etienne.
   [Treatment of delirium tremens; one year's experience
   in 61 cases from the  neuropsychiatric service of the
   Hopital Bellevue,  St.  Etienne.]  85 p.   Lyon,  1955.
   [Thesis—Lyon, 1954/1955, no. 94]
172 
ANCILLARY  SUBJECT  LIST
Alcoholism : Chlorpromazine
Hamon, J., Paraire, J., Velluz, J.  Etats anxieux et bar-
bituriques potentialises.  [Anxiety states  and potenti-
ated  barbiturates.]   Ann.  mid. psychol,  Par.,  1952,
110(2) : 403-407.
 Laborit, H.  Climatisation au lit du malade par refrig-
erateur & air.  [Climatization by an air conditioner at
the patient's bedside.]   Presse me'd., 1957, 65:1240.
---Coirault,  R., Hainaut, J., Weber, B.  Action des
neuropiegiques sur l'excitabllite neuromusculaire; les
 mouvements ioniques  transmembranaires;  l'equilibre
thermocationique; consequences physiologiques et ther-
apeutiques ; une  application clinique: le delirium tre-
mens.   [Effect of neuroplegic drugs on  neuromuscular
excitability; transmembrane ionic movements, thermo-
cationic   equilibrium;  physiologic   and   therapeutic
consequences ; clinical application : delirium tremens.]
Ence'phale, 1956, 45 : 1166-1177.
Laroche, C, Bonnet de la Tour.  Traitement du delirium
tremens par les perfusions  intraveineuses d'ACTH as-
 sociees k de faibles doses de clorpromazine et de pro-
methazine.   [Treatment of  delirium tremens by intra-
venous perfusions of ACTH  associated with small doses
of  chlorpromazine and  promethazine.][English  sum-
 mary]  ThCrapie, Par., 1956, 11: 711-714.
Lereboullet, J., Pluvinage,  R., Vidart,  L., Benoit, P.,
Kapandji, I.  Le traitement du delirium  tremens  par la
 reserpine.   [Treatment of delirium tremens with reser-
 pine.]       [chlorpromazine+promethazine+reserpine]
 Bull. Soc mCd. hdp. Paris, 1956, 72: 604-605.
 Letailleur M., Morin, J.,  Demay, J., Monnerie, R. La
 chlorpromazine dans le traitement des deiires aigus et
 subaigus  alcooliques.   [Chlorpromazine in  the  treat-
 ment  of acute and subacute delirium tremens.]  Ence'-
 phale, 1956, 45: 739-743.
---, ---, Monnerie, R., Demay, J.  Traitement d'atta-
 que du delirium tremens par la synergie chlorpromazine
 (4560 R. P.) mebubarbital.  [Treatment of delirium tre-
 mens  by chlorpromazine  (4560 RP)  and mebubarbital
 synergism.]  Ann. med.  psychol, Par.,  1954,  112(2) :
 76-80.
Meyer, H. H.  Die Behandlung exogener Psychosen mit
 Phenothiazinderivaten.   [The treatment of exogenous
 psychoses with phenothiazine derivatives.]  Ence'phale,
 1956, 45: 524-527.
 Neveu,   P.  L'hibernation,  traitement  d'urgence des
 syndromes de choc decompense en psychiatrie.  [Hiber-
 nation, an emergency treatment of decompensated shock
 syndromes in psychiatry.]   Ence'phale,  1956,  45:377-
381
Pomme,  B., Planche, R., Gilbert, J.   La chlorpromazine
dans le traitement des deiires aigus alcooliques.  [Chlor-
promazine in the treatment of acute alcoholic delirium.]
Ence'phale, 1956, 45 : 744-753.
Ravina, A., Pestel, M.,  Albouy, R.   Alcoolisme aigu et
delirium tremens  en milieu hospitalier parisien.  Con-
siderations cliniques et therapeutiques a propos de 40
cas recents.  [Acute alcoholism and delirium tremens in
a Paris hospital setting.  Clinical and therapeutic con-
siderations regarding 40 recent cases.]   Bull Soc. me'd.
hop. Paris, 1955, 71: 698-703.
Riser, M., Geraud, J., Laboucarie, J., Rascol, A., Clausse,
S,  Garrigues, M. P.  Considerations etiologiques et
therapeutiques sur les delirium tremens; a propos de 75
cas   [Etiologic and therapeutic considerations  of de-
lirium tremens; 75 cases.]  Rev. neur.,  Par., 1956, 94:
662-667.
___ Laboucarie, J., Barres, P.  Hibernation dans les
psychoses  hyperthermiques.  [Hibernation  in hyper-
thermic  psychoses.]  Ann.  med.  psychol, Par.,  1953,
111(2) : 207-212.
Rives   Menager,  V.  Neuropiegie et delirium tremens.
[Neuroplegic therapy and delirium tremens.]  AnesthC-
sie, Par., 1953, 10: 450-453.
  Ruyer, M.  Hibernation dans les confusions alcooliques
  aigues.   [Hibernation  in  acute alcoholic  confusions.]
  82 p.  [Mimeographed]   Strasbourg, 1954.  [Thesis—
  Strasbourg 1954, no. 74]

—with Meprobamate [and Promethazine}
  Fox, V.  Treatment of withdrawal symptoms  in  the
  management  of alcoholism.   J. M.  Ass. Georgia, 1956,
  45:139-142.

—with Promethazine [and Other drugs]
  see Chlorpromazine therapy of alcoholism
       —Various special techniques

—with Reserpine [and Methylphenidylacetate]
  Wells,  R. E.   Use of reserpine (serpasil)  in the man-
  agement  of chronic alcoholism.  J. Am. 31. Ass., 1957,
  163:  426-429.

—with Other drugs:
  CNS depressants
  see Chlorpromazine therapy of alcoholism
       —Various special techniques

  Disulfiram
  Cummins, J.  F., Friend, D. G.  Use of chlorpromazine
  in chronic alcoholics.  Am. J. M. Sc, 1954, 227: 561-564.
  Abstract: Excerpta med., Sect. 8, 1955, 8: No. 3552.
  Friend, D. G., Wells,  J.  C, Jr. The clinical  use of
  chlorpromazine.   Am.  Practitioner, 1955,  6:698-703.
  Also as:  Uso clinico de la cloropromacina.  Rev. me'd.
  cubana, 1956, 67: 645-650.

  [acute]
  Tintera, J.  W.  Office rehabilitation of the alcoholic. N.
  York State J. M., 1956, 56: 3896-3902.

  [chronic]
  MacGregor, J. MacW.   Largactil;  a new psychomotor
  brake.  S. Afr. J. Clin. Sc, 1954, 5:  228-243.  Abstract:
  Excerpta med., Sect. 8, 1956, 9: No. 1724.
  Williams, E.  L.  The management of the chronic alco-
  holic.  Postgrad. M. J., Lond., 1954, 30: 626-630.

  Strychnine
  Gouttebroze, V.   Une annee d'experience de traitement
  du delirium tremens; 61 cas recueillis dans  le service de
  neuro-psychiatrie de  l'Hopital Bellevue,  St. Etienne.
  [Treatment of delirium tremens; one year's experience
  in 61 cases from  the  neuropsychiatric service  of  the
  Hopital  Bellevue, St.   Etienne.]    85 p.   Lyon, 1955.
  [Thesis—Lyon, 1954/1955, no. 94]
  Kammerer, T.,  Ebtinger, R.  Premiers resultats du
  traitement  du delirium tremens par le chlorpromazine
  (Largactil).   [First results of chlorpromazine therapy
  in delirium tremens.]   Strasbourg 'me'd., 1954,  5:287-
  291.  Abstract: Ann. me'd. psychol, Par., 1954, 112(1) •
  102.
  ---, Mengus, M., Ebtinger, R.  Traitement du delirium
  tremens par la chlorpromazine. [Chlorpromazine in the
  treatment of  delirium tremens.]  [Abstract]  Ann. me'd.
  psychol, Par., 1954,112(2) : 439.
  Postel, J., Cossa, P.  Etat actuel de la therapeutique du
  delirium tremens; sur  165 cas.  [Present  state of the
  therapy  of delirium tremens; 165  cases.]  Rev. neur.,
  Par., 1956, 94: 660-662.
  Ravina, A., Pestel, M.,  Albouy, R.   Alcoolisme  aigu  et
  delirium tremens en milieu hospitalier  parisien.  Con-
  siderations cliniques et therapeutiques & propos de 40
  cas recents.  [Acute alcoholism and delirium  tremens  in
  a Paris hospital setting.  Clinical  and therapeutic  con-
  siderations regarding 40 recent cases.]  Bull Soc me'd.
  hop. Paris, 1955, 71: 698-703. 
Alcoholism :  Hydroxyzine
PSYCHOPHARMACA
Hydroxyzine
  [acute]
  Block, M. A.  Medical treatment of alcoholism.   J. Am.
  31. Ass., 1956,162 :1610-1619.

Iproniazid
  [chronic]
  Smith, J. A.  The  use  of the isopropyl derivative of
  isonicotinylhydrazine (marsilid)  in the treatment of
  mental disease;  a  preliminary  report.  Am.  Practi-
  tioner, 1953, 4: 519-520.

Lysergic acid diethylamide
  [chronic]
  Osmond, H.  A review of the clinical effects of psycho-
  tomimetic agents. Ann.  N. York Acad. Sc, 1957, 66:418-
  434.

Mepazine
  [acute]
  Lienau, C. Heilschlaf behandlung mit Pacatal bei Alko-
  holismus und Morphinismus.  [Therapeutic sleep treat-
  ment with  pacatal in  alcoholism and morphinism.]
  Munch, med. Wschr., 1957, 99: 80-81.
  MacGregor, J.  MacW.  Pacatal—a clinical  trial of a
  new  ataractic drug.  S.  Afr. M. J., 1956, 30:1108-1111.

Mephenesin
  Feldman,  D.  J.  Drug therapy of chronic alcoholism.
  [also mephenesin carbamate; mephate]  Med. Clin. N.
  America, 1957,41: 381-392.

  [acute]
  Allen,  E.  B., Prout, C.  T.   Alcoholism,  [mephenesin;
  mephenesin  4-  acetyl carbromal]  Progr.  Neur. Psy-
  chiat, N.  Y., 1955,  10: 510-521; 1956,  11: 338-351.
  Armour,  P. S.  A regimen in acute  alcoholism.  [Me-
  phenesin; mephenesin carbamate; reserpine; also com-
  bined and compared.] Arizona 31., 1956, 13:169-172.
  Block, M. A.  Medical treatment of alcoholism.  J. Am.
  M. Ass., 1956, 162: 1610-1619.
  Feldman, D. J., Zucker, H. D.  Present-day medical man-
  agement of alcoholism.  J. Am. M. Ass., 1953, 153: 895-
  901.
  Goldman,  H. I.  Clinical evaluation  of tolserol  in  the
  post-alcoholic syndrome.   Rocky 3Iountain M.  J., 1954,
  51: 698-699.
  Greenhouse, H. R.  Treatment of the  postintoxication
  state in alcoholics with mephenesin and other  drugs.
  Q. J.  Alcohol, 1954, 15: 43-46. Abstract: Excerpta med.,
  Sect. 8,1954, 7:  No. 4228.
  Herman, M., Effron, A. S.  Tolserol in the treatment of
  the post-alcoholic state.  In: Podolsky,  E. ed. Manage-
  ment of addictions.   New  York, Philosophical Library,
  1955.  p. 209-217.
  Latham, F. A. Symposium on alcoholism. Management
  of the acute phases.  Memphis 31. J., 1953, 28:128-131.
  Mitchell,  E. H.  Chlorpromazine  in  the treatment of
  acute alcoholism,  [mephenesin+barbiturate]   Am. J.
  M. Sc, 1955,  229 : 363-367.  Abstract:  Excerpta med.,
  Sect.  8, 1957, 10: No. 884.  Q. J. Alcohol, 1955, 16: 589-
  590.
  Sainz, A. A.  The treatment of  drug  and alcohol with-
  drawal effects with  thorazine.   Psychiat. Q., 1957, 31:
  275-284.
  Spreng, R. W. E.  Tolserol in acute alcoholism.  J. Nerv.
  3lent. Dis., 1953, 118:545-551.  Abstract: Excerpta
  med., Sect. 8,1955, 8: No.  4384.
 Tavener, R. H.  A new  drug in post-alcoholic tension
  states.  Canad. M. Ass. J., 1954,  71: 387-388.  Abstract:
  Excerpta med.. Sect. 8,1955, 8: No. 3553.
  Tintera, J.  W.  Office rehabilitation of the alcoholic.
  N. York State J. M., 1956,  56: 3896-3902.
   [chronic]
   Ewing, J. A., Mendenhall, J. H.  Clinical evaluation of
   the effect of mephenesin on anxiety.  J. 3Ient Sc, Lond.,
   1953, 99: 464-472.
   Mendenhall, J. H., Ewing,  J. A.  Further psychometric
   evaluation of the effect  of mephenesin on anxiety.  J.
   3Ient.  Sc, Lond., 1954, 100: 2<>2-2(jU.   Abstract:  Ex-
   cerpta med., Sect. 8,1955, 8: No. 927.

 Mephenesin carbamate
   [acute]
   Armour, P. S.   A regimen in acute alcoholism.  [Me-
   phenesin; mephenesin carbamate; reserpine; also com-
   bined and compared]  Arizona 31., 1956, 13: 169-172.
   Block,  M. A.  Medical treatment of alcoholism.  J. Am.
   M. Ass., 1956,162 : 1610-1619.

 Meprobamate
   Selling, L. S.  A clinical study of miltown, a new tran-
   quilizing agent. J.  Clin. Exp. Psychopath., 1956,  17:
   7-14.  Abstract: Excerpta  med.,  Sect. 8, 1957,  10: No
   391.
   ---.   Clinical study of  a  new  tranquilizing drug
   J. Am.  M. Ass., 1955, 157:  1594-1596.
   Thimann, J., Gauthier, J.  W.  Miltown  as a tranquil-
   izer  in the treatment  of alcohol addicts.   Q. J. Alcohol,
   1956, 17: 19-23.
   Turvey, S. E.   Meprobamate (equanil)  for relief of
   anxiety  and  nervous tension  from  various   causes.
   [also with disulfiram]   Canad. M. Ass. J., 1956,  74:
   863-865. Abstract: Excerpta med., Sect. 8, 1957,  10:
   No. 362.

   [acute]
  Allen,  E. B., Prout, C. T.   Alcoholism.   Progr. Neur.
   Psychiat, N. Y., 1956,11: 338-351.
  Block, M. A.  Medical treatment of alcoholism.   J. Am.  .
   M. Ass., 1956,162 :1610-1619.
  Borroni, G., Casadio, V.  Sull'impiego terapeutico di un
   farmaco antiansia muscolorilassante.  [Therapeutic use  '
   of a muscle relaxant anti-anxiety  drug.]  Gazz. med.
   ital, 1956,115 :  365-367.
  Collomb, H., Miletto, G.,  Chaupin, M. Le meprobamate
   dans le traitment des psychoses et  des nevroses. [Me-  i
   probamate in the treatment of psychoses  and neuroses.]
   Rev. prat., Par., 1956, 6 :1200-1204.
  Fox,  V.  Treatment of  withdrawal symptoms  in  the  '
   management  of alcoholism.  J. 31. Ass.  Georgia, 1956,  ]
   45:139-142.

   [chronic]
   Borrus, J.  C.  Meprobamate in psychiatric  disorders.
  Med. Clin. N. America, 1957,  41:327-337.
  ---.  Study of effect of miltown  (2-methyl-2-n-propyl-
   1,3-propanediol dicarbamate) on psychiatric states. J.  '■
  Am,  31. Ass., 1955, 157 : 1596-1598.   Abstract: Excerpta
  med., Sect. 8, 1956, 9:  No. 1720.
  Feldman, D.  J. Drug therapy of  chronic alcoholism.
  Med, Clin, N. America, 1957, 41: 381-392.              !
  Osinski, W. A.  Treatment of anxiety states with mepro-
  bamate (miltown).   Internat. Rec. if.,  1956, 169:589-
  595.
  Smith, J. A., Rutherford, A., Fanning, R. A compari-  i
  son of phenaglycodol (ultran), meprobamate and pla-  1
  cebo  in abstinent  alcoholics.  Am. J. Psychiat, 1957,  i
  114:364-365.

—with Chlorpromazine [and Promethazine]
    see ALCOHOLISM—Meprobamate [acute]  [fox]

—with Promazine
  Fox,  V.  The management of acute alcoholism;  experi-
  ences with an additional series of 61 cases   -im Prac-
  titioner, 1956, 7: 1461-1464.
174 
ANCILLARY  SUBJECT LIST
Alcoholism : Rauwolfia serpentina alkaloids
Mescaline
  [chronic]
  Osmond, H.  A review of the clinical effects of psycho-
  tomimetic agents.   Ann, N. York  Acad. Sc, 1957,  66:
  418-434.

Methylphenidylacetate
  [acute]
    see also ALCOHOLISxM
                 Reserpine with Methylphenidylacetate
  Block, M. A.  Medical treatment of alcoholism.  J. Am.
  31. Ass., 1956, 162:1610-1619.

  [chronic]
  Davidoff, E.,  Best, J. L., McPheeters, H. L.  The effect
  of ritalin  (methyl-phenidylacetate  hydrochloride)  on
  mildly depressed ambulatory patients.  N. York State
  J. M., 1957, 57: 1753-1757.
  Wells, R. E.  Use of reserpine (serpasil) in  the man-
  agement of  chronic alcoholism,  [methylphenidylace-
  tate ; chlorpromazine + reserpine + methylphenidylace-
  tate]  J. Am, 31. Ass.,  1957, 163 : 426-429.

Perphenazine with Reserpine
  [chronic]
  Cahn, C. H.,  Lehmann, H. E.  Perphenazine;  observa-
  tions on the clinical  effects  of a  new tranquillizing
  agent in psychotic conditions.  Canad. Psychiat. Ass. J.,
  1957, 2: 104-112.                                 * *

Phenaglycodol
  [chronic]
  Smith, J. A., Rutherford, A., Fanning, R.   A compari-
  son  of phenaglycodol  (ultran), meprobamate  and  pla-
  cebo  in  abstinent alcoholics.   Am.  J.  Psychiat.,  1957,
  11: 364-365.

Pipradrol
  [acute]
  Antos, R. J.  Meratran.  Use of a new antidepressant
  in internal medicine.  Southwest. M., 1955, 36: 166-167.
  ---.  A preliminary  report  of clinical studies  on a
  new  stimulant.  Arizona 31., 1954, 11: 397-399.
  Block,  M. A.   Medical  treatment  of alcoholism. J.
  Am.  31. Ass., 1956, 162:1610-1619.

  [chronic]
  Bensoussan,  P., Villiaumey, E. M.  Note sur les premiers
  resultats de  l'utilisation d'un nouveau medicament de-
  pressolytique: le chlorhydrate de pipradrol.   [Note on
  the first results with the use of a  new antidepressive
  drug: pipradrol chlorhydrate.]   Ann. me'd.  psychol,
  Par., 1956,114 (1) : 438-443.
  Monroe, R. R., Heath,  R. G., Mickle, W. A. Miller, W.
  Cortical and subcortical recordings  correlated with be-
  havior in patients and animals during the  administra-
  tion  of Rauwolfia, thorazine and meratran.  Psychiat.
  Res. Rep.,  Wash., 1955 (1) : 25-44.  cp. 35:
  Proctor, R. C.  A new  therapeutic approach to certain
  cases of alcoholism.  South. M. J., 1956, 49: 73-75.
  ___  Griffin, R. A.  Clinical studies on alpha- (2-piper-
  idyl) benzhydrol hydrochloride (meratran)  in prophy-
  lactic treatment of alcoholism.   Clin. Res.  Proc, 1955,
  3 • 149
  Rosner, B. S., Fierman, L. B., Kramer, J.  F.  Clinical
  evaluation of meratran and frenquel on a chronic psy-
  chotic population.   Am. J. Psychiat, 1957,  113:993-
  996.

Promazine
  [acute]                      ,
  av^  P  T  Jr  Tranquilizing drugs  in private practice.
  NYork State J. M., 1957, 57 :1742-1747.
  RWk  M  A.  Medical  treatment of  alcoholism. J. Am.
  Miss! 1956,162:1610-1619.
 Burdine, W. E., Shipley, T. E., Papas, T. A.  Studies on
 the use of promazine in acute and chronic nervous and
 mental disturbances.   J. M. Ass.  Georgia, 1957, 46:
 171-173.
 Fazekas, J. F., Schultz, J. D., Sullivan, P. D., Shea, J. G.
 Management of  acutely disturbed patients  with  prom-
 azine  (sparine).  J. Am. 31. Ass., 1956,161: 46-49.  Con-
 densed : Am. Practitioner, 1956, 7 : 1807.
 ---, Sullivan, P. D., Schultz, J. D.  Use of dimethyl-
 amino-n-propylphenothiazine in the management  of pa-
 tients  with acute mental disturbances.  Med. Ann. Dis-
 trict of Columbia, 1956, 25 : 67-69.
 Feldman, D. J.   Drug  therapy  of  chronic  alcoholism.
 Med. Clin. N. America, 1957,41: 381-392.
 Figurelli, F. A.  The promazine treatment of alcoholism;
 a preliminary report.  Indust. 31. d S., 1956, 25:376-
 380.
 Fox, V.  The  management of acute alcoholism;  expe-
 riences with an additional  series of  61 cases.   Am.
 Practitioner, 1956, 7 :1461-1464.
 Hewitt, D. W.  Alcoholism,  a treatment guide for gen-
 eral practitioners. 112 p. Philadelphia, Lea d Febiger,
 1957.
 Mitchell,  E.  H.  Treatment of  acute  alcoholism with
 promazine (sparine).  J. Am. M. Ass., 1956, 161:44—45.
 Condensed : Am. Practitioner, 1956, 7 :1798-1799.  Ab-
 stract : Excerpta med.,  Sect.  8, 1957, 10: No. 359.
 Moyer, J. H., Pevey, K., Kinross-Wright, V.  Tranquiliz-
 ing (ataractic) agents: current evaluation of their clin-
 ical use in patients who are not hospitalized. GP, 1957,
 15 (6) : 97-11S.
 Shea, J. G, Ehrmantraut, W. R., Ticktin, H. E., Sullivan,
 P. D.,  Jr., Fazekas, J. F. Use of promazine  in the man-
 agement  of medical  emergencies.  Mil. M., 1956, 119:
 221-227.                                            *
 Usdin, G. L. Use of promazine in psychiatric practice;
 an early study.  J.  Louisiana M. Soc, 1956, 108: 251-
 257.

—Untoward effects
 Lemere,  F.  Promazine (sparine)  in the treatment of
  psychiatric disorders.  Northwest M., 1956,  55: 790-791.

—with Meprobomate
  see ALCOHOLISM— Promazine [acute]  [fox]

Promethazine
  [acute]
  Fox, V.  Treatment of withdrawal  symptoms  in  the
  management of alcoholism.   J. M. Ass.  Georgia, 1956,
  45:139-142.
  Rives, Menager, V.  Neuroplegic et  delirium  tremens.
   [Neuroplegic therapy  and  delirium  tremens.]   [pro-
  methazine-!-sedatives]  Anesthe'sie, Par.,  1953,  10:450-
  453.
  [chronic]
  Hedqvist, H.   Nagra erfarenheter  av promethazin-
  klorid som  sedativum och hypnoticum.   [Experience
  with  promethazine chloride as  sedative and hypnotic]
  Sven, lak. tidn., 1954, 51:1286-1297.
  Williams, E. L.  The management of the chronic alco-
  holic.    [promethazine-)-disulfiram]  Postgrad.  31.  J.,
  Lond., 1954, 30: 626-630.

—with Chlorpromazine [and other drugs]
  see Chlorpromazine  therapy of alcoholism
        —Various special techniques

—with Chlorpromazine and Meprobamate
  see ALCOHOLISM—Promethazine [acute] [fox]

Rauwolfia  serpentina  alkaloids
  Thimann, J., Bucknam, F.  G., Gauthier, J. W.,  O'Con-
  nell, T. A.  Rauwiloid  therapy in alcoholism.  [: rauwi-
   drine] Am. J. Psychiat., 1957, 113 : 694-697.
175 
Alcoholism : Rauwolfia serpentina alkaloids
PSYCHOPHARMACA
  [acute]
  Feldman, D. J.  The treatment of chronic alcoholism:
  a survey of current methods.  Ann. Int. M., 1956, 44:
  78-87.
  Floris, V.   L'impiego della Rauwolfia serpentina in neu-
  ropsichiatria.   [Use of Rauwolfia serpentina in neuro-
  psychiatry.]   Minerva-  med., Tor.,  1956,  47:944-945.

Reserpine
  Feldman, D. J.  Drug therapy  of chronic  alcoholism.
  Med. Clin.  N.  America, 1957, 41:381-392.
  [acute]
  Allen, E.  B., Prout, C. T.  Alcoholism.  Progr.  Neur.
  Psychiat, N. Y., 1956,11: 338-351.
  Armour,  P. S.  A regimen  in acute alcoholism.   [Me-
  phenesin ; mephenesin carbamate; reserpine; also com-
  bined and  compared]   Arizona 31., 1956, 13:169-172.
  Avol,  M., Vogel, P. J.  Treatment of delirium  tremens
  with reserpine  (serpasil) ;  a preliminary  report   [re-
  serpine ; reserpine+paraldehyde]  J. Am. M. Ass., 1955,
  159:1516-1520.  Abstract: Excerpta med., Sect. 8, 1956,
  9: No. 4001.  Year book of drug  therapy,  1956-1957,
  p. 338.
  Benassi,  P., Fava, D.  Trattamento con reserpina di
  alcune tossicomanie.  [Reserpine treatment of drug ad-
  diction.]    [English summary]  Arch, psicol. neur., Mi-
  lano,  1956, 17 : 601-607.                             *
  Block, M. A.  Medical treatment of alcoholism.  J.  Am.
  31. Ass., 1956,  162 : 1610-1619.
  Cachin, M., Pergola,  F.,  Potet,  F., Debesse,  B.  Le
  traitement  du  delirium tremens  par  la  reserpine.
  [Treatment of delirium tremens with reserpine.]   Bull
  Soc. me'd. hop. Paris, 1956, 72: 597-603.  Abstract: Ex-
  cerpta med,, Sect. 8, 1957, 10: No. 1430.
  Carey, E. F.  A new approach to the emergency treat-
  ment  of sickness caused by narcotic withdrawal.  Illi-
  nois 31. J., 1957,  111:1-7.   Also:  Am. N.  York Acad.
  Sc, 1955, 61: 222-229.
  Fox,  V.  Treatment  of  withdrawal symptons in the
  management of alcoholism.  J.  31. Ass. Georgia, 1956,
  45: 139-142.
  Grandon,  R. C. Heffley, W.,  Hensel, T., Bashore S.  A
  new medical adjunct to the treatment of  alcoholism;
  the  use  of  reserpine   (serpasil).  Am. Practitioner,
  1956,  7: 231-234.
  Greenfield, A. R.  A new type of sedation for the acute
  alcoholic.  Am.  Practitioner,  1956,  7:241-244.  Ab-
  stract: Year book of drug  therapy, 1956-1957, p. 337-
  338
  Lereboullet, J., Pluvinage, R.,  Vidart, L., Benoit, P.,
  Kapandji, I.  Le traitement du delirium tremens  par la
  reserpine.   [Treatment of delirium tremens with reser-
  pine.]  Bull. Soc. me'd.  hdp. Paris, 1956,  72: 604-605.
  Neuer, H.   Serpasil in the treatment of acute alcoholic
  psychoses.  Ohio  M. J., 1955,   51:749-751.  Abstract
  Excerpta med., Sect. 8, 1956, 9 : No. 4004.
  Pivnicki,  D.  Serpasil  u psihijatriskoj praksi.   [Ser-
  pasil in  psychiatric treatment.]   [German summary]
  31 ed,  arh., Sarajevo, 1956, 10: 109-117.
  Rea, E. L., Fazekas,  J. F.  Effects  of parenterally ad-
  ministered  reserpine.  A.  M. A.  Arch. Int. 31., 1955,
  95: 538-539.
  Siguier,  F., Giabicani, A., Betourne, C, Goglin, G.  Le
  serpasil  dans les deiires alcooliques.   [Serpasil in al-
  coholic delirium.]  Bull. Soc. me'd.  hdp. Paris, 1956, 72:
  605-607.   Abstract: Excerpta med., Sect. 8, 1957, 10:
  No. 1976.
  Treatment of alcoholics with reserpine.  In:  Alcohol-
  ism Treatment Digest, New Haven, 1956  (30) : 2-4.

  [chronic]
  Ritter, N.  S.   Experience with reserpine in the treat-
  ment of alcoholism.  Q.  J.  Alcohol, 1956,  17:195-197.
  Abstract: Excerpta med., Sect. 8,1957, 10: No. 883.
  Wells, R. E.  Use of reserpine (serpasil) in the manage-
  ment  of chronic alcoholism,   [reserpine; reserpine-f
  chlorpromazine;   reserpine+chlorpromazine+methyl-
  phenidylacetate]  J. Am. M. Ass., 1957, 163 : 426-429.
  West, L. J., Swegan, W. H.  An approach to alcoholism in
  the military service.   Am. J. Psychiat., 1956,  112:1004-
  1009.  Abstract: Excerpta med., Sept. 8,  1957, 10: No.
  918.

—with Chlorpromazine
    see ALCOHOLISM—Reserpine  [chronic]  [wells]

—with Mephenesin
—with Mephenesin carbamate
    see ALCOHOLISM—Mephenesin carbamate

—with Methylphenidylacetate
  [acute]
  Benassi, P.,  Fava,  D.  Trattamento  con reserpina di
  alcune tossicomanie.  [Reserpine treatment of drug ad-
  diction.]   [English  summary]  Arch,   psicol   neur.,
  Milano, 1956,17 : 601-607.
  Davidoff, E., Best, J. L., McPheeters, H. L.  The effect
  of  ritalin  (methyl-phenidylacetate hydrochloride)  on
  mildly depressed, ambulatory patients.   N. York State
  J. M., 1957, 57 :1753-1757.

—with Methylphenidylacetate  and Chlorpromazine
    see ALCOHOLISM—Reserpine  [chronic]  [wells]

—with Perphenazine
  see ALCOHOLISM—Perphenazine with Reserpine
CHILDRENa

Ataraxics
  Bender, L., Nichtern, S.  Chemotherapy in  child psy-
  chiatry,     [azacylonol: chlorpromazine : mephenesin:
  meprobamate: promethazine: reserpine]  N. York State
  J. 31., 1956, 56: 2791-2795.
  Freedman, A.  M., Effron, A.  S., Bender, L.  Pharma-
  cotherapy in children with psychiatric illness,  [chlor-
  promazine : mephenesin: reserpine] J. Nerv. 3Ient. Dis.,
  1955, 122: 479-486.  Abstract: Year book of  drug  ther-
  apy, 1956-1957, p. 350-351.
  French, E.  G.  Epilepsy,   [chlorpromazine;  meproba-
  mate ; reserpine]  Am. J. Psychiat, 1957,113 : 629-631.
  Kugelmass,  I.  N.  Psychochemotherapy of mental defi-
  ciency  in children,  [chlorpromazine: mephenesin: me-
  probamate : methylphenidylacetate: reserpine]  Inter-
  nal Rec 31., 1956,169: 323-338.
  Mathis, M.  Toniques et sedatifs en neuro-psychiatrie
  infantile.   [Tonics and sedatives in child neuro-psychi-
  atry.]   [chlorpromazine;   chlorpromazine+reserpine;
  N-oblivon ; reserpine]  PCdiatrie, 1956, 11: 807-820.

Azacyclonol
  Bender, L., Nichtern, S.  Chemotherapy in child psy-
  chiatry.   N. York State J. M., 1956, 56: 2791-2795.

Chlorpromazine
  Bair, H. V., Herold, W. Efficacy of  chlorpromazine in
  hyperactive mentally retarded children.   A. M. A.  Arch.
  Neur. Psychiat., 1955, 74: 363-364.  Abstract: Excerpta
  med., Sect. 8,1956,9: No. 1726.
  Bakwin, H.  The uses  of chlorpromazine in pediatrics.
  J. Pediat., S. Louis, 1956, 48: 240-247.
  Bender,  L., Nichtern, S.   Chemotherapy in  child psy-
  chiatry.   N. York State J. M., 1956, 56:  2791-2795.
  Bonafede,  V.  I. Chlorpromazine  (thorazine)   treat-
1 A single asterisk (*)  after a citation indicates that the article
includes data on untoward effects. A double asterisk (**) after
a citation means that the article reports at least one death.
176 
ANCILLARY  SUBJECT LIST
 ment of disturbed epileptic patients.  A.  31. A. Arch.
 Neur. Psychiat, 1957, 77: 243-246.
 ---.  Chlorpromazine  (thorazine)  treatment  of  dis-
 turbed epileptic patients; preliminary report. A. M. A.
 Arch. Neur. Psychiat, 1955, 74:158-162.
 Bonello, F. J.  Chlorpromazine in general practice.  In-
 ternat. Rec. 31., 1956, 169 : 197-212.
 Carter, C. H., Maley, M. C.  Chlorpromazine therapy in
 children at the Florida farm  colony.  Am. J.  31.  Sc,
 1957. 233:131-136.
 Denhoff, E., Holden, R. H.  The effectiveness of chlor-
 promazine (thorazine)  with cerebral palsied children.
 J. Pediat., S. Louis, 1955, 47 : 328-332.
 Durling, D., Esen, F. M., Mautner, H.  Central autonomic
 regulation and mental retardation.   Ann. paediat,
 Basel, 1956, 187 : 467-470.
 Esen, F. M., Durling, D. Thorazine in the  treatment of
 mentally retarded children.  Arch. Pediat., N. Y., 1956
 73:168-173.
 Fabisch,  W.  Chlorpromazine  and  epilepsy.   Lancet,
 Lond., 1955, 1: 1277.                                 *
 Faure, J. L., Abric, J.  Remarques cliniques sur les in-
 dications valables de la chlorpromazine et de la reser-
 pine en neuro-psychiatrie infantile.   [Clinical remarks
 on the indications for  the use of chlorpromazine  and
 reserpine in child neuro-psychiatry.]   Pediatric 1956,
 11: 773-776.
 Flaherty, J. A.  Effect of chlorpromazine medication on
 children with severe emotional  disturbances. Delaware
 31. J., 1955,27 :180-184.
 Freed, H.  Chlorpromazine  and reserpine; new era in
 psychiatry? Am. Practitioner, 1955, 6: 706-708.
 ---, Peifer, C. A.  Some considerations on the use of
 chlorpromazine in a child psychiatry  clinic.  J. Clin.
 Exp. Psychopath., 1956, 17:164-169.                  *
 ---,  ----•  Treatment  of hyperkinetic  emotionally
 disturbed  children  with  prolonged  administration
 of chlorpromazine.  Am. J.  Psychiat., 1956, 113 : 22-26.
 Abstract: Excerpta med., Sect.  8, 1957, 10: No. 1837.
 Freedman, A. M., Effron, A. S., Bender, L.  Pharmaco-
 therapy in children with  psychiatric illness.  J. Nerv.
 Ment. Dis., 1955, 122 : 479-486.  Abstract: Year  book of
 drug therapv, 1956-1957, p. 350-351.
 French, E. G.   Epilepsy.  Am. J. Psychiat., 1957, 113:
 629-631.
 Gatski, R. L.  Chlorpromazine in the treatment  of emo-
 tionally  maladjusted   children;  preliminary   report.
 /. Am. M. Ass., 1955,157:1298-1300.
 Geyer, H. W.  Response to thorazine (chlorpromazine)
 administration in hyperkinetic mongolism.  Delaware
 31. J., 1956, 28 : 189-190.
 Heuyer, G., Dell, C, Pringuet,  G.  Emploi de la chlor-
 promazine en neuropsychiatrie infantile. [Use of chlor-
 promazine in child neuropsychiatry.] Ence'phale, 1956,
 45:576-578.
 ---, Giraud, G., Galibert, J. Traitement de l'excitation
 psycho-motrice chez l'enfant par le 4560 R. P.  [R. P.
 4560 therapy of psychomotor  excitation in children.]
 Arch. fr. pCdiat., 1953,10 : 961-963.
 Hunt, B. R., Frank, T., Krush, T. P.  Chlorpromazine in
 the treatment of severe emotional disorders of children.
 A. M. A. J. Dis. Child., 1956, 91: 268-277.
 Kanner, L.,  Eisenberg, L.  Child psychiatry;  mental
 deficiency.  Am. J. Psychiat., 1957,113: 617-622.
 Kinross-Wright, V. A review of the newer drug thera-
 pies  in psychiatry.  Dis. Nerv.  Syst., 1956,  17:187-190.
 Kohler, C, Bourjade, G.  De l'utilization du 4.560 R. P.
 en  neuro-psychiatrie  infantile.  [Utilization of  4560
 R. P.  in pediatric neuro-psychiatry.]  Pe'diatrie, 1954,
 9: 383-385.  Abstract: J. me'd.  Lyon, 1954,  35 : 948.
Kugelmass, I.  N.  Psychochemotherapy of mental de-
ficiency in children.  Internat.  Rec M., 1956, 169: 323-
338
Lafon  R., Faure, J. L., Abric, J.   Etude semeiologique et
therapeutique des  troubles du  sommeil chez l'enfant.
Children : Chlorpromazine — with Reserpine — Combined
   [Symptomatologic and  therapeutic study of sleep dis-
   orders in children.]  Pe'diatrie, 1956, 11: 743-753.
   Leiberman, D. M., Vaughan, G. F.  The use of some new
   pharmacological  agents in psychiatry.  J. Ment. Sc,
   Lond., 1957, 103 : 110-118.
   Mathis, M. Toniques et sedatifs en neuro-psychiatrie
   infantile.   [Tonics  and  sedatives  in  child  neuro-
   psychiatry.]  Pe'diatrie, 1956,11: 807-820.
   Miksztal, M. W. Chlorpromazine  (thorazine) and reser-
   pine in residential treatment of neuropsychiatric disor-
   ders in children.  J. Nerv. Ment Dis., 1956, 123:477-
   479.
   Nichamin, S. J.  Chlorpromazine in  the treatment of
   mild behavior disturbances.  J. Michigan M. Soc,  1956,
   55:1469-1471.
   Rees, E.  L.  Metabolism  of  the schizophrenic child;
   etiologic hypothesis.  Report of six cases treated with
   chlorpromazine hydrochloride.  J. Am. M. Women Ass.,
   1956,11:11-16.
   Sainz, A.  A.  The management of side effects of chlor-
   promazine  and  reserpine.   [also  chlorpromazine-4-
   amphetamine]  Psychiat. Q., 1956, 30:647-653.
   Sarrouy, C, Saint-Jean, Sendra, L., Sabatini, R.  Etude
   eiectro-encephalographique  de trente cas de toxicoses
   traitees par  le 4560 R. P.   [Electroencephalographic
   study of 30 cases of toxicosis treated with 4560 R. P.]
   Arch. fr. pe'diat, 1955,12: 37-42.
   Scarpalezos, S. Le  traitement ambulatoire par la chlor-
   promazine des  psychonevroses et de certaines manifes-
   tations  epileptiques (troubles caracteriels  et  myoclo-
   nies).   [Ambulatory treatment with chlorpromazine in
   psychoneuroses and in some manifestations of epilepsy
   (character disorders and  myoclonias).]   Ence'phale,
   1956, 45: 722-726.
   Silver,  A. A.  Management of  children with  schizo-
   phrenia.  Am. J. Psychother., 1955, 9: 196-215.
   Steigman, A. J.,  Vallbona,  C.  Experience with chlor-
   promazine  in  pediatrics.  Internat.  Rec. 31.,   1955,
   168: 351-357.
   Winkelman, N. W., Jr.  An appraisal of  chlorproma-
   zine ; general principles for administration of chlorpro-
   mazine  based  on experience with 1,090 patients.  Am.
   J. Psychiat, 1957, 113 : 961-971.

—Lytic cocktail
   Steigman, A. J.,  Vallbona,  C.  Experience with chlor-
   promazine in  pediatrics.   Internat.  Rec. M.,   1955,
   168: 351-357.

—Psychotherapy
   Kinross-Wright, V.  Chlorpromazine in psychiatric dis-
   orders.  Med.   Clin. N.   America, 1957,  41:295-306.
   Lariviere,  P.  Quelques  commentaires sur la chlorpro-
   mazine  en pratique psychiatrique. [Some remarks on
   chlorpromazine in psychiatric practice.]  [English sum-
   mary]  Canad. Psychiat. Ass. J., 1956,1:18-23.

—Untoward effects [see footnote p. 176]
   Beal, J. A.  Chlorpromazine poisoning.  Brit  M.  J.,
   1955, 2:1620.

—with Reserpine—Combined
   Bender, L. Nichtern, S.  Chemotherapy in child psy-
  chiatry.  N. York State J. M., 1956, 56: 2791-2795.
   Bosinelli, M.  Reserpina e reserpina  associata a cloro-
  promazina in  neuropsichiatria  infantile.   [Reserpine
  and  reserpine combined with chlorpromazine in  child
  neuropsychiatry.]   Arch,  psicol  neur., Milano,  1956,
  17: 478-479.
  Eiber,  H.  B.   Chlorpromazine   (thorazine)-Rauwolfia
  combination in neuropsychiatry; preliminary  report.
   [whole root; reserpine]  A. M. A.  Arch. Neur. Psychiat.,
  1955, 74: 36-39.
  Geyer, H. W.  Thorazine (chlorpromazine) and serpasil 
Children :  Chlorpromazine — with Reserpine — Combined
PSYCHOPHARMACA
  therapy in hyperactive patient of low mentality.  Dela-
  ware 31. J., 1955, 27 :187-189.
  Mathis, M.  Toniques  et sedatifs en neuro-psychiatrie
  infantile.   [Tonics and  sedatives  in  child  neuro-psy-
  chiatry.]  Pe'diatrie, 1956, 11: 807-820.
—with Reserpine—Compared
  see also under CHILDREN—Ataraxics
  Beley,  A., Foncin, J. F.,  Leyrie, J.  Quelques inconven-
  ients des  doses  elevees de reserpine chez le jeune  ar-
  riere turbulent;  indications posologiques.   [Complica-
  tions with massive reserpine doses in disturbed retarded
  children;  dosage indications.] Ence'phale, 1956, 45: 802r-
  807.

—with other drugs [CNS depressants]—Combined
  Bakwin, H.  The  uses of chlorpromazine in pediatrics.
  J. Pediat., S. Louis, 1956, 48: 240-247.
  Bonafede, V. I.  Chlorpromazine (thorazine)  treatment
  of disturbed epileptic patients.  A. 31. A. Arch. Neur.
  Psychiat., 1957, 77 : 243-246.
  ---.  Chlorpromazine  (thorazine) treatment  of  dis-
  turbed epileptic patients; preliminary report.  A. M. A.
  Arch. Neur. Psychiat., 1955, 74 :158-162.
  Korganova, A. N.  Lechenie aminazinom podrostkov v
  psikhiatricheskoi  klinike; predvaritel'noe soobshchenie.
   [Aminazine therapy of  adolescents  at  a  psychiatric
  clinic; preliminary  communication.]   Zh.  nevropat.
  psikhiat, Moskva, 195<>: 567-570.
  Steigman, A. J., Vallbona,  C.  Experience with chlor-
  promazine  in pediatrics,   [also chlorpromazine  cock-
  tail]  Internat. Rec.  M., 1955, 168:351-357.

 —with other drugs [CNS stimulants]—Combined
  see CHILDREN—Chlorpromazine  :sainZ]

 Ethylcro tonylu rea
  Asung, C. L., Charcowa, A. I., Villa, A. P.  Effects of a
  new tranquilizing drug  (nostyn) on the behavior pat-
   terns  of  children recovered  from tuberculous menin-
   gitis.  Sea View Hosp. Bull, N. Y., 1956, 16: 80-85.

 Hydroxyzine
   Ayd, F. J., Jr.   Tranquilizing drugs in private practice.
   N. York State J. M.,  1957, 57:1742-1747.
   Farah, L.   Preliminary study on the use of hydroxyzine
   in psychosomatic affections,  [p. 380: dosage.]  Inter-
   nal Rec. M.,  1956,  169:379-389.  Abstract: Excerpta
   med.,  Sect. 8, 1957, 10:  No. 845.
   Fouks, Laine, Francois, Pagot.  Note sure l'utilisation
   en psychiatrie d'un nouveau neuroleptique.   [Note on
   the  use of a new neuroleptic drug in psychiatry.]  Ann.
   mCd. psychol, Par., 1956, 114 (1) : 605-608.
   Heuyer,  G., Lang, J. L.,  Chevreau, J.  P., Juredieu.
   Premiers resultats obtenus par un derive du chlorbenz-
   hydryl en psychiatrie infantile.  [First results with a
   chlorbenzhydryl derivative  in  child  psychiatry.]   En-
   ce'phale, 1956, 45: 579-586.
   Segal, L.  J., Tansley, A. E.  A clinical  trial with hy-
   droxyzine  (atarax) on  a group of maladjusted educa-
   tionally subnormal children.   J. Ment. Sc, Lond., 1957,
   103: 677-681.

 Mepazine
   Braun, M. Pacatal.  Am.  J. Psychiat, 1957, 113: 838-
   839.
   Gillie, A. K.  The use  of pacatal in low-grade mental
   defectives.  J. 31ent. Sc, Lond., 1957,  103 : 402-405.

 Mephenesin
   Bender,  L., Nichtern, S.  Chemotherapy in child  psy-
   chiatry.  N. York State J. M., 1956, 56: 2791-2795.
   Freedman, A. M., Effron, A. S., Bender,  L.   Pharmaco-
   therapy in children  with psychiatric illness.  J. Nerv.
   Ment. Dis., 1955,  122: 479-486.  Abstract: Year book of
   drug therapy, 1956-1957, p. 350-351.
  ---, Kremer, M. W., Robertiello, R., Effron, A. S.  The
  treatment  of  behavior  disorders  in children  with
  tolserol.  J. Pediat., S. Louis, 1955, 47 : 369-372.
  Friedlander,  H.  S.  Anxiety,  tension and  emotional
  stress • a report on the joint use of mephenesin and a
  barbiturate  in  their  treatment in  general practice.
  31ed. Times, Great Neck, 1953, 81: 411-415.
  Kugelmass, I. N.  Psychochemotherapy of mental  de-
  ficiency in children.  Internat. Rec.  M., 1956, 169: 323-
  338
  Mecham, M. J., Stromsta, C, Soderberg, G.  Effects of
  tolserol on  the speech errors of mentally defective chil-
  dren.   Am. J. Phys. 31., 1955, 34 : 535-536.


Meprobamate
  Bender, L, Nichtern,  S.  Chemotherapy in  child  psy-
  chiatry.  N. York  State J. 31., 1956, 56: 2791-2795.
  French,  E.  G.  Epilepsy.  Am.  J.  Psychiat,  1957,
  113: 629-631.
  Gillette, H. E.  Relaxant effects of meprobamate in dis-
  abilities resulting from musculoskeletal and  central
  nervous  system  disorders.  Clinical observations in
  fifty-five cases.  Internat. Rec 31.,  1956, 169:453-468.
  Abstract: Excerpta  med.,  Sect. 8, 1957,  10: No. 1841.
  Kugelmass, I. N.  Psychochemotherapy  of mental de-
  ficiency in  children.  Internat. Rec.  M., 1956, 169: 323-
  338
  Lanzoni, E., Cavazzuti, G. B.   Azione del meprobamato
  sui bambini della prima inf anzia; rilievi clinici ed elet-
  troencefalografici.  [Effect of meprobamate on infants;
  clinical and electroencephalographic studies.]  31inerva
  med., Tor., 1956, 47 : 2191-2192.
  Selling, L. S.  Clinical study of a new tranquilizing
  drug;  use of  miltown  (2-methyl-2-n-propyl-l,3-pro-
  panediol dicarbamate).  J. Am. 31. Ass., 1955,157:1594-
  1596.  Abstract: Excerpta  med.,  Sect. 8, 1956,  9:  No.
  1719.
  ---.  A clinical study of miltown, a new tranquilizing
  agent.  J. Clin. Exp. Psychopath., 1956,17 : 7-14.

Methylphenidylacetate
  Carter, C. H.  The  effects of reserpine and  methyl-
  phenidylacetate (ritalin)  in mental  defectives, spastics,
  and epileptics,   [also methylphenidylacetate-fanticon-
  vulsants]  Psychiat. Res. Rep., Wash., 1956  (4) : 44-48.
  Kugelmass, I. N.  Psychochemotherapy  of  mental de-
  ficiency in children.  Internat. Rec 31., 1956, 169: 323-
  338.

N-Oblivon
  Mathis, M.  Toniques et sedatifs en neuro-psychiatrie
  infantile.  [Tonics  and sedatives in  child neuro-psy-
  chiatry.]   Pe'diatrie, 1956, 11:807-820.

 Pipradrol
  Allin, T. G, Jr., Pogge, R. C.  The use of  azacyclonol
  and  pipradrol in general practice.  Internat. Rec. M.,
  1956, 169: 222-230.
  Fabing, H. D.  The newer analeptic drugs.   Med. Clin.
  N. America, 1957, 41: 339-351.
  Martin, K. E., Overley, H. G., Krone, R. E.  Pipradrol:
  combined  therapy for geriatric and  agitated patients.
  Internat. Rec M., 1957, 170: 33-36.
  Oettinger, L., Jr.  Meratran; preliminary  report  of a
  new  drug for  the treatment of behavior disorders  in
   children.  Dis. Nerv. Syst., 1955, 16: 299-302.

 —Untoward effects—Poisoning
   Fabing, H. D.,  Hawkins, J. R., Moulton, J.  A.   Clinical
   studies on o- (2-piperidyl)  benzhydrol hydrochloride, a
   new antidepressant drug.  Am. J. Psychiat., 1955, 111:
   832-836.   [Report of recovery p. 835]
178 
ANCILLARY  SUBJECT LIST
Prenderol
  Perlstein, M. A.  Prenderol:  a new drug  used with
  retarders in  petit  mal  epilepsv.  Neurology,  1953,
  3:744-751.

Promethazine
  Bender, L.,  Nichtern, S.  Chemotherapy in child psy-
  chiatry.  N. York State  J. 31., 1956, 56: 2791-2795.
  Haggenmiiller,  F.   Atosil-Sirup  in  der  Kinderheil-
  kunde.  [Atosil   elixir  in  pediatrics.]   3Ied.  Klin.,
  Berl, 1952, 47 : 320-321.
  Steigman, A. J., Vallbona, C.  Experience with chlor-
  promazine  in pediatrics,   [lytic  cocktail]  Internat.
  Rec M., 1955,168: 351-357.

Rauwolfia serpentina alkaloids
  Benda, C. E.  The differentiation  between mental  de-
  ficiency and emotional disorders, and some therapeutic
  experiments  with  Rauwolfia serpentina  (koglucoid).
  [In English]  Arch, pediat.  Uruguay,  1955, 26:32-46.
  Eiber,  H. B.   Chlorpromazine (thorazine)-Rauwolfia
  combination  in  neuropsychiatry;  preliminary  report.
  [whole root; reserpine] A. 31. A. Arch. Neur. Psychiat,
  1955, 74: 36-39.
  Lagrue, G.  Rauwolfia serpentina  (ou sarpagandah)  et
  ses  alcaloides.   [Rauwolfia  serpentina  (or sarpagan-
  dah) and its alkaloids.]  Vie med., Par., 1956, 37  (Spe-
  cial-May) : 111-112.
  Leslie, G. Rauwolfia  serpentina  in  the treatment  of
  psoriasis.  Monogr. Ther.  Squibb Inst.  31. Res.,  1956,
  1 (2) : 29-32.
  Prouet, P. E.  Rauwolfia and amphetamine therapy  in
  the  treatment of psychosomatic complaints.  J. Loui-
  siana M. Soc, 1955, 107 :114-116.
  Rosina, P. L.  Gli alcaloidi totali di  Rauwolfia in psi-
  chiatria ; premesse fisiologiche  ed esperienze cliniche.
  [Total Rauwolfia alkaloids in psychiatry; physiologi-
  cal basis and clinical experience.]   3Iinerva med., Tor.,
  1955, 46:1249-1252.
  Vergani, O., Aldeghi, E.  L'impiego degli alcaloidi totali
  di Rauwolfia serpentina in neuropsichiatria infantile.
  [Use of total alkaloids of Rauwolfia serpentina in child
  neuropsychiatry.]   [English summary] Minerva pediat.,
  Tor., 1956, 8: 1161-1165.
  Weir, H. F.,  Anderson, R.  L.  The effects of reserpine
  and  Rauwolfia  in minor disorders of adjustment  in
  children,   [compared]   Monogr. Ther. Squibb Inst. 31.
  Res., 1956, 1(2): 33-39.

Reserpine
  see  also CHILDREN—Rauwolfia  serpentina alkaloids
  Beley, A., Foncin, J. F., Leyrie, J.   Quelques inconveni-
  ents  des  doses  eievees  de  reserpine  chez  le  jeune
  arriere turbulent;  indications posologiques.  [Compli-
  cations with  massive  reserpine  doses in  disturbed re-
  tarded children;  dosage indications.]  Ence'phale,  1956,
  45: 802-807.                                         *
  Bender, L. Nichtern,  S.   Chemotherapy  in child psy-
  chiatry.  N.  York State J. M., 1956, 56: 2791-2795.
  Bosinelli, M.  Reserpina  p  reserpina associata a cloro-
  promazina in neuropsichiatria  infantile.  [Reserpine
  and  reserpine combined  with chlorpromazine in child
  neuropsychiatry.]   Arch, psicol.  neur.,  Milano, 1956,
  17:478-479.
 Carter,  C. H.  The effects of reserpine and methyl-
 phenidylacetate (ritalin)  in mental defectives, spastics,
 and epileptics.  Psychiat. Res. Rep., Wash., 1956 (4)  :
 44_48
Dice, N., Bagchi, B. K., Waggoner, R. W.   Investigation
of effects of intravenous reserpine in disturbed psychotic
and  brain-damaged patients; electroencephalographic
correlation.  J. Nerv. Ment. Dis., 1955, 122: 472-478.
Faure J. L., Abric, J. Remarques cliniques sur les indi-
cation's valables de la chlorpromazine et de la reserpine
 en neuro-psychiatrie  infantile.   [Clinical remarks  on
 the indications for the use of chlorpromazine and reser-
 pine  in child  neuro-psychiatry.]   Pe'diatrie, 1956, 11:
 773-776.
 Freedman, A.  M., Effron, A. S., Bender, L.  Pharmaco-
 therapy in children with psychiatric illness.  J. Nerv.
 Ment Dis., 1955, 122: 479-486.  Abstract: Year book of
 drug therapy, 1956-1957, p. 350-351.
 French, E. G.  Epilepsy.  Am. J. Psychiat.,  1957, 113:
 629-631.
 Gerard, D. L., Weisselberger, D., Kritz,  D.  Reserpine
 in the  postwithdrawal  rehabilitation  of  adolescent
 opiate  addicts.  A. M. A. Arch. Neur. Psychiat., 1956,
 76: 106-108.                                        *
 Gilardi, A. Neuartige sedative Therapie bei Verhaltens-
 storungen im  Kindesalter.   [New sedative therapy of
 behavior disorders in children.]   Praxis, Bern, 1956,
 45:993-995.
 Harris, R. D., Rowley, E. H. Reserpine in cerebral palsy.
 J. Pediat, S. Louis, 1956, 49: 398-400.
 Hunt, B.  R., Frank, T., Krush, T. P.  Chlorpromazine in
 the treatment of severe emotional disorders of children.
 A. M. A. J. Dis. Child., 1956, 91: 268-277.
 Jensen, E. S.  Serpasilbehandling  pa. andssvagehospital.
 [Serpasil  therapy  in  a hospital  for the  mentally de-
 ficient.]  Ugeskr. laeger, 1955, 117:1463-1465.
 Kinross-Wright, V. A review of the newer drug thera-
 pies in psychiatry.  Dis. Nerv. Syst., 1956, 17:187-190.
 Kirk, D. L., Bauer,  A. M.  Effects of reserpine  (serpasil)
 on emotionally maladjusted high  grade mental retard-
 ates.   Am. J. Ment. Defic, 1956, 60: 779-784.  Abstract:
 Excerpta med., Sect. 8, 1957. 10: No. 1528.             *
 Kugelmass, I.  N.  Psychochemotherapy of mental de-
 ficiency in children.  Internat. Rec. M., 1956, 169: 323-
 338.
 Lehman, E., Haber, J., Lesser, S. R. The use of reserpine
 in autistic children. J. Nerv. Ment. Dis., 1957, 125 : 351-
 356.
 Mathis, M.  Toniques et sedatifs en neuro-psychiatrie
 infantile.   [Tonics  and  sedatives in  child   neuro-
 psychiatry.]  Pe'diatrie, 1956,11: 807-820.
 Miksztal, M. W.  Chlorpromazine (thorazine)  and reser-
 pine in residential  treatment of neuropsychiatric disor-
 ders in children.   J.  Nerv. Ment. Dis., 1956, 123:477-
 479.
 Morton, H. G, Warson, S. R.  Control study on reserpine
 in small  group of  children  with  neurologic  disorders.
 J. Florida M. Ass., 1957, 43 : 786.
 Nicolaou, G. T., Kline,  N. S.  Reserpine in the treatment
 of disturbed adolescents.  Psychiat, Res.  Rep., Wash.,
 1955  (1) :122-132.
 Sacerdoti, G., Mantelli, A. La reserpina nel trattamento
 ambulatoriale  nei  disturbi  del comportamento  nell'in-
 fanzia.  [Reserpine in the ambulatory treatment of be-
 havior  disorders in childhood.]   [English summary]
 Gazz. med. ital, 1955, 114: 189-191.
----, Vegro,  G.  La reserpina in  psichiatria infantile.
 [Reserpine in  child psychiatry.]   [English summary]
 Arch, psicol. neur.,  3Iilano, 1956, 17 :459-477.
 Silver,  A. A.  Management  of children  with  schizo-
 phrenia.  Am. J. Psychother., 1955,  9:196-215.
Talbot, M. W., Jr.  The use of reserpine in irritable and
 hypertonic infants.  Ann. N.  York Acad. Sc, 1955, 61:
 188-197.  Abstract: Excerpta med.,  Sect. 8, 1956, 9: No.
 2635.
Tonini, G., Montanari,  C.  Modificazioni elettroencefalo-
 grafiche nel corso della terapia con reserpina.  [Electro-
encephalographic  changes during reserpine  therapy.]
Arch, psicol. neur., Milano,  1956, 17: 592-593.
Wallis,  I.  Ueber  Sedaraupin-Therapie  bei cerebral
geschadigten Kindern.  [Sedaraupin therapy of brain-
damaged  children.] 3Icd. Klin., Berl, 1956, 51: 2221-
2223.   [Not seen]
Walther-Biiel,  H.  Zur Serpasil-Behandlung  neuropsy-
chiatrischer  Zustiinde.  [Serpasil  therapy for  neuro-
179 
Children : Reserpine
PSYCHOPHARMACA
  psychiatric conditions.]  Praxis,  Bern, 1956,  45:733-
  736.
  Watkins, C.  The  use of reserpine in cerebral palsy.
  South. M. J., 1956,49:1488-1494.
  Zimmerman, F. T., Burgemeister, B.  B.  Preliminary
  report upon the effect of reserpine on epilepsy and be-
  havior problems in children.   Ann. N.  York Acad. Sc,
  1955, 61: 215-221.                                  *

—Untoward effects [see footnote p. 176]
  Budnick, I. S„  Leikin, S., Hoeck, L. E.  Effect in the
  newborn infant of  reserpine administered ante partum.
  A. M. A. J. Dis. Child., 1955, 90:286-289.         **

.---Poisoning
  Hubbard, B. A.  Reserpine.  J. Am. M. Ass., 1955, 157:
  468.
  Phillips, T.  Overdose  of reserpine.  Brit. M.  J., 1955,
  2:969.
  Plummer, A. J., Earl, A., Schneider, J. A., Trapold, J.,
  Barrett, W.  Pharmacology of Rauwolfia alkaloids, in-
  cluding  reserpine.  Ann. N. York Acad. Sc, 1954, 59:
  8-21.   [Case report p. 17-18]

—with Chlorpromazine
    see CHILDREN—Chlorpromazine   with  Reserpine

—with Methylphenidylacetate
  Carter C. H.  The effects of reserpine and methyl-phen-
  idylacetate (ritalin)  in mental defectives,  spastics, and
  epileptics.  Psychiat. Res. Rep., Wash.,  1956  (4) : 44^8.

Wy-1107
  Fazekas, J. F., Shea, J. G., Ehrmantraut, W. R., Alman,
  R. W.  Convulsant action of phenothiazine derivatives.
  J. Am.  31.  Ass., 1957,  165:1241-1245.               *
PAIN

Chlorpromazine
  Bonello, F. J.  Chlorpromazine in general practice.  In-
  ternat. Rec. M., 1956, 169 :197-212.
  Dobkin,  A.  B., Lamoureux,  L., Letienne,  R., Gilbert,
  R. G. B.   Some studies with largactil.   Canad. 31. Ass.
  J., 1954, 70 : 626-628.
  Houde, R. W., Wallenstein, S.  L. Analgetic power of
  chlorpromazine alone and in  combination with mor-
  phine [Abstract]  Fed. Proc, Bait, 1955,  15: 353.
  Howell, T. H., Harth, J. A. P., Dietrich,  M.   The use of
  chlorpromazine in geriatrics.  Practitioner, Lond., 1954,
  173: 172-173.
  Kessler, L. N., Barnard, R. D.  A new tranquilizer  me-
  probamate ;  its use  for  pain associated with  cancer.
  Preliminary  report.   Med.  Times,  Great  Neck,  1956,
  84: 431-435.
  Margolis, L. H.  Pharmacotherapy  in  psychiatry; a
  review.   Ann. N. York Acad. Sc, 1957, 66 : 698-718.
  ----, Fischer, A., Butler, R. N., Simon,  A.  Clinical ob-
  servations with chlorpromazine.  In: Kline, N.  S., ed.
  Phychopharmacology.  Washington, Am. Ass. Adv.  Sc,
  1956. p. 1-30.
  Miles, J.  E.   Psychosis with phantom limb pain treated
  by chlorpromazine.   Am. J. Psychiat, 1956, 112:1027-
  1028.
  Monaco, R. N., Leeper, R. D., Robbins, J. J., Calvy, G. L.
  Intermittent acute porphyria treated with  chlorproma-
  zine.  N. England J. M., 1957, 256: 309-311.
  Shea, J.  G., Alman,  R. W., Fazekas, J.  F.   The use of
  chlorpromazine in  the management  of patients  with
  head injury.  A. 31. A. Arch. Int. M.,  1955,  96:168-171.
  Abstract: Year book of drug therapy, 1956-1957, p. 341.

—Lytic cocktail
  see PAIN—Chlorpromazine—Various special techniques
—Studies, animals
—Studies, normal subjects
  see PAIN—Chlorpromazine studies—Animals
             Chlorpromazine studies—Normal subjects

—Untoward effects
  Roberts, S. E.  A chlorpromazine (thorazine)-induced
  cephalalgia and its management.  .1. 31. A. Arch. Otolar.,
  1956, 63: 208-209.
—Various special techniques
    see also PAIN—Chlorpromazine  with other drugs
       [CNS depressants]—-Combined
  Bartsch, W., Sperling, E.  Schmerzbehandlung mit Phe-
  nothiazinderivaten  (Megaphen und  Atosil).   [Pheno-
  thiazine derivatives  (megaphen and  atosil) in therapy
  of pain.] Nervenarzt, 1956, 27: 458-463.
  Engelmeier, M. P.  Die  Methodik der psychiatrischen
  Behandlung mit lytischen Substanzen.  [Methods of psy-
  chiatric therapy  with lytic  substances.]  Nervenarzt,
  1956, 27 : 64-69.  Abstract: Excerpta  med., Sect. 8,  1957,
  10: No. 1551.
  Fabris,  F.  A propos du traitement  de la douleur des
  cancereux.   [Contribution  to the treatment of pain in
  cancer patients.]  Presse me'd., 1955, 63 : 727.
  Fliigel, F.  Erfahrungen  mit  Megaphen in der psychia-
  trischen und neurologischen Klinik.  [Experiences with
  chlorpromazine  in  the  psychiatric   and  neurological
  clinic]  Arch. klin. Chir., 1954, 279: 767-772.
  Linke, H.  Erfahrungen in der  Behandlung akuter und
  chronischer Schmerzzustande  mit  den  Phenothiazin-
  korpern  Megaphen und  Atosil.  [Experiences  in the
  treatment  of acute and  chronic  pain states  with the
  phenothiazine derivatives megaphen  and  atosil.]  [Eng-
  lish summary]   Munch, med.  Wschr., 1955, 97 :1689-
  1692.
  ---. Uber die Wirkung des Phenothiazin-Heilschlafs
  bei   schweren   vegetativ  thalamischen    Schmerz-
  zustanden.  [Effects  of  phenothiazine induced thera-
  peutic sleep in severe pain of autonomic and thalamic
  origin.]  Aerztl. Wschr., 1956,11:  815-819.
  Salomone,  F.  P., Peria,  G., Rodolico, G.,  Cacoiola, R.
  Le medicazioni neuroplegiche nelle  terapia del dolore.
  [Neuroplegics in therapy of pain.]  31inerva chir., Tor.,
  1955,10: 296.
  Seitz, D.  Die Schlafbehandlung  mit Phenothiazinen in
  der Neurologie.   [Sleep therapy with phenothiazines in
  neurology.] Nervenarzt, 1956, 27:19-23.
  Sercl,  M., Bartousek,  V., Jachova, D.  Experiences
  cliniques sur la neuroplegique et  l'hibernation dans les
  affections  du  systeme nerveux.  [Clinical experiences
  with neuroplegia and hibernation  in diseases of the
  nervous system.]  Gaz.  med.  France, 1956,  63:1981-
  1982; 1984; 1987-1988.
  Seyffert, H. M., Strubel, H. Klinische Erfahrungen mit
  dem Schlafmittel und Tagessedativum Doroma.  [Clin-
  ical experience with doroma,  a  hypnotic and diurnal
  sedative.]  Medizinische, 1956,2:  997-999.
  Sollgruber, A.   Erfahrungen  fiber   die  Phenothiazin-
  Schlaftherapie in der internen Medizin.  [Experiences
  with phenothiazine sleep therapy in  internal medicine.]
  Wien. med. Wschr., 1955,105 : 807-808.
  Steigman,  A.  J., Vallbona, C.  Experience with chlor-
  promazine in pediatrics.  Internat.  Rec. M., 1955, 168:
  351-357.
 —with Promethazine  [and other drugs]—Combined
  see PAIN—Chlorpromazine—Various special techniques

 —with other drugs [CNS depressants]—Combined
  see also PAIN—Chlorpromazine—Various special tech-
                    niques
           PAIN—Chlorpromazine studies
  Dobkin, A. B., Gilbert, R. G. B., Lamoureux, L.  Physio-
  logical  effects  of chlorpromazine.   Anaesthesia, Lond.,
  1954, 9:157-174.
180 
ANCILLARY  SUBJECT LIST
Pain : Promethazine
  Faucett, R. L.  Drug addiction and other considerations
  in the management of pain with narcotic drugs.  Proc
  Mayo Clin., 1957,32 : 45-54.
  Gordon, R. A., Campbell, M.  The use of chlorpromazine
  in intractable pain associated with terminal carcinoma.
  Canad. 31. Ass. J., 1956, 75: 420-421.
  Houde, R. W., Wallenstein,  S. L.  Analgesic  power of
  chlorpromazine alone and in combination with morphine.
  [Abstract]  Fed. Proc, Bait., 1955, 14: 353.
  Jackson, G. L., Smith, D. A.  Analgesic properties of mix-
  tures of chlorpromazine with morphine and meperidine.
  Ann. Int. 31., 1956, 45: 640-652.
  Litteral, E. B., Wilkinson, W. E.  The advantages, disad-
  vantages and limitations of the use of chlorpromazine as
  a substitute for certain  somatic treatment methods in
  psychiatry.  Psychiat. Res.  Rep.,   Wash.,  1955  (1) :
  63-71.
  Lucas, J., Albert,  S. N., Bateman, J. C, Klopp, C. T.
  Thorazine as an aid in management of cancer patients.
  [Abstract]  Proc  Am. Ass. Cancer Res., 1954, 1(2): 30.
  Sadove, M. S., Balagot, R. C.  The value of chlorproma-
  zine in the management of pain.  Internat. Rec. M., 1955
  168: 346-350.
  ---, Levin, M. J.,  Rose, R. F., Schwartz, L., Witt, F. W.
  Chlorpromazine  and narcotics in the management of
  pain of malignant lesions.  J. Am. 31. Ass., 1954, 155:
  626-628.
  Vialard, C.  Note sur Tutilisation du largactil  (4560
  R. P.)  comme potentilisateur de medicaments analgesi-
  ques chez  les cancereux  douloureux  resistants  aux
  opiaces.  [Largactil (4560 RP) potentiating  analgesic
  drugs in the treatment of cancer patients who are in pain
  and  resistant  to opiates.]   Anesthcsie, Par.,  1953,  10:
  216-224.
  Wallis,  R.  Potentiation of hypnotics and  analgesics;
  clinical experience with chlorpromazine.  N. York State
  J. M., 1955, 55 : 243-245.

—with Psychosurgery—Compared
  Choppy, M., Le Beau, J.,  Petrie, A.  Modifications de la
  personnalite apres les operations frontales seiectives y
  compris la cingulectomie et  apres  traitement par la
  chlorpromazine.   [Personality changes  after  selective
  frontal operations, including cingulectomy, and  after
  chlorpromazine therapy.]  Rev. neur., Par.,  1955,  93:
  843-849.
  Petrie,  A., Le  Beau, J.   The  effects on personality of
  chlorpromazine as  compared with various brain  oper-
  ations.  Ence'phale, 1956, 45 : 987-995.
  ---, ----.   Psychologic changes in man  after chlor-
  promazine and certain types of brain surgery.  J. CUn.
  Exp. Psychopath., 1956,17:170-179.

Chlorpromazine studies
—Animals
  see also PAIN—Phenothiazines
  Agafonov,  V. G.  Tormoziashchee  vliianie  aminazina
  na tsentral'nyi effekt bolevogo razdrazheniia.   [The in-
  hibiting influence of aminazine on the central effect of
  pain.]  Zh. nevropat. psikhiat., Moskva, 1956, 56:94-
  103.   Abstract: Chem. Abstr., 1956, 50:17174f.
  Eeckhoutte, R.  van. Le chlorhydrate de chloro-3-di-
  methylamino-3'-propyl-10-phenothiazine (4560  R.  P.) ;
  son action sur le systeme nerveux et sur le  systeme neu-
  rovegetatif.  [3-Chloro-10-(3-dimethylaminopropyl) phe-
  nothiazine  (4560 R. P.) ;  its  action on the nervous and
  autonomic  nervous system.]   28  p.  Ambilly,  1953.
  [Thesis—Geneva  1953, no. 2168]
 Friebel, H., Reichle, C.  Zur analgetischen  und analges-
 ieverstfirkenden Wirkung von  Chlorpromazin  (Mega-
 phen).  [Analgesic  and analgesic-potentiating  effect of
 chlorpromazine (megaphen).]  Arch. exp.  Path., Berl,
 1955  226:551-557.   Abstract: Chem. Abstr., 1956, 50:
 2063'de.
   Sadove, M. S., Balagot, R. C, Reyes, R. M.  The poten-
   tiating action of chlorpromazine.  Current Res. Anesth.,
   1956, 35: 165-181.
   Schneider,  J.  A.  Reserpine  antagonism  of morphine
   analgesia  in mice.  Proc. Soc Exp.  Biol, N. Y., 1954,
   87: 614-615.  Abstract: Chem. Abstr., 1955, 49: 4165 ef.
   Wirth,  W.  Vesuche  zur kombinierten  Wirkung von
   Megaphen mit stark wirksamen Analgeticis. [Experi-
   ments  on  megaphen combined with  powerful  analge-
   sics.]   Arch. exp.  Path., Berl, 1954, 222: 75-76.

 —Normal subjects
   Fraser, H. F., Isbell, H.  Chlorpromazine and reserpine.
   A. Effects of each and of combinations of each with mor-
   phine.   B. Failure of each in treatment  of abstinence
   from morphine.  A. M. A. Arch. Neur. Psychiat., 1956,
   76: 257-262.

 Mepazine
   Laurendeau, E.  Essai clinique sur un nouveau  derive
   du phenothiazine:  le pacatal.  [Clinical trial of a new
   phenothiazine  derivative: pacatal.]   Union med. Can-
   ada, 1956, 85: 1424-1425.
   Seitz, D.  Die  Schlafbehandlung  mit Phenothiazinen
   in der Neurologie.  [Sleep therapy with phenothiazines
   in neurology.]   Nervenarzt,  1956, 27 :19-23.

 Mephenesin
   Ende, M., Youngblood, W.  The  use  of myanesin (tol-
   serol) in black widow spider bite.  Virginia 31. Month.,
   1953, 80: 24-25.
   Frankl, V. E.  Zur Behandlung  der  Angst.  [Therapy
   of anxiety.]  Wien. med. Wschr., 1952,  102:535-537.
   Abstract:  Excerpta med., Sect. 8, 1953, 6:  No.  408.

 Meprobamate
   Kessler, L. N., Barnard, R. D.  A  new  tranquilizer
   meprobamate;  its  use for pain associated with cancer.
   Preliminary report.  31ed. Times, Great Neck, 1956, 84:
   431-435.

 Phenothiazines
   Himwich, H. E., Rinaldi, F., Willis, D. An examination
   of phenothiazine derivatives with comparisons of their
   effects on the alerting reaction, chemical structure and
   therapeutic efficacy,   [chlorpromazine: mepazine : NP-
   207 : promazine: promethazine: pyrathiazine: WY-1107]
   J. Nerv. Ment.  Dis., 1956,  124: 53-57.

 Pipradrol
  Monroe,  R. R.,  Heath, R.  G, Mickle,  W. A., Miller, W.
   Cortical  and subcortical recordings correlated with be-
   havior in patients and animals during the administra-
   tion of Rauwolfia, thorazine, and meratran.  Psychiat.
   Res. Rep., Wash., 1955 (1)  : 25-44.   [p. 35]

 Proclorperazine
  Moyer, J. H„ Pevey, K., Kinross-Wright, V.  Tranquil-
  izing  (ataractic) agents:   current evaluation of  their
  clinical use  in patients who are not hospitalized.  GP,
  1957, 15 (6) : 97-118.

Promazine
  Shea, J.  G., Ehrmantraut, W. R., Ticktin, H. E.,  Sulli-
  van, P. D., Jr., Fazekas, J. F.  Use of promazine in the
  management of medical  emergencies.  31 il.  31.,  1956
  119: 221-227.

Promethazine

  Bente, D.  Zur Wirkung des Phenothiazinkorpers Ato-
  sil auf das  Schmerzgeschehen.   [Effect of  the  pheno-
  thiazine  derivative atosil  on pain.]   Arch. exp. Path
  Berl,  1954, 222 : 71-73. 
Pain : Promethazine
PSYCHOPHARMACA
  Lundy, J. S.   Modern  technics for the relief of  pain.
  [promethazine+ethchlorvynol] J. Lancet, 1957, 77: 32-
  37.

—with Chlorpromazine [and other drugs]—Combined
  see PAIN—Chlorpromazine—Various special techniques

Psychopharmaca—Placebo effect
  Houde, R. W., Wallenstein, S. L.  Clinical aspects of the
  evaluation of analgesics.  J. Am. Geriat. Soc, 1956, 4:
  167-171.

Reserpine
  Lereboullet, J., Vidart, L., Amstutz, C.  Membre fantome
  douloureux avec syndrome depressif.  Guerison specta-
  culaire par la reserpine.  [Painful phantom limb with
  a depressive syndrome; spectacular  cure with reser-
  pine.]  Rev. neur., Par., TJ55, 92 : 386-387.

—Studies, animals
  Schneider,  J.  A.   Reserpine antagonism of  morphine
  analgesia in mice.  Proc Soc.  Exp. Biol, N.  Y., 1954,
  87: 614-615. Abstract:  Chem. Abstr.,  1955, 49 : 4165 ef.

—Studies, normal subjects
  Fraser, H. F., Isbell, H.  Chlorpromazine and reserpine.
  A. Effects of each and of combinations  of each with mor-
  phine.  B. Failure of each in treatment of abstinence
  from morphine.  A. M.  A. Arch. Neur. Psychiat., 1956,
  76:257-262.
182 
AUTHOR LIST 
 
                         A

Abdouchelli, A., see Abeiy, P., Abdouchelli, A., Fourment,
  J., Schmitz, B., Delteil, P.
Abdulla, A.  Cannabis indica als Volksseuche in Agypten.
  [Cannabis indica as  a  national  epidemic in Egypt.]
  [English  summary]  Schweiz. med. Wschr.,  1953, 83:
  541-543.
Abeiy,  P., Abdouchelli, A.,  Fourment,  J.,  Schmitz,  B.,
  Delteil,  P.  Suite  aux  essais  therapeutiques  de  re-
  equilibration instincto-affective; essai de traitement par
  la  bromure  tetra-ethyl  d'ammonium  en  comparaison
  avec le R. P. 45-60 et le C. 92-95.  [Further therapeutic
  studies on the restoration of instinctive-affective bal-
  ance; therapeutic  trials with  tetraethylammonium
  bromide in comparison with  R. P.  45-60  and with C.
  92-95.]  Ann. med.  psychol,  Par., 1952, 110  (2) : 262-
  267.
Abood,  L. G., see Walaszek, E. J., Abood, L. G.
Abrams, R. E., Tice, L. F.  Modern medicinals in review.
  Am. J. Pharm., 1955, 127 : 4-22.
Abramson,  H.  A.  Blocking of the LSD-25 reaction in
  Siamese fighting fish.  In: Abramson,  H. A., ed. Neuro-
  pharmacology.  Transactions of the third conference,
  May  1956, Princeton, N. J.  New York, Josiah Macy, Jr.
  Foundation, 1957.  p. 9-27.
---.  Lysergic acid diethylamide (LSD-25).  III. As an
  adjunct  to psychotherapy with elimination of  fear of
  homosexuality.  J. Psychol, Provincet, 1955, 39:127-
  155.
---.  Lysergic acid diethylamide  (LSD-25) : XIX. As
  an adjunct to brief psychotherapy, with special ref-
  erence  to ego enhancement.  J.  Psychol,  Provincet,
  1956, 41:199-229.
---.  Some observations  on normal  volunteers and  pa-
  tients.  In:  Cholden, L.,  ed. Lysergic  acid diethyla-
  mide and  mescaline in experimental psychiatry-  New
  York, Grune d Stratton, 1956.   p. 51-54.
---.  Tolerance to LSD-25 and a theory  of psychoses.
  In: Abramson, H. A., ed. Neuropharmacology.  Trans-
  actions of the second  conference,  May 1955, Princeton,
  N. J.  New York, Josiah 31acy, Jr. Foundation, 1956.
  p. 259-300.
---.  Verbatim recording and transference studies with
  lysergic  acid diethylamide  (LSD-25).  J. Nerv.  31 ent
  Dis., 1957,125 : 444-450.
—  ed.  Neuropharmacology.  Transactions of the sec-
  ond conference, May 1955, Princeton, N. J. 328 p.  Trans-
  actions of the third conference, May 1956, Princeton,
  N. J. 381 p.  New York. Josiah 3facy, Jr. Foundation,
  1956; 1957.  [Articles within the scope  of this bibliog-
  raphy are listed individually.]
---, Evans, L.  T.   Lysergic  acid  diethylamide (LSD-
  25) :  II. Psych obiological effects on the Siamese fighting
  fish.  Science, 1954, 120: 990-991.
---, Jarvik, M. E.  Lvsergic acid  diethylamide (LSD-
  25) : IX. Effect on snails.  J. Psychol, Provincet, 1955,
  40:337-340.
---, ----,  Gorin,  M. H., Hirsch, M. W.  Lysergic acid
  diethvlamide (LSD-25) : XVII. Tolerance development
  and  its  relationship to  a  theory  of  psychosis.  J.
  Psychol, Provincet., 1954, 41 : 81-105..
---, ____, Hirsch, M.  W.  Lysergic acid  diethylamide
  (LSD-25) : X. Effect  on reaction time to  auditory and
  visual stimuli.   J. Psychol, Provincet, 1955.  40: 39-52.
  Abstract:  Excerpta med., Sect. 8, 1956, 9: No. 3942.
___(____)____.  Lysergic acid diethylamide (LSD-25) :
  VII Effect upon two measures of motor  performance.
  J. Psychol, Provincet, 1955, 39: 455-464.
____________t Ewald,  A. T.  Lysergic acid diethylamide
  (LSD-25) • v' Effect on spatial relations abilities.  J.
  Psychol,  Provincet., 1955, 39 : 435-442.
___  ____  Kaufman, M. R., Kornetsky,  C, Levine, A.,
  Wagner   M.   Lysergic acid  diethylamide (LSD-25):
     I. Physiological and perceptual responses.  J. Psychol,
     Provincet, 1955, 39:3-60.  Abstract: Excerpta med.,
     Sect. 8,1955, 8: No. 3172.
   ----, ----,  Levine, A., Kaufman, M.  R., Hirsch, M. W.
     Lysergic acid diethylamide (LSD-25) : XV. The effects
     produced  by substitution of a tap  water placebo.  J.
     Psychol, Provincet, 1955, 40: 367-383.
   ---, Kornetsky,  C, Jarvik, M. E.,  Kaufman, M. R., Fer-
     guson, M.  W.  Lysergic  acid diethylamide (LSD-25)  :
     XL Content  analysis of clinical reactions.  J. Psychol,
     Provincet, 1955, 40: 53-60.
   ----, Sklarofsky, B., Baron, M. O., Gettner, H. H.  Block-
     ing of brain extract on  lysergic  acid diethylamide re-
     action in  Siamese  fighting  fish.  Science, 1957,  125:
     397-398.
   ----,  ----,  ----, ----.  Lysergic   acid   diethylamide
      (LSD-25)  antagonists.  I. Blocking effect of brain ex-
     tract in the  Siamese fighting fish; preliminary report.
     A. 31. A. Arch. Neur. Psychiat, 1957, 77: 439^45.
   ---,  Waxenberg,  S.  E.,  Levine,  A., Kaufman,  M. R..
      Kornetsky, C.   Lysergic acid diethylamide (LSD-25)  :
     XIII. Effect on Bender-Gestalt  test performance.  J.
     Psychol, Provincet., 1955, 40: 341-349.  Abstract: Ex-
     cerpta med., Sect. 8, 1956, 9: No. 3008.
   ---, see Hirsch, M. W., Jarvik, M.  E., Abramson, H. A.
   ---, see Jarvik,  M. E., Abramson, H. A., Hirsch, M. W.
   ---, see Lennard, H., Jarvik, M. E., Abramson, H. A.
   ---,  see  Levine,  A.,  Abramson,  H. A., Kaufman, M. R.,
     Markham, S.
   ---,  see  Levine,  A.,  Abramson,  H. A., Kaufman, M. R.,
     Markham, S., Kornetsky, C.
   Abric, J., see Faure, J. L., Abric, J.
   ----, see  Lafon, R., Due, N., Abric, J., Pouget, R., Come-
     lade, P.
   ---, see  Lafon,  R., Due, N., Boyer, Abric, J., Pouget, R.
   ---, see Lafon, R., Faure, J. L., Abric, J.
   ---, see Lafon, R., Temple, J. P., Abric, J.
   Abse, D. W., Curtis,  T. E., Dahlstrom, W.  G.,  Hawkins,
     D. R., Toops, T. C.   The use of  reserpine in the man-
      agement of acute mental disturbance on  an in-patient
      service: preliminary report.  J. Nerv. Ment. Dis., 1956,
     124: 239-247.
   Achaintre, A., Balvet, P., Beaujard,  M., Broussolle, P.,
     Perrin, J.,  Leveque,  F., Request,  A.  Evaluation  of
      chlorpromazine in psychotic patients.  Internat. Rec.
     M., 1957,170:175-182.
   ---,  Dubor, P.   Les  therapeutiques alternantes  et leur
     emploi en psychiatrie.  [Alternating therapies and their
      use in  psychiatry.]   [Abstract]   J. me'd. Lyon, 1954,
     35: 952.
   ---,----, Lauxerois, G.  Trois modes particuliers d'ad-
      ministration de la  chlorpromazine  dans  les  affections
      psychiatriques  a  longue  evolution.   [Three  special
      methods of chlorpromazine therapy in chronic psychiat-
      ric diseases.]  Encephale, 1956,  45 : 444- 448.
   ---,  Lauxerois, G.  Interet de la  psychotherapie aupres
      des malades mentaux.  II. Psychotherapie explicative
      individuelle  dans  les psychoses de longue  evolution
      traitees par  la chlorpromazine.  [The value of psycho-
      therapy in mental diseases.  II. Individual explanatory
      psychotherapy in chronic psychoses treated with chlor-
      promazine.]   J. me'd. Lyon, 1956, 37:403-406.
   ----, see Revol, L., Achaintre, A., Balvet,  P.,  Beaujard,
      M., Berthier, C, Broussolle,  P., Lambert,  P., Perrin, J.,
      Requet, A.
   Acheson, G. H., see Gottschalk, L.  A., Kapp, F. T., Ross,
      W. D., Kaplan, S. M., Silver, H.,  MacLeod, J. A., Kahn!
      J. B., Jr., Van Maanen, E. F., Acheson, G. H.
   Achor, R. W.  [P.], Hanson, N. O.  Hypertension treated
      with Rauwolfia canescens; a comparison  with Rau-
      wolfia serpentina.  N. England J. M., 1956, 255: 646-650.
   ----,----, Gifford, R. W., Jr.  Hypertension treated with
      Rauwolfia serpentina (whole root) and with reserpine:
      Controlled  study disclosing occasional severe depres-
      sion.  J. Am. M. Ass., 1955, 159: 841-845.

185 
Achor, R. W. [P.]
PSYCHOPHARMACA
 ---, see Faucett, R. L.,  Litin, E. M., Achor, R. W. P.
 ----, see Litin, E. M., Faucett, R. L., Achor, R. W. P.
 Acosta, M. G., see Bosworth, D. M., Fielding, J. W., Acosta,
   M.G.
 Adam, H., Golse, J.  Coma insulinique et coma par hi-
   bernation.  [Insulin coma  and coma by hibernation.]
   Ence'phale, 1956, 45: 471-473.
 Adamkiewicz, L., see Genest, J., Adamkiewicz, L., Robil-
   lard, R. Tremblay, G.
 Acuna, M., see Ayerbe, A., Acuna, M.
 Adasal, R., Ozsan, M., Karan, D., Yener, O. Les resultats
   obtenus par  la  chlorpromazine  a  la clinque psychi-
   atrique de la Faculte de Medecine d'Ankara.  [Results
   obtained with chlorpromazine at the psychiatric clinic
   of the  Faculte  de  Medecine  d'Ankara.]   Ence'phale,
   1956, 45:1204-1209.
 Addison, W.  P., see Kovitz, B., Carter, J. T., Addison, W. P.
 Adler, H. Use of  serpasil on a disturbed  ward.  Dis.
   Nerv.   Syst,  1955,   16:122-124.  Abstract:  Excerpta
   med., Sect. 8,1956,9: No. 4082.
 Agnew,  N.,  Hoffer,  A.  Nicotinic acid  modified lysergic
   acid diethylamide psychosis.  J. Ment. Sc,  Lond., 1955,
   101:12-27.  Abstract: Excerpta med., Sec. 8, 1956, 9 :
   No. 850.
 Aguiar, H., see Pires, N., Pinho, R. de, Fernando, L., Pint,
   M., Cavalcanti, U, Aguiar, H.
 Ainslie, J. D., see Essig, C. F., Ainslie, J. D.
 Aivazian, G. H.  Chlorpromazine in  the  withdrawal of
   habit-forming drugs in addicts.  Dis. Nerv. Syst., 1955,
   16: 57-60.  Abstract: Excerpta med., Sect. 8, 1956, 9:
   No. 413.
 Aksel, J. S.  Etude  clinique et experimentale de l'hiber-
   notherapie.  [Clinical and experimental study  of hi-
   bernotherapy.]  Ence'phale, 1956, 45:566-571.
 Albert, S. N., Rea,  E. L.,  Duverney, C. A., Shea, J.,  Fa-
   zekas, J. F.  The use of chlorpromazine in  the treat-
   ment of acute alcoholism.  Med. Ann. District  of  Co-
   lumbia, 1954, 23: 245-247.
 ----, see Fazekas, J. F., Albert, S.  N., Alman, R. W.
 ----, see Lucas,  J.,  Albert, S. N., Bateman, J.  C, Klopp,
   C.T.
 Albouy R., see Ravina, A., Pestel, M., Albouy, R.
 Aldeghi, E., see Vergani, O., Aldeghi, E.
 Alema, G. Allucinazioni da acido lisergico in cieco senza
   bulbi oculari.  [Lysergic acid hallucinations in blind-
   ness after bilateral enucleation.]   Riv. neur., Nap., 1952,
   22: 720-733.
 ---, Donini, G.  Sugli effetti della intossicazione speri-
   mentale con  dietilamide dell'acido lisergico in due casi
   di anosognosia visiva.  [Effects of experimental lysergic
   acid diethylamide poisoning in 2 cases of visual anosog-
   nosia.]   Riv.  sper. freniat.,  1956, 80:943-952.
 ---, Sergio, C.  Prime esperienze cliniche con una nuova
   sostanza  psicomimetica.  [First  clinical  experiences
   with a new psychomimetic  drug.].  Riv. sper. freniat,
   1956, 80: 989-994.
 Alexander, L.  Therapeutic process in electroshock and
   the newer drug therapies; psychopathological consid-
   erations.   J.  Am.  M. Ass., 1956, 162: 966-969.
---.  Objective approaches to treatment in psychiatry.
   Canad. Psychiat. Ass. J., 1957, 2:77-94.
Allen A., Mackinnon, H. L. Response to  wonder  drugs.
   Dis. Nerv.  Syst., 1956, 17:262-263.
Allen, A.  G.,  Black, A. V.   Near-fatal case of  intoxication
   with meprobamate treated with electro-stimulation and
   levarterenol.   Ohio M. J., 1956, 52:1303.
Allen,  E.  B., Prout, C.  T.  Alcoholism.   Progr. Neur.
   Psychiat,  N.  Y.,  1955,  10:510-521;  1956,  11:338-351.
Alliez, J., see Cremieux, A., Alliez, J., Soulayrol, R.
Allin, T.  G., Jr., Pogge, R. C.  The use of azacyclonol and
   pipradrol in  general practice.  Internat. Rec M., 1956,
   169: 222-230.
Alluaume, R.. see Laborit, H., Huguenard, P., Alluaume, R.
Alman, R. W.,  see Fazekas, J.  F., Albert, S. N., Alman,
   R.W.
---, see Fazekas, J. F., Shea, 3. G., Ehrmantraut, W. R.,
  Alman, R. W.
----, see Fazekas, J. F., Toupin, H., Alman, R. W.
---, see Shea, J. G., Alman, R. W., Fazekas, J. F.
Altschule, M. D.   Use of chlorpromazine and reserpine in
  mental disorders.  N. England J. M., 1956, 254:515-
  519.   Abstract: Chem. Abstr.,  1956, 50: 7318a.
----, Bower, W., Cook, L. Experigncias psiquiatricas com
  novo  agente  terapeutico: a  cloropromazina.  [Psychi-
  atric  experience with  a new therapeutic agent, chlor-
  promazine.]  Resenha clin. dent., S.  Paulo,  1955, 24;
  111-113.
---, see Bower, W. H., Altschule, M.  D., Cook, L.
Altshuler, I. M.  Music potentiating drugs. A preliminary
  report.  3Iusic  therapy, 1955, 5 : 120-126.
American Psychiatric Association.  The contribution  of
  the tranquilizing drugs and the dangers in their casual
  use for relief of everyday tensions.  J. Iowa M. Soc,
  1957, 47: 66.
Amstutz, C, see  Lereboullet,  J., Vidart,  L., Amstutz,  C.
Andermann,  K.,  Lindsay, J. S.   Chlorpromazine.  Med.
  J. Australia, 1955, 42 (2) : 80-82.
Andersen,   H.  Leucopeni  under  Largactilbehandling.
  [Leukopenia  with  chlorpromazine  therapy.]   Ugeskr.
  laeger, 1954,  116 :1733-1734.
Anderson, D. E., see Swenson, W. M., Gislason, S., Ander-
  son, D. E.
Anderson, E. W.. Rawnsley, K.  Clinical studies of lyser-
  gic acid diethylamide.  3Ischr.  Psychiat., Basel, 1954,
  128:38-55.  Abstract: Excerpta med., Sect.  8, 1955, 8:
  No. 1800.
Anderson, R. L., see Weir, H. F., Anderson, R. L.
Anderson, R. W., see Schiele, B. C, Anderson, R. W., Si-
  mon, W.
Anderson, T. E., see Cutler, R. P., Monroe, J. J., Anderson,
  T.E.
Andreev,  A. L.  O lechenii psikhicheskikh  zabolevanii
  serpazilom.   [Treatment  of  mental diseases with ser-
  pasil.] Zh. nevropat. psikhiat, 31oskva, 1956, 56:294-
  295.   Abstract:  Chem. Abstr., 1956, 50:17176gh.
Andren, H. E.  Meratran: a new drug proposed as an al-
  ternative to shock  therapy  in  depressions.  Clin. Res.
  Proc, 1955,3 : 41.
■---.  Treatment  of depression with meratran and elec-
  troshock.  Dis.  Nerv.   Syst.,  1955,  16:275-276.  Ab-
  stract : Excerpta med., Sect. 8, 1956, 9: No. 4541.
Andrew, G., see Sibilio, J. P., Andrew, G., Dart, D., Moore,
  K. B., Stehman, V. A.
Angel,  J. Cures  de sommeil et largactil.  [Sleep thera-
  pies  and largactil.]  Encephale,  1956, 45:416-420.
Angeleri, F., Carreras, M., Urbani,  M.  Modificazioni in-
  dotte  dal 4560 RP sui potenziali evocati registrati nella
  formazione reticolare  del tronco  dell'encefalo  e nella
  corteccia cerebrale.  [Changes induced by RP 4560  in
  potentials recorded in the formatio reticularis  of the
  brain stem and  in the cerebral  cortex.]  Riv. neur.,
  Nap.,  1954, 24: 702-705.   Abstract: Electroencephalog-
  raphy, 3Iontreal, 1954, 6: 532.
----, see Carreras, M., Angeleri, F.
Anton-Stephens,  D.   Preliminary  observations  on the
  psychiatric  uses of  chlorpromazine   (largactil).  J.
  31 ent. Sc., Lond., 1054, 100: 543-557.
Antonelli, F.   Applicazione della  cloropromazina nella
  practica reumatologica, con particolare riferimento alia
  nevrosi reumatica.   [Application  of chlorpromazine in
  rheumatology, with special reference to rheumatic neu-
  rosis.]  Arch, psicol. neur.,  Milano, 1956, 17: 558-561.
Antos, R. J.  Meratran.   Use of a new antidepressant in
  internal  medicine.  Southwest. M., 1955, 36:166-167.
----.  A preliminary report of clinical studies on a new
  stimulant.  Arizona 31., 1954, 11: 397-399.
----.  Use of an antidepressant in general practice  Med.
  Times, Great Neck, 1955, 83: 612-614.
Aprison, M. H., see Nathan, P., Aprison, M. H., Himwich,
186 
AUTHOR LIST
Ayd, F. /., Jr.
Apter, J. T., Pfeiffer, C. C.  Effect of hallucinogenic drugs
  on the electroretinogram.   Am, J. Ophth., 1956, 42 (4,
  Part 2) : 206-211.
----,----.  The effect of the hallucinogenic drugs LSD-
  25 and mescaline  on the electroretinogram.  Ann. N.
  York Acad. Sc, 1957, 66 : 508-514.
.---, Rinsley, D.  B.  Counteraction of  the  effects  of
  mepazine on the eye by means of parasympathomimetic
  drugs.  J. Clin. Exp. Psychopath., 1957, 18: 335-341.
Arbesman,  C. E.  Report of  the  Committee on  drugs of
  the research council of the American Academy of Al-
  lergy, 1954-1955.  Plimasin.  J. Allergy, 1955, 26 : 379-
  381.  Abstract as:  Clinical studies in allergy with sev-
  eral new drugs.  Drug  I.  J. Allergy, 1955, 26: 87.
Archer, J.  D. Effects of chlorpromazine on maze per-
  formance of albino rats.  [Abstract]  Fed. Proc, Bait.,
  1954,13: 332.
Archibald, H. C.  Chlorpromazine for headache.   Am. J.
  Psychiat, 1955,112 : 390.
Ardis, J. A., McKellar, P. Hypnagogic imagery and  mes-
  caline. J. Ment. Sc, Lond., 1956, 102: 22-29.
Arellano.  Effects of  reserpine in psychiatric patients.  J.
  Am. 31. Ass., 1955,157 : 530.
Argelander, H.  Ein Behandlungversuch mit Megaphen
  bei vegetativen Neurosen.   [Therapeutic trial with mag-
  aphen in autonomic neuroses.]  Aerztl. Wschr.,  1954,
  9: 634-639.   Abstract: Excerpta med., Sect. 8,  1955, 8:
  No. 2817.
Arian,  E., Gomirato, G.   Recherches experimentales sur
  l'inhibition des etats d'excitation  d'origin sous-corticale
  par moyen de la  chlorpromazine et de la reserpine;
  communication preliminaire.  [Experimental studies on
  the inhibition of  sub-cortical  excitation by  chlorpro-
  mazine and by reserpine; preliminary communication.]
  Encephale, 1956,45 : 1264-1266.
Armitage, S.  G., see Pearl, D., Vander Kamp, H., Olsen,
  A. L., Greenberg, P. D., Armitage, S. G.
Armour, P. S.  A regimen in acute alcoholism.   [Mephe-
  nesin ; mephenesin  carbamate;  reserpine; also  com-
  bined and compared]  Arizona M., 1956, 13 :169-172.
Arnold. A. L., Freeman, H. Reserpine in hospitalized psy-
  chotics ; a controlled study on chronically disturbed wo-
  men.  A. M. A. Arch. Neur. Psychiat., 1956, 76: 281-285.
----, see Freeman, H., Arnold, A. L., Cline, H. S.
Arnold, O.  H.  Erfahrungsbericht  fiber das Tagessedati-
  vum Covatin.  [Experiences with the day-time sedative
  covatin.]  Wien. med.  Wschr.,  1956, 106:510-512.
---, Hift,  S., Solms, W.  Die  Anwendung von  Largactil
  in der Psychiatrie.  [Use  of largactil  in  psychiatry.]
  Wien. med. Wschr., 1953, 103:  563-566.  Abstract: Ex-
  cerpta med., Sect.  8, 1954,  7: No. 1600.
---,----,----.  Uber die Anwendung eines zentral vege-
  tativen Hemmungsstoffes in der psychiatrischen Thera-
  pie.   [Application  of a new central autonomic inhibitor
  in psychiatric therapy.]  Wien. med.  Wschr., 1952, 102 :
  964-965.
---, Hoff, H.  Untersuchungen fiber die Wirkungsweise
  von  Lysergsaure-Diathylamid.  I.   [Studies   on  the
  mechanism of action of lysergic acid diethylamide.  I.]
  Wien. Zschr. Nervenh., 1953, 6:129-150.
.---, ----.  Korperschemastorungen bei  LSD-25.  [Dis-
  turbances in perception of  body structure caused by
  LSD-25.]   Wien. Zschr. Nervenh., 1953, 6:259-274.
Arnot, R.  The place  of sedatives in  the treatment  of
  psychoneurotics.  Am.  J.  Psychiat, 1956,  113:10-15.
  Abstract: Excerpta med., Sect. 8, 1957, 10: No. 392.
Arsenian,  J.,  see Shubin, H., Heiken, C.  A., Glaskin, A.,
  Pennes, E.,  Arsenian, J.
Asher  L. M.  Use of chlorpromazine in treatment of cer-
  tain gastrointestinal disturbances; preliminary report.
  J. Am. M. Ass., 1956,160: 1281-1285.
Asrican, E., see  Cares. R. M.,  Asrican, E., Fenichel, M.,
  Sack, P., Severing,  J.
Asung, C. L., Charcowa, A. I., Villa, A. P.  Effects of a
  new tranquilizing drug (nostyn) on the behavior pat-
  terns  of children  recovered from  tuberculous  menin-
  gitis. _  Sea View Hosp. Bull, N. Y., 1956, 16: 80-85.
Ataractics.  [Roundtable discussion  at  meeting held in
  Atlantic City, N. J., November 1956.]  Pub. Health Rep.,
  1957, 72: 624-637.
Atkinson, R. P., Tucker, W. I.  Clinical results with chlor-
  promazine (thorazine).  Lahey  Clin. Bull,  1955,  9:
  180-186.
Atti del  symposium  sulla reserpina e cloropromazina in
  neuropsichiatria.  [Proceedings of the symposium  on
  reserpine  and  chlorpromazine  in neuropsychiatry.]
  Arch, psicol.  neur., 3Iilano, 1956,  17:  p. III-XI; 115-
  684.  [Articles within the  scope  of  this bibliography
  are listed individually.]
Attinger, E. O., see Segal, M., Attinger, E. O.
D'Aulnay, J.,  Malineau, R.   Depuis l'avenement  de la
  chlorpromazine la cure  de Sakel est-elle condamnee?
  [Is Sakel's therapy obsolete since the advent of chlor-
  promazine therapy?]   Encephale, 1956, 45 : 656-660.
----, see Bergouignan, M.,  D'Aulnay, J., Malineau, R.
Avenarius, R.   Zur Wirkungsweise von Rauwolfiaalkaloi-
  den und  Phenothiazinderivaten  bei  Schizophrenen.
  [Mechanism of action of Rauwolfia alkaloids and pheno-
  thiazine derivatives  in  schizophrenics.]  Nervenarzt,
  1956, 27: 454-458.
Avol, M., Vogel, P.  J.   Treatment  of  delirium  tremens
  with  reserpine  (serpasil)  ;  a  preliminary report.  J.
  Am. 31. Ass., 1955, 159:1516-1520.  Abstract: Excerpta
  med., Sect.  8, 1956,  9: No. 4001:  Year  book  of drug
  therapy, 1956-1957, p. 338.
----, see Ruskin, I. W., Avol, M.
D'Avossa, B.  Considerazioni sui trattamento di  102 pa-
  zienti  neuropsichiatrici  con reserpina.  [Observations
  regarding reserpine therapy in 102  neuropsychiatric
  patients.] Arch, psicol neur., 31ilano, 1956, 17 : 546-558.
----.  Tentato suicidio con cloropromazina.  [Attempted
  suicide with chlorpromazine.]  Riv. sper. freniat, 1956,
  80: 674-675.
Ayd, F. J., Jr.  Chlorpromazine therapy  for anxiety asso-
  ciated  with  electroshock   therapy.  Confinia  neur.,
  Basel,  1956, 16 : 168-173.
----.  A clinical appraisal of trilafon.   Am. J. Psychiat.,
  1957,114: 554-555.
----.  A clinical evaluation  of frenquel. J. Nerv. 31ent.
  Dis., 1956,124 : 507-509.
----.  A clinical evaluation  of methyl-phenidylacetate
  hydrochloride  (ritalin).  J.  Clin.  Exp.  Psychopath.,
  1957,18: 342-346.
----.  A clinical evaluation of pacatal.  Dis. Nerv. Syst,
  1957,18:142-144.
----.  A critique of chlorpromazine and reserpine ther-
  apy.   In: Himwich,  H. E., ed.  Tranquilizing drugs.
  Washington, Am, Ass. Adv. Sc., 1957.  p. 173-181.
----.  The  dermatologie and systemic manifestations of
  chlorpromazine hypersensitivity; their clinical  signifi-
  cance  and management.  J. Nerv. Ment. Dis., 1956, 124 •
  84-87.
----.  Fatal hyperpyrexia during  chlorpromazine ther-
  apy.   J. Clin.  Exp.  Psychopath.,  1956, 17:189-192.
----.  Large doses of chlorpromazine in the treatment of
  psychiatric patients.  Dis. Nerv. Syst., 1955,16:146-149.
----.  The physiologic and neurologic action of chlorpro-
  mazine.  Psychiat. Res. Rep.,  Wash., 1955 (1) : 14-24
  Abstract: Chem. Abstr., 1956, 50: 2867def.
----.  Physiologic and neurologic responses to chlorpro-
  mazine:  their clinical significance and their manage-
  ment.   Psychiat, Res. Rep., Wash., 1956  (4) : 64-70.
----. A preliminary report on marsilid.  Am J. Psychiat
  1957, 114: 459.
----.  Thorazine and serpasil treatment of private neuro-
  psychiatric patients.   Am. J. Psychiat, 1956,113 :16-21.
----.  Tranquilizing drugs in private practice.   N. York
  State J. M., 1957, 57 : 1742-1747. 
Ayd, F. J., Jr.
PSYCHOPHARMACA
---.  The treatment of anxiety, agitation and excitement
  in the aged; a preliminary report on trilafon.  J. Am.
  Geriat. Soc, 1957, 5 : 92-96.
---.  Treatment of psychiatric patients with thorazine.
  South. M. J.,  1955, 48:177-186.  Abstract:  Excerpta
  med., Sect. 8,1956, 9: No. 4552.
Ayerbe, A., Acuna, M. Resultados obtenidos con la reser-
  pina en clinica psiquiatrica.   [Results obtained with re-
  serpine in psychiatric  practice.]   Sem. me'd., B. Air.,
  1956, 108: 232-234.
Azbukina, V. D., see Galenko, V. E., Osberg, I. IU., Azbu-
  kina, V. D.
Azima, H.  Prolonged sleep treatment in mental disorders;
  some  new  psychopharmacological  considerations.  J.
  Ment. Sc, Lond., 1955,101: 593-603.
---.  Report on the international colloquium on chlorpro-
  mazine and neuroleptic medications in psychiatric treat-
  ment, Paris, October 20-22,1955.  Am. J. Psychiat, 1956,
  112: 749-750.
---.  The use of  chlorpromazine and reserpine in  psy-
  chological  disorders in general practice.  Canad. M.
  Ass. J., 1956, 74: 929-931.
---.  La valeur de la situation anaclitique facilitee par
  la chlorpromazine.  [(Therapeutic)  value of  the  ana-
  clitic  situation,  facilitated  by  chlorpromazine.]  En-
  ce'phale, 1956, 45 : 972-978.
----,  Cramer-Azima, F. J., De Verteuil, R.  A comparative
  behavioral and psychodynamic  study of  reserpine and
  equally potent doses   of raudixin in schizophrenics.
  3Ionogr.  Ther.  Squibb Inst. 31. Res., 1956, 1(2): 15-25.
---,  Durost, H.  Effects of  promazine in mental  syn-
  dromes.   Canad. 31. Ass. J., 1957, 76: 442-446.
---,  Kent, I., Cleghorn,  R. A.  Rauwolfia alkaloids  in
  mental syndromes.  Canad.  M. Ass. J., 1955,  73: 866-
  871.
---,  Ogle, W. Effects of largactil in mental syndromes.
  Canad. 31. Ass. J., 1954, 71:116-121.
Azoulay, see Leyritz, Le Bezu, Azoulay.

                          B

Bader, E.  Extrapyramidal symptoms following thorazine
  medication.  Illinois 31. J., 1056, 109: 2S-29.
Bagchi, B. K., see Dice, N., Bagchi, B. K., Waggoner, R. W.
Bailly, R., see Borel, J., Camar, R., Bailly, R.
Bailly-Salin, see  Le Guillant,  L., Roelens, Corre, Kesten-
  berg,  Plichet, Bequart,  Bailly-Salin.
Bair,  H. V., Herold, W. Efficacy of chlorpromazine in hy-
  peractive mentally retarded children.  A. M.  A. Arch.
  Neur. Psychiat., 1955, 74: 363-364.  Abstract: Excerpta
  med., Sect. 8,1956, 9: No. 1726.
Baker, A. A.  Observations on the effect of largactil in
  psychiatric illness.   J. 3Ient Sc, Loud., 1055, 101: 175-
  182.  Abstract: Excerpta med., Sect. 8,1955, 8 : No. 4918.
---,  Thorpe, J.  G.  Placebo  response.  .1.  31. A. Arch.
  Neur. Psychiat, 1957, 78: 57-60.
---,  ----.  Deteriorated  psychotic patients—their treat-
  ment and  its  assessment.  J. Ment.  Sc, Lond.,  1956,
  102: 780-789.
---, see Thorpe, J.  G., Baker, A. A.
Bakwin, H.  The uses of chlorpromazine in pediatrics.  J.
  Pediat, S. Louis, 1056,  48:240-247.
Balagot, R. C, see Sadove, M. S., Balagot, R. C.
---, see Sadove, M. S., Balagot, R. C, Reyes, R. M.
Balducci, M.  Possibility, limiti, indicazioni e controindi-
  eazioni del  4560  R.  P.  (largactil)  in psichiatria;  con-
  trollo dei primi resultati con osservazione su  110 casi.
  [Possibilities, limitations, indications and contraindica-
  tions  of 4560 RP (largactil)  in psychiatry; review of
  the early results with a  study of 110 cases.] Rass. stud.
  psichiat., 1955, 44:709-729.   Abstract: Excerpta med.,
  Sect. 8, 1956, 9: No. 5010.
Balduzzi, E., Escalar, G.   A proposito delle terapie cosid-
  dette   ganglioplegiche.   [The  so-called  ganglioplegic
  therapies.]  Rass. stud,  psichiat, 1953, 42:1056-1064.
---,---.  Sulle terapie cosiddette ganglioplegiche.  II. II
  4560 R. P.  in psichiatria; osservazioni su 100 casi trat-
  tati.  [The so-called ganglioplegic  therapies.  II.  RP
  4560 in psychiatry; observations on 100 treated cases.]
  [English summary p. 148]  Rass. stud, psichiat, 1954,
  43: 120-151.
---, see Escalar, G, Balduzzi, E.
Balestrieri, A.  Azione della cloropromazina e della  reser-
  pina sui sistema nervoso extrapiramidale.  [The  effect
  of chlorpromazine and reserpine on the extrapyramidal
  nervous  system.]   [English  summary]  Arch, psicol.
  neur., 31 llano 1956, 17 : 483-512.
---, Fadiga,  E.  Intorno all'azione di alcuni derivati della
  fenotiazina sui sistema  nervoso centrale.  [Action of
  some phenothiazine derivatives on the central nervous
  system.] Arch. sc. biol,  Bologna, 1954,  38:620-633.
  Abstract:  Chem.  Abstr.,  1955,  49:11887b.  Excerpta
  med., Sect.  8, 1956, 9 : No. 303.
Ballardini, G., see Reda, G.  C,  Ballardini, G., Riccio, L.
Balvet.  Les  conditions d'environnement qu'exige la thera-
  peutique par  le largactil.   [Environmental conditions
  required by largactil therapy.]   J. med. Lyon, 1954, 35:
  947-948.
Balvet, P., see Achaintre, A., Balvet,  P., Beaujard, M.,
  Broussolle, P., Perrin, J., Leveque, F., Requet, A.
---, see Revol, L., Achaintre, A., Balvet, P., Beaujard, M.,
  Berthier, C,  Broussolle, P.,  Lambert,  P., Perrin, J.,
  Requet, A.
Bamdas, B. S., Glod, G. D., Lando, L. I., Levkovich,  A. P.,
  Tarasov, Y. K., Khazen, I. M.   [The mechanism of ac-
  tion of aminazine.]  Zh. nevropat. psikhiat,  3Ioskva,
  1956, 56:121-138.  Abstract:   Chem. Abstr.,  1956, 50:
  17175d.
Barahona Fernandes, see Fernandes, B.
Barbier, A., see Leconte, M., Barbier, A.
Bare, D., see  Borenstein, P., Dabbah, M., Bare, D.
Barison, F., Massignan, L.  La reserpina nelle schizofrenie
  catatoniche.   [Reserpine in catatonic  schizophrenia.]
  [English summary]  Arch, psicol.  neur., 3Iilano,  1956.
  17 : 347-358.
Barnard, R. D., see Kessler, L. N., Barnard, R. D.
Barnaud, J., see Berthier, C, Bonneru-Couchoud, M., Bar-
  naud, J.
---, see Lambert, P., Barnaud, J.
Baron M. O., see Abramson, H. A., Sklarofsky, B., Baron,
  M. O., Gettner, H. H.
Barres, P., see Laboucarie, J., Barres, P., Rascol, A.
---, see Riser, M.,  Laboucarie, J., Barres, P.
Barrett, B. M., Hansel,  F. K.  Reserpine a new adjunct in
  the management of resistant headache patterns; a pre-
  liminary report.  Ann. N. York Acad. Sc, 1955, 61: 250-
  266.  Abstract: Excerpta  med., Sect.  8,  1956,  9: No.
  1554.
Barrett, J. E. The value of chlorpromazine hydrochloride
  and reserpine in relation to other methods used in  treat-
  ing mental illness.  Virginia 31. Month., 1955. 82 ■ 415-
  417.
Barrett, W. EM see Plummer, A. J., Barrett, W E Waele
  G., Yonkman,  F. F.                     >••.&.
---, see Plummer,  A. J., Earl, A., Schneider, J A  Tra-
  pold, J., Barrett, W.
---, sec Schneider, J. A., Plummer, A. J., Earl, A. E  , Bar-
  rett, W. E., Rinehart, R., Dibble, R. C.
Barrett, W. W., see Clark, L. D„ Ellsworth, R. B , Barrett,
  W. W., Thurman, A. C, Holland, W.
Barsa, J. A.  The dual action of the tranquilizers    im J
  Psychiat, 1957, 114 : 74-75.
---,  Kline, N. S.  Agranulocytosis while receiving com-
  bined reserpine-chlorpromazine therapy.  Report of two
  cases.  Dis.  Nerv.  Syst.,  1956, 17:88-90.  Abstract:
  Excerpta med., Sect. 8,1957,10: No. 2092.
---,  ---. Azacyclonol (frenquel) in the  treatment of
  chronic schizophrenics.  Am.  J. Psychiat.  1956  113'
  255-256.
188 
AUTHOR  LIST
Baumberger, W.
 ---, ---.   Combined reserpine-chlorpromazine in treat-
  ment of  disturbed psychotics.  A. 31.  A.  Arch. Neur.
  Psychiat, 1955, 74: 280-286.  Abstracts:  Am. J. Psy-
  chiat., 1955, 111: 780.  Excerpta med., Sect. 8, 1957, 10:
  No. 368.
 -—, ---.   A comparative  study  of reserpine, chlorpro-
  mazine, and combined therapy.   A. M. A. Arch. Neur.
  Psychiat., 1956, 76 : 90-97.
 .---, ---.   Depression treated with chlorpromazine and
  promethazine.  Am.  J. Psychiat, 1957, 113: 744-745.
 .--,---.   Promazine in chronic schizophrenic patients.
  Am, J. Psychiat., 1957,113 : 654.
 .—,---.  Reserpine in the treatment of psychotics with
  convulsive disorders.  A.  31. A.  Arch. Neur. Psychiat.,
  1955, 74 : 31-35.  Abstract: Excerpta med.,  Sect. 8, 1956,
  9: No. 1730.
 .---, ---.  Treatment of two hundred disturbed psy-
  chotics with reserpine.  J. Am. 31. Ass., 1955, 158: 110-
  113.   Abstract: Excerpta  med.,  Sect. 8, 1956, 9: No.
    2246.
 ---,---.  Use of meprobamate in  the treatment of psy-
  chotic patients.  Am, J. Psychiat, 1956, 112: 1023.
 ---, ---.   Use of reserpine in disturbed psychotic pa-
  tients. Am. J. Psychiat., 1956,112 : 684-691.  Abstract:
  Excerpta med.. Sect. 8, 1956, 9: No. 4543.
 ---, see Kline, N. S., Barsa, J., Gosline, E.
 Barsotti, U., see Mariani, G., Barsotti, U.
 Barry, H., Jr., see Tilley, R. F., Barry, H., Jr.
 Bartfeld, H.  Use of reserpine in psychogenic rheumatism,
  osteoarthritis, and rheumatoid arthritis; a preliminary
  report.  J. Am. 31. Ass., 1955,159: 1510-1513.
 Barton, W. E., see Malamud, W., Barton, W. E., Fleming,
  A. M., Middleton,  P.  McK., Friedman, T. T., Schleifer,
  M. J.
 Bartousek, V., see Sercl, M., Bartousek, V., Jachova, D.
 Bartsch, W., Sperling, E.  Schmerzbehandlung mit Pheno-
  thiazinderivaten (Megaphen und Atosil).   [Therapy of
  pain  with phenothiazine derivatives  (megaphen  and
  atosil) J  Nervenarzt, 1956, 27 : 458-463.
 Baruk,  H.   La catatonie experimentale par la chlorpro-
  mazine ; la posologie et la methode d'administration la
  plus  efficace en therapeutique psychiatrique.   [Experi-
  mental catatonia  produced with chlorpromazine; the
  dosage and  most  effective  method of chlorpromazine
  therapy in psychiatry.]  Encephale, 1956, 45:474-476.
 ---.  Quelques  precisions  sur  la therapeutique par le
  sommeil en psychiatrie ; sommeil et narcose ;  danger des
  facteurs toxiques.   [Notes on sleep therapy in psychia-
  try ;  sleep and narcosis ; danger of toxic factors.]  Ann.
  med. psychol, Par., 1953, 111(2) : 523-525.
 ---.  Les  therapeutiques  psychiatriques.   [Psychiatric
  therapies.]  128 p.   Paris, Presses  universitaires  de
  France   [Que  sais-je?  Le  point  des connaissances
  actuelles  (691)] 1955.  Les therapeutiques physiologi-
  ques   sedatives;  cures de sommeil;  chlorpromazine.
  [Physiologic sedative therapies; sleep  therapy; chlor-
  promazine.]  p. 109-116.
 ---, Launay, C, Lelord.  Etude sur Taction therapeutique
  du 4560 R. P. dans les etats d'excitation et  d'agitation
  impulsive.  Donnees  cliniques et donnees experimen-
  tales sur les  modifications de la  circulation cerebrale.
  [Study on the therapeutic action of 4560 RP in states of
  excitation and  impulsive agitation.  Clinical and ex-
  perimental information on the changes in  cerebral cir-
  culation.]  Ann. med. psychol. Par., 1954, 112(2) : 66-71.
---, Launay, J.,  Berges, J.  La catatonie experimentale
  par la chlorpromazine.   [Experimental catatonia in-
  duced by  chlorpromazine.]   Ann. med. psychol, Par.,
  1955,113(1) : 439-441.
.___t___f___.  La catatonie experimentale  par la chlor-
  promazine a hautes doses chez le singe et dans la serie
  animale;  action therapeutique du 45-60 R.  P. dans le
  traitement des maladies mentales en clinique humaine
  (a  doses  moderees  et sans associations  medicamen-

     456132—59---13
  teuses).   [Experimental catatonia induced in monkeys
  by massive doses of chlorpromazine;  therapeutic effect
  of chlorpromazine in the treatment of mental disorders
  in humans with moderate doses and  without adjuvant
  medication.]   Rev. neur., Par., 1955, 92: 141-143.
---,---,---.  La chlorpromazine en therapeutique psy-
  chiatrique courante; schema de traitement a  l'usage
  des medecins  praticiens.  [Chlorpromazine in  current
  psychiatric therapy; mode of treatment as used in gen-
  eral  practice.]   Rev. prat,  Par., 1955,  5:3511-3517.
---,---,---.  Physiologie psychiatrique experimentale
  de la chlorpromazine chez les animaux et ses  applica-
  tions therapeutiques chez l'homme.  [Experimental psy-
  chopharmacology of chlorpromazine in animals and  its
  therapeutic applications in man.]  Encephale, 1956, 45 :
  1258-1263.
---,---,---.   Sur une serie de resultats therapeutiques
  spectaculaires par la chlorpromazine dans des psychoses
  graves suivant une posologie particuliere sans  associa-
  tion  medicamenteuse.   [Series  of spectacular thera-
  peutic  results with chlorpromazine in  severe psychoses;
  use of  chlorpromazine in particular dosage and  without
  associated medication.]   Ann. med. psychol, Par., 1955,
  113(1) : 442-449.
---,---,---.   La therapeutique par la chlorpromazine ;
  physiologie experimentale; physiologic clinique; resul-
  tats  therapeutiques et progres de la therapeutique psy-
  chiatrique.  [Chlorpromazine   therapy;   experimental
  physiology ; clinical physiology ;  therapeutic results and
  progress in psychiatric treatment.]  Ann. med. psychol,
  Par., 1055, 113(1) : 705-772.
---,---,---, Lanteri-Laura, G.  Etude de Taction de la
  reserpine  sur  Tinitiative psychomotrice et les  grandes
  constantes physiologiques et biologiques.  Comparaison
  sur Taction des  extraits  totaux.  [Study  of the effects
  of reserpine on  psychomotor initiative and the signifi-
  cant physiologic and biologic  values; comparison with
  the effects of total extracts.]   Ann. med. psychol, Par.,
  1957, 115(1) : 708-712.
---,----,----, Mijolla, A. de.  Etude clinique de Taction
  therapeutique  de la  reserpine.   Comparaison avec Tac-
  tion  des extraits totaux.  [Clinical study of the thera-
  peutic effect  of reserpine;  comparison with total ex-
  tracts.]  Ann. med. psychol. Par., 1957,115(1) : 704-708.
---, Launay, S., Berges, J.  Action de la reserpine sur la
  psychomotricite  et catatonie experimentale.   [Effect of
  reserpine  on experimental  psychomotricity  and cata-
  tonia.]  Rev. neur., Par., 1956, 95: 62-63.
Barwise, C, see  Sainz, A., Bigelow, N., Barwise, C.
Bashore, S., see Grandon,  R.  C, Heffley,  W., Hensel,  T.,
  Bashore, S.
Bass, B.  M., see Bryant, J. H., Bass, B. M., Hine, F. R.
Bateman, J. C, see Lucas, J., Albert, S. N., Bateman, J.  C,
  Klopp, C. T.
Bates,  T. J. N., see Douglas, A. D. M., Bates, T. J. N.
Batterman,  R. C.  The evaluation of sedatives.  J. Am.
  Geriat. Soc, 1956, 4:172-176.
---, Leifer, P., Grossman, A. J.  The advantages of a new
  combination sedative mixture.   Am. Practitioner, 1956,
  7: 1795-1798.
Baudoin, de Accident mortel  par association de Telec-
  trochoc a  une  cure de  reserpine.  [Fatal accident with
  combination of  electroshock  and reserpine therapy.]
  [Abstract] Presse med,, 1956, 64: 1174.
Baudrand, C., see Racamier, P. C,  Blanchard, M.,  Bau-
  drand, C.
---, see  Racamier, P. C, Baudrand, C.
Bauer, A. M., see Kirk, D. L., Bauer, A. M.
Baumberger, W.  Erfahrungen  mit dem  Rauwolfiaalka-
  loid  Reserpin  (Serpasil) bei  chronischen Geisteskran-
  ken.   [Experiences with the Rauwolfia alkaloid reser-
  pine  (serpasil)  in chronic mental disorders.]  Praxis,
  Bern.  1955,  44:721-724.  Abstract:  Excerpta  med.
  Sect. 8, 1956, 9 : No. 4542. 
Bazzi, T.
PSYCH0PHAR31ACA
Bazzi,  T.  Reserpina  e psicoterapia.  [Reserpine  and
  psychotherapy.]   [English   summary]  Arch,   psicol
  neur., Milano, 1956,17 : 675-681.
Beal, J. A.  Chlorpromazine poisoning.  Brit. 31. J., 1955,
  2:1620.
Beaudry, A., see Decherney, G., Beaudry, A.
Beaujard, Hamoneau.  Remarque sur Temploi du largactil
  dans les schizophrenies chroniques.  [An observation on
  the use of largactil in chronic schizophrenia.]   J. me'd.
  Lyon,  1955,  36:325-327.  Abstract:  Excerpta med.,
  Sect. 8,1956, 9: No. 1212.
Beaujard, M., see  Achaintre, A., Balvet,  P., Beaujard, M.,
  Broussolle, P., Perrin, J., Leveque, F., Requet, A.
---, see Revol, L., Achaintre, A., Balvet, P., Beaujard, M.,
  Berthier, C, Broussolle, P., Lambert, P., Perrin, J., Re-
  quet, A.
Beck, J. D., see Martin, J. E., Beck, J. D.
Becker, H., see Heiss, R., Becker, H., Hiltmann, H., Hons-
  berg, I.
Becker, J., see Perret, A., Becker, J., Lacoste, G.
Beckett, P. G., see Gottlieb, J. S., Tourney, G., Beckett, P.
  G., Lowinger, P.
Beckman, W. G., see Hollister, L. E., Traub, L., Beckman,
  W. G.
Beecher, H. K., see von Felsinger, J.  M., Lasagna, L.,
  Beecher, H. K.
Beesley, M. L., see Raymond,  M. J., Lucas, C. J., Beesley,
  M. L., O'Connell, B. A., Roberts, J. A. F.
Begany, A. J., Seifter, J., Pless, H. H., Huber, R. D., Bruce,
  W. F.  Tranquilizing effect of phenothiazines  in  cats
  and rabbits.  Fed. Proc, Bait, 1956,15 : 399-400.
Begg,  W. G. A.,  Reid, A. A. "Meratran", a new stimulant
  drug.  Brit. M.  J., 1956, 1:  946-949.
Begoin, J., see Sivadon, P., Schweich, M., Begoin, J.
Bein,  H. J. The pharmacology of Rauwolfia.   Pharm.
  Rev., 1956, 8: 435-483.
---.  Zur Pharmakologie des Reserpin, eines  neuen Alka-
  loids aus Rauwolfia serpentina Benth.  [Pharmacology
  of reserpine, a new alkaloid from Rauwolfia serpentina
  Benth.]   [English summary] Experientia, Basel, 1953,
  9:107-110.
---, Gross, F., Tripod, J., Meier, R.  Experimentelle Un-
  tersuchungen fiber "Serpasil" (Reserpin), ein neues sehr
  wirksames Rauwolfiaalkaloid mit neuartiger zentraler
  Wirkung.   [Experimental  studies   on   serpasil
  (reserpine) a new and very effective Rauwolfia alkaloid
  with a new and different central  effect.]  Schweiz. med.
  Wschr., 1953, 83: 1007-1012.
----, see Meier, R., Bein, H. J., Gross, F., Tripod, J., Tuch-
  mann-Duplessis, H.
---, see Mtiller, J. M., Schlittler, E., Bein, H.  J.
---, see Tripod, J., Bein, H. J., Meier, R.
Beis, M., see Royer, P., Beis, M., Burner, M.
Beley, A., Foncin,  J.  F., Leyrie, J.  Quelques inconvenients
  des doses eievees de reserpine chez le jeune arriere tur-
  bulent; indications posologiques.  [Complications with
  massive reserpine doses in disturbed retarded children;
  dosage indication.]  Ence'phale, 1956,  45 : 802-807.
Bell, J. P.  Magic drugs in psychiatry.  J. Kentucky M.
  Ass., 1954, 52:788-789.
Bellavitis, U., see Germano, V., Bellavitis, U.
Belleville, R. E.  MMPI score changes  induced by  lysergic
  acid  diethylamide  (LSD-25).  J. Clin. Psychol, 1956,
  12:279-282.
---, see Isbell, H., Belleville,  R. E., Fraser, H. F., Wikler,
  A., Logan, C. R.
---, see  Isbell,  H.,  Fraser, H. F.,  Wikler, A., Belleville,
  R. E.
Belot,  P., Decourt, P.  Effet du N68 sur  les perturbations
  psychiques d'origine instinctive chez des chiens.  [The
  effect of N-68 on psycho-sexual disorders of dogs.] Ann.
  me'd. psychol,  Par., 1956,114(2) : 112-116.
---,---.  Etats psycho-nevrotiques chez des chevaux de
  course; leur traitement par un  narcobiotique,  le N68.
  [Neuroses of race  horses; their treatment with the nar-
  cobiotic drug N-68.]   Ann. me'd. psychol, Par., 1956,114
  (2) : 103-112.
Belsanti,  R.  Modificazioni  neuro-psico-biochimiche  in-
  dotte dalla dietilamide  dell'acido lisergico in schizo-
  frenici e frenastenici.  [Neurological, psychological and
  biochemical effects  of  lysergic  acid diethylamide in
  schizophrenic  and phrenasthenic subjects.]   [English
  summary]   Acta neur.,  Nap.,  1952,  7:340-349.  Ab-
  stract : Excerpta med., Sect. 8, 1953, 6: No. 801.
Belsasso,  M.  Terapia  delle malattie mentali con reser-
  pina (serpasil)  e cloropromazina (largactil)  ad  alte
  dosi.  [Treatment of mental disorders with high-dosage
  reserpine  (serpasil)  and chlorpromazine  (largactil).]
  Rass. giuliana med., Trieste, 1956,12: 209-216.
---, see Donini, F. M., Belsasso, M., Ravis, E.
Beltran del Rio, C. A.  Estudio  del peyote en  el Indio
  tarahumara, habituado  a  su masticacion.  [Study of
  habitual peyote-chewing  in the Tarahumara.]  61 p.
  Mexico, 1953.   (Thesis—Mexico)
Benassi,   P.,  Cecacchi,  G.  Rilievi  elettroenceflografici
  nell'uso di  un derivato fenotiazinico  (45-60 R.  P.).
  [Electroencephalographic findings in the use of a pheno-
  thiazine derivative (RP^1560).]  Riv. neur., Nap., 1953,
  23: 535-542.  Abstract: Electroencephalography, Mon-
  treal, 1953, 5: 621.
---, Fava, D.  Trattamento con reserpina di alcune tossi-
  commanie.  [Reserpine treatment of drug addiction.]
  [English summary]   Arch, psicol. neur.,  Milano, 1956,
  17:601-607.
---, see Colombati, S., Benassi, P.
Benciolini P., see Marini, M., Caprini, G., Benciolini, P.
Benda, C. E.  The differentiation between  mental defi-
  ciency  and emotional disorders, and some therapeutic
  experiments  with Rauwolfia  serpentina  (koglucoid).
  [In English]  Arch,  pediat. Uruguay, 1955, 26: 32-46.
Benda, P., see David, M., Benda, P., Klein, F.
Bender, L., Nichtern, S. Chemotherapy in child psychia-
  try.  N. York State J. M., 1956, 56: 2791-2795.
---, see Freedman, A. M., Effron, A. S., Bender, L.
Benditt, E.,  P., Rowley, D. A. Antagonism of 5-hydroxy-
  tryptamine by chlorpromazine.   Science,  1956, 123: 24.
Beneditti  G.  Terapia  reserpinica  in  psichiatria.  [Re-
  serpine  therapy  in  psychiatry.]   [English  summary]
  Arch, psicol. neur., Milano, 1956, 17: 295-309.
Benichou, L., see Laboucarie, J., Rascol, A., Benichou, L.
---, see Monnerot, E.,  Monnerot, E., Benichou, L., Doco.
Bennett, A. E.  Clinical trial  of reserpine  in psychotic
  and  psychoneurotic   illnesses.  In: Kline, N. S., ed.
  Psychopharmacology.  Washington, Am. Ass. Adv. Sc,
  1956.  p. 109-117.
---, Ford,  F. R., Turk, R. E.  Clinical investigation of
  chlorpromazine  and  reserpine  in private psychiatric
  practice.  Am. J.  Psychiat,  1956, 112:782-787.  Con-
  densed : Am. Practitioner, 1956, 7:1576-1577. Abstract:
  Excerpta med., Sect. 8, 1956, 9: No. 4546.
Bennett, I. F., Cohen, D. Starer, E.  Isoniazid in treatment
  of the chronic schizophrenic  patient.  A. M.  A. Arch.
  Neur. Psychiat., 1954, 71: 54-65.
Benoit, P., see Coirault, R.,  Girard, V., Benoit, P.
---, see Coirault, R., Girard, V., Escafit, H., Benoit,  P.
Bensoussan, P. A., Klein, F.  Sur quelques incidents de la
  cure de sommeil au  chlorhydrate de chloro 3  (dimeth-
  ylamino-3'-propyl)-10-phenothiazine.   [Some  incidents
  in  sleep  therapy with  chloro 3  (dimethylamino-3'-
  propyl)-10-phenothiazine  hydrochloride.]  Ann.  me'd.
  psychol, Par., 1953 111(1) : 529-532.
---, Villiaumey, E. M. Note  sur les premiers  resultats
  de Tutilisation  d'un  nouveau medicament depressoly-
  tique: le chlorhydrate de pipradrol.  [Note on the first
  results  with  the  use of a new antidepressive drug:
  pipradrol  chlorhydrate.]  Ann. me'd. psychol, Par., 1956,
  114(1) : 438-443.
---,----, Rousseau, J. Action  symptomatique de Tazacy-
  clonol sur un syndrome  hallucinatoire et interpretatif 
AUTHOR LIST
Bianchetti, L.
  presentation  de malade.  [Symptomatic (therapeutic)
  effect of azacyclonol  on a hallucinatory and paranoid
  syndrome; case presentation]  Ann. me'd. psychol, Par.,
  1956, 114(1): 821-825.
Bente, D. Elektroencephalographische Ergebnisse  zur
  Wirkungsweise  der  neuroleptischen Behandlungsver-
  fahren.   [Mechanism of action of neuroleptic therapies;
  EEG findings.]   Ence'phale, 1956, 45: 898-903.
-—.  Zur Wirkung des Phenothiazinkorpers Atosil  auf
  das Schmerzgeschehen.  [Effect of the phenothiazine
  derivative atosil on pain.]  Arch. exp. Path., Berl, 1954,
  222:71-73.
---,  Itil,  T.   Das  Verhalten  des  Hirnstrombildes  bei
  hochdosierter Behandlung mit Reserpin (Serpasil)  und
  bei medikamentos erzeugten parkinsonahnlichen  Zu-
  standsbildern.   [The  encephalogram during  reserpine
  (serpasil) therapy with  massive doses and in drug-
  induced  parkinsonism.]   Med.  Klin., Berl, 1955,  50:
  1296-1301.
---,---. Zur Wirkung des Phenothiazinkorpers Mega-
  phen auf das menschliche Hirnstrombild.   [The effect
  of the phenothiazine megaphen  on the human EEG.]
  Arzneimitt. Forsch., 1954, 4 : 418-423.  Abstract: Chem.
  Abstr., 1954,  48:13097b.
---, see Flfigel, F., Bente, D.
Bequart, see Le Guillant, L., Roelens, Corre, Kestenberg,
  Plichet, Bequart, Bailly-Salin.
Bequart, P., see Montassut, M.,  Chertok, L., Bequart, P.
Berard, E. [L.] Cures de somnoplegie en clinique neuro-
  psychiatrique.   [Somnoplegic therapy in neuropsychi-
  atric practice.]   Ence'phale, 1956, 45: 401-411.
---, see Ey, H., Berard, E. [L.]
---, see Ey, H., Deschamps, A., Berard, E.
---, see Turner, M., Berard, E.
---, see Turner, M., Berard, E., Turner, N., Franco, N.
Bercel, N. A,  Travis L. E., Olinger, L. B., Dreikurs, E.
  Model psychoses  induced  by LSD-25  in  normals.  I.
  Psychophysiological investigations, with special refer-
  ence to the  mechanism of the  paranoid reaction.   II.
  Rorschach test findings.  A. M. A. Arch. Neur. Psychiat,
  1956,  75: 588-611; 612-618.  Abstract: Excerpta med.,
  Sect. 8,1957,10: No. 1984; 1985.
Berger, F. M.  Meprobamate;  its pharmacologic proper-
  ties and clinical  uses.  Internal  Rec.  M.,  1956,  169:
  184-196.
---.  The pharmacological properties of 2-methyl-2-n-
  propyl-1, 3-propanediol dicarbamate  (miltown), a  new
  interneural blocking agent.  J. Pharm. Exp. Ther., 1954,
  112: 413-423. Abstract: Chem. Abstr., 1955, 49: 2610i.
---, Campbell, G. L., Hendley,  C. D. Ludwig, B. J., Lynes,
  T. E.  The action of tranquilizers on brain potentials
  and serotonin.   Ann. N. York Acad.  Sc, 1957, 66:686-
  694.
---, see Hendley, C. D., Lynes, T. E., Berger, F. M.
Berger, H. Management of neuroses by the internist and
  general practitioner.   N. York  State J. M., 1956, 56:
  1783-1788.
Berges, J., see Baruk, H., Launay, J., Berges, J.
---, see Baruk, H., Launay, J., Berges, J., Lanteri-Laura,
  G.
---, see Baruk, H.,  Launay, J., Berges, J., Mijolla, A. de.
---, see Baruk, H., Launay, S., Berges, J.
Berglund, M.,  Blumenthal, B.,  Flordh, P.  Restenil  (me-
  probamat) pa ett psykiatriskt poliklinikmaterial.   [Re-
  stenil   (meprobamate)  in  psychiatric  outpatients.]
  Sven. lak. tidn., 1956,  53: 3362-3364.
Bergouignan,  M.  Action  de la chlorpromazine en  psy-
  chiatrie: faits  cliniques  et  significations  possibles.
  [The psychiatric effect of chlorpromazine: clinical facts
  and their possible significance.]  Ence'phale, 1956, 45:
  1136-1140.                   .        v. ^ .
___  Le largactil en therapeutique psychiatrique. [Lar-
  gactil in psychiatric  therapy.]  Presse me'd., 1953, 61:
  1133.
---.  Peut-on proposer une interpretation  univoque des
  effets therapeutiques de la chlorpromazine en psychia-
  trie?   [Possibility of unequivocal interpretation of the
  therapeutic effects of  chlorpromazine in psychiatry.]
  Ann. med. psychol, Par., 1956, 114(1) : 409-413.
---, D'Aulnay,  J., Malineau, R.  Retouches & notre ex-
  perience du largactil en psychiatrie.  [Additional ex-
  periences with largactil in psychiatry.]   J. med. Bor-
  deaux,  1955, 132 : 254-261.  Abstract: Excerpta med.,
  Sect. 8,1955, 8 : No. 4917.
---, Got, M., Malineau, R.  Notre experience du largactil
  en psychiatrie.  [Our experience with largactil in psy-
  chiatry.]   J. me'd. Bordeaux, 1954, 131:135-145.
Bergy, G. A.  Drugs of sedation with tranquilizing effects.
  Am. Profes. Pharmacist, 1956, 22:419;  534-538; 619-
  621; 709-710; 797-799; 888-889; 917-919.
Berlin, L. Guthrie, T., Weider, A., Goodell, H., Wolff, H. G.
  Studies in human cerebral function: the effects of mesca-
  line and lysergic acid on cerebral processes pertinent to
  creative activity.  J. Nerv. Ment Dis., 1955, 122:487-
  491.  Text  without drawings: Tr. Am. Neur. Ass.,
  1955, 80th Meeting: 188-190.
Bernstein, I. C, see Resch, J. A., Schut, J. W., Bernstein,
  I. C.
Bernstein, S., Detre, T.   Effects of reserpine  (serpasil)
  on  homeostasis in patients  presenting psychosomatic
  symptoms.  [Abstract]   A. M. A. Arch. Neur. Psychiat.,
  1955, 74: 337.
Berry, J. M., see Gallagher, W. J., Berry, J. M., Durden,
  W. D., Lazenby, W. D.
Berselli  G.,  Vicini, F.  Osservazioni sull'impiego  tera-
  peutico del largactil.  [Observations on the therapeutic
  use of largactil.]  Riv. sper. freniat., 1955, 79: 743-745.
Berthiaume, M.  Actualites therapeutiques  en neuro-psy-
  chiatrie;  la  reserpine  (serpasil).   [Therapeutic  ad-
  vances  in neuropsychiatry;   reserpine  (serpasil).]
  Union me'd. Canada, 1956, 85 :1039-1042.
---.  La diethylamide de Tacide lysergique en psychiatrie.
  [Lysergic  acid diethylamide  in  psychiatry.]   Union
  me'd.  Canada,  1956, 85:555-560.  Abstract: Excerpta
  med., Sect. 8,1957,10: No. 1385.
Berthier, G, Bonneru-Couchoud, M., Barnaud, J.  A pro-
  pos du traitement des deiires alcooliques subaigus et
  chroniques.  [Treatment of subacute and chronic alco-
  holic delirium.]  Rev.  neur., Par., 1956, 94: 673-674.
---,  ---, ---.  Considerations sur le traitement par la
  chlorpromazine associee it la therapeutique specifique
  dans la P.  G.; il propos de deux cas recents.   [Chlorpro-
  mazine therapy combined with specific therapy in gen-
  eral paralysis;  report  of two recent cases.]  J. me'd.
  Lyon,  1956, 37: 293-295.
---,  see Revol, L., Achaintre, A., Balvet,  P., Beaujard,
  M., Berthier, C, Broussolle, P., Lambert,  P., Perrin, J.,
  Requet, A.
Bertolini, O.  L'azione del 4560 R. P. in diverse sindromi
  psichiatriche.  [Effects  of 4560 R.  P. in various psy-
  chiatric syndromes.] Riv. sper. freniat, 1954, 78: 205-
  224.
■---.  Cloropromazina e  reserpina nel trattamento delle
  psicopatie.  [Chlorpromazine and reserpine in the treat-
  ment of mental diseases.]  Arch, psicol. neur., Milano,
  1956, 17: 623-627.
Bertone, J., see Feldman, P. E., Bertone, J., Panthel, H.
Besendorf,  H.,  Pletscher,  A. Beeinflussung  zentraler
  Wirkungen von  Reserpin  und  5-Hydroxytryptamin
  durch  Isonicotinsaurehydrazide.   [The  influence  of
  isonicotinic acid hydrazides on  the  central effects of
  reserpine and of 5-hydroxytryptamine.]   [English sum-
  mary]   Helvet. physiol pharm. acta, 1956, 14: 383-390.
Best, J. L, see Davidoff, E., Best, J. L., McPheeters, H. L.
Betourne, C, see  Siguier, F., Giabicani, A., Betourne, C,
  Goglin, G.
Bianchetti, L., see Ciocatto, E., Cattaneo, A. D.,  Solerio,
  L., Bianchetti, L. 
Bianchi, C.
PSYCH0PHAR3IACA
 Bianchi, C.  Reserpine and serotonin in experimental con-
   vulsions.  Nature, Lond., 1957,179 : 202-203.
 Bickford, R. G., see Schwarz, B. E., Bickford, R. G., Mul-
   der, D. W., Rome, H. P.
 ---, see  Schwarz, B. E., Bickford, R. G., Rome, H. P.
 ---, see  Schwarz, B. E., Wakim, K. G., Bickford, R. G.,
   Lichtenheld, F. R.
 Bigelow,  N., see Sainz, A., Bigelow, N., Barwise, C.
 Bilikiewicz,  T.  Leczenie  largaktylem  w  psychiatrii.
   [Therapeutic use of largactil in psychiatry.]   Wiado-
   mo ci lek., 1955,  8: 82-88.  Abstract: Excerpta med.,
   Sect. 8, 1956, 9 : No. 3611.
 Bini, L.,  see Kalinowsky,  L.  B.  Am. J. Psychiat, 1956,
   113: 79.
 Bird E. G., Goss, J. D. Jr., Denber, H. C. B.  Chlorproma-
   zine in the treatment of mental illness: a study of 750
   patients.  Am. J. Psychiat, 1955, 111: 930.
 ——, see Denber, H. C. B., Bird, E. G.
 Bize, N., see  Scherrer, P., Leclerc, J., Bize, N.
 Bizzi. B. Sorprendente  miglioramento  di una  psicosi
   cronica  irriducible in seguito a trattamento con  dosi
   elevate di  cloropromazina.  [Surprising improvement of
   an irreducible chronic psychosis following treatment
   with massive doses of chlorpromazine.]   Arch,  psicol.
   neur., 3Iilano, 1956, 17 : 640-642.
 ---, see Tonini, G. Bizzi, B.
 Black, A. V., see Allen, A. G., Black, A. V.
 Black, D. A., see Heller, G. C, Walton, D., Black, D. A.
 Blackley, R. J.  Disappearance of chlorpromazine-induced
   photosensitivity on substitution of promazine;  report
   on  eight cases.  Am. Practitioner, 1957, 8: 46-47.
 Blanchard, M., see Racamier, P. C, Blanchard, M., Bau-
   drand,  C.
 Blatt, M.  H., see Kupperman, H. S., Blatt, M. H., Vosburgh,
   L. F., Canis,  J., Wetchler, B.
 Bleuler, M.  Comparaison entre les effets de la chlorpro-
   mazine et de la reserpine en psychiatrie.   [Comparison
   between the  effects of chlorpromazine and reserpine in
   psychiatry.]   Ence'phale, 1956, 45 : 334-348.
 ---.   Fortschritte in der Behandlung von Erregungszus-
   tanden.  [Progress  in  the  treatment  of  excitatory
   states.]  [Abstract]  Praxis, Bern, 1954, 43:1030.
 ---.  Das Wesen  der Serpasil-Behandlung an  Schizo-
   phrenen.   [The mechanism  of  serpasil  treatment in
   schizophrenia.]  Schweiz.  med. Wschr., 1955, 85:443-
   444.
 ---, Stoll, W. A.  Clinical use of reserpine in psychiatry :
   comparison with chlorpromazine. Ann. N. York Acad.
   Sc, 1955, 61:167-173.  Abstract: Excerpta med., Sect.
   8,1956, 9: No. 4080.
 Blickenstorfer, E.  Zum atiologischen Problem der Psy-
   chosen  vom akuten  exogenen Reaktionstypus: Lyserg-
   saurediathylamid, ein psychisch wirksamer  toxischer
   Spurenstoff.  [Etiology of  psychoses of the acute, exo-
   genous reaction type; lysergic acid diethylamide, a psy-
   chotoxic drug effective in  minute  doses.]  Arch. Psy-
   chiat,  Berl,  1052,  188:226-236.  Abstract:  Chem.
   Abstr.,  1952,  46:11418b.  Excerpta med., Sect. 8, 1953,
  6: No. 807.
 Bliss, E. L., see Clark, L. D.,  Bliss, E. L.
 Bloch, C.   Psychopathologie et psychotherapie sous chlor-
  promazine  £  hautes  doses.   [Psychopathology and psy-
  chotherapy with  massive  doses of chlorpromazine.]
  Ence'phale, 1956, 45 : 458-460.
 Bloch, R. G.,  Dooneief, A. S., Buchberg, A. S., Spellman, S.
  The clinical  effect  of isoniazid and iproniazid in the
   treatment  of pulmonary tuberculosis.  Ann. Int. M.,
  1954, 40: 881-900.
Block, M. A.  Medical  treatment of alcoholism.  J. Am.
  M. Ass., 1956, 162 :1610-1619.
Block, S. L.   Effect of mephenesin upon anxiety.  A. M. A.
  Arch. Neur.  Psychiat, 1953,  69: 727-731.  Abstract:
  Excerpta med., Sect. 8, 1954, 7: No. 1605.
Blood dyscrasias associated with chlorpromazine therapy.
  J. Am, 31. Ass., 1056, 160 : 287.
Blough, D. S.  Some effects of drugs on visual discrimina-
  tion in the pigeon.  Ann. N. York Acad. Sc, 1957, 66:
  733—739.
Blumbergj A. G, Cohen, L., Miller, J. S. A.  The effect of
  Rauwolfia serpentina on  anxiety states.  J. Hillside
  Hosp.,  1954,  3: 140-146.  Abstract:  Excerpta  med.,
  Sect. 8, 1955, 8 : No. 3900.
Blumenthal, B., see Berglund, M., Blumenthal, B., Flordh,
  P.
Boardman,  R. H.  Fatal case of toxic hepatitis implicat-
  ing chlorpromazine.   Brit. 31. J., 1954, 2 : 579.
---, Lomas, J., Markowe, M.  Insulin and chlorpromazine
  in schizophrenia; a comparative study in previously un-
  treated cases.  Lancet, Lond., 1956, 2 : 487—491.
---, see Lomas, J., Boardman, R. H., Markowe, M.
Boardman,  W. K., Goldstone, S., Lhamon, W. T.  Effects
  of lysergic acid diethylamide  (LSD)  on the time sense
  of  normals.   A preliminarv  report.   A. M.  A. Arch.
  Neur. Psychiat, 1957, 78 : 321-324.
Bobon, J.  Chlorpromazine  et cure  de sommeil.   [Chlor-
  promazine and sleep  therapy.]  Encephale, 1956, 45:
  421-427.
Boszormenyi, Z., Gimes, M.,  Orthmayr,  A.  A largactil
  pharmakodynamias  hat&sa  es  therapias  eredmenyei a
  psychiatriaban.   [Pharmacodynamic  effects  and the
  therapeutic results  of largactil  in psychiatry.]  Orv.
  hetil,  1955,  96: 1039-1045.  Abstract:  Excerpta  med.,
  Sect. 8, 1956, 9 : No. 223s.
Bohn, L., see Osterman, E., Lassenius, B., Bohn, L., Elk-
  jaer, P.
Bohner, B., see Chen, G., Ensor, C. R., Bohner, B.
Boittelle, G, Boittelle-Lentulo, C.  Quelques remarques
  sur Taction du 3277 R. P. chez les malades  mentaux.
  [Effect  of 3277 R. P. on mental patients.]   Ann. me'd.
  psychol, Par., 1952, 110  (2) : 295-296.
Boittelle-Lentulo, C,  see Boittelle,  G.,  Boittelle-Lentulo,
  C.
Boleman, A. P.  Agranulocytosis associated with adminis-
  tration  of thorazine.  J. Am. 31. Ass., 1955, 157: 364.
Bolsi, D., Donegani, G, Grattarola, F. R.  I ganglioplegici
  ed il sistema neurovegetative negli  schizofrenici.   [Gan-
  glioplegics and the autonomic nervous system in schizo-
  phrenia.]    Minerva  med,,  Tor., 1953,  44:230-231.
  [Not seen]
Bonafede, V. I.  Chlorpromazine (thorazine) treatment of
  disturbed  epileptic  patients.   .4.  M.  A.  Arch. Neur.
  Psychiat, 1957, 77 : 243-246.
---.  Chlorpromazine  (thorazine)   treatment  of  dis-
  turbed epileptic patients ;  preliminary report.  A. 31. A.
  Arch: Neur. Psychiat, 1955, 74: 158-162.
Bonamini, F., Garello, L. Catatonia  sperimentale nei cani
  da 5-idrossitriptamina, introdotta nella cisterna magna.
  [Experimental catatonia in dogs induced by 5-hvdroxv-
  tryp famine,  introduced   into  the  cisterna  magna'.]
  Sistema, nerv., 3Iilano, 1056. 8: 157-166.  [Not seen]
---, see Sacchi, U, Bonamini, F., Dolce, G., Garello, L.
---, see Sacchi, U., Bonamini, F., Garello, L., Dolce, G.
---, see Sacchi, U., Garello, L, Dolce, G., Bonamini, F.
Bonello,  F.  J.  Chlorpromazine  in general practice. In-
  ternat. Rec. 31., 1956, 169: 197-212.
Bonetti,  U.,  Pedrinoni, L.  II largactil  nella cura della
  schizofrenia.  [Largactil  in the  treatment of  schizo-
  phrenia.]   Riv. pat.  nerv., 1955, 76 : 815-828.
Bonfante, B., see Gamma, G, Bonfante, B.,  Villata E.
Bonneru-Couchoud,  M.,  see Berthier,  C,  Bonneru-Cou-
  choud, M., Barnaud,  J.
Bonnet, H.  Chlorpromazine et modifications  de Telectro-
  encephalogramme chez les malades mentaux; correla-
  tions cliniques.  [Chlorpromazine  and EEG changes  In
  ^enSdi^rders ; clinical correlates.]   Ence'phale, 1056,
  45: 858—876.
—-,  Lauxerois, G.   Le largactil  a Thopital  psychia-
  trique ;  a propos  d'une experience d'un an d'utilisation 
AUTHOR LIST
Braun, M.
   du medicament en service ouvert et ferme.  [Largactil
   in a psychiatric hospital;  one year's experience with this
   drug in ambulatory  and in hospitalized patients.]   J.
   me'd. Lyon, 1055, 36 : 165-172.  Abstract: J. me'd. Lyon,
   1954, 35 : 949.  Excerpta med.,  Sect. 8, 1055, 8 : No. 4914.
 Bonnet de la Tour, see Laroche, C, Bonnet de la Tour.
 Bonvallet, M., see Hiebel, G., Bonvallet, M., Dell, P.
 Boon, A. A.  Largactil en verwante middelen in de psychi-
   atrie en neurologie.   [Largactil and related remedies in
   psychiatry and neurology.]   Ned. tschr. geneesk., 1955,
   99 : 2735-2741.
 Boor,  W. de.  Considerations nosologiques sur la thera-
   peutique par les medicaments neuroleptiques.  [Noso-
   logic  considerations   on  treatment   with  neuroleptic
   drugs.]  Encephale, 1956, 45 : 605-608.
 ---.  Pharmakopsychologie und Psychopathologie.  [Psy-
   chopharmacology and psychopathology.]  291 p.  Ber-
   lin, Springer, 1956.
 Booysen, P. J., see Hurst, L. A.,  Reuning, H., Wyk, A. J.
   van, Crouse, H. S., Booysen, P. J.,  Nelson, G.
 Bordeleau, J. M.  Clinical  evaluation  of  chlorpromazine
   and Rauwolfia serpentina in the psychiatric department
   of  a general hospital. J. Florida 31.  Ass.,  1956,  42:
   547-554.
 Borel, J., Camar, R.,  Bailly, R.   La cure de largactil, ses
   doses, sa duree.   [Largactil therapy ; dosage ; duration.]
   Ann. med., psychol, Par.,  1956,  114(1) : 86-91.
 ---, Lacombe, J., Camar, R.  Les poussees de rhumatisme
   chronique  pendant la cure  de largactil.   [Attacks of
   chronic  rheumatism  during  largactil  therapy.]   En-
   cephale, 1956, 45: 813-817.
 Borelli, S., see Korting, G. W., Borelli, S., Kimmig, J.
 Boren, H., see Jenkins, D. E.,  Chofnas,  I., Boren,  H.,
   Guthrie, R.
 Borenstein,  P., Dabbah, M., Bare,  D.   Contribution £
   l'etude de la reserpine en psychiatrie; resultats cliniques
   et eiectro-encephalographiques.   [Research on reserpine
   in psychiatry;  clinical and electroencephalographic re-
   sults.]  Ann, med. psychol, Par., 1956, 114(1) : 545-580.
   Abstract: Excerpta med.,  Sect.  8, 1957, 10: No. 1532.
 Borroni, G.,  Casadio, V. Sull'impiego terapeutico di un
   farmaco  antiansia  muscolorilassante.  [Therapeutic
   use of a muscle relaxant anti-anxiety drug.]   Gazz. med.
   ital, 1956,  115 : 365-367.
 Borrus,  J.  C. Meprobamate  in  psychiatric disorders.
   Med. Clin. N. America, 1957, 41: 327-337.
 ---.   Study  of effect of miltown  (2-methyl-2-n-propyl-l,3-
   propanediol dicarbamate) on psychiatric states.  J. Am.
   M. Ass., 1955,157:1596-1598.  Abstract: Excerpta med.,
   Sect. 8, 1956, 9 : No. 1720.
 Bosinelli, M. Reserpina e reserpina associata a cloro-
   promazina  in  neuropsichiatria  infantile.  [Reserpine
   and  reserpine combined with  chlorpromazine in child
   neuropsychiatry.]   Arch,  psicol.  neur.,  3Iilano,  1956,
   17:478-479.
 Bosworth, D. M.  The  treatment of tuberculous lesions
  of bones  and joints with  iproniazid  (marsilid).  N.
   York State J. 31., 1956, 56: 1281-1284.
 ---, Fielding,  J. W., Acosta, M.  G.  Use of iproniazid in
  nontuberculous bone and joint  infections.  J.  Am. Ass.,
  1955,  157: 132-136.
 Bouchard, M., Larue, G. H., Turmel, J.  Le  frenquel en
  psychiatrie;  rapport  preliminaire.  [Frenquel  in psy-
  chiatry; preliminary  report.]   Laval me'd.,  1956,  21:
  765-776.
 Boudwin, J., Kline, N. S. Use of reserpine in chronic non-
  disturbed psychotics.   Psychiat Res. Rep., Wash., 1956
  (4) : 71-78.
 Bougeant, H., see Cossa, P.,  Bougeant, H.,  Lombard, A.
---, see Cossa, P., Bougeant, H., Postel, J.
Boulanger, M., see Ramee,  F., Lacaton, R., Sanchez, F.,
  Boulanger, M.
Bourguignon, A., see Delay, J., Deniker, P., Bourguignon,
  A., Lemperiere, T.
Bourjade, G., see Kohler, C, Bourjade, G.
Bouthilet, L., see Cole, J. O., Ross, S., Bouthilet, L.
Bouttier, D., see Sigwald, J., Bouttier, D.
---, see Sigwald, J., Bouttier, D., Nicolas-Charles, P.
---, see Sigwald, J.,  Henne, M., Bouttier, D., Raymon-
  deaud, C, Quetin, A.
Bovet, D., see Longo, V. G., Von Berger, G. P., Bovet, D.
Bower, H. M.  A  clinical evaluation of reserpine in the
  treatment of chronic mental patients.  Med. J. Austra-
  lia, 1955, 42 (2) : 82-86. Abstract: Excerpta med.,  Sect.
  8, 1956, 9 : No. 1732.
Bower, W. H.  Chlorpromazine in psychiatric illness.  N.
  England J. 31., 1954, 251: 689-692.
---, Altschule, M. D., Cook, L.  Psychiatric experience
  with chlorpromazine.  Am. Practitioner, 1955, 6: 90-93.
  Abstract: Excerpta med.,  Sect. 8, 1956, 9: No. 4071.
----, see Altschule, M. D., Bower, W., Cook, L.
Bowes, H. A.   The ataractic drugs; the present position
  of chlorpromazine, frenquel, pacatal, and  reserpine in
  the psychiatric hospital.  Am. J. Psychiat., 1956,  113:
  530-539.
Boyd,  E. M., Miller, J.  K.  Inhibition of  locomotive ac-
  tivity  by  chlorpromazine  hydrochloride.  [Abstract]
  Fed. Proc, Bait, 1954, 13 : 338.
Boyer, see Lafon, R., Boyer, Due, N., Minvielle, J., Pouget,
  R.
---, see Lafon, R., Due,  N, Boyer, Abric, J., Pouget, R.
Boyer, R., see Thiebaux, M.,  Boyer, R.
---, see Thiebaux, M., Thiebaux, R., Boyer, R., Leborgne,
  F., Kiffel, M.
Bracha, S., Hes, J. P.  Death occuring during combined
  reserpine-electroshock  treatment.   Am.  J.  Psychiat.,
  1956, 113: 257.
---, see Hes, J. P., Bracha, S.
Bradley, P. B.  The  effect of some drugs on the electrical
  activity of the brain in the cat.  [Abstract]   Electro-
  encephalography, 3Iontreal, 1953,  5:471.  Also:  Elec-
  troencephalography, 3Iontreal, 1953, Suppl. 3 : 21.
---, Elkes,  C, Elkes, J.  On some effects of lysergic acid
  diethylamide  (LSD-25)   in   normal  volunteers.  J.
  Physiol, Lond., 1953, 121: 50P-51P.
----, Elkes, J.  The effect of amphetamine and d-lysergic
  acid diethylamide  (LSD-25) on the electrical activity of
  the brain of the conscious cat.  J. Physiol, Lond., 1953,
  120: 13P-14P.
---, Hance, A. J.  The effect of chlorpromazine and meth-
  opromazine on the electrical activity of the brain in the
  cat.  Electroencephalography, 3Iontreal, 1057, 9: 191-
  215.
---,---.  The effect of chlorpromazine on the electrical
  activity of the brain of the conscious cat.   J. Physiol,
  Lond.,  1955, 129 : 50P-51P.
---,----.   The effects of intraventricular injections of d-
  lysergic acid  diethylamide (LSD-25) and 5-hydroxy-
  tryptamine (serotonin) on the electrical activity of the
  brain of the conscious cat.  J. Physiol, Lond., 1956, 132 :
  50P-51P.
---, see Elkes, J., Elkes, C, Bradley, P. B.
Brady, J. V.  Assessment of drug effects on emotional be-
  havior.  Science, 1956,123 : 1033-1034.  Abstract: Chem.
  Ab»tr., 1956, 50 : 15959b.
---.  A  comparative approach  to the evaluation of drug
  effects upon affective behavior.  Ann. N. York Acad. Sc,
  1956, 64: 632-643.
---.  A  review of comparative  behavioral pharmacology.
  Ann. N. York Acad. Sc, 1957, 66: 719-732.
---, sec Mason, J. W., Brady, J.  V.
Bram, G.   Chlorpromazine in  psychiatry.  Brit. 31. J.,
  1954, 2: 754.
Braun, D. L., see Brown, B.  B., Braun, D. L., Feldman, R.
  G.
---, see Brown, B. B., Feldman,  R., Braun, D. L.
Braun, M.  Pacatal.  Am.  J. Psychiat,  1057,  113: 838-
  839. 
Braun, M.
PSYCHOPHARMACA
 ----.  Treatment of psychoses with a combination of paca-
   tal and thorazine. Am. J. Psychiat., 1957, 114:460.
 ---, Philipsborn, A. Ataractics in private practice.  Am.
   J. Psychiat, 1956, 113 : 80-81.
 Brehmer, G. von,  Ruckdeschel, K. T. Zur Technik der
   Winterschlafbehandlung.  [Technique  of  hibernation
   therapy.]  Deut. med. Wschr., 1953, 78:1724-1725.
 Bridger, W. H., Gantt,  W. H.  The effect of mescaline on
   differentiated  conditional reflexes.   Am.  J. Psychiat.,
   1956, 113:352-360.
 Briggs, G. W., Petersen, J. R.  Agranulocytosis occurring
   during chlorpromazine therapy: a  case  report.  Am.
   Practitioner, 1956, 7:1431-1432.
 Brill, B., see Oharet, R., Brill, B., Elloso, C.
 Brill, H., Patton, R. E.  Analysis of 1955-56 population fall
   in New York state mental hospitals in first year of large-
   scale use of tranquilizing drugs.  Am. J. Psychiat., 1957,
   114: 509-517.
 Bringas Nunez,  E, Seggiaro,  J.  A., Machado,  M. R.
   Primeros resultados obtenidos con el 4560 R. P.   [First
   results obtained with RP 4560.]  Prensa me'd. argent.,
   1953, 40: 2613-2619.
 Brisset, C.  Chlorpromazine  et sommeil.  [Chlorproma-
   zine and  sleep.]   Ence'phale, 1956, 45: 1157-1161.
 ---, see Gachkel, V., Brisset, C.
 Bristow,  M.  E., see Schlichther,  W., Bristown, M.  E.,
   Schultz, S., Henderson, A. L.
 Brodie, B.  B., Olin, J.  S, Kuntzman, R. G., Shore, P. A.
   Possible interrelationship between release of brain nor-
   epinephrine and serotonin by reserpine.  Science, 1957,
   125:1293-1294.
 ---, Pletscher, A., Shore, P. A.  Evidence that serotonin
   has a role in brain function.  Science, 1955, 122: 968.
 ----,----,----.   Possible role of serotonin in brain func-
   tion and reserpine action.  [Abstract]  J. Pharm. Exp.
   Ther., 1956, 116: 9.
 ----, Shore, P. A., Silver, S. L.  Potentiating  action of
   chlorpromazine  and  reserpine.  Nature,  Lond.,  1955,
   175 :1133-1134.  Abstract: Chem. Abstr., 1956, 50: 479g.
 ----, see Hess, S. M., Shore, P. A., Brodie, B. B.
 ----, see Pletscher, A., Shore, P. A., Brodie, B. B.
 ----, see Shore, P. A., Carlsson, A., Brodie, B. B.
 ----, see Shore, P. A., Silver, S. L, Brodie, B. B.
 Brody, N., see Niswander, G.  D., Haslerud, G. M., Brody,
   N., Casey, T. M.
 Broggi, E.  La Rauwolfia serpentina Benth nella cura di
   alcune psicopatie.  [Rauwolfia serpentina Benth in the
   treatment of some mental diseases.]  Arch, psicol neur.,
   Milano, 1956, 17: 399-401.
 ----.  Risultati del convegno nazionale tenuto a Vercelli
   il 24-25  settembre su:  ibernazione artificiale,  sonno
   prolungato e neuroplegici in neuropsichiatria.  [Results
   of the national convention held at Vercelli on September
   24-25 on artificial hibernation, prolonged sleep and neu-
   roplegic drugs in neuropsychiatry.] Ence'phale, 1956, 45:
   1035-1041.
 Broglie, M., Jorgensen} G., Voss, G.  Uber die neuro-gan-
   glioplegische Behandlung innerer Krankheiten mit Phe-
   nothiazinderivaten unter besonderer Berticksichtigung
   des Asthma  bronchiale.  [Neuro-ganglioplegic therapy
   with phenothiazine derivatives in internal diseases, par-
   ticularly bronchial asthma.]  Aerztl. Wschr., 1953, 8:
   1148-1152.
 Bronner, A.  Chlorpromazine (thorazine) in office  prac-
   tice. Am. J. Psychother., 1956, 10: 460-466.
 Brooks, C.  The clinical use of reserpine in mental cases.
  J. Alabama M. Ass., 1956, 26: 9-11.
 Brooks, G. W.  Experience with the use of chlorpromazine
   and reserpine in psychiatry, with special reference to the
  significance and  management  of  extrapyramidal dys-
  function.  N. England J. M., 1956, 254:1119-1123.  Ab-
  stract: Year book of drug therapy, 1956-1957, p. 343-
  344.
Brooks, W.,  Deutsch, L., Dickes, R.  The use of chlorpro-
  mazine hydrochloride in  the  treatment  of barbiturate
194
   addiction with  acute withdrawal syndrome.   Am. J.
   Psychiat., 1955, 111: 696-698.  Abstract: Excerpta med.,
   Sect. 8, 1956, 9: No. 836.
 Bross,  R. B.  Near  fatality  with combined ECT and
   reserpine.  Am. J. Psychiat, 1957, 113: 933.
 Broussolle, P. Chlorpromazine  in  psychiatry.  J. Clin.
   Exp. Psychopath.,  1955,  16:113-119.  Also: Internat.
   Rec. M., 1955, 168: 327-332.  Abstract: Excerpta med.,
   Sect. 8, 1956, 9: No. 2234.
 ---,  Dubor  (Dubon [sic])  P.  Premier bilan des  effets
   cliniques d'un nouveau neuroleptique. [First results of
   a new  neuroleptic's clinical  effects] [Abstract]  Ann.
   me'd. psychol, Par., 1956, 114(2) : 512.
 ---, Hamoneau, G.  Traitement prolonge a la chlorproma-
   zine  (45.60 R.  P.) ; treize observations de psychoses
   graves.  [Prolonged treatment with chlorpromazine;
   thirteen patients with  severe psychoses.]   Lyon  me'd.,
   1953, 85(2) : 389-401.
 ---, Scherr, A.  Une amelioration spectaculaire par chlor-
   promazine intraveineuse apr£s cure de Sakel.  [Spectac-
   ular  improvement  with   intravenous  chlorpromazine
   after Sakel  cure.]  Ann.  me'd. psychol,  Par., 1954, 112
   (2) : 748-751.
 ---,  see  Achaintre, A., Balvet, P.,  Beaujard, M., Brous-
   solle, P., Perrin, J., Leveque,, F., Requet, A.
 ---,  see  Revol, L., Achaintre, A., Balvet, P., Beaujard,
   M., Berthier, C, Broussolle, P., Lambert, P., Perrin, J.,
   Requet, A.
 Brown, B. B.  Lysergic acid diethylamide antagonism of
   certain drugs.  Ann. N. York Acad. Sc, 1957,  66:677-
   685.
 ---,  Braun, D. L., Feldman, R. G.  The pharmacologic
   activity of alpha-(4-piperidyl)-benzhydrol hydrochloride
   (azacyclonol hydrochloride) ; an  ataractive agent.  J.
   Pharm. Exp. Ther., 1956,  118:153-161.
 ---,  Feldman, R„ Braun, D. L.  Pharmacologic studies
   of an LSD antagonist 4-piperidyl diphenyl carbinol hy-
  drochloride.   [Abstract]  Fed. Proc, Bait, 1955,14, 322.
 ---,  Werner, fi.  W.  Pharmacologic  studies  on a new
   central  stimulant,  o-(2-piperidyl) benzhydrol hydro-
   chloride (MRD-108).  J. Pharm. Exp. Ther., 1954, 110:
   180-187. Abstract: Fed. Proc, Bait., 1953, 12: 304.
 Brown, E. G, see Kass, I., Brown, E. C.
 Brown, H., see Fuchs, M., Brown, H.
 Brown, W., see Cronheim, G., Brown, W.,  Cawthorne  J.,
   Toekes, I. M., Ungari, J.
 ---, see Cronheim, G., Stipp, C, Brown, W.
 Brownfield, B., see Hollister, L. E.,  Jones, K. P., Brown-
   field, B., Johnson, F.
 Bruce, W. F., see Begany, A. J., Seifter, J., Pless. H. H.
  Huber, R. D., Bruce, W. F.
 Bruckman, N., Kitchener, M., Saunders, J. C. Kline, N. S.
  Mepazine (pacatal)—further report.  Am.  J. Psychiat,
  1957, 114: 262-263.
 Brunsting, L.  A.   Neurodermatitis.  Minnesota M   1955
  38:291-292.                                   '      '
 Brusa, A., see  Sacchi, U., Brusa, A.,  Gianniotti, G.
 Bryant, J. H., Bass, B. M., Hine, F.  R.  Drug therapy a
  survey of the literature.   State of Louisiana,  Depart-
  ment of Institutions, Division of Research, Baton Rouge,
  1956 (3) : 1-24.
 Buchberg, A. S., see Bloch,  R. G., Dooneief,  A. S  Buch-
  berg, A. S., Spellman, S.
 Bucknam, F. G., see Thimann, J., Bucknam, F.  G., Gauthier.
  J. W., O'Connell, T.  A.
Budnick, I. S, Leikin, S., Hoeck, L. E.   Effect in the new-
  born  infant  of  reserpine administered ante  partum.
  A. M. A. J. Dis. Child., 1955, 90: 286-289.
Buisson, J. E.  Therapeutiques de sommeil en psychiatrie
  et  en medecine psychosomatique.   [Sleep therapy in
  psychiatry and  in psychosomatic medicine.]  Gem hdp
  Paris, 1954, 30:155-158.
Bukowczyk, A.   O zastosowaniu  leczniczym reserpiny
   (serpasilu)  w  psychiatrii;  streszczenie  przegladowe. 
AUTHOR LIST
Carillo-Broatch, A,
   [Therapeutic  application of  reserpine  (aerpasil)  in
   psychiatry.]  Neur. dc polska, 1956, 6: 73-80.
 ---.  Szkic potsepowania podczas leczenia  largaktylem
   w klinice psychiatrycznej A. M. w Lodzi.  [Procedure in
   largactil  therapy at the psychiatric clinic of the Acad-
   emy of Medicine of L6dz.]  [Brief English summary]
   Neur. dc. polska, 1955, 5 : 431-434.
 Burdine, W. E.,  Shipley, T. E., Papas, T. A. Studies on the
   use  of  promazine  in  acute  and chronic  nervous and
   mental disturbances.  J. 31. Ass. Georgia, 1957, 46:171-
   173.
 Bures, I. de, see Henne, M., Durand, V. J., Bures, I. de.
 Burgemeister, B. B., see Zimmerman, F. T., Burgemeister,
   B. B.
 Burke, J. C, Hassert, G. L., High, J. P.  The tranquilizing
   activity  of  10- (3-dimethylaminopropyl) -2- (trifluoro-
   methyl) -phenothiazine  hydrochloride  (MC 4703)  and
   related phenothiazines in animals. [Abstract] J. Pharm.
   Exp. Ther.,  1957, 119 :136.
 ---, see  Piala, J. J., High, J. P., Greenspan, K., Burke,
   J. C.
 ---, see Rubin, B., Malone, M. H., Waugh, M. H., Burke,
   J. C.
 Burner, M., see Royer, P., Beis, M., Burner, M.
 Burrell, R. H.  Depression associated with reserpine ther-
   apy.  N. Zealand M. J., 1956, 55 : 228-231.
 ---.  Reserpine  depression treated with sodium  suc-
   cinate ; a preliminary report.  N. Zealand  M. J., 1955,
   54:565-567.
 Burton,  R. M.   The analeptic  action of lysergic  acid
   diethylamide on reserpine-sedated mice.  Ann. N. York
   Acad. Sc, 1957, 66: 695-697.
 Buscaino, G. A., Frongia, N.  Modificazioni biochimiche,
   elettroencefalografiche, istochimiche ed istopatologiche,
   in cani, durante Tintossicazione sperimentale acuta e
   cronica da dietilamide dell'acido lisergico.   [Biochem-
   ical, electroencephalographic, histochemical and histo-
   pathologic changes in dogs during experimental  acute
   and chronic lysergic acid diethylamide intoxication.]
   [English summary]  Acta neur., Nap., 1953, 8: 641-695.
 Bustamante, M. Invernaci6n curativa en neurologia y psi-
   quiatria ;  resultados con el 4,560 (largactil).  [Artificial
   hibernation  in neurology and psychiatry; results  with
   4560 RP  (largactil).]  Bol.  cult. Cons. gen. col.  m6d.
   Espana, 1954, 17 (81) : 29-42.
 Butler, R. N.,  see Margolis, L.  H., Fischer, A.,  Butler, R.
   N.,  Simon, A.
 Butler, W. M., Jr., see Moran, N. C, Butler, W. M., Jr.

                           c
 Caccialanza, P.  Osservazioni sulTazione antipruriginosa
   di un alcaloide della Rauwolfia serpentina Benth.   [An-
   tipruriginous action of an alkaloid of Rauwolfia serpen-
   tina Benth.]   [English summary]   Gior. ital dem. sif.,
   1955, 96: 82-87.
 Cachin, M.,  Pergola, F., Potet, F., Debesse, B.  Le traite-
   ment du delirium tremens par la reserpine.  [Treatment
   of delirum tremens with reserpine.]   Bull.  Soc me'd.
   hdp. Paris, 1956, 72 : 597-603.  Abstract: Excerpta med.,
   Sect. 8,  1957, 10: No. 1430.
 Cacoiola, R., see Salomone, F. P., Peria,  G., Rodolico, G.,
   Cacoiola, R.
 Cadilhac,  J., see Passouant, P., Passouant-Fontame, T.,
  Cadilhac,  J.
 Cadoret, M., see Deschamps, A., Cadoret, M.
 Cahn, C. H.  Complication during reserpine therapy.  Am.
  J. Psychiat., 1955,  112: 64.  Abstract: Excerpta  med.,
  Sect. 8, 1956, 9: No. 1729.
___f Lehmann, H. E.  Perphenazine; observations on the
  clinical effects of a new tranquillizing agent in psychotic
  conditions.  Canad. Psychiat.  Ass. J., 1957, 2:104-112.
---, see Lindan, O., Cahn, C. H., Lehmann, H. E.
Cahn  M   M.  The use  of tranquilizing drugs in derma-
  tology ; review and side  reactions.  J. Albert Einstein M.
  Center, 1956, 4 :161-165.
Cain, J. C, see Loftus, L. R., Huizenga, K. A., Stauffer,
  M. H., Rome, H. P., Cain, J. C.
Callaway, E., III.  On the production of hallucinated and
  psychosis-like states. Ann. Int. M., 1955, 42: 721-728.
Callaway, J. L., Olansky, S.  Trimeprazine: an adjuvant in
  the management of itching dermatoses. North Carolina
  M. J., 1957, 18: 320-321.
Callieri, B., Ravetta, M.  Contributo alio studio psicopa-
  tologico degli effetti dela monoetilamide dell'acido liser-
  gico.   [Contribution to the psychopathological study of
  the effects of lysergic acid monoethylamide.] [English
  summary]  Arch, psicol. neur., 3Iilano, 1956, 17 : 43-83.
---, ----.  Effetti  della dietilamide  dell'acido lisergico
  sulla  sintomatologia psichica  di  schizofrenici;  studio
  psicopatologico.   [Effects of lysergic acid diethylamide
  on  the psychic symptoms  of schizophrenia;  psycho-
  pathological study.]  [Brief English and French sum-
  maries.]   Rass. stud, psichiat.,  1955,  44:39-88.  Ab-
  stract Excerpta med., Sect. 8, 1956, 9: No.  3091.
Calloway, N .0. Tranquilization and sedation by  the use
  of combination of small doses of reserpine and pento-
  barital sodium.   Illinois M.  J.,  1956,  110:232-234.
Calvy, G. L., see Monaco, R. N., Leeper, R. D., Robbins,
  J. J.,  Calvy, G. L.
---, see Borel, J., Lacombe, J., Camar, R.
Camar,  R., see Borel, J., Camar, R., Bailly, R.
Cameron, A.  In: Fabing, H. D.   Designation of "tran-
  quilizing agents" in neuropharmacology. J. Am. M. Ass.,
  1955,   158:1461.  Also: Am.  J.  Psychiat.,  1955, 112:
  392.
Cameron, D. E.  The recognition and treatment of anxiety
  states. Postgrad. 31., 1954,15 :134-138.
Campbell. G. L., see Berger, F. M., Campbell, G. L., Hend-
  ley, C. D., Ludwig, B. J.,  Lynes, T. E.
Campbell, M., see Gordon, R. A., Campbell, M.
Campden-Main, B.  C,  Wegielski,  Z.  The  control of
  deviant behavior  in  chronically disturbed psychotic pa-
  tients by the oral administration of reserpine.  Ann.
  N. York Acad. Sc, 1955, 61:117-122.
Canestrari, R. E., see Peak, E. C, Canestrari, R. E., Roe-
  buck, B.  E.
Canis. J., see Kupperman, H.  S., Blatt, M. H., Vosburgh,
  L. F., Canis, J., Wetchler, B.
Cant, G. New  medicines for the  mind; their meaning
  and promise.  26 p.  New  York, Public  Affairs  Com-
  mittee, 1955.
Caprini, G., see Marini, M.,  Caprini, G., Benciolini, P.
Cares, R. M., Asrican, E., Fenichel.  M., Sack, P., Severing,
J. Therapeutic and toxic effects of chlorpromazine among
  3,014  hospitalized cases.  Am. J.  Psychiat., 1957, 114:
  318-327.
Carey, B.,  Weber, M., Smith, J.  A. Methyl-phenidylace-
  tate hydrochloride (ritalin)  in the treatment of  chronic
  schizophrenic  patients.  Am.  J.  Pyschiat., 1956, 113:
  546-547.
Carey, E. F. A new  approach to the emergency treatment
  of sickness caused by narcotic withdrawal.  Illinois M.
  J.,  1957,  111: 1-7.  Also:  Ann.  N.  York  Acad.  Sc,
  1955,  61: 222-229.
Carey, J. B., Magraw, R. M. Agranulocytosis with chlor-
  promazine. Am. J. Psychiat, 1956,112 : 565.
Cargnello.  D.  La terapia  reserpinica nelle schizofrenie
  croniche.  [Reserpine  therapy of chronic  schizophre-
  nia.]   [English summary]  Arch, psicol. neur., Milano,
  1956,  17: 359-375.
---. La therapie par la reserpine dans les schizophrenies
  chroniques.   [Reserpine therapy  of chronic schizophre-
  nia.]   Ence'phale, 1956, 45 :1056-1070.
Carillo-Broatch, A.  Le largactil dans  le traitement de
  Tepilepsie essentielle rebelle; resume d'une communica-
  tion preliminaire.    [Largactil therapy of severe idio-
  pathic epilepsy;  summary  of a  preliminary  report.]
  Ence'phale, 1956, 45: 1221-1223.
----.  Largactil en  el tratamiento  de las  psicosis trau-
  maticas; resumen.  [Largactil in the treatment of trau-
195 
Carillo-Broatch, A.
PSYCH0PHAR31ACA
  matic psychoses;  a summary.]  Ence'phale,  1956, 45:
  1224-1225.
---.  Tratamiento de la esquizofrenia cronica.  [Treat-
  ment  of chronic schizophrenia.]   [English  summary]
  Rev. neur. psiquiat, Lima, 1955, 18 : 441-445.   Abstract:
  Excerpta med., Sect. 8, 1057,  10 : No. 1981.
Carl, A., see Turner,  W. J., Merlis, S., Carl, A.
Carlsson, A., see Shore, P. A., Carlsson, A., Brodie, B. B.
Carloni, G. La reserpina e la  cloropromazina nei malati
  mentali  cronici.   [Reserpine  and  chlorpromazine  in
  chronic mental  disease.]   Arch, psicol. neur., 3Iilano,
  1956,  17: 629-630.
Carmel, W. J., Jr., Dannenberg, T. Nonthrombocytopenic
  purpura due to miltown  (2-methyl-2-n-propyl-l,3  pro-
  panediol dicarbamate).  N.  England J. 31.,  1956,  255:
  770-771.
Carmichael, D. M., see Kris, E. B., Carmichael, D. M.
Carmichael, L. P.  Serum  sickness  type of reaction  to
  mepromabate.  J. Florida M.  Ass., 1957, 43 : 779.
Carpitella, A., Cirincione, E.  L'associazione ganglioplegici
  e barbiturici in psichiatria.  [Association of ganglio-
  plegics and barbiturates in psychiatry.]   [English sum-
  mary]  Rass. stud, psichiat., 1954,  43 : 919-936.
Carr, C. J., Kinnard, W. J., Jr. The phrenotropic agents.
  Internal Rec. M., 1957, 170: 493-504.
---, see Kinnard, W. J., Carr, C. J.
Carreras, M., Angeleri, F.   Basi sperimentali alle indica-
  zioni  della cloropromazina e della  reserpina nella te-
  rapia neuropsichiatrica.   [Experimental basis for chlor-
  promazine  and  for reserpine therapy  in neuropsychi-
  atry.]  Riv.  neurobiol,  1955, 1: 473-525.  [Not seen]
  Abstract: Excerpta med., Sect. 8, 1956, 9 : No. 4991.
---, ---.  The  location of action of chlorpromazine  in
  the central  nervous system.  Internat Rec. 31.,  1957,
  170: 67-85.
----,----. SulTazione centrale del potenzializzatore  4560
  R. P.  [Central effect of the potentiator 4560 R. P.]  Boll.
  Soc. ital biol. sper., 1955,  31: 474-477.
---, see Angeleri, F., Carreras, M., Urbani, M.
Carrie,  J., see Gayral, L., Herve, Y., Carrie, J.,  Fourny, L.
----, see  Gayral, L.,  Herve, Y., Fourny, L., Carrie,  J.
Carrier, J., Guyotat,  J., Grandmottet, J.   Electro-choc  et
  largactil dans  les  acces  maniaques.   [Electric shock
  therapy and largactil in manic attacks.]  J. med. Lyon,
  1954,  35: 950-951.
Carter,  C. H.  The effects of reserpine and methyl-pheni-
  dylacetate  (ritalin) in mental defectives, spastics, and
  epileptics.  Psychiat. Res. Rep.,  Wash.,  1956  (4) : 44-48.
---, Maley, M. C.  Chlorpromazine  therapy in children
  at the Florida  farm colony.   Am. J. 31. Sc, 1957,  233:
  131-136.
Carter,  J. T., see  Kovitz, B., Carter, J. T., Addison, W. P.
Carter,  W. W., see Essig, C. F., Carter, W. W.
Casadio, V., see Borroni, G., Casadio, V.
Casey, T. M., see Niswander, G. D., Haslerud, G. M., Brody,
  N, Casey, T. M.
Castells,  C., see  Gastaut,  H., Ferrer,  S., Castells, C,
  Lesevre, N., Luschnat, K.
Castillo, C. R.  Los fenomenos psiquicos  y la terapeutica
  biologica.  [Psychic phenomena and biological thera-
  peutics.]  Prensa me'd. argent, 1954, 3533-3538.
Castro de la Mata, R., see Seguin, A., Castro de la Mata, R.
Castrovilli, G., Ginoulhiac, R., Merli, G. M.   II mepro-
  bamato : alcune indicazioni  del suo uso in  medica in-
  terna ; studio clinico e sperimentale.    [Meprobamate:
  some  indications for its use  in internal medicine;  clin-
  ical and experimental study.]  31inerva med,, Tor., 1956,
  47:1465-1474.
Catalano-Nobili, C, Cerquetelli, G.   Esperienza terapeu-
  tica con i  meprobamati  in  psichiatria.   [Clinical ex-
  perience with mepromabate in psychiatry.]   3Iinerva
  med.,  Tor., 1956, 47:2185-2191.
Catapano, V. D., see Puca, A., Catapano, V. D.
Cattaneo, A. D., see Clocatto, E., Cattaneo, A. D.,  Solerio,
  L., Bianchetti, L.
Cattell, J. P.   The  influence of  mescaline on  Psycho-
  dynamic material.  J. Nerv. Ment. Dis., 1954, 119: 233-
  244.
---, see  Hoch, P.  H., Cattell, J.  P., Pennes, H.  H.
___, see Hoch, P. H., Pennes, H.  H., Cattell, J. P.
Cavalcanti, U., see  Pires,  N.,  Pinho, R. de, Fernando, L.,
  Pint, M., Cavalcanti, U, Aguiar, H.
Cavazzuti, G  B., see Lanzoni, E.,  Cavazzuti, G. B.
Cawthorne, J., see Cronheim, G., Brown, W., Cawthorne, J.
  Toekes, I. M., Ungari, J.
Cazzullo,  C. L., Guareschi, A.  Influenza di un derivato
  della fenotiazina, largactil, sull'attivita elettrica dell'en-
  cefalo del cane.  [Effect of a phenothiazine derivative
  largactil, on  the electric activity of the brain, in dogs.]
  [English summary]  Riv.  neur., Nap., 1954, 24:602-
  632.  Abstract: Chem. Abstr., 1956, 50: 8068b.  Excerpta
  med., Sect. 8, 1955, 8 : No. 3097.
---, see Guareschi, A., Cazzullo,  C. L.
Cecacchi,  G., see Benassi, P.,  Cecacchi, G.
Cerletti, A. Literature on LSD-25.  In : Abramson, H. A.,
  ed.   Neuropharmacology.  Transactions of the second
  conference,  May  1955,  Princeton, N.  J.   New  York,
  Josiah Macy, Jr. Foundation, 1956.  Appendix p. 301-
  308.
---.   Lysergic  acid  diethylamide (LSD)  and related
  compounds.   In: Abramson, H. A., ed.  Neuropharma-
  cology.   Transactions of the second  conference, May
  1955,  Princeton,  N. J.   New York,  Josiah 3Iacy, Jr.
  Foundation,  1956.  p. 9-84.
---, Rothlin, E. Role of 5-hydroxytryptamine  in mental
  diseases and its antagonism to lysergic  acid derivatives.
  Nature,  Lond.,  1955, 176:785-786.  Abstract: Chem.
  Abstr., 1956,  50: 4389fgh.  Excerpta med.,  Sect. 8, 1957,
  10: No. 973.
---, see Rothlin, E., Cerletti,  A.
Cerquetelli, G., see Catalano-Nobili, C, Cerquetelli, G.
Certhaux, A., see Lecomte, G., Certhaux,  A., Garrabe,  J.
Cervos Navarro, J., Unterharnscheidt, F.   Importancia de
  las fenotiacinas en psiquiatria.   [Importance of pheno-
  thiazines in psychiatry.]  Res. espan. otoneuroft, 1956,
  15: 75-92.
Champy, M., see Heimendinger, E., Klotz,  G., Champy, M.
Chanoit, P., see Chatagnon, P., Chanoit, P.
Charatan, F.   B.   An  evaluation  of   chlorpromazine
  ("largactil") in psychiatry. J. 31 ent.  Sc, Lond., 1954,
  100: 882-893.  Abstract: Excerpta med., Sect.  8, 1955,
  8: No. 3639.
Charcowa, A. I., see Asung, C. L., Charcowa, A.  I., Villa
  A. P.
Charet, R., Brill, B„ Elloso, C. Coma after miltown over-
  dose.  Ann. Int. 31., 1956, 45: 1211-1213.
Chareton, J., see Laborit, H., Coirault, R.,  Damasio, R.,
  Laborit, G.,  Charonnat, R.,  Lechat,  P.,  Chareton, J.
Char lin, A. Action respective de  la chlorpromazine et de
  la reserpine; hypotheses pathogeniques.  [The  effect of
  chlorpromazine and of  reserpine;  pathogenic  hypo-
  theses.]  Ence'phale,. 1956, 45 : 1099-1105.
Charonnat, R., see  Laborit, H., Coirault,  R., Damasio, R.,
  Laborit, G., Charonnat, R.,  Lechat, P.,  Chareton, J.
Chatagnon, P.,  Chanoit, P.   Psychopiegie transitoire,
  resultat clinique  observe  dans des  etats d'excitation
  psycho-motrice a la suite de Taction d'un derive de la
  phenothiazine.  [Transient psychoplegia,  a clinical  re-
  sult observed during the treatment of psychomotor exci-
  tation  with  a phenothiazine derivative.]  Ann. mCd.
  psychol, Par., 1953, 111 (1) : 361-364.
Chateau,  R., see Fau, R.,  Chateau, R.
---, see  Fau,  R., Chateau, R., Dusserre.
Chatterjee, P. K., Datta, J. K. Mephenesin in morphine
  addiction.   J.  Ind. M. Ass., 1956, 26: 23-24.  Abstract:
  Excerpta med., Sect. 8,1956, 9: No. 3522.
Chauchard, P., Mazoue, H. Effets du carbamate de methyl-
  3-pentyne-l  ol-3  (N-oblivon) sur les centres  nerveux.
  [Effects of  3-methyl-l-pentyne-3-ol  carbamate  (N-ob-
196 
AUTHOR LIST
Cohen, I. M.
  livon) on nerve centers.]  C. rend. Soc biol, 1956, 150:
  679-680.
---, ----.  Recherches sur le  mode  d'action centropie-
  gique  de quelques sustances psychotropes.   [Research
  on the mode of centriplegic action of some psychotropic
  substances.]  C. rend. Soc.  biol, 1956, 150: 158-160.
Chaupin, M., see Collomb, H., Miletto, G., Chaupin, M.
Cheifetz, I., Paulin, C,  Tuatay,  H, Rubin, E. H. Iproni-
  azid in pulmonary tuberculosis.  Dis.  Chest, 1954, 25:
  390-396.
The  chemical  concept of psychoses.   What's new, 1955
  (189)  :3-7.
Chermak, M.  W., see Tasher, D. C, Chermak, M. W.
Chen, G, Ensor, C. R.,  Bohner, B. A facilitation  action
  of reserpine on the central nervous system.  Proc Soc
  Exp. Biol, N. Y., 1954, 86: 507-510.
Chertok, L.  A propos de Temploi de medicaments  neuro-
  leptiques dans le traitement des psychonevroses.  [Neu-
  roleptic drugs in the treatment of psychoneuroses.]  En-
  cephale, 1956, 45: 705-706.
---, see Montassut, M., Chertok,  L., Bequart, P.
---, see Montassut, M., Chertok,  L., Leroy, C.
Chervin, M., see Steffen, C. G., Chervin, M., Van Vranken,
  B.
Chessin, M., Dubnick, B., Kramer, E. R., Scott, C. C.  Modi-
  fications of pharmacology of reserpine and serotonin by
  iproniazid.   [Abstract] Fed. Proc, Ball, 1956, 15 : 409.
---, see Reinhard, J. F., Chessin, M., Tornaben, J.,  Lewis,
  M. N.
Chevreau, J.  P., see Heuyer,  G.,  Lang,  J. L., Chevreau,
  J. P.,  Juredieu.
Chin, L., see  Swinyard, E. A., Chin, L., Fingl, E.
Chinn, H. I., see Noell, W. K.,  Chinn, H. I., Haberer, C. E.
Chlorpromazine.  Cancer Bull Texas, 1056, 8: 47.
Chlorpromazine and mental health. 200 p.  [Symposium
  held  under the auspices of  Smith,  Kline &  French
  Laboratories in Philadelphia, Pa., June 1055] Philadel-
  phia, Lea d- Febiger, 1955.  [Articles within the scope of
  this bibliography  are listed individually.]
Chofnas, I., see Jenkins, D.  E., Chofnas, I., Boren,  H.,
  Guthrie, R.
Cholden, L., ed.  Lysergic acid diethylamide and  mesca-
  line in experimental  psychiatry.  85 p.  [Round table
  at American Psychiatric Association  annual meeting
  held in Atlantic  City, N. J.,  May  1955]   New York,
  Grune d Stratton, 1956.  [Articles within the scope of
  this bibliography are listed individually.]
---, Kurland, A., Savage, C.  Clinical reactions and toler-
  ance to LSD in chronic schizophrenia.  J.  Nerv. 3Ient.
  Dis., 1055, 122 : 211-221.  Abstract: Excerpta med., Sect.
  8, 1956, 9 : No. 4015.
---, see Savage, C, Cholden, L.
Choppy, M., Le Beau,  J., Petrie, A.  Modifications de la
  personnalite apres les operations frontales seiectives  y
  compris la  cingulectomie et  apres  traitement  par la
  chlorpromazine.   [Personality changes  after  selective
  frontal operations,  including cingulectomy, and after
  chlorpromazine therapy.]   Rev. neur., Par., 1955, 93:
  843-849.
Christe, R.  Action therapeutique comparee  de deux as-
  sociations de  serpasil et de  ritaline.   [Comparative
  therapeutic effect of two serpasil-ritalin combinations.]
  Schweiz. med. Wschr., 1956, 86: 1318-1321.
Chusid,  J.  G., Kopeloff,  L. M., Kopeloff, N.   Reserpine
  (serpasil) effects on epileptic monkeys. Proc. Soc. Exp.
  Biol,  N. Y., 1955, 88: 276-277.
---, see Kopeloff, L. M., Chusid, J. G., Kopeloff, N.
Ciba Pharmaceutical Products, inc.  The Rauwolfia story,
  from primitive medicine  to alkaloidal therapy.   63 p.
  Summit, N. J., 1954.
___  The story of serpasil.  5o p. Summit, N. J., 1955.
Cicaia P  Osservazioni sull'impiego del meprobamato, con
  partico'lare riguardo  agle stati ansiosi di  soggetti en-
  teropatici.  [Use of meprobamate, especially in states of
  anxiety in cases of intestinal diseases.]  Minerva med.,
  Tor., 1956, 47 : 1463-1464.
Ciocatto,  E., Cattaneo, A. D., Solerio,  L., Bianchetti, L.
  Studio  farmacogolico del largactil o  potenzializzatore
  RP 4560;  studio sperimentale sull'uomo.   [Pharma-
  cological study of largactil or RP 4560 potentializer;
  experimental study on humans.]  Gazz. med. ital, 1953,
  112:125-135.
Cirincione, E., see Carpitella, A., Cirincione, E.
Clark, L. D. Evaluation of the therapeutic effects of drugs
  in psychiatric patients.  Dis. Nerv.  Syst, 1956,  17:
  282-286.
----.  Further studies  of the psychological effects of fren-
  quel and a critical review of previous reports. J. Nerv.
  Ment Dis., 1956,  123 : 557-560.
---,  Bliss, E. L.   Psychopharmacological studies of ly-
  sergic  acid  diethylamide (LSD-25)  intoxication.  Ef-
  fects  of  premedication  with  BOL-148   (2-bromo-d-
  lysergic acid diethylamide), mescaline, atropine, amo-
  barbital, and  chlorpromazine.   A. 31.  A. Arch. Neur.
  Psychiat, 1957, 78 : 653-655.
---,  Clark, L.  S.  The effects of cortisone  on LSD-25
  intoxication in schizophrenic patients.  J. Nerv. Ment.
  Dis., 1956, 123 : 561-562.
---,  Ellsworth, R. B., Barrett, W.  W., Thurman, A. C,
  Holland, W.  Studies of the behavioral effects of rit-
  alin.  Dis. Nerv.  Syst., 1956, 17: 317-321.
---,  see Ellsworth, R. B., Clark, L.  D.
Clark, L.  S., see Clark, L.  D., Clark, L. S.
Clark, M. C, see Harned, B. K., Cunningham, R. W., Clark,
  M.  C, Hine, C. H., Kane, M. M., Smith, F. H., Jr., Ves-
  sey, R.  E., Yuda,  N. N.,  Zabransky, F. W.
Clarke, L D.,  see Lindemann, E., Clarke, L. D.
Clausen, J., see Landis, C, Clausen,  J.
Clausse,  S.,  see Riser, M.,  Geraud, J., Laboucarie, J.,
  Rascol, A., Clausse, S., Garrigues, M. P.
Cleghorn, R. A., see Azima, H., Kent, I., Cleghorn, R. A.
Cline, H. S., Freeman, H.  Resistance to lysergic  acid in
  schizophrenic patients.   Psychiat  Q., 1956, 30 : 676-683.
---,  see  Freeman, H., Arnold, A. L., Cline, H. S.
---,  see  Freeman, H., Cline, H. S.
Clough,  P. W.   Reserpine in the  treatment of  neuro-
  psychiatric  disorders.   Ann. Int. M.,  1955, 43: 632-637.
Cloutier,  F.  La cure de sommeil en  therapeutique psychi-
  atrique.  [Sleep  therapy in psychiatry.]  Laval med.,
  1953, 18: 332-342.
Coady, A., Jewesbury, E. C.   A clinical trial  of benacty-
  zine hydrochloride  (suavitil)  as  a physical relaxant.
  Brit  31. J., 1956, 485-487.  Abstract: Excerpta med.,
  Sect. 8,1956, 9 : No. 3890.
Coats, E. A., Gray, R.  W.  Frenquel: clinical  impressions
  of the use of a new drug in the  treatment of mental
  illness.   Nebraska 31. J., 1956, 41:  460-461.
---,  ----.   Quiactin in treatment  of emotional  and
  mental disorders. Dis. Nerv. Syst, 1957, 18: 191-193.
Cobb, S.   Peace of mind.  Am. J.  Psychiat., 1957,  113:
  663-664.
Cocheme, R.  Le delirium tremens  mortel; statistiques;
  recherche des causes de Tinefficacite des traitements.
  [Fatal  delirium  tremens;  statistics; research  on  the
  causes  for the ineffectiveness of the  treatment.]   Rev.
  neur., Par., 1956, 94: 657-660.
Cohen, D., see Bennett, I. F., Cohen, D.,  Starer, E.
Cohen,  I. M.  Complications of  chlorpromazine therapy.
  Am. J.  Psychiat, 1956,  113: 115-121.
---.   Drugs recently introduced  in  the treatment  of
  psychiatric  disorders.  Texas J. 31., 1956, 52 : 683-687.
---.  Effects of chlorpromazine in psychiatric disorders;
  report of clinical observations and impressions in  1000
  cases.   Am. J. M.  Sc,  1955, 229: 355-362.   Abstract:
  Excerpta med., Sect. 8,  1956, 9 : No. 4990.
---.  Undesirable effects and  clinical toxicity of chlor-
  promazine.   /.  Clin. Exp.  Psychopath.,  1956,  17:153-
  163.
456132—59-
-14
197 
Cohen, L.
PSYCHOPHARMACA
Cohen, L., see Blumberg, A. G., Cohen, L., Miller, J. S. A.
Cohen,  S.   Clinical experiences with pipradrol  and  a
  pipradrol-reserpine combination.   Internat. Rec.  M.,
  1956, 169: 751-756.
----,  Parlour, R. R.  Preliminary  observations on  use
  of frenquel in hospital  psychiatry.  J. Am. M. Ass.,
  1956, 162: 948-950.
Coirault, R., Girard, V., Benoit, P. Utilisation du serpasil
  en  neuro-psychiatrie.   [Use of serpasil  in neuropsy-
  chiatry.]   Bull. Soc. me'd.  mil. fr., 1955, 49:249-250.
  Abstract: Presse me'd., 1956, 64: 315.
----,----, Escafit, H., Benoit, P.  Utilisation du 1522 CB
  en  neuro-psychiatrie.    [Use  of  1522  CB  in  neuro-
  psychiatry.]  Bull. Soc me'd. mil. fr., 1955, 49:247-249.
  Abstract: Presse mCd., 1956, 64: 315.
■---,  Laborit, H., Missenard. R., Jolivet,  B., Hainaut, J.,
  Weber, B.  Le delirium  tremens.  [Delirium tremens.]
  Ence'phale,  1956, 45 : 762-770.
---,  see Laborit, H., Coirault, R., Damasio, R., Gaujard,
  R.,  Laborit, G., Charonnat, R., Lechat, P. Chareton J.
----,  see Laborit, H., Coirault, R., Hainaut, J., Weber, B.
Cole,  J., Glees, P.  Ritalin as an antagonist to reserpine
  in monkeys.  Lancet, Lond., 1956,1: 338.
■---,  ----.   Some effects  of methyl-phenidate (ritalin)
  and amphetamine on normal and leucotomized monkeys.
  J. Ment. Sc, Lond., 1957,103: 406-417.
Cole, J. O., Ross, S., Bouthilet, L.  Recommendations for
  reporting studies of psychiatric  drugs.   [Conference
  held in Washington, D. C, January 1957]  Pub. Health
  Rep., 1957, 72: 638-645.
Collins, J. D., see Lasater, J. H., Collins,  J. D.
Collins-Dineen, M.  Meprobamate toxicity; report of a
  case. Ohio M. J., 1956, 52:1304-1305.
Collomb, H., Miletto,  G., Chaupin, M. Le meprobamate
  dans le traitement des psychoses et des nevroses.  [Me-
  probamate in the treatment of psychoses and neuroses.]
  Rev. prat., Par., 1956, 6:1200-1204.
----,----, Robert, H. Le frenquel en therapeutique psy-
  chiatrique.  [Frenquel in psychiatric therapy.]  Presse
  me'd., 1956, 64:1602-1604.
Le colloque international de Paris sur la chlorpromazine
  et les medicaments  neuroleptiques en therapeutique
  psychiatrique.   [International colloquium in  Paris
   (October 1955) on chlorpromazine and neuroleptic drugs
  in psychiatric therapy.]  J. me'd. Lyon, 1956,  37:103-
  105.
Colloque  international  sur  la  chlorpromazine  et  les
  medicaments  neuroleptiques en therapeutique  psychi-
  atrique.   [International colloquium on chlorpromazine
  and neuroleptic drugs in psychiatric therapy.]  [Paris,
  October 1955.]  Encephale, 1956,  45:301-1266.  [Arti-
  cles within the scope of  this bibliography are listed
  individually.]
Colombati, S.  L'azione tranquillante di un nuovo farmaco
  neurolettico.   [Tranquilizing action of a  new  neuro-
  leptic drug.]  Minerva med.,  Tor., 1956,  47:2175-2178.
----.  Modificazioni del tracciato E. E. G. da reserpina.
   [Modifications of electroencephalographic tracings  dur-
  ing  reserpine therapy.]  [English  summary]  Arch.
  psicol. neur., Milano, 1956, 17: 569-580.
----, Benassi, P.  Impiego di un alcaloide della Rauwolfia
  in  neuropsichiatria.  [Use of  a Rauwolfia alkaloid in
  neuropsychiatry.]  Gazz. med. ital, 1954, 113: 301-303.
----, ----.   Osservazioni elettroencefalografiche  su un
  alcaloide  della  Rauwolfia  (serpasil).    [Encephalo-
  graphic  observations  with an alkaloid  of Rauwolfia
   (serpasil).]  Gazz. med. ital, 1955, 114:69-72.
Coltrera, J., see Dickes,  R., Flamm,  G. H., Coltrera, J.,
  Tobin, M.
Combes, P., see Laboucarie,  J., Combes, P.
Comelade, P., see Lafon, R., Due, N., Abric, J., Pouget, R.,
  Comelade, P.
Conigliaro, V., see Pelzman, O., Conigliaro,  V.
Conn, H. F., ed.  Symposium on the efficacy of new drugs.
  Med. Clin. N.  America,  1957, 41:295-615.   [Articles
  within  the  scope  of  this  bibliography  are  listed
  individually.]
Conrad, K., Domanowsky, K., Wieser, S.  Uber extrapyra-
  midale Anfallszustande bei Behandlung mit Phenothia-
  zinen.   [Extrapyramidal  symptoms during  treatment
  with phenothiazines.]  Fortsch. Neur. Psychiat, 1956,
  24:505-512.                                .
Contini, M.   L'uso de ganglioplegico 4560 R. P. in psichi-
  atria.  [Use of the ganglioplegic 4560 RP in psychiatry.]
  Rass. stud, psichiat., 1954, 43:1133-1138.
Cook, L., Weidley, E.  Behavioral effects of some psycho-
  pharmacological agents.   Ann. N. York Acad. Sc, 1957,
  66:740-752.                 m  n     ^T
___,  ____, Morris, R. W., Mattis, P. A.  Neuropharma-
  cological  and  behavioral effects  of  chlorpromazine
  (thorazine hydrochloride). [ Abstract]  J. Pharm. Exp.
  Ther., 1955,113:11-12.
---, see Altschule, M. D., Bower, W., Cook, L.
---, see Bower, W. H., Altschule, M. D., Cook, L.
Cook, L. C, see Vaughan, G. F., Leiberman, D. M., Cook,
  L.C.
Cooper, H. A. Hallucinogenic drugs.  Lancet, Lond., 1955,
  1:1078-1079.
Cooper, W., see Heberden, P., Cooper, W.
Corni, L.   Esperienze cliniche con un nuovo farmaco ad
  azione sui S. N. C, la beatilina in soggeti affetti da
  psicosi  e psiconevrosi.   [Clinical experiences with a
  new drug,  beatiline, acting on the central nervous  sys-
  tem in  patients with  psychoses and psychoneuroses.]
  Gazz. med. ital, 1956,115 : 328-331.
Cornman, H. D., III.  Epilogue.  Internat. Rec. M., 1955,
  168:358.
Corre, see Le  Guillant, L., Roelens, Corre, Kestenberg,
  Plichet, Bequart, Bailly-Salin.
Corriol, J., Mercier, J.  Etude eiectroencephalographique
  de  Tharmine.  [Electroencephalographic  study of  har-
  mine.]  C. rend. Soc.  biol, 1952,  146:1356-1359.  Ab-
  stract : Chem. Abstr.,  1953, 47: 7095h.
Cossa, P., Bougeant, H., Lombard, A.  L'emploi des neuro-
  piegiques en psychiatrie.  [The use of neuroplegic drugs
  in psychiatry.]  Ann. me'd. psychol, Par., 1953, 111  (2) :
  628-633.  Abstract: Excerpta med., Sect. 8, 1954, 7: No.
  746.
---,----, Postel, J.  De quelques indications et de quel-
  ques incidents  d'utilisation  de   la   chlorpromazine.
  [Some indications of and  incidents with chlorpromazine
  therapy.]  Ence'phale, 1956, 45: 779-783.
---, see Postel, J., Cossa, P.
Cossio, M.   Rapporti tra reserpina  (serpasil) e 5-idros-
  sitriptamina;  nota  preventiva.   [Relation  between
  reserpine  (serpasil)   and 5-hydroxytryptamine;  pre-
  liminary note.]  Rvo. sper. freniat.,  1955, 79: 865-867.
Coulter, E.  B.  Nursing care  problems  associated  with
  the use   of  ataraxic drugs.  Hawaii  M.  J.,  1957,
  16:303-304.
Courvoisier, S.  Pharmacodynamic  basis for  the use of
  chlorpormazine in psychiatry. J. Clin. Exp. Psychopath.,
  1956,17:25-37.
---.  Sur les proprietes pharmacodynamiques de la chlor-
  promazine en rapport avec son emploi en psychiatrie.
   [Pharmacodynamic basis for the use of chlorpromazine
  in psychiatry.]  Ence'phale, 1956, 45:1248-1257.
----, Fournel,  J., Ducrot,  R.,  Kolsky,  M.,  Koetschet, P.
   Proprietes pharmacodynamiques  du chlorhydrate  de
   chloro-3- (dimethylamino-3'-propyl) -10    phenothiazine
   (4560 R. P.). [Pharmacodynamic properties of chloro-3-
   (dimethylamino-3'-propyl)-10  phenothiazine   (R.  P.
   4560).]   Arch,  internat.  pharm. dyn., Gand, 1953, 92:
   305-361.
 Cowden, R. C, Zax, M., Finney, R. C  A preliminary note
   on  the  use  of chlorpromazine with neuropsychiatric
   disorders.  A.  M.  A.  Arch.  Neur.  Psychiat,   1955,
   73: 700-701.
 ----,----, Hague, J. R., Finney, R. C.  Chlorpromazine:
   alone and as an adjunct to group psychotherapy in the
198 
AUTHOR LIST
De Busscher, J.
   treatment of psychiatric  patients.   Am. J. Psychiat.,
   1956, 112: 898-902.  Abstract: Excerpta med., Sect. 8,
   1956, 9: No. 4559.
 ---,----, Sproles, J. A.  Group psychotherapy in  con-
   junction with a physical treatment.  J. Clin. Psychol,
   1956,12: 53-54.
 ---,----,----.  Reserpine alone and  as an adjunct to
   psychotherapy  in   the  treatment   of  schizophrenia.
   A. M. A. Arch. Neur. Psychiat., 1955,  74: 518-522.
 Craddock, W. L.  Toxic effects  of chlorpromazine; hepa-
   titis and  agranulocytosis.   U. S. Armed Forces M. J.,
   1956, 7:1726-1740.
 Cramer-Azima, F. J., see Azima, H., Cramer-Azima, F. J.,
   De Verteuil, R.
 Crandell, A., see Ma, J., Crandell, A.
 Crane, G. E.  The psychiatric  side-effects of iproniazid.
   Am. J. Psychiat, 1956,112: 494-501.
 ---.  Further studies on  iproniazid phosphate; isonicot-
   inil-isopropylhydrazine phosphate, marsilid.  J. Nerv.
   Ment. Dis., 1956,124: 322-331.
 Cremieux, A.  Traitement de Tanxiete.   [Treatment of
   anxiety.]   Marseille me'd., 1956, 93: 327-331.
 ---, Alliez, J., Soulayrol, R.   Action de la chlorpromazine
   sur les  etats hallucinatoires durables.  [Effect of chlor-
   promazine on chronic hallucinations.]  Ence'phale, 1956,
   45: 643-646.
 Cronheim, G., Brown, W., Cawthorne, J., Toekes, I. M.,
   Ungari, J. Pharmacological studies with rescinnamine,
   a new  alkaloid  isolated from Rauwolfia  serpentina.
   Proc. Soc. Exp. Biol, N.  Y., 1954, 86:120-124.
 ---, Orcutt, J. A., Toekes, I. M.  Pharmacological prop-
   erties  of canescine  (recanescine), a new alkaloid  iso-
   lated from Rauwolfia canescens Linn.  Proc.  Soc. Exp.
   Biol, N. Y., 1955, 89 : 21-23.
 ---, Stipp,  G,  Brown, W.  Hypotensive  agents  from
   Rauwolfia  serpentina: reserpine  and  other  alkaloids.
   [Abstract]  J. Pharm. Exp. Ther., 1954, 110:13.
 ---.Toekes, I. M.  Comparison of "sedative" properties
   of single  alkaloids  of Rauwolfia and  their  mixtures.
   J. Pharm. Exp. Ther.,  1957, 119:357-360.
 ---,----.  Comparison  of some pharmacological proper-
   ties of rescinnamine and reserpine, two alkaloids isolated
   from Rauwolfia serpentina.  J. Pharm. Exp. Ther., 1955,
   113:13.
 ---,----.  Sedative   effect   of Rauwolfia  serpentina.
   [Abstract]  Fed. Proc, Bait,  1954, 13: 345.
 ---, see Orcutt, J. A., Cronheim, G. E.
 Cronqvist, S., Rayner, S., Wretmark, G.  Chlorpromazin-
   behandling vid neuroser.  [Chlorpromazine therapy of
   neuroses.]   [English  summary]   Nord.  med., 1955,
   53: 730-734.
 Cross, T. N., see Reinhart,  M. J., Silverstein, B.  S., Cross,
   T.N.
 Crouse, H. S., see Hurst, L.  A., Reuning, H.,  Wyk, A. J.
   van, Crouse, H. S., Booysen, P. J., Nelson, G.
 Csank, J., see Lehmann, H. E., Csank, J.
 Cullen, C. F., see Zeller, W. W., Graffagnino, P. N., Cullen,
   C. F., Reitman, H. J.
 Cummins, J. F., Friend, D. G.  Use of  chlorpromazine in
  chronic alcoholics.   Am.  J. M. Sc, 1954, 227:561-564.
  Abstract: Excerpta med., Sect. 8, 1955, 8: No. 3552.
■---, see Friend, D. G., Cummins, J. F.
Cunningham, R. W., see Harned, B. K., Cunningham, R.
  W., Clark, M. C, Hine, C. H., Kane, M. M., Smith, F. H.,
  Jr.. Vessey, R. E., Yuda, N. N„ Zabransky, F. W.
Curtis, T. E., see Abse, D. W., Curtis,  T. E.,  Dahlstrom,
  W. G., Hawkins, D. R., Toops, T. C.
Cutler, R. P., Monroe, J. J., Anderson, T. E.  Effects of
  "tranquilizers" upon pathological activity in  psychotic
  patients   I. Chlorpromazine.  II. Reserpine.   A. M. A.
  Arch.  Neur. Psychiat,  1957,  77: 616-622;  1957,  78:
  61-68.
                          D

Dabbah, M., see Borenstein, P., Dabbah, M., Bare, D.
Dahlstrom, W. G., see Abse, D. W., Curtis, T. E., Dahlstrom,
  W. G., Hawkins, D. R., Toops, T. C.
Dale, P. W.  The actions of reserpine.  Connecticut 31. J.,
  1955,  19:652-655.  Abstract:  Chem.   Abstr.,  1956,
  50:4380h.
Daly, D. D., Yoss, R. E.   The treatment of narcolepsy
  with  methyl phenylpiperidylaceate: a preliminary  re-
  port.   Proc. Mayo Clin., 1956, 31: 620-625.
Damasio, R., see Laborit,  H., Coirault, R., Damasio,  R.,
  Gaujard, R.,  Laborit,  G. Charonnat, R.,  Lechat,  P.,
  Chareton, J.
Dancey, T. E., see  Sarwer-Foner, G. J., Koranyi, E. K.,
  Dancey, T. E.
Dannenberg, T., see Carmel, W. J., Jr., Dannenberg, T.
Dariotis, see Fouks,  L., Laine, Grimaud, Dariotis.
Dart, D., see Sibilio, J. P., Andrew, G., Dart, D.,  Moore,
  K. B., Stehman, V. A.
Das, N. N., Dasgupta, S. R., Werner, G.  Changes of be-
  haviour  and electroencephalogram in rhesus monkeys
  caused by chlorpromazine. Arch, internat. pharm. dyn.,
  Gand, 1954,  99:451-457.  Condensed:  Bull  Calcutta
  School Trop. Med., 1954,  1 (4) : 5-6.  Abstract: Chem.
  Abstr., 1955, 49: 6455e.
----,----,----.   The effect of chlorpromazine on the elec-
  trical activity of the cerveau isole.   Arch.  exp. Path.,
  Berl, 1955, 224: 248-252.
Dasgupta,  S. R.,  Mukherjee,  K. L.,  Werner, G.  The
  activity  of some central depressant drugs in acute de-
  corticate and diencephalic preparations.  Arch, internat.
  pharm. dyn., Gand, 1954, 97:149-156.  Abstract: Chem,
  Abstr., 1954, 48: 11636g.
----, see Das, N. N., Dasgupta,  S. R., Werner, G.
----, see Guha, G., Dasgupta, S. R., Werner, G.
Datta, J. K., see Chatterjee, P. K., Datta, J. K.
David, M., Benda, P., Klein, F.  Traitement  de T6tat  de
  mal epileptique par la chlorpromazine.  [Treatment of
  epilepsy  with chlorpromazine.]  Bull. Soc. med.  hdp.
  Paris, 1953, 69: 691-697.
Davidoff, E., Best, J. L,  McPheeters, H. L.  The effect
  of ritalin  (methyl-phenidylacetate hydrochloride)   on
  mildly depressed  ambulatory patients.  N. York State
  J. M., 1957, 57 : 1753-1757.
Davies, D. L.  Clinical trials with especial reference to
  reserpine.  Ence'phale, 1956, 45:1031-1034.
----, Shepherd, M.  Reserpine in the treatment of anxious
  and depressed patients.  Lancet, Lond., 1955, 2:117-120.
  Abstract: Excerpta med., Sect. 8, 1956, 9: No. 1224.
Davies, E. B.  A new drug to relieve anxiety.   Brit. M. J.,
  1956,1:480-484.
Davies,  T.  S.  Chlorpromazine  in  mental  deficiency.
  Lancet, Lond., 1954, 2: 819.
----.  Chlorpromazine in mental deficiency.   Ence'phale,
  1956,45:830.
Davignon, A., see Lemieux, G., Davignon, A., Genest, J.
Davis, G. D. Effects of central excitant and depressant
  drugs on locomotor activity in the  monkey.   Am  J.
  Physiol,  1957, 188: 619-623.
Davis, W. A., Severinghaus, E. L.  Drug therapy in psy-
  chiatry and neurology;  medical and pharmacological
  aspects.  J. M. Soc N. Jersey, 1956, 53:18-22.
Day, J.  The role and reaction of the psychiatrist in LSD
  therapy.  J. Nerv. Ment. Dis.,  1957,125 : 437-438.
Dazzi, P., see Rossini, R., Dazzi, P.
De, N. N., see Kohli, J. D., De, N. N.
Dean, E. F., see Spratt, R. J., Dean, E. F.
Dean, S. R. Ataractics.  Am. J. Psychiat, 1956, 112: 850.
De  Beer, E. J., see Norton, S., De Beer, E. J.
Debesse, B., see  Cachin,  M., Pergola, F.,  Potet, F.,  De-
  besse, B.
De  Busscher, J.  Impressions  personnelles sur les effets
  de l'atarax, de la chlorpromazine,  de la reserpine et du
  AY 5406-1 (parasan)  en therapeutique psychiatrique. 
De Busscher, J.
PSYCHOPHARMACA
  [Personal impressions of atarax, chlorpromazine, reser-
  pine and AY 5406-1 (parasan) in  psychiatric therapy.]
  Ence'phale, 1956, 45 : 1007-1023.
De Caro, D.  Manifestazioni extrapiramidali e convulsive
  osservate durante la terapia con la reserpina ; contributo
  clinico ed E. E. grafico.  [Extrapyramidal symptons and
  convulsions  during  reserpine therapy;  clinical and elec-
  troencephalographic tracings.]  Acta neur., Nap., 1956,
  11: 426-453.  Abstract: Excerpta med.,  Sect. 8,  1957,
  10: No. 1538.
----.  Modificazioni  E. E.  G. provocate dalla  reserpina
  nell'uomo.   [Electroencephalographic  changes in man
  induced by reserpine.] Arch, psicol. neur., 3Iilano, 1956,
  17: 581-591.
----, Mulas,  L.  L'impiego della terapia ganglioplegica
  mediante il "4560 R. P." nelle malattie  mentali.  Esperi-
  enze  e risultati su  52  casi  trattati.  [Ganglioplegic
  therapy of mental disease with "4560 RP". Experiences
  and results in 52 treated cases.] Acta neur., Nap., 1054,
  9: 611-627.
Decherney, G., Beaudry, A.   Thorazine therapy; difficulty
  in  predicting  the outcome.   Delaware  M.  J.,  1955,
  27 : 186-187.   Abstract: Excerpta  med., Sect. 8, 1956, 9 :
  No. 1216.
Decourt,  P.  Mecanisme  d'action  de  la  therapeutique
  narcobiotique en general, et de  la chlorpromazine en
  particulier,  en  psychiatrie.   [Mechanism of action of
  narcobiotic psychiatric therapy in general, and of chlor-
  promazine in particular.]   Ence'phale,  1956, 45 : 932-944.
----, see Belot, P., Decourt, P.
De Falco,  A.,  Grassi, B.  La reserpina nel  trattamento
  delle malattie mentali.   [Reserpine in the treatment of
  mental diseases.]  Arch, psicol.  neur.,  31ilano, 1956,
  17: 432-438.
Deisher, J. B.  Ingestion of 12 grams of meprobamate
  with recovery.  Northwest 31., 1956, 55 :1083-1085.
Delay, J.  Allocution finale.  [Final address.]  [Interna-
  tional colloquium  on chlorpromazine and neuroleptic
  drugs.    Paris,   October   1955]  Encephale,   1956,
  45:1181-1184.
----.  Introduction au colloque international.  [Introduc-
  tion  to  the  international colloquium.]   [On chlorpro-
  mazine  and  neuroleptic  drugs,  Paris, October  1955]
  Ence'phale, 1956, 45 : 303-306.
----, Denber, Deniker, P.,  Raclot, M., Ropert,  M.  Deux
  auto-observations  d'intoxication  mescalinique  experi-
  mentale.  [Mescaline intoxication;  two  auto-experi-
  ments.]  Ann. med. psychol, Par.,  1956, 114 (2) : 306-
  309.  Abstract: Excerpta med., Sect. 8, 1957,  10:  No.
  1963.
----, Deniker, P.  L'action neuroleptique de la chlorpro-
  mazine  en  therapeutique psychiatrique.   [The neuro-
  leptic action of chlorpromazine in psychiatric therapy.]
  Sud med. chir., 1954, 87: 3289-3296.  Abstract: Excerpta
  med., Sect. 8,1955, 8 : No. 754.
----,----.  Chlorpromazine and neuroleptic treatments in
  psychiatry.  J.  Clin. Exp. Psychopath., 1956, 17: 19-24.
----,----.  La cure  neuroplegique.  [Neuroplegic ther-
  apy.]  Acquis, med. re'c, Par., 1954: 105-115.
----,----.  Neuroleptic  effects  of  chlorpromazine  in
  therapeutics of neuropsychiatry.  J. Clin. Exp. Psycho-
  path., 1955, 16: 104-112.  Also: Internat. Rec. 31., 1955,
  168 : 318-326.  Abstract: Excerpta  med.,  Sect. 8, 1956,
  9: No. 4992.
----,----.  Les neuropiegiques en therapeutique psychia-
  trique.  [Neuroplegic drugs  in  psychiatric therapy.]
  Therapie, Par., 1953, 8: 347-364.
.----,----.  Peut on  comparer la reserpine a la chlorpro-
  mazine?  [Can one  compare  reserpine  with chlorpro-
  mazine?]  Arch, psicol. neur., Milano,  1956, 17 : 631-633.
.----,----.  38 cas de psychoses traitees par la cure pro-
  longee et continue de 4560 R. P.  [Thirty-eight psychotics
  treated by prolonged and continuous  administration of
  4560 RP.]   C.  rend. Congr.  alie'n  neur. France, 1952,
  50: 503-513.  Abstract: Ann. med. psychol, Par., 1952,
  110 (2) : 564.
----,----.   Le traitement des psychoses par une methode
  neurolytique derivee  d'hibernotherapie; le 4560  R.  P.
  utilisee seul en cure prolongee et continue.   [Treatment
  of psychoses by a neurolytic method derived from hiber-
  notherapy ; prolonged continuous therapy with 4560 RP
  alone.]   C.  rend. Congr.  alien,  neur. France,  1952,
  50: 497-502.  Abstract: Ann. med. psychol, Par., 1952,
  110 (2) :564.
----, ____, Bourguignon, A., Lemperiere, T.  Complica-
  tions d'allure extrapyramidale au cours des traitements
  par la  chlorpromazine et la reserpine ; etude clinique et
  electromyographique.  [Extrapyramidal movement dis-
  orders during chlorpromazine  and reserpine  therapy;
  clinical  and  electromyographic  studies.]   Encephale,
  1956, 45 : 1093-1098.
----,----, Harl, J.  M.   Traitement  des etats d'excitation
  et d'agitation par une methode medicamenteuse derivee
  de  Thibernotherapie.  [Therapeutic  method  derived
  from   hiberno-therapy in  excitation  and   agitation
  states.] Ann. med. psychol, Par., 1952,110  (2) : 267-273.
----,----,----.  Utilisation  en  therapeutique psychi-
  atrique d'une phenothiazine d'action centrale elective
  (4560 RP).  [Use of a phenothiazine with elective cen-
  tral effect in psychiatric therapy.] Ann, mM. psychol,
  Par., 1952, 110 (2) : 112-117.
----, ----, ----, Grasset, A.  Traitements d'etats confu-
  sionnels par le chlorhydrate de dimethylaminopropyl-N-
  chlorophenothiazine    (4560  RP).   [Dimethylamino-
  propylchlorophenothiazine (4560 RP)  therapy of confu-
  sional  states.]  Ann,  med.   psychol,   Par.,  1952,
  110  (2): 398-403.  Abstract: Excerpta med., Sect. 8,
  1954, 7 : No. 1603.
----,----, Pauwels, R.   Cures de sommeil et cures neuro-
  leptiques en psychiatrie.   [Sleep therapies and neuro-
  leptic   therapies  in  psychiatry.]  Ence'phale,  1956,
  45: 436-439.
----, ——, Raclot, M.,  Ropert, M.  La  mescaline chez les
  malades  mentaux;    (constatations   cliniques).  [The
  effect of mescaline on mental patients; (clinical  obser-
  vations).]   Ann.  med.   psychol,  Par.,  1956,  114
   (2)300-305.  Abstract: Excerpta med., Sect. 8, 1957,
  10: No. 1962.
----,----, Ropert, R.   Etude de 300 dossiers de malades
  psychotiques traites  par la chlorpromazine en service
  ferme depuis  1952.   [Hospitalized  psychotic  patients
  treated  with chlorpromazine  since  1952;  analysis of
  300 case histories.]   Ence'phale,  1956, 45 : 528-535.
----,----,----.  Quatre annees d'experience de la chlor-
  promazine  dans le  traitement  des  psychoses.  [Four
  years  of experience with chlorpromazine  in therapy of
  psychoses.]  Presse med., 1956, 64 : 493-496.
----,----,----, Wiart,  C.  Les  indications  des  cures
   neuroleptiques prolongees dans le traitement des psy-
   choses  chroniques.   [Indications for the  prolonged
   neuroleptic therapy  in  the treatment of chronic psy-
   choses.]  Arch, psicol. neur., Milano, 1950, 17 : 401-407.
 ----,----, Tardieu, Y.  Hibernotherapie et cure de som-
   meil  en   therapeutique  psychiatrique   et psycho-
   somatique.  [Hibernotherapy and sleep therapy in psy-
   chiatry and psychosomatic  medicine.]  Presse me'd.,
   1953, 61:1165-1166.
 ----,----,----.   Resultats   de  Thibernotherapie  dans
   trois affections psychosomatiques.  [Results of hiberno-
   therapy in three psychosomatic diseases.]  Ann. me'd.
   psychol, Par., 1953,  111  (2) : 224-227.
 ----,  ----, ----, Lemperiere, T.   Medicaments et cures
   neuroleptiques en therapeutique psychiatrique : premiers
   essais de la reserpine; comparaison  avec les effets de la
   chlorpromazine.  [Drugs and neuroleptic therapies in
   the treatment of psychiatric diseases; first trials with
   reserpine; comparison with the effects of chlorproma-
   zine.]  Presse med.,  1955, 63 : 663-665.
200 
AUTHOR  LIST
Deniker, P.
----,----,----,----.  Premiers  essais en  therapeutique
  psychiatrique de  la reserpine alcaloide nouveau de
  "Rauwolfia  serpentina."  [First investigations on  the
  use of reserpine, a new alkaloid of "Rauwolfia serpen-
  tina"  in psychiatric therapy.]  [Abstract]  Ann. me'd.
  psychol, Par., 1954, 112 (2) : 448.
---,----, Wiart, C.  Complements & notre experience de
  la reserpine.  [Additional experiences with reserpine.]
  EncCphale, 1956, 45 : 1042-1048.
■---, Lhermitte, F., Verdeaux, G., Verdeaux, J.  Modifica-
  tions de Teiectrocorticogramme du lapin par la diethyla-
  mide de Tacide  d-lysergique (LSD-25).   [Electrocorti-
  cographic changes produced in the rabbit with lysergic
  acid diethylamide.]  Rev. neur., Par., 1952, 86: 81-88.
---, Pichot, P., Laine, B., Perse, J.  Les modifications de
  la personnalite produits par la diethylamide de Tacide
  lysergique   (LSD 25) ; etude par le test  de Rorschach.
  [Personality changes produced  by lysergic acid diethyla-
  mide;  a study with the  Rorschach test.] Ann. med.
  psychol, Par., 1954, 112 (2) : 1-13.  Abstract: Excerpta
  med., Sect. 8,1955, S : No. 839.
---,----, Ropert,  R.  Un  nouveau medicament  neuro-
  leptique en psychiatrie. Le maieate acide de Tethylone-
  3-dimethylamino-3'-propyl-10-phenothiazine (1522 C. B.)
  [A new neuroleptic drug in psychiatry.   8-Acetyl-10-(3-
  dimethylaminopropyl)   phenothiazine    (CB-1522).]
  Presse med., 1957, 65 : 491-493.
---, Thuillier, J.   Psychiatrie experimentale et psycho-
  pharmacologie.  [Experimental psychiatry and psycho-
  pharmacology.]   Sem, hop. Paris, 1956, 32: 3187-3193.
Delgado, H.  Acerca de  nuestra experiencia con la  clor-
  promacina.   [Our  experience  with  chlorpromazine.]
  Encephale, 1956, 45 : 344-351.
---.   The treatment of compulsive neurosis with chlorpro-
  mazine.  In:  Overholser,  W.,  ed.   Washington, D. C.
  St. Elizabeths  Hospital  Centennial papers, 1855-1055.
  Washington, Centennial Commission, St. Elizabeths Hos-
  pital, 1956.  p. 233-244.
Delgado, J. M., Mihailovic,  L.  Use of intracerebral  elec-
  trodes to evaluate drugs that act on the central nervous
  system.  Ann. N.  York Acad. Sc, 1956, 64: 644-666.
Delgado  Roig, J., Franco  Hernandez, M.  El uso de la
  reserpina en la clinica psiquiatrica ; nota previa.   [Use
  of reserpine in psychiatric practice;  preliminary re-
  port.]   [English  summary]  Hispalis   med,,   1955,
  12: 507-512.
Dell, C, see Heuyer, G., Dell, C, Pringuet, G.
Dell, P., see Hiebel, G., Bonvallet, M., Dell, P.
Delia Pietra,  V., Fina, G.  Un  caso  di edema cerebrale
  acuto in corso di terapia reserpinica.  [A case of acute
  cerebral edema during reserpine  therapy.]  Osp.  psi-
  chiat, Nap., 1956, 24 : 91-95.
Dellaert, R.  De modernste chemopharmaca in de psychi-
  atrie.  [New chemical psychopharmaca.]  Belg. tschr.
  geneesk., 1956, 12 : 314-321.
Delteil, P., see Abeiy, P., Abdouchelli, A., Fourment, J.,
  Schmitz, B., Delteil, P.
Demartino, G.  One year  of chlorpromazine therapy at
  Montana State Hospital.  Northwest M., 1956, 55 :1206-
  1209.
Demay, G., Montremy, J. de, Mises, R.  Les curarisants
  par voie rectale en psychiatrie.  [Rectal administration
  of curare-like drugs in psychiatry.]  Ann. med. psychol,
  Par., 1953, 111  (1) : 660-665.
Demay, J., see Letailleur, M., Morin, J., Demay, J., Mon-
  nerie, R.                                            T
___. see Letailleur, M., Morin, J., Monnerie, R., Demay, J.
Demidova,  L.  P.,  Tarasov,  G.  K.  Aminazin;  obzor
  inostrannoi  literatury  po  primeneniiu  v  psikhiatrn
  odnogo iz proizvodnykh fenotiazina.  [Aminazine; re-
  view of foreign literature on psychiatric use of a pheno-
  thiazine derivative.]  Zh. nevropat. psikhiat., Moskva,
  1956, 56: 192-199.
Denber H  C. B.   Appraisal of drug reactions.  J. Am.
  M. Ass., 1955,158: 586-587.
----.   Chlorpromazine  et  mescaline.   [Chlorpromazine
  and mescaline.]   Encephale, 1956, 45 : 440-443.
----.   Medical and  other measures to  be taken to keep
  the discharged patient from returning to the institution.
  In: Chlorpromazine and mental health.  Philadelphia,
  Lea d Febiger, 1955.  p. 141-153; discussion p. 154-174.
----.   Some aspects of chlorpromazine treatment with ref-
  erence to the  problem of depression.  Dis. Nerv. Syst,
  1957,  18: 35-36.
----.   Studies on  mescaline.  III. Action  in  epileptics.
  Psychiat. Q.,  1955, 29:433-437.  Abstract:  Excerpta
  med., Sect. 8,1956, 9 : No. 3660.
----.   Studies on mescaline.   VII. The role of anxiety in
  the mescaline-induced state and its influence on the
  therapeutic result.  J. Nerv. 3Ient Dis., 1956,124 : 74-77.
----, Bird, E. G.   Chlorpromazine in the  treatment of
  mental illness. II. Side effects and relapse rates. Am.
  J. Psychiat., 1955,112: 465.
----,----.  Chlorpromazine  in the treatment  of mental
  illness.   III. The problem  of depression.  Am. J. Psy-
  chiat, 1956, 112 :1021.  Discussion : ibid., 1956, 113 :
  368-369.
----,----.  Chlorpromazine  in the treatment  of mental
  illness.   IV. Final results  with analysis of  data  on
  1,523 patients. Am. J. Psychiat., 1957, 113 : 972-978.
----, Merlis, S.  A  note on some therapeutic implications
  of  the  mescaline-induced   state. Psychiat.  Q.,  1954,
  28:634-640.   Abstract: Excerpta med., Sect. 8, 1956,
  9: No. 2659.
----,----.  Studies on mescaline.  I. Action  in schizo-
  phrenic patients;  clinical observations  and brain wave
  patterns, showing effects before and after electric con-
  vulsive  treatments.  Psychiat. Q., 1955, 29 : 421^29.
----, ----.   Studies on mescaline.  IV:  Antagonism  be-
  tween mescaline and chlorpromazine.  In: Kline, N. S.,
  ed.  Psychopharmacology.   Washington, Am.  Ass. Adv.
  Sc, 1956.  p. 141-144.
----,----.  Studies on  mescaline.  VI. Therapeutic  as-
  pects of the mescaline-chlorpromazine combination.   J.
  Nerv. Ment.  Dis., 1955, 122: 463-469.   Abstract: Ex-
  cerpta med., Sect. 8,1957,10: No. 889.
----, Rinkel, M., ed. Psychodynamic and therapeutic as-
  pects of mescaline  and   lysergic acid  diethylamide.
  [Round table at  American Psychiatric Association  an-
  nual meeting  held in Chicago, 111., May  1956.]  J. Nerv.
  3Ient. Dis., 1957, 125:423-451.   [Preface p.  423-424;
  Summary  of  discussion p. 450-451]   [All articles  are
  listed individually]
----, see Bird, E. G., Goss, J.  D. Jr., Denber, H.  C. B.
----, see  Delay,  J.,  Denber, Deniker,  P., Raclot,  M.,
  Ropert, M.
----, see Merlis, S., Denber, H. C. B.
Denhoff, E., Holden, R. H. The effectiveness of chlorpro-
  mazine  (thorazine) with cerebral palsied children.  J.
  Pediat, S. Louis,  1955, 47: 328-332.
Deniker, P.   Biological changes in man  following intra-
  venous  administration  of  mescaline.  J.  Nerv. Ment.
  Dis., 1957,125 : 427^31.
----.  Hibernotherapies et medicaments neuroleptiques en
  therapeutique psychiatrique.   [Hibernotherapies  and
  neuroleptic drugs in psychiatric therapy.]  Encephale,
  1957, 46: 281-398.
----.  Psychophysiologic aspects of the new chemothera-
  peutic drugs  in psychiatry; some practical features of
  "neuroleptics" in  order to screen new  drugs.  J. Nerv.
  Ment Dis., 1956,124: 371-376.
----.  Recent  advances  in  "pharmaco-psychiatry."  J.
  Clin.  Exp. Psychopath., 1956, 17:381-384.
----, see  Delay, J., Denber, Deniker,  P., Raclot,  M.,
  Ropert, M.
----, see Delay,  J., Deniker, P.
----, see Delay, J., Deniker,  P.,  Bourguignon,  A., Lem-
  periere, T.
----, see Delay,  J., Deniker, P., Harl, J. M.
----, see Delay, J.,  Deniker,  P., Harl., Grasset, A. 
Deniker, P.
PSYCHOPHARMACA
----, see Delay, J., Deniker, P., Pauwels, R.
----, see Delay, J., Deniker, P., Raclot, M., Ropert, M.
----, see Delay, J., Deniker, P., Ropert, R.
----, see Delay, J., Deniker, P., Ropert, R., Wiart, C.
---, see Delay, J., Deniker, P., Tardieu, Y.
----, see Delay, J., Deniker, P., Tardieu, Y., Lemperiere, T.
---, see Delay,  J., Deniker, P., Wiart, C.
---, see Piedelievre, Deniker, Marmier.
Dennemark, H. G.  Sympathicolytica  (insbes. Yohimbin)
  und ihre pharmakologische Wirkung.  II. [The pharma-
  cological effect of sympatholytics with special reference
  to yohimbine.  II. ]   Ther. Gegenwart, 1953, 92: 262-265.
Dennison, A. D., Jr., White, P. T., Moore, R. B., Pierce,
  W. J.  Effect  of reserpine upon the human electroen-
  cephalogram.  Neurology,  1955,  5:56-58.  Abstract:
  Excerpta med., Sect. 8, 1955, 8: No. 2712.
----, see Moore, R. B., Pierce, W.  J., Dennison, A. D., Jr.
Depression  induced  by Rauwolfia  compounds.  Am. J.
  Psychiat, 1957,113: 950.
De Risio, C, Manghi, E.  Premesse sperimentali e risultati
  clinici riguardanti l'impiego della cloropromazina (lar-
  gactil) in malatti  neuropsichiatriche.   [The  use of
  chlorpromazine (largactil) in neuropsychiatric diseases;
  experimental premises and clinical  results.]  [English
  summary]  Riv. sper. freniat.,  1956, 80: 345-354.  Ab-
  stract: Excerpta med., Sect. 8, 1957, 10: No. 1556.
Derobert, L., see Piedelievre, R., Derobert, L.
Deschamps, A.   Hibernation artificielle en psychiatrie.
  [Artificial  hibernation in psychiatry.]   Presse me'd.,
  1952, 60: 944-946.
----.   Quelques resultats des cures de sommeil en hopital
  psychiatrique  (a  base de chlorpromazine associee  a
  d'autres drogues).   [Some results of sleep therapy in
  a psychiatric hospital (based on chlorpromazine associ-
  ated with other drugs).]   Ence'phale, 1956, 45: 412-415.
----, Cadoret, M.  Cures de sommeil prolonge en pratique
  medico-psychiatrique par la methode dite d'hibernation.
  [Prolonged sleep therapies by the so-called hibernation
  method in medicine and psychiatry.]   Presse me'd., 1953,
  61: 878-880.
----, see Ey, H., Deschamps, A., Berard, E.
DeShon, H. J., Rinkel, M., Solomon, H. C.  Mental changes
  experimentally produced  by d-lysergic acid diethylamide
  tartrate.  Psychiat Q., 1952, 26 : 33-53.
----, see Rinkel, M., DeShon, H. J., Hyde, R. W., Solomon,
  H. C.
De Smedt,  R.  La reserpine en  clinique psychiatrique.
  [Reserpine in  psychiatric practice.]  Acta neur.  psy-
  chiat.  belg., 1955, 55 : 399-408.
Despinoy, M., Saucet, D.  Effets  eiectro-encephalograph-
  iques des  stimulations auditives et lumineuses sur des
  sujets soumis a la chlorpromazine.  [Effects of auditory
  and photic stimulations  on the  EEG of  subjects under
  the  influence  of  chlorpromazine.]  Ence'phale, 1956,
  45:877-883.
Detre, T., see Bernstein, S., Detre, T.
Deutsch, L., Waxenberg, S.  E., Dickes, R.  Brief chlor-
  promazine treatment of disturbed patients in a psychi-
  atric  reception  hospital.  J.  Nerv.  Ment.  Dis., 1957,
  125:273-278.
----, see Brooks, W., Deutsch, L., Dickes, R.
De Verteuil, R., see Azima, H., Cramer-Azima, F. J., De
  Verteuil, R.
Dewhurst, K.  Chlorpromazine in  the management of
  chronic psychotics.   Irish J. M. Sc, 1955, 6: 83-87.  Ab-
  stract : Excerpta med., Sect. 8, 1955, 8: No. 3896.
----, see Pearson, J., Dewhurst, K.
Dibble,  R. C, see Schneider, J.  A., Plummer, A. J., Earl,
  A. E., Barrett, W.  E., Rinehart,  R., Dibble, R. C.
Dice, N., Bagchi, B. K.,  Waggoner, R. W.  Investigation
  of effects of intravenous  reserpine  in  disturbed  psy-
  chotic and brain-damaged patients;  electroencephalo-
  graphic  correlations.    J.  Nerv.  Ment.   Dis., 1955,
  122: 472-478.
Dickel, H. A., Dixon, H. H.  Inherent dangers inuse of
  tranquilizing drugs in anxiety states.   J. Am. M. Ass.,
  1957,163:422-426.
---,----.Wood, J., Shanklin, J. G.  Electromyographic
  studies on patients treated with meprobamate.  West.
  J. Surg., 1956, 64: 197-201.
Dickes, R.,  Flamm, G.  H., Coltrera, J., Tobin, M.  The
  effect of mephenesin on muscle tension.  An experimental
  study.  A. M. A. Arch. Neur. Psychiat, 1955, 74 : 590-597.
  Abstract: Excerpta med., Sect. 8,  1956, 9:  No. 4998.
---, see Brooks, W., Deutsch, L., Dickes, R.
---, see Deutsch, L., Waxenberg, S. E., Dickes, R.
Diederichs,  see Perrin,  J., Diederichs.
Diederichs,  A., see Lambert, P. A., Diederichs, A., Toulet,
  M.
---, see Lambert,  P. A., Toulet, M., Diederichs, A.
Dierkens, J.,  Reeth, P.  C.  van. Essais  cliniques d'un
  nouveau  psychopiegique; le  meprobamate.  [Clinical
  trial  of   a new  psychopiegie drug: meprobamate.]
  [English  summary]  Bruxelles med., 1956,  36:2335-
  2340.
Dietrich, M., see Howell,  T. H., Harth, J. A. P., Dietrich,
  M.
Dillon, D., Swain, J. M.  Gastro-intestinal hemorrhage as
  a complication of reserpine  administration:  report of
  two cases.  Am. J. Psychiat., 1956, 113: 462-463.
Di Mascio,  A., Greenblatt, M., Hyde, R. W.  A study of
  the  effects of  LSD:  Physiologic  and  psychological
  changes  and their interrelations.  Am. J. Psychiat.,
  1957, 114: 309-317.
---, Suter,  E., Hyde, R. W., Greenblatt, M.  Physiological
  effects of  L. S. D.; report of a detailed investigation in
  one subject.  Psychiat. Q., 1957, 31: 57-71.
Ditfurth,  H. von   Anwendungsmoglichkeiten  des  Mega-
  phens  in  der psychiatrischen Klinik und Forschung.
  [Possibilities for  the use  of megaphen in psychiatric
  practice  and  research.]  Nervenarzt,  1955, 26:54-59.
  Abstract: Excerpta med., Sect. 8, 1956, 9: No. 4074.
Ditsova, A., see Temkov, I., Ditsova, A.
Dixon, H. H., see Dickel, H. A., Dixon, H. H.
---, see Dickel, H. A.,  Dixon,  H. H., Wood,  J., Shanklin
  J. G.
Dizon, M., see Moyer, J. H., Kent, B., Morris, G.,  Dizoi*
  M., Rogers, S., Spurr,  C.
Dlin, B. M., see Fischer, H. K., Dlin, B. M.
Dobkin, A.  B., Gilbert,  R. G. B., Lamoureux, L. Physio-
  logical effects of chlorpromazine.   Anaesthesia,  Lond.,
  1954, 9:157-174.
---, Lamoureux, L, Letienne, R., Gilbert, R. G. B.  Some
  studies with largactil.  Canad. 31. Ass. J., 1954, 70: 626-
  628.
Doco, see Monnerot, E., Monnerot, E., Benichou, L., Doco
Dogan, S., Vukadinovic, D., Longhino, A. Djelovanje lar-
  gactila  i  phenergana na  elektroencefalogram kod epi-
  lepticara.  [Effect of largactil and phenergan on elec-
  troencephalography in epilepsy.]   [English summary p.
  95]  Neuropsihijatrija, 1954, 2: 88-100. Abstract: Ex-
  cerpta med., Sect. 8,1955, 8: No. 2385.
Dolce, C, Garello, L.   La catalessia da serotonina nella
  Rana  esculenta:  tecnica  sperimentale.    [Catalepsy
  caused by serotonin  in Rana esculenta;  experimental
  technic]   Boll. Soc  ital. biol sper.,  1956, 32:441-443.
---, see Garello, L., Dolce, G.
---, see Sacchi, U., Bonamini, F.,  Dolce, G., Garello, L.
---, see Sacchi, U., Bonamini, F., Garello, L., Dolce G.
---, see Sacchi, U., Garello, L., Dolce, G., Bonamini, F.
Domanowsky,  K.,   see  Conrad,  K.,  Domanowsky,  K.,
  Wieser, S.
Domino, E. F., see Funderburk, W.  H., King, E. E., Dom-
  ino, E. F., Unna, K. R.
Donegani,  G., see  Bolsi, D.,  Donegani,  G.,  Grattarola,
  F. R.
Donini,  F.  M.,  Belsasso, M.,  Ravis,  E.  Risultati  tera-
  peutici ottenuti  con  il serpasil in 158  ammalati  nien-
202 
UTHOR  LIST
Earl, A. E.
  tali.   [Therapeutic results of  serpasil  in  158 mental
  patients.]   Arch, psicol. neur., Milano, 1956,  17:394-
  398.
Donini, G., see Alema, G., Donini, G.
Donnadieu, A., Florentin, M.,  Florentin.   Les incidents
  au cours du traitement des  troubles mentaux  par le
  largactil.   [Incidents during  chlorpromazine therapy
  of mental disorders.]  Ann. me'd.  psychol,  Par., 1955,
  113 (2): 205-216.   Abstract:  Excerpta med., Sect. 8,
  1956, 9 : No. 4555.
Donnelly, J., Zeller, W.  Clinical research  on chlorproma-
  zine and reserpine  in state and private psychiatric hos-
  pitals; a comparative review of the clinical problems.
  J. Clin.  Exp. Psychopath., 1956, 17:180-188.
Dooneief,  A.  S., see Bloch, R. G., Dooneief, A. S., Buch-
  berg, A. S.,  Spellman, S.
Doshay, L. J.  Problem  situations in the treatment of
  paralysis agitans.   J. Am. M. Ass., 1954, 156:680-684.
Doubrava, O., see  Dubansky, B.,  Doubrava, O.,  Svoboda,
  E., Vyhn&nkov&, M.
Douglas, A. D. M., Bates, T. J. N.  Chlorpromazine as a
  suicidal agent.  Brit. M. J., 1957,1:1514.
Doyle, A. E., Smirk, F. H.  Drug therapy in hypertension ;
  a critical review.  Practitioner, Lond.,  1955, 174:135-
  143.
Doyle, F.  J.  New drugs  in mental  therapy  and the im-
  plications of their  use.  Hosp. Progr., 1955, 36 (3) : 50-
  51.
Doyle, J.  C.   Raudixin (Squibb  Rauwolfia serpentina) :
  a clinical investigation of thirty patients suffering from
  premenstrual tension.   Monogr. Ther. Squibb Inst. M.
  Res., 1956,1 (2) : 9-14.
Drake, C. F., see Hollister, L. E., Stannard, A. N., Drake,
  C. F.
Drake, F. R., Ebaugh, F.  G. The use of  reserpine in of-
  fice  psychiatry: preliminary  report.  Ann.  N. York
  Acad. Sc, 1955, 61:198-205.  Abstract: Excerpta med.,
  Sect. 8,1956, 9: No. 1226.
Draper, M. D., see Klohs,  M. W., Draper, M. D., Keller, F.
Drassdo, A.,  Schmidt, M.  Kreislauf,  geistige Leistungs-
  fahigkeit und  Stoffwechsel unter  dem  Einfluss von  2-
  Diphenylmethylpiperidinhydrochlorid.  [Effect  of   2-
  diphenylmethylpiperidinehydrochlori.de  on  blood circu-
  lation, mental efficacy and metabolism.]  [English sum-
  mary]  Med. Mschr., 1956,10 : 738-743.
---, ----.  Ritalin,  ein  zentrales Stimulans mit neuar-
  tiger  chemischer  Konstitution.   1.  Kreislaufuntersu-
  chungen.  2. Verbesserung der geistigen  Leistungsfa-
  higkeit  und psychische  Wirkung durch  Ritalin.   [Rita-
  lin, a  central  stimulant of  novel  chemical constitu-
  tion.  1. Studies  on  blood   circulation.   2. Improve-
  ment  of mental efficacy and the psychologic  effects  of
  ritalin.]   [English  summaries,  p.  310;   395]  Med.
  Mschr.,  1954, 8: 306-310; 393-395.
Dredge, T. E., see Penman, A.  S., Dredge, T. E.
Dreikurs, E., see Bercel,  N. A., Travis, L. E., Olinger,  L.
  B., Dreikurs, E.
Dressel, P. E., Slater, I. H.  Observations on the pharma-
  cology of mephenesin carbamate.  Proc. Soc. Exp. Biol,
  N. Y., 1952, 79: 286-287.
Drill, V. A., see Sturtevant, F. M., Drill, V. A.
Drop in shock therapy.   Science, 1957, 125 : 229.
Drugs and driving.   J. Am. M. Ass.,  1954, 156:628-629.
Drugs in  the treatment of depression.   Lancet,  Lond.,
  1955, 1:1065.                  n  ^   „    *   ™,   „
Dubansky, B. Neue Wege in der Behandlung der Chorea
  minor   Vorlaufige Mitteilung.   [New methods of treat-
  ing  chorea  minor.  Preliminary  report]  Schweiz.
  med. Wschr., 1956, 86 :122-123.            ,
___ Doubrava, O.,  Svoboda, E., Vyhnankova, M.  Hirn-
  nervenstorungen nach einmaliger  intravenoser Largac-
  tiMos?bei zerebralintakten Personen  [Brain nerve
  damage after  single intravenous  injection  of largactil
  fnTnTviduals wifhout brain disease.]  psyohiat Neur.
  med. Psychol, Lpz., 1956, 8.202-205.
Dubnick, B., see Chessin, M., Dubnick, B., Kramer, E. R.,
  Scott, C. C.
Dubon, P., see Dubor, P.
Dubor, P., see Achaintre, A., Dubor, P.
----,  see Achaintre, A., Dubor, P.,  Lauxerois, G.
----,  see Broussolle, P., Dubor (Dubon [sic]), P.
Duboucher, G.  Etats depressifs d'allure melancolique au
  cours du traitement de Thypertension arterielle par la
  reserpine  ou les alcaloides de  Rauwolfia serpentina.
  [Depressive states with melancholia during  treatment
  of  arterial hypertension with reserpine or  Rauwolfia
  serpentina  alkaloids.]   Alge'rie me'd., 1956, 60:417-420.
Due,  N., see  Lafon, R.,  Boyer,  Due,  N., Minvielle, J.,
  Pouget, R.
----,  see Lafon, R.,  Due,  N., Abric, J., Pouget,  R., Come-
  lade, P.
----,  see Lafon, R., Due, N., Boyer, Abric, J., Pouget, R.
----,  see Lafon, R., Due, N., Labauge, R., Temple, J. P.
----,  see Lafon, R.,  Due,  N., Ribstein, M., Pages, H.
Duchesnay, G.  Interet  du stemetil (6.140 R. P.) en
  therapeutique.   [Stemetil  (6140  RP) ;  its   place  in
  therapeutics.]  Bull, me'd., Par., 1957, 71:13-15.
Ducrot, R., see Courvoisier, S., Fournel, J., Ducrot, R.,
  Kolsky, M., Koetschet, P.
Dukay, A. P.  Chlorpromazine in the treatment of chronic
  psychotic patients.  J. Michigan M. Soc, 1956, 55: 664-
  670.
Duncan, C. J., see Kistner, R. W., Duncan, C. J.
Dundee, J. W.  A review of chlorpromazine hydrochoride.
  Brit. J. Anaesth., 1954, 26: 357-379.
Dunlap, D. J.,  see Hall, R. A., Dunlap, D. J.
Dunlop,  D.  M. The  barbiturates and other  sedatives.
  Practitioner, Lond., 1957, 178: 26-32.
Dupont, A., Maudoux-Joubert.  Resultats obtenus chez 22
  schizophrenes hommes  et 37  schizophrenes  femmes
  traites par le 4560  R.  P.  [Results of chlorpromazine
  treatment  of 22 male  and 37  female schizophrenics.]
  Ann. mCd. psychol, Par., 1955,113 (1) : 634-639.
Durand, V. J., Houillon, G.  De quelques travaux etran-
  gers sur la chlorpromazine.  [Foreign works on chlor-
  promazine.]  Ann. me'd. psychol, Par., 1955, 113 (2) :
  96-101.
----, see Henne, M., Durand, V. J., Bures, I. de
Durden, W.  D., see Gallagher, W.  J., Berry, J. M., Dur-
  den, W. D., Lazenby, W. D.
Durieux, G. P.  Extension de Tintoxication par le canna-
  bis sativa  Linnaeus.  [Distribution of the intoxication
  with Cannabis  sativa  Linaeus.]   30 p.   Paris,  1953.
   [Thesis—Paris 1953, no. 754]
Durlach, J.  Traitement de la maigreur par la reserpine.
   [Treatment  of  underweight  with  reserpine.]  Con-
  cours me'd.,  1956, 78: 725-728.  Condensed :  Bull  Soc.
  me'd. hop. Paris, 1956, 72:165-168.
Durling, D.,  Esen, F. M., Mautner,  H. Central autonomic
  regulation  and  mental   retardation.  Ann.  paediat.,
  Basel, 1956, 187: 467-470.
----, see Esen, F. M., Durling, D.
Durost, H., see Azima, H., Durost, H.
Dusserre, see Fau, R., Chateau, R., Dusserre.
Dutartre,  see Passouant,   P.,  Pelissier,  Minvielle, J.,
  Dutartre.
Duverney, C. A., see Albert, S. N'., Rea, E. L., Duverney,
  C. A., Shea, J., Fazekas, J. F.


                          E

Eagles, J. B.  Chlorpromazine. Brit. 31. J., 1955,1: 46-47.
Earl, A. E.  A report  on  the tranquilizing effect of reser-
  pine (serpasil).  Internat. J. Anesth., 1954,  1:214-219.
----.  Reserpine  (serpasil) in veterinary  practice.  J.
  Am. Vet M. Ass., 1956, 129: 227-233.  Abstract: Chem.
  Abstr., 1956, 50:15890h.
 ----, see Plummer, A. J., Earl, A., Schneider,  J. A., Tra-
   pold, J., Barrett, W.
----, see Plummer,  A. J., Maxwell, R., Earl, A. E.
203 
Earl, A. E.
PSYCHOPHARMACA
----, see Schneider, J. A., Earl, A. E.
----,  see Schneider, J. A.,  Plummer,  A.  J., Earl,  A.  E.,
  Barrett, W. E., Rinehart, R., Dibble, R. C.
----,  see Schneider, J. A.,  Plummer,  A.  J., Earl,  A.  E.,
  Gaunt, R.
Earle, B. V., see Forbes, H. S., Earle, B. V.
Ebaugh, F. G.  The videclinic.  J. Am. 31. Ass., 1955, 158:
  732-733.
----, see Drake, F. R., Ebaugh, F. G.
Ebtinger, R., see Kammerer, T., Ebtinger, R.
----, see Kammerer, T., Mengus, M., Ebtinger, R.
Ederle, W.  Zur zentralnervosen Wirkung des Serpasil.
   [Effects of  serpasil on the central nervous system.]
  Nervenarzt, 1956, 27 : 33.
Edwalds, R. M.  Experimental studies with PM 1090 ; pre-
  liminary report. Internal Rec M., 1956, 169: 469-472.
  Abstract: Excerpta med., Sect. 8., 1957, 10 : No. 1546.
Eeckhoutte,   R.   van.  Le  chlorhydrate  de  chloro-3-
  dimethylamino-3'-propyl-10-phenothiazine (45(50 R. P.) ;
  son  action  sur  le systeme nerveux et  sur  le systeme
  neur ovegetatif.   [3-Chloro-10- (3-dimethylaminopropyl)
  phenothiazine (4560 R. P.) ; its action  on the nervous
   and autonomic  nervous system.]  28 p.  Ambilly, 1953.
   [Thesis—Geneva 1953, no. 2168.]
 Effron, A. S., see Freedman, A. M., Effron, A. S., Bender, L.
---, see Freedman, A. M., Kremer, M. W., Robertiello, R.,
   Effron, A. S.
----, see Herman, M.. Effron, A. S.
Egan, G. P., .see Gore, C. P., Egan, G. P., Walton, D.
Ehrmantraut, W.  R., see Fazekas, J. F., Shea,  J. G., Ehr-
   mantraut, W. R., Alman, R. W.
---, see Shea, J.  G., Ehrmantraut,  W. R., Ticktin, H. E.,
   Sullivan, P. D., Jr., Fazekas, J. F.
 Eiber, H. B.  Chlorpromazine-Rauwolfia serpentina com-
   bination in the treatment of  essential hypertension:
   preliminary report.  J. Am. 31.  Ass., 1955, 158: 730-731.
----.  Chlorpromazine  (thorazine)-Rauwolfia combina-
   tion in neuropsychiatry; preliminary report.  A. M. A.
   Arch. Neur. Psychiat, 1955, 74:36-39.   Abstract:  Ex-
   cerpta med., Sect. 8, 1956, 9: No. 1218.
 Eisenberg, L., see Kanner, L., Eisenberg, L.
 Elkes, C.  Rauwolfia alkaloids and reserpine in the treat-
   ment  of the chronic psychotic patient.  J. Ment  Sc,
   Lond., 1957, 103:464-474.
 ---, Elkes, J., Mayer-Gross,  W.   Hallucinogenic drugs.
   Lancet, Lond., 1955,1: 719.
 ----, see Bradley, P.  B., Elkes,  C, Elkes, J.
 ---, see Elkes, J., Elkes, C.
 ---, see Elkes, J., Elkes, C, Bradley, P. B.
 Elkes,  J.  Effects of  psychosomimetic drugs  in  animals
   and  man.  In: Abramson,  H. A.,  ed.   Neuropharma-
   cology.  Transactions of the third conference, May 1956,
   Princeton,  X. J.  New York, Josiah Macy, Jr. Founda-
   tion,  1957.   p.  205-295.
 ---, Elkes, C. Effect of chlorpromazine  on the behavior
   of  chronically  overactive psychotic patients.  Brit. M.
   J., 1954, 2:560-565.  Abstract: Excerpta med., Sect. 8,
   1955,  8: No. 1794.
 ---,  ----, Bradley, P.  B.  The  effect of some  drugs on
   the electrical activity  of the brain, and on behaviour.
   J. Ment. Sc, Lond., 1954, 100: 125-128.
 ----, see Bradley, P. B., Elkes, C, Elkes, J.
 ----, see Bradley, P. B., Elkes, J.
 ---,  see Elkes, C, Elkes,  J.,  Mayer-Gross, W.
 Elkjaer, P.,  see  Osterman, E.,  Lassenius,  B., Bohn, L.,
   Elkjaer, P.
 Ellermann, M. Virkningen af covatin  (et nyt dagseda-
   tivum) pa et ambulant  patientmateriale.   [The effect
   of covatin  (a new daytime sedative)  in out-patients.]
   [English summary]  Nord. med., 1955, 54: 1531.  Ab-
   stract : Excerpta med., Sect. 8, 1956, 9 : No. 4568.
 Elliott, R. N., Schrut,  A.  H., Marra, J.  J.  Fatal acute
   aseptic necrosis of the liver associated with chlorpro-
   mazine.  Am. J. Psychiat, 1956, 112: 940.
 Elloso, C, see Charet, R., Brill, B., Elloso, C.  •
Ellsworth, R. B., Clark, L. D.  Prediction of the response
  of chronic schizophrenics  to drug therapy,  a prelimin-
  ary report  on the relationship between palmar sweat
  and the behaviorial effects of tranquilizing drugs.   J.
  Clin. Psychol, 1957,13:59-61.
___t see Clark, L. D., Ellsworth, R. B., Barrett,  W. W.,
  Thurman, A. C, Holland, W.
___ see McDonald, R. E., Ellsworth, R. B., Eniss, J.
Endara, J.  El 'Largactil"  y nuestras  primeras  aplica-
  ciones neuro-psiquiatricas.  ["Largactil", and our first
  use of it in neuro-psychiatry.]  Arch.  crim. neuropsiq.,
  Quito, 1054, 2 : 297-312.  Abstract: Excerpta med., Sect.
  8,1955, 8 : No. 3101.
Ende, M.  Clinical evaluation of atarax; a non-barbitur-
  ate calming agent.  Virginia 31. Month., 1956, 83: 503-
  505
___f Youngblood, W.  The use of myanesin (tolserol)  in
  black widow spider bite.  Virginia 31.  Month., 1953,
  80:24-25.
Endo, K.  Experimental study of mescalin intoxication on
  relation between clinical picture and EEG in man. Fol.
  psychiat. neur. jap.,  1952, 6:104-113.
Engelmeier,  M. P.  Lytische Therapie  in  der Nerven-
  klinik.  [Lytic therapy in neuropsychiatric hospitals.]
  [English summary  p.  148]   3Ischr.  Psychiat,  Basel,
  1956, 131: 89-150.
---.  Methoden kombinierter lytischer Therapie.   [Meth-
  ods of combined lytic therapies.]  Encephale, 1056, 45:
  461-468.
■---.  Die Methodik per psychiatrischen Behandlung mit
  lytischen  Substanzen.  [Methods of  psychiatric ther-
  apy with lytic substances.]  Nervenarzt, 1956, 27: 64-
  69.  Abstract:  Excerpta  med.,  Sect.  8,  1957, 10: No.
  1551.
Eniss, J.,  see McDonald, R.  E., Ellsworth, R.  B., Eniss, J.
Ensor, C. R., see Chen, G., Ensor,  C. R., Bohner, B.
Epstein, J.  Drugs and electroconvulsive therapy.   J. Am.
  31. Ass., 1956, 160 : 503.
Erdelyi, S., see Kulcsar, S., Erdelyi, S.
Erdmann, C.  E.  Neues  fiber die  Rauwolfia-Behandlung
  unter besonderer Berucksichtigung der Literatur in den
  USA.  [Review of Rauwolfia therapy with special refer-
  ence to literature in the United  States of  America.]
  Nervenarzt, 1956, 27 : 75-79.
Erickson, J. L.,  see Sommerness, M. D.,  Lucero,  R.  J.,
  Hamlon, J. S., Erickson,  J. L., Matthews, R.
Ermiglia, G.   Sull'impiego del meprobamato in  gineco-
  logia; primi risultati.  [Use  of meprobamate in gyne-
  cology; initial results.]  Minerva med., Tor., 1956, 47:
  1477-1478.
 Ernst,  K.  Psychopathologische Wirkungen  des  Pheno-
  thiazinderivates  "Largactil"  ("Megaphen") im Selbst-
  versuch und  bei  Kranken.   [Psychopathological  ef-
   fects of the phenothiazine derivative "largactil" ("mega-
   phen")  in  self-experimentation  and  in  patients.]
   Arch.  Psychiat,  Berl, 1954, 102:573-590.  Abstract:
   Excerpta med., Sect. S, 1955, 8 : No. 3520.
 Ervin, F., see Wiedorn, W. S., Ervin, F.
 Erwin, H.  J.  Clinical observations  on the use  of pro-
   methazine   hydrochloride  in   psychiatrie  disorders.
   Am. J.  Psychiat,  1957, 113 : 783-787.
 Erzsebet, B. S., see Simko, A., Erzsebet,  B. S.
 Escalar,  G., Balduzzi, E.  Sull'impiego della cloroproma-
   zina come  terapia  di  antishock.  [Use  of chlorproma-
   zine as antishock therapy.]   Arch, psicol. neur., 3lilano,
   1056, 17 : 655-657.
 ---•, see Balduzzi, E., Escalar, G.
 Escafit, H.,  see Coirault, R., Girard, V., Escafit, H.,  Be-
   noit, P.
 Escourolle,  R.  Traitement  des  etats  deiirants  de Tal-
   coolisme chronique.  [Treatment of  delirious  states in
   chronic alcoholism.]  France mCd., 1954, 17  (6) : 15-19,
 Esen, F. M., Durling, D.  Thorazine in the  treatment of
   mentally retarded  children.  Arch. Pediat, N. Y., 1956,
    73:168-173.
204 
AUTHOR  LIST
Fabing, H. D.
---, see I >urling, D., Essen, F. M., Mautner, H.
Essellier, A. F.,  Goerre,  J.,  Wegmann, A.  Zur  medika-
  mentosen   Behandlung   der  Hypertonie.  Klinische
  Erfahrungen mit  Serpasil,  Serpasil-Ritalin und Ser-
  pasil-Nepresol.   [Drug therapy of hypertension.   Clin-
  ical experiences with serpasil, serpasil-ritalin and ser-
  pasil-nepresol.]  Schivciz.  med.  Wschr., 1955, 85:808-
  811.
Essig,  C. F., Ainslie,  J. D.  Addiction to  meprobamate
  (equanil,  miltown).   J. Am,  31.  Ass.,  1957, 164:1382.
■---, Carter, W. W.  Convulsions and bizarre  behavior in
  monkeys  receiving  chlorpromazine.  Proc.  Soc.  Exp.
  Biol, N. Y., 1957, 95 : 726-729.
An  evaluation of the  newer pharmacologic  agents and
  their  role in current psychiatric practice. Psychiat.
  Res.  Rep., Wash.,  1956 (4) : 1-129.   [Symposium; ar-
  ticles within the scope of  this bibliography are listed
  individually].
Evarts, E. [V.]   Brain effects of LSD in animals.  In:
  Cholden, L„  ed.  Lysergic acid diethylamide and mesca-
  line in experimental psychiatry.   New York, Grune  d
  Stratton. 1956.  p.  55-56.
---.  A  review of  the neurophysiological  effects  of
  lysergic acid diethylamide (LSD) and other psycho-
  tomimetic agents.  Ann. N.  York Acad. Sc, 1957, 66:
  479-495.
.---.   Some effects of bufotenine and lysergic acid diethy-
  lamide on the monkey.  A.  31. A. Arch.  Neur. Psychiat,
  1956,  75:49-53.
■---,  Landau, W.,  Freygang,  W.,  Jr., Marshall, W.  H.
  Some effects of lysergic acid diethylamide  and bufote-
  nine on electrical  activity in the cat's visual system.
  Am. J. Physiol, 1955,182 : 594-598.
---, Marshall, W. H.  The effects of lysergic  acid diethy-
  lamide on the  excitability cycle  of the lateral genicu-
  late.  Tr. Am.  Neur. Ass., 1955, 80th  Meeting:  58-60.
---, see Kornetsky, C, Humphries, O., Evarts, E. V.
Everett, G.  M., Toman, J. E.  P., Smith, A. H.,  Jr.  Reduc-
  tion  of electroshock seizure latency and other central
  actions of reserpine.   [Abstract]   Fed. Proc,  Bait.,
  1955,14 : 337.
Evrard, A., Vandierendonck, R.  Over het chloropromazine
  bij de manisch-depressieve en schizophrene psychosen.
  [Chlorpromazine in manic-depressive and schizophrenic
  phychoses.]  Belg. tschr. geneesk,, 1955, 11:401-409.
---, ----.  Een terugblik  op 100 met chloropromazine
  behandelde gevallen.   [100 Cases treated with chlorpro-
  mazine.]  Belg. tschr. geneesk., 1957, 13:43-47.
Ewing, J. A., Mendenhall, J. H.  Clinical evaluation of the
  effect of mephenesin on anxiety.  J. Ment. Sc,  Lond.,
  1953,  99: 464-472.
---, see Mendenhall, J. H., Ewing, J. A.
Expert committee on addiction-producing drugs.  Seventh
  report.  World Health Org. Techn. Rep. Ser., 1957 (116) :
  1-15.
Ey, H.,  Berard, E.  Les nouvelles techniques de cure de
  sommeil dans  la pratique psychiatrique.  [New tech-
  nics of sleep therapy in phychiatric practice.]   Evolut.
  psychiat,  1952: 661-682.
---.  Sobre una tecnica  de  tratamiento  por el  sueno
  prolongado interrumpido.   [Method of intermittent and
  prolonged sleep therapy.]  Dia med., B. Air., 1954, 26:
  1385-1389.
___ Deschamps, A., Berard, E.  Les techniques de cures
  de' sommeil  a  l'aide  de neuropiegiques et l'hibernation
  artificielle en  psychiatrie.   [The  technics  of  sleep
  therapv with neuroplegics and artificial hibernation in
  psychiatry ]   In : Laborit, H., Huguenard, P. Pratique
  de Thibernotherapie  en chirurgie et en  medecine.  [The
  use  of hibernotherapy in surgery  and  in medicine.]
  Paris, Masson,  1954.   p. 181-203.
___ Faure H   Les  diverses  methodes d'emploi  de la
  ehlorDromazine en therapeutique psychiatrique et leurs
  indications   [The various methods of chlorpromazine
 therapies and their indications in psychiatric therapy.]
 Encephale, 195(3, 45 : 361-371.
—,----.  Sleep therapy and the use of chlorpromazine.
 Internat. Rec. 31., 1957, 170: 1-10.
—,----, Lairy, G. C.  Action du largactil sur Telectro-
 encephalogramme de malades mentaux chroniques com-
 paree a Taction  des  barbituriques.   [Comparison  be-
 tween the effects of largactil and barbiturates on  the
 EEG of chronic mental patients.]   Encephale, 1956,  45 :
 843-852.
—, ----,  Rappard, P.  Les reactions d'intoierance  vis-
 a-vis de la chlorpromazine.  [Chlorpromazine intoler-
 ance.]  Encephale, 1056, 45:700-796.
—, Sakellaropoulos, P.  L'etat primordial du deiire et
 Taction therapeutique de la chlorpromazine.   [The  pri-
 mary delusional  state and the therapeutic  action of
 chlorpromazine.]   Evolut, psychiat, 105<i:  489-497.
Fabing, H. D.  Adventures in clinical neuropharmacology.
  Internat. Rec. 31., 1956, 169 : 115-119.
---.   Alpha-(2-piperidyl)  benzhydrol  hydrochloride,  a
  new central stimulant, in the treatment of blepharo-
  spasm, spasmodic  torticollis and narcolepsy;  prelimi-
  nary  report.  Tr. Am. Neur. Ass., 1954, 79th Meeting:
  159-163.
----.   The ataractic drugs: their uses and limitations in
  psychiatry.  Am. Profes. Pharmacist, 1956, 22: 413-418.
---.   Clinical experience with meratran:  a new central
  nervous system  stimulant.  Dis. Nerv. Syst., 1955, 16:
  10-15.
---.   Designation of "tranquilizing agents"  in neuro-
  pharmacology.  J.  Am. 31. Ass., 1955, 158 :1461.  Also :
  Am. J. Psychiat, 1055. 112:302.
---.  The  dimensions of neurology.  Neurology,  1955, 5:
  603-611.  Abstract: Excerpta med., Sect.  8, 1956, 9: No.
  1718.
---.   Experiencia  clinica  con  meratran;  un   nuevo
  estimulante nervioso central.  [Clinical experience with
  meratran;  a  new  central nervous  system stimulant.]
  Rev. med. cubana,  1055, 66: 923-931.
---.  Experimental compound METV17 (frenquel) : anew
  blocking  agent  against  the development of  LSD-25
  psychosis.  Tr.  Am.  Neur.  Ass., 1955, 80th Meeting:
  83-85. Also:  Psychiat.  Res. Rep.,  Wash., 1055  (1):
  140-144.  Abstract: Excerpta med., Sect. 8, 1957, 10 : No.
  1527.
---.  Experimental psychoses which mimic schizophrenia.
  Nebraska 31. J., 1956, 41: 455^59.
---.   Frenquel, a blocking agent  against experimental
  LSD-25 and mescaline psychosis; preliminary note on
  its  clinical application. Neurology, 1955, 5 : 319-328.
---.   New blocking agent against the development of
  LSD-25 psychosis.  Science, 1955,121: 208-210.
---.  The newer analeptic drugs.  Med. Clin, N. America,
  1957, 41:  339-351.
---.  The  new  pharmacologic attack  in  psychiatry.
  Internat.  Rec.  31.,  1956, 169:177-183.   Also:  Drugs
  d Cosmet. Indust, 1956, 78: 32-33 ; 125-129.
---.   On going berserk: a  neuro-chemical inquiry.  Am.
  J. Psychiat., 1956,113 : 409-415.
---.  Trends in biological research in  schizophrenia.  J.
  Nerv. 31 ent Dis., 1956,124:1-7.
---,  Hawkins, J. R.  Intravenous bufotenine injection in
  the human being. Science, 1956,123 : 886-887.
---,----.   A year's experience with frenquel in clinical
  and experimental  schizophrenic psychoses.   Dis. Nerv.
  Syst, 1955, 16 : 329-338. Abstract: Excerpta med., Sect.
  8,1956, 9 : No. 4540.
----, ----, Moulton, J. A.   Clinical studies on «-(2-
  piperidyl)  benzhydrol  hydrochloride,  a  new  anti-
  depressant drug.  Am, J. Psychiat, 1955, 111: 832-836.
205 
Fabing, H. D.
PSYCHOPHARMACA
----. Kropa, E. L, Hawkins, J. R., Leake, C. D.  Bufotenine
  effects in humans.  [Abstract]  Fed. Proc, Bait., 1956,
  15: 421.
Fabisch, W. Chlorpromazine and epilepsy.  Lancet, Lond.,
  1955,  1: 1277.
Fabricant,  N. D.  Tension headache therapeutics.  Eye,
  Ear dc 31onth., 1956,35 : 658; 662.
Fabris,  F.   A propos du  traitement  de la  douleur des
  cancereux.  [Contribution  to  the treatment of pain in
  cancer patients.]  Presse me'd., 1955, 63 : 727.
Fadiga, E.,  see Balestrieri, A., Fadiga, E.
----, see Hyvert, M., Fagard, H., Huchon, J.
Falcon,  M.  Quelques observations cliniques sur Temploi
  de la  chlorpromazine.  [Clinical  observations on the use
  of chlorpromazine.]  Ence'phale, 1956, 45: 587-591.
Falicki, Z., Galuszko,  P., Jaworska, I., Kielak,  L., Sule-
  strowski,   W.  Proba  oceny   wartosci   leczniczej
  largaktylu na podstawie dotychczasowych  spostrzezen
  w  klinice  chor6b  psychicznych A. M.  w  Gdansku.
   [Evaluation of largactil therapy from observations at
   the clinic for  mental diseases of the Academy of Medi-
   cine in Gdansk.]  [English summary p. 320.]   Neur. d
   polska, 1956, 6: 313-320.
Fancher, O. E.,  see Pindell,  M. H., Fancher,  O. E., Lim,
  R. K.  S.
Fang, A. D., see Katzenelbogen, S., Fang, A. D.
Fanning, R., see Smith, J. A., Rutherford, A.,  Fanning, R.
Farah,  L.  Preliminary study on the use of hydroxyzine
  in psychosomatic affections.   Internat. Rec.  M.,  1956,
  169:379-389.  Abstract: Excerpta  med., Sect. 8,  1957,
  10: No. 845.
Farber, I.  J.  Drug fatalities.  Am.  J. Psychiat.,  1957,
  114:371-372.
Farley,  O. R,  Complications  and  concomitants.   Med.
  Ann.  District  of Columbia, 1956, 25: 263-267.
---, see Overholser, W., Waldrop,  F. N., Riesenman, F. R.,
   Fong, T. C. C, Farley, O.  R.,  Hoffman, J.  L.
Fasanaro,  F., Ventra,  D. Un  nuovo farmaco  tranquil-
  lizzante: il  meprobamato;  esperienze cliniche.  [A new
   tranquilizing drug: mepromabate: clinical experience.]
  Mmerva med., Tor., 1956, 47 : 2169-2175.
Fau,  R., Chateau,  R.  La cure de  sommeil et  la chlorpro-
  mazine.   [Sleep therapy  and  chlorpromazine.]   En-
   cephale,  1956, 45:428-435.
----, ----, Dusserre.  Traitement des psychoses aigues
   et  subaigues  par  les neuropiegiques.  [Treatment of
   acute and subacute psychoses with neuroplegic drugs.]
   [Abstract]  J. me'd. Lyon, 1954,35 : 948.
Faucett, R. L.  Drug addiction and other considerations
  in the management of pain with narcotic drugs. Proc
  Mayo Clin., 1957,32: 45-54.
---, Litin, E. M., Achor, R. W. P.  Neuropharmacologic
   action of Rauwolfia compounds and its psychodynamic
   implications.  A. M.  A. Arch.  Neur. Psychiat,  1957,
   77:513-518.
----, see Litin,  E. M., Faucett, R. L.,  Achor,  R. W. P.
Faure, H., see Ey, H., Faure, H.
----, see Ey, H.,  Faure, H., Lairy, G. C.
----, see Ey, H.,  Faure, H., Rappard, P.
Faure,  J. L.,  Abric, J.  Remarques cliniques sur les in-
   dications valables de la chlorpromazine et  de la reser-
   pine  en  neuro-psychiatrie  infantile.  [Clinical remarks
   on  the indications  for the use  of  chlorpromazine and
   reserpine in child neuro-psychiatry.]   Pe'diatrie,  1956,
   11: 773-776.
----, see Lafon, R., Faure, J. L., Abric, J.
Fava, D., see Benassi, P., Fava, D.
Fazekas, J. F., Albert,  S. N., Alman, R. W.  Influence of
   chlorpromazine  and alcohol on  cerebral hemodynamics
   and  metabolism.  Am.  J. M. Sc,  1955, 230:128-132.
  Abstract: Excerpta med., Sect. 8, 1956, 9: No. 2934.
----, Schultz, J. D., Sullivan, P. D., Shea, J. G.  Manage-
  ment of acutely  disturbed  patients  with promazine
   (sparine).  J.  Am.  M. Ass.,  1956,  161:46-49.  Con-
   densed :  Am. Practitioner,  1956, 7 :1807.
---, Shea, J. G., Ehrmantraut, W. R., Alman, R. W.  Con-
  vulsant action of phenothiazine derivatives.  J. Am. M.
  Ass., 1957,165 :1241-1245.
--------Rea, E.  Use of chlorpromazine in the  man-
  agement of acute and postalcoholic states. Internat. Rec
  31.,  1955, 168: 333-339.  Abstract: Excerpta med., Sect.
  8, 1956, 9 : No. 420.                    .
________Sullivan, P. D., Jr.  Ataractics in medical prac-
  tice.  GP, 1956, 14 (6) : 75-81.
___,  Sullivan, P. D., Schultz, J. D.   Use of dimethyl-
  amino-n-propylphenothiazine in  the management  of
  patients  with acute mental  disturbances.  Med.  Ann.
  District of Columbia, 1956, 25 : 67-69.
---, Toupin, H., Alman, R. W. Physiologic and pharma-
  cologic basis for the chemotherapy of psychiatric states.
  Am. J. Med., 1956, 21: 825-831.
---, see Albert, S. N., Rea, E. L., Duverney, C. A., Shea,
  J., Fazekas, J. F.
----, see Rea, E. L., Fazekas, J. F.
---, see Rea, E. L.,  Shea,  J., Fazekas, J. F.
---, see Schultz, J.  D., Rea, E. L., Fazekas, J. F., Shea,
  J.G.
---,  see Shea, J.  G., Alman, R. W., Fazekas, J. F.
---, see Shea, J. G.,  Ehrmantraut, W. R.,  Ticktin, H.  E.,
  Sullivan, P. D., Jr.,  Fazekas, J. F.
Fazio, C.  Risultati  e  considerazioni sull'impiego  della
  reserpina nel trattamento delle psicosi.   [Results and
  considerations on the use of reserpine in the treatment
  of psychoses.]   Arch, psicol. neur., Milano, 1956, 17:
  313-315.
Feinblatt, H. M., see Feinblatt, T. M., Feinblatt, H. M.,
  Ferguson, E. A., Jr.
Feinblatt,  T. M., Feinblatt, H. M., Ferguson, E. A.,  Jr.
  Rauwolfia-ephedrine as a hypotensive-tranquilizer.  J.
  Am.  M. Ass.,  1956, 161:424-^26.   Abstract: Chem.
  Abstr., 1956, 50:14098L
Feldberg, T. M., see Meath, J. A., Feldberg, T.  M., Rosen-
  thal, D., Frank, J. D.
Feldberg, W., Sherwood,  S. L.  Injections of  drugs into
  the lateral  ventricle of the cat.   J. Physiol, Lond.,
  1954,  123:148-167.
---,  ----. Intraventricular  injections of acetylcholine
  and of  5-hydroxytryptamine (serotonin) into the con-
  scious cat. J. Physiol,  Lond., 1953,  120:12P.
Feldman,  D.  J.   Drug therapy  of  chronic alcoholism.
  Med.  Clin. N. America, 1957, 41: 381-392.
---.   The treatment of chronic  alcoholism: a survey of
  current methods.   Ann. Int. 31., 1956, 44: 78-87.
---,  Zucker, H. D.   Present-day medical management of
  alcoholism.   J. Am. M. Ass., 1953, 153: 895-901.
Feldman, P. E.   Clinical  evaluation  of  chlorpromazine
  therapy for  mental  illnesses;  analysis  of  one year's
  experience.  J.  Clin. Exp. Psychopath.,  1957, 18:1-26.
---.   Clinical evaluation of  pacatal.  Am. J. Psychiat,
  1957, 114:143-146.
---.   A  comparative study of various ataractic drugs.
  Am. J. Psychiat., 1957, 113: 589-594.
----.   The personal  element in psychiatric research.
  Am. J. Psychiat, 1956,113 : 52-54.
---.   Two-year fate study of thorazine-treated patients.
  Am. J. Psychiat., 1957,114: 237-240.
----.  An unusual   death  associated with  tranquilizer
  therapy,  ["with   a  phenothiazine  drug"]  Am.  J.
  Psychiat., 1957, 113 :1032-1033.
----,   Bertone, J.,  Panthel,   H.   Fatal   agranulocytosis
  during treatment with pacatal.   Am. J.  Psychiat., 1957,
  113: 842-843.
----, Lacy, B. S., Walker, A. E., Garrez, N. J. A con-
  trolled, blind study of effects of thorazine on psychotic
  behavior.  Bull Merminger  Clin., 1956,  20:25-47.  Ab-
  stract: Excerpta med., Sect. 8,  1956, 9:   No. 4560.
----,  Statman,  J.   Agranulocytosis  during  treatment
  with methylpromazine.   Am. J. Psychiat, 1957, 114:
  464-465.
206 
AUTHOR  LIST
Floris, V.
 Feldman, R. G., see Brown, B. B., Braun, D. L., Feldman,
  R. G.
 ---, see Brown, B. B., Feldman, R., Braun, D. L.
 Felisati, D.,  Fregni,  R.  Effets de  la mianesina  sur
  differents  types  de  nystagmus; enregistrement par la
  methode eiectrographique.  [Effects of myanesin on dif-
  ferent  types   of nystagmus,  electroencephalographic
  study.]   Ann. otolar., Par., 1953, 70: 508-516.
 Fenichel, M., see Cares, R. M., Asrican, E., Fenichel, M.,
  Sack, P., Severing, J.
 Fennelly, J. J.,  see McGrath, S. D., Ryan,  J.  P., Fen-
  nelly, J. J.
 Ferguson, E. A., Jr., see Feinblatt, T. M., Feinblatt, H. M.,
  Ferguson, E. A., Jr.
 Ferguson, J. T.  Azacyclonol: use of a new pharmacologic
  agent in  chronic schizophrenia.  Antibiotic M., 1956,
  3:146-150.
 ---.  Comparison of  reserpine and harmonyl in psychi-
  atric patients; a preliminary report.  J. Lancet, 1956,
  76:389-390.
 .---■.  Further  evaluation  of  the  new drug: methyl-
  phenidylacetate.   [Abstract]  J.  Pharm. Exp.  Ther.,
  1956,116: 20.
 ---.  Improved behavior patterns  in the hospitalized
  mentally ill with reserpine and methyl-phenidylacetate.
  Psychiat. Res.  Rep.,  Wash.,  1956 (4)  : 35-43.
 ---.  A new therapeutic approach to abnormal behavior
  in geriatrics.  Geriatrics, 1956, 11: 217-219.
 ---.  Successful therapeutic  regimen  for the  manage-
  ment of behavior problems in the elderly. J. Am. Geriat.
  Soc, 1956,4:1080-1084.
 ---.  Treatment of reserpine-induced  depression with a
  new analeptic: phenidylate.  Ann. N. York Acad. Sc,
  1955, 61:101-107.  Abstract:  Excerpta med., Sect.  8,
  1956,9: No. 1721.
 ---.  What's new and usable in the chemical treatment
  of abnormal behavior.  J. Michigan  M.  Soc, 1956, 55:
  1095-1101.
 ---, Funderburk, W. H.  Improving senile behavior with
  reserpine and ritalin; new approach with use of methyl
  phenylpiperidylacetate. J. Am. M. Ass., 1956, 160: 259-
  263. Abstract: Excerpta med., Sect. 8,1956, 9 : No. 3520.
  Year book of  drug therapy,  1956-1957, p. 344-346.
 ---, Linn, F. V.  A new compound for the symptomatic
  treatment  of tension and anxiety: 2-ethylcrotonylurea
  (nostyn).  Antibiotic M., 1956, 3:329-333.
 ---,----, Sheets, J. A., Jr., Nickels, M. M.  Methylpheni-
  date  (ritalin)  hydrochloride parenteral solution;  pre-
  liminary report.  J.  Am. M. Ass., 1956, 162:1303-1304.
 Ferguson,  M. W.,  see Abramson, H. A.,  Kornetsky,  C,
  Jarvik, M. E., Kaufman, M.  R., Ferguson, M. W.
 Ferguson, R. S.   A clinical trial of reserpine in the treat-
  ment of anxiety. J. Ment. Sc, Lond., 1956,  102: 30-42.
  Abstract: Excerpta med., Sect. 8, 1957, 10: No. 1534.
 ---.   Influences of reserpine on E. C. T.: preliminary
  observations.   J. 3Ient. Sc, Lond.,  1956, 102: 826-829.
 Fernandes,  B.  Clorpromazina,  reserpina e  a chamada
  "farmacopsiquiatria".   [Chlorpromazine and reserpine
  at the colloquium on "pharmacopsychiatry".]   [Paris,
  October 1955]  J. me'd., Porto, 1956,  29: 237-243.
 ___   Effets  psycho-somatiques  de  la  chlorpromazine.
  [Psychosomatic effects of chlorpromazine.]   Ence'phale,
  1956, 45:328-333.
 ___ Leitao  G.  Incidents and accidents in chlorproma-
  zine therapy-   J- Clin- Exp-  PsVch°Path" 1956» 17: 70~
  76.
 Fernandes da Fonseca, A., see West, E. D., Fernandes da
  Fonseca, A.
 Fernando, L,, see Pires, N., Pinho, R.  de, Fernando,  L.,
  Pint M., Cavalcanti, U, Aguiar, H.
Ferrar'a R J Pinkus, H.  Alseroxylon in the treatment
  of pruritic and psychogenic dermatoses.  A. M. A. Arch.
Derm., 1955, 72 : 23-28.
Ferrari, D.  II meprobamato in psichiatria; osservazioni
  cliniche.   [Meprobamate in  psychiatry; clinical  ob-
  servations.]   Minerva med.,  Tor., 1956, 47:1458-1462.
Ferreira, L. R., see Garcia, J. A., Ferreira, L.  R.
Ferrer, S., see Gastaut, H., Ferrer, S., Castells, C, Lesevre,
  N., Luschnat, K.
Ferro Milone,  F., Gomirato, G.  Observations  experimen-
  tales sur le  comportement de Tactivite corticale spon-
  tanee et  evoquee  sous  Taction  des  neuroleptiques.
  [Changes  in  spontaneous and evoked  cortical  activity
  under the influence of neuroleptic drugs; experimental
  results.]   Ence'phale, 1956, 45:853-857.
Feuss, C. D., Gragg, L., Jr.  Quiactin: an adjunct in the
  treatment of chronic psychoses.  Dis. Nerv. Syst, 1957,
  18:29-33.
Fielding, J. W.,  see Bosworth, D. M., Fielding,  J.  W.,
  Acosta, M. G.
Fierman, L. B., see Rosner,  B.  S., Fierman, L. B., Kra-
  mer, J. F.
Figurelli, F. A.  The promazine treatment of alcoholism;
  a preliminary report.  Indust. M. d S., 1956, 25:376-
  380.
Fina, G., see Delia Pietra, V., Fina, G.
Finch, J.  W.  Experience  with Rauwolfia. Mod. Med.,
  1954, 22 (9) : 22-23.
Fingl, E., see Swinyard, E. A., Chin, L., Fingl, E.
Finke, H.   Beitrag zur Reserpine-Therapie in  de Psychi-
  atrie.  [Contribution to  reserpine therapy  in psychi-
  atry.]  [English  summary]  Munch,   med.   Wschr.,
  1956, 98: 872-874.
Finn, M. H., Nadolski, F.,  Guy, W., Gross,  M.  Clinical,
  psychological and myoneural  changes  in psychotic pa-
  tients under  oral serpasil  medication.   J. Nerv. Ment.
  Dis.,  1955,  122:458-462.  Abstract:  Excerpta  med.,
  Sect. 8, 1957, 10: No. 370.
Finney, R.  C, see Cowden, R. C,  Zax, M., Finney, R. C.
----,  see Cowden, R.  C, Zax, M., Hague, J. R.,  Finney,
  R. C.
Finney, R. M., see Moyer, J. H., Kinross-Wright,  V., Fin-
  ney, R. M.
Fiore,  C.  Risultati terapeutici dell'associazione neuro-
  ganglioplegici-barbiturici ed elettrochock in  alcune ma-
  lattie mentali.  [Therapeutic results of combined neu-
  roganglioplegics, barbiturates and electroshock  in some
  mental diseases.]  Rass. neuropsichiat, 1955, 9: 85-98.
Fischer, A., see Margolis, L. H., Fischer, A., Butler, R. N.,
  Simon, A.
Fischer,  E.  Reserpine  (serpasil)  in mental  deficiency
  practice.   J. Ment Sc, Lond., 1956, 102 : 542-545.
Fischer,  H. K., Dlin,  B. M.  The dynamics  of  placebo
  therapy; a clinical  study.  Am. J. M. Sc,  1956, 232:
  504-512.
Fish,  M. S., Horning, E. C.  Studies on hallucinogenic
  snuffs.  J. Nerv.  Ment Dis.,  1956, 124: 33-37.
Fishbein,  M.  The tranquilizing  drugs.  Postgrad.  M.,
  1956, 19:509-511.
Flach, F. F. Clinical  effectiveness of reserpine.  Ann. N.
  York Acad. Sc, 1955, 61:161-166.  Abstract: Excerpta
  med., Sect. 8,1956, 9: No. 3084.
Flaherty, J. A.  Effect of chlorpromazine medication on
  children  with  severe emotional  disturbances.  Dele-
  ware M. J., 1955, 27:180-184.
Flamm, G. H., see Dickes, R., Flamm, G. H., Coltrera, J.,
  Tobin, M.
Flataker, L., see Winter, C. A., Flataker, L.
Fleming, A. M., see Malamud,  W., Barton,  W. E., Flem-
  ing, A. M., Middleton, P.  McK., Friedman, T. T.f Schlei-
  fer, M. J.
Flordh, P., see Berglund, M., Blumenthal, B., Flordh, P.
Florentin, M., see Donnadieu, A., Florentin, M., Florentin.
---, see Rigal, J., Malet, P., Florentin, M.
Floris, V.   L'impiego della Rauwolfia serpentina in neuro-
  psichiatria.   [Use of  Rauwolfia serpentina in neuro-
  psychiatry.]  Minerva med., Tor., 1956, 47 :  944-945.
207 
Floris, V.
PSYCHOPHARMACA
---,  Rambelli, L.  L'impiego  del  2-metil-2-n-propil-l,3-
  propandiolo  dicarbamato in  psichiatria.   [Use of  2-
  methyl-2-n-propyl-l,3-propanediol  dicarbamate in  psy-
  chiatry.]  3Iinerva med., Tor., 1956, 47 : 1455-1457.
Fliigel, F.  Erfahrungen mit Megaphen in der psychiatri-
  schen  und neurologischen Klinik.  [Experiences with
  chlorpromazine  in  the  psychiatric  and  neurological
  clinic]  Arch. klin. Chir., 1954, 279: 7U7-772.
---.   Neue  klinische Beobachtungen zur Wirkung des
  Phenothiazinkorpers Megaphen auf psychische Krank-
  heitsbilder.  [New clinical observations  on the effect  of
  the phenothiazine derivative megaphen on  the  symp-
  toms of mental disorders.]  3Ied. Klin., Berl, 1953, 48:
  1027-1029.   Abstract:  Excerpta med., Sect. 8, 1954,  7:
  No. 1609.
---•.   Neuro-psychiatrische Erfahrungen  fiber die Wir-
  kung  des  Rauwolfia-Alkaloides Reserpin  (Serpasil).
  [Neuropsychiatric experience  with the effects of the
  Rauwolfia  alkaloid  reserpine (serpasil).]   3Ied. Klin.,
  Berl, 1955, 50: 509-510.
---.   Therapeutique  par medication neuroleptique ob-
  tenue  en realisant systematiquement des etats parkin-
  soniformes.  [Therapeutic results obtained with neuro-
  leptic  drugs  by the systematic provocation  of parkin-
  sonism.]  Ence'phale, 1956, 45 :1090-1092.
---.   Uber  medikamentos  erzeugte parkinsonahnliche
  Zustandsbilder.   [Drug-induced parkinsonism.]   Med.
  Klin., Berl, 1955, 50: 634-635.
---,  Bente,  D.  Das  akinetisch-abulische Syndrom  und
  seine  Bedeutung  ffir  die  pharmakologisch-psychiatri-
  sche  Forschung.  [Akinetic-abulic syndrome and  its
  importance in psychopharmacologic research.]  Deut.
  med. Wschr., 1956, 81: 2071-2074.
Foldes, J., see Policzer, M., Szekely, A., Foldes, J.
Fogel, E. J.  Physiological studies after continuous ser-
  pasil therapy over 18  months.  Dis. Nerv.  Syst., 1956,
  17: 322-323.
Folkson, A., May, A. R.  Use of reserpine  and Rauwolfia
  in  psychoneuroses.  Brit.  31. J.,  1955, 2:1121-1122.
  Abstract: Excerpta  med, Sect. 8,  1956, 9:  No. 2658.
——,  see Garmany,  G., May, A. R.,  Folkson, A.
Follin, S.,  Sigg, B., Pivet, S., Girard, C.  Essais d'une
  nouvelle drogue tranquillisante.  [Clinical study of a
  new tranquilizer.]  [Meprobamate]  Ann.  me'd.  psy-
  chol, Par., 1956, 114 (1) : 825-830.
---,  Soubrier,  P.  Recidives de Tonirisme sous Taction
  de  la  chlorpromazine.  [Recurrent  oneirism during
  treatment  with  chlorpromazine.]   Ann. med.  psychol,
  Par., 1054.  112 (2) : 218-222.
---,  ----.  Sur Tutilisation d'une substance neuroplegi-
  que  dans un service de psychiatrie.   [The  use of a
  neuroplegic drug  in a  psychiatric hospital  service.]
  [Abstract]   Ann. med. psychol, Par., 1953, 111  (2) : 403.
----.   Discussion to:  Delay, J., Deniker,  P., Harl, J. M.
  Ann. me'd. psychol, Par., 1952, 110 (2) : 126-127.
Foncin, J. F., see Beley, A., Foncin, J. F., Leyrie, J.
Fong, T. C.  Chlorpromazine and reserpine in  geriatric
  patients.  Med.  Ann. District of Columbia,  1956, 25:
  260-263.
----, see Overholser, W., Waldrop, F. N., Riesenman, F. R.,
  Fong, T. C. C, Farley, O. R., Hoffman, J.  L.
Foote, E. S.  Reserpine in treatment of chronic psychot-
  ics ;  preliminary observations.  Brit. 31.  J.,  1955,  1:
  1192-1193.  Abstract: Excerpta med.,  Sect. 8, 1956, 9:
  No. 4993.
Forbes, H. S., Earle,  B. V.  Benactyzine in psychoneurosis.
  Brit. 31. J., 1057. 1:226.
Ford, F.  R., see Bennett, A. E., Ford, F. R., Turk, R. E.
Ford, H., Jameson, G.  K.  Chlorpromazine in conjunction
  with other psychiatric therapies: a clinical appraisal.
  Dis. Nerv. Syst, 1955, 16:179-185.
----, see Mitis, Z. K., Ford, H.
Forrer, G.  R.  Thorazine in the treatment of acutely dis-
  turbed psychotic patients.  J.  3Iichigan M. Soc, 1956,
  55:  825-827.
Forsberg, I. A., see Fromm, G. H., Forsberg, I. A.
Forster, W., Henderson, A. L.  A clinical study of frenquel
  (alpha   [4-piperidyl]  benzhydrol   hydrochloride)   in
  chronic schizophrenia.  Canad. 31. Ass. -/., 1957, <0:97-

---,  Henderson, L.,  Schultz, S.  The clinical  effects  of
  alpha-(2-piperidyl)-benzhydrol  hydrochloride  (mera-
  tran)  in states  of inactivity  in  elderly psychiatric
  patients.  Canad. 31. Ass.  J., 1955,  72:678-681.  Ab-
  stract : Digest Neurol. Psychiat, 1955, 23 : 278.  Excerpta
  med., Sect. 8,1956, 9 : No. 2227.
---,  Schlichther,  W.,  Henderson, A. L.  Reserpine  in
  chronic psychoses.  Canad. 31. Ass. J., 1955, 73 : 951-955.
  Abstract: Excerpta med., Sect. 8,1956, 9: No. 4551.
Forzy, G, see Sivadon, P., Forzy, C.
Foster, M. W., Jr., Gayle, R. F., III.  Chlorpromazine and
  reserpine as adjuncts in electroshock treatment. South.
  M. J., 1956, 49: 731-735.
---,  Gayle,  R. F., Jr.  Dangers in combining reserpine
  (serpasil)  with electroconvulsive therapy. J. Am. 31.
  Ass., 1955, 159: 1520-1522.   Abstract: Excerpta  med.,
  Sect. 8, 1956, 9: No. 4067.  Year book of  drug therapy,
  1956-1957, p. 325-326.
Foster, T. L., see Wright, W. T., Jr., Pokorny, C, Foster,
  T. L.
Fouks, [L.],  Laine, Francois, Pagot.   La correction des
  effets secondaires des medications dites neuroleptiques.
  [Correction of  the secondary effects  of so-called neuro-
  leptic drugs.]   Ann. med. psychol, Par., 1956, 114 (1) :
  615-620.
---,---,----,----.   Note sur les medications recentes
  des etats nevrotiques anxieux  et depressifs.  [Note on
  recent  medications for anxious and  depressive neurotic
  states.] Ann. med. psychol, Par., 1956,114 (1) : 608-615.
---,----,----,----.  Note sur Tutilisation  en psychiatrie
  d'un nouveau neuroleptique.  [Note on the use of a new
  neuroleptic  drug in psychiatry.]  Ann. med. psychol,
  Par., 1956, 114(1) : 605-608.
---,---, Grimaud, Dariotis.  La fin des therapeutiques
  de choc et Tavenement de nouvelles therapeutiques psy-
  chiatriques actives; la reserpine (serpasil).  [The end
  of shock therapies and the advent of  the new psychiatric
  therapeutics; reserpine  (serpasil).]  Ann. med. psychol,
  Par., 1954, 112  (2) : 764-768.
---,  ----, Pagaud.  Indications et modalites d'adminis-
  tration des neuroleptiques classiques.  [Indications and
  methods of administration  of  the  classic neuroleptic
  drugs.]  Ann. med. psychol, Par.. 1056.114 (2) : 880-886.
Fourcand, J.  In: Turner, W. J., Merlis, S.,  Carl, A.  Con-
  cerning theories of indoles in schizophrenigenesis.  Am.
  J. Psychiat, 1955,112 : 466-467.
Fourment, J., see Abeiy, P., Abdouchelli, A., Fourment,  J.,
  Schmitz, B., Delteil, P.
Fournel, J., see Courvoisier,  S., Fournel, J., Ducrot, R.,
  Kolsky, M., Koetschet, P.
Fourny, L., see Gayral, L., Herve, Y., Carrie, J., Fourny, L.
----, see Gayral,  L., Herve, Y., Fourny, L., Carrie, J.
Fox, V. The management of acute alcoholism : experiences
  with an additional series of 61 cases.  Am. Practitioner,
  1956, 7:1461-1464.
---.   Treatment of withdrawal symptoms in the manage-
  ment of alcoholism.  J. 31. Ass. Georgia, 1956, 45:139-
  142.
Fox, W.  W., see McPheeters, H., Fox,  W. AV.
Fragoso  Mendes, J. Nota previa sobre o emprego do L. S.
  D.  25  na produgao de psicoses experimentais.   [Pre-
  liminary note on the use of LSD-25  in the production of
  experimental  psychoses.]   31 ed. contemp., Lisb., 1956,
  74: 565-570.
Frain, M. K.  Promazine treatment of chronic psychoses
  in 100 hospitalized patients.  J. Nerv. Ment Dis  1957
  125 : 529-533.
Franco, N., see Turner, M., Berard, E., Turner N  Franco
  N.
208 
AUTHOR LIST
Fries, P. E.
Franco Hernandez, M.,  see  Delgado  Roig,  J., Franco
  Hernandez, M.
Francois, see Fouks, Laine, Frangois, Pagot.
Frank, D. E. Practical significance and treatment of anx-
  iety.  31 ed. Times, Great Neck, 1956, 84 : 024-928.
Frank, J. D., see Hampson, J. L.,  Rosenthal, D., Frank,
  J. D.
---■,  see Meath, J. A.,  Feldberg,  T.  M., Rosenthal, D.,
  Frank, J. D.
---, see Rosenthal, D., Frank, J. D.
Frank, T., see Hunt, B. R.,  Frank, T., Krush, T.  P.
Frankl, V.  E.  Zur Behandlung der Angst.   [Therapy of
  anxiety.]  Wien. med. Wschr., 1952, 102 : 535-537.  Ab-
  stract: Excerpta med,, Sect. 8, 1953, 6: No. 408.
Fraser, H.  F., Isbell, H.  Chlorpromazine and reserpine.
  A Effects of each and  of combinations of each with
  morphine.  B. Failure  of each  in treatment of absti-
  nence from morphine.   .4. 31. A. Arch. Neur. Psychiat.,
  1956, 76: 257-262.
 .---,  see Isbell, H.,  Belleville, R. E., Fraser,  H.  F., Wik-
  ler, A., Logan, C. R.
 .---,  see Isbell, H., Fraser, H.  F.  Wikler, A., Belleville,
  R. E.
Frederickson,  W.  K.,  see  Winter,  W. D., Frederickson,
  W. K.
Frederking, W.  Intoxicant drugs  (mescaline and lyser-
  gic  acid  diethylamide)  in  psychotherapy.  J.  Nerv.
  3Icnt.  Dis.,  1955,  121:262-266.  Abstract:  Excerpta
  med., Sect. 8, 1956, 9: No. 4084.
---.   Uber die Verwendung von  Rauschdrogen  (Meska-
  lin  und Lysergsaurediaethylamid)  in der Psychothera-
  pie.   [The use  of intoxicating  drugs  (mescaline and
  lysergic acid diethylamide) in psychotherapy.]  [Eng-
  lish  summary]   Psyche,  Stuttg., 1953, 7:342-364.
Freed, H.   Chlorpromazine and reserpine;  new era in
  psychiatry?  Am.  Practitioner, 1955, 6: 706-708.
---,  Peifer, C. A.  Some  considerations on the use of
  chlorpromazine  in a child  psychiatry  clinic.  J. Clin.
  Exp. Psychopath., 1956, 17: 164-169.
---,  ----.  Treatment of  hyperkinetic emotionally dis-
  turbed  children  with  prolonged  administration  of
  chlorpromazine.  Am. J. Psychiat., 1956,113 : 22-26.  Ab-
  stract: Excerpta med.,  Sect. 8, 1957, 10: No. 1837.
Freedman,  A. M.,  Effron, A. S., Bender, L.  Pharmaco-
  therapy in children  with psychiatric illness.   J. Nerv.
  31 ent. Dis., 1955, 122: 479-486.  Abstract: Year book of
  dm a therapy, 1956-1957, p. 350-351.
---.,  Kremer, M.  W.,  Robertiello, R., Effron, A. S.  The
  treatment of behavior  disorders in children with tol-
  serol. J. Pediat, S.  Louis, 1955, 47 : 369-372.
Freeman, H. A critique of the tranquilizing drugs, chlor-
  promazine and reserpine, in neuropsychiatry.  N. Eng-
  land J. 31., 1956,  255 : 877-883.
---, Arnold, A. L., Cline,  H. S.  Effects of chlorproma-
  zine  and  reserpine  in  chronic schizophrenic  patients.
  Dis. Nerv. Syst, 1956, 17 : 213-219.  Abstract: Excerpta
  med., Sect. 8, 1957, 10:  No. 1448.
---, Cline, H. S.   Effects  of chlorpromazine on chronic
  Iobotomized  schizophrenic patients; a controlled  study.
  A. 31. A. Arch. Neur. Psychiat,  1956, 76:500-507.
—-, see Arnold, A. L.,  Freeman, H.
---, see Cline, H. S., Freeman, H.
Freeman, J. G., see Kamman, G. R., Freeman, J. G., Lu-
  cero, R. J.
Fregni, R., see Felisati, D., Fregni, R.
Freis, E. D.  Mental depression in hypertensive patients
  treated for long periods with large doses of reserpine.
  N. England J. 31., 1954, 251: 1006-1008.
Fremming  K.  H.  Medikamentel  behandling af synds-
  sygdomme.  [Medical treatment  of mental disorders.]
  Mskr  prakt. laegegern., Kbh., 1956, 34: 331-342.
___  Perregaard,  I.  Serpasil  som  sedativum i psykia-
  trien   [Serpasil as a sedative in psychiatric practice.]
  [English summary]  Ugeskr. laeger, 1955, 117 : 599-603.
  Abstract: Excerpta med., Sect. 8, 1956, 9 : No. 3608.
French, E. G.  Epilepsy.  Am.  J. Psychiat,  1957,  113:
  629-631.
Frenkel, G. M., see Galenko, V. E., Osberg, I. IU., Robiner,
  I. S., Frenkel, G. M.
Freund, R. B. Observations  during the treatment of 175
  psychotic patients with reserpine.  Psychiat.  Q., 1955,
  20:381-389.  Abstract: Excerpta  med.,  Sect. 8, 1956,
  9: No. 4994.
Freygang,  W., Jr., see Evarts, E. V., Landau, W., Frey-
  gang, W., Jr., Marshall, W.  H.
Freyhan, F. A.   Comments on the biological and psycho-
  pathological basis of individual variation in chlorpro-
  mazine therapy.  Encephale, 1956, 45 : 913-919.
---.  The immediate and long range effects of chlorpro-
  mazine  on the  mental hospital.   In: Chlorpromazine
  and mental health.  Philadelphia, Lea d Febiger, 1955.
  p. 71-84 ; discussion p. 84-98.
---.  Psychomotility and parkinsonism  in treatment with
  neuroleptic drugs.  A.  31. A.  Arch.  Neur. Psychiat.,
  1057,  78 : 465-472.
---, Turner, P., Stenzler, R.   New drug therapies  in psy-
  chiatry.  Delaware 31. J., 1956, 28 :180-186.
Frick, P. S., see Rotstein, J.,  Frick, P. S., Schiele, B. C.
Friebel, H., Reichle,  C.  Zur analgetischen und analge-
  sieverstarkenden Wirkung von Chlorpromazin  (Mega-
  phen).   [Analgesic and analgesic-potentiating effect of
  chlorpromazine  (megaphen).]  Arch.  exp. Path., Berl,
  1055,  226:551-557.   Abstract: Chem. Abstr., 1956, 50:
  2063de.
Friedgood, C. E., Ripstein, C. B. Chlorpromazine  (thora-
  zine)  in the treatment of  intractable hiccups.   J. Am.
  31. Ass., 1955, 157 : 309-310.
---, ---. Use  of chlorpromazine in the withdrawal of
  addicting drugs ; preliminary report.   N. England J. 31.,
  1955,  252 : 230-233.
Friedlander, H. S.  Anxiety, tension and emotional  stress ;
  a report on the joint  use  of mephenesin and a barbi-
  turate in their  treatment  in general practice.   31ed,
  Times, Great Neck, 1953, 81: 411-415.
Friedlaender, S.  Report of the Committee on new drugs
  of the research council  of the American Academy of
  Allergy,  1955-1956.  Plimasin.  J.  Allcrgu,  1956,  27:
  288-290.
Friedman,  A. P.  The treatment of headache  with reser-
  pine.  Ann. N. York Acad. Sc, 1955, 61: 276-280.   Also :
  Neurology, 1955, 5:805-808.  Abstract: Excerpta med.,
  Sect. 8,1956, 9 : No. 1555 ; 3226.
---.  Use of tranquilizers in the treatment of headache.
  Am, Practitioner, 1957, 8 : 94-97.
---, Von  Storch, T. J.  A review of headache, 1950-1055.
  N. York State J. 31., 1956, 56 : 3883-3895.
Friedman, H. T., Marmelzat,  W. L.   Adverse reactions to
  meprobamate.   J. Am. 31. Ass., 1956, 162: 628-630.
Friedman, I. H., see Wilkins,  R. W., Judson, W. E., Stone,
  R. W., Hollander, W., Huckabee,  W. E., Friedman,  I.
  H.
Friedman,  T. T., see Malamud, W., Barton, W. E., Flem-
  ing,  A.  M.,  Middleton,  P.  McK., Friedman,  T. T.,
  Schleifer, M. J.
Friend, D.  G, Cummins,  J. F. New  antiemetic drug.
  J. Am. 31. Ass., 1954, 153 : 480-481.
---, McLemore, G. A., Jr.  Some abuses of drugs in ther-
  apy.   N. England J. 31., 1956, 254 : 1223-1231.
---, Wells, J. C, Jr.  The clinical use of chlorpromazine.
  Am. Practitioner, 1955, 6: 698-703.  Also as : Uso clinico
  de la cloropromacina.  Rev. med. cubana, 1956, 67 • 645-
  650.
---, see Cummins, J. F., Friend, D. G.
Fries,  P.  E., Gunne,  L. M., Lundgren,  S.,  Viding, G.,
  Ohrberg,  K.   Orienterande  undersokning  av  chloro-
  promazinets  kliniska  och farmakologiska  effekt  a
  psykiatriskt klientel.   [Investigation of the clinical and
209 
Fries, P. E.
PSYCHOPHARMACA
  pharmacological effects of chlorpromazine on psychiatric
  patients.]  Nord.  psykiat. medl, Kbh., 1955, 9:192-201.
  Abstract: Excerpta med., Sect.  8, 1956, 9: No. 4072.
Friese, K. H. Vorlaufige Erfahrungen bei der Behandlung
  psychiatrischer Kranker mit Phenothiazinen.  [Experi-
  ences with phenothiazine therapy in psychiatry.]  Medi-
  zinische, 1956: 734-735.
Frodl, E., see Heim, F., Frodl, E.
Fromm, G. H., Forsberg, I. A.  Controlled  study on the
  value of chlorpromazine in allaying anxiety. Dis. Nerv.
  Syst, 1956,17 :16-19.
Frongia, N., see Buscaino, G. A., Frongia, N.
Fryers, G. R.  Drugs for tension and anxiety. Brit.  M. J.,
  1957,1:1074.
Fuchs, M., Brown, H.  Plimasin in the treatment of hay
  fever.   Med. Ann. District of Columbia,  1956, 25: 553-
  554.
Fiinfgeld, E. W. Zur Frage der Megaphenprovokation bei
  der  Elektrencephalographie.  [Problem   of megaphen
  activation in electroencephalography.]  Arch. Psychiat.,
  Berl, 1956, 194: 571-583.
Fullerton, A. G. Psychiatric uses  of meratran.  J.  Ment
  Sc, Lond., 1956, 102: 801-804.
Funderburk, W. H.,  King, E. E., Domino, E. F., Unna, K. R.
  Pharmacological properties  of benzazoles.  II.  Sites of
  action in the central  nervous system.  J. Pharm. Exp.
  Ther., 1953,107: 356-367.
----, ----, Unna,  K. R.  Pharmacological  properties of
  benzazoles.  III. Effect of 2-aminobenzothiazoles on the
  electroencephalogram. J. Pharm. Exp. Ther., 1953, 108:
  94-103.
----, Unna, K. R. Site of action of 2,2-diethyl-l,3-propane-
  diol  (prenderol)   on  the central  nervous system.  J.
  Pharm.  Exp. Ther., 1953,107: 344-355.
----, Wilcox, K. W., Wilcox. P. H.  Drug therapy; physio-
  dynamic therapy.  II.  Progr. Neur. Psychiat, N. Y.,
  1956,11: 425-456.
---, see Ferguson, J. T., Funderburk, W. H.
---, see Wilcox, P. H., Funderburk,  W. H., Wilcox,  K. W.
Funk, I. C, see Rockmore, L., Shatin, L., Funk, I. C.
----, see Shatin, L., Rockmore, L., Funk, I. C.
Funkenstein, D. H.  Nor-epinephrine-like and epinephrine-
  like substances in relation to human  behavior.   J. Nerv.
  Ment. Dis., 1956,124: 58-68.
Furr, J. H., see Graffagnino, P. N., FUrr, J. H.
Furtado, D. Action de la chlorpromazine sur Tetat de mal
  epileptique. [(Therapeutic) effect of chlorpromazine on
  epileptic convulsions.]  Ence'phale, 1956, 45:727-729.
----.   Chlorpromazine  dans  les depressions des hyper-
  tendus.   [Chlorpromazine therapy  of depressions in
  hypertensive patients.]  Ence'phale, 1956, 45 :  572-575.


                          G

Gachkel, V., Brisset, C.  La cure de sommeil en psychiatrie.
  [Sleep therapy in psychiatry.]  C. rend. Congr.  alie'n.
  neur. France, 1952, 50: 491-496.  Abstract  [incomplete] :
  Ann. me'd. psychol, Par., 1952,110  (2) : 565.
Gade,  E.  B.,  Heinrich, K.   Die Bedeutung der Pheno-
  thiazinderivate,   insbesondere  des Megaphen,  ffir
  Psychiatrie und Neurologic   [The importance of pheno-
  thiazine derivatives in psychiatry and neurology, with
  special  reference  to  chlorpromazine.]  Fortsch.  Neur.
  Psychiat., 1955, 23: 323-353.
---,  ---.  Klinische  Beobachtungen bei  Megaphenbe-
  handlung in der  Psychiatrie.   [Clinical observations
  with  megaphen  therapy in psychiatry.]   Nervenarzt,
  1955, 26: 49-54.  Abstract: Excerpta med., Sect. 8, 1956,
  9: No. 4073.
Gaitz,  C.  M., Roy, H. Thompson, W., Kimbell, I., Mullen,
  A. J., Pokorny, A. D.  Evaluation  of chlorpromazine in
  comparison with  other methods of treatment of  hos-
  pitalized psychiatric patients,  using the Lorr  multi-
  dimensional  scale for  rating  psychiatric  patients.
  Psychiat. Res. Rep., Wash.,  1955 (1) : 84-95.
Galenko V  E.  Serpazil;  obzor inostrannoi  literatury.
  [Serpasil; review of foreign literature.]   Zh  nevropat.
  psikhiat, Moskva, 1956, 56: 344-352.  Abstract:  Chem.
  Abstr., 1956, 50: 17177g.                  .    .
---, Osberg,  I. IU., Azbukina, V. D.  Aminazin  v psi-
  khiatricheskoi   klinike.   [Aminazine   in  psychiatric
  practice.]   Zh. nevropat.  psikhiat., Moskva,  195b, 5b:
  162-165.                        .    .         -i v- * ■
___t  ___t____Primenenie  aminazina  v psikhiatri-
  cheskoi 'klinike.   [Use of  aminazine  in  psychiatric
  clinics.]  Sovet. med., 1956, 20: 29-35.
___,___, Robiner, I. S., Frenkel, G. M.  Kliniko-elektro-
  fiziologicheskie issledovaniia psikhicheski bol-nykh pri
  lechenii aminazinom.  [Aminazine therapy  of mental
  patients; clinical  and electroencephalographic study.]
  Zh. nevropat. psikhiat, Moskva, 1956, 56: 300-306.  Ab-
  stract : Chem. Abstr., 1956, 50:17176L
Galibert, J., see Heuyer, G.,  Giraud, G., Galibert, J.
Galioni, E. F.  Reserpine and  chlorpromazine, their use
  in alcoholic and geriatric  patients.   California M.t
  1956,85:97-99.                       „ _  r     .
Gallagher, W. J., Berry, J.  M., Durden,  W. D., Lazenby,
  W. D.  Comparative study of reserpine, 11-desmethoxy-
  reserpine, and  Rauwolfia alkaloids  in  treatment of
  schizophrenia.  In: Himwich, H. E., ed.   Tranquilizing
  drugs. Washington, Am.  Ass. Adv. Sc, 1957. p. 133-
  147.
Gallai, Z, see Racz, S., Gallai, Z.
Gallian,  U., Gamna, G.  Primi  tentativi  di  terapia di
  sindromi amenziali con preparati derivati dalle tecniche
  della "ipotensione controllata" e della  "ibernazione
  artificiale"; nota preliminare.  [First attempts to treat
  the syndrome  of amentia  with drugs derived from the
  technics of "controlled hypotension" and "artificial hi-
  bernation";  preliminary  note.]  Minerva  med.,  Tor.,
  1953, 44:357-360.
Galuszko, P., see Falicki, Z., Galuszko, P., Jaworska, I.,
  Kielak, L., Sulestrowski, W.
Galvao, P., see Mendes, F., Galvao, P.
Galvin, J. A., see MacDonald, J. M., Galvin, J. A.
Gambs, A.  Essai d'application de la chlorpromazine en
  cures prolongees au  traitement de diverses  affections
  mentales, a propos  de 58 observations.   [The use of
  chlorpromazine for prolonged sleep therapy of various
  mental   diseases.  58  observations.]   136   p.  Lyon,
  1954.  [Thesis—Lyon 1953/1954, no. 76]
Gamna, G., Bonfante,  B., Villata, E.  Autoesperienze con
  LSD.  [Personal experience with LSD.]  [Brief Eng-
  lish  summary]   Rass. stud,  psichiat,  1954, 43:979-
  988.  Abstract: Excerpta med., Sect. 8,1955, 8: No. 3109.
---, see Gallian, U, Gamna, G.
---, see Gomirato, G., Gamna, G.
Gangloff, H., Monnier, M. Topische Bestimmung des
  zerebralen Angriffs von Reserpin  (Serpasil).   [Local
  determination  of  cerebral effects  of  reserpine.]  Ex-
  perientia, Basel,  1955, 11: 404-407.  Abstract:  Chem.
  Abstr., 1956, 50: 4384b.
Ganry, C. H.  J.  La cure  de sommeil en psychiatrie.
  [Sleep   therapy  in  psychiatry.]  102  p.  [Mimeo-
  graphed]   Paris, 1953. [Thesis—Paris 1953, no. 395]
Gantt, W. H., see Bridger, W. H., Gantt, W. H.
---, see Gliedman, L. H., Gantt, W. H.
---, see Gliedman, L. H., Gantt, W. H., Teitelbaum, H. A.
Garattini,  S.,  Valzelli, L.  Sostanze interferenti sulla at-
  tivita potenziante gli ipnotici svolta  dalla  serotonina.
  [Substances that  interfere with the potentiating effect
  of serotonine  on hypnotics.]   Boll Soc ital  biol. sper.,
  1956, 32: 292-295.
Garavaglia, G.   Risultati  clinici in campo  neuropsichi-
  atrico con alcaloidi totali di Rauwolfia serpentina  (in-
  iettabile ed orale).  [Clinical results of total Rauwolfia
  serpentina alkaloids (injectable and oral) in neuropsy-
  chiatry.]  Minerva med.,  Tor., 1955, 46: 1259-1263.
----,  Negri,  V.  U.  L'uso della  reserpina  negli  stati
  di eccitamento psichico.   [Use of reserpine  in psychic
210 
AUTHOR LIST
Germano, V.
  excitation states.]  [English summary]   Arch,  psicol
  neur., Milano, 1956, 17: 376-387.
 -—, see Negri, V. U., Garavaglia, G.
 Garcia, J. A., Ferreira, L. R.  Investigagoes terap§uticas
  com um dos alcaloides da Rauwolfia serpentina.  [Ther-
  apeutic tests of one of the Rauwolfia serpentina alka-
  loids.]  [English  summary]  Rev.  brasil med., 1955,
  12:291-294.
 Gardner,  A.  Meprobamate—a clinical  study.  Am.  J.
  Psychiat, 1957, 114: 524-526.
 Gardner, M. J., Hawkins, H. M., Judah, L. N., Murphree,
  0.  D. Objective measurement  of  psychiatric changes
  produced  by chlorpromazine  and reserpine in chronic
  schizophrenia.  Psychiat. Res. Rep., Wash., 1955 (1) :
  77-83.
 Garello, L., Dolce, G.  Intorno alia azione risolvente della
  dietilamide dell'acido lisergico e della metilanfetamina
  sulla catalessia  sperimentale  da 5-idrossitriptamina  (5
  H T) ;  ricerche sperimentali sui cane.   [Antagonistic
  effect of diethylamide of lysergic acid and of methylam-
  phetamine on experimental catalepsy caused  by 5-hy-
  droxytryptamine;  experimental  research  on  dogs.]
   [English summary]  Sistema  nerv., Milano, 1956, 8: 61-
  80.  Abstract:  Chem. Abstr., 1956, 50:17196a.
 ---, ----.   Modificazione  degli effetti della  stricnina
  sulla funzione  motoria  della  Rana esculenta  deter-
  minata dalla somministrazione di serotonina.  [Modifi-
  cation of the effects of strychnine on motor function  in
  Rana esculenta  through  administration of serotonin.]
  Boll Soc. ital biol. sper.,  1956, 32: 443-445.
 ---, see Bonamini, F., Garello, L.
 ---, see Dolce, G., Garello,  L.
 ---, see Giberti, F., Garello, L.
 ---, see Sacchi, U.,  Bonamini, F., Dolce, G., Garello,  L.
 ---, see Sacchi, U., Bonamini, F., Garello, L., Dolce, G.
 ---, see Sacchi, U., Garello, L., Dolce, G., Bonamini, F.
 Garmany, G., May, A. R., Folkson, A.  The use and action
  of chlorpromazine in psychoneuroses.  Brit. M. J., 1954,
  2:439^41.
 Garneau, J., see Patton, G. O., Garneau, J.
 Garrabe, J., see Lecomte, G., Certhaux, A., Garrabe, J.
 Garrez, N. J.,  see Feldman,  P. E., Lacy,  B. S., Walker,
  A. E., Garrez, N. J.
 Garrigues, M.  P., see Riser, M. Geraud, J., Laboucarie,
  J.,  Rascol, A., Clausse, S., Garrigues, M. P.
 Gascard, E.   La place  de  la cure de sommeil en the-
  rapeutique.  [The place  of sleep therapy in therapeu-
  tics.]  Marseille me'd., 1953, 90: 516-519.
 Gastaut, H,  Ferrer, S.,  Castells,  C, Lesevre, N., Lusch-
  nat, K.  Action de la diethylamide de Tacide d-lysergique
  (LSD 25) sur  les  fonctions psychiques et  Telectro-
  encephalogramme.   [Effect of  d-lysergic  acid diethy-
  lamide on  psychic functions and the electroencephalo-
  gram.]  [English  summary]  Confinia   neur.,  Basel,
  1953, 13:102-120.  Abstract: Excerpta med., Sect.  8,
  1954, 7: No.  1623.
 ---,  Terzian, H.,  Gastaut,  Y.  Etude d'une activite eiec-
  troencephalographique meconnue:  "le rythme rolandi-
  que  en  arceau".   [Investigation of  a  misunderstood
  electroencephalographic activity: "the rolandic rhythm
  in arc".]  31arseille me'd.. 1952, 89 : 296-310.
 Gastaut, Y., see Gastaut, H., Terzian, H.,  Gastaut, Y.
 Gasteau, E., see Vidart, L.,  Gasteau, E.
 Gatski, R. L.   Chlorpromazine  in the treatment of emo-
  tionally  maladjusted   children;  preliminary report.
  J. Am. M. Ass., 1955, 157:1298-1300.
 Gaujard R.,  see Laborit, H., Coirault,  R., Damasio,  R.,
  Gaujard, R., Laborit, G.,  Charonnat, R., Lechat,  P.,
  Chareton, J.                          ,  ,. ^  ,  k  _
 Gaunt, R., see Schneider, J. A., Plummer, A. J., Earl, A. E.,
  Gaunt, R.                 T  _   ...   T
 Gauthier, J., see Sangowicz, J., Gauthier, «*•
 Gauthier, J. W., see Thimann, J., Bucknam, F. G, Gauthier,
  J. W.- 6'Connell, T. A.
___f see Thimann, J., Gauthier, J. W.
Gayle, R. F., Ill, see Foster, M. W., Jr., Gayle, R. F., III.
Gayle, R. F., Jr., see Foster, M. W., Jr., Gayle, R. F., Jr.
Gayral, L., Herve, Y., Carrie, J.,  Fourny, L.  Les cures
  insuliniques prolongees et la post-cure dans le traitement
  de la demence precoce.  [Prolonged insulin treatment
  and  after treatment in therapy of dementia praecox.]
  Toulouse me'd., 1955, 56: 501-513.
----,  ----,  Fourny,  L.,  Carrie,  J.  Chlorpromazine et
  reserpine  dans  la post-cure  insulinique  des  schizo-
  phrenes.   [Chlorpromazine and  reserpine after insulin
  shock therapy in schizophrenia.] Ence'phale, 1956, 45:
  663-667.
Geller,   W.  Behandlung  depressiver  Vertstimmungs-
  zustfinde mit einem neuen zentralen Stimulans.  [Treat-
  ment of depressive states with a new central stimulant]
  Medizinische, 1955: 606-608.
Gelvin, E. P., McGavack, T. H., Kenigsberg, S.  Alpha-(2-
  piperidyl)  benzhydrol hydrochloride (pipradrol)  as an
  adjunct in the dietary management of obesity. N. York
  State J. M., 1955, 55: 2336-2338.
----,  ----,  Pogge, R. C.  Alpha- (piperidyl)  benzhydrol
  hydrochloride (meratran) as an anorexigenic agent in
  the management of obesity.  Clin. Res. Proc, 1955, 3:
  40-41.
Genest, J.. Adamkiewicz, L., Robillard, R., Tremblay, G.
  Clinical uses of Rauwolfia. II. In psoriasis and in con-
  stitutional leanness.  Canad. M. Ass. J., 1955, 72: 490-
  491.  Also as: Nouvelles applications therapeutiques de
  la reserpine et  des extraits de la  Rauwolfia.   [New
  therapeutic use  of  reserpine and Rauwolfia extracts.]
  Union  me'd.  Canada,  1954, 83:915-916.   Preliminary
  communication: new therapeutic applications of reser-
  pine and of purified extracts of  Rauwolfia.  Canad. M.
  Ass. J., 1954, 71  (August-News and Notes) : 73.
----, see Lemieux, G, Davignon, A., Genest, J.
Genevard, G., see Vernet, A., Genevard, G.
Gentili, E., see Zonta, G., Masciangelo, P. M., Gentili, E.
Gerard, D.  L., Weisselberger, D., Kritz, D.  Reserpine in
  the postwithdrawal rehabilitation  of adolescent opiate
  addicts.  A. 31. A. Arch.  Neur. Psychiat, 1956, 76:106-
  108.
Gerard, R. W. Drugs for the soul;  the  rise of psycho-
  pharmacology.  Science,  1957, 125 : 201-203.
----.   In:  Abramson, H. A.,  ed.  Neuropharmacology.
  Transactions of the second conference, May 1955, Prince-
  ton, N. J.  New York, Josiah Macy, Jr. Foundation, 1956.
  p. 241.
Geraud, J., see Riser, M., Geraud, J., Laboucarie, J., Rascol,
  A., Clausse, S., Garrigues, M. P.
Gerest, F.   Traitement de Tacces  maniaque par la chlor-
  promazine.  [Chlorpromazine therapy of manic states.]
  Encephale, 1956, 45 : 536-540.
----,  Maissoneuve.  Le traitement de Tacces  maniaque.
  [Chlorpromazine therapy of manic states.]   Lyon med.,
  1954, 86  (1) : 3-15. Abstract:  Excerpta med., Sect.  8,
  1955, 8 : No. 3104.
Gerhardt, U., Ziolko, H. U.  Zur Megaphenwirkung bei
  Neurotikern.  [Effects  of megaphen  in   neurotics.]
  Aerztl. Wschr., 1956,11: 750-752.
Gerle,  B.  Striking effects of chlorpromazine treatment
  in paranoid  schizophrenia.  Encephale,  1956, 45: 687-
  690.
Germano, V., Bellavitis, U. Osservazioni cliniche e tera-
  peutiche  sull'use del  cloridrato 6 acetossi-timossi-etil-
  dimetil-amina (opilon) negli stati d'ansia e nelle terapie
  da shock.   [Clinical and therapeutic observations on the
  use  of 6-acetoxythymoxy-ethyl-dimethylamine  hydro-
  chloride (opilon) in anxiety states  and  shock therapy.]
  [English summary]  Riv. neur.,  Nap., 1955, 25 : 928-940.
----,----, Prime osservazioni cliniche sull'uso parenterale
  degli alcaloidi della  rauwolfia  in  psichiatria.   [First
  clinical observations on the parenteral use of Rauwolfia
  alkaloids  in  psychiatry.] Riv. sper.  freniat.,  1955,
  79:713-722.
----, see Montagnari, F., Germano, V.
211 
Germano, V.
PSYCHOPHARMACA
---, see Reda, G. C, Germano, V.
Gerstenbrand, F., Weingarten, K.  Serpasil-Behandlung
  bei  extrapyramidalen Hyperkinesen.   [Serpasil treat-
  ment of  extrapyramidal  hyperkinesia.]   Wien. klin.
  Wschr., 1956, 68 : 656-659.
Gettner, H. H., see xVbramson, H. A., Sklarofsky, B., Baron,
  M. O., Gettner, H. H.
Geyer, H.  W.  Thorazine  (chlorpromazine)  and  serpasil
  therapy in hyperactive patient of low mentality. Dela-
  ware M. J., 1955, 27 : 187-189.
---.   Response  to thorazine (chlorpromazine)  adminis-
  tration  in hyperkinetic  mongolism.  Delaware 31. J.,
  1956, 28: 189-190.
Gherarducci, D.  A propos de Tutilisation de la chlorpro-
  mazine   associee  a  d'autres  therapeutiques  psychi-
  atriques.   [Utilization   of  chlorpromazine  associated
  with other psychiatric therapeutics.]  Encephale, 1956,
  45: 1187-1189.
Giacobini, E., Lassenius,  B.  Clorpromazinbehandling;
  biverkningar   och  komplikationer.  [Chlorpromazine
  therapy;  side   effects  and  complications.]   [English
  summary]   Nord. med., 1054, 52 : 1693-1699.
Giabicani, A., see Siguier,  F., Giabicani, A., Betourne, C,
  Goglin, G.
Giamattei, L., see Maffezzoni, G., Giamattei, L.
Gianniotti, G, see Sacchi, U, Brusa, A., Gianniotti, G.
Gibbons, J. E., see Muller, J. C, Pryor, W.  W.,  Gibbons,
  J. E., Orgain, E. S.
Gibbs, J. J., Wilkens, B., Lauterbach,  C. G.  A controlled
  clinical psychiatric study of [the drug]  chlorpromazine.
  J.  Clin. Exp.  Psychopath.,  1957,  18:258-268.  Con-
  densed: Am. J. Psychiat, 1956, 113:254-255.
Gibert, J., see Pomme, B., Planche, R., Gibert, J.
Giberti, F.  Risultati e considerazioni sull'impiego della
  reserpina nel  trattamento delle  psicosi:  osservazioni
  generali.   [Results of and considerations on the use of
  reserpine in the treatment of psychoses:   general ob-
  servations.]  [English summary]  Arch, psicol neur.,
  3Iilano, 1956, 17 : 316-346.
---, Garello, L.  Risultati del trattamento con reserpina
  in psichiatria.   [Results of reserpine  therapy in  psy-
  chiatry.]   [English summary]  Sistema nerv., 3Iilano,
  1955, 7: 29-42.   Abstract;  Excerpta med.,  Sect. 8, 1956,
  9: No. 4079.
---, Gregoretti,  L.  Prime  esperienze  di  antagonismo
  psicofarmacologico ; psicosi sperimentale da LSD e trat-
  tamento con cloropromazina e reserpina.  [First trials
  of  phychopharmacological  antagonism; experimental
  psychoses induced with d-lysergic acid diethylamide and
  treated with chlorpromazine and  reserpine.]   [English
  summary]    Sistema nerv.,  3Iilano, 1055, 7:301-310.
  Abstract: Excerpta med.. Sect. 8, 1956,  9: No. 4547.
Gibson, W. C.,see Peretz,  D.  I.,  Smythies, J. R., Gibson,
  W. C.
Gifford, R. W., Jr., see Achor,  R.  W. P., Hanson, N.  O.
  Gifford R. W., Jr.
Gilardi, A.  Neuartige  sedative Therapie  bei Verhaltens-
  storungen  im Kindesalter.   [New sedative therapy of
  behavior disorders in children.]   Praxis,  Bern, 1956,
  45: 993-995.
Gilbert, R. G. B.,  see  Dobkin,  A. B., Gilbert,  R. G. B.,
  Lamoureux, L.
■---, see Dobkin, A. B., Lamoureux, L., Letienne, R., Gil-
  bert, R. G. B.
Gillette, H. E.  Relaxant  effects of meprobamate in dis-
  abilities resulting from musculoskeletal   and central
  nervous  system  disorders.   Clinical  observations  in
  fifty-five cases.  Internat.  Rec. 31., 1956,  169:453-468.
  Abstract: Excerpta med., Sect. 8, 1957,  10:  No.  1841.
Gillie, A.  K.   The use of pacatal in low-grade mental de-
  fectives. J. 31 ent, Sc, Lond.,  1057, 103 : 402-405.
Gimes, M., see Boszormenyi, Z., Gimes, M., Orthmayr, A.
Ginoulhiac, R., see Castrovilli, G., Ginoulhiac, R., Merli,
  G. M.
Ginsburg, M., see Shulman, L., Ginsburg, M.
Ginzel,  K. H., Mayer-Gross, W.  Prevention  of Psycho-
  logical effects of d-lysergic acid diethylamide (LSD-25)
  by its 2-brom derivative  (BOL  148).   Nature, Lond.,
  1956,    178:210.  Abstract:   Chem.    Abstr.,   19o6,
  50:17147hi.
Girard,  C, see Follin, S., Sigg, B., Pivet, S., Girard, C.
Girard,  V., see Coirault, R.,  Girard, V., Benoit, P.
---, see Coirault,  R., Girard, V., Escafit, H., Benoit, P.
Giraud,  G., see Heuyer, G., Giraud, G., Galibert, J.
Gislason, S.,  see Swenson,  W. M., Gislason, S., Anderson,
  D. E.
Giua, A. M., see Montanari,  M., Giua, A. M.
Glaser,  E. M., Newling, P.  S. B.  Side effects of chlorpro-
  mazine hydrochloride.  Brit. J. Pharm., 1955, 10:429-
  433.
Glaskin, A.,  see Shubin, H., Heiken,  C.  A., Glaskin, A.,
  Pennes, E., Arsenian, J.
Glass, H. G., see Lim, R. K., Pindell, M. H., Glass, H. G.,
  Rink,  K.
Glasser, J., see Hubbard, O. E., Glasser, J.
Glees, P., see Cole, J., Glees. P.
Gliedman, L. H., Gantt, W. H.  The effects of reserpine and
  chlorpromazine on  orienting behavior and retention of
  conditioned reflexes.  South. 31. J., 1956, 49: 880-889.
---,---, Teitelbaum,  H.  A.  Some implications of con-
  ditional  reflex  studies for placebo research.  Am. J.
  Psychiat, 1957, 113 : 1103-1107.
Glod, G. D., see Bamdas, B.  S., Glod, G. D., Lando, L. I.,
  Levkovich, A. P., Tarasov, Y. K., Khazen, I. M.
Glotfelty, J.  S., Wilson, W.  P.  Effects  of transquilizing
  drugs on reticular system activity in man.  North Caro-
  lina M. J., 1956,17 : 401-405.
Glynn, J. D.   Rauwolfia serpentina (serpasil) in psychi-
  atry.  J. Neur., Lond., 1955, 18: 225-227.
Goerre,  J., see Essellier, A. F., Goerre, J., Wegmann, A.
Goglin,  G, see Siguier, F.,  Giabicani, A., Betourne, C,
  Goglin, G.
Goldberg, N., see Michtom, J., Goldberg, N., Offenkrantz,
  W., Whittier, J.
Goldman, D.  Agranulocytosis associated with  adminis-
  tration of chlorpromazine.  Report of three cases with
  description of treatment and recovery.  .4. 31. A. Arch.
  Int. 31., 1955, 96 : 496-499.
---.  Chlorpromazine treatment of hospitalized psychotic
  patients.  J. Clin.  Exp.  Psychopath..  1956,  17:475-56.
  Abstract: Excerpta med..  Sect. 8, 1057,  10: No. 372.
---.  Comparison of clinical effects of  chlorpromazine
  and reserpine  in psychotic  patients.  Am.  J. 31.  Sc,
  1057, 233: 137-144.
---.  The effect of chlorpromazine on severe mental  and
  emotional disturbances.   In: Chlorpromazine and men-
  tal health.  Philadelphia,  Lea d  Febiger, 1955.   p. 20-
  40; discussion p. 40-69.
---.  The  influence  of  chlorpromazine on  psychotic
  thought content and  mechanism.   Psychiat. Res. Rep.,
  Wash., 1055 (1) : 72-76.
---.  The major  complications of treatment of psychotic
  states with chlorpromazine and reserpine and their man-
  agement.   Psychiat. Res. Rep., Wash., 1056  (4) : 79-88.
---.  Treatment of psychotic states with chlorpromazine.
  J. Am. 31. Ass., 1055, 157 : 1274-1278.
Goldman, H. I.  Clinical evaluation of tolserol in the post-
  alcoholic  syndrome.  Rocky 3lountain 31.  J., 1954,
  51: 698-699.
Goldstein, S. W.   New drugs; old drugs.  Am. J. Pharm.,
  1954,126: 404-408.
Goldstone, S., see Boardman, W. K., Goldstone, S., Lha-
  mon,  W. T.
Golodets, R. G., see  Sereiskii, M. IA., Tolmaskaia, E. S.,
  Golodets, R. G., Samter, N. F.
Golse, J.  Le traitement du deiire aigu  par l'hibernation.
   [Hibernotherapy of  acute delirium.]   Ann. med.  psy-
   chol, Par., 1952, 110 (2) : 731-734.
----, see Adam, II., Golse, J.
212 
AUTHOR  LIST
Gruber, K.
 Gomes d'Araiijo, H., Jr.  Utilizagao da reserpina  (ser-
  pasil) em neuro-psiquiatria.  [Reserpine in neuropsy-
  chiatry.]   3Iedico,  Nova  Goa, 1955, 6:656-669.   Ab-
  stract: Excerpta med,, Sect. 8, 1956, 9: No. 1223.
 Gomirato,   G.  Le applicazioni  della  cloropromazina  e
  della reserpina al  vaglio di due riunioni.   [Uses of
  chlorpromazine and reserpine as  evaluated by two as-
  semblies.] 31inerra med,, Tor., 1955. 46: 1449-1452.
 ---.   L'azione della cloropromazina e della reserpina su
  alcune manifestazioni sintomatologiche delle  psiconev-
  rosi.   [Action of chlorpromazine and reserpine on symp-
  tomatologic manifestations of psychoneuroses.]   [Eng-
  lish  summary.]   Arch,  psicol  neur.,  3Iilano,  1956,
  17: 531-543.
 ---■,  Gamna,  G.  Ricerche  comparative  d'esplorazione
  psicofarmacologica ; studio dell'associazione di un bar-
  biturico ad azione  rapida  (narcovene) con un ganglio-
  plegico   (largactil).  [Comparative  psychopharmaco-
  logic investigations; study of a rapidly acting barbitu-
  rate  (narcovene) combined with  a ganglioplegic  (larg-
  actil).]   Gior.  psichiat, 1954, 82 : 347-359.
 ---,  see Arian, E., Gomirato, G.
 ---,  see Ferro Milone, F., Gomirato, G.
 Gonzalez Mas, R.  Introduccion al estudio de la toxico-
  mania por canamo indiano.  [Introduction to  the study
  of toxicomania for Indian cannabis.]  Medicina, 3Iadr.,
  1953, 21:130-136.
 Gonzalez-Monclus, E., see Ruiz-Ogara, C.„ Marti-Tusquets,
  J. L., Gonzalez-Monclus. E.
 Goodell, H., see Berlin, L, Guthrie T., Weider, A., Goodell,
  H.. Wolff. H. G.
 Goodman, J. J., see Rein, C. R., Goodman, J. J.
 Gordon, R.  A., Campbell, M.  The use of chlorpromazine
  in intractable pain associated with terminal carcinoma.
  Canad. 31. Ass. J., 1956, 75 : 420-421.
 Gore, C. P., Egan, G. P., Walton, D.  The place of reserpine
  in the treatment of the chronic psvehotic patient.  Am. J.
  Psychiat., 1057. 114 : 333-337.
 Gore,  E. M., see Hosko, M. J.,  Gore,  E. M.,  Tislow, R.,
  Seifter, J.
 Gorin, M. H., see Abramson, H.  A., Jarvik, M. E., Gorin,
  M. H., Hirsch, M. W.
 Gosline, E., Kline, N. S.  Use of reserpine on an admission
  service.  Psychiat. Res. Rep.. Wash., 1055 (1)  : 112-121.
 ---, see Kline, N. S., Barsa, J., Gosline, E.
 Goss, J. D., Jr., see Bird,  E. G, Goss, J. D. Jr., Denber,
  H. C. B.
 Gossmann,  K.,  see Kleinsorge, H., Gossmann, K.
 Got, M., see Bergouignan, M., Got, M., Malineau,  R.
 Gottlieb, F. I.  Tranquilizers and purpura hemorrhagica.
  J. Am. 31. Ass., 1956, 161: 96.
 Gottlieb, J. S., Tourney, G., Beckett, P. G, Lowinger, P.
  Drug therapy of the psychoses. 3Ied. Clin. N. America,
  1956, 40: 1385-1399.
 ---,  see Tourney, G., Isberg, E.  M., Gottlieb, J.  S.
 Gottschalk, L. A., Kapp, F. T., Ross, W. D., Kaplan, S. M.,
  Silver, H., MacLeod, J. A., Kahn, J. B., Jr., Van Maanen,
  E. F., Acheson, G. H. Explorations  in testing drugs affect-
  ing physical  and mental activity; studies with a  new
  drug of potential value in psychiatric illness.  J. Am. 31.
  Ass., 1956, 161: 1054-1058.
 Gouttebroze, V.  Une annee d'experience  de traitement
  du delirium tremens ; 61 cas recueillis dans le service de
  neuro-psychiatrie  de  l'H6pital Bellevue, St. Etienne.
  [Treatment of  delirium tremens;  one year's experience
  in 61 cases from  the neuro-psychiatric  service of the
  Hopital  Bellevue,  St. Etienne.]  85  p.  Lyon, 1955.
  [Thesis—Lyon, 1954/1955, no. 94]
Govier, W. M., sec Irwin, S., Govier, W. M.
Goyne, J. B., see Sternberg, U, Spitz, H., Goyne,  J. B.
Graffagnino, P. N., Furr, J. H.  New drugs in the treat-
  ment of  emotional  disorders;  a  review.  Connecticut
  M J 1957, 21: 3IS-43.
.___' s'ee Zeller, W. W.,  Graffagnino, P. N, Cullen, C. F.,
  Reitman, H. J.
Gragg, L.  Chlorpromazine in a state hospital.  J. Ken
  tucky 31. Ass., 1956, 54 : 587-589.
----, see Feuss, C. D., Gragg. L., Jr.
Graham, J. R.  Headache.  D3I, 1057, January : L-45.
Gralnick, A., see Silverberg, J. W., Gralnick, A.
Grana, E.  Recenti acquisizioni su un nuovo medicamento
  neuroplegico: la  cloropromazina.  [Recent  experiences
  with   a  new   neuroplegic  drug:  chlorpromazine.]
  Farmaco, ed. prat, Pavia, 1954, 9: 410-422.
Grandmottet, J.,  see Carrier, J., Guyotat, J., Grandmot-
  tet, J.
Grandon, R. C, HefHey, W.,  Hensel, T.,  Bashore, S.  A
  new medical adjunct to the treatment of alcoholism ; the
  use of  reserpine  (serpasil).  Am. Practitioner, 1956,
  7:231-234.
Grasset,  A., see Delay, J., Deniker, P., Harl, Grasset, A.
Grassi, B., see De Falco, A., Grassi, B.
Grattarola, F. R., see Bolsi, D., Donegani,  G.,  Grattarola,
  F. R.
Graux, P., see Nayrac, P., Graux, P.
Graves,  C.  C.  Drug  therapy for the emotionally  and
  mentally disturbed; the psychiatrist's point of view.
  J. Ioira 31. Soc, 1957, 47 : 15-16.
Gray, R. W., see Coats, E. A., Gray, R. W.
Green, A.  Actualites therapeutiques 1955  en  psychiatrie.
  [Therapeutic progress in psychiatry in 1955.]   Ence-
  phale, 1956, 45 : 172-200.
Greenberg, P. D., see Pearl, D., Vander Kamp, H.,  Olsen,
  A. L., Greenberg, P. D., Armitage, S. G.
Greenblatt, M., see Di Mascio, A., Greenblatt, M.,  Hyde,
  R. W.
---, see Di  Mascio, A., Suter,  E., Hyde,  R.  W.,  Green-
  blatt, M.
Greenblatt, R.  B.  Use of reserpine  (serpasil) in certain
  gynecologic disorders.    Ann, N. York Acad.  Sc, 1954,
  59: 133-135.
Greenfield, A. R.  A new type of sedation for  the acute
  alcoholic.  Am.   Practitioner,  1956,   7:241-244.  Ab-
  stract : Year book of drug therapy, 1956-1957, p. 337-338.
Greenhouse,  H. R. Treatment  of  the  postintoxication
  state  in alcoholics with mephenesin  and other  drugs.
  Q. J. Alcohol, 1054, 15 : 43-46.  Abstract: Excerpta med.,
  Sect. 8, 1954, 7 : No. 4228.
Greenspan, K.,  see Piala, J. J., High, J. P., Greenspan, K.,
  Burke, J. C.
Greff, K., Schumann, H. J.  Zur Pharmakologie des Sym-
  pathicolyticums 6-Acetoxythymoxy-aethyldimethylamin.
  [Pharmacology of the sympatholytic 6-acetoxy-thymoxy-
  ethyldimethylamine.]  Arzneimitt. Forsch., 1953, 3 : 341-
  345.
Gregoretti, see Giberti, F., Gregoretti, L.
Grenier,   J.,  Larue, G.  H., Parent,  R., Turmel,  J. La
  reserpine  en psychiatrie.   [Reserpine  in  psychiatry.]
  Laval me'd., 1956, 21: 181-189.
Griffin, R. A., see Proctor, R.  C, Griffin, R. A.
Grigorova, E. V., see  Ushakov, G. K., Kislenkov,  V. A.,
  Grigorova, E. V., Verbliunskaia, A. A.
Grimaud, see Fouks, L., Laine, Grimaud, Dariotis.
Grimshaw, J. A.  Chlorpromazine and reserpine; limita-
  tions of their use in office practice. J. Kansas 31. Soc,
  1956, 57 : 687-689.
Gross,  F., see Bein, H. J., Gross, F., Tripod, J., Meier, R.
---, see Meier, R., Bein, H. J., Gross, F., Tripod, J., Tuch-
  mann-Duplessis, H.
---, see Meier, R., Gross, F., Tripod, J.
Gross, M., see Finn, M. H., Nadolski, F., Guy, W., Gross, M.
Grossman, A. J., see Batterman, R. C, Leifer,  P.,  Gross-
  man, A. J.
Grosz,  H. J.  Dilantin intoxication, with a report  of one
  case.   Am. Practitioner, 1956, 7 : 1633-1636.
Gruber, K., Hlig,  H., Pflanz,  M.  Zur Prtifung der sogen-
  annten zentralen  Stimulantien am Menschen.  [Evalua-
  tion of so-called central stimulants in man.]   Deut. med.
  Wschr., 1956, 81:1130-1133.
213 
Grupper, C.
PSYCHOPHARMACA
Grupper, C.  Le  traitement  du prurit en dermatologie
  par la Rauwolfia serpentina, note preliminaire.  [Rau-
  wolfia  serpentina therapy of pruritus in dermatology;
  preliminary note.]  Bull  Soc.  fr.  derm, syph.,  1955,
  62:195-162.
Guareschi,  A., Cazzullo, C. L.  SulT  azione centrale del
  fargan:  analisi  sintomatologica  ed  elettroencefalo-
  grafica.  [The central action of fargan.  Symptomatic
  and electroencephalographic analysis.]  [English sum-
  mary.]  Acta neur., Nap., 1954, 9: 274-293.
----, see Cazzullo, C. L., Guareschi, A.
Guha, G., Dasgupta, S. R., Werner,  G.  Effects of some
  central depressant drugs on conditioned reflexes.  Bull.
  Calcutta School Trop. Med., 1954, 2 : 46-47.  Abstract:
  Chem. Abstr., 1955, 49 :12709de.
Guilly, P.  Formes cliniques  et traitement  de Tinsomnie.
  [Clinical forms and treatment of insomnia.]  Rev. prat.,
  Par., 1954,  4:1571-1581.
Guiral, R. J.  Uso de la chlorpromazina en las distonias
  vegetativas de tipo psichosomato.  [Use of chlorproma-
  zine in the psychosomatic type of autonomic dystonias.]
  Ence'phale,  1956, 45: 541-546.
Guiraud, P.  Discussion to: Hamon, Paraire, Velluz.  Re-
  marques  sur Taction du 4560 R. P. sur Tagitation mani-
  aque.   [Effect of R. P. 4560 on manic agitation.]  Ann.
  me'd. psychol, Par., 1952, 110 (1) : 335.
Gunne, L. M., see Fries,  P. E., Gunne, L. M., Lundgren, S.,
  Viding, G., Ohrberg, K.
Gutenkauf, C.  Internal medicine. In: "Happiness pills"
  in medical practice:  a symposium.  J. Iowa M. Soc,
  1957, 47: 59-64.
Guthrie, R.,  see Jenkins, D.  H.,  Chofnas,  I., Boren, H.,
  Guthrie, R.
Guthrie, T., see Berlin, L., Guthrie, T., Weider, A., Goodell,
  H., Wolff, H. G.
Guy, W., see Finn, M. H., Nadolski, F., Guy, W., Gross, M.
Guyotat, J., see Carrier, J., Guyotat, J., Grandmottet,  J.

                          H

Haase, H. J.  Modellpsychosen und deren Bedeutung ftir
  die Vertiefung unserer Kenntnisse fiber  endogene und
  exogene Psychosen.  [Model psychoses and their signifi-
  cance for an improved understanding of endogenous and
  exogenous psychoses.]  Med. Klin., Berl, 1956, 51: 1881-
  1883.   [Not seen.]
----. Psychiatrische Erfahungen mit Megaphen  (Larg-
  actil)  und  dem Rauwolfiaalkaloid  Serpasil unter dem
  Gesichtspunkt  des psychomotorischen  Parkinsonsyn-
  droms.   [Psychiatric  experiences with megaphen (lar-
  gactil) and the Rauwolfia alkaloid serpasil with special
  reference to Parkinson's psychomotor syndrome.]  Ner-
  venarzt,  1955, 26: 507-510.
---. Uber Begriff und Wirkungsweise des therapeutisch
  erstrebten psychomotorischen Serpasil-(Rauwolfia alka-
  loid-) und Largactil-(Megaphen-) Parkinson-Syndroms.
  [Definition and mode of action of the psychomotor Park-
  inson syndrome therapeutically induced by serpasil and
  largactil.]  [English   summary]   Mschr.    Psychiat.,
  Basel, 1956, 131: 201-214.
---. Uber Vorkommen und Deutung des psychomotor-
  ischen Parkinsonsyndroms bei Megaphen-bezw.  Largac-
  til-Dauerbehandlung.   [Occurrence and  interpretation
  of the psychomotor Parkinson syndrome during pro-
  longed therapy  with  megaphen or largactil.]   Nerve-
  narzt, 1954, 25: 486-492.
Haber, J., see Lehman, E., Haber, J., Lesser, S. R.
Haberer, C. E., see Noell, W. K., Chinn, H. I., Haberer, C. E.
Hafkenschiel, J. H., Sellers,  A. M., King, G. A., Thorner,
  M. W.  Preliminary  observations  on the   effects  of
  parenteral reserpine on cerebral blood flow, oxygen and
  glucose metabolism, and electroencephalograms of  pa-
  tients with essential hypertension.  Ann. N. York Acad.
  Sc, 1955, 61: 78-84.  Abstract: Chem. Abstr., 1955, 49:
  127'iii.  '                     ,. ,  T „
---, see Sellers, A. M., Hafkenschiel, J. H.
Hagenauer, F„ Rudy, L. H., Himwich, H. E.  A compara-
  tive evaluation of two new central nervous system stim-
  ulant! in severe psychoses.  J. Clin. Exp. Psychopath
  1957 18 • 248-257.  Condensed  as : A comparative study
  of two central nervous system  stimulants, MER-22 and
  S K.  F. #5,  on chronic, blocked and withdrawn  psy-
  chotic patients.  Am. J. Psychiat., 1957,  113 : 840.
Haggenmiiller,  F.  Atosil-Sirup  in der Kinderheilkunde.
  [Atosil elixir in pediatrics.]  Med. Klin., Berl, 19o2,
  47 ■ 320-321
Hagnell, O.,  Korsfeldt,  B,  Peterson, B., Widmark, M.
  Chlorpromazinebehandling vid  psykosed.  [Chlorproma-
  zine   therapy  of   psychoses.]  [English  summary.]
  Nord. med., 1955, 53: 726-730.
Hague,  J. R., see Cowden, R. C, Zax, M. Hague, J. R.,
  Finney, R. C.
Haight, J.  Newer drug therapies.  Dis. Nerv. Syst., 1956,
  17" 295—296
Hainaut, J.,  see Coirault, R., Laborit, H., Missenard, R.,
  Jolivet, B., Hainaut, J., Weber, B.
---, see Laborit,  H., Coirault, R., Hainaut, J., Weber, B.
Hakas, P., see Pamboukis, G., Paieologue,  A., Montoussis,
  N., Hakas, P.
Haley, T. J., McCormick, W.  G.   Pharmacological effects
  produced by intracerebral injection  of drugs in the con-
  scious mouse.  University of California,  School of Medi-
  cine, Atomic Energy Project, Los Angeles, 1956 (UCLA-
  372) • 1—25
Hall, J.' F., Warren, J. M., Harlow, H. F.   The effects of
  reserpine (serpasil) on the delayed response in monkeys.
  J. Psychol, Provincet, 1955,  40:159-161.  Abstract:
  Excerpta med., Sect. 8,1956, 9 :  No. 2245.
Hall, R. A., Dunlap, D. J.  A study  of chlorpromazine:
  methodology  and results  with chronic semi-disturbed
  schizophrenics.   J. Nerv. Ment. Dis., 1955, 122: 301-314.
  Abstract:  Excerpta  med.,  Sect. 8,  1957,  10:  No. 369.
  Year book of drug therapy, 1956-1957, p. 340-341.
---, Jackson, R.  B., Swain,  J. M.  Neurotoxic reactions
  resulting from  chlorpromazine administration.   J. Am.
  M. Ass., 1956,161: 214-218.
Halpern, B. N.  Proprietes sedatives et anticonvulsivantes
  du carbamate de methyl-3 pentyne-1 ol-3.  [ Sedative and
  anticonvulsant properties of 3-methyl-l-pentyne-3-ol car-
  bamate.]  C. rend. Soc. biol, 1956, 150:1152-1157.
---, Lehmann, A. Bases experimentales  de Taction ther-
  apeutique d'une nouvelle  medication  sedative  et  anti-
  anxieuse : le carbamate de methyl-3 pentyne-1 ol-3.  [Ex-
  perimental bases of  the therapeutic  action  of a new
  sedative and tranquilizing drug:  3-methyl-l-pentyne-3-
  ol carbamate.]   Presse me'd., 1957,  65: 622-625.
Hamilton, M., see Hargreaves, G. R., Hamilton, M., Rob-
  erts, J. M.
Hamister, R.  C.   Chlorpromazine in maze learning and
  retention.  Psychol. Rep., 1956, 2 : 331.
Hamke, H.  Das  Rauwolfia-Alkaloid  Reserpin in der Be-
  handlung der vegetativen Storungen.  [Rauwolfia  alka-
  loid reserpine treatment of autonomic disorders.]  Ther.
  Gegenwart, 1955, 94 : 218-219.
Hamlon, J. S., see Sommerness, M. D., Lucero, R. J., Ham-
  Ion, J. S. Erickson, J. L., Matthews, R.
----, see Sommerness, M. D., Lucero,  R. J., Hamlon, J. S.,
  Mahowald, A. M.
Hamon, J., Paraire, J., Velluz, J.  Etats anxieux et barbi-
  turiques potentialises.  [Anxiety states and potentiated
  barbiturates.]   Ann.  me'd.   psychol,   Par.,   1952,
  110  (2) : 403-407.
----, ----,  ----.  Remarques sur Taction du 4560  R. P.
  sur  Tagitation  maniaque.  [Effect of R. P.  4560 on
  manic agitation.]   Ann. me'd. psychol, Par.,  1952, 110
   (1) : 331-335.
Hamoneau, [G.], see Beaujard, Hamoneau.
■---, see Broussolle, P., Hamoneau, G.
214 
AUTHOR LIST
Henderson, F. G.
 Hampson, J. L., Rosenthal, D„ Frank, J. D.  A compara-
   tive  study of the effect of mephenesin and placebo on
   the symptomatology of a mixed group of psychiatric out-
   patients.  Bull. Johns Hopkins Hosp., 1954, 95 :170-177.
   Abstract: Excerpta med.,  Sect. 8, 1956, 9: No. 2662.
 Hance, A. J., see Bradley, P. B., Hance, A. J.
 Handley, C. A., see Pevey, J.  K., Moyer, J.  H., Handley,
   C. A., Heider, C.
 Hanrahan, G. E., see Lehmann, H. E., Hanrahan, G. E.
 Hansel, F. K., see Barrett, B. M., Hansel, F. K.
 Hanson, N. O.,  see Achor, R. W., Hanson, N. O.
 ---, see Achor, R. W., P., Hanson, N. O., Gifford, R. W., Jr.
 Happiness pills in  medical practice:  a symposium.  J.
   Iowa M. Soc,  1957, 47: 57-65.
 Haq, S. M.,  Smyth, V.  O.  Preliminary observations on
   the use of largactil in psychiatry.  Med. J. Malaya, 1955,
   9: 205-211.  Abstract: Excerpta med., Sect. 8, 1956, 9:
   No. 4070.
 Haranath, P. S. R. K., see Pinakapani, S., Haranath,
   P. S. R. K.
 Hare, E.  H.   The effects of mephenesin in neurotic anx-
   iety. J. 3Ient. Sc, Lond., 1955, 101:172-174. Abstract:
   Excerpta med., Sect. 8,1956, 9: No. 1717.
 ■---, Seager, C. P., Leitch, A.   Reserpine in anxiety states.
   Lancet, Lond., 1956,  1: 545-547. Abstract: Year book
   of drug theraphy, 1956-1957, p. 336-337.
 Hargreaves, G.  R., Hamilton,  M., Roberts, J. M.  Benac-
   tyzine as  an  aid  in treatment of  anxiety  states;  pre-
   liminary report.   Brit. M. J., 1957, 1: 306-310.
 Harl, J. M., see Delay, J., Deniker, P.,  Harl, J. M.
 ---, see Delay, J., Deniker, P., Harl,  Grasset A.
 Harlow, H. F., see Hall, J. F., Warren, J. M., Harlow, H. F.
 Harned, B. K.,  Cunningham, R. W., Clark,  M. G, Hine,
   C. H., Kane,  M. M., Smith, F. H., Jr., Vessey, R. E.,
   Yuda, N. N.,  Zabransky, F. W.  The pharmacology of
   N-benzyl-j8-chloropropionamide  (hibicon),  a new anti-
   convulsant.  J. Pharm. Exp. Ther., 1953, 107: 403-423.
 Harris, R.  Clinical use of reserpine  (serpasil)  in geri-
   atrics.  Ann.  N. York Acad. Sc, 1954, 59: 95-106.  Ab-
   stract :  Chem. Abstr., 1954,48:10220b.
 ---.  Results of reserpine therapy  in hypertension.  J.
   Geront., 1954, 9: 484-485.
 Harris, R. D., Rowley, E. H.  Reserpine in cerebral palsy.
   J. Pediat.,  S. Louis, 1956, 49: 398-400.
 Harris, T. H.  Depression induced  by Rauwolfia com-
   pounds.  Am.  J. Psychiat., 1957, 113: 950.
 Hart, E. R., Langfitt, T. W., Marrazzi, A. S.  Some cerebral
   synaptic aspects of the pharmacology of toxic psychoses,
   tranquilizers  and  antidotes.  [Abstract]   J.   Pharm.
   Exp. Ther., 1956,116 : 27-28.
 ---, see Marrazzi, A. S., Hart, E. R.
 Hart, T. M.  Use of a chlorpromazine-dextroamphetamine
   combination in anxiety  neuroses.    Am. Practitioner,
   1956,  7:1988-1990.
 Harth, J.  A.  P.,  see Howell, T. H., Harth, J.  A. P., Diet-
   rich, M.
 Hartmann, K.  Uber die Bildnereien Geisteskranker  und
   ihre  Bildkommentare; Anmerkungen  zur  Megaphen-
   therapie.   [Artistic  creations  of mental patients  and
   their  own comments on their paintings; notes on mega-
   phen therapy.]  Zschr. Psychother., 1956, 6: 7-15.
 ---, Hiob, J., Hippius, H.  Comparative psychopathology
   of shock therapy and pharmacotherapy.  Internat. Rec.
   M., 1957,170:119-124.
 ___t____t____.   Zur vergleichenden Psychopathologie der
   Schock-'   und   Phenothiazinwirkung.  [Comparative
  psychodynamics of shock therapy and phenothiazines.]
  Fortsch. Neur. Psychiat., 1955, 23: 354-366.
 Haslerud,  G.  M., see Niswander, G. D., Haslerud, G. M.,
  Brody, N., Casey, T. M. t^tt    <.~tttv,tt,
Hassert, G. L., see Burke, J. C, Hassert, G. L., High, J. P.
Hauser  A., Wenner, R.  Serpasil in der Behandlung kli-
  makterischer Ausfallserscheinungen.   [Serpasil in  the
  management  of climacteric dysfunction.]   Gynaecol-
  ogia, Basel, 1956, 142 : 300-303.
 Hawkes, C. D.  N-Benzyl-/3-chlorpropionamide  (hibicon) ;
   a new approach to anticonvulsant therapy.   A. M. A.
   Arch. Neur. Psychiat., 1952, 67: 815-820.
 Hawkins, D. R., see Abse, D. W., Curtis, T. E., Dahlstrom,
   W. G., Hawkins, D. R., Toops, T. C.
 Hawkins,  H. M.,  see Gardner, M.  J.,  Hawkins,  H. M.,
   Judah, L. N., Murphree, O. D.
 Hawkins, J. R., see Fabing, H. D., Hawkins, J. R.
 ----, see Fabing, H. D., Hawkins, J. R., Moulton, J. A.
 ---, see Fabing, H.  D., Kropa, E. L.,  Hawkins, J. R.,
   Leake, CD.
 Haynes, E. E.,  see Rinaldi, F., Haynes, E. E., Rudy, L. H.,
   Himwich, H. E.
 Hazards of tranquillity.  Brit. M. J., 1957, 2: 92-93.
 Heath, R. G, see Monroe, R. R., Heath, R.  G., Mickle, W. A.,
   Miller, W.
 Heberden, P., Cooper, W.  Attempted suicide with  mepro-
   bamate treated with leptazol.  Brit. 31. J., 1957, 1: 1513.
 Hedqvist,  H.  Nagra erfarenheter  av promethazinklorid
   som sedativum och hypnoticum.   [Experience with pro-
   methazine chloride  as  sedative and hypnotic]   Sven.
   lak. tidn., 1954, 51:1286-1297.
 ---, see Schmiterlow, C. G., Hedqvist, H.
 Heffley, W.,  see Grandon, R.  C, Heffley, W., Hensel, T.,
   Bashore,  S.
 Heider, C, see Pevey, J. K., Moyer, J. H., Handley, C. A.,
   Heider, C.
 Heiken, H., see Shubin, H., Heiken, C.  A., Glaskin, A.,
   Pennes, E., Arsenian, J.
 Heilbrunn,  G.  Selection of patients for modern  psychi-
   atric pharmacotherapy in general practice.  Northwest
   M., 1956, 55:1198-1205
 Heim, F.,  Frodl, E.  Der Einflus des Megaphen auf die
   Spontan-und Hypermotilitat der weissen Maus.  [Effect
   of megaphen on spontaneous and hypermotility of white
   mice.]  Arzneimitt.  Forsch.,  1954,   4:514-515.  Ab-
   stract : Chem. Abstr., 1955, 49: 518gh.
 Heimann, H., Witt., P. N.  Die Wirkung  einer einmaligen
   Largactilgabe bei Gesunden; vergleichend psychopathol-
   ogisch-elektroencephalographische     Untersuchungen.
   [Effect of single doses of chlorpromazine in normal in-
   dividuals ; comparative psychopathological-electroence-
   phalographic  studies.]  [English  summary]   Mschr.
   Psychiat, Basel, 1955,129:104-123.
 ---, see Witt,  P. N., Heimann, H.
 Heimendinger, E., Klotz, C, Champy, M.  Essais de cure
   de sommeil dans quelques affections oto-rhino-laryngolo-
   giques.   [Trial sleep therapy in various otorhinolaryn-
   gological diseases.]  Rev. otoneur., Par., 1956, 28:138-
   143.
 Heinrich, K., see Gade, E. B., Heinrich, K.
 Heiss, R., Becker, H., Hiltmann, H., Honsberg, I.  Uber
  psychische Wirkungen eines neuartigen Psychotonikums.
   [Psychological  effects  of  a new central stimulant.]
  Medizinische, 1956: 260-262.
 Helander, S., Hood, B.  Depressionsrisken vid rauwolfla-
  behandling.  [Hazards of depression in Rauwolfia ther-
  apy.]  Sven. lak. tidn., 1956, 53:1021-1023.
 Held, R.  Sur la chlorpromazine et les medicaments neuro-
  leptiques ; incidences psychotherapeutiques.  [Chlorpro-
  mazine and neuroleptic drugs; psychotherapeutic inci-
  dences.]   Encephale, 1956, 45:1000-1004.
 Heller, G. C, Walton, D., Black, D. A.   Meprobamate in
  the treatment of tension states.   J. Ment. Sc,  Lond.,
  1957,  103:581-588.
 Hemmer, R.  Beobachtungen fiber psychische Veranderun-
  gen unter potenzierter Narkose.   [Observations on psy-
  chic changes in potentiated anesthesia.]  [English sum-
  mary]  Zbl. Neurochir., 1953, 13 : 360-364.
 Henderson, A.  L.,  see  Forster, W.,  Henderson,  A.  L.
----, see Forster, W., Schlichther, W., Henderson, A. L.
---, see Schlichther, W., Bristow, M. E.,  Schultz, S., Hen-
  derson, A.  L.
Henderson, F. G., see Slater, I. H., Rathbun, R. C, Hender-
  son,  F. G., Neuss, N.
215 
Henderson, L.
PSYCHOPHARMACA
Henderson, L., see Forster, W., Henderson, L., Schultz, S.
Hendley, C. D., Lynes, T.  E., Berger, F. M.   Effect of
  meprobamate on electrical activity  of  thalamus  and
  other subcortical areas.  In : Himwich, H. E. ed.  Tran-
  quilizing drugs.   Washington, Am. Ass. Adv.  Sc, 1957.
  p. 35-46.
----»  ----, ---•   Effect  of 2-methyl-2-n-propyl-l,3-pro-
  panediol dicarbamate (miltown) on central nervous sys-
  tem.  Proc. Soc. Exp. Biol, N. Y., 1954, 87 : 608-610. Ab-
  stract : Chem. Abstr., 1955, 49 : 4872fg.
---,  ----, ----•   Effect  of 2-methyl-2-n-propyl-l,3-pro-
  panediol dicarbamate  (miltown)  on  electrical activity
  of  the  brain.  [Abstract]  Fed.  Proc,  Bait.,  1955,
  14: 351.
---,  see Berger, F. M., Campbell,  G. L., Hendley, C. D.,
  Ludwig,  B. J., Lynes, T. E.
Henne, M., Durand, V. J., Bures,  I. de  Important  syn-
  drome delirant d'allure paranoide evoluant depuis trois
  ans, disparu apres trois semaines de chlorpromazine per
  os; analyse critique ecrite de  la malade.  [Severe de-
  lirium with  paranoid traits of three years duration; re-
  covery after 3 weeks of oral chlorpromazine therapy;
  critical analysis  written  by the patient.]  Ence'phale,
  1956, 45 : 672-676.
----,  Henne, S. Intoxication aigue au  cours d'une tenta-
  tive de suicide par chlorpromazine.  [Suicide attempted
  with chlorpromazine;  acute intoxication.]  Ann. me'd.
  psychol, Par., 1956, 114(2) : 309-314.
---,  see Sigwald, J., Henne, M.
——,  see Sigwald,  J.,  Henne, M., Bouttier, D.,  Raymon-
  deaud, C, Quetin, A.
Henne, S.,  see Henne, M., Henne, S.
Hensel, T., see Grandon, R. C,  Heffley, W., Hensel, T.,
  Bashore, S.
Hepner, L., see Sapir, M.,  Stroun,  J., Hepner, L., Rever-
  chon. J.,  Selzer, S.
Herman, M.,  Effron, A. S.  Tolserol in the treatment of
  the post-alcoholic state.  In: Podolsky, E. ed.  Manage-
  ment of  addictions.  New York, Philosophical Library,
  1955.  p. 209-217.
Harold, W., see Bair, H. V., Herold, W.
Herve, Y.,  see Gayral,  L., Herve,  Y., Carrie, J. Fourny, L.
---,  see Gayral, L., Herve, Y., Fourny,  L.,  Carrie, J.
Hes, J. P., Bracha, S.   The influence of reserpine on a dis-
  turbed male ward and a method  for assessing this. J.
  3Ient. Sc, Lond.,  1956, 102 : 546-549.
---,----.   [Reserpine in psychiatric treatment.]   [Eng-
  lish abstract] Harefuah, Tel-Aviv, 1956, 51: 101-106.
---,  see Bracha, S., Hes, J. P.
Hess, H., see Rosner, H., Levine, S., Hess, H., Kaye, H.
Hess, R.  Vorlaufige elektroencephalographische Befunde
  bei  Serpasil-Therapie.  [Preliminary  electroencephalog-
  raphic findings  in serpasil  therapy.]  Schiveiz. med.
  Wschr., 1955, 85 : 442-443.
Hess, S. M., Shore, P. A., Brodie,  B. B.  Persistence of
  reserpine action after the disappearance of drug from
  brain: effect of serotonin.  J. Pharm. Exp. Ther., 1956,
  118: 84-89.
Heuyer, G., Dell, C, Pringuet, G.  Emploi  de  la chlor-
  promazine en neuropsychiatrie infantile.  [Use of chlor-
  promazine in child neuropsychiatry.]   Ence'phale, 1956,
  45: 576-578.
---,  Giraud, G., Galibert, J.   Traitement de Texcitation
  psycho-motrice chez  l'enfant par le 4560 R. P.   [R. P.
  4560  therapy of  psychomotor  excitation in  children.]
  Arch. fr. pCdiat.,  1953, 10:961-963.
----,  Lang, J.  L., Chevreau, J. P., Juredieu.   Premiers re-
  sultats obtenus par un derive du chlorbenzhydryl en psy-
  chiatrie infantile.  [First  results with a  chlorbenzhy-
  dryl derivative in child psychiatry.]   Ence'phale, 1956,
  45 : 579-586.
Hewat, J. K., Leach, P. W., Simpson, R. W.   Chlorproma-
  zine, reserpine, and isoniazid treatment in mental disor-
  der ; a preliminary communication.  Brit. 31. J., 1955,
  2:1119-1120.  Abstract: Excerpta  med.,  Sect. 8, 1956,
  9: No. 2657.                             ,  M
Hewitt, D. W.  Alcoholism, a treatment guide for general
  practitioners.  112  p.   Philadelphia, Lea  d  Febiger,
  1957.                                    _, ...   „
Hickerson, G. X., Jr., Swain, J. M., Tempey,  F. W.  Reser-
  pine in  acute psychotic states; report  of a controlled
  study.  J. Nerv. 31 ent. Dis., 1956,124 : 614-617.
Hiebel, G., Bonvallet,  M., Dell,  P.   Action de la  chlor-
  promazine  (Largactil 45 60 RP)  au niveau du systeme
  nerveux central.  [Effects of chlorpromazine on central
  nervous system.]  Sem. hop. Paris,  1954, 30: 2346-2353.
  Abstract:  Excerpta med., Sect. 8, 1955, 8: No. 1219.
Hiestand,  E.  C. Overdosage with meprobamate; presen-
  tation of case. Ohio 31. J., 1956, 52 :1306-1307.
Hift, S., see Arnold, O. H., Hift, S., Solms, W.
High, J. P., see Burke, J. C, Hassert, G. L., High, J. P.
---,  see Piala, J. J., High, J. P., Greenspan,  K., Burke,
  J C
Hildebrand,  H. J.  Erfahrungen bei der Behandlung psy-
  chisch Kranker mit Serpasil.  [Experiences in the treat-
  ment of mental patients with serpasil.]   [English sum-
  mary]   Munch, med. Wschr.,  1956, 98:1093-1096.
Hilliard, E. T.  The use of reserpine,  chlorpromazine and
  allied drugs in medicine and psychiatry.  Med. J. Aus-
  tralia, 1956, 43(1) : 1035-1040.
Hiltmann, H.,  see Heiss, R., Becker, H., Hiltmann, H.,
  Honsberg, I.
Himwich,  H. E. Discussion of papers on basic observa-
  tions of new psychopharmacological agents.  Psychiat,
  Res. Rep.,  Wash., 1956 (4) : 24-31.
---.  The effect of frenquel on EEG changes produced by
  LSD-25 and  mescaline.  In: Cholden, L.,  ed.   Lysergic
  acid diethylamide  and mescaline in experimental psy-
  chiatry.  New York,  Grune d Stratton,  1956.  p.  19-26.
---.  Prospects in psychopharmacology.  J. Nerv. Ment
  Dis.,  1955,  122:  413-423.  Also:   Dis.  Nerv.  Syst,
  1956,17 : 109-116.
---.  Viewpoints obtained from basic and clinical sym-
  posia on tranquilizing drugs.   In:  Himwich,  H.  E., ed.
  Tranquilizing drugs.   Washington, Am. Ass. Adv. Sc,
  1957.  p. 183-192.
■----,  ed.  Tranquilizing  drugs.   197 p.   [Symposium
  held in  Atlanta, Georgia, December 1955] Washington,
  Am. Ass. Adv. Sc., 1957.  [Articles within the scope of
  this bibliography are  listed individually]
---,  Rinaldi, F.  Analysis of the  action of  benztropine
  methanesulfonate against Parkinsonism.  In : Himwich,
  H. E., ed.   Tranquilizing drugs.  Washington, Am. Ass.
  Adv. Sc, 1957.  p. 47-57.
---, ---, Willis,  D.  An examination of  phenothiazine
  derivatives  with  comparisons  of their effects on the
  alerting reaction,  chemical structure   and  therapeutic
  efficacy. J. Nerv. Ment Dis., 1956,124 : 53-57.
---, see Hagenauer. F., Rudy, L. H.. Himwich, H. E.
---■, see Nathan P., Aprison, M. H.,  Himwich, H. E.
---, see Rinaldi, F., Haynes, E. E., Rudy, L. H., Himwich,
  HE.
---, see Rinaldi, F., Himwich, H. E.
---, see Rinaldi, F., Rudy, L. H., Himwich, H. E.
----, see Rudy, L. H., Himwich, H. E., Tasher, D. C.
----, see Rudy, L. H., Rinaldi, F., Himwich, H. E.
---, see Schut, J. W., Himwich, H. E.
Hine, C. H., see Harned, B. K., Cunningham, R.  W., Clark,
  M. C, Hine, C. H., Kane, M. M.. Smith, F. H., Jr., Vessey,
  R. E.. Yuda. N. N.. Zabransky. F. W.
Hine, F.  R.,  See Bryant, J.  H.,  Bass, B. M., Hine, F. R.
Hiob, J.   Klinische Erfahrungen bei  der  Behandlung von
  Psychosen mit  Megaphen.   [Clinical experiences  in
  megaphen therapy of psychoses.]  Aerztl Wschr., 1954,
  9:919-924.
----, Hippius, H.  Klinische Erfahrungen  mit dem Rau-
  wolfia-Alkaloid Reserpin in der Psychiatrie.  [Clinical
  experiences  with  the  Rauwolfia alkaloid reserpine in
  psychiatry.]  Deut. med. Wschr., 1955,  80: 1497-1500.
216 
AUTHOR LIST
Holt, E. K.
---, ----, Uber die Behandlung von Psychosen mit dem
  Phenothiazinderivat Pacatal.   [The treatment of psy-
  choses with the  phenothiazine  derivative pacatal.]
  3Ied.  Klin., Berl, 1955, 50:1746-1748.  Abstract: Ex-
  cerpta med., Sect. 8, 1957, 10 : No. 1544.
---, see Hartmann, K., Hiob, J., Hippius, H.
Hippius, H., Mellin, P., Rosenkotter, L. Megaphen wirkung-
  en im EEG  des Kaninchens.   [Megaphen effects on
  the EEG of rabbits.]  Zschr. ges. exp. Med., 1955, 125:
  128-135.
---, see Hartmann, K., Hiob, J., Hippius, H.
---, see Hiob, J., Hippius, H.
Hiraiwa, K., see Yoshii, N.,  Tsukiyama, K., Hiraiwa, K.
Hirsch, M. W., Jarvik, M. E., Abramson, H. A.  Lysergic
  acid  diethylamide  (LSD-25) : XVIII.  Effects of LSD-
  25 and six related drugs upon handwriting.  J. Psychol,
  Provincet., 1956, 41: 11-22.  Abstract:  Excerpta med.,
  Sect. 8,1956, 9 : No. 3944.
---, see Abramson, H. A., Jarvik,  M.  E., Gorin, M. H.,
  Hirsch, M. W.
---, see Abramson, H. A.,  Jarvik, M. E., Hirsch, M. W.
-—, see Abramson, H. A., Jarvik, M. E., Hirsch, M. W.,
  Ewald, A. T.
---, see  Abramson, H. A., Jarvik, M.  E.,  Levine, A.,
  Kaufman, M. R., Hirsch, M. W.
---, see Jarvik,  M. E., Abramson, H. A., Hirsch, M. W.
Hirsch, S.,  see Shane, A. M., Hirsch, S.
Hivert, P. H., see Rondepierre, J., Hivert, P. H., Honore,
  B., Vaugelade, S.
Hoagland, H., see Rinkel, M., Hyde, R. W., Solomon, H. C,
  Hoagland, H.
Hoch,  P. H.  The effect of chlorpromazine on moderate
  and  mild  mental  and  emotional disturbances.   In:
  Chlorpromazine and mental health.  Philadelphia, Lea
  & Febiger, 1955.  p. 99-111;  discussion p. 111-140.
---.   Experimental psychiatry.   Am. J.  Psychiat, 1955,
  111:787-790.
---.  New drug therapy in psychiatry: clinical uses and
  abuses in mental  disorders.   Bull. N.  York Acad. M.,
  1957, 33: 474-486.
---.   Practical and theoretical  applications of  the new
  drug  therapies in  psychiatry.   A. 31.  A. Arch. Neur.
  Psychiat, 1956, 75 : 325-328.
---.   Progress in psychiatric therapies.  Am. J. Psychiat,
  1955, 112 : 241-247.
---.   Remarks on LSD and  mescaline.  J. Nerv. 3Ient.
  Dis., 1957,  125 : 442-444.
---.   Studies  in  routes of administration and  counter-
  acting drugs.   In: Cholden, L., ed.  Lysergic acid di-
  ethylamide and mescaline in  experimental psychiatry.
  New York, Grune d Stratton, 1956.  p. 8-12.
---, Cattell, J. P., Pennes, H. H. Effect of drugs; theo-
  retical considerations from a  psychological viewpoint.
  Am. J. Psychiat, 1952,108 : 585-589.
___,----, ----.   Effects of mescaline and lysergic acid
  (d-LSD-25).  Am. J. Psychiat., 1952, 108:579-584.
---, Pennes, H. H.,  Cattell, J. P.  Psychoses produced by
  administration of drugs.  .Res. Pub. Ass. Res. Ncrr. Ment,
  Dis., 1953, 32 : 287-296.
---, see Lesse, S., Malitz, S., Hoch, P. [H]
---, see Malitz,  S., Hoch,  P. H.
---, see Malitz, S., Hoch, P. H, Lesse, S.
---, see Pennes, H. H., Hoch, P. H.
Hock  E H  The use of chlorpromazine in  mental dis-
  orders'  J  Christ. 31. Ass., India, 1956, 31: 285-291.
Hodges H H., LaZerte, G. D.   Jaundice and agranulo-
  cytosis with fatality following  chlorpromazine therapy.
  J. Am. M. Ass., 1955,158 : 114-116.
Hodgkinson,  R.  The effects of reserpine  on hypertensive
  patients  over a period  of two years.  Brit Heart J.,
  1956  18 •593-52S.
Hoeck,' L. E., see Budnick, I. S., Leikin, S., Hoeck, L. E.
Hnff W  Advantages and disadvantages  of treatment
  with^chloVpromaline and serpasil.  Enctphale,  1956,
  45: 352-358.
----.  Vorteile und Nachteile der Behandlung mit Largac-
  til und Serpasil.  [Advantages  and  disadvantages  of
  therapy with largactil and with serpasil.]  Wien. klin.
  Wschr., 1956, 68 : 97-101.
---, see Arnold, O. H, Hoff, H.
Hoffer, A.  Adrenolutin as  a psychotomimetic agent.  In:
  Himwich, H. E.  ed. Tranquilizing drugs.  Washington,
  Am, Ass. Adv. Sc, 1957.  p. 73-100.
---.  Epinephrine derivatives as potential schizophrenic
  factors.  J. Clin. Exp. Psychopath., 1957, 18:27-60.
---.   Experimental pharmacodynamics and psychobiol-
  ogy. J. Clin. Exp. Psychopath., 1956,  17: 376-377.
---.  Studies with niacin and LSD.  In: Cholden, L., ed.
  Lysergic acid diethylamide aud mescaline in experi-
  mental psychiatry.  New York, Grune d Stratton, 1956.
  p. 44-15.
---,  Osmond,  H., Smythies, J.   Schizophrenia;  a  new
  approach.  II. Result of a year's  research.   J. 3Ient.
  Sc, Lond., 1954, 100: 29-45.
----, see Agnew, N., Hoffer, A.
----, see Szatmari, A., Hoffer, A., Schneider, R.
Hoffman, J. L.  General summary to: Chlorpromazine and
  reserpine; symposium on  experiences at Saint Elizabeths
  Hospital. Med.  Ann. District of Columbia.  1956, 25:
  2(37-268; 298.
---,  Konchegul, L.  Clinical and psychological observa-
  tions on psychiatric patients treated with reserpine: a
  preliminary report.  Ann. N. York  Acad. Sc, 1955, 61:
  144-149.  Abstract:  Excerpta med.,  Sect.  8,  1956,  9:
  No. 3083.
---, see Overholser, W., Waldrop, F. N., Riesenman, F. R.,
  Fong, T. C. ('., Farley, O. R., Hoffman, J. L.
Hoffman, K., see Tripod, J.,  Sury, E.. Hoffman, K.
Hoffmann, I., see Nieschulz, O., Hoffmann, I., Popendiker,
  K.
---,  see Nieschulz,  O., Popendiker, K., Hoffmann, I.
Hoheisel, H. P.,  see Walch, R., Hoheisel, H. P.
Holden, R. H., see Denhoff, E., Holden, R. H.
Holland, W., see Clark, L. D., Ellsworth, R. B.,  Barrett,
  W.  W. Thurman, A. C, Holland, W.
Hollander, W., see Wilkins, R. W., Judson, W. E., Stone,
  R. W., Hollander, W., Huckabee, W. E., Friedman, I.  H.
Hollister, L. E.  Complications from the use of tranquiliz-
  ing drugs.  N. England J. 31., 1957, 257 : 170-177.
---.  Hematemesis  and melena  complicating  treatment
  with Rauwolfia alkaloids.  A. M. A. Arch. Int. 31., 1957,
  99: 218-221.
---.  Tranquilizing  drugs and  the generalist.  3Ied.
  Times, Great  Neck, 1956, 84: 1021-1026.
---.  Unexpected  asphyxial  death and  tranquilizing
  drugs.  Am. J. Psychiat, 1957,114 : 366-367.
---,  Jones,  K. P.,  Brownfield, B., Johnson, F.  Chlor-
  promazine alone and with reserpine; use in the treat-
  ment of mental diseases.  California  31., 1955, 83: 218-
  221. Abstract: Excerpta med., Sect. 8,1956, 9 : No. 1219.
---,  Krieger, G. E., Kringel, A.,  Roberts, R. H. Treat-
  ment of  chronic schizophrenic reactions with reserpine.
  Ann. N. York Acad. Sc, 1955,  61:92-100.  Abstract:
  Excerpta med., Sect. 8, 1956, 9: No. 1231.
---,  Stannard, A. N., Drake, C. F.  Treatment of anxious
  patients with drugs.  Dis. Nerv. Syst., 1956, 17 : 289-293.
---,  Traub, L., Beckman,  W. G.  Psychiatric use of res-
  erpine  and  chlorpromazine: results  of  double-blind
  studies.   In:  Kline,  N.  S.,  ed.   Psychopharmacology.
  Washington, Am.  Ass. Adv. Sc,  1956.  p.  65-74.
Holmberg, G., Jbnsson, B.,  Mellgren, A., Martens, S.  EEG
  changes in  chlorpromazine  and  reserpine  treatment.
  Acta psychiat. neur. scand., 1956, Suppl. 106: 235-240.
Holmes, C. R., Stone, H. M. Agranulocytosis due to chlor-
  promazine;  report of a case with recovery.  J. S. Caro-
  lina 31. Ass., 1956,  52 : 42-45.
Holt, E. K., Ward-Dunn, G., Nedilsky,  B. T., Niswander,
  G.  D.   Clinical comparison of  raudixin  and  rau-sed
  in  chronic  mental   illness.   Dis. Nerv.  Syst,  1955,
217 
Holt, E. K.
PSYCHOPHARMACA
   16:222-223.   Abstract:  Excerpta med., Sect.  8,  1956,
   9: No. 4564.
 ——, see Niswander, G. D., Holt, E. K.
 Holt, W. E.  Effect of mephenesin on psychotic patients.
   J. Nerv. 3Ient Dis., 1952,115 : 343-350.
 Holten, C. H., Sonne, E.  Action of a series of benactyzine-
   derivatives and other compounds on stress-induced be-
   haviour in the rat. Acta pharm. tox., Kbh., 1955, 11:
   148-155.
 Holtzer, P. A.  Studiereis naar Parijs ter kennismaking
   met het praeparaat largactil (4560 R. P.).  [Study trip
   to Paris to obtain information on largactil (4560 RP).]
   Geneesk. gids, 1953, 31:465-469.
 Honore, B.,  see Rondepierre, J., Hivert, P. H., Honore,
   B., Vaugelade, S.
 Honsberg, I., see Heiss, R.,  Becker,  H., Hiltmann, H.,
   Honsberg, I.
 Hood, B., see Helander, S., Hood, B.
 Hopkin, D. A. B.  The action  of chlorpromazine.  Review
   of French work.  Lancet, Lond., 1955, 1: 605-607.
 Horbaczewski, J.  Agranulocytosis associated with chlor-
   promazine therapy. Canad. M. Ass. J., 1956,  75: 412-
   415.
 Horenstein,  S.  Reserpine and chlorpromazine in hyper-
   active mental defectives.   Am.  J. Ment.  Defic,  1957,
   61: 525-529.
 Hormia, A.  A  comparison between combined reserpine-
   chlorpromazine and chlorpromazine  therapies in psy-
   chiatry. Acta psychiat. neur. scand., 1956, 31: 437-446.
 ----.  Ha vain to j a   klooripromatsiini-reserpiini-insuliini-
   sokkihoitoyhdistelmasta.   [Observations  on combined
   chlorpromazine, reserpine and insulin coma therapy.]
   [English summary] Duodecim, Helsin.,  1956,  72:948-
   955.
 ---.  Klooripromatsiini psykiatriassa.  [Chlorpromazine
   in psychiatry.]  [English summary] Duodecim, Helsin.,
   1955, 71: 1226-1242.
 ----.  Klooripromatsiinihotto  psykiatriassa viiden vuoden
   kokemusten  valossa.   [Chlorpromazine treatment  in
   psychiatry in the light of five years' experience.] Suom.
   laak. lehti, 1956,11: 1154-1158.
 ----.  Meprobamaatista neuropsykiatriassa  saatuja hoi-
   tokokemuksla.   [Meprobamate therapy  in  neuropsy-
   chiatry.]   [English   summary]  Duodecim,   Helsin.,
   1956, 72 : 1019-1024.
 ---.  Yhdistetty serpasil-klooripromatsiinihoito psykia-
   triassa.  [Combined serpasil-chlorpromazine treatment
   in psychiatry.]  [English summary] Duodecim, Helsin.,
   1956, 72: 76-85.
 Horning, E. C, see Fish, M. S., Horning, E. C.
 Horst, L. van der.   Donnees sur Temploi du largactil et
   d'autres derivatives de la phenothiazine en neurologie,
   neuro-chirurgie et radiologie.  [The use of largactil and
   other  phenothiazines in neurology, neurosurgery and
   radiology.]  Ence'phale, 1956, 45 : 717-721.
 Hosko, M. J., Gore, E. M.,  Tislow, R., Seifter, J.  Taming
   effect of promazine in the rhesus monkey.  [Abstract]
   J. Pharm. Exp. Ther., 1957,119 :153-154.
 Houde, R. W.,  Wallenstein,  S. L.  Analgetic power  of
   chlorpromazine  alone  and  in  combination with  mor-
   phine.   [Abstract] Fed. Proc, Bait, 1955, 14:353.
 ----, ----.   Clinical aspects  of the  evaluation of anal-
   gesics.  J. Am. Geriat. Soc, 1956,4 :167-171.
 Houillon, G.,  see Durand, V. J., Houillon, G.
 Houston, F.  Group behaviour in chronic schizophrenics
   treated with meratran.  Brit. M. J., 1956, 1:949-952.
   Abstract: Excerpta med., Sect. 8, 1957,  10: No. 2084.
 Howard, J. C, Jr.,  Vinci, F. J.  Use of the  tranquilizing
   properties  of  reserpine; a review. Internat. Rec. M.,
   1956,169: 213-221.
 Howell, T. H., Harth, J. A. P., Dietrich, M.  The use  of
   chlorpromazine in geriatrics. Practitioner, Lond., 1954,
  173: 172-173.
Howlett, K. S., see O'Connor, J. B., Howlett, K. S.
----, see O'Connor, J. B., Howlett, K. S., Wagner, R. R.
Hubbard, B. A.  Reserpine.  J. Am. M. Ass., 1955, 157:
  468.                                       .   .
Hubbard, O. E., Glasser, J.  Newer psychotropic drugs;
  their characteristics and use in general practice.  North-
  west M., 1956, 55 :1191-1197.
Huber, R. D., see Begany, A. J., Seifter, J., Pless, H. H.,
  Huber, R. D., Bruce, W. F.
Huchon, J., see Hyvert, M., Fagard, H., Huchon, J.
Huchtemann, K., Pflugfelder,  G.   Serpasilkuren  in der
  Psychiatrie; Bericht fiber 100 Kuren.  [Serpasil  ther-
  apy in psychiatry; report on  100 cases.]  Schweiz. med.
  Wschr., 1955,  85:627-630.   Abstract: Excerpta med.,
  Sect. 8,1956, 9 : No. 2242.
Huckabee, W. E., see Wilkins, R. W., Judson, W. E., Stone,
  R. W., Hollander, W., Huckabee, W. E., Friedman, I. H.
Huguenard, P.  Etude clinique d'un nouveau neurople-
  gique, le 1522 CB (maleate d'acetylpromazine).  [Clini-
  cal study of a new neuroplegic drug, CB-1522  (acetyl-
  promazine maleate) ].   Presse me'd., 1957, 65 : 685-688.
---, see Laborit H., Huguenard,  P.
---, see Laborit, H.,Huguenard, P., Alluaume, R.
Huizenga, K. A., see Loftus, L. R., Huizenga, K. A., Stauf-
  fer, M. H, Rome, H. P., Caine, J. C.
Humphries, O., see Kornetsky, C, Humphries, O.
---, see Kornetsky, C. Humphries, O., Evarts, E. V.
Hunt, B. R.,  Frank, T., Krush, T. P. Chlorpromazine in
  the treatment of severe emotional disorders of children.
  A. M. A. J. Dis. Child., 1956, 91: 268-277.
Hunt, H. F.  Some effects of drugs on classical (type S)
  conditioning. Ann, N. York Acad. Sc, 1956, 65: 258-267.
Hunter, W., see Merlis, S., Hunter, W.
Hurst, L. A., Reuning, H., Wyk, A.  J. van,  Crouse, H. S,
  Booysen, P. J., Nelson, G.   Experiences with d-lysergic
  acid diethylamide  (LSD) ;  a symposium.  S.  Afr. J.
  Laborat. Clin. M., 1956, 2: 289-310.
Hussar, A. E. Complications of chlorpromazine and res-
  erpine therapy.  GP, 1957, 15(5) : 85-93.
Hutchinson, J. T.  The value of drugs in the treatment of
  neuroses.  Med. Illust., Lond., 1956, 10: 541-544.
Huxley, A.   The  doors  of perception.  79p. New  York,
  Harper, 1954.
---, Heaven and hell. 88 p.  London, Chatto d Windus,
  1956.
---, Mescaline and the "other world."  In: Cholden, L.,
  ed.  Lysergic acid diethylamide  and mescaline in ex-
  perimental psychiatry.  New York, Grune d Stratton,
  1956.   p. 46-50.
Hyde, R. W.,  Von Mering, O., Morimoto, K.  Hostility in
  the  lysergic psychosis. J.  Nerv. Ment. Dis., 1953,
  118:266-267.
---, see Di Mascio, A., Greenblatt,  M., Hyde, R. W.
---, see Di Mascio, A., Suter, E., Hyde, R. W., Greenblatt,
  M.
---, see Rinkel, M., DeShon, H. J., Hyde, R. W., Solomon,
    H. C.
----, see Rinkel, M., Hyde, R. W., Solomon, H. C.
---, see Rinkel, M., Hyde, R. W., Solomon, H. C, Hoag-
  land,  H.
----, see Salvatore, S., Hyde, R. W.
---, see Slater, P. E., Morimoto, K., Hyde, R. W.
Hyvert, M.  La chlorpromazine, traitement des psychoses
  chroniques. [Chlorpromazine  treatment  in  chronic
  psychoses.]  Ence'phale, 1956, 45:617-627.
---, Fagard, H., Huchon, J.  Premiers resultats du traite-
  ment par la chlorpromazine  d'un nombre important de
  malades chroniques.  [Initial results with chlorproma-
  zine treatment  of a significant number  of chronic pa-
  tients.]  Ann. me'd. psychol, Par., 1955, 113(1): 645-
  653.
                          I

Ibsen, B.,  Pahle,  H., Villumsen,  A. L.  Chlorpromazin
  hydrochlorid (largactil) ;  en oversigt.   [Chlorproma-
  zine hydrochloride (largactil) ; review.]  [Brief Eng-
  lish summary]   Ugeskr.  laeger, 1954, 116 : 1769-1775.
218 
AUTHOR LIST
Jewesbury, E. C.
Ilhg, H., see Gruber, K., Illig, H., Pflanz, M.
Imber, S. D., see Rosenthal, D., Imber, S. D.
Imberciadori,  S.,  Manganaro, D.   Effetti della somminis-
  trazione  di  2-metil-2-n-propil-l,3-propandiolo  dicarba-
  mato (mepro-bainato)  nei malati di mente.  [Effects of
  administration   of  2-methyl-2-n-propyl-l,3-propanediol
  dicarbamate  (mepro-bamate)  in mental  disorders.]
  Minerva med., Tor., 1956, 47 : 2181-2184.
Ingram, W., Jr., see McCullagh, W. H., Ingram, W., Jr.
Ingvar, D.  H.,  Soderberg, U.  Effects of  chlorpromazine
  on cerebral  circulation and electroencephalogram  in
  cats.  A.  M. A. Arch. Neur. Psychiat, 1957, 78: 254-258.
International  symposium on chlorpromazine.  J. Clin.
  Exp. Psychopath., 1956, 17 :15-76 ;  129-188.   [Articles
  within the scope of this bibliography are listed individ-
  ually]
Irwin,  S.,  Govier, W. M.  Chlorpiprozine,  a new tran-
  quilizer :  comparison with chlorpromazine in the  mouse,
  rat, cat, dog, and monkey.  [Abstract]   J. Pharm. Exp.
  Ther., 1957,119 :154-155.
Isaacs, B., see McArthur, J. G., Isaacs, B.
Isbell,  H.,  Belleville,  R. E., Fraser, H.  F., Wikler, A.,
  Logan, C. R.  Studies on lysergic acid  diethylamide
  (LSD-25).  I. Effects  in former morphine addicts and
  development  of tolerance during chronic intoxication.
  A. 31. A.  Arch.  Neur. Psychiat., 1956, 76:468-478.
---, Fraser, H. F., Wikler, A., Belleville, R. E. Tolerance
  to diethylamide of lysergic acid  (LSD-25).  [Abstract]
  Fed. Proc, Bait., 1955,14: 354.
---, Logan, C. R.  Studies on the diethylamide of lysergic
  acid  (LSD-25).  II. Effects of  chlorpromazine,  azacyl-
  onol, and reserpine on the intensity of the LSD-reaction.
  A. 31. A. Arch. Neur. Psychiat.,  1957, 77:350-358.
----, see Fraser, H. F., Isbell, H.
Isberg, E. M., see Tourney, G., Isberg, E. M., Gottlieb, J. S.
Itil, T., see Bente, D., Itil, T.
 Jachova, D., see Sercl, M., Bartousek, V., Jachova, D.
 Jackson, G. L., Smith, D. A.  Analgesic properties of mix-
   tures of chlorpromazine with morphine and meperidine.
   Ann. Int. M., 1956, 45 : 640-652.
 Jackson, R. B., see Hall, R. A., Jackson, R. B., Swain, J. M.
 Jacob, G. M., see Kline, N. S., Jacob, G. M.
 Jacobowsky, B.  Experiences from clinical psychiatry,
   with special reference to general and  methodological
   viewpoints.   Acta psychiat. neur. scand., 1952, Suppl.
   80: 86-101.
 Jacobsen, E.  Suavitil; et nyt stof med specifik virking pa
   centralnervesystemet.   [Suavitil, a new drug with spe-
   cific effect on  the  central nervous  system.]   [English
   summary]   Ugeskr. laeger, 1955,  117:1147-1151.
 ---, Kehlet, H., Larsen, V., Munkvad, I., Skinhoj, K.  The
   autonomic reaction of  psychoneurotics to a new seda-
   tive: benactyzine NFN, suavitil  (R) (benzilic acid di-
   ethylaminoethylester hydrochloride).  Acta  psychiat.
   neur. scand., 1955, 30:627-642.   Abstract:  Excerpta
   med., Sect. 8,1956, 9 : No. 2668.
 ___f  Skaarup, Y.  Experimental  induction  of  conflict-
   behaviour in cats: the effect  of some  anticholinergic
   compounds.   Acta pharm.  tox., Kbh., 1955, 11:125-134.
   Abstract: Chem. Abstr., 1956, 50 : 2045ef.
 ____(  Sonne, E.  The effect  of benactyzine on the condi-
   tioned responses in the rat.  Acta pharm. tox.,  Kbh.,
   1956, 12:310-320.  Abstract:  Chem. Abstr.,  1956, 50:
  2045d; 14967h.                    ..,.,.„.,    •   «.  !
 _________rp^e effect of benzilic acid diethylaminoethyl-
  ester HC1 (benactyzine )on stress-induced behaviour in
  the rat. Acta pharm. tox  Kbh., 19o5, 11:135-147.  Ab-
  stract : Chem. Abstr., 1956, 50 : 2045fg.
Jacobson, A.  Ritalin—a new agent for mild depressions,
  a preliminary report.  Med.  Ann. District of Columbia,
  1956 25: 491-^94; 527-528.
Jameson,  G. K. see Ford, H., Jameson, G. K.
Janzarik, W.  Die bedeutung der neuroplegischen Thera-
  pie ftir die Psychopathologie des schizophrenen Wahns.
  [Significance of neuroplegic therapy  for  the psycho-
  pathology of schizophrenic hallucinations.]  Ence'phale,
  1956, 45 : 635-642.
----.  Zur Psychopathologie der Megaphen wirkung.  [Psy-
  chopathology of the effects of megaphen.]  Nervenarzt,
  1954,  25: 330-335.   Abstract: Excerpta  med., Sect. 8,
  1955, 8 : No. 1795.
Jarvik, M. E.  Effect of LSD-25 on snails. In: Abramson,
  H.  A., ed.  Neuropharmacology.   Transactions of  the
  third conference, May 1956, Princeton, N. J.  New York,
  Josiah Macy, Jr. Foundation, 1957.  p. 29-38.
----.  Mechanism of action of lysergic acid diethylamide,
  serotonin,  and  related drugs.   In: Kline, N.  S.,  ed.
  Psychopharmacology.   Washington, Am.  Ass.  Adv.  Sc,
  1956.  p.145-154.
----,  Abramson, H. A., Hirsch, M. W. Comparative sub-
  jective effects  of seven  drugs  including lysergic acid
  diethylamide  (LSD-25).  J. Abnorm. Psychol, 1955,
  51: 657-662.
----,  ----, ----.   Lysergic acid diethylamide (LSD-25) :
  IV. Effect on attention and concentration.  J.  Psychol,
  Provincet, 1955, 39:373-383.
----,  ----, ----.   Lysergic acid diethylamide (LSD-25) :
  VI. Effect upon recall  and recognition of various stim-
  uli.  J. Psychol, Provincet., 1955,  39:443-4:54.
----,  see Abramson, H. A., Jarvik, M. E.
----,  see Abramson, H. A., Jarvik, M. E.,  Gorin, M.  H.,
  Hirsch, M. W.
----,  see Abramson, H. A., Jarvik, M. E., Hirsch, M. W.
----,  see Abramson,  H. A., Jarvik, M. E., Hirsch, M.  W.,
  Ewald, A. T.
----,  see Abramson, H. A., Jarvik, M. E.,  Kaufman, M. R.,
  Kornetsky, C, Levine, A., Wagner, M.
----,  see Abramson, H.  A., Jarvik,  M. E., Levine,  A.,
  Kaufman, M. R., Hirsch, M. W.
----,  see Abramson, H. A.,  Kornetsky, C., Jarvik, M. E.,
  Kaufman, M. R., Ferguson, M. W.
----,  see Hirsch, M. W., Jarvik, M.  E., Abramson, H. A.
----,  see Lennard, H., Jarvik, M. E., Abramson, H. A.
Jassin, A.  El estado de ansiedad en la  tension premen-
  strual  y  en el climaterio, tratado con tolseron.  [State
  of  anxiety  in premenstrual  tension  in climacteric;
  therapy with tolseron.]  Prensa me'd. argent,  1952  39:
  2653-2655.
Jatzkewitz, H. Pharmakologische Aspekte in der Schizo-
  phrenieforschung.  [Pharmacological aspects in schizo-
  phrenia research.]  Nervenarzt, 1956,  27 :150-152.
Jaulmes, C.,see Laborit, H., Jaulmes, C.
Jaworska,  I., see  Falicki,  Z.,  Galuszko.,  Jaworska, I.,
  Kielak, L., Sulstrowski, W.
Jedeloo,  G. C, see Tolsma, F. J., Jedeloo, G. C, Keme-
  nade, J. J. van.
Jelesic, G., see Vurdelja, N., Jelesic, G.
Jenkins, D. E., Chofnas, I., Boren, H., Guthrie, R.   Clinical
  and laboratory observations  on  iproniazid.   Tr.  12.
  Conf. Chemother. Tuberc, 1953 :141-145.
Jenney, E.  H., see Pfeiffer, C. C, Jenney, E. H.
Jensen,  E. S.  Serpasilbehandling pa andssvagehospital.
  [Serpasil therapy  in  a hospital for the mentally de-
  ficient.]  Ugeskr. laeger, 1955, 117 :1463-1465.
Jensen,  O. 0.  Suavitil  in  the treatment  of  psychoneu-
  roses.  Danish M. Bull, 1955, 2:140-143.
Jeri,  R.  Observaciones con la reserpina  (serpasol) en
  sujetos sanos y en pacientes psiquiatricos.  [Observa-
  tions with reserpine  (serpasol)  in normal subjects  and
  in  psychiatric  patients.]  [English  summary]  Rev.
  neur.  psiquiat, Lima, 1955,  18:108-124.  Abstract as:
  Effects of reserpine in  psychiatric patients.  J. Am. M.
  Ass., 1955, 157 : 530.  Abstract: Excerpta med., Sect. 8,
  1956, 9: No. 1225.
----,  see Sal y Rosas, F., Jeri, R., Sanchez, J.
Jewesbury, E. C, see Coady, A., Jewesbury, E. C.
219 
Jonsson, B.
Jonsson, B., see Holmberg, G.,  Jonsson, B., Mellgren, A.,
  Martens, S.
Jbrgensen, G., see Broglie, M., Jorgensen, G., Voss, G.
Jorstad,  J.  Reserpin ved psykoser.  [Reserpine in psy-
  choses.]   [English summary]  Nord.  med.,  1956,  55:
  794-798.
Johnson, D. M.  The hallucinogenic drugs, the insanity-
  producing drugs: Indian hemp and datura; a neglected
  aspect of forensic medicine, a loophole in the law.  45 p.
  Addendum.   LSD and schizophrenia,  (p. 40) London,
  Johnson, 1953.
---.   Indian  hemp; a social  menace.   112 p.  London,
  Johnson, 1952.
Johnson, F., see Hollister, L. E., Jones, K. P., Brownfield,
  B., Johnson, F.
Johnston, W. C, see McNeill, J. F., Johnston, W. C, Pietu-
  chow, W.
Jolivet, B., see Coirault, R., Laborit, H., Missenard, R.,
  Jolivet, B., Hainaut, J., Weber B.
Jones, D. H., sec Lancaster, N.  P., Jones, D. H.
Jones, G. T., see Slater, I. H, Jones, G. T. Young, W. K.
Jones, H. H., Jr.  Reversible depression and parkinsonian
  occurring during treatment of hypertension with Rau-
  wolfia.   [whole root]  J. Oklahoma 31. Ass., 1955,  48:
  380-381.
Jones, K. P., see Hollister, L. E., Jones, K. P., Brownfield,
  B., Johnson, F.
Jouanneau, H., see Porot, M., .Touanneau,  H.
Judah, L. N., see Gardner, M. J., Hawkins, H. M., Judah,
  L. N., Murphree, O. D.
Judson, W. E.,  see Wilkins, R. W., Judson, W. E.
---,  see Wilkins, R. W., Judson,  W. E., Stone, R.  W.,
  Hollander, W.,  Huckabee, W.  E., Friedman, I. H.
Juredieu, see  Heuyer, G.,  Lang, J. L., Chevreau,  J. P.,
  Juredieu.
Jurquet, A., see Ranee, A. M., Jurquet, A., Roger J.
Justiss, W. A.,  see Kleemeier, R. W., Rich, T. A., Justiss,
  W.  A.
                          K

Kahan, I. H.  Accidental Rauwolfia poisoning in a dog.
  J. Am. Vet. 31. Ass., 1955, 216 : 472.
Kahn, E.  Information values.  Am. J.  Psychiat, 1957,
  114: 375-376.
Kahn, J. B., Jr., see Gottschalk, L. A., Kapp, F. T., Ross,
  W.  D., Kaplan, S. M., Silver,  H, MacLeod, J. A., Kahn,
  J. B., Jr., Van Maanen, E.  F., Acheson, G. H.
Kalinowsky, L. B.  Additional  remarks on the  danger of
  premedication  in electric convulsive therapy.  Am. J.
  Psychiat, 1956, 113 : 79-80.
---  The  danger of various types of medication during
  electric convulsive therapy.   A hi.  J.  Psychiat,  1956,
  112: 745.
Kaminskii, S. D., Savchuk, V. I. O deistvii aminazina na
  vysshuiu nervuiu deiatel'nost' sobak.  [Effect of amina-
  zine on  the  higher  nervous functions in dogs.]  Zh,
  nevropat. psikhiat.,  31oskva, 1956, 56: 104—115.   Ab-
  stract : Chem. Abstr., 1956, 50 :17174hi.
Kaminsky,  A.,  Sevinsky, B.,  Kaplan,  A.   II metil-propil-
  propanediol-dicarbamato  (meprobamato) in  derma-
  tologia.  [Meprobamate in dermatology.]  Minerva med.,
  Tor., 1956,  47: 1478-1480.   Also:  Dia med., B.  Air.,
  1956, 28: 2284-2286.
Kamman, G. R., Freeman, J. G, Lucero, R. J. The effect of
  1-isonicotinyl 2-isopropyl  hydrazide (IIH)  on the be-
  havior of long-term mental  patients.   J. Nerv.  31 ent.
  Dis., 11)53,118:391-407.
Kammerer,  T.,  Ebtinger,   R.  Premiers  resultats   du
  traitement du delirium tremens par le chlorpromazine
  (Largactil).   [First results of chlorpromazine therapy
  in delirium  tremens.]  Strasbourg me'd., 1954,  5:287-
  291. Abstract: Ann. me'd psychol, Par.,  1954, 112(1) :
  102.
---,  Mengus, M., Ebtinger,  R.  Traitement du delirium
  tremens  par la chlorpromazine.  [Chlorpromazine in
PSYCHOPHARMACA
  the treatment of delirium tremens.]   [Abstract]   Ann.
  med. psychol, Par., 1954, 112(2) : 439.
Kane,  M. M., see Harned,  B.  K.,  Cunningham, K. W.,
  Clark, M. C, Hine, C. H, Kane, M. M., Smith, F. H., Jr.,
  Vessey, R. E., Yuda, N. N., Zabransky, F. W.
Kanner, L., Eisenberg, L.  Child psychiatry;  mental de-
  ficiency Am. J. Psychiat., 1957, 113 : 617-622.
Kaplan, A. see Kaminsky, A., Sevinsky, B., Kaplan, A.
Kaplan, S. M.,  see Gottschalk,  L. A., Kapp, F.  T., Ross,
  W. D., Kaplan, S. M., Silver,  H., MacLeod, J. A., Kahn,
  J. B., Jr.,  Van Maanen, E. F., Acheson, G.  H.
---, see Shanon, J.,  Kaplan, S. M., Pierce, C.  M., Ross,
  W. D.
Kapp,  F. T.,  see Gottschalk, L. A., Kapp, F.  T.,  Ross,
  W. D., Kaplan, S. M., Silver,  H., MacLeod, J. A., Kahn,
  J. B., Jr., Van Maanen, E. F., Acheson, G. H.
Karan, D., see Adasal, R., Ozsan, M., Karan, D.,  Yener, O.
Kardos, G, Pertorini, R.  A largactil psychiatriai alkal-
  mazasa.  [Psychiatric applications of chlorpromazine.]
  Ideg. szemle, 1955, 8 : 65-70.
Kasak, M., Schaefer, D. L., Winter,  W.  The use of chlor-
  promazine and reserpine in a psychiatric hospital: one
  year's experience.  Alarquette M. Rev.,  1955, 21: 17-24.
Kass, I., Brown, E. C.  Treatment of hypertensive patients
  with Rauwolfia compounds and  reserpine; depressive
  and psychotic changes.  J. Am. 31. Ass., 1955, 159: 1513-
  1516.
Katzenelbogen, S., Fang, A. D.   Narcosynthesis  effects of
  sodium amytal, methedrine  and  LSD-25.  Dis.  Nerv.
  Syst., 1953, 14:85-88.  Abstract: Excerpta  med.,  Sect.
  8,1954, 7 : No. 3819.
Kaufman, M. R., see Abramson,  H. A., Jarvik, M.  E., Kauf-
  man, M. R., Kornetsky, C, Levine, A., Wagner, M.
---, see Abramson, H. A., Jarvik, M. E., Levine,  A.. Kauf-
  man, M. R., Hirsch, M. W.
---, see Abramson, H. A.  Kornetsky, C, Jarvik, M. E.,
  Kaufman, M. R., Ferguson, M. W.
---, see Abramson, H. A., Waxenberg,  S. E.,  Levine, A.,
  Kaufman, M. R.,  Kornetsky,  C.
---, see Levine, A., Abramson, H. A.,  Kaufman, M. R.,
  Markham,  S.
---, see Levine, A., Abramson, H. A.,  Kaufman, M. R.,
  Markham, S., Kornetsky, C.
Kautz, H. D.  Trends  in  drug therapy.  Hosp. Progr.,
  1957,38(1) : 102-108; 126.
Kavan, E., see Whitman, R. M., Lipton, M. A.. Kavan, E.
Kaye,  H., see Rosner, H, Levine, S.. Hess, H,  Kaye, H.
Kehlet, H., see Jacobsen, E., Kehlet, H., Larsen, V., Munk-
  vad, I., Skinhoj, K.
Kehoe, M.  J., Pollard, J. C.  Some observations on the
  minimal effective dosage of  chlorpromazine.   J. Nerv.
  31cut. Dis.,  1956, 123 : 275-280.
Keil,  C.  Psychoses et neuropiegiques.   [Psychoses and
  neuroplegic drugs.]   Rev. med. Liege, 1955, 10:100-102.
Keller, D. L., Umbreit, W. W.  Chemically altered perma-
  nent behavior patterns in fish and their cure by reser-
  pine. Science, 1956, 124: 407.
---,----.   Permanent alteration of behavior in mice by
  chemical  and psychological means.    Science,  1956,
  124: 723-724.
Keller, F.,  see Klohs, M. W.,  Draper,  M.  D., Keller, F.
Kelley, J. W.  Thorazine-chlorpromazine.  Nebraska 31.
  J.,  1954, 39:305-307.  Abstract:  Excerpta  med.,  Sect.
  8, 1955, 8:  No. 1797.
Kellner, H.   Klinische  Erfahrungen mit einem  neuen
  phenothiazinhaltigen  Schlafmittel.  [Clinical  experi-
  ences with a new  phenothiazine-containing soporific]
  [Adalat] 31 ed. Klin., Berl, 1956,  51:728-729.
Kelly, J.  The  influence of mescaline  on Rorschach re-
  sponses.    [In  English]   Psychol.   Forsch.,   1954,
  24 : 542-556.
Kemenade, J. J. van, sec  Tolsma, F. J.,  Jedeloo, G. C,
  Kemenade, J. J. van.
Kemper, H.  Erfahrungen mit einem neuen Schlafmittel
  aus der Piperidinreihe in der Psychiatrie. [Experiences 
AUTHOR LIST
Kline, TV. S.
  with a new piperidine hypnotic in psychiatry.]  Deut.
  med. Wschr., 1955, 80:1034-1035.  Abstract:  Excerpta
  med., Sect. 8, 1956, 9: No. 30N2.
Kenigsberg, S., see Gelvin, E. P., McGavack, T. H., Kenigs-
  berg, S.
Kent, B., see Knight, R. W., Kent, B., Morris, G-. Rogers, S.
----,  see Moyer,  J.  H., Kent,  B., Morris, G., Dizon, M.,
  Rogers, S. Spurr, C.
Kent, I.,  see Azima, H., Kent, I., Cleghorn, R. A.
Kernohan, G. A.  Stupor during reserpine therapy.  Brit
  M. J., 1957, 1: 1475-1476.
Kessler,  L. N., Barnard, R. D.  A new tranquilizer mepro-
  bamate ;  its use for pain associated with cancer.  Pre-
  liminary  report.  31ed.   Times,  Great  Neck,   1956,
  84: 431-435.
Kestenberg, see Le Guillant, L., Roelens,  Corre, Kesten-
  berg, Plichet, Bequart, Bailly-Salin.
Kety, S.  S.  The  conference and its aims.  Ann. N.  York
  Acad. Sc, 1957, 66: 417.
—-,  ed.  The pharmacology   of  psychotomimetic  and
  psychotherapeutic  drugs.  [Conference  held   in  New
  York,  April 1956] Ann.  N. York Acad. Sc,  1957, 66:
  415-840.  [Articles within the scope of this bibliography
  are listed individually. ]
Keyes, B. L.   Ataraxic drugs.  Pennsylvania 31. J.,  1957,
  60:177-181.
Khairnar, D. B., see Sheth, S.,  Khairnar,  D. B.
Kielak, L., see Falicki,  Z.,  Galuszko,  P., Jaworska, I.,
  Kielak, L.,  Sulestrowski, W.
Kielholz, P.  Behandlung von depressiven und halluzina-
  torischen Zustanden mit  Largactil, Histamin und In-
  sulin.  [Largactil, histamine and insulin therapy of de-
  pressive  and  hallucinatory   states.]   Schweiz. Arch.
  Neur. Psychiat, 1954, 73: 431-436.  Abstract:  Excerpta
  med., Sect. 8, 1955, 8: No.1788.
----.   Uber die  Largactilwirkung bei depressiven Zus-
  tanden und  Manien  sowie  bei  der  Entziehung von
  Morphin-und Barbiturstichtigen.  [Effects of largactil in
  depressive  states  and manias and on  withdrawal in
  morphine and  barbiturate addiction.]   [English  sum-
  maries : p.  304-305; p. 308-309]   Schweiz. Arch. Neur.
  Psychiat, 1954, 73 : 291-309.
----,  Labhardt, F.  Treatment  of mental  disorders with
  chlorpromazine.   J.  Clin.  Exp.  Psychopath.,  1956,
  17: 38^4.  Abstract: Excerpta med., Sect. 8,  1957, 10 :
  No. 371.
---, see  Staehelin,  J. E., Kielholz, P.
Kieser, J., see Meyer, H. H., Schmitt, W., Kieser, J.
Kiessling,  J.  Rauwolfia  serpentina;  Uberblick  uber
  Chemie, Pharmakologie und moderne Therapie.  [Rau-
  wolfia  serpentina;  review on its  chemistry,  pharma-
  cology  and modern therapy.]   Zschr. drztl.  Fortbild.,
  1956, 50: 637-650.
Kiffel, M., see Thiebaux, M., Thiebaux, R., Boyer, R., Le-
  borgne, F., Kiffel, M.
Kimbell,  I., see Gaitz, C. M., Roy, H., Thompson, W., Kim-
  bell, I., Mullen, A. J., Pokorny, A. D.
Kimmig,  J., see Korting, G. W.,  Borelli, S., Kimmig,  J.
Kinard, S., Mills, L. C, Terrell, J., Moyer, J. H.  Use of
  d-amphetamine to curb the increased appetite  and over-
  eating  induced by  reserpine  therapy.  J. Am. Geriat
  Soc, 1956, 4 : 1073-1077.
King,  A., see Mitchell, P. H., Sykes, P., King, A.
King  E  E  Differential action of anesthetics and inter-
  neuron depressants upon EEG arousal and recruitment
  responses   J. Pharm. Exp. Ther., 1956, 116: 404-417.
___tsee  Funderburk, W.  H., King,  E. E., Domino, E. F.,
  Unna, K. R.               „.    _  T.  TT     rr „
___ see  Funderburk, W. H, King, E. E., Unna, K. R.
King,  G.  A., see Hafkenschiel, J. H, Sellers, A.  M., King,
  G. A., Thorner, M. W.
Kinnard, W. J., Jr., Carr, C. J.  A preliminary procedure
  for  the evaluation of central nervous system  depres-
  antsJ harm- Exp. T*cr  lOT* 1»: 354-361.
____f see  Carr, C.  J., Kinnard, W. J., Jr.

      456132—59---15
Kinross-Wright, V.  Chlorpromazine; a major advance in
  psychiatric treatment. Postgrad. 31., 1954, 10 : 297-299.
----.   Chlorpromazine and reserpine in the treatment of
  psychoses.  Ann. N. York Acad, Sc,  1055, 61: 174-182.
  Abstract: Excerpta med,, Sect. 8,  1056,  9:  No. 2236.
----.   Chlorpromazine  in  psychiatric  disorders.   Med.
  Clin. N. America, 1957, 41:295-306.
----.   ('hlorpromazine treatment  of mental  disorders.
  Am, J. Psychiat, 1955, 111: 907 012.
----.   Clinical application of chlorpromazine.  In : Kline,
  N.  S.,  ed.  Psychopharmacology.  Washington,  Am.
  Ass. Adv. Sc, 1956.  p. 31-38.
----.   Clinical  trial of a new phenothiazine compound:
  XP-207.  Psychiat. Res.  Rep.,  Wash,, 1956 (4) : 89-94.
----.   Complications of chlorpromazine   therapy.  Dis.
  Nerv.  Syst.,  1955,  16:114-119.   Abstract: Excerpta
  med., Sect. 8, 1956, 9: No. 2232.
----.   Intensive  chlorpromazine  treatment  of  schizo-
  phrenia.   Psychiat. Res.  Rep.,  Wash., 1055 (1) : 53-62.
----.   A review of the newer drug therapies in psychiatry.
  Dis. Nerv. Syst., 1956, 17 : 187-190.
----.   The uses and limitations of the newer drugs in the
  treatment of nervous conditions.  Wisconsin 31. J.,  1956,
  55 : 1073-1078.
----,  Moyer, J. H.  Observations  upon the therapeutic use
  of benactyzine  suavetil.   Am.  J. Psychiat, 1957,  114:
  73-74.
----,  see Moyer, J. H., Kinross-Wright, V., Finney, R. M.
----,  see Moyer, J. H., Pevey, K., Kinross-Wright, V.
Kirk, D. L., Bauer, A. M.  Effects of reserpine (serpasil)
  on emotionally maladjusted high grade  mental retard-
  ates.  Am. J. 3Ient. Defic, 1056, 60: 770-784.  Abstract:
  Excerpta med., Sect. 8, 1957,10 : No. 1528.
Kirkpatrick, W. L., Sanders, F.  Clinical evaluation of res-
  erpine in a state hospital.  Ann. N. York Acad. Sc,  1955,
  61:123-143.
Kislenkov,  V. A.,  see Ushakov, G. K.,  Kislenkov, V. A.,
  Grigorova, E. V., Verbliunskaia, A. A.
Kistner, R. W., Duncan, C. J.  Use of pipradrol in obstet-
  rics and gynecology.  N.  Em/land J. 31.,  1956, 254: 507-
  510.
Kitchener, M., see Bruckman, N.,  Kitchener, M., Saunders,
  J. C, Kline, N. S.
Kleemeier, R. W., Rich, T.  A., Justiss, W. A.  The effects
  of alpha-(2-piperidyl) benzhydrol hydrochloride (mera-
  tran) on psychomotor performance in a group of  aged
  males. J. Geront, 1956, 11: 165-170.
Klein, F., see Bensoussan, P. A., Klein, F.
----,  see David, M., Benda, P., Klein, F.
Kleinsorge, H.   Erfahrungen mit der Schlaftherapie in-
  nerer Erkankungen.  [Experiences with sleep therapy
  of internal diseases.]  [Abstract]  Med. 3Ischr.,  1953,
  7: 760.
----,  Gossmann, K.  Die Flimmerverschmelzungsfrequenz
  als  Testmethode fur den Nachweis einer potenzieren-
  den  Wirkung von Reserpin auf Barbiturate.   [Flicker
  fusion frequency as a test method for determination of
  the  potentiating effect  of reserpine  on barbiturates.]
  Arzneimitt. Forsch., 1956, 6: 495^96.
----,  Rosner, K. Klinikai  megfigyeiesek  phenothiazin
  keszitmenyekkel.  [Clinical observations on phenothia-
  zine preparations.]  31agy.  belorv. arch., 1956, 9:106-
  109.
----,  ----.  Schlaftherapie  mit  Phenothiazinderivaten.
  [Sleep therapy with phenothiazine derivatives.]   Ther
  Gegenwart, 1956, 95 : 441-446.
----, see Kleinzorge, Rezner.
Kleinzorge, Rezner.  Primenenie proizvodnykh  fenotia-
  zina dlia terapii snom.  [Use  of phenothiazine deriva-
  tives in sleep therapy.]  Zh. nevropat.  psikhiat, 3tosk-
  va, 1956, 56: 296-299.
----, see Kleinsorge, H.
Kline, N.  S.  Chemotherapy in psychiatry; recent ad-
  vances.  Seminar Internat., Hoddesdon,  1956,  5(2) •
  7-10.
221 
Kline, N.  S.
PSYCHOPHARMACA
---.   Clinical  applications  of  reserpine.  In: Kline,
  N.  S.,  ed.  Psychopharmacology.   Washington,  Am.
  Ass. Adv.  Sc, 1956.  p. 81-108.
---.   Pacatal. Am. J. Psychiat, 1056, 113: 565.
---.   Relation of psychiatry to the pharmaceutical in-
  dustry.  A.  M. A.  Arch, Neur. Psychiat, 1057, 77:611-
  615.
---.   Use of Rauwolfia serpentina Benth. in neuropsychi-
  tric conditions.  Ann. N. York Acad. Sc, 1054, 59: 107-
  132.   Abstract: Chem. Abstr., 1054, 48 : 10220c.
---, ed.  Psychopharmacology.  165 p.  [Symposium held
  in Berkeley, Calif., December  1954.]   Washington, Am.
  Ass. Adv.  Sc, 1956.   [Articles within the scope of this
  bibliography are listed individually.]
---,  Barsa, J., Gosline, E.  Management of side effects of
  reserpine  and combined reserpine-chlorpromazine treat-
  ment.   In:  Himwich, H.  E.,  ed. Tranquilizing drugs.
  Washington, Am, Ass. Adv. Sc, 1957.  p. 149-161.
---,----, ----.  Management of the side effects of re-
  serpine and combined reserpine-chlorpromazine  treat-
  ment.   Dis. Nerv. Syst., 1956,17 : 352-35S.
---,  Jacob, G. M.  Use of pacatal (N-methylpiperidyl-
  [3]-methylphenothiazine)  in psychiatric patients.  Am.
  J. Psychiat, 1955, 112:63.  Abstract:  Excerpta med.,
  Sect. 8, 1956, 9: No. 3080.
---,  Saunders,  J.  C.  Reserpine  in  psychiatric  and
  neurologic  disorders.  Med.  Clin.  N.  America, 1957,
  41: 307-326.
---,  Stanley, A. M.  Use of reserpine in a neuropsychi-
  atric hospital.  Ann. N. York Acad. Sc, 1955, 61: 85-91.
  Abstract:  Excerpta med., Sect. 8, 1956, 9: No. 1230.
---,  see Barsa, J. A., Kline, N. S.
■---,  see Boudwin, J., Kline, N. S.
---,  see  Bruckman, N., Kitchener, M., Saunders, J. C,
  Kline, N. S.
---,  see Gosline, E., Kline, N. S.
---,  see Nicolaou, G. T., Kline, N. S.
Klingman, W. O. Neurological and psychiatric disorders ;
  some recent advances in therapy.  Virginia 31. Month.,
  1956, 83: 240-246.
Klohs, M. W., Draper, M. D.,  Keller, F.  Alkaloids  of
  Rauwolfia  serpentina  Benth.  III.  Rescinnamine,   a
  new hypotensive and  sedative principle. J. Am. Chem.
  Soc, 1954, 76 : 2843.
Klopp, C. T., see Lucas, J., Albert, S. N.,  Bateman, J. C,
  Klopp, C. T.
Klose, G., Siemon, G.  Hinweis auf die Moglichkeit einer
  Dauerschlafbehandlung der Tuberkulose mit Megaphen
  und Atosil.   [Suggestion of the possibility  to use pro-
  longed  sleep  therapy with  megaphen  and atosil  in
  tuberculosis.]  Beit. Klin.  Tuberk., 1955, 113:424-431.
Klotz, G., see Heimendinger, E., Klotz, G., Champy, M.
Knight, R. W., Kent, B., Morris, G., Rogers,  S.  Clinical
  studies of an antiemetic agent, chlorpromazine.  [Ab-
  stract]  J. Laborat Clin. 31., 1953, 42: 828.
Knittel, W., Lange, E.  Moderne medikamentose Behand-
  lung  der   Schlafstorungen.   [Modern  medicamentous
  treatment of sleep disorders.]  Psychiat  Neur.  med.
  Psychol, Lpz., 1955, 7 :112-117.
Knutsen, A. T. Reserpine og klorpromazine i psykiatrien.
  [Reserpine and chlorpromazine in psychiatry.]   [Eng-
  lish summary] Tskr. Norske laegeforcn., 1956, 76: 368-
  371.
Koechlin, P., see Sivadon, P., Koechlin, P., Markich, H.
Koetschet,  P.  Can  it  be said  that chlorpromazine has
  specific properties?  Internat. Rec. 31., 1955, 168:295-
  300.
---,  see  Courvoisier, S., Fournel, J., Ducrot, R., Kolsky,
  M., Koetschet, P.
Kohler, C, Bourjade, G. De Tutilisation du 4.560 R. P. en
  neuro-psychiatrie  infantile.   [Utilization of 4560 R. P.
  in pediatric neuro-psychiatry.]   Pediatrie, 1954, 9: 383-
  385. Abstract: J. me'd. Lyon, 1954, 35: 948.
Kohli,  J.  D„ De,  N.  N.  Pharmacological  action  of
  rauwolscine.   Nature,   Lond.,   1956,   17- : UXZ.  Ab-
  stract : Chem, Abstr., 1950, 50 : 14097bc.
___., Mukerji, B. Comparative activity of reserpine and
  total alkaloids of Rauwolfia.  [Abstract]  In: Pharma-
  ceuticals & Drugs Committee,  Council of Scientific  &
  Industrial  Research.   Symposium  on Rauwolfia, Cal-
  cutta  1955.  Lucknow, Pioneer Press, 1055.  p. 33-34.
Kokkoris, P., Kordas, P.,  Nikolopoulos, Yannins,  M. The
  results of chlorpromazine treatment with  chronic psy-
  choses in Dromokaition.   -/. Nerv. 31ent Dis.,  1957,
  125 : 102 111.
Kolle, K.  Siichte und ihre Bekampfung.  [Addictions and
  their  control.]   [English  summary]   3liinch.  med.
  Wschr., 1950, 98: 7-10.
---, Mikorey, M. Kunstlicher Winterschlaf in der Psychi-
  atrie;  vorlaufige  Mitteilung.   [Preliminary report  on
  artificial hibernation in psychiatry.]  Deut med. Wschr.,
  1953, 7S: 1723-1724.
---, Ruckdeschel,  K.  T.  Megaphenbehandlung  in  der
  Psychiatrie.    [Megaphen   therapy   in   psychiatry.]
  Miinch. med, Wschr., 1954,  96: 533-536.
Kolsky,  M., see  Courvoisier,  S., Fournel, J.,  Ducrot, R.,
  Kolsky, M., Koetschet,  P.
Koltonow, L. Reserpine in the treatment of patients with
  chronic mental disease; a controlled  study.  J. Nerv.
  Ment Dis., 1956,  123 : 392-394.
Konchegul, L., see Hoffman, J. L., Konchegul, L.
Kopeloff, L. M., Chusid, J. G, Kopeloff, N. Effect of chlor-
  promazine  upon epileptic  and normal monkeys.  Proc.
  Soc Exp. Biol, N. Y., 1955. 90: 282-284.
---, see Chusid, J. G., Kopeloff, L. M., Kopeloff, N.
Kopeloff, N., see Chusid. J. G, Kopeloff, L. M., Kopeloff, N.
---, see Kopeloff,  L. M., Chusid, J. G., Kopeloff, N.
Kopf,  R.   Phenthiazinderivaternes  farmakologi,  med
  speielt henblik pa N-methylpiperidyl-3-methylphenthia-
  zin (lacumin  [R]).   [Pharmacology of phenothiazine
  derivatives,  particularly  N-methylpiperidyl-3-methyl-
  phenothiazine  (lacumin  [R]).]  [Brief English sum-
  mary]  Nord. med., 1955, 54:1779-1782.
Koranyi, E. K.,  see Sarwer-Foner,  G. J., Koranyi, E.  K.
---, see Sarwer-Foner, G. J., Koranyi, E.  K.,  Dancey,
  T. E.
Kordas,  P., see  Kokkoris, P.,  Kordas, P., Nikolopoulos,
  Yanniris, M.
Korganova, A. N.   Lechenie aminazinom podrostkov  v
  psikhiatricheskoi klinike; predvaritel'noe soobshchenie.
  [Aminazine therapy  of adolescents  at a psychiatric
  clinic;  preliminary  communication.]   Zh. nevropat.
  psikhiat., 3Ioskva, 1956, 56: 567-50.
Kornetsky, C. Relation of physiological and psychological
  effects of lysergic acid diethylamide.  A.  31. A. Arch.
  Neur. Psychiat, 1957, 77: 657-65S.
---, Humphries, O.  Relationship between effects of a
  number  of centrally  acting  drugs  and  personality.
  A. 31. A. Arch. Neur. Psychiat, 1957,  77: 325-327.
---,----, Evarts,  E.  V.  Comparison  of psychological
  effects  of  certain  centrally  acting  drugs  in  man.
  A. M. A. Arch. Neur. Psychiat, 1957,  77 : 318-324.
---, sec Abramson, H. A., Jarvik, M. E. Kaufman, M. R.,
  Kornetsky, C, Levine, A., Wagner,  M.
---, see Abramson, H. A., Kornetsky, C, Jarvik, M. E.,
  Kaufman, M.  R., Ferguson, M. W.
---, see Abramson, H. A., Waxenberg,  S. E.,  Levine, A.,
  Kaufman,  M. R., Kornetsky, C.
---, sec Levine, A., Abramson,  H. A., Kaufman, M. R.
  Markham, S., Kornetsky, ('.
Korsfeldt, B., see Hagnell, O., Korsfeldt, P>., Peterson, B.,
  Widmark, M.
Korting, G. W., Borelli, S., Kimmig, J.  Welche Bedeutung
  besitzen die Phenothiazine fur die Behandlung von Haut-
  krankheiten?   [Of what significance are phenothiazines
  in the treatment of skin diseases?]  Derm.  Wschr 1956
  134: 1245-1252.
222 
AUTHOR LIST
Laborit, H.
 Kositchek, R. J.  Reactions to meprobamate.  J-  Am. 31.
   Ass., 1956, 101: 044.
 Kovitz, B., Carter, J. T., Addison, W. P.  A comparison of
   chlorpromazine and  reserpine  in chronic psychosis.
   A. 31.  A. Arch. Neur. Psychiat, 1955, 74:467-471.  Ab-
   stract : Excerpta med., Sect. 8, 1957, 10: No. 2087.
 ---, see Madi, M. L., Kovitz, B.
 Kozlowski, V. L.  Mentally disturbed patients; a study of
   low dosage  sepasil.   3Ied. Times, Great Neck,  1956,
   84:1219-1224.
 Kramer, E. R.,  see Chessin, M., Dubnick, B., Kramer, E. R.,
   Scott, C. C.
 Kramer, J. F.,  see Rosner, B. S., Fierman, L. B., Kramer,
   J. F.
 Kramer,  M.  Facts  needed  to assess public health and
   social  problems in the widespread use of the tranquiliz-
   ing drugs.  Pub. Health Monogr., 1956 (41) : 1-31.
 Kranz,  H.  Krankheitsdauer und Recidivhaufigkeit  bei
   Chlorpromazinbehandlung endogener Psychosen.  [Du-
   ration of disease  and relapse  rate of endogenous psy-
   choses treated with chlorpromazine.]  Encephale, 1956,
   45 :628-634.
 Krasilowsky, D.  Complications observed  in  50 mental
   patients treated with largactil.  [In  Hebrew]   [Eng-
   lish  summary, p.  III-IV]   Dupitn  Refuiim,  1955,
   14:225-228.   Abstract: Excerpta  med., Sect. 8,  1950,
   9: No. 4553.
 Krehmer, E.  Untersuchungen iiber den Antagonismus des
   Sedaraupin  (Reserpin)  gegeniiber  zentralerregenden
   Substanzen (Pervitin, Coffein, C'ocain).   [Antagonism
   of sedaraupin (reserpine) to central stimulants (pervi-
   tin, caffeine, cocaine).] 5.'! p.   (Jiessen, 1950.  [Thesis—
   Giessen].
 Kremer,  M.  W., see Freedman, A. M.,  Krenier, M.  W.,
   Robertiello, R., Effron, A. S.
 Kress, R.  Chemisches und Medizinisches iiber Rauwolfia
   serpentina Benth.  [Chemical and  medical  data on
   Rauwolfia  serpentia Benth.]   Pharmazie,  1953, 8:726-
   728.
 Krieger, G. E.,  see Hollister, L. E., Krieger, G. E., Kringel,
   A., Roberts, R. H.
 Kringel, A., see Hollister, L. E., Krieger, G. E., Kringel, A.,
   Roberts, R. H.
 Kris, E. B., Carmichael, D. M.  Follow-up  study on  pa-
   tients treated with thorazine; preliminary report.   Am.
   J. Psychiat., 1956,112 : 1022.
 Kritz, D., see Gerard, D. L., Weisselberger, D., Kritz,  1).
 Kron,  R. Zur  medikamentosen Behandlung  von  Herz-
   neurosen.  [Medical management of cardiac neuroses. |
   Praxis, Bern, 1956, 45 : N72 -873.
 Krone, R. E., see Martin, K. E., Overley, H. G., Krone,
   R. E.
 Kroneberg,  G.   Rescinnamin, das zweite  sedative  Alka-
   loid der Rauwolfia serpentina.   [Rescinnamine, the sec-
   ond   sedative  alkaloid   of   Rauwolfia  serpentina.]
   Arzneimitt. Forsch., 1956, 6 : 579  583.
 Kropa, E. L., see Fabing H. D., Kropa, E.  L, Hawkins,
   J. R., Leake, C. D.
 Kruse, W. "Paradoxical" effect of chlorpromazine in a
   case of periodic  catatonia.   Am. J. Psychiat,  1957,
   114: 463^64.
 Krush, T. P., see Hunt, B. R., Frank, T., Krush, T. P.
 Kuehn, A., see  Schallek, W., Kuehn, A., Seppelin, D. K.
 Kugelmass,  I.  N.  Psychochemotherapy  of mental  defi-
  ciency  in children.  Internal  Rec. 31., 1956, 169: 323-
  338
 Kuhn   B   H.  Plimasin;   a  preliminary   evaluation.
  AM A Arch. Derm., 1955, 72: 59-62.
 Kulcsar  S Erdelyi, S.  Recherches sur  le test de Szondi
  au coursdu traitement par la chlorpromazine.  [Studies
  of the  Szondi test during chlorpromazine  therapy.]
  EncCvhale, 1957, 46 : 140-145.
KuntTman, R. G., see Brodie, B. B., Olin, J. S.,  Kuntzman,
  R. G., Shore,  P. A.
Kupperman, H. S., Blatt, M. H., Vosburgh, L. F., Canis, J.,
  Wetchler, B.  Effect of reserpine, with or without hor-
  monal therapy,  upon  the female climacteric.  J. Am.
  Geriat. Soc, 1956, 4 : 160-166.
Kurland, A. A.  Chlorpromazine in the management  of
  the  institutionalized  aged  psychiatric  patient with
  chronic brain syndrome.  Dis. Nerv. Syst, 1055, 16: 366-
  369.   Abstract: Excerpta med., Sect. 8,1956, 9 : No. 3996.
---.  Chlorpromazine in the treatment of schizophrenia;
  a study of 75 cases.  J. New. Ment.  Dis., 1955,121: 321-
  329.
----, see Cholden,  L. S.,  Kurland, A.,  Savage, C.
Kurtzke, J. F.  Seizures with promazine. Preliminary re-
  port.  J. Nerv. 31 cut Dis., 1957, 125: 119-125.
Kurz, C.  A propos  de la  reserpine.   [Reserpine]  Gaz.
  med. France, 1956, 63 : 877-S81.
Kuschinsky, G.  Wichtige neue Arzneimittel.  [Important
  new  drugs.]   Deut.  med. Wschr., 1953, 78:646; 1954,
  79: 1375-1376.
Labauge, R., see Lafon, R., Due, N., Labauge, R., Temple,
  J. P.
Labhardt, F.  Behandlung von psychischen Storungen mit
  Largactil.  [Largactil  therapy of  mental  disorders. ]
  Schweiz. Arch. Neur. Psychiat, 1954, 73: 437-440.
---.  Einige  allgemeine und psychiatrische Gesichts-
  punkte  zur  Behandlung  mit  neuroplegischen  Medi-
  kamenten.  [General and psychiatric views  on therapy
  with  neuroplegic drugs.]   [Short  English  summary I
  Dermatologica, Basel, 1955, 111: 177-JN5.
----.  Erfahrungen  mit  einem  neuen  Neuroplegicum.
  [Experiences with a  new neuroplegic drug.]   [NP-207 |
  Schweiz. Arch. Neur. Psychiat, .195(5, 77:481-485.
---.  Die Largactiltherapie  bei  Schizophrenien  und
  anderen psychotischen Zustanden. [Largactil therapy in
  schizophrenia and other psychotic  conditions.]  [Eng-
  lish  summary:  p.  337-338.]   Schweiz.  Arch.  Keur.
  Psychiat, 1954, 73:309-338.  Abstract: Excerpta mid.,
  Sect. 8,1955, 8 : No. 1789.
---.  Technik, Nebenerscheinungen uud  Komplikationen
  der Largactiltherapie.   [Technic, side  effects and  com-
  plications of largactil therapy.]  [English summary : p.
  345]  Schweiz. Arch, Neur. Psychiat., 1954, 73 : 338-345.
  Abstract: Excerpta med., Sect. 8, 1955, 8 : No. 1790.
---,  see Kielholz,  P., Labhardt, F.
---,  see Staehelin, J. E., Labhardt, F.
Laborit, G., see Laborit, H., Coirault, R., Damasio, R.,
  Gaujard, R.,  Laborit, G.,  Charonnat,   U., Lechat, P.,
  Chareton, J.
Laborit, H.  Climatisation  au  lit  du  malade par re-
  frigerateur h air.  [Climatization by an air conditioner
  at  the patient's  bedside.]  Presse me'd., 1957, 65:1240.
---.  L'homme et son milieu.  [Man and his environ-
  ment.] Presse mid., 1951, 59 : 1037-1038.
---.   Potentiated anesthesia.   Artificial  hibernation.
  General technic of artificial hibernation.  Internat. Rec.
  31., 1954, 167 : 315-320.  321-323.  324-327.
---.  Therapeutique  neuroplegique et hibernation  arti-
  ficielle: essai d'eclaircissement d'une equivoque.   [Neu-
  roplegic therapy and artificial hibernation:  attempt to
  clarify an equivocation.]   Presse me'd., 1954, 62:359-
  362.
---,  Coirault,  R.,  Damasio, R.,  Gaujard, R., Laborit, G.,
  Charonnat, R., Lechat, P., Chareton,  J.  Sur un type
  nouveau d'anesth£sie  chirurgicale  et  sur Temploi  en
  therapeutique d'un   depresseur  du  cortex  cerebral
  (S. C. T. Z.)   [A new type of surgical anesthesia and
  the therapeutic  use of a  cerebral cortex  depressant
  (S. C. T. Z.)]  [thiamine hydrochloride]  Presse med.,
  1957,  65: 1051-1054.
----, ----, Hainaut, J.,  Weber,  B.  Action  des  neuro-
  piegiques sur TexcitabilitS neuromusculaire; les  mouve-
  ments ioniques transmembranaires; Tequilibre thermo-
  cationique;  consequences  physiologiques  et therapeu-
223 
Laborit, H.
PSYCHOPHARMACA  \
  tiques;  une application clinique:  le delirium tremens.
  [Effect of neuroplegic drugs on neuromuscular excita-
  bility ; transmembrane ionic movements, thermocationic
  equilibrium ; physiologic and therapeutic consequences ;
  clinical  application:   delirium  tremens.]  Ence'phale,
  19.10, 45: 1166-1177.
---,  Huguenard, P. L'hibernation artificielle par moyens
  pharmacodynamiques et physiques.  [Artificial hiberna-
  tion by pharmacodynamic  and physical means.]  Presse
  med., 1951, 59 : 1329.
---,  ----.  Pratique de Thibernotherapie en chirurgie et
  en  medecine.  [The use of hibernotherapy in surgery
  and in  medicine.  256 p.   Paris,  31asson, 1954.   [One
  chapter is within the scope  of this bibliography.]  cf.
  EY,  DESCHAMPS, BERARD.
---,  ----.   Technique actuelle de l'hibernation  artifi-
  cielle.   [Current  technique  of  artificial  hibernation.]
  Presse med., 1952, 60:1455-1456.
---,  ----, Alluaume,   R.  Un  nouveau  stabilisateur
  vegetatif; le 4560 RP. [A new autonomic stabilizer;
  4560 RP]  Presse mid., 1952, 60 : 206-208.
---■,  Jaulmes, C.   De Tanesthesie potentialisee a l'hiber-
  nation  artificielle.  [From potentiated  anesthesia to
  artificial hibernation.]  Toulouse  me'd., 1952, 53: 821-
  829.
---,  see Coirault, R., Laborit, H, Missenard, R., Jolivet,
  B.,  Hainaut, J., Weber, B.
—Biographies
  About the guest editor.  Internat. Rec 31, 1954, 167:
  356.
  Parisian pioneer.  31D, 1958, 2(2)  : 107-109.
Laboucarie, J., Barres, P., Rascol, A.  L'action de la chlor-
  promazine dans le traitement des psychoses delirantes
  systematisees et des schizophrenies.  [Effect of chlorpro-
  mazine  therapy in chronic delirium and schizophrenia.]
  Ence'phale, 1956, 45 : 691-697.
---,---,----.  Aspects principaux des  cures  neuro-
  piegiques  en psychiatrie  en  1956.  [Principal features
  of neuroplegic therapy in psychiatry in 1956.]  Toulouse
  me'd., 1956,57: 851-867.
---,---,---.  Les cures  neuropiegiques par la chlor-
  promazine.   [Neuroplegic therapies  with  chlorproma-
  zine.]  Toulouse me'd., 1955, 56 : 515-526.
___, Combes, P. Valeur et limities des cures de sommeil
  en'psychiatrie.  [Value and limitations of sleep therapy
  in  psychiatry.]   Toulouse me'd., 1954, 55: 221-232.
---,  Rascol, A., Benichou,  L.  L'action  de la chlorpro-
  mazine dans les schizophrenies.   [Mechanism of action
  of  chlorpromazine in schizophrenia.]   Ann. med. psy-
  chol, Par., 1954, 112(2) : 751-757.
___, see Riser, M.,  Geraud, J.,  Laboucarie, J., Rascol, A.,
  Clausse, S., Garrigues, M. P.
---, see Riser M., Laboucarie, J.,  Barres, P.
Laburthe-Tolra, J.  Essai sur  Temploi therapeutique de
  Thibernation  artificielle  dans les intoxications barbi-
  turiques graves.   [Clinical study  on artificial hiberna-
  tion in  the  treatment of  severe barbiturate poisoning. 1
  57   p.   Paris, 1954.    [Thesis—Paris,  1954,  no.  9301
   [Not seen]
Lacaton, R., see Ramee, F.,  Lacaton, R., Sanchez, F., B »u-
  langer,  M.
Lacchin,  R.  Osservazioni  cliniche  sulTimpiego  di ui
  nuovo farmaco: il prenderol. [Clinical observations on
  use of a new drug : prenderol.]  Riv. sper. freniat, 1952.
  76: 649-655.
Lacombe, J., see Borel, J., Lacombe, J., Camar, R.
Lacoste, G., see Perret, A., Becker, J., Lacoste, G.
Lacroix-Herpin, M. P.  de   Cure de  sommeil dans les hal-
  lucinations.   [Sleep  therapy in hallucinations.]  00  p.
  Paris, 1954.  [Thesis—Paris, 1954, no. 248]
Lacy, B. S.,  see Feldman, P. E., Lacy, B. S,, Walker, A. E.,
  Garrez, N. J.
Lafon, R., Boyer, Due, N., Minvielle, J., Pouget, R.  Effets
  comparatifs de Tinjection intraveineuse de serotonine  et
  de reserpine; etude  psychometrique  neurol^i^.!
  et eiectroencephalographique.  [The c^Pa^^S*8
  of intravenous serotonin and reserpine; a psychometric,
  neuro-autonomic  and electrocencephalographic  study.]
  Ann. mid.  psychol,  Par., 1956,  114(2) : 463^66.
___,Duc, N., Abric, J., Pouget, R., Comelade, P.  Etude
  comparative du 4.560 R. P. (chlorpromazine)  et de la
  reserpine das les syndromes schizophreniques.   [Com-
  parative study of  R. P. 4560 (chorpromazine) and reser-
  pine in schizophrenic syndromes.]   Encephale,  195b,
  45:668-671.                     „   „  1
________, Boyer, Abric, J., Pouget, R.   Exploration  psy-
  chologique  des malades traites par le 4560 RP (chlor-
  promazine)  et la  reserpine.  [Psychologic examination
  of patients treated with RP 4560 (chlorpromazine) and
  with reserpine.]  Ence'phale, 1956, 45 : 996-999.
___,___, Labauge, R., Temple, J. P.   Incidents  et acci-
  dents lies a l'emploi de la chlorpromazine.   [Incidents
  and  accidents with  the  use of chlorpromazine.]  En-
  cephale, 1956, 45 : 1226-1228.
___>___t____,----.   Le traitement du delirium tremens
  par le 4560 R. P.  [The treatment of delirium tremens
  with 4500 R. P.]  Ence'phale, 1956, 45: 1219-1220.
---,----, Ribstein, M., Pages, H.  Le traitement des syn-
  dromes  schizophreniques par  la 4560 R. P. (chlorpro-
  imjzine).  [Treatment of schizophrenic syndromes with
  chlorpromazine.]   31ontpellier me'd.,  1954, 46:284-291.
  Abstract: Excerpta med., Sect. 8, 1955, 8: No. 3642.
---, Faure, J. L, Abric, J.  Etude semeiologique et thera-
  peutique des troubles du sommeil chez l'enfant.  [Symp-
  tomatologic and therapeutic study of sleep disorders in
  children.]  Pe'diatrie, 1956, 11: 743-754.
---, Temple, J. P.  Abric, J.  Le 4560 R. P. dans le traite-
  ment des etats anxieux.  [4560 R. P. in the treatment of
  anxiety  states.]   [Abstract]   Sem.  hop. Paris,  1953,
  20: 3113.
Lagrue, G.   Rauwolfia serpentina (ou  sarpagandah) et
  ses alcaloides.  [Rauwofiia serpentina (or sarpagandah)
  and its alkaloids.]   Vie med., Par., 1956, 37 (Special-
  May) :  111-112.
Laine, see Fouks, Laine, Frangois, Pagot.
---,  see  Fouks, L., Laine, Grimaud, Dariotis.
---,  see  Fouks, Laine, Pagaud.
Laine, B., see Delay,  J., Pichot, P., Laine,  B., Perse, J.
Lairy, G.  C. see Ey, H., Faure, H., Lairy, G. C.
Lamarche, A.,  Roussel,  A., Rosendorf  Comparaisons des
  resultats  obtenus par la cure de sommeil,  la  cure de
  somnolence, et la cure a la chlorpromazine seule et  a
  dose  elevee;  resultats de quelques electro-encephalo-
  grammes de controle.  [Comparison of results obtained
  with sleep therapy, somnolence therapy and chlorproma-
  zine therapy alone and  with elevated  doses;  results
  controlled  by EEC]   Encephale, 1956, 45: S84-890.
 Lambert, C, see Rees, L.,  Lambert, C.
Lambert, P. A., Barnaud,  J.  Apparition de  deux syn-
  dromes melancoliques au cours de traitements par le
  45.(50 RP.   [Occurrence of two melancholy syndromes
  during  treatment with 4560 RP.]  [Abstract]  J. mid.
   Lyon, 1954, 35 : 951.
  --,  Diederichs, A.,  Toulet, M.   Incidents  et complica-
  tions des  traitements par la chlorpromazine employee
  isolement  chez Tadulte.   [Incidents and complications
  of   treatments   with chlorpromazine  used  alone in
   adults.]  Ence'phale, 1956, 45: 1229-1247.
 ---, Toulet, M., Diederichs, A.  L'emploi de la chlorpro-
   mazine dans le traitement des psychoses de Tadulte; en
   dehors de la cure de sommeil.   [The use of chlorproma-
   zine in the treatment of psychoses in adults (apart from
   sleep therapy.) ]  Vie mid., Par., 1955, 36 : 799-804.
 ---(  see Revol, L., Achaintre, A., Balvet P., Beaujard, M.,
   Berthier,  C, Broussolle,  P.,  Lambert,  P., Perrin, J.,
   Requet, A.
 Lambros, V. S.  The use of reserpine in certain neuro-
  logical disorders;  organic convulsive states,  enuresis,
224 
AUTHOR LIST
Leeper, R. D.
  and head injuries.  Ann. N. York Acad. Sc, 1955, 61 :-
  211-214.   Abstract: Excerpta med., Sect. 8,1956, 9 :  No.
  2481.
Lamoureux, L., see Dobkin, A. B.,  Gilbert, R. G. B.,  La-
  moureux, L.
---, see Dobkin, A. B., Lamoureux, L., Letienne, R., Gil-
  bert, R. G. B.
Lancaster,  N. P., Jones, D. H.  Chlorpromazine and in-
  sulin in psychiatry-  Brit. 31. J., 1954, 2 : 565-567.
Landau, W., see Evarts, E. V., Landau, W., Freygang, W.,
  Jr., Marshall, W. H.
Landgrebe, B. Uber Erfahrungen mit Reserpin (Sedarau-
  pin)  in der psychiatrischen Klinik.   [Experience with
  reserpine  (sedaraupin)  in  a  psychiatric  hospital.]
  Medizinische, 1955: 610-613.
Landis, C,  Clausen, J.  Certain effects of mescaline  and
  lysergic acid on  psychological  functions.  J.  Psychol,
  Provincet,  1954, 38:211-221.  Abstract:  Excerpta
  med., Sect. 8,1955, 8:  No. 1336.
Lando, L. I.,  see Bamdas,  B. S., Glod, G. D., Lando, L. I.,
  Levkovich, A. P.,  Tarasov, Y. K.,  Khazen, I. M.
Lang, J.  L., see Heuyer, G., Lang,  J. L., Chevreau, J. P.
  Juredieu.
Lange, E.   Die  Behandlung psychischer  Erkrankungen
  mit  Propaphenin  (HL   5740,   Winterschlafmittel).
  [Treatment of psychic disorders with propaphenin (HL
  5746, a hibernation drug).]  Deut. Gesundhwes., 1955,
  10: 524-527.  Abstract: Excerpta med., Sect.  8, 1956,
  9: No. 3085.
---, see Knittel, W., Lange, E.
Langfitt, T. W., set Hart,  E. R. Langfitt, T. W„ Marrazzi,
  A. S.
Lanteri-Laura, G.,  see Baruk, H, Launay, J., Berges, J.,
  Lanteri-Laura, G.
Lanzoni, E.,  Cavazzuti, G. B.  Azione del meprobamato
  sui  bambini della prima  infanzia;  rilievi  clinici ed
  elettroencefalografici.   [Effects of meprobamate on in-
  fants;  clinical and  electroencephalographic  studies.]
  Minerva  med.,  Tor., 1956, 47 : 2191-2192.
Lapinsohn, L. I.   Ritalin and serpasil in the  treatment of
  Parkinson's disease.   Dis. Nerv. Syst, 1956,17 : 363-364.
Largactil, chlorpromazinii chloridum (INN.)  Nord. med.,
  1955, 53 :  242-244.
Laricchia, R., see Sanguineti, I., Laricchia, R.
---•, see Sanguineti, I., Laricchia, R., Negri, V.
---, see Sanguineti, I., Negri, V., Laricchia, R.
---, see Sanguineti, I., Negri, V. U., Laricchia, R.
---, see Sanguineti, I., Zapparoli,  G. C, Laricchia, R.
Lariviere, P. Quelques  commentaires sur la chlorproma-
  zine  en  pratique psychiatrique.   [Some  remarks  on
  chlorpromazine in psychiatric practice.]  [English sum-
  mary]  Canad. Psychiat Ass. J.,  1956, 1:18-23.
Laroche,  C, Bonnet de  la Tour  Traitement du delirium
  tremens par les  perfusions intraveineuses d'ACTH as-
  sociees a  de  faibles doses  de  clorpromazine  et  de
  promethazine.   [Treatment of  delirium tremens by in-
  travenous perfusions  of ACTH associated with small
  doses of  chlorpromazine and promethazine.]  [English
  summary]  Thirapie, Par., 1956, 11:711-714.
Larsen,  V., see  Jacobsen, E., Kehlet,  H,  Larsen, V.,
  Munkvad, I., Skinhoj, K.
Larue, G. H„ see Bouchard, M., Larue, G. H  Turmel, J.
___see Grenier J., Larue, G. H.,  Parent, R., Turmel, J.
Larue,  L.   Connaissances  acquises  sur las  r6sultats
  therapeutiques du largactil   [Therapeutic results with
  largactil.]  Enciphale, 1956, 45:497-500.
Lasagna,  L.  The newer hypnotics.  Med. Clin. N. Amer-

— ' * wudv ofhypnotic drugs in patients with chronic
  diseases-  comparative efficacy of  placebo; methyprylon


  3:122-133.
---,  McCann,  W. P.  Effect of "tranquilizing"  drugs on
  amphetamine toxicity  in  aggregated  mice.  Science,
  1957, 125:1241-1242.
---■,  see von Felsinger, J. M., Lasagna, L., Beecher, H. K.
Lasater, J. H.,  Collins, J. D.  Are we causing depression?
  Northwest M., 1956, 55 : 863-864.
Lassenius, B., see Giacobini,  E., Lassenius, B.
---•,  see Osterman, E., Lassenius, B.
---,  see Osterman, E., Lassenius, B., Bohn, L., Elkjaer, P.
Latham, F.  A.   Symposium on alcoholism.  Management
  of the acute phases.  Memphis 31. J., 1953, 28: 128-131.
Launay, C,  see Baruk, H, Launay, C, Lelord.
Launay, J., see Baruk, H., Launay, J., Berges, J.
---, see  Baruk,  H,  Launay,  J.,  Berges,  J.,  Lanteri-
  Laura, G.
---, see Baruk, H, Launay,  J., Berges, J., Mijolla, A. de.
Launay, S., see Baruk, H, Launay, S., Berges, J.
Laurence, D. R. Effect of mephenesin in spastic paralysis.
  Lancet,  Lond., 1952, 1: 178-180.
Laurendeau, E. Essai clinique sur un nouveau derive du
  phenothiazine: le pacatal.   [Clinical  trial of a  new
  phenothiazine   derivative:  pacatal.]   Uniem   mid.
  Canada, 1956, 85:1421-1425.
Lauterbach, C. G., see  Gibbs, J. J., Wilkens, B., Lauter-
  bach, C. G.
Lauterbbck, J. J., Nagy, K. Anstaltserfahrungen mit dem
  Rauwolfia-Alkaloid  Reserpin.   [Hospital  experiences
  with the  Rauwolfia  alkaloid  reserpine.]   Wien.  klin.
  Wschr., 1955, 67 : 839-843.
Lauxerois, G., see Achaintre, A., Dubor, P., Lauxerois, G.
---, see Achaintre, A., Lauxerois, G.
---■,  see Bonnet, H,  Lauxerois, G.
Lazenby, W. D., see Gallagher, W. J., Berry, J- M., Durden,
  W.  D., Lazenby, W. D.
LaZerte, G. D., see Hodges, H. H.. LaZerte, G. D.
Leach, P. W., see Hewat,  J. K., Leach,  P. W.,  Simpson,
  R. W.
Leake, C. D. Drugs affecting mood and behavior.  Texas
  Rep. Biol. 31., 1955,13 : 793-818. Abstract: Chem. Abstr.,
  1956, 50: 9615b.
---.   Introductory  note  [to symposium on tranquilizing
  drugs, Atlanta, Georgia, December 1955]  In: Himwich,
  H.  E., ed. Tranquilizing drugs.  Washington,  Am. Ass.
  Adv. Sc, 1957.  p. 1-5.
---■.   New mood-changing  drugs.   Ohio  31.  J.,  1956,
  52: 369-373.
---, see Fabing, H. D., Kropa, E. L., Hawkins, J. R., Leake,
  C. D.
Le  Beau, J., see Choppy, M., Le Beau, J., Petrie,  A.
---, see Petrie, A., Le Beau, J.
Le  Bezu, see Leyritz, Le Bezu, Azoulay.
Leborgne, F.,  see Thiebaux,  M., Thiebaux R., Boyer,  R.,
  Leborgne, F., Kiffel, M.
Le  Borgne, Y., see Perrot, R. M., Moreau-Gaudry, G., Le
  Borgne, Y.
Le  Bras, R., see Picard, P., Le Bras, R., Navarranne, P.
Lechat, P., see Laborit, H.,  Coirault, R., Damasio,  R.,
  Laborit,  G., Charonnat,  R., Lechat, P., Chareton, J.
Leche, H.  G., see Lundquist, G., Leche, H. G.
Lechner, H., see Mayr, F., Lechner, H.
Leclerc, J., see Scherrer, P., Leclerc, J., Bize, N.
Lecomte,  G, Certhaux, A., Garrabe, J.  Chlorpromazine
  en  perfusions  continues dans quelques etats psycho-
  pa tiques.  [Chlorpromazine in continuous perfusion in
  some psychopathic states.]  Enciphale, 1956, 45: 382-
  387.
Leconte, M., Barbier, A.  Guerison par Tassociation chlor-
  promazine-reserpine d'un grave syndrome hebephreno-
  catatonique datant de 10 ans.  [Combined chlorproma-
  zine-reserpine therapy of a severe hebephrenic-catatonic
  syndrome of ten years'  duration.]  Ann. med. psychol,
  Par., 1956, 114(2) : 637-645.
Leeper, R. D., see Monaco, R. N., Leeper, R. D., Robbins,
  J. J., Calvy, G. L.
225 
Le Guillant, [L.]
PSYCHOPHARMACA
Le Guillant, [L.]  Le syndrome neuroleptique: etude clini-
  que et psychotechnique.  [The neuroleptic syndrome:
  clinical and psychometric study.]  Ann. mid. psychol,
  Par., 1957, 115(1) : 310 329.
---.  Le syndrome neuroleptique: prevention et traite-
  ment.   [The neuroleptic  syndrome:  prevention  and
  treatment.]   Ann. med. psychol,  Par., 1957, 115(1) :
  329-338.
---, Roelens, R.  Travaux sovietiques sur les neurolepti-
  ques.   [Soviet  studies of neuroleptics.]   Presse mid.,
  1956, 64: 1225-1227.
---,  ---, Corre, Kestenberg, Plichet, Bequart, Bailly-
  Salin.    Quelques  remarques  methodologiques   sur
  Taction des  neuroleptiques.   [Certain methodological
  considerations  of the  action  of  neuroleptic  drugs.]
  Enciphale, 1956, 45 :1128-1135.
Lehman, E., Haber, J., Lesser, S. R.  The use of reserpine
  in autistic children.  J. Nerv. Ment. Dis., 1957,125 : 351-
  356.
Lehmann, A., see Halpern, B. N., Lehmann, A.
Lehmann,  H. E.  A dynamic  concept  of the  action of
  chlorpromazine at physiological and psychological levels.
  Encephale, 1956, 45 :1113-1118.
---.  Ein hemmendes Mittel zur Kontrolle  und Behand-
  lung  psychomotorischer  Erregungszustande;  (Chlor-
  promazine, Largactil, Thorazine, Megaphen).  [An in-
  hibiting drug for control and treatment of psychomotor
  excitement: (chlorpromazine, largactil, thorazine, meg-
  aphen).]   Nervenarzt,  1954,  25:322-330.   Abstract:
  Excerpta med., Sect. 8, 1955, 8: No. 1792.
---.  Neurophysiology  activity  of  chlorpromazine  in
  clinical use.  J. Clin. Exp. Psychopath., 1956, 17:129-
  139.
---.  Selective inhibition of affective drive by pharma-
  cological means.  Am. J. Psychiat, 1954, 110: 856-857.
---.  Therapeutic results with  chlorpromazine  (largac-
  til) in psychiatric conditions.  Canad. M.  Ass. J.,  1955,
  72 : 91-99.
---,  Csank, J.  Differential  screening  of  phrenotropic
  agents in man: psychophysiologic  test data.  J.  Clin.
  Exp. Psychopath., 1957,  18: 222-235.
---,  Hanrahan,  G. E.  Chlorpromazine, new  inhibiting
  agent  for  psychomotor excitement  and  manic states.
  A. 31. A. Arch.  Neur. Psychiat, 1954, 71: 227-237.
---,  see Cahn, C. H., Lehmann, H. E.
---,  see Lindan, O., Cahn, C. H., Lehmann,  H.  E.
Lehner, F. H., see Weber,  H. J., Lehner, F. H.
Leiberman, D. M., Vaughan, G. F. Tranquillizers.  Prac-
  titioner, Lond., 1956, 177 : 632-638.
---,  ---.  The use of some new pharmacological agents
  in psychiatry.  J. Ment. Sc, Lond., 1957,  103:110-118.
---,  see Vaughan, G. F., Leiberman, D. M., Cook,  L. C.
Leifer,  P., see Batterman,  R.  C, Leifer, P.,  Grossman,
  A.J.
Leikin,  S.,  see Budnick, I. S., Leikin, S., Hoeck, L. E.
Leitao, G, see Fernandes, B., Leitao, G.
Leitch, A.,  see Hare, E. H, Seager, C. P., Leitch, A.
---,  see Seager, C. P., Leitch, A.
Lelord,  see Baruk, H, Launay,  C, Lelord.
Lemere, F.  Beuactyzine  (Suavetil).  Am.  J.  Psychiat.,
  1957,114: 371.
---.  Combined chlorpromazine-reserpine therapy of psy-
  chiatric  disorders. A.  M.  A. Arch.  Neur.  Psychiat,
  1955,  74: 1-2.  Abstract:  Excerpta med.,  Sect. 8, 1956,
  9: No. 2235.
---.  Drug habituation.  J. Am. M. Ass., 1956, 160:1431.
---.  Failure of azacyclonol  (frenquel) to relieve non-
  experimental  mental  confusion  and hallucinations.
  Am. J. Psychiat., 1957,113 : 840-841.
---.  Habit-forming properties of meprobamate.  A. M.
  A. Arch.  Neur. Psychiat, 1956, 76 : 205-206.
----.  New  tranquilizing drugs.  Northwest  31.,  1955,
  54:1098-1100.
---.  Promazine (sparine) in the  treatment  of psychi-
  atric disorders.  Northwest 31., 1956, 55 : 790-791.
Lemieux, G., Davignon, A., Genest  J, Pj^8^^
  during Rauwolfia therapy for arterial hypertension  a
  report of 30 cases.  Canad. M. Ass J., 19.>0, /4 . ,.-z  o-b.
Lemperiere, T., see Delay, J., Deniker, P.,  Bourguignon,

-^^dSS?^ Deniker, P., Tardieu,  Y., Lemperiere,

Lennard, H., Jarvik, M. E.,  Abramson, H. A.  Lysergic
  acid  diethylamide  (LSD-25):  XII.  A  preliminary
  statement of its effects  upon interpersonal communica-
  tion.  J.  Psychol, Provincet,  1956,  41:185-198.  Ab-
  stract • Excerpta med., Sect. 8, 1956, 9: No. 3943.
Leon  C  A.  The  use of thorazine as an adjunct in the
  treatment of schizophrenia.  Bull. Tulane M. Fac, 1954,
  14:17-28.                        . .  ,_   •     rmu
Lepage, M.  Le traitement de Tanxiete chronique.  [The
  treatment of chronic  anxiety.]  Bull, mid., Par., 1955,
  69:273-275.
Lepetit, see Vallat, J. N., Lepetit.
---, see Vallat, J. N., Lepetit, Texier, M.
Lepson, D., see Tuteur, W., Lepson, D.
---,  see Tuteur, W., Stiller, R., Whitehill, O., Lepson, D.
Lereboullet, J., Vidart, L., Amstutz, C.  Membre fantome
  douloureux avec syndrome depressif.  Guerison spec-
  taculaire par la reserpine.   [Painful phantom limb with
  a depressive syndrome; spectacular cure with  reser-
  pine.]  Rev. neur., Par.,  1955, 92: 386-387.
Leroy, C, Sigwald,  J.  Les myoclonies et  epilepsies ap-
  paraissant chez  certains  malades au  cours de l'ad-
  ministration  de la chlorpromazine.  [Myoclonias  and
  epileptic convulsions occurring in some patients during
  chlorpromazine  therapy.]   Enciphale,  1956, 45:904-
  909.
---,  see Montassut, M., Chertok, L., Leroy, C.
Lesevre, N.,  see Gastaut,  H., Ferrer, S., Castells, C, Le-
  sevre, N., Luschnat, K.
Leslie,  G.   Rauwolfia  serpentina  in  the  treatment of
  psoriasis.   Monogr. Ther.  Squibb Inst.  M. Res., 1956,
  1(2) : 29-32.
Lesse, S.  An evaluation of prochlorperazine in the ambu-
  latory treatment of psychiatric patients.   Internat.
  Rec. M., 1957,  170: 599-602.
---.  An evaluation of promazine hydrochloride in  psy-
  chiatric practice.  Am.  J. Psychiat., 1957, 113:984-987.
---. Psychotherapy and  ataraxics : some observations on
  combined psychotherapy  and  chlorpromazine therapy.
  Am. J. Psychother., 1956, 10: 448-459.
---, Malitz, S., Hoch,  P. [H.]   Chlorpromazine therapy
  in  private practice.   Its benefits and complications.
  J. Nerv. 31ent. Dis., 1957,  125: 25-35.
---, see Malitz, S., Hoch, P. H., Lesse,  S.
Lesser, S. R., see Lehman, E., Haber, J.,  Lesser,  S. R.
Letailleur,  M.,  Morin,  J., Demay, J.,  Monnerie, R.  La
  chlorpromazine dans le traitement des deiires aigus et
  subaigus  alcooliques.   [Chlorpromazine  in the treat-
  ment of acute  and  subacute  delirium tremens.]  En-
  ciphale,  1956, 45: 739-743.
---,---, Monnerie, R.  Syndromes transitoires  pseudo-
  parkinsoniens provoques par la chlorpromazine.   [Tran-
  sient pseudo-parkinson  syndromes provoked by chlorpro-
  mazine.]   Enciphale, 1956, 45 :1106-1109.
---,----,----, Demay, J.   Traitement d'attaque  du de-
  lirium tremens par  la synergie chlorpromazine (4560
  R.  P.) mebubarbital.   [Treatment of delirium tremens
  by chlorpromazine (4560 RP) and mebubarbital syner-
  gism.]   Ann. mid. psychol, Par., 1954,  112(2) : 76-80.
 Letienne, R., see Dobkin, A. B., Lamoureux, L., Letienne,
  R., Gilbert, R. G. B.
 Leupold-Lbwenthal, H., Ringel, E.  Erfahrungen bei Be-
  handlung  der  Angst mit Myocain.   [Experiences  with
  myocaine therapy of  anxiety.]   Wien. med.  Wschr.,
  1952, 102 : 969-970.
 Leutschaft,  R.  Behandlung vegetativer Dysregulationen
  mit Reserpin.   [Treatment of autonomic dysfunction
   with reserpine.]  Med. Klin,, Berl, 1955, 50: 1906-1909.
226 
AUTHOR LIST
Lbnnberg, B.
Levan, N. E., Mundy, C. F.  Untoward reaction to mepro-
  bamate (Equanil.)   California 31., 1956, 85:190.
LeVan,  P., Wright, E.  T.  Use of tranquilizers  in  dis-
  eases  of the skin; a preliminary report.  California 31.,
  1956,  85: 87-88.
Leveque, see Requet,  Leveque.
Leveque, F., see Achaintre, A., Balvet,  P.. Beaujard, M.,
  Broussolle, P., Perrin, J., Leveque, F..  Requet, A.
Levin, M. J.,  see Sadove, M. S., Levin, M. J., Rose, R. F.,
  Schwartz, L, Witt, F. W.
Levine, A., Abramson, H. A., Kaufman, M. R., Markham, S.
  Lysergic acid  diethylamide  (LSD-25) :  XVI.   The
  effect  on intellectual  functioning  as  measured  by the
  Wechsler-Bellevue   intelligence   scale.    J.   Psychol.,
  Provincet, 1955, 40: 385-395.
___.f ___t .---, ----,  Kornetsky, C.  Lysergic  acid di-
  ethylamide (LSD-25) : XIV.  Effect  on personality as
  observed in psychological tests.  J. Psychol, Provincet,
  1955, 40: 351-366.
___, see Abramson, H. A., Jarvik,  M. E., Kaufman, M. R.,
  Kornetsky, C, Levine, A., Wagner, M.
---, see Abramson, H. A., Jarvik,  M. E., Levine, A., Kauf-
  man,  M.  R., Hirsch, M. W.
---, see Abramson, H.  A., Waxenberg, S. E., Levine, A.,
  Kaufman, M. R., Kornetsky, C.
Levine,  S., see Rosner,  H., Levine, S., Hess, H, Kaye, H.
Levkovich, A.  P., see  Bamdas,  B.  S., Glod, G. D., Lando,
  L. L, Levkovich, A.  P., Tarasov,  Y. K., Khazen, I. M.
Levy, S.  Mild  depression states.  Northwest 31.,  1954,
  53:1233-1236.
Lewis, L. F. The use  of chlorpromazine and of serpasil in
  the treatment of psychotic patients.  Carib. M. J., Trini-
  dad, 1956,18: 51-66.
Lewis, M. N., see Reinhard, J. F., Chessin, M., Tornaben,
  J., Lewis, M. N.
Leyrie, J., see Beley, A., Foncin, J. F., Leyrie, J.
Leyritz,  Le Bezu, Azoulay.   Etat depressif avec obses-
  sion resistant au largactil; guerison rapide par la cova-
  tine (N68) ;  resultats moins heureux dans quinze cas
  differents.  [Depressive state with obsession resistant
  to  chlorpromazine   therapy;   rapid  recovery  with
  covatin ; less beneficial results in fifteen other patients.]
  Ann, mid. psychol,  Par., 1956, 114(2) : 856-861.
Lhamon, W. T., see  Boardman,  W.  K., Goldstone, S.,
  Lhamon, W. T.
Lhermitte, F., see Delay, J., Lhermitte, F., Verdeaux, G.,
  Verdeaux, J.
Liberson, W. T.  Effects of chlorpromazine hydrochloride
  (thorazine)   on  EEG and  on  skin  galvanic  activity.
  [Abstract]  Electroencephalography,  31ontreal,  19.>;>,
  7:474.
___  The new tranquilizing drugs.  1. Neuropsychiatric
  aspects.  Am. J. Nurs., 1955, 55: 1465-1467.
Librando, L., Paretti,  E.  Considerazioni su un biennio di
  esperienza  in terapia ganglioplegica,  in  psichiatria
  [Two  years  of  ganglioplegic therapy  in  psychiatry.]
  Riv. sper. freniat, 1955, 79: 696-699.
Lichtenheld, F.  R., see  Schwarz,  B. E.,  Wakim,  K. &.,
  Bickford, R. G., Lichtenheld, F. R.
Liddell,  D. W., Weil-Malherbe, H.   The effects of methe-
  drine  and  of lysergic acid diethylamide on  mental
  processes and on the  blood  adrenaline  level.  J. Neur
  Lond.,  1953,  16:7-13.  Abstract:  Chem. Abstr.,  1953,
  47:11560i.
Lidvall H F   Klinisk provning av Serpasil vid psykoser.
  [Clinical trial with serpasil in  psychoses.]   Sven. lak.
  tidn,, 1956, 53:1729-1732.
Liehert  R  S Wapner,  S., Werner, H.  Studies in the ef-
  fects'of'&eSJc acid diethylamide (LSD-25);  visual
  DerceDtion of vertically in  schizophrenic and  normal
  adults.  A. M. A. Arch. Neur. Psychiat, 1957,  77:193-
  201
Lienau  C   Heilschlafbehandlung mit Pacatal  bei Al-
  kohoiismus  und Morphinismus.   [Therapeutic  sleep
  treatment with pacatal in alcoholism and morphinism.]
  Munch, med. Wschr., 1957, 99: 80-81.
Lieser,  H.   Lasst sich  die  auftretende Angst vor einer
  Schockbehandlung beeinflussen?  [Can one control fear
  of shock  therapy?]  Deut. med. Wschr., 1956, si: 1503-
  1504.
---.  Uber  die   synergistische  Megaphen-Krampfbe-
  handlung.  [Synergistic combination of megaphen with
  shock therapy.]   Nervenarzt, 1956,  27: 69-72.
Lim, R.  K., Pindell, M. H., Glass,  H. G., Rink, K.  The
  experimental evaluation of sedative agents in animals.
  Ann. N. York Acad. Sc, 1956, 64 : 667-678.
Lim, R.  K.  S.,  see  Pindell,  M. H,  Fancher, O. E.t  Lim,
  R. K.  S.
Lindan, O.,  Cahn, C. H., Lehmann,  H. E.  Clinical obser-
  vations with frenquel in chronic schizophrenia.  Canad.
  Psychiat.  Ass. J., 1956, 1: 89-91.
Lindemann,  E.,  Clarke,  L.  D.  Modifications  in  ego
  structure  and personality reactions under the influence
  of  the effects  of  drugs.   Am.  J. Psychiat,  1952,
  108: 561-507.
Lindqvist R.   Nagra  ord  om chlorpromazinbehandling,
  narmast  i anledning av  nagra neuropsykiatriska fall.
  | Comments on chlorpromazine therapy,  with special
  reference to neuropsychiatric cases.]   Sven, lak. tidn.,
  1955, 52 : 2314-2317.
Lindsay, J. S., see Andermann, K., Lindsay, .7. S.
Linke, H. . Erfahrungen in der Behandlung akuter und
  chronischer Schmerzzustande  mit den Phenothiazin-
  korpern  Megaphen  und  Atosil.   [Experiences  in the
  treatment  of acute  and  chronic  pain states with the
  phenothiazine derivatives megaphen and atosil.]   [Eng-
  lish summary]  3Iiinch.  med.  Wschr.,  1955, 97: 1689-
  1692.
----. Uber die Wirkung des Phenothiazin-Heilschlafs bei
  schweren  vegetativ thalamischen  Schmerzzustanden.
  [Effects of phenothiazine induced therapeutic sleep in
  severe pain of autonomic and thalamic origin.]  Aerztl
  Wschr., 1956, 11: 815-819.
Linn, F. V., see Ferguson, J. T., Linn, F.  V.
---, see Ferguson,  J. T., Linn, F. V.,  Sheets, J. A., Jr.,
  Nickels, M. M.
Lipton,  M.  A., see Whitman, R. M., Lipton, M. A., Kavan,
  E.
Litin, E. M., Faucett, R. L., Achor, R. W. P.  Depression
  in hypertensive patients  treated  with Rauwolfia  ser-
  pentina.   Proc. Mayo Clin., 1956, 31: 233-237.
---, see Faucett, R. L, Litin,  E. M., Achor, R. W. P.
Litteral, E.  B.,  Wilkinson,  W. E.  The advantages, dis-
  advantages and limitations of the use of chlorproma-
  zine  as  a substitute  for certain somatic  treatment
  methods   in psychiatry.   Psychiat Res.  Rep.,  Wash.,
  1955(1) : 63-71.
Ljungberg,  E.   Depressionsrisken  vid  rauwolfiabehand-
  ling.   [Risks  of  depression with Rauwolfia therapy.]
  Sven. lak. tidn., 1956, 53: 2875-2880.
---. Om  reserpinbehandling av kroniska schizofrenier
  och akuta orostillsand.   [Reserpine management of
  chronic schizophrenia and acute anxiety.]   Sven. lak.
  tidn.,  1956, 53 : 2128-2140.
Loch, W.  Zur Behandlung fortgeschrittener  Schizophren-
  ien mit Megaphen und Reserpin.  [Megaphen and reser-
  pine therapy of advanced schizophrenia.]  Nervenarzt,
  1956,  27: 463-467.
Locket,  S.   Oral preparations of Rauwolfia serpentina in
  treatment of essential hypertension.  Brit.  31. J., 1955,
  1: 809-813.
Lockhart, W. E.  Suicidal  miltown, hazard of overhy-
  dration in treatment.  Southwest. 31., 1956, 37 : 428.
Lofgren, B.  Sedativa och hypnotica.  [Sedatives and hyp-
  notics.]   [Brief English summary]   Nord. med.,  1955,
  53: 220-222.
Lbnnberg,  B. Leptidrol (pipradrol), ett nytt psykoana-
  lepticum.   [Leptidrol  (pipradrol), a new psychoana-
  leptic] Sven. lak, tidn., 1956, 53 : 3346-3357.
227 
Loewenthal, L. J. A.
PSYCHOPHARMACA
Loewenthal, L. J. A.  Chlorpromazine in dermatological
  practice.  3ted. Proc, Johannesb., 1955, 1: 122-125.
Loftus, L. R., Huizenga, K. A., Stauffer, M. H., Rome, H. P.,
  Cain, J. C.   Jaundice caused by chlorpromazine  (thora-
  zine) .   -/. Am, 31. Ass.,  1955, 157: 1286-1288.
Logan, C. R., see Isbell, H, Belleville, R. E.,  Fraser, H. F.,
  Wikler, A., Logan, C. R.
---,  see Isbell, H, Logan, C. R.
Lomas, J.  Agranulocytosis during chlorpromazine  ther-
  apy.  Brit. 31. J., 1954,  2 : 358-359.
---.   Tranquillizing  drugs  in psychoneurosis.    Brit,
  31. J., 1957, 2 : 23S.
---,   Treatment of schizophrenia ; "pacatal" and chlor-
  promazine compared. Brit. 31. J., 1957, 2: 78-80.
---.   Uses of  chlorpromazine in  mental  hospital pa-
  tients.  Brit. 31. J., 1955, 1:879-882.  Abstract:  Ex-
  cerpta med., Sect. 8,1956, 9 : No. 1725.
---,  Boardman,  R.  H., Markowe,  M.  Complications of
  chlorpromazine therapy in 800 mental-hospital patients.
  Lancet, Lond., 1955,  1:1144—1147.  Abstract: Excerpta
  med., Sect. 8,1956, 9 : No. 4076.
----,  see  Boardman, R. H, Lomas,  J., Markowe,  M.
Lombard, A. see Cossa, P., Bougeant, H., Lombard, A.
Longhino, A. see Dogan, S., Vukadinovic, D., Longhino, A.
Longo, R. H., see Pupo, P. P., Zukerman, E., Longo, R. H.
Longo, V. G., Napolitano,  L.  Effetti della reserpina sulle
  reazioni elettroencefalografiche  e motorie  provocate
  dalla stimolazione dell'ipotalamo.  [Effects of  reser-
  pine on the electroencephalographic and motor reactions
  induced  by  stimulation of  the hypothalamus.]   Far-
  maco, ed. sc, Pavia, 1955, 10: 297-305. Abstract: Chem.
  Abstr., 1955, 49 : 13517gh.
---,  Von Berger, G. P., Bovet, D.  Action of nicotine and
  of the  "ganglioplegiques  centraux" on  the electrical
  activity  of  the brain.  J. Pharm.  Exp.  Ther.,  1954,
  111: 349-359.  Abstract: Chem. Abstr., 1954, 48 :12301d.
Lovett Doust,  J. W.,  see Sloane,  B., Lovett Doust, J.  W.
Lowinger, P., see Gottlieb,  J. S., Tourney, G., Beckett, P. G.,
  Lowinger, P.
Lucas, C. J., see Raymond, M. J., Lucas, C. J.
---,  see  Raymond,  M. J., Lucas, C. J., Beesley,  M. L.,
  O'Connell, B. A., Roberts, J. A. F.
Lucas, J., Albert, S. N., Bateman, J. C, Klopp, C. T.  Thora-
  zine as  an  aid in  management of cancer  patients.
  [Abstract]   Proc Am. Ass. Cancer Res., 1954, 1(2) : 30.
Lucero, R. J., see Kamman, G. R., Freeman, J. G. Lucero,
  R. J.
---, see Sommerness, M.  D., Lucero, R. J., Hamlon,  J. S.,
  Erickson, J. L, Matthews, R.
---, see Sommerness, M.  D., Lucero, R. J., Hamlon,  J. S.,
  Mahowald, A. M.
Ludwig, B. J.,  see Berger,  F. M.,  Campbell, G. L.. Hendley,
  C. D., Ludwig, B. J., Lynes, T.  E.
Luiz,  H. A.  Experiences with the use of reserpine on the
  chronically disturbed mental patient. S. Afr. 31. J., 1956,
  30: 1049-1051.
Lukinovich, N., Vichi, A.   Modifications psychologiques au
  cours du traitement de tuberculeux par le "marsilid".
  [Psychologic modifications in  tuberculous subjects dur-
  ing "marsilid" therapy.] Mschr, Psychiat, Basel,  1956,
  132:364-380.
Lukomskii, 1.1., Pavlenkova, E. F. O primenenii aminazina
  v psikhiatricheskoi klinike.    [Aminazine therapy in a
  psychiatric  clinic]  Zh. nevropat psikhiat, 31oskva,
  1956, 56:575-576.
Lundgren, S., see Fries, P. E., Gunne, L. M., Lundgren, S.,
  Viding, G., Ohrberg, K.
Lundquist, G., Leche, H. G.  Nagra erfarenheter av  lergi-
  ganbehandling vid psykoser.   [Experiences with  lergi-
  gan  therapy of  psychoses.]   Sven. lak. tidn.,  1954,
  51:1402-1412.   Abstract: Excerpta med., Sect. 8, 1955,
  8: No. 1793.
Lundy, J. S.  Modern technics for the relief of pain.  J.
  Lancet, 1957, 77 : 32-37.
Luschnat, K., see Gastaut,  H, Ferrer, S., Castells, C, Le-
  sevre, N., Luschnat, K.                 .
Luttrell, R. R., Morrison, A. V.  A preliminary  report on
  the tranquilizing  effect  of  reserpine.   Ann.  A.  ) ork
  Acad. Sc, 1955, 61: 183-187.  Abstract: Excerpta  med.,
  Sect. 8, 1956, 9: No. 4078.
Lyager, T., Rontorp, P. S.  Behandling af psykotiske pa-
  tienter med reserpin (serpasil).   [Reserpine in therapy
  of psychoses.  [English summary]   Ugeskr.  laeger,
  1955,  117 : 603-610.  Abstract: Excerpta med., Sect. 8,
  1956,' 9: No. 3009.                            tt
Lynes, T. E., see Berger, F. M., Campbell, G. L., Hendley,
  C. D., Ludwig, B. J., Lynes, T. E.
---, see Hendley, C. D., Lynes, T. E., Berger, F. M.
Lysergic  acid  diethylamide   and   mescaline in experi-
  mental psychiatry.  85 p. New York, Grune d Stratton,
  1956.  cf. Cholden, L., ed.


                          M

Ma, J., Crandell, A.  The use of reserpine in the treatment
  of mental  patients who are tuberculous.  Am.  Rev.
  Tuberc, 1956, 74: 457-461.
McAdam, W., see Mayer-Gross, W., McAdam, W., Walker,
  J.  W.
McArthur, J. G, Isaacs, B.  Mental  effects  of reserpine.
  Lancet, Lond., 1955, 2: 347.
Maccagnani, G.  Trattamento di alcune sindromi psichiche
  deU'eta senile con reserpina, con reserpina associata a
  cloropormazina.    [Treatment of senile  psychic  syn-
  dromes with reserpine and with reserpine associated
  with chlorpromazine.]  Arch, psicol. neur., Milano,  1956,
  17: 452-454.
McCann, W. P., see Lasagna, L., McCann, W. P.
Macchi, G. Trattamento combinato di reserpina con altre
  terapie psichiatriche.   [Reserpine combined with  other
  psychiatric  therapies.]   [English  summary]   Arch.
  psicol. neur., Milano,  1956,  17: 661-670.
---, Manghi, E.,  Saginario,  M.   L'impiego  della  reser-
  pina in narcoterapia; primi risultati.   [Use  of reser-
  pine in sleep therapy; first results.]   Gior.  psichiat,
  1954, 82:1130-1134.
---, ----, ----.  Indicazioni e metodi di impiego del lar-
  gactil (4560 R. P.) in terapia neuro-psichiatrica; studio
  su 130 casi trattati.   [Indications  and methods of use
  of largactil in neurophychiatric therapy;  study of 130
  treated cases.]  Riv. sper. freniat., 1954, 78:183-204.
MacColl, K.   Chlorpromazine hydrochloride (largactil)
  in the treatment of the disturbed mental defective.  Am.
  J. 3Ient. Defic, 1956, 61: 378-389.
McCormick, W. G., see Haley,  T. J., McCormick, W. G.
McCubbin, J. W., see Page, I. H.,  McCubbin, J.  W.
McCullagh, W. H.,  Ingram, W., Jr.  Headaches and hot
  tempers.  Dis. Nerv.  Syst,  1956, 17 : 279-281.
MacDonald, J.  M., Galvin,  J.  A.  Experimental  psychotic
  states.  Am. J. Psychiat, 1956, 112: 970-976.
McDonald, R. E., Ellsworth,  R. B., Eniss, J. Behavioral
  changes of chronic schizophrenics in response  to reser-
  pine.   A. M. A. Arch. Neur.  Psychiat, 1956, 75 : 575-578.
  Abstract: Excerpta med., Sect. 8, 1957, 10: No. S88.
McGavack, T.  H., see  Gelvin, E.  P., McGavack, T. H,
  Kenigsberg, S.
---, see Gelvin, E. P.,  McGavack, T. H., Pogge, R. C.
McGrath, S. D., Ryan,  J. P.,  Fennelly, J. J. The use of
  reserpine (serpasil)  in  psychiatry.  J. Irish 31. Ass.,
  1956, 39:1-4.  Abstract: Excerpta med.,  Sect. 8, 1957,
  10: No. 2089.
MacGregor, J.  MacW.  Largactil; a  new  psychomotor
  brake.  S. Afr. J. Clin. Sc,  1954, 5 : 228-243.  Abstract:
  Excerpta med., Sect. 8,1956, 9: No. 1724.
----.  Pacatal-a clinical trial of a  new ataractic  drug.
  S. Afr. 31. J., 1956, 30: 1108-1111.
Machado, M. R., see Bringas Nunez,  E., Seggiaro,  J. A.,
  Machado, M. R.
228 
AUTHOR LIST
Marrazzi, A. S.
 Macias Castro, I.  Notas terapeuticas: uso y abuso de la
   Rauwolfia  serpentina.  [Therapeutic notes:  use and
   abuse  of  Rauwolfia  serpentina.]  Arch.  Hosp.  unw.,
   Habana, 1955, 7: 61-65.
 Mcllwain, H.  Chemotherapy and the central nervous
   system. 328 p. Boston, Little, Brown d Company, 1957.
 McKellar, P., see Ardis, J. A., McKellar, P.
 MacKenzie-Van der Noordaa, M. C.  Depressie na gebruik
   van reserpine  wegens essentiele hypertensie.  [Depres-
   sion after reserpine therapy of essential hypertension.]
   [English summary]   Ned. tschr. geneesk.,  1956, 100:
   1003-1004.
 Mackinnon, H. L., see Allen, A., Mackinnon, H. L.
 McLaughlin, B. E.   Miltown in  the treatment  of chronic-
   ally ill  psychiatric out-patients.  Pennsylvania 31. J.,
   1957, 60: 989-992.
 McLaughlin,  J.  J.,  Schlan, L.  S.   3-o-Toloxy  1,2  pro-
   panediol as an adjunct in the treatment of drug addic-
   tion.  Illinois M. J., 1953,103 : 247-249.
 MacLean,  R. E.  Benactyzine hydrochloride  (suavitil) in
   out-patient  psychiatric treatment:  preliminary  study.
   3Ied. J. Australia, 1957, 44(1)  : 67-70.
 McLemore, G. A., Jr., see Friend, D. G., McLemore,  G. A.,
   Jr.
 MacLeod,  J. A., see Gottschalk, L. A., Kapp, F. T., Ross,
   W. D., Kaplan, S. M.,  Silver, H., MacLeod, J. A., Kahn,
   J. B., Jr., Van Maanen, E.  F., Acheson, G. H.
 McNeill, J. F., Johnston, W. C.,  Pietuchow,  W.  Serpasil
   in a hospital for the mentally  ill with criminal tenden-
   cies.  N. York State  J.  M., 1956, 56:1911-1914.   Ab-
   stract :  Year book of drug therapy, 1956-1957, p. 335-336-
 McPheeters, H.,. Fox., W. W.  Evaluation of reserpine and
   methyl  phenidylacetate used  separately and in combi-
   nation in chronic psychotic patients. J.  Kentucky 31.
   Ass., 1956, 54 : 785-791.
 McPheeters,   H.  L., see Davidoff, E., Best,  J. L., Mq-
   Pheeters, H. L.
 McQueen,  E. G,  see Smirk, F. H., McQueen,  E. G.
 Maderna, A.,  Micheletto, T.  Primi risultati sull'associa-
   zione largactil-insulina nella  terapia di Sakel.  [First
   results  with a largactil-insulin combination in SakeTs
   therapy.]  Pisani, 1954, 68: 587-598.
 Madi, M. L., Kovitz, B. Experiences with methyl-phenidyl-
   acetate hydrochloride (ritalin)  in  psychotic patients.
   Antibiotic M., 1956, 3 : 309-311.
 Maffezzoni, G.,  Giamattei,  L.  La reserpina  nel tratta-
   mento  di ammalati mentali.   [Reserpine  in the  treat-
   ment of  mental disorders.]  Osp. psichiat,  Nap., 1956,
   24:157-164.
 Magraw, R. M., see Carey, J. B., Magraw, R. M.
 Mahowald, A. M., see Sommerness, M. D., Lucero, R. J.,
   Hamlon, J. S., Mahowald, A. M.
 Mailer, A. B.  Effects of mephenesin and prenderol on in-
   tellectual  functions   of   mental  patients.  J.  Clin.
   Psychol, 1954, 10 : 283-285.
 Maisonneuve,  G.  Bilan d'un an  de traitement par  la
   chlorpromazine.  [Chlorpromazine therapy; results of
   one year.]   59 p.   Lyon,  1954.  [Thesis—Lyon, 1953/
   1954, no 93.]
 ---, see Gerest, F., Maisonneuve.
 Malamud, W., Barton, W. E., Fleming, A.  M„  Middleton,
  P. McK., Friedman, T. T., Schleifer, M. J.  The evalua-
  tion of  the  effects of  derivatives of Rauwolfia in  the
  treatment,  of schizophrenia.   Am. J. Psychiat.,  1957,
  114:193-200.
 Malet, P., see Rigal, J., Malet, P.
 ---, see Rigal, J.. Malet, P., Florentin, M.
 Maley, M. C,  see Carter,  C. H., Maley, M. C.
Malineau, R., see D'Aulnay, J., Malineau, R.
___ see Bergouignan, M., D'Aulnay, J., Malineau, R.
___' see Bergouignan, M., Got, M., Malineau, R.
MaliW  <*  Hoch  P. H.  Preliminary evaluation of  a new
  pnenot^hiaz?ne derivative, NP-207.  Psychiat. Q.,  1956,
  30: 633-646.

     456132—59---16
----,----, Lesse, S. A two-year evaluation of chlorprom-
  azine  in  clinical  research  and  practice.  Am.   J.
  Psychiat, 1956, 113 : 540-545.
----, see Lesse, S., Malitz, S., Hoch. P. [H.]
Malmejac, J.,  Plane,   P.   Chlorpromazine et  activity
  nerveuse   superieure.  [Chlorpromazine   and  higher
  nervous activity.]  C. rend. Soc  biol, 1955,  149:077-
  679.
Malone,  M. H., see Rubin,  B., Malone, M. H., Waugh, M.
  H., Burke, J. C.
Mancini, G.  Terapia con largactil e gardenal in distimici
  e  psiconevrotici.  [Largactil  and  gardenal  in  the
  therapy of manic-depressive psychosis and psychoneu-
  roses.]  [Brief English  summary]  Acta neur., Nap.,
  1954, 9: 585-590.
Manganaro, D., see Imberciadori, S., Manganaro, D.
Manghi,  E.,  Saginario,  M.   In tema  di  narcoterapia:
  risultati ottenuti con  Tassociazione  di  farmaci  del
  gruppo della fenotiazina.   [On  sleep therapy:  results
  with phenothiazine combinations.]  [English summary]
  Riv. sper.  freniat,  1955, 79:757-770.  Abstract:  Ex-
  cerpta med., Sect. 8,  1957, 10:  No. 966.
---, see De Risio, C,  Manghi, E.
---, see Macchi, G., Manghi, E., Saginario, M.
Mangun, C. W., Webb, W. W.  Promazine hydrochloride
  in the treatment  of  chronic  catatonic schizophrenics.
  J. Nerv. 31ent Dis., 1956, 123: 553-556.
Mantelli, A., see Sacerdoti,  G., Mantelli, A.
Marck, H.  La cure de  sommeil; <§tude de 103 cas.  [Sleep
  therapy; a  study of 103 cases.]  79  p.   Paris, 1953.
  [Thesis—Paris, 1953, no. 579]
Margolis, L.  H.  Pharmacotherapy in psychiatry; a re-
  view.  Ann. N. York Acad. Sc, 1957, 66: 698-718.
---, Fischer, A., Butler, R. N., Simon, A.  Clinical obser-
  vations with chlorpromazine.   In:  Kline, N.  S.,  ed.
  Psychopharmacology.  Washington, Am. Ass. Adv. Sc,
  1956.   p. 1-30.
Mariani, G.,  Barsotti,  U.   II largactil nella cura delle
  malattie mentali; risultati del trattamento in 100 casi.
  [Largactil  therapy of mental illness; therapeutic re-
  sults in 100 cases.]  Riv.  pat. nerv., 1956, 77: 525-528.
Marini, M., Caprini, G., Benciolini, P.  La  Rauwolfia in
  malate croniche, normotese ed ipertese; contributo clin-
  ico.  [Rauwolfia  in  chronic, normotensive and hyper-
  tensive patients; clinical contribution.]   Arch, psicol
  neur., Milano, 1956,17: 419-432.
Markham, S., see Levine, A., Abramson, H. A., Kaufman,
  M. R.,  Markham,  S.
---, see Levine, A., Abramson, H. A., Kaufman, M. R.,
  Markham, S., Kornetsky, C.
Markich, H., see Sivadon, P., Koechlin,  P., Markich, H.
Markowe, M., see Boardman, R. H, Lomas, J., Markowe, M.
---, sec  Lomas, J., Boardman, R. H., Markowe, M.
Marmelzat, W.  L., see Friedman, H. T., Marmelzat, W. L.
Marmier, see Piedelievre, Deniker, Marmier.
Maroncelli, P.  Trattamento di alcune psicosi con tecnica
  derivata  dall'ibernazione   artificiale.   [Treatment of
  various psychoses with a technic derived from artifi-
  cial hibernation.]  [English summary]  Gior. psichiat.,
  1953,  81:223-244.  Abstract: Riv. neur., Nap., 1953,
  23: 828-829.
Marra, J. J., see Elliott, R.  N., Schrut, A. H., Marra, J. J.
Marrazzi, A.  S.  The effects of certain drugs on cerebral
  synapses.  Ann. N. York Acad. Sc, 1957, 66: 496-507.
---, Hart, E. R. An electrophysiological analysis of drugs
  useful  in  psychotic  states.   In: Himwich, H.  E., ed.
  Tranquilizing drugs.  Washington, Am. Ass. Adv.  Sc,
  1957.  p. 9-21.
---,---.  An electrophysiological analysis of the actions
  of some drugs useful in the therapy of psychotic  dis-
  orders. J. Nerv. 31 ent. Dis., 1956, 124: 388-392.
---,----.  The possible role of inhibition  at adrenergic
  synapses in the mechanism of hallucinogenic and related
  drug actions.  J. Nerv. Ment. Dis., 1955,  122: 453—457.
---, see Hart, E. R.,  Langfitt, T. W., Marrazzi, A. S. 
Marriott, A.
PSYCHOPHARMACA
Marriott, A.  The opened door.  New Yorker, 1954, 30 (32,
  Sept. 25) : 90-101.
Marshall, W. Ambulatory and comparative treatment of
  the  anxiety  neurosis syndrome with  chlorpromazine,
  phenobarbital, and dimethylane.  S. Dakota J. M., 1956,
  9:384-388.
Marshall, W. H., see Evarts, E. V., Landau, W., Freygang,
  W., Jr., Marshall, W. H.
---, see Evarts, E. V., Marshall, W. H.
Martelli, G.  Azione della reserpina a dosi terapeutiche
  sull'elettroencefalogramma di malati mentali.  [The ef-
  fects of reserpine therapy  on the EEG  of mental pa-
  tients.]  [English  summary]  Gior.   psichiat.,  1956,
  84:323-335.
---.  Variazioni E. E.  G da reserpina in neuropsichiatria.
  [Electroencephalographic variations with reserpine  in
  neuropsychiatry.]  Arch,  psicol. neur.,  3Iilano,  1956,
  17: 595-596.
Martens, S.  Intracerebral elektrografi;  ett viktigt hjalp-
  medel i psykiatrisk  forskning.  [Electroencephalogra-
  phy, an  important aid in psychiatric research.]   Sven.
  lak. tidn., 1956, 53 : 2855-2863.
---,  see Holmberg,  G.,  Jonsson,  B.,  Mellgren,  A.,
  Martens, S.
Marti-Ibaiiez, F.  The  historical  and philosophic  back-
  ground  of psychobiology.   J.  Clin. Exp. Psychopath.,
  1956,17: 360-369.
---, Sackler, A. M., Sackler, M. D., Sackler, R. R.  The
  challenge  of  bio-  and  chemotherapy  in  psychiatry.
  J. Clin.  Exp.  Psychopath.,  1956, 17:15-18.  Abstract:
  Exerpta med., Sect. 8, 1957, 10: No. 975.
Marti-Tusquets, J. L., see Ruiz-Ogara, C, Marti-Tusquets,
  J. L., Gonzalez-Monclus, E.
Martin, C. A. Epreuve du largactil en psychiatrie.   [Ex-
  periences  with largactil  in  psychiatry.]  Laval  mid.,
  1954, 19:1079-1094.   Abstract: Excerpta med., Sect. 8,
  1956,9:  No. 1723.
Martin, D. A.  The therapeutic and toxic effects of tran-
  quilizing drugs : medical aspects.  North Carolina  M. J.,
  1956,17: 396-401.
Martin, D. W., see Merlis, S., Martin, D. W.
Martin, E. A., see Moore, J. N., Martin, E. A.
Martin, G.  Uber die sedativen Eigenschaften  des Anti-
  histaminicums Atosil.  [The sedative  qualities of the
  antihistaminic atosil.]  Ther. Gegenwart, 1953, 92: 338-
  340.
Martin, J.  E., Beck, J. D. Some effects of chlorpromazine
  hydrochloride  in horses.  Am.   J. Vet. Res.,  1956,
  17: 678-686.
Martin, K. E.,  Overley, H.  G.,  Krone, R. E. Pipradrol:
  combined therapy for geriatric  and agitated patients.
  Internat. Rec. M., 1957,170 : 33-36.
Martin, P., Vidal, G.,  Portal, H.  Cures de sommeil  et
  4560 R.  P. chez  les  psychopathes dans  les conditions
  habituelles de Thopital psychiatrique.   [Sleep therapy
  and 4560 RP  for mental disorders under ordinary psy-
  chiatric  hospital  conditions.]  Vie mid.,  Par.,  1954,
  35:807-810.
Martini, F.  La terapia del sonno nella pratica psichi-
  atrica; risultati  ottenuti in un  gruppo di 111 malati.
  [Sleep therapy in psychiatric practice; results obtained
  with a group of 111  patients.]  Riv.  pat. nerv., 1956,
  77: 549-550.
Marty, R.,  see Verdeaux, G., Marty, R.
Marzi, F., see Milli, N., Marzi, F.
Masciangelo, P. M., see Zonta,  G., Masciangelo, P. M.,
  Gentili, E.
Mashkovskii, M. D.  [The  pharmacologic properties  of
  aminazine  and of other compounds of the phenothiazine
  order.]   Zh. nevropat. psikhiat., Moskva, 1956, 56:81-
  93.   Abstract: Chem. Abstr., 1956,  50:17174e.
Masini, A., Pescetto, G., Tosca, L.  Effetti somatici ed
  impiego  psichiatrico  della reserpina.   [Somatic effects
  and psychiatric use of reserpine.]  Arch,  psicol neur.,
  Milano, 1956, 17 : 249-256.                      ...
Mason, J. W., Brady, J. V.  Plasma 17-hydroxycorticoste-
  roid changes related to  reserpine effects on emotional
  behavior.   Science, 1956, 124:982-984.
Mason-Browne, N. L.  Perphenazine—a  drug modifying
  consciousness.  Am. J. Psychiat, 1957,  114 : 1 <d-174.
___   Selection of patients  for treatment with alpha-4-
  piperidyl benzhydrol hydrochloride. J. Nerv. 31ent. Dis.,
  1956, 123: 130-140.                 .          .
Massari, M.  Ansieta e blocco vegetativo.  [Anxiety and
  autonomic  block.]   Minerva med.,  Tor., 1953, 44:231-
  232  TNot seen.]
Massenti, C.  Considerazioni pratiche sulla condotta della
  terapia neuroplegia.  [Treatment  with   neuroplegic
  drugs;  practical considerations.]  Riv. sper. freniat.,
  1955, 79: 699-705.
---.   II  trattamento neuroplegico negli stati  di eccita-
  mento  e di agitazione.   [Treatment of excitement and
  agitation with  neuroplegic drugs.]   Lavoro  neuropsi-
  chiat,   1954, 14: 493-505.   Abstract:  Excerpta  med.,
  Sect. 8, 1955, 8 : No. 1785.
Masserman, J. H., Pechtel,  C. An experimental investiga-
  tion of factors  influencing drug action.  Psychiat. Res.
  Rep., Wash., 1956 (4) : 95-113.
---,----. Neurophysiologic and  pharmacologic  influ-
  ences on experimental neuroses.   Am. J. Psychiat, 1956,
  113: 510-514.
Massignan, L., see Barison, F., Massignan, L.
Matarazzo, A. Sui sonno prolungato e su Tuso dei ganglio-
  plegici  in  terapia  psichiatrica; risultati  ottenuti  in
  alcuni  malati di mente trattati con la "cloropromazina"
  (largactil o 4560 R. P.).   [Prolonged sleep and the use
  of ganglioplegic drugs in psychiatric therapy; results ob-
  tained  with "chlorpromazine" (largactil or 4560 RP) in
  the treatment of mental patients.] Pisani, 1954, 68: 599-
  622.  Abstract: Excerpta med., Sect. 8, 1955, 8:  No. 3100.
Matefi, L. Mezcalin-und Lysergsaurediathylamid-Rausch;
  Selbstversuche  mit besonderer Berticksichtigung  eines
  Zeichentests.   [Mescaline  and lysergic acid   diethyla-
  mide intoxication; autoexperiments with special  con-
  sideration of a drawing test.]  [English summary] Con-
  finia neur., Basel, 1952,  12:146-177.   Abstract: Ex-
  cerpta  med., Sect. 8, 1953, 6: No. 1204.
Mathis, M.  Toniques et sedatifs en neuro-psychiatrie in-
  fantile.  [Tonics and sedatives  in child neuro-psychia-
  try.]   Pidiatrie, 1956, 11:  807-820.
Matthews, R., see Sommerness, M. D., Lucero, R. J., Ham-
  lon, J.  S., Erickson, J. L.,  Matthews, R.
Mattis, P. A., see Cook, L., Weidley, E. F., Morris, R.  W..
  Mattis, P. A.
Mauceri, J., Strauss, H.  Effects of chlorpromazine on the
  electroencephalogram with report of a case of chlorpro-
  mazine intoxication.  Electroencephalography,  Mont-
  real, 1956, 8: 671-675.
Maudoux-Joubert, see Dupont, A., Maudoux-Joubert.
Maurel, H., Wilhelm, Spielmann, J. P.  Essai therapeutique
  de la reserpine en psychiatrie hospitaliere; a propos de
  80 observations.  [Reserpine therapy in a mental hospi-
  tal ; 80 observations.]  Concours mid., 1955,  77: 3351-
  3355.  Abstract: Excerpta med., Sect. 8,1956, 9: No. 4545.
----,----,----.  Les indications psychiatriques de la re-
  serpine.  [Psychiatric indications for  reserpine.]   En-
  ciphale, 1956, 45:1049-1055 :
Mautner, H., see  Durling, D., Esen, F. M., Mautner, H.
Maxwell, R., see Plummer, A. J., Maxwell, R., Earl, A. E.
May, A.  R., see Folkson, A.,  May, A. R.
----, see Garmany, G., May, A. R., Folkson, A.
May, R. H., see Voegele, G. E., May, R. H.
Mayer-Gross, W.  A survey of the pharmacological  pos-
  sibilities in psychiatry.   Enciphale, 1956, 45 : 307-312.
----, McAdam, W.,  Walker, J. W. Further observations
  on the effects of lysergic acid diethylamide.   J. Ment.
  Sfc, Lond., 1953, 99 : 804-808.
230 
AUTHOR LIST
Miescher, P.
 ---,----,----.  Lysergsaure-Diathylamid  und  Kohlen-
   hydratstoffwechsel.   [Lysergic  acid diethylamide  and
   carbohydrate metabolism.]   Nervenarzt,  1952, 23 : 30-
   31.
 ---, see Elkes, C, Elkes, J., Mayer-Gross, W.
 ---, see Ginzel, K. H., Mayer-Gross, W.
 Mayr,  F.  Erfahrungen mit der Largactil-Behandlung in
   der  Anstaltspsychiatrie.   [Experience with largactil
   treatment in psychiatric hospitals.]   Ther. Umschau,
   Bern, 1955,11: 184-191; 203-211.
 ---, Lechner,  H.  Zur  Frage der Provokation bei Tem-
   porallappen-Epilepsie  im EEG.  [The  question of pro-
   vocation in temporal lobe epilepsy in the EEG.]  Wien.
   klin. Wschr., 1954, 66: 903-906.
 Mazoue, H., see Chauchard, P., Mazou§,  H.
 Mazza, A.,  Pedrelli,  M.   La cura  con  reserpina nella
   schizofrenia.  [Reserpine  therapy in  schizophrenia.]
   Riv.  sper.  freniat, 1956, 80: 877-886.
 Meath, J. A., Feldberg, T. M., Rosenthal, D., Frank, J. D.
   Comparison of reserpine and placebo  in treatment of
   psychiatric outpatients.  A. 31. A. Arch. Neur. Psychiat.,
   1956, 76: 207-214.
 Mecham, M. J., Stromsta, C, Soderberg, G.  Effects of
   tolserol on the speech errors of mentally defective chil-
   dren. Am. J. Phys. M., 1955, 34: 535-536.
 Medina, F.  Sono prolongado na terapeutica psiquiatrica.
   [Prolonged  sleep in psychiatric therapy.]   31 ed. con-
   temp., Lisb., 1954, 72 : 323-331.
 Meier,  R., Bein, H. J., Gross, F.,  Tripod, J., Tuchmann-
   Duplessis, H. Effets de la reserpine, un nouvel alcaloide
   de la Rauwolfia Serpentina Benth, sur le systeme ner-
   veux central de Tanimal.  [Effect of reserpine, a new
   alkaloid from Rauwolfia serpentina Benth, on the cen-
   tral  nervous system in animals.]  C.  rend.  Acad, sc,
   1954, 238: 961-963.
 ---, Gross,  F., Tripod, J.  Ritalin, eine neuartige syn-
   thetische Verbindung mit spezifischer zentralerregender
   Wirkungskomponente.   [Ritalin, a new synthetic com-
   pound  with  specific analeptic  action.]   Klin.  Wschr.,
   1954,  32:445-450.   Abstract:  Chem.  Abstr.,  1954,
   48: 8945e.
 ---, see Bein, H. J., Gross, F., Tripod, J., Meier, R.
 ---, see Tripod, J., Bein, H. J., Meier, R.
 Meller, R. L.  Reserpine and alseroxylon therapy in emo-
   tionally disturbed patients. J. Lancet, 1955, 75 : 339-342.
   Abstract: Excerpta  med., Sect. 8, 1956, 9: No. 5000.
 Mellgren, A.  Nagot om serpasil och dess anvandning inom
   psykiatrin.   [Psychiatric use of serpasil.]  Sven. lak.
   tidn., 1956, 53 : 1564-1575.
 ---, see  Holmberg, G.,  Jonsson, B., Mellgren, A., Mar-
   tens,  S.
 Mellin,  P., see  Hippius, H., Mellin, P., Rosenkotter, L.
 Menager, V., see Rives,  Menager,  V.
 Mendenhall,  J. H., Ewing, J.  A.  Further  psychometric
   evaluation of the effect of mephenesin on anxiety.  J.
   Ment. Sc, Lond., 1954,100: 262-266. Abstract: Excerpta
   med., Sect. 8, 1955, 8: No. 927.
 ---, see Ewing, J. A.,  Mendenhall, J. H.
 Mendes, F., Galvao, P.  Experiencia clinica com a cloro-
   promazina  (4560 R.  P.) em psicoses.  [Clinical experi-
   ence with chlorpromazine (4560 R. P.) in psychoses.]
   [English summary]  J. mid., Pdrto,  1955,  26: 149-156.
 Menger, P. Serpasil et sclerose en plaques.  [Serpasil and
   multiple sclerosis.]   Ann. mid.  psychol, Par.,  1956,
   114(2) : 886-890.
 Mengus, M., see Kammerer, T., Mengus, M., Ebtinger. R.
 Meprobamate.  J. Am. M. Ass., 1956, 160:1405.
 Meprobamate and other agents used in mental disturb-
 ances.   [Conference  held in  New York, October 1956]
 Ann. N. York Acad.  Sc, 1957, 67:671-894.
Mercier, J., see  Corriol, J., Mercier, J.
Merli, G. M.,  see Castrovilli, G., Ginoulhiac,  R., Merli, G.
 M.
Mprli«  S   The effects of  mescaline sulfate in chronic
 schizophrenia.  J. Nerv. Ment Dis., 1957, 125:432-434.
 ----, Denber, H. C. B.  Studies on mescaline. V. Electro-
   encephalographic evidence for the antagonism between
   mescaline and chlorpromazine hydrochloride.   J. Nerv.
   Ment. Dis., 1956, 123: 542-545.
 ----,  Hunter,  W.  Studies  on mescaline.   II.  Electro-
   encephalogram in schizophrenics; effects of administra-
   tion after electric convulsive treatment of schizophrenic
   patients.  Psychiat  Q.,  1955, 29:430-432.   Abstract:
   Excerpta med., Sect. 8, 1956, 9: No. 3659.
 ----, Martin, D. W.  Hibicon in treatment of epileptics
   with mental disorder.  Psychiat. Q., 1956, 30: 387-401.
 ----, see Denber, H. C. B.,  Merlis, S.
 ----, see Turner, W. J., Merlis,  S.
 ----, see Turner, W. J., Merlis, S., Carl, A.
 Merry, J.,  Pargiter, R. A., Munro, H.   Chlorpromazine
   and chronic neurotic tension. Am. J. Psychiat, 1957,
   113: 988-990.
 Meszaros, A. F., O'Reilly, P. O.  Relation of chlorproma-
   zine  to epilepsy.  Dis. Nerv.  Syst, 1956, 17:159-162.
   Abstract: Excerpta med., Sect. 8, 1957, 10: No. 723.
 Meyer, H. H.  Die Behandlung  exogener Psychosen mit
   Phenothiazinderivaten.  [The  treatment of exogenous
   phychoses with phenothiazine derivatives.]   Enciphale,
   1956, 45:524-527.
 ----.  Die moderne Behandlung psychiatrischer Erkran-
   kungen.  [Modern  treatment  of psychiatric diseases.]
   31 ed. Klin., Berl, 1956, 51:1429-1432.
 ----.  Die Therapie der endogenen Psychosen.   [Therapy
   of endogenous psychoses.]   Deut. med. Wschr.,  1957,
   82:76-80.
 ----. Die Winterschlafbehandlung in der Psychiatrie und
   Neurologie.  [Hibernotherapy  in psychiatry and neurol-
   ogy.]  Deut. med. Wschr.,  1953, 78:1097-1100.
 ---, Schmitt,  W.,  Kieser, J.  Das  Delirium  tremens.
   [Delirium tremens.]  Deut.  med.  Wschr.,  1955, 80:
   1389-1391.
 Meyers, F. H.  Pharmacology of chlorpromazine, reser-
   pine and related drugs.   In: Kline,  N.  S., ed.  Psycho-
   pharmacology. Washington, Am. Ass. Adv. Sc,  1956.
   p. 131-140.
 Micalizzi, F., see Pisani,  D., Micalizzi, F., Motta, E.
 Micheletto, T., see Maderna, A., Micheletto, T.
 Michtom, J., Goldberg, N.,  Offenkrantz, W., Whit tier, J.
   Readmission rates for  state  mental hospital  patients
   discharged on maintenance ataractics.   Findings with a
   matched control  group and methodological considera-
   tions.   J. Nerv. Ment. Dis., 1957, 125: 478-480.
 Mickle, W.  A., see Monroe, R. R.,  Heath, R.  G.,  Mickle.
   W. A., Miller, W.
 Middleton,  P. McK., see  Malamud, W.,  Barton, W. E.,
   Fleming,  A. M., Middleton, P. McK., Friedman, T. T.,
   Schleifer, M. J.
 Mielke, F. A. Methods employed and  results obtained in
   psychiatric studies with new drugs acting on the brain
   stem.  Am. J. Psychiat, 1957,  114:134-139.
 ---. Uber  das Rauwolfia-Alkaloid Reserpin  (Serpasil)
  in der Psychiatrie.   [The Rauwolfia alkaloid reserpine
   (serpasil)  in psychiatry.]  Arch. Psychiat.,  Berl, 1956.
  194: 263-288.
 ---. Uber die medikamentose und psychotherapeutische
   Ftihrung der Serpasil-Kur.  [Medical and psychothera-
  peutic management of serpasil therapy.]  Schweiz. med.
  Wschr., 1956,  86:162-165.  Abstract:  Excerpta med,
  Sect. 8,1957,10: No. 1531.
 ---. tibersicht der klinischen Erfahrungen mit Serpasil
  am Burgholzli. [Review of the clinical experience with
  serpasil at the  Burgholzli hospital.]   Schweiz.  med
  Wschr., 1955, 85 : 440-442.
Miescher, P.  Therapeutische Versuche  zur  symptoma-
  tischen   Behandlung  psychoneurotischer  Storungen.
  [Therapeutic experiments on  the symptomatic treat-
  ment of psychoneurotic disorders.]  Praxis,  Bern  1956
  45: 1041-1043. 
Mignault, G.
PSYCHOPHARMACA
Mignault, G. Two years' experience using the phenothia-
  zine amine derivatives in anaesthesia and artificial hi-
  bernation with special mention of the new  derivative
  pacatal.   Canad. Anaesth. Soc. J., 1957, 4: 37-42.
Mihailovic, L., see Delgado, J. M., Mihailovic, L.
Mijolla, A. de, see Baruk, H., Launay,  J., Berges, J., Mi-
  jolla, A. de.
Mikes, A. Serpasil; pregled literature.   [Serpasil; litera-
  ture review.]   Med. arh., Sarajevo, 1955, 9:161-167.
Mikorey, M., see Kolle, K., Mikorey, M.
Miksztal, M. W.  Chlorpromazine (thorazine)  and reser-
  pine in residential treatment of neuropsychiatric dis-
  orders in  children. J. Nerv. Ment. Dis., 1956, 123: 477-
  479.
Miles, J.  Largactil  and occupational therapy.   Canad. J.
  Occup. Ther., 1956, 23:11-13.
Miles, J. E.  Psychosis with phantom limb pain treated by
  chlorpromazine. Am. J. Psychiat, 1956, 112:1027-1028.
Miletto, G.,  see Collomb, H., Miletto, G., Chaupin, M.
---,  see Collomb, H., Miletto, G., Robert, H.
Millen, F. J. Miltown—clinical experiences in  neuropsy-
  chiatric oflBce use.  Wisconsin 31. J.,  1957, 56:198-201.
Miller, G., see Zatuchni, J., Miller, G.
Miller, J. K., see Boyd, E. M., Miller, J. K.
Miller, J. S. A.,  see Blumberg,  A. G.,  Cohen,  L., Miller,
  J. S. A.
Miller, N. E.  Effects of drugs  on motivation;  the value
  of using a variety of measures.  Ann.  N. York Acad. Sc,
  1956, 65: 318-333.
Miller, R. E., Murphy, J. V., Mirsky, I. A.  Persistent effect
  of chlorpromazine on extinction of avoidance response.
  A. 31. A. Arch. Neur.  Psychiat, 1957,  78: 526-530.
Miller, W., see Monroe,  R. R., Heath, R. G., Mickle, W. A.,
  Miller, W.
Milli,  N., Marzi, F.  II serpasil nelle  malattie mentali.
  [Serpasil  in mental  disease.]   Riv.  pat nerv.,  1956,
  77 • 502—505.
Mills, L. C, see Kinard, S., Mills, L. C,  Terrell, J., Moyer,
  J. H.
Minvielle, J., see Lafon, R., Boyer, Due, N., Minvielle, J.,
  Pouget, R.
---,  see Passouant, P., Pelissier, Minvielle, J., Dutartre.
Miroux, M.   Action  combinee du chlorpromazine, du pro-
  methazine  et   d'un  serum   tissulaire   specifique.
  [Combined action of chlorpromazine,  promethazine and
  of a specific tissue serum.]   Gaz. mid. France,  1955,
  62: 592.
Mirsky, A. F., see Primac, D. W.,  Mirsky, A. F., Rosvold,
  H.  E.
Mirsky, I. A., see Miller, R. E., Murphy,  J. V, Mirsky, I. A.
Mises, R., see Demay, G., Montremy, J.  de, Mises, R.
Missenard,  R.,  see  Coirault, R., Laborit, H., Missenard,
  R.,  Jolivet, B, Hainaut, J., Weber, B.
Mitchell, E. H.   Chlorpromazine in the treatment of acute
  alcoholism.  Am.  J.  M. Sc,  1955, 229:363-367.  Ab-
  stract : Excerpta med., Sect. 8, 1957, 10: No.  884.  Q. J.
  Alcohol, 1955, 16: 589-590.
---.   Treatment of acute  alcoholism with  promazine
  (sparine).  J.  Am. 31. Ass., 1956, 161: 44-45.  Con-
  densed : Am.  Practitioner,  1956,  7:1798-1799.   Ab-
  stract : Excerpta med., Sect. 8, 1957, 10: No. 359.
Mitchell, P. H.   Chlorpromazine in the treatment of  the
  chronic disturbed  schizophrenic patient.  J. 3Ient. Sc,
  Lond.,  1956, 102:  151-154.
---,  Sykes, P., King, A. Effects of pacatal on symptoms
  in  chronic psychotic in-patients.  Brit. M.  J.,  1957,
  1: 204-207.
Mitis, Z. K., Ford,  H.  Functional headaches.   Texas J.
  31.,  1956,  52 : 678-683.
Mitra, S. K., see Sinha, G. B.,  Mitra, S.  K.
Mohun, M.  Globus.  Laryngoscope,  1955, 65: 73-79.
Molina, A.  La Rauwolfia serpentina, con especial refer-
  enda a la reserpina.   [Rauwolfia serpentina, with spe-
  cial reference to reserpine.]  Prensa mid. argent.,^ 1®®>
  43:  423-425.   Also:  Rev. mid.  cubana, 195b, b (.  ^6-
  627
Monaco,  R. N., Leeper, R.  D., Robbins, J. J. Calvy, G. L.
  Intermittent  acute porphyria treated with chlorproma-
  zine.  N. England, J. M., 1957, 256: 309-311.
Monnerie, R., see Letailleur, M., Morin,  J., Demay,  J.,
  Monnerie, R.                           .  ^
---, see Letailleur, M., Morin, J., Monnerie, R.
---, see Letailleur, M., Morin, J., Monnerie, R., Demay, J.
Monnerot,   E.,   Monnerot,   E.,  Benichou,  L.,   Doco
  Analyse des roles  respectifs du largactil et du sommeil
  barbiturique, dans les cures de sommeil potentialisees.
  [Analysis of  the effect of chlorpromazine and of barbi-
  turates respectively  in  potentiated   sleep  therapy.]
  Enciphale, 1956,  45:1190-1196.
Monnier, M., see Gangloff, H., Monnier, M.
Monro, A. B., Steadman, H. H.  Myanesin in psychiatry.
  J. Ment. Sc, Lond.,  1953,  99:285-287.  Abstract: Ex-
  cerpta med.,  Sect. 8,  1954, 7, No.  751.
Monroe,  J. J., see Cutler, R. P., Monroe,  J. J., Anderson,
  T E
Monroe, R. R., Heath, R. G.,  Mickle, W. A., Miller, W.  A
  comparison of  cortical and subcortical brain waves in
  normal,  barbiturate,  reserpine,  and  chlorpromazine
  sleep.  Ann.  N. York Acad. Sc, 1955, 61: 56-71.  Ab-
  stract : Excerpta med., Sect. 8, 1956, 9:  No. 3089.
---,---,----,----.  Cortical and subcortical recordings
  correlated with behavior in patients and animals dur-
  ing the administration  of Rauwolfia,  thorazine, and
  meratran.  Psychiat. Res. Rep., Wash., 1955 (1) : 25-44.
  Abstract: Chem. Abstr., 1956, 50: 2867gh.
Montagnari,  F.,  Germano, V.  Stato preeclamptico con
  episodio confuso  onirico troncato con  reserpina  endo-
  vena.  [Intravenous reserpine  immediately effective in
  treatment of  a pre-eclamptic state with episode of onei-
  ric confusion.]  Riv. sper. freniat., 1956,  80: 977-979.
Montanari, C, Tonini, G.  Azioni della 5-idrossitriptamina
  sui sistema nervoso centrale; suo impiego in psichiatria
  sperimentale.   [Effects of 5-hydroxytryptamine on the
  CNS; its  use in  experimental psychiatry.]  Riv. sper.
  freniat, 1955,  79: 465-483.  Abstract: Excerpta med.,
  Sect. 8, 1956, 9: No. 3076.
---,---.  La  5-idrossitriptamina  in  psichiatria.    [5-
  Hydroxytryptamine  in psychiatry.]  Riv. sper. freniat,
  1955,  79:745-750.  Abstract:  Chem. Abstr.,  1956,  50:
  8065i.
---, see Tonini,  G., Montanari, C.
Montanari, M., Giua, A. M.  II  comportamento di alcune
  funzioni neurovegetative nella terapia  con neuroplegici
  (largactil)  delle  psiconevrosi.   [Behavior  of  various
  autonomic functions  in neuroplegic (largactil)  therapy
  of psychoneuroses.]   [English  summary]  Rass. stud.
  psichiat, 1955, 44 : 433-475.
——,----.  L'influenza del largactil sulle funzioni neuro-
  vegetative nelle psiconevrosi. [The influence of largactil
  on the neuro-vegetative functions in psychoneuroses.]
  Riv. pat. nerv., 1956, 77 :  490-492.
Montassut,  M., Chertok, L., Bequart, P.  Hallucinations
  auditives anciennes sans systematisation deiirante  ac-
  tuelle, traitees par la chlorpromazine.   [Chlorpromazine
  therapy of persistent auditory hallucinations  without
  currently manifest delusion.]   Ann. mid. psychol, Par.,
  1955, 113(1) : 800-804.
----,----, Leroy, C. Crise comitiale et alterations electro-
  encephalographiques au  cours d'un traitement par chlor-
  promazine.  [Epileptic crises  and electroencephalogra-
  phic  changes  during chlorpromazine  therapy.]   Ann.
  mid. psychol,Par., 1955, 113(1) : 804-807.
Montoussis, N.,  see Pamboukis, G.,  Paieologue, A., Mon-
  toussis, N., Hakas, P.
Montremy, J. de, see Demay, G., Montremy, J. de, Mises, R.
Moody, A. C, see Smith, K., Moody, A. C.
Moore, E. W.,  see Payne,  R. B.,  Moore, E. W.
232 
AUTHOR  LIST
Nayrac, P.
 Moore, J. N. Largactil in psychotherapy.  Irish J. 31. Sc,
   1955:  409-412.  Abstract: Excerpta med., Sect. 8, 1956,
   9: No. 3613.
 ---, Martin, E. A.  Trial of reserpine in treatment of
   schizophrenia.  Brit. 31. J., 1957, 1: 8-14.
 Moore, K. B., see Sibilio, J. P., Andrew, G., Dart, D., Moore,
   K. B., Stehman, V. A.
 Moore, R. B., Pierce, W. J., Dennison, A. D., Jr.  The story
   of reserpine.  J. Indiana 31. Ass., 1954, 47 : 853-861.
 ---, see Dennison, A.  D, Jr., White, P. T., Moore, R. B.,
   Pierce, W. J.
 Moran,  N. C, Butler,  W.  M., Jr.  The pharmacological
   properties of chlorpromazine sulfoxide, a major meta-
   bolite of chlorpromazine; a comparison  with chlorpro-
   mazine.  J. Parm. Exp. Ther..  1956, 118: 328-337.
 Moreau-Gaudry, G., see Perrot, R. M., Moreau-Gaudry, G.,
   Le Borgne, Y.
 Morgan, D. R. Chlorpromazine and reserpine in the treat-
   ment of chronic mental illness.  Med. J. Australia, 1956,
   43(2)  : 57-62.
 ---.  The combined use of chlorpromazine and reserpine
   in the treatment of  chronic mental illness:  a  prelim-
   inary  report.  3Ied.  J. Australia,  1955, 42(2): 77-80.
   Abstract: Excerpta  med., Sect. 8, 1956, 9: No. 1728.
 ---.  The experimental use of reserpine in the treatment
   of tremor-rigidity syndromes.   3Ied.  J. Australia, 1956,
   43(1)  : 973-974.
 ---.  The use of reserpine,  chlorpromazine and allied
   drugs in medicine and psychiatry.   Med. J. Australia,
   1956,43(1) : 1029-1035.
 Morimoto, K., see Hyde, R. W., Von Mering,  O., Mori-
   moto,  K.
 ---, see Slater, P. E.,  Morimoto, K., Hyde, R. W.
 Morin, J., see Letailleur,  M.,  Morin, J., Demay, J. Mon-
   nerie,  R.
 ---, see Letailleur, M., Morin, J., Monnerie, R.
 ---, see Letailleur, M., Morin, J., Monnerie,  R., Demay,
   J.
 Morpurgo, V. Osservazioni cliniche su una nuova sostanza
   ad azione eccitante centrale.   [Clinical observations on
   a new  substance with  central  stimulating  effect.]
   [English summary]  Minerva  anest, Tor.,  1956,  22:
   110-114.  Abstract:  J.  Am. M. Ass., 1956, 161:1514.
 Morris, G., see Knight,  R. W., Kent, B., Morris, G., Rogers,
   S.
 ---, see Moyer, J. H., Kent, B., Morris,  G., Dizon, M.,
   Rogers,  S., Spurr, C.
 Morris, R. W., see Cook, L., Weidley, E. F., Morris, R. W.,
   Mattis, P. A.
 Morrison, A. V., see Luttrell, R.  R., Morrison, A. V.
 Morton,  H. G., Warson, S. R.  Control  study on reserpine
   in small group of children with neurologic disorders.
   J. Florida 31. Ass., 1957, 43: 786.
 Motta, E., see Pisani, D., Micalizzi, F., Motta, E.
 Moulton, J. A., see Fabing, H. D., Hawkins,  J. R., Moulton,
   J. A.
 Moyer   J.  H.  The pharmacology of  chlorpromazine.
   Internat. Rec  31., 1955,  168: 301-311.
 --- Kent, B., Morris, G., Dizon, M.,  Rogers, S., Spurr,
   C  Clinical studies of an anti-emetic agent, chlorproma-
   zine.  Am. J. 31. Sc, 1954, 228:174-189.
 ___ Kinross-Wright, V., Finney, R. M.  Chlorpromazine
   as'a therarjeutic agent in clinical medicine.  A. 31. A.
   Arch  Int  31.,  1955,  95:202-218.   Abstract: Chem.
   Abstr., 1955, 49 : 5687h.                       .
 ___ Pevey  K., Kinross-Wright,  V.  Tranquilizing (ata-
   ractic  aeents- current evaluation of their clinical use
   Tn patients who are not hospitalized.   GP, 1957, 15  (6) :
   Q7—118
 — see Kinard, S., Mills,  L C,  Terrell, J., Moyer, J. H.

 =i Z 3£STI™ MoV£ K'i O. A., He,aer,    ^

MUl'ler J  M., Schlittler, E., Bein, H. J.  Reserpin,  der
  sedative Wirkstoff aus  Rauwolfia serpentina  Benth.
  [Reserpine, the sedative principle from Rauwolfia ser-
  pentina  Benth.]   [English  summary]  Experientia,
  Basel, 1952, 8 : 338.
Mukerji, B., see Kohli,  J. D.,  Mukerji, B.
Mukherjee, K. L., see Dasgupta, S. R., Mukherjee, K. L.,
  Werner,  G.
Mulas, L., see De Caro,  D., Mulas, L.
Mulder,  D. W.,  see Schwarz,  B. E.,  Bickford, R.  G.(
  Mulder, D. W., Rome, H.  P.
Mullen, A. J., see Gaitz, C. M., Roy, H., Thompson, W.,
  Kimbell, L, Mullen, A. J., Pokorny, A. D.
Mulier, J. C,  Pryor, W. W., Gibbons, J.  E., Orgain, E. S.
  Depression  and  anxiety  occurring during  Rauwolfia
  therapy.  J. Am. M. Ass., 1955, 159 : 836-839.  Abstract:
  Excerpta med., Sect.  8, 1957,  10: No. 1536.   Year book
  of drug therapy, 1956-1957, p.  323-324.
Munch-Petersen, S.  Chlorpromazine (largactil) in the
  management of psychotic patients.   Acta psychiat neur.
  scand., 1955,  30:643-658.  Abstract:  Excerpta med.,
  Sect. 8, 1950, 9: No. 5009.
---.  Effects of chlorpromazine (largactil) and reserpine
  (serpasil) within the field of neurology; a study of the
  pertinent literature.  Acta psychiat. neur. scand,, 1956,
  Suppl. 108:  269-280.  Abstract: Excerpta med., Sect. 8,
  1957,10 : No. 727.
----.  Et tilfaelde af agranulocytose under largactilbe-
  handling.  [An incident of agranulocytosis during larg-
  actil therapy.]   Ugeskr. laeger, 1954, 116:1787.
Mundy, C. F., see Levan, N. E., Mundy, C. F.
Munkvad, I.  Treatment of psychoses  and psychoneuroses
  with  a new  sedative  (suavitil).   [In  English]   Acta
  psychiat neur.  scand., 1955,  30: 729-739.   Abstract:
  Excerpta med., Sect. 8, 1956, 9: No. 3086.
---, see Jacobsen, E., Kehlet, H., Larsen,  V.,  Munkvad,
  I., Skinhoj, K.
Munro, H., see Merry, J., Pargiter, R.  A., Munro, H.
Munro, H. K.  On  the  effect of suavitil (benzilic acid
  diethylaminoethylester hydrochloride)  on the higher
  mental functions  of  normal  subjects.   Acta psychiat.
  neur. scand., 1955, 30:  721-728.
Muratti, J. B.  Reserpina: su uso terapeutico  en la
  esquizofrenia ; nota previa.  [Reserpine: therapeutic use
  in schizophrenia ; preliminary note.] Dia mid., B. Air.,
  1956,28: 880-883.
Murphree,  O.  D., Peters, J. E.  The  effect of electrocon-
  vulsions, insulin comas and certain chemical agents on
  fixations  in the rat.   J. Nerv.  3Ient  Dis., 1956, 124:
  78-83.
---, see Gardner, M. J., Hawkins, H. M.,  Judah, L.  N.,
  Murphree, O. D.
Murphy, J. V., see Miller, R. E., Murphy, J. V., Mirsky, I. A.
                          N

Nadolski, F.,  see Finn, M.  H.,  Nadolski,  F., Guy, W.,
  Gross, M.
Nagy, K., see  Lauterbock, J. J., Nagy, K.
Naidoo,  D.   The effect of reserpine (serpasil)  on the
  chronic disturbed schizophrenic: a comparative study
  of Rauwolfia  alkaloids and  electroconvulsive therapy.
  J. Nerv. 3Ient. Dis., 1956, 123:1-13.
Napolitano, L., see Longo, V. G., Napolitano, L.
Natenshon, A. L. Clinical evaluation of ritalin.  Dis. Nerv.
  Syst, 1956,17 : 392-396.
Nathan, P., Aprison, M. H., Himwich, H.  E.  Effect of
  some  centrally acting drugs  on compulsive circling.
  Proc.  Soc. Exp. Biol, N.  Y., 1955, 90: 364-367.  Ab-
  stract : Chem.  Abstr., 1956, 50: 3<>32cd.
National Association of Science  Writers.  Drug therapy
  publicity.  Am. J. Psychiat., 1956, 113: 77.
Navarrane, P., see Navarranne, P.
Navarranne, P., see Picard, P., Le Bras, R., Navarranne, P.
     see Picard, P., Navarranne, P.
Nayrac, P., Graux, P. Indications et contre-indications de
  la chlorpromazine  en psychiatrie.  [Indications  and
233 
C,P.
  contraindications of chlorpromazine therapy in psychi-
  atry.]  Enciphale, 1956, 45: 518-523.
Nedilsky, B. T., see Holt, E. K., Ward-Dunn, G., Nedilsky,
  B. T., Niswander, G. D.
Negri, F.  Effetto della reserpina e della reserpina associ-
  ata a psicotonici  in alcune psicopatie senili.  [Effect of
  reserpine and  of  reserpine combined with psychotonics
  in senile psychoses.]  [English summary]  Arch, psicol.
  neur., 31ilano, 1956, 17: 441-451.
Negri, V. U., Garavaglia, G.   Rilievi clinici sulla peculiare
  azione della reserpina  in psichiatria.  [Reserpine, in
  psychiatry;  a clinical study on its characteristic action.]
  Minerva med., Tor., 1955,  46 : 1217-1229.
■---, see Garavaglia, G., Negri, V. U.
---, see Sanguineti,  I., Laricchia, R., Negri, V.
■---, see Sanguineti,  I., Negri, V., Laricchia, R.
----, see Sanguineti,  I., Negri, V. U., Laricchia, R.
Nelson, G., see Hurst, L. A., Reuning, H., Wyk, A. J. van,
  Crouse, H. S., Booysen, P. J., Nelson, G.
Neri, A. Primi risultati ottenuti col largactil nelTospedale
  neuropsichiatrico prov. di Reggio  Calabria.  [First re-
  sults obtained with largactil  in  the neuropsychiatric
  hospital  of  the Reggio  Calabria  province.]  [English
  summary: p.  800-801]  Rass. stud, psichiat., 1956, 45:
  783-804.
---.  Primi risultati ottenuti con l'impiego del largactil
  in  malati mentali.   [First results with chlorpromazine
  therapy of mental patients.]   Enciphale, 1956, 45: 682-
  686.
Neue Mittel  zur  Pharmakotherapie  der   Psychosen?
   [New drugs for the pharmacotherapy of  psychoses?]
  Deut med.  Wschr., 1955, 80:1777.
Neuer, H.  Serpasil  in the treatment  of acute alcoholic
  psychoses.  Ohio  M. J.,  1955, 51: 749-751. Abstract:
  Excerpta med., Sect. 8, 1956, 9: No. 4004.
Neuropharmacology.  328 p. [2. conference 1955]   381 p.
   [3.  conference  1956]  New  York, Josiah Macy,  Jr.
  Foundation,  1956.  1957. cf. Abramson,  H. A., ed.
Neuss, N., see Slater, I.  H., Rathbun, R. C, Henderson,
  F. G., Neuss, N.
Neuwirtova, R., Zwetschke, O., Zahradka, L.  Pokus o
  sebevrazdu   largactilem  a  barbiturany.   [Attempted
  suicide with largactil  and  barbiturates.]  [English
  summary]  Cas. lik. cesk., 1956,  95:1361-1364.
Neveu, P.  L'hibernation, traitement d'urgence des  syn-
  dromes de choc decompense en psychiatrie. [Hiberna-
  tion, an emergency treatment of  decompensated shock
  syndromes  in psychiatry.]  Enciphale, 1956,  45:377-
  381.
Nevzorova, T. A., see Popov, E. A., Nevzorova, T.  A.
New and nonofficial remedies.  J. Am. M. Ass., 1955,  159:
   1206-1207.  1956, 160:  287-289; 390; 1405.  1956,  161:
   457-458.
A  new  drug effective on  the central nervous  system.
   [In English]   Danish M. Bull, 1955, 2:159-160.
New drugs for patients with emotional disorders. J. Am.
  M. Ass., 1955, 157: 665.
Newbold, H.  L., Steed, W. D.  The use of  chlorproma-
   zine in psychotherapy.  J. Nerv. Ment Dis., 1956,  123:
   270-274.
 Newling, P. S. B.,  see Glaser, E. M., Newling, P. S.  B.
Nichamin, S.  J.  Chlorpromazine in the treatment of mild
   behavior disturbances.  J. Michigan M. Soc, 1956, 55:
   1469-1471.
 Nichtern,  S.,  see Bender, L., Nichtern, S.
 Nick, J.  Depressions melancoliques secondaires a Tusage
   therapeutique de Rauwolfia serpentina chez des hyper-
   tendus.   [Melancholia in hypertensive patients caused
   by therapeutic use of Rauwolfia serpentina.]  Bull Soc.
   mid. hdp. Paris, 1955, 71: 884-893.  Abstract: Excerpta
   med., Sect.  8, 1956, 9: No. 4544.
 Nickels, M. M., see  Ferguson,  J. T., Linn, F. V., Sheets,
   J. A., Jr.,  Nickels, M. M.
Nicolaou, G. T, Kline, N. S. Reserpine in the treatment
  of disturbed adolescents.  Psychiat. Res. Rep., wasn.,

NS-Charietp^^e Sigwald, J., Bouttier, D., Nicolas-

NiedermeyePr,  E.  Uber einen Fall von akuter halluzina-
  torischer Psychose durch Phenerganvergif tung.  [A case
  of acute hallucinatory psychosis caused by  phenergan
  poisoning.]  Klin. Med., Wien, 1956  11: 280-284.  Ab-
  stract : Excerpta med., Sect. 8, 1957 10 : No. 872.
Nieschulz, O., Hoffmann, I„ Popendiker, K.  Pharmakol-
  ogische Untersuchungen fiber N-Alkyl-pipendyl-pheno-
  thiazin-Derivate.   [Pharmacological studies of N-alkyl-
  piperidyl-phenothiazine  derivatives.]   [English  sum-
  mary]   Arzneimitt. Forsch., 1956,  6 : 651-660.
---, Popendiker, K., Hoffmann, I. Weitere pharmakolog-
  ische  Untersuchungen  fiber  N-Methyl-pipendyl-(3)-
  methyl-phenothiazin. [Further pharamcological studies
  of   N - methyl - piperidyl - (3) - methyl - phenothiazine]
  [English summary]   Arzneimitt. Forsch., 1955, 5: 680-
  695.
.___,____, Sack, K. H.  Pharmakologische Untersuchungen
  iiber N-Alkyl-piperidyl-phenothiazin-Derivate.   [Phar-
  macological  studies of  N-alkyl-piperidyl-phenothiazine
  derivatives.]  Arzneimitt. Forsch., 1954, 4: 232-242.
Nikolopoulos, see Kokkoris, P., Kordas, P., Nikolopoulos,
  Tanniris, M.                           ,,.,.,-,
Niswander, G. D.,  Haslerud,  G. M., Brody,  N.,  Casey,
  T. M.   Reserpine  and methylphenidylacetate effects on
  socialization and  activity. J. Nerv.  Ment.  Dis., 1957,
  125: 51-56.
 ■---, Holt,  E. K.   Chemotherapy  with  azacyclonol  in
  mental illness. J. Nerv. 3Ient. Dis., 1956, 123: 473-476.
 .---, •---.  Combination reserpine-methylphenidylacetate
  in  epileptics with psychosis.  Dis.  Nerv.  Syst., 1957,
  18:11-15.
---, see Holt, E. K., Ward-Dunn., G., Nedilsky, B. T., Nis-
  wander, G. D.
Nitsch,  W., Thein,  K.  Klinische Erfahrungen mit dem
  neuen Schlafmittel Doroma. [Clinical experiences with
  the new sedative Doroma.]  [Adalat]  Ther.  Gegenwart,
  1956, 95: 264.
 Noce, R. H.,  Williams, D.  B., Rapaport, W.   Reserpine
   (serpasil) in the management of the mentally ill.  J.
  Am. M. Ass., 1955, 158: 11-15.
 ■---,----,----.  Reserpine  (serpasil)  in  the manage-
  ment of the mentally ill and mentally retarded; prelim-
   inary  report.  J.  Am. 31. Ass., 1954, 156: 821-824.  Ab-
   stract : Excerpta  med.,  Sect. 8, 1956, 9: No.  1222.
 Noell, W. K., Chinn, H. I., Haberer, C. E.  Electroencephal-
   ographic evaluation of the  sedative  effects  of antihis-
   taminic drugs.  Air Force School of Aviation Medicine,
   Randolph Air Force Base, Texas, 1955  (55-35) : 1-20.
 Nordman,  L. O.   Reserpinutlosta  depressiva psykoser.
   [Depressive psychosis  precipitated  by reserpine ther-
   apy.]   Sven. lak. tidn.,  1956, 53 :1641-1647.
 Norton, S., De Beer,  E.  J.  Effects of  drugs  on the be-
   havioral patterns of cats. Ann. N. York Acad. Sc, 1956,
   65: 249-257.
 Nuzum, J. W.  The  successful  treatment of  a postgas-
   trectomy schizophrenic psychosis with chlorpromazine;
   report of a case.  Am.  Practitioner, 1955, 6:1849-1851.

                            0

 Obiols,  J.  Notre experience sur la therapeutique par la
   chlorpromazine.  [Our experience with chlorpromazine
   therapy.]  Enciphale, 1956, 45 : 698-699.
 O'Connell, B. A.,  see  Raymond,   M.  J.,  Lucas, C.  J.,
   Beesley, M. L., O'Connell, B. A.,  Roberts, J. A. F.
 O'Connell, T. A., see Thimann,  J.,  Bucknam,  F. G.,  Gau-
   thier, J. W., O'Connell, T. A.
 O'Connor, J.  B., Howlett, K. S.  Side effects  accompany-
   ing use of iproniazid.  Tr. 12.  Conf. Chemother. Tuberc,
   1953: 139-140.
234 
AUTHOR LIST
Panaccio, V.
 ---,---, Wagner, R. R.  Side effects accompanying use
   of iproniazid.  Am, Rev. Tuberc, 1953, 68:270-272.
 Odland, T.  M.  Azacyclonol (frenquel)  hydrochloride in
   the treatment of chronic schizophrenia; a double-blind,
   controlled study.  J. Am. M. Ass., 1957, 165: 333-335.
 ---, see Proctor, R. C, Odland, T.
 Ohrberg, K., see Fries, P. E., Gunne, L. M.,  Lundgren, S.,
   Viding, G., Ohrberg, K.
 Ostergaard Jensen, O.  Suavitil in the treatment of psy-
   choneuroses.  [In English]  Danish  M.  Bull,  1955,
   2:140-143.
 Oettinger, L., Jr.   Meratran; preliminary report of a new
   drug  for the treatment  of behavior disorders in chil-
   dren.  Dis. Nerv.  Syst, 1955, 16 : 299-302.
 Offenkrantz, W.,  see Michtom, J.,  Goldberg,  N.,  Offen-
   krantz, W., Whittier,  J.
 Ogden,  H. D.  Headache.  Ann. Allergy, 1956, 14: 385-428.
 Ogle, W., see Azima, H., Ogle, W.
 ---, see Sarwer-Foner, G. J., Ogle, W.
 Olansky, S., see Callaway, J. L., Olansky, S.
 Olariu,  J., see Tolan, E. J., Olariu, J.
 Olin, J. S., see Brodie, B. B., Olin, J. S., Kuntzman, R. G.,
   Shore, P. A.
 Olinger, L. B., see Bercel, N. A., Travis, L. E., Olinger, L.
   B., Dreikurs, E.
 Olsen, A. L., see Pearl, D., Vander Kamp, H., Olsen, A. L.,
   Greenberg, P. D., Armitage, S. G.
 Orcutt, J. A., Cronheim, G. E.  Quantitative comparison
   of the hypotensive and sedative effects of rescinnamine
   in  dogs.  Fed.  Proc, Bait, 1955, 14:375-376.
 ---, see Cronheim, G.,  Orcutt, J.  A., Toekes, I. M.
 O'Reilly, P. O., see Meszaros, A. F., O'Reilly, P. O.
 Orgain,  E. S., see Mulier,  J. C,  Pryor,  W. W.,  Gibbons,
   J. E.,  Orgain, E. S.
 Ornstein, G. G., see Selikoff, I. J., Robitzek, E.  H., Orn-
   stein, G. G.
 Orsi, C.  I farmaci atarassici.  [Ataraxics]  Boll. chim.
   farm., 1956, 95: 432-436.
 Orthmayr, A., see Boszormenyi, Z., Gimes, M., Orthmayr,
   A.
 Osberg, I. IU., see Galenko, V. E., Osberg, I. IU., Azbukina,
   V.  D.
 ---, see Galenko, V. E.,  Osberg, I. IU., Robiner,  I. S.,
   Frenkel, G. M.
 Osinski, W. A. Treatment of anxiety states with mepro-
   bamate (miltown).  Internal Rec. 31., 1956, 169:589-
   595.
 Osmond,  H.  Ololiuqui: the ancient Aztec narcotic;  re-
   marks on the effects of Rivea  corymbosa  (ololiuqui).
   J. 3Ient. Sc, Lond,, 1955,101: 526-537.
 ---. Research on schizophrenia.  In: Abramson, H. A.,
   ed. Neuropharmacology.  Transactions of the second
   conference, May 1955, Princeton, N. J. New York, Jo-
   siah Macy, Jr., Foundation, 1956.  p. 183-23.
 ___  A review of the clinical effects of psychotomimetic
   agents. Ann. N. York. Acad. Sc, 1957, 66: 418-434.
 ---  Smythies,  J.   Schizophrenia:  a  new  approach.  J.
   3Ient Sc, Lond., 1952, 98: 309-315.
 ___, see Hoffer, A., Osmond,  H., Smythies, J.
 Ostenfeld   I.  Psykiske  urotilstande.  [Mental  excite-
  ment] '[English  summary]  Nord.  med.,  1955,  54:
  1517-1522.                           j£
___  Suavitil • et nyt spasmolytikum med formentlig virk-
  ning  pa anankasmer  og dermed beslaegtede  lidelser.
   [Suavitil;  a new spasmolytic supposedly effective m
  obsessive-compulsive and related disorders ]   [English
  summary]   Nord. med., 1955, 54: lo23-1525.
Osterman  E„ Lassenius,  B.  Lytisk cocktail inom psy-
  kiatrien; behandling av  delirium acutum (delire aigu)
  och fori ingt insulincoma.  [Lytic cocktail  m  psychi-
  atry'treatment  of delirium acutum  (acute delirium
  and Prolonged insulin coma.] [French summary] *ord.
  wed.  195s! ')3 : 722-726.  Abstract: Excerpta med., Sect.
  8,1956, 9 : No. 3079.
■---.  ----, Bohn, L., Elkjaer, P.  Meprobamat i psyki-
  atrisk praxis.  [Meprobamate in psychiatric practice.]
  Sven. lak. tidn., 1956, 53:2689-2698.
O'Sullivan, C. J.  Myanesin in tension states.  J. Irish M.
  Ass., 1955,  36 :167-169.
Oules, J.,  Salles, P., Soubrie, R.  Tentative de suicide au
  phenergan.  [Attempted  suicide  with   phenergan.]
  Ann. mid. psychol, Par., 1956, 114(1) : 271-273.
Overholser, W.   Chlorpromazine and reserpine  in  psy-
  chiatric practice.  Postgrad.  M., 1956, 19: 346-349.
---.   La chlorpromazine, ouvre-t-elle une  ere nouvelle
  dans les hopitaux  psychiatriques?  [Chlorpromazine—
  the beginning of a new era  in psychiatric hospitals?]
  Enciphale,  1956, 45:313-319.
■---.   Has chlorpromazine  inaugurated  a  new era in
  mental hospitals?  J.  Clin. Exp. Psychopath., 1956,  17:
  197-201.
---.   Introductory remarks  [to: Chlorpromazine and re-
  serpine ;  symposium  on experiences at  Saint  Eliza-
  beths Hospital.] Med. Ann. District of Columbia, 1956,
  25:255.
■---.   Psychobiologic advances and the  management of
  hospitalized patients.   J. Clin, Exp.  Psychopath., 1956,
  17:378-380.
---,Waldrop, F.  N., Riesenman, F. R.,  Fong, T. C. C,
  Farley,  O. R.,  Hoffman,  J. L.  Chlorpromazine  and
  reserpine;  symposium on experiences  at  Saint Eliza-
  beths Hospital.  3Ied. Ann., District of Columbia, 1956,
  25 : 255-268; 298.  [All articles are listed individually]
Overley, H. G, see Martin, K. E., Overley, H. G., Krone,
  R. E.
Ozsan, M., see Adasal, R., Ozsan, M., Karan,  D., Yener, O.
Pachter, M.  A clinical evaluation of chlorpromazine ther-
  apy in chronic schizophrenics.  Am. J. Psychiat, 1957,
  113: 931.
Paerregaard, G.  Chlorpromazinbehandling pa en psyki-
  atrisk modtageafdeling.  [Chlorpromazine treatment at
  a psychiatric department.]   [English summary]  Nord.
  med.,  1956, 56:1238-1240.
Pagaud, see Fouks, Laine, Pagaud.
Page, I. H.  Chemistry of the brain. Past imperfect, pres-
  ent indicative,   and—future perfect?   Science,  1957,
  125: 721-727.
---.  Serotonin  (5-hydroxytryptamine).  Physiol. Rev.,
  1954, 34: 563-588.
---, McCubbin, J. W.  Serotonin or tenure for the phar-
  macologist.   Circulation, N. Y., 1956, 14:161-162.
---, see Salmoiraghi, G. C, Sollero, L., Page, I. H.
Pages, H., see Lafon,  R., Due, N., Ribstein, M., Pages,  H.
Pagot, see Fouks, Laine, Francois, Pagot.
Pahle, H., see Ibsen, B., Pahle, H., Villumsen, A.  L.
Paine, R.  Hypertension; precaution in treatment.   Mis-
  souri  M., 1956, 53 : 947-949.
Palazzuoli, M.  Osservazioni preliminari  sull'azione degli
  estratti di Rauwolfia serpentina  (Ra-Valeas) in malati
  di mente eccitati ed ansiosi.   [Preliminary observations
  on the  action of Rauwolfia serpentina extracts  (Ra-
  Valeas) in excited and anxious mental patients.]  Riv.
  pat. nerv., 1956, 77 : 251-254.
Paieologue,  A., see Pamboukis, G., Paieologue, A., Mon-
  toussis,  N., Hakas,  P.
Pamboukis,  G., Paieologue, A., Montoussis, N., Hakas, P.
  Resultats  par Tapplication d'une cure de sommeil  dans
  les psycho-n6vroses.  [Results of sleep therapy in psy-
  choneuroses.]  Enciphale, 1956,  45 : 550-554.
Panaccio, V. L'action de la reserpine dans certaines affec-
  tions  dermatologiques.  [Action of reserpine in various
  dermatological  diseases.]  Union  mid. Canada,  1955,
  84: 672-674.
235 
Pause, F.
PSYCHOPHARMACA
 Panse, F.  Der medikamentose Winterschlaf (ohne Unter-
   kfihlung) in der Psychiatrie.  [Pharmaceutical hiberna-
   tion without hypothermia in psychiatry.]  3Ied. Klin.,
   Berl, 1953, 48: 1344-1345.
 Panthel, H., see Feldman, P. E., Bertone, J., Panthel, H.
 Papas, T. A., see Burdine, W. E., Shipley, T. E., Papas, T. A.
 Paraire, J., see Hamon, J., Paraire,  J., Velluz, J.
 Parent, R., see Grenier, J., Larue, G. H.,  Parent, R., Tur-
   mel, J.
 Paretti, E., see Librando, L., Paretti,  E.
 Pargiter, R. A., see Merry, J., Pargiter, R.  A., Munro, H.
 Paris Ruiz, L.  Aplicaciones  terapeuticas de la cloropro-
   mazina  (largactil).  [Therapeutic  uses of chlorproma-
   zine (largactil).]  Rev. clin.  espan., 1955,  59:47-50;
   110-117.  Abstract: Chem. Abstr., 1956, 50: 8053b.
 Parlour, R. R., see  Cohen, S., Parlour, R. R.
 Parsons, E. H.  New chemical agents in psychiatry. Post-
   grad. 31., 1955,18:193-198.
 Pascalis, G., see Sutter, J. M., Pascalis, G.
 Passouant, P., Passouant-Fontaine, T., Cadilhac, J.  Les
   effets de la reserpine  sur le comportement et les rythmes
   corticaux  et rhinencephaliques  du chat  chronique.
   [Effect  of  reserpine on  cortical  and rhinencephalic
   rhythms in chronic cats.]  C. rend.  Soc biol, 1956, 150:
   779-782.
 ---, Pelissier,  Minvielle,  J.,  Dutartre.  Modifications
   electro-encephalographiques provoquees par la chlorpro-
   mazine au  cours de  Tepilepsie et  de la  schizophrenic
   [EEG  changes induced by chlorpromazine in epilepsy
   and in schizophrenia.]   Enciphale, 1956,  45: 891-897.
 Passouant-Fontaine, T., see Passouant, P., Passouant-
   Fontaine, T.,  Cadilhac,  J.
 Pate, W. H.  Chlorpromazine therapy following transorbi-
   tal lobotomy.  J.  Nerv. Ment. Dis., 1957, 125 : 44-50.
 Patton, G. O., Garneau,  J.  The ataraxic drugs in disturbed
   secluded psychiatric patients.  Canad. Serv. M. J., 1957,
   13:127-133.
 Patton, R. E., see Brill, H., Patton, R. E.
 Paul, L.   Mephenesin in anxiety-tension  states.  Psycho-
   somat. 31., 1952, 14: 378-382.
 Paulin, C, see Cheifetz, I., Paulin, C, Tuatay, H., Rubin,
   E. H.
 Pauly, R.  Nouvelle note sur les dangers de la therapeu-
   tique par le largactil.  (A propos  d'un infarctus  du
   myocarde survenue au cours d'une cure  ambulatoire.)
   [Additional  note on the  danger  of  chlorpromazine
   therapy.  (Myocardial infarct  in the course of ambula-
   tory treatment.)]  J. mid. Bordeaux, 1954, 131:587-
   588.
 ----.  Remarques a propos d'une statistique personnelle
   sur les avantages, les limites et les  accidents de Thiber-
   notherapie a la chlorpromazine.  [Comments on personal
   experiences with  chlorpromazine hibernotherapy, its ad-
   vantages, limitations  and accidents.]  J. mid. Bordeaux,
   1954,131: 235-244.
 Pauwels, R., see Delay,  J., Deniker, P., Pauwels, R.
 Pavlenkova, E. F., see Lukomskii, I. I., Pavlenkova,  E. F.
 Payn, S. B.   Hypothermia following reserpine.  Am. J.
   Psychiat.,  1956,  112: 657.   Abstract:  Excerpta med.,
   Sect. 8, 1956, 9: No. 4995.
 ----, Rockwell, F. V.  Short-term treatment  of psychiatric
   patients with reserpine.  N. York State J.  31.,  1956,
   56:1769-1773.
 Payne, R. B., Moore, E.  W.  Effects of some analeptic and
   depressant drugs on tracking behavior.  J. Pharm. Exp.
   Ther.,  1955, 115:480-484.   Abstract:   Chem.  Abstr.,
   1956, 50:3632ab.
 Peak, E. C, Canestrari, R. E., Roebuck, B. E.  The effects
   of frenquel upon chronic disturbed patients.  J. Nerv.
   Ment  Dis.,  1956,  124:507-509.   Condensed: Am.  J.
   Psychiat, 1957,113 : 653.
 Peak, W.  P.   Meprobamate (miltown) in rheumatic dis-
   eases.  J. Am. M. Ass., 1957,163 : 535-538.
Pearl,  D.,  Vander  Kamp, H., Olsen,  A. L.,  Greenberg,
  P. D.,  Armitage,  S.  G.  The  effects of reserpine  on
  schizophrenic patients.  A. 31. A. Arch. NJu\?s!/cl!.™J->
  1956,  75 :198-204.   Condensed: Am. J.  Psychiat, ly&b,
  112:936.                               ir.   .    „  .,
Pearson, J., Dewhurst, K.  Mescaline: apotheosis of  the
  devil's root. Irish J. 31. Sc, 1956 :139-143.
Pechtel, C, see Masserman, J. H., Pechtel, C.
Pedrelli, M., see Mazza, A., Pedrelli, M.
Pedrinoni, L., see Bonetti, U, Pedrinoni, L.
Peifer, C. A., see Freed, H., Peifer, C. A.
Pelissier, see Passouant,  P., Pelissier, Minvielle,  J., Du-
  t&rtrc
Pelleratj J.  Un noveau medicament sedatif et antiprurig-
  ineux.  [A new sedative and antipruritic drug.]  Lyon
  mid.,  1953, 85  (1) : 270.
---.Teichner,  Y.  La chlorpromazine (4.560 R.  P.)  en
  dermatologie.   [Chlorpromazine  (4560  RP)  in  derma-
  tology.]  J. mid. Lyon, 1953, 34: 611-618.
Pellerito, N. L'azione della cloropromazina e della reser-
  pina sull'ansia dei psiconevrosici.   [Action of chlorpro-
  mazine and reserpine on the anxiety of psychoneurotics.]
  3tinerva med,, Tor., 1956, 47: 628-631.
Pelzman, O., Conigliaro,  V.  Osservazioni  preliminari
  sull'uso clinico di  un derivato di Rauwolfia  serpentina
  in malati di mente.  [Preliminary study of the  clinical
  use of a Rauwolfia serpentina  derivative  in  mental
  patients.]  [English summary]   Gior.  psichiat.,  1955,
  83:131-147.  Abstract:  Excerpta med.,  Sect. 8,  1956,
  9: No. 1221.
Penick,  S. B. and Company.  Rauwolfia and alkaloids, a
  bibliography ; chemistry, pharmacology, pharmacognosy,
  therapeutic uses.  50 p.  New York, 1956.
---  Suppl. 1.  18 p.  New York, 1957.
Penman, A. S., Dredge, T. E.  Effect of reserpine and open-
  ward  privileges on  chronic  schizophrenics.   A. M. A.
  Arch. Neur. Psychiat., 1956, 76: 42-49.
Pennes, E.,  see  Shubin, H.,  Heiken, C. A., Glaskin,  A.,
  Pennes, E.. Arsenian, J.
Pennes, H. H.  Clinical reactions of schizophrenics to  so-
  dium  amytal, pervitin hydrochloride, mescaline  sulfate,
  and d-lysergic acid diethylamide  (LSD-25). J. Nerv.
  Ment. Dis., 1954, 119 : 95-112.
■---. The nature of drugs with mental actions and their
  relation to cerebral  function. Bull. N. York Acad,  31.,
  1957, 33: 81-88.
■---, Hoch, P.  H.  Psychotomimetics, clinical and  theo-
  retical considerations: harmine, WIN-2299 and  nalline.
  Am. J. Psychiat, 1957,113 : 887-892.
---, see Hoch, P. H., Cattell, J. P., Pennes, H. H.
---, see Hoch, P. H.,  Pennes, H.  H., Cattell, J. P.
Pennington, V. M.  A  comparative study of six ataraxics
  in 1130 neuro-psychiatric cases.   Mississippi  Doctor,
  1956, 33: 336-339.
---. Meprobamate,  a tranquilizing drug with  muscle
  relaxant properties  in psychotic cases.  In:  Himwich,
  H. E.. ed.   Tranquilizing drugs.   Washington, Am. Ass.
  Adv. Sc, 1957.  p. 125-131.
---. Meprobamate (Miltown) in premenstrual tension.
  J. Am. 31. Ass., 1957,164: 638-640.
---. Research findings in phrenotropic drugs important
  to every physician.  Mississippi Doctor, 1957,  35:57-
  63.
---. A two-year  comparative study  of ataraxics  in
  neuro-psychiatric patients.  J. Am. Geriat.  Soc, 1957,
  5 : 421-429.  [Not  seen]
----. Use of miltown (meprobamate) with psychotic pa-
  tients.  Am. J. Psychiat.,  1957, 114:257-260.
----. The use of reserpine (serpasil) in three hundred
  and fifty  neuropsychiatric cases.   Psychiat. Res. Rep.,
  Wash., 1955 (1) : 105-111.
Peretz,  D.  I., Smythies, J. R., Gibson, W. C.  A new hal-
  lucinogen : 3,4,5-trimethoxyphenyl-/3-aminopropane with
  notes  on  the stroboscopic phenomenon.  J.  Ment  Sc,
  Lond., 1955, 101: 317-329.
Pergola, F., see Cachin, M., Pergola, F., Potet, F., Debesse
  B.
236 
AUTHOR  LIST
Pierce, W. J.
 Peria, G.,  see  Salomone, F. P., Peria,  G., Rodolico,  G.,
   Cacoiola, R.
 Perlstein,  I. B. The use of pipradrol in the problems of
   obesity.  Internal  Rec. M., 1957, 170:55-58.
 Perlstein,  M. A.  Prenderol:  a new  drug used with  re-
   tarders in petit  mal epilepsy.  Neurology, 1953,  3: 744-
   751.
 Perrault,  M.   Sur les tranquilliseurs.   [Tranquilizers.]
   Progr. med., Par., 1957, 85 : S-A ; 1.
 Perregaard, I.,  see Fremming, K. H., Perregaard,  I.
 Perret,  A.,  Becker, J., Lacoste,  G.  Traitements psychia-
   triques par le 4560  R. P.  [Psychiatric treatments with
   4560 RP.]  Vie mid., Par., 1953, 34: 463-464.
 Perrin,  J.,  Diederichs. Essai d'evaluation de la  valeur
   therapeutique de la chlorpromazine chez 1,400 malades
   mentaux   internes.  [Evaluation   of  chlorpromazine
   therapy  in  1400 hospitalized mental patients.]  En-
   ciphale, 1956, 45: 609-613.
 ---, Toulet, M. Utilisation de la chlorpromazine  dans le
   traitement des  psychoses chroniques.  [Use of chlor-
   promazine  in the  treatment  of  chronic psychoses.]
   Enciphale, 1956,45 :1210-1218.
 ---, see Achaintre, A., Balvet,  P., Beaujard, M., Brous-
   solle, P.. Perrin, J., Leveque, F., Requet, A.
 ---, see Revol, L., Achaintre, A., Balvet, P.,  Beaujard,
   M.,  Berthier,  C, Broussolle, P., Lambert, P.,  Perrin, J.,
   Requet, A.
 Perrot,  R.  M., Moreau-Gaudry, G., Le Borgne, Y.  Mani-
   festations cardiaques d'hypokaliemie dans la cure a la
   chlorpromazine.   [Cardiac  manifestations of  hypoka-
   lemia  in  chlorpromazine therapy.]   Presse mid., 1956,
   64:  2076.
 Perry, H. M., Jr., see Schroeder, H. A., Perry,  H.  M.,  Jr.
 Perse, J., see Delay, J., Pichot, P., Laine, B., Perse, J.
 Persson, I.   Klorpromazin ved arteriosclerotisk sindssyg-
   dom og dementia senilis.  [Chlorpromazine in therapy
   of  arteriosclerotic   psychosis  and  senile  dementia.]
   [English  summary]  Nord. med., 1955, 53 : 235-237.  Ab-
   stract : Excerpta med., Sect. 8, 1955, 8: No. 3897.
 Pertorini, R., see Kardos, G., Pertorini, R.
 Pescetto, G., see Masini, A.,  Pescetto,  G., Tosca, L.
 Pestel, M.,  see Ravina, A., Pestel, M.,  Albouy, R.
 Petelski, M.  Wyniki leczenia largaktylem 109 chorych
   na schizofrenie (67 kobiet i  42 mezczyzn).  [Results of
   largactil  therapy of schizophrenia  in  109 patients  (67
   women and  42  men).]   [English  summary]    Polski
   tygod. lek., 1956, 11:1366-1370.
 Peters, J. E., see Murphree, O.  D., Peters, J. E.
 Peters,  J. J., Vonderahe, A.  R.  Behavior of the sala-
   mander under the  influence of LSD-25 and frenquel,
   and  accompanying electrical  activity of brain and spinal
   cord.  J.  Nerv. Ment. Dis., 1956, 124: 69-73.
 Peters, L.  Pharmacology of the useful  antihypertensive
   drugs.  A. 31. A. Arch. Int.  M., 1956, 98: 409-415.
 Petersen, J. R., see  Briggs, G. W., Petersen, J. R.
 Petersen, M. C, see Schwarz, B. E., Sem-Jacobsen,  C. W.,
   Petersen,  M.  C.
 Petersen, P. V.,  see Weidmann, H., Petersen, P. V.
 Peterson, B., see Hagnell, O., Korsfeldt, B., Peterson, B.,
   Widmark, M.
 Petrie, A., Le Beau, J.   The effects on personality of chlor-
   promazine as  compared with various brain operations.
   Encephale, 1956,  45:987-995.
 ___(____.  Psychologic changes  in man after chlorpro-
   mazine and certain types of brain surgery. J. Clin. Exp.
   Psychopath., 1956, 17:170-179.
 Pevey, J. K., Moyer, J. H., Handley, C. A., Heider, C.  A
  comparison  of clinical  results with phenobarbital, me-
  probamate and two  similar experimental agents. [Ab-
  stract]  J. Pharm. Exp. Ther., 1957, 119: 176.
___( see Moyer, J.  H,  Pevey, K.,  Kinross-Wright,  V.
The peyote  cult. Science, 1952, 115: 503-504.
Pfeiffer  C.  C, Jenney, E. H.  The inhibition of the con-
  ditioned response and the counteraction of schizophrenia
   by muscarinic stimulation of the brain.  Ann. N. York
   Acad. Sc, 1957, 66: 753-764.
 ----, see Apter, J. T., Pfeiffer, C. C.
 Pflanz, M., see Gruber, K., Illig,  H., Pflanz, M.
 Pflugfelder, G, see Huchtemann,  K., Pflugfelder, G.
 Pharmaceuticals &  Drugs Committee, Council of Scien-
   tific & Industrial  Research.  Symposium on Rauwolfia,
   Calcutta, 1955.  [Abstracts]   38 p.  Lucknow, Pioneer
   Press, 1955.   [Abstracts within the scope of this bibliog-
   raphy are listed individually.]
 Pharmacologic products recently introduced in the treat-
   ment  of psychiatric disorders.  Psychiat.  Res.  Rep.,
   Wash., 1955 (1): 1-152.  [Symposium; articles within
   the scope of this  bibliography are listed individually]
 The  pharmacology of  psychotomimetic  and psycho-
   therapeutic drugs.   [Conference held  in  New York,
   April 1956]  Ann. N. York Acad. Sc, 1957, 66: 415-840.
   [Articles within the scope of this bibliography are listed
   individually.]
 Philipsborn, A., see Braun,  M.,  Philipsborn, A.
 Phillip,  E.  Erfahrungen mit  Megaphen  in der Behand-
   lung  psychisch  Erkrankter.   [Experience  with mega-
   phen in the treatment of the mentally ill.] Nervenarzt,
   1955,  26:59-65.  Abstract:  Excerpta  med.,  Sect.  8,
   1956, 9 : No. 4075.
 Phillips, R. E.  Use of meprobamate (miltown) for the
   treatment of  emotional disorders.  Am. Practitioner,
   1956, 7: 1573-1576.
 Phillips, T. Overdose  of reserpine.  Brit.  M. J.,  1955,
   2:969.
 Piala, J. J., High,  J. P., Greenspan, K., Burke, J. C.  Fur-
   ther  laboratory observations on 10-(3-dimethylamino-
   propyl ) -2- (trifluoromethyl) -phenothiazine   hydrochlo-
   ride  (MC 4703).  [Abstract]  J. Pharm. Exp.  Ther.,
   1957,119:176-177.
 Piazzesi, W.  Considerazioni e dati sulla ipnoterapia in
   campo psichiatrico.   [Considerations and data on  sleep
   therapy  in psychiatry.]  Riv. pat. nerv., 1954, 75 : 541-
   579.  Abstract:  Excerpta med.,  Sect.  8, 1955,  8: No.
   3102.
 Picard, P., Le Bras, R., Navarranne,  P.   Un cas de coma
   insulinique prolong^ au cours d'une cure de Sakel traite
   et  gueri par  hibernation.   Constatations   electroen-
   cephalographiques.  [Successful hibernotherapy of pro-
   longed insulin coma  during  Sakel therapy;  electroen-
   cephalographic  tracings.]   Ann. mid.  psychol,  Par.,
   1953,111(2) : 253-259.
 ---, Navarranne, P. Quelques reflexions sur les applica-
   tions  de  l'hibernation artificielle en  neuro-psychiatrie.
   [Artificial hibernation in neuropsychiatry.]  Enciphale,
   1956, 45: 456-457.
 Piccinelli,  O. Farmacologia  e  clinica della  Rauwolfia
   serpentina.  [Pharmacology  and  clinical  aspects  of
   Rauwolfia serpentina.]   Farmaco, ed.  prat.,  Pavia,
   1954,  9:574-582.
 Pichot,  P.,  see Delay, J., Pichot, P., Lain6, B., Perse,  J.
 ■---, see Delay, J.,  Pichot,  P., Ropert, R.
 Piedelievre, [R.], Deniker, Marmier.  Les  toxicomanies et
   les  cures  de  desintoxication.  [Drug   addiction and
   detoxication.]   Concours mid., 1955, 77  :1723-1726.
 ---.Derobert,  L.  Une  intoxication  professionnelle
   devenue  rare; un cas de cannabisme.   [Rare occupa-
   tional poisoning;  case of  cannabism.]   Ann.  mid.
   lig., 1953, 33 : 23-25.
Piekarska,   A. W  sprawie  stosowanta   largaktylu  w
  leczeniu  chorob  psychicznych;  doniesienie  pierwsze.
   [Largactil therapy in  psychic disorders; preliminarv
  report.]   [English summary]  Neur. d  c polaska,  1955.
  5:623-635.
Pierce, C. M., see Shanon, J., Kaplan, S. M., Pierce, C. M.,
  Ross, W.  D.
Pierce, W. J., see Dennison, A. D., Jr., White, P. T., Moore
  R. B., Pierce, W.  J.
---, see Moore, R. B., Pierce,  W. J.,  Dennison, A. D., Jr.
456132—59---17
237 
,C.A.
Pierson, C. A.  La chlorpromazine  et la maitrise de soi
  dans  les  angoisses  collectives.  [Chlorpromazine and
  self-control in mass hysteria.]  Enciphale,  1956, 45:
  562-565.
Pietuchow, W., see McNeill, J. F., Johnston,  W. C, Pietu-
  chow, W.
Pinakapani, S., Haranath, P. S.  R. K.  Chlorpromazine in
  the treatment of hiccough and emesis.  Ind. J. 31. Sc,
  1955,  9:764-766. Abstract:  Excerpta med., Sect.  8,
  1956, 9: No. 3421.
Pindell, M. H.,  Fancher,  O. E, Lim, R.  K.  S.  Sedative-
  hypnotic properties  of 2-ethyl-crotonyturea.  Fed Proc,
  Bait, 1953,12: 357.
---, see Lim, R. K., Pindell, M. H.,  Glass, H. G., Rink, K.
Pinho,  R. de, see Pires,  N., Pinho,  R. de, Fernando,  L.,
  Pint, M., Cavalcanti, U., Aguiar, H.
Pinkus, H., see  Ferrara,  R. J., Pinkus, H.
Pinsky, R., see Wolf, S., Pinsky, R.
Pint, M., see Pires, N., Pinho, R. de, Fernando, L., Pint,
  M., Cavalcanti,  U., Aguiar, H.
Pipradrol hydrochloride.  J. Am. 31. Ass., 1956, 160: 390.
Pires, N., Pinho, R. de, Fernando, L., Pint, M., Cavalcanti,
  U., Aguiar, H.  Sur 110 cas traites par le sommeil  hi-
  bernal.   [Hibernotherapy of 110 patients.]  Enciphale,
   1956, 45: 677-681.
Pisani, D., Micalizzi, F., Motta, E.  Rilievi clinici sull'im-
   piego della reserpina in psichiatria.   [Clinical results
   with reserpine  in  psychiatry.]  Pisani,  1955,  69 (2) :
   85-102.  Abstract: Excerpta  med., Sect. 8, 1956,  9: No.
   4548.
---,----,----.  Risultati  benefici sui  deterioramento
   mentale patologico  (DMP),  in seguito a trattamento
   con reserpina (serpasil).  [Good  results with reserpine
   (serpasil)  in  mental  deterioration.]   Pisani,  1955,
   69  (2): 103-114.  Abstract: Excerpta med.,  Sect. 8,
   1956, 9: No. 4081.
Pivet,  S., see Follin, S.,  Sigg, B., Pivet,  S.,  Girard,  C.
Pivnicki, D.  Serpasil u  psihijatriskoj praksi.  [Serpasil
   in psychiatric treatment.]   [German summary]   Med.
   arh., Sarajevo, 1956, 10:107-117.
 Planche, R., see Pomme, B., Planche, R., Gibert, J.
 Plane, P., see Malmejac, J., Plane,  P.
Piatt, R., Sears, H. T. N.  Reserpine in severe  hyperten-
   sion. Lancet, Lond., 1956, 1: 401-403.
 Plazak, D. J.  A case of corticotropic  hormone-induced
   psychosis treated with promazine hydrochloride.  Mil.
   M., 1957,  120: 99-101.
 Pleasure, H. Psychiatric and neurological  side-effects of
   isoniazid and iproniazid.  A. M. A. Arch. Neur. Psychiat,
   1954, 72: 313-320.
 Pless,  H. H., see Begany, A. J.,  Seifter, J., Pless,  H.  H.,
   Huber, R. D., Bruce, W. F.
 Pletscher, A., Shore,  P. A., Brodie, B. B. Serotonin as a
   mediator  of reserpine  action in brain.  J. Pharm. Exp.
   Ther., 1956, 116: 84-89.
 ---, see Besendorf,  H.,  Pletscher,  A.
 ---, see Brodie,  B. B., Pletscher, A., Shore, P.  A.
 Plichet, see Le Guillant, L, Roelens,  Corre,  Kestenberg,
   Plichet, Bequart, Bailly-Salin.
 Plichet, A.  Un nouveau traitement des psychonevroses;
   le chlorhydrate de Tacide benzilique diethylaminoelhyl-
   ester.  [A new treatment of psychoneuroses: benzilic
   acid  2-diethylaminoethyl  ester.]   Presse  vied., 1955,
   63: 1748.
 Plummer, A. J., Barrett, W. E., Wagle, G, Yonkman, F. F.
   Sedative  and hypnotic action of reserpine in unanes-
   thetized  animals.   Fed. Proc, Bait, 1953,  12:357-358.
 ----, Earl  A., Schneider, J.  A., Trapold, J.,  Barrett, W.
   Pharmacology  of Rauwolfia  alkaloids, including reser-
   pine. Ann. N.  York Acad. Sc, 1954, 59: 8-21.
 ---, Maxwell,  R., Earl, A. E.  Influence of methyl-alpha-
   phenyl-2-piperidine acetate hydrochloride on the phar-
   macological action of reserpine. [Abstract]  Fed. Proc,
   Bait., 1956, 15: 468.
---,see Schneider, J.  A., Plummer,  A.  J., Earl, A. E.,
  Barrett, W. E., Rinehart, R., Dibble, R.  C.
___, see Schneider, J.  A., Plummer,  A.  J., Earl, A. &.,
  Gaunt, R.                            „  ~
Pogge, R. C, see Allin,  T. G., Jr., Pogge, R. O.
—-, see Gelvin, E.  P., McGavack, T. H, Pogge, R. C.
Pokorny, A. D.,  see Gaitz, C. M., Roy, H., Thompson, W.,
  Kimbell, I., Mullen, A. J., Pokorny, A. D.
Pokorny, C, see Wright, W. T., Jr., Pokorny, C, Foster,
  T  T
Polak, F.  tlber eine antiallergische  Wirkung des Rau-
  wolfiaalkaloids Reserpin.   [An antiallergic effect of the
  Rauwolfia alkaloid reserpine.]  Schweiz. med.  Wschr.,
  1955,85:751-752.
Policzer, M., Szekely, A., Foldes, J. A Rauwolfia serpen-
  tina  alkalmazasa  a vegetativ  mfikodesek  regulatio-
  zavaraiban.  [Use of  Rauwolfia serpentina in autonomic
  disorders.]  Orv. hetil, 1955, 96 : 548-549.
Pollack, B.  The addition of chlorpromazine to the treat-
  ment program for emotional and behavior disorders in
  the aging.  Geriatrics, 1956, 11: 253-259.
___.  Drug therapy—clinical  and  operational  effects:
  changes  in mental hospital resulting  from addition of
  chlorpromazine to the total therapeutic program.  Ment.
  Hosp., 1956, 7(4): 14-16.
---.  The  effect  of chlorpromazine  on the return rate
  of 250 patients released from the Rochester State Hospi-
  tal.  Am. J. Psychiat, 1956, 112: 937-938.
---.  Mental  illness.  Med.  Times,  Great Neck, 1955,
  83:439-450.
---.  Preliminary report on  500 patients treated with
  thorazine  at  Rochester  State Hospital.   Psychiat. Q.,
  1955, 29: 439-456.
---.  Recurrent thorazine-induced agranulocytosis. Am.
  J. Psychiat, 1956, 113 : 557-558.
Pollard, J.  C,  see Kehoe,  M. J.,  Pollard, J. C.
Poloni, A.   Esperienze cliniche con  la  serotonina  nelle
  malattie mentali.  [Clinical experiences  with serotonin
  in  mental illness.]   Cervello,  1956, 32:243-246.  Ab-
  stract: Excerpta med., Sect. 8, 1957, 10: No. 1539.
---.  Serotonina e schizofrenia.  1. Osservazioni sulle in-
  terferenze fra l'azione  della  serotonina (S.) e  della
  dietilamide dell'acido lisergico  (LSD. 25), mescalina
   (M.) e bulbocapnina (B.) nell'uomo e nell'animale.  2.
  Azione della  serotonina (S.) sola e associata ai barbi-
  turici (Ba.),  alia dietilamide dell'acido lisergico  (LSD.
  25),  alia mescalina  (M.) e alia bulbocapnina  (B.) sui
  tracciato  EEG.  di schizofrenici, epilettici  e altri am-
  malati di mente.  [Serotonin and schizophrenia.  1. Ob-
  servations on the anagonism between serotonin, lysergic
  acid diethylamide, mescaline and bulbocpanine in man
   and animal.  2. Action of serotonin alone or associated
   with barbiturates, lysergic acid diethylamide, mescaline
   and  bulbocapnine  on the electro-encephalogram of pa-
   tients with schizophrenia, epilepsy, and other mental
   diseases.]  [English summaries p. 292;  381]  Cervello,
   1955,  31:271-294;  355-382. Abstract:  Chem. Abstr.,
   1956, 50: 8911ab.
 Pomeranze, J.  A  new antidepressant (M. R.  D.-108)  in
   geriatrics.  [Abstract] J. Geront,  1954, 9:486.
 ---.   Preliminary observations  on the use of Rauwolfia
   in labile diabetes. Monogr. Ther. Squibb Inst. M. Res.,
   1956, 1(2): 26-28.
 Pomme, B., Planche, R., Gibert, J.  La chlorpromazine dans
   le  traitement des deiires aigus alcooliques.  [Chlorpro-
   mazine in the  treatment of acute alcoholic delirium.]
   Enciphale, 1956, 45  : 744-753.
 Popendiker, K., see Nieschulz,  O., Hoffmann,  I.,  Popen-
   diker,  K.
 ----, see Nieschulz, O., Popendiker, K., Hoffmann, I.
 ---, see Nieschulz, O., Popendiker, K., Sack, K. H.
 Popov, E. A., Nevzorova, T. A.  Opyt primeneniia amina-
   zina v psikhiatricheskoi klinike.   [Result  with amina-
   zine in  psychiatric clinical practice.]   Zh.  nevropat.
   psikhiat, Moskva, 1956, 56: 559-566.
238 
AUTHOR  LIST
Ranee, A. M.
 Porot, M., Jouanneau, H. Traitement par la chlorproma-
   zine seule d'un syndrome melancolique chez une femme
   enceinte.  [Chlorpromazine therapy alone in a melan-
   cholia syndrome in a pregnant woman.]   Algirie mid.,
   1956, 60: 395-397.
 Portal, H., see Martin, P., Vidal, G.,  Portal, H.
 Portella Nunes, E.  Investigates com a dietilamida do
   acido lisergico.   [Clinical studies  with  lysergic  acid
   diethylamide.]  [English summary]  J. brasil psiquiat,
   1955, 4: 407-418.
 ---, see Silva, L. M. da, Zusman, W., Portella Nunes, E.
 Poslavsky, A.  Psychological considerations on continuous
   sleep-treatment.  Fol. psychiat. d c neerl, 1955, 58 : 482-
   485.
 Possible danger from reserpine.  Brit. M. J., 1957, 2 :49.
 Postel, J., Cossa, P.   Etat actuel de la therapeutique du
   delirium  tremens; sur 165 cas.   [Present state of the
   therapy of delirium tremens; 165 cases.]   Rev. neur.,
   Par., 1950, 94 : 660-662.
 ---, see Cossa, P., Bougeant, H., Postel,  J.
 Potential hazards of meprobamate.  J. Am.  31. Ass., 1957,
   164: 1332-1333.
 Potet,  F., see  Cachin, M., Pergola, F., Potet, F., Debesse,
   B.
 Pouget, R., see Lafon, R., Boyer, Due, N.,  Minvielle, J.,
   Pouget, R.
 ---, see Lafon, R., Due, N., Abric, J., Pouget, R., Come-
   lade, P.
 ---, see Lafon, R., Due, X., Boyer, Abric, J., Pouget, R.
 Preston, J. B.  Chlopromazine: a possible mechanism of
   action.  [Abstract.]   Fed.  Proc,  Bait, 1956,  115:468-
   469.
 ---.   Effects  of chlorpromazine on the central nervous
   system of the cat: a possible neural basis for action.
   J. Pharm. Exp. Ther., 1956, 118:100-115.
 Primac, D. W., Mirsky, A. F., Rosvold, H. E.  Effects of
   centrally acting drugs on  two tests of brain  damage.
   A. 31. A. Arch. Neur. Psychiat, 1957, 77: 328-332.
 Pringuet, G., see Heuyer, G., Dell, C, Pringuet, G.
 Proctor, R. C. A new therapeutic approach  to  certain
   cases of alcoholism.   South.  31. J.,  1956, 49: 73-75.
 ---, Griffin, R. A.  Clinical studies on alpha-(2-piper-
   idyl) benzhydrol hydrochloride (meratran) in prophy-
   lactic treatment of alcoholism.  Clin. Res. Proc, 1955,
   3: 149.
 ---, Odland,  T.  Frenquel.  Dis. Nerv. Syst, 1956, 17:
   25-28.  Abstract: Excerpta med., Sect. 8, 1956, 9: No.
   4539.
 ---, see Thompson, L. J., Proctor, R. C.
 Prokopowycz,  V.  Agranulocytosis following use of chlor-
   promazine therapy.  J. Am.  M. Ass.,  1955, 157:1042.
   Also as:  Agranulocytosis  following chlorpromazine
   therapy.  J. Michigan M. Soc, 1955, 54:1468.
 Promethazine  hydrochloride.  J. Am. M. Ass.,  1956,  161:
   457-458.
 Prouet, P.  E.   Rauwolfia and  amphetamine  therapy in
   the treatment of psychosomatic complaints.  J. Louisi-
   ana 31. Soc, 1955, 107:114-116.
 Prout, C. T., see Allen, E. B., Prout, C. T.
 ---, see Ware, L. M., Prout, C. T.
 Pryor, W. W.,  see Mulier, J. C, Pryor, W.  W., Gibbons,
   J. E., Orgain, E. S.
 Psychobiology and drugs.  Internat Rec 31., 1956,  169:
   231—232.
 Psychodynamic and therapeutic aspects of mescaline  and
  lysergic acid diethylamide.  J. Nerv.  3Ient. Dis., 1957,
  125 • 423-451.  cf. Denber,  H. C. B., Rinkel, M., ed.
 Psychopharmacology.   165 p. Washington, Am. Ass. Adv.
  Sc, 1956.   cf. Kline, N. S.,  ed.
 Puca A  Ibernoterapia, sonno  prolungato e neuroplegici
  in terapia psichiatrica.  [Hibernation, prolonged sleep
  and neuroplegic drugs in psychiatric treatment.] Rass.
  tnternaf.7linSter., 1955, 35 : 805-809.
___   Nuove acquisizioni in terapia psichiatrica; iberno-
  terapia, sonno prolungato e neuroplegici.  [New acquisi-
  tions in psychiatric therapy; artificial hibernation, pro-
  longed   sleep   and   neuroplegic   drugs.]   [English
  summary]   Rass.  stud,  psichiat.,  1955,  44:849-856.
  Also: Ann. med. nav., Roma, 1956, 61: 42-49.
---, Catapano, V. D.  Un nuovo psicofarmaco: il fren-
  quel.   [A  new psychopharmacon: frenquel.]   Acta
  neur.,  Nap.,  1956,  11:526-529.  Abstract:  Excerpta
  med., Sect. 8, 1957, 10: No. 2082.
Puech, J., Robin, C.  Etude comparative des effets de la
  cure de sommeil medicamenteux et de la chlorpromazine
  injectable dans les  psychoses.  [Comparative study of
  sleep therapy and chlorpromazine injections in therapy
  of psychoses.]  Sem. hop. Paris,  1956,  32: 3252-3264.
Pupo, P. P., Zukerman, E., Longo, R. H. O uso do amplictil
  (4560 RP, Rhodia) na rotina do diagnostico electrence-
  falografico.   [Use of chlorpromazine in EEG diagnosis.]
  [English summary] Arq. neuropsiquiat, S.  Paulo, 1955,
  13:197-202.
Purpura, D. P.  Electrophysiological  analysis of psycho-
  togenic drug action.   (1)  Effect of LSD on  specific
  afferent systems in the cat.  (2)  General nature of ly-
  sergic  acid  diethylamide  (LSD)  action  on  central
  synapses.  A. M. A. Arch. Neur. Psychiat., 1956, 75 :122-
  131; 132-143.  Abstract:  Excerpta med., Sect. 8, 1956,
  9 : No. 4451; No. 4452.
----.  Electrophysiological analysis of psychotogenic drug
  action on the evoked potentials of the cat's brain.  Tr.
  Am.  New. Ass., 1955, 80th Meeting: 60-67.
----.  Experimental analysis of the inhibitory action of
  lysergic acid diethylamide on cortical dendritic activity.
  Ann. N. York Acad. Sc, 1957, 66: 515-536.
Pytel, A., see Wozowska, J., Pytel,  A.

                          Q

Quetin, A., see Sigwald, J., Henne,  M., Bouttier, D., Ray-
  mondeaud, C, Quetin,  A.

                          R

Racamier,  P. C,  Baudrand,  C.  Les cures prolongees et
  continues de chlorpromazine a Thopital  psychiatrique.
  [Prolonged and continued therapy with chlorpromazine
  in the psychiatric hospital.] [Abstract]  Ann. mid. psy-
  chol, Par., 1954,112(2) : 449-450.
---, Blanchard, M., Baudrand, C.  Les cures prolongees
  de  chlorpromazine dans  les  etats schizophreniques.
  [Prolonged chlorpromazine therapy in schizophrenic re-
  lations.]   Enciphale, 1956, 45:647-655.
Raclot, M., see Delay, J., Denber, Deniker,  P., Raclot,  M.,
  Ropert, M.
---, see  Delay, J., Deniker, P., Raclot, M., Ropert, M.
Racz, S., Gallai, Z.  Angaben zur Rolle des Largactils bei
  der  Behandlung  einiger  Hautkrankheiten.  [Role  of
  largactil in the treatment of several skin  diseases.]
  Derm.  Wschr., 1956, 134: 770-773.
Rambelli, L., see Floris, V., Rambelli, L.
Ramee, F., Lacaton, R., Sanchez, F.,  Boulanger, M.  Effets
  favorables du largactil dans la pratique psychiatrique
  algerienne.  [Good results with chlorpromazine therapy
  of mental diseases in Algeria.]   Enciphale,  1956, 45 :-
  820-827.
Ramirez, F.  El largactil oral en el tratamiento de afec-
  ciones  mentales.  [Oral administration of largactil in
  the treatment  of  mental  disorders.]   Rev. psiquiat.
  Uruguay, 1954, 19 (112) : 37-44.
Ramot, J., see Sabshin, M., Ramot, J.
Ranee, A. M., Jurquet, A., Roger, J.   Remarques  sur la
  therapeutique des  affections  psychiatriques  par  la
  chlorpromazine et la reserpine; elude  comparee  des
  diverses  modalites  d'administration de ces drogues.
  [Therapy of psychiatric disorders with chlorpromazine
  and reserpine; comparative study of the various meth-
  ods of their administration.]   EncepJiale, 1956, 45 : 477-
  487.
239 
Randolph, A. C.
PSYCHOPHARMACA
Randolph, A. C, Thompson, L. J.  The use of dimethyl-
  ane-reserpine  combination in mental disorders; a pre-
  liminary report.  North Carolina M. J., 1957, 18:17-20.
Rapaport, W., see Noce,  R. H.,  Williams,  D. B., Rapa-
  port.W.
Rappard, P., see Ey, H., Faure, H., Rappard, P.
Rascol, A., see Laboucarie, J., Barres, P., Rascol, A.
----, see Laboucarie, J., Rascol,  A., Benichou, L.
---, see Riser, M., Geraud, J., Laboucarie, J., Rascol, A.,
  Clausse, S., Garrigues, M. P.
Rashkis, H. A., Smarr, E. R. Drug and milieu effect with
  chronic schizophrenics.  A. M. A. Arch. Neur. Psychiat,
  1957, 78:  89-94.
---,----.  Psychopharmacotherapeutic research; a tria-
  distic approach.  A. 31. A. Arch. Neur. Psychiat., 1957,
  77: 202-209.
Raskin, N.  Agranulocytosis in patients treated with thor-
  azine; report of a  fatal case.  Am. J.  Psychiat, 1957,
  113:991-992.
Rathbun, R. C,  see Slater, I. H.,  Rathbun, R. C, Hender-
  son, F. G., Neuss, N.
Ratschow, M. Der Heilschlaf mit Phenothiazin-Derivaten
  (Atosil  und  Megaphen).  [Therapeutic   sleep  with
  phenothiazine  derivatives  (atosil  and  megaphen).]
  Medizinische, 1953:1351-1354.
Raudixin  in  the  treatment  of  affective  disorders.
  Original reports by  clinical and laboratory investigators.
  3Ionogr. Ther. Squibb Inst 31. Res., 1956, 1 (2) : 1-44.
  [Articles  within the scope of this bibliography are listed
  individually].
Rauwolfia.  J. Am. 31. Ass., 1955, 159:1206-1207.
Rauwolfia et etats depressifs.  [Rauwolfia and depressive
  states.]  Rev. prat., Par., 1956, 6: 3342.
Rauwolfia serpentina.  Bull. Calcutta School Trop. Med.,
  1954, 1(3): 22-23.
Rauwolfia serpentina: raudixin.  Univ. Michigan M. Bull.
  1953, 19: 278-279.
Ravetta, M., see Callieri, B., Ravetta, M.
Ravina, A.  Une nouvelle medication de  Tanxiete et  des
  psychoses.  [A new medication for anxiety and  psy-
  choses.]   [Meprobamate]  Presse mid., 1955, 63 :1233.
  Abstract: Praxis, Bern, 1956, 45: 749.
---, Pestel, M., Albouy,  R. Alcoolisme aigu et delirium
  tremens en milieu hospitalier parisien. Considerations
  cliniques  et therapeutiques a propos de 40  cas recents.
  [Acute alcoholism and delirium tremens in a Paris  hos-
  pital setting.   Clinical and therapeutic considerations
  regarding 40 recent cases.]  Bull. Soc.  mid. hop. Paris,
  1955, 71:  698-703.
Ravis,  E., see Donini, F.  M., Belsasso, M., Ravis, E.
Ravreby, M.  Pharmacology.  In: "Happiness pills"  in
  medical practice: a symposium.  J. Iowa  M. Soc, 1957,
  47: 57-59.
Rawnsley, K., see Anderson, E. W., Rawnsley, K.
Ray, P. K.  The  use of Rauwolfia  serpentina in psychiatry.
  Ind. J. Neur. Psychiat, 1952, 3 : 380-398.
Raymond, M. J., Lucas, C. J.   Benactyzine  in  psycho-
  neurosis,  with a note on the E. E. G. changes in normal
  subjects.  Brit M. J., 1956, 1: 952-954.
----,----, Beesley,  M.  L., O'Connell,  B.  A.,  Roberts,
  J. A. F.   A trial of five tranquillizing drugs in psycho-
  neurosis.   Brit. 31. J.,  1957, 2: 63-66.
Raymondeaud, C, see Sigwald, J., Henne, M., Bouttier, D.,
  Raymondeaud, C, Quetin, A.
Rayner, S.,  see Cronqvist, S., Rayner, S., Wretmark, G.
Rea, E. L.,  Fazekas, J. F. Effects of parenterally admin-
  istered reserpine.   A. M.  A.  Arch. Int.  M.,  1955,
  95: 538-539.
----, Shea, J., Fazekas, J. F., Hypotensive action of chlor-
  promazine.  J. Am. M. Ass., 1954, 156:1249-1250.
----, see Albert, S. N., Rea, E. L. Duverney,  C. A., Shea,
  J.,  Fazekas, J. F.
----, see Fazekas, J.  F., Shea, J., Rea, E.
----, see Schultz, J. D., Rea, E.  L., Fazekas, J. F., Shea,
  J. G.
Reda, G. C, Ballardini, G., Riccio, L.  Esami psicologici
  in soggetti trattati con largactil.   [Psychological ex-
  amination of patients treated with largactil.]  Riv. sper.
  freniat, 1955, 79 : 509-514.
---, Germano,  V.  L'azione combinata della reserpina e
  cloropromazina nella  pratica psichiatrica.  [Combined
  effect of reserpine  and  chlorpromazine  in  psychiatric
  practice.]   [English  summary]   Arch,  psicol.  neur.,
  3Iilano, 1956, 17 : 647-653.                .
Rees, E. L.  Metabolism of the schizophrenic  child; etio-
  logic hypothesis.  Report of six cases treated with chlor-
  promazine hydrochloride. J. Am. M. Women Ass., 1956,
  11:11-16.                             .   .  ,.
Rees, L.  A controlled trial of  chlorpromazine in the man-
  agement of patients suffering from asthma associated
  with anxiety and tension symptoms.  Enciphale, 1956,
  45: 555—561.
___'  The role of drugs in  the  treatment of  anxiety-
  tension states.   3Ied.  Press, Lond.,  1952, 227: 295-298.
---, Lambert, C.  A controlled study of the value of chlor-
  promazine in the treatment of  anxiety-tension states.
  Enciphale, 1956, 45 : 547-549.
---,---. The value and limitations of chlorpromazine
  in the treatment of anxiety  states.   J. Ment. Sc, Lond.,
  1955, 101: 834-840.
Reeth, P. C. van, see  Dierkens, J., Reeth, P. C. van.
Reggiani, R.  Contributo clinico alio studio di un farmaco
  equilibratore  del sistema nervoso-vegetativo.   [A new
  pharmaceutic stabilizer for  the autonomic nervous sys-
  tem.]  [Nor-Dis]  Policlinico, sez. prat., 1954, 61:1111-
  1115.
Reichle, C, see Friebel,  H, Reichle, C.
Reid, A. A., see Begg,  W. G. A., Reid, A. A.
Rein, C. R., Goodman,  J.  J.  Efficacy of reserpine (serpasil)
  in dermatological therapy.  A. 31. A. Arch. Derm. Syph.,
  1954, 70: 713-717.
---,---.  The tranquilizing efficacy of reserpine in der-
  matological therapy.   Ann. N.  York Acad. Sc,  1955,
  61:230-235.
Reinhard, J. F., Chessin,  Mv  Tornaben, J., Lewis, M. N.
  Pharmacologic  evaluation of  a  new  sedative-hypnotic
  drug combination.  [Abstract]   Fed. Proc, Bait, 1954,
  13: 396.
Reinhart, M. J., Silverstein, B. S., Cross, T. N.  A case of
  agranulocytosis  following  "sparine"  administration.
  Am. J. Psychiat., 1957, 114:  462-463.
Reisner, H.  Zwischenfalle bei Gaben hoher Dosen von
  Reserpin (Serpasil).   [Incidents with massive doses of
  reserpine.]  Wien.  klin. Wschr., 1956, 68:872-874.
Reiss, F.  Psoriasis  and  stress.   Dermatologica, Basel,
  1956, 113:71-78.
Reitan, R. M.  The comparative effects of placebo, ultran,
  and meprobamate  on  psychologic  test  performances.
  Antibiotic M., 1957, 4:158-165.
Reitman, H. J., see Zeller, W. W., Graffagnino, P. N., Cullen,
  C. F., Reitman, H. J.
Remy, M. A propos  d'un nouveau neuroplegique: le NP
  de  Sandoz.  [A new neuroplegic drug: NP  by Sandoz.]
   [Abstract]   Schweiz.   Arch.  Neur. Psychiat.,  1956,
  77: 480.
Rentmeester, J., see  Wardt-Kikkert, N. M. van  de, Rent-
  meester, J.
Requet, [A.], Leveque.  Cure de Sakel et chlorpromazine
  associes.   [Combined  Sakel and chlorpromazine ther-
  apy.]   ,/. med, Lyon, 1956,  37 : 407-409.  Abstract: Ex-
  cerpta med.,  Sect. 8, 1957, 10: No. 954.
----, see Achaintre,  A., Balvet, P., Beaujard, M., Brous-
   solle, P., Perrin, J., Leveque, F., Requet, A.
----,  see Revol, L.,  Achaintre, A., Balvet, P., Beaujard,
  M., Berthier, C, Broussolle, P., Lambert, P., Perrin, J.,
  Requet, A.
Resch, J. A., Schut, J. W., Bernstein, I. C.  Premedication
  in  electric convulsive therapy.   Am. J.  Psychiat, 1956,
  113: 78.
Reserpine.  J. Am. 31. Ass.,  1955, 159:1206-1207.
240 
AUTHOR  LIST
Rinkel, M.
 Reserpine.   Antibiotic  M.,  1957,  4:108-113.   Also:
   Internat. Rec M., 1957, 170: 214-219.
 Reserpine and the mind.. Lancet, Lond., 1955, 2: 330-331.
 Reserpine and  the nervous system.  Lancet, Lond., 1955,
   2:1326.
 Reserpine  (serpasil) and  other alkaloids  of  Rauwolfia
   serpentina: chemistry, pharmacology, and clinical ap-
   plications.  Ann.  N. York Acad.  Sc, 1954,  59:1-140.
   cf. Yonkman, F. F., ed.
 Reserpine in the treatment of  neuropsychiatric, neuro-
   logical, and related clinical  problems.  Ann. N. York
   Acad. Sc, 1955, 61:1-280.  cf. Yonkman, F. F., ed.
 Rettig, J. H.  Chlorpromazine and mysoline in the control
   of  convulsive  epilepsy in  mentally  deficient patients.
   J. Nerv. Ment. Dis., 1956,  124: 607-611.
 ---.  Chlorpromazine for the control of psychomotor ex-
   citement in the mentally deficient; a  preliminary study.
   J. Nerv. Ment Dis., 1955, 122 : 190-194.
 Reuning, H., see Hurst, L. A., Reuning, H., Wyk, A. J. van,
   Crouse, H. S., Booysen, P. J., Nelson, G.
 Reverchon, J., see Sapir, M., Stroun, J., Hepner, L., Rever-
   chon, J.,  Selzer, S.
 Revol, L.  Amplification  par la chlorpromazine de  Teffet
   hypothermisant des barbituriques chez le lapin.  [Ampli-
   fication  of  the hypothermic  effect of barbiturates  by
   chlorpromazine in  rabbits.]   Ann.  pharm.  fr.,  1954,
   12:500.
 ---.  Chlorpromazine et intoxication alcoolique.  [Chlor-
   promazine and alcoholic intoxication.]  Lyon pharm.,
   1954, 5:349-350.
 ---, Achaintre, A., Balvet, P., Beaujard, M., Berthier, C,
   Broussolle, P.,  Lambert,  P., Perrin, J., Requet, A.  La
   therapeutique par  la chlorpromazine en pratique psy-
   chiatrique.   [Chlorpromazine  therapy in  psychiatric
   practice.]   151 p. Paris, Masson, 1956.
 Reyes, R. M., see Sadove, M. S., Balagot, R. C, Reyes, R. M.
 Rezner, see Kleinzorge, Rezner.
 ---, see Rosner, K.
 Rhijn, C. H. van.  De invloed van reserpine (serpasil) op
   acute en chronische geestesziekten.  [The effects of reser-
   pine on acute and chronic mental diseases.]  [English
   summary]  Ned. tschr. geneesk., 1956, 100:1775-1790.
 Rhone-Poulenc, Laboratoires, see Societe parisienne d'ex-
   pansion chimique.
 Ribstein, M., see Lafon, R., Due, N., Ribstein, M., Pages, H.
 Ricci, G.  C, Ricordati, M.   Un alcaloide della Rauwolfia
   serpentina nella terapia della ipertensione e di alcune
   psicopatie;  rassegna  critica  ed  esperienze cliniche.
   [Rauwolfia serpentina  alkaloid in  the treatment of hy-
   pertension and of certain psychopathies ; critical consid-
   erations and  clinical experiences.   [English summary
   p. 128]  Rass. fisiopat, 1954, 26: 91-131.
 Riccio, L., see Reda, G. C, Ballardini, G., Riccio, L.
 Rich, T. A., see Kleemeier, R. W., Rich, T. A., Justiss, W. A.
 Richman, A., Tyhurst, J. S.   An extrapyramidal syndrome
   with reserpine.  Canad. M. Ass. J., 1955, 72: 457-458.
 ---, see Tyhurst, J. S., Richman, A.
 Ricordati, M., see Ricci, G.  C, Ricordati, M.
 Riesenman, F. R.  Chlorpromazine.  Med. Ann. District of
   Columbia, 1956, 25 : 258-260.
 ---, see Overholser, W., Waldrop, F. N., Riesenman, F. R.,
   Fong, T. C. C, Farley, O. R., Hoffman, J. L.
 Rigal, [J.]  Traitement de la manie  et des etats d'hyper-
   thymie par le  3277 R. P.  (phenergan).  [Phenergan
   therapy of mania and of hyperthymic states.]  J. mid.
   Bordeaux, 1952,129: 899-901.
____  Malet, P.   Considerations sur  Temploi du largactil
   en' psychiatrie.  [Largactil therapy in psychiatry.]  J.
   mid. Bordeaux, 1954, 131:1191-1196.
___  ____  Florentin, M.   Quelques  considerations  au
   sujet de 300 cures de chlorpromazine  dans les psychoses
  et les  nervoses.  [Some  remarks on chlorpromazine
  therapy of 300  psychotics and neurotics.]   Enciphale,
  1956, 45: 592-598.
Rigotti, S. Dal blocco del S. N. vegetativo all'ibernazione
  artificiale: primi risultati di un nuovo indirizzo di tera-
  pia psichiatrica.   [From  autonomic  N.  S. blocking to
  artificial hibernation;  first results with a new psychi-
  atric  therapy.]  Rass. neur. vegetal, 1952, 9:197-210.
  Abstract: Riv. neur., Nap., 1953, 23 :186-188.
----.   Sull'impiego clinico di un nuovo farmaco ad azione
  sedativa; il  2  metil-2-n-propil-l,3-propandiolo dicarba-
  mato.  [Clinical use of a new drug with sedative action :
  2 methyl-2-n-propyl-l,3-propanediol dicarbamate.]   Min-
  erva med., Tor., 1956, 47 : 2178-2181.
---.  Ulteriori esperienze sull'impiego in psichiatria della
  dimetilamino - propil - N - clorofenotiazina  (Largactil).
  [Further experiences with the use of  dimethylamino-
  propyl-chlorophenothiazine  (largactil)  in  psychiatry.]
  [English summary]  Gior. psichiat.,  1953, 81:211-222.
Rinaldi, F.  The experimental  electroencephalographic
  approach to psychopharmacology.   Psychiat. Res. Rep.,
  Wash., 1956 (4) : 1-10.
----, Haynes, E.  E., Rudy, L. H.,  Himwich, H. E. Thera-
  peutic effects of azacyclonol in  psychotic patients.   In:
  Himwich, H. E., ed.   Tranquilizing  drugs.  Washing-
  ton, Am. Ass. Adv. Sc, 1957.  p.  115-123.
----, Himwich,  H.  E.  The  cerebral   electrographic
  changes induced by LSD and mescaline are corrected by
  frenquel.  J. Nerv. Ment  Dis.,  1955, 122: 424-432.   Ab-
  stract : Excerpta med., Sec. 8, 1957, 10:  No. 1601.
---, ----.  A comparison of effects of reserpine and some
  barbiturates on the electrical  activity  of cortical  and
  subcortical structures of the brain of rabbits. Ann. N.
  York Acad.  Sc, 1955, 61: 27-35.
----, ----.  Drugs affecting psychotic  behavior and the
  function of  the mesodiencephalic activating  system.
  Dis. Nerv Syst, 1955, 16 :133-141.  Abstract: Excerpta
  med., Sect. 8,1956, 9 : No. 4566.
----, ----.  Frenquel  corrects certain  cerebral  electro-
  graphic changes.  Science, 1955, 122 :198-199.
---,----.  The  site of action of antiparkinson  drugs.
  Confinia neur., Basel, 1955,  15:209-224.  Abstract:
  Am. J. Physiol, 1954, 179: 665.  Excerpta med., Sect. 8,
  1956, 9: No. 3616.
---, Rudy, L. H., Himwich, H. E.  Clinical evaluation of
  azacyclonol, chlorpromazine, and reserpine on a group
  of chronic  psychotic patients.  Am. J. Psychiat, 1956,
  112: 678-683.   Abstract: Excerpta med., Sect. 8, 1956,
  9: No. 4986.
----, ----, ----.   The use of  frenquel  in the treatment
  of disturbed patients with psychoses  of long duration.
  Am. J. Psychiat, 1955, 112: 343-348.
---, see Himwich, H. E., Rinaldi, F.
---,  see Himwich, H. E., Rinaldi, F., Willis, D.
----, see Rudy, L. H., Rinaldi, F., Himwich, H. E.
Rinehart, R., see Schneider,  J. A., Plummer, A. J., Earl,
  A. E.,  Barrett,  W. E.,  Rinehart, R., Dibble, R. C.
Ringel, E., see Leupold-Lowenthal, H., Ringel, E.
Rink, K., see  Lim, R. K, Pindell, M.  H., Glass,  H. G.,
  Rink, K.
Rinkel, M.  Experimentally  induced psychoses in man.
  In: Abramson, H. A., ed.  Neuropharmacology.  Trans-
  actions of the  second conference, May 1955,  Princeton,
  N. J.   New  York, Josiah  Macy, Jr., Foundation, 1956.
  p. 235-258.
----.  Pharmacodynamics  of  LSD  and  mescaline.  J.
  Nerv. Ment Dis., 1957,125 : 424-427.
---.   Summary  of papers  on drugs affecting behavior.
  J. Nerv. Ment  Dis., 1955,  122:496-497.
---, DeShon, H. J., Hyde, R. W.,  Solomon, H. C.  Experi-
  mental schizophrenia-like symptoms.  Am. J. Psychiat
  1952,108:572-578.
---,  Hyde, R. W.,  Solomon,  H. C. Experimental psy-
  chiatry.  III. A  chemical  concept of psychosis.  Dis.
  Nerv. Syst, 1954, 15: 259-264.
---,  ----, ----•   Experimental  psychiatry.   IV. Hallu-
  cinogens : tools in experimental psychiatry.  Dis. Nerv
  Syst., 1955, 16: 229-232. 
Rinkel, M.
PSYCHOPHARMACA
---, Hyde, R. W., Solomon, H. C, Hoagland, H.  Experi-
  mental psychiatry.  II. Clinical and physio-chemical ob-
  servations in experimental psychosis.  Am. J. Psychiat,
  1955, 111: 881-895.
---, Solomon,  H.  C.  Chemical  theories of  psychosis.
  J. Clin. Exp. Psychopath., 1957, 18: 323-334.
----, ed., see Denber, H. C.  B., Rinkel, M., ed.
----, see DeShon, H. J., Rinkel, M.,  Solomon, H. C.
Rinsley, D. B., see Apter, J., Rinsley, D. B.
Riopelle, A. J., see Smith, R. P., Wagman, A. I., Riopelle,
  A.J.
Ripstein, C. B., see  Friedgood, C.  E., Ripstein, C. B.
Riser, M., Geraud, J., Laboucarie, J., Rascol, A., Clausse,
  S,  Garrigues, M.  P. Considerations  etiologiques  et
  therapeutiques sur les delirium tremens; a propos de 75
  cas.  [Etiologic and therapeutic considerations of de-
  lirium  tremens;  75  cases.]  Rev. neur.,  Par.,  1956,
  94: 662-667.
---, Laboucarie,  J.,  Barres,  P.  Hibernation  dans les
  psychoses hyperthermiques.  [Hibernation in hyperther-
  mic psychoses.]   Ann. mid psychol,  Par.,  1953, 111
   (2) : 207-212.
Ritter, N. S.  Experience with reserpine in the treatment
  of  alcoholism.  Q. J. Alcohol,  1956, 17:195-197.  Ab-
  stract : Excerpta med., Sect. 8, 1957, 10: No. 883.
Rivas, M.  La terapia cloropromazinica prolungata ad alte
  dosi in psichiatria.  [Prolonged chlorpromazine therapy
  with massive doses  in psychiatry.]  Enciphale,  1956,
  45: 469-470.
Rives, Menager, V.  Neuropiegie et delirium  tremens.
   [Neuroplegic  therapy and delirium tremens.]   Anes-
  the'sie, Par., 1953, 10: 450-453.
Rizzente, S.  Osservazioni cliniche su di un nuovo ipoten-
  sivo e sedativo in geriatria.  [Clinical observations on a
  new hypotensive and sedative drug in geriatrics. ]  Arch.
  psicol, neur., Milano, 1956, 17: 454-456.
Rizzo, E. M.  SulTazione del largactil associato ai barbi-
  turici  in malati di mente. [The effect of largactil com-
  bined  with barbiturates on  mental  patients.]  Riv.
  neur., Nap., 1953, 23 : 824-828.
---, Russo, S.  Sull'uso dei ganglioplegici in terapia psi-
  chiatrica.   [The  use of  ganglioplegics in  psychiatric
  therapy.]   [English summary]   Gior.  psichiat.,  1954,
  82:127-151.  Abstract: Excerpta med., Sect.  8,  1955,
  8: No. 2815.
Robbins, J. J., see Monaco,  R. N., Leeper, R. D., Robbins,
  J. J., Calvy, G. L.
Robert, H., see Collomb, H., Miletto, G., Robert, H.
Robertiello,  R., see  Freedman,  A. M., Kremer, M. W.,
  Robertiello, R., Effron, A. S.
Roberts, J. A. F., see Raymond, M. J., Lucas, C. J., Bees-
  ley, M. L., O'Connell, B. A., Roberts, J. A. F.
Roberts,  J.  M.,  see Hargreaves,  G. R., Hamilton, M.,
  Roberts, J. M.
Roberts, R. H., see Hollister, L. E. Krieger, G. E., Kringel,
  A., Roberts, R. H.
Roberts,  S.  E.  A   chlorpromazine  (thorazine)-induced
  cephalalgia  and  its  management.  A.  31.  A.  Arch.
  Otolar., 1956, 63 : 208-209.
Robie, T. R.  Pseudo-tabes  syndrome as complication  of
  tranquilizer drug  therapy.   Am. J.  Psychiat,  1956,
  113: 463-464.
Robillard, R., see Genest, J., Adamkiewicz, L.,  Robillard,
  R., Tremblay, G.
Robin, C, see Puech, J., Robin, C.
Robiner, I. S., see Galenko,  V. E., Osberg,  I. IU., Robiner,
  I. S., Frenkel, G. M.
Robinson, C. V., see  Robinson, H. M., Jr., Robinson, C. V.,
  Strahan, J. F.
Robinson,  H. M., Jr., Robinson,  C.  V.,  Strahan, J.  F.
  Hydroxyzine (atarax) hydrochloride in dermatological
  therapy.  J. Am. 31. Ass.,  1956,161: 604-606.
Robitzek, E. H., see Selikoff,  I. J., Robitzek, E. H., Ornstein,
  G. G.
Rockmore, L., Shatin, L., Funk, I. C.  Response of psychi-
  atric patients to massive doses of thorazine.  I. ^^7"
  ioral and clinical analysis.  Psychiat Q., 1956, 30:189-
  203.
---, see Shatin, L., Rockmore, L., Funk, I. C.
Rockwell, F. V., see Payn, S. B., Rockwell, F. V.
Rodolico, G, see  Salomone,  F. P., Peria, G., Rodolico, G.,
  Cacoiola, R.
Roebuck, B. E.  Agranulocytosis associated with chlorpro-
  mazine therapy. J. Nerv. 31ent Dis., 1956, 124 : 248-250.
---, see Peak,  E. C, Canestrari, R. E., Roebuck, B. E.
Roeder, F. D.  Letter from Germany.  Am. J. Psychiat.,
  1956, 113 : 506-509.
Roelens, [R.],  see  Le Guillant,  L., Roelens,  R.
---,  see Le  Guillant,  L.,  Roelens, Corre,  Kestenberg,
  Plichet, Bequart, Bailly-Salin.
Rentorp, P. S., see Lyager, T.,  R0ntorp, P. S.
Rosner, K.  Therapeutische Anwendung der  zentralner-
  vosen  Wirkung  einiger  Phenothiazinderivate in der
  Allgemeinmedizin.  [Therapeutic use of effects of vari-
  ous phenothiazine derivatives  on central nervous sys-
  tem in general practice.]  Med. 31schr., 1956,10: 719-723.
---, see Kleinsorge, H,  Rosner, K.
---, see Kleinzorge, Rezner.
Rogers, J., see  Ranee, A. M., Jurquet, A., Roger, J.
Rogers,  S., see  Knight, R.  W.,  Kent,  B.,  Morris, G.,
  Rogers, S.
---,  see  Moyer, J. H.,  Kent, B.,  Morris, G., Dizon, M.,
  Rogers, S., Spurr, C.
Rogg, S. G.  Thorazine and electroshock.  Delaware M. J.,
  1955,  27: 83-84.
Rolls, E. J., Stafford-Clark, D. Depersonalization treated
  by Cannabis indica and  psychotherapy.  Guy's  Hosp.
  Rep., Lond., 1954,103 :  330-336.
Rome, H. P., see Loftus, L. R., Huizenga, K. A., Stauffer,
  M. H., Rome, H. P., Cain, J. C.
---, see Schwarz, B. E., Bickford, R. G., Mulder, D. W.,
  Rome, H. P.
---, see Schwarz, B. E., Bickford, R. G., Rome, H. P.
Rondepierre, J., Hivert,  P. H., Honore, B., Vaugelade,  S.
  Resultats favorable obtenus par les neuroleptiques dans
  les psychoses de facheux pronostic.  [Favorable results
  obtained with neuroleptics  in  psychoses of poor prog-
  nosis.]  Ann. mid.  psychol, Par., 1955,  113 (2) : 853-
  859.
Ropert, M., see Delay, J., Denber, Deniker, P., Raclot, M.,
  Ropert, M.
---, see Delay, J., Deniker, P., Raclot, M., Ropert,  M.
Ropert, R., see Delay, J., Deniker,  P., Ropert, R.
——, see Delay, J., Deniker, P., Ropert, R., WTiart, C.
---, see Delay, J., Pichot, P., Ropert, R.
"Rose is a rose is a rose is  a rose"  Psychiat 0., 1957,
  31: 346-361.
Rose, R. F., see Sadove, M. S., Levin, M. J., Rose,  R. F.,
  Schwartz, L., Witt, F.  W.
Rosendorf, see Lamarche, A., Roussel, A., Rosendorf.
Rosenkotter, L., see Hippius, H.,  Mellin, P., Rosenkot-
  ter, L.
Rosenthal,  D., Frank,  J.  D.   Psychotherapy  and  the
  placebo effect.  Psychol. Bull, 1956, 53:294.
---,  Imber, S. D.  The effects of mephenesin and prac-
  tice on the Bender-Gestalt performance of psychiatric
  outpatients.  J. Clin.  Psychol, 1955, 11: 90-92.
---,  see Hampson, J. L., Rosenthal, D., Frank, J.  D
----,  see Meath, J.  A., Feldberg, T. M., Rosenthal, D.,
  Frank,  J. D.
Rosina, P. L.   Gli alcaloidi totali di Rauwolfia in psichia-
  tria;   premesse  fisiologiche  ed  esperienze  cliniche.
  [Total Rauwolfia alkaloids in psychiatry; physiological
  basis and clinical  experience.]  Alinerva  med   Tor.,
  1955,  46: 1249-1252.
----.   Reserpina nelle psicosi acute.  [Reserpine in acute
  psychoses.]   Arch, psicol  neur., 31ilano, 1956, 17:417.
Rosner, B. S., Fierman, L.  B., Kramer, J. F.' Clinical
  evaluation of meratran and frenquel on  a chronic psy-
  chotic population.  Am. J. Psychiat., 1957, 113 ; 993-996.
242 
AUTHOR  LIST
Sacchi, U.
 Rosner, H., Levine, S, Hess, H., Kaye, H.  A comparative
   study of the effect on anxiety of chlorpromazine, reser-
   pine, phenobarbital and a placebo.  J. Nerv.  31 ent. Dis.,
   1955,  122: 505-512. Abstract: Excerpta med.,  Sect. 8,
   1957, 10 : No. 2093.
 Ross, S., see Cole, J. O., Ross, S., Bouthilet, L.
 Ross,  W. D.  Mistakes  in the use  of chlorpromazine.
   Ohio 31. J., 1957, 53 : 182-183.
 ----, see Gottschalk, L. A., Kapp, F. T.,  Ross, W. D., Kap-
   lan, S. M., Silver,  H., MacLeod, J. A., Kahn, J. B.,  Jr.,
   Van Maanen, E. F., Acheson, G. H.
 ----, see Shanon,  J., Kaplan,  S. M., Pierce, C. M., Ross,
   W.D.
 Rossi, M.  Moderne terapie psichiatriche a base di gang-
   lioplegici e  di  alcaloidi della Rauwolfia  serpentina.
   [Modern psychiatric therapy with ganglioplegics  and
   Rauwolfia serpentina alkaloids.]   Arch,  psicol. neur.,
   Milano, 1956, 17 : 642-644.
 Rossini, R., Dazzi, P.  Sindromi psichiche  nel morbo di
   Basedow e  tiroidectomia;   efficacia  terapeutica della
   cura del sonno.  [Psychic syndromes  in Basedow's  dis-
   ease and thyroidectomy; effectiveness  of sleep therapy.]
   Gior.  clin. med., 1953,  34:1018-1028.  Abstract:  Rw.
   neur., Nap., 1954, 24: 305.
 Rosvold, H. E.,  see Primac, D.  W., Mirsky, A. F., Rosvold,
   HE.
 Roth, M.  In :  Symposium on  tranquillizers.  Brit. M. J.,
   1957, 2: 221.
 Rothlin, E.  Lysergic acid diethylamide and related sub-
   stances. Ann. N. York Acad. Sc,  1957, 66: 668-676.
 ----.  Die  zentralnervosen Wirkungen von Heilmitteln.
   [The  central-nervous effects of  drugs.]  39 p. Stutt-
   gart, Thieme, 1954.
 ----, Cerletti, A.  Pharmacology of LSD-25.   In: Chol-
   den, L., ed.  Lysergic acid diethylamide and mescaline
   in experimental psychiatry.  New York, Grune d Strat-
   ton, 1956.  p. 1-7.
 ----, ----.  Uber  einige pharmakologische  Untersu-
   chungen an Mausen mit congenitaler Drehsucht.  [Some
   pharmacological studies on mice with congenital waltz-
   ing  syndrome.]  Helvet. physiol. pharm.  acta, 1952,
   10:319-327.   Abstract: Chem,  Abstr., 1953, 47: 766hi.
 ----, see Cerletti, A., Rothlin,  E.
 ----, see Taeschler, M., Rothlin, E.
 Rotstein, J., Frick, P. S.,  Schiele, B. C.  Agranulocytosis
   associated with chlorpromazine therapy.  A.  M. A. Arch.
   Int. M., 1955, 96: 781-786.
 Rotteglia, E.  Miltown:   nuovo sedativo  nell'ansieta  e
   nelle psicosi.  [Miltown : a new sedative in anxiety  and
   psychoses.]   Boll. chim. farm., 1956, 95:10-11.
 Roubicek, J., Srnec, J. Experimentaini psychosa vyvoland
   LSD.  [Experimental psychosis caused by LSD.]  [Eng-
   lish summary]   Cas. lek. cesk., 1955,  94:189-195.   Ab-
   stract : Chem. Abstr., 1955, 49:11875e.  Excerpta med.,
   Sect. 8, 1955, 8 :  No. 4844.
 Rousseau, J., see Bensoussan, P., Villiaumey, E. M., Rous-
   seau, J.
 Roussel, A., see Lamarche, A., Roussel,  A., Rosendorf.
 Rouvroy, M.   Remarques concernant le  traitement  des
  psychoses  chroniques.   [Remarks  on the  therapy of
  chronic psychoses.]  Enciphale,  1956, 45:707-708.
 Rovetta, P. Effects of mescaline and LSD on evoked re-
  sponses  especially  of  the   optic  system' of the   cat.
  Electroencephalography, Alontreal, 1956, 8:15-24.   Ab-
  stract : Excerpta med., Sect.  8, 1957, 10: No.  501.
 Rowley,  D. A., see Benditt, E. P., Rowley, D. A.
 Rowley,  E. H.,  see  Harris, R. D., Rowley, E. H.
 Roxo  H.  Tratamento  moderno  das  doengas mentais.
  [Modern therapy of mental diseases.]  Arq. brasil med.
  nav.,  1956, 17 : 4153-4162.
 Roy H.,  see Gaitz, C.  M., Roy, H., Thompson, W., Kimbell,
  I.' Mullen, A. J., Pokorny, A. D.
Roy[p.K.,seeRay, P.K.
Royer, P., Beis, M., Burner, M.  Essai de traitement d'un
  delire chronique par cure de sommeil.  [Sleep therapy
  of a patient in  chronic  delirium.]  Rev. mid.  Nancy,
  1954,  79:600-607.  Abstract:  Excerpta  med., Sect. 8,
  1955,8: No. 4920.
Ruberti, R., see Terzian, H., Ruberti, R.
Rubin, B., Malone, M.  H.,  Waugh,  M. H., Burke, J. C.
  Comparative activity of Rauwolfia serpentina whole root
  and  reserpine in laboratory animals.  Monogr. Ther.
  Squibb Inst. 31.  Res., 1956, 1 (2) : 40-44.
Rubin, E. H., see Cheifetz, I., Paulin, C, Tuatay, H., Rubin,
  E. H.
Ruchwarger, A.  Meprobamate  in anxiety reactions in-
  volving depression.  Med. Ann. District of  Columbia,
  1956, 25 : 555-556; 586.
Ruckdeschel,  K. T., see Brehmer, G.  von, Ruckdeschel,
  K. T.
■---, see Kolle, E., Ruckdeschel, K. T.
Rudy,  L.  H.,  Himwich,  H. E.,  Tasher, D.  C.   Clinical
  evaluation of  two phenothiazine compounds promazine
  and  mepazine.   Am. J. Psychiat.,  1957,  113: 979-983.
---, Rinaldi,  F., Himwich, H. E.  Comparative  effects of
  azacyclonol, reserpine, and chlorpromazine on  moder-
  ately disturbed  psychotic patients with long histories
  of hospitalization.  Psychiat. Res. Rep.,  Wash.,  1956
  (4) : 49-63.
----, see Hagenauer, F., Rudy, L. H., Himwich, H. E.
----, see Rinaldi, F., Haynes, E. E., Rudy, L. H., Himwich,
  H. E.
----, see Rinaldi, F., Rudy, L. H.,  Himwich, H. E.
Ruiz-Ogara, C, Marti-Tusquets, J. L., Gonzalez-Monclus,
  E.   Psicosis  lisergica.   [Lysergic  psychosis.]   Rev.
  psiquiat. psicol, Parcel, 1956,  2:566-590.  Abstract:
  Excerpta med., Sect. 8, 1957, 10: No. 1986.
Ruskin, I. W., Avol, M.  Rauwolfia tranquilization for the
  disturbed aged.  J.  Am. Geriat.  Soc, 1956, 4:  998-1003.
Russo, S., see Rizzo, E. M., Russo, S.
Rutherford, A., see Smith,  J. A., Rutherford, A., Fanning,
  R.
Ruyer,  M.  Hibernation dans les confusions alcooliques
  aigues.   [Hibernation in acute alcoholic  confusions.]
  82 p.  [Mimeographed]   Strasbourg, 1954.  [Thesis—
  Strasbourg 1954, no. 74.]
Ryan, J. P., see McGrath, S. D., Ryan, J. P., Fennelly, J. J.

                          s

Saavedra, A.,  see Trelles, J. O.,  Saavedra, A.
Sabatini, R., see Sarrouy, C, Saint-Jean, Sendra, L., Saba-
  tini, R.
Sabshin, M., Ramot, J.   Pharmacotherapeutic evaluation
  and  the psychiatric  setting.   A.  M.  A.  Arch.  Neur.
  Psychiat., 1956, 75 : 362-370.
Sacchi, U., Bonamini, F., Dolce, G.,  Garello, L.  Dietila-
  mide dell'acido lisergico  e catalessia da 5-idrossitripta-
  mina nel cane.   [Lysergic acid diethylamide  and 5-
  hydroxytryptamine  catalepsy in dogs.]  Boll  Soc ital
  biol sper., 1955, 31: 665-667.
----, ----, Garello, L., Dolce, G.  Studio dell'azione cata-
  lettizzante  della 5-HT  per  introduzione  nel sistema
  ventricolare o  negli  spazi subaracnoidei  del cane.
  [Cataleptic action of 5-HT introduced into the ventricu-
  lar system or subarachnoid space in  dogs.]  Boll. Soc.
  ital.  biol  sper.,  1956, 32:179-182.   Abstract:  Chem.
  Abstr., 1956, 50:6680gh.
----,  Brusa,  A., Gianniotti, G.  Lesioni del  sistema ner-
  voso centrale del Carassius auratus da 5-HT  ed azione
  protettrice  delTLSD.   [Lesions  of the central nervous
  system  in Carassius  auratus  caused by serotonin and
  the  protective action of lysergic acid  diethylamide.]
  Boll. Soc ital biol. sper.,  1956, 32: 438-441.
----, Garello, L., Dolce, G., Bonamini, F.  L'azione cata-
  lettizzante  della 5-idrossitriptamina  introdotta  nella
  cisterna magna  del cane.   [Cataleptic action of 5-hy- 
Sacchi, U.
PSYCHOPHARMACA
  droxytryptamine introduced into the cisterna magna of
  dogs.]  Boll. Soc. ital. biol sper., 1955, 31: 663-665.
Sacerdoti,  G.  Prime esperienze in neuropsichiatria con
  nuovo alcaloide della Rauwolfia serpentina : il serpasil;
  nota preventiva.  [First experience in neuropsychia-
  try with a new  alkaloid of Rauwolfia serpentina: ser-
  pasil; preliminary note.]  Gazz. med. ital, 1955, 114:
  63-65.   Abstract: Excerpta med., Sect. 8, 1956, 9: No.
  1220.
---, Mantelli, A.  La reserpina nel trattamento ambula-
  toriale  nei  disturbi  del  comportamento nell'infanzia.
  [Reserpine in the ambulatory treatment of behavior dis-
  orders in childhood.]   [English summary]  Gazz. med.
  ital, 1955, 114:189-191.
---, Vegro,  G.  La reserpina  in psichiatria  infantile.
  [Reserpine  in child psychiatry.]   [English summary]
  Arch, psicol. neur., Milano, 1956, 17: 459-477.
Sack, K. H., see Nieschulz, O., Popendiker, K, Sack, K. H.
Sack, P., see Cares, R. M., Asrican, E., Fenichel, M., Sack,
  P., Severing, J.
Sackler, A. M., see Marti-Ib&iiez, F., Sackler, A. M., Sack-
  ler, M. D., Sackler, R. R.
Sackler, M. D., see Marti-Ibauez, F., Sackler, A. M., Sack-
  ler, M. D., Sackler, R. R.
Sackler, R. R., see Marti-Ib&nez, F., Sackler, A. M., Sack-
  ler M.  D., Sackler, R. R.
Sadove, M. S., Balagot,  R. C.  The value of chlorproma-
  zine in the management of pain.   Internat. Rec. M.,
  1955, 168: 346-350.
---, ----, Reyes, R. M. The potentiating action of chlor-
  promazine.  Current Res. Anesth., 1956, 35 :165-181.
----, Levin, M. J., Rose, R. F., Schwartz, L., Witt, F. W.
  Chlorpromazine and  narcotics in the management of
  pain of malignant lesions.  J. Am. M. Ass., 1954, 155:
  626-628.
Safe dosage levels in reserpine.  Am. J. Psychiat, 1956,
  113: 376-377.
Saginario, M., see Macchi, G., Manghi, E., Saginario, M.
----, see Manghi, E., Saginario, M.
Saglia, N.  Osservazioni di carattere tecnico sulla terapia
  degli schizofrenici cronici con cloropromazina.  [Tech-
  nical observations on chlorpromazine therapy in chronic
  schizophrenia.]  Arch, psicol. neur., Milano,  1956, 17:
  634-635.
Sagripanti, P. Ipnoterapia  con largactil  in psichiatria.
  [Sleep therapy with largactil in psychiatry.]  Riv. sper.
  freniat, 1954, 78:155-182.
---.  Leucotomia  e ipnoterapia in un  caso di psicosi
  ossessiva.   [Leukotomy  and sleep therapy  in an obses-
  sive psychotic patient.]  Minerva med.,  Tor., 1953, 44:
  259-260.  [Not seen.]
----.  Primi risultati clinici dell'ipnoterapia eseguita con
  nuovi preparati.   [First clinical results of sleep therapy
  with new preparations.]  Minerva med., Tor., 1953, 44:
  232-233.  [Not seen]
Saint-Jean, see Sarrouy, C, Saint-Jean, Sendra, L., Saba-
  tini, R.
Sainz, A. A.  Clinical applications of chlorpromazine in
  psychiatry.  In: Kline, N. S., ed. Psychopharmacology.
  Washington, Am. Ass. Adv. Sc, 1956.  p. 39-58.
----.  Considerations on the cerebral action of reserpine.
  In:  Kline, N. S., ed.   Psychopharmacology.  Washing-
  ton, Am. Ass. Adv. Sc, 1956.  p. 59-63.
---.  The management of side effects of chlorpromazine
  and reserpine.   Psychiat. Q., 1956, 30: 647-653.
---.  The treatment of  drug and  alcohol withdrawal
  effects with thorazine. Psychiat. Q., 1957, 31: 275-284.
----.  The use of reserpine in  ambulatory and hospital-
  ized geriatric psychotics.  Ann. N. York Acad. Sc, 1955,
  61: 72-77.   Abstract:  Excerpta med. Sect. 8, 1956, 9 :
  No. 1229.
---,  Bigelow, N.,  Barwise,  C. On a methodology  for
  the clinical evaluation of phrenopraxic drugs.  Psychiat.
  Q., 1957, 31:10-16.
Sakellaropoulos, P., see Ey, H., Sakellaropoulos, P.
Salles, P., see Ouies, J., Salles, P., Soubrie, R.
Salmoiraghi, G. C, Sollero, L., Page, I. H.  Blockade by
  brom-lysergic-acid-diethylamide (BOL) of the potentiat-
  ing action of serotonin and reserpine on  hexobarbital
  hypnosis.   J. Pharm.  Exp.  Ther., 1956, 117: 166-168.
  Abstract: Chem. Abstr., 1956, 50 :14105gh.
Salomon, F., see Sizaret,  P., Salomon,  F.
Salomone, F. P., Peria, G., Rodolico, G., Cacoiola,  R.  Le
  medicazioni  neuroplegiche  nelle terapia  del   dolore.
  [Neuroplegics in therapy of pain.]  Minerva chir., Tor.,
  1955 10: 296.
Salvatore, S., Hyde, R. W.  Progression of effects of ly-
  sergic acid diethylamide (LSD).  A.  M. A. Arch. Neur.
  Psychiat, 1956,  76 : 50-59.
Sal y Rosas, F., Jeri, R., Sanchez, J. La chlorpromazine
  chez les malades mentaux peruviens.   [Chlorpromazine
  therapy of mental patients in Peru.]   Enciphale, 1956,
  45: 599-604.
---,  ----,  ----.   Chlorpromazine in  neuropsychiatry.
  J. Am. M.  Ass., 1954, 156: 558.
Samad, I. A.  Complications of chlorpromazine therapy.
  Lancet, Lond., 1955, 1:1327.
Samter, N.  F., see Sereiskii,  M. IA., Tolmaskaia, E. S.,
  Golodets,  R. G.,  Samter, N. F.
Samuels, A. S. Acute chlorpromazine poisoning.   Am. J.
  Psychiat, 1957,  113 : 746-748.
---.  Phenergan  in treatment  of psychiatric patients.
  Dis. Nerv. Syst., 1957, 18:183-188.
Sanchez, A. J., see Stevenson, I., Sanchez, A. J.
Sanchez, F., see Ramee, F., Lacaton, R.,  Sanchez, F., Bou-
  langer, M.
Sanchez Garcia, J., see Sanchez, J.
Sanchez, J., see Sal y Rosas, F., Jeri, R., Sanchez, J.
Sander, F., see Kirkpatrick, W. L., Sanders, F.
Sandison, R. A.  The clinical uses of lysergic acid diethyl-
  amide.  In:  Cholden, L., ed. Lysergic acid diethylamide
  and mescaline in experimental psychiatry.   New York,
  Grune d Stratton, 1956.  p. 27-34.
---.   Psychological aspects of the LSD treatment of the
  neuroses.   J. 31 ent. Sc, Lond., 1954, 100: 508-515.  Ab-
  stract : Excerpta med., Sect.  8, 1955, 8: No.  3895.
---, Spencer, A. M., Whitelaw, J. D. A.  The therapeutic
  value of lysergic acid  diethylamide  in mental  illness.
  J. Ment. Sc, Lond.,  1954, 100: 491-507.  Abstract: Ex-
  cerpta med., Sect. 8, 1955, 8: No. 930.
---, Whitelaw, J.  D. A. Further studies in the therapeutic
  value of lysergic acid  diethylamide  in mental  illness.
  J. 31ent. Sc, Lond.,  1957, 103:332-343.
Sandoz Chemical  Works,  inc., Sandoz  Pharmaceuticals.
  Annotated bibliography;  LSD 25—Delysid  (d-lysergic
  acid diethylamide).  56 p.  Hanover, N.  J., 1956.
Sands, S. L.  Psychiatry.  In: "Happiness pills" in medical
  practice : a symposium.  J. Iowa 31. Soc, 1957, 47: 64-65.
Sangowicz,  J. Gauthier, J.  Resume d'une etude clinique
  sur pacatal et medomine, portant respectivement sur 40
  cas.  [Results of a clinical study on  pacatal and medo-
  min concerning 40 cases  respectively.]   Union  mid.
  Canada, 1956, 85 :1170-1171.
Sanguineti,  I., Laricchia, R.   La chlorpromazine dans les
  maladies  mentales;  indications de son emploi et limites
  de  son efficacite therapeutique.   [Chlorpromazine  in
  mental disorders; indications for its use and limits of
  its therapeutic efficacy.]  Enciphale, 1956, 45 :1197-1203.
---, ----,  Negri, V. [IL]  Sull'impiego di  un derivato
  della fenotiazina nella cura  delle   malattie mentali.
   [The use of a phenothiazine derivative in the treatment
  of mental diseases.]  Acta neur., Nap., 1953, S: 801-823.
  Abstract: Excerpta med., Sect.  8, 1954, 7: No. 3806.
---, Negri, V., Laricchia, R.  Le  modificazioni dell'EEG
  in malati di mente sottoposti  all'azione di un derivato
  della  fenotiazina  (largactil-Farmitalia).  [Modifica-
  tions in the EEG of mental patients under the influence
  of  a phenothiazine derivative  (largactil).]  [English
  summary]  Riv. neur., Nap., 1953, 23 : 513-534.
244 
AUTHOR  LIST
Schneider, G.
   ~>----,----.  Ritmi elettrici cerebrali dopo somminis-
   trazione di  mescalina e di acido lisergico  (LSD 25) in
   malati di mente.  [Electrical rhythms of the brain fol-
   lowing  administration of  mescaline and lysergic acid
   (LSD  25)  to  mental patients.]  Riv.  sper.  freniat.,
   1955,  79: 771-797.  Abstract:  Excerpta med., Sect.  8,
   1957, 10:  No. 1060.
 ----, Zapparoli,  G.  C, Laricchia, R.   Studio  clinico-
   biologico delle reazioni indotte dal solfato di mescalina
   e  dall'acido lisergico (LSD-25) in  malati di mente.
   [Clinical and physiological study of mescaline sulfate-
   and lysergic acid (LSD)-induced reactions in mental
   patients.]  Riv.  sper. freniat, 1956, 80: 887-918.
 Santangelo, F.  Effetti terapeutici del serpasil su  un
   gruppo di malati mentali.  [Therapeutic effects of ser-
   pasil  in a  group of mental patients.]   Arch, psicol.
   neur., 3tilano, 1956, 17: 408-411.
 Santangelo, G.  Modificazioni  indotte dal  trattamento
   reserpinico protrato sulla sintomatologia psichica e com-
   portamentale nelle schizofrenie croniche.  [Modifications
   induced by  prolonged reserpine treatment on psychic
   symptomatology and behavior in chronic schizophrenia.]
   [English summary]   Arch, psicol. neur., Milano, 1956,
   17: 388-393.
 Sapir, M., Stroun, J., Hepner, L., Reverchon,  J., Selzer, S.
   A  propos  de Taction psycho-somatique  de la  chlorpro-
   mazine et de la  reserpine.  [Psychosomatic action of
   chlorpromazine  and  reserpine.]   Enciphale,  1956,
   45: 488-493.
 Sargant, W. On chemical tranquillizers. Brit. 31. J., 1956,
   1:939-943.
 Sarro, R.   Recents developpements de la therapeutique
   narcobiotique.   [Recent  developments  in  narcobiotic
   therapy.]  Enciphale, 1956, 45 : 501-510.
 Sarrouy,  G, Saint-Jean, Sendra L., Sabatini, R. Etude
   eiectro-encephalographique de trente cas de  toxicoses
   traitees par le 4560 R.  P.   [Electroencephalographic
   study of 30 cases of toxicosis treated with  4560 R. P.]
   Arch. fr. pidiat., 1955, 12:37-42.
 Sarwer-Foner, G. J., Koranyi,  E. K.  Clinical investiga-
   tion of azacyclonol hydrochloride, an alleged antihallu-
   cinatory, anticonfusional agent.   Canad. Psychiat. Ass.
   J., 1956, 1: 92-98.
 ---, ----, Dancey, T.  E.  Clinical investigation  of suv-
   ren—a  new  sedative preparation.  Canad.  M. Ass. J.,
   1957, 76: 933-937.
 ---, Ogle, W.   Psychodynamic aspects of reserpine: its
   uses and effects  in open psychiatric settings.   Canad.
   Psychiat. Ass. J., 1956, 1:11-17.
 ---,----.  Psychosis and enhanced anxiety  produced by
   reserpine and chlorpromazine.  Canad. 31. Ass. J., 1956,
   74: 526-532.
 ---, ----.  The use of reserpine in an open psychiatric
   setting.   Canad.  31. Ass. J., 1955, 73 :187-191.
 Saucet, D., see Despinoy, M., Saucet,  D.
 Saunders, J. C,  see Bruckman, N., Kitchener, M., Saun-
   ders, J. C, Kline, N.  S.
 ---, see Kline, N.  S.,  Saunders, J. C.
 Sauri, J. J.  El pendiomid (C. 9295) y el ampliactyl (R. P.
   4560) en la cura del suefio.  [Pendiomide (C. 9295) and
   chlorpromazine (4560 RP) in sleep therapy.]   Prensa
   mid. argent, 1955, 42 : 447-452.
 Savage, C.  The LSD psychosis as a transaction  between
   the psychiatrist and  patient.   In: Cholden, L., ed.  Ly-
   sergic acid diethylamide and  mescaline in experimental
   psychiatry.  New York, Grune  d Stratton, 1956.   p.
   35-43.
___   Lysergic acid diethylamide; a clinical-psychological
   study   Am. J. Psychiat, 1952,108: 896-900. Abstract:
   Excerpta med., Sect.  8, 1953, 6: No. 419.
___   The  resolution  and  subsequent  remobilization of
  resistance  by LSD in psychotherapy. J. Nerv. Ment.
  Dis., 1957, 125 : 434-437.
____   Variations in ego feeling induced by d-lysergic acid
  diethylamide  (LSD-25).   Psychoanal. Rev., 1955,  42:
   1-16.  Abstract: Excerpta med.,  Sect. 8, 1956,  9:  No.
   3007.
 ----, Cholden,  L.  Schizophrenia  and the  model  psy-
   choses.  J. Clin. Exp. Psychopath., 1956,  17: 405-413.
 ----, see Cholden, L. S., Kurland, A., Savage, C.
 Savchuk, V. I., see Kaminskii, S. D., Savchuk, V. I.
 Scarpalezos, S.  Le traitement  ambulatoire par la chlor-
   promazine des psychonevroses et  de  certaines manifes-
   tations epileptiques  (troubles caracteriels et myoclo-
   nies).  [Ambulatory treatment with  chlorpromazine in
   psychoneuroses and in some manifestations of epilepsy
   (character  disorders and myoclonias).]  Enciphale,
   1956, 45: 722-726.
 Schadelijke bijwerkingen van largactil.  [Untoward side
   effects  of  largactil.]  Ned. tschr. geneesk.,  1955,  99:
   2537-2538.
 Schaefer, D. L., see Kasak, M., Schaefer, D.  L., Winter, W.
 Schallek, W., Kuehn, A., Seppelin, D. K.  Central depres-
   sant  effects of  methyprylon.  J. Pharm. Exp.  Ther.,
   1956,118: 139-147.
 ----, Walz, D.  Effects of isoniazid  and iproniazid  on  the
   central nervous system of the dog.   Am. Rev. Tuberc,
   1954, 69: 261-266.
 Schauwecker, R., see Schnyder,  U. W., Schauwecker, R.
 Scherr, A.  Le largactil en psychiatrie  extra-hospitaliere.
   [Largactil in ambulatory psychiatry.]  Enciphale, 1956,
   45:388-391.
 ----, see Broussolle, P., Scherr, A.
 Scherrer, P.,  Leclerc, J., Bize,  N.  Un cas d'encephalite
   psychosique azotemique gueri par hibernation chez une
   cesarisee.   [A case  of uremic psychotic encephalitis
   after cesarean section cured by artificial hibernation.]
   Ann.  mid.  psychol, Par., 1953, 111 (1) : 519-523.
 Schick, G.,  Virks, J.  Agranulocytosis associated  with
   chlorpromazine therapy;  report of a case and review
   of the literature.  N. England J. M., 1956, 255 : 798-802.
 Schiele, B. C, Anderson, R. W., Simons, W.  Current status
   of chlorpromazine and reserpine in psychiatric practice.
   J. Lancet, 1956, 76:179-185.
 ---:, see Rotstein, J., Frick, P.  S., Schiele, B. C.
 Schipa, S.  Basi farmacologiche e farmacodinamiche delle
   cure neuroganglioplegiche.  [Pharmacologic  and phar-
   macodynamic  basis  of neuroganglioplegic   therapy.]
   Osp. psichiat, Nap., 1956, 24: 75-90.
 Schlan, L. S„ see McLaughlin, J. J.,  Schlan, L.  S.
 Schleifer, M. J., see Malamud, W., Barton, W. E., Fleming,
   A. M., Middleton, P.  McK., Friedman, T. T.,  Schleifer,
   M.J.
 Schlichther, W.,  Bristow, M. E., Schultz, S., Henderson,
   A. L.  Seizures occurring during intensive chlorproma-
   zine therapy.   Canad. M. Ass. J., 1956, 74: 364-366.
 ----, see Forster, W. Schlichther, W., Henderson, A. L.
 Schlittler, E., see Mtiller, J. M.,  Schlittler, E., Bein, H. J.
 ---, see Woodson, R. E., Youngken, H. W., Schlittler, E.,
   Schneider,  J. A.
 Schmidt, K. E.  Combined treatment with chlorpromazine
   and reserpine.   J. 3Ient. Sc, Lond., 1957, 103: 200-208.
 Schmidt, M., see Drassdo, A., Schmidt, M.
 Schmiterlow,  C.  G., Hedqvist, H.   Cetiproman, ett nytt
   preparat for psykiatriskt  bruk.   [Cetiproman, a new
  preparation for psychiatric use.]   Sven. lak. tidn,, 1955
  52: 2318-2326.
 Schmitt, R. J.  The psychodynamics of the tranquilizing
   agents. Psychiat. Q., 1957, 31:17-30.
 Schmitt, W.   Klinische  Prfifung einer neuen  Piperidin-
  verbindung  als Schlafmittel.   [Clinical trial of a new
  piperidine compound as soporific]   31ed. Klin., Berl,
   1955,  50:1223-1224.  Abstract: Excerpta med., Sect 8
   1956, 9 : No. 3610.
----, see Meyer, H. H.,  Schmitt, W.,  Kieser, J.
 Schmitz, B., see Abeiy, P., Abdouchelli, A.,  Fourment J
   Schmitz, B., Delteil, P.
 Schneider, G.  Les cures prolongees a la chlorpromazine.
   [Prolonged chlorpromazine therapy.]   Enciphale, 1956
   45:372-376.
245 
Schneider, G.
PSYCHOPHARMACA
----.   Les  indications de  divers  neuroleptiques et les
  resultats  obtenus  a la  clinique psychiatrique de  Lau-
  sanne.  [Indications for various  neuroleptic drugs and
  the results  obtained at the psychiatric clinic  of  Lau-
  sanne.]  Enciphale, 1956, 45 :1024-1030.
Schneider,  H. Erfahrungsbericht  fiber Rauwolfia-Alka-
  loid-Behandlung.   [Experiences with Rauwolfia alkaloid
  therapy.]   Nervenarzt,  1956, 27:72-75.  Abstract: Ex-
  cerpta med., Sect.  8, 1957, 10: No. 2088.
Schneider, J.  A.  Further characterization of central ef-
  fects of reserpine (serpasil).   Am.  J.  Physiol,  1955,
  181:64-68.  Abstract:  Chem.  Abstr., 1955, 49: 11187e.
---.  The  pharmacology of Rauwolfia.  In: Woodson,
  R. E., Youngken, H. W., Schlittler, E., Schneider,  J. A.
  Rauwolfia:  botany, pharmacognosy, chemistry & phar-
  macology.  Boston, Little, Brown d Company, 1957. p.
  109-143.
----.  Reserpine antagonism of morphine analgesia in
  mice.  Proc. Soc.  Exp.  Biol,  N. Y.,  1954, 87: 614-615.
  Abstract: Chem. Abstr., 1955, 49 : 4165ef.
---, Earl,  A. E.  Behavior and electroencephalographic
  studies with serpasil (reserpine) : a new alkaloid  from
  Rauwolfia serpentina.   [Abstract]  Fed. Proc, Bait,
  1954, 13:130.
---, ----.  Effects  of serpasil on behavior and autonomic
  regulating mechanisms.  Neurology,  1954, 4: 657-667.
----, Plummer, A. J., Earl, A. E.,  Barrett, W. E., Rinehart,
  R., Dibble, R. C.  Pharmacological studies  with deser-
  pidine, a new  alkaloid from Rauwolfia canescens. J.
  Pharm. Exp. Ther., 1955,114:10-13.
---, ----,  ----, Gaunt,  R.  Neuropharmacological as-
  pects  of  reserpine.  Ann.  N.  York  Acad. Sc,  1955,
  61:17-26. Abstract: Excerpta  med., Sect. 8,1956, 9: No.
  2480.
---, Sigg,  E. B.  Neuropharmacological studies  on ibo-
  gaine, an indole alkaloid with central-stimulant proper-
  ties.  Ann. N. York Acad. Sc, 1957, 66: 765-776.
---, see Plummer, A. J., Earl, A.,  Schneider, J. A., Trapold,
  J.,  Barrett,  W.
Schneider, R., see Szatmari, A.,  Hoffer, A. Schneider R.
Schnyder, U. W., Schauwecker, R.  Largactil und Serpasil
  in der Dermatologie. [Largactil and serpasil in derma-
  tology.]   [English  summary]    Dermatologica, Basel,
  1955, 111: 185-197.
Scholten, C. tiber besondere therapeutische Eigenschaften
  des  Antihistaminicums Atosil.   [Special  therapeutic
  qualities  of the antihistaminic  atosil.]  Med.  3Ischr.,
  1953, 7:552-554.
Schott, M. B.  Bases pharmaco-dynamiques et indications
  therapeutiques generales des neuropiegiques. [Pharma-
  codynamic bases and general therapeutic indications of
  neuroplegics.]  J.  mid. Lyon,  1954,  35:925-932.
Schroeder,  H. A., Perry, H. M., Jr.  Psychosis apparently
  produced by reserpine.  J. Am. 31.  Ass., 1955, 159: 839-
  840.  Abstract: Excerpta med., Sect. 8,1957,10: No. 1536.
  Year book of drug therapy, 1956-1957, p. 324-325.
Schrut, A. H.  Controlled study on clinical use of reserpine
  in psychotic patients with special comments on sources
  of error.  J. Nerv. Ment. Dis., 1955,  122: 513-517.  Ab-
  stract : Excerpta med., Sect. 8,1957, 10: No. 1533.
----, see Elliott, R.  N., Schrut, A. H., Marra,  J. J.
Schultz, J.  D. El uso de cloropromazina (thorazine) en
  los estados  alcoholicos agudos.  [Use of chlorpromazine
   (thorazine)  in acute  alcoholic states.]   Arch.   mid.
  Cuba, 1956, 7:18-20.
----, Rea, E. L., Fazekas, J. F., Shea, J. G.  Chlorproma-
  zine in the management of acute alcoholic states.   Q. J.
  Alcohol, 1955,  16:245-250.  Abstract:  Excerpta  med.,
  Sect. 8, 1956, 9: No. 2598.
----, see  Fazekas, J.  F.,  Schultz,  J. D., Sullivan, P. D.,
  Shea, J. G.
---, see Fazekas, J. F., Sullivan, P.  D., Schultz, J.  D.
Schultz, S., see Forster, W., Henderson, L., Schultz, S.
---, see Schlichther, W.,  Bristow, M. E., Schultz, S., Hend-
  erson, A. L.
Schumann, H. J., see Greff, K., Schumann, H. J.
Schut, J. W., Himwich, H. E.  The effect of meratran on
  twenty-five institutionalized mental patients.   Am. J.
  Psychiat, 1955, 111:837-840.
---, see Resch, J. A.,  Schut, J. W., Bernstein,  I. O.
Schwartz, L., see Sadove, M.  S., Levin, M. J., Rose, R. F.,
  Schwartz, L, Witt, F. W.
Schwartzbaum, J.  S.  Effects of  reserpine and chlorpro-
  mazine on nest building and thermal preference in rats.
  Proc. Soc. Exp.  Biol,  N.  Y.,  1955,  90:275-277.  Ab-
  stract :  Chem. Abstr., 1956, 50: 2853ab.
Schwarz,  B.  E.  Electroencephalographic studies of  ani-
  mals and human  beings under hypnosis.   40 p.  [Type-
  written]  Rochester, 1955.   (Thesis—Minnesota).
---, Bickford, R. G., Mulder, D. W., Rome, H. P.  Mesca-
  line and LSD-25 in  activation of temporal lobe epilepsy.
  Neurology, 1956, 6: 275-280.
---,___, Rome, H. P. Reversibility of induced psychosis
  with chlorpromazine.   Proc. Mayo Clin., 1955,  30:407-
  417.
---, Sem-Jacobsen, C.  W.,  Petersen, M. C.   Effects of
  mescaline, LSD-25,  and adrenochrome on  depth electro-
  grams in man.  A. M. A. Arch.  Neur. Psychiat, 1956,
  75' 579—587
---, Wakim, K. G, Bickford, R. G., Lichtenheld, F. R.
  Behavioral and  electroencephalographic  effects of  hal-
  lucinogenic drugs;  changes in cats on intraventricular
  injection.  A. M. A. Arch. Neur. Psychiat., 1956, 75: 83-
  90.   Abstract: Excerpta med., Sect. 8, 1957,  10: No.  328.
 Schweich, M., see Sivadon, P., Schweich, M., Begoin,  J.
 Schweitzer,  A.  Old  black magic  reborn.   In:  Garrett,
  E.  J., ed.  Beyond the five senses.  Philadelphia,  Lip-
  pincott, 1957.  p. 203-208.
 Scott, C.  C, see Chessin, M., Dubnick, B., Kramer, E. R.,
  Scott, C. C.
 Scott, P. A.  A controlled study of the effect of mephenesin
  on  psychiatric out-patients.  J. Ment. Sc, Lond., 1955,
  101:163-171.  Abstract: Excerpta med.,  Sect. 8, 1956,
  9:  No.  1716.
 ---, see Trethowan, W. H.,  Scott, P. A.
 Seabra-Dinis, J.  A  terapeutica  pelo sono  prolongado.
  [Prolonged sleep therapy.]  J. mid., Porto, 1954, 23:
  233-251.
 Seager, C. P.   Chlorpromazine in  treatment of elderly
  psychotic  women.  Brit  M. J.,  1955, 1: 882-885.  Ab-
  stract : Excerpta med., Sect. 8, 1956, 9 : No. 1727.
 ---, Leitch, A. Benactyzine in  psychoneurosis;  a  con-
  trolled clinical trial  in hospital patients.  Brit. M. J.,
  1956, 2:1407-1409.
 ---,  see Hare, E.  H, Seager, C. P., Leitch, A.
 Sears, H. T. N, see Piatt, R., Sears, H. T.  N.
 Sebrell, W. H., Jr.  Chemistry in chronic disease  research.
   Chem.  Eng. News, 1955, 33:1856-1860.
 Seemann, D.  Erfahrungen  fiber Reserpinbehandlung in
   der Geriatrie.  [Reserpine in  geriatrics.]   Wien.  med.
   Wschr., 1956, 106 : 930.
 Segal, L. J., Tansley, A. E.  A clinical trial with  hydroxy-
  zine (atarax) on a group of maladjusted educationally
  subnormal children.  J.  Ment.  Sc,  Lond., 1957,  103:
  677-681.
 Segal, M., Attinger, E. O. The use of reserpine  as an ad-
   junct in the management of patients with chronic bron-
   chial  asthma  and  chronic   pulmonary  emphysema:
   preliminary studies.   Ann. N. York Acad. Sc,  1955, 61:
   267-275.
 Segerath,  F.  Uber  Erfahrungen  mit  der  Megaphenbe-
   handlung in  der Psychiatrie.   [Experience with mega-
   phen treatment in psychiatry.]  31iinch. med. Wschr.,
   1954, 96: 260-261.
 Seggiaro, J. A., see Bringas Nunez, E., Seggiaro, J. A.,
   Machado, M. R.
 Seguin, A., Castro de la Mata, R.   Chlorpromazine in neu-
   ropsychiatry.  J. Am. M.  Ass., 1954, 156: 558.
246 
AUTHOR  LIST
Sherwood, S. L.
Seifter,  J. see Begany,  A. J., Seifter, J.,  Pless, H.  H.,
  Huber, R.  D., Bruce, W. F.
---, see Hosko, M. J., Gore, E. M., Tislow,  R., Seifter, J.
Seitz,  D.  Die Schlafbehandlung mit Phenothiazinen  in
  der Neurologie.   [Sleep therapy with phenothiazines in
  neurology.]  Nervenarzt, 1956, 27:19-23.
Selbach,  C,  Selbach,   H.  Phenothiazinwirkung   und
  somato-psychische  Dynamik.   [Phenothiazine  action
  and  psychosomatic dynamics.]  Nervenarzt,  1956, 27:
  145-149.
Selbach, H. see Selbach, C, Selbach, H.
Selikoff, I. J., Robitzek, E. H., Ornstein, G. G. Treatment
  of pulmonary tuberculosis with hydrazide derivatives
  of isonicotinic acid.  J. Am. M. Ass., 1952, 150: 973-980.
---,  ----, ----.  Withdrawal  symptoms  upon  discon-
  tinuance of iproniazid and isoniazid therapy.  Am. Rev.
  Tuberc, 1953, 67: 212-216.
Sellers, A. M., Hafkenschiel, J. H.  Sedative and antihy-
  pertensive  effect of intravenous reserpine  in man.  [Ab-
  stract]   Fed. Proc, Ball, 1954, 13: 404.
---,  ---.   Studies  of intravenous reserpine  in  man.
  [Abstract]   Am. J. 31. Sc, 1954, 228: 114.
---,  see Hafkenschiel, J.  H., Sellers, A. M.,  King, G. A.,
  Thorner, M. W.
Selling, L. S. A clinical study of miltown, a new  tran-
  quilizing agent.  J. Clin. Exp. Psychopath., 1956, 17: 7-
  14.  Abstract: Excerpta med., Sect. 8, 1957, 10: No. 391.
---.   Clinical study of a new tranquilizing drug; use of
  miltown (2-methyl-2-n-propyl-l,3-propanediol  dicarba-
  mate).  J.   Am.  M.  Ass.,  1955,   157:1594-1596.   Ab-
  stract: Excerpta med., Sect. 8, 1956, 9:  No. 1719.
---.   Findings  in patients suffering from  anxiety states
  treated with a  muscle relaxant.   South. M.  J.,  1953,
  46:1204-1210.
Selzer, S., see Sapir, M., Stroun, J., Hepner,  L., Reverchon,
  J., Selzer,  S.
Sem-Jacobsen, C.  W.,  see  Schwarz,  B. E.,  Sem-Jacobsen,
  C. W., Petersen, M.  C.
Sendra, L., see Sarrouy, C, Saint-Jean, Sendra, L., Saba-
  tini, R.
Seneca, H. Hydroxyzine (atarax) as a therapeutic agent.
  Antibiotic 31., 1957, 4: 25-30.
Senseman, L. A.  Tranquilizing  drugs; uses and abuses
  for  the nervous patient.  Rhode  Island M.  J.,  1956,
  39:675-677; 680; 686.
Seppelin, D.  K., see Schallek, W.,  Kuehn, A., Seppelin,
  D. K.
Sercl, M., Bartousek, V., Jachova, D.  Experiences clini-
  ques  sur la neuroplegique  et l'hibernation dans  les
  affections du  systeme nerveux.   [Clinical experiences
  with  neuroplegia  and hibernation in  diseases of  the
  nervous  system.]  Gaz. mid.  France, 1956,  63:1981-
  1982; 1984; 1987-1988.
Sereiskii, M.  IA., Tolmaskaia, E.  S., Golodets, R. G., Sam-
  ter, N. F.  Lechenie bol'nykh shizofreniei aminazinom.
  [Treatment of  schizophrenia  with aminazine.]    Zh.
  nevropat. psikhiat., Moskva, 1956,  56:155-161.
Sergio, C.  see Alema, G., Sergio, C.
Serotonin. J. Am. M.  Ass., 1956, 161: 460-461.
Serra,  C, Severgini, B.  Ricerche elettroencefalografiche
  sopra un nuovo simpaticolitico di  sintesi.  [Electroen-
  cephalographic studies of a new  synthetic sympatho-
  lytic]   Riv. neur., Nap., 1953,  23: 494-504.
Settel, E.  Chlorpromazine in  the home treatment of the
  agitated senile patient.  GP, 1956, 14 (5) : 97-100.
___  Chlorpromazine in the treatment of senile agitation.
  GP   1955  12  (6) : 74-76.  Abstract:  Excerpta  med.,
  Sect. 8, 1956, 9:  No. 3612.
Severgini, B., see Serra, C, Severgini, B.
Severing, J.,  see Cares, R. M., Asrican, E., Fenichel, M.,
  Sack, P., Severing, J.
Severinghaus, E. L., see Davis, W. A., Severinghaus, E. L.
Sevinsky, B.,  see Kaminsky, A., Sevinsky, B., Kaplan, A.
Seyffert, H. M., Strubel, H.  Klinische Erfahrungen mit
  dem Schlafmittel und Tagessedativum Doroma.  [Clin-
  ical  experience with  doroma, a  hypnotic  and diurnal
  sedative.]  Medizinische, 1956, 2:997-999.
Shagass, C. Effects of intravenous chlorpromazine on the
  electroencephalogram.   Electroencephalography,  31ont-
  trcal, 1955,  7:306-308.   Abstract:  Chem. Abstr.,  1956,
  50:  1184e.  Excerpta med., Sect. 8, 1956, 9: No. 40.
Shalowitz, M.  Hydroxyzine: a new therapeutic agent for
  senile anxiety states;  a preliminary report.  Geriatrics,
  1956, 11:312-315.  Abstract: Excerpta med., Sect.  8,
  1957, 10: No. 1417.
Shane,  A. M.,  Hirsch, S.  Three  cases  of meprobamate
  poisoning.  Canad. 31. Ass. J., 1956, 74: 908-909.
Shankel, L. W., Whittier, J. R.  Effects of reserpine therapy
  on Funkenstein test reactions in  maladapting patients.
  Dis. Nerv. Syst, 1956,  17 : 258-261.
Shanklin, J. G., see Dickel, H. A., Dixon, H. H., Wood, J.,
  Shanklin, J. G.
Shanon, J., Kaplan, S. M., Pierce, C. M., Ross, W. D. An
  interesting  reaction to a  tranquilizer: tonic seizures
  with perphenazine  (trilafon).  Am. J. Psychiat.,  1957,
  114: 556.
Shapiro, J. Serpasil—its use as a sedative in certain dis-
  turbed mental patients.  J. Oklahoma  M. Ass.,  1955,
  48:171-173.  Abstract: Excerpta med., Sect. 8,1956, 9:
  No. 1731.
Shatin, L., Rockmore, L., Funk, I. C.  Response of psychi-
  atric patients to massive doses  of  thorazine.  II. Psy-
  chological  test  performance and  comparative  drug
  evaluation.   Psychiat. Q., 1956, 30: 402-416.
---•,  see Rockmore, L., Shatin, L.,  Funk, I. C.
Shaw, E. (N.), Woolley, D. W.  Methylserotonins as potent
  antimetabolites of serotonin active  both in vitro and in
  vivo.  J. Pharm. Exp. Ther., 1956, 116:164-176.
---,----.  Pharmacological properties of some antimeta-
  bolites of serotonin having unusually high activity on
  isolated tissues.  J. Pharm. Exp. Ther., 1954, 111: 43-
  53.
----,  ----. Yohimbine and ergot alkaloids  as  naturally
  occurring antimetabolites of serotonin.   J. Biol Chem,,
  1953, 203: 97!>-9S9.
---,  see Woolley, D. W., Shaw, E.  (N.)
Shea,  J.  G,  Alman,  R.  W.,  Fazekas, J. F.  The use of
  chlorpromazine in the management of patients with head
  injury.  A. M. A. Arch. Int. 31., 1955, 96:168-171.  Ab-
  stract :  Year book of drug therapy, 1956-1957, p.  341.
----, Ehrmantraut, W. R., Ticktin, H. E.,  Sullivan, P. D.,
  Jr., Fazekas, J. F.  Use of promazine in the management
  of medical emergencies. Mil. 31., 1956,  119: 221-227.
----, see Albert, S. N., Rea, E. L., Duverney, C. A.,  Shea,
  J., Fazekas, J. F.
---, see Fazekas,  J. F., Schultz, J. D., Sullivan,  P.  D.,
  Shea, J. G.
---, see Fazekas, J.  F., Shea, J. G., Ehrmantraut, W. R.,
  Alman, R. W.
----, see Fazekas, J.  F., Shea, J.  [G.], Rea, E.
---, see Fazekas, J.  F., Shea, J. G., Sullivan, P. D., Jr.
----, see Rea, E. L., Shea, J., Fazekas, J. F.
---, see Schultz, J. D., Rea, E. L., Fazekas, J. F.,  Shea,
  J.G.
Sheatz, G. C.  Studies  on chlorpromazine in decerebrate
  dogs and patients with irreversible  brain damage.  [Ab-
  stract]  J. Pharm. Exp. Ther., 1955, 113 : 47-48.
Sheets, J. A., Jr., see Ferguson, J. T., Linn, F. V., Sheets,
  J. A., Jr., Nickels, M. M.
Shepherd, M., Watt, D. C.  A controlled clinical study of
  chlorpromazine and reserpine in chronic schizophrenia
  J. Neur., Lond., 1956, 19 : 232-235.
----, see Davies, D. L., Shepherd, M.
Sherwood, S. L.  Effects of drugs on the behavior of ani-
  mals and on psychoses of  man.  In: Abramson, H. A.,
  ed.  Neuropharmacology.  Transactions of the  second
  conference,  May  1955,  Princeton, N.  J.  New  York,
  Josiah Macy, Jr., Foundation, 1956.  p. 85-182. 
Sherwood, S.  L.
PSYCHOPHARMACA
----.   The response of psychotic patients to intraventri-
  cular injections.  Proc R. Soc M., Lond., 1955, 48: 855-
  863.
----,  see Feldberg, W., Sherwood, S.  L.
Sherwood, W.  K.  Experience with "BGE",  a naturally
  occurring indole compound.  J. Nerv. Ment. Dis., 1957,
  125: 490-491.
Sheth, S., Khairnar, D. B.  Study of reserpine in mental
  diseases.  Ind. Practitioner, Bombay, 1956,  9: 259-269.
  Abstract: Excerpta med., Sect. 8, 1957, 10: No. 1530.
----,----.  Use  of  reserpine  in  mental diseases.  Ind.
  Practitioner, Bombay, 1955, 8: 893-903.  Abstract:  Ex-
  cerpta med.,  Sect. 8, 1956, 9: No. 2244.
Shipley,  T. E.,  see Burdine, W. E., Shipley, T. E., Papas,
  T. A.
Shore, P. A., Carlsson, A., Brodie, B. B.  Mechanism  of
  serotonin-release by reserpine.  [Abstract].  Fed. Proc,
  Bait., 1956, 15: 483.
---,  Silver, S.  L., Brodie, B. B. Interaction of reserpine,
  serotonin,  and  lysergic  acid  diethylamide  in  brain.
  Science, 1955, 122: 284-285.
----,----,----.  Interaction  of serotonin and lysergic
  acid diethylamide (LSD) in the central nervous system.
  Experientia,  Basel, 1955,11: 272-273.
----,  see Brodie, B. B., Olin, J. S., Kuntzman, R. G., Shore,
  P. A.
----,  see Brodie, B. B., Pletscher, A., Shore, P. A.
---,  see Brodie, B. B., Shore, P. A., Silver,  S. L.
---,  see Hess,  S. M., Shore, P. A., Brodie, B. B.
----,  see Pletscher, A., Shore, P. A., Brodie, B. B.
Shorvon, H. J.  Drug therapy in psychiatry.  Practitioner,
  Lond., 1955, 175:161-169.
Shubin, H., Heiken, C. A., Glaskin, A., Pennes, E., Arsenian,
  J.  Chlorpromazine as an adjunct in managing tubercu-
  lous patients.  Internat. Rec 31., 1957, 170: 369-373.
Shulman, L., Ginsburg, M. A preliminary review  of the
  uses of chlorpromazine  in psychiatric diseases.  S. Afr.
  M.  J.,  1956, 30: 815-818.
Shuman, J.  Paralysis agitans developing during reserpine
  therapy.  J.  Am. M. Ass., 1955,  158:73.
Shumilina, A.  I.   [The character of conditioned reflex
  activity of dogs following the administration of amina-
  zine.]  Zh. nevropat. psikhiat., Moskva,  1956, 56:116-
  120. Abstract: Chem. Abstr., 1956, 50:17175bi.
Sibilio, J. P., Andrew, G., Dart, D., Moore, K. B., Stehman,
  V. A.  Treatment of chronic schizophrenia with proma-
  zine hydrochloride. A. 31. A. Arch. Neur. Psychiat, 1957,
  78: 419-424.
Sidman,  M.  Drug-behavior interaction.   Ann. N.  York
  Acad. Sc, 1956, 65: 282-302.
Siemon, G., see Klose, G.,  Siemon, G.
Sigg,  B.,  see Follin, S., Sigg, B., Pivet, S., Girard, C.
Sigg,  E.  B.,  see Schneider, J. A., Sigg, E. B.
Siguier, F., Giabicani, A., Betourne, G, Goglin, G.  Le ser-
  pasil dans les deiires alcooliques.  [Serpasil in alcoholic
  delirium.]  Bull Soc mid.  hdp.  Paris, 1956, 72:605-
  607.  Abstract: Excerpta med.,  Sect. 8,  1957, 10: No.
  1976.
Sigwald, J.  La cure ambulatoire par la chlorpromazine.
  [Ambulatory therapy with chlorpromazine.]  Enciphale,
  1956, 45: 392-400.
----.   Les indications du traitement de diverses affections
  neuropsychiatriques par la chloropromazine; utilisation
  pratique des proprietes neuropiegiques  et psychopieg-
  iques de ce corps, posologie.  [Indications for chlorpro-
  mazine therapy of neuropsychiatric disorders ; practical
  use of  its neuroplegic and psychopiegie properties; dos-
  age.]  Bull mid., Par., 1953, 67: 319-322.
---,  Bouttier,  D. Le chlorhydrate de chloro-3 (dimethyl-
  amino-3'-propyl)-10-phenothiazine en pratique  neuro-
  psychiatrique courante.  [3-Chloro-10-(3'-dimethylam-
  inopropyl)-phenothiazine  hydrochloride   in   current
  neuropsychiatry.]  Ann.  mid., Par., 1953,  54:150-182.
----,----.  L'utilisation des proprietes neuropiegiques  du
  chlorhydrate   de  chloro-3- (dimethylamino-3'-propyl) -
  10-phenothiazine en therapeutique  neuro-psychiatrique.
  [Utilization of the neuroplegic properties  of chloro-3-
  (dimethylamino-3-propyl) -10-phenothiazine   hydrochlo-
  ride in  neuropsychiatric therapy.]   Presse mid., 1953,
  61:607-609.                                .    .   ...
.________, Nicolas-Charles P. Ambulatory treatment with
  chlorpromazine.   J.  Clin.  Exp.  Psychopath.,  1956,
  17' 57—69.
---, Henne,  M.  L'utilisation  des  proprietes neuropiegi-
  ques de la  chlorpromazine dans le traitement de divers
  cas de  psychoses  deiirantes  chroniques et subaigues.
  [Utilization of the neuroplegic properties  of chlorpro-
  mazine in the treatment of various  cases of chronic and
  subacute delusional psychosis.]   Sem. hop. Paris, 1954,
  30: 2978-2984.  Abstract: Excerpta med., Sect. 8, 1955,
  8 : No. 3641.                                    .
---,----, Bouttier,   D.,  Raymondeaud,  C,  Quetin, A.
  Activite d'une nouvelle phenothiazine en psychiatrie et
  en  neurologie; proprietes therapeutiques  du  maleate
  acide de  levo  methoxy-3(dimethylamino-3'  methyl-2'
  propyl) 10 phenothiazine (7044 RP).  [Activity of a new
  phenothiazine in psychiatry and neurology; therapeutic
  properties  of  10- (3-dimethylamino-2-methyl-propyl) -3-
  methoxyphenothiazine.]   Presse mid., 1956, 64:2011-
  2014.
---, see Leroy, C, Sigwald, J.
Sikes, Z. S.   Korsakoff and  Wernicke syndromes: history
  and treatment. J. Nerv. Ment Dis., 1956, 123: 448-451.
Silva, L. M. da, Zusman, W., Portella Nunes, E.  Tecnicas
  de  sono prolongado em psiquiatria.   [Prolonged sleep
  technics in psychiatry.]   [English summary]   Hospi-
  tal, Rio, 1954, 46: 355-367.
Silver, A. A.  Management of children with schizophrenia.
  Am. J. Psychother., 1955, 9 : 196-215.
Silver, H., see Gottschalk, L. A., Kapp, F. T., Ross, W. D.,
  Kaplan, S. M.,  Silver, H., MacLeod, J.  A., Kahn, J. B.,
  Jr., Van Maanen, E. F., Acheson, G. H.
Silver, S. L.,  see Brodie, B. B., Shore, P. A., Silver, S. L.
---, see Shore, P. A., Silver, S. L., Brodie,  B. B.
Silverberg, J. W., Gralnick, A.  Possible synergistic action
  of chlorpromazine, reserpine and frenquel.  A prelim-
  inary report.  Am.  J. Psychiat., 1957, 114:173.
Silverman, M. The  clinical response of psychoneurotics
  to chlorpromazine.  J. Ment Sc, Lond., 1955, 101: 640-
  643. Abstract: Excerpta med., Sect. 8,1956, 9 : No. 4985.
Silverstein, B. S., see Reinhart,  M. J., Silverstein, B. S.,
  Cross, T.  N.
Simko, A., Erzsebet, B. S.  Das Reserpin  (Sedaraupin) in
  der psychiatrischen  Praxis; geschichtliche  Ubersicht
  und Erfahrungen aus der ambulanten  Praxis.  [Reser-
  pine (sedaraupin)  in psychiatry; historical review and
  experiences in ambulatory patients.]   Psychiat. Neur.
  med. Psychol, Lpz., 1956, 8 :134-143.
---, Stiaszny, E.  Psychiatriai betegek reserpin kezeiese.
  [Reserpine therapy of  psychiatric   patients.]  Ideg.
  szemle, 1956, 9: 53-59.
Simon, A., see Margolis, L. H., Fischer, A., Butler, R. N.,
  Simon,  A.
Simon, W., see Schiele, B. C, Anderson, R. W.,  Simon, W.
Simonetti, L. I neuroplegici nel trattamento delle psicosi
  confusionali acute.  [Neuroplegic drugs in the treatment
  of  acute confusional psychoses.]  [English  summary]
  Neuropsichiatria,  1954,  10: 265-275.   Abstract:  Ex-
  cerpta med., Sect.  8, 1955, 8: No. 3640.
Simpson, R.  W.  The effects of pacatal on chronic mental
  illness.  J. Ment. Sc, Lond., 1957, 103: 610-613.
---, see Hewat,  J. K., Leach, P. W., Simpson, R. W.
Sinha, G. B., Mitra, S. K.  A case of acute chlorpromazine
  hydrochloride poisoning.  J. Ind. M. Ass., 1955, 24: 557-
  558.
Sinsi, C, Vizioli, R.  Chlorpromazina e reserpina in tera-
  pia psichiatrica.   [Chlorpromazine  and  reserpine  in
  psychiatric therapy.]  [English summary]   Osp.  psi-
  chiat, Nap., 1955, 23 : 83-96.
248 
AUTHOR LIST
Sommerness, M. D.
 Sivadon, P., Forzy, C.  Etude critique de 150 cas de cure
   de sommeil.  [Critical study of sleep therapy; 150 ob-
   servations.]   Ann. mid. psychol, Par., 1955, 113 (1) :
   433^38.
 ---, Koechlin, P., Markich, H.  Trois observations de cure
   de sommeil &  Taide du 4560 R. P.  [Three cases of sleep
   therapy with  4560 RP.]  Ann. mid. psychol, Par., 1953,
   111(1) : 204-207.
 ---, Schweich, M.,  Begoin, J. Chlorpromazine  et  ac-
   tivites ergotherapiques.  [Chlorpromazine and occupa-
   tional therapy.]  Enciphale, 1956, 45 : 449-455.
 Sizaret, P.  La  chlorpromazine dans les psychoses  aigues
   alcooliques.   [Chlorpromazine in acute alcoholic  psy-
   choses.]  Ence'phale, 1956, 45 : 736-738.
 ---,  Salomon,  F.  Action  d'un  neuroplegique  sym-
   pathicolytique dans les etats confusionnels alcooliques.
   [Action of a neuroplegic sympatholytic drug in alcoholic
   confusions.]   Ann. mid. psychol, Par., 1953, 111 (1) :
   88-92.
 Skaarup, Y. see Jacobsen, E., Skaarup, Y.
 Skinhoj, K., see Jacobsen, E., Kehlet, H., Larsen, V.,  Munk-
   vad, I., Skinhoj, K.
 Sklarofsky,  B., see Abramson,  H.  A.,  Sklarofsky,  B.,
   Baron, M. O.,  Gettner, H. H.
 Skliarenko, E.  A. O primenenii aminazina v psikhiat-
   richeskoi praktike; pradvaritel'noe soobshchenie.   [Use
   of aminazine  in psychiatric practice; preliminary com-
   munication.]  Zh.  nevropat.  psikhiat.,  Moskva, 1956,
   56:166-171.
 Skobba, J.  S.   Drugs in the management of  emotional
   conditions.  J. 31. Ass. Georgia,  1956, 45:397-399.
 Slater, I. H., Jones, G. T., Young, W. K.  Mode of  action
   of phenaglycodol, a  new  neurosedative  agent.  Proc
   Soc Exp. Biol, N. Y., 1956, 93: 528-531.
 ---, Rathbun,  R. C, Henderson, F. G., Neuss, N.  Phar-
   macological properties of  recanescine, a new sedative
   alkaloid from Rauwolfia  canescens  Linn.  Proc.  Soc.
   Exp. Biol, N. Y., 1955, 88: 293-295.
 ---, see Dressel, P. E., Slater, I. H.
 Slater,  P. E., Morimoto, K., Hyde,  R.  W.  The effect of
   group administration upon symptom formation  under
   LSD.  J.  Nerv. 3Ient Dis., 1957,  125: 312-315.
 Sloane, B., Lovett Doust, J. W.  Psychophysiological in-
   vestigations in experimental psychoses; results  of  the
   exhibition of d-lysergic acid diethylamide to psychiatric
   patients.  J. Ment. Sc, Lond., 1954, 100:129-144.  Ab-
   stract : Excerpta med., Sect. 8, 1955, 8: No. 843.
 Smarr, E. R., see Rashkis, H. A., Smarr, E. R.
 Smigel,  J. O. Mood therapy in the aged.   Med. Times,
   Great Neck, 1957, 85 :149-158.
 Smirk, F. H., McQueen,  E. G.  Comparison of rescinna-
   mine  and  reserpine as hypotensive agents. Lancet,
   Lond., 1955, 2 :115-116.
 ---, see Doyle, A. E., Smirk, F. H.
 Smith, Kline & French  Laboratories.   Thorazine  refer-
   ence manual:  2d ed.  80 p.  Philadelphia, 1956.
 ---. Chlorpromazine and mental health.  200 p.   [Sym-
   posium held  under the auspices  of Smith, Kline &
   French Laboratories in Philadelphia, Pa., June 1955]
   Philadelphia,  Lea d Febiger, 1955.   [Articles  within
   the scope  of this bibliography are listed individually]
 Smith, A. H., Jr., see Everett,  G.  M.,  Toman, J.  E.  P.,
   Smith, A. H., Jr.
 Smith, D. A., see Jackson, G. L., Smith, D. A.
 Smith F. H., Jr., see Harned, B. K., Cunningham, R. W.,
   Clark  M C, Hine, C. H, Kane, M. M., Smith, F. H., Jr.,
   Vessey R. E.,  Yuda, N. N., Zabransky, F. W.
 Smith, j. A.  The use of the isopropyl derivative of iso-
  nicotinylhydrazine   (marsilid)  in the treatment  of
  mental disease;  a  preliminary  report.   Am. Practi-
  tioner, 1953, 4: 519-520.
___ Rutherford, A., Fanning, R. A comparison of phena-
  fflvcodol (ultran), meprobamate  and placebo in  absti-
  nent alcoholics.  Am. J. Psychiat, 1957, 114:364-365.
     „„,,  n.ar-ov "R . Weber. M., Smith, J. A.
Smith, K., Moody, A. C.  Schizophrenia and the  Siamese
  fighting fish.  Dis. Nerv. Syst., 1956, 17: 327-328.
Smith, L.  H.  Progress  in psychiatry.  J.  Am. 31.  Ass.,
  1955,  158:46-47
Smith, R.  The CNS action of d-lysergic acid diethylamide
  LSD-25).  Mod. Hosp., 1953,  80 (1) : 106-110.
Smith, R.  P., Wagman,  A. I., Riopelle, A. J.  Effects of
  reserpine on conditioned avoidance behavior in normal
  and brain-operated  monkeys.  J. Pharm. Exp. Ther.,
  1956,   117:136-141.    Abstract:  Chem.  Abstr.,  1956,
  50:13278d.
Smith, S. K.  The use of reserpine in private psychiatric
  practice.   Ann.  N.  York Acad.  Sc, 1955, 61:206-210.
  Abstract: Excerpta med., Sect. 8, 1956, 9: No. 1227.
Smyth, V. O., see Haq, S. M., Smyth, V. O.
Smythies, J. [R.], see Hoffer, A., Osmond, H, Smythies, J.
---, see Osmond, H., Smythies, J.
---, see Peretz, D.  I.,  Smythies, J. R., Gibson, W.  C.
Societe parisienne d'expansion chimique.  Largactil, 4560
  R.  P.  Bibliographie.  182  p.  Paris,  Specia [Labora-
  toires Rhone-Poulenc] 1955.
---. Largactil, 4560 R. P. Information medicale.  Paris,
  Specia [Laboratoires Rhone-Poulenc]  1954-1956.
Soderberg,  G., see Mecham,  M. J., Stromsta, C,  Soder-
  berg, G.
Soderberg, IL, see Ingvar, D.  H, Soderberg, U.
Sogliani, G.  Ipnoterapia con  cloropromazina e Rauwolfia;
  posologia, associazioni,  confronti.  [Sleep  therapy with
  chlorpromazine and  Rauwolfia; posology,  combinations
  and comparisons.]  3Iinerva med., Tor., 1955, 46:1253-
  1259.
Sokoloff, O. J.  Meprobamate  (miltown)  as  adjunct  in
  treatment of anogenital pruritus.  A. M. A. Arch. Derm.,
  1956, 74:393-396.
Solerio, L.,  see Ciocatto, E.,  Cattaneo, A.  D.,  Solerio, L.,
  Bianchetti, L.
Sollero, L., see Salmoiraghi, G. C, Sollero, L., Page, I. H.
Sollgruber, A.  Erfahrungen fiber die Phenothiazin-Schlaf-
  therapie in der  internen Medizin.  [Experiences with
  phenothiazine sleep  therapy  in  internal  medicine.]
  Wien. med. Wschr.,  1955, 105: 807-808.
Solms, H.  Chemische  Struktur und Psychose bei  Lyserg-
  saure-Derivaten.  [Chemical structure of and psychosis
  produced  by lysergic acid  derivatives.]   Praxis, Bern,
  1956, 45: 746-749.
---.  Lysergsaure-athylamid (LAE), ein  neues, stark
  sedativ wirkendes Psychoticum aus dem Mutterkorn.
  [Lysergic acid ethylamide (LAE), a new strongly seda-
  tive psychotomimetic   drug  from  Mother  of  Rye.]
  Schweiz. med. Wschr.,  1953, 83: 356-360.
---.  Lysergsaure-monoathylamid (LAE), ein neuartiges
  Psychotikum mit sedativer Wirkung aus  dem Mutter-
  korn.   [Lysergic  acid  monoethylamide  (LAE), a  new
  psychotomimetic drug with sedative effect from Mother
  of Rye.]   Schweiz. Arch. Neur. Psychiat, 1954, 73: 440-
  444.
---.  Relationships between chemical structure and psy-
  choses  with the use  of psychotoxic  substances.   "Com-
  parative  pharmacopsychiatric analysis:"  A new re-
  search   method.   J.  Clin. Exp. Psychopath.,  1956,
  17: 429^33.
Solms, W.,  see Arnold, O. H, Hift, S., Solms, W.
Solomon, H. C, see DeShon,  H. J., Rinkel, M., Solomon,
  H. C.
---, see  Rinkel, M., DeShon,  H. J., Hyde, R. W., Solomon,
  H. C.
---, see  Rinkel, M., Hyde, R. W.,  Solomon,  H. C.
---, see Rinkel, M., Hyde, R. W., Solomon, H. C, Hoag-
  land, H.
---,  see Rinkel, M., Solomon, H. C.
Sommerness, M. D., Lucero, R. J., Hamlon, J. S., Erickson,
  J. L., Matthews, R.   A controlled study of reserpine on
  chronically disturbed patients.  A.  M. A. Arch. Neur.
  Psychiat, 1955, 74 : 316-319. Abstract:  Excerpta med.,
  Sect. 8,1956, 9: No. 3607. 
Sommerness, M. D.
PSYCHOPHARMACA
---,  Lucero, R. J.,  Hamlon, J.  S.,  Mahowald,  A. M.
  Chlorpromazine:  a  controlled study with  highly dis-
  turbed patients. Dis. Nerv. Syst., 1957,18:16-20.
Sonne, E., see Holten, C. H., Sonne, E.
----,   see Jacobsen, E., Sonne, E.
Sottong, P. C.  The use and abuse of the tranquilizing
  drugs.  J.  Tennessee M.  Ass., 1956, 49 : 413-418.
Soubrie, R. see Oules,  J., Salles, P., Soubrie, R.
Soubrier, P.,  see Follin, S.,  Soubrier, P.
Souder, C. L. Thorazine in surgical-psychiatric emergen-
  cies.  Delaware M. J., 1955, 27 :191-193.
Soulairac, A., Soulairac, M.  L. Etude experimentale  de
  Taction  de la chlorpromazine sur  le comportement
  alimentaire et Tactivite spontanee du rat.  [Experi-
  mental study of te effect of chlorpromazine on the feed-
  ing behavior  and spontaneous  activity of  rats.] En-
  ciphale, 1956, 45: 927-931.
Soulairac, M. L., see Soulairac, A., Soulairac,  M. L.
Soulayrol, R., see Cremieux, A., Alliez, J., Soulayrol, R.
Spagno, A., see Tenenblatt, S.  S., Spagno, A.
Specia, see Societe  parisienne d'expansion chimique.
Spellman, S., see Bloch, R. G., Dooneief, A. S., Buchberg,
  A. S., Spellman, S.
Spencer, A.  M., see   Sandison, R.  A.,  Spencer,  A. M.,
  Whitelaw, J. D.
Spencer, R.  S.  The use of ataraxic drugs in mental  ill-
  ness.  Hawaii 31. J., 1957,16 : 302.
Sperling, E., see Bartsch, W.,  Sperling, E.
Spielmann, J.  P., see Maurel,  H,  Wilhelm,  Spielmann,
  J. P.
Spinka,  I. E.  Thorazine in  the treatment of mental  ill-
  ness  in  a state hospital.   Illinois M. J.,  1956, 109:
  126-128.  Condensed:  Am. Practitioner, 1956, 7:1433.
Spitz, H., see Sternberg, U., Spitz, H., Goyne,  J. B.
 Spratt,  R.  J.,  Dean, E.  F.  Unsuccessful suicide with
   chlorpromazine.  Rocky    Mountain   M.   J.,   1957,
  54:153-154.
Spreng, R. W. E.  Tolserol in acute alcoholism.  J. Nerv.
  Ment Dis.,  1953,  118:545-551.   Abstract:  Excerpta
   med., Sect. 8,1955, 8 : No. 4384.
 Sproles, J. A.,  see Cowden, R. C, Zax, M., Sproles, J. A.
 Sprowls, J.  B.  Drugs  for   a  changing world.  Am.  J.
  Pharm., 1955, 127: 42-52.
 Spurr, C, see Moyer, J. H,  Kent,  B., Morris, G., Dizon,
   M., Rogers, S., Spurr, C.
 Srnec, J., see Roubicek, J.,  Srnec, J.
 Staehelin, J. E.  Einige allgemeine Bemerkungen fiber die
   Largactiltherapie in der psychiatrischen Universitats-
   klinik Basel.  [General comments on largactil therapy
   at  the Basel University psychiatric clinic]  Schweiz.
   Arch. Neur.  Psychiat., 1954,  73:288-291.  Abstract:
   Excerpta med., Sect. 8, 1955, 8: No. 1787.
 ---, Kielholz,  P.  Largactil,  ein  neues   vegetatives
   Dampfungsmittel  bei  psychischen  Storungen.   [Lar-
   gactil, a new autonomic inhibitor in mental disorders.]
   Schweiz.  med. Wschr.,  1953,  83:581-586.  Abstract:
   Excerpta med., Sect. 8,1954, 7 :  No. 1601.
 ---, Labhardt, F.  Les resultats atteints par les neuro-
   piegiques  dans  le  traitement des  psychoses  et  des
   nevroses.  [Results in the treatment of psychoses and
   neuroses  with neuroplegic drugs.]  Enciphale, 1956,
   45: 511-517.
 Stafford-Clark, D., see Rolls, E. J., Stafford-Clark, D.
 Stangl, E.  Klinische Erfahrungen fiber die  muskeldy-
   namische  Wirkung des Adrenoxyls  (Monosemikarba-
   zonderivat des Adrenochroms.)  [Clinical  experiences
   with  the  muscle dynamic effect  of adrenoxyl  (mono-
   semicarbazone derivative  of  adrenochrome.) ]  Ther.
   Umschau, Bern,  1953, 10 : 65-66.
 Stanley, A. M., see Kline, N. S., Stanley, A. M.
 Stannard, A.  N., see Hollister, L. E., Stannard, A. N.,
   Drake, C. F.
 Starer,  E., see Bennett, I. F., Cohen, D., Starer, E.
Statman, J., see Feldman, P. E-, Statman, J.
Stauffer, M. H., see Loftus, L. R., Huizenga, K. A., Stauf-
  fer M. H., Rome, H. P., Cain, J. C.        ....
Stead, J. S., Wing, J. K.  Parkinsonism during treatment
  with reserpine.  Lancet, Lond., 1955, 1: &&*-&-».
Steadman, H. H., see Monro, A. B., Steadman  H. H.
Steck H  Le syndrome extrapyramidal dans les cures de
  chlorpromazine et serpasil; sa symptomatologie clinique
  et son role therapeutique.  [Extrapyramidal syndrome
  in chlorpromazine  and serpasil therapy;  its clinical
  symptoms  and  therapeutic  role.]   Enciphale,  1956,
  45:1083-1089.
___  Le syndrome extrapyramidal et diencephalique au
  cours  des traitements  au largactil  et au  serpasil.
  [Extrapyramidal and diencephalic syndrome  during
  largactil and  serpasil therapy.]  Ann.  mid. psychol,
  Par., 1954, 112 (2) : 737-744.
Steed, W. D., see Newbold, H. L.,  Steed, W. D.
Steelman, H. F.  The use of serpasil for  restlessness in
  acute  closed  head injuries:  a preliminary  report.
  Arizona M., 1955,12 : 22.
Steffen,  C. G.,  Chervin, M.,  Van  Vranken, B.  Reaction
  following the use  of meprobamate  (miltown).   Cali-
  fornia M., 1956, 85 :189-190.
Stehman, V. A., see Sibilio, J. P.,  Andrew, G.,  Dart, D.,
  Moore, K. B., Stehman, V. A.
Steigman, A. J., Vallbona, C.  Experience with chlorpro-
  mazine in pediatrics. Internat.  Rec. 31., 1955,168: 351-
  357.
Stein, L. Reserpine  and the learning of  fear.  Science,
  1956, 124: 1082-1083.
Steinmann, H.  Der  Einfluss von  Megaphen auf  das
  Elektrokortikogramm der  Katze.  [The  effects  of
  chlorpromazine  on the  electrocorticogram of the cat.]
  [English summary]  Zbl. Neurochir., 1954, 14 : 233-237.
  Abstract: Excerpta med.,  Sect. 8, 1956, 9:  No. 534.
Stenback,  A.   Psykiatrisk klorpromazinbehandling  med
  letalt forlopp.  [Psychiatric chlorpromazine therapy
  with  fatal outcome.]  [English  summary]  Nord. med.,
  1956, 56: 1622-1623.
Stenzler, R., see Freyhan, F. A., Turner, P.,  Stenzler, R.
Sternberg,  IL,  Spitz,  H., Goyne, J. B.  Evaluation of
  chlorpromazine and reserpine therapy  with  follow-up
  study.  J. Clin. Exp. Psychopath., 1957, 18: 258-268.
Stevenson,  I.  Comments on  the  psychological effects of
  mescaline and allied drugs.  J. Nerv. Ment. Dis., 1957,
  125: 438-442.
 ---, Sanchez, A.  J.  The antidotal action of sodium suc-
   cinate in the  mescaline psychosis.  Am. J.  Psychiat.,
   1957,  114: 328-332.
 Stewart, R. H.   The use of tranquilizing drugs in gyne-
   cology.  West. J. Surg., 1956, 64: 650-657.
 Stiaszny, E., see Simko, A. B., Stiaszny, E.
 Stier, C. Die Anwendung des zentralen Stimulans Ritalin
   bei depressiven Zustanden und zur Unterstutzung der
   Elektroschoektherapie.  [The use of ritalin, a stimulant
   of the central nervous system,  in depressive states and
   as adjuvant in electroshock therapy.]  Ther. Gegenwart,
   1955, 94: 92-95.
 Stiess,  A.  Klinische Erfahrungen mit Dihydroxy-2-me-
   thylphenoxy-propan (Byk-M 1.)  [Clinical experience
   with  dihydroxy-2-methylphenoxy-propanediol  (Byk-M
   1).]   Th er. Gegenwart, 1953, 92: 289-292.
 Stiller, R., see Tuteur, W., Stiller, R., Whitehill, O.
 ---, see Tuteur, W., Stiller, R., Whitehill, O., Lepson, D.
 Stimulants and depressants. Brit. M. J., 1956, 1: 969-970.
 Stipp,  C, see Cronheim,  G., Stipp, C, Brown, W.
 Stokholm,  H.,  Zahle, V.  Medicatmentel neurosebehan-
   dling; nogle  bemaerkninger.   [Medical treatment  of
   neuroses;  some  remarks.]    Ugeskr.  laeger,   1955,
   117:1511-1513.
 Stoll,  W. A.  Conference on  reserpine in the treatment
   of neuropsychiatric, neurological,  and related  clinical
   problems.  [New York, February 1955]  [English  title—
   German text] Schweiz. med, Wschr., 1955, 85:439-440.
250 
AUTHOR LIST
Tatum, A. L.
 ---.  Rorschach-Versuche unter  LSD-Wirkung.   [Ror-
   schach tests  under the influence  of  LSD.]   [English
   summary p. 269.]  Rorschachiana, Bern,  1952, 1: 249-
   270.  Abstract:  Excerpta mod., Sect. 8, 1954, 7 : No. 3119.
 ---, see Bleuler, M., Stoll, W. A.
 Stone, H. M., see  Holmes, C.  R., Stone, H. M.
 Stone, R. W., see Wilkins, R. W., Judson,  W. E., Stone,
   R. W., Hollander, W., Huckabee, W. E., Friedman, I. H.
 Strahan, J. F., see Robinson,  H. M.,  Jr., Robinson,  C. V.,
   Strahan, J. F.
 Strauss, H., see Mauceri, J., Strauss, H.
 Stromsta,  C, see  Mecham,  M.  J., Stromsta, C,  Soder-
   berg,  G.
 Stroun,  J., see  Sapir, M., Stroun, J., Hepner, L., Rever-
   chon,  J., Selzer,  S.
 Strubel, H., see Seyffert,  H. M., Strubel, H.
 Struck,  G.  Zur Rauwolfia-Therapie in der Psychiatrie;
   vorlaufige  Mitteilung  fiber 65  behandelte Patienten.
   [Rauwolfia therapy in psychiatry; preliminary report
   on 65  treated patients.] Nervenarzt, 1956, 27: 79-82.
 Sturtevant, F. M., Drill, V. A.   Effects of mescaline in lab-
   oratory animals and influence of ataraxics on mescaline-
   response.  Proc. Soc. Exp. Biol, N. Y., 1956, 92 : 383-387.
   Abstract: Chem. Abstr., 1956, 50: 15956b.
 Sulestrowski, W., see Falicki Z., Galuszko, P., Jaworska,
   I., Kielak,  L., Sulestrowski, W.
 Sullivan, P. D., see Fazekas, J. F., Schultz, J. D., Sullivan,
   P. D.,  Shea, J. G.
 ---, see Fazekas, J. F., Shea, J. G., Sullivan, P. D.,  Jr.
 ---, see Fazekas, J. F., Sullivan, P.  D., Schultz, J. D.
 ---, see Shea, J.  G., Ehrmantraut, W. R., Ticktin,  H. E.,
   Sullivan, P. D., Jr., Fazekas, J. F.
 Sury, E., see Tripod, J., Sury, E., Hoffman, K.
 Suter, E., see Di Mascio, A., Suter, E., Hyde,  R. W., Green-
   blatt,  M.
 Sutter,  J.  M.,  Pascalis,  G.  Effets psychologiques  de la
   chlorpromazine.   [Psychologic effects of  chlorproma-
   zine.]  Enciphale, 1956, 45 : 979-986.
 Svoboda, E.,  see Dubansky, B., Doubrava, O., Svoboda, E.,
   Vyhnankova,  M.
 Swain, J. M., see Dillon,  D., Swain, J.  M.
 ---, see Hall, R.  A., Jackson, R. B., Swain, J. M.
 ---, see Hickerson, G. X., Jr., Swain, J. M., Tempey, F. W.
 Swegan, W. H., see West, L. J.,  Swegan, W. H.
 Swenson, W. M., Gislason, S., Anderson, D. E.  Behavioral
   evaluation of chronic mental hospital patients treated
   with reserpine.   A. M. A. Arch. Neur. Psychiat, 1956,
   76:60-64.
 Swinyard, E. A., Chin, L., Fingl, E. Withdrawal hyper-
   excitability following chronic administration of mepro-
   bamate to  mice.  Science, 1957, 125: 739-741.
 Swyer, G. I. M.  Treatment of  the premenstrual syndrome;
   value  of ethisterone, mephenesin,  and a  placebo com-
   pared. Brit. M. J., 1955, 1:1410-1412.
 Sykes, P., see Mitchell, P. H., Sykes, P.,  King, A.
 Symposium:  Clinical value and limitations of chlorpro-
   mazine.  Psychiat. Res. Rep., Wash., 1955 (1) : 53-104.
   [All articles are listed individually.]
 Symposium:  Clinical value and limitations  of reserpine,
   meratran, and a "new blocking agent". Psychiat. Res.
   Rep., Wash., 1955 (1) :  105-152.  [All articles are listed
   individually.]                 .      .
 Symposium on chlorpromazine in clinical medicine.  In-
   ternat. Rec. M., 1955,168: 295-358.  [Articles within the
   scope of this bibliography are listed individually.]
 Symposium on the efficacy of new drugs.  Med. Clin. N.
  America, 1957, 41: 295-615.  [Articles within the scope
   of this bibliography are listed individually]
 Symposium on the evaluation of pharmacologic agents in
  psychiatry.  J. Clin.  Exp.  Psychopath., 1957,  18:221-
  283.  [Articles within the scope of this bibliography are
  listed individually.]                    .
Symposium on tranquilizing agents  in clinical medicine.
  Zternat Rec. M., 1956, 169:177-232.   [All articles  are
  listed individually.]
Symposium on tranquillizers.  [Summary of proceedings.
  British Medical Association annual meeting, Newcastle
  upon Tyne,  July 1957] Brit. M. J., 1957, 2:219-221.
Symposium: Physiologic, pharmacologic, neurologic, and
  psychologic  actions of drugs recently introduced in the
  treatment of psychiatric disorders. Psychiat. Res. Rep.,
  Wash., 1955 (1) :  1-51.  [Articles within  the scope of
  this bibliography are listed individually.]
Symposium: The neurophysiology and neuropharmacology
  of the new drugs.  Psychiat.  Res.  Rep.,  Wash., 1956
  (4) : 1-34.   [Articles within the scope of  this bibliog-
  raphy are listed individually.]
Symposium: The relative values of drugs in the various
  psychiatric  syndromes.  Psychiat. Res. Rep.,  Wash.,
  1956 (4) : 35-87.   [All articles are listed individually.]
Symposium: The  role of drug therapies in  current and
  future psychiatric practice. Psychiat. Res. Rep., Wash.,
  1956(4) :95-129.
Symposium:  The significance and  management  of the
  complications resulting from new drugs.  Psychiat. Res.
  Rep., Wash., 1956  (4) : 79-94.   [Both articles are listed
  individually.]
Szasz, T. S. Some observations on the use of tranquilizing
  drugs.  A. M. A. Arch. Neur. Psychiat, 1957, 77: 86-92.
Szatmari,  A.  Clinical and electroencephalogram investi-
  gation on largactil in psychosis (preliminary study).
  Am. J.  Psychiat.,  1956, 112:788-794.  Abstract: Ex-
  cerpta med., Sect. 8, 1956, 9: No. 4557.
---,  Hoffer,  A.,  Schneider, R.   The effect  of  adreno-
  chrome   and  niacin  on the electroencephalogram  of
  epileptics.   Am. J. Psychiat, 1955, 111: 603-616.
Szekely, A., see Policzer, M., Szekely, A., Foldes, J.
Taeschler, M., Rothlin, E.  Zur  Charakterisierung  der
  zentralen Wirkung  von Phenothiazinderivaten.  [The
  specific central effect  of  phenothiazine derivatives.]
  Arch. exp. Path., Berl, 1956, 228:184-186.  Abstract:
  Chem. Abstr., 1956, 50: 8902de.
Talbot, M. W., Jr.  The use of reserpine in irritable  and
  hypertonic  infants.  Ann.  N.  York  Acad.  Sc, 1955,
  61:188-197.  Abstract: Excerpta med., Sect.  8, 1956,
  9: No. 2635.
Talley, J. E.  Meratran, a new cerebral stimulant: report
  on the results of clinical investigation.   Psychiat. Res.
  Rep., Wash., 1955 (1) : 133-139.
Tansley, A. E., see Segal, L. J., Tansley, A. E.
Tarasov, G. K. Obzory, kritika, retsenzii aminazin: obzor
  literatury  po  primeneniiu  v  psikiatrii  odnogo  iz
  proizvodnykh fenotiazina.   [Aminazin:  review of the
  literature on one  of the phenothiazine  derivatives in
  psychiatric practice.]  Zh. nevropat. psikhiat,  Moskva,
  1955, 55: 296-310.
---.  Rezul'taty  klinicheskogo  issledovaniia  deistviia
  aminazina pri lechenii psikhicheski bol'nykh.   [Results
  of clinical investigations on the effect of aminazine in
  mental  patients.]    Zh.  nevropat. psikhiat.,  Moskva,
  1956, 56:146-154.
----, see Demidova, L. P., Tarasov, G. K.
Tarasov, Y. K., see Bamdas, B. S., Glod, G. D., Lando, L.
  I., Levkovich, A. P.,  Tarasov, Y. K., Khazen, I. M.
Tardieu, Y., see Delay, J., Deniker,  P., Tardieu,  Y.
---, see Delay, J., Deniker,  P., Tardieu,  Y., Lemperiere,
  T.
Tasher, D. C, Chermak, M. W.  The use of reserpine in
  shock-reversible patients and shock-resistant patients.
  Ann. N. York Acad. Sc, 1955, 61:108-116.  Abstract:
  Excerpta med., Sect. 8, 1956, 9:  No.  1733.
---, see Rudy, L. H, Himwich, H. E., Tasher,  D. C.
Tasker, J. R.  Fatal  agranulocytosis during  treatment
  with chlorpromazine.  Brit M. J., 1955, 1: 950-951.
Tatum, A. L.  Complications of chlorpromazine therapy in
  800  mental  hospital patients.  Wisconsin  31.  J., 1955,
  54: 521.
251 
Tavener, R. H.
PSYCHOPHARMACA
Tavener, R.  H.  A  new  drug in post-alcoholic tension
  states.  Canad. M. Ass. J., 1954, 71: 387-388.  Abstract:
  Excerpta med., Sect. 8,  1955, 8: No. 3553.
Teani, E. La cloropromazina  nella pratica  neuropsichi-
  atrica.  [Chlorpromazine in neuropsychiatric practice.]
  minerva med., Tor., 1956, 47:1677-1686.
■---  La reserpina  in neuropsichiatria.  [Reserpine in
  neuropsychiatry.]   Riv.  sper.  freniat.,  1956, 80:615-
  637.  Abstract:  Excerpta med., Sect.  8, 1957, 10:  No.
  2086.
Tedeschi, G. F.  Psicoterapia e farmaco terapia.  [Psycho-
  therapy and  pharmacotherapy.]  Arch, psicol.  neur.,
  Milano, 1956, 17: 682-684.
Teichner, Y.  Etudes  d'un nouveau derive de la pheno-
  thiazine (chloropromazine—4560 R. P.) en dermatologie.
  [A new phenothiazine derivative (chlorpromazine 4560
  R. P.) in dermatology.]  74p.  [Mimeographed]  Lyon,
  1953.   (Thesis—Lyon, 1952/1953 no. 117)
----, see Pellerat, J., Teichner,  Y.
Teirich, H.   Uber eine Meskalinschadigung.  [Injurious
  effect of mescaline.]  Psyche, Stuttg., 1954, 7: 637-640.
Teitelbaum,  H.  A.,  see Gliedman,  L.  H.,  Gantt, W. H.,
  Teitelbaum, H.  A.
Telatin, L.  La Rauwolfia in neuropsichiatria.  [Rauwolfia
  in neuropsychiatry.]  Arch,  psicol.  neur., Milano, 1956,
  17: 411-413.
Temkov, I., Ditsova, A.  Nashi rezultati ot lechenieto na
  niakoi dushevni zaboliavaniia s largaktil.   [Results of
  the treatment of certain mental diseases with largactil.]
  Suvrem. med., Sofia, 1956, 7 : 61-68.
Tempey, F. W., see Hickerson, G.  X., Jr., Swain, J. M.
  Tempey, F. W.
Temple, J. P., see Lafon, R., Due, N., Labauge, R., Temple,
  J. P.
---, see Lafon,  R., Temple, J. P., Abric,  J.
Tenenblatt, S. S., Spagno, A.  A controlled study of chlor-
  promazine therapy in chronic psychotic patients. J. Clin.
  Exp.  Psychopath., 1956, 17: 81-92.
Tennenbaum, L.  Largactil. [In Hebrew]  [English sum-
  mary p. IV-V]  Dapim Refuiim, 1955, 14: 229-242.
■---, see Winnik, H. Z., Tennenbaum, L.
Terman, L. A.   Treatment of senile agitation with chlor-
  promazine.   Geriatrics, 1955,  10: 520-522.  Abstract:
  Excerpta med., Sect. 8, 1956,  9 : No. 2582.
Terrell, J., see Kinard, S., Mills,  L. C, Terrell, J., Moyer,
  J. H.
Terzian, H.  Etude de Taction du largactil (4560 RP) et
  du pendiomide  sur Tactivite  electrique cerebrale du
  lapin. [Study of the action of largactil and pendiomide
  on  the electrical  activity  of the rabbit brain.]   Rev.
  neur., Par., 1954, 91: 445^53.
---.  Etude eiectroencephalographique de  Taction  cen-
  trale de la chlorpromazine  (4560 R.  P.)   [Electroen-
  cephalographic study of the  central action of chlorpro-
  mazine (4560 R. P.).]   Bern. hdp. Paris, 1954, 30: 838-
  841.  Abstract:  Excerpta med., Sect. 8, 1955, 8: No. 47.
----.  Etude experimentale de  Taction de  la  reserpine
  (serpasil)  sur les structures nerveuses centrales.  [Ex-
  perimental study  of the effects of reserpine (serpasil)
  on  the central  nervous system.]    Enciphale,  1956,
  45 : 835-S42.
---. Studio elettroencefalografico dell'azione centrale del
  largactil (4560 RP).  [Electroencephalographic study of
  the central action of largactil (4560 RP).]  Rass. neur.
  vegetal, 1952, 9:211-215.
---, Ruberti, R.  Studio sperimentale dell'azione del larg-
  actil  e del pendiomid  sull'attivita elettrica  cerebrale
  del coniglio.   [Experimental study of  the effect of larg-
  actil  and  pendiomide on cerebral electrical activity in
  rabbits.]  Riv. neur., Nap., 1954, 24 :  686-702. Abstract:
  Excerpta med., Sect. 8, 1955, 8: No. 2717.
---, see Gastaut, H, Terzian, H., Gastaut, Y.
Texier, M., see Vallat, J. N., Lepetit, Texier, M.
Thai, N.  Clinical evaluation  of chlorpromazine therapy
  for psychiatric disorders.  Northwest 31., 1956, 55: t>0d
  656.                                          _,„ .
---.  Premedication for  electroshock treatment. Effect
  of meprobamate in 120 psychotic patients.  Dis. Nerv.
  Syst., 1956, 17: 52-57.
Thein, K., see Nitsch, W., Thein, K.
Theriault, J. C.  A fatality associated with chlorpromazine
  (largactil) therapy.  Canad. M. Ass. J., 1956, 74:148-
  149.
Thiebaux, M., Boyer, R.  Le 4560 RP (largactil) en thera-
  peutique psychiatrique. A propos de quelques observa-
  tions.  [Experiences with 4560 RP  (largactil) in psy-
  chiatric therapy.]   [Abstract] Ann. mid. psychol, Par.,
  1953, 111 (2)  : 84.
---.Thiebaux,  R.,  Boyer,  R., Leborgne, F.,  Kiffel,  M.
  Note  sur Tapparition de  troubles extrapyramidaux au
  cours du traitement par le 4560 R. P.  [The occurrence
  of  extrapyramidal symptoms  during treatment  with
  4560 RP.]  Ann. mid. psychol,  Par., 1954, 112  (1)  : 732.
Thiebaux, R.,  see Thiebaux, M., Thiebaux, R.,  Boyer,  R.,
  Leborgne, F., Kiffel, M.
Thimann, J., Bucknam, F. G., Gauthier, J. W.,  O'Connell,
  T.  A.  Rauwiloid  therapy in  alcoholism.  Am.  J.
  Psychiat, 1957, 113 : 694-697.
---, Gauthier,  J. W.  Miltown as a  tranquilizer in  the
  treatment  of   alcohol  addicts.  Q.  J.  Alcohol,  1956,
  17:19-23.
Thompson, J.  From snake pit to  snake root.   Bull. 31.
  Libr. Ass., 1956, 44: 465-A12.
Thompson, L. J., Proctor, R. C. The use of pyrahexyl in
  the treatment of alcoholic and drug withdrawal condi-
  tions.  North Carolina 31. J., 1953, 14 : 520-523.
---, see Randolph, A. C, Thompson, L. J.
Thompson, W., see Gaitz, C. M.,  Roy, H., Thompson,  W.,
  Kimbell, I.,  Mullen, A. J., Pokorny, A. D.
Thorner, M. W., see Hafkenschiel, J. H.,  Sellers, A.  M.,
  King, G. A., Thorner, M. W.
Thorpe, J. G., Baker, A. A.  A research method  to assess
  a  new tranquilizing  drug.  J. Ment. Sc,  Lond.,  1956,
  102: 790-795.
---, see Baker, A. A., Thorpe, J. G.
Thuillier, J.  Rauwolfia serpentina.  Concours mid., 1954,
  76: 3353-3354.
■---.  La serotonine.  [Serotonin.]   Concours mid., 1956,
  78:3177-3181.
----, see Delay, J., Thuillier, J.
Thurman, A. C, see Clark, L. D., Ellsworth, R. B., Bar-
  rett, W. W., Thurman, A. C, Holland, W.
Tice, L. F.  Some important  drug  developments of 1956.
  Am. J. Pharm., 1956,128:  398-409.
---, see Abrams, R. E., Tice, L. F.
Ticktin, H. E., see Shea, J.  G., Ehrmantraut, W. R., Tick-
  tin, H. E., Sullivan, P.  D., Jr.,  Fazekas, J. F.
Tilley, R. F., Barry, H., Jr.  Chlorpromazine treatment for
  relief of itching  in severe and refractory neuroderma-
  titis. N. England J. 31.,  1955,  252: 229-230.
Tillim, S. J.  Agranulocytosis associated with chlorproma-
  zine therapy.   Am. J. Psychiat, 1956, 112 :1028.
Tintera, J. W.  Office rehabilitation of the alcoholic.  N.
  York State J. 31., 1956, 56 : 3896-3902.
Tislow, R., see  Hosko,  M. J., Gore, E. M., Tislow, R.,
  Seifter, J.
Tobin,  M., see  Dickes, R., Flamm,  G. H., Coltrera, J.,
  Tobin, M.
Toekes, I. M., see Cronheim, G., Brown, W., Cawthorne, J.,
  Toekes, I. M.,  Ungari, J.
---, see Cronheim, G., Orcutt, J. A., Toekes, I. M.
----, see Cronheim, G., Toekes, I. M.
Tolan,  E.  J.,  Olariu, J.  Treatment of  parkinsonism.
  Preliminary report on  use  of promethazine in 12  cases.
  Am. J. Psychiat, 1957,114 : 518-523.
Toll, N.  Azacyclonol  as an  adjunct to  psychotherapy.
  In: Himwich, H. E., ed. Tranquilizing drugs.   Washing-
  ton, Am. Ass.  Adv. Sc, 1957. p. 103-113.
252 
AUTHOR LIST
Turner, M.
 Tolmaskaia, E. S., see Sereiskii, M. IA., Tolmaskaia, E. S.,
   Golodets, R. G., Samter, N. F.
 Tolsma,  F. J.  Les neuroleptiques  et  le  probleme  de
   Tadaptation  humaine.   [Neuroleptic  drugs  and  the
   problem  of   human  adaptation.]  Enciphale,  1956,
   45:1141-1149.
 .---, Jedeloo, G. C, Kemenade, J. J. van.  De betekenis
   van 4560 R. P.  (largactil) in de psychiatrie.  [Use of
   4560 R. P. (largactil)  in psychiatry.]   [English sum-
   mary]   Ned. tschr.  geneesk., 1954,  98: 997-1001.   Ab-
   stract :  Excerpta med.,  Sect. 8, 1955, 8:  No. 3103.
 Toman, J. E. P., see Everett, G. M., Toman, J. E. P., Smith,
   A. H., Jr.
 Tonini, G, Bizzi, B.  La  terapia del sonno come ausilio
   nella  comprensione  della  fisiopatologia  dell' attivita
   nervosa superiore nell'uomo.  I. La terapia del sonno:
   basi teoriche; tecnica; risultati.   [Sleep therapy as an
   aid in comprehension of the physiopathology of activity
   of  the  higher nervous  system in  humans.  I. Sleep
   therapy:  theoretical bases; technic;  results.]   [Eng-
   lish summary]   Rass. stud, psichiat., 1954, 43 : 780-803.
 ---, Montanari, C. Effects  of  experimentally induced
   psychoses on artistic expression.   [In English]  Con-
   finia neur.,  Basel, 1955,  15:225-239.   Abstract:   Ex-
   cerpta med., Sect. 8,1957,10: No. 1439.
 ---, ----. Effetti psichici della monoetilamide dell'acido
   lisergico  (LAE 32).   [Psychological effects of lysergic
   acid monoethylamide  (LAE 32).]  Gior. psichiat., 1955,
   83:355-357.
 ---, ----.  Modificazioni elettroencefalografiche nel  cor-
   so della terapia con reserpina.   [Electroencephalogra-
   phic changes during reserpine  therapy.]  Arch, psicol.
   neur., 31ilano, 1956, 17: 592-593.
 ---, see Montanari, C, Tonini, G.
 Toops, T. C, see Abse, D. W., Curtis, T. E.,  Dahlstrom,
   W. G., Hawkins, D. R., Toops, T. C.
 Tornaben, J., see Reinhard, J.  F., Chessin, M., Tornaben,
   J., Lewis, M. N.
 Torsegno,  M.,  Zucchi,  M.  Trattamento  di   ammalati
   mentali con un preparato iniettabile di alcaloidi totali
   di Rauwolfia serpentina Benth.   [Therapy of mental pa-
   tients with an injectable preparation of total alkaloids
   from Rauwolfia serpentina Benth.]  Minerva med., Tor.,
   1955, 46:604-607.  Abstract: Excerpta  med., Sect. 8,
   1956, 9 : No. 3087.
 Tosca, L., see Masini, A., Pescetto, G., Tosca, L.
 Toulet, M., see Lambert, P. A., Toulet, M., Diederichs, A.
 ---, see Lambert, P. A.,  Diederichs, A., Toulet, M.
 ---, see Perrin, J., Toulet, M.
 Toupin, H., see Fazekas, J. F., Toupin, H., Alman, R. W.
 Touraine,  Y.  Action du  45-60 RP  sur  les deiires  avec
   agitation des  traumatises  craniens.  [Effect of  4560
   R. P. on  delirium  with  agitation  in  head  trauma.]
   Presse mid., 1953, 61: 470.
 Tourney, G.,  Isberg, E. M.,  Gottlieb, J. S.  The use of
   reserpine in  an  acute  psychiatric  treatment setting.
   A. 31. A. Arch. Neur. Psychiat.,  1955, 74:325-328.   Ab-
   stract: Excerpta med.,  Sect. 8, 1956, 9: No. 3088.
 ---, see Gottlieb,  J.  S.,  Tourney, G.,  Beckett, P.  G.,
   Lowinger, P.
 Toxic effects of meprobamate. Brit. M. J., 1957, 2:300.
 Tranquilizers.  Nebraska M. J., 1956, 41: 417.
 Tranquilizing agents. N. England J. 31., 1955,  252: 74-75.
 Tranquilizing drugs. 197  p.  Washington, Am. Ass. Adv.
  Sc, 1957.  cf. Himwich, H. E., ed.
 Tranquillizers.  Scot. M. J., 1957, 2: 46-47.
Tranquillizers  and  divorce.  Brit. M. J., 1957, 2:1122-
  1123.
Tranquillizers in psychiatry.  [Report on Royal Medico-
  Psychological Association meeting, London, February
  1956]  Brit M. J., 1956, 1: 512-513.
Trapold, J., see Plummer, A. J., Earl, A., Schneider, J. A.,
  Trapold, J., Barrett, W.
Traub, L., see Hollister, L. E., Traub, L., Beckman, W. G.
Travis, L. E., see Bercel, N. A., Travis, L. E., Olinger, L. B.,
  Dreikurs, E.
Treatment  of alcoholics  with  reserpine.   Alcoholism
  Treatment Digest, New Haven, 1956  (30) : 2-4.
Trelles, J. O., Saavedra, A.  Cura de suefio con largactil en
  el tratamiento de algunos desordenes mentales;  (Prim-
  eros resultadoes en el Peru).  [Sleep therapy with lar-
  gactil in the treatment of some mental disorders.  (First
  results  in Peru.)]   Rev. neur. psiquiat,  Lima, 1954,
  17: 125-161.
Tremblay, G., see Genest, J., Adamkiewicz, L., Robillard,
  R., Tremblay, G.
Trethowan, W. H.  Persistent sensory symptoms following
  spontaneous hypoglycemia: response to chlorpromazine.
  J. Nerv. 3Ient. Dis., 1955, 121: 274-278.  Abstract:  Ex-
  cerpta med., Sect. 8, 1956, 9: No. 1424.
---, Scott, P. A.  Chlorpromazine in obsessive-compulsive
  and  allied disorders.  Lancet, Lond., 1955, 1: 781-785.
  Abstract: Excerpta med., Sect. 8, 1956, 9:  No. 2231.
Trinity, G. J.  Management of the depressed patient. 31 ed.
  Times, Great Neck,  1954, 82: 753-757.
Tripi,  G.  L'associazione  ganglioplegici  e  barbiturici in
  psichiatria.  I.  [Association of ganglioplegics and bar-
  biturates in psychiatry.  I.]    [Brief English summary]
  Rass. stud, psichiat., 1954, 43: 907-918.
---.  Considerazioni generali  sull'uso  della cloroproma-
  zina e della reserpina nel trattamento di circa trecento
  psicopatici.  [Observations on the use of chlorpromazine
  and  reserpine in the treatment of about 300 mental pa-
  tients.]   Rass. neuropsichiat, 1955,  9 : 463-469.  Also:
  Arch, psicol, neur., Milano,  1956,  17:635-639.
Tripod, J., Bein, H. J., Meier, R.  Characterization  of cen-
  tral  effects of serpasil (reserpin, a new alkaloid of Rau-
  wolfia  serpentina B.)  and of their  antagonistic reac-
  tions. Arch, internat. pharm. dyn., Gand, 1954, 96: 406-
  425.
---, Sury,  E., Hoffman, K.  Zentralerregende Wirkung
  eines neuen Piperidinderivatives.   [Centrally stimulat-
  ing effect  of a new piperidine derivative.]  Experientia,
  Basel, 1955, 10: 261-262.  Abstract: Chem. Abstr., 1955,
  48:10920g.
---, see Bein, H. J., Gross, F., Tripod, J., Meier, R.
---, see Meier, R., Bein, H. J., Gross, F., Tripod, J., Tuch-
  mann-Duplessis, H.
---, see Meier, R., Gross, F., Tripod, J.
Tsukiyama, K., see Yoshii, N., Tsukiyama, K., Hiraiwa, K.
Tuatay, H., see Cheifetz, I., Paulin, C, Tuatay, H,  Rubin,
  E. H.
Tuchmann-Duplessis, H., see Meier,  R., Bein, H. J., Gross,
  F., Tripod, J., Tuchmann-Duplessis,  H.
Tucker, K., Wilensky, H.   A clinical evaluation of  mepro-
  bamate  therapy in a chronic schizophrenic  population.
  Am.  J. Psychiat., 1957, 113: 698-703.
Tucker, W. I., see Atkinson, R. P., Tucker, W. I.
Turk, R. E.,  see Bennett, A. E., Ford, F. R., Turk, R. E.
Turmel, J., see Bouchard, M., Larue, G. H, Turmel, J.
---, see Grenier, J., Larue, G. H., Parent, R., Turmel, J.
Turner, M.,  Berard, E. Estudio del efecto  de la cloropro-
  mazina  (4560 RP)  sobre el electroencefalograma y el
  electrodermograma.  [Effect  of chlorpromazine  on  the
  EEG and  electrodermogram.]   [English  summary]
  Rev. Soc. argent, biol, 1954, 30:163-169.
---,----, Turner, N., Franco, N.  Etude des modifications
  electro-encephalographiques, eiectro-dermographiques et
  eiectro-myographiques provoquees par la clorpromazine.
  [Electroencephalographic, electrodermographic and elec-
  tromyographic  changes  induced  by chlorpromazine.]
  [English summary]   Anesthisie, Par., 1955,12: 453-465.
  Abstract:  Chem. Abstr., 1956,  50:3633f.  As: Modifica-
  ciones electroencefalograficas, electrodermatograficas y
  electromiograficas provocadas en el hombre por la cloro-
  promazina.  [English summary]  Rev. Soc. argent, biol,
  1955, 31: 54-63.  As:  Modifications eiectro-encphalo-
  graphiques,  eiectro-dermographiques  et  eiectro-myo-
  graphiques  provoquees par  la  chloropromazine  chez 
Turner, M.
PSYCHOPHARMACA
  l'homme.  [English summary]  Electroencephalography,
  Montreal, 1956, 8: 25-34.
Turner, N., see Turner, M., Berard, E., Turner, N., Franco,
  N.
Turner, P., see Freyhan, F. A., Turner, P., Stenzler, R.
Turner, W. J.  The effect of lysergic acid diethylamide on
  Betta  splendens:  I. II. Frenquel.  Dis. Nerv.  Syst,
  1956, 17: 193-197;  198.
---, Merlis, S.  Chemotherapeutic trials in psychosis.  I.
  Frenquel  and  pilocarpine.   Am. J.  Psychiat.,  1956,
  113: 248-249.
---,----, Carl,  A.  Concerning  theories  of  indoles  in
  schizophrenigenesis.  Am. J. Psychiat, 1955, 112: 466-
  467.
Turvey,  S.  E.  Meprobamate  (equanil)  for  relief  of
  anxiety  and  nervous  tension  from  various causes.
  Canad. M. Ass. J., 1956, 74: 863-865.  Abstract: Excerpta
  med., Sect. 8, 1957, 10: No. 362.
Tuteur, W.  A case of fatal agranulocytosis due to chlor-
  promazine.  Am. J. Psychiat, 1956, 113: 76.
■---.   Combined  reserpine-chlorpromazine  therapy  in
  highly disturbed psychotics.  Am. J. Psychiat, 1955,
  112 : 206.  Abstract: Excerpta med., Sect. 8,1956, 9: No.
  2243.
■---.   Effect of  chlorpromazine and reserpine on budgets
  of mental hospitals.  Am. J. Psychiat, 1957, 113: 657-
  659.
•---,  Lepson,   D.  Combined  reserpine-chlorpromazine
  therapy in highly  disturbed psychotics.  In: Himwich,
  H.  E., ed. Tranquilizing drugs.  Washington, Am. Ass.
  Adv. Sc, 1957.  p. 163-172.
---,  Stiller, R.,  Whitehill,  O.  Treatment of regressed
  schizophrenics with chlorpromazine, reserpine and  a
  combination of both drugs.   Dis.  Nerv.  Syst, 1957,
  18:100-105.
■---,---,----, Lepson, D.  Results with chlorpromazine
  and reserpine on chronically nude, untidy, destructive
  and combative patients:  their sustained improvement
  after  discharge with  continued medication.   Am. J.
  Psychiat, 1956, 112 : 741.
Tweedy, P. S.  Treatment of hypertension.  Lancet, Lond.,
  1955, 2: 249.
Tyhurst, J. S., Richman, A.  Clinical experience with psy-
  chiatric patients on reserpine-preliminary impressions.
  Canad. 31. Ass. J., 1955, 72: 458-459.
■---,----.  An  evaluation of the clinical  significance of
  reserpine.  J. Nerv. Ment. Dis., 1955, 122 : 492-495.
---,  see Richman, A., Tyhurst, J. S.

                          u

Ugelstad, E.  Chlorpromazine treatment  in  senile psy-
  choses. Acta psychiat. neur. scand., 1956, Suppl. 106:
  60-62.
Umbreit, W. W., see Keller, D. L., Umbreit, W. W.
Ungari,  J., see Cronheim, G.,  Brown, W.,  Cawthorne, J.,
  Toekes, I. M.,  Ungari, J.
Unna, K. R., see Funderburk, W.  H., King, E. E., Domino,
  E. F., Unna, K. R.
----,  see Funderburk, W. H., King, E. E., Unna, K. R.
----,  see Funderburk, W. H., Unna, K. R.
Unterharnscheidt, F., see Cerv6s Navarro, J., Unterharn-
  scheidt, F.
Urbani, M., see Angeleri,  F., Carreras, M., Urbani, M.
Usdin, G. L.  Use of promazine  in psychiatric  practice;
  an  early study. J. Louisiana  M. Soc, 1956,  108:251-
  257.
Ushakov, G.  K.,  Kislenkov,  V.  A.,  Grigorova,  E.  V.,
  Verbliunskaia,  A.   A.   Okupirovanii   aminazinom
  psikhomotornogo vozbuzhdeniia.  [Treatment of  psy-
  chomotor excitation  with aminazine.]  Zh.  nevropat.
  psikhiat,  Moskva, 1956, 56 : 571-574.  Abstract:  Chem.
  Abstr., 1956, 50:17178e.
                          V

Vallat, J. N., Lepetit.  Intoxication par la chlorpromazine
  (largactil)  au cours d'une tentative  de suicide.  [At-
  tempted  suicide with  chlorpromazine   (largactil).]
  Presse mid., 1954, 62 : 752.
---, ----, Texier, M.  Quelques reflexions sur les inci-
  dents et accidents du  traitement par la chlorpromazine
  en pratique psychiatrique.  [ Some remarks to the inci-
  dents and  accidents  of chlorpromazine therapy  in
  psychiatry.]  Enciphale, 1956, 45 : 784-789.
Vallbona, C, see Steigman, A. J., Vallbona, C.
Valzelli, L., see Garattini, S., Valzelli, L.
Vander Kamp, H.,  see Pearl, D., Vander Kamp, H, Olsen,
  A. L., Greenberg, P. D., Armitage, S .G.
Vandierendonck, R., see  Evrard,  A., Vandierendonck,  R.
Vanecek, M., see Votava, Z., Vanecek, M.
Van Maanen,  E. F., see Gottschalk, L. A., Kapp, F.  T.,
  Ross, W. D., Kaplan,  S. M., Silver, H., MacLeod, J.  A.,
  Kahn, J. B., Jr., Van  Maanen, E. F., Acheson, G. H.
Van Vranken,  B., see  Steffen,  C. G.,  Chervin, M., Van
  Vranken, B.
Vargas Romero, J.  Mecanismo de acci6n de la clorproma-
  zina  (45-60 R. P. Largactil).  [The mechanism of  ac-
  tion  of chlorpromazine (45-60 R.  P. largactil).]  Rev.
  clin.  espan.,  1955, 58: 205-211. Abstract: Chem. Abstr.,
  1956, 50:1199gh.
Vaugelade, S., see Rondepierre, J., Hivert, P. H., Honore,
  B., Vaugelade, S.
Vaughan,  G. F., Leiberman, D. M., Cook, L.  C.  Chlor-
  promazine in psychiatry.  Lancet, Lond., 1955, 1:1083-
  1087.
---, see Leiberman, D. M., Vaughan, G. F.
Vegro, G, see Sacerdoti, G., Vegro, G.
Velluz, J., see Hamon, J.,  Paraire, J., Velluz,  J.
Ventra, D., see Fasanaro, F., Ventra, D.
Verbliunskaia, A.  A., see Ushakov,  G.  K., Kislenkov, V.
  A., Grigorova, E. V.,  Verbliunskaia, A. A.
Verdeaux,  G.,  Marty, R.  Action  sur l'eiectroencephalo-
  gramme  de substances pharmacodynamiques d'interet
  clinique.  [Effect of clinically  important drugs on  the
  encephalogram.]  Rev. neur., Par., 1954, 91: 405—427.
----, see Delay, J., Lhermitte, F., Verdeaux, G., Verdeaux,
  J.
Verdeaux, J.,  see Delay, J., Lhermitte, F., Verdeaux,  G.,
  Verdeaux, J.
Vergani, O., Aldeghi, E.  L'impiego degli  alcoloidi totali
  di Rauwolfia serpentina in neuropsichiatria infantile.
  [Use of total  alkaloids of Rauwolfia  serpentina in
  child neuropsychiatry.]  [English summary]  Minerva
  pediat., Tor., 1956, 8:1161-1165.
Vernet, A., Genevard, G. Applications de la chlorproma-
  zine en pratique medicale courante et en medecine psy-
  chosomatique.  [Uses of chlorpromazine in current med-
  ical  practice and in psychosomatic medicine.]  [German
  summary]   Praxis, Bern, 1956,  45: 385-389.  Abstract:
  Excerpta med.,  Sect.  8, 1957, 10: No. 1400.
Vessey, R. E., see Harned, B. K., Cunningham, R. W., Clark,
  M. C, Hine, C. H., Kane, M. M., Smith, F. H., Jr., Vessey,
  R. E., Yuda, N. N., Zabransky,  F. W.
Vialard, C.   Note sur Tutilisation du largactil  (4560
  R. P.) comme potentilisateur de medicaments analgesi-
  ques chez  les  cancereux douloureux  resistants  aux
  opiaces.  [Largactil  (4560 RP) potentiating analgesic
  drugs in  the treatment of cancer patients who are in
  pain and resistant to opiates.]   Anesthesie, Par., 1953,
  10: 216-224.
Viaud, P.  Les amines derivees de la phenothiazine.  [The
  amino-derivatives of phenothiazine.]   J. Pharm. Lond.,
  1954, 6:361-389.
Vichi, A., see Lukinovich, N., Vichi, A.
Vicini, F, see Berselli, G., Vicini, F.
254 
AUTHOR LIST
Walz,D.
 Vidal, G., see Martin, P., Vidal, G., Portal, H.
 Vidart, L., Gasteau, E.  La cure de sommeil en pratique
  neuro-psychiatrique.   [Sleep therapy in neuropsychi-
  atric practice.]  Rev.  prat., Par., 1954, 4: 1583-1588.
 ---, see Lereboullet, J., Vidart, L., Amstutz, C.
 Viding, G, see Fries, P. E., Gunne, L. M., Lundgren, S.,
  Viding, G., Ohrberg, K-
 Villa, A. P., see Asung, C. L., Charcowa, A. I., Villa, A. P.
 Villata, E., see Gamna, G., Bonfante, B., Villata, E.
 Villiaumey, E. M., see Bensoussan, P., Villiaumey, E. M.
 ---, see Bensoussan, P., Villiaumey, E. M., Rousseau, J.
 Villien, L. M.  The  use  of reserpine  in  the treatment of
  disturbed geriatric patients.  J. Louisiana M. Soc, 1956,
  108:126-129.
 Villumsen, A. L., see Ibsen, B., Pahle, H., Villumsen, A. L.
 Vinci, F. J., see Howard, J. C, Jr., Vinci, F. J.
 Virks, J., see Schick, G., Virks, J.
 Vischer, T. J.  Clinical  study of proclorperazine,  a new
  tranquilizer for the treatment of nonhopistalized psy-
  choneurotic patients.  N.  England J. 31., 1957, 256: 26-
  27.
 Visintini, F.  Cloropromazina  e  reserpina in  psichiatria.
  [Chlorpromazine and  reserpine in psychiatry.]   [Eng-
  lish  summary]    Arch,  psicol.  neur.,  Milano,  1956,
  17:611-621.
 Vivien, P. Les  effets  neuro-psychiques du Rauwolfia et
  de  ses alcaloides.   [Neurological and psychological ef-
  fects of Rauwolfia and its alkaloids.]  Ann. mid. psy-
  chol, Par., 1955,113 (1) : 217-226.
 Vizioli, R., see Sinsi, C,  Vizioli, R.
 Voegele, G. E., May, R. H.  Epileptiform seizures under
  promazine therapy; occurence in two cases without his-
  tory  of former  seizures.   Am.  J.  Psychiat,  1957,
  113: 655-656.
 Voelkel, A.  Beitrag sur Sedaraupin-Therapie bei psy-
  chisch Kranken.  [Sedaraupin therapy of mental pa-
  tients.]  3Iedizinische, 1955: 227-228.
 ---.  Zur Reserpin-Therapie bei psychisch Kranken. II.
  [Reserpine therapy  of mental disorders.   II.]   Deut.
  med. J., 1956,  7: 72-74.
 Vogel, P. J., see Avol, M., Vogel, P. J.
 Vogt, W.  Beitrag  zum klinischen  Vergleich  der  Wir-
  kung von Largactil und Serpasil.  [Clinical comparison
  of the effects of  largactil and serpasil.]  Schweiz. Arch.
  Neur. Psychiat., 1956, 77: 330-336.
 Von Berger, G.  P., see Longo, V. G., Von Berger,  G. P.,
  Bovet, D.
 Vonderahe, A. R.,  see Peters, J. J., Vonderahe, A. R.
 von Felsinger, J.  M.,  Lasagna, L., Beecher,  H. K.  The
  response of normal men  to lysergic acid derivatives
  (di- and mono-ethyl  amides).  J.  Clin. Exp. Psycho-
  path., 1956, 17:414-428.
 Von Mering, O., see Hyde,  R.  W., Von Mering, O., Mori-
  moto, K.
 Von Storch, T. J., see Friedman, A. P., Von Storch, T. J.
 Vosburgh, L. F.,  see  Kupperman, H. S.,  Blatt, M. H,
  Vosburgh, L. F., Canis, J., Wetchler, B.
 Voss, G., see Broglie, M., Jorgensen, G., Voss, G.
 Votava, Z., Vanecek, M.   The influence of some antihista-
  mines and  neuroplegics on  the higher nervous activity
  of rats and dogs.  Physiol, bohem., 1956, 5  (Suppl.) :
  58-62.
 Vukadinovic,  D., see Dogan,  S., Vukadinovic, D.,  Lon-
  ghino, A.
Vurdelja,   N.,   Jelesic,  G.  Psychosenbehandlung   mit
  Hibernation  nach  Laborit.  [Psychoses   treated by
  Laborit's hibernation  method.]  Wien, Arch. Psychol,
  1955,  5:193-197.  Abstract:  Excerpta med., Sect. 8,
  1957,' 10: No. 1982.
Vyhnankova, M., see Dubansky, B., Doubrava, O., Svoboda,
  E., Vyhnankova, M.
                          w

Wachsmuth, R.  Phenothiazinderivate (Megaphen) in der
  Psychiatrie.  [Phenothiazine  derivatives  (megaphen)
  in psychiatry.]   Medizinische, 1955:328-529.
---.  Psychovegetative   Umstimmungsbehandlung  mit
  Phenothiazinderivaten, insbesondere in der Psychiatrie.
  [Psycho-autonomic therapy with phenothiazine  deriva-
  tives, with  special reference to psychiatry.]   Aerztl.
  Forsch., 1955, 9: 261-274.
Waggoner, R.  W., see Dice, N., Bagchi, B. K., Waggoner,
  R.W.
Wagle, G., see Plummer, A. J., Barrett, W. E., Wagle, G.,
  Yonkman, F. F.
Wagman, A. I., see  Smith, R. P., Wagman, A. I., Riopelle,
  A. J.
Wagner, M., see Abramson, H. A., Jarvik,  M. E., Kauf-
  man, M. R.,  Kornetsky, C, Levine, A., Wagner, M.
Wagner, R. R., see  O'Connor, J. B., Howlett, K. S., Wag-
  ner, R. R.
Wakim, K. G, see  Schwarz, B.  E., Wakim, K. G, Bick-
  ford, R. G., Lichtenheld, F. R.
Walaszek,  E.  J., Abood, L. G.  Effect of  tranquilizing
  drugs on fighting  response of  Siamese  fighting fish.
  Science, 1956, 124: 440-441.
Walch,  R., Hoheisel, H.  P. Uber die Behandlung von
  vegetativen  Zustanden  nach Kopftrauma mit  Opilon.
  [Opilon therapy of autonomic nervous conditions after
  head injuries.]   Deut. med. Wschr.,  1952, 77:767-768.
Waldrop,   F.  N.   Reserpine.  Med.  Ann.   District  of
  Columbia, 1956, 25 : 256-258.
---, see Overholser, W., Waldrop, F. N., Riesenman, F. R.,
  Fong, T. C.  C, Farley, O. R., Hoffman, J. L.
Walker, A. Las nuevas drogas ataraxicas.   [New ataraxic
  drugs.]  Prensa mid. argent, 1956, 43 : 2667-2669.
Walker, A. E., see  Feldman, P.  E., Lacy, B. S., Walker,
  A. E., Garrez, N.  J.
Walker, J. W., see Mayer-Gross, W., McAdam, W., Walker,
  J. W.
Wallace, D. C. Treatment of hypertension; hypotensive
  drugs and mental changes. Lancet, Lond., 1955,  2:116-
  117.
Wallace  Laboratories.  Miltown—the  tranquilizer  with
  muscle relaxant action.  33 p.   New  Brunswick, N. J.,
  1957.
Wallenstein, S. L., see Houde, R. W., Wallenstein,  S. L.
Wallis,  I.  Ueber  Sedaraupin-Therapie bei cerebral ge-
  schadigten  Kindern.   [Sedaraupin  therapy of brain-
  damaged children.]  Med. Klin., Berl,  1956, 51: 2221-
  2223.  [Not  seen]
Wallis, R.  Potentiation of hypnotics and analgesics ; clin-
  ical experience with  chlorpromazine.  N. York State
  J. 31., 1955, 55 : 243-245.
Walther-Biiel, H.   L'action des  medicaments neurolepti-
  ques dans la maladie de Huntington.  [Effect of neuro-
  leptic drugs on Huntington's chorea.] Enciphale, 1956,
  45: 771-772.
■---.  Das  neuroplegische  Prinzip  in pharmakopsychi-
  atrischer Betrachtung.   [The neuroplegic principle in
  pharmacopsychiatric  considerations.]  [Brief  English
  summary]   3Ischr. Psychiat, Basel, 1955, 129: 286-296.
  Abstract: Excerpta med., Sect. 8, 1956, 9: No. 3891.
---.  tiber Pharmakopsychiatrie.   [Pharmaco-psychia-
  try.]   Schweiz.  med.  Wschr., 1953,  83:483-487.  Ab-
  stract : Excerpta  med., Sect. 8, 1954, 7: No. 1940.
---.  Zur klinischen Therapie der endogenen Psychosen.
  [On clinical therapy of endogenic psychoses.]  Nerven-
  arzt, 1954, 25:191-194.
---.  Zur Serpasil-Behandlung neuropsychiatrischer Zu-
  stande.   [Serpasil therapy for neuropsychiatric condi-
  tions.]  Praxis, Bern, 1956, 45: 733-736.
Walton, D., see Gore, C. P., Egan,  G. P., Walton, D.
---, see Heller, G. C, Walton,  D., Black, D. A.
Walz, D., see  Schallek,  W., Walz, D. 
Wapner, S.
PSYCH0PHAR3IACA
Wapner, S., see Liebert, R. S., Wapner, S., Werner, H.
Ward, R.  H.  A  drug-taker's notes.  222  p.  London,
  Gollancz, 1957.
Ward-Dunn, G., see Holt, E. K., Ward-Dunn, G., Nedilsky,
  B. T., Niswander, G. D.
Wardell, D. W.    Untoward  reactions to  tranquilizing
  drugs.  Am. J. Psychiat, 1957,  113: 745.
Wardt-Kikkert, N. M. van de.  Quelques aspects de Tap-
  plication de la chlorpromazine dans un  hopital psychi-
  atrique hollandais.  [Observations on the use of chlor-
  promazine in a Dutch psychiatric hospital.] Enciphale,
  1956, 45: 700-704.
---,  Rentmeester, J.  Het largactil en zijn toepassing in
  de  psychiatrie.   [The  use of largactil  in psychiatry.]
  Geneesk. gids, 1953, 31: 499-507.
Ware, L. M., Prout, C. T.   A controlled study of reserpine
  in the treatment of mental illness.  Bull. N. York Acad.
  31., 1956, 32 : 643-650.
Warren, J. M., see Hall, J. F., Warren, J. M., Harlow, H. F.
Warson, S. R., see Morton, H. G., Warson,  S. R.
Warter, P. J.  Prednisolone-hydroxyzine  combination  in
  rheumatoid  arthritis.  J. M.  Soc.  N.  Jersey,  1957,
  54: 7-10.
Watkins,   C.  The use  of  reserpine  in  cerebral  palsy.
  South. 31. J., 1956, 49:1488-1494.
Watt, D. B., see Watt, D. C.
Watt, D. C. Reserpine and chlorpromazine in the treat-
  ment  of  chronic  schizophrenics.  Enciphale,  1956,
  45: 661-662.
---,  see Shepherd, M., Watt, D. C.
Watterson, D. J.  Chlorpromazine, depersonalization, and
  visual hallucinosis.  Bull. Menninger Clin., 1956, 20: 20-
  24.   Abstract: Excerpta med., Sect. 8,1956, 9: No. 4558.
Waugh, M. H., see Rubin, B.,  Malone, M.  H., Waugh,  M.
  H., Burke, J. C.
Waxenberg, S. E., see Abramson, H. A., Waxenberg, S. E.,
  Levine, A., Kaufman, M. R., Kornetsky, C.
---,  see Deutsch, L., Waxenberg, S.  E., Dickes, R.
Webb, R. R. Largactil in psychiatry.   31ed. J. Australia,
  1955, 42 (1) : 759-761.  Abstract: Excerpta med., Sect.
  8 1956 9: No 2233.
Webb, W.  W, see Mangun, C.  W., Webb, W. W.
Weber, B., see Coirault,  R., Laborit, H.,  Missenard, R.,
  Jolivet, B., Hainaut, J., Weber, B.
---,  see Laborit, H., Coirault, R., Hainaut, J., Weber, B.
Weber, E. Ein  Rauwolfiaalkaloid in  der Psychiatrie:
  seine Wirkungsahnlichkeit  mit  Chloropromazin.   [A
  Rauwolfia alkaloid in psychiatry:  similarity of its  ef-
  fects to  those  of chlorpromazine.]   Schweiz.  med.
  Wschr., 1954, 84 : 968-970.
Weber, H. J., Lehner, F. H.   Erfahrungen mit Dihydro-
  methylphenoxy-propan  (BYK-M 1).  [Experiences with
  3-o-toloxy-l, 2-propanediol (BYK-M 1)].  Schweiz. Arch.
  Neur. Psychiat, 1954, 73 : 370-378.
Weber, M., see Carey, B., Weber,  M., Smith, J. A.
Wegielski, Z., see Campden-Main, B. G, Wegielski, Z.
Wegmann, A., see Essellier, A. F., Goerre, J., Wegmann,
  A.
Weider,  A., see  Berlin,  L.,   Guthrie,  T., Weider,   A.,
  Goodell,  H, Wolff, H. G.
Weidley, E., see Cook, L., Weidley, E.
---,  see Cook, L., Weidley, E. F., Morris, R. W., Mattis,
  P. A.
Weidmann, H., Petersen, P.  V.  Farmakologisk  nnder-
  s0gelse  af Covatin, et  nyt stoff med  sedativ virkning.
  [Pharmacological investigation of covatin, a new sub-
  stance  with  sedative  action.]  [English  summary]
  Ugeskr. laeger, 1955, 117 : 378-381.
---,  ----.   A new group of potent sedatives.  J. Pharm.
  Exp. Ther., 1953,108: 201-216.
Weil-Malherbe, H., see Liddell, D. W., Weil-Malherbe, H.
Weinberg,  H. B.  Drug  therapy for  the emotionally and
  mentally disturbed; the  internist's point of view.  J.
  Iowa M.  Soc, 1957, 47 :17-19.
Weingarten, K., see Gerstenbrand, F., Weingarten, K.
Weir, H. F., Anderson, R. L.  The effects of reserpine and
  Rauwolfia in minor disorders of adjustment in children.
  31onogr.  Ther. Squibb Inst. 31. Res., 1956, 1 (2) : 33-39.
Weishaus,  J.  Use  of reserpine  (serpasil)  in  psychotic
  patients; a preliminary report.  Dis. Nerv. Syst, 1955,
  16: 347-350.  Abstract: Excerpta med.,  Sect. 8,  1956,
  9: No. 4996.
Weiskrantz, L., Wilson, W. A., Jr.  Effect of reserpine on
  learning  and  performance.  Science, 1956,  123: 1116-
  1118.   Abstract:  Excerpta med., Sect. 8,  1956, 9: No.
  1705.   Chem. Abstr., 1956, 50 : 13281L
---,____.   The effects of reserpine on emotional behavior
  of'normal and brain-operated monkeys.   Ann. N. York
  Acad. Sc, 1955, 61: 36-55.
Weiss, D. M.  Changes in blood pressure with electroshock
  therapy  in a  patient receiving chlorpromazine hydro-
  chloride  (thorazine).  Am. J. Psychiat., 1955, 111:617-
  619.
Weisselberger, D.,  see Gerard, D. L., Weisselberger,  D.,
  Kritz,  D.
Wells, J. C, Jr., see Friend, D. G., Wells, J. C, Jr.
Wells, R. E.  Use of reserpine (serpasil) in the manage-
  ment  of chronic  alcoholism.   J. Am. 31. Ass.,  1957.
  163 : 426-429.
Wenner, R., see Hauser, A., Wenner, R.
Werenberg, H.  Covatin et nyt sedativum.   [Covatin, a
  new sedative.]  Ugeskr. laeger, 1955, 117 : 381-3S3.
---. Covatinbehandling af psykoser og neuroser.  [Co-
  vatin   therapy of  psychoses and neuroses.]   Ugeskr.
  laeger, 1956, 118:1099-1100.
---. Lacuminterapi ved svaere  sindsygdomme.  [Lacu-
  min therapy in severe mental disorders.]   [English sum-
  mary].   Nord. med.,  1955, 54:1787-1789.   Abstract:
  Excerpta med., Sect. 8, 1956, 9 : No. 4567.
Werner, G.  The  central  actions  of chlorpromazine.
  Enciphale, 1956, 45 : 920-926.
---. The effects of chlorpromazine.   [Abstract] J. Am.
  31. Ass.,  1955, 157: 837.
---, see Das, N. N., Dasgupta, S. R..  Werner, G.
---, see Dasgupta,  S. R., Mukherjee. K. L., Werner, G.
---, see Guha, G., Dasgupta,  S. R., Werner, G.
Werner, H., see Liebert,  R. S., Wapner, S., Werner, H.
Werner, H. W., see  Brown, B. B., Werner, H. W.
West, E. D., Fernandes  da Fonseca, A.  Controlled trial
  of meprobamate.   Brit. 31. J., 1956, 2:1206-1209.
West, L. J.  Problems in measuring the effects of drugs
  on emotions.  Psychiat. Res. Rep., Wash., 1955 (1) : 45.
---, Swegan, W. H.  An  approach to alcoholism in  the
  military  service.    Am. J.  Psychiat, 1956, 112:1104-
  1009.   Abstract:  Excerpta med., Sect. 8, 1957,  10: No.
  918.
Westcott, G. F.  Serpasil as an adjunct to brief intensive
  psychotherapy with two psychotic  patients.  J.  Nerv.
  Mcnt: Dis., 1956, 123 : 53-56.
Westerink, D.   De farmacologie en toepassing der feno-
  thiazinederivaten.  [The pharmacology and use of phen-
  othiazine  derivatives.]   Pharm.   ivbl,   Amst,  1956,
  91:113-125.
Wetchler,  B., see Kupperman, H. S., Blatt,  M. H., Vos-
  burgh, L. F., Canis, J., Wetchler, B.
White, P. T., sec Dennison, A. D., Jr., White, P. T., Moore,
  R. B., Pierce, W. J.
Whitehill,  O., see Tuteur, W., Stiller.  R., Whitehill, O.
---, see Tuteur, W., Stiller, R., Whitehill,  O., Lepson. P.
Whitelaw,  J. D., see Sandison, R. A., Spencer, A. M., White-
  law, J. D.
---, see Sandison,  R. A., Whitelaw, J. D. A.
Whitman,  R. M., Lipton, M. A., Kavan, E.  Rauwiloid  and
  preoperative anxiety; a double blind placebo study.  Q.
  Bull.  Northwest  Univ. M. School, 1956, 30:170-174.
Whittier, J., see Michtom, J., Goldberg, N., Offenkrantz, W.,
  Whittier, J.
Whittier, J. R., see Shankel, L. W., Whittier, J. R.
Wiart, C,  see Delay, J.,  Deniker, P., Ropert, R., Wiart, C.
---, see Delay, J.,  Deniker, P., Wiart, C.
256 
AUTHOR LIST
Woodson, R.  E.
Widmark, M., see Hagnell, O., Korsfeldt, B., Peterson, B.,
  Widmark, M.
Wiedorn, W. S, Ervin, F.  Schizophrenic-like psychotic re-
  actions with administration of isoniazid.  A. 31. A. Arch.
  Neur. Psychiat, 1954, 72: 321-324.
Wieser, S., see Conrad, K., Domanowsky, K., Wieser, S.
Wikler, A. Clinical and electroencephalographic studies
  on the effects of mescaline, N-allylnormorphine and mor-
  phine in man: a pharmacologic analysis of the functions
  of the spontaneous electrical activity of the cerebral
  cortex.  J. Nerv. Ment. Dis., 1954, 120:157-175.
---.   Mechanisms  of  action of drugs  that modify per-
  sonality function.  Am. J. Psychiat., 1952, 108: 590-599.
---.   The relation  of psychiatry to pharmacology. 322 p.
  Baltimore, Williams d Wilkins  [for the American So-
  ciety for Pharmacology and Experimental Therapeutics]
  1957.
---.   The uses  of drugs in psychiatric  research.  Am. J.
  Psychiat, 1956, 112 : 961-969.
---, see Isbell, H., Belleville, R. E., Fraser, H. F., Wikler,
  A., Logan, C. R.
---, see Isbell,  H., Fraser, H. F., Wikler, A., Belleville,
  R. E.
Wilcox, K. W., see Funderburk, W. H, Wilcox,  K. W., Wil-
  cox,  P.  H.
---, see Wilcox, P. H., Funderburk, W.  H., Wilcox, K. W.
---, see Wilcox, P. H., Wilcox, K. W.
Wilcox, P. H., Funderburk, W. H., Wilcox, K. W.  Drug
  therapy; physiodynamic  therapy.  II.   Progr.  Neur.
  Psychiat., N. Y., 1955, 10 : 595-608.
---, Wilcox, K. W.  Shock  therapy; physiodynamic ther-
  apy.   I. Progr. Neur. Psychiat., N. Y., 1956,  11: 401-
  424.
---, see Funderburk, W. H, Wilcox, K. W., Wilcox, P. H.
Wilensky, H., see Tucker, K., Wilensky,  H.
Wilhelm, M. T. J.  Interet de T epreuve mescalinique dans
  les maladies  mentales.   [The mescaline test in mental
  diseases.]   153  p.   [Typewritten]   Strasbourg,  1955.
  [Thesis—Strasbourg 1955, no. 48]
---, see Maurel, H, Wilhelm, Spielmann, J. P.
Wilkens,  B., see Gibbs, J.  J., Wilkens,  B., Lauterbach,
  C. G.
Wilkins, R. W.   Clinical usage of Rauwolfia alkaloids, in-
  cluding reserpine (serpasil).  Ann. N.  York Acad. Sc,
  1954, 59: 36-44.   Also : N. England J. M., 1954, 59 :1-7.
---.  Current   therapeutics:  Rauwolfia   serpentina.
  Practitioner, Lond., 1954,  173: 84-89.
---.  Hvpertension:  recent trends in treatment.  3Ied.
  Clin. N. America, 1953, 37:1303-1312.
■---.   New drug therapies in arterial  hypertension.  A.
  M. A. Arch. Int. M., 1952, 37:1144-1155.
---, Judson, W. E.  The use  of Rauwolfia serpentina in
  hypertensive patients.  N. England J. M., 1953, 248 : 48-
  53.   Abstract: Proc N. England Cardiovas. Soc, 1951-
  1952 • 34
___, -__\ Stone, R. W., Hollander, W., Huckabee, W. E.,
  Friedman, I. H.  Reserpine in the  treatment of hyper-
  tension : A note  on the relative dosage and effects.  N.
  England J. M., 1954, 250: 477-478.
Wilkinson, W. E.,  see  Litteral, E. B., Wilkinson, WE.
Williams, D.  B., see Noce, R. H., Williams, D. B., Rapa-
  port, W.                                     .  .  ..
Williams  E L.  The management of the chronic alcoholic.
  Postgrad. 31. J., Lond., 1954,30: 626-630.
Williamson, P. Office treatment  of atopic   dermatitis.
  Med. Times,  Great Neck, 1956  84:1086-1087 _
Willis, D., see Himwich, H. E., Rmaldi, F., Willis, D.
Wilson G.  M., Wood,  D. R.  Chlorpromazine.  Practi-
  tioner. Lond.,  1955, 174 : 494-501.
Wilson, W. A.,  Jr.,  see  Weiskrantz, L   Wilson, Tl. A., Jr.
Wilson! W. P.,  see  Glotfelty, J. S Wilson, W. P.
Wing, J. K„ see  Stead, J. S., Wing, J. K.
Wi™  T  ThP use of reserpine in chronic psychotic  pa-
  tents   a  controlled  trial.   J. Ment. Sc, Lond., 1956,
  102:530-541.
Winkelman, N. W., Jr.  An appraisal of chlorpromazine;
  general principles  for  administration  of  chlorproma-
  zine, based on experience with 1,090 patients.   Am. J.
  Psychiat., 1957,113 : 961-971.
---.   Chlorpromazine in  the treatment  of neuropsychi-
  atric disorders.  J. Am.  31. Ass., 1954, 155:18-21.  Ab-
  stract :  Chem. Abstr., 1954, 48: 9562c.
Winnik, H. Z.,  Tennenbaum, L.  Largactil in psychiatric
  treatment.  [English summary]   Harefuah, Tel-Aviv,
  1954, 47: 95-100.
Winsor, T.  Human pharmacology of reserpine.  Ann. N.
  York Acad. Sc, 1954, 59: 61-81.
Winter, C. A., Flataker,  L.  Effects of lysergic  acid  di-
  ethylamide  upon performance  of  trained  rats.  Proc
  Soc. Exp.  Biol, N. Y., 1956,  92:285-289.  Abstract:
  C7t-em. Abstr., 1956, 50 :14891i
Winter, W. D., Frederickson, W. K. The short-term  ef-
  fects of chlorpromazine on psychiatric  patients.  J.
  Consult Psychol, 1956,  20: 431-434.
---,  see Kasak, M.,  Schaefer, D. L., Winter, W.
Winton,  S.  S.  Therapeutic value and  limitations of  an
  ataractic drug (rescinnamine). Internat. Rec. 31., 1957,
  170: 665-671.
Wirth, W.  Versuche zur kombinierten Wirkung von Mega-
  phen mit stark  wirksamen Analgeticis.  [Experiments
  on   megaphen  combined with  powerful  analgesics.]
  Arch. exp. Path., Berl, 1954, 222 : 75-76.
Witherspoon, F. G.  Toxic purpura from meprobamate.
  Am. Practitioner, 1957,  8: 270-271.
Witt, F. W., see Sadove, M. S., Levin, M. J., Rose, R.  F.,
  Schwartz, L., Witt, F.  W.
Witt,  P. N.  Ein  einfaches Prinzip  zur Deutung einiger
  Proportionen im Spinnennetz.  [A simple principle for
  the  interpretation  of  several  proportions  in  spider
  webs.]   [English summary]  Behaviour, Leiden, 1951-
  1952, 4: 172-189.
 ---.  Der Netzbau der Spinne als Test zur Prufung zen-
  tralnervos angreifender Substanzen.   [Construction of
  spider  webs as  a test  for drugs with CNS  action.]
  Arzneimitt. Forsch., 1956, 6 : 628-635.
 ---.  Die Wirkung einer einmaligen Gabe von Largactil
  auf den Netzbau der Spinne Zilla-x-notata.  [Effect of
  a single dose of chlorpromazine  on  the web construc-
  tion of the spider Zilla-x-notata.]   [English  summary]
  Mschr. Psychiat, Basel, 1955, 129  :123-128.
---, Heimann, H.  Prufung der Wirkung einer einmal-
  igen Gabe von Largactil am Menschen  mit dem Durch-
  streichtest von Meili und an der Spinne beim Netzbauver-
  halten.  [The effect of  a single dose of largactil tested
   in  man by Meili's  cross-out test and in spiders  by the
  web-building test.]  Helvet. physiol  pharm.  acta, 1954,
   12: C 98-99.
 ---, see Heimann, H, Witt, P. N.
 Wodraska,  T. W. The effects of  reserpine on  chronic
   schizophrenia.  3Ied. Times, Great Neck, 1955, S3 : 1029-
   1033.
 Wolf, R.  Das Raum-und Zeiterleben unter  abnormen
   Bedingungen,  besonders im  Meskalinrausch.    [Space
   and time perception under anomalous  conditions, espe-
   cially  during  mescaline  intoxication.]   Deut. med-
   Wschr., 1952, 77 : 168-170.
 Wolf, S.  The evaluation of therapeutic agents, with spe-
   cial reference to the tranquilizing drugs.  23 p.  Wash-
   ington, Am. Psychiat.   Ass. 3Iental Hospital Service
   [Monograph series (2)] 1957.
 ---, Pinsky, R.   Effects of placebo administration and
   occurrence of toxic reactions.  J. Am. 31.  Ass., 1954,
   155: 339-341.
 Wolff, H. G, see Berlin, L, Guthrie, T., Weider, A., Goodell,
   H, Wolff, H. G.
 Wood, D. R., see Wilson, G. M., Wood, D. R.
 Wood, J., see Dickel, H. A., Dixon, H. H.,  Wood, J., Shank-
   lin, J. G.
 Woodson, R. E., Youngken, H. W.,  Schlittler,  E., Schnei-
   der, J. A. Rauwolfia : botany, pharmacognosy, chemistry
257 
Woodson, R. E.
PSYCHOPHARMACA
  & pharmacology.  149 p.  Boston, Little, Brown d Com-
  pany, 1957.   [One chapter is within the scope of this
  bibliography] cf. schneideb, j. a.
Woolley, D. W.  Production of abnormal (psychotic?) be-
  havior in mice with lysergic acid diethylamide, and its
  partial prevention with cholinergic drugs and serotonin.
  Proc. Nat. Acad. Sc. U. S., 1955, 41: 338-344.  Abstract:
  Chem. Abstr.,  1956, 50:12286def.
----,  Shaw, E. [N.]  A biochemical and pharmacological
  suggestion about certain mental disorders.  Proc. Nat.
  Acad. Sc. U. S., 1954, 40: 228-231.   Abstract: Science,
  1954, 119: 587-588.
---,----.  Evidence for the participation of serotonin in
  mental processes.  Ann.  N. York Acad. Sc, 1957, 66:
  649-667.
----,----.   Some neurophysiological aspects of serotonin.
  Brit. M. J., 1954, 2: 122-126.
---, see Shaw, E., Woolley, D.  W.
World Health  Organization.  Expert committee on addic-
  tion-producing drugs.  Seventh report. World Health
  Org. Techn. Rep. Ser., 1957 (116) : 1-15.
Wortis, J.   Physiological treatment.   Am.  J.  Psychiat,
  1954, 110 : 505-511; 1955, 111: 515-518 ; 1956, 112: 526-
  529; 1957, 113 : 611-615.
Wortmann, F.  Erfahrungen mit einem neuartigen anti-
  allergisch wirksamen Kombinationspraparat.  [Experi-
  ences with a new antiallergic combination preparation.]
  [Plimasin]  Schweiz. med. Wschr., 1954, 84: 715-716.
Wozowska, J.,  Pytel, A.  Largaktyl (chloropromazyna).
  [Largactil (chlorpromazine).]  Polski tygod. lek., 1955,
  10: 772-779.
Wretmark, G, see Cronqvist, S., Rayner, S., Wretmark, G.
Wright, E.  T.,  see LeVan, P., Wright, E. T.
Wright, W. T., Jr., Pokorny, C, Foster, T. L.  Alseroxy-
  lon; a study  of the psychological effects of the drug.
  J. Kansas M. Soc, 1956, 57 : 410-411.
Wyk,  A. J.  van,  see Hurst, L. A., Reuning, H., Wyk, A. J.
  van, Crouse, H. S., Booysen, P. J., Nelson, G.

                          Y

Yanniris, M., see Kokkoris, P., Kordas,  P., Nikolopoulos,
  Yanniris, M.
Yener, O.,  see Adasal, R., Ozsan, M., Karan, D., Yener, O.
Yohe, C.  Preliminary report  on eighteen months' ex-
  perience  with chlorpromazine at the Yankton  State
  Hospital, Yankton, South Dakota.  S. Dakota J. M.,
  1956, 9: 59-62; 74.
Yonkman, F. F., ed. Reserpine  (serpasil) and other alka-
  loids of Rauwolfia serpentina : chemistry, pharmacology,
  and clinical applications.  Reserpine in the treatment
  of neuropsychiatric, neurological, and related clinical
  problems.  [Conferences held in New York, February
  1954 and February 1955.]  Ann. N. York Acad. Sc, 1954,
  59 :1-140; 1955, 61:1-280.  [Articles within the scope
  of this bibliography  are  listed individually.]
----,  see Plummer, A. J., Barrett, W. E., Wagle, G., Yonk-
  man, F. F.
Yoshii, N., Tsukiyama, K.,  Hiraiwa, K.  Effect of myane-
  sin  on the flexion and on the electrical activities of the
  cerebral  cortex  and  the brain  stem. Fol psychiat.
  neur. jap., 1954, 7 : 285-292.
Yoss, R. E., see Daly, D. D., Yoss, R. E.
Young, W.  K.,  see Slater, I. H,  Jones, G. T., Young, W. K.
   Youngblood, W., see Ende, M., Youngblood, W.
   Youngken, H. W., see Woodson, R. E., Youngken, H. W.,
     Schlittler, E., Schneider, J. A.          #
   Yuda,  N. N, see Harned, B.  K.,  Cunningham, R.  W.,
     Clark,  M. C, Hine, C. H, Kane, M. M., Smith, F. H.,
     Jr., Vessey, R. E., Yuda, N.  N., Zabransky,  F.  W.

                             Z

   Zabransky, F. W., see Harned, B. K., Cunningham, R. W.,
     Clark,  M. C, Hine, C. H., Kane, M. M., Smith, F. H.,
     Jr., Vessey, R. E., Yuda, N.  N., Zabransky,  F.  W.
   Zahle, V., see Stokholm, H., Zahle, V.
   Zahradka, L., see Neuwirtova,  R., Zwetschke, O.,  Zahrad-
     ka, L.
   Zambianchi,  A. Echo du symposium de  Milan sur la
     reserpine et la chlorpromazine en  psychiatrie.   [Re-
     view of the symposium in  Milan  on reserpine and
     chlorpromazine   in  psychiatry.]  Enciphale,  1956,
     45:1071-1075.
   Zapparoli, G. C, see  Sanguineti,  I.,  Zapparoli, G. C,
     Laricchia, R.
   Zatuchni, J.,  Miller,  G.  Jaundice during chlorpromazine
     therapy. N. England J. 31., 1954, 251: 1003-1006.
   Zax, M.,  see Cowden, R. C, Zax, M., Finney, R. C.
   ---, see  Cowden, R. C, Zax, M., Hague,  J. R., Finney,
     R. C.
   ---, see Cowden, R. C, Zax, M., Sproles, J. A.
   Zeller, W. W., Graffagnino, P.  N, Cullen, C. F., Reitman,
     H. J.  Use of chlorpromazine and reserpine in the treat-
     ment of emotional disorders.  J. Am. M.  Ass., 1956,
     160:179-184.  Abstract: Year book of  drug therapy,
     1956-1957, p. 341-342.
   ---, see  Donnelly, J., Zeller, W.
   Zellermayer,  J.  [Largactil  as   a  psychotherapeutic
     adjuvant.]    [In  Hebrew]  Harefuah, Tel-Aviv, 1955,
     48:31.
   Zethraeus, S.  Klorpromazinbehandling vid psykisk sjuk-
     dom.   [Chlorpromazine therapy  of mental  disease.]
     Sven. lak. tidn., 1955, 52:1087-1103.
   Zettel, G.  Zur Therapie der Schlafstorungen.   [Therapy
     of sleep disorders.]  [Adalat]  Ther. Gegenwart, 1956,
     95: 455-456.
   Zimmerman, F. T.,  Burgemeister, B. B.  Preliminary re-
     port upon  the effect of reserpine on epilepsy  and be-
     havior problems in children.  Ann. N. York Acad. Sc,
     1955, 61: 215-221.
   Ziolko, H. U., see Gerhardt, U., Ziolko, H. U.
   Zonta, G.,  Masciangelo,  P.  M.,  Gentili,  E.  Risultati
     dell'impiego di serpasil  nella cura di soggetti psicotici.
     [Results of the use of serpasil in therapy of psychotic
     patients.]  Riv. sper. freniat., 1955, 79: 521-526.
   Zucchi, M., see Torsegno, M., Zucchi, M.
   Zucker, H. D., see Feldman, D. J., Zucker, H. D.
   Zukerman, E., see Pupo, P. P., Zukerman, E., Longo, R. H.
   Zurabashvili,  A. D. Ob osnovnykh  voprosakh terapii
     shizofrenii.   [Basic problems  in  the  treatment  of
     schizophrenia.]  Zh. nevropat. psikhiat., 3Ioskva, 1956,
     56:605-611.
   Zusman, W.,  see Silva, L. M. da Zusman, W.,  Portella
     Nunes,  E.
   Zwetschke, O., see Neuwirtova, R., Zwetschke, O., Zahrad-
     ka, L.


O
258 
 
 
 
PUBLIC HEALTH SERVICE PUBLICATION NO. 581
Public Health Bibliography Series No. 19
ir 415-/3
(?) 
 

"*   3NI3I0.3W JO UIIIM IVNOIIVN   3 N I 3 I Q 3 W J 0 A a V a B I 1 1 V N O 11 V N  3 N I 3 I 0 3 W J O A B V B B II 1 V N O II V N   3 N I 3 I 0 3 W J O A « V I « II 1 V N 0 11 VN
Xf^,
Ml   NATIONAL LIBRARY OF MEDICINE   NATIONAL LIBRARY OF MEDICINE  NATIONAL LIBRARY OF MEDICINE   NATIONAL LIBRARY OF MEDICINI

                                                                                     :'
IH  3NI3I03W JO ABVaail IVNOIIVN   3NI3IQ3W JO ABVaail IVNOIIVN  3NI3IQ3W JO A I V a a I 1 IVNOIIVN   3NI3I03W JO ABVBBM IVNOIIVN
 1    V''   i
I  NATIONAL LIBRARY OF MEDICINE   NATIONAL LIBRARY OF MEDICINE   NATIONAL LIBRARY OF MEDICINE   NATIONAL LIBRARY OF MEDICINI




                                                                                                   i"   ^

1NI3IQ3W JO ABVaeil IVNOIIVN   3NI3IQ3W JO ABVBBM IVNOIIVN   JNI3I03W JO UUIII IVNOIIVN  JNI3I03W JO ABVBBIl IVNOIIVN
 
'^Cs  /^ -   w.
                                 19 e\      -



a    ^- ££ ;    •    ( )£A ^^   •    v  Ai H^   •
a    v sy   •    'J?a /    a     Xv >fc£ ;    •     I
1  v-$
Hijiaiw jo Aavaan ivnoiivn   inoioiw jo Aavaan ivnoiivn  indioiw jo Aavaan ivnoiivn  inoiqiw jo Aavaan ivnoiivn   jnidio














IATI0N At LIBRARY OF MEDICINE   NATIONAL LIBRARY OF MEDICINI  NATIONAL LIBRARY OF MEDICINE  NATIONAL LIBRARY OF MEDICINE   NATIOf
ATONAL LIBRARY OF MEDICINE  NATIONAL LIBRARY OF MEDICINE   NATIONAL LIBRARY OF MEDICINE   NATIONAL LIBRARY OF MEDICINE   NATION

^%?  >f
MONAL LIBRARY OF MEDICINE  NATIONAL LIBRARY OF MEDICINE  NATIONAL LIBRARY OF MEDICINE  NATIONAL LIBRARY OF MEDICINE  NATIOI




                                                                                                           ;   ]   ^
3iaiw jo Aavaan tvnbjjiVvn  in i 3 io 3 w jo ab vaa n tvno ii vn  3n i 3 i a 3w jo Aavaa ii i vnouv n  3n is ia jw jo abv aan ivnoiivn  snoic
«/  /vSfctm  5  inputs  >; <  /^3^l\   •
 
OF MEDICINE
NLfl 0302^50 D
NLM030296500